data_3pdz_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 3pdz _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.436 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 1.4 mp . . . . . 0 N--CA 1.451 -0.413 0 CA-C-O 120.872 0.368 . . . . 15.0 111.243 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.441 ' O ' ' N ' ' A' ' 89' ' ' LEU . 2.8 p90 -140.43 164.95 28.76 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.088 -0.506 . . . . 15.0 110.261 178.621 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.465 ' HB2' HD11 ' A' ' 88' ' ' LEU . 6.3 pt-20 -130.09 142.09 50.64 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.362 0.601 . . . . 15.0 111.867 -179.047 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.434 ' CG2' ' HB3' ' A' ' 51' ' ' ARG . 0.2 OUTLIER -101.56 114.74 41.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.037 -0.983 . . . . 15.0 109.728 178.915 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -105.87 72.11 0.93 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.156 -0.475 . . . . 15.0 111.916 -178.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.417 HD13 ' CB ' ' A' ' 49' ' ' ASP . 6.3 tp -88.33 165.67 14.82 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.098 -0.501 . . . . 15.0 110.061 179.056 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -95.57 92.26 6.55 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.93 0.395 . . . . 15.0 111.138 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.469 ' HG3' ' HB ' ' A' ' 81' ' ' THR . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 115.982 -0.554 . . . . 15.0 110.977 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.408 ' N ' ' CD2' ' A' ' 18' ' ' LEU . 1.3 mm? . . . . . 0 N--CA 1.454 -0.236 0 CA-C-O 120.896 0.379 . . . . 15.0 110.653 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.714 ' O ' ' HB ' ' A' ' 41' ' ' ILE . . . -161.0 40.16 0.42 Allowed Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.908 -0.663 . . . . 15.0 111.973 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.694 HG12 ' O ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -112.83 139.77 36.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 120.961 0.41 . . . . 15.0 111.998 -179.414 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 21.8 t -96.04 105.76 17.84 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.132 -1.062 . . . . 15.0 108.132 177.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.496 HG11 ' CG2' ' A' ' 20' ' ' ILE . 18.5 m -93.84 156.0 3.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 113.435 0.902 . . . . 15.0 113.435 -176.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.5 -172.76 4.22 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 114.981 -1.009 . . . . 15.0 110.437 179.438 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.418 ' O ' ' CB ' ' A' ' 71' ' ' HIS . . . 68.65 -120.2 10.93 Favored Glycine 0 C--N 1.331 0.251 0 C-N-CA 120.773 -0.727 . . . . 15.0 112.72 179.594 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.555 ' HA3' ' N ' ' A' ' 71' ' ' HIS . . . 68.48 -66.59 0.41 Allowed Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.82 -0.705 . . . . 15.0 113.367 179.651 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.418 ' N ' ' HA ' ' A' ' 70' ' ' THR . 2.1 m -33.13 144.33 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 N-CA-C 112.024 0.379 . . . . 15.0 112.024 -179.374 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 13.0 p-10 -75.57 62.67 1.44 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.059 -0.518 . . . . 15.0 111.008 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -151.71 -67.68 0.17 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.219 -0.446 . . . . 15.0 110.945 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 21.1 m -67.21 -33.33 75.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.129 -0.487 . . . . 15.0 110.949 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 29.5 m -88.02 -174.01 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 15.0 111.209 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -64.26 -60.53 3.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.181 -0.463 . . . . 15.0 111.146 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 52.2 m80 -132.88 -57.36 0.93 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.388 -0.369 . . . . 15.0 111.225 -179.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -167.13 21.45 0.1 Allowed Glycine 0 CA--C 1.518 0.246 0 C-N-CA 120.816 -0.707 . . . . 15.0 112.718 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -83.74 152.77 29.16 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.467 -0.873 . . . . 15.0 110.921 178.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.451 ' CG1' ' HA ' ' A' ' 71' ' ' HIS . 0.0 OUTLIER -89.12 153.7 3.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 117.482 0.641 . . . . 15.0 111.633 -179.357 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -141.35 108.26 5.42 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.084 -0.962 . . . . 15.0 109.661 179.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.65 HG21 ' N ' ' A' ' 55' ' ' GLY . 0.8 OUTLIER -56.09 154.85 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.18 0.514 . . . . 15.0 111.573 -178.939 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.464 ' O ' ' HG2' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -85.45 -47.94 9.46 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.379 -0.971 . . . . 15.0 108.379 178.239 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.694 ' O ' HG12 ' A' ' 20' ' ' ILE . . . -172.39 172.99 4.25 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 115.349 -0.841 . . . . 15.0 110.224 178.693 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.513 ' HA ' ' CG1' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -96.76 110.91 25.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 109.273 -0.64 . . . . 15.0 109.273 179.125 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.714 ' HB ' ' O ' ' A' ' 19' ' ' GLY . 0.4 OUTLIER -78.24 116.57 60.0 Favored Pre-proline 0 C--N 1.328 -0.364 0 N-CA-C 113.4 0.889 . . . . 15.0 113.4 -177.11 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.528 ' HA ' ' CG ' ' A' ' 47' ' ' GLU . 37.8 Cg_exo -61.56 61.56 0.11 Allowed 'Trans proline' 0 C--N 1.358 1.054 0 C-N-CA 123.76 2.973 . . . . 15.0 113.1 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.54 ' H ' ' HG2' ' A' ' 47' ' ' GLU . 3.0 mt-30 -149.93 -47.94 0.13 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.609 0.242 . . . . 15.0 111.592 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.65 ' HA3' ' HA3' ' A' ' 19' ' ' GLY . . . -87.79 168.04 37.28 Favored Glycine 0 C--N 1.329 0.176 0 C-N-CA 120.324 -0.941 . . . . 15.0 113.781 -179.167 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -57.51 -13.23 3.4 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.721 0.637 . . . . 15.0 112.721 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.0 -57.56 4.19 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 120.988 -0.285 . . . . 15.0 110.663 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.541 ' HG3' ' O ' ' A' ' 44' ' ' GLY . 2.7 pp20? -57.55 -42.84 83.79 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.97 -0.559 . . . . 15.0 110.379 179.097 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 69.4 m -53.64 -71.12 0.08 Allowed 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 115.806 -0.634 . . . . 15.0 110.571 -179.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.417 ' CB ' HD13 ' A' ' 11' ' ' LEU . 0.3 OUTLIER -58.13 -41.14 83.02 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.12 -0.696 . . . . 15.0 109.12 178.872 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.57 40.19 13.21 Favored Glycine 0 N--CA 1.446 -0.7 0 CA-C-N 115.357 -0.838 . . . . 15.0 111.631 179.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.434 ' HB3' ' CG2' ' A' ' 9' ' ' VAL . 1.2 mmp_? -79.71 -50.07 11.15 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.867 0.365 . . . . 15.0 110.658 -179.253 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 8.4 tp -80.91 162.54 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 CA-C-N 116.021 -0.536 . . . . 15.0 110.198 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . 0.471 ' O ' ' HB2' ' A' ' 56' ' ' ASP . 79.6 m80 -146.88 159.88 42.99 Favored 'General case' 0 CA--C 1.514 -0.432 0 CA-C-O 121.641 0.734 . . . . 15.0 112.241 -179.067 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.499 ' HA ' ' CG2' ' A' ' 37' ' ' VAL . 0.1 OUTLIER -43.49 133.43 4.38 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.407 -1.269 . . . . 15.0 112.526 -178.77 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.65 ' N ' HG21 ' A' ' 37' ' ' VAL . . . 49.91 35.12 24.17 Favored Glycine 0 C--N 1.333 0.381 0 CA-C-N 115.927 -0.579 . . . . 15.0 113.377 179.328 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.506 ' HB2' HG12 ' A' ' 37' ' ' VAL . 0.4 OUTLIER -65.92 132.5 48.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 117.08 0.44 . . . . 15.0 110.682 179.632 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.5 85.9 7.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.04 -0.527 . . . . 15.0 110.618 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.47 ' HA ' HD22 ' A' ' 89' ' ' LEU . 1.4 m -79.49 116.33 23.31 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 CA-C-O 120.998 0.428 . . . . 15.0 110.955 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 18.7 mt -107.01 -18.11 14.0 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.809 -0.632 . . . . 15.0 112.329 -179.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.422 ' CB ' HD22 ' A' ' 88' ' ' LEU . . . -147.84 149.67 32.73 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.246 0.546 . . . . 15.0 112.389 -178.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.465 HG12 ' HA ' ' A' ' 78' ' ' LEU . 17.6 t -138.93 101.67 1.66 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.31 0 CA-C-N 115.312 -0.858 . . . . 15.0 109.138 178.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.407 ' HB2' ' O ' ' A' ' 61' ' ' VAL . 1.7 m-80 64.95 15.51 10.0 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.637 -0.505 . . . . 15.0 109.637 -177.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 107.04 5.46 35.22 Favored Glycine 0 C--N 1.338 0.642 0 CA-C-N 115.811 -0.631 . . . . 15.0 113.471 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.485 ' O ' ' CG1' ' A' ' 64' ' ' VAL . 6.3 p -93.91 107.18 18.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 117.085 0.442 . . . . 15.0 111.059 179.549 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.3 m -56.96 134.67 55.86 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.216 -0.447 . . . . 15.0 111.07 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.83 -20.59 17.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.009 -0.542 . . . . 15.0 111.173 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -45.64 110.91 0.29 Allowed 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.384 -0.371 . . . . 15.0 111.123 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 97.62 64.25 0.89 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.781 -0.723 . . . . 15.0 112.251 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.428 ' HB3' ' HB3' ' A' ' 73' ' ' GLN . . . -173.03 166.85 5.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.916 0.389 . . . . 15.0 111.148 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.418 ' HA ' ' N ' ' A' ' 26' ' ' VAL . 15.3 p -93.49 -172.63 2.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.18 -0.463 . . . . 15.0 111.301 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.555 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 0.0 OUTLIER -63.57 -59.07 5.09 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.72 -0.673 . . . . 15.0 110.557 179.816 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.4 ' O ' ' HG3' ' A' ' 76' ' ' GLU . 9.4 ttpp -52.36 -31.2 32.53 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.868 -0.606 . . . . 15.0 110.627 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . 0.428 ' HB3' ' HB3' ' A' ' 69' ' ' ALA . 0.0 OUTLIER -59.3 -53.77 54.42 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.239 -0.437 . . . . 15.0 109.932 179.444 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.456 ' O ' ' N ' ' A' ' 77' ' ' THR . . . -66.78 -43.91 82.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.173 -0.467 . . . . 15.0 109.86 178.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.412 HG22 ' CG2' ' A' ' 22' ' ' VAL . 0.5 OUTLIER -42.37 -41.79 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.225 0 N-CA-C 109.129 -0.693 . . . . 15.0 109.129 178.376 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.4 ' HG3' ' O ' ' A' ' 72' ' ' LYS . 18.4 mt-10 -67.46 -44.54 78.36 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 114.875 -1.057 . . . . 15.0 110.289 178.458 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.456 ' N ' ' O ' ' A' ' 74' ' ' ALA . 69.0 p -64.09 -54.27 36.58 Favored 'General case' 0 N--CA 1.461 0.117 0 C-N-CA 121.161 -0.215 . . . . 15.0 111.508 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.465 ' HA ' HG12 ' A' ' 61' ' ' VAL . 7.6 mt -53.55 -47.88 69.61 Favored 'General case' 0 CA--C 1.518 -0.25 0 CA-C-O 121.313 0.578 . . . . 15.0 109.867 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 11.1 ttp85 -68.42 -59.95 2.79 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.242 -0.89 . . . . 15.0 110.651 179.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 68.6 m-20 -66.06 58.52 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.865 -0.607 . . . . 15.0 112.498 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.469 ' HB ' ' HG3' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -95.57 -71.46 0.67 Allowed 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.89 -0.411 . . . . 15.0 109.89 178.872 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 121.11 -104.15 0.94 Allowed Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.703 -0.76 . . . . 15.0 113.344 178.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.67 -82.77 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 112.104 0.409 . . . . 15.0 112.104 -178.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.413 ' CG1' ' N ' ' A' ' 85' ' ' VAL . 75.6 t -109.79 158.66 9.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.107 0.479 . . . . 15.0 111.232 -179.114 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.441 ' O ' ' CG1' ' A' ' 85' ' ' VAL . 6.7 t -97.79 82.03 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.992 -0.549 . . . . 15.0 110.498 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -99.06 82.18 2.7 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.76 -0.655 . . . . 15.0 110.291 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.438 ' CD2' ' CD2' ' A' ' 89' ' ' LEU . 0.1 OUTLIER -103.97 118.74 37.4 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.046 -0.524 . . . . 15.0 112.061 -178.988 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.465 HD11 ' HB2' ' A' ' 8' ' ' GLU . 0.2 OUTLIER -95.46 101.4 13.11 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.111 -0.7 . . . . 15.0 109.111 178.252 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.47 HD22 ' HA ' ' A' ' 58' ' ' VAL . 0.2 OUTLIER -104.11 -164.91 1.1 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.439 0.638 . . . . 15.0 112.094 -178.312 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.436 ' HA ' ' HA ' ' A' ' 6' ' ' ILE . 2.3 tt0 -139.37 139.84 37.31 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.999 -1.0 . . . . 15.0 109.817 179.205 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 6.7 tptt -52.11 102.04 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.009 0.433 . . . . 15.0 111.06 -179.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.363 0 C-N-CA 120.973 -0.632 . . . . 15.0 112.784 -179.658 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.425 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 1.1 mp . . . . . 0 N--CA 1.451 -0.419 0 CA-C-O 120.977 0.418 . . . . 15.0 111.324 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.413 ' O ' ' N ' ' A' ' 89' ' ' LEU . 6.0 p90 -140.29 152.02 45.55 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.902 -0.59 . . . . 15.0 110.193 178.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.483 ' CB ' HD11 ' A' ' 88' ' ' LEU . 1.4 pm0 -120.93 143.06 49.17 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.373 0.606 . . . . 15.0 111.713 -179.22 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.455 ' CG2' ' HB3' ' A' ' 51' ' ' ARG . 0.2 OUTLIER -101.47 115.51 43.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.119 -0.946 . . . . 15.0 109.558 178.948 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -106.18 74.33 1.03 Allowed 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 112.321 0.489 . . . . 15.0 112.321 -178.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.497 ' HB3' ' HB ' ' A' ' 85' ' ' VAL . 6.7 tp -88.11 164.84 15.51 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.339 -0.615 . . . . 15.0 109.339 178.466 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -96.33 97.72 9.71 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.047 0.451 . . . . 15.0 111.379 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.403 ' HD3' ' O ' ' A' ' 13' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.423 0 CA-C-N 115.77 -0.65 . . . . 15.0 111.064 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.406 ' CD2' ' N ' ' A' ' 18' ' ' LEU . 1.9 mm? . . . . . 0 N--CA 1.451 -0.402 0 CA-C-O 120.95 0.405 . . . . 15.0 110.612 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.744 ' O ' ' HB ' ' A' ' 41' ' ' ILE . . . -160.88 43.53 0.41 Allowed Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.939 -0.648 . . . . 15.0 111.698 -179.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.682 HG12 ' O ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -112.78 138.46 41.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 120.948 0.404 . . . . 15.0 111.615 -179.453 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 31.4 t -91.73 103.5 16.06 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 107.813 -1.18 . . . . 15.0 107.813 177.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.449 HG22 ' CD2' ' A' ' 71' ' ' HIS . 32.8 m -93.72 154.42 3.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 113.079 0.77 . . . . 15.0 113.079 -177.012 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.29 -175.22 4.9 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.132 -0.94 . . . . 15.0 110.72 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 68.67 -119.88 10.54 Favored Glycine 0 C--N 1.332 0.306 0 C-N-CA 120.829 -0.701 . . . . 15.0 112.424 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.527 ' HA3' ' N ' ' A' ' 71' ' ' HIS . . . 68.12 -64.21 0.37 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.876 -0.678 . . . . 15.0 113.525 179.4 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -30.63 138.58 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 N-CA-C 112.337 0.495 . . . . 15.0 112.337 -179.323 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 28.3 p30 -75.55 62.72 1.44 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.897 -0.592 . . . . 15.0 111.012 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.0 m -151.7 -50.76 0.12 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.277 -0.42 . . . . 15.0 111.106 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -87.65 -40.54 14.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.232 -0.44 . . . . 15.0 111.192 -179.703 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.434 HG13 ' CD1' ' A' ' 36' ' ' TYR . 31.1 m -72.62 -174.9 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.317 -0.402 . . . . 15.0 111.366 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 2.1 ttm180 -60.31 -40.78 91.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.2 -0.455 . . . . 15.0 111.239 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . 0.454 ' N ' ' CD2' ' A' ' 32' ' ' HIS . 0.1 OUTLIER -163.9 -46.76 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.688 -0.233 . . . . 15.0 111.515 179.799 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -170.22 19.96 0.07 OUTLIER Glycine 0 CA--C 1.519 0.288 0 C-N-CA 120.649 -0.786 . . . . 15.0 112.979 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -89.76 153.85 23.48 Favored Glycine 0 N--CA 1.45 -0.385 0 N-CA-C 111.005 -0.838 . . . . 15.0 111.005 179.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.45 ' CG2' ' CG2' ' A' ' 58' ' ' VAL . 0.0 OUTLIER -89.13 155.62 3.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 117.478 0.639 . . . . 15.0 111.773 -179.396 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.443 ' CE2' ' HG2' ' A' ' 57' ' ' ARG . 29.5 m-85 -140.19 106.75 5.32 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.082 -0.963 . . . . 15.0 109.804 179.023 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.64 HG21 ' N ' ' A' ' 55' ' ' GLY . 0.6 OUTLIER -55.35 147.05 4.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.913 -0.585 . . . . 15.0 111.361 -178.956 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.453 ' O ' ' HG2' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -80.35 -48.61 12.68 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.449 -0.945 . . . . 15.0 108.449 178.379 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.682 ' O ' HG12 ' A' ' 20' ' ' ILE . . . -172.2 173.95 4.12 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 115.416 -0.811 . . . . 15.0 110.142 178.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.536 ' HA ' HG12 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -97.03 110.09 24.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 109.657 -0.498 . . . . 15.0 109.657 179.295 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.744 ' HB ' ' O ' ' A' ' 19' ' ' GLY . 0.6 OUTLIER -78.4 116.48 59.57 Favored Pre-proline 0 C--N 1.328 -0.333 0 N-CA-C 113.39 0.885 . . . . 15.0 113.39 -177.518 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.542 ' HA ' ' CG ' ' A' ' 47' ' ' GLU . 35.2 Cg_exo -62.01 59.94 0.13 Allowed 'Trans proline' 0 C--N 1.357 1.02 0 C-N-CA 123.663 2.909 . . . . 15.0 113.064 179.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.519 ' H ' ' HG2' ' A' ' 47' ' ' GLU . 0.6 OUTLIER -147.53 -47.69 0.17 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.642 0.258 . . . . 15.0 111.579 179.913 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.696 ' HA3' ' HA3' ' A' ' 19' ' ' GLY . . . -87.86 168.81 37.94 Favored Glycine 0 C--N 1.331 0.279 0 C-N-CA 120.393 -0.908 . . . . 15.0 114.047 -179.022 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -57.51 -13.72 4.09 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.592 0.59 . . . . 15.0 112.592 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.11 -57.72 4.03 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.712 0.291 . . . . 15.0 110.797 -179.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.549 ' HG3' ' O ' ' A' ' 44' ' ' GLY . 2.9 pp20? -57.57 -42.37 82.96 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.77 -0.65 . . . . 15.0 110.381 179.276 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -53.76 -71.49 0.07 Allowed 'General case' 0 CA--C 1.519 -0.241 0 CA-C-N 115.814 -0.63 . . . . 15.0 110.486 -179.404 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -58.36 -41.15 84.09 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.125 -0.694 . . . . 15.0 109.125 178.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.78 40.46 12.15 Favored Glycine 0 N--CA 1.446 -0.643 0 CA-C-N 115.416 -0.811 . . . . 15.0 111.726 179.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.455 ' HB3' ' CG2' ' A' ' 9' ' ' VAL . 0.6 OUTLIER -79.92 -48.19 13.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.907 0.384 . . . . 15.0 110.726 -179.402 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.41 ' CD1' HD12 ' A' ' 89' ' ' LEU . 9.4 tp -81.11 162.07 3.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.037 -0.528 . . . . 15.0 110.275 179.56 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . 0.489 ' O ' HG21 ' A' ' 37' ' ' VAL . 78.8 m80 -147.51 157.63 43.65 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-O 121.61 0.719 . . . . 15.0 112.021 -179.073 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.521 ' HA ' ' CG2' ' A' ' 37' ' ' VAL . 0.1 OUTLIER -42.4 132.2 3.55 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.327 -1.306 . . . . 15.0 113.027 -178.564 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.64 ' N ' HG21 ' A' ' 37' ' ' VAL . . . 50.35 30.31 18.29 Favored Glycine 0 C--N 1.333 0.416 0 CA-C-N 115.672 -0.694 . . . . 15.0 113.4 179.235 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.475 ' OD2' ' N ' ' A' ' 53' ' ' HIS . 16.8 m-20 -65.87 129.59 40.33 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.716 -0.394 . . . . 15.0 110.58 179.521 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.443 ' HG2' ' CE2' ' A' ' 36' ' ' TYR . 15.8 mtt-85 -80.85 96.84 7.13 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.229 -0.441 . . . . 15.0 110.846 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.467 ' O ' ' CG2' ' A' ' 58' ' ' VAL . 1.4 m -86.96 114.02 25.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.079 0.466 . . . . 15.0 110.749 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 21.5 mt -107.02 -16.42 14.44 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.799 -0.637 . . . . 15.0 112.397 -179.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.42 ' HA ' ' O ' ' A' ' 64' ' ' VAL . . . -148.13 147.67 29.75 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.509 0.559 . . . . 15.0 112.509 -178.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.455 HG22 HD23 ' A' ' 87' ' ' LEU . 21.4 t -139.03 101.12 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.316 -0.856 . . . . 15.0 109.16 178.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 65.14 15.98 10.3 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.72 -0.474 . . . . 15.0 109.72 -177.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 107.07 4.58 35.73 Favored Glycine 0 C--N 1.337 0.598 0 CA-C-N 115.969 -0.56 . . . . 15.0 113.469 179.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.484 ' O ' ' CG1' ' A' ' 64' ' ' VAL . 5.4 p -93.9 108.4 20.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 117.122 0.461 . . . . 15.0 111.164 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 61.5 m -56.87 138.14 54.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.296 -0.411 . . . . 15.0 110.996 -179.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.75 -21.88 16.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.063 -0.517 . . . . 15.0 111.085 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -46.53 106.17 0.08 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.361 -0.381 . . . . 15.0 111.21 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 104.33 62.16 0.67 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.808 -0.711 . . . . 15.0 112.453 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -173.18 163.48 4.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.86 0.362 . . . . 15.0 111.086 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.7 p -92.33 -171.96 2.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.457 . . . . 15.0 110.983 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.527 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 0.0 OUTLIER -62.19 -59.45 5.03 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.844 -0.616 . . . . 15.0 110.458 179.949 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.408 ' O ' ' HG3' ' A' ' 76' ' ' GLU . 24.9 ttpp -52.68 -34.29 51.23 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.768 -0.651 . . . . 15.0 110.836 179.612 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -59.28 -50.77 72.7 Favored 'General case' 0 CA--C 1.518 -0.272 0 N-CA-C 109.527 -0.546 . . . . 15.0 109.527 179.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.457 ' O ' ' N ' ' A' ' 77' ' ' THR . . . -66.29 -45.42 80.47 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.69 -0.687 . . . . 15.0 109.672 178.519 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.428 ' CG2' ' CG2' ' A' ' 22' ' ' VAL . 0.5 OUTLIER -43.15 -40.51 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.243 0 N-CA-C 108.976 -0.749 . . . . 15.0 108.976 178.243 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.408 ' HG3' ' O ' ' A' ' 72' ' ' LYS . 11.1 mt-10 -67.26 -44.96 78.08 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 114.871 -1.058 . . . . 15.0 110.076 178.405 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.457 ' N ' ' O ' ' A' ' 74' ' ' ALA . 41.2 p -64.3 -53.41 49.29 Favored 'General case' 0 N--CA 1.461 0.098 0 CA-C-O 120.572 0.225 . . . . 15.0 111.318 179.606 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.437 ' HG ' ' O ' ' A' ' 74' ' ' ALA . 6.1 mt -53.42 -48.86 68.35 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 121.245 0.545 . . . . 15.0 109.97 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -68.38 -59.05 3.46 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.317 -0.856 . . . . 15.0 110.665 179.502 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -65.88 62.9 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.946 -0.57 . . . . 15.0 111.931 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -91.7 -70.87 0.67 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.785 0.326 . . . . 15.0 110.302 179.425 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 122.28 -109.97 1.52 Allowed Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.978 -0.63 . . . . 15.0 112.852 179.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -65.25 -77.88 0.06 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.884 0.373 . . . . 15.0 111.438 -179.437 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.425 ' CG1' ' N ' ' A' ' 85' ' ' VAL . 51.0 t -110.26 159.07 10.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.198 -0.455 . . . . 15.0 110.678 -179.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.497 ' HB ' ' HB3' ' A' ' 11' ' ' LEU . 19.7 t -98.12 79.92 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.051 0.453 . . . . 15.0 110.429 179.648 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 3.0 t60 -100.51 84.22 2.73 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.842 -0.617 . . . . 15.0 110.426 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.455 HD23 HG22 ' A' ' 61' ' ' VAL . 0.1 OUTLIER -101.45 117.53 35.13 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.003 -0.544 . . . . 15.0 111.655 -179.325 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.483 HD11 ' CB ' ' A' ' 8' ' ' GLU . 4.3 mp -92.87 100.23 12.74 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.807 -0.442 . . . . 15.0 109.807 179.038 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.467 HD22 ' HA ' ' A' ' 58' ' ' VAL . 0.2 OUTLIER -103.88 -162.83 0.93 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.92 -0.582 . . . . 15.0 111.655 -178.871 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.425 ' HA ' ' HA ' ' A' ' 6' ' ' ILE . 3.8 tt0 -139.09 148.18 42.97 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.259 -0.882 . . . . 15.0 110.056 179.285 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.04 113.41 1.69 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.298 -0.41 . . . . 15.0 111.136 -179.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.27 0 C-N-CA 120.879 -0.677 . . . . 15.0 112.722 -179.741 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.429 HG13 ' HB2' ' A' ' 90' ' ' GLU . 1.4 mp . . . . . 0 N--CA 1.45 -0.435 0 CA-C-O 120.8 0.334 . . . . 15.0 111.101 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.42 ' O ' ' N ' ' A' ' 89' ' ' LEU . 3.4 p90 -140.66 163.33 33.18 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.185 -0.461 . . . . 15.0 110.574 178.741 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.473 ' HB2' HD11 ' A' ' 88' ' ' LEU . 10.2 pt-20 -129.04 143.6 50.92 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.204 0.526 . . . . 15.0 111.466 -179.364 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.463 ' CG2' ' HB3' ' A' ' 51' ' ' ARG . 0.3 OUTLIER -101.54 115.7 43.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.335 -0.848 . . . . 15.0 109.818 178.969 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -105.98 70.54 0.86 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.154 -0.475 . . . . 15.0 111.727 -179.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.412 ' HB3' ' HB ' ' A' ' 85' ' ' VAL . 4.9 tp -88.05 165.74 14.94 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.117 -0.492 . . . . 15.0 110.064 179.167 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -95.71 94.43 7.69 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.919 0.39 . . . . 15.0 111.125 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.445 ' O ' ' HD3' ' A' ' 13' ' ' LYS . 0.2 OUTLIER . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 115.96 -0.564 . . . . 15.0 111.095 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.3 mm? . . . . . 0 N--CA 1.453 -0.321 0 CA-C-O 120.773 0.321 . . . . 15.0 110.736 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.753 ' O ' ' HB ' ' A' ' 41' ' ' ILE . . . -169.02 43.67 0.22 Allowed Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.72 -0.752 . . . . 15.0 112.314 -179.709 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.699 HG12 ' O ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -112.72 139.39 37.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 120.928 0.394 . . . . 15.0 111.516 -179.806 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.43 ' HB3' HD13 ' A' ' 41' ' ' ILE . 18.3 t -96.23 105.41 17.46 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.572 -0.899 . . . . 15.0 108.572 178.004 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.496 HG22 ' CD2' ' A' ' 71' ' ' HIS . 5.7 m -93.94 155.21 3.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 112.722 0.638 . . . . 15.0 112.722 -177.511 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.657 ' O ' ' O ' ' A' ' 36' ' ' TYR . 0.2 OUTLIER -149.68 153.28 36.72 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.627 -0.715 . . . . 15.0 111.463 -179.7 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.434 ' O ' HG12 ' A' ' 35' ' ' ILE . . . 67.5 121.53 0.02 OUTLIER Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.484 -0.865 . . . . 15.0 113.351 178.648 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.522 ' HA3' ' N ' ' A' ' 71' ' ' HIS . . . -166.3 -39.3 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.962 -0.637 . . . . 15.0 112.455 179.27 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.45 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 0.1 OUTLIER -40.46 161.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 CA-C-O 120.849 0.357 . . . . 15.0 111.645 179.87 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 6.8 m-80 -85.84 52.51 2.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.22 -0.445 . . . . 15.0 110.952 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.4 m -151.71 -58.23 0.15 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.195 -0.457 . . . . 15.0 110.8 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.4 m -68.91 -51.76 36.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 15.0 110.847 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 17.5 m -87.99 -169.08 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.166 -0.47 . . . . 15.0 110.934 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 4.3 mmt180 -93.41 125.67 38.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.937 0.399 . . . . 15.0 111.073 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 74.6 m80 61.67 -80.61 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.945 -0.571 . . . . 15.0 111.52 179.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -175.25 34.59 0.1 OUTLIER Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.9 -0.667 . . . . 15.0 112.422 -179.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -95.15 158.24 22.3 Favored Glycine 0 N--CA 1.449 -0.487 0 N-CA-C 110.659 -0.976 . . . . 15.0 110.659 179.027 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.487 HG21 HG22 ' A' ' 58' ' ' VAL . 0.1 OUTLIER -101.12 153.11 4.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 C-N-CA 119.852 -0.739 . . . . 15.0 112.058 -179.326 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.657 ' O ' ' O ' ' A' ' 23' ' ' THR . 11.7 m-85 -133.22 108.29 8.68 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.13 -0.941 . . . . 15.0 109.308 179.343 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.557 HG21 ' N ' ' A' ' 55' ' ' GLY . 0.7 OUTLIER -54.84 169.61 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 C-N-CA 120.359 -0.536 . . . . 15.0 111.113 -178.33 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.413 ' N ' HG22 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -100.77 -49.22 4.23 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.806 -0.813 . . . . 15.0 108.806 178.936 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.699 ' O ' HG12 ' A' ' 20' ' ' ILE . . . -171.96 173.13 4.52 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 115.523 -0.762 . . . . 15.0 110.054 179.03 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.517 ' HA ' ' CG1' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -96.42 103.3 14.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 109.244 -0.65 . . . . 15.0 109.244 179.15 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.753 ' HB ' ' O ' ' A' ' 19' ' ' GLY . 0.6 OUTLIER -69.13 115.74 34.88 Favored Pre-proline 0 C--N 1.328 -0.353 0 N-CA-C 113.376 0.88 . . . . 15.0 113.376 -177.066 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.514 ' HA ' ' HG2' ' A' ' 47' ' ' GLU . 37.5 Cg_exo -61.16 62.01 0.1 OUTLIER 'Trans proline' 0 C--N 1.358 1.038 0 C-N-CA 123.655 2.903 . . . . 15.0 112.951 179.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.509 ' H ' ' HG2' ' A' ' 47' ' ' GLU . 7.3 mt-30 -150.55 -48.6 0.13 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.635 0.255 . . . . 15.0 111.524 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.727 ' HA3' ' HA3' ' A' ' 19' ' ' GLY . . . -87.73 167.82 37.16 Favored Glycine 0 C--N 1.33 0.232 0 C-N-CA 120.387 -0.911 . . . . 15.0 113.861 -179.128 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -58.5 -13.52 5.77 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.087 -0.556 . . . . 15.0 112.43 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.16 -56.74 5.06 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.696 0.284 . . . . 15.0 110.784 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.514 ' HG2' ' HA ' ' A' ' 42' ' ' PRO . 2.8 pp20? -57.59 -41.99 82.3 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.059 -0.519 . . . . 15.0 110.502 179.239 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -53.55 -69.54 0.12 Allowed 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 115.769 -0.651 . . . . 15.0 110.567 -179.25 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -60.25 -41.25 92.81 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.149 -0.685 . . . . 15.0 109.149 178.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.8 46.47 7.18 Favored Glycine 0 N--CA 1.446 -0.663 0 CA-C-N 115.436 -0.802 . . . . 15.0 111.866 179.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.463 ' HB3' ' CG2' ' A' ' 9' ' ' VAL . 0.9 OUTLIER -79.78 -44.77 20.03 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.695 0.283 . . . . 15.0 110.969 -179.285 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.452 ' CG2' ' CD1' ' A' ' 20' ' ' ILE . 3.5 mm -91.42 160.92 2.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.055 0.455 . . . . 15.0 111.187 179.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . 0.444 ' N ' ' CG2' ' A' ' 52' ' ' ILE . 75.9 m80 -140.52 148.92 41.78 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-N 115.741 -0.663 . . . . 15.0 110.438 179.52 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.545 ' HA ' ' CG2' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -36.23 133.76 0.47 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.935 -1.03 . . . . 15.0 112.575 -178.237 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.557 ' N ' HG21 ' A' ' 37' ' ' VAL . . . 55.14 33.0 57.3 Favored Glycine 0 N--CA 1.453 -0.2 0 CA-C-N 115.309 -0.86 . . . . 15.0 113.707 179.5 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.493 ' HB2' HG12 ' A' ' 37' ' ' VAL . 0.4 OUTLIER -66.13 127.75 33.36 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 117.603 0.701 . . . . 15.0 110.541 179.217 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 50.8 ttt-85 -80.71 86.6 5.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.464 -0.335 . . . . 15.0 110.529 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.487 HG22 HG21 ' A' ' 35' ' ' ILE . 1.3 m -79.95 115.3 22.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 CA-C-O 121.174 0.512 . . . . 15.0 111.173 -179.588 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 20.4 mt -107.43 -12.73 15.25 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 115.432 -0.804 . . . . 15.0 112.165 -179.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -150.06 144.6 25.87 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.202 0.525 . . . . 15.0 112.388 -178.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.455 HG21 ' CD2' ' A' ' 78' ' ' LEU . 44.9 t -139.04 101.73 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.452 -0.795 . . . . 15.0 109.457 178.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 64.87 15.87 10.15 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.822 -0.436 . . . . 15.0 109.822 -178.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 107.08 5.75 34.87 Favored Glycine 0 C--N 1.335 0.512 0 CA-C-N 115.956 -0.566 . . . . 15.0 113.469 179.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.499 ' O ' ' CG1' ' A' ' 64' ' ' VAL . 5.8 p -93.85 105.49 16.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 117.275 0.537 . . . . 15.0 110.949 179.405 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 72.3 m -58.41 131.75 51.65 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.122 -0.49 . . . . 15.0 110.936 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -87.65 -18.93 28.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.015 -0.539 . . . . 15.0 110.91 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -48.23 95.07 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.876 0.37 . . . . 15.0 110.858 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.66 66.82 0.59 Allowed Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.81 -0.709 . . . . 15.0 111.96 -179.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.406 ' HB3' ' HB3' ' A' ' 73' ' ' GLN . . . -172.73 161.9 4.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.915 0.388 . . . . 15.0 110.9 -179.646 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.45 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 8.3 p -93.19 -173.68 3.32 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.188 -0.46 . . . . 15.0 111.436 -179.562 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.522 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 0.1 OUTLIER -62.38 -60.76 3.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.832 -0.622 . . . . 15.0 110.39 -179.967 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.425 ' O ' ' HG3' ' A' ' 76' ' ' GLU . 17.7 ttpp -52.54 -30.69 31.94 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.746 -0.661 . . . . 15.0 110.442 179.36 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . 0.406 ' HB3' ' HB3' ' A' ' 69' ' ' ALA . 0.9 OUTLIER -59.39 -51.43 69.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.072 -0.513 . . . . 15.0 110.075 179.567 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.464 ' O ' ' N ' ' A' ' 77' ' ' THR . . . -66.94 -45.23 78.44 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 109.717 -0.475 . . . . 15.0 109.717 178.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -42.65 -43.14 1.11 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.269 0 N-CA-C 108.946 -0.761 . . . . 15.0 108.946 178.167 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.425 ' HG3' ' O ' ' A' ' 72' ' ' LYS . 24.3 mt-10 -67.42 -44.02 79.79 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 114.925 -1.034 . . . . 15.0 110.005 178.267 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.464 ' N ' ' O ' ' A' ' 74' ' ' ALA . 72.0 p -64.2 -54.18 37.58 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 116.744 -0.207 . . . . 15.0 111.397 179.718 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.463 ' HG ' ' O ' ' A' ' 74' ' ' ALA . 6.6 mt -53.28 -49.03 67.79 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-O 121.277 0.56 . . . . 15.0 109.947 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 4.3 ttp180 -68.51 -59.87 2.84 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.322 -0.854 . . . . 15.0 110.699 179.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.412 ' CB ' ' O ' ' A' ' 76' ' ' GLU . 43.4 m-20 -66.0 62.28 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.024 -0.535 . . . . 15.0 112.057 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.422 ' HB ' ' HG3' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -93.8 -68.68 0.79 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.83 0.348 . . . . 15.0 110.077 179.044 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 122.09 -109.85 1.51 Allowed Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 120.957 -0.64 . . . . 15.0 112.874 179.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -65.47 -77.26 0.06 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.52 -0.34 . . . . 15.0 111.701 -179.314 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.419 ' CG1' ' N ' ' A' ' 85' ' ' VAL . 55.8 t -110.17 157.68 10.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.174 -0.466 . . . . 15.0 111.295 -179.4 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.443 ' O ' ' CG1' ' A' ' 85' ' ' VAL . 8.6 t -98.0 81.16 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.026 -0.534 . . . . 15.0 110.48 179.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -100.43 86.08 3.1 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.796 -0.638 . . . . 15.0 110.506 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.452 ' O ' ' N ' ' A' ' 9' ' ' VAL . 0.1 OUTLIER -103.86 126.03 50.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.058 -0.519 . . . . 15.0 111.807 -179.265 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.473 HD11 ' HB2' ' A' ' 8' ' ' GLU . 4.9 mp -101.64 101.59 12.15 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.305 -0.628 . . . . 15.0 109.305 178.536 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.446 ' CD2' ' CD2' ' A' ' 87' ' ' LEU . 0.1 OUTLIER -105.66 -165.19 1.09 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.502 0.667 . . . . 15.0 112.089 -178.448 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.429 ' HB2' HG13 ' A' ' 6' ' ' ILE . 1.0 OUTLIER -140.12 136.23 33.33 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.873 -1.058 . . . . 15.0 109.619 178.97 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 10.2 tppt? -46.89 103.63 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.93 0.395 . . . . 15.0 111.293 -179.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.399 0 C-N-CA 120.866 -0.683 . . . . 15.0 112.565 -179.878 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.452 HG13 ' HB2' ' A' ' 90' ' ' GLU . 1.4 mp . . . . . 0 N--CA 1.45 -0.449 0 CA-C-O 120.714 0.292 . . . . 15.0 111.099 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.439 ' CD1' ' C ' ' A' ' 7' ' ' PHE . 2.2 p90 -140.59 163.75 32.03 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.318 -0.401 . . . . 15.0 110.561 178.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.479 ' HB2' HD11 ' A' ' 88' ' ' LEU . 11.0 pt-20 -128.97 143.05 50.76 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.257 0.551 . . . . 15.0 111.424 -179.453 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.436 HG12 ' CB ' ' A' ' 87' ' ' LEU . 0.2 OUTLIER -101.44 114.6 41.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.227 -0.897 . . . . 15.0 109.572 178.924 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -106.09 72.42 0.94 Allowed 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 112.397 0.518 . . . . 15.0 112.397 -178.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.444 ' HB3' ' HB ' ' A' ' 85' ' ' VAL . 6.5 tp -88.35 166.7 14.1 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.517 -0.549 . . . . 15.0 109.517 178.554 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -95.97 94.0 7.34 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.961 0.41 . . . . 15.0 111.305 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.514 ' O ' ' HD3' ' A' ' 13' ' ' LYS . 0.2 OUTLIER . . . . . 0 C--N 1.328 -0.361 0 CA-C-N 115.884 -0.598 . . . . 15.0 111.057 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 9.6 mt . . . . . 0 N--CA 1.454 -0.235 0 CA-C-O 120.939 0.4 . . . . 15.0 110.763 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.738 ' O ' ' HB ' ' A' ' 41' ' ' ILE . . . -164.71 40.72 0.3 Allowed Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 121.01 -0.614 . . . . 15.0 111.826 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.61 HG12 ' O ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -112.7 138.86 40.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 121.004 0.43 . . . . 15.0 111.773 -179.441 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.436 ' O ' ' HB3' ' A' ' 38' ' ' LYS . 21.1 t -94.49 100.4 12.4 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 107.704 -1.221 . . . . 15.0 107.704 177.282 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.547 HG23 ' CD2' ' A' ' 71' ' ' HIS . 1.4 m -93.79 152.69 3.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 112.463 0.542 . . . . 15.0 112.463 -177.076 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.529 ' HA ' ' ND1' ' A' ' 71' ' ' HIS . 14.8 t -149.29 -174.64 4.71 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.444 -0.798 . . . . 15.0 110.71 179.564 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.429 ' O ' ' N ' ' A' ' 26' ' ' VAL . . . 75.18 -115.51 4.66 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 120.721 -0.752 . . . . 15.0 112.153 -179.713 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.541 ' HA3' ' N ' ' A' ' 71' ' ' HIS . . . 64.33 -65.34 0.06 OUTLIER Glycine 0 N--CA 1.453 -0.215 0 C-N-CA 121.015 -0.612 . . . . 15.0 113.841 179.024 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.429 ' N ' ' O ' ' A' ' 24' ' ' GLY . 0.0 OUTLIER -30.54 145.13 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 N-CA-C 112.362 0.504 . . . . 15.0 112.362 -179.143 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -79.63 56.25 2.18 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.961 -0.563 . . . . 15.0 111.031 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -151.69 -64.96 0.18 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.234 -0.439 . . . . 15.0 110.641 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.63 -48.23 70.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.11 -0.495 . . . . 15.0 110.559 179.7 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 34.5 m -88.09 -171.15 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.024 -0.534 . . . . 15.0 110.77 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -92.4 127.17 37.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.91 0.386 . . . . 15.0 111.155 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 34.4 m80 58.18 -84.71 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.937 -0.574 . . . . 15.0 111.464 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -167.7 26.18 0.14 Allowed Glycine 0 C--N 1.331 0.263 0 C-N-CA 120.977 -0.63 . . . . 15.0 112.274 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -83.83 149.16 25.28 Favored Glycine 0 N--CA 1.448 -0.529 0 N-CA-C 110.769 -0.932 . . . . 15.0 110.769 178.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.445 ' CG1' ' HA ' ' A' ' 71' ' ' HIS . 0.0 OUTLIER -88.29 153.45 3.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 117.537 0.669 . . . . 15.0 111.777 -179.165 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.462 ' CZ ' ' HG2' ' A' ' 57' ' ' ARG . 30.7 m-85 -139.76 107.94 5.78 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.026 -0.988 . . . . 15.0 109.732 179.571 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.644 HG21 ' N ' ' A' ' 55' ' ' GLY . 0.8 OUTLIER -55.99 151.29 2.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.046 0.45 . . . . 15.0 111.284 -179.111 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.449 ' O ' ' HG2' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -83.8 -45.3 13.46 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.493 -0.928 . . . . 15.0 108.493 178.29 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.61 ' O ' HG12 ' A' ' 20' ' ' ILE . . . -172.28 172.43 4.5 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 115.853 -0.612 . . . . 15.0 110.32 178.333 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.552 ' HA ' HG12 ' A' ' 20' ' ' ILE . 0.1 OUTLIER -96.86 109.71 23.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.205 -0.665 . . . . 15.0 109.205 179.04 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.738 ' HB ' ' O ' ' A' ' 19' ' ' GLY . 0.5 OUTLIER -78.24 115.29 49.76 Favored Pre-proline 0 C--N 1.327 -0.371 0 N-CA-C 113.51 0.93 . . . . 15.0 113.51 -177.148 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.552 ' HA ' ' CG ' ' A' ' 47' ' ' GLU . 32.8 Cg_exo -62.0 60.58 0.13 Allowed 'Trans proline' 0 C--N 1.357 1.01 0 C-N-CA 123.619 2.879 . . . . 15.0 112.949 179.619 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.515 ' H ' ' HG2' ' A' ' 47' ' ' GLU . 6.0 tt0 -147.33 -48.38 0.18 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.62 0.248 . . . . 15.0 111.345 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.68 ' HA3' ' HA3' ' A' ' 19' ' ' GLY . . . -87.86 169.02 38.16 Favored Glycine 0 C--N 1.33 0.217 0 C-N-CA 120.403 -0.903 . . . . 15.0 113.807 -179.192 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -57.91 -13.84 5.17 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.749 0.648 . . . . 15.0 112.749 -179.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.9 -56.47 5.64 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.936 -0.306 . . . . 15.0 110.711 -179.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.553 ' HG3' ' O ' ' A' ' 44' ' ' GLY . 2.9 pp20? -57.57 -42.96 84.1 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.992 -0.549 . . . . 15.0 110.322 179.009 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -53.86 -70.75 0.09 Allowed 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 115.828 -0.624 . . . . 15.0 110.567 -179.497 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -58.11 -41.18 83.01 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.046 -0.724 . . . . 15.0 109.046 178.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.73 40.56 12.12 Favored Glycine 0 N--CA 1.446 -0.655 0 CA-C-N 115.345 -0.843 . . . . 15.0 111.779 179.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.416 ' HB3' ' CG2' ' A' ' 9' ' ' VAL . 2.7 mmp_? -79.78 -50.49 10.48 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.931 0.396 . . . . 15.0 110.644 -179.438 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.427 ' CD1' HD12 ' A' ' 89' ' ' LEU . 9.4 tp -81.1 160.1 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 CA-C-N 115.989 -0.55 . . . . 15.0 110.378 179.543 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . 0.468 ' O ' HG21 ' A' ' 37' ' ' VAL . 75.7 m80 -145.31 159.01 43.69 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-O 121.599 0.714 . . . . 15.0 112.083 -179.217 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.504 ' HA ' ' CG2' ' A' ' 37' ' ' VAL . 0.1 OUTLIER -42.21 132.91 3.25 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.512 -1.222 . . . . 15.0 112.642 -178.687 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.644 ' N ' HG21 ' A' ' 37' ' ' VAL . . . 49.98 34.24 22.89 Favored Glycine 0 C--N 1.333 0.395 0 CA-C-N 115.761 -0.654 . . . . 15.0 113.425 179.277 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.496 ' HB2' HG12 ' A' ' 37' ' ' VAL . 0.3 OUTLIER -65.84 132.66 49.21 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.538 -0.465 . . . . 15.0 110.617 179.475 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.462 ' HG2' ' CZ ' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -85.73 92.13 8.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.321 -0.4 . . . . 15.0 110.499 179.664 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.479 ' HA ' HD22 ' A' ' 89' ' ' LEU . 2.0 m -83.14 114.43 23.9 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 CA-C-O 120.988 0.423 . . . . 15.0 111.143 -179.566 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -107.15 -16.39 14.43 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 115.747 -0.66 . . . . 15.0 112.494 -179.236 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -147.78 146.91 29.35 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.112 0.482 . . . . 15.0 112.222 -178.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.451 ' HB ' ' CG1' ' A' ' 64' ' ' VAL . 61.5 t -138.78 102.18 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.578 -0.737 . . . . 15.0 109.194 178.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 65.07 16.1 10.37 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.103 -0.499 . . . . 15.0 109.763 -178.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 105.83 5.18 38.94 Favored Glycine 0 C--N 1.336 0.564 0 CA-C-N 115.821 -0.627 . . . . 15.0 113.247 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.487 ' O ' ' CG1' ' A' ' 64' ' ' VAL . 5.5 p -93.84 108.3 20.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.983 0.392 . . . . 15.0 110.979 179.6 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 21.4 m -57.99 124.89 20.83 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.204 0.526 . . . . 15.0 110.777 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.41 ' CD1' HG23 ' A' ' 58' ' ' VAL . 0.3 OUTLIER -87.72 -21.06 25.41 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.444 -0.798 . . . . 15.0 111.327 -179.499 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -46.7 103.6 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.843 0.354 . . . . 15.0 110.986 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.89 63.11 0.54 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.764 -0.731 . . . . 15.0 112.55 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -172.98 164.64 4.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.835 0.35 . . . . 15.0 111.024 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.415 ' HA ' ' N ' ' A' ' 26' ' ' VAL . 5.9 p -93.26 -172.89 3.08 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.067 0.46 . . . . 15.0 111.118 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.547 ' CD2' HG23 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -62.35 -61.34 2.52 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.733 -0.667 . . . . 15.0 110.212 179.985 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 22.4 ttpp -52.85 -35.68 57.77 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.789 -0.641 . . . . 15.0 110.345 179.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -59.68 -48.31 82.19 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.432 -0.581 . . . . 15.0 109.432 179.137 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.457 ' O ' ' N ' ' A' ' 77' ' ' THR . . . -66.79 -47.87 70.75 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 115.789 -0.641 . . . . 15.0 109.441 178.361 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.429 ' O ' ' HB2' ' A' ' 79' ' ' ARG . 0.5 OUTLIER -41.66 -40.26 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.271 0 N-CA-C 108.827 -0.805 . . . . 15.0 108.827 178.203 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.483 ' O ' ' HB2' ' A' ' 80' ' ' ASN . 1.5 mm-40 -67.2 -47.02 72.13 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.734 -1.121 . . . . 15.0 110.509 178.542 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.457 ' N ' ' O ' ' A' ' 74' ' ' ALA . 16.5 p -64.08 -53.06 55.69 Favored 'General case' 0 N--CA 1.461 0.117 0 C-N-CA 120.913 -0.315 . . . . 15.0 111.469 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.432 ' HG ' ' O ' ' A' ' 74' ' ' ALA . 3.6 mt -53.44 -47.43 69.68 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.174 0.511 . . . . 15.0 110.047 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.429 ' HB2' ' O ' ' A' ' 75' ' ' VAL . 0.0 OUTLIER -68.64 -57.9 5.03 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.571 -0.741 . . . . 15.0 110.657 179.331 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.483 ' HB2' ' O ' ' A' ' 76' ' ' GLU . 11.9 m-80 -65.92 63.05 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.163 -0.472 . . . . 15.0 111.966 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.44 ' HB ' ' HG3' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -94.0 -71.95 0.64 Allowed 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 110.096 -0.335 . . . . 15.0 110.096 179.103 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 122.06 -105.22 0.96 Allowed Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.774 -0.727 . . . . 15.0 113.124 179.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -64.8 -82.86 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 111.885 0.328 . . . . 15.0 111.885 -179.16 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.44 HG13 ' N ' ' A' ' 85' ' ' VAL . 72.9 t -109.64 159.85 8.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.921 0.391 . . . . 15.0 110.869 -179.508 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.444 ' HB ' ' HB3' ' A' ' 11' ' ' LEU . 14.9 t -97.76 80.83 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.054 0.454 . . . . 15.0 110.593 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -102.84 85.09 2.48 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.765 -0.652 . . . . 15.0 110.44 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.465 ' CD2' ' CD2' ' A' ' 89' ' ' LEU . 0.1 OUTLIER -102.42 119.9 39.6 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.948 -0.569 . . . . 15.0 111.742 -179.207 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.479 HD11 ' HB2' ' A' ' 8' ' ' GLU . 4.3 mp -94.52 100.66 12.6 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.773 -0.454 . . . . 15.0 109.773 178.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.479 HD22 ' HA ' ' A' ' 58' ' ' VAL . 0.1 OUTLIER -105.81 -163.53 0.95 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.517 0.675 . . . . 15.0 112.173 -178.531 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.452 ' HB2' HG13 ' A' ' 6' ' ' ILE . 3.4 tt0 -141.36 140.15 33.67 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 114.824 -1.08 . . . . 15.0 109.505 179.02 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 2.7 tptp -55.98 96.66 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.025 0.441 . . . . 15.0 111.014 -179.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.518 0.254 0 CA-C-N 115.732 -0.667 . . . . 15.0 113.188 -179.677 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.416 ' CD1' ' HB2' ' A' ' 90' ' ' GLU . 1.2 mp . . . . . 0 N--CA 1.45 -0.458 0 CA-C-O 120.897 0.38 . . . . 15.0 111.244 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.45 ' CZ ' HD11 ' A' ' 89' ' ' LEU . 2.1 p90 -140.28 164.32 30.4 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.012 -0.54 . . . . 15.0 110.253 178.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.48 ' CB ' HD11 ' A' ' 88' ' ' LEU . 10.0 pt-20 -130.06 143.96 51.08 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.254 0.55 . . . . 15.0 111.701 -179.33 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.491 ' CG2' ' HB3' ' A' ' 51' ' ' ARG . 0.3 OUTLIER -101.5 116.99 46.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.327 -0.851 . . . . 15.0 109.815 178.895 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -106.01 70.97 0.87 Allowed 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.278 -0.419 . . . . 15.0 111.854 -179.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.426 ' HB3' ' HB ' ' A' ' 85' ' ' VAL . 6.0 tp -87.83 164.75 15.75 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.124 -0.489 . . . . 15.0 109.853 179.088 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -95.91 94.03 7.38 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.993 0.425 . . . . 15.0 111.346 -179.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.497 ' HG3' ' HB ' ' A' ' 81' ' ' THR . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.367 0 CA-C-N 115.904 -0.589 . . . . 15.0 110.881 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.413 ' N ' ' CD2' ' A' ' 18' ' ' LEU . 1.3 mm? . . . . . 0 N--CA 1.453 -0.304 0 CA-C-O 121.019 0.438 . . . . 15.0 110.66 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.576 ' O ' ' HB ' ' A' ' 41' ' ' ILE . . . -165.78 31.46 0.22 Allowed Glycine 0 C--O 1.224 -0.529 0 N-CA-C 111.336 -0.706 . . . . 15.0 111.336 -179.677 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.515 HG12 ' O ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -114.07 140.87 32.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 112.314 0.487 . . . . 15.0 112.314 -179.497 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.7 t -96.43 106.32 18.54 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 107.962 -1.125 . . . . 15.0 107.962 176.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.484 ' O ' ' CE1' ' A' ' 71' ' ' HIS . 21.1 m -93.59 149.59 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 N-CA-C 112.947 0.721 . . . . 15.0 112.947 -177.246 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.507 ' HA ' ' CE1' ' A' ' 71' ' ' HIS . 8.8 t -150.37 -179.96 7.63 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.357 -0.838 . . . . 15.0 110.887 179.266 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.43 ' O ' ' N ' ' A' ' 26' ' ' VAL . . . 74.11 -114.83 4.68 Favored Glycine 0 C--N 1.334 0.467 0 C-N-CA 120.973 -0.632 . . . . 15.0 112.526 179.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.531 ' HA3' ' N ' ' A' ' 71' ' ' HIS . . . 63.88 -65.3 0.05 OUTLIER Glycine 0 C--N 1.331 0.251 0 C-N-CA 121.093 -0.575 . . . . 15.0 113.885 179.082 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.43 ' N ' ' O ' ' A' ' 24' ' ' GLY . 0.0 OUTLIER -28.68 141.81 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 N-CA-C 112.329 0.492 . . . . 15.0 112.329 -179.159 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -75.53 62.24 1.38 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.965 -0.561 . . . . 15.0 111.001 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 9.7 m -151.71 -65.34 0.18 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.258 -0.428 . . . . 15.0 111.011 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -69.52 -48.92 58.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.118 -0.492 . . . . 15.0 111.087 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.431 HG13 ' CD1' ' A' ' 36' ' ' TYR . 34.8 m -72.69 -174.51 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.217 -0.447 . . . . 15.0 111.247 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.45 -74.56 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.184 -0.462 . . . . 15.0 111.258 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 8.8 p-80 -132.52 -45.71 0.9 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.35 -0.386 . . . . 15.0 111.179 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -168.39 24.05 0.11 Allowed Glycine 0 N--CA 1.453 -0.19 0 C-N-CA 120.8 -0.714 . . . . 15.0 112.732 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -90.31 153.71 22.99 Favored Glycine 0 N--CA 1.449 -0.448 0 N-CA-C 110.836 -0.906 . . . . 15.0 110.836 178.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.477 HG21 HG22 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -92.21 154.11 3.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.504 0.669 . . . . 15.0 111.888 -179.335 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.482 ' CZ ' ' HG2' ' A' ' 57' ' ' ARG . 24.1 m-85 -139.49 110.97 7.07 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.857 -1.065 . . . . 15.0 109.136 178.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.552 HG21 ' N ' ' A' ' 55' ' ' GLY . 0.8 OUTLIER -56.44 156.42 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.46 0.648 . . . . 15.0 110.953 -178.762 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.497 ' O ' ' HG2' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -90.39 -46.85 8.11 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 108.281 -1.007 . . . . 15.0 108.281 178.667 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.515 ' O ' HG12 ' A' ' 20' ' ' ILE . . . -172.84 166.74 5.23 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.088 -0.96 . . . . 15.0 110.566 178.326 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.511 ' HB ' ' HG2' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -97.24 119.94 45.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.789 0.328 . . . . 15.0 110.493 179.75 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.576 ' HB ' ' O ' ' A' ' 19' ' ' GLY . 1.4 mm -78.31 109.28 9.8 Favored Pre-proline 0 N--CA 1.466 0.358 0 N-CA-C 113.028 0.751 . . . . 15.0 113.028 -178.394 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.495 ' HA ' ' OE1' ' A' ' 47' ' ' GLU . 41.0 Cg_endo -66.54 64.42 0.53 Allowed 'Trans proline' 0 C--N 1.352 0.753 0 C-N-CA 122.846 2.364 . . . . 15.0 112.28 179.474 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 11.5 mt-30 -159.37 -45.91 0.05 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.362 -0.835 . . . . 15.0 109.436 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.49 ' HA3' ' HA3' ' A' ' 19' ' ' GLY . . . -87.4 151.6 23.56 Favored Glycine 0 N--CA 1.446 -0.678 0 CA-C-N 115.611 -0.722 . . . . 15.0 112.222 179.232 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -40.59 -18.28 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 113.367 0.877 . . . . 15.0 113.367 -179.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.465 ' N ' ' O ' ' A' ' 44' ' ' GLY . . . -71.66 -71.64 0.26 Allowed 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.893 -0.323 . . . . 15.0 111.267 -179.593 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.558 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 9.4 tm-20 -58.16 -37.79 75.36 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.832 0.348 . . . . 15.0 110.341 179.578 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 16.0 m -53.92 -66.4 0.4 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.1 -0.5 . . . . 15.0 110.47 179.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -63.3 -37.64 88.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.103 -0.499 . . . . 15.0 109.922 179.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.55 43.68 8.32 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.928 -0.653 . . . . 15.0 112.523 179.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.491 ' HB3' ' CG2' ' A' ' 9' ' ' VAL . 0.0 OUTLIER -80.13 -51.72 8.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.75 0.309 . . . . 15.0 110.724 179.943 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.435 ' CG2' ' N ' ' A' ' 53' ' ' HIS . 1.2 mm -91.24 163.41 2.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.973 0.416 . . . . 15.0 111.15 179.736 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . 0.435 ' N ' ' CG2' ' A' ' 52' ' ' ILE . 47.6 m80 -139.39 153.29 47.62 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-O 121.368 0.604 . . . . 15.0 110.485 179.463 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.497 ' HG2' ' O ' ' A' ' 38' ' ' LYS . 0.6 OUTLIER -35.21 132.96 0.35 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.747 -1.115 . . . . 15.0 112.354 -178.459 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.552 ' N ' HG21 ' A' ' 37' ' ' VAL . . . 52.11 35.57 41.9 Favored Glycine 0 C--N 1.332 0.31 0 CA-C-N 115.892 -0.594 . . . . 15.0 114.01 179.644 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.487 ' HB2' HG12 ' A' ' 37' ' ' VAL . 0.4 OUTLIER -66.16 130.57 43.68 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 117.676 0.738 . . . . 15.0 110.561 179.205 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.482 ' HG2' ' CZ ' ' A' ' 36' ' ' TYR . 26.4 mtt-85 -81.63 91.55 6.43 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.462 -0.335 . . . . 15.0 110.586 179.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.492 ' HB ' ' CD2' ' A' ' 87' ' ' LEU . 1.1 m -85.86 116.29 28.67 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 CA-C-O 121.178 0.513 . . . . 15.0 111.384 -179.645 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -107.26 -10.59 15.78 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 115.589 -0.732 . . . . 15.0 112.248 -179.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -152.01 145.16 24.6 Favored 'General case' 0 N--CA 1.462 0.17 0 N-CA-C 112.301 0.482 . . . . 15.0 112.301 -178.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.441 ' HB ' ' CG1' ' A' ' 64' ' ' VAL . 59.7 t -138.94 101.41 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.57 -0.741 . . . . 15.0 109.264 178.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.414 ' ND2' ' CG2' ' A' ' 81' ' ' THR . 1.1 m-80 64.96 16.04 10.31 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.02 0.438 . . . . 15.0 109.919 -178.286 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 107.06 4.76 35.68 Favored Glycine 0 C--N 1.336 0.578 0 CA-C-N 115.932 -0.577 . . . . 15.0 113.376 179.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.49 ' O ' ' CG1' ' A' ' 64' ' ' VAL . 5.2 p -93.85 107.54 19.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 117.084 0.442 . . . . 15.0 110.857 179.529 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.6 m -56.82 130.74 46.97 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.3 -0.409 . . . . 15.0 111.111 -179.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -90.76 -22.03 21.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.04 -0.527 . . . . 15.0 110.95 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -46.6 96.68 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.889 0.376 . . . . 15.0 111.047 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.76 66.45 0.58 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.801 -0.714 . . . . 15.0 112.428 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -173.09 162.77 4.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.838 0.351 . . . . 15.0 111.052 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 15.0 p -93.12 -174.1 3.45 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.016 0.436 . . . . 15.0 111.106 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.531 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 0.2 OUTLIER -63.95 -59.7 4.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.841 -0.618 . . . . 15.0 110.296 179.946 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.426 ' O ' ' HG3' ' A' ' 76' ' ' GLU . 30.4 ttmt -52.69 -33.52 47.89 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.153 -0.476 . . . . 15.0 110.235 178.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.39 -51.25 70.73 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.565 -0.532 . . . . 15.0 109.565 179.258 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.452 ' O ' ' N ' ' A' ' 77' ' ' THR . . . -66.91 -43.87 82.22 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-N 116.041 -0.527 . . . . 15.0 109.711 178.425 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.458 ' CG2' ' CG2' ' A' ' 22' ' ' VAL . 0.5 OUTLIER -42.83 -41.91 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.23 0 N-CA-C 108.896 -0.779 . . . . 15.0 108.896 178.395 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.432 ' N ' HG11 ' A' ' 75' ' ' VAL . 17.2 mt-10 -67.32 -45.15 77.31 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.794 -1.093 . . . . 15.0 110.078 178.275 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.452 ' N ' ' O ' ' A' ' 74' ' ' ALA . 82.1 p -64.17 -54.58 31.47 Favored 'General case' 0 N--CA 1.461 0.114 0 CA-C-N 116.612 -0.267 . . . . 15.0 111.436 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.437 ' HG ' ' O ' ' A' ' 74' ' ' ALA . 4.2 mt -53.51 -48.17 69.24 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 121.145 0.498 . . . . 15.0 110.141 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.52 -59.02 3.45 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.561 -0.745 . . . . 15.0 110.564 179.478 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 74.6 m-20 -66.04 59.4 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.933 -0.576 . . . . 15.0 112.43 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.497 ' HB ' ' HG3' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -95.73 -71.97 0.65 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.889 -0.412 . . . . 15.0 109.889 178.855 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 122.13 -105.16 0.96 Allowed Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.72 -0.752 . . . . 15.0 113.451 178.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.56 -83.0 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.071 0.397 . . . . 15.0 112.071 -178.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.423 HG13 ' N ' ' A' ' 85' ' ' VAL . 76.2 t -109.64 158.84 9.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.077 0.465 . . . . 15.0 111.167 -179.199 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.439 ' O ' ' CG1' ' A' ' 85' ' ' VAL . 9.1 t -97.86 81.23 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.011 -0.54 . . . . 15.0 110.499 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -99.06 85.54 3.26 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.76 -0.655 . . . . 15.0 110.344 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.492 ' CD2' ' HB ' ' A' ' 58' ' ' VAL . 0.1 OUTLIER -104.02 126.52 51.2 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.041 -0.527 . . . . 15.0 111.917 -179.16 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.48 HD11 ' CB ' ' A' ' 8' ' ' GLU . 5.0 mp -102.41 99.96 10.06 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.751 -0.463 . . . . 15.0 109.751 178.695 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.478 ' HB3' ' HA ' ' A' ' 58' ' ' VAL . 0.1 OUTLIER -105.85 -162.56 0.87 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.646 0.736 . . . . 15.0 112.29 -178.633 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.416 ' HB2' ' CD1' ' A' ' 6' ' ' ILE . 3.3 tt0 -137.68 138.64 39.6 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 114.639 -1.164 . . . . 15.0 109.48 178.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.3 tppt? -49.49 107.35 0.14 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.947 0.403 . . . . 15.0 111.151 -179.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.272 0 C-N-CA 120.928 -0.653 . . . . 15.0 112.935 -179.707 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.453 HG13 ' HB2' ' A' ' 90' ' ' GLU . 1.3 mp . . . . . 0 N--CA 1.452 -0.366 0 CA-C-O 120.665 0.269 . . . . 15.0 110.709 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.447 ' O ' ' N ' ' A' ' 89' ' ' LEU . 2.5 p90 -144.8 165.14 28.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.793 0.33 . . . . 15.0 110.686 179.177 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.492 ' CB ' HD11 ' A' ' 88' ' ' LEU . 9.7 pt-20 -130.18 143.91 51.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.22 0.534 . . . . 15.0 111.426 -179.472 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.435 ' CG2' ' HB3' ' A' ' 51' ' ' ARG . 0.2 OUTLIER -101.38 115.3 42.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.434 -0.803 . . . . 15.0 109.521 178.905 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -106.02 72.03 0.92 Allowed 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.524 0.565 . . . . 15.0 112.524 -178.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.435 ' HB3' ' HB ' ' A' ' 85' ' ' VAL . 5.7 tp -88.2 166.3 14.46 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.448 -0.575 . . . . 15.0 109.448 178.462 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -96.18 92.15 6.26 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.897 0.379 . . . . 15.0 111.203 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.469 ' O ' ' HD3' ' A' ' 13' ' ' LYS . 0.2 OUTLIER . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 115.914 -0.584 . . . . 15.0 111.018 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.403 ' N ' ' CD2' ' A' ' 18' ' ' LEU . 1.9 mm? . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.878 0.37 . . . . 15.0 110.748 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.761 ' O ' ' HB ' ' A' ' 41' ' ' ILE . . . -163.63 44.32 0.32 Allowed Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 121.053 -0.594 . . . . 15.0 111.871 -179.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.661 HG12 ' O ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -112.88 135.58 51.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 121.012 0.434 . . . . 15.0 111.876 -179.353 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.4 ' HB3' HD13 ' A' ' 41' ' ' ILE . 29.9 t -89.81 104.4 16.97 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 107.668 -1.234 . . . . 15.0 107.668 177.366 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.461 HG11 ' CG2' ' A' ' 20' ' ' ILE . 14.1 m -93.44 151.91 3.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 112.953 0.723 . . . . 15.0 112.953 -176.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -149.57 -177.72 6.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 114.977 -1.01 . . . . 15.0 110.678 -179.685 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.414 ' O ' ' CB ' ' A' ' 71' ' ' HIS . . . 73.26 -120.52 7.16 Favored Glycine 0 C--N 1.331 0.256 0 C-N-CA 120.675 -0.774 . . . . 15.0 112.381 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.52 ' HA3' ' N ' ' A' ' 71' ' ' HIS . . . 66.94 -65.57 0.19 Allowed Glycine 0 C--N 1.33 0.214 0 C-N-CA 120.943 -0.646 . . . . 15.0 113.565 179.31 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.437 ' C ' ' O ' ' A' ' 25' ' ' GLY . 0.0 OUTLIER -25.87 133.08 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 N-CA-C 112.621 0.6 . . . . 15.0 112.621 -179.298 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -75.65 63.17 1.54 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.784 -0.644 . . . . 15.0 111.018 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.4 m -151.67 -47.27 0.11 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.287 -0.415 . . . . 15.0 111.0 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 12.5 t -90.28 -41.65 11.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 15.0 111.001 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 33.9 m -71.99 -176.3 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.471 . . . . 15.0 111.166 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.412 ' O ' ' CD2' ' A' ' 32' ' ' HIS . 0.0 OUTLIER -57.0 -51.32 69.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.218 -0.446 . . . . 15.0 110.983 -179.995 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . 0.412 ' CD2' ' O ' ' A' ' 31' ' ' ARG . 27.0 m80 -151.21 -51.98 0.13 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.28 -0.418 . . . . 15.0 111.012 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -168.1 27.42 0.14 Allowed Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.803 -0.713 . . . . 15.0 112.5 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -91.13 149.14 19.71 Favored Glycine 0 N--CA 1.45 -0.411 0 N-CA-C 111.037 -0.825 . . . . 15.0 111.037 179.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.446 ' CG1' ' HA ' ' A' ' 71' ' ' HIS . 0.0 OUTLIER -88.18 154.78 3.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.388 0.613 . . . . 15.0 111.719 -179.299 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.507 ' CZ ' ' HG2' ' A' ' 57' ' ' ARG . 51.2 m-85 -141.35 106.91 5.06 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.008 -0.996 . . . . 15.0 109.737 179.272 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.656 HG21 ' N ' ' A' ' 55' ' ' GLY . 0.8 OUTLIER -56.16 148.11 4.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.021 0.438 . . . . 15.0 111.317 -179.193 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.482 ' O ' ' HG2' ' A' ' 54' ' ' LYS . 0.4 OUTLIER -80.37 -46.46 16.01 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.49 -0.93 . . . . 15.0 108.49 178.248 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.661 ' O ' HG12 ' A' ' 20' ' ' ILE . . . -172.1 172.58 4.59 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.594 -0.73 . . . . 15.0 110.508 178.626 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.517 ' HA ' HG12 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -96.87 111.42 26.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 109.545 -0.539 . . . . 15.0 109.545 179.248 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.761 ' HB ' ' O ' ' A' ' 19' ' ' GLY . 0.4 OUTLIER -78.47 117.05 64.02 Favored Pre-proline 0 C--N 1.329 -0.324 0 N-CA-C 113.273 0.842 . . . . 15.0 113.273 -177.422 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.547 ' HA ' ' CG ' ' A' ' 47' ' ' GLU . 37.9 Cg_endo -65.29 59.76 0.34 Allowed 'Trans proline' 0 C--N 1.356 0.924 0 C-N-CA 123.437 2.758 . . . . 15.0 112.785 179.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.505 ' N ' ' HG2' ' A' ' 47' ' ' GLU . 0.5 OUTLIER -147.47 -46.32 0.17 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.517 -0.31 . . . . 15.0 111.296 -179.996 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.684 ' HA3' ' HA3' ' A' ' 19' ' ' GLY . . . -87.77 168.02 37.3 Favored Glycine 0 C--N 1.331 0.269 0 C-N-CA 120.332 -0.937 . . . . 15.0 113.722 -179.258 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -57.83 -14.35 5.85 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.862 0.69 . . . . 15.0 112.862 -179.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.14 -55.86 6.57 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.935 -0.306 . . . . 15.0 110.932 -179.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.567 ' HG3' ' O ' ' A' ' 44' ' ' GLY . 2.9 pp20? -57.36 -43.02 83.15 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.923 -0.58 . . . . 15.0 110.231 179.196 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.5 m -53.84 -69.89 0.11 Allowed 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 115.882 -0.599 . . . . 15.0 110.483 -179.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -58.07 -41.74 84.01 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.072 -0.714 . . . . 15.0 109.072 178.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.75 40.03 12.97 Favored Glycine 0 N--CA 1.446 -0.648 0 CA-C-N 115.293 -0.867 . . . . 15.0 111.711 179.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.435 ' HB3' ' CG2' ' A' ' 9' ' ' VAL . 0.2 OUTLIER -79.79 -50.07 11.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.895 0.378 . . . . 15.0 110.599 -179.362 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.44 ' CD1' HD12 ' A' ' 89' ' ' LEU . 8.7 tp -81.12 161.44 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 CA-C-N 116.075 -0.511 . . . . 15.0 110.367 179.571 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . 0.479 ' O ' ' HB2' ' A' ' 56' ' ' ASP . 78.3 m80 -146.27 158.78 43.91 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-O 121.635 0.731 . . . . 15.0 112.16 -179.192 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.523 ' HA ' ' CG2' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -43.12 133.97 3.71 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 114.382 -1.281 . . . . 15.0 112.645 -178.752 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.656 ' N ' HG21 ' A' ' 37' ' ' VAL . . . 49.97 34.0 22.37 Favored Glycine 0 C--N 1.333 0.414 0 CA-C-N 115.841 -0.618 . . . . 15.0 113.354 179.403 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.494 ' HB2' HG12 ' A' ' 37' ' ' VAL . 0.3 OUTLIER -65.96 131.9 47.33 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.635 -0.426 . . . . 15.0 110.618 179.525 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.507 ' HG2' ' CZ ' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -85.32 90.89 8.03 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.169 -0.468 . . . . 15.0 110.403 179.553 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.478 ' HA ' HD22 ' A' ' 89' ' ' LEU . 1.5 m -83.57 112.95 21.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.079 0.466 . . . . 15.0 111.207 -179.524 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -107.32 -16.54 14.37 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 115.764 -0.653 . . . . 15.0 112.615 -179.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -147.5 150.21 34.12 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 112.518 0.562 . . . . 15.0 112.518 -178.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.424 ' HB ' ' CG1' ' A' ' 64' ' ' VAL . 3.3 t -139.07 101.66 1.62 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.267 0 CA-C-N 115.311 -0.859 . . . . 15.0 109.281 178.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.407 ' ND2' ' CG2' ' A' ' 81' ' ' THR . 2.3 m-80 64.96 15.59 10.05 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.64 -0.504 . . . . 15.0 109.64 -178.112 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 105.95 6.71 36.93 Favored Glycine 0 C--N 1.336 0.54 0 CA-C-N 115.816 -0.629 . . . . 15.0 113.126 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.499 ' O ' ' CG1' ' A' ' 64' ' ' VAL . 7.2 p -93.76 105.32 16.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.118 0.485 . . . . 15.0 110.727 179.283 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -59.3 116.35 3.85 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.127 -0.488 . . . . 15.0 110.733 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.2 mt -87.59 -12.07 46.75 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.826 -0.624 . . . . 15.0 111.295 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -46.29 102.51 0.03 OUTLIER 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.827 0.346 . . . . 15.0 110.936 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.86 64.25 0.55 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.8 -0.714 . . . . 15.0 112.264 -179.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -172.91 148.44 1.79 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.9 0.381 . . . . 15.0 110.855 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.423 ' CB ' ' HA ' ' A' ' 26' ' ' VAL . 11.8 p -72.83 -173.75 1.29 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.198 -0.456 . . . . 15.0 111.157 -179.65 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.52 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 0.0 OUTLIER -61.89 -59.46 5.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.882 -0.599 . . . . 15.0 110.572 -179.847 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 25.0 ttpt -52.34 -35.51 51.14 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.84 -0.618 . . . . 15.0 110.689 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -59.31 -46.22 89.16 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.647 -0.501 . . . . 15.0 109.647 179.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.593 ' HA ' ' OG1' ' A' ' 77' ' ' THR . . . -66.96 -50.34 62.61 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 109.472 -0.566 . . . . 15.0 109.472 178.195 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.438 ' CG2' ' CG2' ' A' ' 22' ' ' VAL . 0.6 OUTLIER -40.85 -43.58 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.192 0 CA-C-N 115.237 -0.892 . . . . 15.0 109.614 178.567 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -67.37 -43.85 80.39 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.01 -0.996 . . . . 15.0 110.663 179.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.593 ' OG1' ' HA ' ' A' ' 74' ' ' ALA . 0.6 OUTLIER -64.68 -55.78 17.92 Favored 'General case' 0 C--O 1.23 0.075 0 C-N-CA 120.796 -0.362 . . . . 15.0 111.272 179.937 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.423 ' CD2' HG21 ' A' ' 61' ' ' VAL . 3.2 mt -53.43 -46.03 69.65 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 121.116 0.484 . . . . 15.0 110.132 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.22 -55.06 13.6 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.612 -0.722 . . . . 15.0 110.359 179.4 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 8.1 m-20 -66.26 57.81 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 115.919 -0.582 . . . . 15.0 112.01 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.407 ' CG2' ' ND2' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -95.66 -70.54 0.71 Allowed 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 110.203 -0.295 . . . . 15.0 110.203 179.332 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 115.25 -98.15 0.84 Allowed Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.691 -0.766 . . . . 15.0 113.412 178.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . 0.41 ' O ' ' HB3' ' A' ' 13' ' ' LYS . 0.5 OUTLIER -64.39 -86.24 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.063 0.394 . . . . 15.0 112.063 -178.827 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.421 ' CG1' ' N ' ' A' ' 85' ' ' VAL . 77.7 t -109.73 159.76 9.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.924 0.392 . . . . 15.0 110.978 -179.397 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.444 ' O ' ' CG1' ' A' ' 85' ' ' VAL . 13.4 t -97.99 79.4 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.145 0.497 . . . . 15.0 110.466 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -101.41 84.14 2.56 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.746 -0.661 . . . . 15.0 110.495 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.455 ' CD2' ' CD2' ' A' ' 89' ' ' LEU . 0.1 OUTLIER -101.02 128.64 46.97 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.014 -0.539 . . . . 15.0 111.54 -179.302 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.492 HD11 ' CB ' ' A' ' 8' ' ' GLU . 4.8 mp -102.2 99.67 9.8 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.737 -0.468 . . . . 15.0 109.737 178.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.478 HD22 ' HA ' ' A' ' 58' ' ' VAL . 0.1 OUTLIER -105.73 -160.86 0.77 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.394 0.616 . . . . 15.0 112.011 -178.677 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.453 ' HB2' HG13 ' A' ' 6' ' ' ILE . 3.6 tt0 -141.77 132.69 25.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.051 -0.977 . . . . 15.0 109.897 179.136 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 3.6 tmtp? -49.26 95.51 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.378 -0.374 . . . . 15.0 111.146 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.365 0 C-N-CA 120.85 -0.691 . . . . 15.0 112.639 -179.964 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.403 ' CD1' ' HB2' ' A' ' 90' ' ' GLU . 1.2 mp . . . . . 0 N--CA 1.451 -0.409 0 CA-C-O 120.921 0.391 . . . . 15.0 111.335 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.411 ' O ' ' N ' ' A' ' 89' ' ' LEU . 1.8 p90 -140.54 153.91 46.33 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.026 -0.533 . . . . 15.0 110.407 178.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.493 ' CB ' HD11 ' A' ' 88' ' ' LEU . 0.1 OUTLIER -121.37 143.61 49.11 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.369 0.604 . . . . 15.0 111.759 -179.192 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.477 ' CG2' ' HB3' ' A' ' 51' ' ' ARG . 0.2 OUTLIER -101.43 116.02 44.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.063 -0.971 . . . . 15.0 109.628 178.956 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -106.24 72.59 0.94 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.239 -0.437 . . . . 15.0 112.145 -178.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.449 ' HB3' ' HB ' ' A' ' 85' ' ' VAL . 7.1 tp -88.3 161.69 17.01 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.319 -0.4 . . . . 15.0 110.007 178.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -97.1 94.67 7.28 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.654 0.264 . . . . 15.0 111.686 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.425 ' HB2' ' CG2' ' A' ' 85' ' ' VAL . 0.6 OUTLIER . . . . . 0 N--CA 1.466 0.325 0 N-CA-C 112.738 0.644 . . . . 15.0 112.738 179.623 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.5 mp . . . . . 0 N--CA 1.452 -0.341 0 CA-C-O 120.729 0.3 . . . . 15.0 110.357 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.664 ' O ' ' HB ' ' A' ' 41' ' ' ILE . . . -160.61 38.88 0.44 Allowed Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.901 -0.666 . . . . 15.0 111.719 -179.728 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.634 HG12 ' O ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -112.9 138.4 42.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 120.998 0.428 . . . . 15.0 111.805 -179.53 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.402 ' O ' ' HB3' ' A' ' 38' ' ' LYS . 28.9 t -95.78 100.92 12.57 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 107.801 -1.185 . . . . 15.0 107.801 177.395 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.521 HG23 ' CD2' ' A' ' 71' ' ' HIS . 1.0 OUTLIER -93.66 154.82 3.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.162 0.506 . . . . 15.0 112.299 -177.151 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.466 ' HA ' ' CE1' ' A' ' 71' ' ' HIS . 14.5 t -149.34 -176.19 5.28 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.421 -0.809 . . . . 15.0 110.516 179.647 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.474 ' O ' ' HB2' ' A' ' 71' ' ' HIS . . . 77.1 -112.07 3.42 Favored Glycine 0 C--N 1.331 0.287 0 C-N-CA 120.555 -0.831 . . . . 15.0 112.253 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.557 ' HA3' ' N ' ' A' ' 71' ' ' HIS . . . 62.8 -65.89 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 121.037 -0.601 . . . . 15.0 113.812 179.133 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.467 ' N ' ' O ' ' A' ' 24' ' ' GLY . 0.0 OUTLIER -30.27 145.01 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 N-CA-C 112.47 0.544 . . . . 15.0 112.47 -179.068 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -80.28 56.26 2.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.863 -0.608 . . . . 15.0 110.967 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -151.04 -65.38 0.19 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.212 -0.449 . . . . 15.0 110.585 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.09 -47.11 75.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 15.0 110.251 179.57 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 33.7 m -88.07 -170.3 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.923 -0.581 . . . . 15.0 110.567 179.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -95.83 128.49 42.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.933 0.396 . . . . 15.0 111.152 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 25.6 m80 59.47 -83.35 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.947 -0.57 . . . . 15.0 111.464 179.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.407 ' O ' ' O ' ' A' ' 69' ' ' ALA . . . -170.36 30.61 0.14 Allowed Glycine 0 C--N 1.33 0.244 0 C-N-CA 121.056 -0.592 . . . . 15.0 112.026 -179.548 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -89.96 151.88 21.95 Favored Glycine 0 N--CA 1.447 -0.583 0 N-CA-C 110.667 -0.973 . . . . 15.0 110.667 178.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.425 ' CG1' ' HA ' ' A' ' 71' ' ' HIS . 0.0 OUTLIER -94.25 152.6 3.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.546 0.689 . . . . 15.0 112.149 -179.034 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -136.76 108.14 6.88 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.661 -1.154 . . . . 15.0 109.39 179.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.658 HG21 ' N ' ' A' ' 55' ' ' GLY . 0.8 OUTLIER -55.32 152.19 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.123 0.487 . . . . 15.0 111.563 -178.622 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.443 ' O ' ' HG2' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -84.51 -46.33 11.72 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.457 -0.942 . . . . 15.0 108.457 178.088 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.634 ' O ' HG12 ' A' ' 20' ' ' ILE . . . -172.35 173.17 4.23 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 115.75 -0.659 . . . . 15.0 110.448 178.438 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.519 ' HA ' HG12 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -96.96 111.52 27.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 109.519 -0.548 . . . . 15.0 109.519 179.196 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.664 ' HB ' ' O ' ' A' ' 19' ' ' GLY . 0.4 OUTLIER -78.39 117.01 63.7 Favored Pre-proline 0 C--N 1.33 -0.264 0 N-CA-C 113.408 0.892 . . . . 15.0 113.408 -177.306 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.539 ' HA ' ' CG ' ' A' ' 47' ' ' GLU . 27.1 Cg_exo -62.86 59.79 0.15 Allowed 'Trans proline' 0 C--N 1.357 0.989 0 C-N-CA 123.651 2.9 . . . . 15.0 113.001 179.637 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.508 ' H ' ' HG2' ' A' ' 47' ' ' GLU . 3.9 tt0 -147.51 -47.06 0.17 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.582 0.229 . . . . 15.0 111.394 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.592 ' HA3' ' HA3' ' A' ' 19' ' ' GLY . . . -87.82 167.8 36.98 Favored Glycine 0 CA--C 1.518 0.24 0 C-N-CA 120.368 -0.92 . . . . 15.0 113.884 -179.051 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -57.34 -14.45 4.61 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.722 0.638 . . . . 15.0 112.722 -179.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.17 -56.59 5.31 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.662 0.267 . . . . 15.0 110.934 -179.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.561 ' HG3' ' O ' ' A' ' 44' ' ' GLY . 3.0 pp20? -57.45 -42.69 82.98 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.965 -0.561 . . . . 15.0 110.287 179.309 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -53.77 -70.76 0.09 Allowed 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 115.845 -0.616 . . . . 15.0 110.535 -179.433 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.412 ' CB ' HD13 ' A' ' 11' ' ' LEU . 0.1 OUTLIER -58.43 -41.3 84.73 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.154 -0.684 . . . . 15.0 109.154 178.829 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.75 41.2 11.14 Favored Glycine 0 N--CA 1.445 -0.702 0 CA-C-N 115.361 -0.836 . . . . 15.0 111.718 179.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.477 ' HB3' ' CG2' ' A' ' 9' ' ' VAL . 0.5 OUTLIER -79.7 -50.3 10.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.883 0.373 . . . . 15.0 110.655 -179.363 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.408 ' CD1' HD12 ' A' ' 89' ' ' LEU . 7.9 tp -81.04 163.3 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 CA-C-N 116.062 -0.517 . . . . 15.0 110.282 179.439 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . 0.48 ' O ' ' HB2' ' A' ' 56' ' ' ASP . 64.0 m80 -147.37 160.82 42.1 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-O 121.687 0.756 . . . . 15.0 112.252 -179.087 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.511 ' HA ' ' CG2' ' A' ' 37' ' ' VAL . 6.1 mtpt -43.82 134.11 4.55 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.309 -1.314 . . . . 15.0 112.576 -178.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.658 ' N ' HG21 ' A' ' 37' ' ' VAL . . . 49.88 33.12 19.83 Favored Glycine 0 C--N 1.333 0.369 0 CA-C-N 115.914 -0.585 . . . . 15.0 113.589 179.324 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.49 ' HB2' HG12 ' A' ' 37' ' ' VAL . 0.3 OUTLIER -65.93 130.5 43.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 117.16 0.48 . . . . 15.0 110.598 179.38 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.424 ' HA ' ' O ' ' A' ' 35' ' ' ILE . 35.4 ttt180 -82.74 87.91 6.76 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.794 0.331 . . . . 15.0 110.313 179.485 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.473 ' HA ' HD22 ' A' ' 89' ' ' LEU . 2.3 m -79.32 112.45 17.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.148 0.499 . . . . 15.0 111.063 -179.388 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 44.5 mt -107.21 -11.85 15.5 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 115.645 -0.707 . . . . 15.0 112.625 -179.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -151.35 146.41 25.98 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 112.693 0.627 . . . . 15.0 112.693 -178.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.445 ' HB ' ' CG1' ' A' ' 64' ' ' VAL . 40.0 t -139.59 93.53 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.192 -0.913 . . . . 15.0 109.459 178.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.5 m120 69.92 17.68 7.45 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.086 -0.507 . . . . 15.0 109.98 -178.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 107.27 4.72 35.2 Favored Glycine 0 C--N 1.334 0.456 0 CA-C-N 115.841 -0.618 . . . . 15.0 113.482 179.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.515 ' O ' ' CG1' ' A' ' 64' ' ' VAL . 5.1 p -93.72 103.25 14.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.207 0.527 . . . . 15.0 110.645 179.198 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 24.3 m -56.89 133.62 54.74 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.995 -0.548 . . . . 15.0 111.117 -179.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -88.09 -19.35 27.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.036 -0.529 . . . . 15.0 110.935 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -47.47 95.86 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 120.91 0.386 . . . . 15.0 110.897 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.73 65.17 0.57 Allowed Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.783 -0.722 . . . . 15.0 112.271 -179.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.407 ' O ' ' O ' ' A' ' 33' ' ' GLY . . . -172.76 156.89 3.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.94 0.4 . . . . 15.0 110.859 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.426 ' HA ' ' N ' ' A' ' 26' ' ' VAL . 11.3 p -93.07 -171.11 2.59 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.104 0.478 . . . . 15.0 111.336 -179.572 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.557 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 0.4 OUTLIER -59.61 -60.99 2.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.621 -0.718 . . . . 15.0 110.158 179.737 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 20.0 ttpp -52.79 -35.93 57.52 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.519 -0.764 . . . . 15.0 110.806 179.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -59.6 -54.43 46.55 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.298 -0.41 . . . . 15.0 109.935 179.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.435 ' O ' ' N ' ' A' ' 77' ' ' THR . . . -65.17 -43.88 90.32 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.1 -0.5 . . . . 15.0 109.721 178.728 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -43.38 -42.39 1.42 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.223 0 N-CA-C 108.987 -0.745 . . . . 15.0 108.987 178.289 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.402 ' O ' ' HB2' ' A' ' 80' ' ' ASN . 1.8 mt-10 -67.41 -43.28 81.63 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 114.9 -1.046 . . . . 15.0 110.323 178.522 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.435 ' N ' ' O ' ' A' ' 74' ' ' ALA . 70.4 p -63.94 -56.87 12.04 Favored 'General case' 0 N--CA 1.461 0.116 0 CA-C-O 120.615 0.245 . . . . 15.0 111.521 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.41 ' HG ' ' O ' ' A' ' 74' ' ' ALA . 4.0 mt -53.31 -46.86 69.58 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-O 121.118 0.485 . . . . 15.0 110.185 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.5 -58.2 4.67 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.644 -0.707 . . . . 15.0 110.708 179.467 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.402 ' HB2' ' O ' ' A' ' 76' ' ' GLU . 68.7 m-20 -65.85 63.03 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.053 -0.521 . . . . 15.0 111.956 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -92.93 -78.31 0.42 Allowed 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 110.073 -0.343 . . . . 15.0 110.073 179.233 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 122.34 -107.89 1.21 Allowed Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.807 -0.711 . . . . 15.0 112.965 179.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -65.23 -80.23 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.665 0.269 . . . . 15.0 111.415 -179.318 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.434 ' CG1' ' N ' ' A' ' 85' ' ' VAL . 75.9 t -110.19 159.47 9.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.054 0.454 . . . . 15.0 111.179 -179.646 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.458 ' O ' ' CG1' ' A' ' 85' ' ' VAL . 6.4 t -97.9 80.88 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.015 -0.539 . . . . 15.0 110.225 179.528 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 11.2 t60 -97.07 80.39 2.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.846 -0.615 . . . . 15.0 110.403 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.454 ' HB3' ' CD2' ' A' ' 89' ' ' LEU . 0.1 OUTLIER -103.78 120.93 41.98 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.884 -0.598 . . . . 15.0 111.818 -179.118 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.493 HD11 ' CB ' ' A' ' 8' ' ' GLU . 4.0 mp -98.87 101.92 13.48 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.49 -0.559 . . . . 15.0 109.49 178.645 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.473 HD22 ' HA ' ' A' ' 58' ' ' VAL . 0.1 OUTLIER -105.64 -162.37 0.87 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.488 0.661 . . . . 15.0 112.061 -178.334 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.403 ' HB2' ' CD1' ' A' ' 6' ' ' ILE . 2.1 tt0 -140.67 139.39 34.79 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 114.73 -1.123 . . . . 15.0 109.736 179.124 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 2.0 tptp -52.08 105.65 0.12 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.91 0.386 . . . . 15.0 111.069 -179.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.289 0 C-N-CA 120.814 -0.708 . . . . 15.0 112.544 -179.888 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.453 HG13 ' HB2' ' A' ' 90' ' ' GLU . 1.3 mp . . . . . 0 N--CA 1.45 -0.463 0 CA-C-O 120.711 0.291 . . . . 15.0 110.96 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.433 ' O ' ' N ' ' A' ' 89' ' ' LEU . 4.0 p90 -141.05 165.22 28.15 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.298 -0.41 . . . . 15.0 110.555 178.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.473 ' CB ' HD11 ' A' ' 88' ' ' LEU . 9.7 pt-20 -130.15 144.27 51.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.243 0.544 . . . . 15.0 111.543 -179.352 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.429 HG22 ' CG ' ' A' ' 51' ' ' ARG . 0.5 OUTLIER -101.34 114.13 39.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.31 -0.859 . . . . 15.0 109.539 178.948 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -106.03 71.12 0.88 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.152 -0.476 . . . . 15.0 111.922 -178.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.459 ' HB3' ' HB ' ' A' ' 85' ' ' VAL . 7.5 tp -88.28 165.04 15.29 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.08 -0.509 . . . . 15.0 109.914 178.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -95.3 93.29 7.19 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.983 0.421 . . . . 15.0 111.041 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.459 ' HG3' ' HB ' ' A' ' 81' ' ' THR . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 115.913 -0.585 . . . . 15.0 111.033 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.2 mp . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.884 0.373 . . . . 15.0 110.749 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.755 ' O ' ' HB ' ' A' ' 41' ' ' ILE . . . -161.05 45.08 0.4 Allowed Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 121.152 -0.547 . . . . 15.0 111.935 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.692 HG12 ' O ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -112.77 139.69 36.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 120.974 0.416 . . . . 15.0 111.77 -179.549 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 45.0 t -94.98 104.05 15.91 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.084 -1.08 . . . . 15.0 108.084 177.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.479 HG11 ' CG2' ' A' ' 20' ' ' ILE . 10.6 m -93.73 153.9 3.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 113.124 0.787 . . . . 15.0 113.124 -177.037 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.33 -179.66 7.23 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 114.981 -1.009 . . . . 15.0 110.391 179.632 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.448 ' O ' ' CB ' ' A' ' 71' ' ' HIS . . . 76.71 -121.77 6.1 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.562 -0.828 . . . . 15.0 112.563 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.548 ' HA3' ' N ' ' A' ' 71' ' ' HIS . . . 68.2 -66.27 0.37 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.831 -0.699 . . . . 15.0 113.388 179.437 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.456 ' N ' ' HA ' ' A' ' 70' ' ' THR . 1.6 m -28.34 138.76 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 N-CA-C 112.39 0.515 . . . . 15.0 112.39 -179.208 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 10.9 m-80 -76.25 60.08 1.46 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.951 -0.568 . . . . 15.0 111.041 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -151.78 -55.71 0.14 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.331 -0.395 . . . . 15.0 110.956 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.4 m -78.15 -46.23 21.16 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.17 -0.468 . . . . 15.0 111.019 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.426 HG13 ' CD1' ' A' ' 36' ' ' TYR . 21.9 m -71.36 -173.72 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.244 -0.435 . . . . 15.0 111.192 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 6.1 mtp85 -57.34 -54.59 45.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.281 -0.418 . . . . 15.0 111.078 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 48.6 p-80 -151.8 -44.69 0.11 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.363 -0.38 . . . . 15.0 111.174 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -169.59 23.6 0.1 OUTLIER Glycine 0 CA--C 1.518 0.223 0 C-N-CA 120.816 -0.707 . . . . 15.0 112.615 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -93.88 153.93 21.39 Favored Glycine 0 N--CA 1.449 -0.499 0 N-CA-C 110.429 -1.068 . . . . 15.0 110.429 178.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.578 HG13 ' HA ' ' A' ' 71' ' ' HIS . 0.1 OUTLIER -96.67 153.36 3.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 C-N-CA 119.601 -0.84 . . . . 15.0 112.371 -179.078 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.454 ' CE2' ' HG2' ' A' ' 57' ' ' ARG . 32.5 m-85 -135.67 106.96 6.79 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.63 -1.168 . . . . 15.0 109.27 179.289 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.637 HG21 ' N ' ' A' ' 55' ' ' GLY . 0.7 OUTLIER -55.03 149.36 2.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.147 0.499 . . . . 15.0 111.357 -178.554 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.476 ' O ' ' HG2' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -80.16 -50.46 10.25 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.628 -0.879 . . . . 15.0 108.628 178.739 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.692 ' O ' HG12 ' A' ' 20' ' ' ILE . . . -172.3 173.27 4.24 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 115.72 -0.673 . . . . 15.0 110.081 178.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.509 ' HA ' ' CG1' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -96.76 112.8 29.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 108.983 -0.747 . . . . 15.0 108.983 178.778 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.755 ' HB ' ' O ' ' A' ' 19' ' ' GLY . 0.4 OUTLIER -77.96 118.07 69.84 Favored Pre-proline 0 C--N 1.328 -0.338 0 N-CA-C 113.231 0.826 . . . . 15.0 113.231 -176.978 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.532 ' HA ' ' HG2' ' A' ' 47' ' ' GLU . 37.3 Cg_endo -64.88 61.67 0.29 Allowed 'Trans proline' 0 C--N 1.357 0.974 0 C-N-CA 123.457 2.771 . . . . 15.0 112.745 179.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.501 ' H ' ' HG2' ' A' ' 47' ' ' GLU . 4.3 mm-40 -151.51 -46.35 0.11 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.536 -0.302 . . . . 15.0 111.489 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.688 ' HA3' ' HA3' ' A' ' 19' ' ' GLY . . . -87.68 166.87 36.29 Favored Glycine 0 C--N 1.33 0.222 0 C-N-CA 120.312 -0.947 . . . . 15.0 113.618 -179.259 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -56.95 -13.91 3.09 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.616 0.599 . . . . 15.0 112.616 -179.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.04 -57.19 4.48 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.734 0.302 . . . . 15.0 110.782 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.532 ' HG2' ' HA ' ' A' ' 42' ' ' PRO . 2.8 pp20? -57.21 -42.93 82.25 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.19 -0.459 . . . . 15.0 110.397 179.383 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 22.9 t -53.95 -71.47 0.07 Allowed 'General case' 0 CA--C 1.52 -0.176 0 CA-C-N 115.976 -0.556 . . . . 15.0 110.626 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.63 -40.78 84.33 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.391 -0.596 . . . . 15.0 109.391 178.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.93 45.02 7.89 Favored Glycine 0 N--CA 1.446 -0.65 0 CA-C-N 115.393 -0.822 . . . . 15.0 111.67 179.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.429 ' CG ' HG22 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -79.43 -54.36 6.0 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.892 0.377 . . . . 15.0 110.477 -179.325 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.417 ' HA ' HD12 ' A' ' 52' ' ' ILE . 8.3 tp -81.08 164.29 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 CA-C-N 115.991 -0.55 . . . . 15.0 110.362 179.55 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . 0.481 ' O ' HG21 ' A' ' 37' ' ' VAL . 74.5 m80 -146.34 157.13 43.76 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-O 121.659 0.742 . . . . 15.0 112.135 -179.063 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.524 ' HA ' ' CG2' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -44.13 133.52 5.19 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.229 -1.351 . . . . 15.0 112.975 -178.605 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.637 ' N ' HG21 ' A' ' 37' ' ' VAL . . . 49.99 31.28 17.61 Favored Glycine 0 C--N 1.336 0.538 0 CA-C-N 115.809 -0.632 . . . . 15.0 113.268 179.206 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.441 ' OD2' ' N ' ' A' ' 53' ' ' HIS . 5.3 m-20 -65.72 129.31 39.32 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.887 -0.325 . . . . 15.0 110.733 179.691 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.454 ' HG2' ' CE2' ' A' ' 36' ' ' TYR . 50.6 mtt180 -80.74 88.32 5.79 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.233 -0.439 . . . . 15.0 110.313 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.531 ' HA ' HD22 ' A' ' 89' ' ' LEU . 1.4 m -79.45 112.05 17.01 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 CA-C-O 121.158 0.504 . . . . 15.0 111.058 -179.62 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 33.3 mt -107.49 -15.27 14.65 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 115.441 -0.8 . . . . 15.0 112.47 -179.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.411 ' HA ' ' O ' ' A' ' 64' ' ' VAL . . . -149.49 148.28 29.22 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 112.765 0.654 . . . . 15.0 112.765 -178.673 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.433 ' HB ' ' CG1' ' A' ' 64' ' ' VAL . 15.4 t -139.11 99.87 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.263 -0.88 . . . . 15.0 109.083 178.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.0 m120 65.19 16.42 10.54 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.28 -0.418 . . . . 15.0 109.881 -177.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 107.23 4.79 35.29 Favored Glycine 0 C--N 1.336 0.56 0 CA-C-N 115.924 -0.58 . . . . 15.0 113.531 179.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.496 ' O ' ' CG1' ' A' ' 64' ' ' VAL . 5.3 p -93.78 107.46 19.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 117.175 0.488 . . . . 15.0 110.882 179.511 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -56.57 135.6 54.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.211 -0.449 . . . . 15.0 111.163 -179.603 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -97.16 -21.35 17.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.988 -0.551 . . . . 15.0 110.915 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -46.7 98.71 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.399 -0.364 . . . . 15.0 110.93 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.83 63.08 0.54 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.804 -0.713 . . . . 15.0 112.139 -179.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -173.0 143.18 1.14 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.841 0.353 . . . . 15.0 110.865 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.456 ' HA ' ' N ' ' A' ' 26' ' ' VAL . 12.2 p -72.99 -173.16 1.18 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.255 -0.43 . . . . 15.0 111.208 -179.717 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.578 ' HA ' HG13 ' A' ' 35' ' ' ILE . 0.0 OUTLIER -61.93 -59.69 4.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.89 -0.596 . . . . 15.0 110.514 -179.987 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.401 ' O ' ' HG3' ' A' ' 76' ' ' GLU . 20.4 ttmt -52.64 -33.69 48.03 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.849 -0.614 . . . . 15.0 110.632 179.405 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -59.5 -52.66 64.64 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.784 -0.45 . . . . 15.0 109.784 179.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.446 ' O ' ' N ' ' A' ' 77' ' ' THR . . . -66.86 -44.24 81.48 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.704 -0.48 . . . . 15.0 109.704 178.516 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.414 HG22 ' CG2' ' A' ' 22' ' ' VAL . 0.5 OUTLIER -43.01 -40.79 1.08 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.262 0 N-CA-C 109.012 -0.736 . . . . 15.0 109.012 178.412 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.406 ' O ' ' CB ' ' A' ' 80' ' ' ASN . 46.3 mt-10 -67.39 -44.65 78.35 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 114.789 -1.096 . . . . 15.0 110.369 178.533 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.446 ' N ' ' O ' ' A' ' 74' ' ' ALA . 40.9 p -64.14 -54.52 32.5 Favored 'General case' 0 N--CA 1.462 0.151 0 C-N-CA 120.99 -0.284 . . . . 15.0 111.414 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.409 ' HG ' ' O ' ' A' ' 74' ' ' ALA . 5.7 mt -53.56 -47.93 69.61 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-O 121.211 0.529 . . . . 15.0 110.012 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 1.9 ttt-85 -68.35 -59.47 3.16 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.429 -0.805 . . . . 15.0 110.397 179.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.406 ' CB ' ' O ' ' A' ' 76' ' ' GLU . 14.2 m-20 -65.99 62.03 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.933 -0.576 . . . . 15.0 111.94 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.459 ' HB ' ' HG3' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -93.23 -71.36 0.66 Allowed 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 110.043 -0.355 . . . . 15.0 110.043 179.234 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 122.0 -108.02 1.25 Allowed Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.939 -0.648 . . . . 15.0 112.993 179.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . 0.4 ' O ' ' HB3' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -65.17 -79.69 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.917 0.389 . . . . 15.0 111.623 -179.359 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.42 HG13 ' N ' ' A' ' 85' ' ' VAL . 77.6 t -110.21 158.25 10.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.952 -0.567 . . . . 15.0 111.087 -179.319 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.459 ' HB ' ' HB3' ' A' ' 11' ' ' LEU . 6.8 t -97.93 82.35 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.056 -0.52 . . . . 15.0 110.46 179.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -101.91 85.02 2.62 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.793 -0.639 . . . . 15.0 110.379 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.467 ' HB3' ' CD2' ' A' ' 89' ' ' LEU . 0.1 OUTLIER -103.86 122.94 46.19 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.925 -0.58 . . . . 15.0 111.808 -179.136 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.473 HD11 ' CB ' ' A' ' 8' ' ' GLU . 4.4 mp -97.69 101.37 12.86 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.586 -0.524 . . . . 15.0 109.586 178.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.531 HD22 ' HA ' ' A' ' 58' ' ' VAL . 0.1 OUTLIER -105.93 -161.8 0.82 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.456 0.646 . . . . 15.0 111.961 -178.46 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.453 ' HB2' HG13 ' A' ' 6' ' ' ILE . 4.6 tt0 -143.27 133.56 24.59 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 114.948 -1.024 . . . . 15.0 109.77 179.174 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -46.95 106.14 0.08 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.994 0.426 . . . . 15.0 111.174 -179.669 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.318 0 C-N-CA 120.868 -0.682 . . . . 15.0 112.759 -179.663 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.459 HG13 ' HB2' ' A' ' 90' ' ' GLU . 1.2 mp . . . . . 0 N--CA 1.447 -0.593 0 CA-C-O 120.821 0.343 . . . . 15.0 111.034 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.429 ' O ' ' N ' ' A' ' 89' ' ' LEU . 3.4 p90 -140.19 163.87 31.59 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.224 -0.444 . . . . 15.0 110.261 178.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.483 ' HB2' HD11 ' A' ' 88' ' ' LEU . 4.9 pt-20 -130.17 143.24 50.67 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.295 0.569 . . . . 15.0 111.848 -178.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.436 ' CG2' ' HB3' ' A' ' 51' ' ' ARG . 0.2 OUTLIER -101.61 115.34 43.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.23 -0.895 . . . . 15.0 109.696 178.74 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -105.84 72.54 0.96 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.243 -0.435 . . . . 15.0 112.121 -178.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.436 ' HB3' ' HB ' ' A' ' 85' ' ' VAL . 6.3 tp -88.12 165.6 15.0 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.561 -0.533 . . . . 15.0 109.561 178.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -96.13 92.7 6.54 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.993 0.425 . . . . 15.0 111.331 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.528 ' O ' ' HD3' ' A' ' 13' ' ' LYS . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.354 0 CA-C-N 115.892 -0.595 . . . . 15.0 111.061 179.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.426 ' N ' ' CD2' ' A' ' 18' ' ' LEU . 1.4 mm? . . . . . 0 N--CA 1.453 -0.317 0 CA-C-O 120.914 0.388 . . . . 15.0 110.726 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.632 ' O ' ' HB ' ' A' ' 41' ' ' ILE . . . -162.84 33.75 0.31 Allowed Glycine 0 N--CA 1.449 -0.465 0 CA-C-N 115.91 -0.586 . . . . 15.0 111.717 -179.678 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.571 HG12 ' O ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -112.72 139.96 35.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 121.131 0.491 . . . . 15.0 112.033 -179.261 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.446 ' O ' ' HB3' ' A' ' 38' ' ' LYS . 43.2 t -96.33 100.96 12.53 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 107.396 -1.335 . . . . 15.0 107.396 176.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.498 HG23 ' CD2' ' A' ' 71' ' ' HIS . 1.1 m -93.62 153.82 3.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 112.769 0.655 . . . . 15.0 112.769 -176.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.468 ' HA ' ' ND1' ' A' ' 71' ' ' HIS . 11.1 t -149.6 -173.48 4.42 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.223 -0.899 . . . . 15.0 110.369 179.317 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.482 ' O ' ' HB2' ' A' ' 71' ' ' HIS . . . 75.88 -113.94 4.05 Favored Glycine 0 C--N 1.33 0.23 0 C-N-CA 120.517 -0.849 . . . . 15.0 112.347 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.574 ' HA3' ' N ' ' A' ' 71' ' ' HIS . . . 63.59 -65.84 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 121.06 -0.591 . . . . 15.0 113.724 179.175 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.434 ' N ' ' O ' ' A' ' 24' ' ' GLY . 0.0 OUTLIER -26.07 139.55 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 N-CA-C 112.51 0.559 . . . . 15.0 112.51 -179.015 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 17.5 m-20 -75.64 61.21 1.33 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.806 -0.634 . . . . 15.0 111.046 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -151.75 -66.49 0.18 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.317 -0.402 . . . . 15.0 111.095 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.8 m -67.79 -34.26 76.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.129 -0.487 . . . . 15.0 111.061 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.432 HG13 ' CD1' ' A' ' 36' ' ' TYR . 21.0 m -85.67 -174.33 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.302 -0.408 . . . . 15.0 111.171 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 8.9 mtp180 -57.78 -61.26 2.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.251 -0.431 . . . . 15.0 111.033 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 11.0 p-80 -143.25 -45.95 0.29 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.253 -0.43 . . . . 15.0 111.018 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -169.18 25.7 0.11 Allowed Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.901 -0.666 . . . . 15.0 112.491 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -90.9 151.31 21.1 Favored Glycine 0 N--CA 1.447 -0.588 0 N-CA-C 110.519 -1.032 . . . . 15.0 110.519 178.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.439 HG13 ' HA ' ' A' ' 71' ' ' HIS . 0.0 OUTLIER -94.74 152.87 3.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 C-N-CA 119.9 -0.72 . . . . 15.0 112.238 -179.112 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.439 ' CZ ' ' HG2' ' A' ' 57' ' ' ARG . 18.9 m-85 -135.29 107.4 7.17 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.652 -1.158 . . . . 15.0 109.364 179.396 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.656 HG21 ' N ' ' A' ' 55' ' ' GLY . 0.8 OUTLIER -55.14 149.42 2.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 116.102 -0.499 . . . . 15.0 111.462 -178.581 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.454 ' O ' ' HG2' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -81.19 -48.03 12.64 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.668 -0.864 . . . . 15.0 108.668 178.266 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.571 ' O ' HG12 ' A' ' 20' ' ' ILE . . . -172.29 170.77 4.99 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 115.757 -0.656 . . . . 15.0 110.234 178.5 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.508 ' HA ' HG12 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -97.18 111.81 27.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.055 0.455 . . . . 15.0 110.344 179.575 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.632 ' HB ' ' O ' ' A' ' 19' ' ' GLY . 0.4 OUTLIER -78.56 109.14 9.58 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 115.74 -0.663 . . . . 15.0 112.238 -178.428 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.473 ' HA ' ' CG ' ' A' ' 47' ' ' GLU . 30.2 Cg_endo -63.12 65.54 0.16 Allowed 'Trans proline' 0 C--N 1.356 0.944 0 C-N-CA 123.192 2.595 . . . . 15.0 112.591 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 42.2 tt0 -147.44 -53.37 0.21 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.392 -0.822 . . . . 15.0 109.317 179.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.533 ' HA3' ' HA3' ' A' ' 19' ' ' GLY . . . -88.02 157.32 28.21 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.684 -0.769 . . . . 15.0 112.528 179.147 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -41.73 -16.73 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 113.51 0.93 . . . . 15.0 113.51 -179.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.442 ' N ' ' O ' ' A' ' 44' ' ' GLY . . . -71.5 -71.38 0.27 Allowed 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.768 -0.373 . . . . 15.0 111.159 -179.464 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.492 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 4.3 tp10 -58.59 -40.51 83.39 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-O 120.958 0.409 . . . . 15.0 110.312 179.364 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.7 t -55.51 -63.98 0.99 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.976 -0.556 . . . . 15.0 110.278 179.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.419 ' CB ' HD13 ' A' ' 11' ' ' LEU . 5.6 t0 -62.69 -39.08 92.88 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.146 0.498 . . . . 15.0 109.89 179.053 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.55 36.81 18.95 Favored Glycine 0 N--CA 1.448 -0.512 0 CA-C-N 115.58 -0.736 . . . . 15.0 112.651 179.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.436 ' HB3' ' CG2' ' A' ' 9' ' ' VAL . 1.7 mmt85 -83.69 -53.44 5.64 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.928 0.394 . . . . 15.0 110.607 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.455 HG21 ' CG1' ' A' ' 40' ' ' VAL . 11.0 tp -81.15 157.85 4.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.977 -0.556 . . . . 15.0 110.183 179.581 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . 0.434 ' O ' HG21 ' A' ' 37' ' ' VAL . 53.1 m80 -139.75 160.37 40.03 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-O 121.832 0.825 . . . . 15.0 113.097 -178.554 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.561 ' HA ' ' CG2' ' A' ' 37' ' ' VAL . 1.0 OUTLIER -45.28 135.13 6.08 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 113.821 -1.536 . . . . 15.0 112.742 -178.865 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.656 ' N ' HG21 ' A' ' 37' ' ' VAL . . . 49.69 32.75 17.67 Favored Glycine 0 C--N 1.335 0.499 0 CA-C-N 116.031 -0.531 . . . . 15.0 113.116 179.146 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.441 ' HB2' HG12 ' A' ' 37' ' ' VAL . 3.5 m-20 -65.72 130.65 44.02 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.95 -0.3 . . . . 15.0 110.821 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.439 ' HG2' ' CZ ' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -84.4 86.37 7.28 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.11 -0.495 . . . . 15.0 110.345 179.579 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.477 ' HA ' HD22 ' A' ' 89' ' ' LEU . 1.5 m -79.39 113.44 18.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 CA-C-N 116.162 -0.472 . . . . 15.0 111.17 -179.466 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.427 ' CD2' ' CD ' ' A' ' 57' ' ' ARG . 19.2 mt -107.26 -13.06 15.22 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.819 -0.628 . . . . 15.0 112.41 -179.332 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.435 ' CB ' HD22 ' A' ' 88' ' ' LEU . . . -150.62 147.35 27.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.192 0.52 . . . . 15.0 112.313 -178.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.456 ' HB ' ' CG1' ' A' ' 64' ' ' VAL . 60.6 t -138.72 102.88 1.97 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.275 0 CA-C-N 115.484 -0.78 . . . . 15.0 109.047 178.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 64.94 16.32 10.46 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.71 -0.478 . . . . 15.0 109.71 -178.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 105.32 5.17 40.4 Favored Glycine 0 C--N 1.337 0.617 0 CA-C-N 115.82 -0.627 . . . . 15.0 113.23 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.492 ' O ' ' CG1' ' A' ' 64' ' ' VAL . 6.7 p -93.85 107.53 19.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.006 0.432 . . . . 15.0 111.046 179.6 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.2 m -55.8 133.08 50.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.269 -0.423 . . . . 15.0 111.083 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -91.59 -21.68 20.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.001 -0.545 . . . . 15.0 111.026 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -43.85 97.41 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 120.905 0.383 . . . . 15.0 110.978 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.85 64.26 0.56 Allowed Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.866 -0.683 . . . . 15.0 112.058 -179.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -172.98 135.68 0.62 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.895 0.379 . . . . 15.0 110.982 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.423 ' HA ' ' N ' ' A' ' 26' ' ' VAL . 10.2 p -72.9 -171.45 0.87 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.112 0.482 . . . . 15.0 111.31 -179.66 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.574 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 0.4 OUTLIER -58.33 -63.08 1.4 Allowed 'General case' 0 CA--C 1.517 -0.315 0 CA-C-N 115.721 -0.672 . . . . 15.0 109.814 179.812 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 13.5 ttpp -53.23 -36.12 60.71 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.316 -0.856 . . . . 15.0 110.574 179.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 5.8 mt-30 -59.32 -50.75 72.79 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 116.149 -0.478 . . . . 15.0 109.715 179.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.534 ' HA ' ' HG1' ' A' ' 77' ' ' THR . . . -66.96 -47.39 71.75 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.059 -0.519 . . . . 15.0 109.665 178.495 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.416 HG22 HG21 ' A' ' 22' ' ' VAL . 0.5 OUTLIER -40.84 -41.19 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.23 0 CA-C-N 115.522 -0.763 . . . . 15.0 109.472 178.643 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.402 ' O ' ' HB2' ' A' ' 80' ' ' ASN . 14.8 mt-10 -67.18 -46.05 75.1 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 114.884 -1.053 . . . . 15.0 110.781 179.092 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.534 ' HG1' ' HA ' ' A' ' 74' ' ' ALA . 2.5 p -64.6 -53.28 50.17 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 120.79 -0.364 . . . . 15.0 111.529 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.405 ' HA ' HG12 ' A' ' 61' ' ' VAL . 3.8 mt -53.4 -48.41 68.71 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-O 121.185 0.517 . . . . 15.0 110.07 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 4.1 ttt85 -68.46 -57.4 5.89 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.575 -0.739 . . . . 15.0 110.492 179.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.402 ' HB2' ' O ' ' A' ' 76' ' ' GLU . 63.3 m-20 -66.0 62.77 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.879 -0.6 . . . . 15.0 111.948 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.453 ' HB ' ' HG3' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -95.37 -71.71 0.66 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.769 0.318 . . . . 15.0 110.22 179.221 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 122.04 -104.05 0.89 Allowed Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.744 -0.741 . . . . 15.0 113.185 179.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . 0.402 ' O ' ' HB3' ' A' ' 13' ' ' LYS . 0.4 OUTLIER -64.59 -84.49 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 111.975 0.361 . . . . 15.0 111.975 -179.072 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.431 HG13 ' N ' ' A' ' 85' ' ' VAL . 74.1 t -109.65 160.17 8.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.873 0.368 . . . . 15.0 110.897 -179.528 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.436 ' HB ' ' HB3' ' A' ' 11' ' ' LEU . 12.9 t -97.83 81.23 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.118 0.485 . . . . 15.0 110.56 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -101.15 84.69 2.69 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.778 -0.646 . . . . 15.0 110.429 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.45 ' HG ' ' HA ' ' A' ' 61' ' ' VAL . 0.1 OUTLIER -103.19 121.06 41.89 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.06 -0.518 . . . . 15.0 111.743 -179.226 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.483 HD11 ' HB2' ' A' ' 8' ' ' GLU . 0.2 OUTLIER -97.52 101.53 13.08 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.374 -0.602 . . . . 15.0 109.374 178.636 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.477 HD22 ' HA ' ' A' ' 58' ' ' VAL . 0.1 OUTLIER -105.89 -161.89 0.83 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.598 0.713 . . . . 15.0 112.347 -178.451 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.459 ' HB2' HG13 ' A' ' 6' ' ' ILE . 3.4 tt0 -142.17 132.66 25.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 114.609 -1.178 . . . . 15.0 109.059 178.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.54 100.13 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.003 0.43 . . . . 15.0 111.19 -179.393 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.404 0 CA-C-N 115.766 -0.652 . . . . 15.0 112.703 -179.737 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.42 HG13 ' HB2' ' A' ' 90' ' ' GLU . 1.4 mp . . . . . 0 N--CA 1.449 -0.49 0 CA-C-O 120.705 0.288 . . . . 15.0 110.883 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.463 ' O ' ' N ' ' A' ' 89' ' ' LEU . 4.2 p90 -140.61 165.74 26.64 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.378 -0.374 . . . . 15.0 110.446 178.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.477 ' CB ' HD11 ' A' ' 88' ' ' LEU . 10.7 pt-20 -130.11 143.09 50.59 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.295 0.569 . . . . 15.0 111.55 -179.32 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.434 ' CG2' ' HB3' ' A' ' 51' ' ' ARG . 0.2 OUTLIER -101.54 115.44 43.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.203 -0.908 . . . . 15.0 109.548 178.84 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -106.0 72.28 0.94 Allowed 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.193 0.442 . . . . 15.0 112.193 -178.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.412 ' O ' HG11 ' A' ' 84' ' ' VAL . 5.8 tp -88.33 166.55 14.21 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 109.685 -0.487 . . . . 15.0 109.685 178.636 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -95.73 95.31 8.23 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.006 0.431 . . . . 15.0 111.167 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.521 ' O ' ' HD3' ' A' ' 13' ' ' LYS . 0.2 OUTLIER . . . . . 0 C--N 1.327 -0.401 0 CA-C-N 115.803 -0.635 . . . . 15.0 111.225 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.414 ' N ' ' CD2' ' A' ' 18' ' ' LEU . 1.0 OUTLIER . . . . . 0 N--CA 1.453 -0.309 0 CA-C-O 120.931 0.396 . . . . 15.0 110.775 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.726 ' O ' ' HB ' ' A' ' 41' ' ' ILE . . . -162.38 44.1 0.36 Allowed Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.966 -0.635 . . . . 15.0 111.932 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.637 HG12 ' O ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -112.67 140.27 33.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 120.979 0.419 . . . . 15.0 111.622 -179.571 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.409 ' HB3' HD13 ' A' ' 41' ' ' ILE . 15.5 t -94.59 102.41 14.33 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 107.613 -1.255 . . . . 15.0 107.613 177.415 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.486 HG22 ' CD2' ' A' ' 71' ' ' HIS . 3.8 m -93.63 148.95 4.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 113.212 0.819 . . . . 15.0 113.212 -176.629 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.559 ' O ' ' O ' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -149.62 158.02 43.78 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 115.335 -0.848 . . . . 15.0 111.026 179.996 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.431 ' O ' HG12 ' A' ' 35' ' ' ILE . . . 67.7 116.5 0.02 OUTLIER Glycine 0 N--CA 1.453 -0.182 0 C-N-CA 120.589 -0.815 . . . . 15.0 113.421 178.664 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.512 ' HA3' ' N ' ' A' ' 71' ' ' HIS . . . -164.65 -39.05 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.964 -0.636 . . . . 15.0 112.501 179.225 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.474 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 0.2 OUTLIER -39.86 160.09 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-O 120.803 0.335 . . . . 15.0 111.736 179.791 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -85.45 52.18 2.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.314 -0.403 . . . . 15.0 111.024 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -151.8 -63.03 0.17 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.156 -0.475 . . . . 15.0 110.767 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.83 -51.8 51.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.216 -0.447 . . . . 15.0 110.689 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 17.7 m -88.06 -177.8 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.107 -0.497 . . . . 15.0 110.76 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.41 ' O ' ' N ' ' A' ' 33' ' ' GLY . 0.2 OUTLIER -85.48 134.28 34.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.974 0.416 . . . . 15.0 111.062 -179.926 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 54.26 -85.42 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.657 -0.701 . . . . 15.0 111.578 179.635 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 31' ' ' ARG . . . -172.46 31.78 0.12 Allowed Glycine 0 C--N 1.331 0.272 0 C-N-CA 120.977 -0.63 . . . . 15.0 112.196 -179.498 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -95.25 158.67 22.37 Favored Glycine 0 N--CA 1.449 -0.446 0 N-CA-C 110.807 -0.917 . . . . 15.0 110.807 179.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.492 HG22 HD12 ' A' ' 35' ' ' ILE . 0.1 OUTLIER -98.31 154.99 3.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 C-N-CA 119.996 -0.682 . . . . 15.0 111.993 -179.355 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.559 ' O ' ' O ' ' A' ' 23' ' ' THR . 14.1 m-85 -135.16 108.94 8.04 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.365 -0.834 . . . . 15.0 109.767 179.498 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.639 HG21 ' N ' ' A' ' 55' ' ' GLY . 0.8 OUTLIER -54.8 149.54 2.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 121.262 0.553 . . . . 15.0 111.626 -178.45 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.485 ' O ' ' HG2' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -80.17 -47.46 14.67 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.32 -0.992 . . . . 15.0 108.32 178.516 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.637 ' O ' HG12 ' A' ' 20' ' ' ILE . . . -172.51 174.16 3.86 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.349 -0.841 . . . . 15.0 110.114 178.614 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.522 ' HA ' HG12 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -96.81 110.09 24.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 108.938 -0.764 . . . . 15.0 108.938 178.741 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.726 ' HB ' ' O ' ' A' ' 19' ' ' GLY . 0.7 OUTLIER -78.12 116.43 58.75 Favored Pre-proline 0 C--N 1.328 -0.365 0 N-CA-C 113.488 0.922 . . . . 15.0 113.488 -176.916 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.537 ' HA ' ' CG ' ' A' ' 47' ' ' GLU . 39.1 Cg_exo -61.33 61.39 0.1 Allowed 'Trans proline' 0 C--N 1.358 1.074 0 C-N-CA 123.752 2.968 . . . . 15.0 112.969 179.725 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.525 ' H ' ' HG2' ' A' ' 47' ' ' GLU . 2.9 mm-40 -149.83 -48.63 0.13 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.619 0.247 . . . . 15.0 111.554 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.71 ' HA3' ' HA3' ' A' ' 19' ' ' GLY . . . -87.79 168.69 37.95 Favored Glycine 0 CA--C 1.517 0.195 0 C-N-CA 120.362 -0.923 . . . . 15.0 113.905 -179.116 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -57.72 -12.35 2.89 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.549 0.574 . . . . 15.0 112.549 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.78 -58.5 3.41 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.854 0.359 . . . . 15.0 110.435 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.537 ' CG ' ' HA ' ' A' ' 42' ' ' PRO . 2.9 pp20? -57.67 -43.43 85.02 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.686 -0.688 . . . . 15.0 110.473 179.159 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -53.78 -71.31 0.08 Allowed 'General case' 0 CA--C 1.519 -0.225 0 CA-C-N 115.87 -0.604 . . . . 15.0 110.581 -179.398 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.405 ' CB ' HD13 ' A' ' 11' ' ' LEU . 0.7 OUTLIER -58.13 -41.24 83.22 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.141 -0.688 . . . . 15.0 109.141 178.778 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.79 39.57 13.61 Favored Glycine 0 N--CA 1.445 -0.702 0 CA-C-N 115.319 -0.855 . . . . 15.0 111.665 179.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.434 ' HB3' ' CG2' ' A' ' 9' ' ' VAL . 0.8 OUTLIER -79.72 -49.44 12.07 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.873 0.368 . . . . 15.0 110.573 -179.3 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.414 ' CD1' HD12 ' A' ' 89' ' ' LEU . 9.3 tp -81.01 160.6 3.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 116.037 -0.528 . . . . 15.0 110.181 179.411 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . 0.48 ' O ' ' HB2' ' A' ' 56' ' ' ASP . 63.5 m80 -144.31 158.68 43.61 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-O 121.644 0.735 . . . . 15.0 112.146 -179.13 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.522 ' HA ' ' CG2' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -43.81 134.01 4.57 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.437 -1.256 . . . . 15.0 112.607 -178.734 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.639 ' N ' HG21 ' A' ' 37' ' ' VAL . . . 49.98 34.34 23.1 Favored Glycine 0 C--N 1.333 0.394 0 CA-C-N 115.827 -0.624 . . . . 15.0 113.44 179.397 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.49 ' HB2' HG12 ' A' ' 37' ' ' VAL . 0.4 OUTLIER -65.99 130.37 43.01 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.584 -0.446 . . . . 15.0 110.561 179.481 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.427 ' HG3' ' CZ ' ' A' ' 36' ' ' TYR . 39.0 ttt180 -84.58 87.65 7.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.175 -0.466 . . . . 15.0 110.12 179.502 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.466 ' O ' ' CG2' ' A' ' 58' ' ' VAL . 1.5 m -79.26 113.01 18.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 CA-C-O 121.187 0.518 . . . . 15.0 111.032 -179.413 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 23.7 mt -107.34 -11.77 15.48 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 115.424 -0.807 . . . . 15.0 112.304 -179.179 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.401 ' CB ' ' HB2' ' A' ' 88' ' ' LEU . . . -150.81 144.48 25.1 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.165 0.507 . . . . 15.0 112.323 -178.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.438 HG22 HD23 ' A' ' 87' ' ' LEU . 14.8 t -139.24 102.21 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.487 -0.779 . . . . 15.0 109.569 178.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.408 ' ND2' ' CG2' ' A' ' 81' ' ' THR . 1.7 m-80 64.71 15.39 9.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.017 0.437 . . . . 15.0 109.83 -178.377 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 107.15 6.03 34.43 Favored Glycine 0 C--N 1.336 0.554 0 CA-C-N 115.903 -0.589 . . . . 15.0 113.409 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.498 ' O ' ' CG1' ' A' ' 64' ' ' VAL . 6.4 p -93.77 105.41 16.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 117.213 0.506 . . . . 15.0 110.907 179.413 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -58.76 127.91 34.57 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.099 -0.501 . . . . 15.0 110.986 -179.692 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -87.66 -20.01 26.89 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.029 -0.532 . . . . 15.0 110.864 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -47.77 97.91 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.896 0.379 . . . . 15.0 110.768 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.8 64.48 0.56 Allowed Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.738 -0.744 . . . . 15.0 112.022 -179.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.427 ' HB3' ' HB3' ' A' ' 73' ' ' GLN . . . -172.68 166.76 5.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.882 0.373 . . . . 15.0 110.949 -179.655 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.474 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 11.5 p -93.38 -174.42 3.51 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.064 0.459 . . . . 15.0 111.506 -179.461 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.512 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 0.0 OUTLIER -62.95 -60.36 3.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.745 -0.661 . . . . 15.0 110.51 -179.862 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.438 ' O ' ' HG3' ' A' ' 76' ' ' GLU . 8.3 ttpp -52.37 -29.5 24.25 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.88 -0.6 . . . . 15.0 110.343 179.511 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . 0.427 ' HB3' ' HB3' ' A' ' 69' ' ' ALA . 0.4 OUTLIER -59.31 -50.24 74.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.138 -0.483 . . . . 15.0 109.842 179.371 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.47 ' O ' ' N ' ' A' ' 77' ' ' THR . . . -67.09 -47.46 71.16 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 109.597 -0.52 . . . . 15.0 109.597 178.572 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.415 HG22 ' CG2' ' A' ' 22' ' ' VAL . 0.5 OUTLIER -41.44 -41.05 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.251 0 N-CA-C 108.95 -0.759 . . . . 15.0 108.95 178.202 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.45 ' O ' ' N ' ' A' ' 80' ' ' ASN . 62.0 mt-10 -67.64 -46.49 72.33 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 114.711 -1.131 . . . . 15.0 110.317 178.434 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.47 ' N ' ' O ' ' A' ' 74' ' ' ALA . 32.6 p -64.34 -51.4 63.59 Favored 'General case' 0 C--O 1.231 0.119 0 C-N-CA 120.851 -0.34 . . . . 15.0 111.193 179.708 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.449 ' HG ' ' O ' ' A' ' 74' ' ' ALA . 5.3 mt -53.67 -50.55 65.57 Favored 'General case' 0 CA--C 1.521 -0.168 0 CA-C-O 121.249 0.547 . . . . 15.0 109.801 179.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 21.8 ttt180 -68.46 -61.9 1.63 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.31 -0.859 . . . . 15.0 110.472 179.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.45 ' N ' ' O ' ' A' ' 76' ' ' GLU . 9.5 m-20 -66.04 61.68 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.878 -0.601 . . . . 15.0 111.997 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.423 ' HB ' ' HG3' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -94.16 -67.18 0.87 Allowed 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 110.062 -0.348 . . . . 15.0 110.062 179.193 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 122.28 -108.96 1.34 Allowed Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.864 -0.684 . . . . 15.0 113.118 179.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -65.39 -79.17 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.772 0.32 . . . . 15.0 111.696 -179.157 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.429 HG13 ' N ' ' A' ' 85' ' ' VAL . 63.8 t -109.94 159.2 9.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.023 0.44 . . . . 15.0 111.034 -179.337 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.44 ' O ' ' CG1' ' A' ' 85' ' ' VAL . 9.4 t -97.86 81.26 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.095 -0.502 . . . . 15.0 110.402 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -100.78 85.0 2.8 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.748 -0.66 . . . . 15.0 110.28 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.454 ' CD2' ' CD2' ' A' ' 89' ' ' LEU . 0.1 OUTLIER -103.32 119.61 39.21 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.009 -0.541 . . . . 15.0 111.893 -179.003 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.477 HD11 ' CB ' ' A' ' 8' ' ' GLU . 4.6 mp -94.59 101.64 13.52 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.451 -0.574 . . . . 15.0 109.451 178.564 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.463 ' N ' ' O ' ' A' ' 7' ' ' PHE . 0.2 OUTLIER -105.64 -163.48 0.94 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.346 0.594 . . . . 15.0 111.982 -178.55 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.42 ' HB2' HG13 ' A' ' 6' ' ' ILE . 2.6 tt0 -140.97 131.77 25.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.01 -0.996 . . . . 15.0 109.796 179.143 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.62 94.92 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.863 0.363 . . . . 15.0 111.122 -179.63 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.357 0 C-N-CA 120.945 -0.645 . . . . 15.0 112.729 -179.73 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.472 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 1.4 mp . . . . . 0 N--CA 1.452 -0.373 0 CA-C-O 120.984 0.421 . . . . 15.0 111.529 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.427 ' O ' ' N ' ' A' ' 89' ' ' LEU . 7.6 p90 -144.71 164.22 31.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.913 -0.585 . . . . 15.0 110.048 178.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.472 ' HB2' HD11 ' A' ' 88' ' ' LEU . 5.6 pt-20 -130.26 142.54 50.55 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.369 0.604 . . . . 15.0 111.907 -179.289 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.431 ' CG2' ' HB3' ' A' ' 51' ' ' ARG . 0.2 OUTLIER -101.65 114.4 40.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.117 -0.947 . . . . 15.0 109.638 178.85 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -106.15 72.74 0.95 Allowed 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 112.351 0.501 . . . . 15.0 112.351 -178.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.446 ' CD1' ' HG3' ' A' ' 51' ' ' ARG . 6.0 tp -88.36 165.91 14.63 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.668 -0.493 . . . . 15.0 109.668 178.609 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -96.15 94.43 7.52 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.003 0.43 . . . . 15.0 111.149 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.485 ' HG3' ' HB ' ' A' ' 81' ' ' THR . 0.1 OUTLIER . . . . . 0 C--N 1.327 -0.404 0 CA-C-N 115.764 -0.653 . . . . 15.0 111.315 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.426 ' N ' ' CD2' ' A' ' 18' ' ' LEU . 0.4 OUTLIER . . . . . 0 N--CA 1.456 -0.173 0 CA-C-O 120.813 0.34 . . . . 15.0 110.689 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.767 ' O ' ' HB ' ' A' ' 41' ' ' ILE . . . -173.2 44.68 0.16 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.921 -0.657 . . . . 15.0 111.913 -179.747 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.718 HG12 ' O ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -112.61 137.29 46.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 120.996 0.427 . . . . 15.0 111.579 -179.611 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.404 ' HB3' HD13 ' A' ' 41' ' ' ILE . 29.1 t -88.86 105.5 17.78 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 107.865 -1.161 . . . . 15.0 107.865 177.516 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.447 HG11 ' CG2' ' A' ' 20' ' ' ILE . 34.8 m -93.37 152.5 3.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 112.618 0.599 . . . . 15.0 112.618 -177.155 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.424 ' OG1' ' CB ' ' A' ' 38' ' ' LYS . 0.8 OUTLIER -149.14 -178.62 6.48 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.245 -0.889 . . . . 15.0 110.807 -179.565 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.403 ' O ' ' HB3' ' A' ' 71' ' ' HIS . . . 70.16 -119.36 8.67 Favored Glycine 0 C--N 1.333 0.372 0 C-N-CA 120.856 -0.688 . . . . 15.0 112.421 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.51 ' HA3' ' N ' ' A' ' 71' ' ' HIS . . . 66.61 -65.62 0.17 Allowed Glycine 0 C--N 1.331 0.259 0 C-N-CA 121.013 -0.613 . . . . 15.0 113.61 179.402 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.447 ' HA ' ' CB ' ' A' ' 70' ' ' THR . 0.0 OUTLIER -28.14 140.33 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 N-CA-C 112.457 0.54 . . . . 15.0 112.457 -179.353 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.408 ' HA ' ' O ' ' A' ' 32' ' ' HIS . 59.5 t-20 -77.33 58.07 1.59 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.904 -0.589 . . . . 15.0 111.075 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.0 m -151.83 -48.28 0.11 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.283 -0.417 . . . . 15.0 110.935 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 21.6 m -83.2 -46.68 12.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 15.0 111.053 -179.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.427 HG13 ' CD1' ' A' ' 36' ' ' TYR . 33.2 m -69.95 -174.62 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.262 -0.426 . . . . 15.0 111.169 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 10.0 mmp_? -67.59 -44.85 77.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.242 -0.436 . . . . 15.0 111.052 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . 0.408 ' O ' ' HA ' ' A' ' 27' ' ' ASN . 43.3 m80 -143.28 -68.41 0.34 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.306 -0.406 . . . . 15.0 111.004 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -161.43 19.52 0.19 Allowed Glycine 0 CA--C 1.517 0.189 0 C-N-CA 120.892 -0.671 . . . . 15.0 112.559 -179.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -83.64 150.67 27.06 Favored Glycine 0 N--CA 1.449 -0.493 0 N-CA-C 110.767 -0.933 . . . . 15.0 110.767 178.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.48 HG21 HG22 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -85.79 154.94 3.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 C-N-CA 120.031 -0.667 . . . . 15.0 111.745 -179.294 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.509 ' CE2' ' HG2' ' A' ' 57' ' ' ARG . 30.4 m-85 -139.2 106.8 5.59 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.041 -0.981 . . . . 15.0 109.736 178.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.651 HG21 ' N ' ' A' ' 55' ' ' GLY . 0.7 OUTLIER -55.17 146.11 4.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 116.041 -0.527 . . . . 15.0 111.025 -179.072 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.458 ' HG3' ' N ' ' A' ' 39' ' ' ALA . 0.2 OUTLIER -80.23 -46.24 16.61 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.502 -0.925 . . . . 15.0 108.502 178.616 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.718 ' O ' HG12 ' A' ' 20' ' ' ILE . . . -172.07 171.45 4.97 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 115.764 -0.653 . . . . 15.0 110.242 178.471 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.536 ' HA ' ' CG1' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -96.63 109.49 23.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 109.118 -0.697 . . . . 15.0 109.118 179.135 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.767 ' HB ' ' O ' ' A' ' 19' ' ' GLY . 0.5 OUTLIER -78.16 118.31 71.43 Favored Pre-proline 0 C--N 1.326 -0.44 0 N-CA-C 113.261 0.837 . . . . 15.0 113.261 -177.106 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.555 ' HA ' ' CG ' ' A' ' 47' ' ' GLU . 36.9 Cg_endo -64.71 60.46 0.28 Allowed 'Trans proline' 0 C--N 1.357 0.992 0 C-N-CA 123.539 2.826 . . . . 15.0 112.793 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.499 ' N ' ' HG2' ' A' ' 47' ' ' GLU . 11.2 tt0 -147.41 -46.75 0.17 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.52 -0.309 . . . . 15.0 111.244 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.757 ' HA3' ' HA3' ' A' ' 19' ' ' GLY . . . -87.87 169.33 38.53 Favored Glycine 0 C--N 1.33 0.229 0 C-N-CA 120.36 -0.924 . . . . 15.0 113.851 -179.285 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -59.36 -13.3 7.81 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.465 0.542 . . . . 15.0 112.465 -179.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.94 -56.15 6.2 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.934 -0.306 . . . . 15.0 110.578 -179.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.585 ' HG3' ' O ' ' A' ' 44' ' ' GLY . 2.8 pp20? -57.61 -43.89 85.08 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 115.988 -0.551 . . . . 15.0 110.354 179.001 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 50.1 m -53.84 -70.55 0.09 Allowed 'General case' 0 CA--C 1.519 -0.225 0 CA-C-N 115.825 -0.625 . . . . 15.0 110.583 -179.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -58.1 -41.24 83.08 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.058 -0.719 . . . . 15.0 109.058 178.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.63 39.06 15.07 Favored Glycine 0 N--CA 1.446 -0.672 0 CA-C-N 115.295 -0.866 . . . . 15.0 111.771 179.285 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.446 ' HG3' ' CD1' ' A' ' 11' ' ' LEU . 0.5 OUTLIER -79.67 -51.05 9.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.976 0.417 . . . . 15.0 110.571 -179.388 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.423 ' CD1' HD12 ' A' ' 89' ' ' LEU . 10.8 tp -81.12 158.36 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 CA-C-N 115.93 -0.577 . . . . 15.0 110.106 179.465 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . 0.472 ' O ' HG21 ' A' ' 37' ' ' VAL . 80.4 m80 -145.54 159.27 43.36 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-O 121.591 0.71 . . . . 15.0 112.36 -178.812 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.535 ' HA ' ' CG2' ' A' ' 37' ' ' VAL . 5.0 mtpt -42.13 132.63 3.24 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.213 -1.358 . . . . 15.0 113.01 -178.595 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.651 ' N ' HG21 ' A' ' 37' ' ' VAL . . . 49.9 31.28 16.9 Favored Glycine 0 C--N 1.334 0.455 0 CA-C-N 115.697 -0.683 . . . . 15.0 113.279 179.187 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.453 ' OD2' ' N ' ' A' ' 53' ' ' HIS . 6.2 m-20 -65.7 129.39 39.6 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.726 -0.39 . . . . 15.0 110.526 179.531 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.509 ' HG2' ' CE2' ' A' ' 36' ' ' TYR . 0.5 OUTLIER -82.57 95.96 7.92 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.222 -0.445 . . . . 15.0 110.677 -179.921 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.48 HG22 HG21 ' A' ' 35' ' ' ILE . 1.4 m -86.63 117.06 30.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 CA-C-O 120.927 0.394 . . . . 15.0 110.873 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.405 ' CD2' ' N ' ' A' ' 59' ' ' LEU . 3.1 mm? -107.0 -17.0 14.3 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.915 -0.584 . . . . 15.0 112.482 -179.064 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.432 ' CB ' HD22 ' A' ' 88' ' ' LEU . . . -149.05 148.73 30.05 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.199 0.524 . . . . 15.0 112.411 -178.83 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.437 ' HA ' ' HG ' ' A' ' 87' ' ' LEU . 17.5 t -139.13 101.36 1.55 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.26 0 CA-C-N 115.446 -0.797 . . . . 15.0 109.409 178.853 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.405 ' ND2' ' CG2' ' A' ' 81' ' ' THR . 1.6 m-80 64.79 15.5 9.86 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.658 -0.497 . . . . 15.0 109.658 -178.066 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 107.06 4.82 35.66 Favored Glycine 0 C--N 1.337 0.613 0 CA-C-N 115.832 -0.622 . . . . 15.0 113.331 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.497 ' O ' ' CG1' ' A' ' 64' ' ' VAL . 4.5 p -93.87 107.83 19.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.022 0.439 . . . . 15.0 110.886 179.487 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 67.2 m -56.5 133.7 53.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.21 -0.45 . . . . 15.0 111.079 -179.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.76 -26.23 16.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.016 -0.538 . . . . 15.0 110.902 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 14.3 tt0 -46.03 104.12 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.308 -0.406 . . . . 15.0 111.048 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.75 60.13 0.54 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.79 -0.719 . . . . 15.0 112.464 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -173.04 166.94 5.02 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.959 0.409 . . . . 15.0 111.148 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.447 ' CB ' ' HA ' ' A' ' 26' ' ' VAL . 9.1 p -93.18 -172.3 2.92 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.125 -0.489 . . . . 15.0 111.053 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.51 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 0.0 OUTLIER -63.86 -58.91 5.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.787 -0.642 . . . . 15.0 110.583 179.868 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.43 ' O ' ' HG3' ' A' ' 76' ' ' GLU . 18.0 ttpp -52.59 -34.06 48.95 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.003 -0.544 . . . . 15.0 110.557 179.396 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 9.5 mt-30 -59.36 -49.35 78.16 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.613 -0.514 . . . . 15.0 109.613 179.241 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.441 ' O ' ' N ' ' A' ' 77' ' ' THR . . . -67.06 -44.75 79.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.932 -0.577 . . . . 15.0 109.512 178.431 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.433 ' CG2' ' CG2' ' A' ' 22' ' ' VAL . 0.5 OUTLIER -43.96 -40.88 1.63 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.27 0 N-CA-C 108.797 -0.816 . . . . 15.0 108.797 178.202 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.43 ' HG3' ' O ' ' A' ' 72' ' ' LYS . 9.0 mt-10 -67.42 -44.08 79.64 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 114.744 -1.117 . . . . 15.0 110.19 178.462 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.441 ' N ' ' O ' ' A' ' 74' ' ' ALA . 42.5 p -64.13 -55.48 21.65 Favored 'General case' 0 C--O 1.231 0.131 0 C-N-CA 121.056 -0.258 . . . . 15.0 111.509 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.427 ' CD2' HG21 ' A' ' 61' ' ' VAL . 4.6 mt -53.38 -47.26 69.64 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 121.127 0.489 . . . . 15.0 109.9 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.53 -59.49 3.11 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.518 -0.765 . . . . 15.0 110.529 179.29 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 68.5 m-20 -66.06 60.27 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.931 -0.577 . . . . 15.0 112.154 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.485 ' HB ' ' HG3' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -95.76 -73.02 0.61 Allowed 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 110.127 -0.323 . . . . 15.0 110.127 179.1 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 122.01 -103.71 0.87 Allowed Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.702 -0.761 . . . . 15.0 113.439 179.029 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -64.53 -84.43 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 111.965 0.357 . . . . 15.0 111.965 -178.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.432 HG13 ' N ' ' A' ' 85' ' ' VAL . 69.9 t -109.72 160.02 8.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.946 0.403 . . . . 15.0 110.873 -179.398 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.436 ' O ' ' CG1' ' A' ' 85' ' ' VAL . 8.7 t -97.81 81.65 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.156 0.503 . . . . 15.0 110.457 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 20.5 t60 -101.13 83.87 2.56 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.72 -0.673 . . . . 15.0 110.33 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.458 ' CD2' ' CD2' ' A' ' 89' ' ' LEU . 0.1 OUTLIER -103.85 115.58 30.72 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.921 -0.581 . . . . 15.0 111.873 -179.115 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.472 HD11 ' HB2' ' A' ' 8' ' ' GLU . 0.2 OUTLIER -92.15 100.49 13.1 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.327 -0.62 . . . . 15.0 109.327 178.573 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.458 ' CD2' ' CD2' ' A' ' 87' ' ' LEU . 0.1 OUTLIER -104.04 -159.46 0.72 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.26 0.553 . . . . 15.0 111.725 -178.658 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.472 ' HA ' ' HA ' ' A' ' 6' ' ' ILE . 5.3 tt0 -140.57 143.7 35.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.35 -0.841 . . . . 15.0 110.32 179.322 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 7.9 tppt? -55.48 105.89 0.21 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.227 -0.442 . . . . 15.0 110.954 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.336 0 C-N-CA 120.869 -0.681 . . . . 15.0 112.616 -179.899 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.43 HG13 ' HB2' ' A' ' 90' ' ' GLU . 1.3 mp . . . . . 0 N--CA 1.451 -0.379 0 CA-C-O 120.829 0.347 . . . . 15.0 110.944 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.446 ' O ' ' N ' ' A' ' 89' ' ' LEU . 2.9 p90 -140.82 164.96 28.82 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.214 -0.448 . . . . 15.0 110.415 178.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.469 ' HB2' HD11 ' A' ' 88' ' ' LEU . 1.9 pt-20 -130.17 143.85 51.02 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.234 0.54 . . . . 15.0 111.6 -179.438 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.474 ' N ' ' O ' ' A' ' 87' ' ' LEU . 0.3 OUTLIER -101.26 114.52 40.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.277 -0.874 . . . . 15.0 109.706 179.111 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -106.04 69.88 0.83 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.076 -0.511 . . . . 15.0 111.772 -179.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.455 ' HB3' ' HB ' ' A' ' 85' ' ' VAL . 8.5 tp -88.19 161.89 16.99 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.006 -0.543 . . . . 15.0 110.316 179.223 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -96.69 98.6 10.3 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.537 -0.301 . . . . 15.0 111.151 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.424 ' HB3' ' O ' ' A' ' 83' ' ' GLN . 0.3 OUTLIER . . . . . 0 CA--C 1.533 0.312 0 N-CA-C 112.706 0.632 . . . . 15.0 112.706 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.5 mm? . . . . . 0 N--CA 1.453 -0.312 0 CA-C-O 120.986 0.422 . . . . 15.0 110.74 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.685 ' O ' ' HB ' ' A' ' 41' ' ' ILE . . . -160.8 40.07 0.43 Allowed Glycine 0 N--CA 1.448 -0.532 0 N-CA-C 111.439 -0.664 . . . . 15.0 111.439 -179.818 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.649 HG12 ' O ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -112.7 139.08 39.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 120.907 0.384 . . . . 15.0 111.876 -179.227 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.402 ' HB3' HD13 ' A' ' 41' ' ' ILE . 30.3 t -96.03 104.96 16.93 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 107.924 -1.139 . . . . 15.0 107.924 177.371 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.472 HG22 ' CD2' ' A' ' 71' ' ' HIS . 32.6 m -93.63 156.84 3.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 113.09 0.774 . . . . 15.0 113.09 -177.091 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.31 -175.03 4.83 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.128 -0.942 . . . . 15.0 110.703 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.422 ' O ' ' HB3' ' A' ' 71' ' ' HIS . . . 68.71 -119.52 10.09 Favored Glycine 0 C--N 1.332 0.309 0 C-N-CA 120.831 -0.699 . . . . 15.0 112.542 179.794 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.519 ' HA3' ' N ' ' A' ' 71' ' ' HIS . . . 67.1 -66.65 0.21 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.922 -0.656 . . . . 15.0 113.336 179.563 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -32.62 142.48 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 N-CA-C 112.063 0.394 . . . . 15.0 112.063 -179.492 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -75.63 59.6 1.17 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.065 -0.516 . . . . 15.0 110.857 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.5 m -151.6 -66.3 0.18 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.231 -0.44 . . . . 15.0 110.566 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 29.5 t -65.44 -51.25 61.51 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.111 -0.495 . . . . 15.0 110.424 179.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 27.0 m -88.07 -175.35 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.02 -0.536 . . . . 15.0 110.689 179.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 38.1 ttm180 -90.4 137.63 32.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.969 0.414 . . . . 15.0 111.096 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 42.1 m170 55.53 -86.36 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.756 -0.656 . . . . 15.0 111.345 179.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.411 ' O ' ' O ' ' A' ' 69' ' ' ALA . . . -171.94 27.79 0.1 OUTLIER Glycine 0 C--N 1.33 0.24 0 C-N-CA 120.922 -0.656 . . . . 15.0 112.48 -179.709 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -81.7 151.79 31.13 Favored Glycine 0 N--CA 1.451 -0.363 0 N-CA-C 110.857 -0.897 . . . . 15.0 110.857 179.029 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.47 HG21 HG22 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -88.94 154.1 3.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 119.99 -0.684 . . . . 15.0 111.704 -179.346 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.466 ' CZ ' ' HG2' ' A' ' 57' ' ' ARG . 29.4 m-85 -141.73 107.52 5.13 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.154 -0.93 . . . . 15.0 110.008 179.114 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.652 HG21 ' N ' ' A' ' 55' ' ' GLY . 0.7 OUTLIER -55.81 153.16 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.191 0.52 . . . . 15.0 111.295 -179.131 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.504 ' O ' ' HG2' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -85.72 -48.33 8.93 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.379 -0.971 . . . . 15.0 108.379 178.33 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.649 ' O ' HG12 ' A' ' 20' ' ' ILE . . . -172.39 173.78 4.04 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 115.354 -0.839 . . . . 15.0 110.145 178.722 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.575 ' HA ' HG12 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -96.97 112.16 28.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 109.436 -0.579 . . . . 15.0 109.436 179.125 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.685 ' HB ' ' O ' ' A' ' 19' ' ' GLY . 0.4 OUTLIER -78.36 118.72 73.96 Favored Pre-proline 0 C--N 1.329 -0.298 0 N-CA-C 113.349 0.87 . . . . 15.0 113.349 -177.245 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.534 ' HA ' ' HG2' ' A' ' 47' ' ' GLU . 36.9 Cg_endo -64.36 61.66 0.25 Allowed 'Trans proline' 0 C--N 1.357 0.998 0 C-N-CA 123.509 2.806 . . . . 15.0 112.918 179.706 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.515 ' H ' ' HG2' ' A' ' 47' ' ' GLU . 2.2 mm-40 -150.8 -46.6 0.12 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.611 -0.268 . . . . 15.0 111.618 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.627 ' HA3' ' HA3' ' A' ' 19' ' ' GLY . . . -87.82 166.65 35.89 Favored Glycine 0 C--N 1.331 0.268 0 C-N-CA 120.311 -0.947 . . . . 15.0 113.879 -179.142 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -55.96 -14.83 2.76 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.703 0.631 . . . . 15.0 112.703 -179.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.16 -57.5 4.2 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.707 0.289 . . . . 15.0 111.109 -179.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.534 ' HG2' ' HA ' ' A' ' 42' ' ' PRO . 2.9 pp20? -57.11 -41.91 79.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 15.0 110.478 179.545 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 40.1 t -53.7 -70.37 0.1 Allowed 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 115.896 -0.593 . . . . 15.0 110.668 -179.508 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -61.1 -39.57 90.48 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.219 0.533 . . . . 15.0 109.575 179.049 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.01 44.21 8.32 Favored Glycine 0 N--CA 1.447 -0.599 0 CA-C-N 115.439 -0.801 . . . . 15.0 111.835 179.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.445 ' CG ' HG22 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -79.5 -53.4 6.91 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.962 0.411 . . . . 15.0 110.647 -179.397 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.41 ' HA ' HD12 ' A' ' 52' ' ' ILE . 10.3 tp -81.08 163.1 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 CA-C-N 115.936 -0.575 . . . . 15.0 110.442 179.695 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . 0.46 ' O ' HG21 ' A' ' 37' ' ' VAL . 42.3 m80 -146.57 158.82 43.97 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-O 121.606 0.717 . . . . 15.0 112.126 -179.072 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.53 ' HA ' ' CG2' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -43.15 133.33 3.95 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.246 -1.343 . . . . 15.0 112.928 -178.58 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.652 ' N ' HG21 ' A' ' 37' ' ' VAL . . . 49.84 32.14 17.83 Favored Glycine 0 C--N 1.336 0.545 0 CA-C-N 115.841 -0.618 . . . . 15.0 113.053 179.275 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.444 ' HB2' HG12 ' A' ' 37' ' ' VAL . 4.6 m-20 -65.47 124.75 23.11 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.706 -0.397 . . . . 15.0 110.216 179.498 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.466 ' HG2' ' CZ ' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -81.82 92.85 6.74 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.203 -0.453 . . . . 15.0 110.505 -179.959 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.487 ' HA ' HD22 ' A' ' 89' ' ' LEU . 1.3 m -84.76 120.85 36.04 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 CA-C-N 116.195 -0.457 . . . . 15.0 111.383 -179.372 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -107.24 -20.88 13.15 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 115.73 -0.668 . . . . 15.0 112.455 -179.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.409 ' CB ' HD22 ' A' ' 88' ' ' LEU . . . -147.75 153.74 39.64 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.33 0.586 . . . . 15.0 112.569 -178.585 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.451 HG12 ' HA ' ' A' ' 78' ' ' LEU . 25.9 t -138.97 99.56 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.331 0 CA-C-N 115.231 -0.895 . . . . 15.0 109.048 178.788 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.404 ' HB2' ' O ' ' A' ' 61' ' ' VAL . 1.6 m-80 65.37 16.36 10.49 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.535 -0.543 . . . . 15.0 109.535 -177.806 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 107.07 5.59 35.02 Favored Glycine 0 C--N 1.337 0.633 0 CA-C-N 115.689 -0.687 . . . . 15.0 113.63 179.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.505 ' O ' ' CG1' ' A' ' 64' ' ' VAL . 5.9 p -93.88 105.34 16.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 117.339 0.57 . . . . 15.0 110.809 179.306 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -55.58 130.73 44.13 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.053 -0.521 . . . . 15.0 111.11 -179.57 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -97.76 -24.16 15.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.97 -0.559 . . . . 15.0 111.036 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -45.41 106.23 0.07 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.426 -0.352 . . . . 15.0 110.999 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.85 58.95 0.53 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.785 -0.721 . . . . 15.0 112.289 -179.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.411 ' O ' ' O ' ' A' ' 33' ' ' GLY . . . -172.98 171.75 4.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.848 0.356 . . . . 15.0 110.945 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 13.5 p -93.37 -172.64 2.99 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.092 0.472 . . . . 15.0 111.376 -179.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.519 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 0.0 OUTLIER -64.24 -59.58 4.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.654 -0.703 . . . . 15.0 110.668 -179.975 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.409 ' O ' ' HG3' ' A' ' 76' ' ' GLU . 29.9 ttpt -52.44 -32.78 41.13 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.895 -0.593 . . . . 15.0 110.643 179.777 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 10.4 mt-30 -59.45 -51.76 68.49 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.542 -0.54 . . . . 15.0 109.542 179.264 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.442 ' O ' ' N ' ' A' ' 77' ' ' THR . . . -67.23 -44.49 79.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.008 -0.542 . . . . 15.0 110.033 178.511 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.451 ' CG2' ' CG2' ' A' ' 22' ' ' VAL . 0.5 OUTLIER -41.9 -41.76 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.239 0 N-CA-C 109.249 -0.649 . . . . 15.0 109.249 178.688 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.47 ' O ' ' HB2' ' A' ' 80' ' ' ASN . 54.0 mt-10 -67.3 -44.88 78.12 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 114.882 -1.054 . . . . 15.0 110.453 178.639 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.442 ' N ' ' O ' ' A' ' 74' ' ' ALA . 37.2 p -64.05 -55.1 24.64 Favored 'General case' 0 N--CA 1.461 0.122 0 C-N-CA 121.159 -0.216 . . . . 15.0 111.555 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.451 ' HA ' HG12 ' A' ' 61' ' ' VAL . 6.5 mt -53.31 -45.98 69.23 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-O 121.237 0.542 . . . . 15.0 109.997 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.35 -58.91 3.65 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.334 -0.848 . . . . 15.0 110.643 179.493 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.47 ' HB2' ' O ' ' A' ' 76' ' ' GLU . 11.2 m-80 -66.08 62.71 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.074 -0.512 . . . . 15.0 111.928 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -92.74 -76.26 0.47 Allowed 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 110.155 -0.313 . . . . 15.0 110.155 179.284 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 122.2 -105.17 0.95 Allowed Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.728 -0.749 . . . . 15.0 113.052 179.165 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . 0.424 ' O ' ' HB3' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -64.87 -84.07 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.753 0.311 . . . . 15.0 111.209 -179.42 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 79.0 t -110.17 158.61 10.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.021 0.439 . . . . 15.0 111.083 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.455 ' HB ' ' HB3' ' A' ' 11' ' ' LEU . 3.3 t -97.68 83.15 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.176 0.513 . . . . 15.0 110.213 179.68 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -100.09 82.08 2.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.736 -0.666 . . . . 15.0 110.242 179.778 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.474 ' O ' ' N ' ' A' ' 9' ' ' VAL . 0.1 OUTLIER -103.98 127.04 51.52 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.914 -0.584 . . . . 15.0 111.85 -179.022 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.469 HD11 ' HB2' ' A' ' 8' ' ' GLU . 0.2 OUTLIER -102.17 100.54 10.76 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.292 -0.633 . . . . 15.0 109.292 178.433 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.487 HD22 ' HA ' ' A' ' 58' ' ' VAL . 0.1 OUTLIER -104.85 -161.49 0.82 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.405 0.621 . . . . 15.0 111.795 -178.582 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.43 ' HB2' HG13 ' A' ' 6' ' ' ILE . 3.2 tt0 -141.5 135.55 30.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.064 -0.971 . . . . 15.0 109.876 179.232 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.1 105.56 0.07 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.951 0.405 . . . . 15.0 111.169 -179.663 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.342 0 C-N-CA 120.938 -0.648 . . . . 15.0 112.641 -179.794 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.458 HG13 ' HB2' ' A' ' 90' ' ' GLU . 1.4 mp . . . . . 0 N--CA 1.45 -0.438 0 CA-C-O 120.799 0.333 . . . . 15.0 111.097 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.426 ' O ' ' N ' ' A' ' 89' ' ' LEU . 3.0 p90 -140.65 166.37 24.93 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.274 -0.421 . . . . 15.0 110.569 178.647 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.494 ' CB ' HD11 ' A' ' 88' ' ' LEU . 9.5 pt-20 -129.43 143.87 51.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.196 0.522 . . . . 15.0 111.432 -179.336 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.447 ' N ' ' O ' ' A' ' 87' ' ' LEU . 0.3 OUTLIER -101.37 117.26 46.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.424 -0.807 . . . . 15.0 109.382 178.82 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 55.1 tt0 -105.97 75.71 1.13 Allowed 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.456 0.539 . . . . 15.0 112.456 -178.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.579 ' HB3' ' HB ' ' A' ' 85' ' ' VAL . 6.4 tp -87.93 161.21 17.58 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.24 -0.652 . . . . 15.0 109.24 178.179 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -96.8 94.55 7.32 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 120.816 -0.354 . . . . 15.0 111.819 -179.516 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.454 ' HB3' ' O ' ' A' ' 83' ' ' GLN . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.319 0 CA-C-O 121.334 0.588 . . . . 15.0 111.203 179.283 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.1 mm? . . . . . 0 N--CA 1.45 -0.449 0 CA-C-O 121.165 0.507 . . . . 15.0 111.066 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.6 ' O ' ' HB ' ' A' ' 41' ' ' ILE . . . -162.87 31.85 0.29 Allowed Glycine 0 CA--C 1.505 -0.561 0 N-CA-C 110.931 -0.868 . . . . 15.0 110.931 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.626 HG12 ' O ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -112.5 143.65 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 CA-C-O 121.104 0.478 . . . . 15.0 112.146 -178.709 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 27.1 t -96.07 102.47 14.27 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 107.014 -1.476 . . . . 15.0 107.014 176.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.453 HG11 ' CG2' ' A' ' 20' ' ' ILE . 32.8 m -93.36 155.28 3.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 113.439 0.903 . . . . 15.0 113.439 -176.23 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.3 -175.44 4.99 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 114.8 -1.091 . . . . 15.0 110.609 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.412 ' O ' ' CB ' ' A' ' 71' ' ' HIS . . . 68.73 -120.23 10.84 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 120.823 -0.703 . . . . 15.0 112.602 179.725 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.537 ' HA3' ' N ' ' A' ' 71' ' ' HIS . . . 69.07 -66.38 0.49 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.795 -0.717 . . . . 15.0 113.431 179.449 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.432 ' N ' ' HA ' ' A' ' 70' ' ' THR . 1.0 OUTLIER -27.66 140.25 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 N-CA-C 112.471 0.545 . . . . 15.0 112.471 -179.271 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -76.61 60.14 1.61 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.983 -0.553 . . . . 15.0 111.034 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -151.72 -50.45 0.11 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.373 -0.376 . . . . 15.0 111.01 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.8 t -84.21 -37.58 21.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.202 -0.453 . . . . 15.0 111.071 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.429 HG13 ' CD1' ' A' ' 36' ' ' TYR . 21.7 m -80.75 -174.75 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.306 -0.406 . . . . 15.0 111.238 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.425 ' HB3' ' CD2' ' A' ' 32' ' ' HIS . 2.8 mtt-85 -58.8 -54.17 50.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.449 . . . . 15.0 111.022 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . 0.425 ' CD2' ' HB3' ' A' ' 31' ' ' ARG . 47.6 m-70 -146.37 -50.47 0.22 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.264 -0.426 . . . . 15.0 111.043 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -169.28 26.24 0.11 Allowed Glycine 0 N--CA 1.453 -0.19 0 C-N-CA 120.825 -0.702 . . . . 15.0 112.512 -179.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -90.58 149.18 19.95 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.684 -0.769 . . . . 15.0 111.197 179.101 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.473 ' CG1' ' HA ' ' A' ' 71' ' ' HIS . 0.0 OUTLIER -87.68 154.69 3.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 117.341 0.571 . . . . 15.0 111.568 -179.39 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.429 ' CD1' HG13 ' A' ' 30' ' ' VAL . 26.6 m-85 -140.76 106.83 5.19 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.241 -0.891 . . . . 15.0 109.829 179.312 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.675 HG21 ' N ' ' A' ' 55' ' ' GLY . 0.8 OUTLIER -55.58 148.25 3.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.18 0.514 . . . . 15.0 111.553 -178.938 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.403 ' O ' ' HG2' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -80.41 -47.7 14.01 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.316 -0.994 . . . . 15.0 108.316 178.2 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.626 ' O ' HG12 ' A' ' 20' ' ' ILE . . . -172.02 172.76 4.59 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 115.254 -0.885 . . . . 15.0 110.291 178.606 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.611 ' HA ' HG12 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -97.42 107.84 20.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.936 0.398 . . . . 15.0 110.889 179.946 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.6 ' HB ' ' O ' ' A' ' 19' ' ' GLY . 0.6 OUTLIER -78.86 108.03 7.28 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 115.789 -0.641 . . . . 15.0 112.611 -178.671 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.503 ' HA ' ' CG ' ' A' ' 47' ' ' GLU . 30.7 Cg_endo -62.93 69.67 0.13 Allowed 'Trans proline' 0 C--N 1.355 0.904 0 C-N-CA 123.139 2.559 . . . . 15.0 112.535 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.415 ' N ' ' O ' ' A' ' 41' ' ' ILE . 0.7 OUTLIER -151.79 -52.93 0.12 Allowed 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.365 -0.834 . . . . 15.0 109.675 179.501 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.515 ' HA3' ' CA ' ' A' ' 19' ' ' GLY . . . -87.93 155.99 27.07 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.611 -0.804 . . . . 15.0 112.402 179.254 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -39.11 -18.81 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 113.638 0.977 . . . . 15.0 113.638 -179.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.478 ' N ' ' O ' ' A' ' 44' ' ' GLY . . . -71.68 -71.89 0.25 Allowed 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 111.783 0.29 . . . . 15.0 111.783 -179.31 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.505 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 3.9 tp10 -58.22 -40.4 81.57 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 120.423 -0.511 . . . . 15.0 110.379 179.827 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 16.5 m -54.27 -59.18 5.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.974 -0.557 . . . . 15.0 110.463 179.439 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.433 ' CB ' HD13 ' A' ' 11' ' ' LEU . 3.6 t70 -68.46 -38.37 81.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.155 -0.475 . . . . 15.0 110.107 179.303 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.81 42.8 8.7 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.695 -0.684 . . . . 15.0 112.988 179.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.406 ' HB3' ' CG2' ' A' ' 9' ' ' VAL . 2.8 mmp_? -90.2 -50.68 5.85 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.877 0.37 . . . . 15.0 110.521 179.475 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.469 HG21 ' CG1' ' A' ' 40' ' ' VAL . 10.1 tp -81.22 158.9 4.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.048 -0.524 . . . . 15.0 110.773 179.69 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . 0.437 ' O ' ' HB2' ' A' ' 56' ' ' ASP . 72.8 m80 -141.0 158.24 44.22 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-O 121.645 0.736 . . . . 15.0 112.244 -179.407 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.538 ' HA ' ' CG2' ' A' ' 37' ' ' VAL . 2.3 mtpt -42.25 134.12 2.96 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.407 -1.269 . . . . 15.0 112.794 -178.704 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.675 ' N ' HG21 ' A' ' 37' ' ' VAL . . . 49.76 33.41 19.46 Favored Glycine 0 C--N 1.334 0.444 0 CA-C-N 115.815 -0.63 . . . . 15.0 113.616 179.157 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.497 ' HB2' HG12 ' A' ' 37' ' ' VAL . 0.2 OUTLIER -66.01 133.17 50.25 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 117.169 0.485 . . . . 15.0 110.679 179.529 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.425 ' HG3' ' CZ ' ' A' ' 36' ' ' TYR . 6.2 ttt85 -86.47 88.42 7.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.193 -0.458 . . . . 15.0 110.363 179.604 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.482 ' HA ' HD22 ' A' ' 89' ' ' LEU . 1.7 m -79.43 114.77 20.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.057 0.456 . . . . 15.0 111.003 -179.558 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 32.0 mt -107.09 -16.71 14.36 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.762 -0.654 . . . . 15.0 112.46 -179.244 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.4 ' HA ' ' O ' ' A' ' 64' ' ' VAL . . . -147.88 146.46 29.08 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 112.563 0.579 . . . . 15.0 112.563 -178.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.457 HG12 ' HA ' ' A' ' 78' ' ' LEU . 57.3 t -139.02 102.77 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.368 -0.833 . . . . 15.0 109.098 178.674 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 64.9 14.94 9.61 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.87 -0.419 . . . . 15.0 109.87 -178.163 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 107.0 5.47 35.29 Favored Glycine 0 C--N 1.336 0.552 0 CA-C-N 115.989 -0.55 . . . . 15.0 113.361 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.489 ' O ' ' CG1' ' A' ' 64' ' ' VAL . 6.1 p -93.87 107.59 19.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 117.077 0.439 . . . . 15.0 111.192 179.645 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 44.2 m -58.48 133.04 55.44 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.294 -0.412 . . . . 15.0 110.798 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -91.1 -21.86 21.0 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.07 -0.514 . . . . 15.0 111.185 -179.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -43.55 98.06 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 120.912 0.387 . . . . 15.0 111.149 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.87 63.28 0.55 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.817 -0.706 . . . . 15.0 112.333 -179.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -173.13 150.65 1.97 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.907 0.384 . . . . 15.0 111.098 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.432 ' HA ' ' N ' ' A' ' 26' ' ' VAL . 2.9 p -81.05 -171.96 3.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 15.0 111.015 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.537 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 0.0 OUTLIER -62.08 -59.68 4.71 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.847 -0.615 . . . . 15.0 110.537 -179.953 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 13.3 ttpp -52.65 -34.64 52.45 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.685 -0.689 . . . . 15.0 111.046 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -59.31 -49.97 75.78 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.71 -0.478 . . . . 15.0 109.71 179.526 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.446 ' O ' ' N ' ' A' ' 77' ' ' THR . . . -66.2 -45.68 79.93 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.929 -0.578 . . . . 15.0 109.532 178.423 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.429 ' CG2' ' CG2' ' A' ' 22' ' ' VAL . 0.5 OUTLIER -43.59 -40.81 1.41 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.209 0 N-CA-C 108.853 -0.795 . . . . 15.0 108.853 178.158 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -67.28 -44.87 78.23 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 114.845 -1.071 . . . . 15.0 110.126 178.365 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.446 ' N ' ' O ' ' A' ' 74' ' ' ALA . 61.3 p -64.19 -54.24 36.76 Favored 'General case' 0 N--CA 1.461 0.08 0 CA-C-N 116.621 -0.263 . . . . 15.0 111.349 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.457 ' HA ' HG12 ' A' ' 61' ' ' VAL . 4.4 mt -53.43 -48.59 68.62 Favored 'General case' 0 CA--C 1.521 -0.146 0 CA-C-O 121.099 0.476 . . . . 15.0 110.138 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -68.54 -58.16 4.71 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.559 -0.746 . . . . 15.0 110.748 179.558 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -65.88 63.53 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.089 -0.505 . . . . 15.0 111.952 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.407 ' HB ' ' HG3' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -94.99 -73.53 0.58 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.65 0.262 . . . . 15.0 110.468 179.362 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 122.2 -105.22 0.96 Allowed Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.828 -0.701 . . . . 15.0 113.132 179.4 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . 0.454 ' O ' ' HB3' ' A' ' 13' ' ' LYS . 0.4 OUTLIER -64.67 -82.17 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.705 0.288 . . . . 15.0 111.484 -179.279 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.423 ' CG1' ' N ' ' A' ' 85' ' ' VAL . 50.0 t -109.76 158.05 10.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.904 0.383 . . . . 15.0 110.423 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.579 ' HB ' ' HB3' ' A' ' 11' ' ' LEU . 50.7 t -98.23 77.85 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.231 -0.441 . . . . 15.0 110.627 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -98.63 88.37 4.06 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.021 -0.536 . . . . 15.0 110.893 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.447 ' O ' ' N ' ' A' ' 9' ' ' VAL . 0.1 OUTLIER -103.89 125.84 50.59 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.104 -0.498 . . . . 15.0 111.633 -179.474 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.494 HD11 ' CB ' ' A' ' 8' ' ' GLU . 4.6 mp -101.59 101.85 12.47 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.428 -0.582 . . . . 15.0 109.428 178.657 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.482 HD22 ' HA ' ' A' ' 58' ' ' VAL . 0.1 OUTLIER -105.83 -163.62 0.95 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.536 0.684 . . . . 15.0 112.119 -178.325 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.458 ' HB2' HG13 ' A' ' 6' ' ' ILE . 2.2 tt0 -142.47 137.62 30.42 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 114.803 -1.09 . . . . 15.0 109.758 179.063 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.95 106.85 0.13 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.942 0.401 . . . . 15.0 111.05 -179.687 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.267 0 C-N-CA 120.955 -0.64 . . . . 15.0 112.765 -179.641 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.42 HG13 ' HB2' ' A' ' 90' ' ' GLU . 1.4 mp . . . . . 0 N--CA 1.452 -0.349 0 CA-C-O 120.734 0.302 . . . . 15.0 111.088 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.41 ' CD1' ' C ' ' A' ' 7' ' ' PHE . 3.9 p90 -140.65 165.53 27.22 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.327 -0.397 . . . . 15.0 110.729 178.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.468 ' HB2' HD11 ' A' ' 88' ' ' LEU . 11.0 pt-20 -130.14 143.52 50.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.117 0.484 . . . . 15.0 111.467 -179.642 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.451 HG13 ' CD1' ' A' ' 52' ' ' ILE . 0.5 OUTLIER -101.55 117.45 46.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.582 -0.735 . . . . 15.0 109.998 179.115 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -106.43 71.81 0.89 Allowed 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 112.243 0.46 . . . . 15.0 112.243 -179.221 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.527 ' HB3' ' HB ' ' A' ' 85' ' ' VAL . 7.9 tp -88.0 164.25 15.89 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.538 -0.542 . . . . 15.0 109.538 178.697 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -96.09 93.02 6.72 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.025 0.441 . . . . 15.0 111.297 -179.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.541 ' O ' ' HD3' ' A' ' 13' ' ' LYS . 0.1 OUTLIER . . . . . 0 C--N 1.327 -0.376 0 CA-C-N 115.857 -0.61 . . . . 15.0 110.935 179.769 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.431 ' O ' ' HA3' ' A' ' 44' ' ' GLY . 0.4 OUTLIER . . . . . 0 N--CA 1.456 -0.161 0 CA-C-O 120.826 0.346 . . . . 15.0 110.702 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.608 ' O ' ' HB ' ' A' ' 41' ' ' ILE . . . -166.77 34.09 0.22 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 121.09 -0.576 . . . . 15.0 112.183 -179.665 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.567 HG12 ' O ' ' A' ' 39' ' ' ALA . 0.1 OUTLIER -112.63 140.65 31.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 121.023 0.439 . . . . 15.0 111.892 -179.464 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 31.3 t -96.3 107.16 19.48 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 107.735 -1.209 . . . . 15.0 107.735 177.221 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.426 HG11 ' CG2' ' A' ' 20' ' ' ILE . 30.4 m -93.31 152.5 3.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 N-CA-C 113.061 0.763 . . . . 15.0 113.061 -176.807 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 35.4 p -149.42 178.68 8.58 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 115.036 -0.984 . . . . 15.0 110.874 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.423 ' O ' ' CB ' ' A' ' 71' ' ' HIS . . . 71.83 -118.69 7.14 Favored Glycine 0 C--N 1.332 0.345 0 C-N-CA 120.987 -0.625 . . . . 15.0 112.697 179.813 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.53 ' HA3' ' N ' ' A' ' 71' ' ' HIS . . . 68.21 -66.28 0.37 Allowed Glycine 0 C--N 1.331 0.254 0 C-N-CA 120.874 -0.679 . . . . 15.0 113.585 179.563 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.42 ' HA ' ' CB ' ' A' ' 70' ' ' THR . 0.0 OUTLIER -29.64 137.89 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 N-CA-C 112.247 0.462 . . . . 15.0 112.247 -179.355 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -75.46 63.5 1.48 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.905 -0.589 . . . . 15.0 111.038 -179.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 29.5 m -151.71 -50.3 0.11 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.247 -0.433 . . . . 15.0 111.067 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 11.0 t -88.04 -29.27 20.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.231 -0.441 . . . . 15.0 111.146 -179.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.43 HG13 ' CD1' ' A' ' 36' ' ' TYR . 34.4 m -85.4 -176.85 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.367 -0.379 . . . . 15.0 111.312 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -61.47 -46.95 87.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.14 -0.482 . . . . 15.0 111.101 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 74.6 m-70 -148.29 -61.94 0.25 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.405 -0.361 . . . . 15.0 111.226 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.4 ' O ' ' O ' ' A' ' 69' ' ' ALA . . . -163.67 24.98 0.19 Allowed Glycine 0 N--CA 1.453 -0.205 0 C-N-CA 120.853 -0.689 . . . . 15.0 112.586 -179.642 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -89.61 156.97 26.14 Favored Glycine 0 N--CA 1.449 -0.462 0 N-CA-C 110.626 -0.99 . . . . 15.0 110.626 178.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.524 HG21 HG22 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -93.69 151.5 3.69 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.388 0 CA-C-N 117.66 0.73 . . . . 15.0 112.013 -179.366 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.491 ' CZ ' ' HG2' ' A' ' 57' ' ' ARG . 49.9 m-85 -133.46 107.65 8.17 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.718 -1.128 . . . . 15.0 109.162 178.707 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.562 HG21 ' N ' ' A' ' 55' ' ' GLY . 0.6 OUTLIER -54.85 152.91 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 121.261 0.553 . . . . 15.0 110.723 -178.575 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.637 ' HG3' ' N ' ' A' ' 39' ' ' ALA . 1.4 ppmt? -88.17 -47.32 8.55 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 108.795 -0.817 . . . . 15.0 108.795 179.313 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.637 ' N ' ' HG3' ' A' ' 38' ' ' LYS . . . -173.06 167.14 4.98 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.669 -0.696 . . . . 15.0 110.202 178.305 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.501 ' HB ' ' HG2' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -96.84 111.87 27.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.647 -0.501 . . . . 15.0 109.647 179.14 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.608 ' HB ' ' O ' ' A' ' 19' ' ' GLY . 0.3 OUTLIER -78.39 111.37 18.36 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 115.728 -0.669 . . . . 15.0 112.664 -177.676 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.474 ' HA ' ' OE1' ' A' ' 47' ' ' GLU . 37.1 Cg_endo -65.23 65.35 0.33 Allowed 'Trans proline' 0 C--N 1.355 0.899 0 C-N-CA 123.07 2.514 . . . . 15.0 112.763 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -149.52 -52.03 0.15 Allowed 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.402 -0.817 . . . . 15.0 109.196 179.293 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.528 ' HA3' ' HA3' ' A' ' 19' ' ' GLY . . . -88.03 154.34 25.42 Favored Glycine 0 N--CA 1.445 -0.719 0 CA-C-N 115.443 -0.799 . . . . 15.0 112.516 179.109 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -40.61 -17.73 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 113.804 1.038 . . . . 15.0 113.804 -179.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.446 ' N ' ' O ' ' A' ' 44' ' ' GLY . . . -71.67 -70.54 0.32 Allowed 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.707 -0.397 . . . . 15.0 111.477 -179.247 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.501 ' HG2' ' HB ' ' A' ' 40' ' ' VAL . 6.8 tm-20 -58.08 -37.17 73.98 Favored 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 120.678 -0.409 . . . . 15.0 110.039 179.508 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 37.4 m -56.25 -65.76 0.55 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.021 -0.536 . . . . 15.0 110.335 179.265 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.479 ' CB ' HD12 ' A' ' 11' ' ' LEU . 18.6 m-20 -62.55 -38.4 89.86 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.123 0.487 . . . . 15.0 109.931 179.135 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.51 43.56 8.42 Favored Glycine 0 N--CA 1.449 -0.493 0 CA-C-N 115.59 -0.732 . . . . 15.0 112.446 179.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.437 ' CG ' HG22 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -79.8 -58.26 3.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.867 0.365 . . . . 15.0 110.616 -179.982 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.498 ' CG2' HG12 ' A' ' 37' ' ' VAL . 1.4 mm -86.13 163.41 2.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.114 -0.494 . . . . 15.0 110.887 179.809 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . 0.466 ' N ' ' CG2' ' A' ' 52' ' ' ILE . 43.2 m80 -139.37 154.67 47.88 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-O 121.61 0.719 . . . . 15.0 111.415 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.503 ' HA ' ' CG2' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -36.07 133.93 0.43 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.368 -1.287 . . . . 15.0 113.016 -178.549 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.562 ' N ' HG21 ' A' ' 37' ' ' VAL . . . 50.74 34.16 28.45 Favored Glycine 0 C--N 1.334 0.468 0 CA-C-N 115.806 -0.633 . . . . 15.0 113.929 179.091 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -65.4 130.62 43.99 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 117.296 0.548 . . . . 15.0 110.525 179.203 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.491 ' HG2' ' CZ ' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -82.34 85.73 6.82 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.002 -0.545 . . . . 15.0 110.543 179.818 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.524 HG22 HG21 ' A' ' 35' ' ' ILE . 1.0 OUTLIER -81.67 114.33 22.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.15 0.5 . . . . 15.0 111.266 -179.549 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 18.6 mt -107.23 -15.74 14.58 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.702 -0.681 . . . . 15.0 112.142 -179.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.413 ' HA ' ' O ' ' A' ' 64' ' ' VAL . . . -147.58 151.01 35.55 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.292 0.567 . . . . 15.0 112.337 -178.767 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.415 HG21 ' CD2' ' A' ' 78' ' ' LEU . 10.7 t -139.04 102.83 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.257 -0.883 . . . . 15.0 109.105 178.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 65.0 14.73 9.54 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.575 -0.528 . . . . 15.0 109.575 -177.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 106.49 6.57 35.63 Favored Glycine 0 C--N 1.337 0.606 0 CA-C-N 115.824 -0.626 . . . . 15.0 113.336 179.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.484 ' O ' ' CG1' ' A' ' 64' ' ' VAL . 8.9 p -93.86 106.64 18.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.098 0.475 . . . . 15.0 111.066 179.54 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 49.1 m -58.8 124.62 20.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.187 -0.46 . . . . 15.0 110.716 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.417 ' CD1' HG23 ' A' ' 58' ' ' VAL . 0.2 OUTLIER -92.05 -14.58 29.09 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.169 -0.469 . . . . 15.0 111.467 -179.654 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -45.23 103.77 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.89 0.376 . . . . 15.0 111.183 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.85 63.82 0.55 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.793 -0.717 . . . . 15.0 112.525 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.4 ' O ' ' O ' ' A' ' 33' ' ' GLY . . . -173.13 166.86 4.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.837 0.351 . . . . 15.0 111.077 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.42 ' CB ' ' HA ' ' A' ' 26' ' ' VAL . 2.6 p -93.23 -170.49 2.41 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.023 0.44 . . . . 15.0 110.943 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.53 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 0.0 OUTLIER -63.96 -58.37 6.94 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.782 -0.645 . . . . 15.0 110.613 179.979 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.427 ' O ' ' HG3' ' A' ' 76' ' ' GLU . 28.9 ttmt -52.84 -35.51 57.47 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.095 -0.502 . . . . 15.0 110.823 179.392 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -59.21 -46.88 87.29 Favored 'General case' 0 CA--C 1.518 -0.287 0 N-CA-C 109.497 -0.557 . . . . 15.0 109.497 179.277 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.476 ' HA ' ' OG1' ' A' ' 77' ' ' THR . . . -66.88 -47.8 70.72 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.596 -0.729 . . . . 15.0 109.717 178.458 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.413 ' CG2' ' CG2' ' A' ' 22' ' ' VAL . 0.5 OUTLIER -41.75 -42.03 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.254 0 CA-C-O 121.62 0.724 . . . . 15.0 109.182 178.575 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.427 ' HG3' ' O ' ' A' ' 72' ' ' LYS . 20.8 mt-10 -67.35 -44.02 80.07 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.644 -1.162 . . . . 15.0 110.884 179.006 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.476 ' OG1' ' HA ' ' A' ' 74' ' ' ALA . 4.9 p -64.42 -56.33 14.98 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 120.845 -0.342 . . . . 15.0 111.606 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.415 ' CD2' HG21 ' A' ' 61' ' ' VAL . 5.2 mt -53.28 -45.49 68.9 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-O 121.177 0.513 . . . . 15.0 109.931 -179.745 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -68.37 -58.32 4.55 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.462 -0.79 . . . . 15.0 110.232 179.345 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 32.9 m-20 -66.14 58.51 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.845 -0.616 . . . . 15.0 112.196 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.435 ' HB ' ' HG3' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -95.7 -72.82 0.61 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.742 0.306 . . . . 15.0 110.234 179.249 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 122.15 -103.36 0.84 Allowed Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.72 -0.752 . . . . 15.0 113.332 179.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -64.54 -84.66 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.105 0.409 . . . . 15.0 112.105 -178.857 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.433 HG13 ' N ' ' A' ' 85' ' ' VAL . 78.5 t -109.6 158.98 9.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.937 0.399 . . . . 15.0 110.976 -179.322 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.527 ' HB ' ' HB3' ' A' ' 11' ' ' LEU . 9.4 t -98.04 80.65 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.231 0.538 . . . . 15.0 110.596 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -99.71 86.96 3.43 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.73 -0.668 . . . . 15.0 110.038 179.603 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.474 ' CD2' ' HB ' ' A' ' 58' ' ' VAL . 0.1 OUTLIER -103.86 121.19 42.56 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.926 -0.579 . . . . 15.0 111.983 -178.873 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.468 HD11 ' HB2' ' A' ' 8' ' ' GLU . 4.6 mp -97.19 101.25 12.77 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.421 -0.585 . . . . 15.0 109.421 178.488 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.44 ' HB3' ' HA ' ' A' ' 58' ' ' VAL . 0.1 OUTLIER -105.61 -162.14 0.85 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.488 0.661 . . . . 15.0 111.964 -178.649 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.42 ' HB2' HG13 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -142.01 136.9 30.72 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 114.836 -1.075 . . . . 15.0 109.34 178.874 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -46.69 105.03 0.06 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.03 0.443 . . . . 15.0 111.114 -179.486 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.333 0 CA-C-N 115.738 -0.664 . . . . 15.0 112.849 -179.462 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.413 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 1.2 mp . . . . . 0 N--CA 1.449 -0.522 0 CA-C-O 120.908 0.385 . . . . 15.0 110.797 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.488 ' O ' ' N ' ' A' ' 89' ' ' LEU . 0.3 OUTLIER -146.91 158.35 43.9 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.024 -0.535 . . . . 15.0 110.305 179.479 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.474 ' HB2' HD11 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -126.64 142.85 51.41 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.348 0.594 . . . . 15.0 111.937 -178.955 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.427 ' CG2' ' HB3' ' A' ' 51' ' ' ARG . 0.2 OUTLIER -101.45 114.97 42.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.083 -0.962 . . . . 15.0 109.397 178.79 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -105.8 73.08 0.99 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.198 -0.455 . . . . 15.0 112.183 -178.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.422 ' O ' HG11 ' A' ' 84' ' ' VAL . 5.7 tp -88.36 166.14 14.48 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.714 -0.476 . . . . 15.0 109.714 178.707 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -95.39 94.2 7.69 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.048 0.452 . . . . 15.0 111.266 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.532 ' O ' ' HD3' ' A' ' 13' ' ' LYS . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.364 0 CA-C-N 115.807 -0.633 . . . . 15.0 111.114 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.416 ' N ' ' CD2' ' A' ' 18' ' ' LEU . 1.6 mm? . . . . . 0 N--CA 1.453 -0.29 0 CA-C-O 120.937 0.399 . . . . 15.0 110.779 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.676 ' HA3' ' HA3' ' A' ' 44' ' ' GLY . . . -160.89 42.83 0.41 Allowed Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.924 -0.655 . . . . 15.0 111.915 -179.772 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.628 HG12 ' O ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -112.74 141.29 28.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 120.915 0.388 . . . . 15.0 111.768 -179.471 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.402 ' HB3' HD13 ' A' ' 41' ' ' ILE . 43.0 t -96.18 103.44 15.34 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 107.721 -1.214 . . . . 15.0 107.721 177.29 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.449 HG11 ' CG2' ' A' ' 20' ' ' ILE . 27.3 m -93.51 155.39 3.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 113.339 0.866 . . . . 15.0 113.339 -176.714 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.33 -178.4 6.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 114.811 -1.086 . . . . 15.0 110.19 179.498 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.448 ' O ' ' CB ' ' A' ' 71' ' ' HIS . . . 73.0 -120.58 7.32 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.486 -0.864 . . . . 15.0 112.523 179.724 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.565 ' HA3' ' N ' ' A' ' 71' ' ' HIS . . . 68.3 -63.69 0.4 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.945 -0.645 . . . . 15.0 113.522 179.361 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.463 ' N ' ' HA ' ' A' ' 70' ' ' THR . 1.7 m -32.32 146.96 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 N-CA-C 112.233 0.457 . . . . 15.0 112.233 -179.123 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.412 ' CB ' ' O ' ' A' ' 32' ' ' HIS . 15.1 m-20 -79.84 57.85 2.68 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.951 -0.568 . . . . 15.0 111.195 -179.714 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -151.76 -61.43 0.17 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.832 0.349 . . . . 15.0 111.238 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.4 m -71.93 -35.22 69.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 15.0 111.347 -179.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.427 HG13 ' CD1' ' A' ' 36' ' ' TYR . 24.7 m -84.77 -173.78 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.895 0.379 . . . . 15.0 111.445 -179.613 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 41.4 ttt85 -57.08 -39.67 75.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.082 -0.508 . . . . 15.0 111.486 -179.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . 0.412 ' O ' ' CB ' ' A' ' 27' ' ' ASN . 1.6 p-80 -174.63 -35.7 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.592 -0.276 . . . . 15.0 111.656 -179.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -173.77 20.62 0.06 OUTLIER Glycine 0 CA--C 1.519 0.324 0 C-N-CA 120.594 -0.813 . . . . 15.0 113.104 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -97.31 152.06 19.92 Favored Glycine 0 N--CA 1.448 -0.516 0 N-CA-C 110.294 -1.122 . . . . 15.0 110.294 178.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.57 HG13 ' HA ' ' A' ' 71' ' ' HIS . 0.1 OUTLIER -95.35 154.18 3.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 119.668 -0.813 . . . . 15.0 112.382 -178.962 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.427 ' CD1' HG13 ' A' ' 30' ' ' VAL . 31.8 m-85 -136.06 107.51 6.9 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.649 -1.16 . . . . 15.0 109.206 179.224 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.648 HG21 ' N ' ' A' ' 55' ' ' GLY . 0.6 OUTLIER -55.05 148.1 3.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.035 -0.529 . . . . 15.0 111.557 -178.446 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.451 ' O ' ' HG2' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -80.26 -49.6 11.37 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.452 -0.944 . . . . 15.0 108.452 178.397 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.628 ' O ' HG12 ' A' ' 20' ' ' ILE . . . -172.27 173.11 4.31 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-N 115.661 -0.7 . . . . 15.0 110.338 178.687 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.53 ' HA ' HG12 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -96.96 112.01 28.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 109.388 -0.597 . . . . 15.0 109.388 179.041 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.674 ' HB ' ' O ' ' A' ' 19' ' ' GLY . 0.5 OUTLIER -78.28 118.81 74.52 Favored Pre-proline 0 C--N 1.328 -0.328 0 N-CA-C 113.18 0.808 . . . . 15.0 113.18 -177.301 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.533 ' HA ' ' CG ' ' A' ' 47' ' ' GLU . 36.2 Cg_endo -64.09 62.38 0.23 Allowed 'Trans proline' 0 C--N 1.357 1.012 0 C-N-CA 123.592 2.861 . . . . 15.0 112.874 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.535 ' H ' ' HG2' ' A' ' 47' ' ' GLU . 9.8 mt-30 -152.03 -47.14 0.11 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.524 -0.307 . . . . 15.0 111.596 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.676 ' HA3' ' HA3' ' A' ' 19' ' ' GLY . . . -87.9 167.47 36.52 Favored Glycine 0 C--N 1.331 0.258 0 C-N-CA 120.354 -0.927 . . . . 15.0 113.825 -179.191 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -56.99 -12.68 2.16 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.634 0.605 . . . . 15.0 112.634 -179.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.79 -58.56 3.36 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 120.762 0.315 . . . . 15.0 110.406 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.535 ' HG2' ' H ' ' A' ' 43' ' ' GLN . 2.6 pp20? -57.68 -43.16 84.88 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.763 -0.653 . . . . 15.0 110.525 179.079 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 66.7 m -53.65 -70.96 0.08 Allowed 'General case' 0 CA--C 1.518 -0.265 0 CA-C-N 115.931 -0.577 . . . . 15.0 110.574 -179.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.412 ' CB ' HD13 ' A' ' 11' ' ' LEU . 1.6 t0 -58.13 -41.51 83.8 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.128 -0.693 . . . . 15.0 109.128 178.736 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.67 40.12 13.03 Favored Glycine 0 N--CA 1.446 -0.645 0 CA-C-N 115.31 -0.859 . . . . 15.0 111.632 179.378 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.427 ' HB3' ' CG2' ' A' ' 9' ' ' VAL . 0.2 OUTLIER -79.76 -50.63 10.28 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.935 0.398 . . . . 15.0 110.723 -179.252 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.437 ' CD1' HD12 ' A' ' 89' ' ' LEU . 9.3 tp -81.07 162.34 3.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.043 -0.526 . . . . 15.0 110.249 179.433 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . 0.474 ' N ' ' OD2' ' A' ' 56' ' ' ASP . 76.1 m80 -147.54 158.71 44.11 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-O 121.644 0.735 . . . . 15.0 112.281 -178.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.528 ' HA ' ' CG2' ' A' ' 37' ' ' VAL . 8.1 mtpt -43.09 133.28 3.89 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 114.13 -1.396 . . . . 15.0 112.956 -178.68 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.648 ' N ' HG21 ' A' ' 37' ' ' VAL . . . 50.06 29.44 14.78 Favored Glycine 0 C--N 1.332 0.34 0 CA-C-N 115.587 -0.733 . . . . 15.0 113.364 179.206 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.474 ' OD2' ' N ' ' A' ' 53' ' ' HIS . 17.4 m-20 -65.86 130.29 42.74 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.759 -0.376 . . . . 15.0 110.605 179.568 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 8.9 ttt180 -80.85 94.97 6.56 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.307 -0.406 . . . . 15.0 111.123 -179.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.494 ' O ' ' CG2' ' A' ' 58' ' ' VAL . 1.4 m -84.44 112.72 22.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 CA-C-N 116.315 -0.402 . . . . 15.0 110.621 179.743 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 30.5 mt -107.4 -13.18 15.16 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 112.628 0.603 . . . . 15.0 112.628 -179.116 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.464 ' CB ' HD22 ' A' ' 88' ' ' LEU . . . -151.77 148.15 27.52 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.511 0.56 . . . . 15.0 112.511 -178.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.45 HG12 ' HA ' ' A' ' 78' ' ' LEU . 19.0 t -139.2 101.6 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.24 -0.891 . . . . 15.0 109.409 178.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.408 ' ND2' ' CG2' ' A' ' 81' ' ' THR . 1.6 m-80 64.9 15.32 9.84 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.667 -0.494 . . . . 15.0 109.667 -178.141 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 107.22 6.17 34.15 Favored Glycine 0 C--N 1.336 0.575 0 CA-C-N 115.867 -0.606 . . . . 15.0 113.46 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.504 ' O ' ' CG1' ' A' ' 64' ' ' VAL . 6.3 p -93.83 103.94 15.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 117.25 0.525 . . . . 15.0 110.786 179.313 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -55.8 132.29 49.0 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.055 -0.52 . . . . 15.0 111.22 -179.561 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -87.64 -20.33 26.48 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.971 -0.559 . . . . 15.0 110.714 179.679 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -43.39 96.1 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.295 -0.411 . . . . 15.0 111.131 179.833 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 104.36 69.65 0.78 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.802 -0.713 . . . . 15.0 112.216 -179.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -173.02 159.35 3.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.787 0.327 . . . . 15.0 111.038 -179.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.463 ' HA ' ' N ' ' A' ' 26' ' ' VAL . 15.9 p -93.04 -173.96 3.43 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.219 -0.446 . . . . 15.0 111.275 -179.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.57 ' HA ' HG13 ' A' ' 35' ' ' ILE . 0.0 OUTLIER -61.22 -60.79 3.2 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.862 -0.608 . . . . 15.0 110.438 -179.978 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -52.65 -31.96 39.6 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.717 -0.674 . . . . 15.0 110.473 179.449 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -59.56 -53.93 52.44 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.007 -0.542 . . . . 15.0 109.955 179.424 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.458 ' O ' ' N ' ' A' ' 77' ' ' THR . . . -64.89 -44.78 88.52 Favored 'General case' 0 CA--C 1.518 -0.267 0 N-CA-C 109.432 -0.581 . . . . 15.0 109.432 178.581 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.414 ' CG2' ' CG2' ' A' ' 22' ' ' VAL . 0.5 OUTLIER -44.04 -40.6 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.21 0 N-CA-C 108.68 -0.859 . . . . 15.0 108.68 178.021 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.415 ' O ' ' HB2' ' A' ' 80' ' ' ASN . 1.8 mm-40 -67.36 -45.03 77.53 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 114.835 -1.075 . . . . 15.0 109.828 178.093 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.458 ' N ' ' O ' ' A' ' 74' ' ' ALA . 80.3 p -64.13 -53.81 43.71 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 116.616 -0.265 . . . . 15.0 111.398 179.751 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.45 ' HA ' HG12 ' A' ' 61' ' ' VAL . 5.4 mt -53.37 -48.84 68.23 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-O 121.237 0.541 . . . . 15.0 109.851 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 16.2 ttt180 -68.57 -60.67 2.25 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.356 -0.838 . . . . 15.0 110.636 179.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.415 ' HB2' ' O ' ' A' ' 76' ' ' GLU . 36.6 m-20 -65.97 61.47 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.93 -0.577 . . . . 15.0 112.133 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.449 ' HB ' ' HG3' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -95.56 -68.77 0.78 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.779 0.323 . . . . 15.0 110.174 179.178 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 121.92 -105.9 1.03 Allowed Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.883 -0.675 . . . . 15.0 112.889 179.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -64.81 -83.05 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 111.943 0.349 . . . . 15.0 111.943 -179.241 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.444 HG13 ' N ' ' A' ' 85' ' ' VAL . 78.1 t -109.78 160.31 8.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.979 0.418 . . . . 15.0 110.944 -179.475 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.444 ' N ' HG13 ' A' ' 84' ' ' VAL . 8.7 t -97.65 82.24 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.109 0.48 . . . . 15.0 110.402 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 2.8 t60 -101.01 82.26 2.35 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.769 -0.65 . . . . 15.0 110.624 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.452 ' HB3' ' CD2' ' A' ' 89' ' ' LEU . 0.1 OUTLIER -100.56 120.24 39.73 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.919 -0.582 . . . . 15.0 111.679 -179.332 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.474 HD11 ' HB2' ' A' ' 8' ' ' GLU . 0.2 OUTLIER -97.11 101.48 13.06 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.464 -0.569 . . . . 15.0 109.464 178.794 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.488 ' N ' ' O ' ' A' ' 7' ' ' PHE . 0.1 OUTLIER -105.86 -162.99 0.9 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.694 0.759 . . . . 15.0 112.388 -178.392 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.413 ' HA ' ' HA ' ' A' ' 6' ' ' ILE . 7.4 tt0 -139.58 120.91 14.94 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 114.475 -1.239 . . . . 15.0 109.116 178.731 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -46.86 101.92 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.005 0.431 . . . . 15.0 111.398 -179.094 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.401 0 C-N-CA 120.946 -0.645 . . . . 15.0 112.499 -179.89 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.433 HG13 ' HB2' ' A' ' 90' ' ' GLU . 1.2 mp . . . . . 0 N--CA 1.453 -0.312 0 CA-C-O 120.685 0.278 . . . . 15.0 110.791 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.441 ' CZ ' HD11 ' A' ' 89' ' ' LEU . 5.8 p90 -140.69 156.77 46.13 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.413 -0.358 . . . . 15.0 110.678 179.102 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.47 ' CB ' HD11 ' A' ' 88' ' ' LEU . 10.2 pt-20 -124.22 142.84 50.91 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.339 0.59 . . . . 15.0 111.551 -179.399 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.479 ' CG2' ' HB3' ' A' ' 51' ' ' ARG . 0.2 OUTLIER -101.54 116.47 45.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.132 -0.94 . . . . 15.0 109.716 178.978 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -106.21 73.53 0.99 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.292 -0.413 . . . . 15.0 112.101 -179.017 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.516 ' HB3' ' HB ' ' A' ' 85' ' ' VAL . 9.7 tp -88.25 160.28 17.75 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.219 -0.446 . . . . 15.0 109.867 178.809 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -96.94 95.0 7.53 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.683 0.277 . . . . 15.0 111.716 -179.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.428 ' HB2' ' CG2' ' A' ' 85' ' ' VAL . 0.6 OUTLIER . . . . . 0 CA--C 1.533 0.304 0 N-CA-C 112.619 0.6 . . . . 15.0 112.619 179.565 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 51.2 mt . . . . . 0 N--CA 1.451 -0.391 0 CA-C-O 120.734 0.302 . . . . 15.0 110.699 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.775 ' HA3' ' HA3' ' A' ' 44' ' ' GLY . . . -170.86 45.33 0.19 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.729 -0.748 . . . . 15.0 112.347 -179.72 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.739 HG12 ' O ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -112.52 139.12 38.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 120.827 0.346 . . . . 15.0 111.231 -179.913 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.422 ' HB3' HD13 ' A' ' 41' ' ' ILE . 13.0 t -90.28 103.32 16.01 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.419 -0.956 . . . . 15.0 108.419 177.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.461 HG22 ' CD2' ' A' ' 71' ' ' HIS . 34.7 m -93.94 155.81 3.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 112.645 0.609 . . . . 15.0 112.645 -177.443 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.36 -177.08 5.64 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.31 -0.859 . . . . 15.0 110.779 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.421 ' O ' ' HB3' ' A' ' 71' ' ' HIS . . . 68.83 -119.46 9.87 Favored Glycine 0 C--N 1.332 0.336 0 C-N-CA 120.84 -0.695 . . . . 15.0 112.532 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.525 ' HA3' ' N ' ' A' ' 71' ' ' HIS . . . 68.11 -66.26 0.36 Allowed Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.833 -0.698 . . . . 15.0 113.492 179.466 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.424 ' N ' ' HA ' ' A' ' 70' ' ' THR . 1.7 m -30.36 144.74 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 N-CA-C 112.384 0.513 . . . . 15.0 112.384 -179.322 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 49.5 t-20 -75.68 61.08 1.33 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.964 -0.562 . . . . 15.0 110.935 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.4 m -151.73 -66.37 0.18 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.204 -0.453 . . . . 15.0 111.028 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.8 m -68.43 -42.59 78.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.213 -0.449 . . . . 15.0 111.084 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.426 HG13 ' CD1' ' A' ' 36' ' ' TYR . 16.6 m -75.12 -173.01 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.269 -0.423 . . . . 15.0 111.202 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.02 -58.36 6.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.204 -0.453 . . . . 15.0 110.934 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 93.0 m-70 -137.12 -54.56 0.7 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.23 -0.441 . . . . 15.0 111.061 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -167.76 22.05 0.1 Allowed Glycine 0 CA--C 1.517 0.215 0 C-N-CA 120.807 -0.711 . . . . 15.0 112.756 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -85.63 152.86 26.71 Favored Glycine 0 N--CA 1.449 -0.453 0 N-CA-C 110.882 -0.887 . . . . 15.0 110.882 178.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.491 HG21 HG22 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -89.73 154.39 3.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 117.522 0.661 . . . . 15.0 111.929 -179.357 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.446 ' CE2' ' HG2' ' A' ' 57' ' ' ARG . 35.3 m-85 -139.28 107.86 5.88 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.98 -1.009 . . . . 15.0 109.998 178.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.57 HG21 ' N ' ' A' ' 55' ' ' GLY . 0.6 OUTLIER -55.29 156.22 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.857 -0.61 . . . . 15.0 111.037 -179.097 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.538 ' O ' ' HG2' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -91.09 -47.24 7.66 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.344 -0.984 . . . . 15.0 108.344 178.526 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.739 ' O ' HG12 ' A' ' 20' ' ' ILE . . . -172.48 171.96 4.49 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.329 -0.85 . . . . 15.0 110.062 178.611 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.549 ' HA ' ' CG1' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -96.45 108.41 21.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 109.178 -0.675 . . . . 15.0 109.178 179.191 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.735 ' HB ' ' O ' ' A' ' 19' ' ' GLY . 0.7 OUTLIER -77.99 118.43 72.11 Favored Pre-proline 0 C--N 1.328 -0.362 0 N-CA-C 113.528 0.936 . . . . 15.0 113.528 -176.904 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.524 ' HA ' ' CG ' ' A' ' 47' ' ' GLU . 36.8 Cg_endo -64.31 61.81 0.25 Allowed 'Trans proline' 0 C--N 1.356 0.971 0 C-N-CA 123.602 2.868 . . . . 15.0 112.907 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.509 ' H ' ' HG2' ' A' ' 47' ' ' GLU . 5.4 mm100 -149.42 -46.42 0.14 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.513 -0.312 . . . . 15.0 111.398 179.779 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.775 ' HA3' ' HA3' ' A' ' 19' ' ' GLY . . . -87.88 167.74 36.82 Favored Glycine 0 C--N 1.33 0.204 0 C-N-CA 120.443 -0.884 . . . . 15.0 113.825 -179.249 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -59.61 -13.53 9.85 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.168 -0.516 . . . . 15.0 112.244 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.22 -55.99 6.28 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 120.701 0.286 . . . . 15.0 110.79 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.552 ' HG3' ' O ' ' A' ' 44' ' ' GLY . 2.9 pp20? -57.73 -42.48 83.95 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-N 115.973 -0.558 . . . . 15.0 110.45 179.144 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 32.8 t -53.51 -69.44 0.12 Allowed 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 115.804 -0.635 . . . . 15.0 110.459 -179.244 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.42 -42.04 90.92 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.07 -0.715 . . . . 15.0 109.07 178.729 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.75 43.02 9.34 Favored Glycine 0 N--CA 1.447 -0.622 0 CA-C-N 115.36 -0.836 . . . . 15.0 111.645 179.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.479 ' HB3' ' CG2' ' A' ' 9' ' ' VAL . 0.7 OUTLIER -79.89 -41.63 25.79 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.712 0.291 . . . . 15.0 111.071 -179.111 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.541 ' CG2' HG12 ' A' ' 37' ' ' VAL . 5.9 mm -91.25 161.49 2.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 120.921 0.391 . . . . 15.0 110.922 179.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . 0.465 ' N ' ' CG2' ' A' ' 52' ' ' ILE . 75.8 m80 -142.38 154.91 45.03 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-O 121.447 0.641 . . . . 15.0 111.083 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.538 ' HG2' ' O ' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -37.68 133.13 0.83 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.552 -1.203 . . . . 15.0 112.934 -178.552 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.57 ' N ' HG21 ' A' ' 37' ' ' VAL . . . 50.05 33.48 21.87 Favored Glycine 0 C--N 1.335 0.489 0 CA-C-N 115.822 -0.626 . . . . 15.0 113.716 179.243 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -65.34 130.71 44.3 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 117.178 0.489 . . . . 15.0 110.181 179.16 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.446 ' HG2' ' CE2' ' A' ' 36' ' ' TYR . 30.9 mtt180 -83.28 94.83 8.0 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.341 -0.39 . . . . 15.0 110.522 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.491 HG22 HG21 ' A' ' 35' ' ' ILE . 1.1 m -87.87 117.22 31.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 121.039 0.447 . . . . 15.0 111.055 -179.713 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.422 ' CD2' ' N ' ' A' ' 59' ' ' LEU . 2.9 mm? -107.17 -14.23 14.96 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 115.797 -0.638 . . . . 15.0 112.567 -179.129 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -149.98 146.56 27.08 Favored 'General case' 0 N--CA 1.462 0.162 0 N-CA-C 112.591 0.589 . . . . 15.0 112.591 -178.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.446 ' HA ' ' HG ' ' A' ' 87' ' ' LEU . 45.9 t -139.25 100.26 1.37 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.224 0 CA-C-N 115.32 -0.854 . . . . 15.0 109.385 178.751 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 65.05 16.57 10.64 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.086 -0.507 . . . . 15.0 109.937 -178.157 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 107.05 4.39 35.83 Favored Glycine 0 C--N 1.336 0.531 0 CA-C-N 115.848 -0.614 . . . . 15.0 113.387 179.601 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.501 ' O ' ' CG1' ' A' ' 64' ' ' VAL . 4.3 p -93.79 107.04 18.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 121.087 0.47 . . . . 15.0 110.78 179.499 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -57.55 130.73 47.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 15.0 111.049 -179.526 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -87.69 -27.06 22.65 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.067 -0.515 . . . . 15.0 110.811 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 82.2 mt-10 -47.39 103.49 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.338 -0.392 . . . . 15.0 111.019 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.8 58.73 0.54 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.756 -0.735 . . . . 15.0 112.425 -179.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -173.1 165.61 4.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.901 0.382 . . . . 15.0 111.07 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.424 ' HA ' ' N ' ' A' ' 26' ' ' VAL . 17.3 p -93.13 -172.93 3.11 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.095 -0.502 . . . . 15.0 111.046 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.525 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 0.0 OUTLIER -63.07 -59.7 4.43 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.797 -0.638 . . . . 15.0 110.563 -179.924 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 7.6 ttpt -52.56 -33.77 47.28 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.838 -0.619 . . . . 15.0 110.807 179.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 7.0 mt-30 -59.5 -50.79 72.57 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.688 -0.486 . . . . 15.0 109.688 179.339 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.459 ' O ' ' N ' ' A' ' 77' ' ' THR . . . -66.97 -43.82 82.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.95 -0.568 . . . . 15.0 109.697 178.416 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.444 ' CG2' ' CG2' ' A' ' 22' ' ' VAL . 0.5 OUTLIER -43.34 -41.76 1.35 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.289 0 N-CA-C 108.878 -0.786 . . . . 15.0 108.878 178.319 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.407 ' O ' ' CB ' ' A' ' 80' ' ' ASN . 2.0 mt-10 -67.17 -44.3 80.07 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 114.822 -1.081 . . . . 15.0 110.022 178.323 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.459 ' N ' ' O ' ' A' ' 74' ' ' ALA . 59.4 p -64.06 -54.38 34.96 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-N 116.665 -0.243 . . . . 15.0 111.596 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.438 ' HG ' ' O ' ' A' ' 74' ' ' ALA . 8.8 mt -53.45 -48.98 68.35 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.317 0.58 . . . . 15.0 110.03 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.44 -59.15 3.38 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.251 -0.886 . . . . 15.0 110.723 179.722 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.407 ' CB ' ' O ' ' A' ' 76' ' ' GLU . 71.4 m-20 -65.97 62.87 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.1 -0.5 . . . . 15.0 111.909 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.46 -73.66 0.58 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 110.146 -0.316 . . . . 15.0 110.146 179.205 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 122.15 -105.4 0.98 Allowed Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.696 -0.764 . . . . 15.0 113.268 179.048 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . 0.402 ' O ' ' HB3' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -64.88 -83.64 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.761 0.315 . . . . 15.0 111.18 -179.39 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.423 HG13 ' N ' ' A' ' 85' ' ' VAL . 79.7 t -109.82 160.18 8.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.257 -0.428 . . . . 15.0 110.864 -179.755 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.516 ' HB ' ' HB3' ' A' ' 11' ' ' LEU . 3.6 t -97.63 81.64 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.137 0.494 . . . . 15.0 110.18 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -96.41 80.23 3.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.727 -0.669 . . . . 15.0 110.391 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.451 ' CD2' ' CD2' ' A' ' 89' ' ' LEU . 0.1 OUTLIER -102.12 124.68 48.15 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.063 -0.517 . . . . 15.0 111.649 -179.269 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.47 HD11 ' CB ' ' A' ' 8' ' ' GLU . 4.7 mp -102.01 99.01 9.13 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.658 -0.497 . . . . 15.0 109.658 178.825 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.451 ' CD2' ' CD2' ' A' ' 87' ' ' LEU . 0.1 OUTLIER -102.93 -161.42 0.84 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.383 0.611 . . . . 15.0 111.841 -178.772 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.433 ' HB2' HG13 ' A' ' 6' ' ' ILE . 3.1 tt0 -140.93 144.01 34.92 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.059 -0.973 . . . . 15.0 109.772 179.108 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 7.1 tptp -55.17 104.95 0.14 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.877 0.37 . . . . 15.0 110.961 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.36 0 C-N-CA 120.845 -0.693 . . . . 15.0 112.6 -179.897 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.442 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 1.3 mp . . . . . 0 N--CA 1.45 -0.462 0 CA-C-O 120.893 0.377 . . . . 15.0 111.176 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.463 ' O ' ' N ' ' A' ' 89' ' ' LEU . 6.8 p90 -140.64 164.31 30.53 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.063 -0.517 . . . . 15.0 110.203 178.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.493 ' HB2' HD11 ' A' ' 88' ' ' LEU . 0.3 OUTLIER -130.2 143.24 50.66 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.284 0.564 . . . . 15.0 111.66 -179.506 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.439 ' CG2' ' HB3' ' A' ' 51' ' ' ARG . 0.2 OUTLIER -101.42 114.35 40.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.184 -0.916 . . . . 15.0 109.397 178.859 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -106.01 72.25 0.93 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.213 -0.449 . . . . 15.0 112.137 -178.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.408 ' HB3' ' HB ' ' A' ' 85' ' ' VAL . 5.4 tp -88.21 166.39 14.39 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.429 -0.582 . . . . 15.0 109.429 178.61 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -96.02 97.66 9.77 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.05 0.453 . . . . 15.0 111.262 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.48 ' O ' ' HD3' ' A' ' 13' ' ' LYS . 0.1 OUTLIER . . . . . 0 C--N 1.327 -0.37 0 CA-C-N 115.735 -0.666 . . . . 15.0 111.42 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.4 mp . . . . . 0 N--CA 1.455 -0.204 0 CA-C-O 120.955 0.407 . . . . 15.0 110.715 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.787 ' O ' ' HB ' ' A' ' 41' ' ' ILE . . . -161.12 46.07 0.39 Allowed Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 121.034 -0.603 . . . . 15.0 111.794 -179.791 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.746 HG12 ' O ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -112.77 136.67 48.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 120.927 0.394 . . . . 15.0 111.581 -179.609 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 37.4 t -88.65 103.13 15.64 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.285 -1.006 . . . . 15.0 108.285 177.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.527 HG21 HG22 ' A' ' 75' ' ' VAL . 8.0 m -93.6 149.11 4.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 112.643 0.609 . . . . 15.0 112.643 -177.433 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.478 ' HA ' ' CE1' ' A' ' 71' ' ' HIS . 5.4 t -150.02 179.24 8.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.39 -0.823 . . . . 15.0 110.468 179.185 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.482 ' O ' ' HB2' ' A' ' 71' ' ' HIS . . . 82.78 -117.32 4.38 Favored Glycine 0 C--N 1.331 0.298 0 C-N-CA 120.542 -0.837 . . . . 15.0 112.649 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.572 ' HA3' ' N ' ' A' ' 71' ' ' HIS . . . 63.34 -65.87 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 121.084 -0.579 . . . . 15.0 113.742 179.184 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.439 ' N ' ' O ' ' A' ' 24' ' ' GLY . 0.0 OUTLIER -26.57 139.86 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 N-CA-C 112.633 0.605 . . . . 15.0 112.633 -178.994 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.421 ' HA ' ' O ' ' A' ' 32' ' ' HIS . 54.2 t-20 -77.62 57.67 1.65 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.768 -0.651 . . . . 15.0 110.927 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 5.9 m -151.69 -61.18 0.17 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.24 -0.437 . . . . 15.0 110.767 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.64 -34.77 77.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.15 -0.477 . . . . 15.0 110.692 179.755 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 33.2 m -88.02 -174.34 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.064 -0.516 . . . . 15.0 111.003 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -70.53 -51.5 28.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.394 -0.367 . . . . 15.0 111.241 -179.764 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . 0.421 ' O ' ' HA ' ' A' ' 27' ' ' ASN . 86.4 m-70 -132.52 -70.97 0.54 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.401 -0.363 . . . . 15.0 111.255 -179.745 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -162.75 24.84 0.21 Allowed Glycine 0 C--O 1.23 -0.145 0 C-N-CA 120.904 -0.665 . . . . 15.0 112.388 -179.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -86.89 148.19 21.5 Favored Glycine 0 N--CA 1.448 -0.522 0 N-CA-C 110.171 -1.172 . . . . 15.0 110.171 178.658 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.534 HG13 ' HA ' ' A' ' 71' ' ' HIS . 0.3 OUTLIER -88.68 153.78 3.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 C-N-CA 119.574 -0.85 . . . . 15.0 112.297 -178.894 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.477 ' CE2' ' CG ' ' A' ' 57' ' ' ARG . 32.4 m-85 -134.16 107.89 7.97 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.644 -1.162 . . . . 15.0 109.056 179.321 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.633 HG21 ' N ' ' A' ' 55' ' ' GLY . 0.7 OUTLIER -54.96 148.02 3.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.144 0.497 . . . . 15.0 111.189 -178.479 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.433 ' O ' ' HG2' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -80.05 -49.06 12.31 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.882 -0.784 . . . . 15.0 108.882 178.91 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.746 ' O ' HG12 ' A' ' 20' ' ' ILE . . . -172.33 172.45 4.46 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 115.999 -0.546 . . . . 15.0 110.184 178.439 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.544 ' HA ' ' CG1' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -96.72 110.01 24.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 108.957 -0.757 . . . . 15.0 108.957 178.905 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.787 ' HB ' ' O ' ' A' ' 19' ' ' GLY . 0.5 OUTLIER -78.0 115.25 48.98 Favored Pre-proline 0 C--N 1.326 -0.433 0 N-CA-C 113.275 0.843 . . . . 15.0 113.275 -177.053 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.543 ' HA ' ' CG ' ' A' ' 47' ' ' GLU . 30.3 Cg_exo -62.56 59.49 0.14 Allowed 'Trans proline' 0 C--N 1.358 1.07 0 C-N-CA 123.612 2.875 . . . . 15.0 112.95 179.706 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.509 ' N ' ' HG2' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -147.45 -47.38 0.17 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.594 0.235 . . . . 15.0 111.341 -179.985 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.717 ' HA3' ' HA3' ' A' ' 19' ' ' GLY . . . -87.67 168.89 38.37 Favored Glycine 0 C--N 1.33 0.217 0 C-N-CA 120.398 -0.906 . . . . 15.0 113.801 -179.136 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -58.12 -13.78 5.52 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.702 0.63 . . . . 15.0 112.702 -179.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.03 -56.46 5.59 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.97 -0.292 . . . . 15.0 110.69 -179.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.564 ' HG3' ' O ' ' A' ' 44' ' ' GLY . 2.8 pp20? -57.61 -43.33 84.68 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.997 -0.547 . . . . 15.0 110.434 179.172 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -53.81 -70.21 0.1 Allowed 'General case' 0 CA--C 1.518 -0.256 0 CA-C-N 115.902 -0.59 . . . . 15.0 110.523 -179.473 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.406 ' CB ' HD13 ' A' ' 11' ' ' LEU . 0.1 OUTLIER -58.13 -41.59 83.99 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.137 -0.69 . . . . 15.0 109.137 178.786 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.72 40.49 12.26 Favored Glycine 0 N--CA 1.445 -0.702 0 CA-C-N 115.305 -0.861 . . . . 15.0 111.676 179.309 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.439 ' HB3' ' CG2' ' A' ' 9' ' ' VAL . 0.1 OUTLIER -79.74 -49.9 11.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.891 0.376 . . . . 15.0 110.65 -179.351 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.433 ' CD1' HD12 ' A' ' 89' ' ' LEU . 8.8 tp -81.14 161.21 3.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.02 -0.536 . . . . 15.0 110.241 179.464 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . 0.496 ' O ' HG21 ' A' ' 37' ' ' VAL . 75.2 m80 -146.07 156.77 43.69 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-O 121.581 0.705 . . . . 15.0 112.258 -179.047 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.519 ' HA ' ' CG2' ' A' ' 37' ' ' VAL . 0.6 OUTLIER -43.28 132.51 4.37 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.3 -1.318 . . . . 15.0 112.902 -178.666 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.633 ' N ' HG21 ' A' ' 37' ' ' VAL . . . 50.98 29.87 21.34 Favored Glycine 0 C--N 1.335 0.475 0 CA-C-N 115.785 -0.643 . . . . 15.0 113.456 179.137 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.444 ' OD2' ' N ' ' A' ' 53' ' ' HIS . 6.4 m-20 -65.76 128.81 37.46 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.827 -0.349 . . . . 15.0 110.51 179.516 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.477 ' CG ' ' CE2' ' A' ' 36' ' ' TYR . 2.3 mtp85 -80.62 95.45 6.56 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.476 -0.329 . . . . 15.0 110.663 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.468 ' O ' ' CG2' ' A' ' 58' ' ' VAL . 1.5 m -85.76 113.42 23.91 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-O 121.094 0.474 . . . . 15.0 111.177 -179.654 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -107.35 -12.08 15.41 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 115.677 -0.692 . . . . 15.0 112.505 -179.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -150.71 148.25 28.33 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 112.762 0.653 . . . . 15.0 112.762 -178.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.439 ' HB ' ' CG1' ' A' ' 64' ' ' VAL . 15.4 t -139.12 99.51 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.231 -0.895 . . . . 15.0 109.107 178.741 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 9.2 m120 65.22 16.41 10.53 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.871 -0.418 . . . . 15.0 109.871 -177.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 107.2 4.93 35.3 Favored Glycine 0 C--N 1.336 0.544 0 CA-C-N 116.039 -0.528 . . . . 15.0 113.465 179.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.502 ' O ' ' CG1' ' A' ' 64' ' ' VAL . 5.2 p -93.8 106.37 17.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 117.168 0.484 . . . . 15.0 110.783 179.506 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.2 m -56.33 130.15 43.38 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.171 -0.468 . . . . 15.0 111.051 -179.609 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -89.44 -21.38 23.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.075 -0.511 . . . . 15.0 110.997 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -45.76 101.5 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.869 0.366 . . . . 15.0 111.062 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.78 63.11 0.55 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.791 -0.718 . . . . 15.0 112.4 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -173.02 160.59 4.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.89 0.376 . . . . 15.0 111.035 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.439 ' HA ' ' C ' ' A' ' 25' ' ' GLY . 3.0 p -93.17 -170.54 2.43 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.084 0.468 . . . . 15.0 111.055 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.572 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 0.2 OUTLIER -60.75 -61.02 2.89 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.691 -0.686 . . . . 15.0 110.13 179.908 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.451 ' O ' HG11 ' A' ' 75' ' ' VAL . 12.7 ttpp -53.21 -34.79 58.55 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.716 -0.674 . . . . 15.0 110.863 179.234 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -59.42 -54.9 41.37 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.645 -0.502 . . . . 15.0 109.645 179.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.428 ' O ' ' N ' ' A' ' 77' ' ' THR . . . -63.9 -43.55 95.65 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.823 -0.626 . . . . 15.0 109.536 178.458 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.527 HG22 HG21 ' A' ' 22' ' ' VAL . 0.5 OUTLIER -44.25 -40.06 1.68 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.296 0 N-CA-C 108.771 -0.825 . . . . 15.0 108.771 178.176 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.528 ' O ' ' HB2' ' A' ' 80' ' ' ASN . 3.6 mm-40 -67.42 -45.01 77.39 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 114.793 -1.094 . . . . 15.0 110.302 178.377 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.428 ' N ' ' O ' ' A' ' 74' ' ' ALA . 32.9 p -64.02 -54.64 31.08 Favored 'General case' 0 C--O 1.231 0.124 0 C-N-CA 121.055 -0.258 . . . . 15.0 111.509 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.424 ' HG ' ' O ' ' A' ' 74' ' ' ALA . 6.5 mt -53.37 -46.6 69.68 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-O 121.262 0.553 . . . . 15.0 109.8 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.407 ' HB2' ' O ' ' A' ' 75' ' ' VAL . 8.9 tpp180 -68.49 -59.81 2.88 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.266 -0.879 . . . . 15.0 110.5 179.284 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.528 ' HB2' ' O ' ' A' ' 76' ' ' GLU . 10.9 m-80 -66.12 62.11 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.98 -0.554 . . . . 15.0 111.833 179.801 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.452 ' HB ' ' HG3' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -93.74 -74.16 0.54 Allowed 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.804 -0.443 . . . . 15.0 109.804 179.182 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 122.03 -106.15 1.05 Allowed Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.802 -0.713 . . . . 15.0 113.195 179.019 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -64.7 -82.13 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 111.984 0.365 . . . . 15.0 111.984 -179.067 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.417 HG13 ' N ' ' A' ' 85' ' ' VAL . 62.4 t -109.87 158.29 10.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.06 0.457 . . . . 15.0 110.87 -179.335 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.428 ' O ' ' CG1' ' A' ' 85' ' ' VAL . 14.0 t -97.93 80.96 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 116.084 -0.507 . . . . 15.0 110.569 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -103.13 83.39 2.2 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.901 -0.591 . . . . 15.0 110.265 179.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.443 ' CD2' ' CD2' ' A' ' 89' ' ' LEU . 0.1 OUTLIER -99.93 118.32 36.11 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.952 -0.567 . . . . 15.0 111.756 -179.088 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.493 HD11 ' HB2' ' A' ' 8' ' ' GLU . 4.3 mp -92.14 101.1 13.62 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.757 -0.46 . . . . 15.0 109.757 178.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.468 HD22 ' HA ' ' A' ' 58' ' ' VAL . 0.2 OUTLIER -105.65 -159.71 0.72 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.303 0.573 . . . . 15.0 111.66 -178.836 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.442 ' HA ' ' HA ' ' A' ' 6' ' ' ILE . 3.1 tt0 -140.58 145.23 36.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.311 -0.859 . . . . 15.0 110.195 179.243 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.85 106.87 0.34 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.249 -0.432 . . . . 15.0 110.977 -179.837 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.379 0 C-N-CA 120.842 -0.695 . . . . 15.0 112.581 -179.849 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.499 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 1.5 mp . . . . . 0 N--CA 1.45 -0.425 0 CA-C-O 120.893 0.378 . . . . 15.0 111.301 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.433 ' O ' ' N ' ' A' ' 89' ' ' LEU . 3.8 p90 -144.56 165.03 29.15 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.061 -0.518 . . . . 15.0 110.415 178.799 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.492 ' CB ' HD11 ' A' ' 88' ' ' LEU . 10.7 pt-20 -130.19 143.84 51.01 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.201 0.524 . . . . 15.0 111.6 -179.05 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.429 ' N ' ' O ' ' A' ' 87' ' ' LEU . 0.2 OUTLIER -101.64 117.13 46.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.441 -0.799 . . . . 15.0 109.542 178.615 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 -106.14 74.86 1.06 Allowed 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 112.33 0.493 . . . . 15.0 112.33 -178.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.498 ' HB3' ' HB ' ' A' ' 85' ' ' VAL . 6.8 tp -88.19 166.34 14.44 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.389 -0.597 . . . . 15.0 109.389 178.43 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -96.2 95.76 8.35 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.041 0.448 . . . . 15.0 111.28 -179.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.51 ' O ' ' HD3' ' A' ' 13' ' ' LYS . 0.2 OUTLIER . . . . . 0 C--N 1.327 -0.396 0 CA-C-N 115.73 -0.668 . . . . 15.0 111.195 179.869 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.0 mp . . . . . 0 N--CA 1.454 -0.231 0 CA-C-O 120.826 0.346 . . . . 15.0 110.561 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.629 ' O ' ' HB ' ' A' ' 41' ' ' ILE . . . -160.99 36.86 0.42 Allowed Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 121.136 -0.554 . . . . 15.0 111.782 -179.636 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.595 HG12 ' O ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -112.66 141.68 27.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 120.996 0.427 . . . . 15.0 112.027 -179.291 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 31.4 t -96.24 102.69 14.52 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 107.301 -1.37 . . . . 15.0 107.301 176.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.423 ' CG1' ' CG2' ' A' ' 20' ' ' ILE . 14.1 m -93.33 148.26 4.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 113.536 0.939 . . . . 15.0 113.536 -176.293 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.533 ' O ' ' O ' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -149.86 157.92 43.66 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.005 -0.998 . . . . 15.0 110.699 179.586 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.425 ' O ' HG12 ' A' ' 35' ' ' ILE . . . 67.71 112.67 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.444 -0.884 . . . . 15.0 113.42 178.653 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.506 ' HA3' ' N ' ' A' ' 71' ' ' HIS . . . -163.74 -38.97 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 121.112 -0.566 . . . . 15.0 112.301 179.244 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.472 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 0.2 OUTLIER -40.78 162.58 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-O 120.868 0.366 . . . . 15.0 111.823 179.935 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -87.91 51.72 2.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.454 . . . . 15.0 110.887 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -151.63 -62.15 0.17 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.094 -0.503 . . . . 15.0 110.663 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.75 -52.34 51.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.192 -0.458 . . . . 15.0 110.609 179.753 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 16.4 m -87.98 -177.68 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.137 -0.483 . . . . 15.0 110.771 179.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 5.1 ppt_? -88.41 127.1 35.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.851 0.358 . . . . 15.0 111.184 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 57.1 m80 62.76 -82.14 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.005 -0.543 . . . . 15.0 111.424 179.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -177.25 33.08 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.721 -0.752 . . . . 15.0 112.661 -179.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -93.52 156.35 22.58 Favored Glycine 0 N--CA 1.45 -0.388 0 N-CA-C 110.846 -0.902 . . . . 15.0 110.846 179.079 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.474 HG21 HG22 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -97.64 153.6 3.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 119.854 -0.738 . . . . 15.0 111.997 -179.29 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.533 ' O ' ' O ' ' A' ' 23' ' ' THR . 26.8 m-85 -134.17 106.82 7.37 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.963 -1.017 . . . . 15.0 109.7 179.225 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.653 HG21 ' N ' ' A' ' 55' ' ' GLY . 0.7 OUTLIER -54.63 146.64 3.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.106 0.479 . . . . 15.0 111.282 -178.593 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.462 ' HB3' ' OG1' ' A' ' 23' ' ' THR . 0.0 OUTLIER -79.94 -48.87 12.71 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.319 -0.993 . . . . 15.0 108.319 178.78 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.595 ' O ' HG12 ' A' ' 20' ' ' ILE . . . -172.23 171.07 4.95 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.285 -0.87 . . . . 15.0 110.119 178.612 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.517 ' HA ' HG12 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -97.1 110.26 24.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.085 0.469 . . . . 15.0 110.182 179.558 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.629 ' HB ' ' O ' ' A' ' 19' ' ' GLY . 0.4 OUTLIER -78.47 109.58 10.99 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 115.701 -0.682 . . . . 15.0 112.32 -178.326 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.471 ' HA ' ' CG ' ' A' ' 47' ' ' GLU . 31.4 Cg_endo -63.45 65.88 0.18 Allowed 'Trans proline' 0 C--N 1.355 0.919 0 C-N-CA 123.159 2.572 . . . . 15.0 112.568 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 5.2 tp60 -147.32 -53.34 0.21 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.322 -0.854 . . . . 15.0 109.112 179.469 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.551 ' HA3' ' HA3' ' A' ' 19' ' ' GLY . . . -87.93 157.18 28.19 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.667 -0.778 . . . . 15.0 112.51 179.175 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -41.58 -17.38 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 113.588 0.958 . . . . 15.0 113.588 -179.531 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.43 ' N ' ' O ' ' A' ' 44' ' ' GLY . . . -71.65 -70.72 0.31 Allowed 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.75 -0.38 . . . . 15.0 111.345 -179.409 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.497 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 4.3 tp10 -58.54 -40.6 83.43 Favored 'General case' 0 N--CA 1.463 0.179 0 C-N-CA 120.587 -0.445 . . . . 15.0 110.436 179.546 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.8 m -54.15 -63.56 1.11 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.997 -0.547 . . . . 15.0 110.338 179.355 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.421 ' CB ' HD13 ' A' ' 11' ' ' LEU . 1.9 t70 -63.5 -40.05 96.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.108 -0.496 . . . . 15.0 109.899 179.081 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.58 43.37 8.49 Favored Glycine 0 N--CA 1.449 -0.437 0 CA-C-N 115.678 -0.692 . . . . 15.0 112.836 179.472 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.421 ' HB3' ' CG2' ' A' ' 9' ' ' VAL . 1.1 mmt-85 -89.34 -52.81 4.85 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.938 0.399 . . . . 15.0 110.557 179.696 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.47 HG21 ' CG1' ' A' ' 40' ' ' VAL . 9.7 tp -81.0 159.16 4.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.036 -0.529 . . . . 15.0 110.398 179.546 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . 0.456 ' O ' HG21 ' A' ' 37' ' ' VAL . 80.3 m80 -139.69 160.88 38.87 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-O 121.794 0.807 . . . . 15.0 112.758 -178.871 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.53 ' HA ' ' CG2' ' A' ' 37' ' ' VAL . 0.2 OUTLIER -44.67 134.29 5.53 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.002 -1.453 . . . . 15.0 113.1 -178.657 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.653 ' N ' HG21 ' A' ' 37' ' ' VAL . . . 49.66 31.8 15.97 Favored Glycine 0 C--N 1.334 0.442 0 CA-C-N 115.738 -0.664 . . . . 15.0 113.636 178.802 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.48 ' HB2' HG12 ' A' ' 37' ' ' VAL . 0.3 OUTLIER -65.97 131.71 46.88 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.506 -0.478 . . . . 15.0 110.683 179.442 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.486 ' HG2' ' CE2' ' A' ' 36' ' ' TYR . 6.6 mtp85 -82.65 87.41 6.73 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.351 -0.386 . . . . 15.0 110.113 179.411 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.474 HG22 HG21 ' A' ' 35' ' ' ILE . 1.3 m -79.31 113.25 18.4 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 CA-C-O 121.158 0.504 . . . . 15.0 111.087 -179.379 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 21.3 mt -107.56 -14.48 14.82 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 115.472 -0.786 . . . . 15.0 112.493 -179.173 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -147.5 150.41 34.51 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.604 0.594 . . . . 15.0 112.604 -178.414 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.452 HG22 HD23 ' A' ' 87' ' ' LEU . 80.9 t -139.05 102.72 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.175 -0.92 . . . . 15.0 109.018 178.746 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.41 ' ND2' ' CG2' ' A' ' 81' ' ' THR . 1.7 m-80 65.11 14.89 9.68 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.723 -0.473 . . . . 15.0 109.723 -177.901 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 106.4 6.71 35.72 Favored Glycine 0 C--N 1.336 0.566 0 CA-C-N 115.839 -0.619 . . . . 15.0 113.366 179.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.497 ' O ' ' CG1' ' A' ' 64' ' ' VAL . 6.5 p -93.79 104.96 16.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 117.17 0.485 . . . . 15.0 110.874 179.486 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 50.8 m -58.47 121.3 10.55 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.148 -0.478 . . . . 15.0 110.733 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -87.56 -10.04 52.7 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.031 -0.532 . . . . 15.0 111.185 -179.879 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -46.12 98.48 0.01 OUTLIER 'General case' 0 C--N 1.334 -0.105 0 CA-C-O 120.916 0.389 . . . . 15.0 110.799 179.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.94 68.66 0.62 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.75 -0.738 . . . . 15.0 112.193 -179.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -172.87 167.7 5.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.783 0.325 . . . . 15.0 110.863 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.472 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 7.0 p -92.98 -175.05 3.76 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.238 -0.437 . . . . 15.0 111.335 -179.604 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.506 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 0.0 OUTLIER -63.32 -61.2 2.51 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.928 -0.578 . . . . 15.0 110.283 -179.873 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.4 ' N ' ' CG ' ' A' ' 71' ' ' HIS . 3.0 ttpp -52.7 -33.06 45.92 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.772 -0.649 . . . . 15.0 110.732 179.568 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -59.41 -48.25 82.36 Favored 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 109.403 -0.591 . . . . 15.0 109.403 179.236 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.456 ' HA ' ' OG1' ' A' ' 77' ' ' THR . . . -65.37 -47.99 74.5 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.719 -0.673 . . . . 15.0 109.214 178.307 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.409 ' CG2' ' CG2' ' A' ' 22' ' ' VAL . 0.5 OUTLIER -43.39 -39.42 1.17 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.242 0 N-CA-C 108.74 -0.837 . . . . 15.0 108.74 178.07 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -67.31 -45.92 75.06 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 114.739 -1.119 . . . . 15.0 110.349 178.468 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.456 ' OG1' ' HA ' ' A' ' 74' ' ' ALA . 10.0 p -64.37 -53.18 52.6 Favored 'General case' 0 C--O 1.231 0.129 0 C-N-CA 120.893 -0.323 . . . . 15.0 111.309 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.441 ' HG ' ' O ' ' A' ' 74' ' ' ALA . 5.7 mt -53.36 -48.28 68.69 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-O 121.219 0.533 . . . . 15.0 109.944 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -68.4 -59.04 3.47 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.353 -0.84 . . . . 15.0 110.351 179.357 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 75.1 m-20 -66.02 61.47 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.846 -0.615 . . . . 15.0 111.911 179.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.46 ' HB ' ' HG3' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -95.72 -71.01 0.69 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.693 0.282 . . . . 15.0 110.51 179.519 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 122.15 -104.42 0.91 Allowed Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.824 -0.703 . . . . 15.0 113.186 179.345 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . 0.408 ' O ' ' HB3' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -64.64 -83.41 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 111.965 0.357 . . . . 15.0 111.965 -179.066 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.426 HG13 ' N ' ' A' ' 85' ' ' VAL . 53.9 t -109.46 159.91 8.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.94 0.4 . . . . 15.0 110.839 -179.543 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.498 ' HB ' ' HB3' ' A' ' 11' ' ' LEU . 24.5 t -97.87 79.59 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.161 -0.472 . . . . 15.0 110.52 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -100.63 85.39 2.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.856 -0.611 . . . . 15.0 110.594 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.464 ' CD2' ' CD2' ' A' ' 89' ' ' LEU . 0.1 OUTLIER -99.57 123.11 43.53 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.083 -0.508 . . . . 15.0 111.513 -179.468 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.492 HD11 ' CB ' ' A' ' 8' ' ' GLU . 4.7 mp -98.5 100.74 12.02 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.891 -0.411 . . . . 15.0 109.891 179.014 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.464 ' CD2' ' CD2' ' A' ' 87' ' ' LEU . 0.1 OUTLIER -105.93 -162.29 0.85 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.428 0.632 . . . . 15.0 111.903 -178.87 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.499 ' HA ' ' HA ' ' A' ' 6' ' ' ILE . 3.1 tt0 -138.25 142.26 39.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 114.977 -1.01 . . . . 15.0 109.952 178.88 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 4.2 tptt -54.25 103.32 0.08 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.36 -0.382 . . . . 15.0 111.129 -179.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.37 0 C-N-CA 120.862 -0.685 . . . . 15.0 112.522 -179.971 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.415 HG13 ' HB2' ' A' ' 90' ' ' GLU . 1.4 mp . . . . . 0 N--CA 1.45 -0.425 0 CA-C-O 120.86 0.362 . . . . 15.0 111.181 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.421 ' CE1' HD13 ' A' ' 89' ' ' LEU . 2.3 p90 -140.66 158.17 44.37 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.122 -0.49 . . . . 15.0 110.456 178.794 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.492 ' HB2' HD11 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -123.96 143.6 50.3 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.289 0.566 . . . . 15.0 111.566 -179.37 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.43 HG22 ' CG ' ' A' ' 51' ' ' ARG . 0.5 OUTLIER -101.31 114.6 41.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.295 -0.866 . . . . 15.0 109.6 179.08 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -106.24 70.38 0.84 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.261 -0.427 . . . . 15.0 112.021 -178.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.477 ' HB3' ' HB ' ' A' ' 85' ' ' VAL . 8.6 tp -88.26 162.1 16.82 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.137 -0.483 . . . . 15.0 110.007 179.069 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -96.58 99.28 10.92 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.703 0.287 . . . . 15.0 111.042 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.453 ' HB3' ' O ' ' A' ' 83' ' ' GLN . 0.3 OUTLIER . . . . . 0 CA--C 1.533 0.324 0 N-CA-C 112.651 0.611 . . . . 15.0 112.651 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.9 mp . . . . . 0 N--CA 1.451 -0.391 0 CA-C-O 120.847 0.356 . . . . 15.0 110.581 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.619 ' O ' ' HB ' ' A' ' 41' ' ' ILE . . . -160.78 38.42 0.43 Allowed Glycine 0 N--CA 1.449 -0.48 0 N-CA-C 111.527 -0.629 . . . . 15.0 111.527 -179.774 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.703 HG12 ' O ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -112.62 140.78 30.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-O 120.937 0.399 . . . . 15.0 111.835 -179.363 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.413 ' HB3' HD11 ' A' ' 41' ' ' ILE . 30.8 t -96.09 105.92 18.03 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 107.79 -1.189 . . . . 15.0 107.79 177.491 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.473 HG11 ' CG2' ' A' ' 20' ' ' ILE . 14.5 m -93.67 151.91 3.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 113.087 0.773 . . . . 15.0 113.087 -176.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -149.46 174.02 12.94 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 114.752 -1.113 . . . . 15.0 110.489 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.433 ' O ' ' CB ' ' A' ' 71' ' ' HIS . . . 80.94 -118.54 4.65 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.491 -0.861 . . . . 15.0 112.356 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.541 ' HA3' ' N ' ' A' ' 71' ' ' HIS . . . 66.66 -65.72 0.18 Allowed Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.967 -0.635 . . . . 15.0 113.497 179.268 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.417 ' C ' ' O ' ' A' ' 25' ' ' GLY . 0.0 OUTLIER -28.43 139.78 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 N-CA-C 112.38 0.511 . . . . 15.0 112.38 -179.188 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 11.2 m-80 -75.53 61.3 1.29 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.913 -0.585 . . . . 15.0 111.024 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -151.7 -64.46 0.18 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.28 -0.418 . . . . 15.0 110.927 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 59.7 p -69.1 -49.13 59.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.176 -0.465 . . . . 15.0 110.954 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.425 HG13 ' CD1' ' A' ' 36' ' ' TYR . 23.1 m -70.6 -173.56 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.159 -0.473 . . . . 15.0 111.114 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.69 -67.13 0.31 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.291 -0.413 . . . . 15.0 111.055 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 10.1 p-80 -139.32 -45.3 0.46 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.315 -0.402 . . . . 15.0 111.052 -179.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -168.38 25.54 0.12 Allowed Glycine 0 N--CA 1.453 -0.212 0 C-N-CA 120.894 -0.669 . . . . 15.0 112.508 -179.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -94.47 152.53 20.64 Favored Glycine 0 N--CA 1.448 -0.509 0 N-CA-C 110.443 -1.063 . . . . 15.0 110.443 178.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.563 HG13 ' HA ' ' A' ' 71' ' ' HIS . 0.1 OUTLIER -95.79 153.22 3.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 C-N-CA 119.731 -0.787 . . . . 15.0 112.329 -179.021 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.439 ' CZ ' ' HG2' ' A' ' 57' ' ' ARG . 29.3 m-85 -135.04 106.55 6.86 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.699 -1.137 . . . . 15.0 109.158 179.117 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.664 HG21 ' N ' ' A' ' 55' ' ' GLY . 0.8 OUTLIER -55.22 148.05 3.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.127 0.489 . . . . 15.0 111.571 -178.392 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.42 ' O ' ' HG2' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -80.37 -49.59 11.29 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.509 -0.923 . . . . 15.0 108.509 178.3 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.703 ' O ' HG12 ' A' ' 20' ' ' ILE . . . -172.17 172.71 4.5 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.963 -0.562 . . . . 15.0 110.879 178.808 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.5 ' HA ' ' CG1' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -96.81 112.72 29.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 N-CA-C 109.598 -0.519 . . . . 15.0 109.598 179.296 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.619 ' HB ' ' O ' ' A' ' 19' ' ' GLY . 0.3 OUTLIER -78.45 119.33 76.92 Favored Pre-proline 0 C--N 1.328 -0.327 0 N-CA-C 113.334 0.864 . . . . 15.0 113.334 -177.403 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.535 ' HA ' ' CG ' ' A' ' 47' ' ' GLU . 38.0 Cg_endo -65.15 61.1 0.32 Allowed 'Trans proline' 0 C--N 1.356 0.966 0 C-N-CA 123.448 2.766 . . . . 15.0 112.944 179.676 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.511 ' H ' ' HG2' ' A' ' 47' ' ' GLU . 0.1 OUTLIER -151.32 -44.75 0.11 Allowed 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 111.663 0.246 . . . . 15.0 111.663 179.903 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.577 ' HA3' ' HA3' ' A' ' 19' ' ' GLY . . . -87.71 165.54 35.16 Favored Glycine 0 CA--C 1.518 0.255 0 C-N-CA 120.328 -0.939 . . . . 15.0 113.719 -179.159 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -55.47 -15.88 3.19 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.796 0.665 . . . . 15.0 112.796 -179.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.2 -57.11 4.51 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.648 0.261 . . . . 15.0 111.204 -179.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.535 ' CG ' ' HA ' ' A' ' 42' ' ' PRO . 2.6 pp20? -56.93 -41.72 78.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.913 0.387 . . . . 15.0 110.386 179.711 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -53.91 -68.82 0.15 Allowed 'General case' 0 CA--C 1.52 -0.182 0 CA-C-N 115.91 -0.587 . . . . 15.0 110.851 -179.393 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -63.2 -39.13 93.75 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.57 -0.529 . . . . 15.0 109.57 179.13 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.07 45.55 7.52 Favored Glycine 0 N--CA 1.447 -0.595 0 CA-C-N 115.452 -0.795 . . . . 15.0 111.758 179.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.43 ' CG ' HG22 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -79.41 -53.15 7.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.966 0.413 . . . . 15.0 110.578 -179.377 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.415 ' CD1' HD12 ' A' ' 89' ' ' LEU . 7.9 tp -82.34 164.97 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 CA-C-N 115.947 -0.569 . . . . 15.0 110.392 179.676 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . 0.46 ' O ' ' HB2' ' A' ' 56' ' ' ASP . 76.3 m80 -147.68 158.01 43.81 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-O 121.674 0.75 . . . . 15.0 112.285 -179.147 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.511 ' HA ' ' CG2' ' A' ' 37' ' ' VAL . 8.5 mtpt -43.4 134.08 4.03 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.302 -1.317 . . . . 15.0 112.94 -178.617 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.664 ' N ' HG21 ' A' ' 37' ' ' VAL . . . 49.9 31.12 16.63 Favored Glycine 0 C--N 1.334 0.432 0 CA-C-N 115.692 -0.686 . . . . 15.0 113.659 179.051 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.483 ' HB2' HG12 ' A' ' 37' ' ' VAL . 0.4 OUTLIER -66.09 129.94 41.52 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 117.094 0.447 . . . . 15.0 110.786 179.563 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.439 ' HG2' ' CZ ' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -81.33 89.96 6.12 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.299 -0.41 . . . . 15.0 110.138 179.371 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.503 ' HA ' HD22 ' A' ' 89' ' ' LEU . 1.4 m -82.8 114.17 23.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 CA-C-O 121.073 0.463 . . . . 15.0 111.584 -179.146 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -107.69 -12.84 15.16 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 115.614 -0.721 . . . . 15.0 112.501 -179.498 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -149.72 149.0 29.91 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 112.659 0.614 . . . . 15.0 112.659 -178.527 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.454 ' HB ' ' CG1' ' A' ' 64' ' ' VAL . 23.1 t -142.29 99.04 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.27 0 CA-C-N 115.304 -0.862 . . . . 15.0 109.441 178.842 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 65.05 16.67 10.69 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.155 -0.475 . . . . 15.0 109.896 -178.282 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 107.17 6.04 34.36 Favored Glycine 0 C--N 1.336 0.536 0 CA-C-N 115.813 -0.631 . . . . 15.0 113.564 179.48 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.526 ' O ' ' CG1' ' A' ' 64' ' ' VAL . 4.6 p -93.75 103.71 14.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 117.292 0.546 . . . . 15.0 110.628 179.155 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -57.91 127.69 33.35 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.134 -0.484 . . . . 15.0 111.071 -179.417 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -87.69 -15.86 35.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.021 -0.536 . . . . 15.0 111.063 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -45.24 95.32 0.01 OUTLIER 'General case' 0 N--CA 1.461 0.114 0 CA-C-O 120.871 0.367 . . . . 15.0 111.008 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 103.75 69.35 0.79 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.79 -0.719 . . . . 15.0 112.238 -179.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -173.03 142.73 1.09 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.901 0.381 . . . . 15.0 111.049 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.411 ' CB ' ' HA ' ' A' ' 26' ' ' VAL . 13.7 p -74.3 -172.5 1.45 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.162 -0.472 . . . . 15.0 111.241 -179.774 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.563 ' HA ' HG13 ' A' ' 35' ' ' ILE . 0.1 OUTLIER -62.19 -59.49 4.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.914 -0.584 . . . . 15.0 110.475 179.99 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.403 ' HA ' ' HB ' ' A' ' 75' ' ' VAL . 6.6 ttmt -52.81 -33.8 50.77 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.871 -0.604 . . . . 15.0 110.623 179.399 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -59.54 -52.93 63.45 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.708 -0.478 . . . . 15.0 109.708 179.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.429 ' O ' ' N ' ' A' ' 77' ' ' THR . . . -67.08 -42.4 84.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.099 -0.501 . . . . 15.0 109.725 178.48 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.415 HG11 ' N ' ' A' ' 76' ' ' GLU . 0.5 OUTLIER -44.31 -39.51 1.63 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.221 0 N-CA-C 108.985 -0.746 . . . . 15.0 108.985 178.528 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.417 ' O ' ' N ' ' A' ' 80' ' ' ASN . 4.5 mm-40 -67.3 -44.17 79.88 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.751 -1.113 . . . . 15.0 110.314 178.586 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.429 ' N ' ' O ' ' A' ' 74' ' ' ALA . 27.6 p -64.04 -56.15 17.11 Favored 'General case' 0 N--CA 1.462 0.151 0 C-N-CA 121.047 -0.261 . . . . 15.0 111.375 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.433 ' CD2' HG21 ' A' ' 61' ' ' VAL . 4.6 mt -53.49 -46.94 70.22 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 121.179 0.514 . . . . 15.0 109.958 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 3.3 tmt_? -68.49 -60.27 2.55 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.434 -0.803 . . . . 15.0 110.739 179.53 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.417 ' N ' ' O ' ' A' ' 76' ' ' GLU . 15.2 m-20 -65.96 60.83 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.846 -0.615 . . . . 15.0 112.222 -179.76 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.57 -76.08 0.51 Allowed 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.744 -0.465 . . . . 15.0 109.744 178.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 112.75 -98.51 0.96 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.634 -0.793 . . . . 15.0 113.58 178.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . 0.453 ' O ' ' HB3' ' A' ' 13' ' ' LYS . 0.5 OUTLIER -63.92 -87.92 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 111.682 0.252 . . . . 15.0 111.682 -178.907 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.412 ' CG1' ' N ' ' A' ' 85' ' ' VAL . 72.0 t -110.06 158.23 10.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.066 0.46 . . . . 15.0 110.925 -179.738 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.478 ' O ' ' CG1' ' A' ' 85' ' ' VAL . 3.8 t -97.87 81.92 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.094 -0.503 . . . . 15.0 110.256 179.698 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . 0.43 ' CE1' HD13 ' A' ' 88' ' ' LEU . 1.4 t60 -100.7 82.81 2.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.766 -0.652 . . . . 15.0 109.99 179.585 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.471 ' HB3' ' CD2' ' A' ' 89' ' ' LEU . 0.1 OUTLIER -103.79 115.97 31.44 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.799 -0.637 . . . . 15.0 112.05 -178.745 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.492 HD11 ' HB2' ' A' ' 8' ' ' GLU . 4.0 mp -92.21 102.13 14.64 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.451 -0.574 . . . . 15.0 109.451 178.576 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.503 HD22 ' HA ' ' A' ' 58' ' ' VAL . 0.1 OUTLIER -105.81 -161.74 0.82 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.487 0.661 . . . . 15.0 112.102 -178.317 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.415 ' HB2' HG13 ' A' ' 6' ' ' ILE . 3.5 tt0 -143.98 135.38 25.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 114.879 -1.055 . . . . 15.0 109.621 179.148 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.08 103.56 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.005 0.431 . . . . 15.0 111.087 -179.566 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.299 0 C-N-CA 120.944 -0.646 . . . . 15.0 112.706 -179.706 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.484 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 1.2 mp . . . . . 0 N--CA 1.45 -0.426 0 CA-C-O 120.508 0.194 . . . . 15.0 110.624 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.429 ' CD1' ' C ' ' A' ' 7' ' ' PHE . 3.0 p90 -141.93 141.32 32.96 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.035 0.445 . . . . 15.0 111.206 179.418 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.511 ' HB2' HD11 ' A' ' 88' ' ' LEU . 5.6 pm0 -113.53 141.8 46.71 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.804 -0.635 . . . . 15.0 111.15 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.429 ' N ' ' O ' ' A' ' 87' ' ' LEU . 0.2 OUTLIER -101.41 114.02 39.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.45 -0.796 . . . . 15.0 109.839 179.335 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -105.96 71.16 0.88 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.033 -0.53 . . . . 15.0 111.896 -178.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.417 ' HB3' ' HB ' ' A' ' 85' ' ' VAL . 5.4 tp -88.65 166.83 13.84 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.155 -0.475 . . . . 15.0 109.949 179.016 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -96.08 96.88 9.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.028 0.442 . . . . 15.0 111.163 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.49 ' O ' ' HD3' ' A' ' 13' ' ' LYS . 0.1 OUTLIER . . . . . 0 C--N 1.327 -0.393 0 CA-C-N 115.725 -0.671 . . . . 15.0 111.442 -179.721 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 9.8 mt . . . . . 0 N--CA 1.455 -0.188 0 CA-C-O 120.968 0.413 . . . . 15.0 110.794 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.642 ' O ' ' HB ' ' A' ' 41' ' ' ILE . . . -161.13 38.59 0.42 Allowed Glycine 0 N--CA 1.449 -0.459 0 CA-C-N 115.867 -0.606 . . . . 15.0 111.752 -179.831 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.711 HG12 ' O ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -112.69 140.75 30.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 121.02 0.438 . . . . 15.0 111.94 -179.358 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 41.0 t -96.11 106.18 18.32 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 107.837 -1.171 . . . . 15.0 107.837 177.296 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.435 HG22 ' CD2' ' A' ' 71' ' ' HIS . 31.2 m -93.54 152.5 3.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 113.083 0.771 . . . . 15.0 113.083 -177.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -149.46 179.27 8.09 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 114.863 -1.062 . . . . 15.0 110.728 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.431 ' O ' ' CB ' ' A' ' 71' ' ' HIS . . . 74.22 -120.23 6.56 Favored Glycine 0 C--N 1.33 0.24 0 C-N-CA 120.672 -0.775 . . . . 15.0 112.327 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.532 ' HA3' ' N ' ' A' ' 71' ' ' HIS . . . 67.52 -65.69 0.27 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.848 -0.691 . . . . 15.0 113.631 179.31 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.444 ' N ' ' HA ' ' A' ' 70' ' ' THR . 2.0 m -31.22 140.84 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 N-CA-C 112.328 0.492 . . . . 15.0 112.328 -179.17 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 14.2 p-10 -75.47 64.62 1.62 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.944 -0.571 . . . . 15.0 111.035 -179.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.5 m -151.67 -61.52 0.17 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.263 -0.426 . . . . 15.0 111.075 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 91.3 p -76.45 -42.88 42.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.18 -0.464 . . . . 15.0 111.155 -179.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.428 HG13 ' CD1' ' A' ' 36' ' ' TYR . 35.3 m -73.78 -176.17 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.274 -0.421 . . . . 15.0 111.275 -179.858 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.14 -59.96 4.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.118 -0.492 . . . . 15.0 111.078 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 10.5 m80 -143.55 -47.93 0.3 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.306 -0.407 . . . . 15.0 111.149 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -169.44 22.56 0.09 OUTLIER Glycine 0 CA--C 1.519 0.292 0 C-N-CA 120.668 -0.777 . . . . 15.0 112.888 -179.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -87.55 154.46 26.02 Favored Glycine 0 N--CA 1.451 -0.354 0 N-CA-C 110.788 -0.925 . . . . 15.0 110.788 178.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.473 ' CG1' ' HA ' ' A' ' 71' ' ' HIS . 0.0 OUTLIER -92.5 152.02 3.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 C-N-CA 119.895 -0.722 . . . . 15.0 111.906 -179.242 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.494 ' CZ ' ' HG2' ' A' ' 57' ' ' ARG . 53.8 m-85 -137.3 106.64 6.08 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.835 -1.075 . . . . 15.0 109.892 179.333 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.696 HG21 ' N ' ' A' ' 55' ' ' GLY . 0.6 OUTLIER -57.46 146.0 7.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.977 -0.556 . . . . 15.0 111.144 -179.089 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.477 ' O ' ' HG2' ' A' ' 54' ' ' LYS . 0.6 OUTLIER -80.33 -48.87 12.32 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.947 -0.76 . . . . 15.0 108.947 178.837 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.711 ' O ' HG12 ' A' ' 20' ' ' ILE . . . -172.07 172.6 4.61 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.906 -0.588 . . . . 15.0 110.736 178.811 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.484 ' HA ' ' CG1' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -96.86 112.93 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 N-CA-C 109.781 -0.451 . . . . 15.0 109.781 179.433 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.642 ' HB ' ' O ' ' A' ' 19' ' ' GLY . 0.3 OUTLIER -78.56 118.49 72.65 Favored Pre-proline 0 C--N 1.328 -0.331 0 N-CA-C 113.021 0.749 . . . . 15.0 113.021 -177.764 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.536 ' HA ' ' CG ' ' A' ' 47' ' ' GLU . 37.2 Cg_endo -64.8 60.63 0.29 Allowed 'Trans proline' 0 C--N 1.356 0.935 0 C-N-CA 123.416 2.744 . . . . 15.0 112.91 179.842 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.507 ' H ' ' HG2' ' A' ' 47' ' ' GLU . 41.1 tt0 -149.87 -46.26 0.13 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.632 -0.258 . . . . 15.0 111.511 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.583 ' HA3' ' HA3' ' A' ' 19' ' ' GLY . . . -87.8 166.91 36.12 Favored Glycine 0 CA--C 1.519 0.314 0 C-N-CA 120.417 -0.897 . . . . 15.0 114.008 -178.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -55.29 -15.43 2.45 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.911 0.708 . . . . 15.0 112.911 -179.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.97 -57.4 4.33 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 121.005 -0.278 . . . . 15.0 111.051 -179.418 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.536 ' CG ' ' HA ' ' A' ' 42' ' ' PRO . 2.9 pp20? -57.05 -42.99 81.57 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.035 -0.529 . . . . 15.0 110.378 179.358 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -53.88 -70.47 0.1 Allowed 'General case' 0 CA--C 1.52 -0.194 0 CA-C-N 115.893 -0.594 . . . . 15.0 110.498 -179.623 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.411 ' CB ' HD13 ' A' ' 11' ' ' LEU . 14.4 t0 -58.21 -39.92 80.26 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.349 -0.611 . . . . 15.0 109.349 178.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.76 35.02 26.24 Favored Glycine 0 N--CA 1.447 -0.631 0 CA-C-N 115.384 -0.825 . . . . 15.0 111.595 179.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.415 ' HB3' ' CG2' ' A' ' 9' ' ' VAL . 0.3 OUTLIER -79.73 -46.5 16.94 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.05 0.452 . . . . 15.0 110.524 -179.431 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.439 ' CG2' HG13 ' A' ' 20' ' ' ILE . 7.0 tp -80.94 149.95 4.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.697 -0.683 . . . . 15.0 109.616 179.371 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . 0.461 ' O ' HG21 ' A' ' 37' ' ' VAL . 80.4 m80 -139.7 156.94 46.52 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 113.14 0.793 . . . . 15.0 113.14 -178.269 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.521 ' HA ' ' CG2' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -45.31 133.28 7.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 113.784 -1.553 . . . . 15.0 112.961 -178.897 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.696 ' N ' HG21 ' A' ' 37' ' ' VAL . . . 49.04 27.25 6.66 Favored Glycine 0 C--N 1.335 0.486 0 CA-C-N 115.766 -0.652 . . . . 15.0 113.784 178.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.44 ' OD2' ' CG1' ' A' ' 37' ' ' VAL . 1.2 p30 -66.32 133.23 50.11 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 119.485 -0.886 . . . . 15.0 110.077 179.512 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.494 ' HG2' ' CZ ' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -80.76 97.58 7.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 15.0 110.434 -179.845 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.507 ' O ' ' CG2' ' A' ' 58' ' ' VAL . 1.3 m -82.24 112.74 20.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.265 -0.425 . . . . 15.0 110.392 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -107.26 -21.62 12.89 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 115.826 -0.625 . . . . 15.0 112.384 -179.041 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -147.45 150.47 34.67 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.251 0.548 . . . . 15.0 112.365 -178.56 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.432 ' HB ' ' CG1' ' A' ' 64' ' ' VAL . 60.4 t -138.92 102.46 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.264 -0.88 . . . . 15.0 109.022 178.846 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.405 ' HB2' ' O ' ' A' ' 61' ' ' VAL . 1.8 m-80 65.09 15.62 10.1 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.706 -0.479 . . . . 15.0 109.706 -177.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 105.69 6.46 37.92 Favored Glycine 0 C--N 1.336 0.539 0 CA-C-N 115.785 -0.643 . . . . 15.0 113.349 179.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.506 ' O ' ' CG1' ' A' ' 64' ' ' VAL . 6.1 p -93.76 105.69 17.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 121.124 0.488 . . . . 15.0 110.843 179.398 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -58.78 115.45 3.09 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.148 -0.478 . . . . 15.0 110.726 -179.748 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.4 ' CD1' HG23 ' A' ' 58' ' ' VAL . 3.1 mt -89.45 -16.44 30.86 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.718 -0.674 . . . . 15.0 111.339 -179.619 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -45.79 105.44 0.06 Allowed 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.878 0.371 . . . . 15.0 111.017 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.96 66.15 0.57 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.814 -0.707 . . . . 15.0 112.433 -179.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -172.9 172.71 3.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.807 0.337 . . . . 15.0 110.851 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.444 ' HA ' ' N ' ' A' ' 26' ' ' VAL . 19.3 p -93.16 -175.83 3.97 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.961 0.41 . . . . 15.0 111.091 -179.768 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.532 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 0.0 OUTLIER -62.42 -60.98 2.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.969 -0.559 . . . . 15.0 110.428 -179.994 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.404 ' O ' ' HG3' ' A' ' 76' ' ' GLU . 7.3 ttmt -52.49 -33.68 45.9 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.773 -0.649 . . . . 15.0 110.497 179.455 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -59.4 -49.01 79.46 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.567 -0.531 . . . . 15.0 109.567 179.194 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.561 ' HA ' ' OG1' ' A' ' 77' ' ' THR . . . -66.96 -48.57 68.16 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 116.009 -0.541 . . . . 15.0 109.658 178.392 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.426 ' CG2' ' CG2' ' A' ' 22' ' ' VAL . 0.5 OUTLIER -40.39 -42.1 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.212 0 CA-C-N 115.476 -0.784 . . . . 15.0 109.444 178.48 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.404 ' HG3' ' O ' ' A' ' 72' ' ' LYS . 21.9 mt-10 -67.4 -46.07 74.33 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 114.843 -1.071 . . . . 15.0 110.45 178.795 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.561 ' OG1' ' HA ' ' A' ' 74' ' ' ALA . 2.0 p -64.64 -53.08 53.18 Favored 'General case' 0 C--O 1.231 0.099 0 C-N-CA 120.918 -0.313 . . . . 15.0 111.378 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.437 ' HG ' ' O ' ' A' ' 74' ' ' ALA . 4.4 mt -53.66 -48.38 69.48 Favored 'General case' 0 CA--C 1.52 -0.18 0 CA-C-O 121.135 0.493 . . . . 15.0 110.15 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 3.0 ttm-85 -68.34 -56.65 7.81 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.558 -0.747 . . . . 15.0 110.493 179.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -66.0 62.51 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.017 -0.538 . . . . 15.0 111.752 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.403 ' HB ' ' HG3' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -95.55 -71.94 0.65 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.783 0.325 . . . . 15.0 110.438 179.426 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 122.17 -103.82 0.87 Allowed Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.753 -0.737 . . . . 15.0 113.157 179.272 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.58 -83.66 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 111.866 0.321 . . . . 15.0 111.866 -179.089 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.415 HG13 ' N ' ' A' ' 85' ' ' VAL . 67.3 t -109.47 157.59 9.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.105 0.478 . . . . 15.0 111.082 -179.416 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.425 ' O ' ' CG1' ' A' ' 85' ' ' VAL . 10.6 t -97.81 81.86 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.011 -0.54 . . . . 15.0 110.559 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 59.6 t60 -104.96 86.54 2.47 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.747 -0.66 . . . . 15.0 110.892 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.45 ' O ' ' HA ' ' A' ' 8' ' ' GLU . 0.1 OUTLIER -103.81 129.75 51.28 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.996 -0.547 . . . . 15.0 111.537 -179.601 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.511 HD11 ' HB2' ' A' ' 8' ' ' GLU . 5.2 mp -102.33 101.3 11.54 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.928 -0.397 . . . . 15.0 109.928 178.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.447 HD22 HG13 ' A' ' 58' ' ' VAL . 0.4 OUTLIER -105.84 -161.94 0.83 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.3 0.572 . . . . 15.0 111.939 -178.699 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.484 ' HA ' ' HA ' ' A' ' 6' ' ' ILE . 26.0 tt0 -146.28 134.91 22.18 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.159 -0.928 . . . . 15.0 109.951 179.238 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 4.7 tptt -46.83 111.86 0.44 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.311 -0.404 . . . . 15.0 111.096 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.369 0 C-N-CA 120.785 -0.721 . . . . 15.0 112.614 -179.631 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.51 HG13 ' HB2' ' A' ' 90' ' ' GLU . 1.3 mp . . . . . 0 N--CA 1.45 -0.439 0 CA-C-O 120.657 0.265 . . . . 15.0 110.62 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.461 ' O ' ' N ' ' A' ' 89' ' ' LEU . 4.9 p90 -140.65 165.51 27.28 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.594 -0.275 . . . . 15.0 110.544 178.912 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.476 ' CB ' HD11 ' A' ' 88' ' ' LEU . 4.9 pt-20 -130.07 142.62 50.59 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.381 0.61 . . . . 15.0 111.417 -179.546 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.45 ' CG2' ' HB3' ' A' ' 51' ' ' ARG . 0.2 OUTLIER -101.44 114.97 42.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.073 -0.967 . . . . 15.0 109.718 179.143 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -105.89 71.46 0.9 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.118 -0.492 . . . . 15.0 111.874 -178.976 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.413 ' HB3' ' HB ' ' A' ' 85' ' ' VAL . 6.2 tp -88.05 167.99 13.2 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.942 -0.572 . . . . 15.0 110.007 179.121 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -94.64 98.84 11.09 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.98 0.419 . . . . 15.0 110.867 179.88 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.498 ' HG3' ' HB ' ' A' ' 81' ' ' THR . 0.2 OUTLIER . . . . . 0 C--N 1.328 -0.365 0 CA-C-N 115.899 -0.592 . . . . 15.0 111.13 -179.827 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.408 ' O ' ' HA3' ' A' ' 44' ' ' GLY . 3.9 mm? . . . . . 0 N--CA 1.449 -0.48 0 N-CA-C 110.627 -0.138 . . . . 15.0 110.627 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.728 ' O ' ' HB ' ' A' ' 41' ' ' ILE . . . -160.56 21.44 0.24 Allowed Glycine 0 C--O 1.226 -0.378 0 C-N-CA 120.4 -0.905 . . . . 15.0 113.395 -179.495 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.63 ' HB ' ' O ' ' A' ' 39' ' ' ALA . 2.9 pt -113.13 139.16 39.82 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.382 0 CA-C-N 117.394 0.597 . . . . 15.0 111.709 178.738 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.509 ' O ' ' HB3' ' A' ' 38' ' ' LYS . 6.2 t -84.98 116.09 23.18 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 105.167 -2.16 . . . . 15.0 105.167 174.841 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.401 ' CG2' ' CG2' ' A' ' 75' ' ' VAL . 35.6 m -93.74 152.35 3.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 113.58 0.955 . . . . 15.0 113.58 -175.521 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.57 -179.18 6.89 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 114.782 -1.099 . . . . 15.0 110.564 179.642 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.453 ' O ' ' CB ' ' A' ' 71' ' ' HIS . . . 71.4 -121.03 8.68 Favored Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.814 -0.708 . . . . 15.0 112.613 179.658 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.514 ' HA3' ' N ' ' A' ' 71' ' ' HIS . . . 66.82 -65.71 0.19 Allowed Glycine 0 C--N 1.331 0.251 0 C-N-CA 121.028 -0.606 . . . . 15.0 113.576 179.43 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.43 ' HA ' ' CB ' ' A' ' 70' ' ' THR . 0.0 OUTLIER -32.83 137.78 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 N-CA-C 112.375 0.509 . . . . 15.0 112.375 -179.208 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.406 ' CB ' ' O ' ' A' ' 32' ' ' HIS . 1.6 m-20 -76.58 59.64 1.53 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.826 -0.625 . . . . 15.0 111.103 -179.856 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -151.74 -48.48 0.11 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.373 -0.376 . . . . 15.0 110.884 179.972 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 22.0 t -87.12 -31.84 20.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.203 -0.453 . . . . 15.0 110.962 -179.929 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 33.4 m -87.9 -175.62 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.459 . . . . 15.0 111.223 -179.965 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 3.4 ttt85 -58.11 -60.81 3.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.23 -0.441 . . . . 15.0 111.102 -179.86 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . 0.406 ' O ' ' CB ' ' A' ' 27' ' ' ASN . 22.9 m80 -136.3 -58.45 0.74 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.371 -0.377 . . . . 15.0 111.163 -179.87 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -166.72 26.11 0.15 Allowed Glycine 0 N--CA 1.453 -0.223 0 C-N-CA 120.806 -0.711 . . . . 15.0 112.599 -179.723 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -90.69 153.25 22.41 Favored Glycine 0 N--CA 1.449 -0.488 0 N-CA-C 110.828 -0.909 . . . . 15.0 110.828 179.024 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.415 HG21 HG22 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -90.72 153.6 3.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 C-N-CA 120.028 -0.669 . . . . 15.0 111.648 -179.358 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.412 ' CE2' ' HG2' ' A' ' 57' ' ' ARG . 47.5 m-85 -134.43 108.39 8.12 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 114.98 -1.009 . . . . 15.0 109.534 179.4 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.575 ' HB ' HD12 ' A' ' 20' ' ' ILE . 0.6 OUTLIER -54.94 148.45 2.89 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.45 0 CA-C-O 121.105 0.479 . . . . 15.0 110.731 -178.835 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.509 ' HB3' ' O ' ' A' ' 21' ' ' SER . 0.1 OUTLIER -86.17 -45.66 11.13 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 108.37 -0.974 . . . . 15.0 108.37 178.167 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.63 ' O ' ' HB ' ' A' ' 20' ' ' ILE . . . -173.76 171.37 3.78 Favored 'General case' 0 C--O 1.226 -0.157 0 C-N-CA 120.512 -0.475 . . . . 15.0 112.214 178.762 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -97.32 81.57 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.291 0.567 . . . . 15.0 109.75 178.889 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.728 ' HB ' ' O ' ' A' ' 19' ' ' GLY . 27.2 mm -47.95 120.79 8.19 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 115.263 -0.88 . . . . 15.0 113.039 -178.351 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.525 ' HA ' ' HG2' ' A' ' 47' ' ' GLU . 40.8 Cg_endo -66.16 60.94 0.48 Allowed 'Trans proline' 0 C--N 1.354 0.831 0 C-N-CA 123.336 2.691 . . . . 15.0 112.762 179.682 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.536 ' H ' ' HG2' ' A' ' 47' ' ' GLU . 4.6 mt-30 -158.85 -41.08 0.06 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.646 0.26 . . . . 15.0 111.63 179.878 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.496 ' HA3' ' CA ' ' A' ' 19' ' ' GLY . . . -87.29 163.0 33.95 Favored Glycine 0 CA--C 1.519 0.318 0 C-N-CA 120.629 -0.796 . . . . 15.0 113.652 -179.151 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -53.28 -15.21 0.88 Allowed 'General case' 0 N--CA 1.462 0.166 0 N-CA-C 112.708 0.633 . . . . 15.0 112.708 -179.721 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.99 -59.35 2.79 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.651 0.262 . . . . 15.0 110.946 -179.554 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.536 ' HG2' ' H ' ' A' ' 43' ' ' GLN . 2.6 pp20? -56.97 -42.82 80.88 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.109 -0.496 . . . . 15.0 110.824 179.557 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.3 m -53.69 -70.77 0.09 Allowed 'General case' 0 CA--C 1.519 -0.22 0 CA-C-N 115.965 -0.561 . . . . 15.0 110.597 -179.333 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -61.19 -39.43 90.17 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.472 -0.566 . . . . 15.0 109.472 178.981 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.92 38.66 15.15 Favored Glycine 0 N--CA 1.447 -0.571 0 CA-C-N 115.438 -0.801 . . . . 15.0 111.638 179.802 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.45 ' HB3' ' CG2' ' A' ' 9' ' ' VAL . 21.7 mmt-85 -79.71 -33.71 40.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.872 0.368 . . . . 15.0 111.106 -179.18 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.48 ' CG2' ' N ' ' A' ' 53' ' ' HIS . 21.2 mm -91.21 159.12 2.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.091 -0.504 . . . . 15.0 111.181 -179.737 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . 0.48 ' N ' ' CG2' ' A' ' 52' ' ' ILE . 29.2 m80 -141.69 138.5 32.49 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-N 115.69 -0.686 . . . . 15.0 110.663 179.394 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.495 ' HA ' ' CG2' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -35.59 131.11 0.51 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.479 -1.237 . . . . 15.0 113.039 -178.373 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.553 ' N ' HG21 ' A' ' 37' ' ' VAL . . . 56.28 29.08 55.99 Favored Glycine 0 C--N 1.332 0.353 0 CA-C-N 115.665 -0.698 . . . . 15.0 113.629 179.176 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.45 ' OD2' ' N ' ' A' ' 53' ' ' HIS . 0.4 OUTLIER -65.34 130.48 43.49 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.941 -0.304 . . . . 15.0 110.597 179.346 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.412 ' HG2' ' CE2' ' A' ' 36' ' ' TYR . 2.2 mtt180 -80.63 90.04 5.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.436 -0.347 . . . . 15.0 110.672 179.934 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.447 ' O ' ' CG2' ' A' ' 58' ' ' VAL . 1.4 m -79.37 116.82 23.98 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 CA-C-O 121.017 0.437 . . . . 15.0 110.613 -179.875 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 29.1 mt -107.04 -15.09 14.77 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.785 -0.643 . . . . 15.0 112.559 -178.946 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.401 ' HA ' ' O ' ' A' ' 64' ' ' VAL . . . -149.11 148.49 29.74 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 112.595 0.591 . . . . 15.0 112.595 -178.8 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.442 ' HB ' ' CG1' ' A' ' 64' ' ' VAL . 20.8 t -139.18 100.5 1.42 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.251 0 CA-C-N 115.115 -0.948 . . . . 15.0 109.115 178.795 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.418 ' ND2' ' CG2' ' A' ' 81' ' ' THR . 1.7 m-80 65.03 16.08 10.36 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.76 -0.459 . . . . 15.0 109.76 -178.096 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 107.21 5.24 35.05 Favored Glycine 0 C--N 1.336 0.566 0 CA-C-N 115.925 -0.58 . . . . 15.0 113.558 179.666 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.5 ' O ' ' CG1' ' A' ' 64' ' ' VAL . 5.7 p -93.84 106.34 17.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 117.275 0.538 . . . . 15.0 110.988 179.417 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -56.59 136.33 54.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.201 -0.454 . . . . 15.0 110.914 -179.808 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -95.55 -20.16 19.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.06 -0.518 . . . . 15.0 111.065 -179.964 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -46.53 99.96 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.876 0.369 . . . . 15.0 111.082 179.984 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 104.88 66.4 0.69 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.767 -0.73 . . . . 15.0 112.207 -179.799 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -173.09 162.02 4.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.841 0.353 . . . . 15.0 111.117 -179.771 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.43 ' CB ' ' HA ' ' A' ' 26' ' ' VAL . 15.6 p -93.22 -173.75 3.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.002 0.429 . . . . 15.0 111.019 -179.873 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.514 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 0.0 OUTLIER -62.59 -58.79 6.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.907 -0.588 . . . . 15.0 110.329 179.841 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.413 ' HA ' ' HB ' ' A' ' 75' ' ' VAL . 28.4 ttmt -52.56 -33.9 47.82 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.017 -0.538 . . . . 15.0 110.534 179.117 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -59.45 -50.04 75.45 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.5 -0.555 . . . . 15.0 109.5 179.32 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.431 ' O ' ' N ' ' A' ' 77' ' ' THR . . . -66.86 -44.48 80.88 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 109.531 -0.544 . . . . 15.0 109.531 178.313 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.413 ' HB ' ' HA ' ' A' ' 72' ' ' LYS . 0.5 OUTLIER -43.57 -39.4 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.363 0 N-CA-C 108.732 -0.84 . . . . 15.0 108.732 178.099 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.523 ' O ' ' HB2' ' A' ' 80' ' ' ASN . 1.5 mm-40 -67.06 -46.32 74.68 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.573 -1.194 . . . . 15.0 110.381 178.577 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.431 ' N ' ' O ' ' A' ' 74' ' ' ALA . 31.4 p -64.09 -53.24 52.77 Favored 'General case' 0 N--CA 1.462 0.161 0 C-N-CA 120.951 -0.3 . . . . 15.0 111.575 -179.969 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.423 ' CD2' HG21 ' A' ' 61' ' ' VAL . 6.0 mt -53.49 -48.15 69.19 Favored 'General case' 0 CA--C 1.52 -0.18 0 CA-C-O 121.261 0.553 . . . . 15.0 109.866 179.929 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 18.1 ttp180 -68.64 -60.77 2.17 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.318 -0.855 . . . . 15.0 110.833 179.505 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.523 ' HB2' ' O ' ' A' ' 76' ' ' GLU . 15.1 m-80 -66.11 58.23 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 112.476 0.547 . . . . 15.0 112.476 -179.677 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.498 ' HB ' ' HG3' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -95.67 -69.28 0.76 Allowed 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.809 -0.441 . . . . 15.0 109.809 178.804 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 118.37 -104.42 1.12 Allowed Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.817 -0.706 . . . . 15.0 113.386 178.891 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . 0.437 ' O ' ' HB3' ' A' ' 13' ' ' LYS . 0.4 OUTLIER -64.93 -80.95 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 112.525 0.565 . . . . 15.0 112.525 -178.724 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.418 ' CG1' ' N ' ' A' ' 85' ' ' VAL . 55.1 t -110.07 158.11 10.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.113 0.482 . . . . 15.0 111.298 -178.89 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.446 ' O ' ' CG1' ' A' ' 85' ' ' VAL . 8.0 t -97.99 81.15 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.986 -0.552 . . . . 15.0 110.426 179.867 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 78.9 t60 -100.42 84.66 2.82 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.754 -0.657 . . . . 15.0 110.362 179.79 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.439 ' CB ' HG12 ' A' ' 9' ' ' VAL . 0.1 OUTLIER -103.52 119.44 38.9 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.949 -0.568 . . . . 15.0 111.986 -179.008 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.476 HD11 ' CB ' ' A' ' 8' ' ' GLU . 4.3 mp -92.87 103.23 15.58 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.52 -0.548 . . . . 15.0 109.52 178.673 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.461 ' N ' ' O ' ' A' ' 7' ' ' PHE . 0.2 OUTLIER -105.48 -163.32 0.94 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.273 0.559 . . . . 15.0 111.635 -178.69 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.51 ' HB2' HG13 ' A' ' 6' ' ' ILE . 8.3 tt0 -145.27 134.58 22.96 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.385 -0.825 . . . . 15.0 110.354 179.476 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 4.0 tptt -48.04 104.04 0.05 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.106 -0.497 . . . . 15.0 111.009 -179.92 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.341 0 C-N-CA 120.919 -0.658 . . . . 15.0 112.68 -179.647 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.511 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 1.4 mp . . . . . 0 N--CA 1.449 -0.48 0 CA-C-O 120.811 0.339 . . . . 15.0 111.375 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.455 ' O ' ' N ' ' A' ' 89' ' ' LEU . 3.6 p90 -140.62 165.67 26.84 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.123 -0.49 . . . . 15.0 110.112 178.514 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.46 ' CB ' HD11 ' A' ' 88' ' ' LEU . 4.8 pt-20 -130.13 144.38 51.32 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.427 0.632 . . . . 15.0 111.842 -178.93 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.492 ' CG2' ' HB3' ' A' ' 51' ' ' ARG . 0.2 OUTLIER -101.42 115.25 42.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.034 -0.984 . . . . 15.0 109.354 178.75 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -105.92 72.72 0.96 Allowed 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 112.4 0.518 . . . . 15.0 112.4 -178.523 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.445 ' HB3' ' HB ' ' A' ' 85' ' ' VAL . 5.2 tp -88.06 162.56 16.72 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.465 -0.569 . . . . 15.0 109.465 178.467 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -96.52 93.31 6.72 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.947 0.403 . . . . 15.0 111.343 -179.868 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.527 ' O ' ' HD3' ' A' ' 13' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.43 0 CA-C-N 115.957 -0.565 . . . . 15.0 110.714 179.644 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.416 ' N ' ' CD2' ' A' ' 18' ' ' LEU . 2.1 mm? . . . . . 0 N--CA 1.45 -0.448 0 CA-C-O 120.961 0.41 . . . . 15.0 110.714 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.752 ' HA3' ' HA3' ' A' ' 44' ' ' GLY . . . -160.88 45.61 0.4 Allowed Glycine 0 N--CA 1.449 -0.499 0 N-CA-C 111.481 -0.648 . . . . 15.0 111.481 -179.771 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.666 HG12 ' O ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -112.53 139.19 38.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 120.843 0.354 . . . . 15.0 111.4 -179.326 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.437 ' HB3' HD13 ' A' ' 41' ' ' ILE . 8.1 t -91.78 102.64 15.25 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 107.999 -1.111 . . . . 15.0 107.999 177.723 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.45 ' CG2' ' CG2' ' A' ' 75' ' ' VAL . 35.5 m -93.8 155.27 3.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 113.033 0.753 . . . . 15.0 113.033 -176.995 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.22 -176.39 5.35 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.174 -0.921 . . . . 15.0 110.92 -179.69 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.447 ' O ' ' HB3' ' A' ' 71' ' ' HIS . . . 68.73 -119.46 9.99 Favored Glycine 0 C--N 1.333 0.389 0 C-N-CA 120.951 -0.642 . . . . 15.0 112.611 179.834 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.553 ' HA3' ' N ' ' A' ' 71' ' ' HIS . . . 68.6 -66.53 0.42 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.823 -0.703 . . . . 15.0 113.612 179.468 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.439 ' N ' ' HA ' ' A' ' 70' ' ' THR . 1.3 m -29.38 141.82 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 N-CA-C 112.087 0.403 . . . . 15.0 112.087 -179.262 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -75.45 61.59 1.28 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.122 -0.49 . . . . 15.0 111.074 -179.602 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.6 m -151.73 -51.86 0.12 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.26 -0.427 . . . . 15.0 111.11 179.942 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -85.36 -44.39 12.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.446 . . . . 15.0 111.204 -179.793 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 17.5 m -70.33 -173.77 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.333 -0.394 . . . . 15.0 111.258 -179.875 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -57.98 -51.73 68.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 15.0 111.073 -179.892 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 19.6 p-80 -153.31 -46.88 0.09 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.343 -0.389 . . . . 15.0 111.058 -179.865 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -167.44 19.24 0.09 OUTLIER Glycine 0 CA--C 1.519 0.291 0 C-N-CA 120.739 -0.743 . . . . 15.0 112.881 -179.767 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -90.12 152.3 22.13 Favored Glycine 0 N--CA 1.449 -0.468 0 N-CA-C 110.249 -1.14 . . . . 15.0 110.249 178.493 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.541 ' HA ' ' HA2' ' A' ' 25' ' ' GLY . 0.0 OUTLIER -97.58 147.38 6.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 117.893 0.847 . . . . 15.0 111.658 -179.263 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.437 ' CE2' ' HG2' ' A' ' 57' ' ' ARG . 2.9 m-85 -130.96 113.59 14.19 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.563 -0.744 . . . . 15.0 109.755 -179.313 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.645 HG21 ' N ' ' A' ' 55' ' ' GLY . 0.8 OUTLIER -55.16 161.16 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-O 121.308 0.575 . . . . 15.0 111.238 -179.216 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.518 ' O ' ' HG2' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -91.6 -46.21 8.07 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.456 -0.942 . . . . 15.0 108.456 178.388 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.666 ' O ' HG12 ' A' ' 20' ' ' ILE . . . -172.27 173.71 4.14 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 115.302 -0.863 . . . . 15.0 110.193 178.772 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.574 ' HA ' HG12 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -96.81 108.75 21.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 109.472 -0.566 . . . . 15.0 109.472 179.268 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.729 ' HB ' ' O ' ' A' ' 19' ' ' GLY . 0.7 OUTLIER -78.28 116.33 58.16 Favored Pre-proline 0 C--N 1.328 -0.369 0 N-CA-C 113.482 0.919 . . . . 15.0 113.482 -177.245 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.542 ' HA ' ' CG ' ' A' ' 47' ' ' GLU . 36.0 Cg_exo -61.78 60.02 0.12 Allowed 'Trans proline' 0 C--N 1.358 1.045 0 C-N-CA 123.707 2.938 . . . . 15.0 113.271 179.821 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.52 ' H ' ' HG2' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -147.44 -46.97 0.17 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.649 0.261 . . . . 15.0 111.484 179.769 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.752 ' HA3' ' HA3' ' A' ' 19' ' ' GLY . . . -87.87 169.06 38.18 Favored Glycine 0 C--N 1.331 0.264 0 C-N-CA 120.386 -0.911 . . . . 15.0 114.007 -179.124 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -58.1 -14.88 7.64 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.023 -0.588 . . . . 15.0 112.499 -179.765 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.22 -56.26 5.85 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.587 0.232 . . . . 15.0 110.996 -179.656 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.558 ' HG3' ' O ' ' A' ' 44' ' ' GLY . 2.9 pp20? -57.41 -42.91 83.19 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.222 -0.445 . . . . 15.0 110.309 179.256 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -53.71 -71.12 0.08 Allowed 'General case' 0 CA--C 1.519 -0.221 0 CA-C-N 115.801 -0.636 . . . . 15.0 110.488 -179.457 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -58.34 -40.07 81.18 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.286 -0.635 . . . . 15.0 109.286 178.826 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.83 37.79 18.27 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 115.359 -0.837 . . . . 15.0 111.756 179.415 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.492 ' HB3' ' CG2' ' A' ' 9' ' ' VAL . 2.8 mmp_? -79.85 -48.09 14.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.861 0.362 . . . . 15.0 110.775 -179.447 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.431 HG12 HD12 ' A' ' 20' ' ' ILE . 10.5 tp -81.04 155.7 4.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.104 -0.498 . . . . 15.0 110.391 179.62 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . 0.528 ' O ' ' HB2' ' A' ' 56' ' ' ASP . 53.1 m80 -142.33 161.49 37.91 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-O 121.694 0.759 . . . . 15.0 112.345 -179.032 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.518 ' HG2' ' O ' ' A' ' 38' ' ' LYS . 0.8 OUTLIER -44.27 133.33 5.47 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.445 -1.252 . . . . 15.0 112.561 -178.707 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.645 ' N ' HG21 ' A' ' 37' ' ' VAL . . . 49.59 36.62 25.05 Favored Glycine 0 C--N 1.334 0.441 0 C-N-CA 121.009 -0.615 . . . . 15.0 113.101 179.45 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.528 ' HB2' ' O ' ' A' ' 53' ' ' HIS . 1.4 t0 -65.46 125.11 24.12 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.816 -0.353 . . . . 15.0 110.261 179.539 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.437 ' HG2' ' CE2' ' A' ' 36' ' ' TYR . 1.3 mtt180 -83.15 81.69 8.58 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.321 -0.4 . . . . 15.0 110.05 179.614 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.558 HG22 ' O ' ' A' ' 58' ' ' VAL . 1.1 m -79.23 119.77 29.16 Favored 'Isoleucine or valine' 0 C--O 1.24 0.556 0 CA-C-O 121.276 0.56 . . . . 15.0 110.747 -179.502 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -107.64 -13.63 15.0 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 115.236 -0.893 . . . . 15.0 112.516 -179.091 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.417 ' CB ' HD22 ' A' ' 88' ' ' LEU . . . -149.63 151.25 33.45 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 112.82 0.674 . . . . 15.0 112.82 -178.543 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.483 ' HA ' ' HG ' ' A' ' 87' ' ' LEU . 20.8 t -140.7 100.76 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.171 -0.922 . . . . 15.0 109.198 178.71 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 12.1 m120 64.87 15.29 9.8 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.779 -0.452 . . . . 15.0 109.779 -177.968 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 107.19 6.64 33.77 Favored Glycine 0 C--N 1.336 0.561 0 CA-C-N 115.926 -0.579 . . . . 15.0 113.476 179.602 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.515 ' O ' ' CG1' ' A' ' 64' ' ' VAL . 5.7 p -93.76 104.08 15.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 117.273 0.537 . . . . 15.0 110.588 179.206 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -56.07 134.16 52.44 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.099 -0.5 . . . . 15.0 111.318 -179.336 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -97.78 -21.23 17.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.881 -0.6 . . . . 15.0 110.81 179.887 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -44.35 99.27 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 116.339 -0.392 . . . . 15.0 111.219 179.988 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.49 64.74 0.57 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.798 -0.715 . . . . 15.0 112.328 -179.774 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.464 ' HB3' ' CB ' ' A' ' 73' ' ' GLN . . . -173.03 169.03 4.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.89 0.376 . . . . 15.0 111.185 -179.774 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.439 ' HA ' ' N ' ' A' ' 26' ' ' VAL . 5.7 p -93.28 -171.7 2.73 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.184 -0.462 . . . . 15.0 111.27 -179.855 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.553 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 0.0 OUTLIER -65.69 -59.61 3.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.737 -0.665 . . . . 15.0 110.866 -179.859 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.447 ' O ' ' HG3' ' A' ' 76' ' ' GLU . 16.7 ttmt -52.4 -32.27 38.06 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.804 -0.634 . . . . 15.0 110.647 179.952 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . 0.464 ' CB ' ' HB3' ' A' ' 69' ' ' ALA . 8.4 mt-30 -59.23 -49.85 76.26 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.778 -0.453 . . . . 15.0 109.778 179.432 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.463 ' O ' ' N ' ' A' ' 77' ' ' THR . . . -67.39 -46.42 73.33 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 109.615 -0.513 . . . . 15.0 109.615 178.302 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.45 ' CG2' ' CG2' ' A' ' 22' ' ' VAL . 0.5 OUTLIER -40.97 -40.3 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.283 0 N-CA-C 108.97 -0.752 . . . . 15.0 108.97 178.324 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.47 ' O ' ' HB2' ' A' ' 80' ' ' ASN . 46.9 mt-10 -67.36 -47.48 70.29 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 114.666 -1.152 . . . . 15.0 110.541 178.659 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.463 ' N ' ' O ' ' A' ' 74' ' ' ALA . 67.4 p -64.2 -52.45 58.82 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 121.045 -0.262 . . . . 15.0 111.511 179.974 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.434 ' HG ' ' O ' ' A' ' 74' ' ' ALA . 5.0 mt -53.4 -47.68 69.35 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-O 121.193 0.521 . . . . 15.0 109.761 179.959 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 5.2 ttm180 -68.62 -62.37 1.42 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.375 -0.829 . . . . 15.0 110.42 179.112 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.47 ' HB2' ' O ' ' A' ' 76' ' ' GLU . 15.8 m-80 -66.01 62.35 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.02 -0.537 . . . . 15.0 111.78 179.766 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.421 ' HB ' ' HG3' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -88.11 -70.4 0.64 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.865 0.364 . . . . 15.0 110.213 179.442 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 121.99 -107.85 1.23 Allowed Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 121.047 -0.597 . . . . 15.0 112.686 179.54 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . 0.479 ' O ' ' HB3' ' A' ' 13' ' ' LYS . 0.4 OUTLIER -65.0 -82.99 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.773 0.32 . . . . 15.0 111.664 -179.567 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.43 ' CG1' ' N ' ' A' ' 85' ' ' VAL . 63.1 t -110.2 160.61 9.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.327 -0.397 . . . . 15.0 110.436 179.999 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.445 ' HB ' ' HB3' ' A' ' 11' ' ' LEU . 19.9 t -98.01 80.89 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.127 0.489 . . . . 15.0 110.503 179.83 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 7.1 t60 -100.45 82.05 2.43 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 115.762 -0.654 . . . . 15.0 110.241 179.832 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.605 ' HB3' HD23 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -102.0 126.26 48.89 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.777 -0.647 . . . . 15.0 111.909 -178.961 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.46 HD11 ' CB ' ' A' ' 8' ' ' GLU . 0.2 OUTLIER -102.3 103.44 13.91 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.648 -0.501 . . . . 15.0 109.648 178.813 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.605 HD23 ' HB3' ' A' ' 87' ' ' LEU . 0.1 OUTLIER -105.76 -163.82 0.97 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.366 0.603 . . . . 15.0 111.782 -178.955 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.511 ' HA ' ' HA ' ' A' ' 6' ' ' ILE . 3.6 tt0 -138.11 134.2 34.35 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.052 -0.976 . . . . 15.0 109.676 178.996 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.67 97.99 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.316 -0.402 . . . . 15.0 111.414 -179.356 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.287 0 C-N-CA 120.944 -0.646 . . . . 15.0 112.579 179.988 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.419 HG13 ' HB2' ' A' ' 90' ' ' GLU . 1.4 mp . . . . . 0 N--CA 1.45 -0.434 0 CA-C-O 120.871 0.367 . . . . 15.0 111.27 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.418 ' O ' ' N ' ' A' ' 89' ' ' LEU . 4.0 p90 -140.91 166.39 24.9 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.098 -0.501 . . . . 15.0 110.465 178.797 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.481 ' CB ' HD11 ' A' ' 88' ' ' LEU . 9.4 pt-20 -130.07 144.95 51.62 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.235 0.54 . . . . 15.0 111.613 -179.287 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.485 HG12 ' HB3' ' A' ' 87' ' ' LEU . 0.4 OUTLIER -101.57 116.18 44.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.395 -0.82 . . . . 15.0 109.93 179.019 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -106.56 69.14 0.77 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.236 -0.438 . . . . 15.0 111.807 -179.448 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.426 ' O ' ' N ' ' A' ' 85' ' ' VAL . 6.1 tp -88.07 160.75 17.69 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.298 -0.41 . . . . 15.0 109.961 179.058 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -97.1 95.71 7.96 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.292 0.479 . . . . 15.0 112.292 -179.177 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.471 ' CG ' ' O ' ' A' ' 13' ' ' LYS . 3.5 tppt? . . . . . 0 CA--C 1.537 0.453 0 N-CA-C 112.131 0.419 . . . . 15.0 112.131 178.894 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.451 -0.414 0 CA-C-O 120.821 0.344 . . . . 15.0 110.841 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.692 ' O ' ' HB ' ' A' ' 41' ' ' ILE . . . -161.05 36.27 0.41 Allowed Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.968 -0.634 . . . . 15.0 112.279 -179.703 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.573 HG12 ' O ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -112.82 136.95 47.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 120.993 0.425 . . . . 15.0 111.719 -179.676 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.411 ' O ' ' HB3' ' A' ' 38' ' ' LYS . 27.5 t -95.96 100.41 12.09 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 107.845 -1.168 . . . . 15.0 107.845 177.294 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.501 ' O ' ' CE1' ' A' ' 71' ' ' HIS . 1.0 OUTLIER -93.78 155.74 3.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 112.334 0.494 . . . . 15.0 112.334 -177.226 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.461 ' HA ' ' CE1' ' A' ' 71' ' ' HIS . 6.0 t -149.82 176.02 11.1 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.47 -0.787 . . . . 15.0 110.472 179.429 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.504 ' O ' ' HB2' ' A' ' 71' ' ' HIS . . . 86.95 -112.03 3.74 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.558 -0.829 . . . . 15.0 112.505 179.849 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.583 ' HA3' ' N ' ' A' ' 71' ' ' HIS . . . 62.58 -66.2 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 121.067 -0.587 . . . . 15.0 113.653 179.199 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.468 ' N ' ' O ' ' A' ' 24' ' ' GLY . 0.0 OUTLIER -28.94 143.12 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 N-CA-C 112.528 0.566 . . . . 15.0 112.528 -179.038 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.402 ' CB ' ' O ' ' A' ' 32' ' ' HIS . 13.4 p30 -75.67 61.87 1.41 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.738 -0.664 . . . . 15.0 110.968 -179.844 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -151.65 -66.97 0.18 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.376 -0.375 . . . . 15.0 111.045 179.994 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 72.4 m -65.4 -49.76 68.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.183 -0.462 . . . . 15.0 110.877 -179.939 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.419 HG13 ' CD1' ' A' ' 36' ' ' TYR . 34.5 m -75.95 -174.1 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.185 -0.462 . . . . 15.0 111.119 -179.966 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.81 -78.89 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.337 -0.392 . . . . 15.0 111.258 -179.755 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . 0.402 ' O ' ' CB ' ' A' ' 27' ' ' ASN . 34.4 p-80 -126.92 -42.85 1.72 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.431 -0.35 . . . . 15.0 111.223 -179.818 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -170.06 26.62 0.11 Allowed Glycine 0 N--CA 1.453 -0.2 0 C-N-CA 120.745 -0.74 . . . . 15.0 112.554 -179.772 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -92.61 154.75 22.3 Favored Glycine 0 N--CA 1.448 -0.521 0 N-CA-C 110.33 -1.108 . . . . 15.0 110.33 178.723 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.496 HG13 ' HA ' ' A' ' 71' ' ' HIS . 0.2 OUTLIER -98.86 152.82 4.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 119.768 -0.773 . . . . 15.0 112.318 -179.154 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.42 ' CZ ' ' HG3' ' A' ' 57' ' ' ARG . 14.7 m-85 -137.19 111.21 8.31 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.65 -1.159 . . . . 15.0 109.087 179.406 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.572 HG21 ' N ' ' A' ' 55' ' ' GLY . 0.8 OUTLIER -55.37 168.69 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.42 0.628 . . . . 15.0 111.572 -178.315 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.513 ' O ' ' HG2' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -99.75 -45.12 5.85 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.374 -0.973 . . . . 15.0 108.374 178.189 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.573 ' O ' HG12 ' A' ' 20' ' ' ILE . . . -172.66 171.45 4.48 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 115.437 -0.801 . . . . 15.0 110.363 178.466 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.436 ' HA ' ' CG1' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -96.76 110.68 25.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 108.803 -0.814 . . . . 15.0 108.803 178.877 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.692 ' HB ' ' O ' ' A' ' 19' ' ' GLY . 0.4 OUTLIER -77.55 115.66 51.51 Favored Pre-proline 0 C--N 1.329 -0.288 0 N-CA-C 113.597 0.962 . . . . 15.0 113.597 -176.693 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.534 ' HA ' ' HG2' ' A' ' 47' ' ' GLU . 38.9 Cg_exo -61.55 61.14 0.11 Allowed 'Trans proline' 0 C--N 1.358 1.073 0 C-N-CA 123.726 2.951 . . . . 15.0 113.003 179.578 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.524 ' H ' ' HG2' ' A' ' 47' ' ' GLU . 3.5 mt-30 -150.57 -47.93 0.12 Allowed 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 111.738 0.273 . . . . 15.0 111.738 179.957 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.591 ' HA3' ' HA3' ' A' ' 19' ' ' GLY . . . -87.81 166.66 35.91 Favored Glycine 0 CA--C 1.519 0.303 0 C-N-CA 120.356 -0.926 . . . . 15.0 113.79 -179.082 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -55.48 -14.87 2.22 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.66 0.615 . . . . 15.0 112.66 -179.817 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.93 -57.95 3.87 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.702 0.287 . . . . 15.0 110.945 -179.397 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.534 ' HG2' ' HA ' ' A' ' 42' ' ' PRO . 2.8 pp20? -56.94 -42.2 79.64 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.989 0.423 . . . . 15.0 110.391 179.415 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -53.82 -72.25 0.06 Allowed 'General case' 0 CA--C 1.519 -0.214 0 CA-C-N 115.883 -0.598 . . . . 15.0 110.466 -179.636 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -58.68 -40.4 83.46 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.456 -0.572 . . . . 15.0 109.456 179.01 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.93 50.03 5.38 Favored Glycine 0 N--CA 1.447 -0.584 0 CA-C-N 115.388 -0.824 . . . . 15.0 111.766 179.604 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.471 ' HG2' HG22 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -79.49 -51.59 9.13 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.764 0.316 . . . . 15.0 110.775 -179.34 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.442 ' CG2' ' N ' ' A' ' 53' ' ' HIS . 3.1 mm -91.45 162.72 2.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.993 0.425 . . . . 15.0 111.083 179.694 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . 0.442 ' N ' ' CG2' ' A' ' 52' ' ' ILE . 52.0 m80 -141.5 157.6 44.93 Favored 'General case' 0 CA--C 1.513 -0.466 0 CA-C-N 115.797 -0.638 . . . . 15.0 110.616 179.718 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.513 ' HG2' ' O ' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -35.61 132.58 0.44 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.848 -1.069 . . . . 15.0 112.647 -178.501 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.572 ' N ' HG21 ' A' ' 37' ' ' VAL . . . 49.71 38.02 28.58 Favored Glycine 0 C--N 1.332 0.338 0 CA-C-N 115.923 -0.58 . . . . 15.0 113.64 179.524 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.496 ' HB2' HG12 ' A' ' 37' ' ' VAL . 0.5 OUTLIER -65.88 128.59 36.62 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 117.499 0.65 . . . . 15.0 110.523 179.388 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.43 ' HA ' ' O ' ' A' ' 35' ' ' ILE . 56.3 ttt180 -83.25 88.02 6.94 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.429 -0.35 . . . . 15.0 110.537 179.808 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.471 ' O ' ' CG2' ' A' ' 58' ' ' VAL . 1.8 m -82.94 112.53 20.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.17 0.509 . . . . 15.0 111.353 -179.44 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 35.6 mt -107.27 -9.47 16.06 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 115.685 -0.689 . . . . 15.0 112.654 -179.306 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -151.25 144.81 24.94 Favored 'General case' 0 N--CA 1.463 0.194 0 N-CA-C 112.565 0.58 . . . . 15.0 112.565 -178.857 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.459 ' HA ' ' HG ' ' A' ' 87' ' ' LEU . 32.7 t -139.07 98.96 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.258 0 CA-C-N 115.497 -0.774 . . . . 15.0 109.452 178.878 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 65.06 17.76 11.2 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.066 -0.516 . . . . 15.0 109.874 -178.415 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 107.24 4.57 35.33 Favored Glycine 0 C--N 1.336 0.536 0 CA-C-N 115.836 -0.62 . . . . 15.0 113.676 179.488 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.511 ' O ' ' CG1' ' A' ' 64' ' ' VAL . 4.9 p -93.87 105.28 16.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 117.323 0.562 . . . . 15.0 110.818 179.319 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -56.87 134.59 55.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.142 -0.481 . . . . 15.0 110.983 -179.692 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -87.64 -19.35 27.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.121 -0.49 . . . . 15.0 111.034 -179.998 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -46.92 95.56 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 120.892 0.377 . . . . 15.0 110.888 179.943 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.77 66.75 0.59 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.785 -0.721 . . . . 15.0 112.217 -179.588 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -172.95 154.36 2.82 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.859 0.362 . . . . 15.0 110.976 -179.867 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.421 ' HA ' ' N ' ' A' ' 26' ' ' VAL . 13.7 p -93.04 -170.91 2.54 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.114 -0.494 . . . . 15.0 111.396 -179.626 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.583 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 1.5 t-160 -58.12 -62.17 2.02 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.618 -0.719 . . . . 15.0 110.063 179.75 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 3.4 ttpt -53.02 -36.23 60.3 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.236 -0.893 . . . . 15.0 111.051 179.483 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 7.0 mt-30 -59.41 -57.31 13.53 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.304 -0.407 . . . . 15.0 110.163 179.88 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.424 ' O ' ' N ' ' A' ' 77' ' ' THR . . . -63.27 -43.63 97.4 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.715 -0.476 . . . . 15.0 109.715 178.835 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -43.66 -42.74 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.223 0 N-CA-C 108.807 -0.812 . . . . 15.0 108.807 178.176 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.408 ' O ' ' CB ' ' A' ' 80' ' ' ASN . 21.7 mt-10 -67.45 -42.91 82.3 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 114.856 -1.066 . . . . 15.0 110.535 178.556 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.424 ' N ' ' O ' ' A' ' 74' ' ' ALA . 69.9 p -63.9 -56.18 17.22 Favored 'General case' 0 N--CA 1.462 0.135 0 C-N-CA 120.997 -0.281 . . . . 15.0 111.5 -179.924 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.424 ' HA ' HG12 ' A' ' 61' ' ' VAL . 5.6 mt -53.37 -47.14 69.71 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-O 121.197 0.523 . . . . 15.0 110.007 179.953 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 7.1 tpp85 -68.53 -59.12 3.37 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.395 -0.82 . . . . 15.0 110.691 179.489 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.408 ' CB ' ' O ' ' A' ' 76' ' ' GLU . 2.9 m-20 -65.92 63.0 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.035 -0.53 . . . . 15.0 111.848 179.909 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -91.79 -73.55 0.54 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.728 0.299 . . . . 15.0 110.33 179.322 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.42 ' O ' ' HG3' ' A' ' 13' ' ' LYS . . . 120.98 -103.43 0.9 Allowed Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.773 -0.727 . . . . 15.0 112.672 179.431 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -64.85 -87.03 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.723 0.297 . . . . 15.0 111.05 -179.841 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.439 HG13 ' N ' ' A' ' 85' ' ' VAL . 93.7 t -110.07 161.9 8.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.881 0.372 . . . . 15.0 110.625 179.956 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.465 ' O ' ' CG1' ' A' ' 85' ' ' VAL . 3.3 t -97.43 84.54 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.176 0.512 . . . . 15.0 110.368 179.825 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 10.9 t60 -101.28 82.63 2.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.59 -0.732 . . . . 15.0 110.001 179.493 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.485 ' HB3' HG12 ' A' ' 9' ' ' VAL . 0.1 OUTLIER -103.92 126.36 50.98 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.818 -0.628 . . . . 15.0 112.01 -178.907 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.481 HD11 ' CB ' ' A' ' 8' ' ' GLU . 4.9 mp -102.38 100.48 10.63 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.4 -0.593 . . . . 15.0 109.4 178.487 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.463 HD22 ' HA ' ' A' ' 58' ' ' VAL . 0.1 OUTLIER -105.57 -162.24 0.86 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.611 0.719 . . . . 15.0 112.027 -178.566 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.419 ' HB2' HG13 ' A' ' 6' ' ' ILE . 1.3 tt0 -139.89 133.88 30.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 114.73 -1.123 . . . . 15.0 109.485 178.856 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.15 93.81 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.89 0.376 . . . . 15.0 111.069 -179.562 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.322 0 C-N-CA 120.959 -0.639 . . . . 15.0 112.738 -179.769 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.437 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 1.1 mp . . . . . 0 N--CA 1.451 -0.405 0 CA-C-O 120.859 0.362 . . . . 15.0 111.125 . . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.464 ' CE1' HD13 ' A' ' 89' ' ' LEU . 2.3 p90 -140.41 151.3 44.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.171 -0.468 . . . . 15.0 110.611 179.119 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.486 ' CB ' HD11 ' A' ' 88' ' ' LEU . 13.7 pt-20 -116.9 143.08 46.12 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.206 0.527 . . . . 15.0 111.402 -179.467 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.456 ' N ' ' O ' ' A' ' 87' ' ' LEU . 0.4 OUTLIER -101.46 116.92 45.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.401 -0.818 . . . . 15.0 109.766 179.056 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.404 ' OE1' ' CE1' ' A' ' 86' ' ' HIS . 3.8 tp10 -106.0 72.25 0.93 Allowed 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.198 0.444 . . . . 15.0 112.198 -178.932 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.474 ' HB3' ' HB ' ' A' ' 85' ' ' VAL . 6.7 tp -88.23 165.41 15.07 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.035 -0.53 . . . . 15.0 109.592 178.699 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -96.03 96.33 8.8 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.004 0.431 . . . . 15.0 110.991 179.952 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.481 ' HG3' ' HB ' ' A' ' 81' ' ' THR . 0.1 OUTLIER . . . . . 0 C--N 1.327 -0.395 0 CA-C-N 115.785 -0.643 . . . . 15.0 111.261 -179.863 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.419 ' N ' ' CD2' ' A' ' 18' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.455 -0.196 0 CA-C-O 121.051 0.453 . . . . 15.0 110.721 . . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.572 ' O ' ' HB ' ' A' ' 41' ' ' ILE . . . -169.73 34.87 0.18 Allowed Glycine 0 CA--C 1.506 -0.53 0 N-CA-C 111.102 -0.799 . . . . 15.0 111.102 -179.673 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.523 HD13 ' HB ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -114.23 142.11 28.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 112.652 0.612 . . . . 15.0 112.652 -179.188 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.3 t -96.86 104.1 16.08 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 107.903 -1.147 . . . . 15.0 107.903 176.315 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.481 ' O ' ' CE1' ' A' ' 71' ' ' HIS . 27.5 m -93.63 147.36 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 N-CA-C 112.981 0.734 . . . . 15.0 112.981 -177.248 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.541 ' HA ' ' CE1' ' A' ' 71' ' ' HIS . 6.4 t -150.04 -177.46 5.93 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 115.553 -0.749 . . . . 15.0 111.327 179.205 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.44 ' O ' ' CB ' ' A' ' 71' ' ' HIS . . . 73.58 -115.95 5.23 Favored Glycine 0 C--N 1.336 0.565 0 C-N-CA 121.067 -0.587 . . . . 15.0 112.457 179.86 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.555 ' HA3' ' N ' ' A' ' 71' ' ' HIS . . . 64.18 -65.22 0.05 OUTLIER Glycine 0 C--N 1.33 0.233 0 C-N-CA 121.091 -0.576 . . . . 15.0 114.05 178.977 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.419 ' N ' ' O ' ' A' ' 24' ' ' GLY . 0.0 OUTLIER -30.11 144.0 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 N-CA-C 112.145 0.424 . . . . 15.0 112.145 -179.121 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -75.51 58.21 1.01 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.137 -0.483 . . . . 15.0 110.974 -179.644 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 5.3 m -151.92 -60.7 0.16 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.243 -0.435 . . . . 15.0 110.792 179.965 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 9.0 t -70.31 -46.67 63.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.069 -0.514 . . . . 15.0 110.914 -179.927 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 14.2 m -77.05 -170.03 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.237 -0.438 . . . . 15.0 111.093 -179.959 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 5.2 mmt180 -57.42 -71.47 0.1 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.273 -0.421 . . . . 15.0 111.009 -179.997 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . 0.442 ' CD2' ' N ' ' A' ' 33' ' ' GLY . 8.5 p-80 -134.93 -42.3 0.74 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.318 -0.401 . . . . 15.0 111.37 -179.817 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.442 ' N ' ' CD2' ' A' ' 32' ' ' HIS . . . -170.16 22.49 0.09 OUTLIER Glycine 0 CA--C 1.52 0.344 0 C-N-CA 120.504 -0.855 . . . . 15.0 113.086 -179.66 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -92.58 154.25 22.06 Favored Glycine 0 N--CA 1.451 -0.33 0 N-CA-C 110.163 -1.175 . . . . 15.0 110.163 178.405 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.515 ' CG2' HG22 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -101.34 147.33 8.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 118.181 0.99 . . . . 15.0 111.795 -179.209 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.439 ' CZ ' ' HG3' ' A' ' 57' ' ' ARG . 13.5 m-85 -131.28 113.18 13.49 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-N 115.433 -0.803 . . . . 15.0 109.537 -179.61 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.645 HG21 ' N ' ' A' ' 55' ' ' GLY . 0.7 OUTLIER -54.87 148.68 2.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 115.471 -0.786 . . . . 15.0 111.363 -178.736 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.47 ' O ' ' HG2' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -81.08 -48.39 12.24 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.775 -0.824 . . . . 15.0 108.775 178.654 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.497 ' O ' HG12 ' A' ' 20' ' ' ILE . . . -172.5 169.04 5.27 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.567 -0.742 . . . . 15.0 110.766 178.572 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.503 ' HA ' HG12 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -97.49 122.08 48.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.793 0.33 . . . . 15.0 110.526 179.676 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.572 ' HB ' ' O ' ' A' ' 19' ' ' GLY . 1.5 mm -78.5 109.26 9.93 Favored Pre-proline 0 N--CA 1.464 0.229 0 N-CA-C 112.956 0.724 . . . . 15.0 112.956 -178.627 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.501 ' HA ' ' OE1' ' A' ' 47' ' ' GLU . 38.2 Cg_endo -65.72 65.46 0.4 Allowed 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 122.828 2.352 . . . . 15.0 112.246 179.49 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -162.55 -44.94 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.434 -0.803 . . . . 15.0 109.508 179.816 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.534 ' HA3' ' HA3' ' A' ' 19' ' ' GLY . . . -87.43 151.35 23.31 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.774 -0.727 . . . . 15.0 112.338 179.351 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -40.19 -19.6 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 113.465 0.913 . . . . 15.0 113.465 -179.312 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.445 ' N ' ' O ' ' A' ' 44' ' ' GLY . . . -71.58 -71.13 0.28 Allowed 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.809 -0.356 . . . . 15.0 111.076 -179.654 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.566 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 9.0 tm-20 -58.22 -36.58 73.35 Favored 'General case' 0 N--CA 1.462 0.153 0 C-N-CA 120.81 -0.356 . . . . 15.0 110.284 179.36 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 53.6 m -56.16 -67.69 0.27 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.173 -0.467 . . . . 15.0 110.395 179.464 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -62.11 -37.64 85.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.129 -0.487 . . . . 15.0 109.932 179.179 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.32 38.19 15.63 Favored Glycine 0 N--CA 1.448 -0.521 0 CA-C-N 115.694 -0.684 . . . . 15.0 112.028 179.943 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.446 ' CG ' HG22 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -79.69 -53.58 6.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.124 0.487 . . . . 15.0 110.286 -179.846 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.507 ' CD1' HD12 ' A' ' 89' ' ' LEU . 11.0 tp -87.82 158.04 3.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.587 -0.733 . . . . 15.0 110.158 179.477 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . 0.449 ' O ' HG21 ' A' ' 37' ' ' VAL . 67.6 m80 -139.78 160.52 39.71 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-O 121.777 0.799 . . . . 15.0 112.898 -178.705 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.551 ' HA ' ' CG2' ' A' ' 37' ' ' VAL . 1.1 mtpt -43.97 134.7 4.49 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 114.007 -1.451 . . . . 15.0 112.702 -178.843 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.645 ' N ' HG21 ' A' ' 37' ' ' VAL . . . 49.75 31.95 16.87 Favored Glycine 0 C--N 1.333 0.408 0 CA-C-N 115.945 -0.571 . . . . 15.0 113.284 179.282 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.45 ' CB ' HD11 ' A' ' 52' ' ' ILE . 2.9 m-20 -65.56 122.59 17.57 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.629 -0.428 . . . . 15.0 109.874 179.15 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.439 ' HG3' ' CZ ' ' A' ' 36' ' ' TYR . 36.9 ttt85 -80.98 85.44 6.26 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.429 -0.35 . . . . 15.0 110.421 -179.859 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.526 HG22 ' O ' ' A' ' 58' ' ' VAL . 1.3 m -79.67 121.76 33.58 Favored 'Isoleucine or valine' 0 C--O 1.24 0.601 0 CA-C-O 121.211 0.529 . . . . 15.0 111.559 -179.365 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -107.91 -15.63 14.5 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 115.09 -0.959 . . . . 15.0 111.984 -179.861 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -147.91 148.16 30.51 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.113 0.483 . . . . 15.0 112.263 -178.565 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.449 ' HB ' ' CG1' ' A' ' 64' ' ' VAL . 39.6 t -139.02 102.69 1.8 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.249 0 CA-C-N 115.577 -0.738 . . . . 15.0 109.451 178.825 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 64.83 14.46 9.21 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.763 -0.458 . . . . 15.0 109.763 -178.195 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 107.01 6.49 34.3 Favored Glycine 0 C--N 1.336 0.573 0 CA-C-N 115.863 -0.608 . . . . 15.0 113.244 179.828 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.507 ' O ' ' CG1' ' A' ' 64' ' ' VAL . 6.3 p -93.67 105.22 16.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 121.098 0.475 . . . . 15.0 110.579 179.216 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -58.46 123.67 16.98 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.145 -0.479 . . . . 15.0 111.142 -179.442 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -92.07 -16.96 25.69 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.918 -0.583 . . . . 15.0 111.096 179.877 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -43.43 95.26 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.874 0.369 . . . . 15.0 111.239 -179.994 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 107.83 71.42 0.74 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.799 -0.715 . . . . 15.0 112.301 -179.73 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.433 ' HB3' ' HB3' ' A' ' 73' ' ' GLN . . . -173.02 169.46 4.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.831 0.348 . . . . 15.0 111.107 -179.778 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 15.6 p -93.42 -175.21 3.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.927 0.394 . . . . 15.0 111.27 -179.749 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.555 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 0.1 OUTLIER -65.78 -58.56 5.35 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.882 -0.599 . . . . 15.0 110.623 -179.902 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.448 ' O ' ' HG3' ' A' ' 76' ' ' GLU . 23.3 ttpp -52.21 -31.03 30.09 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.747 -0.464 . . . . 15.0 109.747 178.925 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . 0.433 ' HB3' ' HB3' ' A' ' 69' ' ' ALA . 1.1 tt0 -59.5 -49.19 78.73 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.916 -0.584 . . . . 15.0 109.609 178.813 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.449 ' O ' ' N ' ' A' ' 77' ' ' THR . . . -67.11 -45.79 76.15 Favored 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 109.568 -0.53 . . . . 15.0 109.568 178.512 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.452 ' CG2' ' CG2' ' A' ' 22' ' ' VAL . 0.5 OUTLIER -42.2 -42.12 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.27 0 N-CA-C 108.792 -0.818 . . . . 15.0 108.792 178.257 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.506 ' O ' ' HB2' ' A' ' 80' ' ' ASN . 8.9 mt-10 -67.3 -45.28 77.01 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 114.651 -1.159 . . . . 15.0 110.361 178.477 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.449 ' N ' ' O ' ' A' ' 74' ' ' ALA . 72.9 p -64.1 -54.54 32.42 Favored 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 111.545 0.202 . . . . 15.0 111.545 -179.949 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.439 ' HA ' HG12 ' A' ' 61' ' ' VAL . 8.3 mt -53.47 -46.35 69.92 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 121.308 0.575 . . . . 15.0 109.881 -179.989 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.435 ' HB2' ' O ' ' A' ' 75' ' ' VAL . 0.2 OUTLIER -68.51 -58.89 3.63 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.204 -0.907 . . . . 15.0 110.805 179.677 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.506 ' HB2' ' O ' ' A' ' 76' ' ' GLU . 6.5 m-80 -66.23 56.98 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 112.393 0.516 . . . . 15.0 112.393 -179.86 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.481 ' HB ' ' HG3' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -95.69 -75.02 0.53 Allowed 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.94 -0.393 . . . . 15.0 109.94 178.853 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 122.06 -104.02 0.89 Allowed Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.641 -0.79 . . . . 15.0 113.537 178.804 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -63.08 -84.9 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.06 0.393 . . . . 15.0 112.06 -178.699 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.432 HG13 ' N ' ' A' ' 85' ' ' VAL . 55.4 t -109.46 160.18 8.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.891 0.377 . . . . 15.0 110.706 -179.408 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.474 ' HB ' ' HB3' ' A' ' 11' ' ' LEU . 9.3 t -97.8 81.42 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-O 121.118 0.485 . . . . 15.0 110.382 -179.926 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . 0.404 ' CE1' ' OE1' ' A' ' 10' ' ' GLU . 0.5 OUTLIER -99.66 86.29 3.3 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.736 -0.665 . . . . 15.0 110.229 179.863 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.501 ' CD2' ' HB ' ' A' ' 58' ' ' VAL . 0.1 OUTLIER -103.82 127.33 51.33 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.882 -0.599 . . . . 15.0 111.718 -179.018 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.486 HD11 ' CB ' ' A' ' 8' ' ' GLU . 4.4 mp -102.18 99.44 9.57 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.552 -0.536 . . . . 15.0 109.552 178.742 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.507 HD12 ' CD1' ' A' ' 52' ' ' ILE . 0.1 OUTLIER -105.88 -162.66 0.88 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.56 0.695 . . . . 15.0 112.406 -178.317 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.437 ' HA ' ' HA ' ' A' ' 6' ' ' ILE . 1.9 tt0 -138.37 142.27 39.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 114.617 -1.174 . . . . 15.0 109.288 178.669 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -53.79 100.75 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.002 0.429 . . . . 15.0 111.107 -179.522 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.323 0 C-N-CA 120.956 -0.64 . . . . 15.0 112.604 -179.768 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.413 HG13 ' HB2' ' A' ' 90' ' ' GLU . 1.2 mp . . . . . 0 N--CA 1.45 -0.456 0 CA-C-O 120.704 0.288 . . . . 15.0 110.651 . . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.43 ' O ' ' N ' ' A' ' 89' ' ' LEU . 2.0 p90 -140.67 160.25 40.44 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.438 -0.346 . . . . 15.0 110.532 179.085 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.492 ' CB ' HD11 ' A' ' 88' ' ' LEU . 9.5 pt-20 -126.46 144.95 50.68 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.249 0.547 . . . . 15.0 111.48 -179.338 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.461 HG12 ' HB3' ' A' ' 87' ' ' LEU . 0.5 OUTLIER -101.29 115.07 42.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.331 -0.85 . . . . 15.0 109.722 179.157 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -106.13 69.56 0.81 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.107 -0.497 . . . . 15.0 111.643 -179.302 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.443 ' HB3' ' HB ' ' A' ' 85' ' ' VAL . 7.0 tp -88.15 161.68 17.14 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.013 -0.54 . . . . 15.0 110.082 179.213 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -96.63 101.0 12.53 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.717 0.294 . . . . 15.0 111.113 179.918 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.473 ' HB3' ' O ' ' A' ' 83' ' ' GLN . 0.4 OUTLIER . . . . . 0 CA--C 1.534 0.365 0 N-CA-C 112.511 0.56 . . . . 15.0 112.511 179.882 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.7 mm? . . . . . 0 N--CA 1.45 -0.461 0 CA-C-O 120.889 0.376 . . . . 15.0 110.709 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.609 ' O ' ' HB ' ' A' ' 41' ' ' ILE . . . -160.85 35.64 0.42 Allowed Glycine 0 CA--C 1.506 -0.513 0 N-CA-C 111.308 -0.717 . . . . 15.0 111.308 179.987 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.66 HG12 ' O ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -112.61 140.13 33.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.011 0.434 . . . . 15.0 111.948 -179.169 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.423 ' HB3' HD13 ' A' ' 41' ' ' ILE . 33.2 t -96.01 105.82 17.91 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 107.696 -1.224 . . . . 15.0 107.696 177.275 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.462 HG22 ' CD2' ' A' ' 71' ' ' HIS . 33.2 m -93.57 152.77 3.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 112.984 0.735 . . . . 15.0 112.984 -176.908 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -149.42 -178.8 6.62 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 115.014 -0.994 . . . . 15.0 110.823 -179.736 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.412 ' O ' ' HB3' ' A' ' 71' ' ' HIS . . . 71.17 -119.19 7.81 Favored Glycine 0 C--N 1.332 0.308 0 C-N-CA 120.744 -0.741 . . . . 15.0 112.319 -179.95 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.53 ' HA3' ' N ' ' A' ' 71' ' ' HIS . . . 68.47 -66.46 0.41 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.784 -0.722 . . . . 15.0 113.448 179.338 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.446 ' N ' ' HA ' ' A' ' 70' ' ' THR . 0.9 OUTLIER -26.27 138.69 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 N-CA-C 112.5 0.555 . . . . 15.0 112.5 -179.297 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 8.1 p-10 -76.72 57.47 1.28 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.97 -0.559 . . . . 15.0 111.093 -179.929 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.2 m -151.85 -51.84 0.12 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.332 -0.395 . . . . 15.0 110.895 179.971 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 6.0 m -80.53 -41.18 24.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.108 -0.496 . . . . 15.0 110.934 -179.918 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 13.9 m -79.21 -169.96 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.284 -0.416 . . . . 15.0 111.095 -179.948 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.59 -62.94 1.5 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.284 -0.416 . . . . 15.0 111.05 -179.853 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . 0.431 ' CD2' ' HG3' ' A' ' 67' ' ' GLU . 11.0 p-80 -139.22 -51.51 0.53 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.356 -0.384 . . . . 15.0 111.257 -179.764 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -168.28 24.75 0.11 Allowed Glycine 0 CA--C 1.518 0.241 0 C-N-CA 120.791 -0.719 . . . . 15.0 112.628 -179.872 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -91.43 154.08 22.55 Favored Glycine 0 N--CA 1.45 -0.398 0 N-CA-C 110.681 -0.967 . . . . 15.0 110.681 178.891 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.49 HG21 HG22 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -92.55 154.72 3.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 117.685 0.742 . . . . 15.0 111.928 -179.265 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.429 ' CE2' ' HG2' ' A' ' 57' ' ' ARG . 30.4 m-85 -139.19 106.07 5.41 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.042 -0.981 . . . . 15.0 109.691 178.849 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.671 HG21 ' N ' ' A' ' 55' ' ' GLY . 0.7 OUTLIER -55.39 146.4 4.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.929 -0.578 . . . . 15.0 111.335 -178.873 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.422 ' O ' ' HG2' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -80.32 -48.51 12.88 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.475 -0.935 . . . . 15.0 108.475 178.356 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.66 ' O ' HG12 ' A' ' 20' ' ' ILE . . . -172.16 172.36 4.62 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.667 -0.697 . . . . 15.0 110.703 178.68 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.549 ' HA ' HG12 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -96.9 113.07 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 N-CA-C 109.712 -0.477 . . . . 15.0 109.712 179.397 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.609 ' HB ' ' O ' ' A' ' 19' ' ' GLY . 0.3 OUTLIER -78.6 119.34 76.92 Favored Pre-proline 0 C--N 1.33 -0.268 0 N-CA-C 113.281 0.845 . . . . 15.0 113.281 -177.411 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.534 ' HA ' ' CG ' ' A' ' 47' ' ' GLU . 38.3 Cg_endo -65.27 61.2 0.34 Allowed 'Trans proline' 0 C--N 1.355 0.904 0 C-N-CA 123.512 2.808 . . . . 15.0 112.958 179.713 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.536 ' H ' ' HG2' ' A' ' 47' ' ' GLU . 1.8 mm-40 -152.11 -44.63 0.11 Allowed 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 111.767 0.284 . . . . 15.0 111.767 179.81 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.554 ' HA3' ' HA3' ' A' ' 19' ' ' GLY . . . -87.77 164.77 34.47 Favored Glycine 0 CA--C 1.519 0.299 0 C-N-CA 120.347 -0.93 . . . . 15.0 113.828 -179.049 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -53.95 -16.34 1.83 Allowed 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 112.847 0.684 . . . . 15.0 112.847 -179.559 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.29 -57.85 3.88 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.609 0.243 . . . . 15.0 111.27 -179.35 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.536 ' HG2' ' H ' ' A' ' 43' ' ' GLN . 2.9 pp20? -56.74 -40.84 76.47 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.03 0.443 . . . . 15.0 110.312 179.552 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 33.4 t -53.85 -69.79 0.11 Allowed 'General case' 0 CA--C 1.52 -0.182 0 CA-C-N 115.818 -0.628 . . . . 15.0 110.753 -179.449 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -62.61 -38.42 90.11 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.598 -0.519 . . . . 15.0 109.598 179.257 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.03 44.53 8.11 Favored Glycine 0 N--CA 1.447 -0.611 0 CA-C-N 115.573 -0.739 . . . . 15.0 111.703 179.851 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.428 ' CG ' HG22 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -79.43 -53.46 6.88 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.884 0.373 . . . . 15.0 110.832 -179.273 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.403 ' CD1' HD12 ' A' ' 89' ' ' LEU . 8.4 tp -81.93 164.55 2.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.996 -0.547 . . . . 15.0 110.482 179.72 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . 0.447 ' O ' ' HB2' ' A' ' 56' ' ' ASP . 78.8 m80 -147.44 156.98 43.38 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.701 0.762 . . . . 15.0 112.181 -179.142 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.53 ' HA ' ' CG2' ' A' ' 37' ' ' VAL . 6.1 mtpt -42.31 133.73 3.11 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.31 -1.314 . . . . 15.0 112.99 -178.646 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.671 ' N ' HG21 ' A' ' 37' ' ' VAL . . . 49.81 31.87 17.19 Favored Glycine 0 C--N 1.334 0.449 0 CA-C-N 115.635 -0.711 . . . . 15.0 113.644 179.061 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.487 ' HB2' HG12 ' A' ' 37' ' ' VAL . 0.3 OUTLIER -65.9 130.5 43.47 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 117.179 0.49 . . . . 15.0 110.493 179.413 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.429 ' HG2' ' CE2' ' A' ' 36' ' ' TYR . 40.3 mtt180 -83.9 87.23 7.09 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.242 -0.435 . . . . 15.0 110.17 179.62 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.502 ' HA ' HD22 ' A' ' 89' ' ' LEU . 1.3 m -79.66 117.93 26.27 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 CA-C-O 121.086 0.469 . . . . 15.0 111.566 -179.12 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 27.7 mt -107.48 -18.84 13.75 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 115.504 -0.771 . . . . 15.0 112.493 -179.423 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.404 ' HA ' ' O ' ' A' ' 64' ' ' VAL . . . -148.79 148.52 30.04 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 112.946 0.721 . . . . 15.0 112.946 -178.575 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.453 ' CG2' HD22 ' A' ' 78' ' ' LEU . 56.7 t -139.2 94.53 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 CA-C-N 115.101 -0.954 . . . . 15.0 109.076 178.892 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 6.0 m120 70.5 16.6 6.98 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.047 -0.524 . . . . 15.0 109.87 -178.101 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 107.17 4.75 35.44 Favored Glycine 0 C--N 1.336 0.549 0 CA-C-N 115.851 -0.613 . . . . 15.0 113.429 179.559 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.496 ' O ' ' CG1' ' A' ' 64' ' ' VAL . 5.9 p -93.82 105.58 17.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.131 0.491 . . . . 15.0 110.845 179.446 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.6 t -55.71 139.4 45.09 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.057 -0.52 . . . . 15.0 111.206 -179.518 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.43 -22.97 16.28 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.966 -0.561 . . . . 15.0 110.78 179.875 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.431 ' HG3' ' CD2' ' A' ' 32' ' ' HIS . 1.6 tt0 -46.38 103.36 0.04 OUTLIER 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.237 -0.438 . . . . 15.0 111.125 -179.952 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 102.89 61.63 0.71 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.759 -0.734 . . . . 15.0 112.309 -179.865 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -173.09 142.57 1.06 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.874 0.368 . . . . 15.0 111.079 -179.823 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.446 ' HA ' ' N ' ' A' ' 26' ' ' VAL . 2.3 p -72.87 -171.85 0.93 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.252 -0.431 . . . . 15.0 110.953 -179.959 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.53 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 0.0 OUTLIER -62.95 -58.43 7.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.95 -0.568 . . . . 15.0 110.447 179.827 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.418 ' O ' HG11 ' A' ' 75' ' ' VAL . 1.8 ttpp -52.5 -33.91 47.05 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.826 -0.625 . . . . 15.0 110.855 179.691 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -59.31 -51.47 69.82 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.35 -0.611 . . . . 15.0 109.35 179.32 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.45 ' O ' ' N ' ' A' ' 77' ' ' THR . . . -66.86 -43.96 82.22 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.804 -0.634 . . . . 15.0 109.797 178.532 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.433 ' CG2' ' CG2' ' A' ' 22' ' ' VAL . 0.5 OUTLIER -43.35 -39.94 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.236 0 N-CA-C 109.029 -0.73 . . . . 15.0 109.029 178.419 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -67.22 -45.83 75.61 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 114.778 -1.101 . . . . 15.0 110.048 178.342 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.45 ' N ' ' O ' ' A' ' 74' ' ' ALA . 35.4 p -64.28 -53.48 48.26 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-N 116.526 -0.306 . . . . 15.0 111.454 179.848 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.453 HD22 ' CG2' ' A' ' 61' ' ' VAL . 4.5 mt -53.88 -48.53 69.99 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 121.205 0.526 . . . . 15.0 110.102 179.914 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.34 -57.68 5.55 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.405 -0.816 . . . . 15.0 110.737 179.655 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 64.8 m-20 -65.84 62.49 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.961 -0.563 . . . . 15.0 112.088 -179.86 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.41 -73.99 0.57 Allowed 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.798 -0.445 . . . . 15.0 109.798 179.015 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 114.87 -101.11 1.04 Allowed Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.744 -0.741 . . . . 15.0 113.263 178.781 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . 0.473 ' O ' ' HB3' ' A' ' 13' ' ' LYS . 0.1 OUTLIER -64.63 -86.27 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.612 0.244 . . . . 15.0 111.527 -179.208 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.422 HG13 ' N ' ' A' ' 85' ' ' VAL . 79.0 t -110.3 159.52 10.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.98 0.419 . . . . 15.0 110.738 -179.893 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.462 ' O ' ' CG1' ' A' ' 85' ' ' VAL . 3.6 t -97.62 83.66 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.146 0.498 . . . . 15.0 110.228 179.648 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -101.75 83.89 2.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.707 -0.679 . . . . 15.0 110.238 179.727 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.481 ' CD2' ' HB ' ' A' ' 58' ' ' VAL . 0.1 OUTLIER -103.92 128.18 51.43 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.87 -0.605 . . . . 15.0 111.827 -179.106 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.492 HD11 ' CB ' ' A' ' 8' ' ' GLU . 4.6 mp -102.28 100.86 11.08 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.629 -0.508 . . . . 15.0 109.629 178.805 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.502 HD22 ' HA ' ' A' ' 58' ' ' VAL . 0.1 OUTLIER -105.64 -161.78 0.83 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.388 0.613 . . . . 15.0 111.848 -178.552 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.413 ' HB2' HG13 ' A' ' 6' ' ' ILE . 3.1 tt0 -142.23 135.38 28.8 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.052 -0.976 . . . . 15.0 109.878 179.21 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 2.8 tptt -47.47 103.95 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.919 0.39 . . . . 15.0 111.188 -179.681 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.295 0 C-N-CA 120.785 -0.721 . . . . 15.0 112.5 -179.943 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.482 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 1.4 mp . . . . . 0 N--CA 1.451 -0.377 0 CA-C-O 120.77 0.319 . . . . 15.0 111.215 . . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.47 ' CE1' ' CD1' ' A' ' 89' ' ' LEU . 10.8 p90 -141.82 143.59 33.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.264 -0.425 . . . . 15.0 110.882 178.874 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.492 ' HB2' HD11 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -109.96 142.42 41.36 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.339 0.59 . . . . 15.0 111.534 -179.404 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.478 ' CG2' ' HB3' ' A' ' 51' ' ' ARG . 0.2 OUTLIER -101.55 114.89 42.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.117 -0.947 . . . . 15.0 109.831 179.124 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -105.95 71.45 0.9 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.015 -0.539 . . . . 15.0 111.931 -178.988 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.412 ' O ' HG11 ' A' ' 84' ' ' VAL . 5.6 tp -87.98 165.76 14.98 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.151 -0.477 . . . . 15.0 109.727 178.972 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -94.71 94.2 7.98 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.916 0.389 . . . . 15.0 111.057 -179.995 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.445 ' HG3' ' HB ' ' A' ' 81' ' ' THR . 0.2 OUTLIER . . . . . 0 C--N 1.328 -0.358 0 CA-C-N 115.977 -0.556 . . . . 15.0 110.885 179.924 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.1 mm? . . . . . 0 N--CA 1.452 -0.352 0 CA-C-O 120.877 0.37 . . . . 15.0 110.779 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.601 ' HA3' ' HA3' ' A' ' 44' ' ' GLY . . . -160.98 39.44 0.42 Allowed Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 121.043 -0.599 . . . . 15.0 112.024 -179.794 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.608 HG12 ' O ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -112.51 144.71 19.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 121.06 0.457 . . . . 15.0 111.686 -179.493 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 55.0 p -96.06 101.49 13.16 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.267 -1.012 . . . . 15.0 108.267 177.958 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.461 ' O ' ' CE1' ' A' ' 71' ' ' HIS . 33.8 m -93.77 145.61 7.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 113.092 0.775 . . . . 15.0 113.092 -177.273 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.542 ' HA ' ' ND1' ' A' ' 71' ' ' HIS . 0.9 OUTLIER -149.49 -177.65 5.98 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 115.384 -0.826 . . . . 15.0 110.773 178.74 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.458 ' O ' ' HB3' ' A' ' 71' ' ' HIS . . . 76.32 -118.19 5.23 Favored Glycine 0 C--N 1.333 0.401 0 C-N-CA 120.87 -0.681 . . . . 15.0 112.361 -179.753 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.523 ' HA3' ' N ' ' A' ' 71' ' ' HIS . . . 64.42 -64.66 0.06 OUTLIER Glycine 0 CA--C 1.519 0.31 0 C-N-CA 121.139 -0.553 . . . . 15.0 114.116 178.956 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.429 ' N ' ' HA ' ' A' ' 70' ' ' THR . 1.5 m -25.97 142.18 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 N-CA-C 112.892 0.701 . . . . 15.0 112.892 -178.999 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 44.4 t-20 -78.4 55.41 1.57 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.681 -0.69 . . . . 15.0 110.934 179.856 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 15.0 m -152.03 -63.92 0.17 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.915 0.388 . . . . 15.0 110.938 -179.933 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 47.7 t -68.86 -49.99 53.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.029 -0.532 . . . . 15.0 110.885 -179.892 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.419 HG13 ' CD1' ' A' ' 36' ' ' TYR . 35.8 m -84.4 -176.74 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.25 -0.432 . . . . 15.0 111.027 179.912 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -89.09 121.86 31.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.956 0.408 . . . . 15.0 111.158 -179.867 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 65.08 -91.36 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.951 -0.568 . . . . 15.0 111.384 179.722 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.456 ' O ' ' O ' ' A' ' 69' ' ' ALA . . . -164.85 27.97 0.2 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.78 -0.724 . . . . 15.0 112.131 -179.717 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -84.81 149.47 24.37 Favored Glycine 0 N--CA 1.449 -0.47 0 N-CA-C 110.523 -1.031 . . . . 15.0 110.523 178.845 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.577 HG21 HG22 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -90.13 150.92 3.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 119.923 -0.711 . . . . 15.0 111.78 -179.215 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.45 ' CZ ' ' HG3' ' A' ' 57' ' ' ARG . 44.1 m-85 -136.49 108.54 7.19 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 114.904 -1.044 . . . . 15.0 109.124 178.942 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.679 HG21 ' N ' ' A' ' 55' ' ' GLY . 0.8 OUTLIER -55.17 153.72 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 121.269 0.557 . . . . 15.0 111.266 -178.567 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.551 ' O ' ' HG2' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -86.34 -46.05 10.65 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.745 -0.835 . . . . 15.0 108.745 178.848 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.608 ' O ' HG12 ' A' ' 20' ' ' ILE . . . -172.34 169.34 5.34 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.804 -0.635 . . . . 15.0 110.683 178.527 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.478 ' HA ' HG12 ' A' ' 20' ' ' ILE . 0.1 OUTLIER -96.73 109.86 23.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 N-CA-C 109.288 -0.634 . . . . 15.0 109.288 179.049 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.575 ' HB ' ' O ' ' A' ' 19' ' ' GLY . 0.3 OUTLIER -78.36 118.48 72.54 Favored Pre-proline 0 C--N 1.328 -0.348 0 N-CA-C 113.522 0.934 . . . . 15.0 113.522 -176.967 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.554 ' HA ' ' CG ' ' A' ' 47' ' ' GLU . 36.9 Cg_endo -64.48 61.59 0.26 Allowed 'Trans proline' 0 C--N 1.358 1.042 0 C-N-CA 123.536 2.824 . . . . 15.0 112.991 179.865 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.508 ' H ' ' HG2' ' A' ' 47' ' ' GLU . 41.8 mt-30 -149.88 -46.72 0.13 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.597 -0.274 . . . . 15.0 111.54 179.763 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.601 ' HA3' ' HA3' ' A' ' 19' ' ' GLY . . . -88.03 167.59 36.41 Favored Glycine 0 CA--C 1.518 0.27 0 C-N-CA 120.332 -0.937 . . . . 15.0 113.946 -179.212 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -56.6 -13.48 2.44 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.678 0.622 . . . . 15.0 112.678 -179.852 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.426 ' HB3' HG23 ' A' ' 52' ' ' ILE . . . -71.95 -58.23 3.63 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-O 120.773 0.321 . . . . 15.0 110.868 -179.618 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.554 ' CG ' ' HA ' ' A' ' 42' ' ' PRO . 2.6 pp20? -57.38 -42.0 81.33 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.732 -0.667 . . . . 15.0 110.423 179.285 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -53.78 -71.28 0.08 Allowed 'General case' 0 CA--C 1.519 -0.22 0 CA-C-N 115.783 -0.644 . . . . 15.0 110.549 -179.359 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -58.24 -40.71 82.47 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.137 -0.69 . . . . 15.0 109.137 178.838 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.416 ' O ' ' CE1' ' A' ' 53' ' ' HIS . . . 80.98 39.54 13.02 Favored Glycine 0 N--CA 1.446 -0.683 0 CA-C-N 115.197 -0.91 . . . . 15.0 112.011 179.212 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.478 ' HB3' ' CG2' ' A' ' 9' ' ' VAL . 3.0 mmt-85 -80.07 -59.31 2.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.963 0.411 . . . . 15.0 110.386 -179.773 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.441 HG12 HD12 ' A' ' 20' ' ' ILE . 6.6 tp -80.86 146.18 7.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.86 -0.609 . . . . 15.0 109.568 179.115 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . 0.512 ' O ' ' HB2' ' A' ' 56' ' ' ASP . 57.4 m80 -139.47 167.37 22.24 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-O 121.77 0.795 . . . . 15.0 112.762 -178.253 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.551 ' HG2' ' O ' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -40.29 132.72 1.94 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.109 -1.405 . . . . 15.0 113.27 -178.353 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.679 ' N ' HG21 ' A' ' 37' ' ' VAL . . . 49.7 36.23 25.0 Favored Glycine 0 C--N 1.335 0.511 0 CA-C-N 115.613 -0.721 . . . . 15.0 113.566 179.115 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.512 ' HB2' ' O ' ' A' ' 53' ' ' HIS . 1.7 t0 -65.66 132.32 48.51 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.99 0.395 . . . . 15.0 110.34 179.206 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.45 ' HG3' ' CZ ' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -85.11 77.25 10.11 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.983 -0.553 . . . . 15.0 110.134 179.545 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.577 HG22 HG21 ' A' ' 35' ' ' ILE . 0.8 OUTLIER -79.23 115.62 21.82 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 CA-C-O 121.293 0.568 . . . . 15.0 111.027 -179.25 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 35.0 mt -107.32 -14.12 14.96 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 115.555 -0.748 . . . . 15.0 112.522 -178.967 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.405 ' HA ' ' O ' ' A' ' 64' ' ' VAL . . . -147.56 149.9 33.46 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 112.642 0.608 . . . . 15.0 112.642 -178.51 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.447 ' HA ' ' HG ' ' A' ' 87' ' ' LEU . 15.6 t -139.12 101.54 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.27 0 CA-C-N 115.255 -0.884 . . . . 15.0 109.139 178.741 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.408 ' HB2' ' O ' ' A' ' 61' ' ' VAL . 1.7 m-80 65.04 15.54 10.05 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.668 -0.493 . . . . 15.0 109.668 -177.901 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 106.82 4.9 36.29 Favored Glycine 0 C--N 1.337 0.614 0 CA-C-N 115.822 -0.626 . . . . 15.0 113.286 179.77 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.485 ' O ' ' CG1' ' A' ' 64' ' ' VAL . 5.8 p -93.83 108.67 20.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 117.017 0.408 . . . . 15.0 111.046 179.616 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -57.11 137.98 55.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.259 -0.428 . . . . 15.0 111.064 -179.741 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.74 -23.08 16.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.076 -0.511 . . . . 15.0 111.003 179.96 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -47.57 104.0 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.389 -0.369 . . . . 15.0 111.091 179.937 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.76 54.87 0.58 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.744 -0.741 . . . . 15.0 112.288 -179.871 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.456 ' O ' ' O ' ' A' ' 33' ' ' GLY . . . -173.07 146.85 1.53 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.857 0.36 . . . . 15.0 111.012 -179.953 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.429 ' HA ' ' N ' ' A' ' 26' ' ' VAL . 11.3 p -72.94 -172.33 1.02 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.146 0.498 . . . . 15.0 111.097 -179.771 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.542 ' ND1' ' HA ' ' A' ' 23' ' ' THR . 0.0 OUTLIER -65.29 -57.83 7.44 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.636 -0.711 . . . . 15.0 110.751 -179.806 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.414 ' O ' HG11 ' A' ' 75' ' ' VAL . 5.4 ttpp -52.5 -32.91 42.52 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.352 -0.385 . . . . 15.0 110.285 179.316 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -59.56 -48.93 79.74 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.32 -0.622 . . . . 15.0 109.32 178.843 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.456 ' O ' ' N ' ' A' ' 77' ' ' THR . . . -67.16 -44.12 80.56 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-N 115.944 -0.571 . . . . 15.0 109.582 178.24 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.454 ' CG2' ' CG2' ' A' ' 22' ' ' VAL . 0.5 OUTLIER -44.03 -39.28 1.47 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.26 0 N-CA-C 108.706 -0.85 . . . . 15.0 108.706 178.312 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.425 ' N ' HG11 ' A' ' 75' ' ' VAL . 1.1 mt-10 -67.17 -45.3 77.41 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 114.668 -1.151 . . . . 15.0 110.132 178.249 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.456 ' N ' ' O ' ' A' ' 74' ' ' ALA . 39.0 p -64.12 -54.79 28.43 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.634 -0.257 . . . . 15.0 111.599 179.851 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.416 ' CD2' HG21 ' A' ' 61' ' ' VAL . 5.9 mt -53.33 -47.68 69.12 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-O 121.215 0.531 . . . . 15.0 109.851 -179.853 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.49 -59.09 3.41 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.423 -0.808 . . . . 15.0 110.551 179.403 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.403 ' HB2' ' O ' ' A' ' 76' ' ' GLU . 78.6 m-20 -66.15 59.71 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.947 -0.57 . . . . 15.0 112.411 -179.903 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.445 ' HB ' ' HG3' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -95.63 -71.51 0.67 Allowed 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 110.006 -0.368 . . . . 15.0 110.006 178.917 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 121.97 -105.39 0.98 Allowed Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.833 -0.699 . . . . 15.0 113.157 179.118 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.75 -81.62 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 112.151 0.426 . . . . 15.0 112.151 -179.06 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.417 HG13 ' N ' ' A' ' 85' ' ' VAL . 72.2 t -109.97 159.1 9.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.136 0.493 . . . . 15.0 111.21 -179.136 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.45 ' O ' ' CG1' ' A' ' 85' ' ' VAL . 6.8 t -97.82 81.56 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.909 -0.587 . . . . 15.0 110.553 179.935 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -100.45 84.34 2.76 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.729 -0.668 . . . . 15.0 110.419 179.786 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.459 ' CB ' HG12 ' A' ' 9' ' ' VAL . 0.1 OUTLIER -103.55 118.62 37.15 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.985 -0.552 . . . . 15.0 111.916 -179.102 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.492 HD11 ' HB2' ' A' ' 8' ' ' GLU . 3.8 mp -92.01 103.65 16.14 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.17 -0.678 . . . . 15.0 109.17 178.445 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.47 ' CD1' ' CE1' ' A' ' 7' ' ' PHE . 0.1 OUTLIER -105.61 -164.91 1.06 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.615 0.721 . . . . 15.0 112.352 -178.035 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.482 ' HA ' ' HA ' ' A' ' 6' ' ' ILE . 0.7 OUTLIER -144.93 135.86 24.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 114.626 -1.17 . . . . 15.0 109.487 179.146 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -46.81 98.65 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.942 0.401 . . . . 15.0 111.253 -179.497 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.364 0 C-N-CA 120.869 -0.681 . . . . 15.0 112.641 -179.83 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.494 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 1.2 mp . . . . . 0 N--CA 1.451 -0.402 0 CA-C-O 120.786 0.327 . . . . 15.0 111.129 . . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.467 ' CZ ' HD11 ' A' ' 89' ' ' LEU . 2.3 p90 -140.44 153.79 46.41 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.234 -0.439 . . . . 15.0 110.557 178.949 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.516 ' CB ' HD11 ' A' ' 88' ' ' LEU . 13.3 pt-20 -119.86 143.12 48.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.29 0.567 . . . . 15.0 111.748 -179.164 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.483 ' CG2' ' HB3' ' A' ' 51' ' ' ARG . 0.2 OUTLIER -101.67 117.79 47.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.277 -0.874 . . . . 15.0 109.72 178.817 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 51.5 tt0 -106.2 73.38 0.98 Allowed 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.094 0.405 . . . . 15.0 112.094 -179.165 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.505 ' HB3' ' HB ' ' A' ' 85' ' ' VAL . 9.5 tp -88.43 160.69 17.43 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.245 -0.434 . . . . 15.0 109.975 178.9 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -97.0 94.69 7.32 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 111.853 0.316 . . . . 15.0 111.853 -179.615 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.43 ' HB2' ' CG2' ' A' ' 85' ' ' VAL . 0.5 OUTLIER . . . . . 0 N--CA 1.466 0.337 0 N-CA-C 112.522 0.564 . . . . 15.0 112.522 179.476 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.2 mm? . . . . . 0 N--CA 1.453 -0.307 0 CA-C-O 121.066 0.46 . . . . 15.0 110.865 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.591 ' O ' ' HB ' ' A' ' 41' ' ' ILE . . . -161.0 33.68 0.39 Allowed Glycine 0 C--O 1.223 -0.55 0 N-CA-C 110.84 -0.904 . . . . 15.0 110.84 -179.815 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.572 HG12 ' O ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -114.0 139.94 37.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 112.445 0.535 . . . . 15.0 112.445 -179.217 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.426 ' CB ' HD11 ' A' ' 41' ' ' ILE . 4.3 t -96.17 105.47 17.53 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 107.882 -1.155 . . . . 15.0 107.882 176.492 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.416 ' CG2' HG22 ' A' ' 75' ' ' VAL . 6.8 m -93.69 154.91 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 N-CA-C 113.28 0.844 . . . . 15.0 113.28 -176.952 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.52 -178.74 6.6 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.191 -0.913 . . . . 15.0 111.032 179.852 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.413 ' O ' ' CB ' ' A' ' 71' ' ' HIS . . . 69.04 -119.07 9.29 Favored Glycine 0 C--N 1.333 0.364 0 C-N-CA 120.968 -0.634 . . . . 15.0 112.531 179.719 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.549 ' HA3' ' N ' ' A' ' 71' ' ' HIS . . . 68.11 -65.79 0.36 Allowed Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.919 -0.658 . . . . 15.0 113.615 179.339 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.443 ' C ' ' O ' ' A' ' 25' ' ' GLY . 0.0 OUTLIER -27.36 139.29 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 N-CA-C 112.209 0.448 . . . . 15.0 112.209 -179.337 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 7.8 p-10 -75.22 61.99 1.2 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.08 -0.509 . . . . 15.0 111.006 -179.59 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.5 m -151.75 -59.68 0.16 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.274 -0.421 . . . . 15.0 111.055 179.957 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 91.4 p -74.86 -47.65 29.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.118 -0.492 . . . . 15.0 111.168 -179.779 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 35.1 m -70.12 -174.14 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.328 -0.396 . . . . 15.0 111.154 -179.89 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 6.8 mmp_? -54.5 -59.1 5.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.227 -0.442 . . . . 15.0 111.217 -179.792 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 1.7 p-80 -149.92 -44.83 0.13 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.44 -0.346 . . . . 15.0 111.325 -179.782 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.402 ' O ' ' O ' ' A' ' 69' ' ' ALA . . . -167.53 24.45 0.12 Allowed Glycine 0 CA--C 1.517 0.179 0 C-N-CA 120.605 -0.807 . . . . 15.0 112.894 -179.689 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -91.92 154.04 22.28 Favored Glycine 0 N--CA 1.45 -0.406 0 N-CA-C 110.074 -1.21 . . . . 15.0 110.074 178.341 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.514 ' HA ' ' HA2' ' A' ' 25' ' ' GLY . 0.0 OUTLIER -101.39 147.13 8.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 118.184 0.992 . . . . 15.0 111.767 -179.249 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 -130.94 109.2 10.36 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-N 115.307 -0.861 . . . . 15.0 109.539 -179.634 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.64 HG21 ' N ' ' A' ' 55' ' ' GLY . 0.7 OUTLIER -55.46 167.11 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.916 -0.583 . . . . 15.0 110.739 -179.27 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.42 -48.14 4.66 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.059 -0.719 . . . . 15.0 109.059 178.77 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.572 ' O ' HG12 ' A' ' 20' ' ' ILE . . . -171.5 169.18 6.22 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.269 -0.878 . . . . 15.0 110.463 179.341 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.513 ' HB ' ' HB2' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -97.24 123.57 49.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.727 0.298 . . . . 15.0 110.838 -179.908 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.707 ' O ' ' HB3' ' A' ' 47' ' ' GLU . 1.7 mm -78.68 108.14 7.37 Favored Pre-proline 0 N--CA 1.468 0.443 0 N-CA-C 113.199 0.815 . . . . 15.0 113.199 -178.651 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.48 ' HA ' ' CG ' ' A' ' 47' ' ' GLU . 25.8 Cg_exo -62.35 72.52 0.11 Allowed 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 122.99 2.46 . . . . 15.0 112.264 179.341 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.422 ' N ' ' O ' ' A' ' 41' ' ' ILE . 0.6 OUTLIER -174.32 -41.66 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.687 -0.688 . . . . 15.0 110.245 179.926 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.565 ' HA3' ' HA3' ' A' ' 19' ' ' GLY . . . -87.3 150.63 22.85 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.651 -0.785 . . . . 15.0 112.409 179.613 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -39.5 -22.73 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 113.191 0.811 . . . . 15.0 113.191 -179.369 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.427 ' N ' ' O ' ' A' ' 44' ' ' GLY . . . -71.82 -70.2 0.34 Allowed 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.937 -0.305 . . . . 15.0 111.294 -179.625 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.707 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 4.3 tp10 -58.03 -38.94 77.17 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.904 0.383 . . . . 15.0 110.657 179.653 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -53.82 -60.6 3.11 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.092 -0.504 . . . . 15.0 110.358 179.867 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.413 ' CB ' HD13 ' A' ' 11' ' ' LEU . 0.7 OUTLIER -66.71 -38.73 87.32 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.142 -0.481 . . . . 15.0 109.982 179.07 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.48 41.05 10.3 Favored Glycine 0 N--CA 1.449 -0.486 0 CA-C-N 115.699 -0.682 . . . . 15.0 112.486 179.664 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.483 ' HB3' ' CG2' ' A' ' 9' ' ' VAL . 5.3 mmp_? -86.3 -55.91 3.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.906 0.384 . . . . 15.0 110.74 179.858 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.463 ' CD1' HD12 ' A' ' 89' ' ' LEU . 9.0 tp -81.12 160.63 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 CA-C-N 116.037 -0.529 . . . . 15.0 110.71 179.808 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . 0.467 ' O ' ' HB2' ' A' ' 56' ' ' ASP . 62.2 m80 -141.17 160.54 39.88 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-O 121.73 0.776 . . . . 15.0 112.575 -179.077 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.588 ' HA ' ' CG2' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -45.77 137.45 5.44 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.398 -1.274 . . . . 15.0 112.497 -178.671 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.64 ' N ' HG21 ' A' ' 37' ' ' VAL . . . 49.73 32.7 17.88 Favored Glycine 0 C--N 1.334 0.452 0 CA-C-N 115.874 -0.603 . . . . 15.0 113.467 179.676 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.467 ' HB2' ' O ' ' A' ' 53' ' ' HIS . 0.3 OUTLIER -66.06 127.59 32.72 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.314 -0.554 . . . . 15.0 110.205 179.09 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 5.8 ttt180 -83.17 83.32 7.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.277 -0.42 . . . . 15.0 110.097 179.713 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.501 ' CG2' ' CG2' ' A' ' 35' ' ' ILE . 1.0 OUTLIER -79.47 123.6 36.59 Favored 'Isoleucine or valine' 0 C--O 1.241 0.646 0 CA-C-O 121.089 0.471 . . . . 15.0 111.329 -179.259 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -107.62 -18.78 13.75 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.189 -0.914 . . . . 15.0 112.491 -179.461 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -147.87 149.1 31.64 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 112.799 0.666 . . . . 15.0 112.799 -178.35 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.439 ' HB ' ' CG1' ' A' ' 64' ' ' VAL . 43.7 t -139.33 100.6 1.4 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.225 0 CA-C-N 115.297 -0.865 . . . . 15.0 109.281 178.596 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 65.46 15.9 10.25 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.135 -0.484 . . . . 15.0 109.833 -178.149 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 106.79 5.47 35.89 Favored Glycine 0 C--N 1.336 0.559 0 CA-C-N 115.868 -0.605 . . . . 15.0 113.321 179.615 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.504 ' O ' ' CG1' ' A' ' 64' ' ' VAL . 5.4 p -93.8 106.17 17.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.092 0.473 . . . . 15.0 110.713 179.405 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -57.66 127.84 34.03 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.159 -0.473 . . . . 15.0 111.147 -179.472 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -88.87 -23.96 22.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.986 -0.552 . . . . 15.0 110.741 179.81 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -45.25 97.16 0.01 OUTLIER 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 116.374 -0.375 . . . . 15.0 110.928 179.863 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.79 62.6 0.54 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.791 -0.718 . . . . 15.0 112.073 -179.544 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.402 ' O ' ' O ' ' A' ' 33' ' ' GLY . . . -172.93 146.22 1.51 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.897 0.379 . . . . 15.0 110.86 -179.789 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 6.8 p -72.81 -171.85 0.92 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.072 0.463 . . . . 15.0 111.304 -179.62 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.549 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 0.0 OUTLIER -65.39 -58.47 5.81 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.753 -0.658 . . . . 15.0 110.724 -179.91 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.404 ' HA ' ' HB ' ' A' ' 75' ' ' VAL . 15.6 ttpp -52.52 -31.46 35.54 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.018 -0.537 . . . . 15.0 110.52 179.725 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -59.59 -49.03 79.34 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.651 -0.5 . . . . 15.0 109.651 179.239 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.463 ' O ' ' N ' ' A' ' 77' ' ' THR . . . -67.2 -45.16 77.72 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 109.495 -0.557 . . . . 15.0 109.495 178.404 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.416 HG22 ' CG2' ' A' ' 22' ' ' VAL . 0.5 OUTLIER -43.06 -41.92 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.272 0 N-CA-C 108.888 -0.782 . . . . 15.0 108.888 178.305 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.509 ' O ' ' HB2' ' A' ' 80' ' ' ASN . 1.6 mt-10 -67.17 -44.59 79.33 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 114.861 -1.063 . . . . 15.0 110.073 178.212 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.463 ' N ' ' O ' ' A' ' 74' ' ' ALA . 68.7 p -64.08 -54.4 34.67 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-N 116.566 -0.288 . . . . 15.0 111.577 179.93 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.441 ' HG ' ' O ' ' A' ' 74' ' ' ALA . 8.6 mt -53.56 -47.02 70.44 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.351 0.596 . . . . 15.0 109.903 179.855 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.41 ' HB2' ' O ' ' A' ' 75' ' ' VAL . 0.1 OUTLIER -68.44 -59.49 3.13 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.194 -0.912 . . . . 15.0 110.837 179.728 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.509 ' HB2' ' O ' ' A' ' 76' ' ' GLU . 12.0 m-80 -66.09 61.06 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.161 -0.472 . . . . 15.0 112.131 -179.859 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.7 -71.46 0.67 Allowed 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 110.0 -0.37 . . . . 15.0 110.0 179.02 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 116.85 -102.02 1.0 Allowed Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.838 -0.696 . . . . 15.0 112.979 179.055 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.81 -87.51 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.632 0.253 . . . . 15.0 111.437 -179.456 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.434 HG13 ' N ' ' A' ' 85' ' ' VAL . 84.1 t -109.85 160.69 8.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.951 0.405 . . . . 15.0 110.873 -179.816 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.505 ' HB ' ' HB3' ' A' ' 11' ' ' LEU . 3.3 t -97.71 81.43 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 121.258 0.551 . . . . 15.0 110.143 179.804 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -96.03 81.32 3.37 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.668 -0.697 . . . . 15.0 110.107 179.827 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.463 ' CD2' ' HB ' ' A' ' 58' ' ' VAL . 0.1 OUTLIER -103.21 124.38 48.51 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.963 -0.562 . . . . 15.0 111.891 -178.947 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.516 HD11 ' CB ' ' A' ' 8' ' ' GLU . 0.0 OUTLIER -102.34 101.98 12.29 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.371 -0.603 . . . . 15.0 109.371 178.548 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.467 HD11 ' CZ ' ' A' ' 7' ' ' PHE . 0.1 OUTLIER -105.65 -163.57 0.95 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.553 0.692 . . . . 15.0 112.09 -178.581 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.494 ' HA ' ' HA ' ' A' ' 6' ' ' ILE . 0.9 OUTLIER -138.79 134.87 34.01 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.731 -1.122 . . . . 15.0 109.433 178.845 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.87 105.15 0.06 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.857 0.36 . . . . 15.0 111.379 -179.219 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.39 0 C-N-CA 120.777 -0.725 . . . . 15.0 112.581 -179.912 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.403 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 1.1 mp . . . . . 0 N--CA 1.451 -0.414 0 CA-C-O 120.825 0.345 . . . . 15.0 111.0 . . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.443 ' O ' ' N ' ' A' ' 89' ' ' LEU . 4.0 p90 -140.65 157.71 45.05 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.191 -0.459 . . . . 15.0 110.58 179.087 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.472 ' CB ' HD11 ' A' ' 88' ' ' LEU . 11.3 pt-20 -124.71 141.83 51.83 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.226 0.536 . . . . 15.0 111.362 -179.557 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.481 ' CG2' ' HB3' ' A' ' 51' ' ' ARG . 0.2 OUTLIER -101.56 117.98 47.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.38 -0.827 . . . . 15.0 109.771 178.984 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -106.22 75.47 1.09 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.29 -0.414 . . . . 15.0 112.115 -179.064 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.551 ' HB3' ' HB ' ' A' ' 85' ' ' VAL . 11.4 tp -88.45 159.98 17.74 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.615 -0.513 . . . . 15.0 109.615 178.728 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -96.9 94.26 7.12 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 112.043 0.386 . . . . 15.0 112.043 -179.393 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.424 ' HB2' ' CG2' ' A' ' 85' ' ' VAL . 0.6 OUTLIER . . . . . 0 CA--C 1.534 0.352 0 N-CA-C 112.435 0.531 . . . . 15.0 112.435 179.312 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.2 mm? . . . . . 0 N--CA 1.451 -0.405 0 CA-C-O 121.109 0.48 . . . . 15.0 110.722 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.575 ' O ' ' HB ' ' A' ' 41' ' ' ILE . . . -162.96 33.4 0.3 Allowed Glycine 0 C--O 1.223 -0.572 0 N-CA-C 110.83 -0.908 . . . . 15.0 110.83 -179.766 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.557 HD13 ' HB ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -113.87 143.26 23.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 112.243 0.46 . . . . 15.0 112.243 -179.159 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.405 ' CB ' HD11 ' A' ' 41' ' ' ILE . 1.7 t -96.41 103.45 15.36 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 107.745 -1.206 . . . . 15.0 107.745 176.676 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.434 ' CG2' ' CG2' ' A' ' 75' ' ' VAL . 29.6 m -93.5 149.82 4.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.368 0.604 . . . . 15.0 112.612 -177.367 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -149.51 -178.46 6.44 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.167 -0.924 . . . . 15.0 110.949 -179.411 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.406 ' O ' ' HB3' ' A' ' 71' ' ' HIS . . . 69.52 -117.64 7.86 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 120.802 -0.713 . . . . 15.0 112.251 -179.973 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.505 ' HA3' ' N ' ' A' ' 71' ' ' HIS . . . 67.2 -64.25 0.23 Allowed Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.904 -0.665 . . . . 15.0 113.668 179.362 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.417 ' HA ' ' CB ' ' A' ' 70' ' ' THR . 0.0 OUTLIER -28.99 137.51 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 N-CA-C 112.459 0.54 . . . . 15.0 112.459 -179.255 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 11.5 m-80 -75.56 61.3 1.3 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.802 -0.635 . . . . 15.0 111.016 -179.729 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -151.74 -53.76 0.13 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.341 -0.39 . . . . 15.0 111.074 179.971 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.6 m -81.92 -45.64 15.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.155 -0.475 . . . . 15.0 111.133 -179.812 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 34.8 m -72.15 -175.23 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.22 -0.445 . . . . 15.0 111.271 -179.838 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.5 -60.55 3.16 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.204 -0.453 . . . . 15.0 111.202 -179.942 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 5.4 p-80 -146.62 -46.81 0.19 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.357 -0.383 . . . . 15.0 111.235 -179.847 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -169.2 25.81 0.11 Allowed Glycine 0 N--CA 1.453 -0.2 0 C-N-CA 120.749 -0.738 . . . . 15.0 112.686 -179.73 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -94.28 153.41 21.05 Favored Glycine 0 N--CA 1.449 -0.47 0 N-CA-C 110.629 -0.989 . . . . 15.0 110.629 178.838 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.503 HG21 HG22 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -94.18 152.77 3.52 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.321 0 CA-C-N 117.727 0.764 . . . . 15.0 112.073 -179.252 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.486 ' CZ ' ' HG2' ' A' ' 57' ' ' ARG . 44.5 m-85 -136.04 106.29 6.39 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.84 -1.073 . . . . 15.0 109.613 178.849 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.661 HG21 ' N ' ' A' ' 55' ' ' GLY . 0.6 OUTLIER -55.22 145.74 5.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.911 -0.586 . . . . 15.0 111.491 -178.846 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.45 ' O ' ' HG2' ' A' ' 54' ' ' LYS . 1.2 ttpt -81.91 -47.45 12.74 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.342 -0.984 . . . . 15.0 108.342 178.213 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.543 ' O ' HG12 ' A' ' 20' ' ' ILE . . . -172.2 169.79 5.35 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.625 -0.716 . . . . 15.0 111.366 178.679 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.513 ' HA ' HG12 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -97.5 121.04 47.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-N 116.254 -0.43 . . . . 15.0 111.131 -179.871 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.596 ' O ' ' HB3' ' A' ' 47' ' ' GLU . 1.5 mm -78.98 110.33 14.16 Favored Pre-proline 0 N--CA 1.466 0.368 0 N-CA-C 113.135 0.791 . . . . 15.0 113.135 -178.919 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.545 ' HA ' ' OE1' ' A' ' 47' ' ' GLU . 17.8 Cg_exo -65.8 63.68 0.42 Allowed 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 122.858 2.372 . . . . 15.0 112.213 179.243 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 1.9 mm-40 -159.48 -45.81 0.05 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.654 -0.703 . . . . 15.0 109.85 179.873 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.496 ' HA3' ' HA3' ' A' ' 19' ' ' GLY . . . -87.42 151.51 23.47 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.68 -0.772 . . . . 15.0 112.374 179.518 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -39.96 -19.58 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 113.494 0.924 . . . . 15.0 113.494 -179.326 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.448 ' N ' ' O ' ' A' ' 44' ' ' GLY . . . -71.72 -70.95 0.29 Allowed 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.829 -0.348 . . . . 15.0 111.426 -179.453 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.596 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 9.9 tm-20 -58.2 -38.25 76.37 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.823 0.344 . . . . 15.0 110.336 179.599 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.3 m -53.9 -64.97 0.66 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.164 -0.471 . . . . 15.0 110.449 179.821 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.415 ' CB ' HD13 ' A' ' 11' ' ' LEU . 0.4 OUTLIER -63.21 -37.51 87.54 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.151 -0.477 . . . . 15.0 109.979 179.112 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.49 37.46 17.31 Favored Glycine 0 N--CA 1.449 -0.439 0 CA-C-N 115.726 -0.67 . . . . 15.0 112.377 179.695 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.481 ' HB3' ' CG2' ' A' ' 9' ' ' VAL . 0.9 OUTLIER -82.8 -54.65 4.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.938 0.399 . . . . 15.0 110.543 179.91 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.516 ' CD1' HD12 ' A' ' 89' ' ' LEU . 11.4 tp -81.18 159.07 4.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.979 -0.555 . . . . 15.0 110.177 179.458 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . 0.439 ' O ' HG21 ' A' ' 37' ' ' VAL . 76.1 m80 -142.16 160.67 39.76 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 121.766 0.793 . . . . 15.0 112.813 -178.784 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.544 ' HA ' ' CG2' ' A' ' 37' ' ' VAL . 1.2 mtpt -44.01 134.73 4.53 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 113.93 -1.486 . . . . 15.0 112.762 -178.788 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.661 ' N ' HG21 ' A' ' 37' ' ' VAL . . . 49.75 29.82 13.54 Favored Glycine 0 C--N 1.334 0.428 0 CA-C-N 115.791 -0.64 . . . . 15.0 113.448 179.261 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.412 ' CB ' HD11 ' A' ' 52' ' ' ILE . 6.2 m-20 -65.78 128.75 37.26 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.761 -0.376 . . . . 15.0 110.413 179.359 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.486 ' HG2' ' CZ ' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -82.08 93.49 7.02 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.362 -0.381 . . . . 15.0 110.54 -179.988 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.503 HG22 HG21 ' A' ' 35' ' ' ILE . 1.2 m -86.26 115.7 27.86 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 CA-C-O 121.112 0.482 . . . . 15.0 111.586 -179.32 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -107.68 -14.67 14.76 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 115.633 -0.712 . . . . 15.0 112.542 -179.496 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -147.56 150.33 34.27 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 112.743 0.646 . . . . 15.0 112.743 -178.394 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.444 ' HB ' ' CG1' ' A' ' 64' ' ' VAL . 98.2 t -139.21 103.01 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.202 -0.908 . . . . 15.0 109.066 178.808 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 65.23 16.9 10.79 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.516 -0.55 . . . . 15.0 109.516 -178.038 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.0 6.97 44.98 Favored Glycine 0 C--N 1.335 0.49 0 CA-C-N 115.789 -0.641 . . . . 15.0 113.135 179.814 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.487 ' O ' ' CG1' ' A' ' 64' ' ' VAL . 6.0 p -93.86 106.56 18.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.062 0.458 . . . . 15.0 110.724 179.394 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -58.3 122.98 14.56 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.179 -0.464 . . . . 15.0 110.955 -179.488 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.7 mt -94.38 -12.53 27.73 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.836 -0.62 . . . . 15.0 111.286 -179.92 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -44.65 98.05 0.01 OUTLIER 'General case' 0 N--CA 1.461 0.1 0 CA-C-O 120.865 0.364 . . . . 15.0 110.894 179.855 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.85 67.53 0.6 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.838 -0.696 . . . . 15.0 112.102 -179.46 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -172.91 148.16 1.76 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.78 0.324 . . . . 15.0 110.837 -179.683 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.417 ' CB ' ' HA ' ' A' ' 26' ' ' VAL . 1.4 p -72.86 -174.2 1.41 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.019 0.438 . . . . 15.0 111.041 -179.731 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.505 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 0.0 OUTLIER -63.51 -59.03 5.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.885 -0.598 . . . . 15.0 110.658 -179.822 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.404 ' HA ' ' HB ' ' A' ' 75' ' ' VAL . 18.1 ttpp -52.44 -33.19 43.09 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.987 -0.551 . . . . 15.0 110.75 179.669 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -59.57 -49.98 75.65 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.428 -0.582 . . . . 15.0 109.428 179.123 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.451 ' HA ' ' OG1' ' A' ' 77' ' ' THR . . . -67.05 -45.93 75.93 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.743 -0.662 . . . . 15.0 109.836 178.482 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.434 ' CG2' ' CG2' ' A' ' 22' ' ' VAL . 0.5 OUTLIER -41.87 -41.49 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.27 0 CA-C-O 121.524 0.678 . . . . 15.0 109.218 178.553 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.401 ' HG3' ' O ' ' A' ' 72' ' ' LYS . 21.4 mt-10 -67.33 -44.93 77.88 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.762 -1.108 . . . . 15.0 110.681 178.941 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.451 ' OG1' ' HA ' ' A' ' 74' ' ' ALA . 15.3 p -64.38 -54.9 25.61 Favored 'General case' 0 N--CA 1.463 0.184 0 C-N-CA 121.028 -0.269 . . . . 15.0 111.599 -179.96 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.411 ' HA ' HG12 ' A' ' 61' ' ' VAL . 6.5 mt -53.43 -47.79 69.32 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-O 121.122 0.487 . . . . 15.0 110.188 -179.752 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.406 ' HB2' ' O ' ' A' ' 75' ' ' VAL . 3.1 ttp180 -68.32 -57.48 5.87 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.554 -0.748 . . . . 15.0 110.479 179.521 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -66.11 61.69 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.016 -0.538 . . . . 15.0 111.906 179.859 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.57 -74.97 0.54 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.719 0.295 . . . . 15.0 110.234 179.236 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 120.36 -102.33 0.86 Allowed Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.775 -0.726 . . . . 15.0 112.88 179.381 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -64.7 -86.02 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.609 0.242 . . . . 15.0 111.209 -179.627 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.446 HG13 ' N ' ' A' ' 85' ' ' VAL . 86.8 t -109.77 160.36 8.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.886 0.374 . . . . 15.0 110.778 -179.924 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.551 ' HB ' ' HB3' ' A' ' 11' ' ' LEU . 3.1 t -97.66 81.86 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.214 0.53 . . . . 15.0 110.195 179.868 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -96.08 82.29 3.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.687 -0.688 . . . . 15.0 110.344 179.895 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.475 ' CD2' ' CD2' ' A' ' 89' ' ' LEU . 0.1 OUTLIER -101.95 121.83 42.89 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.933 -0.576 . . . . 15.0 111.719 -179.281 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.472 HD11 ' CB ' ' A' ' 8' ' ' GLU . 4.7 mp -99.4 100.76 11.86 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.521 -0.548 . . . . 15.0 109.521 178.745 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.516 HD12 ' CD1' ' A' ' 52' ' ' ILE . 0.1 OUTLIER -105.52 -161.52 0.81 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.456 0.646 . . . . 15.0 112.031 -178.501 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.403 ' HA ' ' HA ' ' A' ' 6' ' ' ILE . 1.1 tt0 -138.88 142.58 38.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 114.862 -1.063 . . . . 15.0 109.629 178.969 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 2.5 tppp? -54.48 106.04 0.18 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.978 0.418 . . . . 15.0 111.242 -179.421 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.382 0 C-N-CA 120.971 -0.633 . . . . 15.0 112.438 179.914 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.412 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 1.4 mp . . . . . 0 N--CA 1.449 -0.516 0 CA-C-O 120.818 0.342 . . . . 15.0 111.034 . . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.448 ' O ' ' N ' ' A' ' 89' ' ' LEU . 4.8 p90 -140.45 166.81 23.71 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.182 -0.463 . . . . 15.0 110.37 178.871 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.468 ' HB2' HD11 ' A' ' 88' ' ' LEU . 4.2 pt-20 -130.22 142.87 50.53 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.269 0.557 . . . . 15.0 111.88 -179.21 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.429 HG12 ' HB3' ' A' ' 87' ' ' LEU . 0.2 OUTLIER -101.38 115.93 44.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.237 -0.892 . . . . 15.0 109.332 178.805 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -105.96 76.37 1.17 Allowed 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 112.696 0.628 . . . . 15.0 112.696 -178.394 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.502 ' HB3' ' HB ' ' A' ' 85' ' ' VAL . 6.9 tp -88.16 162.03 16.93 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.018 -0.734 . . . . 15.0 109.018 177.995 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -96.92 89.98 5.05 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 112.431 0.53 . . . . 15.0 112.431 -179.185 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.033 -0.531 . . . . 15.0 111.552 178.9 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.4 mm? . . . . . 0 N--CA 1.45 -0.425 0 CA-C-O 120.811 0.338 . . . . 15.0 110.457 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.646 ' O ' ' HB ' ' A' ' 41' ' ' ILE . . . -167.51 37.1 0.22 Allowed Glycine 0 CA--C 1.506 -0.52 0 N-CA-C 111.566 -0.614 . . . . 15.0 111.566 -179.609 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.593 HG12 ' O ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -112.5 142.28 25.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 112.216 0.45 . . . . 15.0 112.216 -179.04 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 30.9 t -95.46 101.66 13.4 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 107.079 -1.452 . . . . 15.0 107.079 176.657 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.451 HG22 ' CD2' ' A' ' 71' ' ' HIS . 35.5 m -93.26 156.7 3.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 113.236 0.828 . . . . 15.0 113.236 -176.364 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.25 -175.03 4.82 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 114.966 -1.016 . . . . 15.0 110.647 -179.694 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.407 ' O ' ' HB3' ' A' ' 71' ' ' HIS . . . 68.79 -121.38 12.15 Favored Glycine 0 C--N 1.332 0.32 0 C-N-CA 120.868 -0.682 . . . . 15.0 112.469 179.8 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.513 ' HA3' ' N ' ' A' ' 71' ' ' HIS . . . 66.76 -64.42 0.18 Allowed Glycine 0 CA--C 1.518 0.269 0 C-N-CA 120.997 -0.621 . . . . 15.0 113.679 179.285 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.407 ' N ' ' HA ' ' A' ' 70' ' ' THR . 0.0 OUTLIER -30.46 146.97 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 N-CA-C 112.591 0.589 . . . . 15.0 112.591 -179.204 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -75.75 56.31 0.92 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.872 -0.604 . . . . 15.0 111.066 -179.946 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.3 m -151.96 -63.61 0.17 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.914 0.388 . . . . 15.0 111.202 -179.986 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 30.9 t -67.07 -50.43 61.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.046 -0.524 . . . . 15.0 111.325 -179.575 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.439 HG13 ' CD1' ' A' ' 36' ' ' TYR . 19.6 m -69.45 -175.94 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.378 -0.374 . . . . 15.0 111.415 -179.644 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.401 ' HD3' ' NH2' ' A' ' 57' ' ' ARG . 46.2 mtp85 -62.4 -53.06 60.53 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.162 -0.472 . . . . 15.0 111.089 -179.859 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 42.1 p-80 -142.24 -52.79 0.41 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.449 -0.341 . . . . 15.0 111.201 179.939 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -169.18 19.01 0.08 OUTLIER Glycine 0 CA--C 1.519 0.328 0 C-N-CA 120.522 -0.847 . . . . 15.0 113.097 -179.802 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -85.27 152.92 27.21 Favored Glycine 0 N--CA 1.45 -0.401 0 N-CA-C 110.797 -0.921 . . . . 15.0 110.797 178.89 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.486 HG21 HG22 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -90.54 154.97 3.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 117.642 0.721 . . . . 15.0 111.851 -179.352 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.439 ' CD1' HG13 ' A' ' 30' ' ' VAL . 30.4 m-85 -141.8 107.34 5.06 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.028 -0.987 . . . . 15.0 109.737 178.918 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.662 HG21 ' N ' ' A' ' 55' ' ' GLY . 0.8 OUTLIER -55.3 150.83 2.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.035 -0.53 . . . . 15.0 111.315 -178.9 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.486 ' O ' ' HG2' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -82.37 -47.04 12.78 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.416 -0.957 . . . . 15.0 108.416 178.412 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.593 ' O ' HG12 ' A' ' 20' ' ' ILE . . . -172.17 173.37 4.3 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.361 -0.836 . . . . 15.0 110.231 178.569 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.58 ' HA ' HG12 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -97.36 108.69 22.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.892 0.377 . . . . 15.0 110.349 179.647 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.646 ' HB ' ' O ' ' A' ' 19' ' ' GLY . 0.8 OUTLIER -78.96 110.53 14.86 Favored Pre-proline 0 C--O 1.234 0.245 0 N-CA-C 113.046 0.758 . . . . 15.0 113.046 -178.322 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.605 ' HA ' ' OE1' ' A' ' 47' ' ' GLU . 22.7 Cg_exo -64.28 66.58 0.24 Allowed 'Trans proline' 0 C--N 1.356 0.96 0 C-N-CA 123.177 2.585 . . . . 15.0 112.721 179.771 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 12.8 mt-30 -148.42 -52.88 0.18 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.483 -0.781 . . . . 15.0 109.258 179.233 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.616 ' HA3' ' HA3' ' A' ' 19' ' ' GLY . . . -88.24 156.19 26.91 Favored Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.612 -0.804 . . . . 15.0 112.474 179.044 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -42.5 -16.46 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 113.432 0.901 . . . . 15.0 113.432 -179.696 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.437 ' N ' ' O ' ' A' ' 44' ' ' GLY . . . -71.57 -70.27 0.33 Allowed 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.92 -0.312 . . . . 15.0 111.474 -179.258 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.605 ' OE1' ' HA ' ' A' ' 42' ' ' PRO . 10.2 tm-20 -58.31 -36.13 72.89 Favored 'General case' 0 N--CA 1.463 0.211 0 C-N-CA 120.504 -0.479 . . . . 15.0 110.064 179.408 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 48.8 m -57.57 -66.99 0.37 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.925 -0.58 . . . . 15.0 110.186 179.411 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.442 ' CB ' HD13 ' A' ' 11' ' ' LEU . 0.8 OUTLIER -60.55 -37.65 81.94 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.096 0.475 . . . . 15.0 109.881 179.004 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.44 37.43 17.54 Favored Glycine 0 N--CA 1.449 -0.461 0 CA-C-N 115.58 -0.736 . . . . 15.0 112.504 179.585 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.424 ' HB3' ' CG2' ' A' ' 9' ' ' VAL . 14.3 mmt180 -84.77 -49.75 8.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.94 0.4 . . . . 15.0 110.621 179.999 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.444 HG21 ' CG1' ' A' ' 40' ' ' VAL . 11.1 tp -81.19 157.22 4.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.016 -0.538 . . . . 15.0 110.347 179.537 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . 0.423 ' O ' HG21 ' A' ' 37' ' ' VAL . 76.6 m80 -139.65 158.1 44.67 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-O 121.753 0.787 . . . . 15.0 112.71 -179.006 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.565 ' HA ' ' CG2' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -44.25 134.95 4.72 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.137 -1.392 . . . . 15.0 112.477 -178.893 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.662 ' N ' HG21 ' A' ' 37' ' ' VAL . . . 49.7 34.32 21.0 Favored Glycine 0 C--N 1.334 0.456 0 C-N-CA 121.135 -0.555 . . . . 15.0 112.907 179.569 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.44 ' HB2' HG12 ' A' ' 37' ' ' VAL . 1.1 m-20 -65.5 130.64 44.04 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 121.003 -0.279 . . . . 15.0 110.439 179.636 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.401 ' NH2' ' HD3' ' A' ' 31' ' ' ARG . 59.7 ttt180 -86.33 86.45 7.34 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.112 -0.494 . . . . 15.0 110.432 179.792 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.486 HG22 HG21 ' A' ' 35' ' ' ILE . 1.3 m -79.41 116.68 23.79 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 CA-C-O 121.095 0.474 . . . . 15.0 110.948 -179.618 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 20.0 mt -107.19 -18.71 13.81 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.563 -0.744 . . . . 15.0 112.254 -179.323 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.424 ' CB ' HD22 ' A' ' 88' ' ' LEU . . . -148.29 148.79 30.83 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 112.479 0.548 . . . . 15.0 112.479 -178.898 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.457 HG21 ' CD2' ' A' ' 78' ' ' LEU . 26.1 t -139.16 102.18 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.339 -0.846 . . . . 15.0 109.173 178.878 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 64.8 15.03 9.58 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.699 -0.482 . . . . 15.0 109.699 -177.966 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 107.1 5.76 34.79 Favored Glycine 0 C--N 1.337 0.606 0 CA-C-N 115.86 -0.609 . . . . 15.0 113.425 179.727 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.498 ' O ' ' CG1' ' A' ' 64' ' ' VAL . 6.2 p -93.92 106.83 18.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 117.181 0.49 . . . . 15.0 111.083 179.474 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.99 134.24 55.6 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.217 -0.447 . . . . 15.0 110.995 -179.877 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -95.5 -22.78 17.44 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.024 -0.535 . . . . 15.0 111.015 -179.958 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -46.27 100.42 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.899 0.38 . . . . 15.0 111.064 179.942 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.73 63.67 0.55 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.814 -0.708 . . . . 15.0 112.222 -179.719 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -173.03 167.12 5.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.829 0.347 . . . . 15.0 111.117 -179.798 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.407 ' HA ' ' N ' ' A' ' 26' ' ' VAL . 16.2 p -93.23 -175.11 3.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.227 -0.442 . . . . 15.0 111.095 -179.883 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.513 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 0.0 OUTLIER -62.17 -60.49 3.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.918 -0.583 . . . . 15.0 110.447 179.977 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.428 ' O ' ' HG3' ' A' ' 76' ' ' GLU . 8.0 ttpp -52.41 -31.12 32.66 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.814 -0.63 . . . . 15.0 110.517 179.448 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -59.32 -52.02 67.42 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.64 -0.504 . . . . 15.0 109.64 179.335 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.475 ' O ' ' N ' ' A' ' 77' ' ' THR . . . -66.95 -45.96 76.18 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.092 -0.504 . . . . 15.0 109.706 178.495 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.433 ' CG2' ' CG2' ' A' ' 22' ' ' VAL . 0.5 OUTLIER -41.43 -40.04 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.221 0 N-CA-C 109.123 -0.695 . . . . 15.0 109.123 178.43 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.432 ' O ' ' N ' ' A' ' 80' ' ' ASN . 22.5 mt-10 -67.47 -46.72 72.18 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 114.731 -1.122 . . . . 15.0 110.244 178.488 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.475 ' N ' ' O ' ' A' ' 74' ' ' ALA . 44.8 p -64.33 -51.9 61.14 Favored 'General case' 0 N--CA 1.461 0.102 0 C-N-CA 120.991 -0.283 . . . . 15.0 111.24 179.637 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.457 ' CD2' HG21 ' A' ' 61' ' ' VAL . 5.6 mt -53.53 -49.98 66.44 Favored 'General case' 0 CA--C 1.521 -0.168 0 CA-C-O 121.22 0.533 . . . . 15.0 109.878 179.934 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.46 -61.45 1.83 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.357 -0.838 . . . . 15.0 110.467 179.387 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.432 ' N ' ' O ' ' A' ' 76' ' ' GLU . 1.4 m-20 -65.92 62.71 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.926 -0.579 . . . . 15.0 111.792 179.844 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -91.85 -69.81 0.72 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.648 0.261 . . . . 15.0 110.443 179.52 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 122.32 -107.19 1.13 Allowed Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.872 -0.68 . . . . 15.0 112.939 179.441 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.81 -83.56 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.775 0.321 . . . . 15.0 111.545 -179.45 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.429 ' CG1' ' N ' ' A' ' 85' ' ' VAL . 62.7 t -109.82 159.92 9.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.855 0.36 . . . . 15.0 110.335 179.999 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.502 ' HB ' ' HB3' ' A' ' 11' ' ' LEU . 24.4 t -97.85 80.16 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-O 121.016 0.436 . . . . 15.0 110.687 -179.943 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -98.46 81.89 2.79 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.893 -0.594 . . . . 15.0 110.447 179.865 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.45 ' CD2' ' CD2' ' A' ' 89' ' ' LEU . 0.1 OUTLIER -101.15 118.03 36.19 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.045 -0.525 . . . . 15.0 111.742 -179.229 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.468 HD11 ' HB2' ' A' ' 8' ' ' GLU . 0.2 OUTLIER -94.99 101.47 13.23 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.302 -0.629 . . . . 15.0 109.302 178.657 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.461 HD22 ' HA ' ' A' ' 58' ' ' VAL . 0.2 OUTLIER -104.6 -162.29 0.88 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.417 0.627 . . . . 15.0 111.752 -178.629 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.412 ' HA ' ' HA ' ' A' ' 6' ' ' ILE . 2.2 tt0 -139.86 143.1 36.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.085 -0.961 . . . . 15.0 109.888 179.062 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -54.03 102.99 0.07 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.904 0.383 . . . . 15.0 110.96 -179.642 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.294 0 C-N-CA 120.84 -0.695 . . . . 15.0 112.65 -179.757 . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.428 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 1.3 mp . . . . . 0 N--CA 1.451 -0.395 0 CA-C-O 121.024 0.44 . . . . 15.0 111.655 . . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.449 ' O ' ' N ' ' A' ' 89' ' ' LEU . 3.3 p90 -141.68 165.06 28.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.884 -0.598 . . . . 15.0 110.263 178.759 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.504 ' HB2' HD11 ' A' ' 88' ' ' LEU . 0.2 OUTLIER -130.16 142.21 50.6 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.272 0.558 . . . . 15.0 111.615 -179.442 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.438 ' CG2' ' HB3' ' A' ' 51' ' ' ARG . 0.2 OUTLIER -101.49 117.29 46.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.327 -0.851 . . . . 15.0 109.819 178.958 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -106.24 74.44 1.03 Allowed 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 112.166 0.432 . . . . 15.0 112.166 -179.031 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.478 ' HB3' ' HB ' ' A' ' 85' ' ' VAL . 8.7 tp -88.42 165.64 14.78 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.847 -0.427 . . . . 15.0 109.847 178.778 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -94.75 94.7 8.25 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.039 0.447 . . . . 15.0 111.186 -179.945 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.453 ' HG3' ' HB ' ' A' ' 81' ' ' THR . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.363 0 CA-C-N 115.797 -0.638 . . . . 15.0 111.2 179.945 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.4 mm? . . . . . 0 N--CA 1.452 -0.373 0 CA-C-O 120.915 0.388 . . . . 15.0 110.449 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.623 ' O ' ' HB ' ' A' ' 41' ' ' ILE . . . -161.57 31.02 0.32 Allowed Glycine 0 CA--C 1.507 -0.431 0 N-CA-C 111.535 -0.626 . . . . 15.0 111.535 -179.835 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.558 HG12 ' O ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -112.62 139.76 35.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 121.061 0.458 . . . . 15.0 111.936 -179.206 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.449 ' O ' ' HB3' ' A' ' 38' ' ' LYS . 42.4 t -96.25 100.22 11.87 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 107.587 -1.264 . . . . 15.0 107.587 176.951 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.55 HG23 ' CD2' ' A' ' 71' ' ' HIS . 1.3 m -93.68 152.01 3.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 112.622 0.601 . . . . 15.0 112.622 -176.971 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.494 ' HA ' ' ND1' ' A' ' 71' ' ' HIS . 15.3 t -149.47 177.52 9.64 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.393 -0.822 . . . . 15.0 110.689 179.632 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.433 ' O ' ' N ' ' A' ' 26' ' ' VAL . . . 83.05 -115.07 3.95 Favored Glycine 0 C--N 1.332 0.353 0 C-N-CA 120.723 -0.751 . . . . 15.0 112.136 -179.779 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.557 ' HA3' ' N ' ' A' ' 71' ' ' HIS . . . 63.79 -65.24 0.04 OUTLIER Glycine 0 C--N 1.331 0.266 0 C-N-CA 121.002 -0.618 . . . . 15.0 113.781 178.933 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.433 ' N ' ' O ' ' A' ' 24' ' ' GLY . 0.0 OUTLIER -30.73 143.13 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 N-CA-C 112.234 0.457 . . . . 15.0 112.234 -179.116 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.409 ' CB ' ' O ' ' A' ' 32' ' ' HIS . 14.3 p-10 -75.59 62.26 1.41 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.956 -0.565 . . . . 15.0 111.0 -179.692 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 40.9 m -151.73 -67.13 0.17 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.308 -0.405 . . . . 15.0 111.088 -179.96 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -68.98 -32.45 72.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.137 -0.483 . . . . 15.0 111.071 -179.8 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 19.8 m -88.09 -172.85 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.239 -0.437 . . . . 15.0 111.269 -179.895 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -61.94 -63.14 1.35 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.138 -0.483 . . . . 15.0 111.031 -179.984 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . 0.409 ' O ' ' CB ' ' A' ' 27' ' ' ASN . 90.8 m-70 -136.26 -49.72 0.68 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.294 -0.412 . . . . 15.0 111.103 -179.853 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -171.13 26.13 0.1 OUTLIER Glycine 0 C--N 1.329 0.155 0 C-N-CA 120.789 -0.72 . . . . 15.0 112.595 -179.755 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -89.51 154.43 24.13 Favored Glycine 0 N--CA 1.449 -0.472 0 N-CA-C 110.749 -0.94 . . . . 15.0 110.749 178.836 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.411 ' CG1' ' HA ' ' A' ' 71' ' ' HIS . 0.0 OUTLIER -93.6 153.82 3.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 117.648 0.724 . . . . 15.0 111.828 -179.265 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.511 ' CE2' ' CG ' ' A' ' 57' ' ' ARG . 42.7 m-85 -138.39 106.28 5.67 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.957 -1.02 . . . . 15.0 109.859 179.69 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.667 HG21 ' N ' ' A' ' 55' ' ' GLY . 0.7 OUTLIER -55.27 145.29 5.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.164 -0.471 . . . . 15.0 111.002 -179.179 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.449 ' HB3' ' O ' ' A' ' 21' ' ' SER . 0.2 OUTLIER -80.13 -47.57 14.55 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.661 -0.866 . . . . 15.0 108.661 178.512 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.558 ' O ' HG12 ' A' ' 20' ' ' ILE . . . -172.23 170.45 5.14 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 115.698 -0.683 . . . . 15.0 110.309 178.397 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.542 ' HA ' HG12 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -97.07 111.7 27.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.928 0.394 . . . . 15.0 110.264 179.638 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.623 ' HB ' ' O ' ' A' ' 19' ' ' GLY . 0.4 OUTLIER -78.65 109.99 12.57 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 115.781 -0.645 . . . . 15.0 112.632 -178.293 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.469 ' HA ' ' CG ' ' A' ' 47' ' ' GLU . 24.5 Cg_exo -62.47 68.55 0.12 Allowed 'Trans proline' 0 C--N 1.356 0.935 0 C-N-CA 123.211 2.607 . . . . 15.0 112.507 179.828 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.423 ' N ' ' O ' ' A' ' 41' ' ' ILE . 8.1 mm-40 -153.43 -52.93 0.1 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.628 -0.715 . . . . 15.0 109.825 179.638 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.493 ' HA3' ' CA ' ' A' ' 19' ' ' GLY . . . -87.78 155.9 27.15 Favored Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.66 -0.781 . . . . 15.0 112.481 179.393 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -41.05 -16.8 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 113.517 0.932 . . . . 15.0 113.517 -179.546 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.463 ' N ' ' O ' ' A' ' 44' ' ' GLY . . . -71.68 -71.76 0.26 Allowed 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.819 -0.353 . . . . 15.0 111.155 -179.739 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.536 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 4.1 tp10 -58.27 -39.78 80.13 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 121.033 0.445 . . . . 15.0 110.402 179.569 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.2 m -53.98 -64.5 0.81 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.904 -0.589 . . . . 15.0 110.434 179.537 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.428 ' CB ' HD13 ' A' ' 11' ' ' LEU . 3.7 m-20 -64.79 -37.62 88.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.163 -0.471 . . . . 15.0 110.175 179.273 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.62 38.22 14.85 Favored Glycine 0 N--CA 1.45 -0.41 0 CA-C-N 115.744 -0.662 . . . . 15.0 112.571 179.581 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.438 ' HB3' ' CG2' ' A' ' 9' ' ' VAL . 0.2 OUTLIER -82.33 -54.47 5.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.968 0.413 . . . . 15.0 110.614 179.864 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.467 ' CD1' HD12 ' A' ' 89' ' ' LEU . 9.6 tp -81.09 159.72 4.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.873 -0.603 . . . . 15.0 110.379 179.705 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . 0.441 ' O ' HG21 ' A' ' 37' ' ' VAL . 53.2 m80 -140.74 159.47 42.14 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-O 121.742 0.782 . . . . 15.0 112.728 -178.875 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.551 ' HA ' ' CG2' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -44.14 134.45 4.8 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.054 -1.43 . . . . 15.0 113.057 -178.728 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.667 ' N ' HG21 ' A' ' 37' ' ' VAL . . . 49.83 31.4 16.58 Favored Glycine 0 C--N 1.335 0.483 0 CA-C-N 115.779 -0.646 . . . . 15.0 113.618 178.934 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.429 ' HB2' ' O ' ' A' ' 53' ' ' HIS . 0.4 OUTLIER -65.92 130.22 42.51 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.628 -0.429 . . . . 15.0 110.655 179.504 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.511 ' CG ' ' CE2' ' A' ' 36' ' ' TYR . 3.5 mtt180 -82.08 88.35 6.44 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.177 -0.465 . . . . 15.0 110.407 179.564 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.474 ' O ' ' CG2' ' A' ' 58' ' ' VAL . 1.5 m -79.45 111.93 16.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 CA-C-O 121.199 0.523 . . . . 15.0 111.061 -179.554 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -107.38 -15.14 14.7 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 115.558 -0.746 . . . . 15.0 112.33 -179.224 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -147.91 145.68 28.72 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.099 0.476 . . . . 15.0 112.217 -178.782 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.438 ' HB ' ' CG1' ' A' ' 64' ' ' VAL . 47.1 t -138.93 103.48 2.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.624 -0.716 . . . . 15.0 109.378 178.918 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.413 ' ND2' ' CG2' ' A' ' 81' ' ' THR . 1.7 m-80 64.97 16.43 10.55 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.727 -0.471 . . . . 15.0 109.727 -178.114 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.99 5.81 43.61 Favored Glycine 0 C--N 1.336 0.545 0 CA-C-N 115.744 -0.662 . . . . 15.0 113.103 179.958 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.492 ' O ' ' CG1' ' A' ' 64' ' ' VAL . 5.7 p -93.78 108.33 20.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 121.007 0.432 . . . . 15.0 110.915 179.573 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 13.7 m -58.74 124.41 19.67 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.178 0.514 . . . . 15.0 110.796 -179.781 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.414 ' CD2' ' CB ' ' A' ' 74' ' ' ALA . 0.2 OUTLIER -89.11 -18.7 26.69 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.489 -0.778 . . . . 15.0 111.21 -179.652 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -46.66 101.84 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 120.832 0.349 . . . . 15.0 110.985 179.88 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.75 66.38 0.58 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.788 -0.72 . . . . 15.0 112.291 -179.707 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -173.03 164.21 4.88 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.849 0.357 . . . . 15.0 111.031 -179.821 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.412 ' HA ' ' N ' ' A' ' 26' ' ' VAL . 18.5 p -93.24 -174.66 3.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.998 0.428 . . . . 15.0 111.232 -179.831 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.557 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 0.0 OUTLIER -61.53 -61.88 2.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.85 -0.614 . . . . 15.0 109.826 179.774 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 16.1 ttpt -52.88 -35.61 58.09 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.876 -0.602 . . . . 15.0 110.085 179.005 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -59.64 -48.96 79.62 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.944 -0.571 . . . . 15.0 109.501 179.035 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.458 ' HA ' ' OG1' ' A' ' 77' ' ' THR . . . -66.93 -46.71 73.94 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-N 115.92 -0.582 . . . . 15.0 109.491 178.344 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.432 ' O ' ' HB2' ' A' ' 79' ' ' ARG . 0.5 OUTLIER -42.54 -39.72 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.27 0 N-CA-C 108.814 -0.81 . . . . 15.0 108.814 178.218 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.47 ' O ' ' HB2' ' A' ' 80' ' ' ASN . 1.0 OUTLIER -67.29 -46.34 73.9 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 114.663 -1.153 . . . . 15.0 110.57 178.59 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.458 ' OG1' ' HA ' ' A' ' 74' ' ' ALA . 6.9 p -64.07 -53.74 44.98 Favored 'General case' 0 N--CA 1.462 0.16 0 C-N-CA 120.974 -0.29 . . . . 15.0 111.636 -179.87 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.422 ' HA ' HG12 ' A' ' 61' ' ' VAL . 6.9 mt -53.31 -46.8 69.55 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-O 121.259 0.552 . . . . 15.0 110.017 179.982 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.432 ' HB2' ' O ' ' A' ' 75' ' ' VAL . 0.0 OUTLIER -68.45 -57.41 5.89 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.344 -0.844 . . . . 15.0 110.784 179.576 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.47 ' HB2' ' O ' ' A' ' 76' ' ' GLU . 9.3 m-80 -66.14 61.53 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.103 -0.499 . . . . 15.0 112.155 -179.882 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.453 ' HB ' ' HG3' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -95.67 -68.44 0.8 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.836 0.35 . . . . 15.0 110.158 179.098 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 122.14 -108.33 1.28 Allowed Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 121.004 -0.617 . . . . 15.0 112.957 179.396 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . 0.423 ' O ' ' HB3' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -65.26 -79.08 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.912 0.387 . . . . 15.0 111.773 -179.326 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.444 HG13 ' N ' ' A' ' 85' ' ' VAL . 75.6 t -109.88 159.42 9.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.942 -0.572 . . . . 15.0 111.035 -179.219 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.478 ' HB ' ' HB3' ' A' ' 11' ' ' LEU . 5.9 t -97.9 81.14 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.122 0.486 . . . . 15.0 110.485 179.96 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 13.7 t60 -97.94 82.83 3.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.784 -0.644 . . . . 15.0 110.297 179.67 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.467 ' CD2' ' CD2' ' A' ' 89' ' ' LEU . 0.1 OUTLIER -101.2 119.72 39.17 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.928 -0.578 . . . . 15.0 111.857 -179.132 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.504 HD11 ' HB2' ' A' ' 8' ' ' GLU . 4.0 mp -96.05 100.71 12.34 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.557 -0.535 . . . . 15.0 109.557 178.841 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.467 HD12 ' CD1' ' A' ' 52' ' ' ILE . 0.1 OUTLIER -105.61 -160.86 0.77 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.42 0.629 . . . . 15.0 111.974 -178.589 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.428 ' HA ' ' HA ' ' A' ' 6' ' ' ILE . 3.5 tt0 -138.91 139.89 38.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 114.978 -1.01 . . . . 15.0 109.979 179.107 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 14.0 tppt? -51.17 106.71 0.14 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.312 -0.404 . . . . 15.0 111.003 -179.913 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.328 0 C-N-CA 120.872 -0.68 . . . . 15.0 112.714 -179.789 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo . . . . . 0 N--CA 1.489 1.222 0 CA-C-O 120.953 0.314 . . . . 15.0 111.688 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 11.4 pttp -155.24 150.69 21.32 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.146 -0.479 . . . . 15.0 110.849 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -63.89 -162.78 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.552 2.168 . . . . 15.0 112.136 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 88.32 -20.5 29.9 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.516 -0.85 . . . . 15.0 112.44 -179.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -62.12 144.45 55.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.194 0.521 . . . . 15.0 110.727 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.436 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 1.4 mp -104.33 143.13 16.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.335 -0.848 . . . . 15.0 111.243 -179.192 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.441 ' O ' ' N ' ' A' ' 89' ' ' LEU . 2.8 p90 -140.43 164.95 28.76 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.088 -0.506 . . . . 15.0 110.261 178.621 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.465 ' HB2' HD11 ' A' ' 88' ' ' LEU . 6.3 pt-20 -130.09 142.09 50.64 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.362 0.601 . . . . 15.0 111.867 -179.047 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.434 ' CG2' ' HB3' ' A' ' 51' ' ' ARG . 0.2 OUTLIER -101.56 114.74 41.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.037 -0.983 . . . . 15.0 109.728 178.915 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -105.87 72.11 0.93 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.156 -0.475 . . . . 15.0 111.916 -178.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.417 HD13 ' CB ' ' A' ' 49' ' ' ASP . 6.3 tp -88.33 165.67 14.82 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.098 -0.501 . . . . 15.0 110.061 179.056 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -95.57 92.26 6.55 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.93 0.395 . . . . 15.0 111.138 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.469 ' HG3' ' HB ' ' A' ' 81' ' ' THR . 0.0 OUTLIER -54.42 -32.11 56.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.982 -0.554 . . . . 15.0 110.977 179.96 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.474 ' O ' ' CB ' ' A' ' 15' ' ' ASP . 0.9 OUTLIER -84.8 138.37 32.63 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.233 -0.439 . . . . 15.0 110.7 179.958 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.474 ' CB ' ' O ' ' A' ' 14' ' ' ASN . 9.8 t70 88.67 -27.91 0.05 Allowed 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.944 -0.571 . . . . 15.0 111.218 -179.588 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -161.86 133.89 5.64 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.827 0.346 . . . . 15.0 110.816 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.426 ' O ' ' CB ' ' A' ' 45' ' ' ALA . 0.0 OUTLIER -86.04 -162.76 0.78 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.259 -0.428 . . . . 15.0 110.665 179.856 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.408 ' N ' ' CD2' ' A' ' 18' ' ' LEU . 1.3 mm? -93.27 -171.64 2.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.896 0.379 . . . . 15.0 110.653 179.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.714 ' O ' ' HB ' ' A' ' 41' ' ' ILE . . . -161.0 40.16 0.42 Allowed Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.908 -0.663 . . . . 15.0 111.973 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.694 HG12 ' O ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -112.83 139.77 36.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 120.961 0.41 . . . . 15.0 111.998 -179.414 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 21.8 t -96.04 105.76 17.84 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.132 -1.062 . . . . 15.0 108.132 177.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.496 HG11 ' CG2' ' A' ' 20' ' ' ILE . 18.5 m -93.84 156.0 3.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 113.435 0.902 . . . . 15.0 113.435 -176.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.5 -172.76 4.22 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 114.981 -1.009 . . . . 15.0 110.437 179.438 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.418 ' O ' ' CB ' ' A' ' 71' ' ' HIS . . . 68.65 -120.2 10.93 Favored Glycine 0 C--N 1.331 0.251 0 C-N-CA 120.773 -0.727 . . . . 15.0 112.72 179.594 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.555 ' HA3' ' N ' ' A' ' 71' ' ' HIS . . . 68.48 -66.59 0.41 Allowed Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.82 -0.705 . . . . 15.0 113.367 179.651 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.418 ' N ' ' HA ' ' A' ' 70' ' ' THR . 2.1 m -33.13 144.33 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 N-CA-C 112.024 0.379 . . . . 15.0 112.024 -179.374 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 13.0 p-10 -75.57 62.67 1.44 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.059 -0.518 . . . . 15.0 111.008 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -151.71 -67.68 0.17 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.219 -0.446 . . . . 15.0 110.945 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 21.1 m -67.21 -33.33 75.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.129 -0.487 . . . . 15.0 110.949 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 29.5 m -88.02 -174.01 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 15.0 111.209 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -64.26 -60.53 3.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.181 -0.463 . . . . 15.0 111.146 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 52.2 m80 -132.88 -57.36 0.93 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.388 -0.369 . . . . 15.0 111.225 -179.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -167.13 21.45 0.1 Allowed Glycine 0 CA--C 1.518 0.246 0 C-N-CA 120.816 -0.707 . . . . 15.0 112.718 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -83.74 152.77 29.16 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.467 -0.873 . . . . 15.0 110.921 178.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.451 ' CG1' ' HA ' ' A' ' 71' ' ' HIS . 0.0 OUTLIER -89.12 153.7 3.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 117.482 0.641 . . . . 15.0 111.633 -179.357 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -141.35 108.26 5.42 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.084 -0.962 . . . . 15.0 109.661 179.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.65 HG21 ' N ' ' A' ' 55' ' ' GLY . 0.8 OUTLIER -56.09 154.85 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.18 0.514 . . . . 15.0 111.573 -178.939 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.464 ' O ' ' HG2' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -85.45 -47.94 9.46 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.379 -0.971 . . . . 15.0 108.379 178.239 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.694 ' O ' HG12 ' A' ' 20' ' ' ILE . . . -172.39 172.99 4.25 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 115.349 -0.841 . . . . 15.0 110.224 178.693 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.513 ' HA ' ' CG1' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -96.76 110.91 25.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 109.273 -0.64 . . . . 15.0 109.273 179.125 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.714 ' HB ' ' O ' ' A' ' 19' ' ' GLY . 0.4 OUTLIER -78.24 116.57 60.0 Favored Pre-proline 0 C--N 1.328 -0.364 0 N-CA-C 113.4 0.889 . . . . 15.0 113.4 -177.11 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.528 ' HA ' ' CG ' ' A' ' 47' ' ' GLU . 37.8 Cg_exo -61.56 61.56 0.11 Allowed 'Trans proline' 0 C--N 1.358 1.054 0 C-N-CA 123.76 2.973 . . . . 15.0 113.1 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.54 ' H ' ' HG2' ' A' ' 47' ' ' GLU . 3.0 mt-30 -149.93 -47.94 0.13 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.609 0.242 . . . . 15.0 111.592 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.65 ' HA3' ' HA3' ' A' ' 19' ' ' GLY . . . -87.79 168.04 37.28 Favored Glycine 0 C--N 1.329 0.176 0 C-N-CA 120.324 -0.941 . . . . 15.0 113.781 -179.167 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.426 ' CB ' ' O ' ' A' ' 17' ' ' SER . . . -57.51 -13.23 3.4 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.721 0.637 . . . . 15.0 112.721 -179.644 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.0 -57.56 4.19 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 120.988 -0.285 . . . . 15.0 110.663 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.541 ' HG3' ' O ' ' A' ' 44' ' ' GLY . 2.7 pp20? -57.55 -42.84 83.79 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.97 -0.559 . . . . 15.0 110.379 179.097 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 69.4 m -53.64 -71.12 0.08 Allowed 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 115.806 -0.634 . . . . 15.0 110.571 -179.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.417 ' CB ' HD13 ' A' ' 11' ' ' LEU . 0.3 OUTLIER -58.13 -41.14 83.02 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.12 -0.696 . . . . 15.0 109.12 178.872 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.57 40.19 13.21 Favored Glycine 0 N--CA 1.446 -0.7 0 CA-C-N 115.357 -0.838 . . . . 15.0 111.631 179.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.434 ' HB3' ' CG2' ' A' ' 9' ' ' VAL . 1.2 mmp_? -79.71 -50.07 11.15 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.867 0.365 . . . . 15.0 110.658 -179.253 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 8.4 tp -80.91 162.54 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 CA-C-N 116.021 -0.536 . . . . 15.0 110.198 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . 0.471 ' O ' ' HB2' ' A' ' 56' ' ' ASP . 79.6 m80 -146.88 159.88 42.99 Favored 'General case' 0 CA--C 1.514 -0.432 0 CA-C-O 121.641 0.734 . . . . 15.0 112.241 -179.067 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.499 ' HA ' ' CG2' ' A' ' 37' ' ' VAL . 0.1 OUTLIER -43.49 133.43 4.38 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.407 -1.269 . . . . 15.0 112.526 -178.77 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.65 ' N ' HG21 ' A' ' 37' ' ' VAL . . . 49.91 35.12 24.17 Favored Glycine 0 C--N 1.333 0.381 0 CA-C-N 115.927 -0.579 . . . . 15.0 113.377 179.328 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.506 ' HB2' HG12 ' A' ' 37' ' ' VAL . 0.4 OUTLIER -65.92 132.5 48.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 117.08 0.44 . . . . 15.0 110.682 179.632 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.5 85.9 7.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.04 -0.527 . . . . 15.0 110.618 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.47 ' HA ' HD22 ' A' ' 89' ' ' LEU . 1.4 m -79.49 116.33 23.31 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 CA-C-O 120.998 0.428 . . . . 15.0 110.955 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 18.7 mt -107.01 -18.11 14.0 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.809 -0.632 . . . . 15.0 112.329 -179.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.422 ' CB ' HD22 ' A' ' 88' ' ' LEU . . . -147.84 149.67 32.73 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.246 0.546 . . . . 15.0 112.389 -178.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.465 HG12 ' HA ' ' A' ' 78' ' ' LEU . 17.6 t -138.93 101.67 1.66 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.31 0 CA-C-N 115.312 -0.858 . . . . 15.0 109.138 178.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.407 ' HB2' ' O ' ' A' ' 61' ' ' VAL . 1.7 m-80 64.95 15.51 10.0 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.637 -0.505 . . . . 15.0 109.637 -177.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 107.04 5.46 35.22 Favored Glycine 0 C--N 1.338 0.642 0 CA-C-N 115.811 -0.631 . . . . 15.0 113.471 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.485 ' O ' ' CG1' ' A' ' 64' ' ' VAL . 6.3 p -93.91 107.18 18.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 117.085 0.442 . . . . 15.0 111.059 179.549 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.3 m -56.96 134.67 55.86 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.216 -0.447 . . . . 15.0 111.07 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.83 -20.59 17.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.009 -0.542 . . . . 15.0 111.173 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -45.64 110.91 0.29 Allowed 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.384 -0.371 . . . . 15.0 111.123 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 97.62 64.25 0.89 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.781 -0.723 . . . . 15.0 112.251 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.428 ' HB3' ' HB3' ' A' ' 73' ' ' GLN . . . -173.03 166.85 5.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.916 0.389 . . . . 15.0 111.148 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.418 ' HA ' ' N ' ' A' ' 26' ' ' VAL . 15.3 p -93.49 -172.63 2.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.18 -0.463 . . . . 15.0 111.301 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.555 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 0.0 OUTLIER -63.57 -59.07 5.09 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.72 -0.673 . . . . 15.0 110.557 179.816 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.4 ' O ' ' HG3' ' A' ' 76' ' ' GLU . 9.4 ttpp -52.36 -31.2 32.53 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.868 -0.606 . . . . 15.0 110.627 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.428 ' HB3' ' HB3' ' A' ' 69' ' ' ALA . 0.0 OUTLIER -59.3 -53.77 54.42 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.239 -0.437 . . . . 15.0 109.932 179.444 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.456 ' O ' ' N ' ' A' ' 77' ' ' THR . . . -66.78 -43.91 82.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.173 -0.467 . . . . 15.0 109.86 178.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.412 HG22 ' CG2' ' A' ' 22' ' ' VAL . 0.5 OUTLIER -42.37 -41.79 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.225 0 N-CA-C 109.129 -0.693 . . . . 15.0 109.129 178.376 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.4 ' HG3' ' O ' ' A' ' 72' ' ' LYS . 18.4 mt-10 -67.46 -44.54 78.36 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 114.875 -1.057 . . . . 15.0 110.289 178.458 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.456 ' N ' ' O ' ' A' ' 74' ' ' ALA . 69.0 p -64.09 -54.27 36.58 Favored 'General case' 0 N--CA 1.461 0.117 0 C-N-CA 121.161 -0.215 . . . . 15.0 111.508 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.465 ' HA ' HG12 ' A' ' 61' ' ' VAL . 7.6 mt -53.55 -47.88 69.61 Favored 'General case' 0 CA--C 1.518 -0.25 0 CA-C-O 121.313 0.578 . . . . 15.0 109.867 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 11.1 ttp85 -68.42 -59.95 2.79 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.242 -0.89 . . . . 15.0 110.651 179.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 68.6 m-20 -66.06 58.52 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.865 -0.607 . . . . 15.0 112.498 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.469 ' HB ' ' HG3' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -95.57 -71.46 0.67 Allowed 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.89 -0.411 . . . . 15.0 109.89 178.872 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 121.11 -104.15 0.94 Allowed Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.703 -0.76 . . . . 15.0 113.344 178.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.67 -82.77 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 112.104 0.409 . . . . 15.0 112.104 -178.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.413 ' CG1' ' N ' ' A' ' 85' ' ' VAL . 75.6 t -109.79 158.66 9.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.107 0.479 . . . . 15.0 111.232 -179.114 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.441 ' O ' ' CG1' ' A' ' 85' ' ' VAL . 6.7 t -97.79 82.03 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.992 -0.549 . . . . 15.0 110.498 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -99.06 82.18 2.7 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.76 -0.655 . . . . 15.0 110.291 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.438 ' CD2' ' CD2' ' A' ' 89' ' ' LEU . 0.1 OUTLIER -103.97 118.74 37.4 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.046 -0.524 . . . . 15.0 112.061 -178.988 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.465 HD11 ' HB2' ' A' ' 8' ' ' GLU . 0.2 OUTLIER -95.46 101.4 13.11 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.111 -0.7 . . . . 15.0 109.111 178.252 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.47 HD22 ' HA ' ' A' ' 58' ' ' VAL . 0.2 OUTLIER -104.11 -164.91 1.1 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.439 0.638 . . . . 15.0 112.094 -178.312 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.436 ' HA ' ' HA ' ' A' ' 6' ' ' ILE . 2.3 tt0 -139.37 139.84 37.31 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.999 -1.0 . . . . 15.0 109.817 179.205 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 6.7 tptt -52.11 102.04 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.009 0.433 . . . . 15.0 111.06 -179.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -72.17 135.54 22.76 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.973 -0.632 . . . . 15.0 112.784 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -86.38 176.01 8.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.801 0.334 . . . . 15.0 110.787 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -90.18 165.48 23.73 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.205 -0.452 . . . . 15.0 110.9 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_exo -51.43 -58.6 1.53 Allowed 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.583 2.189 . . . . 15.0 112.269 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.7 t . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.195 -0.907 . . . . 15.0 110.912 179.959 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo . . . . . 0 N--CA 1.488 1.168 0 CA-C-O 120.941 0.309 . . . . 15.0 111.821 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -155.27 146.4 16.58 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.16 -0.473 . . . . 15.0 110.795 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -69.06 -166.77 0.17 Allowed 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.431 2.087 . . . . 15.0 112.162 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 84.67 -15.34 42.35 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.452 -0.88 . . . . 15.0 112.344 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -62.04 151.34 35.62 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 121.111 0.481 . . . . 15.0 110.518 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.425 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 1.1 mp -104.34 146.07 12.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.672 -0.694 . . . . 15.0 111.324 -179.226 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.413 ' O ' ' N ' ' A' ' 89' ' ' LEU . 6.0 p90 -140.29 152.02 45.55 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.902 -0.59 . . . . 15.0 110.193 178.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.483 ' CB ' HD11 ' A' ' 88' ' ' LEU . 1.4 pm0 -120.93 143.06 49.17 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.373 0.606 . . . . 15.0 111.713 -179.22 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.455 ' CG2' ' HB3' ' A' ' 51' ' ' ARG . 0.2 OUTLIER -101.47 115.51 43.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.119 -0.946 . . . . 15.0 109.558 178.948 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -106.18 74.33 1.03 Allowed 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 112.321 0.489 . . . . 15.0 112.321 -178.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.497 ' HB3' ' HB ' ' A' ' 85' ' ' VAL . 6.7 tp -88.11 164.84 15.51 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.339 -0.615 . . . . 15.0 109.339 178.466 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -96.33 97.72 9.71 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.047 0.451 . . . . 15.0 111.379 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.403 ' HD3' ' O ' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -64.23 -34.08 77.29 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.77 -0.65 . . . . 15.0 111.064 179.948 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.455 ' N ' ' O ' ' A' ' 83' ' ' GLN . 2.1 t30 -84.94 62.57 7.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.194 -0.457 . . . . 15.0 110.813 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 13.0 t0 179.81 -38.27 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.721 -0.672 . . . . 15.0 110.199 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 11.1 t30 -164.93 149.73 9.32 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.628 -0.714 . . . . 15.0 110.291 179.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.407 ' O ' ' CB ' ' A' ' 45' ' ' ALA . 0.5 OUTLIER -85.85 -171.47 3.6 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.422 -0.354 . . . . 15.0 110.573 179.966 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.406 ' CD2' ' N ' ' A' ' 18' ' ' LEU . 1.9 mm? -88.67 -174.65 4.63 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.225 -0.443 . . . . 15.0 110.612 179.479 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.744 ' O ' ' HB ' ' A' ' 41' ' ' ILE . . . -160.88 43.53 0.41 Allowed Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.939 -0.648 . . . . 15.0 111.698 -179.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.682 HG12 ' O ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -112.78 138.46 41.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 120.948 0.404 . . . . 15.0 111.615 -179.453 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 31.4 t -91.73 103.5 16.06 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 107.813 -1.18 . . . . 15.0 107.813 177.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.449 HG22 ' CD2' ' A' ' 71' ' ' HIS . 32.8 m -93.72 154.42 3.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 113.079 0.77 . . . . 15.0 113.079 -177.012 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.29 -175.22 4.9 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.132 -0.94 . . . . 15.0 110.72 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 68.67 -119.88 10.54 Favored Glycine 0 C--N 1.332 0.306 0 C-N-CA 120.829 -0.701 . . . . 15.0 112.424 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.527 ' HA3' ' N ' ' A' ' 71' ' ' HIS . . . 68.12 -64.21 0.37 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.876 -0.678 . . . . 15.0 113.525 179.4 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -30.63 138.58 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 N-CA-C 112.337 0.495 . . . . 15.0 112.337 -179.323 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 28.3 p30 -75.55 62.72 1.44 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.897 -0.592 . . . . 15.0 111.012 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.0 m -151.7 -50.76 0.12 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.277 -0.42 . . . . 15.0 111.106 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -87.65 -40.54 14.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.232 -0.44 . . . . 15.0 111.192 -179.703 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.434 HG13 ' CD1' ' A' ' 36' ' ' TYR . 31.1 m -72.62 -174.9 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.317 -0.402 . . . . 15.0 111.366 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 2.1 ttm180 -60.31 -40.78 91.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.2 -0.455 . . . . 15.0 111.239 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . 0.454 ' N ' ' CD2' ' A' ' 32' ' ' HIS . 0.1 OUTLIER -163.9 -46.76 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.688 -0.233 . . . . 15.0 111.515 179.799 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -170.22 19.96 0.07 OUTLIER Glycine 0 CA--C 1.519 0.288 0 C-N-CA 120.649 -0.786 . . . . 15.0 112.979 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -89.76 153.85 23.48 Favored Glycine 0 N--CA 1.45 -0.385 0 N-CA-C 111.005 -0.838 . . . . 15.0 111.005 179.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.45 ' CG2' ' CG2' ' A' ' 58' ' ' VAL . 0.0 OUTLIER -89.13 155.62 3.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 117.478 0.639 . . . . 15.0 111.773 -179.396 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.443 ' CE2' ' HG2' ' A' ' 57' ' ' ARG . 29.5 m-85 -140.19 106.75 5.32 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.082 -0.963 . . . . 15.0 109.804 179.023 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.64 HG21 ' N ' ' A' ' 55' ' ' GLY . 0.6 OUTLIER -55.35 147.05 4.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.913 -0.585 . . . . 15.0 111.361 -178.956 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.453 ' O ' ' HG2' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -80.35 -48.61 12.68 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.449 -0.945 . . . . 15.0 108.449 178.379 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.682 ' O ' HG12 ' A' ' 20' ' ' ILE . . . -172.2 173.95 4.12 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 115.416 -0.811 . . . . 15.0 110.142 178.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.536 ' HA ' HG12 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -97.03 110.09 24.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 109.657 -0.498 . . . . 15.0 109.657 179.295 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.744 ' HB ' ' O ' ' A' ' 19' ' ' GLY . 0.6 OUTLIER -78.4 116.48 59.57 Favored Pre-proline 0 C--N 1.328 -0.333 0 N-CA-C 113.39 0.885 . . . . 15.0 113.39 -177.518 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.542 ' HA ' ' CG ' ' A' ' 47' ' ' GLU . 35.2 Cg_exo -62.01 59.94 0.13 Allowed 'Trans proline' 0 C--N 1.357 1.02 0 C-N-CA 123.663 2.909 . . . . 15.0 113.064 179.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.519 ' H ' ' HG2' ' A' ' 47' ' ' GLU . 0.6 OUTLIER -147.53 -47.69 0.17 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.642 0.258 . . . . 15.0 111.579 179.913 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.696 ' HA3' ' HA3' ' A' ' 19' ' ' GLY . . . -87.86 168.81 37.94 Favored Glycine 0 C--N 1.331 0.279 0 C-N-CA 120.393 -0.908 . . . . 15.0 114.047 -179.022 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.407 ' CB ' ' O ' ' A' ' 17' ' ' SER . . . -57.51 -13.72 4.09 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.592 0.59 . . . . 15.0 112.592 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.11 -57.72 4.03 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.712 0.291 . . . . 15.0 110.797 -179.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.549 ' HG3' ' O ' ' A' ' 44' ' ' GLY . 2.9 pp20? -57.57 -42.37 82.96 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.77 -0.65 . . . . 15.0 110.381 179.276 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -53.76 -71.49 0.07 Allowed 'General case' 0 CA--C 1.519 -0.241 0 CA-C-N 115.814 -0.63 . . . . 15.0 110.486 -179.404 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -58.36 -41.15 84.09 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.125 -0.694 . . . . 15.0 109.125 178.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.78 40.46 12.15 Favored Glycine 0 N--CA 1.446 -0.643 0 CA-C-N 115.416 -0.811 . . . . 15.0 111.726 179.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.455 ' HB3' ' CG2' ' A' ' 9' ' ' VAL . 0.6 OUTLIER -79.92 -48.19 13.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.907 0.384 . . . . 15.0 110.726 -179.402 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.41 ' CD1' HD12 ' A' ' 89' ' ' LEU . 9.4 tp -81.11 162.07 3.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.037 -0.528 . . . . 15.0 110.275 179.56 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . 0.489 ' O ' HG21 ' A' ' 37' ' ' VAL . 78.8 m80 -147.51 157.63 43.65 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-O 121.61 0.719 . . . . 15.0 112.021 -179.073 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.521 ' HA ' ' CG2' ' A' ' 37' ' ' VAL . 0.1 OUTLIER -42.4 132.2 3.55 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.327 -1.306 . . . . 15.0 113.027 -178.564 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.64 ' N ' HG21 ' A' ' 37' ' ' VAL . . . 50.35 30.31 18.29 Favored Glycine 0 C--N 1.333 0.416 0 CA-C-N 115.672 -0.694 . . . . 15.0 113.4 179.235 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.475 ' OD2' ' N ' ' A' ' 53' ' ' HIS . 16.8 m-20 -65.87 129.59 40.33 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.716 -0.394 . . . . 15.0 110.58 179.521 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.443 ' HG2' ' CE2' ' A' ' 36' ' ' TYR . 15.8 mtt-85 -80.85 96.84 7.13 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.229 -0.441 . . . . 15.0 110.846 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.467 ' O ' ' CG2' ' A' ' 58' ' ' VAL . 1.4 m -86.96 114.02 25.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.079 0.466 . . . . 15.0 110.749 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 21.5 mt -107.02 -16.42 14.44 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.799 -0.637 . . . . 15.0 112.397 -179.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.42 ' HA ' ' O ' ' A' ' 64' ' ' VAL . . . -148.13 147.67 29.75 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.509 0.559 . . . . 15.0 112.509 -178.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.455 HG22 HD23 ' A' ' 87' ' ' LEU . 21.4 t -139.03 101.12 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.316 -0.856 . . . . 15.0 109.16 178.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 65.14 15.98 10.3 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.72 -0.474 . . . . 15.0 109.72 -177.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 107.07 4.58 35.73 Favored Glycine 0 C--N 1.337 0.598 0 CA-C-N 115.969 -0.56 . . . . 15.0 113.469 179.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.484 ' O ' ' CG1' ' A' ' 64' ' ' VAL . 5.4 p -93.9 108.4 20.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 117.122 0.461 . . . . 15.0 111.164 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 61.5 m -56.87 138.14 54.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.296 -0.411 . . . . 15.0 110.996 -179.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.75 -21.88 16.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.063 -0.517 . . . . 15.0 111.085 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -46.53 106.17 0.08 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.361 -0.381 . . . . 15.0 111.21 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 104.33 62.16 0.67 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.808 -0.711 . . . . 15.0 112.453 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -173.18 163.48 4.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.86 0.362 . . . . 15.0 111.086 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.7 p -92.33 -171.96 2.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.457 . . . . 15.0 110.983 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.527 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 0.0 OUTLIER -62.19 -59.45 5.03 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.844 -0.616 . . . . 15.0 110.458 179.949 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.408 ' O ' ' HG3' ' A' ' 76' ' ' GLU . 24.9 ttpp -52.68 -34.29 51.23 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.768 -0.651 . . . . 15.0 110.836 179.612 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -59.28 -50.77 72.7 Favored 'General case' 0 CA--C 1.518 -0.272 0 N-CA-C 109.527 -0.546 . . . . 15.0 109.527 179.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.457 ' O ' ' N ' ' A' ' 77' ' ' THR . . . -66.29 -45.42 80.47 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.69 -0.687 . . . . 15.0 109.672 178.519 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.428 ' CG2' ' CG2' ' A' ' 22' ' ' VAL . 0.5 OUTLIER -43.15 -40.51 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.243 0 N-CA-C 108.976 -0.749 . . . . 15.0 108.976 178.243 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.408 ' HG3' ' O ' ' A' ' 72' ' ' LYS . 11.1 mt-10 -67.26 -44.96 78.08 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 114.871 -1.058 . . . . 15.0 110.076 178.405 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.457 ' N ' ' O ' ' A' ' 74' ' ' ALA . 41.2 p -64.3 -53.41 49.29 Favored 'General case' 0 N--CA 1.461 0.098 0 CA-C-O 120.572 0.225 . . . . 15.0 111.318 179.606 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.437 ' HG ' ' O ' ' A' ' 74' ' ' ALA . 6.1 mt -53.42 -48.86 68.35 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 121.245 0.545 . . . . 15.0 109.97 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -68.38 -59.05 3.46 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.317 -0.856 . . . . 15.0 110.665 179.502 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -65.88 62.9 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.946 -0.57 . . . . 15.0 111.931 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -91.7 -70.87 0.67 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.785 0.326 . . . . 15.0 110.302 179.425 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 122.28 -109.97 1.52 Allowed Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.978 -0.63 . . . . 15.0 112.852 179.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.455 ' O ' ' N ' ' A' ' 14' ' ' ASN . 0.8 OUTLIER -65.25 -77.88 0.06 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.884 0.373 . . . . 15.0 111.438 -179.437 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.425 ' CG1' ' N ' ' A' ' 85' ' ' VAL . 51.0 t -110.26 159.07 10.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.198 -0.455 . . . . 15.0 110.678 -179.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.497 ' HB ' ' HB3' ' A' ' 11' ' ' LEU . 19.7 t -98.12 79.92 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.051 0.453 . . . . 15.0 110.429 179.648 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 3.0 t60 -100.51 84.22 2.73 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.842 -0.617 . . . . 15.0 110.426 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.455 HD23 HG22 ' A' ' 61' ' ' VAL . 0.1 OUTLIER -101.45 117.53 35.13 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.003 -0.544 . . . . 15.0 111.655 -179.325 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.483 HD11 ' CB ' ' A' ' 8' ' ' GLU . 4.3 mp -92.87 100.23 12.74 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.807 -0.442 . . . . 15.0 109.807 179.038 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.467 HD22 ' HA ' ' A' ' 58' ' ' VAL . 0.2 OUTLIER -103.88 -162.83 0.93 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.92 -0.582 . . . . 15.0 111.655 -178.871 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.425 ' HA ' ' HA ' ' A' ' 6' ' ' ILE . 3.8 tt0 -139.09 148.18 42.97 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.259 -0.882 . . . . 15.0 110.056 179.285 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.04 113.41 1.69 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.298 -0.41 . . . . 15.0 111.136 -179.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -71.34 88.31 0.42 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.879 -0.677 . . . . 15.0 112.722 -179.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -86.42 139.93 30.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.773 0.32 . . . . 15.0 110.748 179.789 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -60.19 136.13 91.14 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.276 -0.42 . . . . 15.0 110.887 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -53.47 109.19 0.33 Allowed 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.467 2.111 . . . . 15.0 112.274 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 39.6 p . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.259 -0.877 . . . . 15.0 110.941 179.969 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_endo . . . . . 0 N--CA 1.488 1.158 0 CA-C-O 120.809 0.254 . . . . 15.0 111.78 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.11 144.2 16.51 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.225 -0.443 . . . . 15.0 110.901 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.73 -161.78 0.09 OUTLIER 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.584 2.189 . . . . 15.0 112.305 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 90.57 -23.67 21.21 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.612 -0.804 . . . . 15.0 112.27 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 58.7 m-20 -62.18 145.64 52.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.241 0.543 . . . . 15.0 110.827 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.429 HG13 ' HB2' ' A' ' 90' ' ' GLU . 1.4 mp -104.38 142.52 17.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.281 -0.872 . . . . 15.0 111.101 -179.356 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.42 ' O ' ' N ' ' A' ' 89' ' ' LEU . 3.4 p90 -140.66 163.33 33.18 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.185 -0.461 . . . . 15.0 110.574 178.741 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.473 ' HB2' HD11 ' A' ' 88' ' ' LEU . 10.2 pt-20 -129.04 143.6 50.92 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.204 0.526 . . . . 15.0 111.466 -179.364 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.463 ' CG2' ' HB3' ' A' ' 51' ' ' ARG . 0.3 OUTLIER -101.54 115.7 43.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.335 -0.848 . . . . 15.0 109.818 178.969 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -105.98 70.54 0.86 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.154 -0.475 . . . . 15.0 111.727 -179.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.412 ' HB3' ' HB ' ' A' ' 85' ' ' VAL . 4.9 tp -88.05 165.74 14.94 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.117 -0.492 . . . . 15.0 110.064 179.167 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -95.71 94.43 7.69 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.919 0.39 . . . . 15.0 111.125 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.445 ' O ' ' HD3' ' A' ' 13' ' ' LYS . 0.2 OUTLIER -54.08 -28.22 37.79 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.96 -0.564 . . . . 15.0 111.095 179.962 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.449 ' O ' ' CB ' ' A' ' 15' ' ' ASP . 25.0 m-20 -84.5 154.96 22.39 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.252 -0.431 . . . . 15.0 110.596 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.449 ' CB ' ' O ' ' A' ' 14' ' ' ASN . 10.0 t0 84.02 -42.93 0.08 Allowed 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.217 -0.447 . . . . 15.0 110.794 -179.343 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.4 ' HB3' ' HB2' ' A' ' 45' ' ' ALA . 1.0 OUTLIER -155.09 145.34 21.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.326 -0.397 . . . . 15.0 110.37 179.687 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.414 ' O ' ' CB ' ' A' ' 45' ' ' ALA . 0.0 OUTLIER -86.04 -164.41 1.03 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.369 -0.378 . . . . 15.0 110.873 -179.677 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -93.3 -170.64 2.44 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.167 -0.47 . . . . 15.0 110.736 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.753 ' O ' ' HB ' ' A' ' 41' ' ' ILE . . . -169.02 43.67 0.22 Allowed Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.72 -0.752 . . . . 15.0 112.314 -179.709 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.699 HG12 ' O ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -112.72 139.39 37.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 120.928 0.394 . . . . 15.0 111.516 -179.806 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.43 ' HB3' HD13 ' A' ' 41' ' ' ILE . 18.3 t -96.23 105.41 17.46 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.572 -0.899 . . . . 15.0 108.572 178.004 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.496 HG22 ' CD2' ' A' ' 71' ' ' HIS . 5.7 m -93.94 155.21 3.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 112.722 0.638 . . . . 15.0 112.722 -177.511 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.657 ' O ' ' O ' ' A' ' 36' ' ' TYR . 0.2 OUTLIER -149.68 153.28 36.72 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.627 -0.715 . . . . 15.0 111.463 -179.7 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.434 ' O ' HG12 ' A' ' 35' ' ' ILE . . . 67.5 121.53 0.02 OUTLIER Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.484 -0.865 . . . . 15.0 113.351 178.648 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.522 ' HA3' ' N ' ' A' ' 71' ' ' HIS . . . -166.3 -39.3 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.962 -0.637 . . . . 15.0 112.455 179.27 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.45 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 0.1 OUTLIER -40.46 161.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 CA-C-O 120.849 0.357 . . . . 15.0 111.645 179.87 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 6.8 m-80 -85.84 52.51 2.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.22 -0.445 . . . . 15.0 110.952 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.4 m -151.71 -58.23 0.15 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.195 -0.457 . . . . 15.0 110.8 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.4 m -68.91 -51.76 36.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 15.0 110.847 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 17.5 m -87.99 -169.08 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.166 -0.47 . . . . 15.0 110.934 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 4.3 mmt180 -93.41 125.67 38.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.937 0.399 . . . . 15.0 111.073 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 74.6 m80 61.67 -80.61 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.945 -0.571 . . . . 15.0 111.52 179.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -175.25 34.59 0.1 OUTLIER Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.9 -0.667 . . . . 15.0 112.422 -179.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -95.15 158.24 22.3 Favored Glycine 0 N--CA 1.449 -0.487 0 N-CA-C 110.659 -0.976 . . . . 15.0 110.659 179.027 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.487 HG21 HG22 ' A' ' 58' ' ' VAL . 0.1 OUTLIER -101.12 153.11 4.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 C-N-CA 119.852 -0.739 . . . . 15.0 112.058 -179.326 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.657 ' O ' ' O ' ' A' ' 23' ' ' THR . 11.7 m-85 -133.22 108.29 8.68 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.13 -0.941 . . . . 15.0 109.308 179.343 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.557 HG21 ' N ' ' A' ' 55' ' ' GLY . 0.7 OUTLIER -54.84 169.61 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 C-N-CA 120.359 -0.536 . . . . 15.0 111.113 -178.33 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.413 ' N ' HG22 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -100.77 -49.22 4.23 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.806 -0.813 . . . . 15.0 108.806 178.936 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.699 ' O ' HG12 ' A' ' 20' ' ' ILE . . . -171.96 173.13 4.52 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 115.523 -0.762 . . . . 15.0 110.054 179.03 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.517 ' HA ' ' CG1' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -96.42 103.3 14.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 109.244 -0.65 . . . . 15.0 109.244 179.15 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.753 ' HB ' ' O ' ' A' ' 19' ' ' GLY . 0.6 OUTLIER -69.13 115.74 34.88 Favored Pre-proline 0 C--N 1.328 -0.353 0 N-CA-C 113.376 0.88 . . . . 15.0 113.376 -177.066 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.514 ' HA ' ' HG2' ' A' ' 47' ' ' GLU . 37.5 Cg_exo -61.16 62.01 0.1 OUTLIER 'Trans proline' 0 C--N 1.358 1.038 0 C-N-CA 123.655 2.903 . . . . 15.0 112.951 179.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.509 ' H ' ' HG2' ' A' ' 47' ' ' GLU . 7.3 mt-30 -150.55 -48.6 0.13 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.635 0.255 . . . . 15.0 111.524 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.727 ' HA3' ' HA3' ' A' ' 19' ' ' GLY . . . -87.73 167.82 37.16 Favored Glycine 0 C--N 1.33 0.232 0 C-N-CA 120.387 -0.911 . . . . 15.0 113.861 -179.128 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.414 ' CB ' ' O ' ' A' ' 17' ' ' SER . . . -58.5 -13.52 5.77 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.087 -0.556 . . . . 15.0 112.43 -179.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.16 -56.74 5.06 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.696 0.284 . . . . 15.0 110.784 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.514 ' HG2' ' HA ' ' A' ' 42' ' ' PRO . 2.8 pp20? -57.59 -41.99 82.3 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.059 -0.519 . . . . 15.0 110.502 179.239 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -53.55 -69.54 0.12 Allowed 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 115.769 -0.651 . . . . 15.0 110.567 -179.25 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -60.25 -41.25 92.81 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.149 -0.685 . . . . 15.0 109.149 178.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.8 46.47 7.18 Favored Glycine 0 N--CA 1.446 -0.663 0 CA-C-N 115.436 -0.802 . . . . 15.0 111.866 179.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.463 ' HB3' ' CG2' ' A' ' 9' ' ' VAL . 0.9 OUTLIER -79.78 -44.77 20.03 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.695 0.283 . . . . 15.0 110.969 -179.285 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.452 ' CG2' ' CD1' ' A' ' 20' ' ' ILE . 3.5 mm -91.42 160.92 2.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.055 0.455 . . . . 15.0 111.187 179.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . 0.444 ' N ' ' CG2' ' A' ' 52' ' ' ILE . 75.9 m80 -140.52 148.92 41.78 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-N 115.741 -0.663 . . . . 15.0 110.438 179.52 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.545 ' HA ' ' CG2' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -36.23 133.76 0.47 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.935 -1.03 . . . . 15.0 112.575 -178.237 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.557 ' N ' HG21 ' A' ' 37' ' ' VAL . . . 55.14 33.0 57.3 Favored Glycine 0 N--CA 1.453 -0.2 0 CA-C-N 115.309 -0.86 . . . . 15.0 113.707 179.5 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.493 ' HB2' HG12 ' A' ' 37' ' ' VAL . 0.4 OUTLIER -66.13 127.75 33.36 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 117.603 0.701 . . . . 15.0 110.541 179.217 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 50.8 ttt-85 -80.71 86.6 5.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.464 -0.335 . . . . 15.0 110.529 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.487 HG22 HG21 ' A' ' 35' ' ' ILE . 1.3 m -79.95 115.3 22.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 CA-C-O 121.174 0.512 . . . . 15.0 111.173 -179.588 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 20.4 mt -107.43 -12.73 15.25 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 115.432 -0.804 . . . . 15.0 112.165 -179.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -150.06 144.6 25.87 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.202 0.525 . . . . 15.0 112.388 -178.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.455 HG21 ' CD2' ' A' ' 78' ' ' LEU . 44.9 t -139.04 101.73 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.452 -0.795 . . . . 15.0 109.457 178.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 64.87 15.87 10.15 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.822 -0.436 . . . . 15.0 109.822 -178.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 107.08 5.75 34.87 Favored Glycine 0 C--N 1.335 0.512 0 CA-C-N 115.956 -0.566 . . . . 15.0 113.469 179.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.499 ' O ' ' CG1' ' A' ' 64' ' ' VAL . 5.8 p -93.85 105.49 16.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 117.275 0.537 . . . . 15.0 110.949 179.405 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 72.3 m -58.41 131.75 51.65 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.122 -0.49 . . . . 15.0 110.936 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -87.65 -18.93 28.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.015 -0.539 . . . . 15.0 110.91 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -48.23 95.07 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.876 0.37 . . . . 15.0 110.858 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.66 66.82 0.59 Allowed Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.81 -0.709 . . . . 15.0 111.96 -179.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.406 ' HB3' ' HB3' ' A' ' 73' ' ' GLN . . . -172.73 161.9 4.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.915 0.388 . . . . 15.0 110.9 -179.646 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.45 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 8.3 p -93.19 -173.68 3.32 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.188 -0.46 . . . . 15.0 111.436 -179.562 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.522 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 0.1 OUTLIER -62.38 -60.76 3.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.832 -0.622 . . . . 15.0 110.39 -179.967 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.425 ' O ' ' HG3' ' A' ' 76' ' ' GLU . 17.7 ttpp -52.54 -30.69 31.94 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.746 -0.661 . . . . 15.0 110.442 179.36 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.406 ' HB3' ' HB3' ' A' ' 69' ' ' ALA . 0.9 OUTLIER -59.39 -51.43 69.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.072 -0.513 . . . . 15.0 110.075 179.567 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.464 ' O ' ' N ' ' A' ' 77' ' ' THR . . . -66.94 -45.23 78.44 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 109.717 -0.475 . . . . 15.0 109.717 178.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -42.65 -43.14 1.11 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.269 0 N-CA-C 108.946 -0.761 . . . . 15.0 108.946 178.167 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.425 ' HG3' ' O ' ' A' ' 72' ' ' LYS . 24.3 mt-10 -67.42 -44.02 79.79 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 114.925 -1.034 . . . . 15.0 110.005 178.267 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.464 ' N ' ' O ' ' A' ' 74' ' ' ALA . 72.0 p -64.2 -54.18 37.58 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 116.744 -0.207 . . . . 15.0 111.397 179.718 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.463 ' HG ' ' O ' ' A' ' 74' ' ' ALA . 6.6 mt -53.28 -49.03 67.79 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-O 121.277 0.56 . . . . 15.0 109.947 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 4.3 ttp180 -68.51 -59.87 2.84 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.322 -0.854 . . . . 15.0 110.699 179.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.412 ' CB ' ' O ' ' A' ' 76' ' ' GLU . 43.4 m-20 -66.0 62.28 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.024 -0.535 . . . . 15.0 112.057 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.422 ' HB ' ' HG3' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -93.8 -68.68 0.79 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.83 0.348 . . . . 15.0 110.077 179.044 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 122.09 -109.85 1.51 Allowed Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 120.957 -0.64 . . . . 15.0 112.874 179.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -65.47 -77.26 0.06 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.52 -0.34 . . . . 15.0 111.701 -179.314 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.419 ' CG1' ' N ' ' A' ' 85' ' ' VAL . 55.8 t -110.17 157.68 10.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.174 -0.466 . . . . 15.0 111.295 -179.4 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.443 ' O ' ' CG1' ' A' ' 85' ' ' VAL . 8.6 t -98.0 81.16 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.026 -0.534 . . . . 15.0 110.48 179.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -100.43 86.08 3.1 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.796 -0.638 . . . . 15.0 110.506 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.452 ' O ' ' N ' ' A' ' 9' ' ' VAL . 0.1 OUTLIER -103.86 126.03 50.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.058 -0.519 . . . . 15.0 111.807 -179.265 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.473 HD11 ' HB2' ' A' ' 8' ' ' GLU . 4.9 mp -101.64 101.59 12.15 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.305 -0.628 . . . . 15.0 109.305 178.536 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.446 ' CD2' ' CD2' ' A' ' 87' ' ' LEU . 0.1 OUTLIER -105.66 -165.19 1.09 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.502 0.667 . . . . 15.0 112.089 -178.448 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.429 ' HB2' HG13 ' A' ' 6' ' ' ILE . 1.0 OUTLIER -140.12 136.23 33.33 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.873 -1.058 . . . . 15.0 109.619 178.97 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 10.2 tppt? -46.89 103.63 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.93 0.395 . . . . 15.0 111.293 -179.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -64.06 151.65 49.56 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.866 -0.683 . . . . 15.0 112.565 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -86.19 99.2 11.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.752 0.311 . . . . 15.0 110.842 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -89.37 162.82 35.84 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.211 -0.45 . . . . 15.0 110.878 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_exo -51.45 -26.77 22.46 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.535 2.157 . . . . 15.0 112.368 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 21.6 p . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.238 -0.886 . . . . 15.0 110.86 179.987 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_endo . . . . . 0 N--CA 1.488 1.192 0 CA-C-O 120.878 0.282 . . . . 15.0 111.816 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 3.3 mtmp? -155.17 89.26 3.07 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.183 -0.462 . . . . 15.0 110.935 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.418 ' HD2' ' CB ' ' A' ' 93' ' ' GLN . 71.6 Cg_exo -49.19 -62.03 0.49 Allowed 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.632 2.221 . . . . 15.0 112.457 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 88.19 -20.67 28.44 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.502 -0.856 . . . . 15.0 112.677 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -61.88 155.1 24.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.299 0.571 . . . . 15.0 110.934 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.452 HG13 ' HB2' ' A' ' 90' ' ' GLU . 1.4 mp -103.03 144.47 13.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.185 -0.916 . . . . 15.0 111.099 -179.257 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.439 ' CD1' ' C ' ' A' ' 7' ' ' PHE . 2.2 p90 -140.59 163.75 32.03 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.318 -0.401 . . . . 15.0 110.561 178.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.479 ' HB2' HD11 ' A' ' 88' ' ' LEU . 11.0 pt-20 -128.97 143.05 50.76 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.257 0.551 . . . . 15.0 111.424 -179.453 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.436 HG12 ' CB ' ' A' ' 87' ' ' LEU . 0.2 OUTLIER -101.44 114.6 41.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.227 -0.897 . . . . 15.0 109.572 178.924 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -106.09 72.42 0.94 Allowed 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 112.397 0.518 . . . . 15.0 112.397 -178.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.444 ' HB3' ' HB ' ' A' ' 85' ' ' VAL . 6.5 tp -88.35 166.7 14.1 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.517 -0.549 . . . . 15.0 109.517 178.554 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -95.97 94.0 7.34 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.961 0.41 . . . . 15.0 111.305 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.514 ' O ' ' HD3' ' A' ' 13' ' ' LYS . 0.2 OUTLIER -58.4 -26.38 63.16 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.884 -0.598 . . . . 15.0 111.057 179.838 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -84.06 -34.84 24.13 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.296 -0.411 . . . . 15.0 110.893 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -70.84 -42.76 69.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.005 0.431 . . . . 15.0 110.326 179.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.401 ' HB3' ' HB2' ' A' ' 45' ' ' ALA . 0.6 OUTLIER -165.47 163.27 19.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.857 -0.61 . . . . 15.0 110.632 179.789 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.442 ' O ' ' CB ' ' A' ' 45' ' ' ALA . 0.3 OUTLIER -85.87 -162.75 0.77 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.362 -0.381 . . . . 15.0 110.236 179.664 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 9.6 mt -101.14 -168.68 1.59 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.939 0.4 . . . . 15.0 110.763 179.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.738 ' O ' ' HB ' ' A' ' 41' ' ' ILE . . . -164.71 40.72 0.3 Allowed Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 121.01 -0.614 . . . . 15.0 111.826 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.61 HG12 ' O ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -112.7 138.86 40.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 121.004 0.43 . . . . 15.0 111.773 -179.441 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.436 ' O ' ' HB3' ' A' ' 38' ' ' LYS . 21.1 t -94.49 100.4 12.4 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 107.704 -1.221 . . . . 15.0 107.704 177.282 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.547 HG23 ' CD2' ' A' ' 71' ' ' HIS . 1.4 m -93.79 152.69 3.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 112.463 0.542 . . . . 15.0 112.463 -177.076 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.529 ' HA ' ' ND1' ' A' ' 71' ' ' HIS . 14.8 t -149.29 -174.64 4.71 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.444 -0.798 . . . . 15.0 110.71 179.564 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.429 ' O ' ' N ' ' A' ' 26' ' ' VAL . . . 75.18 -115.51 4.66 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 120.721 -0.752 . . . . 15.0 112.153 -179.713 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.541 ' HA3' ' N ' ' A' ' 71' ' ' HIS . . . 64.33 -65.34 0.06 OUTLIER Glycine 0 N--CA 1.453 -0.215 0 C-N-CA 121.015 -0.612 . . . . 15.0 113.841 179.024 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.429 ' N ' ' O ' ' A' ' 24' ' ' GLY . 0.0 OUTLIER -30.54 145.13 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 N-CA-C 112.362 0.504 . . . . 15.0 112.362 -179.143 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -79.63 56.25 2.18 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.961 -0.563 . . . . 15.0 111.031 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -151.69 -64.96 0.18 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.234 -0.439 . . . . 15.0 110.641 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.63 -48.23 70.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.11 -0.495 . . . . 15.0 110.559 179.7 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 34.5 m -88.09 -171.15 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.024 -0.534 . . . . 15.0 110.77 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -92.4 127.17 37.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.91 0.386 . . . . 15.0 111.155 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 34.4 m80 58.18 -84.71 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.937 -0.574 . . . . 15.0 111.464 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -167.7 26.18 0.14 Allowed Glycine 0 C--N 1.331 0.263 0 C-N-CA 120.977 -0.63 . . . . 15.0 112.274 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -83.83 149.16 25.28 Favored Glycine 0 N--CA 1.448 -0.529 0 N-CA-C 110.769 -0.932 . . . . 15.0 110.769 178.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.445 ' CG1' ' HA ' ' A' ' 71' ' ' HIS . 0.0 OUTLIER -88.29 153.45 3.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 117.537 0.669 . . . . 15.0 111.777 -179.165 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.462 ' CZ ' ' HG2' ' A' ' 57' ' ' ARG . 30.7 m-85 -139.76 107.94 5.78 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.026 -0.988 . . . . 15.0 109.732 179.571 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.644 HG21 ' N ' ' A' ' 55' ' ' GLY . 0.8 OUTLIER -55.99 151.29 2.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.046 0.45 . . . . 15.0 111.284 -179.111 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.449 ' O ' ' HG2' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -83.8 -45.3 13.46 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.493 -0.928 . . . . 15.0 108.493 178.29 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.61 ' O ' HG12 ' A' ' 20' ' ' ILE . . . -172.28 172.43 4.5 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 115.853 -0.612 . . . . 15.0 110.32 178.333 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.552 ' HA ' HG12 ' A' ' 20' ' ' ILE . 0.1 OUTLIER -96.86 109.71 23.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.205 -0.665 . . . . 15.0 109.205 179.04 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.738 ' HB ' ' O ' ' A' ' 19' ' ' GLY . 0.5 OUTLIER -78.24 115.29 49.76 Favored Pre-proline 0 C--N 1.327 -0.371 0 N-CA-C 113.51 0.93 . . . . 15.0 113.51 -177.148 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.552 ' HA ' ' CG ' ' A' ' 47' ' ' GLU . 32.8 Cg_exo -62.0 60.58 0.13 Allowed 'Trans proline' 0 C--N 1.357 1.01 0 C-N-CA 123.619 2.879 . . . . 15.0 112.949 179.619 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.515 ' H ' ' HG2' ' A' ' 47' ' ' GLU . 6.0 tt0 -147.33 -48.38 0.18 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.62 0.248 . . . . 15.0 111.345 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.68 ' HA3' ' HA3' ' A' ' 19' ' ' GLY . . . -87.86 169.02 38.16 Favored Glycine 0 C--N 1.33 0.217 0 C-N-CA 120.403 -0.903 . . . . 15.0 113.807 -179.192 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.442 ' CB ' ' O ' ' A' ' 17' ' ' SER . . . -57.91 -13.84 5.17 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.749 0.648 . . . . 15.0 112.749 -179.624 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.9 -56.47 5.64 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.936 -0.306 . . . . 15.0 110.711 -179.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.553 ' HG3' ' O ' ' A' ' 44' ' ' GLY . 2.9 pp20? -57.57 -42.96 84.1 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.992 -0.549 . . . . 15.0 110.322 179.009 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -53.86 -70.75 0.09 Allowed 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 115.828 -0.624 . . . . 15.0 110.567 -179.497 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -58.11 -41.18 83.01 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.046 -0.724 . . . . 15.0 109.046 178.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.73 40.56 12.12 Favored Glycine 0 N--CA 1.446 -0.655 0 CA-C-N 115.345 -0.843 . . . . 15.0 111.779 179.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.416 ' HB3' ' CG2' ' A' ' 9' ' ' VAL . 2.7 mmp_? -79.78 -50.49 10.48 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.931 0.396 . . . . 15.0 110.644 -179.438 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.427 ' CD1' HD12 ' A' ' 89' ' ' LEU . 9.4 tp -81.1 160.1 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 CA-C-N 115.989 -0.55 . . . . 15.0 110.378 179.543 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . 0.468 ' O ' HG21 ' A' ' 37' ' ' VAL . 75.7 m80 -145.31 159.01 43.69 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-O 121.599 0.714 . . . . 15.0 112.083 -179.217 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.504 ' HA ' ' CG2' ' A' ' 37' ' ' VAL . 0.1 OUTLIER -42.21 132.91 3.25 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.512 -1.222 . . . . 15.0 112.642 -178.687 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.644 ' N ' HG21 ' A' ' 37' ' ' VAL . . . 49.98 34.24 22.89 Favored Glycine 0 C--N 1.333 0.395 0 CA-C-N 115.761 -0.654 . . . . 15.0 113.425 179.277 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.496 ' HB2' HG12 ' A' ' 37' ' ' VAL . 0.3 OUTLIER -65.84 132.66 49.21 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.538 -0.465 . . . . 15.0 110.617 179.475 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.462 ' HG2' ' CZ ' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -85.73 92.13 8.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.321 -0.4 . . . . 15.0 110.499 179.664 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.479 ' HA ' HD22 ' A' ' 89' ' ' LEU . 2.0 m -83.14 114.43 23.9 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 CA-C-O 120.988 0.423 . . . . 15.0 111.143 -179.566 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -107.15 -16.39 14.43 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 115.747 -0.66 . . . . 15.0 112.494 -179.236 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -147.78 146.91 29.35 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.112 0.482 . . . . 15.0 112.222 -178.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.451 ' HB ' ' CG1' ' A' ' 64' ' ' VAL . 61.5 t -138.78 102.18 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.578 -0.737 . . . . 15.0 109.194 178.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 65.07 16.1 10.37 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.103 -0.499 . . . . 15.0 109.763 -178.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 105.83 5.18 38.94 Favored Glycine 0 C--N 1.336 0.564 0 CA-C-N 115.821 -0.627 . . . . 15.0 113.247 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.487 ' O ' ' CG1' ' A' ' 64' ' ' VAL . 5.5 p -93.84 108.3 20.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.983 0.392 . . . . 15.0 110.979 179.6 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 21.4 m -57.99 124.89 20.83 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.204 0.526 . . . . 15.0 110.777 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.41 ' CD1' HG23 ' A' ' 58' ' ' VAL . 0.3 OUTLIER -87.72 -21.06 25.41 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.444 -0.798 . . . . 15.0 111.327 -179.499 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -46.7 103.6 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.843 0.354 . . . . 15.0 110.986 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.89 63.11 0.54 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.764 -0.731 . . . . 15.0 112.55 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -172.98 164.64 4.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.835 0.35 . . . . 15.0 111.024 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.415 ' HA ' ' N ' ' A' ' 26' ' ' VAL . 5.9 p -93.26 -172.89 3.08 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.067 0.46 . . . . 15.0 111.118 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.547 ' CD2' HG23 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -62.35 -61.34 2.52 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.733 -0.667 . . . . 15.0 110.212 179.985 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 22.4 ttpp -52.85 -35.68 57.77 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.789 -0.641 . . . . 15.0 110.345 179.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -59.68 -48.31 82.19 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.432 -0.581 . . . . 15.0 109.432 179.137 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.457 ' O ' ' N ' ' A' ' 77' ' ' THR . . . -66.79 -47.87 70.75 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 115.789 -0.641 . . . . 15.0 109.441 178.361 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.429 ' O ' ' HB2' ' A' ' 79' ' ' ARG . 0.5 OUTLIER -41.66 -40.26 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.271 0 N-CA-C 108.827 -0.805 . . . . 15.0 108.827 178.203 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.483 ' O ' ' HB2' ' A' ' 80' ' ' ASN . 1.5 mm-40 -67.2 -47.02 72.13 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.734 -1.121 . . . . 15.0 110.509 178.542 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.457 ' N ' ' O ' ' A' ' 74' ' ' ALA . 16.5 p -64.08 -53.06 55.69 Favored 'General case' 0 N--CA 1.461 0.117 0 C-N-CA 120.913 -0.315 . . . . 15.0 111.469 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.432 ' HG ' ' O ' ' A' ' 74' ' ' ALA . 3.6 mt -53.44 -47.43 69.68 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.174 0.511 . . . . 15.0 110.047 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.429 ' HB2' ' O ' ' A' ' 75' ' ' VAL . 0.0 OUTLIER -68.64 -57.9 5.03 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.571 -0.741 . . . . 15.0 110.657 179.331 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.483 ' HB2' ' O ' ' A' ' 76' ' ' GLU . 11.9 m-80 -65.92 63.05 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.163 -0.472 . . . . 15.0 111.966 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.44 ' HB ' ' HG3' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -94.0 -71.95 0.64 Allowed 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 110.096 -0.335 . . . . 15.0 110.096 179.103 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 122.06 -105.22 0.96 Allowed Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.774 -0.727 . . . . 15.0 113.124 179.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -64.8 -82.86 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 111.885 0.328 . . . . 15.0 111.885 -179.16 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.44 HG13 ' N ' ' A' ' 85' ' ' VAL . 72.9 t -109.64 159.85 8.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.921 0.391 . . . . 15.0 110.869 -179.508 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.444 ' HB ' ' HB3' ' A' ' 11' ' ' LEU . 14.9 t -97.76 80.83 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.054 0.454 . . . . 15.0 110.593 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -102.84 85.09 2.48 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.765 -0.652 . . . . 15.0 110.44 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.465 ' CD2' ' CD2' ' A' ' 89' ' ' LEU . 0.1 OUTLIER -102.42 119.9 39.6 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.948 -0.569 . . . . 15.0 111.742 -179.207 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.479 HD11 ' HB2' ' A' ' 8' ' ' GLU . 4.3 mp -94.52 100.66 12.6 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.773 -0.454 . . . . 15.0 109.773 178.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.479 HD22 ' HA ' ' A' ' 58' ' ' VAL . 0.1 OUTLIER -105.81 -163.53 0.95 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.517 0.675 . . . . 15.0 112.173 -178.531 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.452 ' HB2' HG13 ' A' ' 6' ' ' ILE . 3.4 tt0 -141.36 140.15 33.67 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 114.824 -1.08 . . . . 15.0 109.505 179.02 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 2.7 tptp -55.98 96.66 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.025 0.441 . . . . 15.0 111.014 -179.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -72.65 56.04 1.68 Allowed Glycine 0 CA--C 1.518 0.254 0 CA-C-N 115.732 -0.667 . . . . 15.0 113.188 -179.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.418 ' CB ' ' HD2' ' A' ' 3' ' ' PRO . 0.0 OUTLIER -86.67 129.9 34.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.749 0.309 . . . . 15.0 110.93 179.754 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -87.4 164.34 35.74 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.298 -0.41 . . . . 15.0 110.78 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -49.82 -25.85 12.61 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.548 2.165 . . . . 15.0 112.3 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.247 -0.882 . . . . 15.0 110.888 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo . . . . . 0 N--CA 1.488 1.179 0 CA-C-O 120.815 0.256 . . . . 15.0 111.689 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 20.9 mtmt -151.35 160.72 31.42 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.161 -0.472 . . . . 15.0 110.912 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.43 ' C ' ' H ' ' A' ' 5' ' ' ASP . 54.4 Cg_exo -52.85 148.92 27.44 Favored 'Trans proline' 0 CA--C 1.518 -0.3 0 C-N-CA 122.556 2.171 . . . . 15.0 112.487 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 82.39 -25.15 4.5 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.157 -1.02 . . . . 15.0 111.019 -179.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.43 ' H ' ' C ' ' A' ' 3' ' ' PRO . 10.2 t70 -61.96 164.27 6.76 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.268 0.556 . . . . 15.0 110.691 179.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.416 ' CD1' ' HB2' ' A' ' 90' ' ' GLU . 1.2 mp -102.02 147.54 8.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.344 -0.844 . . . . 15.0 111.244 -179.149 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.45 ' CZ ' HD11 ' A' ' 89' ' ' LEU . 2.1 p90 -140.28 164.32 30.4 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.012 -0.54 . . . . 15.0 110.253 178.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.48 ' CB ' HD11 ' A' ' 88' ' ' LEU . 10.0 pt-20 -130.06 143.96 51.08 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.254 0.55 . . . . 15.0 111.701 -179.33 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.491 ' CG2' ' HB3' ' A' ' 51' ' ' ARG . 0.3 OUTLIER -101.5 116.99 46.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.327 -0.851 . . . . 15.0 109.815 178.895 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -106.01 70.97 0.87 Allowed 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.278 -0.419 . . . . 15.0 111.854 -179.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.426 ' HB3' ' HB ' ' A' ' 85' ' ' VAL . 6.0 tp -87.83 164.75 15.75 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.124 -0.489 . . . . 15.0 109.853 179.088 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -95.91 94.03 7.38 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.993 0.425 . . . . 15.0 111.346 -179.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.497 ' HG3' ' HB ' ' A' ' 81' ' ' THR . 0.1 OUTLIER -57.27 -31.96 66.11 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.904 -0.589 . . . . 15.0 110.881 179.872 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.41 ' O ' ' CB ' ' A' ' 15' ' ' ASP . 38.2 t30 -84.7 140.45 31.28 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.19 -0.459 . . . . 15.0 110.75 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.41 ' CB ' ' O ' ' A' ' 14' ' ' ASN . 4.1 m-20 80.77 -12.53 1.02 Allowed 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.021 -0.536 . . . . 15.0 111.507 -179.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 18.9 m-80 -165.55 136.11 3.71 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.767 0.318 . . . . 15.0 110.677 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.41 ' O ' ' CB ' ' A' ' 45' ' ' ALA . 0.2 OUTLIER -85.97 -159.41 0.46 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.236 -0.438 . . . . 15.0 110.461 179.815 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.413 ' N ' ' CD2' ' A' ' 18' ' ' LEU . 1.3 mm? -92.67 -168.93 2.07 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 121.019 0.438 . . . . 15.0 110.66 179.55 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.576 ' O ' ' HB ' ' A' ' 41' ' ' ILE . . . -165.78 31.46 0.22 Allowed Glycine 0 C--O 1.224 -0.529 0 N-CA-C 111.336 -0.706 . . . . 15.0 111.336 -179.677 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.515 HG12 ' O ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -114.07 140.87 32.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 112.314 0.487 . . . . 15.0 112.314 -179.497 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.7 t -96.43 106.32 18.54 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 107.962 -1.125 . . . . 15.0 107.962 176.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.484 ' O ' ' CE1' ' A' ' 71' ' ' HIS . 21.1 m -93.59 149.59 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 N-CA-C 112.947 0.721 . . . . 15.0 112.947 -177.246 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.507 ' HA ' ' CE1' ' A' ' 71' ' ' HIS . 8.8 t -150.37 -179.96 7.63 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.357 -0.838 . . . . 15.0 110.887 179.266 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.43 ' O ' ' N ' ' A' ' 26' ' ' VAL . . . 74.11 -114.83 4.68 Favored Glycine 0 C--N 1.334 0.467 0 C-N-CA 120.973 -0.632 . . . . 15.0 112.526 179.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.531 ' HA3' ' N ' ' A' ' 71' ' ' HIS . . . 63.88 -65.3 0.05 OUTLIER Glycine 0 C--N 1.331 0.251 0 C-N-CA 121.093 -0.575 . . . . 15.0 113.885 179.082 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.43 ' N ' ' O ' ' A' ' 24' ' ' GLY . 0.0 OUTLIER -28.68 141.81 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 N-CA-C 112.329 0.492 . . . . 15.0 112.329 -179.159 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -75.53 62.24 1.38 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.965 -0.561 . . . . 15.0 111.001 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 9.7 m -151.71 -65.34 0.18 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.258 -0.428 . . . . 15.0 111.011 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -69.52 -48.92 58.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.118 -0.492 . . . . 15.0 111.087 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.431 HG13 ' CD1' ' A' ' 36' ' ' TYR . 34.8 m -72.69 -174.51 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.217 -0.447 . . . . 15.0 111.247 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.45 -74.56 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.184 -0.462 . . . . 15.0 111.258 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 8.8 p-80 -132.52 -45.71 0.9 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.35 -0.386 . . . . 15.0 111.179 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -168.39 24.05 0.11 Allowed Glycine 0 N--CA 1.453 -0.19 0 C-N-CA 120.8 -0.714 . . . . 15.0 112.732 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -90.31 153.71 22.99 Favored Glycine 0 N--CA 1.449 -0.448 0 N-CA-C 110.836 -0.906 . . . . 15.0 110.836 178.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.477 HG21 HG22 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -92.21 154.11 3.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.504 0.669 . . . . 15.0 111.888 -179.335 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.482 ' CZ ' ' HG2' ' A' ' 57' ' ' ARG . 24.1 m-85 -139.49 110.97 7.07 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.857 -1.065 . . . . 15.0 109.136 178.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.552 HG21 ' N ' ' A' ' 55' ' ' GLY . 0.8 OUTLIER -56.44 156.42 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.46 0.648 . . . . 15.0 110.953 -178.762 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.497 ' O ' ' HG2' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -90.39 -46.85 8.11 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 108.281 -1.007 . . . . 15.0 108.281 178.667 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.515 ' O ' HG12 ' A' ' 20' ' ' ILE . . . -172.84 166.74 5.23 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.088 -0.96 . . . . 15.0 110.566 178.326 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.511 ' HB ' ' HG2' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -97.24 119.94 45.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.789 0.328 . . . . 15.0 110.493 179.75 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.576 ' HB ' ' O ' ' A' ' 19' ' ' GLY . 1.4 mm -78.31 109.28 9.8 Favored Pre-proline 0 N--CA 1.466 0.358 0 N-CA-C 113.028 0.751 . . . . 15.0 113.028 -178.394 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.495 ' HA ' ' OE1' ' A' ' 47' ' ' GLU . 41.0 Cg_endo -66.54 64.42 0.53 Allowed 'Trans proline' 0 C--N 1.352 0.753 0 C-N-CA 122.846 2.364 . . . . 15.0 112.28 179.474 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 11.5 mt-30 -159.37 -45.91 0.05 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.362 -0.835 . . . . 15.0 109.436 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.49 ' HA3' ' HA3' ' A' ' 19' ' ' GLY . . . -87.4 151.6 23.56 Favored Glycine 0 N--CA 1.446 -0.678 0 CA-C-N 115.611 -0.722 . . . . 15.0 112.222 179.232 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.41 ' CB ' ' O ' ' A' ' 17' ' ' SER . . . -40.59 -18.28 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 113.367 0.877 . . . . 15.0 113.367 -179.435 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.465 ' N ' ' O ' ' A' ' 44' ' ' GLY . . . -71.66 -71.64 0.26 Allowed 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.893 -0.323 . . . . 15.0 111.267 -179.593 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.558 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 9.4 tm-20 -58.16 -37.79 75.36 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.832 0.348 . . . . 15.0 110.341 179.578 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 16.0 m -53.92 -66.4 0.4 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.1 -0.5 . . . . 15.0 110.47 179.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -63.3 -37.64 88.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.103 -0.499 . . . . 15.0 109.922 179.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.55 43.68 8.32 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.928 -0.653 . . . . 15.0 112.523 179.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.491 ' HB3' ' CG2' ' A' ' 9' ' ' VAL . 0.0 OUTLIER -80.13 -51.72 8.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.75 0.309 . . . . 15.0 110.724 179.943 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.435 ' CG2' ' N ' ' A' ' 53' ' ' HIS . 1.2 mm -91.24 163.41 2.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.973 0.416 . . . . 15.0 111.15 179.736 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . 0.435 ' N ' ' CG2' ' A' ' 52' ' ' ILE . 47.6 m80 -139.39 153.29 47.62 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-O 121.368 0.604 . . . . 15.0 110.485 179.463 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.497 ' HG2' ' O ' ' A' ' 38' ' ' LYS . 0.6 OUTLIER -35.21 132.96 0.35 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.747 -1.115 . . . . 15.0 112.354 -178.459 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.552 ' N ' HG21 ' A' ' 37' ' ' VAL . . . 52.11 35.57 41.9 Favored Glycine 0 C--N 1.332 0.31 0 CA-C-N 115.892 -0.594 . . . . 15.0 114.01 179.644 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.487 ' HB2' HG12 ' A' ' 37' ' ' VAL . 0.4 OUTLIER -66.16 130.57 43.68 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 117.676 0.738 . . . . 15.0 110.561 179.205 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.482 ' HG2' ' CZ ' ' A' ' 36' ' ' TYR . 26.4 mtt-85 -81.63 91.55 6.43 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.462 -0.335 . . . . 15.0 110.586 179.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.492 ' HB ' ' CD2' ' A' ' 87' ' ' LEU . 1.1 m -85.86 116.29 28.67 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 CA-C-O 121.178 0.513 . . . . 15.0 111.384 -179.645 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -107.26 -10.59 15.78 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 115.589 -0.732 . . . . 15.0 112.248 -179.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -152.01 145.16 24.6 Favored 'General case' 0 N--CA 1.462 0.17 0 N-CA-C 112.301 0.482 . . . . 15.0 112.301 -178.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.441 ' HB ' ' CG1' ' A' ' 64' ' ' VAL . 59.7 t -138.94 101.41 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.57 -0.741 . . . . 15.0 109.264 178.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.414 ' ND2' ' CG2' ' A' ' 81' ' ' THR . 1.1 m-80 64.96 16.04 10.31 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.02 0.438 . . . . 15.0 109.919 -178.286 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 107.06 4.76 35.68 Favored Glycine 0 C--N 1.336 0.578 0 CA-C-N 115.932 -0.577 . . . . 15.0 113.376 179.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.49 ' O ' ' CG1' ' A' ' 64' ' ' VAL . 5.2 p -93.85 107.54 19.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 117.084 0.442 . . . . 15.0 110.857 179.529 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.6 m -56.82 130.74 46.97 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.3 -0.409 . . . . 15.0 111.111 -179.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -90.76 -22.03 21.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.04 -0.527 . . . . 15.0 110.95 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -46.6 96.68 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.889 0.376 . . . . 15.0 111.047 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.76 66.45 0.58 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.801 -0.714 . . . . 15.0 112.428 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -173.09 162.77 4.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.838 0.351 . . . . 15.0 111.052 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 15.0 p -93.12 -174.1 3.45 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.016 0.436 . . . . 15.0 111.106 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.531 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 0.2 OUTLIER -63.95 -59.7 4.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.841 -0.618 . . . . 15.0 110.296 179.946 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.426 ' O ' ' HG3' ' A' ' 76' ' ' GLU . 30.4 ttmt -52.69 -33.52 47.89 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.153 -0.476 . . . . 15.0 110.235 178.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.39 -51.25 70.73 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.565 -0.532 . . . . 15.0 109.565 179.258 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.452 ' O ' ' N ' ' A' ' 77' ' ' THR . . . -66.91 -43.87 82.22 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-N 116.041 -0.527 . . . . 15.0 109.711 178.425 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.458 ' CG2' ' CG2' ' A' ' 22' ' ' VAL . 0.5 OUTLIER -42.83 -41.91 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.23 0 N-CA-C 108.896 -0.779 . . . . 15.0 108.896 178.395 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.432 ' N ' HG11 ' A' ' 75' ' ' VAL . 17.2 mt-10 -67.32 -45.15 77.31 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.794 -1.093 . . . . 15.0 110.078 178.275 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.452 ' N ' ' O ' ' A' ' 74' ' ' ALA . 82.1 p -64.17 -54.58 31.47 Favored 'General case' 0 N--CA 1.461 0.114 0 CA-C-N 116.612 -0.267 . . . . 15.0 111.436 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.437 ' HG ' ' O ' ' A' ' 74' ' ' ALA . 4.2 mt -53.51 -48.17 69.24 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 121.145 0.498 . . . . 15.0 110.141 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.52 -59.02 3.45 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.561 -0.745 . . . . 15.0 110.564 179.478 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 74.6 m-20 -66.04 59.4 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.933 -0.576 . . . . 15.0 112.43 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.497 ' HB ' ' HG3' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -95.73 -71.97 0.65 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.889 -0.412 . . . . 15.0 109.889 178.855 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 122.13 -105.16 0.96 Allowed Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.72 -0.752 . . . . 15.0 113.451 178.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.56 -83.0 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.071 0.397 . . . . 15.0 112.071 -178.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.423 HG13 ' N ' ' A' ' 85' ' ' VAL . 76.2 t -109.64 158.84 9.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.077 0.465 . . . . 15.0 111.167 -179.199 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.439 ' O ' ' CG1' ' A' ' 85' ' ' VAL . 9.1 t -97.86 81.23 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.011 -0.54 . . . . 15.0 110.499 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -99.06 85.54 3.26 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.76 -0.655 . . . . 15.0 110.344 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.492 ' CD2' ' HB ' ' A' ' 58' ' ' VAL . 0.1 OUTLIER -104.02 126.52 51.2 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.041 -0.527 . . . . 15.0 111.917 -179.16 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.48 HD11 ' CB ' ' A' ' 8' ' ' GLU . 5.0 mp -102.41 99.96 10.06 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.751 -0.463 . . . . 15.0 109.751 178.695 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.478 ' HB3' ' HA ' ' A' ' 58' ' ' VAL . 0.1 OUTLIER -105.85 -162.56 0.87 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.646 0.736 . . . . 15.0 112.29 -178.633 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.416 ' HB2' ' CD1' ' A' ' 6' ' ' ILE . 3.3 tt0 -137.68 138.64 39.6 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 114.639 -1.164 . . . . 15.0 109.48 178.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.3 tppt? -49.49 107.35 0.14 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.947 0.403 . . . . 15.0 111.151 -179.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -61.97 100.13 0.27 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.928 -0.653 . . . . 15.0 112.935 -179.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.34 -165.58 1.3 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.77 0.319 . . . . 15.0 110.709 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.4 m -61.03 148.57 83.98 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.345 -0.389 . . . . 15.0 110.734 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -50.6 139.46 38.48 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.556 2.171 . . . . 15.0 112.369 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 7.0 t . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.253 -0.88 . . . . 15.0 110.861 -179.931 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo . . . . . 0 N--CA 1.489 1.249 0 CA-C-O 120.937 0.307 . . . . 15.0 111.828 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 4.2 tttt -146.66 84.4 7.68 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.177 -0.465 . . . . 15.0 110.555 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -68.61 -90.32 0.0 OUTLIER 'Trans proline' 0 CA--C 1.531 0.373 0 C-N-CA 122.423 2.082 . . . . 15.0 112.256 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 86.22 -44.0 3.3 Favored Glycine 0 C--N 1.333 0.401 0 C-N-CA 120.596 -0.811 . . . . 15.0 112.957 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -62.09 139.67 58.43 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.501 0.667 . . . . 15.0 111.505 -179.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.453 HG13 ' HB2' ' A' ' 90' ' ' GLU . 1.3 mp -77.25 151.67 5.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 114.829 -1.078 . . . . 15.0 110.709 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.447 ' O ' ' N ' ' A' ' 89' ' ' LEU . 2.5 p90 -144.8 165.14 28.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.793 0.33 . . . . 15.0 110.686 179.177 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.492 ' CB ' HD11 ' A' ' 88' ' ' LEU . 9.7 pt-20 -130.18 143.91 51.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.22 0.534 . . . . 15.0 111.426 -179.472 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.435 ' CG2' ' HB3' ' A' ' 51' ' ' ARG . 0.2 OUTLIER -101.38 115.3 42.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.434 -0.803 . . . . 15.0 109.521 178.905 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -106.02 72.03 0.92 Allowed 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.524 0.565 . . . . 15.0 112.524 -178.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.435 ' HB3' ' HB ' ' A' ' 85' ' ' VAL . 5.7 tp -88.2 166.3 14.46 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.448 -0.575 . . . . 15.0 109.448 178.462 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -96.18 92.15 6.26 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.897 0.379 . . . . 15.0 111.203 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.469 ' O ' ' HD3' ' A' ' 13' ' ' LYS . 0.2 OUTLIER -54.18 -27.87 36.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.914 -0.584 . . . . 15.0 111.018 179.879 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -84.32 -47.04 11.15 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.16 -0.473 . . . . 15.0 110.671 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -63.71 -37.8 88.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 15.0 110.634 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 26.3 p30 -165.46 156.34 13.85 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.264 -0.425 . . . . 15.0 111.135 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.419 ' O ' ' CB ' ' A' ' 45' ' ' ALA . 0.8 OUTLIER -86.08 -149.16 0.13 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.141 -0.482 . . . . 15.0 110.254 179.526 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.403 ' N ' ' CD2' ' A' ' 18' ' ' LEU . 1.9 mm? -119.52 -171.87 2.21 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.878 0.37 . . . . 15.0 110.748 179.589 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.761 ' O ' ' HB ' ' A' ' 41' ' ' ILE . . . -163.63 44.32 0.32 Allowed Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 121.053 -0.594 . . . . 15.0 111.871 -179.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.661 HG12 ' O ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -112.88 135.58 51.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 121.012 0.434 . . . . 15.0 111.876 -179.353 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.4 ' HB3' HD13 ' A' ' 41' ' ' ILE . 29.9 t -89.81 104.4 16.97 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 107.668 -1.234 . . . . 15.0 107.668 177.366 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.461 HG11 ' CG2' ' A' ' 20' ' ' ILE . 14.1 m -93.44 151.91 3.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 112.953 0.723 . . . . 15.0 112.953 -176.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -149.57 -177.72 6.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 114.977 -1.01 . . . . 15.0 110.678 -179.685 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.414 ' O ' ' CB ' ' A' ' 71' ' ' HIS . . . 73.26 -120.52 7.16 Favored Glycine 0 C--N 1.331 0.256 0 C-N-CA 120.675 -0.774 . . . . 15.0 112.381 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.52 ' HA3' ' N ' ' A' ' 71' ' ' HIS . . . 66.94 -65.57 0.19 Allowed Glycine 0 C--N 1.33 0.214 0 C-N-CA 120.943 -0.646 . . . . 15.0 113.565 179.31 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.437 ' C ' ' O ' ' A' ' 25' ' ' GLY . 0.0 OUTLIER -25.87 133.08 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 N-CA-C 112.621 0.6 . . . . 15.0 112.621 -179.298 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -75.65 63.17 1.54 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.784 -0.644 . . . . 15.0 111.018 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.4 m -151.67 -47.27 0.11 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.287 -0.415 . . . . 15.0 111.0 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 12.5 t -90.28 -41.65 11.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 15.0 111.001 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 33.9 m -71.99 -176.3 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.471 . . . . 15.0 111.166 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.412 ' O ' ' CD2' ' A' ' 32' ' ' HIS . 0.0 OUTLIER -57.0 -51.32 69.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.218 -0.446 . . . . 15.0 110.983 -179.995 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . 0.412 ' CD2' ' O ' ' A' ' 31' ' ' ARG . 27.0 m80 -151.21 -51.98 0.13 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.28 -0.418 . . . . 15.0 111.012 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -168.1 27.42 0.14 Allowed Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.803 -0.713 . . . . 15.0 112.5 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -91.13 149.14 19.71 Favored Glycine 0 N--CA 1.45 -0.411 0 N-CA-C 111.037 -0.825 . . . . 15.0 111.037 179.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.446 ' CG1' ' HA ' ' A' ' 71' ' ' HIS . 0.0 OUTLIER -88.18 154.78 3.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.388 0.613 . . . . 15.0 111.719 -179.299 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.507 ' CZ ' ' HG2' ' A' ' 57' ' ' ARG . 51.2 m-85 -141.35 106.91 5.06 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.008 -0.996 . . . . 15.0 109.737 179.272 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.656 HG21 ' N ' ' A' ' 55' ' ' GLY . 0.8 OUTLIER -56.16 148.11 4.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.021 0.438 . . . . 15.0 111.317 -179.193 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.482 ' O ' ' HG2' ' A' ' 54' ' ' LYS . 0.4 OUTLIER -80.37 -46.46 16.01 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.49 -0.93 . . . . 15.0 108.49 178.248 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.661 ' O ' HG12 ' A' ' 20' ' ' ILE . . . -172.1 172.58 4.59 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.594 -0.73 . . . . 15.0 110.508 178.626 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.517 ' HA ' HG12 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -96.87 111.42 26.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 109.545 -0.539 . . . . 15.0 109.545 179.248 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.761 ' HB ' ' O ' ' A' ' 19' ' ' GLY . 0.4 OUTLIER -78.47 117.05 64.02 Favored Pre-proline 0 C--N 1.329 -0.324 0 N-CA-C 113.273 0.842 . . . . 15.0 113.273 -177.422 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.547 ' HA ' ' CG ' ' A' ' 47' ' ' GLU . 37.9 Cg_endo -65.29 59.76 0.34 Allowed 'Trans proline' 0 C--N 1.356 0.924 0 C-N-CA 123.437 2.758 . . . . 15.0 112.785 179.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.505 ' N ' ' HG2' ' A' ' 47' ' ' GLU . 0.5 OUTLIER -147.47 -46.32 0.17 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.517 -0.31 . . . . 15.0 111.296 -179.996 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.684 ' HA3' ' HA3' ' A' ' 19' ' ' GLY . . . -87.77 168.02 37.3 Favored Glycine 0 C--N 1.331 0.269 0 C-N-CA 120.332 -0.937 . . . . 15.0 113.722 -179.258 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.419 ' CB ' ' O ' ' A' ' 17' ' ' SER . . . -57.83 -14.35 5.85 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.862 0.69 . . . . 15.0 112.862 -179.473 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.14 -55.86 6.57 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.935 -0.306 . . . . 15.0 110.932 -179.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.567 ' HG3' ' O ' ' A' ' 44' ' ' GLY . 2.9 pp20? -57.36 -43.02 83.15 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.923 -0.58 . . . . 15.0 110.231 179.196 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.5 m -53.84 -69.89 0.11 Allowed 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 115.882 -0.599 . . . . 15.0 110.483 -179.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -58.07 -41.74 84.01 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.072 -0.714 . . . . 15.0 109.072 178.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.75 40.03 12.97 Favored Glycine 0 N--CA 1.446 -0.648 0 CA-C-N 115.293 -0.867 . . . . 15.0 111.711 179.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.435 ' HB3' ' CG2' ' A' ' 9' ' ' VAL . 0.2 OUTLIER -79.79 -50.07 11.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.895 0.378 . . . . 15.0 110.599 -179.362 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.44 ' CD1' HD12 ' A' ' 89' ' ' LEU . 8.7 tp -81.12 161.44 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 CA-C-N 116.075 -0.511 . . . . 15.0 110.367 179.571 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . 0.479 ' O ' ' HB2' ' A' ' 56' ' ' ASP . 78.3 m80 -146.27 158.78 43.91 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-O 121.635 0.731 . . . . 15.0 112.16 -179.192 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.523 ' HA ' ' CG2' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -43.12 133.97 3.71 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 114.382 -1.281 . . . . 15.0 112.645 -178.752 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.656 ' N ' HG21 ' A' ' 37' ' ' VAL . . . 49.97 34.0 22.37 Favored Glycine 0 C--N 1.333 0.414 0 CA-C-N 115.841 -0.618 . . . . 15.0 113.354 179.403 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.494 ' HB2' HG12 ' A' ' 37' ' ' VAL . 0.3 OUTLIER -65.96 131.9 47.33 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.635 -0.426 . . . . 15.0 110.618 179.525 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.507 ' HG2' ' CZ ' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -85.32 90.89 8.03 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.169 -0.468 . . . . 15.0 110.403 179.553 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.478 ' HA ' HD22 ' A' ' 89' ' ' LEU . 1.5 m -83.57 112.95 21.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.079 0.466 . . . . 15.0 111.207 -179.524 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -107.32 -16.54 14.37 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 115.764 -0.653 . . . . 15.0 112.615 -179.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -147.5 150.21 34.12 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 112.518 0.562 . . . . 15.0 112.518 -178.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.424 ' HB ' ' CG1' ' A' ' 64' ' ' VAL . 3.3 t -139.07 101.66 1.62 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.267 0 CA-C-N 115.311 -0.859 . . . . 15.0 109.281 178.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.407 ' ND2' ' CG2' ' A' ' 81' ' ' THR . 2.3 m-80 64.96 15.59 10.05 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.64 -0.504 . . . . 15.0 109.64 -178.112 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 105.95 6.71 36.93 Favored Glycine 0 C--N 1.336 0.54 0 CA-C-N 115.816 -0.629 . . . . 15.0 113.126 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.499 ' O ' ' CG1' ' A' ' 64' ' ' VAL . 7.2 p -93.76 105.32 16.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.118 0.485 . . . . 15.0 110.727 179.283 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -59.3 116.35 3.85 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.127 -0.488 . . . . 15.0 110.733 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.2 mt -87.59 -12.07 46.75 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.826 -0.624 . . . . 15.0 111.295 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -46.29 102.51 0.03 OUTLIER 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.827 0.346 . . . . 15.0 110.936 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.86 64.25 0.55 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.8 -0.714 . . . . 15.0 112.264 -179.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -172.91 148.44 1.79 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.9 0.381 . . . . 15.0 110.855 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.423 ' CB ' ' HA ' ' A' ' 26' ' ' VAL . 11.8 p -72.83 -173.75 1.29 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.198 -0.456 . . . . 15.0 111.157 -179.65 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.52 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 0.0 OUTLIER -61.89 -59.46 5.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.882 -0.599 . . . . 15.0 110.572 -179.847 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 25.0 ttpt -52.34 -35.51 51.14 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.84 -0.618 . . . . 15.0 110.689 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -59.31 -46.22 89.16 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.647 -0.501 . . . . 15.0 109.647 179.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.593 ' HA ' ' OG1' ' A' ' 77' ' ' THR . . . -66.96 -50.34 62.61 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 109.472 -0.566 . . . . 15.0 109.472 178.195 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.438 ' CG2' ' CG2' ' A' ' 22' ' ' VAL . 0.6 OUTLIER -40.85 -43.58 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.192 0 CA-C-N 115.237 -0.892 . . . . 15.0 109.614 178.567 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -67.37 -43.85 80.39 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.01 -0.996 . . . . 15.0 110.663 179.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.593 ' OG1' ' HA ' ' A' ' 74' ' ' ALA . 0.6 OUTLIER -64.68 -55.78 17.92 Favored 'General case' 0 C--O 1.23 0.075 0 C-N-CA 120.796 -0.362 . . . . 15.0 111.272 179.937 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.423 ' CD2' HG21 ' A' ' 61' ' ' VAL . 3.2 mt -53.43 -46.03 69.65 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 121.116 0.484 . . . . 15.0 110.132 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.22 -55.06 13.6 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.612 -0.722 . . . . 15.0 110.359 179.4 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 8.1 m-20 -66.26 57.81 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 115.919 -0.582 . . . . 15.0 112.01 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.407 ' CG2' ' ND2' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -95.66 -70.54 0.71 Allowed 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 110.203 -0.295 . . . . 15.0 110.203 179.332 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 115.25 -98.15 0.84 Allowed Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.691 -0.766 . . . . 15.0 113.412 178.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.41 ' O ' ' HB3' ' A' ' 13' ' ' LYS . 0.5 OUTLIER -64.39 -86.24 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.063 0.394 . . . . 15.0 112.063 -178.827 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.421 ' CG1' ' N ' ' A' ' 85' ' ' VAL . 77.7 t -109.73 159.76 9.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.924 0.392 . . . . 15.0 110.978 -179.397 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.444 ' O ' ' CG1' ' A' ' 85' ' ' VAL . 13.4 t -97.99 79.4 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.145 0.497 . . . . 15.0 110.466 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -101.41 84.14 2.56 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.746 -0.661 . . . . 15.0 110.495 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.455 ' CD2' ' CD2' ' A' ' 89' ' ' LEU . 0.1 OUTLIER -101.02 128.64 46.97 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.014 -0.539 . . . . 15.0 111.54 -179.302 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.492 HD11 ' CB ' ' A' ' 8' ' ' GLU . 4.8 mp -102.2 99.67 9.8 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.737 -0.468 . . . . 15.0 109.737 178.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.478 HD22 ' HA ' ' A' ' 58' ' ' VAL . 0.1 OUTLIER -105.73 -160.86 0.77 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.394 0.616 . . . . 15.0 112.011 -178.677 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.453 ' HB2' HG13 ' A' ' 6' ' ' ILE . 3.6 tt0 -141.77 132.69 25.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.051 -0.977 . . . . 15.0 109.897 179.136 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 3.6 tmtp? -49.26 95.51 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.378 -0.374 . . . . 15.0 111.146 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -68.3 131.12 27.11 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.85 -0.691 . . . . 15.0 112.639 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -86.39 130.68 34.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.828 0.347 . . . . 15.0 110.874 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 15.2 p -69.46 164.65 47.68 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.221 -0.445 . . . . 15.0 110.916 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_exo -51.73 -54.12 5.86 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.59 2.193 . . . . 15.0 112.267 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 28.7 m . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.242 -0.885 . . . . 15.0 110.933 -179.984 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo . . . . . 0 N--CA 1.488 1.173 0 CA-C-O 120.852 0.271 . . . . 15.0 111.757 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.466 ' CB ' ' HD3' ' A' ' 3' ' ' PRO . 7.0 mttp -155.38 -63.89 0.02 OUTLIER Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.146 -0.479 . . . . 15.0 111.057 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.466 ' HD3' ' CB ' ' A' ' 2' ' ' LYS . 88.4 Cg_exo -42.95 92.14 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.633 2.222 . . . . 15.0 112.707 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 88.35 -21.68 23.8 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.488 -0.863 . . . . 15.0 112.209 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -61.86 151.12 35.4 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 121.193 0.52 . . . . 15.0 110.668 179.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.403 ' CD1' ' HB2' ' A' ' 90' ' ' GLU . 1.2 mp -98.45 145.44 9.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.473 -0.785 . . . . 15.0 111.335 -179.179 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.411 ' O ' ' N ' ' A' ' 89' ' ' LEU . 1.8 p90 -140.54 153.91 46.33 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.026 -0.533 . . . . 15.0 110.407 178.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.493 ' CB ' HD11 ' A' ' 88' ' ' LEU . 0.1 OUTLIER -121.37 143.61 49.11 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.369 0.604 . . . . 15.0 111.759 -179.192 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.477 ' CG2' ' HB3' ' A' ' 51' ' ' ARG . 0.2 OUTLIER -101.43 116.02 44.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.063 -0.971 . . . . 15.0 109.628 178.956 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -106.24 72.59 0.94 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.239 -0.437 . . . . 15.0 112.145 -178.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.449 ' HB3' ' HB ' ' A' ' 85' ' ' VAL . 7.1 tp -88.3 161.69 17.01 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.319 -0.4 . . . . 15.0 110.007 178.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.527 ' C ' ' H ' ' A' ' 14' ' ' ASN . . . -97.1 94.67 7.28 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.654 0.264 . . . . 15.0 111.686 -179.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.425 ' HB2' ' CG2' ' A' ' 85' ' ' VAL . 0.6 OUTLIER -65.84 32.37 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 112.738 0.644 . . . . 15.0 112.738 179.623 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.527 ' H ' ' C ' ' A' ' 12' ' ' ALA . 0.6 OUTLIER -108.8 -68.56 0.91 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.79 0.329 . . . . 15.0 111.289 -179.57 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -46.68 -42.58 16.73 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.286 -0.415 . . . . 15.0 111.128 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -165.42 174.15 10.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 15.0 110.876 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -86.07 -165.52 1.27 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.242 -0.435 . . . . 15.0 110.355 179.636 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.5 mp -84.14 -170.2 2.97 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.357 -0.383 . . . . 15.0 110.357 179.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.664 ' O ' ' HB ' ' A' ' 41' ' ' ILE . . . -160.61 38.88 0.44 Allowed Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.901 -0.666 . . . . 15.0 111.719 -179.728 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.634 HG12 ' O ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -112.9 138.4 42.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 120.998 0.428 . . . . 15.0 111.805 -179.53 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.402 ' O ' ' HB3' ' A' ' 38' ' ' LYS . 28.9 t -95.78 100.92 12.57 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 107.801 -1.185 . . . . 15.0 107.801 177.395 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.521 HG23 ' CD2' ' A' ' 71' ' ' HIS . 1.0 OUTLIER -93.66 154.82 3.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.162 0.506 . . . . 15.0 112.299 -177.151 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.466 ' HA ' ' CE1' ' A' ' 71' ' ' HIS . 14.5 t -149.34 -176.19 5.28 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.421 -0.809 . . . . 15.0 110.516 179.647 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.474 ' O ' ' HB2' ' A' ' 71' ' ' HIS . . . 77.1 -112.07 3.42 Favored Glycine 0 C--N 1.331 0.287 0 C-N-CA 120.555 -0.831 . . . . 15.0 112.253 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.557 ' HA3' ' N ' ' A' ' 71' ' ' HIS . . . 62.8 -65.89 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 121.037 -0.601 . . . . 15.0 113.812 179.133 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.467 ' N ' ' O ' ' A' ' 24' ' ' GLY . 0.0 OUTLIER -30.27 145.01 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 N-CA-C 112.47 0.544 . . . . 15.0 112.47 -179.068 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -80.28 56.26 2.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.863 -0.608 . . . . 15.0 110.967 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -151.04 -65.38 0.19 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.212 -0.449 . . . . 15.0 110.585 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.09 -47.11 75.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 15.0 110.251 179.57 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 33.7 m -88.07 -170.3 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.923 -0.581 . . . . 15.0 110.567 179.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -95.83 128.49 42.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.933 0.396 . . . . 15.0 111.152 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 25.6 m80 59.47 -83.35 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.947 -0.57 . . . . 15.0 111.464 179.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.407 ' O ' ' O ' ' A' ' 69' ' ' ALA . . . -170.36 30.61 0.14 Allowed Glycine 0 C--N 1.33 0.244 0 C-N-CA 121.056 -0.592 . . . . 15.0 112.026 -179.548 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -89.96 151.88 21.95 Favored Glycine 0 N--CA 1.447 -0.583 0 N-CA-C 110.667 -0.973 . . . . 15.0 110.667 178.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.425 ' CG1' ' HA ' ' A' ' 71' ' ' HIS . 0.0 OUTLIER -94.25 152.6 3.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.546 0.689 . . . . 15.0 112.149 -179.034 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -136.76 108.14 6.88 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.661 -1.154 . . . . 15.0 109.39 179.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.658 HG21 ' N ' ' A' ' 55' ' ' GLY . 0.8 OUTLIER -55.32 152.19 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.123 0.487 . . . . 15.0 111.563 -178.622 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.443 ' O ' ' HG2' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -84.51 -46.33 11.72 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.457 -0.942 . . . . 15.0 108.457 178.088 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.634 ' O ' HG12 ' A' ' 20' ' ' ILE . . . -172.35 173.17 4.23 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 115.75 -0.659 . . . . 15.0 110.448 178.438 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.519 ' HA ' HG12 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -96.96 111.52 27.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 109.519 -0.548 . . . . 15.0 109.519 179.196 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.664 ' HB ' ' O ' ' A' ' 19' ' ' GLY . 0.4 OUTLIER -78.39 117.01 63.7 Favored Pre-proline 0 C--N 1.33 -0.264 0 N-CA-C 113.408 0.892 . . . . 15.0 113.408 -177.306 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.539 ' HA ' ' CG ' ' A' ' 47' ' ' GLU . 27.1 Cg_exo -62.86 59.79 0.15 Allowed 'Trans proline' 0 C--N 1.357 0.989 0 C-N-CA 123.651 2.9 . . . . 15.0 113.001 179.637 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.508 ' H ' ' HG2' ' A' ' 47' ' ' GLU . 3.9 tt0 -147.51 -47.06 0.17 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.582 0.229 . . . . 15.0 111.394 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.592 ' HA3' ' HA3' ' A' ' 19' ' ' GLY . . . -87.82 167.8 36.98 Favored Glycine 0 CA--C 1.518 0.24 0 C-N-CA 120.368 -0.92 . . . . 15.0 113.884 -179.051 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -57.34 -14.45 4.61 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.722 0.638 . . . . 15.0 112.722 -179.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.17 -56.59 5.31 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.662 0.267 . . . . 15.0 110.934 -179.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.561 ' HG3' ' O ' ' A' ' 44' ' ' GLY . 3.0 pp20? -57.45 -42.69 82.98 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.965 -0.561 . . . . 15.0 110.287 179.309 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -53.77 -70.76 0.09 Allowed 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 115.845 -0.616 . . . . 15.0 110.535 -179.433 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.412 ' CB ' HD13 ' A' ' 11' ' ' LEU . 0.1 OUTLIER -58.43 -41.3 84.73 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.154 -0.684 . . . . 15.0 109.154 178.829 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.75 41.2 11.14 Favored Glycine 0 N--CA 1.445 -0.702 0 CA-C-N 115.361 -0.836 . . . . 15.0 111.718 179.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.477 ' HB3' ' CG2' ' A' ' 9' ' ' VAL . 0.5 OUTLIER -79.7 -50.3 10.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.883 0.373 . . . . 15.0 110.655 -179.363 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.408 ' CD1' HD12 ' A' ' 89' ' ' LEU . 7.9 tp -81.04 163.3 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 CA-C-N 116.062 -0.517 . . . . 15.0 110.282 179.439 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . 0.48 ' O ' ' HB2' ' A' ' 56' ' ' ASP . 64.0 m80 -147.37 160.82 42.1 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-O 121.687 0.756 . . . . 15.0 112.252 -179.087 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.511 ' HA ' ' CG2' ' A' ' 37' ' ' VAL . 6.1 mtpt -43.82 134.11 4.55 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.309 -1.314 . . . . 15.0 112.576 -178.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.658 ' N ' HG21 ' A' ' 37' ' ' VAL . . . 49.88 33.12 19.83 Favored Glycine 0 C--N 1.333 0.369 0 CA-C-N 115.914 -0.585 . . . . 15.0 113.589 179.324 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.49 ' HB2' HG12 ' A' ' 37' ' ' VAL . 0.3 OUTLIER -65.93 130.5 43.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 117.16 0.48 . . . . 15.0 110.598 179.38 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.424 ' HA ' ' O ' ' A' ' 35' ' ' ILE . 35.4 ttt180 -82.74 87.91 6.76 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.794 0.331 . . . . 15.0 110.313 179.485 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.473 ' HA ' HD22 ' A' ' 89' ' ' LEU . 2.3 m -79.32 112.45 17.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.148 0.499 . . . . 15.0 111.063 -179.388 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 44.5 mt -107.21 -11.85 15.5 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 115.645 -0.707 . . . . 15.0 112.625 -179.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -151.35 146.41 25.98 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 112.693 0.627 . . . . 15.0 112.693 -178.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.445 ' HB ' ' CG1' ' A' ' 64' ' ' VAL . 40.0 t -139.59 93.53 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.192 -0.913 . . . . 15.0 109.459 178.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.5 m120 69.92 17.68 7.45 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.086 -0.507 . . . . 15.0 109.98 -178.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 107.27 4.72 35.2 Favored Glycine 0 C--N 1.334 0.456 0 CA-C-N 115.841 -0.618 . . . . 15.0 113.482 179.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.515 ' O ' ' CG1' ' A' ' 64' ' ' VAL . 5.1 p -93.72 103.25 14.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.207 0.527 . . . . 15.0 110.645 179.198 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 24.3 m -56.89 133.62 54.74 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.995 -0.548 . . . . 15.0 111.117 -179.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -88.09 -19.35 27.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.036 -0.529 . . . . 15.0 110.935 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -47.47 95.86 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 120.91 0.386 . . . . 15.0 110.897 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.73 65.17 0.57 Allowed Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.783 -0.722 . . . . 15.0 112.271 -179.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.407 ' O ' ' O ' ' A' ' 33' ' ' GLY . . . -172.76 156.89 3.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.94 0.4 . . . . 15.0 110.859 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.426 ' HA ' ' N ' ' A' ' 26' ' ' VAL . 11.3 p -93.07 -171.11 2.59 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.104 0.478 . . . . 15.0 111.336 -179.572 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.557 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 0.4 OUTLIER -59.61 -60.99 2.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.621 -0.718 . . . . 15.0 110.158 179.737 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 20.0 ttpp -52.79 -35.93 57.52 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.519 -0.764 . . . . 15.0 110.806 179.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -59.6 -54.43 46.55 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.298 -0.41 . . . . 15.0 109.935 179.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.435 ' O ' ' N ' ' A' ' 77' ' ' THR . . . -65.17 -43.88 90.32 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.1 -0.5 . . . . 15.0 109.721 178.728 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -43.38 -42.39 1.42 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.223 0 N-CA-C 108.987 -0.745 . . . . 15.0 108.987 178.289 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.402 ' O ' ' HB2' ' A' ' 80' ' ' ASN . 1.8 mt-10 -67.41 -43.28 81.63 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 114.9 -1.046 . . . . 15.0 110.323 178.522 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.435 ' N ' ' O ' ' A' ' 74' ' ' ALA . 70.4 p -63.94 -56.87 12.04 Favored 'General case' 0 N--CA 1.461 0.116 0 CA-C-O 120.615 0.245 . . . . 15.0 111.521 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.41 ' HG ' ' O ' ' A' ' 74' ' ' ALA . 4.0 mt -53.31 -46.86 69.58 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-O 121.118 0.485 . . . . 15.0 110.185 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.5 -58.2 4.67 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.644 -0.707 . . . . 15.0 110.708 179.467 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.402 ' HB2' ' O ' ' A' ' 76' ' ' GLU . 68.7 m-20 -65.85 63.03 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.053 -0.521 . . . . 15.0 111.956 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -92.93 -78.31 0.42 Allowed 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 110.073 -0.343 . . . . 15.0 110.073 179.233 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 122.34 -107.89 1.21 Allowed Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.807 -0.711 . . . . 15.0 112.965 179.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -65.23 -80.23 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.665 0.269 . . . . 15.0 111.415 -179.318 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.434 ' CG1' ' N ' ' A' ' 85' ' ' VAL . 75.9 t -110.19 159.47 9.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.054 0.454 . . . . 15.0 111.179 -179.646 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.458 ' O ' ' CG1' ' A' ' 85' ' ' VAL . 6.4 t -97.9 80.88 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.015 -0.539 . . . . 15.0 110.225 179.528 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 11.2 t60 -97.07 80.39 2.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.846 -0.615 . . . . 15.0 110.403 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.454 ' HB3' ' CD2' ' A' ' 89' ' ' LEU . 0.1 OUTLIER -103.78 120.93 41.98 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.884 -0.598 . . . . 15.0 111.818 -179.118 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.493 HD11 ' CB ' ' A' ' 8' ' ' GLU . 4.0 mp -98.87 101.92 13.48 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.49 -0.559 . . . . 15.0 109.49 178.645 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.473 HD22 ' HA ' ' A' ' 58' ' ' VAL . 0.1 OUTLIER -105.64 -162.37 0.87 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.488 0.661 . . . . 15.0 112.061 -178.334 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.403 ' HB2' ' CD1' ' A' ' 6' ' ' ILE . 2.1 tt0 -140.67 139.39 34.79 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 114.73 -1.123 . . . . 15.0 109.736 179.124 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 2.0 tptp -52.08 105.65 0.12 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.91 0.386 . . . . 15.0 111.069 -179.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -69.44 129.72 22.91 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.814 -0.708 . . . . 15.0 112.544 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -86.25 87.75 7.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.817 0.341 . . . . 15.0 110.831 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 4.0 t -67.34 147.88 98.81 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.121 -0.491 . . . . 15.0 110.937 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -52.17 -36.82 68.12 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.575 2.183 . . . . 15.0 112.317 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 76.6 p . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.186 -0.912 . . . . 15.0 110.867 -179.986 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_endo . . . . . 0 N--CA 1.488 1.152 0 CA-C-O 120.88 0.283 . . . . 15.0 111.761 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -145.07 118.37 5.46 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.117 -0.492 . . . . 15.0 110.41 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -63.78 -86.22 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.412 2.075 . . . . 15.0 112.481 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 93.13 -30.26 7.32 Favored Glycine 0 C--N 1.332 0.328 0 C-N-CA 120.612 -0.804 . . . . 15.0 112.507 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.21 164.82 6.46 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-O 121.422 0.63 . . . . 15.0 111.181 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.453 HG13 ' HB2' ' A' ' 90' ' ' GLU . 1.3 mp -104.34 146.28 11.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.067 -0.97 . . . . 15.0 110.96 -179.282 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.433 ' O ' ' N ' ' A' ' 89' ' ' LEU . 4.0 p90 -141.05 165.22 28.15 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.298 -0.41 . . . . 15.0 110.555 178.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.473 ' CB ' HD11 ' A' ' 88' ' ' LEU . 9.7 pt-20 -130.15 144.27 51.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.243 0.544 . . . . 15.0 111.543 -179.352 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.429 HG22 ' CG ' ' A' ' 51' ' ' ARG . 0.5 OUTLIER -101.34 114.13 39.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.31 -0.859 . . . . 15.0 109.539 178.948 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -106.03 71.12 0.88 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.152 -0.476 . . . . 15.0 111.922 -178.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.459 ' HB3' ' HB ' ' A' ' 85' ' ' VAL . 7.5 tp -88.28 165.04 15.29 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.08 -0.509 . . . . 15.0 109.914 178.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -95.3 93.29 7.19 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.983 0.421 . . . . 15.0 111.041 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.459 ' HG3' ' HB ' ' A' ' 81' ' ' THR . 0.0 OUTLIER -54.34 -30.63 52.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.913 -0.585 . . . . 15.0 111.033 179.911 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.478 ' O ' ' CB ' ' A' ' 15' ' ' ASP . 39.5 t30 -84.62 137.58 33.2 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.224 -0.444 . . . . 15.0 110.816 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.478 ' CB ' ' O ' ' A' ' 14' ' ' ASN . 4.7 t70 89.47 -24.25 0.09 Allowed 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.902 -0.59 . . . . 15.0 111.305 -179.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -165.39 136.12 3.81 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.868 0.366 . . . . 15.0 111.097 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.439 ' O ' ' CB ' ' A' ' 45' ' ' ALA . 0.5 OUTLIER -86.09 -156.17 0.28 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.141 -0.481 . . . . 15.0 110.205 179.547 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.2 mp -104.78 -172.11 2.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.884 0.373 . . . . 15.0 110.749 179.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.755 ' O ' ' HB ' ' A' ' 41' ' ' ILE . . . -161.05 45.08 0.4 Allowed Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 121.152 -0.547 . . . . 15.0 111.935 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.692 HG12 ' O ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -112.77 139.69 36.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 120.974 0.416 . . . . 15.0 111.77 -179.549 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 45.0 t -94.98 104.05 15.91 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.084 -1.08 . . . . 15.0 108.084 177.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.479 HG11 ' CG2' ' A' ' 20' ' ' ILE . 10.6 m -93.73 153.9 3.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 113.124 0.787 . . . . 15.0 113.124 -177.037 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.33 -179.66 7.23 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 114.981 -1.009 . . . . 15.0 110.391 179.632 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.448 ' O ' ' CB ' ' A' ' 71' ' ' HIS . . . 76.71 -121.77 6.1 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.562 -0.828 . . . . 15.0 112.563 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.548 ' HA3' ' N ' ' A' ' 71' ' ' HIS . . . 68.2 -66.27 0.37 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.831 -0.699 . . . . 15.0 113.388 179.437 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.456 ' N ' ' HA ' ' A' ' 70' ' ' THR . 1.6 m -28.34 138.76 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 N-CA-C 112.39 0.515 . . . . 15.0 112.39 -179.208 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 10.9 m-80 -76.25 60.08 1.46 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.951 -0.568 . . . . 15.0 111.041 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -151.78 -55.71 0.14 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.331 -0.395 . . . . 15.0 110.956 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.4 m -78.15 -46.23 21.16 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.17 -0.468 . . . . 15.0 111.019 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.426 HG13 ' CD1' ' A' ' 36' ' ' TYR . 21.9 m -71.36 -173.72 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.244 -0.435 . . . . 15.0 111.192 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 6.1 mtp85 -57.34 -54.59 45.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.281 -0.418 . . . . 15.0 111.078 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 48.6 p-80 -151.8 -44.69 0.11 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.363 -0.38 . . . . 15.0 111.174 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -169.59 23.6 0.1 OUTLIER Glycine 0 CA--C 1.518 0.223 0 C-N-CA 120.816 -0.707 . . . . 15.0 112.615 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -93.88 153.93 21.39 Favored Glycine 0 N--CA 1.449 -0.499 0 N-CA-C 110.429 -1.068 . . . . 15.0 110.429 178.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.578 HG13 ' HA ' ' A' ' 71' ' ' HIS . 0.1 OUTLIER -96.67 153.36 3.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 C-N-CA 119.601 -0.84 . . . . 15.0 112.371 -179.078 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.454 ' CE2' ' HG2' ' A' ' 57' ' ' ARG . 32.5 m-85 -135.67 106.96 6.79 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.63 -1.168 . . . . 15.0 109.27 179.289 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.637 HG21 ' N ' ' A' ' 55' ' ' GLY . 0.7 OUTLIER -55.03 149.36 2.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.147 0.499 . . . . 15.0 111.357 -178.554 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.476 ' O ' ' HG2' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -80.16 -50.46 10.25 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.628 -0.879 . . . . 15.0 108.628 178.739 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.692 ' O ' HG12 ' A' ' 20' ' ' ILE . . . -172.3 173.27 4.24 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 115.72 -0.673 . . . . 15.0 110.081 178.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.509 ' HA ' ' CG1' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -96.76 112.8 29.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 108.983 -0.747 . . . . 15.0 108.983 178.778 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.755 ' HB ' ' O ' ' A' ' 19' ' ' GLY . 0.4 OUTLIER -77.96 118.07 69.84 Favored Pre-proline 0 C--N 1.328 -0.338 0 N-CA-C 113.231 0.826 . . . . 15.0 113.231 -176.978 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.532 ' HA ' ' HG2' ' A' ' 47' ' ' GLU . 37.3 Cg_endo -64.88 61.67 0.29 Allowed 'Trans proline' 0 C--N 1.357 0.974 0 C-N-CA 123.457 2.771 . . . . 15.0 112.745 179.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.501 ' H ' ' HG2' ' A' ' 47' ' ' GLU . 4.3 mm-40 -151.51 -46.35 0.11 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.536 -0.302 . . . . 15.0 111.489 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.688 ' HA3' ' HA3' ' A' ' 19' ' ' GLY . . . -87.68 166.87 36.29 Favored Glycine 0 C--N 1.33 0.222 0 C-N-CA 120.312 -0.947 . . . . 15.0 113.618 -179.259 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.439 ' CB ' ' O ' ' A' ' 17' ' ' SER . . . -56.95 -13.91 3.09 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.616 0.599 . . . . 15.0 112.616 -179.613 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.04 -57.19 4.48 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.734 0.302 . . . . 15.0 110.782 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.532 ' HG2' ' HA ' ' A' ' 42' ' ' PRO . 2.8 pp20? -57.21 -42.93 82.25 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.19 -0.459 . . . . 15.0 110.397 179.383 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 22.9 t -53.95 -71.47 0.07 Allowed 'General case' 0 CA--C 1.52 -0.176 0 CA-C-N 115.976 -0.556 . . . . 15.0 110.626 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.63 -40.78 84.33 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.391 -0.596 . . . . 15.0 109.391 178.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.93 45.02 7.89 Favored Glycine 0 N--CA 1.446 -0.65 0 CA-C-N 115.393 -0.822 . . . . 15.0 111.67 179.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.429 ' CG ' HG22 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -79.43 -54.36 6.0 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.892 0.377 . . . . 15.0 110.477 -179.325 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.417 ' HA ' HD12 ' A' ' 52' ' ' ILE . 8.3 tp -81.08 164.29 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 CA-C-N 115.991 -0.55 . . . . 15.0 110.362 179.55 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . 0.481 ' O ' HG21 ' A' ' 37' ' ' VAL . 74.5 m80 -146.34 157.13 43.76 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-O 121.659 0.742 . . . . 15.0 112.135 -179.063 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.524 ' HA ' ' CG2' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -44.13 133.52 5.19 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.229 -1.351 . . . . 15.0 112.975 -178.605 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.637 ' N ' HG21 ' A' ' 37' ' ' VAL . . . 49.99 31.28 17.61 Favored Glycine 0 C--N 1.336 0.538 0 CA-C-N 115.809 -0.632 . . . . 15.0 113.268 179.206 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.441 ' OD2' ' N ' ' A' ' 53' ' ' HIS . 5.3 m-20 -65.72 129.31 39.32 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.887 -0.325 . . . . 15.0 110.733 179.691 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.454 ' HG2' ' CE2' ' A' ' 36' ' ' TYR . 50.6 mtt180 -80.74 88.32 5.79 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.233 -0.439 . . . . 15.0 110.313 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.531 ' HA ' HD22 ' A' ' 89' ' ' LEU . 1.4 m -79.45 112.05 17.01 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 CA-C-O 121.158 0.504 . . . . 15.0 111.058 -179.62 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 33.3 mt -107.49 -15.27 14.65 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 115.441 -0.8 . . . . 15.0 112.47 -179.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.411 ' HA ' ' O ' ' A' ' 64' ' ' VAL . . . -149.49 148.28 29.22 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 112.765 0.654 . . . . 15.0 112.765 -178.673 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.433 ' HB ' ' CG1' ' A' ' 64' ' ' VAL . 15.4 t -139.11 99.87 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.263 -0.88 . . . . 15.0 109.083 178.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.0 m120 65.19 16.42 10.54 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.28 -0.418 . . . . 15.0 109.881 -177.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 107.23 4.79 35.29 Favored Glycine 0 C--N 1.336 0.56 0 CA-C-N 115.924 -0.58 . . . . 15.0 113.531 179.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.496 ' O ' ' CG1' ' A' ' 64' ' ' VAL . 5.3 p -93.78 107.46 19.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 117.175 0.488 . . . . 15.0 110.882 179.511 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -56.57 135.6 54.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.211 -0.449 . . . . 15.0 111.163 -179.603 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -97.16 -21.35 17.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.988 -0.551 . . . . 15.0 110.915 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -46.7 98.71 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.399 -0.364 . . . . 15.0 110.93 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.83 63.08 0.54 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.804 -0.713 . . . . 15.0 112.139 -179.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -173.0 143.18 1.14 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.841 0.353 . . . . 15.0 110.865 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.456 ' HA ' ' N ' ' A' ' 26' ' ' VAL . 12.2 p -72.99 -173.16 1.18 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.255 -0.43 . . . . 15.0 111.208 -179.717 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.578 ' HA ' HG13 ' A' ' 35' ' ' ILE . 0.0 OUTLIER -61.93 -59.69 4.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.89 -0.596 . . . . 15.0 110.514 -179.987 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.401 ' O ' ' HG3' ' A' ' 76' ' ' GLU . 20.4 ttmt -52.64 -33.69 48.03 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.849 -0.614 . . . . 15.0 110.632 179.405 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -59.5 -52.66 64.64 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.784 -0.45 . . . . 15.0 109.784 179.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.446 ' O ' ' N ' ' A' ' 77' ' ' THR . . . -66.86 -44.24 81.48 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.704 -0.48 . . . . 15.0 109.704 178.516 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.414 HG22 ' CG2' ' A' ' 22' ' ' VAL . 0.5 OUTLIER -43.01 -40.79 1.08 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.262 0 N-CA-C 109.012 -0.736 . . . . 15.0 109.012 178.412 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.406 ' O ' ' CB ' ' A' ' 80' ' ' ASN . 46.3 mt-10 -67.39 -44.65 78.35 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 114.789 -1.096 . . . . 15.0 110.369 178.533 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.446 ' N ' ' O ' ' A' ' 74' ' ' ALA . 40.9 p -64.14 -54.52 32.5 Favored 'General case' 0 N--CA 1.462 0.151 0 C-N-CA 120.99 -0.284 . . . . 15.0 111.414 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.409 ' HG ' ' O ' ' A' ' 74' ' ' ALA . 5.7 mt -53.56 -47.93 69.61 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-O 121.211 0.529 . . . . 15.0 110.012 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 1.9 ttt-85 -68.35 -59.47 3.16 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.429 -0.805 . . . . 15.0 110.397 179.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.406 ' CB ' ' O ' ' A' ' 76' ' ' GLU . 14.2 m-20 -65.99 62.03 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.933 -0.576 . . . . 15.0 111.94 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.459 ' HB ' ' HG3' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -93.23 -71.36 0.66 Allowed 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 110.043 -0.355 . . . . 15.0 110.043 179.234 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 122.0 -108.02 1.25 Allowed Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.939 -0.648 . . . . 15.0 112.993 179.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.4 ' O ' ' HB3' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -65.17 -79.69 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.917 0.389 . . . . 15.0 111.623 -179.359 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.42 HG13 ' N ' ' A' ' 85' ' ' VAL . 77.6 t -110.21 158.25 10.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.952 -0.567 . . . . 15.0 111.087 -179.319 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.459 ' HB ' ' HB3' ' A' ' 11' ' ' LEU . 6.8 t -97.93 82.35 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.056 -0.52 . . . . 15.0 110.46 179.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -101.91 85.02 2.62 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.793 -0.639 . . . . 15.0 110.379 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.467 ' HB3' ' CD2' ' A' ' 89' ' ' LEU . 0.1 OUTLIER -103.86 122.94 46.19 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.925 -0.58 . . . . 15.0 111.808 -179.136 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.473 HD11 ' CB ' ' A' ' 8' ' ' GLU . 4.4 mp -97.69 101.37 12.86 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.586 -0.524 . . . . 15.0 109.586 178.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.531 HD22 ' HA ' ' A' ' 58' ' ' VAL . 0.1 OUTLIER -105.93 -161.8 0.82 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.456 0.646 . . . . 15.0 111.961 -178.46 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.453 ' HB2' HG13 ' A' ' 6' ' ' ILE . 4.6 tt0 -143.27 133.56 24.59 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 114.948 -1.024 . . . . 15.0 109.77 179.174 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -46.95 106.14 0.08 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.994 0.426 . . . . 15.0 111.174 -179.669 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -70.61 -162.43 4.29 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.868 -0.682 . . . . 15.0 112.759 -179.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -76.26 152.35 36.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.847 0.356 . . . . 15.0 110.906 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -90.22 121.57 68.47 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.196 -0.457 . . . . 15.0 110.803 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_exo -51.53 -47.49 25.92 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.49 2.127 . . . . 15.0 112.27 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 2.9 p . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.233 -0.889 . . . . 15.0 110.887 179.98 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo . . . . . 0 N--CA 1.487 1.133 0 CA-C-O 120.799 0.25 . . . . 15.0 111.717 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 2.1 ptpt -145.37 107.6 4.46 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.207 -0.452 . . . . 15.0 110.855 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.475 ' HG2' ' HG2' ' A' ' 91' ' ' LYS . 21.2 Cg_endo -61.63 -73.79 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.407 2.071 . . . . 15.0 112.488 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 93.54 -28.56 9.79 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.513 -0.851 . . . . 15.0 112.011 -179.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -61.96 155.86 22.55 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-O 121.607 0.718 . . . . 15.0 110.874 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.459 HG13 ' HB2' ' A' ' 90' ' ' GLU . 1.2 mp -78.56 146.51 7.98 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 114.652 -1.158 . . . . 15.0 111.034 -179.58 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.429 ' O ' ' N ' ' A' ' 89' ' ' LEU . 3.4 p90 -140.19 163.87 31.59 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.224 -0.444 . . . . 15.0 110.261 178.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.483 ' HB2' HD11 ' A' ' 88' ' ' LEU . 4.9 pt-20 -130.17 143.24 50.67 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.295 0.569 . . . . 15.0 111.848 -178.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.436 ' CG2' ' HB3' ' A' ' 51' ' ' ARG . 0.2 OUTLIER -101.61 115.34 43.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.23 -0.895 . . . . 15.0 109.696 178.74 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -105.84 72.54 0.96 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.243 -0.435 . . . . 15.0 112.121 -178.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.436 ' HB3' ' HB ' ' A' ' 85' ' ' VAL . 6.3 tp -88.12 165.6 15.0 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.561 -0.533 . . . . 15.0 109.561 178.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -96.13 92.7 6.54 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.993 0.425 . . . . 15.0 111.331 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.528 ' O ' ' HD3' ' A' ' 13' ' ' LYS . 0.1 OUTLIER -56.84 -26.61 58.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.892 -0.595 . . . . 15.0 111.061 179.824 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -83.95 -48.81 9.58 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.238 -0.437 . . . . 15.0 110.776 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -58.48 -38.68 78.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.995 0.426 . . . . 15.0 110.301 179.615 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -165.52 162.76 19.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.841 -0.618 . . . . 15.0 110.671 179.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -86.03 -161.37 0.63 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.432 -0.349 . . . . 15.0 110.292 179.653 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.426 ' N ' ' CD2' ' A' ' 18' ' ' LEU . 1.4 mm? -94.54 -172.29 2.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.914 0.388 . . . . 15.0 110.726 179.556 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.632 ' O ' ' HB ' ' A' ' 41' ' ' ILE . . . -162.84 33.75 0.31 Allowed Glycine 0 N--CA 1.449 -0.465 0 CA-C-N 115.91 -0.586 . . . . 15.0 111.717 -179.678 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.571 HG12 ' O ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -112.72 139.96 35.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 121.131 0.491 . . . . 15.0 112.033 -179.261 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.446 ' O ' ' HB3' ' A' ' 38' ' ' LYS . 43.2 t -96.33 100.96 12.53 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 107.396 -1.335 . . . . 15.0 107.396 176.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.498 HG23 ' CD2' ' A' ' 71' ' ' HIS . 1.1 m -93.62 153.82 3.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 112.769 0.655 . . . . 15.0 112.769 -176.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.468 ' HA ' ' ND1' ' A' ' 71' ' ' HIS . 11.1 t -149.6 -173.48 4.42 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.223 -0.899 . . . . 15.0 110.369 179.317 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.482 ' O ' ' HB2' ' A' ' 71' ' ' HIS . . . 75.88 -113.94 4.05 Favored Glycine 0 C--N 1.33 0.23 0 C-N-CA 120.517 -0.849 . . . . 15.0 112.347 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.574 ' HA3' ' N ' ' A' ' 71' ' ' HIS . . . 63.59 -65.84 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 121.06 -0.591 . . . . 15.0 113.724 179.175 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.434 ' N ' ' O ' ' A' ' 24' ' ' GLY . 0.0 OUTLIER -26.07 139.55 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 N-CA-C 112.51 0.559 . . . . 15.0 112.51 -179.015 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 17.5 m-20 -75.64 61.21 1.33 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.806 -0.634 . . . . 15.0 111.046 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -151.75 -66.49 0.18 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.317 -0.402 . . . . 15.0 111.095 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.8 m -67.79 -34.26 76.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.129 -0.487 . . . . 15.0 111.061 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.432 HG13 ' CD1' ' A' ' 36' ' ' TYR . 21.0 m -85.67 -174.33 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.302 -0.408 . . . . 15.0 111.171 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 8.9 mtp180 -57.78 -61.26 2.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.251 -0.431 . . . . 15.0 111.033 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 11.0 p-80 -143.25 -45.95 0.29 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.253 -0.43 . . . . 15.0 111.018 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -169.18 25.7 0.11 Allowed Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.901 -0.666 . . . . 15.0 112.491 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -90.9 151.31 21.1 Favored Glycine 0 N--CA 1.447 -0.588 0 N-CA-C 110.519 -1.032 . . . . 15.0 110.519 178.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.439 HG13 ' HA ' ' A' ' 71' ' ' HIS . 0.0 OUTLIER -94.74 152.87 3.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 C-N-CA 119.9 -0.72 . . . . 15.0 112.238 -179.112 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.439 ' CZ ' ' HG2' ' A' ' 57' ' ' ARG . 18.9 m-85 -135.29 107.4 7.17 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.652 -1.158 . . . . 15.0 109.364 179.396 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.656 HG21 ' N ' ' A' ' 55' ' ' GLY . 0.8 OUTLIER -55.14 149.42 2.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 116.102 -0.499 . . . . 15.0 111.462 -178.581 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.454 ' O ' ' HG2' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -81.19 -48.03 12.64 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.668 -0.864 . . . . 15.0 108.668 178.266 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.571 ' O ' HG12 ' A' ' 20' ' ' ILE . . . -172.29 170.77 4.99 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 115.757 -0.656 . . . . 15.0 110.234 178.5 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.508 ' HA ' HG12 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -97.18 111.81 27.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.055 0.455 . . . . 15.0 110.344 179.575 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.632 ' HB ' ' O ' ' A' ' 19' ' ' GLY . 0.4 OUTLIER -78.56 109.14 9.58 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 115.74 -0.663 . . . . 15.0 112.238 -178.428 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.473 ' HA ' ' CG ' ' A' ' 47' ' ' GLU . 30.2 Cg_endo -63.12 65.54 0.16 Allowed 'Trans proline' 0 C--N 1.356 0.944 0 C-N-CA 123.192 2.595 . . . . 15.0 112.591 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 42.2 tt0 -147.44 -53.37 0.21 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.392 -0.822 . . . . 15.0 109.317 179.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.533 ' HA3' ' HA3' ' A' ' 19' ' ' GLY . . . -88.02 157.32 28.21 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.684 -0.769 . . . . 15.0 112.528 179.147 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -41.73 -16.73 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 113.51 0.93 . . . . 15.0 113.51 -179.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.442 ' N ' ' O ' ' A' ' 44' ' ' GLY . . . -71.5 -71.38 0.27 Allowed 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.768 -0.373 . . . . 15.0 111.159 -179.464 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.492 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 4.3 tp10 -58.59 -40.51 83.39 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-O 120.958 0.409 . . . . 15.0 110.312 179.364 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.7 t -55.51 -63.98 0.99 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.976 -0.556 . . . . 15.0 110.278 179.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.419 ' CB ' HD13 ' A' ' 11' ' ' LEU . 5.6 t0 -62.69 -39.08 92.88 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.146 0.498 . . . . 15.0 109.89 179.053 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.55 36.81 18.95 Favored Glycine 0 N--CA 1.448 -0.512 0 CA-C-N 115.58 -0.736 . . . . 15.0 112.651 179.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.436 ' HB3' ' CG2' ' A' ' 9' ' ' VAL . 1.7 mmt85 -83.69 -53.44 5.64 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.928 0.394 . . . . 15.0 110.607 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.455 HG21 ' CG1' ' A' ' 40' ' ' VAL . 11.0 tp -81.15 157.85 4.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.977 -0.556 . . . . 15.0 110.183 179.581 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . 0.434 ' O ' HG21 ' A' ' 37' ' ' VAL . 53.1 m80 -139.75 160.37 40.03 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-O 121.832 0.825 . . . . 15.0 113.097 -178.554 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.561 ' HA ' ' CG2' ' A' ' 37' ' ' VAL . 1.0 OUTLIER -45.28 135.13 6.08 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 113.821 -1.536 . . . . 15.0 112.742 -178.865 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.656 ' N ' HG21 ' A' ' 37' ' ' VAL . . . 49.69 32.75 17.67 Favored Glycine 0 C--N 1.335 0.499 0 CA-C-N 116.031 -0.531 . . . . 15.0 113.116 179.146 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.441 ' HB2' HG12 ' A' ' 37' ' ' VAL . 3.5 m-20 -65.72 130.65 44.02 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.95 -0.3 . . . . 15.0 110.821 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.439 ' HG2' ' CZ ' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -84.4 86.37 7.28 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.11 -0.495 . . . . 15.0 110.345 179.579 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.477 ' HA ' HD22 ' A' ' 89' ' ' LEU . 1.5 m -79.39 113.44 18.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 CA-C-N 116.162 -0.472 . . . . 15.0 111.17 -179.466 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.427 ' CD2' ' CD ' ' A' ' 57' ' ' ARG . 19.2 mt -107.26 -13.06 15.22 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.819 -0.628 . . . . 15.0 112.41 -179.332 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.435 ' CB ' HD22 ' A' ' 88' ' ' LEU . . . -150.62 147.35 27.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.192 0.52 . . . . 15.0 112.313 -178.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.456 ' HB ' ' CG1' ' A' ' 64' ' ' VAL . 60.6 t -138.72 102.88 1.97 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.275 0 CA-C-N 115.484 -0.78 . . . . 15.0 109.047 178.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 64.94 16.32 10.46 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.71 -0.478 . . . . 15.0 109.71 -178.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 105.32 5.17 40.4 Favored Glycine 0 C--N 1.337 0.617 0 CA-C-N 115.82 -0.627 . . . . 15.0 113.23 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.492 ' O ' ' CG1' ' A' ' 64' ' ' VAL . 6.7 p -93.85 107.53 19.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.006 0.432 . . . . 15.0 111.046 179.6 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.2 m -55.8 133.08 50.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.269 -0.423 . . . . 15.0 111.083 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -91.59 -21.68 20.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.001 -0.545 . . . . 15.0 111.026 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -43.85 97.41 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 120.905 0.383 . . . . 15.0 110.978 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.85 64.26 0.56 Allowed Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.866 -0.683 . . . . 15.0 112.058 -179.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -172.98 135.68 0.62 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.895 0.379 . . . . 15.0 110.982 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.423 ' HA ' ' N ' ' A' ' 26' ' ' VAL . 10.2 p -72.9 -171.45 0.87 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.112 0.482 . . . . 15.0 111.31 -179.66 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.574 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 0.4 OUTLIER -58.33 -63.08 1.4 Allowed 'General case' 0 CA--C 1.517 -0.315 0 CA-C-N 115.721 -0.672 . . . . 15.0 109.814 179.812 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 13.5 ttpp -53.23 -36.12 60.71 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.316 -0.856 . . . . 15.0 110.574 179.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 5.8 mt-30 -59.32 -50.75 72.79 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 116.149 -0.478 . . . . 15.0 109.715 179.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.534 ' HA ' ' HG1' ' A' ' 77' ' ' THR . . . -66.96 -47.39 71.75 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.059 -0.519 . . . . 15.0 109.665 178.495 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.416 HG22 HG21 ' A' ' 22' ' ' VAL . 0.5 OUTLIER -40.84 -41.19 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.23 0 CA-C-N 115.522 -0.763 . . . . 15.0 109.472 178.643 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.402 ' O ' ' HB2' ' A' ' 80' ' ' ASN . 14.8 mt-10 -67.18 -46.05 75.1 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 114.884 -1.053 . . . . 15.0 110.781 179.092 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.534 ' HG1' ' HA ' ' A' ' 74' ' ' ALA . 2.5 p -64.6 -53.28 50.17 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 120.79 -0.364 . . . . 15.0 111.529 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.405 ' HA ' HG12 ' A' ' 61' ' ' VAL . 3.8 mt -53.4 -48.41 68.71 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-O 121.185 0.517 . . . . 15.0 110.07 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 4.1 ttt85 -68.46 -57.4 5.89 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.575 -0.739 . . . . 15.0 110.492 179.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.402 ' HB2' ' O ' ' A' ' 76' ' ' GLU . 63.3 m-20 -66.0 62.77 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.879 -0.6 . . . . 15.0 111.948 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.453 ' HB ' ' HG3' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -95.37 -71.71 0.66 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.769 0.318 . . . . 15.0 110.22 179.221 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 122.04 -104.05 0.89 Allowed Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.744 -0.741 . . . . 15.0 113.185 179.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.402 ' O ' ' HB3' ' A' ' 13' ' ' LYS . 0.4 OUTLIER -64.59 -84.49 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 111.975 0.361 . . . . 15.0 111.975 -179.072 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.431 HG13 ' N ' ' A' ' 85' ' ' VAL . 74.1 t -109.65 160.17 8.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.873 0.368 . . . . 15.0 110.897 -179.528 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.436 ' HB ' ' HB3' ' A' ' 11' ' ' LEU . 12.9 t -97.83 81.23 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.118 0.485 . . . . 15.0 110.56 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -101.15 84.69 2.69 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.778 -0.646 . . . . 15.0 110.429 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.45 ' HG ' ' HA ' ' A' ' 61' ' ' VAL . 0.1 OUTLIER -103.19 121.06 41.89 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.06 -0.518 . . . . 15.0 111.743 -179.226 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.483 HD11 ' HB2' ' A' ' 8' ' ' GLU . 0.2 OUTLIER -97.52 101.53 13.08 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.374 -0.602 . . . . 15.0 109.374 178.636 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.477 HD22 ' HA ' ' A' ' 58' ' ' VAL . 0.1 OUTLIER -105.89 -161.89 0.83 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.598 0.713 . . . . 15.0 112.347 -178.451 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.459 ' HB2' HG13 ' A' ' 6' ' ' ILE . 3.4 tt0 -142.17 132.66 25.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 114.609 -1.178 . . . . 15.0 109.059 178.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.475 ' HG2' ' HG2' ' A' ' 3' ' ' PRO . 0.0 OUTLIER -49.54 100.13 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.003 0.43 . . . . 15.0 111.19 -179.393 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -65.36 -129.74 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.404 0 CA-C-N 115.766 -0.652 . . . . 15.0 112.703 -179.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -76.15 111.65 11.78 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.834 0.349 . . . . 15.0 110.951 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -74.74 152.52 87.1 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.172 -0.467 . . . . 15.0 110.906 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_exo -51.28 175.52 0.05 OUTLIER 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.607 2.205 . . . . 15.0 112.295 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 3.5 t . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.209 -0.901 . . . . 15.0 110.85 -179.969 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_endo . . . . . 0 N--CA 1.488 1.192 0 CA-C-O 120.861 0.275 . . . . 15.0 111.778 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.97 66.94 9.86 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.162 -0.472 . . . . 15.0 110.827 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -65.09 -169.31 0.13 Allowed 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.411 2.074 . . . . 15.0 112.51 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 86.09 -19.8 24.39 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.768 -0.729 . . . . 15.0 112.003 -179.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -72.55 162.8 29.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.293 0.568 . . . . 15.0 111.04 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.42 HG13 ' HB2' ' A' ' 90' ' ' GLU . 1.4 mp -104.39 144.08 15.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.185 -0.916 . . . . 15.0 110.883 -179.655 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.463 ' O ' ' N ' ' A' ' 89' ' ' LEU . 4.2 p90 -140.61 165.74 26.64 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.378 -0.374 . . . . 15.0 110.446 178.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.477 ' CB ' HD11 ' A' ' 88' ' ' LEU . 10.7 pt-20 -130.11 143.09 50.59 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.295 0.569 . . . . 15.0 111.55 -179.32 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.434 ' CG2' ' HB3' ' A' ' 51' ' ' ARG . 0.2 OUTLIER -101.54 115.44 43.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.203 -0.908 . . . . 15.0 109.548 178.84 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -106.0 72.28 0.94 Allowed 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.193 0.442 . . . . 15.0 112.193 -178.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.412 ' O ' HG11 ' A' ' 84' ' ' VAL . 5.8 tp -88.33 166.55 14.21 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 109.685 -0.487 . . . . 15.0 109.685 178.636 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -95.73 95.31 8.23 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.006 0.431 . . . . 15.0 111.167 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.521 ' O ' ' HD3' ' A' ' 13' ' ' LYS . 0.2 OUTLIER -58.64 -26.3 63.6 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.803 -0.635 . . . . 15.0 111.225 -179.972 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -83.95 -49.44 8.97 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.373 -0.376 . . . . 15.0 111.045 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -56.06 -41.52 75.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.972 0.415 . . . . 15.0 110.453 179.616 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -165.57 159.25 16.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.842 -0.617 . . . . 15.0 110.632 179.717 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.438 ' O ' ' CB ' ' A' ' 45' ' ' ALA . 0.6 OUTLIER -85.94 -168.31 2.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.404 -0.362 . . . . 15.0 110.358 179.657 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.414 ' N ' ' CD2' ' A' ' 18' ' ' LEU . 1.0 OUTLIER -96.12 -174.31 3.06 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.931 0.396 . . . . 15.0 110.775 179.539 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.726 ' O ' ' HB ' ' A' ' 41' ' ' ILE . . . -162.38 44.1 0.36 Allowed Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.966 -0.635 . . . . 15.0 111.932 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.637 HG12 ' O ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -112.67 140.27 33.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 120.979 0.419 . . . . 15.0 111.622 -179.571 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.409 ' HB3' HD13 ' A' ' 41' ' ' ILE . 15.5 t -94.59 102.41 14.33 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 107.613 -1.255 . . . . 15.0 107.613 177.415 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.486 HG22 ' CD2' ' A' ' 71' ' ' HIS . 3.8 m -93.63 148.95 4.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 113.212 0.819 . . . . 15.0 113.212 -176.629 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.559 ' O ' ' O ' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -149.62 158.02 43.78 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 115.335 -0.848 . . . . 15.0 111.026 179.996 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.431 ' O ' HG12 ' A' ' 35' ' ' ILE . . . 67.7 116.5 0.02 OUTLIER Glycine 0 N--CA 1.453 -0.182 0 C-N-CA 120.589 -0.815 . . . . 15.0 113.421 178.664 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.512 ' HA3' ' N ' ' A' ' 71' ' ' HIS . . . -164.65 -39.05 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.964 -0.636 . . . . 15.0 112.501 179.225 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.474 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 0.2 OUTLIER -39.86 160.09 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-O 120.803 0.335 . . . . 15.0 111.736 179.791 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -85.45 52.18 2.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.314 -0.403 . . . . 15.0 111.024 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -151.8 -63.03 0.17 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.156 -0.475 . . . . 15.0 110.767 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.83 -51.8 51.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.216 -0.447 . . . . 15.0 110.689 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 17.7 m -88.06 -177.8 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.107 -0.497 . . . . 15.0 110.76 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.41 ' O ' ' N ' ' A' ' 33' ' ' GLY . 0.2 OUTLIER -85.48 134.28 34.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.974 0.416 . . . . 15.0 111.062 -179.926 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 54.26 -85.42 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.657 -0.701 . . . . 15.0 111.578 179.635 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 31' ' ' ARG . . . -172.46 31.78 0.12 Allowed Glycine 0 C--N 1.331 0.272 0 C-N-CA 120.977 -0.63 . . . . 15.0 112.196 -179.498 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -95.25 158.67 22.37 Favored Glycine 0 N--CA 1.449 -0.446 0 N-CA-C 110.807 -0.917 . . . . 15.0 110.807 179.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.492 HG22 HD12 ' A' ' 35' ' ' ILE . 0.1 OUTLIER -98.31 154.99 3.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 C-N-CA 119.996 -0.682 . . . . 15.0 111.993 -179.355 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.559 ' O ' ' O ' ' A' ' 23' ' ' THR . 14.1 m-85 -135.16 108.94 8.04 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.365 -0.834 . . . . 15.0 109.767 179.498 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.639 HG21 ' N ' ' A' ' 55' ' ' GLY . 0.8 OUTLIER -54.8 149.54 2.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 121.262 0.553 . . . . 15.0 111.626 -178.45 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.485 ' O ' ' HG2' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -80.17 -47.46 14.67 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.32 -0.992 . . . . 15.0 108.32 178.516 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.637 ' O ' HG12 ' A' ' 20' ' ' ILE . . . -172.51 174.16 3.86 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.349 -0.841 . . . . 15.0 110.114 178.614 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.522 ' HA ' HG12 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -96.81 110.09 24.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 108.938 -0.764 . . . . 15.0 108.938 178.741 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.726 ' HB ' ' O ' ' A' ' 19' ' ' GLY . 0.7 OUTLIER -78.12 116.43 58.75 Favored Pre-proline 0 C--N 1.328 -0.365 0 N-CA-C 113.488 0.922 . . . . 15.0 113.488 -176.916 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.537 ' HA ' ' CG ' ' A' ' 47' ' ' GLU . 39.1 Cg_exo -61.33 61.39 0.1 Allowed 'Trans proline' 0 C--N 1.358 1.074 0 C-N-CA 123.752 2.968 . . . . 15.0 112.969 179.725 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.525 ' H ' ' HG2' ' A' ' 47' ' ' GLU . 2.9 mm-40 -149.83 -48.63 0.13 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.619 0.247 . . . . 15.0 111.554 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.71 ' HA3' ' HA3' ' A' ' 19' ' ' GLY . . . -87.79 168.69 37.95 Favored Glycine 0 CA--C 1.517 0.195 0 C-N-CA 120.362 -0.923 . . . . 15.0 113.905 -179.116 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.438 ' CB ' ' O ' ' A' ' 17' ' ' SER . . . -57.72 -12.35 2.89 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.549 0.574 . . . . 15.0 112.549 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.78 -58.5 3.41 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.854 0.359 . . . . 15.0 110.435 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.537 ' CG ' ' HA ' ' A' ' 42' ' ' PRO . 2.9 pp20? -57.67 -43.43 85.02 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.686 -0.688 . . . . 15.0 110.473 179.159 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -53.78 -71.31 0.08 Allowed 'General case' 0 CA--C 1.519 -0.225 0 CA-C-N 115.87 -0.604 . . . . 15.0 110.581 -179.398 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.405 ' CB ' HD13 ' A' ' 11' ' ' LEU . 0.7 OUTLIER -58.13 -41.24 83.22 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.141 -0.688 . . . . 15.0 109.141 178.778 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.79 39.57 13.61 Favored Glycine 0 N--CA 1.445 -0.702 0 CA-C-N 115.319 -0.855 . . . . 15.0 111.665 179.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.434 ' HB3' ' CG2' ' A' ' 9' ' ' VAL . 0.8 OUTLIER -79.72 -49.44 12.07 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.873 0.368 . . . . 15.0 110.573 -179.3 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.414 ' CD1' HD12 ' A' ' 89' ' ' LEU . 9.3 tp -81.01 160.6 3.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 116.037 -0.528 . . . . 15.0 110.181 179.411 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . 0.48 ' O ' ' HB2' ' A' ' 56' ' ' ASP . 63.5 m80 -144.31 158.68 43.61 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-O 121.644 0.735 . . . . 15.0 112.146 -179.13 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.522 ' HA ' ' CG2' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -43.81 134.01 4.57 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.437 -1.256 . . . . 15.0 112.607 -178.734 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.639 ' N ' HG21 ' A' ' 37' ' ' VAL . . . 49.98 34.34 23.1 Favored Glycine 0 C--N 1.333 0.394 0 CA-C-N 115.827 -0.624 . . . . 15.0 113.44 179.397 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.49 ' HB2' HG12 ' A' ' 37' ' ' VAL . 0.4 OUTLIER -65.99 130.37 43.01 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.584 -0.446 . . . . 15.0 110.561 179.481 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.427 ' HG3' ' CZ ' ' A' ' 36' ' ' TYR . 39.0 ttt180 -84.58 87.65 7.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.175 -0.466 . . . . 15.0 110.12 179.502 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.466 ' O ' ' CG2' ' A' ' 58' ' ' VAL . 1.5 m -79.26 113.01 18.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 CA-C-O 121.187 0.518 . . . . 15.0 111.032 -179.413 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 23.7 mt -107.34 -11.77 15.48 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 115.424 -0.807 . . . . 15.0 112.304 -179.179 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.401 ' CB ' ' HB2' ' A' ' 88' ' ' LEU . . . -150.81 144.48 25.1 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.165 0.507 . . . . 15.0 112.323 -178.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.438 HG22 HD23 ' A' ' 87' ' ' LEU . 14.8 t -139.24 102.21 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.487 -0.779 . . . . 15.0 109.569 178.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.408 ' ND2' ' CG2' ' A' ' 81' ' ' THR . 1.7 m-80 64.71 15.39 9.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.017 0.437 . . . . 15.0 109.83 -178.377 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 107.15 6.03 34.43 Favored Glycine 0 C--N 1.336 0.554 0 CA-C-N 115.903 -0.589 . . . . 15.0 113.409 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.498 ' O ' ' CG1' ' A' ' 64' ' ' VAL . 6.4 p -93.77 105.41 16.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 117.213 0.506 . . . . 15.0 110.907 179.413 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -58.76 127.91 34.57 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.099 -0.501 . . . . 15.0 110.986 -179.692 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -87.66 -20.01 26.89 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.029 -0.532 . . . . 15.0 110.864 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -47.77 97.91 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.896 0.379 . . . . 15.0 110.768 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.8 64.48 0.56 Allowed Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.738 -0.744 . . . . 15.0 112.022 -179.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.427 ' HB3' ' HB3' ' A' ' 73' ' ' GLN . . . -172.68 166.76 5.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.882 0.373 . . . . 15.0 110.949 -179.655 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.474 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 11.5 p -93.38 -174.42 3.51 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.064 0.459 . . . . 15.0 111.506 -179.461 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.512 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 0.0 OUTLIER -62.95 -60.36 3.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.745 -0.661 . . . . 15.0 110.51 -179.862 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.438 ' O ' ' HG3' ' A' ' 76' ' ' GLU . 8.3 ttpp -52.37 -29.5 24.25 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.88 -0.6 . . . . 15.0 110.343 179.511 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.427 ' HB3' ' HB3' ' A' ' 69' ' ' ALA . 0.4 OUTLIER -59.31 -50.24 74.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.138 -0.483 . . . . 15.0 109.842 179.371 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.47 ' O ' ' N ' ' A' ' 77' ' ' THR . . . -67.09 -47.46 71.16 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 109.597 -0.52 . . . . 15.0 109.597 178.572 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.415 HG22 ' CG2' ' A' ' 22' ' ' VAL . 0.5 OUTLIER -41.44 -41.05 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.251 0 N-CA-C 108.95 -0.759 . . . . 15.0 108.95 178.202 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.45 ' O ' ' N ' ' A' ' 80' ' ' ASN . 62.0 mt-10 -67.64 -46.49 72.33 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 114.711 -1.131 . . . . 15.0 110.317 178.434 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.47 ' N ' ' O ' ' A' ' 74' ' ' ALA . 32.6 p -64.34 -51.4 63.59 Favored 'General case' 0 C--O 1.231 0.119 0 C-N-CA 120.851 -0.34 . . . . 15.0 111.193 179.708 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.449 ' HG ' ' O ' ' A' ' 74' ' ' ALA . 5.3 mt -53.67 -50.55 65.57 Favored 'General case' 0 CA--C 1.521 -0.168 0 CA-C-O 121.249 0.547 . . . . 15.0 109.801 179.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 21.8 ttt180 -68.46 -61.9 1.63 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.31 -0.859 . . . . 15.0 110.472 179.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.45 ' N ' ' O ' ' A' ' 76' ' ' GLU . 9.5 m-20 -66.04 61.68 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.878 -0.601 . . . . 15.0 111.997 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.423 ' HB ' ' HG3' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -94.16 -67.18 0.87 Allowed 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 110.062 -0.348 . . . . 15.0 110.062 179.193 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 122.28 -108.96 1.34 Allowed Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.864 -0.684 . . . . 15.0 113.118 179.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -65.39 -79.17 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.772 0.32 . . . . 15.0 111.696 -179.157 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.429 HG13 ' N ' ' A' ' 85' ' ' VAL . 63.8 t -109.94 159.2 9.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.023 0.44 . . . . 15.0 111.034 -179.337 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.44 ' O ' ' CG1' ' A' ' 85' ' ' VAL . 9.4 t -97.86 81.26 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.095 -0.502 . . . . 15.0 110.402 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -100.78 85.0 2.8 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.748 -0.66 . . . . 15.0 110.28 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.454 ' CD2' ' CD2' ' A' ' 89' ' ' LEU . 0.1 OUTLIER -103.32 119.61 39.21 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.009 -0.541 . . . . 15.0 111.893 -179.003 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.477 HD11 ' CB ' ' A' ' 8' ' ' GLU . 4.6 mp -94.59 101.64 13.52 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.451 -0.574 . . . . 15.0 109.451 178.564 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.463 ' N ' ' O ' ' A' ' 7' ' ' PHE . 0.2 OUTLIER -105.64 -163.48 0.94 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.346 0.594 . . . . 15.0 111.982 -178.55 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.42 ' HB2' HG13 ' A' ' 6' ' ' ILE . 2.6 tt0 -140.97 131.77 25.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.01 -0.996 . . . . 15.0 109.796 179.143 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.62 94.92 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.863 0.363 . . . . 15.0 111.122 -179.63 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -63.71 164.03 31.57 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.945 -0.645 . . . . 15.0 112.729 -179.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 8.4 mm100 -86.31 122.3 30.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.825 0.345 . . . . 15.0 110.747 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 36.4 m -89.59 144.01 31.33 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.22 -0.445 . . . . 15.0 110.87 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -52.81 -62.07 0.4 Allowed 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.533 2.155 . . . . 15.0 112.271 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 7.7 p . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.262 -0.875 . . . . 15.0 110.833 -179.988 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo . . . . . 0 N--CA 1.487 1.127 0 CA-C-O 120.839 0.266 . . . . 15.0 111.871 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.509 ' HB3' ' HD3' ' A' ' 3' ' ' PRO . 1.5 tttm -155.19 -63.14 0.02 OUTLIER Pre-proline 0 CA--C 1.534 0.327 0 CA-C-N 116.168 -0.469 . . . . 15.0 110.851 -179.781 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.509 ' HD3' ' HB3' ' A' ' 2' ' ' LYS . 74.1 Cg_exo -41.58 109.82 0.12 Allowed 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.694 2.262 . . . . 15.0 113.107 179.769 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 83.11 -23.46 6.04 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.433 -0.889 . . . . 15.0 112.728 179.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.409 ' HB2' ' O ' ' A' ' 2' ' ' LYS . 0.7 OUTLIER -61.56 150.8 34.97 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-O 121.473 0.654 . . . . 15.0 110.823 -179.921 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.472 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 1.4 mp -89.62 149.7 3.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 114.949 -1.023 . . . . 15.0 111.529 -178.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.427 ' O ' ' N ' ' A' ' 89' ' ' LEU . 7.6 p90 -144.71 164.22 31.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.913 -0.585 . . . . 15.0 110.048 178.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.472 ' HB2' HD11 ' A' ' 88' ' ' LEU . 5.6 pt-20 -130.26 142.54 50.55 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.369 0.604 . . . . 15.0 111.907 -179.289 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.431 ' CG2' ' HB3' ' A' ' 51' ' ' ARG . 0.2 OUTLIER -101.65 114.4 40.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.117 -0.947 . . . . 15.0 109.638 178.85 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -106.15 72.74 0.95 Allowed 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 112.351 0.501 . . . . 15.0 112.351 -178.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.446 ' CD1' ' HG3' ' A' ' 51' ' ' ARG . 6.0 tp -88.36 165.91 14.63 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.668 -0.493 . . . . 15.0 109.668 178.609 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -96.15 94.43 7.52 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.003 0.43 . . . . 15.0 111.149 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.485 ' HG3' ' HB ' ' A' ' 81' ' ' THR . 0.1 OUTLIER -60.18 -30.84 69.61 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.764 -0.653 . . . . 15.0 111.315 -179.927 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.403 ' N ' ' O ' ' A' ' 83' ' ' GLN . 1.5 t30 -84.44 -30.48 25.26 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.322 -0.399 . . . . 15.0 110.964 -179.616 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -78.0 -36.59 48.62 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.013 0.435 . . . . 15.0 110.12 179.255 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.4 ' HB3' ' CB ' ' A' ' 45' ' ' ALA . 1.1 m-20 -165.49 156.71 14.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.806 -0.634 . . . . 15.0 110.625 179.634 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.442 ' O ' ' CB ' ' A' ' 45' ' ' ALA . 0.3 OUTLIER -86.02 -158.27 0.39 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.353 -0.385 . . . . 15.0 110.297 179.695 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.426 ' N ' ' CD2' ' A' ' 18' ' ' LEU . 0.4 OUTLIER -109.66 -166.14 1.07 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.813 0.34 . . . . 15.0 110.689 179.603 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.767 ' O ' ' HB ' ' A' ' 41' ' ' ILE . . . -173.2 44.68 0.16 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.921 -0.657 . . . . 15.0 111.913 -179.747 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.718 HG12 ' O ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -112.61 137.29 46.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 120.996 0.427 . . . . 15.0 111.579 -179.611 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.404 ' HB3' HD13 ' A' ' 41' ' ' ILE . 29.1 t -88.86 105.5 17.78 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 107.865 -1.161 . . . . 15.0 107.865 177.516 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.447 HG11 ' CG2' ' A' ' 20' ' ' ILE . 34.8 m -93.37 152.5 3.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 112.618 0.599 . . . . 15.0 112.618 -177.155 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.424 ' OG1' ' CB ' ' A' ' 38' ' ' LYS . 0.8 OUTLIER -149.14 -178.62 6.48 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.245 -0.889 . . . . 15.0 110.807 -179.565 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.403 ' O ' ' HB3' ' A' ' 71' ' ' HIS . . . 70.16 -119.36 8.67 Favored Glycine 0 C--N 1.333 0.372 0 C-N-CA 120.856 -0.688 . . . . 15.0 112.421 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.51 ' HA3' ' N ' ' A' ' 71' ' ' HIS . . . 66.61 -65.62 0.17 Allowed Glycine 0 C--N 1.331 0.259 0 C-N-CA 121.013 -0.613 . . . . 15.0 113.61 179.402 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.447 ' HA ' ' CB ' ' A' ' 70' ' ' THR . 0.0 OUTLIER -28.14 140.33 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 N-CA-C 112.457 0.54 . . . . 15.0 112.457 -179.353 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.408 ' HA ' ' O ' ' A' ' 32' ' ' HIS . 59.5 t-20 -77.33 58.07 1.59 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.904 -0.589 . . . . 15.0 111.075 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.0 m -151.83 -48.28 0.11 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.283 -0.417 . . . . 15.0 110.935 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 21.6 m -83.2 -46.68 12.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 15.0 111.053 -179.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.427 HG13 ' CD1' ' A' ' 36' ' ' TYR . 33.2 m -69.95 -174.62 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.262 -0.426 . . . . 15.0 111.169 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 10.0 mmp_? -67.59 -44.85 77.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.242 -0.436 . . . . 15.0 111.052 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . 0.408 ' O ' ' HA ' ' A' ' 27' ' ' ASN . 43.3 m80 -143.28 -68.41 0.34 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.306 -0.406 . . . . 15.0 111.004 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -161.43 19.52 0.19 Allowed Glycine 0 CA--C 1.517 0.189 0 C-N-CA 120.892 -0.671 . . . . 15.0 112.559 -179.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -83.64 150.67 27.06 Favored Glycine 0 N--CA 1.449 -0.493 0 N-CA-C 110.767 -0.933 . . . . 15.0 110.767 178.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.48 HG21 HG22 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -85.79 154.94 3.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 C-N-CA 120.031 -0.667 . . . . 15.0 111.745 -179.294 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.509 ' CE2' ' HG2' ' A' ' 57' ' ' ARG . 30.4 m-85 -139.2 106.8 5.59 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.041 -0.981 . . . . 15.0 109.736 178.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.651 HG21 ' N ' ' A' ' 55' ' ' GLY . 0.7 OUTLIER -55.17 146.11 4.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 116.041 -0.527 . . . . 15.0 111.025 -179.072 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.458 ' HG3' ' N ' ' A' ' 39' ' ' ALA . 0.2 OUTLIER -80.23 -46.24 16.61 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.502 -0.925 . . . . 15.0 108.502 178.616 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.718 ' O ' HG12 ' A' ' 20' ' ' ILE . . . -172.07 171.45 4.97 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 115.764 -0.653 . . . . 15.0 110.242 178.471 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.536 ' HA ' ' CG1' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -96.63 109.49 23.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 109.118 -0.697 . . . . 15.0 109.118 179.135 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.767 ' HB ' ' O ' ' A' ' 19' ' ' GLY . 0.5 OUTLIER -78.16 118.31 71.43 Favored Pre-proline 0 C--N 1.326 -0.44 0 N-CA-C 113.261 0.837 . . . . 15.0 113.261 -177.106 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.555 ' HA ' ' CG ' ' A' ' 47' ' ' GLU . 36.9 Cg_endo -64.71 60.46 0.28 Allowed 'Trans proline' 0 C--N 1.357 0.992 0 C-N-CA 123.539 2.826 . . . . 15.0 112.793 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.499 ' N ' ' HG2' ' A' ' 47' ' ' GLU . 11.2 tt0 -147.41 -46.75 0.17 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.52 -0.309 . . . . 15.0 111.244 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.757 ' HA3' ' HA3' ' A' ' 19' ' ' GLY . . . -87.87 169.33 38.53 Favored Glycine 0 C--N 1.33 0.229 0 C-N-CA 120.36 -0.924 . . . . 15.0 113.851 -179.285 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.442 ' CB ' ' O ' ' A' ' 17' ' ' SER . . . -59.36 -13.3 7.81 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.465 0.542 . . . . 15.0 112.465 -179.783 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.94 -56.15 6.2 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.934 -0.306 . . . . 15.0 110.578 -179.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.585 ' HG3' ' O ' ' A' ' 44' ' ' GLY . 2.8 pp20? -57.61 -43.89 85.08 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 115.988 -0.551 . . . . 15.0 110.354 179.001 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 50.1 m -53.84 -70.55 0.09 Allowed 'General case' 0 CA--C 1.519 -0.225 0 CA-C-N 115.825 -0.625 . . . . 15.0 110.583 -179.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -58.1 -41.24 83.08 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.058 -0.719 . . . . 15.0 109.058 178.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.63 39.06 15.07 Favored Glycine 0 N--CA 1.446 -0.672 0 CA-C-N 115.295 -0.866 . . . . 15.0 111.771 179.285 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.446 ' HG3' ' CD1' ' A' ' 11' ' ' LEU . 0.5 OUTLIER -79.67 -51.05 9.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.976 0.417 . . . . 15.0 110.571 -179.388 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.423 ' CD1' HD12 ' A' ' 89' ' ' LEU . 10.8 tp -81.12 158.36 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 CA-C-N 115.93 -0.577 . . . . 15.0 110.106 179.465 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . 0.472 ' O ' HG21 ' A' ' 37' ' ' VAL . 80.4 m80 -145.54 159.27 43.36 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-O 121.591 0.71 . . . . 15.0 112.36 -178.812 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.535 ' HA ' ' CG2' ' A' ' 37' ' ' VAL . 5.0 mtpt -42.13 132.63 3.24 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.213 -1.358 . . . . 15.0 113.01 -178.595 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.651 ' N ' HG21 ' A' ' 37' ' ' VAL . . . 49.9 31.28 16.9 Favored Glycine 0 C--N 1.334 0.455 0 CA-C-N 115.697 -0.683 . . . . 15.0 113.279 179.187 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.453 ' OD2' ' N ' ' A' ' 53' ' ' HIS . 6.2 m-20 -65.7 129.39 39.6 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.726 -0.39 . . . . 15.0 110.526 179.531 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.509 ' HG2' ' CE2' ' A' ' 36' ' ' TYR . 0.5 OUTLIER -82.57 95.96 7.92 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.222 -0.445 . . . . 15.0 110.677 -179.921 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.48 HG22 HG21 ' A' ' 35' ' ' ILE . 1.4 m -86.63 117.06 30.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 CA-C-O 120.927 0.394 . . . . 15.0 110.873 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.405 ' CD2' ' N ' ' A' ' 59' ' ' LEU . 3.1 mm? -107.0 -17.0 14.3 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.915 -0.584 . . . . 15.0 112.482 -179.064 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.432 ' CB ' HD22 ' A' ' 88' ' ' LEU . . . -149.05 148.73 30.05 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.199 0.524 . . . . 15.0 112.411 -178.83 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.437 ' HA ' ' HG ' ' A' ' 87' ' ' LEU . 17.5 t -139.13 101.36 1.55 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.26 0 CA-C-N 115.446 -0.797 . . . . 15.0 109.409 178.853 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.405 ' ND2' ' CG2' ' A' ' 81' ' ' THR . 1.6 m-80 64.79 15.5 9.86 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.658 -0.497 . . . . 15.0 109.658 -178.066 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 107.06 4.82 35.66 Favored Glycine 0 C--N 1.337 0.613 0 CA-C-N 115.832 -0.622 . . . . 15.0 113.331 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.497 ' O ' ' CG1' ' A' ' 64' ' ' VAL . 4.5 p -93.87 107.83 19.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.022 0.439 . . . . 15.0 110.886 179.487 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 67.2 m -56.5 133.7 53.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.21 -0.45 . . . . 15.0 111.079 -179.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.76 -26.23 16.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.016 -0.538 . . . . 15.0 110.902 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 14.3 tt0 -46.03 104.12 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.308 -0.406 . . . . 15.0 111.048 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.75 60.13 0.54 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.79 -0.719 . . . . 15.0 112.464 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -173.04 166.94 5.02 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.959 0.409 . . . . 15.0 111.148 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.447 ' CB ' ' HA ' ' A' ' 26' ' ' VAL . 9.1 p -93.18 -172.3 2.92 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.125 -0.489 . . . . 15.0 111.053 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.51 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 0.0 OUTLIER -63.86 -58.91 5.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.787 -0.642 . . . . 15.0 110.583 179.868 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.43 ' O ' ' HG3' ' A' ' 76' ' ' GLU . 18.0 ttpp -52.59 -34.06 48.95 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.003 -0.544 . . . . 15.0 110.557 179.396 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 9.5 mt-30 -59.36 -49.35 78.16 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.613 -0.514 . . . . 15.0 109.613 179.241 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.441 ' O ' ' N ' ' A' ' 77' ' ' THR . . . -67.06 -44.75 79.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.932 -0.577 . . . . 15.0 109.512 178.431 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.433 ' CG2' ' CG2' ' A' ' 22' ' ' VAL . 0.5 OUTLIER -43.96 -40.88 1.63 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.27 0 N-CA-C 108.797 -0.816 . . . . 15.0 108.797 178.202 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.43 ' HG3' ' O ' ' A' ' 72' ' ' LYS . 9.0 mt-10 -67.42 -44.08 79.64 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 114.744 -1.117 . . . . 15.0 110.19 178.462 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.441 ' N ' ' O ' ' A' ' 74' ' ' ALA . 42.5 p -64.13 -55.48 21.65 Favored 'General case' 0 C--O 1.231 0.131 0 C-N-CA 121.056 -0.258 . . . . 15.0 111.509 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.427 ' CD2' HG21 ' A' ' 61' ' ' VAL . 4.6 mt -53.38 -47.26 69.64 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 121.127 0.489 . . . . 15.0 109.9 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.53 -59.49 3.11 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.518 -0.765 . . . . 15.0 110.529 179.29 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 68.5 m-20 -66.06 60.27 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.931 -0.577 . . . . 15.0 112.154 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.485 ' HB ' ' HG3' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -95.76 -73.02 0.61 Allowed 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 110.127 -0.323 . . . . 15.0 110.127 179.1 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 122.01 -103.71 0.87 Allowed Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.702 -0.761 . . . . 15.0 113.439 179.029 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.403 ' O ' ' N ' ' A' ' 14' ' ' ASN . 0.3 OUTLIER -64.53 -84.43 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 111.965 0.357 . . . . 15.0 111.965 -178.884 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.432 HG13 ' N ' ' A' ' 85' ' ' VAL . 69.9 t -109.72 160.02 8.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.946 0.403 . . . . 15.0 110.873 -179.398 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.436 ' O ' ' CG1' ' A' ' 85' ' ' VAL . 8.7 t -97.81 81.65 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.156 0.503 . . . . 15.0 110.457 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 20.5 t60 -101.13 83.87 2.56 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.72 -0.673 . . . . 15.0 110.33 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.458 ' CD2' ' CD2' ' A' ' 89' ' ' LEU . 0.1 OUTLIER -103.85 115.58 30.72 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.921 -0.581 . . . . 15.0 111.873 -179.115 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.472 HD11 ' HB2' ' A' ' 8' ' ' GLU . 0.2 OUTLIER -92.15 100.49 13.1 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.327 -0.62 . . . . 15.0 109.327 178.573 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.458 ' CD2' ' CD2' ' A' ' 87' ' ' LEU . 0.1 OUTLIER -104.04 -159.46 0.72 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.26 0.553 . . . . 15.0 111.725 -178.658 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.472 ' HA ' ' HA ' ' A' ' 6' ' ' ILE . 5.3 tt0 -140.57 143.7 35.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.35 -0.841 . . . . 15.0 110.32 179.322 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 7.9 tppt? -55.48 105.89 0.21 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.227 -0.442 . . . . 15.0 110.954 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -66.1 150.1 51.72 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.869 -0.681 . . . . 15.0 112.616 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -86.1 124.19 32.24 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.837 0.351 . . . . 15.0 110.857 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.6 m -82.77 163.4 51.64 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.149 -0.478 . . . . 15.0 110.92 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_exo -51.27 -57.61 2.12 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.594 2.196 . . . . 15.0 112.329 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 5.8 p . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.221 -0.895 . . . . 15.0 110.893 179.973 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo . . . . . 0 N--CA 1.488 1.189 0 CA-C-O 120.876 0.282 . . . . 15.0 111.805 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 4.7 mttp -150.75 100.86 3.08 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.45 . . . . 15.0 110.811 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -62.15 -82.95 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.391 2.06 . . . . 15.0 112.422 -179.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 92.91 -34.77 4.36 Favored Glycine 0 C--N 1.332 0.311 0 C-N-CA 120.68 -0.772 . . . . 15.0 112.599 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -62.16 159.09 15.41 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.345 0.593 . . . . 15.0 111.126 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.43 HG13 ' HB2' ' A' ' 90' ' ' GLU . 1.3 mp -104.4 147.31 10.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.195 -0.912 . . . . 15.0 110.944 -179.429 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.446 ' O ' ' N ' ' A' ' 89' ' ' LEU . 2.9 p90 -140.82 164.96 28.82 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.214 -0.448 . . . . 15.0 110.415 178.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.469 ' HB2' HD11 ' A' ' 88' ' ' LEU . 1.9 pt-20 -130.17 143.85 51.02 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.234 0.54 . . . . 15.0 111.6 -179.438 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.474 ' N ' ' O ' ' A' ' 87' ' ' LEU . 0.3 OUTLIER -101.26 114.52 40.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.277 -0.874 . . . . 15.0 109.706 179.111 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -106.04 69.88 0.83 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.076 -0.511 . . . . 15.0 111.772 -179.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.455 ' HB3' ' HB ' ' A' ' 85' ' ' VAL . 8.5 tp -88.19 161.89 16.99 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.006 -0.543 . . . . 15.0 110.316 179.223 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.551 ' C ' ' H ' ' A' ' 14' ' ' ASN . . . -96.69 98.6 10.3 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.537 -0.301 . . . . 15.0 111.151 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.424 ' HB3' ' O ' ' A' ' 83' ' ' GLN . 0.3 OUTLIER -65.38 26.46 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 112.706 0.632 . . . . 15.0 112.706 -179.995 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.551 ' H ' ' C ' ' A' ' 12' ' ' ALA . 15.6 m-20 -112.82 148.15 35.46 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.665 0.269 . . . . 15.0 110.579 179.765 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.431 ' CB ' ' O ' ' A' ' 14' ' ' ASN . 1.0 OUTLIER 82.29 -45.45 0.16 Allowed 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.267 -0.424 . . . . 15.0 111.293 -179.832 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -155.07 156.44 35.87 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.861 0.363 . . . . 15.0 110.819 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -86.07 -159.71 0.49 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.134 -0.484 . . . . 15.0 110.652 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -83.41 -169.37 2.51 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 120.986 0.422 . . . . 15.0 110.74 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.685 ' O ' ' HB ' ' A' ' 41' ' ' ILE . . . -160.8 40.07 0.43 Allowed Glycine 0 N--CA 1.448 -0.532 0 N-CA-C 111.439 -0.664 . . . . 15.0 111.439 -179.818 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.649 HG12 ' O ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -112.7 139.08 39.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 120.907 0.384 . . . . 15.0 111.876 -179.227 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.402 ' HB3' HD13 ' A' ' 41' ' ' ILE . 30.3 t -96.03 104.96 16.93 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 107.924 -1.139 . . . . 15.0 107.924 177.371 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.472 HG22 ' CD2' ' A' ' 71' ' ' HIS . 32.6 m -93.63 156.84 3.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 113.09 0.774 . . . . 15.0 113.09 -177.091 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.31 -175.03 4.83 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.128 -0.942 . . . . 15.0 110.703 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.422 ' O ' ' HB3' ' A' ' 71' ' ' HIS . . . 68.71 -119.52 10.09 Favored Glycine 0 C--N 1.332 0.309 0 C-N-CA 120.831 -0.699 . . . . 15.0 112.542 179.794 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.519 ' HA3' ' N ' ' A' ' 71' ' ' HIS . . . 67.1 -66.65 0.21 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.922 -0.656 . . . . 15.0 113.336 179.563 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -32.62 142.48 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 N-CA-C 112.063 0.394 . . . . 15.0 112.063 -179.492 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -75.63 59.6 1.17 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.065 -0.516 . . . . 15.0 110.857 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.5 m -151.6 -66.3 0.18 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.231 -0.44 . . . . 15.0 110.566 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 29.5 t -65.44 -51.25 61.51 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.111 -0.495 . . . . 15.0 110.424 179.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 27.0 m -88.07 -175.35 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.02 -0.536 . . . . 15.0 110.689 179.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 38.1 ttm180 -90.4 137.63 32.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.969 0.414 . . . . 15.0 111.096 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 42.1 m170 55.53 -86.36 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.756 -0.656 . . . . 15.0 111.345 179.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.411 ' O ' ' O ' ' A' ' 69' ' ' ALA . . . -171.94 27.79 0.1 OUTLIER Glycine 0 C--N 1.33 0.24 0 C-N-CA 120.922 -0.656 . . . . 15.0 112.48 -179.709 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -81.7 151.79 31.13 Favored Glycine 0 N--CA 1.451 -0.363 0 N-CA-C 110.857 -0.897 . . . . 15.0 110.857 179.029 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.47 HG21 HG22 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -88.94 154.1 3.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 119.99 -0.684 . . . . 15.0 111.704 -179.346 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.466 ' CZ ' ' HG2' ' A' ' 57' ' ' ARG . 29.4 m-85 -141.73 107.52 5.13 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.154 -0.93 . . . . 15.0 110.008 179.114 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.652 HG21 ' N ' ' A' ' 55' ' ' GLY . 0.7 OUTLIER -55.81 153.16 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.191 0.52 . . . . 15.0 111.295 -179.131 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.504 ' O ' ' HG2' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -85.72 -48.33 8.93 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.379 -0.971 . . . . 15.0 108.379 178.33 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.649 ' O ' HG12 ' A' ' 20' ' ' ILE . . . -172.39 173.78 4.04 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 115.354 -0.839 . . . . 15.0 110.145 178.722 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.575 ' HA ' HG12 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -96.97 112.16 28.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 109.436 -0.579 . . . . 15.0 109.436 179.125 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.685 ' HB ' ' O ' ' A' ' 19' ' ' GLY . 0.4 OUTLIER -78.36 118.72 73.96 Favored Pre-proline 0 C--N 1.329 -0.298 0 N-CA-C 113.349 0.87 . . . . 15.0 113.349 -177.245 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.534 ' HA ' ' HG2' ' A' ' 47' ' ' GLU . 36.9 Cg_endo -64.36 61.66 0.25 Allowed 'Trans proline' 0 C--N 1.357 0.998 0 C-N-CA 123.509 2.806 . . . . 15.0 112.918 179.706 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.515 ' H ' ' HG2' ' A' ' 47' ' ' GLU . 2.2 mm-40 -150.8 -46.6 0.12 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.611 -0.268 . . . . 15.0 111.618 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.627 ' HA3' ' HA3' ' A' ' 19' ' ' GLY . . . -87.82 166.65 35.89 Favored Glycine 0 C--N 1.331 0.268 0 C-N-CA 120.311 -0.947 . . . . 15.0 113.879 -179.142 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -55.96 -14.83 2.76 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.703 0.631 . . . . 15.0 112.703 -179.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.16 -57.5 4.2 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.707 0.289 . . . . 15.0 111.109 -179.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.534 ' HG2' ' HA ' ' A' ' 42' ' ' PRO . 2.9 pp20? -57.11 -41.91 79.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 15.0 110.478 179.545 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 40.1 t -53.7 -70.37 0.1 Allowed 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 115.896 -0.593 . . . . 15.0 110.668 -179.508 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -61.1 -39.57 90.48 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.219 0.533 . . . . 15.0 109.575 179.049 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.01 44.21 8.32 Favored Glycine 0 N--CA 1.447 -0.599 0 CA-C-N 115.439 -0.801 . . . . 15.0 111.835 179.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.445 ' CG ' HG22 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -79.5 -53.4 6.91 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.962 0.411 . . . . 15.0 110.647 -179.397 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.41 ' HA ' HD12 ' A' ' 52' ' ' ILE . 10.3 tp -81.08 163.1 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 CA-C-N 115.936 -0.575 . . . . 15.0 110.442 179.695 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . 0.46 ' O ' HG21 ' A' ' 37' ' ' VAL . 42.3 m80 -146.57 158.82 43.97 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-O 121.606 0.717 . . . . 15.0 112.126 -179.072 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.53 ' HA ' ' CG2' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -43.15 133.33 3.95 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.246 -1.343 . . . . 15.0 112.928 -178.58 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.652 ' N ' HG21 ' A' ' 37' ' ' VAL . . . 49.84 32.14 17.83 Favored Glycine 0 C--N 1.336 0.545 0 CA-C-N 115.841 -0.618 . . . . 15.0 113.053 179.275 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.444 ' HB2' HG12 ' A' ' 37' ' ' VAL . 4.6 m-20 -65.47 124.75 23.11 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.706 -0.397 . . . . 15.0 110.216 179.498 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.466 ' HG2' ' CZ ' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -81.82 92.85 6.74 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.203 -0.453 . . . . 15.0 110.505 -179.959 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.487 ' HA ' HD22 ' A' ' 89' ' ' LEU . 1.3 m -84.76 120.85 36.04 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 CA-C-N 116.195 -0.457 . . . . 15.0 111.383 -179.372 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -107.24 -20.88 13.15 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 115.73 -0.668 . . . . 15.0 112.455 -179.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.409 ' CB ' HD22 ' A' ' 88' ' ' LEU . . . -147.75 153.74 39.64 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.33 0.586 . . . . 15.0 112.569 -178.585 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.451 HG12 ' HA ' ' A' ' 78' ' ' LEU . 25.9 t -138.97 99.56 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.331 0 CA-C-N 115.231 -0.895 . . . . 15.0 109.048 178.788 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.404 ' HB2' ' O ' ' A' ' 61' ' ' VAL . 1.6 m-80 65.37 16.36 10.49 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.535 -0.543 . . . . 15.0 109.535 -177.806 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 107.07 5.59 35.02 Favored Glycine 0 C--N 1.337 0.633 0 CA-C-N 115.689 -0.687 . . . . 15.0 113.63 179.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.505 ' O ' ' CG1' ' A' ' 64' ' ' VAL . 5.9 p -93.88 105.34 16.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 117.339 0.57 . . . . 15.0 110.809 179.306 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -55.58 130.73 44.13 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.053 -0.521 . . . . 15.0 111.11 -179.57 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -97.76 -24.16 15.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.97 -0.559 . . . . 15.0 111.036 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -45.41 106.23 0.07 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.426 -0.352 . . . . 15.0 110.999 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.85 58.95 0.53 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.785 -0.721 . . . . 15.0 112.289 -179.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.411 ' O ' ' O ' ' A' ' 33' ' ' GLY . . . -172.98 171.75 4.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.848 0.356 . . . . 15.0 110.945 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 13.5 p -93.37 -172.64 2.99 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.092 0.472 . . . . 15.0 111.376 -179.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.519 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 0.0 OUTLIER -64.24 -59.58 4.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.654 -0.703 . . . . 15.0 110.668 -179.975 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.409 ' O ' ' HG3' ' A' ' 76' ' ' GLU . 29.9 ttpt -52.44 -32.78 41.13 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.895 -0.593 . . . . 15.0 110.643 179.777 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 10.4 mt-30 -59.45 -51.76 68.49 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.542 -0.54 . . . . 15.0 109.542 179.264 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.442 ' O ' ' N ' ' A' ' 77' ' ' THR . . . -67.23 -44.49 79.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.008 -0.542 . . . . 15.0 110.033 178.511 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.451 ' CG2' ' CG2' ' A' ' 22' ' ' VAL . 0.5 OUTLIER -41.9 -41.76 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.239 0 N-CA-C 109.249 -0.649 . . . . 15.0 109.249 178.688 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.47 ' O ' ' HB2' ' A' ' 80' ' ' ASN . 54.0 mt-10 -67.3 -44.88 78.12 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 114.882 -1.054 . . . . 15.0 110.453 178.639 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.442 ' N ' ' O ' ' A' ' 74' ' ' ALA . 37.2 p -64.05 -55.1 24.64 Favored 'General case' 0 N--CA 1.461 0.122 0 C-N-CA 121.159 -0.216 . . . . 15.0 111.555 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.451 ' HA ' HG12 ' A' ' 61' ' ' VAL . 6.5 mt -53.31 -45.98 69.23 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-O 121.237 0.542 . . . . 15.0 109.997 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.35 -58.91 3.65 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.334 -0.848 . . . . 15.0 110.643 179.493 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.47 ' HB2' ' O ' ' A' ' 76' ' ' GLU . 11.2 m-80 -66.08 62.71 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.074 -0.512 . . . . 15.0 111.928 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -92.74 -76.26 0.47 Allowed 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 110.155 -0.313 . . . . 15.0 110.155 179.284 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 122.2 -105.17 0.95 Allowed Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.728 -0.749 . . . . 15.0 113.052 179.165 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.424 ' O ' ' HB3' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -64.87 -84.07 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.753 0.311 . . . . 15.0 111.209 -179.42 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 79.0 t -110.17 158.61 10.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.021 0.439 . . . . 15.0 111.083 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.455 ' HB ' ' HB3' ' A' ' 11' ' ' LEU . 3.3 t -97.68 83.15 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.176 0.513 . . . . 15.0 110.213 179.68 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -100.09 82.08 2.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.736 -0.666 . . . . 15.0 110.242 179.778 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.474 ' O ' ' N ' ' A' ' 9' ' ' VAL . 0.1 OUTLIER -103.98 127.04 51.52 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.914 -0.584 . . . . 15.0 111.85 -179.022 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.469 HD11 ' HB2' ' A' ' 8' ' ' GLU . 0.2 OUTLIER -102.17 100.54 10.76 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.292 -0.633 . . . . 15.0 109.292 178.433 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.487 HD22 ' HA ' ' A' ' 58' ' ' VAL . 0.1 OUTLIER -104.85 -161.49 0.82 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.405 0.621 . . . . 15.0 111.795 -178.582 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.43 ' HB2' HG13 ' A' ' 6' ' ' ILE . 3.2 tt0 -141.5 135.55 30.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.064 -0.971 . . . . 15.0 109.876 179.232 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.1 105.56 0.07 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.951 0.405 . . . . 15.0 111.169 -179.663 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -72.11 -160.29 4.68 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.938 -0.648 . . . . 15.0 112.641 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -76.4 125.47 29.25 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.846 0.355 . . . . 15.0 110.862 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 94.2 p -79.37 160.28 70.65 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 15.0 110.876 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_exo -51.19 148.63 17.81 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.609 2.206 . . . . 15.0 112.299 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 6.3 t . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.237 -0.887 . . . . 15.0 110.858 -179.985 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_endo . . . . . 0 N--CA 1.489 1.225 0 CA-C-O 120.812 0.255 . . . . 15.0 111.759 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.476 ' CB ' ' CD ' ' A' ' 3' ' ' PRO . 7.8 mttt -155.28 -66.42 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.198 -0.455 . . . . 15.0 111.138 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.476 ' CD ' ' CB ' ' A' ' 2' ' ' LYS . 13.4 Cg_endo -55.97 -80.77 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.388 2.059 . . . . 15.0 112.242 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 88.81 -22.95 19.09 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.58 -0.819 . . . . 15.0 112.763 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -62.08 145.75 52.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.36 0.6 . . . . 15.0 110.962 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.458 HG13 ' HB2' ' A' ' 90' ' ' GLU . 1.4 mp -104.38 141.22 20.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.149 -0.932 . . . . 15.0 111.097 -179.352 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.426 ' O ' ' N ' ' A' ' 89' ' ' LEU . 3.0 p90 -140.65 166.37 24.93 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.274 -0.421 . . . . 15.0 110.569 178.647 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.494 ' CB ' HD11 ' A' ' 88' ' ' LEU . 9.5 pt-20 -129.43 143.87 51.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.196 0.522 . . . . 15.0 111.432 -179.336 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.447 ' N ' ' O ' ' A' ' 87' ' ' LEU . 0.3 OUTLIER -101.37 117.26 46.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.424 -0.807 . . . . 15.0 109.382 178.82 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 55.1 tt0 -105.97 75.71 1.13 Allowed 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.456 0.539 . . . . 15.0 112.456 -178.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.579 ' HB3' ' HB ' ' A' ' 85' ' ' VAL . 6.4 tp -87.93 161.21 17.58 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.24 -0.652 . . . . 15.0 109.24 178.179 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.406 ' O ' ' N ' ' A' ' 14' ' ' ASN . . . -96.8 94.55 7.32 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 120.816 -0.354 . . . . 15.0 111.819 -179.516 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.468 ' CE ' ' HA ' ' A' ' 17' ' ' SER . 0.3 OUTLIER -65.09 61.82 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.334 0.588 . . . . 15.0 111.203 179.283 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.406 ' N ' ' O ' ' A' ' 12' ' ' ALA . 9.4 m-20 -116.16 -80.25 0.6 Allowed 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.799 -0.637 . . . . 15.0 111.585 -179.655 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.28 -24.62 59.28 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.112 -0.495 . . . . 15.0 111.721 -179.206 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -155.15 162.94 40.84 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.881 0.372 . . . . 15.0 111.219 -179.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.468 ' HA ' ' CE ' ' A' ' 13' ' ' LYS . 0.5 OUTLIER -93.66 -79.04 0.42 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.043 -0.526 . . . . 15.0 111.019 -179.904 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -139.11 -168.44 2.44 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 121.165 0.507 . . . . 15.0 111.066 -179.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.6 ' O ' ' HB ' ' A' ' 41' ' ' ILE . . . -162.87 31.85 0.29 Allowed Glycine 0 CA--C 1.505 -0.561 0 N-CA-C 110.931 -0.868 . . . . 15.0 110.931 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.626 HG12 ' O ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -112.5 143.65 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 CA-C-O 121.104 0.478 . . . . 15.0 112.146 -178.709 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 27.1 t -96.07 102.47 14.27 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 107.014 -1.476 . . . . 15.0 107.014 176.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.453 HG11 ' CG2' ' A' ' 20' ' ' ILE . 32.8 m -93.36 155.28 3.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 113.439 0.903 . . . . 15.0 113.439 -176.23 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.3 -175.44 4.99 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 114.8 -1.091 . . . . 15.0 110.609 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.412 ' O ' ' CB ' ' A' ' 71' ' ' HIS . . . 68.73 -120.23 10.84 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 120.823 -0.703 . . . . 15.0 112.602 179.725 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.537 ' HA3' ' N ' ' A' ' 71' ' ' HIS . . . 69.07 -66.38 0.49 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.795 -0.717 . . . . 15.0 113.431 179.449 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.432 ' N ' ' HA ' ' A' ' 70' ' ' THR . 1.0 OUTLIER -27.66 140.25 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 N-CA-C 112.471 0.545 . . . . 15.0 112.471 -179.271 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -76.61 60.14 1.61 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.983 -0.553 . . . . 15.0 111.034 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -151.72 -50.45 0.11 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.373 -0.376 . . . . 15.0 111.01 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.8 t -84.21 -37.58 21.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.202 -0.453 . . . . 15.0 111.071 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.429 HG13 ' CD1' ' A' ' 36' ' ' TYR . 21.7 m -80.75 -174.75 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.306 -0.406 . . . . 15.0 111.238 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.425 ' HB3' ' CD2' ' A' ' 32' ' ' HIS . 2.8 mtt-85 -58.8 -54.17 50.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.449 . . . . 15.0 111.022 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . 0.425 ' CD2' ' HB3' ' A' ' 31' ' ' ARG . 47.6 m-70 -146.37 -50.47 0.22 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.264 -0.426 . . . . 15.0 111.043 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -169.28 26.24 0.11 Allowed Glycine 0 N--CA 1.453 -0.19 0 C-N-CA 120.825 -0.702 . . . . 15.0 112.512 -179.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -90.58 149.18 19.95 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.684 -0.769 . . . . 15.0 111.197 179.101 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.473 ' CG1' ' HA ' ' A' ' 71' ' ' HIS . 0.0 OUTLIER -87.68 154.69 3.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 117.341 0.571 . . . . 15.0 111.568 -179.39 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.429 ' CD1' HG13 ' A' ' 30' ' ' VAL . 26.6 m-85 -140.76 106.83 5.19 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.241 -0.891 . . . . 15.0 109.829 179.312 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.675 HG21 ' N ' ' A' ' 55' ' ' GLY . 0.8 OUTLIER -55.58 148.25 3.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.18 0.514 . . . . 15.0 111.553 -178.938 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.403 ' O ' ' HG2' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -80.41 -47.7 14.01 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.316 -0.994 . . . . 15.0 108.316 178.2 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.626 ' O ' HG12 ' A' ' 20' ' ' ILE . . . -172.02 172.76 4.59 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 115.254 -0.885 . . . . 15.0 110.291 178.606 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.611 ' HA ' HG12 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -97.42 107.84 20.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.936 0.398 . . . . 15.0 110.889 179.946 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.6 ' HB ' ' O ' ' A' ' 19' ' ' GLY . 0.6 OUTLIER -78.86 108.03 7.28 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 115.789 -0.641 . . . . 15.0 112.611 -178.671 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.503 ' HA ' ' CG ' ' A' ' 47' ' ' GLU . 30.7 Cg_endo -62.93 69.67 0.13 Allowed 'Trans proline' 0 C--N 1.355 0.904 0 C-N-CA 123.139 2.559 . . . . 15.0 112.535 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.415 ' N ' ' O ' ' A' ' 41' ' ' ILE . 0.7 OUTLIER -151.79 -52.93 0.12 Allowed 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.365 -0.834 . . . . 15.0 109.675 179.501 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.515 ' HA3' ' CA ' ' A' ' 19' ' ' GLY . . . -87.93 155.99 27.07 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.611 -0.804 . . . . 15.0 112.402 179.254 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -39.11 -18.81 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 113.638 0.977 . . . . 15.0 113.638 -179.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.478 ' N ' ' O ' ' A' ' 44' ' ' GLY . . . -71.68 -71.89 0.25 Allowed 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 111.783 0.29 . . . . 15.0 111.783 -179.31 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.505 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 3.9 tp10 -58.22 -40.4 81.57 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 120.423 -0.511 . . . . 15.0 110.379 179.827 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 16.5 m -54.27 -59.18 5.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.974 -0.557 . . . . 15.0 110.463 179.439 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.433 ' CB ' HD13 ' A' ' 11' ' ' LEU . 3.6 t70 -68.46 -38.37 81.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.155 -0.475 . . . . 15.0 110.107 179.303 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.81 42.8 8.7 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.695 -0.684 . . . . 15.0 112.988 179.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.406 ' HB3' ' CG2' ' A' ' 9' ' ' VAL . 2.8 mmp_? -90.2 -50.68 5.85 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.877 0.37 . . . . 15.0 110.521 179.475 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.469 HG21 ' CG1' ' A' ' 40' ' ' VAL . 10.1 tp -81.22 158.9 4.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.048 -0.524 . . . . 15.0 110.773 179.69 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . 0.437 ' O ' ' HB2' ' A' ' 56' ' ' ASP . 72.8 m80 -141.0 158.24 44.22 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-O 121.645 0.736 . . . . 15.0 112.244 -179.407 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.538 ' HA ' ' CG2' ' A' ' 37' ' ' VAL . 2.3 mtpt -42.25 134.12 2.96 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.407 -1.269 . . . . 15.0 112.794 -178.704 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.675 ' N ' HG21 ' A' ' 37' ' ' VAL . . . 49.76 33.41 19.46 Favored Glycine 0 C--N 1.334 0.444 0 CA-C-N 115.815 -0.63 . . . . 15.0 113.616 179.157 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.497 ' HB2' HG12 ' A' ' 37' ' ' VAL . 0.2 OUTLIER -66.01 133.17 50.25 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 117.169 0.485 . . . . 15.0 110.679 179.529 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.425 ' HG3' ' CZ ' ' A' ' 36' ' ' TYR . 6.2 ttt85 -86.47 88.42 7.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.193 -0.458 . . . . 15.0 110.363 179.604 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.482 ' HA ' HD22 ' A' ' 89' ' ' LEU . 1.7 m -79.43 114.77 20.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.057 0.456 . . . . 15.0 111.003 -179.558 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 32.0 mt -107.09 -16.71 14.36 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.762 -0.654 . . . . 15.0 112.46 -179.244 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.4 ' HA ' ' O ' ' A' ' 64' ' ' VAL . . . -147.88 146.46 29.08 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 112.563 0.579 . . . . 15.0 112.563 -178.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.457 HG12 ' HA ' ' A' ' 78' ' ' LEU . 57.3 t -139.02 102.77 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.368 -0.833 . . . . 15.0 109.098 178.674 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 64.9 14.94 9.61 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.87 -0.419 . . . . 15.0 109.87 -178.163 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 107.0 5.47 35.29 Favored Glycine 0 C--N 1.336 0.552 0 CA-C-N 115.989 -0.55 . . . . 15.0 113.361 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.489 ' O ' ' CG1' ' A' ' 64' ' ' VAL . 6.1 p -93.87 107.59 19.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 117.077 0.439 . . . . 15.0 111.192 179.645 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 44.2 m -58.48 133.04 55.44 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.294 -0.412 . . . . 15.0 110.798 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -91.1 -21.86 21.0 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.07 -0.514 . . . . 15.0 111.185 -179.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -43.55 98.06 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 120.912 0.387 . . . . 15.0 111.149 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.87 63.28 0.55 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.817 -0.706 . . . . 15.0 112.333 -179.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -173.13 150.65 1.97 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.907 0.384 . . . . 15.0 111.098 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.432 ' HA ' ' N ' ' A' ' 26' ' ' VAL . 2.9 p -81.05 -171.96 3.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 15.0 111.015 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.537 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 0.0 OUTLIER -62.08 -59.68 4.71 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.847 -0.615 . . . . 15.0 110.537 -179.953 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 13.3 ttpp -52.65 -34.64 52.45 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.685 -0.689 . . . . 15.0 111.046 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -59.31 -49.97 75.78 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.71 -0.478 . . . . 15.0 109.71 179.526 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.446 ' O ' ' N ' ' A' ' 77' ' ' THR . . . -66.2 -45.68 79.93 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.929 -0.578 . . . . 15.0 109.532 178.423 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.429 ' CG2' ' CG2' ' A' ' 22' ' ' VAL . 0.5 OUTLIER -43.59 -40.81 1.41 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.209 0 N-CA-C 108.853 -0.795 . . . . 15.0 108.853 178.158 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -67.28 -44.87 78.23 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 114.845 -1.071 . . . . 15.0 110.126 178.365 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.446 ' N ' ' O ' ' A' ' 74' ' ' ALA . 61.3 p -64.19 -54.24 36.76 Favored 'General case' 0 N--CA 1.461 0.08 0 CA-C-N 116.621 -0.263 . . . . 15.0 111.349 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.457 ' HA ' HG12 ' A' ' 61' ' ' VAL . 4.4 mt -53.43 -48.59 68.62 Favored 'General case' 0 CA--C 1.521 -0.146 0 CA-C-O 121.099 0.476 . . . . 15.0 110.138 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -68.54 -58.16 4.71 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.559 -0.746 . . . . 15.0 110.748 179.558 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -65.88 63.53 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.089 -0.505 . . . . 15.0 111.952 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.407 ' HB ' ' HG3' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -94.99 -73.53 0.58 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.65 0.262 . . . . 15.0 110.468 179.362 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 122.2 -105.22 0.96 Allowed Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.828 -0.701 . . . . 15.0 113.132 179.4 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.454 ' O ' ' HB3' ' A' ' 13' ' ' LYS . 0.4 OUTLIER -64.67 -82.17 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.705 0.288 . . . . 15.0 111.484 -179.279 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.423 ' CG1' ' N ' ' A' ' 85' ' ' VAL . 50.0 t -109.76 158.05 10.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.904 0.383 . . . . 15.0 110.423 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.579 ' HB ' ' HB3' ' A' ' 11' ' ' LEU . 50.7 t -98.23 77.85 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.231 -0.441 . . . . 15.0 110.627 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -98.63 88.37 4.06 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.021 -0.536 . . . . 15.0 110.893 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.447 ' O ' ' N ' ' A' ' 9' ' ' VAL . 0.1 OUTLIER -103.89 125.84 50.59 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.104 -0.498 . . . . 15.0 111.633 -179.474 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.494 HD11 ' CB ' ' A' ' 8' ' ' GLU . 4.6 mp -101.59 101.85 12.47 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.428 -0.582 . . . . 15.0 109.428 178.657 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.482 HD22 ' HA ' ' A' ' 58' ' ' VAL . 0.1 OUTLIER -105.83 -163.62 0.95 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.536 0.684 . . . . 15.0 112.119 -178.325 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.458 ' HB2' HG13 ' A' ' 6' ' ' ILE . 2.2 tt0 -142.47 137.62 30.42 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 114.803 -1.09 . . . . 15.0 109.758 179.063 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.95 106.85 0.13 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.942 0.401 . . . . 15.0 111.05 -179.687 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -68.02 170.94 36.33 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.955 -0.64 . . . . 15.0 112.765 -179.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -86.27 61.96 7.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.855 0.36 . . . . 15.0 110.832 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 4.7 m -74.78 113.06 20.79 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.236 -0.438 . . . . 15.0 110.938 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -53.95 -26.71 41.45 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.445 2.096 . . . . 15.0 112.254 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 32.2 p . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.163 -0.922 . . . . 15.0 110.913 179.969 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_endo . . . . . 0 N--CA 1.489 1.214 0 CA-C-O 120.801 0.25 . . . . 15.0 111.805 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.18 137.56 13.42 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 15.0 110.835 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -61.69 -78.03 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.477 2.118 . . . . 15.0 112.411 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 94.53 -33.52 5.27 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.699 -0.762 . . . . 15.0 112.622 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -63.8 147.2 52.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.353 0.597 . . . . 15.0 111.143 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.42 HG13 ' HB2' ' A' ' 90' ' ' GLU . 1.4 mp -104.41 144.18 14.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.135 -0.939 . . . . 15.0 111.088 -179.553 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.41 ' CD1' ' C ' ' A' ' 7' ' ' PHE . 3.9 p90 -140.65 165.53 27.22 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.327 -0.397 . . . . 15.0 110.729 178.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.468 ' HB2' HD11 ' A' ' 88' ' ' LEU . 11.0 pt-20 -130.14 143.52 50.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.117 0.484 . . . . 15.0 111.467 -179.642 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.451 HG13 ' CD1' ' A' ' 52' ' ' ILE . 0.5 OUTLIER -101.55 117.45 46.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.582 -0.735 . . . . 15.0 109.998 179.115 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -106.43 71.81 0.89 Allowed 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 112.243 0.46 . . . . 15.0 112.243 -179.221 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.527 ' HB3' ' HB ' ' A' ' 85' ' ' VAL . 7.9 tp -88.0 164.25 15.89 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.538 -0.542 . . . . 15.0 109.538 178.697 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -96.09 93.02 6.72 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.025 0.441 . . . . 15.0 111.297 -179.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.541 ' O ' ' HD3' ' A' ' 13' ' ' LYS . 0.1 OUTLIER -57.74 -26.13 61.4 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.857 -0.61 . . . . 15.0 110.935 179.769 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -83.94 -44.69 13.97 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.189 -0.46 . . . . 15.0 110.926 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -54.72 -41.66 70.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.989 0.423 . . . . 15.0 110.544 179.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -165.53 175.65 8.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.93 -0.577 . . . . 15.0 110.757 179.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -86.09 -158.71 0.42 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.27 -0.423 . . . . 15.0 110.299 179.647 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.431 ' O ' ' HA3' ' A' ' 44' ' ' GLY . 0.4 OUTLIER -102.32 -170.81 1.86 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.826 0.346 . . . . 15.0 110.702 179.57 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.608 ' O ' ' HB ' ' A' ' 41' ' ' ILE . . . -166.77 34.09 0.22 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 121.09 -0.576 . . . . 15.0 112.183 -179.665 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.567 HG12 ' O ' ' A' ' 39' ' ' ALA . 0.1 OUTLIER -112.63 140.65 31.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 121.023 0.439 . . . . 15.0 111.892 -179.464 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 31.3 t -96.3 107.16 19.48 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 107.735 -1.209 . . . . 15.0 107.735 177.221 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.426 HG11 ' CG2' ' A' ' 20' ' ' ILE . 30.4 m -93.31 152.5 3.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 N-CA-C 113.061 0.763 . . . . 15.0 113.061 -176.807 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 35.4 p -149.42 178.68 8.58 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 115.036 -0.984 . . . . 15.0 110.874 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.423 ' O ' ' CB ' ' A' ' 71' ' ' HIS . . . 71.83 -118.69 7.14 Favored Glycine 0 C--N 1.332 0.345 0 C-N-CA 120.987 -0.625 . . . . 15.0 112.697 179.813 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.53 ' HA3' ' N ' ' A' ' 71' ' ' HIS . . . 68.21 -66.28 0.37 Allowed Glycine 0 C--N 1.331 0.254 0 C-N-CA 120.874 -0.679 . . . . 15.0 113.585 179.563 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.42 ' HA ' ' CB ' ' A' ' 70' ' ' THR . 0.0 OUTLIER -29.64 137.89 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 N-CA-C 112.247 0.462 . . . . 15.0 112.247 -179.355 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -75.46 63.5 1.48 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.905 -0.589 . . . . 15.0 111.038 -179.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 29.5 m -151.71 -50.3 0.11 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.247 -0.433 . . . . 15.0 111.067 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 11.0 t -88.04 -29.27 20.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.231 -0.441 . . . . 15.0 111.146 -179.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.43 HG13 ' CD1' ' A' ' 36' ' ' TYR . 34.4 m -85.4 -176.85 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.367 -0.379 . . . . 15.0 111.312 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -61.47 -46.95 87.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.14 -0.482 . . . . 15.0 111.101 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 74.6 m-70 -148.29 -61.94 0.25 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.405 -0.361 . . . . 15.0 111.226 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.4 ' O ' ' O ' ' A' ' 69' ' ' ALA . . . -163.67 24.98 0.19 Allowed Glycine 0 N--CA 1.453 -0.205 0 C-N-CA 120.853 -0.689 . . . . 15.0 112.586 -179.642 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -89.61 156.97 26.14 Favored Glycine 0 N--CA 1.449 -0.462 0 N-CA-C 110.626 -0.99 . . . . 15.0 110.626 178.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.524 HG21 HG22 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -93.69 151.5 3.69 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.388 0 CA-C-N 117.66 0.73 . . . . 15.0 112.013 -179.366 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.491 ' CZ ' ' HG2' ' A' ' 57' ' ' ARG . 49.9 m-85 -133.46 107.65 8.17 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.718 -1.128 . . . . 15.0 109.162 178.707 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.562 HG21 ' N ' ' A' ' 55' ' ' GLY . 0.6 OUTLIER -54.85 152.91 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 121.261 0.553 . . . . 15.0 110.723 -178.575 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.637 ' HG3' ' N ' ' A' ' 39' ' ' ALA . 1.4 ppmt? -88.17 -47.32 8.55 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 108.795 -0.817 . . . . 15.0 108.795 179.313 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.637 ' N ' ' HG3' ' A' ' 38' ' ' LYS . . . -173.06 167.14 4.98 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.669 -0.696 . . . . 15.0 110.202 178.305 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.501 ' HB ' ' HG2' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -96.84 111.87 27.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.647 -0.501 . . . . 15.0 109.647 179.14 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.608 ' HB ' ' O ' ' A' ' 19' ' ' GLY . 0.3 OUTLIER -78.39 111.37 18.36 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 115.728 -0.669 . . . . 15.0 112.664 -177.676 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.474 ' HA ' ' OE1' ' A' ' 47' ' ' GLU . 37.1 Cg_endo -65.23 65.35 0.33 Allowed 'Trans proline' 0 C--N 1.355 0.899 0 C-N-CA 123.07 2.514 . . . . 15.0 112.763 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -149.52 -52.03 0.15 Allowed 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.402 -0.817 . . . . 15.0 109.196 179.293 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.528 ' HA3' ' HA3' ' A' ' 19' ' ' GLY . . . -88.03 154.34 25.42 Favored Glycine 0 N--CA 1.445 -0.719 0 CA-C-N 115.443 -0.799 . . . . 15.0 112.516 179.109 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -40.61 -17.73 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 113.804 1.038 . . . . 15.0 113.804 -179.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.446 ' N ' ' O ' ' A' ' 44' ' ' GLY . . . -71.67 -70.54 0.32 Allowed 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.707 -0.397 . . . . 15.0 111.477 -179.247 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.501 ' HG2' ' HB ' ' A' ' 40' ' ' VAL . 6.8 tm-20 -58.08 -37.17 73.98 Favored 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 120.678 -0.409 . . . . 15.0 110.039 179.508 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 37.4 m -56.25 -65.76 0.55 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.021 -0.536 . . . . 15.0 110.335 179.265 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.479 ' CB ' HD12 ' A' ' 11' ' ' LEU . 18.6 m-20 -62.55 -38.4 89.86 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.123 0.487 . . . . 15.0 109.931 179.135 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.51 43.56 8.42 Favored Glycine 0 N--CA 1.449 -0.493 0 CA-C-N 115.59 -0.732 . . . . 15.0 112.446 179.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.437 ' CG ' HG22 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -79.8 -58.26 3.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.867 0.365 . . . . 15.0 110.616 -179.982 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.498 ' CG2' HG12 ' A' ' 37' ' ' VAL . 1.4 mm -86.13 163.41 2.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.114 -0.494 . . . . 15.0 110.887 179.809 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . 0.466 ' N ' ' CG2' ' A' ' 52' ' ' ILE . 43.2 m80 -139.37 154.67 47.88 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-O 121.61 0.719 . . . . 15.0 111.415 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.503 ' HA ' ' CG2' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -36.07 133.93 0.43 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.368 -1.287 . . . . 15.0 113.016 -178.549 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.562 ' N ' HG21 ' A' ' 37' ' ' VAL . . . 50.74 34.16 28.45 Favored Glycine 0 C--N 1.334 0.468 0 CA-C-N 115.806 -0.633 . . . . 15.0 113.929 179.091 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -65.4 130.62 43.99 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 117.296 0.548 . . . . 15.0 110.525 179.203 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.491 ' HG2' ' CZ ' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -82.34 85.73 6.82 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.002 -0.545 . . . . 15.0 110.543 179.818 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.524 HG22 HG21 ' A' ' 35' ' ' ILE . 1.0 OUTLIER -81.67 114.33 22.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.15 0.5 . . . . 15.0 111.266 -179.549 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 18.6 mt -107.23 -15.74 14.58 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.702 -0.681 . . . . 15.0 112.142 -179.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.413 ' HA ' ' O ' ' A' ' 64' ' ' VAL . . . -147.58 151.01 35.55 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.292 0.567 . . . . 15.0 112.337 -178.767 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.415 HG21 ' CD2' ' A' ' 78' ' ' LEU . 10.7 t -139.04 102.83 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.257 -0.883 . . . . 15.0 109.105 178.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 65.0 14.73 9.54 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.575 -0.528 . . . . 15.0 109.575 -177.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 106.49 6.57 35.63 Favored Glycine 0 C--N 1.337 0.606 0 CA-C-N 115.824 -0.626 . . . . 15.0 113.336 179.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.484 ' O ' ' CG1' ' A' ' 64' ' ' VAL . 8.9 p -93.86 106.64 18.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.098 0.475 . . . . 15.0 111.066 179.54 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 49.1 m -58.8 124.62 20.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.187 -0.46 . . . . 15.0 110.716 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.417 ' CD1' HG23 ' A' ' 58' ' ' VAL . 0.2 OUTLIER -92.05 -14.58 29.09 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.169 -0.469 . . . . 15.0 111.467 -179.654 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -45.23 103.77 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.89 0.376 . . . . 15.0 111.183 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.85 63.82 0.55 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.793 -0.717 . . . . 15.0 112.525 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.4 ' O ' ' O ' ' A' ' 33' ' ' GLY . . . -173.13 166.86 4.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.837 0.351 . . . . 15.0 111.077 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.42 ' CB ' ' HA ' ' A' ' 26' ' ' VAL . 2.6 p -93.23 -170.49 2.41 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.023 0.44 . . . . 15.0 110.943 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.53 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 0.0 OUTLIER -63.96 -58.37 6.94 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.782 -0.645 . . . . 15.0 110.613 179.979 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.427 ' O ' ' HG3' ' A' ' 76' ' ' GLU . 28.9 ttmt -52.84 -35.51 57.47 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.095 -0.502 . . . . 15.0 110.823 179.392 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -59.21 -46.88 87.29 Favored 'General case' 0 CA--C 1.518 -0.287 0 N-CA-C 109.497 -0.557 . . . . 15.0 109.497 179.277 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.476 ' HA ' ' OG1' ' A' ' 77' ' ' THR . . . -66.88 -47.8 70.72 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.596 -0.729 . . . . 15.0 109.717 178.458 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.413 ' CG2' ' CG2' ' A' ' 22' ' ' VAL . 0.5 OUTLIER -41.75 -42.03 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.254 0 CA-C-O 121.62 0.724 . . . . 15.0 109.182 178.575 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.427 ' HG3' ' O ' ' A' ' 72' ' ' LYS . 20.8 mt-10 -67.35 -44.02 80.07 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.644 -1.162 . . . . 15.0 110.884 179.006 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.476 ' OG1' ' HA ' ' A' ' 74' ' ' ALA . 4.9 p -64.42 -56.33 14.98 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 120.845 -0.342 . . . . 15.0 111.606 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.415 ' CD2' HG21 ' A' ' 61' ' ' VAL . 5.2 mt -53.28 -45.49 68.9 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-O 121.177 0.513 . . . . 15.0 109.931 -179.745 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -68.37 -58.32 4.55 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.462 -0.79 . . . . 15.0 110.232 179.345 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 32.9 m-20 -66.14 58.51 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.845 -0.616 . . . . 15.0 112.196 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.435 ' HB ' ' HG3' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -95.7 -72.82 0.61 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.742 0.306 . . . . 15.0 110.234 179.249 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 122.15 -103.36 0.84 Allowed Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.72 -0.752 . . . . 15.0 113.332 179.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -64.54 -84.66 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.105 0.409 . . . . 15.0 112.105 -178.857 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.433 HG13 ' N ' ' A' ' 85' ' ' VAL . 78.5 t -109.6 158.98 9.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.937 0.399 . . . . 15.0 110.976 -179.322 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.527 ' HB ' ' HB3' ' A' ' 11' ' ' LEU . 9.4 t -98.04 80.65 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.231 0.538 . . . . 15.0 110.596 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -99.71 86.96 3.43 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.73 -0.668 . . . . 15.0 110.038 179.603 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.474 ' CD2' ' HB ' ' A' ' 58' ' ' VAL . 0.1 OUTLIER -103.86 121.19 42.56 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.926 -0.579 . . . . 15.0 111.983 -178.873 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.468 HD11 ' HB2' ' A' ' 8' ' ' GLU . 4.6 mp -97.19 101.25 12.77 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.421 -0.585 . . . . 15.0 109.421 178.488 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.44 ' HB3' ' HA ' ' A' ' 58' ' ' VAL . 0.1 OUTLIER -105.61 -162.14 0.85 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.488 0.661 . . . . 15.0 111.964 -178.649 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.42 ' HB2' HG13 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -142.01 136.9 30.72 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 114.836 -1.075 . . . . 15.0 109.34 178.874 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -46.69 105.03 0.06 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.03 0.443 . . . . 15.0 111.114 -179.486 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -70.02 -162.09 3.59 Favored Glycine 0 N--CA 1.451 -0.333 0 CA-C-N 115.738 -0.664 . . . . 15.0 112.849 -179.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -76.22 120.17 21.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.817 0.341 . . . . 15.0 110.888 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.4 m -88.38 145.48 35.76 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.249 -0.432 . . . . 15.0 110.8 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -52.25 -175.53 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.51 2.14 . . . . 15.0 112.327 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 69.1 p . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.222 -0.894 . . . . 15.0 110.863 179.985 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_endo . . . . . 0 N--CA 1.489 1.218 0 CA-C-O 120.776 0.24 . . . . 15.0 111.727 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.491 ' CB ' ' HD3' ' A' ' 3' ' ' PRO . 1.3 mtpp -155.31 -58.85 0.02 OUTLIER Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.264 -0.425 . . . . 15.0 111.369 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.491 ' HD3' ' CB ' ' A' ' 2' ' ' LYS . 41.7 Cg_exo -56.96 -163.11 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.166 1.91 . . . . 15.0 112.419 -179.794 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 90.37 -23.51 21.45 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.658 -0.782 . . . . 15.0 112.041 -179.531 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -72.19 143.55 48.85 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 121.334 0.588 . . . . 15.0 110.646 179.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.413 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 1.2 mp -74.09 150.99 7.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.18 -0.918 . . . . 15.0 110.797 -179.641 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.488 ' O ' ' N ' ' A' ' 89' ' ' LEU . 0.3 OUTLIER -146.91 158.35 43.9 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.024 -0.535 . . . . 15.0 110.305 179.479 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.474 ' HB2' HD11 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -126.64 142.85 51.41 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.348 0.594 . . . . 15.0 111.937 -178.955 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.427 ' CG2' ' HB3' ' A' ' 51' ' ' ARG . 0.2 OUTLIER -101.45 114.97 42.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.083 -0.962 . . . . 15.0 109.397 178.79 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -105.8 73.08 0.99 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.198 -0.455 . . . . 15.0 112.183 -178.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.422 ' O ' HG11 ' A' ' 84' ' ' VAL . 5.7 tp -88.36 166.14 14.48 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.714 -0.476 . . . . 15.0 109.714 178.707 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -95.39 94.2 7.69 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.048 0.452 . . . . 15.0 111.266 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.532 ' O ' ' HD3' ' A' ' 13' ' ' LYS . 0.1 OUTLIER -57.2 -27.1 61.68 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.807 -0.633 . . . . 15.0 111.114 179.901 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 99.8 m-20 -83.99 -45.09 13.49 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.3 -0.409 . . . . 15.0 110.875 -179.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -58.77 -43.32 90.34 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.041 0.448 . . . . 15.0 110.411 179.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -165.58 163.57 19.33 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.837 -0.62 . . . . 15.0 110.642 179.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.448 ' O ' ' CB ' ' A' ' 45' ' ' ALA . 0.5 OUTLIER -85.9 -166.94 1.67 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.379 -0.373 . . . . 15.0 110.176 179.595 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.416 ' N ' ' CD2' ' A' ' 18' ' ' LEU . 1.6 mm? -96.77 -173.53 2.75 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.937 0.399 . . . . 15.0 110.779 179.473 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.676 ' HA3' ' HA3' ' A' ' 44' ' ' GLY . . . -160.89 42.83 0.41 Allowed Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.924 -0.655 . . . . 15.0 111.915 -179.772 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.628 HG12 ' O ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -112.74 141.29 28.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 120.915 0.388 . . . . 15.0 111.768 -179.471 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.402 ' HB3' HD13 ' A' ' 41' ' ' ILE . 43.0 t -96.18 103.44 15.34 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 107.721 -1.214 . . . . 15.0 107.721 177.29 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.449 HG11 ' CG2' ' A' ' 20' ' ' ILE . 27.3 m -93.51 155.39 3.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 113.339 0.866 . . . . 15.0 113.339 -176.714 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.33 -178.4 6.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 114.811 -1.086 . . . . 15.0 110.19 179.498 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.448 ' O ' ' CB ' ' A' ' 71' ' ' HIS . . . 73.0 -120.58 7.32 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.486 -0.864 . . . . 15.0 112.523 179.724 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.565 ' HA3' ' N ' ' A' ' 71' ' ' HIS . . . 68.3 -63.69 0.4 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.945 -0.645 . . . . 15.0 113.522 179.361 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.463 ' N ' ' HA ' ' A' ' 70' ' ' THR . 1.7 m -32.32 146.96 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 N-CA-C 112.233 0.457 . . . . 15.0 112.233 -179.123 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.412 ' CB ' ' O ' ' A' ' 32' ' ' HIS . 15.1 m-20 -79.84 57.85 2.68 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.951 -0.568 . . . . 15.0 111.195 -179.714 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -151.76 -61.43 0.17 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.832 0.349 . . . . 15.0 111.238 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.4 m -71.93 -35.22 69.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 15.0 111.347 -179.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.427 HG13 ' CD1' ' A' ' 36' ' ' TYR . 24.7 m -84.77 -173.78 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.895 0.379 . . . . 15.0 111.445 -179.613 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 41.4 ttt85 -57.08 -39.67 75.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.082 -0.508 . . . . 15.0 111.486 -179.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . 0.412 ' O ' ' CB ' ' A' ' 27' ' ' ASN . 1.6 p-80 -174.63 -35.7 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.592 -0.276 . . . . 15.0 111.656 -179.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -173.77 20.62 0.06 OUTLIER Glycine 0 CA--C 1.519 0.324 0 C-N-CA 120.594 -0.813 . . . . 15.0 113.104 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -97.31 152.06 19.92 Favored Glycine 0 N--CA 1.448 -0.516 0 N-CA-C 110.294 -1.122 . . . . 15.0 110.294 178.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.57 HG13 ' HA ' ' A' ' 71' ' ' HIS . 0.1 OUTLIER -95.35 154.18 3.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 119.668 -0.813 . . . . 15.0 112.382 -178.962 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.427 ' CD1' HG13 ' A' ' 30' ' ' VAL . 31.8 m-85 -136.06 107.51 6.9 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.649 -1.16 . . . . 15.0 109.206 179.224 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.648 HG21 ' N ' ' A' ' 55' ' ' GLY . 0.6 OUTLIER -55.05 148.1 3.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.035 -0.529 . . . . 15.0 111.557 -178.446 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.451 ' O ' ' HG2' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -80.26 -49.6 11.37 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.452 -0.944 . . . . 15.0 108.452 178.397 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.628 ' O ' HG12 ' A' ' 20' ' ' ILE . . . -172.27 173.11 4.31 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-N 115.661 -0.7 . . . . 15.0 110.338 178.687 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.53 ' HA ' HG12 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -96.96 112.01 28.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 109.388 -0.597 . . . . 15.0 109.388 179.041 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.674 ' HB ' ' O ' ' A' ' 19' ' ' GLY . 0.5 OUTLIER -78.28 118.81 74.52 Favored Pre-proline 0 C--N 1.328 -0.328 0 N-CA-C 113.18 0.808 . . . . 15.0 113.18 -177.301 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.533 ' HA ' ' CG ' ' A' ' 47' ' ' GLU . 36.2 Cg_endo -64.09 62.38 0.23 Allowed 'Trans proline' 0 C--N 1.357 1.012 0 C-N-CA 123.592 2.861 . . . . 15.0 112.874 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.535 ' H ' ' HG2' ' A' ' 47' ' ' GLU . 9.8 mt-30 -152.03 -47.14 0.11 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.524 -0.307 . . . . 15.0 111.596 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.676 ' HA3' ' HA3' ' A' ' 19' ' ' GLY . . . -87.9 167.47 36.52 Favored Glycine 0 C--N 1.331 0.258 0 C-N-CA 120.354 -0.927 . . . . 15.0 113.825 -179.191 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.448 ' CB ' ' O ' ' A' ' 17' ' ' SER . . . -56.99 -12.68 2.16 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.634 0.605 . . . . 15.0 112.634 -179.762 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.79 -58.56 3.36 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 120.762 0.315 . . . . 15.0 110.406 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.535 ' HG2' ' H ' ' A' ' 43' ' ' GLN . 2.6 pp20? -57.68 -43.16 84.88 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.763 -0.653 . . . . 15.0 110.525 179.079 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 66.7 m -53.65 -70.96 0.08 Allowed 'General case' 0 CA--C 1.518 -0.265 0 CA-C-N 115.931 -0.577 . . . . 15.0 110.574 -179.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.412 ' CB ' HD13 ' A' ' 11' ' ' LEU . 1.6 t0 -58.13 -41.51 83.8 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.128 -0.693 . . . . 15.0 109.128 178.736 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.67 40.12 13.03 Favored Glycine 0 N--CA 1.446 -0.645 0 CA-C-N 115.31 -0.859 . . . . 15.0 111.632 179.378 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.427 ' HB3' ' CG2' ' A' ' 9' ' ' VAL . 0.2 OUTLIER -79.76 -50.63 10.28 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.935 0.398 . . . . 15.0 110.723 -179.252 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.437 ' CD1' HD12 ' A' ' 89' ' ' LEU . 9.3 tp -81.07 162.34 3.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.043 -0.526 . . . . 15.0 110.249 179.433 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . 0.474 ' N ' ' OD2' ' A' ' 56' ' ' ASP . 76.1 m80 -147.54 158.71 44.11 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-O 121.644 0.735 . . . . 15.0 112.281 -178.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.528 ' HA ' ' CG2' ' A' ' 37' ' ' VAL . 8.1 mtpt -43.09 133.28 3.89 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 114.13 -1.396 . . . . 15.0 112.956 -178.68 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.648 ' N ' HG21 ' A' ' 37' ' ' VAL . . . 50.06 29.44 14.78 Favored Glycine 0 C--N 1.332 0.34 0 CA-C-N 115.587 -0.733 . . . . 15.0 113.364 179.206 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.474 ' OD2' ' N ' ' A' ' 53' ' ' HIS . 17.4 m-20 -65.86 130.29 42.74 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.759 -0.376 . . . . 15.0 110.605 179.568 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 8.9 ttt180 -80.85 94.97 6.56 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.307 -0.406 . . . . 15.0 111.123 -179.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.494 ' O ' ' CG2' ' A' ' 58' ' ' VAL . 1.4 m -84.44 112.72 22.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 CA-C-N 116.315 -0.402 . . . . 15.0 110.621 179.743 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 30.5 mt -107.4 -13.18 15.16 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 112.628 0.603 . . . . 15.0 112.628 -179.116 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.464 ' CB ' HD22 ' A' ' 88' ' ' LEU . . . -151.77 148.15 27.52 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.511 0.56 . . . . 15.0 112.511 -178.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.45 HG12 ' HA ' ' A' ' 78' ' ' LEU . 19.0 t -139.2 101.6 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.24 -0.891 . . . . 15.0 109.409 178.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.408 ' ND2' ' CG2' ' A' ' 81' ' ' THR . 1.6 m-80 64.9 15.32 9.84 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.667 -0.494 . . . . 15.0 109.667 -178.141 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 107.22 6.17 34.15 Favored Glycine 0 C--N 1.336 0.575 0 CA-C-N 115.867 -0.606 . . . . 15.0 113.46 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.504 ' O ' ' CG1' ' A' ' 64' ' ' VAL . 6.3 p -93.83 103.94 15.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 117.25 0.525 . . . . 15.0 110.786 179.313 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -55.8 132.29 49.0 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.055 -0.52 . . . . 15.0 111.22 -179.561 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -87.64 -20.33 26.48 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.971 -0.559 . . . . 15.0 110.714 179.679 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -43.39 96.1 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.295 -0.411 . . . . 15.0 111.131 179.833 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 104.36 69.65 0.78 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.802 -0.713 . . . . 15.0 112.216 -179.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -173.02 159.35 3.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.787 0.327 . . . . 15.0 111.038 -179.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.463 ' HA ' ' N ' ' A' ' 26' ' ' VAL . 15.9 p -93.04 -173.96 3.43 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.219 -0.446 . . . . 15.0 111.275 -179.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.57 ' HA ' HG13 ' A' ' 35' ' ' ILE . 0.0 OUTLIER -61.22 -60.79 3.2 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.862 -0.608 . . . . 15.0 110.438 -179.978 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -52.65 -31.96 39.6 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.717 -0.674 . . . . 15.0 110.473 179.449 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -59.56 -53.93 52.44 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.007 -0.542 . . . . 15.0 109.955 179.424 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.458 ' O ' ' N ' ' A' ' 77' ' ' THR . . . -64.89 -44.78 88.52 Favored 'General case' 0 CA--C 1.518 -0.267 0 N-CA-C 109.432 -0.581 . . . . 15.0 109.432 178.581 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.414 ' CG2' ' CG2' ' A' ' 22' ' ' VAL . 0.5 OUTLIER -44.04 -40.6 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.21 0 N-CA-C 108.68 -0.859 . . . . 15.0 108.68 178.021 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.415 ' O ' ' HB2' ' A' ' 80' ' ' ASN . 1.8 mm-40 -67.36 -45.03 77.53 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 114.835 -1.075 . . . . 15.0 109.828 178.093 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.458 ' N ' ' O ' ' A' ' 74' ' ' ALA . 80.3 p -64.13 -53.81 43.71 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 116.616 -0.265 . . . . 15.0 111.398 179.751 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.45 ' HA ' HG12 ' A' ' 61' ' ' VAL . 5.4 mt -53.37 -48.84 68.23 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-O 121.237 0.541 . . . . 15.0 109.851 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 16.2 ttt180 -68.57 -60.67 2.25 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.356 -0.838 . . . . 15.0 110.636 179.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.415 ' HB2' ' O ' ' A' ' 76' ' ' GLU . 36.6 m-20 -65.97 61.47 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.93 -0.577 . . . . 15.0 112.133 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.449 ' HB ' ' HG3' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -95.56 -68.77 0.78 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.779 0.323 . . . . 15.0 110.174 179.178 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 121.92 -105.9 1.03 Allowed Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.883 -0.675 . . . . 15.0 112.889 179.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -64.81 -83.05 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 111.943 0.349 . . . . 15.0 111.943 -179.241 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.444 HG13 ' N ' ' A' ' 85' ' ' VAL . 78.1 t -109.78 160.31 8.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.979 0.418 . . . . 15.0 110.944 -179.475 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.444 ' N ' HG13 ' A' ' 84' ' ' VAL . 8.7 t -97.65 82.24 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.109 0.48 . . . . 15.0 110.402 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 2.8 t60 -101.01 82.26 2.35 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.769 -0.65 . . . . 15.0 110.624 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.452 ' HB3' ' CD2' ' A' ' 89' ' ' LEU . 0.1 OUTLIER -100.56 120.24 39.73 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.919 -0.582 . . . . 15.0 111.679 -179.332 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.474 HD11 ' HB2' ' A' ' 8' ' ' GLU . 0.2 OUTLIER -97.11 101.48 13.06 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.464 -0.569 . . . . 15.0 109.464 178.794 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.488 ' N ' ' O ' ' A' ' 7' ' ' PHE . 0.1 OUTLIER -105.86 -162.99 0.9 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.694 0.759 . . . . 15.0 112.388 -178.392 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.413 ' HA ' ' HA ' ' A' ' 6' ' ' ILE . 7.4 tt0 -139.58 120.91 14.94 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 114.475 -1.239 . . . . 15.0 109.116 178.731 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -46.86 101.92 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.005 0.431 . . . . 15.0 111.398 -179.094 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -62.04 137.28 45.89 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.946 -0.645 . . . . 15.0 112.499 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -85.25 134.44 34.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.836 0.35 . . . . 15.0 110.904 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -90.19 169.95 11.24 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 15.0 110.872 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -52.77 -49.83 16.18 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.563 2.175 . . . . 15.0 112.301 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 3.1 p . . . . . 0 C--O 1.25 1.089 0 CA-C-O 118.214 -0.898 . . . . 15.0 110.892 179.983 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo . . . . . 0 N--CA 1.486 1.08 0 CA-C-O 120.811 0.254 . . . . 15.0 111.698 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.465 ' CB ' ' CD ' ' A' ' 3' ' ' PRO . 1.2 mtpt -155.24 -66.56 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.25 -0.432 . . . . 15.0 111.198 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.465 ' CD ' ' CB ' ' A' ' 2' ' ' LYS . 59.1 Cg_endo -71.0 -94.88 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.206 1.937 . . . . 15.0 112.266 -179.839 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 87.1 -39.44 3.1 Favored Glycine 0 C--N 1.334 0.443 0 C-N-CA 120.527 -0.844 . . . . 15.0 112.865 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -62.07 163.32 8.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.31 0.576 . . . . 15.0 111.349 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.433 HG13 ' HB2' ' A' ' 90' ' ' GLU . 1.2 mp -104.39 150.17 7.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.135 -0.939 . . . . 15.0 110.791 -179.494 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.441 ' CZ ' HD11 ' A' ' 89' ' ' LEU . 5.8 p90 -140.69 156.77 46.13 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.413 -0.358 . . . . 15.0 110.678 179.102 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.47 ' CB ' HD11 ' A' ' 88' ' ' LEU . 10.2 pt-20 -124.22 142.84 50.91 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.339 0.59 . . . . 15.0 111.551 -179.399 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.479 ' CG2' ' HB3' ' A' ' 51' ' ' ARG . 0.2 OUTLIER -101.54 116.47 45.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.132 -0.94 . . . . 15.0 109.716 178.978 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -106.21 73.53 0.99 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.292 -0.413 . . . . 15.0 112.101 -179.017 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.516 ' HB3' ' HB ' ' A' ' 85' ' ' VAL . 9.7 tp -88.25 160.28 17.75 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.219 -0.446 . . . . 15.0 109.867 178.809 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.544 ' C ' ' H ' ' A' ' 14' ' ' ASN . . . -96.94 95.0 7.53 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.683 0.277 . . . . 15.0 111.716 -179.62 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.428 ' HB2' ' CG2' ' A' ' 85' ' ' VAL . 0.6 OUTLIER -65.82 28.53 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 112.619 0.6 . . . . 15.0 112.619 179.565 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.544 ' H ' ' C ' ' A' ' 12' ' ' ALA . 76.7 m-20 -109.97 -62.64 1.48 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.744 0.307 . . . . 15.0 111.154 -179.658 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -48.83 -43.77 38.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.272 -0.422 . . . . 15.0 111.05 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 7.9 m-80 -165.41 172.2 12.49 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.14 -0.482 . . . . 15.0 110.811 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.403 ' O ' ' CB ' ' A' ' 45' ' ' ALA . 0.6 OUTLIER -86.07 -168.85 2.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 15.0 110.696 179.834 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 51.2 mt -86.54 -170.26 3.0 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 116.153 -0.476 . . . . 15.0 110.699 179.469 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.775 ' HA3' ' HA3' ' A' ' 44' ' ' GLY . . . -170.86 45.33 0.19 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.729 -0.748 . . . . 15.0 112.347 -179.72 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.739 HG12 ' O ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -112.52 139.12 38.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 120.827 0.346 . . . . 15.0 111.231 -179.913 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.422 ' HB3' HD13 ' A' ' 41' ' ' ILE . 13.0 t -90.28 103.32 16.01 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.419 -0.956 . . . . 15.0 108.419 177.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.461 HG22 ' CD2' ' A' ' 71' ' ' HIS . 34.7 m -93.94 155.81 3.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 112.645 0.609 . . . . 15.0 112.645 -177.443 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.36 -177.08 5.64 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.31 -0.859 . . . . 15.0 110.779 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.421 ' O ' ' HB3' ' A' ' 71' ' ' HIS . . . 68.83 -119.46 9.87 Favored Glycine 0 C--N 1.332 0.336 0 C-N-CA 120.84 -0.695 . . . . 15.0 112.532 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.525 ' HA3' ' N ' ' A' ' 71' ' ' HIS . . . 68.11 -66.26 0.36 Allowed Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.833 -0.698 . . . . 15.0 113.492 179.466 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.424 ' N ' ' HA ' ' A' ' 70' ' ' THR . 1.7 m -30.36 144.74 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 N-CA-C 112.384 0.513 . . . . 15.0 112.384 -179.322 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 49.5 t-20 -75.68 61.08 1.33 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.964 -0.562 . . . . 15.0 110.935 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.4 m -151.73 -66.37 0.18 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.204 -0.453 . . . . 15.0 111.028 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.8 m -68.43 -42.59 78.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.213 -0.449 . . . . 15.0 111.084 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.426 HG13 ' CD1' ' A' ' 36' ' ' TYR . 16.6 m -75.12 -173.01 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.269 -0.423 . . . . 15.0 111.202 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.02 -58.36 6.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.204 -0.453 . . . . 15.0 110.934 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 93.0 m-70 -137.12 -54.56 0.7 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.23 -0.441 . . . . 15.0 111.061 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -167.76 22.05 0.1 Allowed Glycine 0 CA--C 1.517 0.215 0 C-N-CA 120.807 -0.711 . . . . 15.0 112.756 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -85.63 152.86 26.71 Favored Glycine 0 N--CA 1.449 -0.453 0 N-CA-C 110.882 -0.887 . . . . 15.0 110.882 178.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.491 HG21 HG22 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -89.73 154.39 3.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 117.522 0.661 . . . . 15.0 111.929 -179.357 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.446 ' CE2' ' HG2' ' A' ' 57' ' ' ARG . 35.3 m-85 -139.28 107.86 5.88 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.98 -1.009 . . . . 15.0 109.998 178.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.57 HG21 ' N ' ' A' ' 55' ' ' GLY . 0.6 OUTLIER -55.29 156.22 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.857 -0.61 . . . . 15.0 111.037 -179.097 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.538 ' O ' ' HG2' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -91.09 -47.24 7.66 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.344 -0.984 . . . . 15.0 108.344 178.526 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.739 ' O ' HG12 ' A' ' 20' ' ' ILE . . . -172.48 171.96 4.49 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.329 -0.85 . . . . 15.0 110.062 178.611 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.549 ' HA ' ' CG1' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -96.45 108.41 21.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 109.178 -0.675 . . . . 15.0 109.178 179.191 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.735 ' HB ' ' O ' ' A' ' 19' ' ' GLY . 0.7 OUTLIER -77.99 118.43 72.11 Favored Pre-proline 0 C--N 1.328 -0.362 0 N-CA-C 113.528 0.936 . . . . 15.0 113.528 -176.904 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.524 ' HA ' ' CG ' ' A' ' 47' ' ' GLU . 36.8 Cg_endo -64.31 61.81 0.25 Allowed 'Trans proline' 0 C--N 1.356 0.971 0 C-N-CA 123.602 2.868 . . . . 15.0 112.907 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.509 ' H ' ' HG2' ' A' ' 47' ' ' GLU . 5.4 mm100 -149.42 -46.42 0.14 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.513 -0.312 . . . . 15.0 111.398 179.779 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.775 ' HA3' ' HA3' ' A' ' 19' ' ' GLY . . . -87.88 167.74 36.82 Favored Glycine 0 C--N 1.33 0.204 0 C-N-CA 120.443 -0.884 . . . . 15.0 113.825 -179.249 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.403 ' CB ' ' O ' ' A' ' 17' ' ' SER . . . -59.61 -13.53 9.85 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.168 -0.516 . . . . 15.0 112.244 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.22 -55.99 6.28 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 120.701 0.286 . . . . 15.0 110.79 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.552 ' HG3' ' O ' ' A' ' 44' ' ' GLY . 2.9 pp20? -57.73 -42.48 83.95 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-N 115.973 -0.558 . . . . 15.0 110.45 179.144 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 32.8 t -53.51 -69.44 0.12 Allowed 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 115.804 -0.635 . . . . 15.0 110.459 -179.244 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.42 -42.04 90.92 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.07 -0.715 . . . . 15.0 109.07 178.729 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.75 43.02 9.34 Favored Glycine 0 N--CA 1.447 -0.622 0 CA-C-N 115.36 -0.836 . . . . 15.0 111.645 179.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.479 ' HB3' ' CG2' ' A' ' 9' ' ' VAL . 0.7 OUTLIER -79.89 -41.63 25.79 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.712 0.291 . . . . 15.0 111.071 -179.111 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.541 ' CG2' HG12 ' A' ' 37' ' ' VAL . 5.9 mm -91.25 161.49 2.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 120.921 0.391 . . . . 15.0 110.922 179.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . 0.465 ' N ' ' CG2' ' A' ' 52' ' ' ILE . 75.8 m80 -142.38 154.91 45.03 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-O 121.447 0.641 . . . . 15.0 111.083 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.538 ' HG2' ' O ' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -37.68 133.13 0.83 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.552 -1.203 . . . . 15.0 112.934 -178.552 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.57 ' N ' HG21 ' A' ' 37' ' ' VAL . . . 50.05 33.48 21.87 Favored Glycine 0 C--N 1.335 0.489 0 CA-C-N 115.822 -0.626 . . . . 15.0 113.716 179.243 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -65.34 130.71 44.3 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 117.178 0.489 . . . . 15.0 110.181 179.16 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.446 ' HG2' ' CE2' ' A' ' 36' ' ' TYR . 30.9 mtt180 -83.28 94.83 8.0 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.341 -0.39 . . . . 15.0 110.522 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.491 HG22 HG21 ' A' ' 35' ' ' ILE . 1.1 m -87.87 117.22 31.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 121.039 0.447 . . . . 15.0 111.055 -179.713 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.422 ' CD2' ' N ' ' A' ' 59' ' ' LEU . 2.9 mm? -107.17 -14.23 14.96 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 115.797 -0.638 . . . . 15.0 112.567 -179.129 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -149.98 146.56 27.08 Favored 'General case' 0 N--CA 1.462 0.162 0 N-CA-C 112.591 0.589 . . . . 15.0 112.591 -178.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.446 ' HA ' ' HG ' ' A' ' 87' ' ' LEU . 45.9 t -139.25 100.26 1.37 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.224 0 CA-C-N 115.32 -0.854 . . . . 15.0 109.385 178.751 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 65.05 16.57 10.64 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.086 -0.507 . . . . 15.0 109.937 -178.157 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 107.05 4.39 35.83 Favored Glycine 0 C--N 1.336 0.531 0 CA-C-N 115.848 -0.614 . . . . 15.0 113.387 179.601 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.501 ' O ' ' CG1' ' A' ' 64' ' ' VAL . 4.3 p -93.79 107.04 18.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 121.087 0.47 . . . . 15.0 110.78 179.499 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -57.55 130.73 47.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 15.0 111.049 -179.526 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -87.69 -27.06 22.65 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.067 -0.515 . . . . 15.0 110.811 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 82.2 mt-10 -47.39 103.49 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.338 -0.392 . . . . 15.0 111.019 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.8 58.73 0.54 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.756 -0.735 . . . . 15.0 112.425 -179.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -173.1 165.61 4.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.901 0.382 . . . . 15.0 111.07 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.424 ' HA ' ' N ' ' A' ' 26' ' ' VAL . 17.3 p -93.13 -172.93 3.11 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.095 -0.502 . . . . 15.0 111.046 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.525 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 0.0 OUTLIER -63.07 -59.7 4.43 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.797 -0.638 . . . . 15.0 110.563 -179.924 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 7.6 ttpt -52.56 -33.77 47.28 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.838 -0.619 . . . . 15.0 110.807 179.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 7.0 mt-30 -59.5 -50.79 72.57 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.688 -0.486 . . . . 15.0 109.688 179.339 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.459 ' O ' ' N ' ' A' ' 77' ' ' THR . . . -66.97 -43.82 82.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.95 -0.568 . . . . 15.0 109.697 178.416 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.444 ' CG2' ' CG2' ' A' ' 22' ' ' VAL . 0.5 OUTLIER -43.34 -41.76 1.35 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.289 0 N-CA-C 108.878 -0.786 . . . . 15.0 108.878 178.319 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.407 ' O ' ' CB ' ' A' ' 80' ' ' ASN . 2.0 mt-10 -67.17 -44.3 80.07 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 114.822 -1.081 . . . . 15.0 110.022 178.323 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.459 ' N ' ' O ' ' A' ' 74' ' ' ALA . 59.4 p -64.06 -54.38 34.96 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-N 116.665 -0.243 . . . . 15.0 111.596 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.438 ' HG ' ' O ' ' A' ' 74' ' ' ALA . 8.8 mt -53.45 -48.98 68.35 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.317 0.58 . . . . 15.0 110.03 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.44 -59.15 3.38 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.251 -0.886 . . . . 15.0 110.723 179.722 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.407 ' CB ' ' O ' ' A' ' 76' ' ' GLU . 71.4 m-20 -65.97 62.87 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.1 -0.5 . . . . 15.0 111.909 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.46 -73.66 0.58 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 110.146 -0.316 . . . . 15.0 110.146 179.205 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 122.15 -105.4 0.98 Allowed Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.696 -0.764 . . . . 15.0 113.268 179.048 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.402 ' O ' ' HB3' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -64.88 -83.64 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.761 0.315 . . . . 15.0 111.18 -179.39 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.423 HG13 ' N ' ' A' ' 85' ' ' VAL . 79.7 t -109.82 160.18 8.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.257 -0.428 . . . . 15.0 110.864 -179.755 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.516 ' HB ' ' HB3' ' A' ' 11' ' ' LEU . 3.6 t -97.63 81.64 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.137 0.494 . . . . 15.0 110.18 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -96.41 80.23 3.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.727 -0.669 . . . . 15.0 110.391 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.451 ' CD2' ' CD2' ' A' ' 89' ' ' LEU . 0.1 OUTLIER -102.12 124.68 48.15 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.063 -0.517 . . . . 15.0 111.649 -179.269 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.47 HD11 ' CB ' ' A' ' 8' ' ' GLU . 4.7 mp -102.01 99.01 9.13 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.658 -0.497 . . . . 15.0 109.658 178.825 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.451 ' CD2' ' CD2' ' A' ' 87' ' ' LEU . 0.1 OUTLIER -102.93 -161.42 0.84 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.383 0.611 . . . . 15.0 111.841 -178.772 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.433 ' HB2' HG13 ' A' ' 6' ' ' ILE . 3.1 tt0 -140.93 144.01 34.92 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.059 -0.973 . . . . 15.0 109.772 179.108 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 7.1 tptp -55.17 104.95 0.14 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.877 0.37 . . . . 15.0 110.961 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -62.42 105.91 1.1 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.845 -0.693 . . . . 15.0 112.6 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -84.21 108.83 17.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.855 0.36 . . . . 15.0 110.849 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -86.55 139.43 33.6 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.19 -0.459 . . . . 15.0 110.911 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -53.28 -46.92 30.41 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.501 2.134 . . . . 15.0 112.267 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 17.1 m . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.217 -0.897 . . . . 15.0 110.915 179.971 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo . . . . . 0 N--CA 1.487 1.138 0 CA-C-O 120.852 0.272 . . . . 15.0 111.745 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -155.18 159.36 31.83 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.149 -0.478 . . . . 15.0 110.782 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -56.46 -164.05 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.585 2.19 . . . . 15.0 112.19 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 85.69 -17.24 36.47 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.533 -0.841 . . . . 15.0 112.505 -179.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -62.01 162.88 8.59 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-O 121.226 0.536 . . . . 15.0 110.941 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.442 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 1.3 mp -104.38 146.2 12.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.318 -0.856 . . . . 15.0 111.176 -179.226 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.463 ' O ' ' N ' ' A' ' 89' ' ' LEU . 6.8 p90 -140.64 164.31 30.53 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.063 -0.517 . . . . 15.0 110.203 178.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.493 ' HB2' HD11 ' A' ' 88' ' ' LEU . 0.3 OUTLIER -130.2 143.24 50.66 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.284 0.564 . . . . 15.0 111.66 -179.506 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.439 ' CG2' ' HB3' ' A' ' 51' ' ' ARG . 0.2 OUTLIER -101.42 114.35 40.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.184 -0.916 . . . . 15.0 109.397 178.859 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -106.01 72.25 0.93 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.213 -0.449 . . . . 15.0 112.137 -178.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.408 ' HB3' ' HB ' ' A' ' 85' ' ' VAL . 5.4 tp -88.21 166.39 14.39 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.429 -0.582 . . . . 15.0 109.429 178.61 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -96.02 97.66 9.77 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.05 0.453 . . . . 15.0 111.262 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.48 ' O ' ' HD3' ' A' ' 13' ' ' LYS . 0.1 OUTLIER -63.88 -29.44 70.62 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.735 -0.666 . . . . 15.0 111.42 -179.861 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 22.9 t30 -84.3 -30.9 25.21 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.426 -0.352 . . . . 15.0 111.039 -179.524 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -77.59 -37.01 51.36 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.03 0.443 . . . . 15.0 110.132 179.319 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -165.6 156.12 13.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.802 -0.635 . . . . 15.0 110.702 179.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.452 ' O ' ' CB ' ' A' ' 45' ' ' ALA . 0.3 OUTLIER -85.86 -162.83 0.78 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.421 -0.354 . . . . 15.0 110.163 179.589 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.4 mp -108.2 -175.72 2.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.955 0.407 . . . . 15.0 110.715 179.452 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.787 ' O ' ' HB ' ' A' ' 41' ' ' ILE . . . -161.12 46.07 0.39 Allowed Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 121.034 -0.603 . . . . 15.0 111.794 -179.791 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.746 HG12 ' O ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -112.77 136.67 48.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 120.927 0.394 . . . . 15.0 111.581 -179.609 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 37.4 t -88.65 103.13 15.64 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.285 -1.006 . . . . 15.0 108.285 177.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.527 HG21 HG22 ' A' ' 75' ' ' VAL . 8.0 m -93.6 149.11 4.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 112.643 0.609 . . . . 15.0 112.643 -177.433 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.478 ' HA ' ' CE1' ' A' ' 71' ' ' HIS . 5.4 t -150.02 179.24 8.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.39 -0.823 . . . . 15.0 110.468 179.185 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.482 ' O ' ' HB2' ' A' ' 71' ' ' HIS . . . 82.78 -117.32 4.38 Favored Glycine 0 C--N 1.331 0.298 0 C-N-CA 120.542 -0.837 . . . . 15.0 112.649 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.572 ' HA3' ' N ' ' A' ' 71' ' ' HIS . . . 63.34 -65.87 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 121.084 -0.579 . . . . 15.0 113.742 179.184 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.439 ' N ' ' O ' ' A' ' 24' ' ' GLY . 0.0 OUTLIER -26.57 139.86 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 N-CA-C 112.633 0.605 . . . . 15.0 112.633 -178.994 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.421 ' HA ' ' O ' ' A' ' 32' ' ' HIS . 54.2 t-20 -77.62 57.67 1.65 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.768 -0.651 . . . . 15.0 110.927 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 5.9 m -151.69 -61.18 0.17 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.24 -0.437 . . . . 15.0 110.767 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.64 -34.77 77.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.15 -0.477 . . . . 15.0 110.692 179.755 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 33.2 m -88.02 -174.34 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.064 -0.516 . . . . 15.0 111.003 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -70.53 -51.5 28.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.394 -0.367 . . . . 15.0 111.241 -179.764 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . 0.421 ' O ' ' HA ' ' A' ' 27' ' ' ASN . 86.4 m-70 -132.52 -70.97 0.54 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.401 -0.363 . . . . 15.0 111.255 -179.745 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -162.75 24.84 0.21 Allowed Glycine 0 C--O 1.23 -0.145 0 C-N-CA 120.904 -0.665 . . . . 15.0 112.388 -179.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -86.89 148.19 21.5 Favored Glycine 0 N--CA 1.448 -0.522 0 N-CA-C 110.171 -1.172 . . . . 15.0 110.171 178.658 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.534 HG13 ' HA ' ' A' ' 71' ' ' HIS . 0.3 OUTLIER -88.68 153.78 3.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 C-N-CA 119.574 -0.85 . . . . 15.0 112.297 -178.894 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.477 ' CE2' ' CG ' ' A' ' 57' ' ' ARG . 32.4 m-85 -134.16 107.89 7.97 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.644 -1.162 . . . . 15.0 109.056 179.321 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.633 HG21 ' N ' ' A' ' 55' ' ' GLY . 0.7 OUTLIER -54.96 148.02 3.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.144 0.497 . . . . 15.0 111.189 -178.479 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.433 ' O ' ' HG2' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -80.05 -49.06 12.31 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.882 -0.784 . . . . 15.0 108.882 178.91 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.746 ' O ' HG12 ' A' ' 20' ' ' ILE . . . -172.33 172.45 4.46 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 115.999 -0.546 . . . . 15.0 110.184 178.439 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.544 ' HA ' ' CG1' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -96.72 110.01 24.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 108.957 -0.757 . . . . 15.0 108.957 178.905 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.787 ' HB ' ' O ' ' A' ' 19' ' ' GLY . 0.5 OUTLIER -78.0 115.25 48.98 Favored Pre-proline 0 C--N 1.326 -0.433 0 N-CA-C 113.275 0.843 . . . . 15.0 113.275 -177.053 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.543 ' HA ' ' CG ' ' A' ' 47' ' ' GLU . 30.3 Cg_exo -62.56 59.49 0.14 Allowed 'Trans proline' 0 C--N 1.358 1.07 0 C-N-CA 123.612 2.875 . . . . 15.0 112.95 179.706 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.509 ' N ' ' HG2' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -147.45 -47.38 0.17 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.594 0.235 . . . . 15.0 111.341 -179.985 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.717 ' HA3' ' HA3' ' A' ' 19' ' ' GLY . . . -87.67 168.89 38.37 Favored Glycine 0 C--N 1.33 0.217 0 C-N-CA 120.398 -0.906 . . . . 15.0 113.801 -179.136 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.452 ' CB ' ' O ' ' A' ' 17' ' ' SER . . . -58.12 -13.78 5.52 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.702 0.63 . . . . 15.0 112.702 -179.673 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.03 -56.46 5.59 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.97 -0.292 . . . . 15.0 110.69 -179.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.564 ' HG3' ' O ' ' A' ' 44' ' ' GLY . 2.8 pp20? -57.61 -43.33 84.68 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.997 -0.547 . . . . 15.0 110.434 179.172 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -53.81 -70.21 0.1 Allowed 'General case' 0 CA--C 1.518 -0.256 0 CA-C-N 115.902 -0.59 . . . . 15.0 110.523 -179.473 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.406 ' CB ' HD13 ' A' ' 11' ' ' LEU . 0.1 OUTLIER -58.13 -41.59 83.99 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.137 -0.69 . . . . 15.0 109.137 178.786 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.72 40.49 12.26 Favored Glycine 0 N--CA 1.445 -0.702 0 CA-C-N 115.305 -0.861 . . . . 15.0 111.676 179.309 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.439 ' HB3' ' CG2' ' A' ' 9' ' ' VAL . 0.1 OUTLIER -79.74 -49.9 11.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.891 0.376 . . . . 15.0 110.65 -179.351 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.433 ' CD1' HD12 ' A' ' 89' ' ' LEU . 8.8 tp -81.14 161.21 3.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.02 -0.536 . . . . 15.0 110.241 179.464 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . 0.496 ' O ' HG21 ' A' ' 37' ' ' VAL . 75.2 m80 -146.07 156.77 43.69 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-O 121.581 0.705 . . . . 15.0 112.258 -179.047 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.519 ' HA ' ' CG2' ' A' ' 37' ' ' VAL . 0.6 OUTLIER -43.28 132.51 4.37 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.3 -1.318 . . . . 15.0 112.902 -178.666 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.633 ' N ' HG21 ' A' ' 37' ' ' VAL . . . 50.98 29.87 21.34 Favored Glycine 0 C--N 1.335 0.475 0 CA-C-N 115.785 -0.643 . . . . 15.0 113.456 179.137 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.444 ' OD2' ' N ' ' A' ' 53' ' ' HIS . 6.4 m-20 -65.76 128.81 37.46 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.827 -0.349 . . . . 15.0 110.51 179.516 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.477 ' CG ' ' CE2' ' A' ' 36' ' ' TYR . 2.3 mtp85 -80.62 95.45 6.56 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.476 -0.329 . . . . 15.0 110.663 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.468 ' O ' ' CG2' ' A' ' 58' ' ' VAL . 1.5 m -85.76 113.42 23.91 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-O 121.094 0.474 . . . . 15.0 111.177 -179.654 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -107.35 -12.08 15.41 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 115.677 -0.692 . . . . 15.0 112.505 -179.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -150.71 148.25 28.33 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 112.762 0.653 . . . . 15.0 112.762 -178.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.439 ' HB ' ' CG1' ' A' ' 64' ' ' VAL . 15.4 t -139.12 99.51 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.231 -0.895 . . . . 15.0 109.107 178.741 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 9.2 m120 65.22 16.41 10.53 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.871 -0.418 . . . . 15.0 109.871 -177.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 107.2 4.93 35.3 Favored Glycine 0 C--N 1.336 0.544 0 CA-C-N 116.039 -0.528 . . . . 15.0 113.465 179.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.502 ' O ' ' CG1' ' A' ' 64' ' ' VAL . 5.2 p -93.8 106.37 17.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 117.168 0.484 . . . . 15.0 110.783 179.506 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.2 m -56.33 130.15 43.38 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.171 -0.468 . . . . 15.0 111.051 -179.609 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -89.44 -21.38 23.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.075 -0.511 . . . . 15.0 110.997 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -45.76 101.5 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.869 0.366 . . . . 15.0 111.062 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.78 63.11 0.55 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.791 -0.718 . . . . 15.0 112.4 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -173.02 160.59 4.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.89 0.376 . . . . 15.0 111.035 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.439 ' HA ' ' C ' ' A' ' 25' ' ' GLY . 3.0 p -93.17 -170.54 2.43 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.084 0.468 . . . . 15.0 111.055 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.572 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 0.2 OUTLIER -60.75 -61.02 2.89 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.691 -0.686 . . . . 15.0 110.13 179.908 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.451 ' O ' HG11 ' A' ' 75' ' ' VAL . 12.7 ttpp -53.21 -34.79 58.55 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.716 -0.674 . . . . 15.0 110.863 179.234 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -59.42 -54.9 41.37 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.645 -0.502 . . . . 15.0 109.645 179.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.428 ' O ' ' N ' ' A' ' 77' ' ' THR . . . -63.9 -43.55 95.65 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.823 -0.626 . . . . 15.0 109.536 178.458 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.527 HG22 HG21 ' A' ' 22' ' ' VAL . 0.5 OUTLIER -44.25 -40.06 1.68 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.296 0 N-CA-C 108.771 -0.825 . . . . 15.0 108.771 178.176 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.528 ' O ' ' HB2' ' A' ' 80' ' ' ASN . 3.6 mm-40 -67.42 -45.01 77.39 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 114.793 -1.094 . . . . 15.0 110.302 178.377 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.428 ' N ' ' O ' ' A' ' 74' ' ' ALA . 32.9 p -64.02 -54.64 31.08 Favored 'General case' 0 C--O 1.231 0.124 0 C-N-CA 121.055 -0.258 . . . . 15.0 111.509 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.424 ' HG ' ' O ' ' A' ' 74' ' ' ALA . 6.5 mt -53.37 -46.6 69.68 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-O 121.262 0.553 . . . . 15.0 109.8 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.407 ' HB2' ' O ' ' A' ' 75' ' ' VAL . 8.9 tpp180 -68.49 -59.81 2.88 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.266 -0.879 . . . . 15.0 110.5 179.284 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.528 ' HB2' ' O ' ' A' ' 76' ' ' GLU . 10.9 m-80 -66.12 62.11 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.98 -0.554 . . . . 15.0 111.833 179.801 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.452 ' HB ' ' HG3' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -93.74 -74.16 0.54 Allowed 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.804 -0.443 . . . . 15.0 109.804 179.182 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 122.03 -106.15 1.05 Allowed Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.802 -0.713 . . . . 15.0 113.195 179.019 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -64.7 -82.13 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 111.984 0.365 . . . . 15.0 111.984 -179.067 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.417 HG13 ' N ' ' A' ' 85' ' ' VAL . 62.4 t -109.87 158.29 10.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.06 0.457 . . . . 15.0 110.87 -179.335 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.428 ' O ' ' CG1' ' A' ' 85' ' ' VAL . 14.0 t -97.93 80.96 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 116.084 -0.507 . . . . 15.0 110.569 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -103.13 83.39 2.2 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.901 -0.591 . . . . 15.0 110.265 179.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.443 ' CD2' ' CD2' ' A' ' 89' ' ' LEU . 0.1 OUTLIER -99.93 118.32 36.11 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.952 -0.567 . . . . 15.0 111.756 -179.088 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.493 HD11 ' HB2' ' A' ' 8' ' ' GLU . 4.3 mp -92.14 101.1 13.62 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.757 -0.46 . . . . 15.0 109.757 178.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.468 HD22 ' HA ' ' A' ' 58' ' ' VAL . 0.2 OUTLIER -105.65 -159.71 0.72 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.303 0.573 . . . . 15.0 111.66 -178.836 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.442 ' HA ' ' HA ' ' A' ' 6' ' ' ILE . 3.1 tt0 -140.58 145.23 36.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.311 -0.859 . . . . 15.0 110.195 179.243 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.85 106.87 0.34 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.249 -0.432 . . . . 15.0 110.977 -179.837 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -69.59 167.03 48.2 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.842 -0.695 . . . . 15.0 112.581 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -86.2 142.77 28.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.783 0.325 . . . . 15.0 110.896 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -81.76 150.63 66.41 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.224 -0.444 . . . . 15.0 110.884 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_exo -51.47 -53.25 7.4 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.594 2.196 . . . . 15.0 112.34 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 23.3 m . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.206 -0.902 . . . . 15.0 110.861 -179.996 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_endo . . . . . 0 N--CA 1.488 1.187 0 CA-C-O 120.857 0.274 . . . . 15.0 111.81 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 13.9 pttp -149.49 129.08 6.43 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 15.0 110.867 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.9 -160.26 0.07 OUTLIER 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.491 2.127 . . . . 15.0 112.222 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 92.18 -25.94 15.37 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.622 -0.799 . . . . 15.0 112.18 -179.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -62.33 133.88 55.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.271 0.558 . . . . 15.0 110.633 179.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.499 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 1.5 mp -104.46 144.98 13.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.342 -0.844 . . . . 15.0 111.301 -179.188 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.433 ' O ' ' N ' ' A' ' 89' ' ' LEU . 3.8 p90 -144.56 165.03 29.15 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.061 -0.518 . . . . 15.0 110.415 178.799 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.492 ' CB ' HD11 ' A' ' 88' ' ' LEU . 10.7 pt-20 -130.19 143.84 51.01 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.201 0.524 . . . . 15.0 111.6 -179.05 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.429 ' N ' ' O ' ' A' ' 87' ' ' LEU . 0.2 OUTLIER -101.64 117.13 46.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.441 -0.799 . . . . 15.0 109.542 178.615 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 -106.14 74.86 1.06 Allowed 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 112.33 0.493 . . . . 15.0 112.33 -178.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.498 ' HB3' ' HB ' ' A' ' 85' ' ' VAL . 6.8 tp -88.19 166.34 14.44 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.389 -0.597 . . . . 15.0 109.389 178.43 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -96.2 95.76 8.35 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.041 0.448 . . . . 15.0 111.28 -179.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.51 ' O ' ' HD3' ' A' ' 13' ' ' LYS . 0.2 OUTLIER -60.47 -26.03 66.48 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.73 -0.668 . . . . 15.0 111.195 179.869 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 54.1 m-20 -83.81 -39.69 19.67 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.322 -0.399 . . . . 15.0 110.641 -179.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -69.98 -37.68 75.8 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.078 0.466 . . . . 15.0 109.994 179.243 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -165.52 163.21 19.5 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.73 -0.668 . . . . 15.0 110.673 179.572 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.431 ' O ' ' HB2' ' A' ' 45' ' ' ALA . 1.5 m -85.97 -137.73 0.08 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.333 -0.394 . . . . 15.0 110.052 179.651 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.0 mp -116.87 -174.54 2.6 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 120.826 0.346 . . . . 15.0 110.561 179.318 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.629 ' O ' ' HB ' ' A' ' 41' ' ' ILE . . . -160.99 36.86 0.42 Allowed Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 121.136 -0.554 . . . . 15.0 111.782 -179.636 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.595 HG12 ' O ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -112.66 141.68 27.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 120.996 0.427 . . . . 15.0 112.027 -179.291 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 31.4 t -96.24 102.69 14.52 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 107.301 -1.37 . . . . 15.0 107.301 176.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.423 ' CG1' ' CG2' ' A' ' 20' ' ' ILE . 14.1 m -93.33 148.26 4.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 113.536 0.939 . . . . 15.0 113.536 -176.293 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.533 ' O ' ' O ' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -149.86 157.92 43.66 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.005 -0.998 . . . . 15.0 110.699 179.586 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.425 ' O ' HG12 ' A' ' 35' ' ' ILE . . . 67.71 112.67 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.444 -0.884 . . . . 15.0 113.42 178.653 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.506 ' HA3' ' N ' ' A' ' 71' ' ' HIS . . . -163.74 -38.97 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 121.112 -0.566 . . . . 15.0 112.301 179.244 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.472 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 0.2 OUTLIER -40.78 162.58 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-O 120.868 0.366 . . . . 15.0 111.823 179.935 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -87.91 51.72 2.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.454 . . . . 15.0 110.887 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -151.63 -62.15 0.17 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.094 -0.503 . . . . 15.0 110.663 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.75 -52.34 51.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.192 -0.458 . . . . 15.0 110.609 179.753 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 16.4 m -87.98 -177.68 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.137 -0.483 . . . . 15.0 110.771 179.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 5.1 ppt_? -88.41 127.1 35.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.851 0.358 . . . . 15.0 111.184 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 57.1 m80 62.76 -82.14 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.005 -0.543 . . . . 15.0 111.424 179.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -177.25 33.08 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.721 -0.752 . . . . 15.0 112.661 -179.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -93.52 156.35 22.58 Favored Glycine 0 N--CA 1.45 -0.388 0 N-CA-C 110.846 -0.902 . . . . 15.0 110.846 179.079 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.474 HG21 HG22 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -97.64 153.6 3.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 119.854 -0.738 . . . . 15.0 111.997 -179.29 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.533 ' O ' ' O ' ' A' ' 23' ' ' THR . 26.8 m-85 -134.17 106.82 7.37 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.963 -1.017 . . . . 15.0 109.7 179.225 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.653 HG21 ' N ' ' A' ' 55' ' ' GLY . 0.7 OUTLIER -54.63 146.64 3.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.106 0.479 . . . . 15.0 111.282 -178.593 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.462 ' HB3' ' OG1' ' A' ' 23' ' ' THR . 0.0 OUTLIER -79.94 -48.87 12.71 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.319 -0.993 . . . . 15.0 108.319 178.78 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.595 ' O ' HG12 ' A' ' 20' ' ' ILE . . . -172.23 171.07 4.95 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.285 -0.87 . . . . 15.0 110.119 178.612 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.517 ' HA ' HG12 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -97.1 110.26 24.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.085 0.469 . . . . 15.0 110.182 179.558 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.629 ' HB ' ' O ' ' A' ' 19' ' ' GLY . 0.4 OUTLIER -78.47 109.58 10.99 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 115.701 -0.682 . . . . 15.0 112.32 -178.326 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.471 ' HA ' ' CG ' ' A' ' 47' ' ' GLU . 31.4 Cg_endo -63.45 65.88 0.18 Allowed 'Trans proline' 0 C--N 1.355 0.919 0 C-N-CA 123.159 2.572 . . . . 15.0 112.568 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 5.2 tp60 -147.32 -53.34 0.21 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.322 -0.854 . . . . 15.0 109.112 179.469 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.551 ' HA3' ' HA3' ' A' ' 19' ' ' GLY . . . -87.93 157.18 28.19 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.667 -0.778 . . . . 15.0 112.51 179.175 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.431 ' HB2' ' O ' ' A' ' 17' ' ' SER . . . -41.58 -17.38 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 113.588 0.958 . . . . 15.0 113.588 -179.531 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.43 ' N ' ' O ' ' A' ' 44' ' ' GLY . . . -71.65 -70.72 0.31 Allowed 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.75 -0.38 . . . . 15.0 111.345 -179.409 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.497 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 4.3 tp10 -58.54 -40.6 83.43 Favored 'General case' 0 N--CA 1.463 0.179 0 C-N-CA 120.587 -0.445 . . . . 15.0 110.436 179.546 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.8 m -54.15 -63.56 1.11 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.997 -0.547 . . . . 15.0 110.338 179.355 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.421 ' CB ' HD13 ' A' ' 11' ' ' LEU . 1.9 t70 -63.5 -40.05 96.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.108 -0.496 . . . . 15.0 109.899 179.081 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.58 43.37 8.49 Favored Glycine 0 N--CA 1.449 -0.437 0 CA-C-N 115.678 -0.692 . . . . 15.0 112.836 179.472 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.421 ' HB3' ' CG2' ' A' ' 9' ' ' VAL . 1.1 mmt-85 -89.34 -52.81 4.85 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.938 0.399 . . . . 15.0 110.557 179.696 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.47 HG21 ' CG1' ' A' ' 40' ' ' VAL . 9.7 tp -81.0 159.16 4.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.036 -0.529 . . . . 15.0 110.398 179.546 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . 0.456 ' O ' HG21 ' A' ' 37' ' ' VAL . 80.3 m80 -139.69 160.88 38.87 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-O 121.794 0.807 . . . . 15.0 112.758 -178.871 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.53 ' HA ' ' CG2' ' A' ' 37' ' ' VAL . 0.2 OUTLIER -44.67 134.29 5.53 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.002 -1.453 . . . . 15.0 113.1 -178.657 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.653 ' N ' HG21 ' A' ' 37' ' ' VAL . . . 49.66 31.8 15.97 Favored Glycine 0 C--N 1.334 0.442 0 CA-C-N 115.738 -0.664 . . . . 15.0 113.636 178.802 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.48 ' HB2' HG12 ' A' ' 37' ' ' VAL . 0.3 OUTLIER -65.97 131.71 46.88 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.506 -0.478 . . . . 15.0 110.683 179.442 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.486 ' HG2' ' CE2' ' A' ' 36' ' ' TYR . 6.6 mtp85 -82.65 87.41 6.73 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.351 -0.386 . . . . 15.0 110.113 179.411 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.474 HG22 HG21 ' A' ' 35' ' ' ILE . 1.3 m -79.31 113.25 18.4 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 CA-C-O 121.158 0.504 . . . . 15.0 111.087 -179.379 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 21.3 mt -107.56 -14.48 14.82 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 115.472 -0.786 . . . . 15.0 112.493 -179.173 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -147.5 150.41 34.51 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.604 0.594 . . . . 15.0 112.604 -178.414 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.452 HG22 HD23 ' A' ' 87' ' ' LEU . 80.9 t -139.05 102.72 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.175 -0.92 . . . . 15.0 109.018 178.746 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.41 ' ND2' ' CG2' ' A' ' 81' ' ' THR . 1.7 m-80 65.11 14.89 9.68 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.723 -0.473 . . . . 15.0 109.723 -177.901 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 106.4 6.71 35.72 Favored Glycine 0 C--N 1.336 0.566 0 CA-C-N 115.839 -0.619 . . . . 15.0 113.366 179.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.497 ' O ' ' CG1' ' A' ' 64' ' ' VAL . 6.5 p -93.79 104.96 16.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 117.17 0.485 . . . . 15.0 110.874 179.486 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 50.8 m -58.47 121.3 10.55 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.148 -0.478 . . . . 15.0 110.733 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -87.56 -10.04 52.7 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.031 -0.532 . . . . 15.0 111.185 -179.879 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -46.12 98.48 0.01 OUTLIER 'General case' 0 C--N 1.334 -0.105 0 CA-C-O 120.916 0.389 . . . . 15.0 110.799 179.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.94 68.66 0.62 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.75 -0.738 . . . . 15.0 112.193 -179.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -172.87 167.7 5.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.783 0.325 . . . . 15.0 110.863 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.472 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 7.0 p -92.98 -175.05 3.76 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.238 -0.437 . . . . 15.0 111.335 -179.604 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.506 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 0.0 OUTLIER -63.32 -61.2 2.51 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.928 -0.578 . . . . 15.0 110.283 -179.873 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.4 ' N ' ' CG ' ' A' ' 71' ' ' HIS . 3.0 ttpp -52.7 -33.06 45.92 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.772 -0.649 . . . . 15.0 110.732 179.568 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -59.41 -48.25 82.36 Favored 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 109.403 -0.591 . . . . 15.0 109.403 179.236 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.456 ' HA ' ' OG1' ' A' ' 77' ' ' THR . . . -65.37 -47.99 74.5 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.719 -0.673 . . . . 15.0 109.214 178.307 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.409 ' CG2' ' CG2' ' A' ' 22' ' ' VAL . 0.5 OUTLIER -43.39 -39.42 1.17 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.242 0 N-CA-C 108.74 -0.837 . . . . 15.0 108.74 178.07 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -67.31 -45.92 75.06 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 114.739 -1.119 . . . . 15.0 110.349 178.468 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.456 ' OG1' ' HA ' ' A' ' 74' ' ' ALA . 10.0 p -64.37 -53.18 52.6 Favored 'General case' 0 C--O 1.231 0.129 0 C-N-CA 120.893 -0.323 . . . . 15.0 111.309 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.441 ' HG ' ' O ' ' A' ' 74' ' ' ALA . 5.7 mt -53.36 -48.28 68.69 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-O 121.219 0.533 . . . . 15.0 109.944 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -68.4 -59.04 3.47 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.353 -0.84 . . . . 15.0 110.351 179.357 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 75.1 m-20 -66.02 61.47 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.846 -0.615 . . . . 15.0 111.911 179.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.46 ' HB ' ' HG3' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -95.72 -71.01 0.69 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.693 0.282 . . . . 15.0 110.51 179.519 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 122.15 -104.42 0.91 Allowed Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.824 -0.703 . . . . 15.0 113.186 179.345 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.408 ' O ' ' HB3' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -64.64 -83.41 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 111.965 0.357 . . . . 15.0 111.965 -179.066 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.426 HG13 ' N ' ' A' ' 85' ' ' VAL . 53.9 t -109.46 159.91 8.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.94 0.4 . . . . 15.0 110.839 -179.543 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.498 ' HB ' ' HB3' ' A' ' 11' ' ' LEU . 24.5 t -97.87 79.59 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.161 -0.472 . . . . 15.0 110.52 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -100.63 85.39 2.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.856 -0.611 . . . . 15.0 110.594 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.464 ' CD2' ' CD2' ' A' ' 89' ' ' LEU . 0.1 OUTLIER -99.57 123.11 43.53 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.083 -0.508 . . . . 15.0 111.513 -179.468 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.492 HD11 ' CB ' ' A' ' 8' ' ' GLU . 4.7 mp -98.5 100.74 12.02 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.891 -0.411 . . . . 15.0 109.891 179.014 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.464 ' CD2' ' CD2' ' A' ' 87' ' ' LEU . 0.1 OUTLIER -105.93 -162.29 0.85 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.428 0.632 . . . . 15.0 111.903 -178.87 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.499 ' HA ' ' HA ' ' A' ' 6' ' ' ILE . 3.1 tt0 -138.25 142.26 39.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 114.977 -1.01 . . . . 15.0 109.952 178.88 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 4.2 tptt -54.25 103.32 0.08 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.36 -0.382 . . . . 15.0 111.129 -179.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -72.09 145.44 37.93 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.862 -0.685 . . . . 15.0 112.522 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 15.1 tt0 -81.18 144.49 31.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.847 0.356 . . . . 15.0 110.892 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.25 111.76 48.83 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.161 -0.472 . . . . 15.0 110.972 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -58.44 149.67 73.1 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.48 2.12 . . . . 15.0 112.163 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 2.2 t . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.284 -0.865 . . . . 15.0 110.882 179.967 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo . . . . . 0 N--CA 1.487 1.12 0 CA-C-O 120.828 0.262 . . . . 15.0 111.709 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.497 ' CB ' ' HD3' ' A' ' 3' ' ' PRO . 22.3 mttt -155.33 -58.85 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.144 -0.48 . . . . 15.0 111.147 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.497 ' HD3' ' CB ' ' A' ' 2' ' ' LYS . 35.0 Cg_exo -57.65 -161.25 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.197 1.931 . . . . 15.0 112.17 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 87.15 -19.5 30.57 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.619 -0.801 . . . . 15.0 112.559 -179.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.0 160.1 13.06 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-O 121.341 0.591 . . . . 15.0 110.855 179.858 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.415 HG13 ' HB2' ' A' ' 90' ' ' GLU . 1.4 mp -104.58 142.66 17.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.168 -0.924 . . . . 15.0 111.181 -179.224 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.421 ' CE1' HD13 ' A' ' 89' ' ' LEU . 2.3 p90 -140.66 158.17 44.37 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.122 -0.49 . . . . 15.0 110.456 178.794 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.492 ' HB2' HD11 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -123.96 143.6 50.3 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.289 0.566 . . . . 15.0 111.566 -179.37 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.43 HG22 ' CG ' ' A' ' 51' ' ' ARG . 0.5 OUTLIER -101.31 114.6 41.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.295 -0.866 . . . . 15.0 109.6 179.08 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -106.24 70.38 0.84 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.261 -0.427 . . . . 15.0 112.021 -178.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.477 ' HB3' ' HB ' ' A' ' 85' ' ' VAL . 8.6 tp -88.26 162.1 16.82 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.137 -0.483 . . . . 15.0 110.007 179.069 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.553 ' C ' ' H ' ' A' ' 14' ' ' ASN . . . -96.58 99.28 10.92 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.703 0.287 . . . . 15.0 111.042 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.453 ' HB3' ' O ' ' A' ' 83' ' ' GLN . 0.3 OUTLIER -65.45 27.04 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 112.651 0.611 . . . . 15.0 112.651 -179.892 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.553 ' H ' ' C ' ' A' ' 12' ' ' ALA . 1.0 OUTLIER -109.69 150.26 28.55 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.672 0.272 . . . . 15.0 110.673 179.86 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.412 ' CB ' ' O ' ' A' ' 14' ' ' ASN . 5.9 t0 80.79 -46.48 0.26 Allowed 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.311 -0.404 . . . . 15.0 111.105 -179.811 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -154.94 158.53 39.38 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.775 0.322 . . . . 15.0 110.69 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.97 -163.0 0.8 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.342 -0.39 . . . . 15.0 110.845 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.9 mp -77.41 -168.35 1.13 Allowed 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 116.163 -0.471 . . . . 15.0 110.581 179.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.619 ' O ' ' HB ' ' A' ' 41' ' ' ILE . . . -160.78 38.42 0.43 Allowed Glycine 0 N--CA 1.449 -0.48 0 N-CA-C 111.527 -0.629 . . . . 15.0 111.527 -179.774 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.703 HG12 ' O ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -112.62 140.78 30.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-O 120.937 0.399 . . . . 15.0 111.835 -179.363 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.413 ' HB3' HD11 ' A' ' 41' ' ' ILE . 30.8 t -96.09 105.92 18.03 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 107.79 -1.189 . . . . 15.0 107.79 177.491 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.473 HG11 ' CG2' ' A' ' 20' ' ' ILE . 14.5 m -93.67 151.91 3.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 113.087 0.773 . . . . 15.0 113.087 -176.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -149.46 174.02 12.94 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 114.752 -1.113 . . . . 15.0 110.489 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.433 ' O ' ' CB ' ' A' ' 71' ' ' HIS . . . 80.94 -118.54 4.65 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.491 -0.861 . . . . 15.0 112.356 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.541 ' HA3' ' N ' ' A' ' 71' ' ' HIS . . . 66.66 -65.72 0.18 Allowed Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.967 -0.635 . . . . 15.0 113.497 179.268 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.417 ' C ' ' O ' ' A' ' 25' ' ' GLY . 0.0 OUTLIER -28.43 139.78 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 N-CA-C 112.38 0.511 . . . . 15.0 112.38 -179.188 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 11.2 m-80 -75.53 61.3 1.29 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.913 -0.585 . . . . 15.0 111.024 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -151.7 -64.46 0.18 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.28 -0.418 . . . . 15.0 110.927 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 59.7 p -69.1 -49.13 59.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.176 -0.465 . . . . 15.0 110.954 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.425 HG13 ' CD1' ' A' ' 36' ' ' TYR . 23.1 m -70.6 -173.56 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.159 -0.473 . . . . 15.0 111.114 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.69 -67.13 0.31 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.291 -0.413 . . . . 15.0 111.055 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 10.1 p-80 -139.32 -45.3 0.46 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.315 -0.402 . . . . 15.0 111.052 -179.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -168.38 25.54 0.12 Allowed Glycine 0 N--CA 1.453 -0.212 0 C-N-CA 120.894 -0.669 . . . . 15.0 112.508 -179.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -94.47 152.53 20.64 Favored Glycine 0 N--CA 1.448 -0.509 0 N-CA-C 110.443 -1.063 . . . . 15.0 110.443 178.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.563 HG13 ' HA ' ' A' ' 71' ' ' HIS . 0.1 OUTLIER -95.79 153.22 3.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 C-N-CA 119.731 -0.787 . . . . 15.0 112.329 -179.021 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.439 ' CZ ' ' HG2' ' A' ' 57' ' ' ARG . 29.3 m-85 -135.04 106.55 6.86 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.699 -1.137 . . . . 15.0 109.158 179.117 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.664 HG21 ' N ' ' A' ' 55' ' ' GLY . 0.8 OUTLIER -55.22 148.05 3.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.127 0.489 . . . . 15.0 111.571 -178.392 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.42 ' O ' ' HG2' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -80.37 -49.59 11.29 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.509 -0.923 . . . . 15.0 108.509 178.3 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.703 ' O ' HG12 ' A' ' 20' ' ' ILE . . . -172.17 172.71 4.5 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.963 -0.562 . . . . 15.0 110.879 178.808 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.5 ' HA ' ' CG1' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -96.81 112.72 29.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 N-CA-C 109.598 -0.519 . . . . 15.0 109.598 179.296 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.619 ' HB ' ' O ' ' A' ' 19' ' ' GLY . 0.3 OUTLIER -78.45 119.33 76.92 Favored Pre-proline 0 C--N 1.328 -0.327 0 N-CA-C 113.334 0.864 . . . . 15.0 113.334 -177.403 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.535 ' HA ' ' CG ' ' A' ' 47' ' ' GLU . 38.0 Cg_endo -65.15 61.1 0.32 Allowed 'Trans proline' 0 C--N 1.356 0.966 0 C-N-CA 123.448 2.766 . . . . 15.0 112.944 179.676 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.511 ' H ' ' HG2' ' A' ' 47' ' ' GLU . 0.1 OUTLIER -151.32 -44.75 0.11 Allowed 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 111.663 0.246 . . . . 15.0 111.663 179.903 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.577 ' HA3' ' HA3' ' A' ' 19' ' ' GLY . . . -87.71 165.54 35.16 Favored Glycine 0 CA--C 1.518 0.255 0 C-N-CA 120.328 -0.939 . . . . 15.0 113.719 -179.159 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -55.47 -15.88 3.19 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.796 0.665 . . . . 15.0 112.796 -179.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.2 -57.11 4.51 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.648 0.261 . . . . 15.0 111.204 -179.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.535 ' CG ' ' HA ' ' A' ' 42' ' ' PRO . 2.6 pp20? -56.93 -41.72 78.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.913 0.387 . . . . 15.0 110.386 179.711 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -53.91 -68.82 0.15 Allowed 'General case' 0 CA--C 1.52 -0.182 0 CA-C-N 115.91 -0.587 . . . . 15.0 110.851 -179.393 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -63.2 -39.13 93.75 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.57 -0.529 . . . . 15.0 109.57 179.13 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.07 45.55 7.52 Favored Glycine 0 N--CA 1.447 -0.595 0 CA-C-N 115.452 -0.795 . . . . 15.0 111.758 179.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.43 ' CG ' HG22 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -79.41 -53.15 7.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.966 0.413 . . . . 15.0 110.578 -179.377 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.415 ' CD1' HD12 ' A' ' 89' ' ' LEU . 7.9 tp -82.34 164.97 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 CA-C-N 115.947 -0.569 . . . . 15.0 110.392 179.676 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . 0.46 ' O ' ' HB2' ' A' ' 56' ' ' ASP . 76.3 m80 -147.68 158.01 43.81 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-O 121.674 0.75 . . . . 15.0 112.285 -179.147 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.511 ' HA ' ' CG2' ' A' ' 37' ' ' VAL . 8.5 mtpt -43.4 134.08 4.03 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.302 -1.317 . . . . 15.0 112.94 -178.617 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.664 ' N ' HG21 ' A' ' 37' ' ' VAL . . . 49.9 31.12 16.63 Favored Glycine 0 C--N 1.334 0.432 0 CA-C-N 115.692 -0.686 . . . . 15.0 113.659 179.051 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.483 ' HB2' HG12 ' A' ' 37' ' ' VAL . 0.4 OUTLIER -66.09 129.94 41.52 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 117.094 0.447 . . . . 15.0 110.786 179.563 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.439 ' HG2' ' CZ ' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -81.33 89.96 6.12 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.299 -0.41 . . . . 15.0 110.138 179.371 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.503 ' HA ' HD22 ' A' ' 89' ' ' LEU . 1.4 m -82.8 114.17 23.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 CA-C-O 121.073 0.463 . . . . 15.0 111.584 -179.146 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -107.69 -12.84 15.16 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 115.614 -0.721 . . . . 15.0 112.501 -179.498 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -149.72 149.0 29.91 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 112.659 0.614 . . . . 15.0 112.659 -178.527 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.454 ' HB ' ' CG1' ' A' ' 64' ' ' VAL . 23.1 t -142.29 99.04 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.27 0 CA-C-N 115.304 -0.862 . . . . 15.0 109.441 178.842 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 65.05 16.67 10.69 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.155 -0.475 . . . . 15.0 109.896 -178.282 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 107.17 6.04 34.36 Favored Glycine 0 C--N 1.336 0.536 0 CA-C-N 115.813 -0.631 . . . . 15.0 113.564 179.48 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.526 ' O ' ' CG1' ' A' ' 64' ' ' VAL . 4.6 p -93.75 103.71 14.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 117.292 0.546 . . . . 15.0 110.628 179.155 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -57.91 127.69 33.35 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.134 -0.484 . . . . 15.0 111.071 -179.417 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -87.69 -15.86 35.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.021 -0.536 . . . . 15.0 111.063 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -45.24 95.32 0.01 OUTLIER 'General case' 0 N--CA 1.461 0.114 0 CA-C-O 120.871 0.367 . . . . 15.0 111.008 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 103.75 69.35 0.79 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.79 -0.719 . . . . 15.0 112.238 -179.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -173.03 142.73 1.09 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.901 0.381 . . . . 15.0 111.049 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.411 ' CB ' ' HA ' ' A' ' 26' ' ' VAL . 13.7 p -74.3 -172.5 1.45 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.162 -0.472 . . . . 15.0 111.241 -179.774 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.563 ' HA ' HG13 ' A' ' 35' ' ' ILE . 0.1 OUTLIER -62.19 -59.49 4.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.914 -0.584 . . . . 15.0 110.475 179.99 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.403 ' HA ' ' HB ' ' A' ' 75' ' ' VAL . 6.6 ttmt -52.81 -33.8 50.77 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.871 -0.604 . . . . 15.0 110.623 179.399 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -59.54 -52.93 63.45 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.708 -0.478 . . . . 15.0 109.708 179.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.429 ' O ' ' N ' ' A' ' 77' ' ' THR . . . -67.08 -42.4 84.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.099 -0.501 . . . . 15.0 109.725 178.48 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.415 HG11 ' N ' ' A' ' 76' ' ' GLU . 0.5 OUTLIER -44.31 -39.51 1.63 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.221 0 N-CA-C 108.985 -0.746 . . . . 15.0 108.985 178.528 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.417 ' O ' ' N ' ' A' ' 80' ' ' ASN . 4.5 mm-40 -67.3 -44.17 79.88 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.751 -1.113 . . . . 15.0 110.314 178.586 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.429 ' N ' ' O ' ' A' ' 74' ' ' ALA . 27.6 p -64.04 -56.15 17.11 Favored 'General case' 0 N--CA 1.462 0.151 0 C-N-CA 121.047 -0.261 . . . . 15.0 111.375 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.433 ' CD2' HG21 ' A' ' 61' ' ' VAL . 4.6 mt -53.49 -46.94 70.22 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 121.179 0.514 . . . . 15.0 109.958 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 3.3 tmt_? -68.49 -60.27 2.55 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.434 -0.803 . . . . 15.0 110.739 179.53 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.417 ' N ' ' O ' ' A' ' 76' ' ' GLU . 15.2 m-20 -65.96 60.83 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.846 -0.615 . . . . 15.0 112.222 -179.76 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.57 -76.08 0.51 Allowed 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.744 -0.465 . . . . 15.0 109.744 178.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 112.75 -98.51 0.96 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.634 -0.793 . . . . 15.0 113.58 178.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.453 ' O ' ' HB3' ' A' ' 13' ' ' LYS . 0.5 OUTLIER -63.92 -87.92 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 111.682 0.252 . . . . 15.0 111.682 -178.907 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.412 ' CG1' ' N ' ' A' ' 85' ' ' VAL . 72.0 t -110.06 158.23 10.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.066 0.46 . . . . 15.0 110.925 -179.738 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.478 ' O ' ' CG1' ' A' ' 85' ' ' VAL . 3.8 t -97.87 81.92 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.094 -0.503 . . . . 15.0 110.256 179.698 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . 0.43 ' CE1' HD13 ' A' ' 88' ' ' LEU . 1.4 t60 -100.7 82.81 2.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.766 -0.652 . . . . 15.0 109.99 179.585 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.471 ' HB3' ' CD2' ' A' ' 89' ' ' LEU . 0.1 OUTLIER -103.79 115.97 31.44 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.799 -0.637 . . . . 15.0 112.05 -178.745 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.492 HD11 ' HB2' ' A' ' 8' ' ' GLU . 4.0 mp -92.21 102.13 14.64 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.451 -0.574 . . . . 15.0 109.451 178.576 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.503 HD22 ' HA ' ' A' ' 58' ' ' VAL . 0.1 OUTLIER -105.81 -161.74 0.82 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.487 0.661 . . . . 15.0 112.102 -178.317 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.415 ' HB2' HG13 ' A' ' 6' ' ' ILE . 3.5 tt0 -143.98 135.38 25.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 114.879 -1.055 . . . . 15.0 109.621 179.148 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.08 103.56 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.005 0.431 . . . . 15.0 111.087 -179.566 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -63.12 137.59 43.48 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.944 -0.646 . . . . 15.0 112.706 -179.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -86.38 91.67 8.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.794 0.33 . . . . 15.0 110.818 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -72.88 148.08 89.21 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.231 -0.441 . . . . 15.0 110.871 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -52.25 -34.98 61.9 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.596 2.197 . . . . 15.0 112.307 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 70.2 p . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.232 -0.889 . . . . 15.0 110.911 179.972 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo . . . . . 0 N--CA 1.488 1.2 0 CA-C-O 120.788 0.245 . . . . 15.0 111.812 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.19 110.97 4.68 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.218 -0.446 . . . . 15.0 110.859 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -67.42 -165.42 0.11 Allowed 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.403 2.069 . . . . 15.0 112.477 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 87.02 -19.34 30.87 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.781 -0.723 . . . . 15.0 112.328 -179.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -72.3 161.83 30.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.317 0.58 . . . . 15.0 111.216 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.484 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 1.2 mp -97.88 145.78 8.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.177 -0.919 . . . . 15.0 110.624 -179.73 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.429 ' CD1' ' C ' ' A' ' 7' ' ' PHE . 3.0 p90 -141.93 141.32 32.96 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.035 0.445 . . . . 15.0 111.206 179.418 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.511 ' HB2' HD11 ' A' ' 88' ' ' LEU . 5.6 pm0 -113.53 141.8 46.71 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.804 -0.635 . . . . 15.0 111.15 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.429 ' N ' ' O ' ' A' ' 87' ' ' LEU . 0.2 OUTLIER -101.41 114.02 39.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.45 -0.796 . . . . 15.0 109.839 179.335 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -105.96 71.16 0.88 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.033 -0.53 . . . . 15.0 111.896 -178.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.417 ' HB3' ' HB ' ' A' ' 85' ' ' VAL . 5.4 tp -88.65 166.83 13.84 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.155 -0.475 . . . . 15.0 109.949 179.016 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.425 ' CB ' ' HB2' ' A' ' 15' ' ' ASP . . . -96.08 96.88 9.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.028 0.442 . . . . 15.0 111.163 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.49 ' O ' ' HD3' ' A' ' 13' ' ' LYS . 0.1 OUTLIER -63.46 -28.43 69.96 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.725 -0.671 . . . . 15.0 111.442 -179.721 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -84.32 -19.06 34.36 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.466 -0.334 . . . . 15.0 111.524 -179.37 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.425 ' HB2' ' CB ' ' A' ' 12' ' ' ALA . 0.3 OUTLIER -92.18 -36.71 13.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.879 0.371 . . . . 15.0 110.462 179.538 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -165.45 161.23 18.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.006 -0.543 . . . . 15.0 110.74 179.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -85.95 -157.5 0.34 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.266 -0.425 . . . . 15.0 110.234 179.675 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 9.8 mt -105.49 -169.69 1.63 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.968 0.413 . . . . 15.0 110.794 179.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.642 ' O ' ' HB ' ' A' ' 41' ' ' ILE . . . -161.13 38.59 0.42 Allowed Glycine 0 N--CA 1.449 -0.459 0 CA-C-N 115.867 -0.606 . . . . 15.0 111.752 -179.831 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.711 HG12 ' O ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -112.69 140.75 30.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 121.02 0.438 . . . . 15.0 111.94 -179.358 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 41.0 t -96.11 106.18 18.32 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 107.837 -1.171 . . . . 15.0 107.837 177.296 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.435 HG22 ' CD2' ' A' ' 71' ' ' HIS . 31.2 m -93.54 152.5 3.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 113.083 0.771 . . . . 15.0 113.083 -177.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -149.46 179.27 8.09 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 114.863 -1.062 . . . . 15.0 110.728 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.431 ' O ' ' CB ' ' A' ' 71' ' ' HIS . . . 74.22 -120.23 6.56 Favored Glycine 0 C--N 1.33 0.24 0 C-N-CA 120.672 -0.775 . . . . 15.0 112.327 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.532 ' HA3' ' N ' ' A' ' 71' ' ' HIS . . . 67.52 -65.69 0.27 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.848 -0.691 . . . . 15.0 113.631 179.31 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.444 ' N ' ' HA ' ' A' ' 70' ' ' THR . 2.0 m -31.22 140.84 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 N-CA-C 112.328 0.492 . . . . 15.0 112.328 -179.17 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 14.2 p-10 -75.47 64.62 1.62 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.944 -0.571 . . . . 15.0 111.035 -179.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.5 m -151.67 -61.52 0.17 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.263 -0.426 . . . . 15.0 111.075 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 91.3 p -76.45 -42.88 42.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.18 -0.464 . . . . 15.0 111.155 -179.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.428 HG13 ' CD1' ' A' ' 36' ' ' TYR . 35.3 m -73.78 -176.17 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.274 -0.421 . . . . 15.0 111.275 -179.858 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.14 -59.96 4.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.118 -0.492 . . . . 15.0 111.078 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 10.5 m80 -143.55 -47.93 0.3 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.306 -0.407 . . . . 15.0 111.149 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -169.44 22.56 0.09 OUTLIER Glycine 0 CA--C 1.519 0.292 0 C-N-CA 120.668 -0.777 . . . . 15.0 112.888 -179.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -87.55 154.46 26.02 Favored Glycine 0 N--CA 1.451 -0.354 0 N-CA-C 110.788 -0.925 . . . . 15.0 110.788 178.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.473 ' CG1' ' HA ' ' A' ' 71' ' ' HIS . 0.0 OUTLIER -92.5 152.02 3.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 C-N-CA 119.895 -0.722 . . . . 15.0 111.906 -179.242 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.494 ' CZ ' ' HG2' ' A' ' 57' ' ' ARG . 53.8 m-85 -137.3 106.64 6.08 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.835 -1.075 . . . . 15.0 109.892 179.333 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.696 HG21 ' N ' ' A' ' 55' ' ' GLY . 0.6 OUTLIER -57.46 146.0 7.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.977 -0.556 . . . . 15.0 111.144 -179.089 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.477 ' O ' ' HG2' ' A' ' 54' ' ' LYS . 0.6 OUTLIER -80.33 -48.87 12.32 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.947 -0.76 . . . . 15.0 108.947 178.837 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.711 ' O ' HG12 ' A' ' 20' ' ' ILE . . . -172.07 172.6 4.61 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.906 -0.588 . . . . 15.0 110.736 178.811 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.484 ' HA ' ' CG1' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -96.86 112.93 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 N-CA-C 109.781 -0.451 . . . . 15.0 109.781 179.433 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.642 ' HB ' ' O ' ' A' ' 19' ' ' GLY . 0.3 OUTLIER -78.56 118.49 72.65 Favored Pre-proline 0 C--N 1.328 -0.331 0 N-CA-C 113.021 0.749 . . . . 15.0 113.021 -177.764 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.536 ' HA ' ' CG ' ' A' ' 47' ' ' GLU . 37.2 Cg_endo -64.8 60.63 0.29 Allowed 'Trans proline' 0 C--N 1.356 0.935 0 C-N-CA 123.416 2.744 . . . . 15.0 112.91 179.842 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.507 ' H ' ' HG2' ' A' ' 47' ' ' GLU . 41.1 tt0 -149.87 -46.26 0.13 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.632 -0.258 . . . . 15.0 111.511 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.583 ' HA3' ' HA3' ' A' ' 19' ' ' GLY . . . -87.8 166.91 36.12 Favored Glycine 0 CA--C 1.519 0.314 0 C-N-CA 120.417 -0.897 . . . . 15.0 114.008 -178.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -55.29 -15.43 2.45 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.911 0.708 . . . . 15.0 112.911 -179.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.97 -57.4 4.33 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 121.005 -0.278 . . . . 15.0 111.051 -179.418 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.536 ' CG ' ' HA ' ' A' ' 42' ' ' PRO . 2.9 pp20? -57.05 -42.99 81.57 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.035 -0.529 . . . . 15.0 110.378 179.358 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -53.88 -70.47 0.1 Allowed 'General case' 0 CA--C 1.52 -0.194 0 CA-C-N 115.893 -0.594 . . . . 15.0 110.498 -179.623 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.411 ' CB ' HD13 ' A' ' 11' ' ' LEU . 14.4 t0 -58.21 -39.92 80.26 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.349 -0.611 . . . . 15.0 109.349 178.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.76 35.02 26.24 Favored Glycine 0 N--CA 1.447 -0.631 0 CA-C-N 115.384 -0.825 . . . . 15.0 111.595 179.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.415 ' HB3' ' CG2' ' A' ' 9' ' ' VAL . 0.3 OUTLIER -79.73 -46.5 16.94 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.05 0.452 . . . . 15.0 110.524 -179.431 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.439 ' CG2' HG13 ' A' ' 20' ' ' ILE . 7.0 tp -80.94 149.95 4.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.697 -0.683 . . . . 15.0 109.616 179.371 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . 0.461 ' O ' HG21 ' A' ' 37' ' ' VAL . 80.4 m80 -139.7 156.94 46.52 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 113.14 0.793 . . . . 15.0 113.14 -178.269 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.521 ' HA ' ' CG2' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -45.31 133.28 7.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 113.784 -1.553 . . . . 15.0 112.961 -178.897 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.696 ' N ' HG21 ' A' ' 37' ' ' VAL . . . 49.04 27.25 6.66 Favored Glycine 0 C--N 1.335 0.486 0 CA-C-N 115.766 -0.652 . . . . 15.0 113.784 178.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.44 ' OD2' ' CG1' ' A' ' 37' ' ' VAL . 1.2 p30 -66.32 133.23 50.11 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 119.485 -0.886 . . . . 15.0 110.077 179.512 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.494 ' HG2' ' CZ ' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -80.76 97.58 7.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 15.0 110.434 -179.845 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.507 ' O ' ' CG2' ' A' ' 58' ' ' VAL . 1.3 m -82.24 112.74 20.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.265 -0.425 . . . . 15.0 110.392 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -107.26 -21.62 12.89 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 115.826 -0.625 . . . . 15.0 112.384 -179.041 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -147.45 150.47 34.67 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.251 0.548 . . . . 15.0 112.365 -178.56 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.432 ' HB ' ' CG1' ' A' ' 64' ' ' VAL . 60.4 t -138.92 102.46 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.264 -0.88 . . . . 15.0 109.022 178.846 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.405 ' HB2' ' O ' ' A' ' 61' ' ' VAL . 1.8 m-80 65.09 15.62 10.1 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.706 -0.479 . . . . 15.0 109.706 -177.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 105.69 6.46 37.92 Favored Glycine 0 C--N 1.336 0.539 0 CA-C-N 115.785 -0.643 . . . . 15.0 113.349 179.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.506 ' O ' ' CG1' ' A' ' 64' ' ' VAL . 6.1 p -93.76 105.69 17.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 121.124 0.488 . . . . 15.0 110.843 179.398 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -58.78 115.45 3.09 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.148 -0.478 . . . . 15.0 110.726 -179.748 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.4 ' CD1' HG23 ' A' ' 58' ' ' VAL . 3.1 mt -89.45 -16.44 30.86 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.718 -0.674 . . . . 15.0 111.339 -179.619 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -45.79 105.44 0.06 Allowed 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.878 0.371 . . . . 15.0 111.017 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.96 66.15 0.57 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.814 -0.707 . . . . 15.0 112.433 -179.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -172.9 172.71 3.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.807 0.337 . . . . 15.0 110.851 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.444 ' HA ' ' N ' ' A' ' 26' ' ' VAL . 19.3 p -93.16 -175.83 3.97 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.961 0.41 . . . . 15.0 111.091 -179.768 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.532 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 0.0 OUTLIER -62.42 -60.98 2.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.969 -0.559 . . . . 15.0 110.428 -179.994 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.404 ' O ' ' HG3' ' A' ' 76' ' ' GLU . 7.3 ttmt -52.49 -33.68 45.9 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.773 -0.649 . . . . 15.0 110.497 179.455 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -59.4 -49.01 79.46 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.567 -0.531 . . . . 15.0 109.567 179.194 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.561 ' HA ' ' OG1' ' A' ' 77' ' ' THR . . . -66.96 -48.57 68.16 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 116.009 -0.541 . . . . 15.0 109.658 178.392 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.426 ' CG2' ' CG2' ' A' ' 22' ' ' VAL . 0.5 OUTLIER -40.39 -42.1 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.212 0 CA-C-N 115.476 -0.784 . . . . 15.0 109.444 178.48 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.404 ' HG3' ' O ' ' A' ' 72' ' ' LYS . 21.9 mt-10 -67.4 -46.07 74.33 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 114.843 -1.071 . . . . 15.0 110.45 178.795 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.561 ' OG1' ' HA ' ' A' ' 74' ' ' ALA . 2.0 p -64.64 -53.08 53.18 Favored 'General case' 0 C--O 1.231 0.099 0 C-N-CA 120.918 -0.313 . . . . 15.0 111.378 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.437 ' HG ' ' O ' ' A' ' 74' ' ' ALA . 4.4 mt -53.66 -48.38 69.48 Favored 'General case' 0 CA--C 1.52 -0.18 0 CA-C-O 121.135 0.493 . . . . 15.0 110.15 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 3.0 ttm-85 -68.34 -56.65 7.81 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.558 -0.747 . . . . 15.0 110.493 179.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -66.0 62.51 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.017 -0.538 . . . . 15.0 111.752 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.403 ' HB ' ' HG3' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -95.55 -71.94 0.65 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.783 0.325 . . . . 15.0 110.438 179.426 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 122.17 -103.82 0.87 Allowed Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.753 -0.737 . . . . 15.0 113.157 179.272 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.58 -83.66 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 111.866 0.321 . . . . 15.0 111.866 -179.089 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.415 HG13 ' N ' ' A' ' 85' ' ' VAL . 67.3 t -109.47 157.59 9.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.105 0.478 . . . . 15.0 111.082 -179.416 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.425 ' O ' ' CG1' ' A' ' 85' ' ' VAL . 10.6 t -97.81 81.86 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.011 -0.54 . . . . 15.0 110.559 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 59.6 t60 -104.96 86.54 2.47 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.747 -0.66 . . . . 15.0 110.892 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.45 ' O ' ' HA ' ' A' ' 8' ' ' GLU . 0.1 OUTLIER -103.81 129.75 51.28 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.996 -0.547 . . . . 15.0 111.537 -179.601 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.511 HD11 ' HB2' ' A' ' 8' ' ' GLU . 5.2 mp -102.33 101.3 11.54 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.928 -0.397 . . . . 15.0 109.928 178.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.447 HD22 HG13 ' A' ' 58' ' ' VAL . 0.4 OUTLIER -105.84 -161.94 0.83 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.3 0.572 . . . . 15.0 111.939 -178.699 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.484 ' HA ' ' HA ' ' A' ' 6' ' ' ILE . 26.0 tt0 -146.28 134.91 22.18 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.159 -0.928 . . . . 15.0 109.951 179.238 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 4.7 tptt -46.83 111.86 0.44 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.311 -0.404 . . . . 15.0 111.096 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -61.91 151.74 44.08 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.785 -0.721 . . . . 15.0 112.614 -179.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -76.33 119.44 20.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.859 0.361 . . . . 15.0 110.973 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -85.64 168.46 19.73 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.099 -0.5 . . . . 15.0 110.843 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_exo -51.12 -33.63 44.46 Favored 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 122.592 2.195 . . . . 15.0 112.236 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.22 -0.895 . . . . 15.0 110.9 179.929 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_endo . . . . . 0 N--CA 1.488 1.155 0 CA-C-O 120.836 0.265 . . . . 15.0 111.831 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 11.3 mttt -145.15 127.99 8.27 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.113 -0.494 . . . . 15.0 110.687 179.946 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_exo -56.23 -165.59 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.342 2.028 . . . . 15.0 112.505 -179.822 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 87.32 -20.3 27.08 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.8 -0.714 . . . . 15.0 112.253 -179.625 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -72.55 158.86 34.89 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.381 0.61 . . . . 15.0 111.273 -179.979 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.51 HG13 ' HB2' ' A' ' 90' ' ' GLU . 1.3 mp -104.33 144.11 14.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.051 -0.977 . . . . 15.0 110.62 -179.714 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.461 ' O ' ' N ' ' A' ' 89' ' ' LEU . 4.9 p90 -140.65 165.51 27.28 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.594 -0.275 . . . . 15.0 110.544 178.912 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.476 ' CB ' HD11 ' A' ' 88' ' ' LEU . 4.9 pt-20 -130.07 142.62 50.59 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.381 0.61 . . . . 15.0 111.417 -179.546 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.45 ' CG2' ' HB3' ' A' ' 51' ' ' ARG . 0.2 OUTLIER -101.44 114.97 42.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.073 -0.967 . . . . 15.0 109.718 179.143 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -105.89 71.46 0.9 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.118 -0.492 . . . . 15.0 111.874 -178.976 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.413 ' HB3' ' HB ' ' A' ' 85' ' ' VAL . 6.2 tp -88.05 167.99 13.2 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.942 -0.572 . . . . 15.0 110.007 179.121 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -94.64 98.84 11.09 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.98 0.419 . . . . 15.0 110.867 179.88 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.498 ' HG3' ' HB ' ' A' ' 81' ' ' THR . 0.2 OUTLIER -54.05 -27.2 30.85 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.899 -0.592 . . . . 15.0 111.13 -179.827 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.433 ' O ' ' CB ' ' A' ' 15' ' ' ASP . 2.9 m-80 -84.64 154.19 22.69 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.357 -0.383 . . . . 15.0 110.551 179.692 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.433 ' CB ' ' O ' ' A' ' 14' ' ' ASN . 5.9 t70 82.82 -48.1 0.16 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.219 -0.446 . . . . 15.0 110.884 -179.356 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -155.11 147.46 23.94 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.402 -0.363 . . . . 15.0 110.582 179.768 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -86.17 -169.17 2.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.054 0.454 . . . . 15.0 111.311 -179.642 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.408 ' O ' ' HA3' ' A' ' 44' ' ' GLY . 3.9 mm? -62.79 -163.62 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.745 -0.661 . . . . 15.0 110.627 179.581 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.728 ' O ' ' HB ' ' A' ' 41' ' ' ILE . . . -160.56 21.44 0.24 Allowed Glycine 0 C--O 1.226 -0.378 0 C-N-CA 120.4 -0.905 . . . . 15.0 113.395 -179.495 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.63 ' HB ' ' O ' ' A' ' 39' ' ' ALA . 2.9 pt -113.13 139.16 39.82 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.382 0 CA-C-N 117.394 0.597 . . . . 15.0 111.709 178.738 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.509 ' O ' ' HB3' ' A' ' 38' ' ' LYS . 6.2 t -84.98 116.09 23.18 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 105.167 -2.16 . . . . 15.0 105.167 174.841 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.401 ' CG2' ' CG2' ' A' ' 75' ' ' VAL . 35.6 m -93.74 152.35 3.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 113.58 0.955 . . . . 15.0 113.58 -175.521 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.57 -179.18 6.89 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 114.782 -1.099 . . . . 15.0 110.564 179.642 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.453 ' O ' ' CB ' ' A' ' 71' ' ' HIS . . . 71.4 -121.03 8.68 Favored Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.814 -0.708 . . . . 15.0 112.613 179.658 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.514 ' HA3' ' N ' ' A' ' 71' ' ' HIS . . . 66.82 -65.71 0.19 Allowed Glycine 0 C--N 1.331 0.251 0 C-N-CA 121.028 -0.606 . . . . 15.0 113.576 179.43 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.43 ' HA ' ' CB ' ' A' ' 70' ' ' THR . 0.0 OUTLIER -32.83 137.78 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 N-CA-C 112.375 0.509 . . . . 15.0 112.375 -179.208 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.406 ' CB ' ' O ' ' A' ' 32' ' ' HIS . 1.6 m-20 -76.58 59.64 1.53 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.826 -0.625 . . . . 15.0 111.103 -179.856 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -151.74 -48.48 0.11 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.373 -0.376 . . . . 15.0 110.884 179.972 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 22.0 t -87.12 -31.84 20.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.203 -0.453 . . . . 15.0 110.962 -179.929 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 33.4 m -87.9 -175.62 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.459 . . . . 15.0 111.223 -179.965 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 3.4 ttt85 -58.11 -60.81 3.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.23 -0.441 . . . . 15.0 111.102 -179.86 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . 0.406 ' O ' ' CB ' ' A' ' 27' ' ' ASN . 22.9 m80 -136.3 -58.45 0.74 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.371 -0.377 . . . . 15.0 111.163 -179.87 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -166.72 26.11 0.15 Allowed Glycine 0 N--CA 1.453 -0.223 0 C-N-CA 120.806 -0.711 . . . . 15.0 112.599 -179.723 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -90.69 153.25 22.41 Favored Glycine 0 N--CA 1.449 -0.488 0 N-CA-C 110.828 -0.909 . . . . 15.0 110.828 179.024 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.415 HG21 HG22 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -90.72 153.6 3.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 C-N-CA 120.028 -0.669 . . . . 15.0 111.648 -179.358 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.412 ' CE2' ' HG2' ' A' ' 57' ' ' ARG . 47.5 m-85 -134.43 108.39 8.12 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 114.98 -1.009 . . . . 15.0 109.534 179.4 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.575 ' HB ' HD12 ' A' ' 20' ' ' ILE . 0.6 OUTLIER -54.94 148.45 2.89 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.45 0 CA-C-O 121.105 0.479 . . . . 15.0 110.731 -178.835 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.509 ' HB3' ' O ' ' A' ' 21' ' ' SER . 0.1 OUTLIER -86.17 -45.66 11.13 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 108.37 -0.974 . . . . 15.0 108.37 178.167 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.63 ' O ' ' HB ' ' A' ' 20' ' ' ILE . . . -173.76 171.37 3.78 Favored 'General case' 0 C--O 1.226 -0.157 0 C-N-CA 120.512 -0.475 . . . . 15.0 112.214 178.762 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -97.32 81.57 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.291 0.567 . . . . 15.0 109.75 178.889 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.728 ' HB ' ' O ' ' A' ' 19' ' ' GLY . 27.2 mm -47.95 120.79 8.19 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 115.263 -0.88 . . . . 15.0 113.039 -178.351 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.525 ' HA ' ' HG2' ' A' ' 47' ' ' GLU . 40.8 Cg_endo -66.16 60.94 0.48 Allowed 'Trans proline' 0 C--N 1.354 0.831 0 C-N-CA 123.336 2.691 . . . . 15.0 112.762 179.682 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.536 ' H ' ' HG2' ' A' ' 47' ' ' GLU . 4.6 mt-30 -158.85 -41.08 0.06 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.646 0.26 . . . . 15.0 111.63 179.878 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.496 ' HA3' ' CA ' ' A' ' 19' ' ' GLY . . . -87.29 163.0 33.95 Favored Glycine 0 CA--C 1.519 0.318 0 C-N-CA 120.629 -0.796 . . . . 15.0 113.652 -179.151 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -53.28 -15.21 0.88 Allowed 'General case' 0 N--CA 1.462 0.166 0 N-CA-C 112.708 0.633 . . . . 15.0 112.708 -179.721 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.99 -59.35 2.79 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.651 0.262 . . . . 15.0 110.946 -179.554 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.536 ' HG2' ' H ' ' A' ' 43' ' ' GLN . 2.6 pp20? -56.97 -42.82 80.88 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.109 -0.496 . . . . 15.0 110.824 179.557 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.3 m -53.69 -70.77 0.09 Allowed 'General case' 0 CA--C 1.519 -0.22 0 CA-C-N 115.965 -0.561 . . . . 15.0 110.597 -179.333 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -61.19 -39.43 90.17 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.472 -0.566 . . . . 15.0 109.472 178.981 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.92 38.66 15.15 Favored Glycine 0 N--CA 1.447 -0.571 0 CA-C-N 115.438 -0.801 . . . . 15.0 111.638 179.802 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.45 ' HB3' ' CG2' ' A' ' 9' ' ' VAL . 21.7 mmt-85 -79.71 -33.71 40.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.872 0.368 . . . . 15.0 111.106 -179.18 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.48 ' CG2' ' N ' ' A' ' 53' ' ' HIS . 21.2 mm -91.21 159.12 2.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.091 -0.504 . . . . 15.0 111.181 -179.737 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . 0.48 ' N ' ' CG2' ' A' ' 52' ' ' ILE . 29.2 m80 -141.69 138.5 32.49 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-N 115.69 -0.686 . . . . 15.0 110.663 179.394 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.495 ' HA ' ' CG2' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -35.59 131.11 0.51 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.479 -1.237 . . . . 15.0 113.039 -178.373 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.553 ' N ' HG21 ' A' ' 37' ' ' VAL . . . 56.28 29.08 55.99 Favored Glycine 0 C--N 1.332 0.353 0 CA-C-N 115.665 -0.698 . . . . 15.0 113.629 179.176 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.45 ' OD2' ' N ' ' A' ' 53' ' ' HIS . 0.4 OUTLIER -65.34 130.48 43.49 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.941 -0.304 . . . . 15.0 110.597 179.346 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.412 ' HG2' ' CE2' ' A' ' 36' ' ' TYR . 2.2 mtt180 -80.63 90.04 5.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.436 -0.347 . . . . 15.0 110.672 179.934 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.447 ' O ' ' CG2' ' A' ' 58' ' ' VAL . 1.4 m -79.37 116.82 23.98 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 CA-C-O 121.017 0.437 . . . . 15.0 110.613 -179.875 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 29.1 mt -107.04 -15.09 14.77 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.785 -0.643 . . . . 15.0 112.559 -178.946 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.401 ' HA ' ' O ' ' A' ' 64' ' ' VAL . . . -149.11 148.49 29.74 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 112.595 0.591 . . . . 15.0 112.595 -178.8 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.442 ' HB ' ' CG1' ' A' ' 64' ' ' VAL . 20.8 t -139.18 100.5 1.42 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.251 0 CA-C-N 115.115 -0.948 . . . . 15.0 109.115 178.795 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.418 ' ND2' ' CG2' ' A' ' 81' ' ' THR . 1.7 m-80 65.03 16.08 10.36 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.76 -0.459 . . . . 15.0 109.76 -178.096 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 107.21 5.24 35.05 Favored Glycine 0 C--N 1.336 0.566 0 CA-C-N 115.925 -0.58 . . . . 15.0 113.558 179.666 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.5 ' O ' ' CG1' ' A' ' 64' ' ' VAL . 5.7 p -93.84 106.34 17.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 117.275 0.538 . . . . 15.0 110.988 179.417 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -56.59 136.33 54.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.201 -0.454 . . . . 15.0 110.914 -179.808 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -95.55 -20.16 19.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.06 -0.518 . . . . 15.0 111.065 -179.964 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -46.53 99.96 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.876 0.369 . . . . 15.0 111.082 179.984 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 104.88 66.4 0.69 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.767 -0.73 . . . . 15.0 112.207 -179.799 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -173.09 162.02 4.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.841 0.353 . . . . 15.0 111.117 -179.771 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.43 ' CB ' ' HA ' ' A' ' 26' ' ' VAL . 15.6 p -93.22 -173.75 3.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.002 0.429 . . . . 15.0 111.019 -179.873 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.514 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 0.0 OUTLIER -62.59 -58.79 6.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.907 -0.588 . . . . 15.0 110.329 179.841 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.413 ' HA ' ' HB ' ' A' ' 75' ' ' VAL . 28.4 ttmt -52.56 -33.9 47.82 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.017 -0.538 . . . . 15.0 110.534 179.117 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -59.45 -50.04 75.45 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.5 -0.555 . . . . 15.0 109.5 179.32 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.431 ' O ' ' N ' ' A' ' 77' ' ' THR . . . -66.86 -44.48 80.88 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 109.531 -0.544 . . . . 15.0 109.531 178.313 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.413 ' HB ' ' HA ' ' A' ' 72' ' ' LYS . 0.5 OUTLIER -43.57 -39.4 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.363 0 N-CA-C 108.732 -0.84 . . . . 15.0 108.732 178.099 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.523 ' O ' ' HB2' ' A' ' 80' ' ' ASN . 1.5 mm-40 -67.06 -46.32 74.68 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.573 -1.194 . . . . 15.0 110.381 178.577 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.431 ' N ' ' O ' ' A' ' 74' ' ' ALA . 31.4 p -64.09 -53.24 52.77 Favored 'General case' 0 N--CA 1.462 0.161 0 C-N-CA 120.951 -0.3 . . . . 15.0 111.575 -179.969 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.423 ' CD2' HG21 ' A' ' 61' ' ' VAL . 6.0 mt -53.49 -48.15 69.19 Favored 'General case' 0 CA--C 1.52 -0.18 0 CA-C-O 121.261 0.553 . . . . 15.0 109.866 179.929 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 18.1 ttp180 -68.64 -60.77 2.17 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.318 -0.855 . . . . 15.0 110.833 179.505 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.523 ' HB2' ' O ' ' A' ' 76' ' ' GLU . 15.1 m-80 -66.11 58.23 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 112.476 0.547 . . . . 15.0 112.476 -179.677 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.498 ' HB ' ' HG3' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -95.67 -69.28 0.76 Allowed 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.809 -0.441 . . . . 15.0 109.809 178.804 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 118.37 -104.42 1.12 Allowed Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.817 -0.706 . . . . 15.0 113.386 178.891 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.437 ' O ' ' HB3' ' A' ' 13' ' ' LYS . 0.4 OUTLIER -64.93 -80.95 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 112.525 0.565 . . . . 15.0 112.525 -178.724 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.418 ' CG1' ' N ' ' A' ' 85' ' ' VAL . 55.1 t -110.07 158.11 10.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.113 0.482 . . . . 15.0 111.298 -178.89 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.446 ' O ' ' CG1' ' A' ' 85' ' ' VAL . 8.0 t -97.99 81.15 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.986 -0.552 . . . . 15.0 110.426 179.867 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 78.9 t60 -100.42 84.66 2.82 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.754 -0.657 . . . . 15.0 110.362 179.79 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.439 ' CB ' HG12 ' A' ' 9' ' ' VAL . 0.1 OUTLIER -103.52 119.44 38.9 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.949 -0.568 . . . . 15.0 111.986 -179.008 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.476 HD11 ' CB ' ' A' ' 8' ' ' GLU . 4.3 mp -92.87 103.23 15.58 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.52 -0.548 . . . . 15.0 109.52 178.673 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.461 ' N ' ' O ' ' A' ' 7' ' ' PHE . 0.2 OUTLIER -105.48 -163.32 0.94 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.273 0.559 . . . . 15.0 111.635 -178.69 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.51 ' HB2' HG13 ' A' ' 6' ' ' ILE . 8.3 tt0 -145.27 134.58 22.96 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.385 -0.825 . . . . 15.0 110.354 179.476 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 4.0 tptt -48.04 104.04 0.05 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.106 -0.497 . . . . 15.0 111.009 -179.92 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -62.06 162.21 27.72 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.919 -0.658 . . . . 15.0 112.68 -179.647 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -84.93 107.62 17.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.807 0.337 . . . . 15.0 110.85 179.975 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.2 m -61.7 130.62 92.39 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.22 -0.445 . . . . 15.0 110.851 179.977 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -53.1 -31.09 52.78 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.479 2.119 . . . . 15.0 112.259 -179.973 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.179 -0.915 . . . . 15.0 110.878 -179.969 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo . . . . . 0 N--CA 1.487 1.108 0 CA-C-O 120.835 0.264 . . . . 15.0 111.668 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.59 154.45 38.05 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.152 -0.476 . . . . 15.0 110.737 179.974 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -61.99 -164.57 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.488 2.126 . . . . 15.0 112.266 179.958 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 89.21 -22.43 23.13 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.676 -0.773 . . . . 15.0 112.202 -179.578 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -72.33 145.25 47.93 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-O 121.24 0.543 . . . . 15.0 110.849 179.763 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.511 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 1.4 mp -104.53 141.42 20.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.425 -0.807 . . . . 15.0 111.375 -179.379 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.455 ' O ' ' N ' ' A' ' 89' ' ' LEU . 3.6 p90 -140.62 165.67 26.84 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.123 -0.49 . . . . 15.0 110.112 178.514 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.46 ' CB ' HD11 ' A' ' 88' ' ' LEU . 4.8 pt-20 -130.13 144.38 51.32 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.427 0.632 . . . . 15.0 111.842 -178.93 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.492 ' CG2' ' HB3' ' A' ' 51' ' ' ARG . 0.2 OUTLIER -101.42 115.25 42.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.034 -0.984 . . . . 15.0 109.354 178.75 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -105.92 72.72 0.96 Allowed 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 112.4 0.518 . . . . 15.0 112.4 -178.523 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.445 ' HB3' ' HB ' ' A' ' 85' ' ' VAL . 5.2 tp -88.06 162.56 16.72 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.465 -0.569 . . . . 15.0 109.465 178.467 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -96.52 93.31 6.72 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.947 0.403 . . . . 15.0 111.343 -179.868 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.527 ' O ' ' HD3' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -58.15 -28.8 65.04 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.957 -0.565 . . . . 15.0 110.714 179.644 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -84.27 67.77 9.92 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.032 -0.531 . . . . 15.0 110.83 179.932 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 171.18 -39.88 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.076 -0.511 . . . . 15.0 110.414 179.912 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -165.42 149.31 8.37 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.788 -0.642 . . . . 15.0 110.487 179.802 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -85.94 -168.4 2.22 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.356 -0.384 . . . . 15.0 110.518 179.908 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.416 ' N ' ' CD2' ' A' ' 18' ' ' LEU . 2.1 mm? -89.14 -175.57 4.84 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 116.171 -0.468 . . . . 15.0 110.714 179.432 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.752 ' HA3' ' HA3' ' A' ' 44' ' ' GLY . . . -160.88 45.61 0.4 Allowed Glycine 0 N--CA 1.449 -0.499 0 N-CA-C 111.481 -0.648 . . . . 15.0 111.481 -179.771 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.666 HG12 ' O ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -112.53 139.19 38.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 120.843 0.354 . . . . 15.0 111.4 -179.326 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.437 ' HB3' HD13 ' A' ' 41' ' ' ILE . 8.1 t -91.78 102.64 15.25 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 107.999 -1.111 . . . . 15.0 107.999 177.723 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.45 ' CG2' ' CG2' ' A' ' 75' ' ' VAL . 35.5 m -93.8 155.27 3.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 113.033 0.753 . . . . 15.0 113.033 -176.995 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.22 -176.39 5.35 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.174 -0.921 . . . . 15.0 110.92 -179.69 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.447 ' O ' ' HB3' ' A' ' 71' ' ' HIS . . . 68.73 -119.46 9.99 Favored Glycine 0 C--N 1.333 0.389 0 C-N-CA 120.951 -0.642 . . . . 15.0 112.611 179.834 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.553 ' HA3' ' N ' ' A' ' 71' ' ' HIS . . . 68.6 -66.53 0.42 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.823 -0.703 . . . . 15.0 113.612 179.468 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.439 ' N ' ' HA ' ' A' ' 70' ' ' THR . 1.3 m -29.38 141.82 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 N-CA-C 112.087 0.403 . . . . 15.0 112.087 -179.262 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -75.45 61.59 1.28 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.122 -0.49 . . . . 15.0 111.074 -179.602 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.6 m -151.73 -51.86 0.12 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.26 -0.427 . . . . 15.0 111.11 179.942 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -85.36 -44.39 12.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.446 . . . . 15.0 111.204 -179.793 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 17.5 m -70.33 -173.77 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.333 -0.394 . . . . 15.0 111.258 -179.875 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -57.98 -51.73 68.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 15.0 111.073 -179.892 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 19.6 p-80 -153.31 -46.88 0.09 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.343 -0.389 . . . . 15.0 111.058 -179.865 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -167.44 19.24 0.09 OUTLIER Glycine 0 CA--C 1.519 0.291 0 C-N-CA 120.739 -0.743 . . . . 15.0 112.881 -179.767 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -90.12 152.3 22.13 Favored Glycine 0 N--CA 1.449 -0.468 0 N-CA-C 110.249 -1.14 . . . . 15.0 110.249 178.493 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.541 ' HA ' ' HA2' ' A' ' 25' ' ' GLY . 0.0 OUTLIER -97.58 147.38 6.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 117.893 0.847 . . . . 15.0 111.658 -179.263 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.437 ' CE2' ' HG2' ' A' ' 57' ' ' ARG . 2.9 m-85 -130.96 113.59 14.19 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.563 -0.744 . . . . 15.0 109.755 -179.313 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.645 HG21 ' N ' ' A' ' 55' ' ' GLY . 0.8 OUTLIER -55.16 161.16 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-O 121.308 0.575 . . . . 15.0 111.238 -179.216 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.518 ' O ' ' HG2' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -91.6 -46.21 8.07 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.456 -0.942 . . . . 15.0 108.456 178.388 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.666 ' O ' HG12 ' A' ' 20' ' ' ILE . . . -172.27 173.71 4.14 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 115.302 -0.863 . . . . 15.0 110.193 178.772 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.574 ' HA ' HG12 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -96.81 108.75 21.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 109.472 -0.566 . . . . 15.0 109.472 179.268 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.729 ' HB ' ' O ' ' A' ' 19' ' ' GLY . 0.7 OUTLIER -78.28 116.33 58.16 Favored Pre-proline 0 C--N 1.328 -0.369 0 N-CA-C 113.482 0.919 . . . . 15.0 113.482 -177.245 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.542 ' HA ' ' CG ' ' A' ' 47' ' ' GLU . 36.0 Cg_exo -61.78 60.02 0.12 Allowed 'Trans proline' 0 C--N 1.358 1.045 0 C-N-CA 123.707 2.938 . . . . 15.0 113.271 179.821 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.52 ' H ' ' HG2' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -147.44 -46.97 0.17 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.649 0.261 . . . . 15.0 111.484 179.769 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.752 ' HA3' ' HA3' ' A' ' 19' ' ' GLY . . . -87.87 169.06 38.18 Favored Glycine 0 C--N 1.331 0.264 0 C-N-CA 120.386 -0.911 . . . . 15.0 114.007 -179.124 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -58.1 -14.88 7.64 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.023 -0.588 . . . . 15.0 112.499 -179.765 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.22 -56.26 5.85 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.587 0.232 . . . . 15.0 110.996 -179.656 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.558 ' HG3' ' O ' ' A' ' 44' ' ' GLY . 2.9 pp20? -57.41 -42.91 83.19 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.222 -0.445 . . . . 15.0 110.309 179.256 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -53.71 -71.12 0.08 Allowed 'General case' 0 CA--C 1.519 -0.221 0 CA-C-N 115.801 -0.636 . . . . 15.0 110.488 -179.457 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -58.34 -40.07 81.18 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.286 -0.635 . . . . 15.0 109.286 178.826 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.83 37.79 18.27 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 115.359 -0.837 . . . . 15.0 111.756 179.415 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.492 ' HB3' ' CG2' ' A' ' 9' ' ' VAL . 2.8 mmp_? -79.85 -48.09 14.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.861 0.362 . . . . 15.0 110.775 -179.447 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.431 HG12 HD12 ' A' ' 20' ' ' ILE . 10.5 tp -81.04 155.7 4.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.104 -0.498 . . . . 15.0 110.391 179.62 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . 0.528 ' O ' ' HB2' ' A' ' 56' ' ' ASP . 53.1 m80 -142.33 161.49 37.91 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-O 121.694 0.759 . . . . 15.0 112.345 -179.032 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.518 ' HG2' ' O ' ' A' ' 38' ' ' LYS . 0.8 OUTLIER -44.27 133.33 5.47 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.445 -1.252 . . . . 15.0 112.561 -178.707 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.645 ' N ' HG21 ' A' ' 37' ' ' VAL . . . 49.59 36.62 25.05 Favored Glycine 0 C--N 1.334 0.441 0 C-N-CA 121.009 -0.615 . . . . 15.0 113.101 179.45 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.528 ' HB2' ' O ' ' A' ' 53' ' ' HIS . 1.4 t0 -65.46 125.11 24.12 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.816 -0.353 . . . . 15.0 110.261 179.539 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.437 ' HG2' ' CE2' ' A' ' 36' ' ' TYR . 1.3 mtt180 -83.15 81.69 8.58 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.321 -0.4 . . . . 15.0 110.05 179.614 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.558 HG22 ' O ' ' A' ' 58' ' ' VAL . 1.1 m -79.23 119.77 29.16 Favored 'Isoleucine or valine' 0 C--O 1.24 0.556 0 CA-C-O 121.276 0.56 . . . . 15.0 110.747 -179.502 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -107.64 -13.63 15.0 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 115.236 -0.893 . . . . 15.0 112.516 -179.091 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.417 ' CB ' HD22 ' A' ' 88' ' ' LEU . . . -149.63 151.25 33.45 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 112.82 0.674 . . . . 15.0 112.82 -178.543 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.483 ' HA ' ' HG ' ' A' ' 87' ' ' LEU . 20.8 t -140.7 100.76 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.171 -0.922 . . . . 15.0 109.198 178.71 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 12.1 m120 64.87 15.29 9.8 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.779 -0.452 . . . . 15.0 109.779 -177.968 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 107.19 6.64 33.77 Favored Glycine 0 C--N 1.336 0.561 0 CA-C-N 115.926 -0.579 . . . . 15.0 113.476 179.602 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.515 ' O ' ' CG1' ' A' ' 64' ' ' VAL . 5.7 p -93.76 104.08 15.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 117.273 0.537 . . . . 15.0 110.588 179.206 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -56.07 134.16 52.44 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.099 -0.5 . . . . 15.0 111.318 -179.336 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -97.78 -21.23 17.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.881 -0.6 . . . . 15.0 110.81 179.887 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -44.35 99.27 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 116.339 -0.392 . . . . 15.0 111.219 179.988 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.49 64.74 0.57 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.798 -0.715 . . . . 15.0 112.328 -179.774 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.464 ' HB3' ' CB ' ' A' ' 73' ' ' GLN . . . -173.03 169.03 4.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.89 0.376 . . . . 15.0 111.185 -179.774 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.439 ' HA ' ' N ' ' A' ' 26' ' ' VAL . 5.7 p -93.28 -171.7 2.73 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.184 -0.462 . . . . 15.0 111.27 -179.855 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.553 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 0.0 OUTLIER -65.69 -59.61 3.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.737 -0.665 . . . . 15.0 110.866 -179.859 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.447 ' O ' ' HG3' ' A' ' 76' ' ' GLU . 16.7 ttmt -52.4 -32.27 38.06 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.804 -0.634 . . . . 15.0 110.647 179.952 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.464 ' CB ' ' HB3' ' A' ' 69' ' ' ALA . 8.4 mt-30 -59.23 -49.85 76.26 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.778 -0.453 . . . . 15.0 109.778 179.432 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.463 ' O ' ' N ' ' A' ' 77' ' ' THR . . . -67.39 -46.42 73.33 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 109.615 -0.513 . . . . 15.0 109.615 178.302 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.45 ' CG2' ' CG2' ' A' ' 22' ' ' VAL . 0.5 OUTLIER -40.97 -40.3 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.283 0 N-CA-C 108.97 -0.752 . . . . 15.0 108.97 178.324 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.47 ' O ' ' HB2' ' A' ' 80' ' ' ASN . 46.9 mt-10 -67.36 -47.48 70.29 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 114.666 -1.152 . . . . 15.0 110.541 178.659 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.463 ' N ' ' O ' ' A' ' 74' ' ' ALA . 67.4 p -64.2 -52.45 58.82 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 121.045 -0.262 . . . . 15.0 111.511 179.974 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.434 ' HG ' ' O ' ' A' ' 74' ' ' ALA . 5.0 mt -53.4 -47.68 69.35 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-O 121.193 0.521 . . . . 15.0 109.761 179.959 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 5.2 ttm180 -68.62 -62.37 1.42 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.375 -0.829 . . . . 15.0 110.42 179.112 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.47 ' HB2' ' O ' ' A' ' 76' ' ' GLU . 15.8 m-80 -66.01 62.35 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.02 -0.537 . . . . 15.0 111.78 179.766 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.421 ' HB ' ' HG3' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -88.11 -70.4 0.64 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.865 0.364 . . . . 15.0 110.213 179.442 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 121.99 -107.85 1.23 Allowed Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 121.047 -0.597 . . . . 15.0 112.686 179.54 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.479 ' O ' ' HB3' ' A' ' 13' ' ' LYS . 0.4 OUTLIER -65.0 -82.99 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.773 0.32 . . . . 15.0 111.664 -179.567 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.43 ' CG1' ' N ' ' A' ' 85' ' ' VAL . 63.1 t -110.2 160.61 9.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.327 -0.397 . . . . 15.0 110.436 179.999 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.445 ' HB ' ' HB3' ' A' ' 11' ' ' LEU . 19.9 t -98.01 80.89 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.127 0.489 . . . . 15.0 110.503 179.83 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 7.1 t60 -100.45 82.05 2.43 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 115.762 -0.654 . . . . 15.0 110.241 179.832 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.605 ' HB3' HD23 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -102.0 126.26 48.89 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.777 -0.647 . . . . 15.0 111.909 -178.961 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.46 HD11 ' CB ' ' A' ' 8' ' ' GLU . 0.2 OUTLIER -102.3 103.44 13.91 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.648 -0.501 . . . . 15.0 109.648 178.813 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.605 HD23 ' HB3' ' A' ' 87' ' ' LEU . 0.1 OUTLIER -105.76 -163.82 0.97 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.366 0.603 . . . . 15.0 111.782 -178.955 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.511 ' HA ' ' HA ' ' A' ' 6' ' ' ILE . 3.6 tt0 -138.11 134.2 34.35 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.052 -0.976 . . . . 15.0 109.676 178.996 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.67 97.99 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.316 -0.402 . . . . 15.0 111.414 -179.356 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -66.49 -161.8 1.15 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.944 -0.646 . . . . 15.0 112.579 179.988 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -76.3 100.64 5.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.783 0.325 . . . . 15.0 110.819 179.994 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 79.2 p -90.04 153.74 47.1 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.214 -0.448 . . . . 15.0 111.002 179.997 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_exo -51.82 126.66 20.53 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.61 2.207 . . . . 15.0 112.277 179.939 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 59.4 p . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.242 -0.885 . . . . 15.0 110.901 179.974 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo . . . . . 0 N--CA 1.488 1.19 0 CA-C-O 120.87 0.279 . . . . 15.0 111.809 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.5 ' CB ' ' HD3' ' A' ' 3' ' ' PRO . 2.5 mtmm -155.21 -62.77 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.464 . . . . 15.0 111.068 179.884 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.5 ' HD3' ' CB ' ' A' ' 2' ' ' LYS . 89.1 Cg_exo -47.65 89.16 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.546 2.164 . . . . 15.0 112.577 179.818 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 2' ' ' LYS . . . 88.88 -23.24 18.06 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.538 -0.839 . . . . 15.0 112.435 -179.783 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -61.88 143.22 56.72 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-O 121.412 0.625 . . . . 15.0 110.749 179.859 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.419 HG13 ' HB2' ' A' ' 90' ' ' GLU . 1.4 mp -88.44 144.85 8.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.069 -0.969 . . . . 15.0 111.27 -179.289 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.418 ' O ' ' N ' ' A' ' 89' ' ' LEU . 4.0 p90 -140.91 166.39 24.9 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.098 -0.501 . . . . 15.0 110.465 178.797 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.481 ' CB ' HD11 ' A' ' 88' ' ' LEU . 9.4 pt-20 -130.07 144.95 51.62 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.235 0.54 . . . . 15.0 111.613 -179.287 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.485 HG12 ' HB3' ' A' ' 87' ' ' LEU . 0.4 OUTLIER -101.57 116.18 44.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.395 -0.82 . . . . 15.0 109.93 179.019 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -106.56 69.14 0.77 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.236 -0.438 . . . . 15.0 111.807 -179.448 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.426 ' O ' ' N ' ' A' ' 85' ' ' VAL . 6.1 tp -88.07 160.75 17.69 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.298 -0.41 . . . . 15.0 109.961 179.058 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.562 ' C ' ' H ' ' A' ' 14' ' ' ASN . . . -97.1 95.71 7.96 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.292 0.479 . . . . 15.0 112.292 -179.177 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.473 ' NZ ' ' HA ' ' A' ' 17' ' ' SER . 3.5 tppt? -65.82 26.72 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 112.131 0.419 . . . . 15.0 112.131 178.894 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.562 ' H ' ' C ' ' A' ' 12' ' ' ALA . 25.7 m-80 -115.58 123.64 48.95 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.947 0.403 . . . . 15.0 111.58 -179.425 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 65.04 11.3 7.0 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.929 -0.578 . . . . 15.0 111.89 179.4 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 35.8 m-80 -165.39 120.21 1.28 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.804 0.335 . . . . 15.0 110.891 179.771 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.473 ' HA ' ' NZ ' ' A' ' 13' ' ' LYS . 0.4 OUTLIER -85.86 -166.84 1.65 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.229 -0.441 . . . . 15.0 110.16 179.552 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -90.18 -172.58 3.53 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.717 -0.393 . . . . 15.0 110.841 179.579 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.692 ' O ' ' HB ' ' A' ' 41' ' ' ILE . . . -161.05 36.27 0.41 Allowed Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.968 -0.634 . . . . 15.0 112.279 -179.703 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.573 HG12 ' O ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -112.82 136.95 47.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 120.993 0.425 . . . . 15.0 111.719 -179.676 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.411 ' O ' ' HB3' ' A' ' 38' ' ' LYS . 27.5 t -95.96 100.41 12.09 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 107.845 -1.168 . . . . 15.0 107.845 177.294 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.501 ' O ' ' CE1' ' A' ' 71' ' ' HIS . 1.0 OUTLIER -93.78 155.74 3.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 112.334 0.494 . . . . 15.0 112.334 -177.226 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.461 ' HA ' ' CE1' ' A' ' 71' ' ' HIS . 6.0 t -149.82 176.02 11.1 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.47 -0.787 . . . . 15.0 110.472 179.429 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.504 ' O ' ' HB2' ' A' ' 71' ' ' HIS . . . 86.95 -112.03 3.74 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.558 -0.829 . . . . 15.0 112.505 179.849 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.583 ' HA3' ' N ' ' A' ' 71' ' ' HIS . . . 62.58 -66.2 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 121.067 -0.587 . . . . 15.0 113.653 179.199 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.468 ' N ' ' O ' ' A' ' 24' ' ' GLY . 0.0 OUTLIER -28.94 143.12 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 N-CA-C 112.528 0.566 . . . . 15.0 112.528 -179.038 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.402 ' CB ' ' O ' ' A' ' 32' ' ' HIS . 13.4 p30 -75.67 61.87 1.41 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.738 -0.664 . . . . 15.0 110.968 -179.844 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -151.65 -66.97 0.18 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.376 -0.375 . . . . 15.0 111.045 179.994 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 72.4 m -65.4 -49.76 68.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.183 -0.462 . . . . 15.0 110.877 -179.939 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.419 HG13 ' CD1' ' A' ' 36' ' ' TYR . 34.5 m -75.95 -174.1 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.185 -0.462 . . . . 15.0 111.119 -179.966 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.81 -78.89 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.337 -0.392 . . . . 15.0 111.258 -179.755 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . 0.402 ' O ' ' CB ' ' A' ' 27' ' ' ASN . 34.4 p-80 -126.92 -42.85 1.72 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.431 -0.35 . . . . 15.0 111.223 -179.818 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -170.06 26.62 0.11 Allowed Glycine 0 N--CA 1.453 -0.2 0 C-N-CA 120.745 -0.74 . . . . 15.0 112.554 -179.772 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -92.61 154.75 22.3 Favored Glycine 0 N--CA 1.448 -0.521 0 N-CA-C 110.33 -1.108 . . . . 15.0 110.33 178.723 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.496 HG13 ' HA ' ' A' ' 71' ' ' HIS . 0.2 OUTLIER -98.86 152.82 4.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 119.768 -0.773 . . . . 15.0 112.318 -179.154 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.42 ' CZ ' ' HG3' ' A' ' 57' ' ' ARG . 14.7 m-85 -137.19 111.21 8.31 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.65 -1.159 . . . . 15.0 109.087 179.406 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.572 HG21 ' N ' ' A' ' 55' ' ' GLY . 0.8 OUTLIER -55.37 168.69 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.42 0.628 . . . . 15.0 111.572 -178.315 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.513 ' O ' ' HG2' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -99.75 -45.12 5.85 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.374 -0.973 . . . . 15.0 108.374 178.189 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.573 ' O ' HG12 ' A' ' 20' ' ' ILE . . . -172.66 171.45 4.48 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 115.437 -0.801 . . . . 15.0 110.363 178.466 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.436 ' HA ' ' CG1' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -96.76 110.68 25.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 108.803 -0.814 . . . . 15.0 108.803 178.877 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.692 ' HB ' ' O ' ' A' ' 19' ' ' GLY . 0.4 OUTLIER -77.55 115.66 51.51 Favored Pre-proline 0 C--N 1.329 -0.288 0 N-CA-C 113.597 0.962 . . . . 15.0 113.597 -176.693 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.534 ' HA ' ' HG2' ' A' ' 47' ' ' GLU . 38.9 Cg_exo -61.55 61.14 0.11 Allowed 'Trans proline' 0 C--N 1.358 1.073 0 C-N-CA 123.726 2.951 . . . . 15.0 113.003 179.578 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.524 ' H ' ' HG2' ' A' ' 47' ' ' GLU . 3.5 mt-30 -150.57 -47.93 0.12 Allowed 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 111.738 0.273 . . . . 15.0 111.738 179.957 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.591 ' HA3' ' HA3' ' A' ' 19' ' ' GLY . . . -87.81 166.66 35.91 Favored Glycine 0 CA--C 1.519 0.303 0 C-N-CA 120.356 -0.926 . . . . 15.0 113.79 -179.082 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.449 ' CB ' ' O ' ' A' ' 17' ' ' SER . . . -55.48 -14.87 2.22 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.66 0.615 . . . . 15.0 112.66 -179.817 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.93 -57.95 3.87 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.702 0.287 . . . . 15.0 110.945 -179.397 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.534 ' HG2' ' HA ' ' A' ' 42' ' ' PRO . 2.8 pp20? -56.94 -42.2 79.64 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.989 0.423 . . . . 15.0 110.391 179.415 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -53.82 -72.25 0.06 Allowed 'General case' 0 CA--C 1.519 -0.214 0 CA-C-N 115.883 -0.598 . . . . 15.0 110.466 -179.636 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -58.68 -40.4 83.46 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.456 -0.572 . . . . 15.0 109.456 179.01 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.93 50.03 5.38 Favored Glycine 0 N--CA 1.447 -0.584 0 CA-C-N 115.388 -0.824 . . . . 15.0 111.766 179.604 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.471 ' HG2' HG22 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -79.49 -51.59 9.13 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.764 0.316 . . . . 15.0 110.775 -179.34 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.442 ' CG2' ' N ' ' A' ' 53' ' ' HIS . 3.1 mm -91.45 162.72 2.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.993 0.425 . . . . 15.0 111.083 179.694 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . 0.442 ' N ' ' CG2' ' A' ' 52' ' ' ILE . 52.0 m80 -141.5 157.6 44.93 Favored 'General case' 0 CA--C 1.513 -0.466 0 CA-C-N 115.797 -0.638 . . . . 15.0 110.616 179.718 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.513 ' HG2' ' O ' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -35.61 132.58 0.44 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.848 -1.069 . . . . 15.0 112.647 -178.501 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.572 ' N ' HG21 ' A' ' 37' ' ' VAL . . . 49.71 38.02 28.58 Favored Glycine 0 C--N 1.332 0.338 0 CA-C-N 115.923 -0.58 . . . . 15.0 113.64 179.524 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.496 ' HB2' HG12 ' A' ' 37' ' ' VAL . 0.5 OUTLIER -65.88 128.59 36.62 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 117.499 0.65 . . . . 15.0 110.523 179.388 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.43 ' HA ' ' O ' ' A' ' 35' ' ' ILE . 56.3 ttt180 -83.25 88.02 6.94 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.429 -0.35 . . . . 15.0 110.537 179.808 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.471 ' O ' ' CG2' ' A' ' 58' ' ' VAL . 1.8 m -82.94 112.53 20.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.17 0.509 . . . . 15.0 111.353 -179.44 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 35.6 mt -107.27 -9.47 16.06 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 115.685 -0.689 . . . . 15.0 112.654 -179.306 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -151.25 144.81 24.94 Favored 'General case' 0 N--CA 1.463 0.194 0 N-CA-C 112.565 0.58 . . . . 15.0 112.565 -178.857 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.459 ' HA ' ' HG ' ' A' ' 87' ' ' LEU . 32.7 t -139.07 98.96 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.258 0 CA-C-N 115.497 -0.774 . . . . 15.0 109.452 178.878 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 65.06 17.76 11.2 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.066 -0.516 . . . . 15.0 109.874 -178.415 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 107.24 4.57 35.33 Favored Glycine 0 C--N 1.336 0.536 0 CA-C-N 115.836 -0.62 . . . . 15.0 113.676 179.488 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.511 ' O ' ' CG1' ' A' ' 64' ' ' VAL . 4.9 p -93.87 105.28 16.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 117.323 0.562 . . . . 15.0 110.818 179.319 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -56.87 134.59 55.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.142 -0.481 . . . . 15.0 110.983 -179.692 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -87.64 -19.35 27.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.121 -0.49 . . . . 15.0 111.034 -179.998 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -46.92 95.56 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 120.892 0.377 . . . . 15.0 110.888 179.943 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.77 66.75 0.59 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.785 -0.721 . . . . 15.0 112.217 -179.588 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -172.95 154.36 2.82 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.859 0.362 . . . . 15.0 110.976 -179.867 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.421 ' HA ' ' N ' ' A' ' 26' ' ' VAL . 13.7 p -93.04 -170.91 2.54 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.114 -0.494 . . . . 15.0 111.396 -179.626 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.583 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 1.5 t-160 -58.12 -62.17 2.02 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.618 -0.719 . . . . 15.0 110.063 179.75 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 3.4 ttpt -53.02 -36.23 60.3 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.236 -0.893 . . . . 15.0 111.051 179.483 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 7.0 mt-30 -59.41 -57.31 13.53 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.304 -0.407 . . . . 15.0 110.163 179.88 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.424 ' O ' ' N ' ' A' ' 77' ' ' THR . . . -63.27 -43.63 97.4 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.715 -0.476 . . . . 15.0 109.715 178.835 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -43.66 -42.74 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.223 0 N-CA-C 108.807 -0.812 . . . . 15.0 108.807 178.176 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.408 ' O ' ' CB ' ' A' ' 80' ' ' ASN . 21.7 mt-10 -67.45 -42.91 82.3 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 114.856 -1.066 . . . . 15.0 110.535 178.556 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.424 ' N ' ' O ' ' A' ' 74' ' ' ALA . 69.9 p -63.9 -56.18 17.22 Favored 'General case' 0 N--CA 1.462 0.135 0 C-N-CA 120.997 -0.281 . . . . 15.0 111.5 -179.924 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.424 ' HA ' HG12 ' A' ' 61' ' ' VAL . 5.6 mt -53.37 -47.14 69.71 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-O 121.197 0.523 . . . . 15.0 110.007 179.953 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 7.1 tpp85 -68.53 -59.12 3.37 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.395 -0.82 . . . . 15.0 110.691 179.489 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.408 ' CB ' ' O ' ' A' ' 76' ' ' GLU . 2.9 m-20 -65.92 63.0 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.035 -0.53 . . . . 15.0 111.848 179.909 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -91.79 -73.55 0.54 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.728 0.299 . . . . 15.0 110.33 179.322 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.42 ' O ' ' HG3' ' A' ' 13' ' ' LYS . . . 120.98 -103.43 0.9 Allowed Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.773 -0.727 . . . . 15.0 112.672 179.431 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -64.85 -87.03 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.723 0.297 . . . . 15.0 111.05 -179.841 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.439 HG13 ' N ' ' A' ' 85' ' ' VAL . 93.7 t -110.07 161.9 8.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.881 0.372 . . . . 15.0 110.625 179.956 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.465 ' O ' ' CG1' ' A' ' 85' ' ' VAL . 3.3 t -97.43 84.54 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.176 0.512 . . . . 15.0 110.368 179.825 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 10.9 t60 -101.28 82.63 2.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.59 -0.732 . . . . 15.0 110.001 179.493 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.485 ' HB3' HG12 ' A' ' 9' ' ' VAL . 0.1 OUTLIER -103.92 126.36 50.98 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.818 -0.628 . . . . 15.0 112.01 -178.907 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.481 HD11 ' CB ' ' A' ' 8' ' ' GLU . 4.9 mp -102.38 100.48 10.63 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.4 -0.593 . . . . 15.0 109.4 178.487 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.463 HD22 ' HA ' ' A' ' 58' ' ' VAL . 0.1 OUTLIER -105.57 -162.24 0.86 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.611 0.719 . . . . 15.0 112.027 -178.566 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.419 ' HB2' HG13 ' A' ' 6' ' ' ILE . 1.3 tt0 -139.89 133.88 30.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 114.73 -1.123 . . . . 15.0 109.485 178.856 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.15 93.81 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.89 0.376 . . . . 15.0 111.069 -179.562 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -72.09 75.92 0.76 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.959 -0.639 . . . . 15.0 112.738 -179.769 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.46 99.63 11.79 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.829 0.347 . . . . 15.0 110.796 179.898 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 99.1 p -71.86 155.29 92.25 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.203 -0.453 . . . . 15.0 110.992 -179.963 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -52.48 -36.98 72.21 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.648 2.232 . . . . 15.0 112.287 179.987 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.3 m . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.29 -0.862 . . . . 15.0 110.915 -179.982 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_endo . . . . . 0 N--CA 1.489 1.211 0 CA-C-O 120.79 0.246 . . . . 15.0 111.768 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.469 ' HB3' ' CD ' ' A' ' 3' ' ' PRO . 45.6 tptt -155.06 -66.5 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.21 -0.45 . . . . 15.0 110.797 179.81 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.469 ' CD ' ' HB3' ' A' ' 2' ' ' LYS . 55.3 Cg_endo -69.62 -167.99 0.25 Allowed 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.146 1.897 . . . . 15.0 112.209 179.772 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 84.55 -15.35 41.66 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.538 -0.839 . . . . 15.0 112.246 -179.704 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -62.12 159.18 15.11 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-O 121.102 0.477 . . . . 15.0 110.673 179.837 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.437 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 1.1 mp -104.3 144.44 14.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.593 -0.73 . . . . 15.0 111.125 -179.274 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.464 ' CE1' HD13 ' A' ' 89' ' ' LEU . 2.3 p90 -140.41 151.3 44.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.171 -0.468 . . . . 15.0 110.611 179.119 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.486 ' CB ' HD11 ' A' ' 88' ' ' LEU . 13.7 pt-20 -116.9 143.08 46.12 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.206 0.527 . . . . 15.0 111.402 -179.467 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.456 ' N ' ' O ' ' A' ' 87' ' ' LEU . 0.4 OUTLIER -101.46 116.92 45.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.401 -0.818 . . . . 15.0 109.766 179.056 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.404 ' OE1' ' CE1' ' A' ' 86' ' ' HIS . 3.8 tp10 -106.0 72.25 0.93 Allowed 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.198 0.444 . . . . 15.0 112.198 -178.932 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.474 ' HB3' ' HB ' ' A' ' 85' ' ' VAL . 6.7 tp -88.23 165.41 15.07 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.035 -0.53 . . . . 15.0 109.592 178.699 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -96.03 96.33 8.8 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.004 0.431 . . . . 15.0 110.991 179.952 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.481 ' HG3' ' HB ' ' A' ' 81' ' ' THR . 0.1 OUTLIER -63.29 -29.78 71.04 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.785 -0.643 . . . . 15.0 111.261 -179.863 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.403 ' N ' ' O ' ' A' ' 83' ' ' GLN . 55.1 t30 -84.44 -37.07 21.87 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.228 -0.442 . . . . 15.0 110.96 -179.639 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -64.75 -36.16 83.39 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.03 0.443 . . . . 15.0 110.283 179.454 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 11.8 m-20 -165.5 171.11 13.63 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.881 -0.6 . . . . 15.0 110.776 179.68 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.418 ' O ' ' CB ' ' A' ' 45' ' ' ALA . 0.5 OUTLIER -86.0 -155.27 0.24 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.251 -0.431 . . . . 15.0 110.142 179.637 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.419 ' N ' ' CD2' ' A' ' 18' ' ' LEU . 0.3 OUTLIER -105.05 -167.42 1.34 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.051 0.453 . . . . 15.0 110.721 179.413 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.572 ' O ' ' HB ' ' A' ' 41' ' ' ILE . . . -169.73 34.87 0.18 Allowed Glycine 0 CA--C 1.506 -0.53 0 N-CA-C 111.102 -0.799 . . . . 15.0 111.102 -179.673 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.523 HD13 ' HB ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -114.23 142.11 28.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 112.652 0.612 . . . . 15.0 112.652 -179.188 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.3 t -96.86 104.1 16.08 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 107.903 -1.147 . . . . 15.0 107.903 176.315 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.481 ' O ' ' CE1' ' A' ' 71' ' ' HIS . 27.5 m -93.63 147.36 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 N-CA-C 112.981 0.734 . . . . 15.0 112.981 -177.248 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.541 ' HA ' ' CE1' ' A' ' 71' ' ' HIS . 6.4 t -150.04 -177.46 5.93 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 115.553 -0.749 . . . . 15.0 111.327 179.205 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.44 ' O ' ' CB ' ' A' ' 71' ' ' HIS . . . 73.58 -115.95 5.23 Favored Glycine 0 C--N 1.336 0.565 0 C-N-CA 121.067 -0.587 . . . . 15.0 112.457 179.86 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.555 ' HA3' ' N ' ' A' ' 71' ' ' HIS . . . 64.18 -65.22 0.05 OUTLIER Glycine 0 C--N 1.33 0.233 0 C-N-CA 121.091 -0.576 . . . . 15.0 114.05 178.977 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.419 ' N ' ' O ' ' A' ' 24' ' ' GLY . 0.0 OUTLIER -30.11 144.0 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 N-CA-C 112.145 0.424 . . . . 15.0 112.145 -179.121 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -75.51 58.21 1.01 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.137 -0.483 . . . . 15.0 110.974 -179.644 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 5.3 m -151.92 -60.7 0.16 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.243 -0.435 . . . . 15.0 110.792 179.965 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 9.0 t -70.31 -46.67 63.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.069 -0.514 . . . . 15.0 110.914 -179.927 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 14.2 m -77.05 -170.03 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.237 -0.438 . . . . 15.0 111.093 -179.959 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 5.2 mmt180 -57.42 -71.47 0.1 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.273 -0.421 . . . . 15.0 111.009 -179.997 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . 0.442 ' CD2' ' N ' ' A' ' 33' ' ' GLY . 8.5 p-80 -134.93 -42.3 0.74 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.318 -0.401 . . . . 15.0 111.37 -179.817 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.442 ' N ' ' CD2' ' A' ' 32' ' ' HIS . . . -170.16 22.49 0.09 OUTLIER Glycine 0 CA--C 1.52 0.344 0 C-N-CA 120.504 -0.855 . . . . 15.0 113.086 -179.66 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -92.58 154.25 22.06 Favored Glycine 0 N--CA 1.451 -0.33 0 N-CA-C 110.163 -1.175 . . . . 15.0 110.163 178.405 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.515 ' CG2' HG22 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -101.34 147.33 8.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 118.181 0.99 . . . . 15.0 111.795 -179.209 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.439 ' CZ ' ' HG3' ' A' ' 57' ' ' ARG . 13.5 m-85 -131.28 113.18 13.49 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-N 115.433 -0.803 . . . . 15.0 109.537 -179.61 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.645 HG21 ' N ' ' A' ' 55' ' ' GLY . 0.7 OUTLIER -54.87 148.68 2.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 115.471 -0.786 . . . . 15.0 111.363 -178.736 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.47 ' O ' ' HG2' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -81.08 -48.39 12.24 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.775 -0.824 . . . . 15.0 108.775 178.654 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.497 ' O ' HG12 ' A' ' 20' ' ' ILE . . . -172.5 169.04 5.27 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.567 -0.742 . . . . 15.0 110.766 178.572 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.503 ' HA ' HG12 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -97.49 122.08 48.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.793 0.33 . . . . 15.0 110.526 179.676 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.572 ' HB ' ' O ' ' A' ' 19' ' ' GLY . 1.5 mm -78.5 109.26 9.93 Favored Pre-proline 0 N--CA 1.464 0.229 0 N-CA-C 112.956 0.724 . . . . 15.0 112.956 -178.627 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.501 ' HA ' ' OE1' ' A' ' 47' ' ' GLU . 38.2 Cg_endo -65.72 65.46 0.4 Allowed 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 122.828 2.352 . . . . 15.0 112.246 179.49 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -162.55 -44.94 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.434 -0.803 . . . . 15.0 109.508 179.816 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.534 ' HA3' ' HA3' ' A' ' 19' ' ' GLY . . . -87.43 151.35 23.31 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.774 -0.727 . . . . 15.0 112.338 179.351 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.418 ' CB ' ' O ' ' A' ' 17' ' ' SER . . . -40.19 -19.6 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 113.465 0.913 . . . . 15.0 113.465 -179.312 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.445 ' N ' ' O ' ' A' ' 44' ' ' GLY . . . -71.58 -71.13 0.28 Allowed 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.809 -0.356 . . . . 15.0 111.076 -179.654 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.566 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 9.0 tm-20 -58.22 -36.58 73.35 Favored 'General case' 0 N--CA 1.462 0.153 0 C-N-CA 120.81 -0.356 . . . . 15.0 110.284 179.36 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 53.6 m -56.16 -67.69 0.27 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.173 -0.467 . . . . 15.0 110.395 179.464 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -62.11 -37.64 85.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.129 -0.487 . . . . 15.0 109.932 179.179 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.32 38.19 15.63 Favored Glycine 0 N--CA 1.448 -0.521 0 CA-C-N 115.694 -0.684 . . . . 15.0 112.028 179.943 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.446 ' CG ' HG22 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -79.69 -53.58 6.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.124 0.487 . . . . 15.0 110.286 -179.846 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.507 ' CD1' HD12 ' A' ' 89' ' ' LEU . 11.0 tp -87.82 158.04 3.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.587 -0.733 . . . . 15.0 110.158 179.477 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . 0.449 ' O ' HG21 ' A' ' 37' ' ' VAL . 67.6 m80 -139.78 160.52 39.71 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-O 121.777 0.799 . . . . 15.0 112.898 -178.705 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.551 ' HA ' ' CG2' ' A' ' 37' ' ' VAL . 1.1 mtpt -43.97 134.7 4.49 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 114.007 -1.451 . . . . 15.0 112.702 -178.843 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.645 ' N ' HG21 ' A' ' 37' ' ' VAL . . . 49.75 31.95 16.87 Favored Glycine 0 C--N 1.333 0.408 0 CA-C-N 115.945 -0.571 . . . . 15.0 113.284 179.282 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.45 ' CB ' HD11 ' A' ' 52' ' ' ILE . 2.9 m-20 -65.56 122.59 17.57 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.629 -0.428 . . . . 15.0 109.874 179.15 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.439 ' HG3' ' CZ ' ' A' ' 36' ' ' TYR . 36.9 ttt85 -80.98 85.44 6.26 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.429 -0.35 . . . . 15.0 110.421 -179.859 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.526 HG22 ' O ' ' A' ' 58' ' ' VAL . 1.3 m -79.67 121.76 33.58 Favored 'Isoleucine or valine' 0 C--O 1.24 0.601 0 CA-C-O 121.211 0.529 . . . . 15.0 111.559 -179.365 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -107.91 -15.63 14.5 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 115.09 -0.959 . . . . 15.0 111.984 -179.861 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -147.91 148.16 30.51 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.113 0.483 . . . . 15.0 112.263 -178.565 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.449 ' HB ' ' CG1' ' A' ' 64' ' ' VAL . 39.6 t -139.02 102.69 1.8 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.249 0 CA-C-N 115.577 -0.738 . . . . 15.0 109.451 178.825 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 64.83 14.46 9.21 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.763 -0.458 . . . . 15.0 109.763 -178.195 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 107.01 6.49 34.3 Favored Glycine 0 C--N 1.336 0.573 0 CA-C-N 115.863 -0.608 . . . . 15.0 113.244 179.828 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.507 ' O ' ' CG1' ' A' ' 64' ' ' VAL . 6.3 p -93.67 105.22 16.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 121.098 0.475 . . . . 15.0 110.579 179.216 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -58.46 123.67 16.98 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.145 -0.479 . . . . 15.0 111.142 -179.442 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -92.07 -16.96 25.69 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.918 -0.583 . . . . 15.0 111.096 179.877 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -43.43 95.26 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.874 0.369 . . . . 15.0 111.239 -179.994 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 107.83 71.42 0.74 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.799 -0.715 . . . . 15.0 112.301 -179.73 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.433 ' HB3' ' HB3' ' A' ' 73' ' ' GLN . . . -173.02 169.46 4.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.831 0.348 . . . . 15.0 111.107 -179.778 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 15.6 p -93.42 -175.21 3.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.927 0.394 . . . . 15.0 111.27 -179.749 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.555 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 0.1 OUTLIER -65.78 -58.56 5.35 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.882 -0.599 . . . . 15.0 110.623 -179.902 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.448 ' O ' ' HG3' ' A' ' 76' ' ' GLU . 23.3 ttpp -52.21 -31.03 30.09 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.747 -0.464 . . . . 15.0 109.747 178.925 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.433 ' HB3' ' HB3' ' A' ' 69' ' ' ALA . 1.1 tt0 -59.5 -49.19 78.73 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.916 -0.584 . . . . 15.0 109.609 178.813 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.449 ' O ' ' N ' ' A' ' 77' ' ' THR . . . -67.11 -45.79 76.15 Favored 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 109.568 -0.53 . . . . 15.0 109.568 178.512 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.452 ' CG2' ' CG2' ' A' ' 22' ' ' VAL . 0.5 OUTLIER -42.2 -42.12 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.27 0 N-CA-C 108.792 -0.818 . . . . 15.0 108.792 178.257 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.506 ' O ' ' HB2' ' A' ' 80' ' ' ASN . 8.9 mt-10 -67.3 -45.28 77.01 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 114.651 -1.159 . . . . 15.0 110.361 178.477 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.449 ' N ' ' O ' ' A' ' 74' ' ' ALA . 72.9 p -64.1 -54.54 32.42 Favored 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 111.545 0.202 . . . . 15.0 111.545 -179.949 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.439 ' HA ' HG12 ' A' ' 61' ' ' VAL . 8.3 mt -53.47 -46.35 69.92 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 121.308 0.575 . . . . 15.0 109.881 -179.989 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.435 ' HB2' ' O ' ' A' ' 75' ' ' VAL . 0.2 OUTLIER -68.51 -58.89 3.63 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.204 -0.907 . . . . 15.0 110.805 179.677 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.506 ' HB2' ' O ' ' A' ' 76' ' ' GLU . 6.5 m-80 -66.23 56.98 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 112.393 0.516 . . . . 15.0 112.393 -179.86 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.481 ' HB ' ' HG3' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -95.69 -75.02 0.53 Allowed 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.94 -0.393 . . . . 15.0 109.94 178.853 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 122.06 -104.02 0.89 Allowed Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.641 -0.79 . . . . 15.0 113.537 178.804 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.403 ' O ' ' N ' ' A' ' 14' ' ' ASN . 0.2 OUTLIER -63.08 -84.9 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.06 0.393 . . . . 15.0 112.06 -178.699 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.432 HG13 ' N ' ' A' ' 85' ' ' VAL . 55.4 t -109.46 160.18 8.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.891 0.377 . . . . 15.0 110.706 -179.408 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.474 ' HB ' ' HB3' ' A' ' 11' ' ' LEU . 9.3 t -97.8 81.42 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-O 121.118 0.485 . . . . 15.0 110.382 -179.926 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . 0.404 ' CE1' ' OE1' ' A' ' 10' ' ' GLU . 0.5 OUTLIER -99.66 86.29 3.3 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.736 -0.665 . . . . 15.0 110.229 179.863 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.501 ' CD2' ' HB ' ' A' ' 58' ' ' VAL . 0.1 OUTLIER -103.82 127.33 51.33 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.882 -0.599 . . . . 15.0 111.718 -179.018 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.486 HD11 ' CB ' ' A' ' 8' ' ' GLU . 4.4 mp -102.18 99.44 9.57 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.552 -0.536 . . . . 15.0 109.552 178.742 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.507 HD12 ' CD1' ' A' ' 52' ' ' ILE . 0.1 OUTLIER -105.88 -162.66 0.88 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.56 0.695 . . . . 15.0 112.406 -178.317 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.437 ' HA ' ' HA ' ' A' ' 6' ' ' ILE . 1.9 tt0 -138.37 142.27 39.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 114.617 -1.174 . . . . 15.0 109.288 178.669 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -53.79 100.75 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.002 0.429 . . . . 15.0 111.107 -179.522 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -62.06 97.17 0.15 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.956 -0.64 . . . . 15.0 112.604 -179.768 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.36 112.31 21.32 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.826 0.346 . . . . 15.0 110.86 179.935 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -84.41 146.43 47.48 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.163 -0.471 . . . . 15.0 110.923 -179.964 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -52.87 -36.06 72.87 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.595 2.197 . . . . 15.0 112.25 179.994 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 2.4 t . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.223 -0.894 . . . . 15.0 110.89 -179.957 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo . . . . . 0 N--CA 1.487 1.099 0 CA-C-O 120.864 0.277 . . . . 15.0 111.848 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 10.5 mttt -145.14 99.35 4.61 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.114 -0.494 . . . . 15.0 110.687 179.993 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -55.16 -167.49 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.458 2.105 . . . . 15.0 112.661 -179.735 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 87.46 -21.49 21.39 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.812 -0.709 . . . . 15.0 112.033 -179.473 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -72.72 143.27 48.08 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 121.439 0.638 . . . . 15.0 111.142 179.851 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.413 HG13 ' HB2' ' A' ' 90' ' ' GLU . 1.2 mp -74.76 147.56 8.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 115.002 -0.999 . . . . 15.0 110.651 179.799 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.43 ' O ' ' N ' ' A' ' 89' ' ' LEU . 2.0 p90 -140.67 160.25 40.44 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.438 -0.346 . . . . 15.0 110.532 179.085 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.492 ' CB ' HD11 ' A' ' 88' ' ' LEU . 9.5 pt-20 -126.46 144.95 50.68 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.249 0.547 . . . . 15.0 111.48 -179.338 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.461 HG12 ' HB3' ' A' ' 87' ' ' LEU . 0.5 OUTLIER -101.29 115.07 42.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.331 -0.85 . . . . 15.0 109.722 179.157 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -106.13 69.56 0.81 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.107 -0.497 . . . . 15.0 111.643 -179.302 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.443 ' HB3' ' HB ' ' A' ' 85' ' ' VAL . 7.0 tp -88.15 161.68 17.14 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.013 -0.54 . . . . 15.0 110.082 179.213 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.56 ' C ' ' H ' ' A' ' 14' ' ' ASN . . . -96.63 101.0 12.53 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.717 0.294 . . . . 15.0 111.113 179.918 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.473 ' HB3' ' O ' ' A' ' 83' ' ' GLN . 0.4 OUTLIER -65.49 26.59 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 112.511 0.56 . . . . 15.0 112.511 179.882 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.56 ' H ' ' C ' ' A' ' 12' ' ' ALA . 49.5 t30 -109.49 152.53 25.3 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.672 0.272 . . . . 15.0 110.541 179.665 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.407 ' CB ' ' O ' ' A' ' 14' ' ' ASN . 6.3 t70 80.69 -49.21 0.3 Allowed 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.323 -0.399 . . . . 15.0 111.26 -179.91 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -154.99 162.18 41.16 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.855 0.359 . . . . 15.0 110.988 -179.912 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -86.03 -166.02 1.41 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.179 -0.464 . . . . 15.0 110.892 179.955 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -72.25 -167.83 0.35 Allowed 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 116.12 -0.491 . . . . 15.0 110.709 179.698 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.609 ' O ' ' HB ' ' A' ' 41' ' ' ILE . . . -160.85 35.64 0.42 Allowed Glycine 0 CA--C 1.506 -0.513 0 N-CA-C 111.308 -0.717 . . . . 15.0 111.308 179.987 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.66 HG12 ' O ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -112.61 140.13 33.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.011 0.434 . . . . 15.0 111.948 -179.169 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.423 ' HB3' HD13 ' A' ' 41' ' ' ILE . 33.2 t -96.01 105.82 17.91 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 107.696 -1.224 . . . . 15.0 107.696 177.275 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.462 HG22 ' CD2' ' A' ' 71' ' ' HIS . 33.2 m -93.57 152.77 3.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 112.984 0.735 . . . . 15.0 112.984 -176.908 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -149.42 -178.8 6.62 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 115.014 -0.994 . . . . 15.0 110.823 -179.736 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.412 ' O ' ' HB3' ' A' ' 71' ' ' HIS . . . 71.17 -119.19 7.81 Favored Glycine 0 C--N 1.332 0.308 0 C-N-CA 120.744 -0.741 . . . . 15.0 112.319 -179.95 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.53 ' HA3' ' N ' ' A' ' 71' ' ' HIS . . . 68.47 -66.46 0.41 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.784 -0.722 . . . . 15.0 113.448 179.338 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.446 ' N ' ' HA ' ' A' ' 70' ' ' THR . 0.9 OUTLIER -26.27 138.69 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 N-CA-C 112.5 0.555 . . . . 15.0 112.5 -179.297 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 8.1 p-10 -76.72 57.47 1.28 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.97 -0.559 . . . . 15.0 111.093 -179.929 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.2 m -151.85 -51.84 0.12 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.332 -0.395 . . . . 15.0 110.895 179.971 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 6.0 m -80.53 -41.18 24.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.108 -0.496 . . . . 15.0 110.934 -179.918 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 13.9 m -79.21 -169.96 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.284 -0.416 . . . . 15.0 111.095 -179.948 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.59 -62.94 1.5 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.284 -0.416 . . . . 15.0 111.05 -179.853 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . 0.431 ' CD2' ' HG3' ' A' ' 67' ' ' GLU . 11.0 p-80 -139.22 -51.51 0.53 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.356 -0.384 . . . . 15.0 111.257 -179.764 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -168.28 24.75 0.11 Allowed Glycine 0 CA--C 1.518 0.241 0 C-N-CA 120.791 -0.719 . . . . 15.0 112.628 -179.872 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -91.43 154.08 22.55 Favored Glycine 0 N--CA 1.45 -0.398 0 N-CA-C 110.681 -0.967 . . . . 15.0 110.681 178.891 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.49 HG21 HG22 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -92.55 154.72 3.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 117.685 0.742 . . . . 15.0 111.928 -179.265 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.429 ' CE2' ' HG2' ' A' ' 57' ' ' ARG . 30.4 m-85 -139.19 106.07 5.41 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.042 -0.981 . . . . 15.0 109.691 178.849 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.671 HG21 ' N ' ' A' ' 55' ' ' GLY . 0.7 OUTLIER -55.39 146.4 4.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.929 -0.578 . . . . 15.0 111.335 -178.873 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.422 ' O ' ' HG2' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -80.32 -48.51 12.88 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.475 -0.935 . . . . 15.0 108.475 178.356 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.66 ' O ' HG12 ' A' ' 20' ' ' ILE . . . -172.16 172.36 4.62 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.667 -0.697 . . . . 15.0 110.703 178.68 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.549 ' HA ' HG12 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -96.9 113.07 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 N-CA-C 109.712 -0.477 . . . . 15.0 109.712 179.397 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.609 ' HB ' ' O ' ' A' ' 19' ' ' GLY . 0.3 OUTLIER -78.6 119.34 76.92 Favored Pre-proline 0 C--N 1.33 -0.268 0 N-CA-C 113.281 0.845 . . . . 15.0 113.281 -177.411 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.534 ' HA ' ' CG ' ' A' ' 47' ' ' GLU . 38.3 Cg_endo -65.27 61.2 0.34 Allowed 'Trans proline' 0 C--N 1.355 0.904 0 C-N-CA 123.512 2.808 . . . . 15.0 112.958 179.713 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.536 ' H ' ' HG2' ' A' ' 47' ' ' GLU . 1.8 mm-40 -152.11 -44.63 0.11 Allowed 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 111.767 0.284 . . . . 15.0 111.767 179.81 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.554 ' HA3' ' HA3' ' A' ' 19' ' ' GLY . . . -87.77 164.77 34.47 Favored Glycine 0 CA--C 1.519 0.299 0 C-N-CA 120.347 -0.93 . . . . 15.0 113.828 -179.049 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -53.95 -16.34 1.83 Allowed 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 112.847 0.684 . . . . 15.0 112.847 -179.559 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.29 -57.85 3.88 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.609 0.243 . . . . 15.0 111.27 -179.35 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.536 ' HG2' ' H ' ' A' ' 43' ' ' GLN . 2.9 pp20? -56.74 -40.84 76.47 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.03 0.443 . . . . 15.0 110.312 179.552 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 33.4 t -53.85 -69.79 0.11 Allowed 'General case' 0 CA--C 1.52 -0.182 0 CA-C-N 115.818 -0.628 . . . . 15.0 110.753 -179.449 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -62.61 -38.42 90.11 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.598 -0.519 . . . . 15.0 109.598 179.257 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.03 44.53 8.11 Favored Glycine 0 N--CA 1.447 -0.611 0 CA-C-N 115.573 -0.739 . . . . 15.0 111.703 179.851 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.428 ' CG ' HG22 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -79.43 -53.46 6.88 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.884 0.373 . . . . 15.0 110.832 -179.273 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.403 ' CD1' HD12 ' A' ' 89' ' ' LEU . 8.4 tp -81.93 164.55 2.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.996 -0.547 . . . . 15.0 110.482 179.72 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . 0.447 ' O ' ' HB2' ' A' ' 56' ' ' ASP . 78.8 m80 -147.44 156.98 43.38 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.701 0.762 . . . . 15.0 112.181 -179.142 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.53 ' HA ' ' CG2' ' A' ' 37' ' ' VAL . 6.1 mtpt -42.31 133.73 3.11 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.31 -1.314 . . . . 15.0 112.99 -178.646 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.671 ' N ' HG21 ' A' ' 37' ' ' VAL . . . 49.81 31.87 17.19 Favored Glycine 0 C--N 1.334 0.449 0 CA-C-N 115.635 -0.711 . . . . 15.0 113.644 179.061 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.487 ' HB2' HG12 ' A' ' 37' ' ' VAL . 0.3 OUTLIER -65.9 130.5 43.47 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 117.179 0.49 . . . . 15.0 110.493 179.413 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.429 ' HG2' ' CE2' ' A' ' 36' ' ' TYR . 40.3 mtt180 -83.9 87.23 7.09 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.242 -0.435 . . . . 15.0 110.17 179.62 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.502 ' HA ' HD22 ' A' ' 89' ' ' LEU . 1.3 m -79.66 117.93 26.27 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 CA-C-O 121.086 0.469 . . . . 15.0 111.566 -179.12 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 27.7 mt -107.48 -18.84 13.75 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 115.504 -0.771 . . . . 15.0 112.493 -179.423 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.404 ' HA ' ' O ' ' A' ' 64' ' ' VAL . . . -148.79 148.52 30.04 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 112.946 0.721 . . . . 15.0 112.946 -178.575 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.453 ' CG2' HD22 ' A' ' 78' ' ' LEU . 56.7 t -139.2 94.53 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 CA-C-N 115.101 -0.954 . . . . 15.0 109.076 178.892 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 6.0 m120 70.5 16.6 6.98 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.047 -0.524 . . . . 15.0 109.87 -178.101 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 107.17 4.75 35.44 Favored Glycine 0 C--N 1.336 0.549 0 CA-C-N 115.851 -0.613 . . . . 15.0 113.429 179.559 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.496 ' O ' ' CG1' ' A' ' 64' ' ' VAL . 5.9 p -93.82 105.58 17.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.131 0.491 . . . . 15.0 110.845 179.446 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.6 t -55.71 139.4 45.09 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.057 -0.52 . . . . 15.0 111.206 -179.518 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.43 -22.97 16.28 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.966 -0.561 . . . . 15.0 110.78 179.875 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.431 ' HG3' ' CD2' ' A' ' 32' ' ' HIS . 1.6 tt0 -46.38 103.36 0.04 OUTLIER 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.237 -0.438 . . . . 15.0 111.125 -179.952 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 102.89 61.63 0.71 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.759 -0.734 . . . . 15.0 112.309 -179.865 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -173.09 142.57 1.06 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.874 0.368 . . . . 15.0 111.079 -179.823 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.446 ' HA ' ' N ' ' A' ' 26' ' ' VAL . 2.3 p -72.87 -171.85 0.93 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.252 -0.431 . . . . 15.0 110.953 -179.959 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.53 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 0.0 OUTLIER -62.95 -58.43 7.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.95 -0.568 . . . . 15.0 110.447 179.827 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.418 ' O ' HG11 ' A' ' 75' ' ' VAL . 1.8 ttpp -52.5 -33.91 47.05 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.826 -0.625 . . . . 15.0 110.855 179.691 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -59.31 -51.47 69.82 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.35 -0.611 . . . . 15.0 109.35 179.32 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.45 ' O ' ' N ' ' A' ' 77' ' ' THR . . . -66.86 -43.96 82.22 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.804 -0.634 . . . . 15.0 109.797 178.532 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.433 ' CG2' ' CG2' ' A' ' 22' ' ' VAL . 0.5 OUTLIER -43.35 -39.94 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.236 0 N-CA-C 109.029 -0.73 . . . . 15.0 109.029 178.419 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -67.22 -45.83 75.61 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 114.778 -1.101 . . . . 15.0 110.048 178.342 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.45 ' N ' ' O ' ' A' ' 74' ' ' ALA . 35.4 p -64.28 -53.48 48.26 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-N 116.526 -0.306 . . . . 15.0 111.454 179.848 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.453 HD22 ' CG2' ' A' ' 61' ' ' VAL . 4.5 mt -53.88 -48.53 69.99 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 121.205 0.526 . . . . 15.0 110.102 179.914 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.34 -57.68 5.55 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.405 -0.816 . . . . 15.0 110.737 179.655 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 64.8 m-20 -65.84 62.49 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.961 -0.563 . . . . 15.0 112.088 -179.86 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.41 -73.99 0.57 Allowed 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.798 -0.445 . . . . 15.0 109.798 179.015 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 114.87 -101.11 1.04 Allowed Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.744 -0.741 . . . . 15.0 113.263 178.781 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.473 ' O ' ' HB3' ' A' ' 13' ' ' LYS . 0.1 OUTLIER -64.63 -86.27 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.612 0.244 . . . . 15.0 111.527 -179.208 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.422 HG13 ' N ' ' A' ' 85' ' ' VAL . 79.0 t -110.3 159.52 10.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.98 0.419 . . . . 15.0 110.738 -179.893 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.462 ' O ' ' CG1' ' A' ' 85' ' ' VAL . 3.6 t -97.62 83.66 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.146 0.498 . . . . 15.0 110.228 179.648 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -101.75 83.89 2.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.707 -0.679 . . . . 15.0 110.238 179.727 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.481 ' CD2' ' HB ' ' A' ' 58' ' ' VAL . 0.1 OUTLIER -103.92 128.18 51.43 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.87 -0.605 . . . . 15.0 111.827 -179.106 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.492 HD11 ' CB ' ' A' ' 8' ' ' GLU . 4.6 mp -102.28 100.86 11.08 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.629 -0.508 . . . . 15.0 109.629 178.805 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.502 HD22 ' HA ' ' A' ' 58' ' ' VAL . 0.1 OUTLIER -105.64 -161.78 0.83 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.388 0.613 . . . . 15.0 111.848 -178.552 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.413 ' HB2' HG13 ' A' ' 6' ' ' ILE . 3.1 tt0 -142.23 135.38 28.8 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.052 -0.976 . . . . 15.0 109.878 179.21 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 2.8 tptt -47.47 103.95 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.919 0.39 . . . . 15.0 111.188 -179.681 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -70.38 76.4 0.49 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.785 -0.721 . . . . 15.0 112.5 -179.943 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -80.48 120.66 24.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.78 0.324 . . . . 15.0 110.872 179.957 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.2 t -77.74 150.02 78.28 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.241 -0.436 . . . . 15.0 110.987 179.968 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_exo -51.27 -26.51 20.57 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.582 2.188 . . . . 15.0 112.312 179.932 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 62.2 p . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.209 -0.9 . . . . 15.0 110.887 -179.989 . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo . . . . . 0 N--CA 1.487 1.127 0 CA-C-O 120.818 0.257 . . . . 15.0 111.688 . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 39.0 mtmt -146.32 153.91 48.82 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.454 . . . . 15.0 110.941 -179.954 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -65.5 -161.51 0.05 OUTLIER 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.636 2.224 . . . . 15.0 112.364 179.975 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 90.69 -23.73 21.26 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.676 -0.773 . . . . 15.0 112.28 -179.711 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -62.22 136.19 57.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.236 0.541 . . . . 15.0 110.729 179.839 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.482 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 1.4 mp -104.38 138.51 28.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.405 -0.816 . . . . 15.0 111.215 -179.415 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.47 ' CE1' ' CD1' ' A' ' 89' ' ' LEU . 10.8 p90 -141.82 143.59 33.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.264 -0.425 . . . . 15.0 110.882 178.874 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.492 ' HB2' HD11 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -109.96 142.42 41.36 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.339 0.59 . . . . 15.0 111.534 -179.404 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.478 ' CG2' ' HB3' ' A' ' 51' ' ' ARG . 0.2 OUTLIER -101.55 114.89 42.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.117 -0.947 . . . . 15.0 109.831 179.124 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -105.95 71.45 0.9 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.015 -0.539 . . . . 15.0 111.931 -178.988 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.412 ' O ' HG11 ' A' ' 84' ' ' VAL . 5.6 tp -87.98 165.76 14.98 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.151 -0.477 . . . . 15.0 109.727 178.972 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -94.71 94.2 7.98 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.916 0.389 . . . . 15.0 111.057 -179.995 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.445 ' HG3' ' HB ' ' A' ' 81' ' ' THR . 0.2 OUTLIER -54.11 -28.97 43.0 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.977 -0.556 . . . . 15.0 110.885 179.924 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.409 ' O ' ' CB ' ' A' ' 15' ' ' ASP . 41.7 m-20 -84.78 145.76 27.72 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.197 -0.456 . . . . 15.0 110.839 179.799 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.409 ' CB ' ' O ' ' A' ' 14' ' ' ASN . 4.9 m-20 81.69 -23.32 0.22 Allowed 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.096 -0.502 . . . . 15.0 112.0 179.711 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -165.36 138.38 4.45 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.873 0.368 . . . . 15.0 111.134 -179.917 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -86.11 -163.3 0.86 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.122 -0.49 . . . . 15.0 110.541 179.693 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -91.91 -172.46 3.18 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 116.383 -0.372 . . . . 15.0 110.779 179.503 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.601 ' HA3' ' HA3' ' A' ' 44' ' ' GLY . . . -160.98 39.44 0.42 Allowed Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 121.043 -0.599 . . . . 15.0 112.024 -179.794 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.608 HG12 ' O ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -112.51 144.71 19.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 121.06 0.457 . . . . 15.0 111.686 -179.493 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 55.0 p -96.06 101.49 13.16 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.267 -1.012 . . . . 15.0 108.267 177.958 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.461 ' O ' ' CE1' ' A' ' 71' ' ' HIS . 33.8 m -93.77 145.61 7.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 113.092 0.775 . . . . 15.0 113.092 -177.273 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.542 ' HA ' ' ND1' ' A' ' 71' ' ' HIS . 0.9 OUTLIER -149.49 -177.65 5.98 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 115.384 -0.826 . . . . 15.0 110.773 178.74 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.458 ' O ' ' HB3' ' A' ' 71' ' ' HIS . . . 76.32 -118.19 5.23 Favored Glycine 0 C--N 1.333 0.401 0 C-N-CA 120.87 -0.681 . . . . 15.0 112.361 -179.753 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.523 ' HA3' ' N ' ' A' ' 71' ' ' HIS . . . 64.42 -64.66 0.06 OUTLIER Glycine 0 CA--C 1.519 0.31 0 C-N-CA 121.139 -0.553 . . . . 15.0 114.116 178.956 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.429 ' N ' ' HA ' ' A' ' 70' ' ' THR . 1.5 m -25.97 142.18 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 N-CA-C 112.892 0.701 . . . . 15.0 112.892 -178.999 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 44.4 t-20 -78.4 55.41 1.57 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.681 -0.69 . . . . 15.0 110.934 179.856 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 15.0 m -152.03 -63.92 0.17 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.915 0.388 . . . . 15.0 110.938 -179.933 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 47.7 t -68.86 -49.99 53.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.029 -0.532 . . . . 15.0 110.885 -179.892 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.419 HG13 ' CD1' ' A' ' 36' ' ' TYR . 35.8 m -84.4 -176.74 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.25 -0.432 . . . . 15.0 111.027 179.912 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -89.09 121.86 31.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.956 0.408 . . . . 15.0 111.158 -179.867 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 65.08 -91.36 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.951 -0.568 . . . . 15.0 111.384 179.722 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.456 ' O ' ' O ' ' A' ' 69' ' ' ALA . . . -164.85 27.97 0.2 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.78 -0.724 . . . . 15.0 112.131 -179.717 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -84.81 149.47 24.37 Favored Glycine 0 N--CA 1.449 -0.47 0 N-CA-C 110.523 -1.031 . . . . 15.0 110.523 178.845 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.577 HG21 HG22 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -90.13 150.92 3.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 119.923 -0.711 . . . . 15.0 111.78 -179.215 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.45 ' CZ ' ' HG3' ' A' ' 57' ' ' ARG . 44.1 m-85 -136.49 108.54 7.19 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 114.904 -1.044 . . . . 15.0 109.124 178.942 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.679 HG21 ' N ' ' A' ' 55' ' ' GLY . 0.8 OUTLIER -55.17 153.72 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 121.269 0.557 . . . . 15.0 111.266 -178.567 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.551 ' O ' ' HG2' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -86.34 -46.05 10.65 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.745 -0.835 . . . . 15.0 108.745 178.848 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.608 ' O ' HG12 ' A' ' 20' ' ' ILE . . . -172.34 169.34 5.34 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.804 -0.635 . . . . 15.0 110.683 178.527 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.478 ' HA ' HG12 ' A' ' 20' ' ' ILE . 0.1 OUTLIER -96.73 109.86 23.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 N-CA-C 109.288 -0.634 . . . . 15.0 109.288 179.049 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.575 ' HB ' ' O ' ' A' ' 19' ' ' GLY . 0.3 OUTLIER -78.36 118.48 72.54 Favored Pre-proline 0 C--N 1.328 -0.348 0 N-CA-C 113.522 0.934 . . . . 15.0 113.522 -176.967 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.554 ' HA ' ' CG ' ' A' ' 47' ' ' GLU . 36.9 Cg_endo -64.48 61.59 0.26 Allowed 'Trans proline' 0 C--N 1.358 1.042 0 C-N-CA 123.536 2.824 . . . . 15.0 112.991 179.865 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.508 ' H ' ' HG2' ' A' ' 47' ' ' GLU . 41.8 mt-30 -149.88 -46.72 0.13 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.597 -0.274 . . . . 15.0 111.54 179.763 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.601 ' HA3' ' HA3' ' A' ' 19' ' ' GLY . . . -88.03 167.59 36.41 Favored Glycine 0 CA--C 1.518 0.27 0 C-N-CA 120.332 -0.937 . . . . 15.0 113.946 -179.212 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -56.6 -13.48 2.44 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.678 0.622 . . . . 15.0 112.678 -179.852 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.426 ' HB3' HG23 ' A' ' 52' ' ' ILE . . . -71.95 -58.23 3.63 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-O 120.773 0.321 . . . . 15.0 110.868 -179.618 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.554 ' CG ' ' HA ' ' A' ' 42' ' ' PRO . 2.6 pp20? -57.38 -42.0 81.33 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.732 -0.667 . . . . 15.0 110.423 179.285 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -53.78 -71.28 0.08 Allowed 'General case' 0 CA--C 1.519 -0.22 0 CA-C-N 115.783 -0.644 . . . . 15.0 110.549 -179.359 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -58.24 -40.71 82.47 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.137 -0.69 . . . . 15.0 109.137 178.838 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.416 ' O ' ' CE1' ' A' ' 53' ' ' HIS . . . 80.98 39.54 13.02 Favored Glycine 0 N--CA 1.446 -0.683 0 CA-C-N 115.197 -0.91 . . . . 15.0 112.011 179.212 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.478 ' HB3' ' CG2' ' A' ' 9' ' ' VAL . 3.0 mmt-85 -80.07 -59.31 2.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.963 0.411 . . . . 15.0 110.386 -179.773 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.441 HG12 HD12 ' A' ' 20' ' ' ILE . 6.6 tp -80.86 146.18 7.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.86 -0.609 . . . . 15.0 109.568 179.115 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . 0.512 ' O ' ' HB2' ' A' ' 56' ' ' ASP . 57.4 m80 -139.47 167.37 22.24 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-O 121.77 0.795 . . . . 15.0 112.762 -178.253 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.551 ' HG2' ' O ' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -40.29 132.72 1.94 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.109 -1.405 . . . . 15.0 113.27 -178.353 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.679 ' N ' HG21 ' A' ' 37' ' ' VAL . . . 49.7 36.23 25.0 Favored Glycine 0 C--N 1.335 0.511 0 CA-C-N 115.613 -0.721 . . . . 15.0 113.566 179.115 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.512 ' HB2' ' O ' ' A' ' 53' ' ' HIS . 1.7 t0 -65.66 132.32 48.51 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.99 0.395 . . . . 15.0 110.34 179.206 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.45 ' HG3' ' CZ ' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -85.11 77.25 10.11 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.983 -0.553 . . . . 15.0 110.134 179.545 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.577 HG22 HG21 ' A' ' 35' ' ' ILE . 0.8 OUTLIER -79.23 115.62 21.82 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 CA-C-O 121.293 0.568 . . . . 15.0 111.027 -179.25 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 35.0 mt -107.32 -14.12 14.96 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 115.555 -0.748 . . . . 15.0 112.522 -178.967 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.405 ' HA ' ' O ' ' A' ' 64' ' ' VAL . . . -147.56 149.9 33.46 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 112.642 0.608 . . . . 15.0 112.642 -178.51 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.447 ' HA ' ' HG ' ' A' ' 87' ' ' LEU . 15.6 t -139.12 101.54 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.27 0 CA-C-N 115.255 -0.884 . . . . 15.0 109.139 178.741 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.408 ' HB2' ' O ' ' A' ' 61' ' ' VAL . 1.7 m-80 65.04 15.54 10.05 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.668 -0.493 . . . . 15.0 109.668 -177.901 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 106.82 4.9 36.29 Favored Glycine 0 C--N 1.337 0.614 0 CA-C-N 115.822 -0.626 . . . . 15.0 113.286 179.77 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.485 ' O ' ' CG1' ' A' ' 64' ' ' VAL . 5.8 p -93.83 108.67 20.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 117.017 0.408 . . . . 15.0 111.046 179.616 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -57.11 137.98 55.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.259 -0.428 . . . . 15.0 111.064 -179.741 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.74 -23.08 16.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.076 -0.511 . . . . 15.0 111.003 179.96 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -47.57 104.0 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.389 -0.369 . . . . 15.0 111.091 179.937 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.76 54.87 0.58 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.744 -0.741 . . . . 15.0 112.288 -179.871 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.456 ' O ' ' O ' ' A' ' 33' ' ' GLY . . . -173.07 146.85 1.53 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.857 0.36 . . . . 15.0 111.012 -179.953 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.429 ' HA ' ' N ' ' A' ' 26' ' ' VAL . 11.3 p -72.94 -172.33 1.02 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.146 0.498 . . . . 15.0 111.097 -179.771 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.542 ' ND1' ' HA ' ' A' ' 23' ' ' THR . 0.0 OUTLIER -65.29 -57.83 7.44 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.636 -0.711 . . . . 15.0 110.751 -179.806 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.414 ' O ' HG11 ' A' ' 75' ' ' VAL . 5.4 ttpp -52.5 -32.91 42.52 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.352 -0.385 . . . . 15.0 110.285 179.316 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -59.56 -48.93 79.74 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.32 -0.622 . . . . 15.0 109.32 178.843 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.456 ' O ' ' N ' ' A' ' 77' ' ' THR . . . -67.16 -44.12 80.56 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-N 115.944 -0.571 . . . . 15.0 109.582 178.24 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.454 ' CG2' ' CG2' ' A' ' 22' ' ' VAL . 0.5 OUTLIER -44.03 -39.28 1.47 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.26 0 N-CA-C 108.706 -0.85 . . . . 15.0 108.706 178.312 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.425 ' N ' HG11 ' A' ' 75' ' ' VAL . 1.1 mt-10 -67.17 -45.3 77.41 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 114.668 -1.151 . . . . 15.0 110.132 178.249 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.456 ' N ' ' O ' ' A' ' 74' ' ' ALA . 39.0 p -64.12 -54.79 28.43 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.634 -0.257 . . . . 15.0 111.599 179.851 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.416 ' CD2' HG21 ' A' ' 61' ' ' VAL . 5.9 mt -53.33 -47.68 69.12 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-O 121.215 0.531 . . . . 15.0 109.851 -179.853 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.49 -59.09 3.41 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.423 -0.808 . . . . 15.0 110.551 179.403 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.403 ' HB2' ' O ' ' A' ' 76' ' ' GLU . 78.6 m-20 -66.15 59.71 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.947 -0.57 . . . . 15.0 112.411 -179.903 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.445 ' HB ' ' HG3' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -95.63 -71.51 0.67 Allowed 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 110.006 -0.368 . . . . 15.0 110.006 178.917 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 121.97 -105.39 0.98 Allowed Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.833 -0.699 . . . . 15.0 113.157 179.118 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.75 -81.62 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 112.151 0.426 . . . . 15.0 112.151 -179.06 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.417 HG13 ' N ' ' A' ' 85' ' ' VAL . 72.2 t -109.97 159.1 9.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.136 0.493 . . . . 15.0 111.21 -179.136 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.45 ' O ' ' CG1' ' A' ' 85' ' ' VAL . 6.8 t -97.82 81.56 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.909 -0.587 . . . . 15.0 110.553 179.935 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -100.45 84.34 2.76 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.729 -0.668 . . . . 15.0 110.419 179.786 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.459 ' CB ' HG12 ' A' ' 9' ' ' VAL . 0.1 OUTLIER -103.55 118.62 37.15 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.985 -0.552 . . . . 15.0 111.916 -179.102 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.492 HD11 ' HB2' ' A' ' 8' ' ' GLU . 3.8 mp -92.01 103.65 16.14 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.17 -0.678 . . . . 15.0 109.17 178.445 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.47 ' CD1' ' CE1' ' A' ' 7' ' ' PHE . 0.1 OUTLIER -105.61 -164.91 1.06 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.615 0.721 . . . . 15.0 112.352 -178.035 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.482 ' HA ' ' HA ' ' A' ' 6' ' ' ILE . 0.7 OUTLIER -144.93 135.86 24.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 114.626 -1.17 . . . . 15.0 109.487 179.146 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -46.81 98.65 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.942 0.401 . . . . 15.0 111.253 -179.497 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -61.99 -165.01 0.38 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.869 -0.681 . . . . 15.0 112.641 -179.83 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 12.0 mt-30 -76.43 134.88 39.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.829 0.347 . . . . 15.0 110.945 -179.961 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -90.18 111.59 47.75 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 15.0 110.887 179.933 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -55.25 129.64 36.32 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.441 2.094 . . . . 15.0 112.278 -179.981 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 11.7 t . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.234 -0.889 . . . . 15.0 110.856 -179.989 . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo . . . . . 0 N--CA 1.487 1.142 0 CA-C-O 120.799 0.25 . . . . 15.0 111.666 . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.11 91.98 5.4 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 15.0 110.897 -179.973 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_exo -56.4 -163.04 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.573 2.182 . . . . 15.0 112.218 -179.944 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 87.68 -19.98 30.14 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.591 -0.814 . . . . 15.0 112.339 -179.712 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -62.16 154.04 28.44 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.169 0.509 . . . . 15.0 110.844 179.855 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.494 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 1.2 mp -104.35 141.34 20.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.496 -0.775 . . . . 15.0 111.129 -179.376 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.467 ' CZ ' HD11 ' A' ' 89' ' ' LEU . 2.3 p90 -140.44 153.79 46.41 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.234 -0.439 . . . . 15.0 110.557 178.949 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.516 ' CB ' HD11 ' A' ' 88' ' ' LEU . 13.3 pt-20 -119.86 143.12 48.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.29 0.567 . . . . 15.0 111.748 -179.164 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.483 ' CG2' ' HB3' ' A' ' 51' ' ' ARG . 0.2 OUTLIER -101.67 117.79 47.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.277 -0.874 . . . . 15.0 109.72 178.817 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 51.5 tt0 -106.2 73.38 0.98 Allowed 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.094 0.405 . . . . 15.0 112.094 -179.165 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.505 ' HB3' ' HB ' ' A' ' 85' ' ' VAL . 9.5 tp -88.43 160.69 17.43 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.245 -0.434 . . . . 15.0 109.975 178.9 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.544 ' C ' ' H ' ' A' ' 14' ' ' ASN . . . -97.0 94.69 7.32 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 111.853 0.316 . . . . 15.0 111.853 -179.615 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.43 ' HB2' ' CG2' ' A' ' 85' ' ' VAL . 0.5 OUTLIER -65.74 27.56 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 112.522 0.564 . . . . 15.0 112.522 179.476 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.544 ' H ' ' C ' ' A' ' 12' ' ' ALA . 33.3 m-20 -115.41 126.51 54.46 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.944 0.402 . . . . 15.0 111.569 -179.45 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.3 t70 75.85 -1.89 2.88 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.989 -0.55 . . . . 15.0 112.107 179.381 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -165.52 138.96 4.49 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.943 0.401 . . . . 15.0 111.281 179.993 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -88.04 -151.79 0.2 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.953 -0.567 . . . . 15.0 110.345 179.569 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -91.83 -170.69 2.64 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 121.066 0.46 . . . . 15.0 110.865 179.716 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.591 ' O ' ' HB ' ' A' ' 41' ' ' ILE . . . -161.0 33.68 0.39 Allowed Glycine 0 C--O 1.223 -0.55 0 N-CA-C 110.84 -0.904 . . . . 15.0 110.84 -179.815 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.572 HG12 ' O ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -114.0 139.94 37.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 112.445 0.535 . . . . 15.0 112.445 -179.217 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.426 ' CB ' HD11 ' A' ' 41' ' ' ILE . 4.3 t -96.17 105.47 17.53 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 107.882 -1.155 . . . . 15.0 107.882 176.492 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.416 ' CG2' HG22 ' A' ' 75' ' ' VAL . 6.8 m -93.69 154.91 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 N-CA-C 113.28 0.844 . . . . 15.0 113.28 -176.952 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.52 -178.74 6.6 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.191 -0.913 . . . . 15.0 111.032 179.852 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.413 ' O ' ' CB ' ' A' ' 71' ' ' HIS . . . 69.04 -119.07 9.29 Favored Glycine 0 C--N 1.333 0.364 0 C-N-CA 120.968 -0.634 . . . . 15.0 112.531 179.719 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.549 ' HA3' ' N ' ' A' ' 71' ' ' HIS . . . 68.11 -65.79 0.36 Allowed Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.919 -0.658 . . . . 15.0 113.615 179.339 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.443 ' C ' ' O ' ' A' ' 25' ' ' GLY . 0.0 OUTLIER -27.36 139.29 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 N-CA-C 112.209 0.448 . . . . 15.0 112.209 -179.337 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 7.8 p-10 -75.22 61.99 1.2 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.08 -0.509 . . . . 15.0 111.006 -179.59 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.5 m -151.75 -59.68 0.16 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.274 -0.421 . . . . 15.0 111.055 179.957 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 91.4 p -74.86 -47.65 29.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.118 -0.492 . . . . 15.0 111.168 -179.779 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 35.1 m -70.12 -174.14 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.328 -0.396 . . . . 15.0 111.154 -179.89 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 6.8 mmp_? -54.5 -59.1 5.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.227 -0.442 . . . . 15.0 111.217 -179.792 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 1.7 p-80 -149.92 -44.83 0.13 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.44 -0.346 . . . . 15.0 111.325 -179.782 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.402 ' O ' ' O ' ' A' ' 69' ' ' ALA . . . -167.53 24.45 0.12 Allowed Glycine 0 CA--C 1.517 0.179 0 C-N-CA 120.605 -0.807 . . . . 15.0 112.894 -179.689 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -91.92 154.04 22.28 Favored Glycine 0 N--CA 1.45 -0.406 0 N-CA-C 110.074 -1.21 . . . . 15.0 110.074 178.341 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.514 ' HA ' ' HA2' ' A' ' 25' ' ' GLY . 0.0 OUTLIER -101.39 147.13 8.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 118.184 0.992 . . . . 15.0 111.767 -179.249 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 -130.94 109.2 10.36 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-N 115.307 -0.861 . . . . 15.0 109.539 -179.634 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.64 HG21 ' N ' ' A' ' 55' ' ' GLY . 0.7 OUTLIER -55.46 167.11 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.916 -0.583 . . . . 15.0 110.739 -179.27 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.42 -48.14 4.66 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.059 -0.719 . . . . 15.0 109.059 178.77 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.572 ' O ' HG12 ' A' ' 20' ' ' ILE . . . -171.5 169.18 6.22 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.269 -0.878 . . . . 15.0 110.463 179.341 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.513 ' HB ' ' HB2' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -97.24 123.57 49.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.727 0.298 . . . . 15.0 110.838 -179.908 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.707 ' O ' ' HB3' ' A' ' 47' ' ' GLU . 1.7 mm -78.68 108.14 7.37 Favored Pre-proline 0 N--CA 1.468 0.443 0 N-CA-C 113.199 0.815 . . . . 15.0 113.199 -178.651 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.48 ' HA ' ' CG ' ' A' ' 47' ' ' GLU . 25.8 Cg_exo -62.35 72.52 0.11 Allowed 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 122.99 2.46 . . . . 15.0 112.264 179.341 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.422 ' N ' ' O ' ' A' ' 41' ' ' ILE . 0.6 OUTLIER -174.32 -41.66 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.687 -0.688 . . . . 15.0 110.245 179.926 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.565 ' HA3' ' HA3' ' A' ' 19' ' ' GLY . . . -87.3 150.63 22.85 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.651 -0.785 . . . . 15.0 112.409 179.613 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -39.5 -22.73 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 113.191 0.811 . . . . 15.0 113.191 -179.369 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.427 ' N ' ' O ' ' A' ' 44' ' ' GLY . . . -71.82 -70.2 0.34 Allowed 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.937 -0.305 . . . . 15.0 111.294 -179.625 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.707 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 4.3 tp10 -58.03 -38.94 77.17 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.904 0.383 . . . . 15.0 110.657 179.653 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -53.82 -60.6 3.11 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.092 -0.504 . . . . 15.0 110.358 179.867 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.413 ' CB ' HD13 ' A' ' 11' ' ' LEU . 0.7 OUTLIER -66.71 -38.73 87.32 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.142 -0.481 . . . . 15.0 109.982 179.07 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.48 41.05 10.3 Favored Glycine 0 N--CA 1.449 -0.486 0 CA-C-N 115.699 -0.682 . . . . 15.0 112.486 179.664 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.483 ' HB3' ' CG2' ' A' ' 9' ' ' VAL . 5.3 mmp_? -86.3 -55.91 3.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.906 0.384 . . . . 15.0 110.74 179.858 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.463 ' CD1' HD12 ' A' ' 89' ' ' LEU . 9.0 tp -81.12 160.63 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 CA-C-N 116.037 -0.529 . . . . 15.0 110.71 179.808 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . 0.467 ' O ' ' HB2' ' A' ' 56' ' ' ASP . 62.2 m80 -141.17 160.54 39.88 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-O 121.73 0.776 . . . . 15.0 112.575 -179.077 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.588 ' HA ' ' CG2' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -45.77 137.45 5.44 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.398 -1.274 . . . . 15.0 112.497 -178.671 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.64 ' N ' HG21 ' A' ' 37' ' ' VAL . . . 49.73 32.7 17.88 Favored Glycine 0 C--N 1.334 0.452 0 CA-C-N 115.874 -0.603 . . . . 15.0 113.467 179.676 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.467 ' HB2' ' O ' ' A' ' 53' ' ' HIS . 0.3 OUTLIER -66.06 127.59 32.72 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.314 -0.554 . . . . 15.0 110.205 179.09 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 5.8 ttt180 -83.17 83.32 7.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.277 -0.42 . . . . 15.0 110.097 179.713 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.501 ' CG2' ' CG2' ' A' ' 35' ' ' ILE . 1.0 OUTLIER -79.47 123.6 36.59 Favored 'Isoleucine or valine' 0 C--O 1.241 0.646 0 CA-C-O 121.089 0.471 . . . . 15.0 111.329 -179.259 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -107.62 -18.78 13.75 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.189 -0.914 . . . . 15.0 112.491 -179.461 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -147.87 149.1 31.64 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 112.799 0.666 . . . . 15.0 112.799 -178.35 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.439 ' HB ' ' CG1' ' A' ' 64' ' ' VAL . 43.7 t -139.33 100.6 1.4 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.225 0 CA-C-N 115.297 -0.865 . . . . 15.0 109.281 178.596 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 65.46 15.9 10.25 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.135 -0.484 . . . . 15.0 109.833 -178.149 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 106.79 5.47 35.89 Favored Glycine 0 C--N 1.336 0.559 0 CA-C-N 115.868 -0.605 . . . . 15.0 113.321 179.615 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.504 ' O ' ' CG1' ' A' ' 64' ' ' VAL . 5.4 p -93.8 106.17 17.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.092 0.473 . . . . 15.0 110.713 179.405 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -57.66 127.84 34.03 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.159 -0.473 . . . . 15.0 111.147 -179.472 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -88.87 -23.96 22.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.986 -0.552 . . . . 15.0 110.741 179.81 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -45.25 97.16 0.01 OUTLIER 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 116.374 -0.375 . . . . 15.0 110.928 179.863 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.79 62.6 0.54 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.791 -0.718 . . . . 15.0 112.073 -179.544 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.402 ' O ' ' O ' ' A' ' 33' ' ' GLY . . . -172.93 146.22 1.51 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.897 0.379 . . . . 15.0 110.86 -179.789 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 6.8 p -72.81 -171.85 0.92 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.072 0.463 . . . . 15.0 111.304 -179.62 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.549 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 0.0 OUTLIER -65.39 -58.47 5.81 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.753 -0.658 . . . . 15.0 110.724 -179.91 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.404 ' HA ' ' HB ' ' A' ' 75' ' ' VAL . 15.6 ttpp -52.52 -31.46 35.54 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.018 -0.537 . . . . 15.0 110.52 179.725 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -59.59 -49.03 79.34 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.651 -0.5 . . . . 15.0 109.651 179.239 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.463 ' O ' ' N ' ' A' ' 77' ' ' THR . . . -67.2 -45.16 77.72 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 109.495 -0.557 . . . . 15.0 109.495 178.404 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.416 HG22 ' CG2' ' A' ' 22' ' ' VAL . 0.5 OUTLIER -43.06 -41.92 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.272 0 N-CA-C 108.888 -0.782 . . . . 15.0 108.888 178.305 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.509 ' O ' ' HB2' ' A' ' 80' ' ' ASN . 1.6 mt-10 -67.17 -44.59 79.33 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 114.861 -1.063 . . . . 15.0 110.073 178.212 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.463 ' N ' ' O ' ' A' ' 74' ' ' ALA . 68.7 p -64.08 -54.4 34.67 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-N 116.566 -0.288 . . . . 15.0 111.577 179.93 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.441 ' HG ' ' O ' ' A' ' 74' ' ' ALA . 8.6 mt -53.56 -47.02 70.44 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.351 0.596 . . . . 15.0 109.903 179.855 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.41 ' HB2' ' O ' ' A' ' 75' ' ' VAL . 0.1 OUTLIER -68.44 -59.49 3.13 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.194 -0.912 . . . . 15.0 110.837 179.728 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.509 ' HB2' ' O ' ' A' ' 76' ' ' GLU . 12.0 m-80 -66.09 61.06 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.161 -0.472 . . . . 15.0 112.131 -179.859 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.7 -71.46 0.67 Allowed 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 110.0 -0.37 . . . . 15.0 110.0 179.02 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 116.85 -102.02 1.0 Allowed Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.838 -0.696 . . . . 15.0 112.979 179.055 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.81 -87.51 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.632 0.253 . . . . 15.0 111.437 -179.456 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.434 HG13 ' N ' ' A' ' 85' ' ' VAL . 84.1 t -109.85 160.69 8.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.951 0.405 . . . . 15.0 110.873 -179.816 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.505 ' HB ' ' HB3' ' A' ' 11' ' ' LEU . 3.3 t -97.71 81.43 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 121.258 0.551 . . . . 15.0 110.143 179.804 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -96.03 81.32 3.37 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.668 -0.697 . . . . 15.0 110.107 179.827 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.463 ' CD2' ' HB ' ' A' ' 58' ' ' VAL . 0.1 OUTLIER -103.21 124.38 48.51 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.963 -0.562 . . . . 15.0 111.891 -178.947 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.516 HD11 ' CB ' ' A' ' 8' ' ' GLU . 0.0 OUTLIER -102.34 101.98 12.29 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.371 -0.603 . . . . 15.0 109.371 178.548 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.467 HD11 ' CZ ' ' A' ' 7' ' ' PHE . 0.1 OUTLIER -105.65 -163.57 0.95 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.553 0.692 . . . . 15.0 112.09 -178.581 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.494 ' HA ' ' HA ' ' A' ' 6' ' ' ILE . 0.9 OUTLIER -138.79 134.87 34.01 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.731 -1.122 . . . . 15.0 109.433 178.845 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.87 105.15 0.06 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.857 0.36 . . . . 15.0 111.379 -179.219 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -63.0 144.36 49.44 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.777 -0.725 . . . . 15.0 112.581 -179.912 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -84.06 146.48 27.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.802 0.334 . . . . 15.0 110.91 179.972 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -83.31 143.83 45.63 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.234 -0.439 . . . . 15.0 110.89 -179.947 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -53.24 -48.02 24.32 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.554 2.169 . . . . 15.0 112.301 179.987 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 3.1 m . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.246 -0.883 . . . . 15.0 110.891 -179.943 . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_endo . . . . . 0 N--CA 1.488 1.168 0 CA-C-O 120.806 0.253 . . . . 15.0 111.868 . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.461 ' HB2' ' HD3' ' A' ' 3' ' ' PRO . 0.0 OUTLIER -147.41 -66.48 0.02 OUTLIER Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.227 -0.442 . . . . 15.0 110.991 179.809 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.461 ' HD3' ' HB2' ' A' ' 2' ' ' LYS . 72.2 Cg_endo -76.34 -169.14 0.65 Allowed 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.19 1.927 . . . . 15.0 112.371 179.908 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 83.15 -14.27 40.05 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.676 -0.773 . . . . 15.0 112.409 -179.764 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -72.36 134.24 45.36 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.31 0.576 . . . . 15.0 110.932 179.962 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.403 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 1.1 mp -81.96 147.3 6.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.217 -0.901 . . . . 15.0 111.0 -179.728 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.443 ' O ' ' N ' ' A' ' 89' ' ' LEU . 4.0 p90 -140.65 157.71 45.05 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.191 -0.459 . . . . 15.0 110.58 179.087 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.472 ' CB ' HD11 ' A' ' 88' ' ' LEU . 11.3 pt-20 -124.71 141.83 51.83 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.226 0.536 . . . . 15.0 111.362 -179.557 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.481 ' CG2' ' HB3' ' A' ' 51' ' ' ARG . 0.2 OUTLIER -101.56 117.98 47.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.38 -0.827 . . . . 15.0 109.771 178.984 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -106.22 75.47 1.09 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.29 -0.414 . . . . 15.0 112.115 -179.064 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.551 ' HB3' ' HB ' ' A' ' 85' ' ' VAL . 11.4 tp -88.45 159.98 17.74 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.615 -0.513 . . . . 15.0 109.615 178.728 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.541 ' C ' ' H ' ' A' ' 14' ' ' ASN . . . -96.9 94.26 7.12 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 112.043 0.386 . . . . 15.0 112.043 -179.393 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.424 ' HB2' ' CG2' ' A' ' 85' ' ' VAL . 0.6 OUTLIER -65.82 29.21 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 112.435 0.531 . . . . 15.0 112.435 179.312 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.541 ' H ' ' C ' ' A' ' 12' ' ' ALA . 37.9 t30 -110.45 123.89 50.74 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.951 0.405 . . . . 15.0 111.68 -179.346 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.5 t0 64.78 11.24 6.71 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.864 -0.607 . . . . 15.0 112.039 179.333 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -165.63 133.05 2.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.969 0.414 . . . . 15.0 111.323 179.78 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -89.78 -162.57 0.9 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.899 -0.592 . . . . 15.0 110.386 179.503 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -81.99 -169.97 2.64 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 121.109 0.48 . . . . 15.0 110.722 179.476 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.575 ' O ' ' HB ' ' A' ' 41' ' ' ILE . . . -162.96 33.4 0.3 Allowed Glycine 0 C--O 1.223 -0.572 0 N-CA-C 110.83 -0.908 . . . . 15.0 110.83 -179.766 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.557 HD13 ' HB ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -113.87 143.26 23.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 112.243 0.46 . . . . 15.0 112.243 -179.159 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.405 ' CB ' HD11 ' A' ' 41' ' ' ILE . 1.7 t -96.41 103.45 15.36 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 107.745 -1.206 . . . . 15.0 107.745 176.676 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.434 ' CG2' ' CG2' ' A' ' 75' ' ' VAL . 29.6 m -93.5 149.82 4.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.368 0.604 . . . . 15.0 112.612 -177.367 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -149.51 -178.46 6.44 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.167 -0.924 . . . . 15.0 110.949 -179.411 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.406 ' O ' ' HB3' ' A' ' 71' ' ' HIS . . . 69.52 -117.64 7.86 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 120.802 -0.713 . . . . 15.0 112.251 -179.973 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.505 ' HA3' ' N ' ' A' ' 71' ' ' HIS . . . 67.2 -64.25 0.23 Allowed Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.904 -0.665 . . . . 15.0 113.668 179.362 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.417 ' HA ' ' CB ' ' A' ' 70' ' ' THR . 0.0 OUTLIER -28.99 137.51 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 N-CA-C 112.459 0.54 . . . . 15.0 112.459 -179.255 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 11.5 m-80 -75.56 61.3 1.3 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.802 -0.635 . . . . 15.0 111.016 -179.729 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -151.74 -53.76 0.13 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.341 -0.39 . . . . 15.0 111.074 179.971 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.6 m -81.92 -45.64 15.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.155 -0.475 . . . . 15.0 111.133 -179.812 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 34.8 m -72.15 -175.23 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.22 -0.445 . . . . 15.0 111.271 -179.838 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.5 -60.55 3.16 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.204 -0.453 . . . . 15.0 111.202 -179.942 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 5.4 p-80 -146.62 -46.81 0.19 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.357 -0.383 . . . . 15.0 111.235 -179.847 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -169.2 25.81 0.11 Allowed Glycine 0 N--CA 1.453 -0.2 0 C-N-CA 120.749 -0.738 . . . . 15.0 112.686 -179.73 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -94.28 153.41 21.05 Favored Glycine 0 N--CA 1.449 -0.47 0 N-CA-C 110.629 -0.989 . . . . 15.0 110.629 178.838 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.503 HG21 HG22 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -94.18 152.77 3.52 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.321 0 CA-C-N 117.727 0.764 . . . . 15.0 112.073 -179.252 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.486 ' CZ ' ' HG2' ' A' ' 57' ' ' ARG . 44.5 m-85 -136.04 106.29 6.39 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.84 -1.073 . . . . 15.0 109.613 178.849 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.661 HG21 ' N ' ' A' ' 55' ' ' GLY . 0.6 OUTLIER -55.22 145.74 5.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.911 -0.586 . . . . 15.0 111.491 -178.846 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.45 ' O ' ' HG2' ' A' ' 54' ' ' LYS . 1.2 ttpt -81.91 -47.45 12.74 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.342 -0.984 . . . . 15.0 108.342 178.213 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.543 ' O ' HG12 ' A' ' 20' ' ' ILE . . . -172.2 169.79 5.35 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.625 -0.716 . . . . 15.0 111.366 178.679 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.513 ' HA ' HG12 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -97.5 121.04 47.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-N 116.254 -0.43 . . . . 15.0 111.131 -179.871 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.596 ' O ' ' HB3' ' A' ' 47' ' ' GLU . 1.5 mm -78.98 110.33 14.16 Favored Pre-proline 0 N--CA 1.466 0.368 0 N-CA-C 113.135 0.791 . . . . 15.0 113.135 -178.919 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.545 ' HA ' ' OE1' ' A' ' 47' ' ' GLU . 17.8 Cg_exo -65.8 63.68 0.42 Allowed 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 122.858 2.372 . . . . 15.0 112.213 179.243 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 1.9 mm-40 -159.48 -45.81 0.05 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.654 -0.703 . . . . 15.0 109.85 179.873 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.496 ' HA3' ' HA3' ' A' ' 19' ' ' GLY . . . -87.42 151.51 23.47 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.68 -0.772 . . . . 15.0 112.374 179.518 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -39.96 -19.58 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 113.494 0.924 . . . . 15.0 113.494 -179.326 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.448 ' N ' ' O ' ' A' ' 44' ' ' GLY . . . -71.72 -70.95 0.29 Allowed 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.829 -0.348 . . . . 15.0 111.426 -179.453 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.596 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 9.9 tm-20 -58.2 -38.25 76.37 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.823 0.344 . . . . 15.0 110.336 179.599 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.3 m -53.9 -64.97 0.66 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.164 -0.471 . . . . 15.0 110.449 179.821 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.415 ' CB ' HD13 ' A' ' 11' ' ' LEU . 0.4 OUTLIER -63.21 -37.51 87.54 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.151 -0.477 . . . . 15.0 109.979 179.112 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.49 37.46 17.31 Favored Glycine 0 N--CA 1.449 -0.439 0 CA-C-N 115.726 -0.67 . . . . 15.0 112.377 179.695 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.481 ' HB3' ' CG2' ' A' ' 9' ' ' VAL . 0.9 OUTLIER -82.8 -54.65 4.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.938 0.399 . . . . 15.0 110.543 179.91 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.516 ' CD1' HD12 ' A' ' 89' ' ' LEU . 11.4 tp -81.18 159.07 4.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.979 -0.555 . . . . 15.0 110.177 179.458 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . 0.439 ' O ' HG21 ' A' ' 37' ' ' VAL . 76.1 m80 -142.16 160.67 39.76 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 121.766 0.793 . . . . 15.0 112.813 -178.784 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.544 ' HA ' ' CG2' ' A' ' 37' ' ' VAL . 1.2 mtpt -44.01 134.73 4.53 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 113.93 -1.486 . . . . 15.0 112.762 -178.788 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.661 ' N ' HG21 ' A' ' 37' ' ' VAL . . . 49.75 29.82 13.54 Favored Glycine 0 C--N 1.334 0.428 0 CA-C-N 115.791 -0.64 . . . . 15.0 113.448 179.261 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.412 ' CB ' HD11 ' A' ' 52' ' ' ILE . 6.2 m-20 -65.78 128.75 37.26 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.761 -0.376 . . . . 15.0 110.413 179.359 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.486 ' HG2' ' CZ ' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -82.08 93.49 7.02 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.362 -0.381 . . . . 15.0 110.54 -179.988 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.503 HG22 HG21 ' A' ' 35' ' ' ILE . 1.2 m -86.26 115.7 27.86 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 CA-C-O 121.112 0.482 . . . . 15.0 111.586 -179.32 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -107.68 -14.67 14.76 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 115.633 -0.712 . . . . 15.0 112.542 -179.496 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -147.56 150.33 34.27 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 112.743 0.646 . . . . 15.0 112.743 -178.394 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.444 ' HB ' ' CG1' ' A' ' 64' ' ' VAL . 98.2 t -139.21 103.01 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.202 -0.908 . . . . 15.0 109.066 178.808 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 65.23 16.9 10.79 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.516 -0.55 . . . . 15.0 109.516 -178.038 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.0 6.97 44.98 Favored Glycine 0 C--N 1.335 0.49 0 CA-C-N 115.789 -0.641 . . . . 15.0 113.135 179.814 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.487 ' O ' ' CG1' ' A' ' 64' ' ' VAL . 6.0 p -93.86 106.56 18.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.062 0.458 . . . . 15.0 110.724 179.394 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -58.3 122.98 14.56 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.179 -0.464 . . . . 15.0 110.955 -179.488 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.7 mt -94.38 -12.53 27.73 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.836 -0.62 . . . . 15.0 111.286 -179.92 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -44.65 98.05 0.01 OUTLIER 'General case' 0 N--CA 1.461 0.1 0 CA-C-O 120.865 0.364 . . . . 15.0 110.894 179.855 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.85 67.53 0.6 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.838 -0.696 . . . . 15.0 112.102 -179.46 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -172.91 148.16 1.76 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.78 0.324 . . . . 15.0 110.837 -179.683 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.417 ' CB ' ' HA ' ' A' ' 26' ' ' VAL . 1.4 p -72.86 -174.2 1.41 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.019 0.438 . . . . 15.0 111.041 -179.731 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.505 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 0.0 OUTLIER -63.51 -59.03 5.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.885 -0.598 . . . . 15.0 110.658 -179.822 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.404 ' HA ' ' HB ' ' A' ' 75' ' ' VAL . 18.1 ttpp -52.44 -33.19 43.09 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.987 -0.551 . . . . 15.0 110.75 179.669 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -59.57 -49.98 75.65 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.428 -0.582 . . . . 15.0 109.428 179.123 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.451 ' HA ' ' OG1' ' A' ' 77' ' ' THR . . . -67.05 -45.93 75.93 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.743 -0.662 . . . . 15.0 109.836 178.482 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.434 ' CG2' ' CG2' ' A' ' 22' ' ' VAL . 0.5 OUTLIER -41.87 -41.49 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.27 0 CA-C-O 121.524 0.678 . . . . 15.0 109.218 178.553 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.401 ' HG3' ' O ' ' A' ' 72' ' ' LYS . 21.4 mt-10 -67.33 -44.93 77.88 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.762 -1.108 . . . . 15.0 110.681 178.941 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.451 ' OG1' ' HA ' ' A' ' 74' ' ' ALA . 15.3 p -64.38 -54.9 25.61 Favored 'General case' 0 N--CA 1.463 0.184 0 C-N-CA 121.028 -0.269 . . . . 15.0 111.599 -179.96 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.411 ' HA ' HG12 ' A' ' 61' ' ' VAL . 6.5 mt -53.43 -47.79 69.32 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-O 121.122 0.487 . . . . 15.0 110.188 -179.752 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.406 ' HB2' ' O ' ' A' ' 75' ' ' VAL . 3.1 ttp180 -68.32 -57.48 5.87 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.554 -0.748 . . . . 15.0 110.479 179.521 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -66.11 61.69 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.016 -0.538 . . . . 15.0 111.906 179.859 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.57 -74.97 0.54 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.719 0.295 . . . . 15.0 110.234 179.236 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 120.36 -102.33 0.86 Allowed Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.775 -0.726 . . . . 15.0 112.88 179.381 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -64.7 -86.02 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.609 0.242 . . . . 15.0 111.209 -179.627 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.446 HG13 ' N ' ' A' ' 85' ' ' VAL . 86.8 t -109.77 160.36 8.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.886 0.374 . . . . 15.0 110.778 -179.924 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.551 ' HB ' ' HB3' ' A' ' 11' ' ' LEU . 3.1 t -97.66 81.86 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.214 0.53 . . . . 15.0 110.195 179.868 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -96.08 82.29 3.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.687 -0.688 . . . . 15.0 110.344 179.895 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.475 ' CD2' ' CD2' ' A' ' 89' ' ' LEU . 0.1 OUTLIER -101.95 121.83 42.89 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.933 -0.576 . . . . 15.0 111.719 -179.281 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.472 HD11 ' CB ' ' A' ' 8' ' ' GLU . 4.7 mp -99.4 100.76 11.86 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.521 -0.548 . . . . 15.0 109.521 178.745 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.516 HD12 ' CD1' ' A' ' 52' ' ' ILE . 0.1 OUTLIER -105.52 -161.52 0.81 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.456 0.646 . . . . 15.0 112.031 -178.501 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.403 ' HA ' ' HA ' ' A' ' 6' ' ' ILE . 1.1 tt0 -138.88 142.58 38.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 114.862 -1.063 . . . . 15.0 109.629 178.969 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 2.5 tppp? -54.48 106.04 0.18 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.978 0.418 . . . . 15.0 111.242 -179.421 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -72.32 66.55 1.25 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.971 -0.633 . . . . 15.0 112.438 179.914 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -76.35 122.69 24.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.876 0.369 . . . . 15.0 110.976 -179.935 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.7 m -78.56 163.45 61.23 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.164 -0.471 . . . . 15.0 110.904 179.941 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -53.46 -62.44 0.33 Allowed 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.601 2.201 . . . . 15.0 112.297 -179.97 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 3.1 m . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.261 -0.876 . . . . 15.0 110.934 179.972 . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_endo . . . . . 0 N--CA 1.488 1.199 0 CA-C-O 120.922 0.301 . . . . 15.0 111.81 . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.17 149.3 19.32 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.087 -0.506 . . . . 15.0 110.803 179.946 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -55.09 -168.18 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.438 2.092 . . . . 15.0 112.31 -179.975 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 83.27 -14.02 42.14 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.583 -0.818 . . . . 15.0 112.332 -179.616 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -69.4 155.94 39.64 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-O 121.268 0.556 . . . . 15.0 110.867 179.884 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.412 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 1.4 mp -104.32 143.85 15.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.257 -0.883 . . . . 15.0 111.034 -179.441 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.448 ' O ' ' N ' ' A' ' 89' ' ' LEU . 4.8 p90 -140.45 166.81 23.71 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.182 -0.463 . . . . 15.0 110.37 178.871 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.468 ' HB2' HD11 ' A' ' 88' ' ' LEU . 4.2 pt-20 -130.22 142.87 50.53 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.269 0.557 . . . . 15.0 111.88 -179.21 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.429 HG12 ' HB3' ' A' ' 87' ' ' LEU . 0.2 OUTLIER -101.38 115.93 44.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.237 -0.892 . . . . 15.0 109.332 178.805 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -105.96 76.37 1.17 Allowed 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 112.696 0.628 . . . . 15.0 112.696 -178.394 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.502 ' HB3' ' HB ' ' A' ' 85' ' ' VAL . 6.9 tp -88.16 162.03 16.93 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.018 -0.734 . . . . 15.0 109.018 177.995 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -96.92 89.98 5.05 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 112.431 0.53 . . . . 15.0 112.431 -179.185 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.463 ' CE ' ' HA ' ' A' ' 17' ' ' SER . 0.1 OUTLIER -65.58 54.67 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.033 -0.531 . . . . 15.0 111.552 178.9 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 42.6 t-20 -108.98 -87.53 0.5 Allowed 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 111.734 0.272 . . . . 15.0 111.734 -179.347 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -101.35 24.29 9.79 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.666 0.27 . . . . 15.0 111.373 -179.462 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -165.41 128.86 2.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.95 0.405 . . . . 15.0 111.113 179.897 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.463 ' HA ' ' CE ' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -89.73 -162.63 0.9 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.928 -0.578 . . . . 15.0 110.545 179.615 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -80.15 -166.43 1.04 Allowed 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 116.359 -0.382 . . . . 15.0 110.457 179.595 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.646 ' O ' ' HB ' ' A' ' 41' ' ' ILE . . . -167.51 37.1 0.22 Allowed Glycine 0 CA--C 1.506 -0.52 0 N-CA-C 111.566 -0.614 . . . . 15.0 111.566 -179.609 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.593 HG12 ' O ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -112.5 142.28 25.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 112.216 0.45 . . . . 15.0 112.216 -179.04 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 30.9 t -95.46 101.66 13.4 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 107.079 -1.452 . . . . 15.0 107.079 176.657 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.451 HG22 ' CD2' ' A' ' 71' ' ' HIS . 35.5 m -93.26 156.7 3.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 113.236 0.828 . . . . 15.0 113.236 -176.364 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.25 -175.03 4.82 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 114.966 -1.016 . . . . 15.0 110.647 -179.694 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.407 ' O ' ' HB3' ' A' ' 71' ' ' HIS . . . 68.79 -121.38 12.15 Favored Glycine 0 C--N 1.332 0.32 0 C-N-CA 120.868 -0.682 . . . . 15.0 112.469 179.8 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.513 ' HA3' ' N ' ' A' ' 71' ' ' HIS . . . 66.76 -64.42 0.18 Allowed Glycine 0 CA--C 1.518 0.269 0 C-N-CA 120.997 -0.621 . . . . 15.0 113.679 179.285 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.407 ' N ' ' HA ' ' A' ' 70' ' ' THR . 0.0 OUTLIER -30.46 146.97 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 N-CA-C 112.591 0.589 . . . . 15.0 112.591 -179.204 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -75.75 56.31 0.92 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.872 -0.604 . . . . 15.0 111.066 -179.946 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.3 m -151.96 -63.61 0.17 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.914 0.388 . . . . 15.0 111.202 -179.986 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 30.9 t -67.07 -50.43 61.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.046 -0.524 . . . . 15.0 111.325 -179.575 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.439 HG13 ' CD1' ' A' ' 36' ' ' TYR . 19.6 m -69.45 -175.94 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.378 -0.374 . . . . 15.0 111.415 -179.644 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.401 ' HD3' ' NH2' ' A' ' 57' ' ' ARG . 46.2 mtp85 -62.4 -53.06 60.53 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.162 -0.472 . . . . 15.0 111.089 -179.859 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 42.1 p-80 -142.24 -52.79 0.41 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.449 -0.341 . . . . 15.0 111.201 179.939 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -169.18 19.01 0.08 OUTLIER Glycine 0 CA--C 1.519 0.328 0 C-N-CA 120.522 -0.847 . . . . 15.0 113.097 -179.802 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -85.27 152.92 27.21 Favored Glycine 0 N--CA 1.45 -0.401 0 N-CA-C 110.797 -0.921 . . . . 15.0 110.797 178.89 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.486 HG21 HG22 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -90.54 154.97 3.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 117.642 0.721 . . . . 15.0 111.851 -179.352 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.439 ' CD1' HG13 ' A' ' 30' ' ' VAL . 30.4 m-85 -141.8 107.34 5.06 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.028 -0.987 . . . . 15.0 109.737 178.918 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.662 HG21 ' N ' ' A' ' 55' ' ' GLY . 0.8 OUTLIER -55.3 150.83 2.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.035 -0.53 . . . . 15.0 111.315 -178.9 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.486 ' O ' ' HG2' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -82.37 -47.04 12.78 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.416 -0.957 . . . . 15.0 108.416 178.412 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.593 ' O ' HG12 ' A' ' 20' ' ' ILE . . . -172.17 173.37 4.3 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.361 -0.836 . . . . 15.0 110.231 178.569 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.58 ' HA ' HG12 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -97.36 108.69 22.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.892 0.377 . . . . 15.0 110.349 179.647 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.646 ' HB ' ' O ' ' A' ' 19' ' ' GLY . 0.8 OUTLIER -78.96 110.53 14.86 Favored Pre-proline 0 C--O 1.234 0.245 0 N-CA-C 113.046 0.758 . . . . 15.0 113.046 -178.322 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.605 ' HA ' ' OE1' ' A' ' 47' ' ' GLU . 22.7 Cg_exo -64.28 66.58 0.24 Allowed 'Trans proline' 0 C--N 1.356 0.96 0 C-N-CA 123.177 2.585 . . . . 15.0 112.721 179.771 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 12.8 mt-30 -148.42 -52.88 0.18 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.483 -0.781 . . . . 15.0 109.258 179.233 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.616 ' HA3' ' HA3' ' A' ' 19' ' ' GLY . . . -88.24 156.19 26.91 Favored Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.612 -0.804 . . . . 15.0 112.474 179.044 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.402 ' CB ' ' O ' ' A' ' 17' ' ' SER . . . -42.5 -16.46 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 113.432 0.901 . . . . 15.0 113.432 -179.696 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.437 ' N ' ' O ' ' A' ' 44' ' ' GLY . . . -71.57 -70.27 0.33 Allowed 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.92 -0.312 . . . . 15.0 111.474 -179.258 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.605 ' OE1' ' HA ' ' A' ' 42' ' ' PRO . 10.2 tm-20 -58.31 -36.13 72.89 Favored 'General case' 0 N--CA 1.463 0.211 0 C-N-CA 120.504 -0.479 . . . . 15.0 110.064 179.408 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 48.8 m -57.57 -66.99 0.37 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.925 -0.58 . . . . 15.0 110.186 179.411 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.442 ' CB ' HD13 ' A' ' 11' ' ' LEU . 0.8 OUTLIER -60.55 -37.65 81.94 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.096 0.475 . . . . 15.0 109.881 179.004 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.44 37.43 17.54 Favored Glycine 0 N--CA 1.449 -0.461 0 CA-C-N 115.58 -0.736 . . . . 15.0 112.504 179.585 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.424 ' HB3' ' CG2' ' A' ' 9' ' ' VAL . 14.3 mmt180 -84.77 -49.75 8.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.94 0.4 . . . . 15.0 110.621 179.999 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.444 HG21 ' CG1' ' A' ' 40' ' ' VAL . 11.1 tp -81.19 157.22 4.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.016 -0.538 . . . . 15.0 110.347 179.537 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . 0.423 ' O ' HG21 ' A' ' 37' ' ' VAL . 76.6 m80 -139.65 158.1 44.67 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-O 121.753 0.787 . . . . 15.0 112.71 -179.006 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.565 ' HA ' ' CG2' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -44.25 134.95 4.72 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.137 -1.392 . . . . 15.0 112.477 -178.893 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.662 ' N ' HG21 ' A' ' 37' ' ' VAL . . . 49.7 34.32 21.0 Favored Glycine 0 C--N 1.334 0.456 0 C-N-CA 121.135 -0.555 . . . . 15.0 112.907 179.569 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.44 ' HB2' HG12 ' A' ' 37' ' ' VAL . 1.1 m-20 -65.5 130.64 44.04 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 121.003 -0.279 . . . . 15.0 110.439 179.636 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.401 ' NH2' ' HD3' ' A' ' 31' ' ' ARG . 59.7 ttt180 -86.33 86.45 7.34 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.112 -0.494 . . . . 15.0 110.432 179.792 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.486 HG22 HG21 ' A' ' 35' ' ' ILE . 1.3 m -79.41 116.68 23.79 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 CA-C-O 121.095 0.474 . . . . 15.0 110.948 -179.618 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 20.0 mt -107.19 -18.71 13.81 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.563 -0.744 . . . . 15.0 112.254 -179.323 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.424 ' CB ' HD22 ' A' ' 88' ' ' LEU . . . -148.29 148.79 30.83 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 112.479 0.548 . . . . 15.0 112.479 -178.898 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.457 HG21 ' CD2' ' A' ' 78' ' ' LEU . 26.1 t -139.16 102.18 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.339 -0.846 . . . . 15.0 109.173 178.878 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 64.8 15.03 9.58 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.699 -0.482 . . . . 15.0 109.699 -177.966 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 107.1 5.76 34.79 Favored Glycine 0 C--N 1.337 0.606 0 CA-C-N 115.86 -0.609 . . . . 15.0 113.425 179.727 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.498 ' O ' ' CG1' ' A' ' 64' ' ' VAL . 6.2 p -93.92 106.83 18.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 117.181 0.49 . . . . 15.0 111.083 179.474 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.99 134.24 55.6 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.217 -0.447 . . . . 15.0 110.995 -179.877 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -95.5 -22.78 17.44 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.024 -0.535 . . . . 15.0 111.015 -179.958 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -46.27 100.42 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.899 0.38 . . . . 15.0 111.064 179.942 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.73 63.67 0.55 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.814 -0.708 . . . . 15.0 112.222 -179.719 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -173.03 167.12 5.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.829 0.347 . . . . 15.0 111.117 -179.798 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.407 ' HA ' ' N ' ' A' ' 26' ' ' VAL . 16.2 p -93.23 -175.11 3.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.227 -0.442 . . . . 15.0 111.095 -179.883 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.513 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 0.0 OUTLIER -62.17 -60.49 3.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.918 -0.583 . . . . 15.0 110.447 179.977 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.428 ' O ' ' HG3' ' A' ' 76' ' ' GLU . 8.0 ttpp -52.41 -31.12 32.66 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.814 -0.63 . . . . 15.0 110.517 179.448 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -59.32 -52.02 67.42 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.64 -0.504 . . . . 15.0 109.64 179.335 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.475 ' O ' ' N ' ' A' ' 77' ' ' THR . . . -66.95 -45.96 76.18 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.092 -0.504 . . . . 15.0 109.706 178.495 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.433 ' CG2' ' CG2' ' A' ' 22' ' ' VAL . 0.5 OUTLIER -41.43 -40.04 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.221 0 N-CA-C 109.123 -0.695 . . . . 15.0 109.123 178.43 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.432 ' O ' ' N ' ' A' ' 80' ' ' ASN . 22.5 mt-10 -67.47 -46.72 72.18 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 114.731 -1.122 . . . . 15.0 110.244 178.488 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.475 ' N ' ' O ' ' A' ' 74' ' ' ALA . 44.8 p -64.33 -51.9 61.14 Favored 'General case' 0 N--CA 1.461 0.102 0 C-N-CA 120.991 -0.283 . . . . 15.0 111.24 179.637 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.457 ' CD2' HG21 ' A' ' 61' ' ' VAL . 5.6 mt -53.53 -49.98 66.44 Favored 'General case' 0 CA--C 1.521 -0.168 0 CA-C-O 121.22 0.533 . . . . 15.0 109.878 179.934 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.46 -61.45 1.83 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.357 -0.838 . . . . 15.0 110.467 179.387 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.432 ' N ' ' O ' ' A' ' 76' ' ' GLU . 1.4 m-20 -65.92 62.71 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.926 -0.579 . . . . 15.0 111.792 179.844 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -91.85 -69.81 0.72 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.648 0.261 . . . . 15.0 110.443 179.52 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 122.32 -107.19 1.13 Allowed Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.872 -0.68 . . . . 15.0 112.939 179.441 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.81 -83.56 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.775 0.321 . . . . 15.0 111.545 -179.45 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.429 ' CG1' ' N ' ' A' ' 85' ' ' VAL . 62.7 t -109.82 159.92 9.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.855 0.36 . . . . 15.0 110.335 179.999 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.502 ' HB ' ' HB3' ' A' ' 11' ' ' LEU . 24.4 t -97.85 80.16 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-O 121.016 0.436 . . . . 15.0 110.687 -179.943 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -98.46 81.89 2.79 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.893 -0.594 . . . . 15.0 110.447 179.865 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.45 ' CD2' ' CD2' ' A' ' 89' ' ' LEU . 0.1 OUTLIER -101.15 118.03 36.19 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.045 -0.525 . . . . 15.0 111.742 -179.229 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.468 HD11 ' HB2' ' A' ' 8' ' ' GLU . 0.2 OUTLIER -94.99 101.47 13.23 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.302 -0.629 . . . . 15.0 109.302 178.657 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.461 HD22 ' HA ' ' A' ' 58' ' ' VAL . 0.2 OUTLIER -104.6 -162.29 0.88 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.417 0.627 . . . . 15.0 111.752 -178.629 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.412 ' HA ' ' HA ' ' A' ' 6' ' ' ILE . 2.2 tt0 -139.86 143.1 36.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.085 -0.961 . . . . 15.0 109.888 179.062 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -54.03 102.99 0.07 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.904 0.383 . . . . 15.0 110.96 -179.642 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -69.11 -169.32 6.1 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.84 -0.695 . . . . 15.0 112.65 -179.757 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 7.9 mm-40 -82.48 122.2 27.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.833 0.349 . . . . 15.0 110.895 -179.956 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 33.6 m -87.54 161.61 44.79 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.162 -0.472 . . . . 15.0 110.849 179.948 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -50.16 -33.76 36.81 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.529 2.153 . . . . 15.0 112.344 -179.976 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.22 -0.895 . . . . 15.0 110.878 179.94 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo . . . . . 0 N--CA 1.488 1.183 0 CA-C-O 120.892 0.288 . . . . 15.0 111.793 . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.473 ' HB3' ' HD3' ' A' ' 3' ' ' PRO . 0.0 OUTLIER -155.43 -64.82 0.02 OUTLIER Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.13 -0.487 . . . . 15.0 110.739 179.893 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.473 ' HD3' ' HB3' ' A' ' 2' ' ' LYS . 72.9 Cg_exo -40.96 120.66 1.11 Allowed 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.717 2.278 . . . . 15.0 113.017 179.621 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 82.9 -24.12 5.44 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.27 -0.967 . . . . 15.0 112.295 179.651 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.417 ' HB2' ' O ' ' A' ' 2' ' ' LYS . 1.5 m-20 -61.43 141.63 57.53 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-O 121.457 0.646 . . . . 15.0 110.853 -179.926 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.428 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 1.3 mp -74.19 147.32 9.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 114.894 -1.048 . . . . 15.0 111.655 -179.112 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.449 ' O ' ' N ' ' A' ' 89' ' ' LEU . 3.3 p90 -141.68 165.06 28.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.884 -0.598 . . . . 15.0 110.263 178.759 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.504 ' HB2' HD11 ' A' ' 88' ' ' LEU . 0.2 OUTLIER -130.16 142.21 50.6 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.272 0.558 . . . . 15.0 111.615 -179.442 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.438 ' CG2' ' HB3' ' A' ' 51' ' ' ARG . 0.2 OUTLIER -101.49 117.29 46.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.327 -0.851 . . . . 15.0 109.819 178.958 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -106.24 74.44 1.03 Allowed 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 112.166 0.432 . . . . 15.0 112.166 -179.031 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.478 ' HB3' ' HB ' ' A' ' 85' ' ' VAL . 8.7 tp -88.42 165.64 14.78 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.847 -0.427 . . . . 15.0 109.847 178.778 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -94.75 94.7 8.25 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.039 0.447 . . . . 15.0 111.186 -179.945 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.453 ' HG3' ' HB ' ' A' ' 81' ' ' THR . 0.0 OUTLIER -54.56 -29.89 52.45 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.797 -0.638 . . . . 15.0 111.2 179.945 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.457 ' O ' ' CB ' ' A' ' 15' ' ' ASP . 93.0 m-20 -84.51 147.46 27.04 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.239 -0.437 . . . . 15.0 110.617 179.908 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.457 ' CB ' ' O ' ' A' ' 14' ' ' ASN . 1.8 t0 86.03 -39.01 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.054 -0.521 . . . . 15.0 111.157 -179.617 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 34.6 m-20 -155.31 145.5 21.78 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.818 0.342 . . . . 15.0 110.973 179.938 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -86.09 -163.77 0.93 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.128 -0.487 . . . . 15.0 110.698 179.908 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -80.48 -170.27 2.5 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 116.245 -0.434 . . . . 15.0 110.449 179.35 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.623 ' O ' ' HB ' ' A' ' 41' ' ' ILE . . . -161.57 31.02 0.32 Allowed Glycine 0 CA--C 1.507 -0.431 0 N-CA-C 111.535 -0.626 . . . . 15.0 111.535 -179.835 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.558 HG12 ' O ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -112.62 139.76 35.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 121.061 0.458 . . . . 15.0 111.936 -179.206 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.449 ' O ' ' HB3' ' A' ' 38' ' ' LYS . 42.4 t -96.25 100.22 11.87 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 107.587 -1.264 . . . . 15.0 107.587 176.951 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.55 HG23 ' CD2' ' A' ' 71' ' ' HIS . 1.3 m -93.68 152.01 3.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 112.622 0.601 . . . . 15.0 112.622 -176.971 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.494 ' HA ' ' ND1' ' A' ' 71' ' ' HIS . 15.3 t -149.47 177.52 9.64 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.393 -0.822 . . . . 15.0 110.689 179.632 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.433 ' O ' ' N ' ' A' ' 26' ' ' VAL . . . 83.05 -115.07 3.95 Favored Glycine 0 C--N 1.332 0.353 0 C-N-CA 120.723 -0.751 . . . . 15.0 112.136 -179.779 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.557 ' HA3' ' N ' ' A' ' 71' ' ' HIS . . . 63.79 -65.24 0.04 OUTLIER Glycine 0 C--N 1.331 0.266 0 C-N-CA 121.002 -0.618 . . . . 15.0 113.781 178.933 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.433 ' N ' ' O ' ' A' ' 24' ' ' GLY . 0.0 OUTLIER -30.73 143.13 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 N-CA-C 112.234 0.457 . . . . 15.0 112.234 -179.116 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.409 ' CB ' ' O ' ' A' ' 32' ' ' HIS . 14.3 p-10 -75.59 62.26 1.41 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.956 -0.565 . . . . 15.0 111.0 -179.692 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 40.9 m -151.73 -67.13 0.17 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.308 -0.405 . . . . 15.0 111.088 -179.96 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -68.98 -32.45 72.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.137 -0.483 . . . . 15.0 111.071 -179.8 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 19.8 m -88.09 -172.85 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.239 -0.437 . . . . 15.0 111.269 -179.895 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -61.94 -63.14 1.35 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.138 -0.483 . . . . 15.0 111.031 -179.984 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . 0.409 ' O ' ' CB ' ' A' ' 27' ' ' ASN . 90.8 m-70 -136.26 -49.72 0.68 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.294 -0.412 . . . . 15.0 111.103 -179.853 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -171.13 26.13 0.1 OUTLIER Glycine 0 C--N 1.329 0.155 0 C-N-CA 120.789 -0.72 . . . . 15.0 112.595 -179.755 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -89.51 154.43 24.13 Favored Glycine 0 N--CA 1.449 -0.472 0 N-CA-C 110.749 -0.94 . . . . 15.0 110.749 178.836 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.411 ' CG1' ' HA ' ' A' ' 71' ' ' HIS . 0.0 OUTLIER -93.6 153.82 3.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 117.648 0.724 . . . . 15.0 111.828 -179.265 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.511 ' CE2' ' CG ' ' A' ' 57' ' ' ARG . 42.7 m-85 -138.39 106.28 5.67 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.957 -1.02 . . . . 15.0 109.859 179.69 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.667 HG21 ' N ' ' A' ' 55' ' ' GLY . 0.7 OUTLIER -55.27 145.29 5.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.164 -0.471 . . . . 15.0 111.002 -179.179 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.449 ' HB3' ' O ' ' A' ' 21' ' ' SER . 0.2 OUTLIER -80.13 -47.57 14.55 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.661 -0.866 . . . . 15.0 108.661 178.512 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.558 ' O ' HG12 ' A' ' 20' ' ' ILE . . . -172.23 170.45 5.14 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 115.698 -0.683 . . . . 15.0 110.309 178.397 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.542 ' HA ' HG12 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -97.07 111.7 27.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.928 0.394 . . . . 15.0 110.264 179.638 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.623 ' HB ' ' O ' ' A' ' 19' ' ' GLY . 0.4 OUTLIER -78.65 109.99 12.57 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 115.781 -0.645 . . . . 15.0 112.632 -178.293 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.469 ' HA ' ' CG ' ' A' ' 47' ' ' GLU . 24.5 Cg_exo -62.47 68.55 0.12 Allowed 'Trans proline' 0 C--N 1.356 0.935 0 C-N-CA 123.211 2.607 . . . . 15.0 112.507 179.828 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.423 ' N ' ' O ' ' A' ' 41' ' ' ILE . 8.1 mm-40 -153.43 -52.93 0.1 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.628 -0.715 . . . . 15.0 109.825 179.638 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.493 ' HA3' ' CA ' ' A' ' 19' ' ' GLY . . . -87.78 155.9 27.15 Favored Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.66 -0.781 . . . . 15.0 112.481 179.393 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -41.05 -16.8 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 113.517 0.932 . . . . 15.0 113.517 -179.546 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.463 ' N ' ' O ' ' A' ' 44' ' ' GLY . . . -71.68 -71.76 0.26 Allowed 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.819 -0.353 . . . . 15.0 111.155 -179.739 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.536 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 4.1 tp10 -58.27 -39.78 80.13 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 121.033 0.445 . . . . 15.0 110.402 179.569 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.2 m -53.98 -64.5 0.81 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.904 -0.589 . . . . 15.0 110.434 179.537 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.428 ' CB ' HD13 ' A' ' 11' ' ' LEU . 3.7 m-20 -64.79 -37.62 88.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.163 -0.471 . . . . 15.0 110.175 179.273 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.62 38.22 14.85 Favored Glycine 0 N--CA 1.45 -0.41 0 CA-C-N 115.744 -0.662 . . . . 15.0 112.571 179.581 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.438 ' HB3' ' CG2' ' A' ' 9' ' ' VAL . 0.2 OUTLIER -82.33 -54.47 5.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.968 0.413 . . . . 15.0 110.614 179.864 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.467 ' CD1' HD12 ' A' ' 89' ' ' LEU . 9.6 tp -81.09 159.72 4.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.873 -0.603 . . . . 15.0 110.379 179.705 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . 0.441 ' O ' HG21 ' A' ' 37' ' ' VAL . 53.2 m80 -140.74 159.47 42.14 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-O 121.742 0.782 . . . . 15.0 112.728 -178.875 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.551 ' HA ' ' CG2' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -44.14 134.45 4.8 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.054 -1.43 . . . . 15.0 113.057 -178.728 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.667 ' N ' HG21 ' A' ' 37' ' ' VAL . . . 49.83 31.4 16.58 Favored Glycine 0 C--N 1.335 0.483 0 CA-C-N 115.779 -0.646 . . . . 15.0 113.618 178.934 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.429 ' HB2' ' O ' ' A' ' 53' ' ' HIS . 0.4 OUTLIER -65.92 130.22 42.51 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.628 -0.429 . . . . 15.0 110.655 179.504 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.511 ' CG ' ' CE2' ' A' ' 36' ' ' TYR . 3.5 mtt180 -82.08 88.35 6.44 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.177 -0.465 . . . . 15.0 110.407 179.564 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.474 ' O ' ' CG2' ' A' ' 58' ' ' VAL . 1.5 m -79.45 111.93 16.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 CA-C-O 121.199 0.523 . . . . 15.0 111.061 -179.554 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -107.38 -15.14 14.7 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 115.558 -0.746 . . . . 15.0 112.33 -179.224 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -147.91 145.68 28.72 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.099 0.476 . . . . 15.0 112.217 -178.782 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.438 ' HB ' ' CG1' ' A' ' 64' ' ' VAL . 47.1 t -138.93 103.48 2.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.624 -0.716 . . . . 15.0 109.378 178.918 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.413 ' ND2' ' CG2' ' A' ' 81' ' ' THR . 1.7 m-80 64.97 16.43 10.55 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.727 -0.471 . . . . 15.0 109.727 -178.114 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.99 5.81 43.61 Favored Glycine 0 C--N 1.336 0.545 0 CA-C-N 115.744 -0.662 . . . . 15.0 113.103 179.958 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.492 ' O ' ' CG1' ' A' ' 64' ' ' VAL . 5.7 p -93.78 108.33 20.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 121.007 0.432 . . . . 15.0 110.915 179.573 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 13.7 m -58.74 124.41 19.67 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.178 0.514 . . . . 15.0 110.796 -179.781 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.414 ' CD2' ' CB ' ' A' ' 74' ' ' ALA . 0.2 OUTLIER -89.11 -18.7 26.69 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.489 -0.778 . . . . 15.0 111.21 -179.652 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -46.66 101.84 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 120.832 0.349 . . . . 15.0 110.985 179.88 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.75 66.38 0.58 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.788 -0.72 . . . . 15.0 112.291 -179.707 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -173.03 164.21 4.88 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.849 0.357 . . . . 15.0 111.031 -179.821 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.412 ' HA ' ' N ' ' A' ' 26' ' ' VAL . 18.5 p -93.24 -174.66 3.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.998 0.428 . . . . 15.0 111.232 -179.831 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.557 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 0.0 OUTLIER -61.53 -61.88 2.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.85 -0.614 . . . . 15.0 109.826 179.774 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 16.1 ttpt -52.88 -35.61 58.09 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.876 -0.602 . . . . 15.0 110.085 179.005 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -59.64 -48.96 79.62 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.944 -0.571 . . . . 15.0 109.501 179.035 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.458 ' HA ' ' OG1' ' A' ' 77' ' ' THR . . . -66.93 -46.71 73.94 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-N 115.92 -0.582 . . . . 15.0 109.491 178.344 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.432 ' O ' ' HB2' ' A' ' 79' ' ' ARG . 0.5 OUTLIER -42.54 -39.72 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.27 0 N-CA-C 108.814 -0.81 . . . . 15.0 108.814 178.218 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.47 ' O ' ' HB2' ' A' ' 80' ' ' ASN . 1.0 OUTLIER -67.29 -46.34 73.9 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 114.663 -1.153 . . . . 15.0 110.57 178.59 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.458 ' OG1' ' HA ' ' A' ' 74' ' ' ALA . 6.9 p -64.07 -53.74 44.98 Favored 'General case' 0 N--CA 1.462 0.16 0 C-N-CA 120.974 -0.29 . . . . 15.0 111.636 -179.87 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.422 ' HA ' HG12 ' A' ' 61' ' ' VAL . 6.9 mt -53.31 -46.8 69.55 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-O 121.259 0.552 . . . . 15.0 110.017 179.982 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.432 ' HB2' ' O ' ' A' ' 75' ' ' VAL . 0.0 OUTLIER -68.45 -57.41 5.89 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.344 -0.844 . . . . 15.0 110.784 179.576 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.47 ' HB2' ' O ' ' A' ' 76' ' ' GLU . 9.3 m-80 -66.14 61.53 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.103 -0.499 . . . . 15.0 112.155 -179.882 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.453 ' HB ' ' HG3' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -95.67 -68.44 0.8 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.836 0.35 . . . . 15.0 110.158 179.098 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 122.14 -108.33 1.28 Allowed Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 121.004 -0.617 . . . . 15.0 112.957 179.396 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.423 ' O ' ' HB3' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -65.26 -79.08 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.912 0.387 . . . . 15.0 111.773 -179.326 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.444 HG13 ' N ' ' A' ' 85' ' ' VAL . 75.6 t -109.88 159.42 9.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.942 -0.572 . . . . 15.0 111.035 -179.219 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.478 ' HB ' ' HB3' ' A' ' 11' ' ' LEU . 5.9 t -97.9 81.14 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.122 0.486 . . . . 15.0 110.485 179.96 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 13.7 t60 -97.94 82.83 3.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.784 -0.644 . . . . 15.0 110.297 179.67 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.467 ' CD2' ' CD2' ' A' ' 89' ' ' LEU . 0.1 OUTLIER -101.2 119.72 39.17 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.928 -0.578 . . . . 15.0 111.857 -179.132 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.504 HD11 ' HB2' ' A' ' 8' ' ' GLU . 4.0 mp -96.05 100.71 12.34 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.557 -0.535 . . . . 15.0 109.557 178.841 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.467 HD12 ' CD1' ' A' ' 52' ' ' ILE . 0.1 OUTLIER -105.61 -160.86 0.77 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.42 0.629 . . . . 15.0 111.974 -178.589 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.428 ' HA ' ' HA ' ' A' ' 6' ' ' ILE . 3.5 tt0 -138.91 139.89 38.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 114.978 -1.01 . . . . 15.0 109.979 179.107 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 14.0 tppt? -51.17 106.71 0.14 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.312 -0.404 . . . . 15.0 111.003 -179.913 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -68.1 146.03 45.6 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.872 -0.68 . . . . 15.0 112.714 -179.789 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 41.2 tt0 -86.37 123.2 31.34 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.791 0.329 . . . . 15.0 110.819 179.845 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -77.3 140.27 65.11 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.284 -0.416 . . . . 15.0 110.98 -179.877 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -53.44 -61.3 0.47 Allowed 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.561 2.174 . . . . 15.0 112.227 179.969 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 5.0 m . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.255 -0.879 . . . . 15.0 110.941 -179.996 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.467 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 1.4 mp . . . . . 0 N--CA 1.451 -0.413 0 CA-C-O 120.872 0.368 . . . . 15.0 111.243 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.545 ' CE1' HD12 ' A' ' 89' ' ' LEU . 2.8 p90 -140.43 164.95 28.76 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.088 -0.506 . . . . 15.0 110.261 178.621 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.727 ' HB3' HD12 ' A' ' 88' ' ' LEU . 6.3 pt-20 -130.09 142.09 50.64 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.362 0.601 . . . . 15.0 111.867 -179.047 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.593 ' CG1' HD11 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -101.56 114.74 41.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.037 -0.983 . . . . 15.0 109.728 178.915 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -105.87 72.11 0.93 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.156 -0.475 . . . . 15.0 111.916 -178.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.594 HD13 ' HG3' ' A' ' 51' ' ' ARG . 6.3 tp -88.33 165.67 14.82 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.098 -0.501 . . . . 15.0 110.061 179.056 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -95.57 92.26 6.55 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.93 0.395 . . . . 15.0 111.138 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.611 ' CB ' HG23 ' A' ' 85' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 115.982 -0.554 . . . . 15.0 110.977 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.652 ' N ' HD22 ' A' ' 18' ' ' LEU . 1.3 mm? . . . . . 0 N--CA 1.454 -0.236 0 CA-C-O 120.896 0.379 . . . . 15.0 110.653 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.735 ' O ' ' HB ' ' A' ' 41' ' ' ILE . . . -161.0 40.16 0.42 Allowed Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.908 -0.663 . . . . 15.0 111.973 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.703 HG12 ' O ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -112.83 139.77 36.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 120.961 0.41 . . . . 15.0 111.998 -179.414 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 21.8 t -96.04 105.76 17.84 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.132 -1.062 . . . . 15.0 108.132 177.505 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.919 HG21 HG23 ' A' ' 75' ' ' VAL . 18.5 m -93.84 156.0 3.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 113.435 0.902 . . . . 15.0 113.435 -176.913 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.5 -172.76 4.22 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 114.981 -1.009 . . . . 15.0 110.437 179.438 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.418 ' O ' ' CB ' ' A' ' 71' ' ' HIS . . . 68.65 -120.2 10.93 Favored Glycine 0 C--N 1.331 0.251 0 C-N-CA 120.773 -0.727 . . . . 15.0 112.72 179.594 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.561 ' HA3' ' N ' ' A' ' 71' ' ' HIS . . . 68.48 -66.59 0.41 Allowed Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.82 -0.705 . . . . 15.0 113.367 179.651 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.599 ' O ' HG22 ' A' ' 30' ' ' VAL . 2.1 m -33.13 144.33 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 N-CA-C 112.024 0.379 . . . . 15.0 112.024 -179.374 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 13.0 p-10 -75.57 62.67 1.44 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.059 -0.518 . . . . 15.0 111.008 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -151.71 -67.68 0.17 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.219 -0.446 . . . . 15.0 110.945 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 21.1 m -67.21 -33.33 75.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.129 -0.487 . . . . 15.0 110.949 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.599 HG22 ' O ' ' A' ' 26' ' ' VAL . 29.5 m -88.02 -174.01 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 15.0 111.209 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -64.26 -60.53 3.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.181 -0.463 . . . . 15.0 111.146 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 52.2 m80 -132.88 -57.36 0.93 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.388 -0.369 . . . . 15.0 111.225 -179.647 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -167.13 21.45 0.1 Allowed Glycine 0 CA--C 1.518 0.246 0 C-N-CA 120.816 -0.707 . . . . 15.0 112.718 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -83.74 152.77 29.16 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.467 -0.873 . . . . 15.0 110.921 178.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.815 HG22 HG22 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -89.12 153.7 3.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 117.482 0.641 . . . . 15.0 111.633 -179.357 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.424 ' CZ ' ' HG2' ' A' ' 57' ' ' ARG . 25.3 m-85 -141.35 108.26 5.42 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.084 -0.962 . . . . 15.0 109.661 179.324 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.763 HG22 ' N ' ' A' ' 55' ' ' GLY . 0.8 OUTLIER -56.09 154.85 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.18 0.514 . . . . 15.0 111.573 -178.939 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.47 ' O ' ' HG2' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -85.45 -47.94 9.46 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.379 -0.971 . . . . 15.0 108.379 178.239 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.703 ' O ' HG12 ' A' ' 20' ' ' ILE . . . -172.39 172.99 4.25 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 115.349 -0.841 . . . . 15.0 110.224 178.693 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.529 ' HA ' ' CG1' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -96.76 110.91 25.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 109.273 -0.64 . . . . 15.0 109.273 179.125 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.735 ' HB ' ' O ' ' A' ' 19' ' ' GLY . 0.4 OUTLIER -78.24 116.57 60.0 Favored Pre-proline 0 C--N 1.328 -0.364 0 N-CA-C 113.4 0.889 . . . . 15.0 113.4 -177.11 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.604 ' HA ' ' CG ' ' A' ' 47' ' ' GLU . 37.8 Cg_exo -61.56 61.56 0.11 Allowed 'Trans proline' 0 C--N 1.358 1.054 0 C-N-CA 123.76 2.973 . . . . 15.0 113.1 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.533 ' H ' ' HG2' ' A' ' 47' ' ' GLU . 3.0 mt-30 -149.93 -47.94 0.13 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.609 0.242 . . . . 15.0 111.592 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.67 ' HA3' ' HA3' ' A' ' 19' ' ' GLY . . . -87.79 168.04 37.28 Favored Glycine 0 C--N 1.329 0.176 0 C-N-CA 120.324 -0.941 . . . . 15.0 113.781 -179.167 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -57.51 -13.23 3.4 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.721 0.637 . . . . 15.0 112.721 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.0 -57.56 4.19 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 120.988 -0.285 . . . . 15.0 110.663 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.604 ' CG ' ' HA ' ' A' ' 42' ' ' PRO . 2.7 pp20? -57.55 -42.84 83.79 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.97 -0.559 . . . . 15.0 110.379 179.097 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 69.4 m -53.64 -71.12 0.08 Allowed 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 115.806 -0.634 . . . . 15.0 110.571 -179.429 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.569 ' HB2' HD11 ' A' ' 11' ' ' LEU . 0.3 OUTLIER -58.13 -41.14 83.02 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.12 -0.696 . . . . 15.0 109.12 178.872 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.57 40.19 13.21 Favored Glycine 0 N--CA 1.446 -0.7 0 CA-C-N 115.357 -0.838 . . . . 15.0 111.631 179.411 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.594 ' HG3' HD13 ' A' ' 11' ' ' LEU . 1.2 mmp_? -79.71 -50.07 11.15 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.867 0.365 . . . . 15.0 110.658 -179.253 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.62 ' CG1' HD12 ' A' ' 20' ' ' ILE . 8.4 tp -80.91 162.54 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 CA-C-N 116.021 -0.536 . . . . 15.0 110.198 179.457 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' HIS . . . . . 0.464 ' O ' ' HB2' ' A' ' 56' ' ' ASP . 79.6 m80 -146.88 159.88 42.99 Favored 'General case' 0 CA--C 1.514 -0.432 0 CA-C-O 121.641 0.734 . . . . 15.0 112.241 -179.067 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.53 ' HA ' ' CG2' ' A' ' 37' ' ' VAL . 0.1 OUTLIER -43.49 133.43 4.38 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.407 -1.269 . . . . 15.0 112.526 -178.77 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.763 ' N ' HG22 ' A' ' 37' ' ' VAL . . . 49.91 35.12 24.17 Favored Glycine 0 C--N 1.333 0.381 0 CA-C-N 115.927 -0.579 . . . . 15.0 113.377 179.328 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.464 ' HB2' ' O ' ' A' ' 53' ' ' HIS . 0.4 OUTLIER -65.92 132.5 48.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 117.08 0.44 . . . . 15.0 110.682 179.632 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.737 ' CD ' HD21 ' A' ' 59' ' ' LEU . 0.0 OUTLIER -85.5 85.9 7.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.04 -0.527 . . . . 15.0 110.618 179.799 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.815 HG22 HG22 ' A' ' 35' ' ' ILE . 1.4 m -79.49 116.33 23.31 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 CA-C-O 120.998 0.428 . . . . 15.0 110.955 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.737 HD21 ' CD ' ' A' ' 57' ' ' ARG . 18.7 mt -107.01 -18.11 14.0 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.809 -0.632 . . . . 15.0 112.329 -179.146 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.483 ' O ' HD23 ' A' ' 87' ' ' LEU . . . -147.84 149.67 32.73 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.246 0.546 . . . . 15.0 112.389 -178.858 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.663 HG11 ' O ' ' A' ' 77' ' ' THR . 17.6 t -138.93 101.67 1.66 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.31 0 CA-C-N 115.312 -0.858 . . . . 15.0 109.138 178.902 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.638 ' OD1' HG22 ' A' ' 81' ' ' THR . 2.9 m120 64.95 15.51 10.0 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.637 -0.505 . . . . 15.0 109.637 -177.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 107.04 5.46 35.22 Favored Glycine 0 C--N 1.338 0.642 0 CA-C-N 115.811 -0.631 . . . . 15.0 113.471 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.653 HG13 ' O ' ' A' ' 64' ' ' VAL . 6.3 p -93.91 107.18 18.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 117.085 0.442 . . . . 15.0 111.059 179.549 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.3 m -56.96 134.67 55.86 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.216 -0.447 . . . . 15.0 111.07 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.675 HD21 ' HA ' ' A' ' 74' ' ' ALA . 0.2 OUTLIER -97.83 -20.59 17.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.009 -0.542 . . . . 15.0 111.173 -179.994 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -45.64 110.91 0.29 Allowed 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.384 -0.371 . . . . 15.0 111.123 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 97.62 64.25 0.89 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.781 -0.723 . . . . 15.0 112.251 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.606 ' HB1' ' CG ' ' A' ' 73' ' ' GLN . . . -173.03 166.85 5.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.916 0.389 . . . . 15.0 111.148 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.435 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 15.3 p -93.49 -172.63 2.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.18 -0.463 . . . . 15.0 111.301 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' HIS . . . . . 0.621 ' CE1' HG23 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -63.57 -59.07 5.09 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.72 -0.673 . . . . 15.0 110.557 179.816 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 9.4 ttpp -52.36 -31.2 32.53 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.868 -0.606 . . . . 15.0 110.627 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.606 ' CG ' ' HB1' ' A' ' 69' ' ' ALA . 0.0 OUTLIER -59.3 -53.77 54.42 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.239 -0.437 . . . . 15.0 109.932 179.444 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.675 ' HA ' HD21 ' A' ' 66' ' ' LEU . . . -66.78 -43.91 82.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.173 -0.467 . . . . 15.0 109.86 178.734 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.919 HG23 HG21 ' A' ' 22' ' ' VAL . 0.5 OUTLIER -42.37 -41.79 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.225 0 N-CA-C 109.129 -0.693 . . . . 15.0 109.129 178.376 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -67.46 -44.54 78.36 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 114.875 -1.057 . . . . 15.0 110.289 178.458 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.663 ' O ' HG11 ' A' ' 61' ' ' VAL . 69.0 p -64.09 -54.27 36.58 Favored 'General case' 0 N--CA 1.461 0.117 0 C-N-CA 121.161 -0.215 . . . . 15.0 111.508 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.562 HD21 HG21 ' A' ' 58' ' ' VAL . 7.6 mt -53.55 -47.88 69.61 Favored 'General case' 0 CA--C 1.518 -0.25 0 CA-C-O 121.313 0.578 . . . . 15.0 109.867 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.404 ' HB2' ' O ' ' A' ' 75' ' ' VAL . 11.1 ttp85 -68.42 -59.95 2.79 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.242 -0.89 . . . . 15.0 110.651 179.484 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -66.06 58.52 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.865 -0.607 . . . . 15.0 112.498 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.638 HG22 ' OD1' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -95.57 -71.46 0.67 Allowed 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.89 -0.411 . . . . 15.0 109.89 178.872 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 121.11 -104.15 0.94 Allowed Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.703 -0.76 . . . . 15.0 113.344 178.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.401 ' O ' ' HB3' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -64.67 -82.77 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 112.104 0.409 . . . . 15.0 112.104 -178.943 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.441 HG12 ' N ' ' A' ' 85' ' ' VAL . 75.6 t -109.79 158.66 9.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.107 0.479 . . . . 15.0 111.232 -179.114 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.675 ' O ' HG12 ' A' ' 85' ' ' VAL . 6.7 t -97.79 82.03 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.992 -0.549 . . . . 15.0 110.498 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -99.06 82.18 2.7 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.76 -0.655 . . . . 15.0 110.291 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.812 ' HB3' HD21 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -103.97 118.74 37.4 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.046 -0.524 . . . . 15.0 112.061 -178.988 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.727 HD12 ' HB3' ' A' ' 8' ' ' GLU . 0.2 OUTLIER -95.46 101.4 13.11 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.111 -0.7 . . . . 15.0 109.111 178.252 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.812 HD21 ' HB3' ' A' ' 87' ' ' LEU . 0.2 OUTLIER -104.11 -164.91 1.1 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.439 0.638 . . . . 15.0 112.094 -178.312 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.467 ' HA ' ' HA ' ' A' ' 6' ' ' ILE . 2.3 tt0 -139.37 139.84 37.31 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.999 -1.0 . . . . 15.0 109.817 179.205 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 6.7 tptt -52.11 102.04 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.009 0.433 . . . . 15.0 111.06 -179.665 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.363 0 C-N-CA 120.973 -0.632 . . . . 15.0 112.784 -179.658 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.455 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 1.1 mp . . . . . 0 N--CA 1.451 -0.419 0 CA-C-O 120.977 0.418 . . . . 15.0 111.324 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.749 ' CE1' HD12 ' A' ' 89' ' ' LEU . 6.0 p90 -140.29 152.02 45.55 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.902 -0.59 . . . . 15.0 110.193 178.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.741 ' HB2' HD12 ' A' ' 88' ' ' LEU . 1.4 pm0 -120.93 143.06 49.17 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.373 0.606 . . . . 15.0 111.713 -179.22 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.559 ' CG1' HD11 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -101.47 115.51 43.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.119 -0.946 . . . . 15.0 109.558 178.948 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -106.18 74.33 1.03 Allowed 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 112.321 0.489 . . . . 15.0 112.321 -178.68 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.66 HD13 ' HG3' ' A' ' 51' ' ' ARG . 6.7 tp -88.11 164.84 15.51 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.339 -0.615 . . . . 15.0 109.339 178.466 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -96.33 97.72 9.71 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.047 0.451 . . . . 15.0 111.379 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.607 ' CB ' HG23 ' A' ' 85' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.423 0 CA-C-N 115.77 -0.65 . . . . 15.0 111.064 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.64 ' N ' HD22 ' A' ' 18' ' ' LEU . 1.9 mm? . . . . . 0 N--CA 1.451 -0.402 0 CA-C-O 120.95 0.405 . . . . 15.0 110.612 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.761 ' O ' ' HB ' ' A' ' 41' ' ' ILE . . . -160.88 43.53 0.41 Allowed Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.939 -0.648 . . . . 15.0 111.698 -179.825 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.687 HG12 ' O ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -112.78 138.46 41.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 120.948 0.404 . . . . 15.0 111.615 -179.453 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.441 ' H ' HD13 ' A' ' 41' ' ' ILE . 31.4 t -91.73 103.5 16.06 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 107.813 -1.18 . . . . 15.0 107.813 177.443 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.978 HG21 HG23 ' A' ' 75' ' ' VAL . 32.8 m -93.72 154.42 3.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 113.079 0.77 . . . . 15.0 113.079 -177.012 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.29 -175.22 4.9 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.132 -0.94 . . . . 15.0 110.72 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.533 ' O ' HG22 ' A' ' 26' ' ' VAL . . . 68.67 -119.88 10.54 Favored Glycine 0 C--N 1.332 0.306 0 C-N-CA 120.829 -0.701 . . . . 15.0 112.424 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.533 ' HA3' ' N ' ' A' ' 71' ' ' HIS . . . 68.12 -64.21 0.37 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.876 -0.678 . . . . 15.0 113.525 179.4 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.533 HG22 ' O ' ' A' ' 24' ' ' GLY . 0.0 OUTLIER -30.63 138.58 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 N-CA-C 112.337 0.495 . . . . 15.0 112.337 -179.323 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 28.3 p30 -75.55 62.72 1.44 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.897 -0.592 . . . . 15.0 111.012 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.0 m -151.7 -50.76 0.12 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.277 -0.42 . . . . 15.0 111.106 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -87.65 -40.54 14.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.232 -0.44 . . . . 15.0 111.192 -179.703 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.506 HG22 ' O ' ' A' ' 26' ' ' VAL . 31.1 m -72.62 -174.9 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.317 -0.402 . . . . 15.0 111.366 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 2.1 ttm180 -60.31 -40.78 91.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.2 -0.455 . . . . 15.0 111.239 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -163.9 -46.76 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.688 -0.233 . . . . 15.0 111.515 179.799 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -170.22 19.96 0.07 OUTLIER Glycine 0 CA--C 1.519 0.288 0 C-N-CA 120.649 -0.786 . . . . 15.0 112.979 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.405 ' O ' HG11 ' A' ' 30' ' ' VAL . . . -89.76 153.85 23.48 Favored Glycine 0 N--CA 1.45 -0.385 0 N-CA-C 111.005 -0.838 . . . . 15.0 111.005 179.018 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.831 HG22 HG22 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -89.13 155.62 3.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 117.478 0.639 . . . . 15.0 111.773 -179.396 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.47 ' CE2' ' HG2' ' A' ' 57' ' ' ARG . 29.5 m-85 -140.19 106.75 5.32 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.082 -0.963 . . . . 15.0 109.804 179.023 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.793 HG22 ' N ' ' A' ' 55' ' ' GLY . 0.6 OUTLIER -55.35 147.05 4.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.913 -0.585 . . . . 15.0 111.361 -178.956 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.459 ' O ' ' HG2' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -80.35 -48.61 12.68 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.449 -0.945 . . . . 15.0 108.449 178.379 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.687 ' O ' HG12 ' A' ' 20' ' ' ILE . . . -172.2 173.95 4.12 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 115.416 -0.811 . . . . 15.0 110.142 178.704 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.575 ' HA ' HG12 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -97.03 110.09 24.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 109.657 -0.498 . . . . 15.0 109.657 179.295 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.761 ' HB ' ' O ' ' A' ' 19' ' ' GLY . 0.6 OUTLIER -78.4 116.48 59.57 Favored Pre-proline 0 C--N 1.328 -0.333 0 N-CA-C 113.39 0.885 . . . . 15.0 113.39 -177.518 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.621 ' HA ' ' CG ' ' A' ' 47' ' ' GLU . 35.2 Cg_exo -62.01 59.94 0.13 Allowed 'Trans proline' 0 C--N 1.357 1.02 0 C-N-CA 123.663 2.909 . . . . 15.0 113.064 179.728 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.538 ' N ' ' HG2' ' A' ' 47' ' ' GLU . 0.6 OUTLIER -147.53 -47.69 0.17 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.642 0.258 . . . . 15.0 111.579 179.913 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.725 ' HA3' ' HA3' ' A' ' 19' ' ' GLY . . . -87.86 168.81 37.94 Favored Glycine 0 C--N 1.331 0.279 0 C-N-CA 120.393 -0.908 . . . . 15.0 114.047 -179.022 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -57.51 -13.72 4.09 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.592 0.59 . . . . 15.0 112.592 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.11 -57.72 4.03 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.712 0.291 . . . . 15.0 110.797 -179.714 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.621 ' CG ' ' HA ' ' A' ' 42' ' ' PRO . 2.9 pp20? -57.57 -42.37 82.96 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.77 -0.65 . . . . 15.0 110.381 179.276 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -53.76 -71.49 0.07 Allowed 'General case' 0 CA--C 1.519 -0.241 0 CA-C-N 115.814 -0.63 . . . . 15.0 110.486 -179.404 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.581 ' HB2' HD11 ' A' ' 11' ' ' LEU . 0.2 OUTLIER -58.36 -41.15 84.09 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.125 -0.694 . . . . 15.0 109.125 178.801 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.78 40.46 12.15 Favored Glycine 0 N--CA 1.446 -0.643 0 CA-C-N 115.416 -0.811 . . . . 15.0 111.726 179.365 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.66 ' HG3' HD13 ' A' ' 11' ' ' LEU . 0.6 OUTLIER -79.92 -48.19 13.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.907 0.384 . . . . 15.0 110.726 -179.402 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.595 ' CG1' HD12 ' A' ' 20' ' ' ILE . 9.4 tp -81.11 162.07 3.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.037 -0.528 . . . . 15.0 110.275 179.56 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' HIS . . . . . 0.475 ' N ' ' OD2' ' A' ' 56' ' ' ASP . 78.8 m80 -147.51 157.63 43.65 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-O 121.61 0.719 . . . . 15.0 112.021 -179.073 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.558 ' HA ' ' CG2' ' A' ' 37' ' ' VAL . 0.1 OUTLIER -42.4 132.2 3.55 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.327 -1.306 . . . . 15.0 113.027 -178.564 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.793 ' N ' HG22 ' A' ' 37' ' ' VAL . . . 50.35 30.31 18.29 Favored Glycine 0 C--N 1.333 0.416 0 CA-C-N 115.672 -0.694 . . . . 15.0 113.4 179.235 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.475 ' OD2' ' N ' ' A' ' 53' ' ' HIS . 16.8 m-20 -65.87 129.59 40.33 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.716 -0.394 . . . . 15.0 110.58 179.521 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.47 ' HG2' ' CE2' ' A' ' 36' ' ' TYR . 15.8 mtt-85 -80.85 96.84 7.13 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.229 -0.441 . . . . 15.0 110.846 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.831 HG22 HG22 ' A' ' 35' ' ' ILE . 1.4 m -86.96 114.02 25.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.079 0.466 . . . . 15.0 110.749 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 21.5 mt -107.02 -16.42 14.44 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.799 -0.637 . . . . 15.0 112.397 -179.05 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.79 ' HB3' ' HB2' ' A' ' 88' ' ' LEU . . . -148.13 147.67 29.75 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.509 0.559 . . . . 15.0 112.509 -178.887 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.863 HG11 ' O ' ' A' ' 77' ' ' THR . 21.4 t -139.03 101.12 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.316 -0.856 . . . . 15.0 109.16 178.826 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.535 ' OD1' HG22 ' A' ' 81' ' ' THR . 2.5 m120 65.14 15.98 10.3 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.72 -0.474 . . . . 15.0 109.72 -177.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 107.07 4.58 35.73 Favored Glycine 0 C--N 1.337 0.598 0 CA-C-N 115.969 -0.56 . . . . 15.0 113.469 179.672 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.644 HG13 ' O ' ' A' ' 64' ' ' VAL . 5.4 p -93.9 108.4 20.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 117.122 0.461 . . . . 15.0 111.164 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 61.5 m -56.87 138.14 54.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.296 -0.411 . . . . 15.0 110.996 -179.812 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.912 HD11 ' HB2' ' A' ' 74' ' ' ALA . 0.2 OUTLIER -97.75 -21.88 16.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.063 -0.517 . . . . 15.0 111.085 -179.903 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -46.53 106.17 0.08 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.361 -0.381 . . . . 15.0 111.21 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 104.33 62.16 0.67 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.808 -0.711 . . . . 15.0 112.453 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.666 ' HB1' ' CB ' ' A' ' 73' ' ' GLN . . . -173.18 163.48 4.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.86 0.362 . . . . 15.0 111.086 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.46 ' HB ' HG13 ' A' ' 26' ' ' VAL . 1.7 p -92.33 -171.96 2.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.457 . . . . 15.0 110.983 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' HIS . . . . . 0.732 ' CE1' HG23 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -62.19 -59.45 5.03 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.844 -0.616 . . . . 15.0 110.458 179.949 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.41 ' O ' HG12 ' A' ' 75' ' ' VAL . 24.9 ttpp -52.68 -34.29 51.23 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.768 -0.651 . . . . 15.0 110.836 179.612 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.666 ' CB ' ' HB1' ' A' ' 69' ' ' ALA . 3.2 mt-30 -59.28 -50.77 72.7 Favored 'General case' 0 CA--C 1.518 -0.272 0 N-CA-C 109.527 -0.546 . . . . 15.0 109.527 179.35 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.912 ' HB2' HD11 ' A' ' 66' ' ' LEU . . . -66.29 -45.42 80.47 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.69 -0.687 . . . . 15.0 109.672 178.519 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.978 HG23 HG21 ' A' ' 22' ' ' VAL . 0.5 OUTLIER -43.15 -40.51 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.243 0 N-CA-C 108.976 -0.749 . . . . 15.0 108.976 178.243 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -67.26 -44.96 78.08 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 114.871 -1.058 . . . . 15.0 110.076 178.405 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.863 ' O ' HG11 ' A' ' 61' ' ' VAL . 41.2 p -64.3 -53.41 49.29 Favored 'General case' 0 N--CA 1.461 0.098 0 CA-C-O 120.572 0.225 . . . . 15.0 111.318 179.606 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.718 HD21 HG21 ' A' ' 58' ' ' VAL . 6.1 mt -53.42 -48.86 68.35 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 121.245 0.545 . . . . 15.0 109.97 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.413 ' O ' ' N ' ' A' ' 81' ' ' THR . 0.2 OUTLIER -68.38 -59.05 3.46 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.317 -0.856 . . . . 15.0 110.665 179.502 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -65.88 62.9 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.946 -0.57 . . . . 15.0 111.931 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.535 HG22 ' OD1' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -91.7 -70.87 0.67 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.785 0.326 . . . . 15.0 110.302 179.425 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 122.28 -109.97 1.52 Allowed Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.978 -0.63 . . . . 15.0 112.852 179.377 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.4 ' O ' ' HB3' ' A' ' 13' ' ' LYS . 0.8 OUTLIER -65.25 -77.88 0.06 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.884 0.373 . . . . 15.0 111.438 -179.437 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.44 HG12 ' N ' ' A' ' 85' ' ' VAL . 51.0 t -110.26 159.07 10.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.198 -0.455 . . . . 15.0 110.678 -179.729 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.655 ' O ' HG12 ' A' ' 85' ' ' VAL . 19.7 t -98.12 79.92 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.051 0.453 . . . . 15.0 110.429 179.648 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 3.0 t60 -100.51 84.22 2.73 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.842 -0.617 . . . . 15.0 110.426 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.794 ' HB3' HD21 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -101.45 117.53 35.13 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.003 -0.544 . . . . 15.0 111.655 -179.325 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.79 ' HB2' ' HB3' ' A' ' 60' ' ' ALA . 4.3 mp -92.87 100.23 12.74 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.807 -0.442 . . . . 15.0 109.807 179.038 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.794 HD21 ' HB3' ' A' ' 87' ' ' LEU . 0.2 OUTLIER -103.88 -162.83 0.93 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.92 -0.582 . . . . 15.0 111.655 -178.871 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.455 ' HA ' ' HA ' ' A' ' 6' ' ' ILE . 3.8 tt0 -139.09 148.18 42.97 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.259 -0.882 . . . . 15.0 110.056 179.285 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.04 113.41 1.69 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.298 -0.41 . . . . 15.0 111.136 -179.637 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.27 0 C-N-CA 120.879 -0.677 . . . . 15.0 112.722 -179.741 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.459 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 1.4 mp . . . . . 0 N--CA 1.45 -0.435 0 CA-C-O 120.8 0.334 . . . . 15.0 111.101 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.682 ' CZ ' HD12 ' A' ' 89' ' ' LEU . 3.4 p90 -140.66 163.33 33.18 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.185 -0.461 . . . . 15.0 110.574 178.741 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.737 ' HB2' HD12 ' A' ' 88' ' ' LEU . 10.2 pt-20 -129.04 143.6 50.92 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.204 0.526 . . . . 15.0 111.466 -179.364 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.499 ' CG1' HD11 ' A' ' 89' ' ' LEU . 0.3 OUTLIER -101.54 115.7 43.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.335 -0.848 . . . . 15.0 109.818 178.969 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -105.98 70.54 0.86 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.154 -0.475 . . . . 15.0 111.727 -179.202 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.77 HD13 ' CG ' ' A' ' 51' ' ' ARG . 4.9 tp -88.05 165.74 14.94 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.117 -0.492 . . . . 15.0 110.064 179.167 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -95.71 94.43 7.69 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.919 0.39 . . . . 15.0 111.125 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.674 ' CB ' HG23 ' A' ' 85' ' ' VAL . 0.2 OUTLIER . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 115.96 -0.564 . . . . 15.0 111.095 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.649 ' N ' HD22 ' A' ' 18' ' ' LEU . 1.3 mm? . . . . . 0 N--CA 1.453 -0.321 0 CA-C-O 120.773 0.321 . . . . 15.0 110.736 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.773 ' O ' ' HB ' ' A' ' 41' ' ' ILE . . . -169.02 43.67 0.22 Allowed Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.72 -0.752 . . . . 15.0 112.314 -179.709 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.707 HD12 ' HB ' ' A' ' 52' ' ' ILE . 0.0 OUTLIER -112.72 139.39 37.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 120.928 0.394 . . . . 15.0 111.516 -179.806 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.401 ' HB3' HD11 ' A' ' 41' ' ' ILE . 18.3 t -96.23 105.41 17.46 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.572 -0.899 . . . . 15.0 108.572 178.004 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.804 ' CG2' HG23 ' A' ' 75' ' ' VAL . 5.7 m -93.94 155.21 3.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 112.722 0.638 . . . . 15.0 112.722 -177.511 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.657 ' O ' ' O ' ' A' ' 36' ' ' TYR . 0.2 OUTLIER -149.68 153.28 36.72 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.627 -0.715 . . . . 15.0 111.463 -179.7 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.418 ' O ' HG12 ' A' ' 35' ' ' ILE . . . 67.5 121.53 0.02 OUTLIER Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.484 -0.865 . . . . 15.0 113.351 178.648 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.523 ' HA3' ' N ' ' A' ' 71' ' ' HIS . . . -166.3 -39.3 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.962 -0.637 . . . . 15.0 112.455 179.27 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.553 ' O ' HG22 ' A' ' 30' ' ' VAL . 0.1 OUTLIER -40.46 161.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 CA-C-O 120.849 0.357 . . . . 15.0 111.645 179.87 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.434 ' ND2' ' O ' ' A' ' 32' ' ' HIS . 6.6 m120 -85.84 52.51 2.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.22 -0.445 . . . . 15.0 110.952 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.4 m -151.71 -58.23 0.15 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.195 -0.457 . . . . 15.0 110.8 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.4 m -68.91 -51.76 36.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 15.0 110.847 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.673 HG21 ' O ' ' A' ' 34' ' ' GLY . 17.5 m -87.99 -169.08 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.166 -0.47 . . . . 15.0 110.934 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 4.3 mmt180 -93.41 125.67 38.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.937 0.399 . . . . 15.0 111.073 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' HIS . . . . . 0.434 ' O ' ' ND2' ' A' ' 27' ' ' ASN . 74.6 m80 61.67 -80.61 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.945 -0.571 . . . . 15.0 111.52 179.605 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -175.25 34.59 0.1 OUTLIER Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.9 -0.667 . . . . 15.0 112.422 -179.472 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.673 ' O ' HG21 ' A' ' 30' ' ' VAL . . . -95.15 158.24 22.3 Favored Glycine 0 N--CA 1.449 -0.487 0 N-CA-C 110.659 -0.976 . . . . 15.0 110.659 179.027 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 1.051 HG22 HG22 ' A' ' 58' ' ' VAL . 0.1 OUTLIER -101.12 153.11 4.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 C-N-CA 119.852 -0.739 . . . . 15.0 112.058 -179.326 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.657 ' O ' ' O ' ' A' ' 23' ' ' THR . 11.7 m-85 -133.22 108.29 8.68 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.13 -0.941 . . . . 15.0 109.308 179.343 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.705 HG22 ' N ' ' A' ' 55' ' ' GLY . 0.7 OUTLIER -54.84 169.61 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 C-N-CA 120.359 -0.536 . . . . 15.0 111.113 -178.33 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.77 -49.22 4.23 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.806 -0.813 . . . . 15.0 108.806 178.936 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.707 ' O ' HG12 ' A' ' 20' ' ' ILE . . . -171.96 173.13 4.52 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 115.523 -0.762 . . . . 15.0 110.054 179.03 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.533 ' HA ' ' CG1' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -96.42 103.3 14.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 109.244 -0.65 . . . . 15.0 109.244 179.15 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.773 ' HB ' ' O ' ' A' ' 19' ' ' GLY . 0.6 OUTLIER -69.13 115.74 34.88 Favored Pre-proline 0 C--N 1.328 -0.353 0 N-CA-C 113.376 0.88 . . . . 15.0 113.376 -177.066 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.591 ' HA ' ' HG2' ' A' ' 47' ' ' GLU . 37.5 Cg_exo -61.16 62.01 0.1 OUTLIER 'Trans proline' 0 C--N 1.358 1.038 0 C-N-CA 123.655 2.903 . . . . 15.0 112.951 179.72 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.515 ' HB2' HG22 ' A' ' 41' ' ' ILE . 7.3 mt-30 -150.55 -48.6 0.13 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.635 0.255 . . . . 15.0 111.524 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.751 ' HA3' ' HA3' ' A' ' 19' ' ' GLY . . . -87.73 167.82 37.16 Favored Glycine 0 C--N 1.33 0.232 0 C-N-CA 120.387 -0.911 . . . . 15.0 113.861 -179.128 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -58.5 -13.52 5.77 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.087 -0.556 . . . . 15.0 112.43 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.16 -56.74 5.06 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.696 0.284 . . . . 15.0 110.784 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.591 ' HG2' ' HA ' ' A' ' 42' ' ' PRO . 2.8 pp20? -57.59 -41.99 82.3 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.059 -0.519 . . . . 15.0 110.502 179.239 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -53.55 -69.54 0.12 Allowed 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 115.769 -0.651 . . . . 15.0 110.567 -179.25 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.665 ' CB ' HD11 ' A' ' 11' ' ' LEU . 0.1 OUTLIER -60.25 -41.25 92.81 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.149 -0.685 . . . . 15.0 109.149 178.867 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.8 46.47 7.18 Favored Glycine 0 N--CA 1.446 -0.663 0 CA-C-N 115.436 -0.802 . . . . 15.0 111.866 179.395 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.77 ' CG ' HD13 ' A' ' 11' ' ' LEU . 0.9 OUTLIER -79.78 -44.77 20.03 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.695 0.283 . . . . 15.0 110.969 -179.285 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.707 ' HB ' HD12 ' A' ' 20' ' ' ILE . 3.5 mm -91.42 160.92 2.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.055 0.455 . . . . 15.0 111.187 179.838 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' HIS . . . . . 0.57 ' N ' HG22 ' A' ' 52' ' ' ILE . 75.9 m80 -140.52 148.92 41.78 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-N 115.741 -0.663 . . . . 15.0 110.438 179.52 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.568 ' HA ' ' CG2' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -36.23 133.76 0.47 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.935 -1.03 . . . . 15.0 112.575 -178.237 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.705 ' N ' HG22 ' A' ' 37' ' ' VAL . . . 55.14 33.0 57.3 Favored Glycine 0 N--CA 1.453 -0.2 0 CA-C-N 115.309 -0.86 . . . . 15.0 113.707 179.5 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -66.13 127.75 33.36 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 117.603 0.701 . . . . 15.0 110.541 179.217 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.572 ' NH1' HD11 ' A' ' 59' ' ' LEU . 50.8 ttt-85 -80.71 86.6 5.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.464 -0.335 . . . . 15.0 110.529 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 1.051 HG22 HG22 ' A' ' 35' ' ' ILE . 1.3 m -79.95 115.3 22.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 CA-C-O 121.174 0.512 . . . . 15.0 111.173 -179.588 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.572 HD11 ' NH1' ' A' ' 57' ' ' ARG . 20.4 mt -107.43 -12.73 15.25 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 115.432 -0.804 . . . . 15.0 112.165 -179.41 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.864 ' HB3' ' HB2' ' A' ' 88' ' ' LEU . . . -150.06 144.6 25.87 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.202 0.525 . . . . 15.0 112.388 -178.878 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.832 HG11 ' O ' ' A' ' 77' ' ' THR . 44.9 t -139.04 101.73 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.452 -0.795 . . . . 15.0 109.457 178.864 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.71 ' OD1' HG22 ' A' ' 81' ' ' THR . 2.4 m120 64.87 15.87 10.15 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.822 -0.436 . . . . 15.0 109.822 -178.327 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 107.08 5.75 34.87 Favored Glycine 0 C--N 1.335 0.512 0 CA-C-N 115.956 -0.566 . . . . 15.0 113.469 179.683 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.654 HG13 ' O ' ' A' ' 64' ' ' VAL . 5.8 p -93.85 105.49 16.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 117.275 0.537 . . . . 15.0 110.949 179.405 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 72.3 m -58.41 131.75 51.65 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.122 -0.49 . . . . 15.0 110.936 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.464 HD11 ' HB2' ' A' ' 74' ' ' ALA . 0.2 OUTLIER -87.65 -18.93 28.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.015 -0.539 . . . . 15.0 110.91 179.942 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -48.23 95.07 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.876 0.37 . . . . 15.0 110.858 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.66 66.82 0.59 Allowed Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.81 -0.709 . . . . 15.0 111.96 -179.458 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.615 ' HB1' ' CG ' ' A' ' 73' ' ' GLN . . . -172.73 161.9 4.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.915 0.388 . . . . 15.0 110.9 -179.646 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.489 ' HB ' HG13 ' A' ' 26' ' ' VAL . 8.3 p -93.19 -173.68 3.32 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.188 -0.46 . . . . 15.0 111.436 -179.562 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' HIS . . . . . 0.585 ' CE1' HG23 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -62.38 -60.76 3.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.832 -0.622 . . . . 15.0 110.39 -179.967 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.418 ' O ' ' HG3' ' A' ' 76' ' ' GLU . 17.7 ttpp -52.54 -30.69 31.94 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.746 -0.661 . . . . 15.0 110.442 179.36 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.615 ' CG ' ' HB1' ' A' ' 69' ' ' ALA . 0.9 OUTLIER -59.39 -51.43 69.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.072 -0.513 . . . . 15.0 110.075 179.567 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.479 ' O ' ' HG ' ' A' ' 78' ' ' LEU . . . -66.94 -45.23 78.44 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 109.717 -0.475 . . . . 15.0 109.717 178.773 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.804 HG23 ' CG2' ' A' ' 22' ' ' VAL . 0.5 OUTLIER -42.65 -43.14 1.11 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.269 0 N-CA-C 108.946 -0.761 . . . . 15.0 108.946 178.167 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.418 ' HG3' ' O ' ' A' ' 72' ' ' LYS . 24.3 mt-10 -67.42 -44.02 79.79 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 114.925 -1.034 . . . . 15.0 110.005 178.267 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.832 ' O ' HG11 ' A' ' 61' ' ' VAL . 72.0 p -64.2 -54.18 37.58 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 116.744 -0.207 . . . . 15.0 111.397 179.718 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.776 HD21 HG21 ' A' ' 58' ' ' VAL . 6.6 mt -53.28 -49.03 67.79 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-O 121.277 0.56 . . . . 15.0 109.947 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.407 ' O ' ' N ' ' A' ' 81' ' ' THR . 4.3 ttp180 -68.51 -59.87 2.84 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.322 -0.854 . . . . 15.0 110.699 179.508 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.412 ' CB ' ' O ' ' A' ' 76' ' ' GLU . 43.4 m-20 -66.0 62.28 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.024 -0.535 . . . . 15.0 112.057 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.71 HG22 ' OD1' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -93.8 -68.68 0.79 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.83 0.348 . . . . 15.0 110.077 179.044 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 122.09 -109.85 1.51 Allowed Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 120.957 -0.64 . . . . 15.0 112.874 179.211 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -65.47 -77.26 0.06 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.52 -0.34 . . . . 15.0 111.701 -179.314 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.433 HG12 ' N ' ' A' ' 85' ' ' VAL . 55.8 t -110.17 157.68 10.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.174 -0.466 . . . . 15.0 111.295 -179.4 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.676 ' O ' HG12 ' A' ' 85' ' ' VAL . 8.6 t -98.0 81.16 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.026 -0.534 . . . . 15.0 110.48 179.772 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -100.43 86.08 3.1 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.796 -0.638 . . . . 15.0 110.506 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.731 ' HB3' HD21 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -103.86 126.03 50.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.058 -0.519 . . . . 15.0 111.807 -179.265 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.864 ' HB2' ' HB3' ' A' ' 60' ' ' ALA . 4.9 mp -101.64 101.59 12.15 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.305 -0.628 . . . . 15.0 109.305 178.536 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.731 HD21 ' HB3' ' A' ' 87' ' ' LEU . 0.1 OUTLIER -105.66 -165.19 1.09 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.502 0.667 . . . . 15.0 112.089 -178.448 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.459 ' HA ' ' HA ' ' A' ' 6' ' ' ILE . 1.0 OUTLIER -140.12 136.23 33.33 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.873 -1.058 . . . . 15.0 109.619 178.97 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 10.2 tppt? -46.89 103.63 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.93 0.395 . . . . 15.0 111.293 -179.545 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.399 0 C-N-CA 120.866 -0.683 . . . . 15.0 112.565 -179.878 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.45 HG13 ' HB2' ' A' ' 90' ' ' GLU . 1.4 mp . . . . . 0 N--CA 1.45 -0.449 0 CA-C-O 120.714 0.292 . . . . 15.0 111.099 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.524 ' CZ ' HD12 ' A' ' 89' ' ' LEU . 2.2 p90 -140.59 163.75 32.03 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.318 -0.401 . . . . 15.0 110.561 178.81 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.759 ' HB2' HD12 ' A' ' 88' ' ' LEU . 11.0 pt-20 -128.97 143.05 50.76 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.257 0.551 . . . . 15.0 111.424 -179.453 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.489 ' CG1' HD11 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -101.44 114.6 41.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.227 -0.897 . . . . 15.0 109.572 178.924 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -106.09 72.42 0.94 Allowed 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 112.397 0.518 . . . . 15.0 112.397 -178.647 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.938 HD13 ' HG3' ' A' ' 51' ' ' ARG . 6.5 tp -88.35 166.7 14.1 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.517 -0.549 . . . . 15.0 109.517 178.554 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -95.97 94.0 7.34 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.961 0.41 . . . . 15.0 111.305 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.713 ' CB ' HG23 ' A' ' 85' ' ' VAL . 0.2 OUTLIER . . . . . 0 C--N 1.328 -0.361 0 CA-C-N 115.884 -0.598 . . . . 15.0 111.057 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 9.6 mt . . . . . 0 N--CA 1.454 -0.235 0 CA-C-O 120.939 0.4 . . . . 15.0 110.763 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.757 ' O ' ' HB ' ' A' ' 41' ' ' ILE . . . -164.71 40.72 0.3 Allowed Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 121.01 -0.614 . . . . 15.0 111.826 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.625 HD12 ' CG1' ' A' ' 52' ' ' ILE . 0.0 OUTLIER -112.7 138.86 40.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 121.004 0.43 . . . . 15.0 111.773 -179.441 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.455 ' O ' ' HB3' ' A' ' 38' ' ' LYS . 21.1 t -94.49 100.4 12.4 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 107.704 -1.221 . . . . 15.0 107.704 177.282 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.619 ' CG2' HG23 ' A' ' 75' ' ' VAL . 1.4 m -93.79 152.69 3.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 112.463 0.542 . . . . 15.0 112.463 -177.076 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.744 ' HA ' ' CD2' ' A' ' 71' ' ' HIS . 14.8 t -149.29 -174.64 4.71 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.444 -0.798 . . . . 15.0 110.71 179.564 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.652 ' O ' HG22 ' A' ' 26' ' ' VAL . . . 75.18 -115.51 4.66 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 120.721 -0.752 . . . . 15.0 112.153 -179.713 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.544 ' HA3' ' N ' ' A' ' 71' ' ' HIS . . . 64.33 -65.34 0.06 OUTLIER Glycine 0 N--CA 1.453 -0.215 0 C-N-CA 121.015 -0.612 . . . . 15.0 113.841 179.024 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.652 HG22 ' O ' ' A' ' 24' ' ' GLY . 0.0 OUTLIER -30.54 145.13 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 N-CA-C 112.362 0.504 . . . . 15.0 112.362 -179.143 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.446 ' ND2' ' O ' ' A' ' 32' ' ' HIS . 4.8 m120 -79.63 56.25 2.18 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.961 -0.563 . . . . 15.0 111.031 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -151.69 -64.96 0.18 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.234 -0.439 . . . . 15.0 110.641 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.63 -48.23 70.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.11 -0.495 . . . . 15.0 110.559 179.7 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.643 HG22 ' O ' ' A' ' 26' ' ' VAL . 34.5 m -88.09 -171.15 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.024 -0.534 . . . . 15.0 110.77 179.711 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -92.4 127.17 37.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.91 0.386 . . . . 15.0 111.155 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' HIS . . . . . 0.446 ' O ' ' ND2' ' A' ' 27' ' ' ASN . 34.4 m80 58.18 -84.71 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.937 -0.574 . . . . 15.0 111.464 179.683 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -167.7 26.18 0.14 Allowed Glycine 0 C--N 1.331 0.263 0 C-N-CA 120.977 -0.63 . . . . 15.0 112.274 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.41 ' O ' HG21 ' A' ' 30' ' ' VAL . . . -83.83 149.16 25.28 Favored Glycine 0 N--CA 1.448 -0.529 0 N-CA-C 110.769 -0.932 . . . . 15.0 110.769 178.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.8 HG22 HG22 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -88.29 153.45 3.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 117.537 0.669 . . . . 15.0 111.777 -179.165 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.49 ' CZ ' ' HG2' ' A' ' 57' ' ' ARG . 30.7 m-85 -139.76 107.94 5.78 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.026 -0.988 . . . . 15.0 109.732 179.571 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.763 HG22 ' N ' ' A' ' 55' ' ' GLY . 0.8 OUTLIER -55.99 151.29 2.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.046 0.45 . . . . 15.0 111.284 -179.111 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.457 ' O ' ' HG2' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -83.8 -45.3 13.46 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.493 -0.928 . . . . 15.0 108.493 178.29 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.613 ' O ' HG12 ' A' ' 20' ' ' ILE . . . -172.28 172.43 4.5 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 115.853 -0.612 . . . . 15.0 110.32 178.333 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.591 ' HA ' HG12 ' A' ' 20' ' ' ILE . 0.1 OUTLIER -96.86 109.71 23.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.205 -0.665 . . . . 15.0 109.205 179.04 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.757 ' HB ' ' O ' ' A' ' 19' ' ' GLY . 0.5 OUTLIER -78.24 115.29 49.76 Favored Pre-proline 0 C--N 1.327 -0.371 0 N-CA-C 113.51 0.93 . . . . 15.0 113.51 -177.148 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.631 ' HA ' ' CG ' ' A' ' 47' ' ' GLU . 32.8 Cg_exo -62.0 60.58 0.13 Allowed 'Trans proline' 0 C--N 1.357 1.01 0 C-N-CA 123.619 2.879 . . . . 15.0 112.949 179.619 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.528 ' N ' ' HG2' ' A' ' 47' ' ' GLU . 6.0 tt0 -147.33 -48.38 0.18 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.62 0.248 . . . . 15.0 111.345 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.703 ' HA3' ' HA3' ' A' ' 19' ' ' GLY . . . -87.86 169.02 38.16 Favored Glycine 0 C--N 1.33 0.217 0 C-N-CA 120.403 -0.903 . . . . 15.0 113.807 -179.192 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -57.91 -13.84 5.17 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.749 0.648 . . . . 15.0 112.749 -179.624 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.9 -56.47 5.64 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.936 -0.306 . . . . 15.0 110.711 -179.59 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.631 ' CG ' ' HA ' ' A' ' 42' ' ' PRO . 2.9 pp20? -57.57 -42.96 84.1 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.992 -0.549 . . . . 15.0 110.322 179.009 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -53.86 -70.75 0.09 Allowed 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 115.828 -0.624 . . . . 15.0 110.567 -179.497 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.426 ' CB ' HD11 ' A' ' 11' ' ' LEU . 0.5 OUTLIER -58.11 -41.18 83.01 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.046 -0.724 . . . . 15.0 109.046 178.872 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.73 40.56 12.12 Favored Glycine 0 N--CA 1.446 -0.655 0 CA-C-N 115.345 -0.843 . . . . 15.0 111.779 179.241 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.938 ' HG3' HD13 ' A' ' 11' ' ' LEU . 2.7 mmp_? -79.78 -50.49 10.48 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.931 0.396 . . . . 15.0 110.644 -179.438 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.625 ' CG1' HD12 ' A' ' 20' ' ' ILE . 9.4 tp -81.1 160.1 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 CA-C-N 115.989 -0.55 . . . . 15.0 110.378 179.543 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' HIS . . . . . 0.459 ' O ' ' HB2' ' A' ' 56' ' ' ASP . 75.7 m80 -145.31 159.01 43.69 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-O 121.599 0.714 . . . . 15.0 112.083 -179.217 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.534 ' HA ' ' CG2' ' A' ' 37' ' ' VAL . 0.1 OUTLIER -42.21 132.91 3.25 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.512 -1.222 . . . . 15.0 112.642 -178.687 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.763 ' N ' HG22 ' A' ' 37' ' ' VAL . . . 49.98 34.24 22.89 Favored Glycine 0 C--N 1.333 0.395 0 CA-C-N 115.761 -0.654 . . . . 15.0 113.425 179.277 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.459 ' HB2' ' O ' ' A' ' 53' ' ' HIS . 0.3 OUTLIER -65.84 132.66 49.21 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.538 -0.465 . . . . 15.0 110.617 179.475 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.797 ' HD2' HD21 ' A' ' 59' ' ' LEU . 0.0 OUTLIER -85.73 92.13 8.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.321 -0.4 . . . . 15.0 110.499 179.664 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.8 HG22 HG22 ' A' ' 35' ' ' ILE . 2.0 m -83.14 114.43 23.9 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 CA-C-O 120.988 0.423 . . . . 15.0 111.143 -179.566 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.797 HD21 ' HD2' ' A' ' 57' ' ' ARG . 3.4 mm? -107.15 -16.39 14.43 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 115.747 -0.66 . . . . 15.0 112.494 -179.236 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.711 ' HB3' ' HB2' ' A' ' 88' ' ' LEU . . . -147.78 146.91 29.35 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.112 0.482 . . . . 15.0 112.222 -178.76 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.902 HG23 HD11 ' A' ' 66' ' ' LEU . 61.5 t -138.78 102.18 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.578 -0.737 . . . . 15.0 109.194 178.869 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.661 ' OD1' HG22 ' A' ' 81' ' ' THR . 2.5 m120 65.07 16.1 10.37 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.103 -0.499 . . . . 15.0 109.763 -178.096 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 105.83 5.18 38.94 Favored Glycine 0 C--N 1.336 0.564 0 CA-C-N 115.821 -0.627 . . . . 15.0 113.247 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.646 HG13 ' O ' ' A' ' 64' ' ' VAL . 5.5 p -93.84 108.3 20.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.983 0.392 . . . . 15.0 110.979 179.6 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 21.4 m -57.99 124.89 20.83 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.204 0.526 . . . . 15.0 110.777 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.902 HD11 HG23 ' A' ' 61' ' ' VAL . 0.3 OUTLIER -87.72 -21.06 25.41 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.444 -0.798 . . . . 15.0 111.327 -179.499 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -46.7 103.6 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.843 0.354 . . . . 15.0 110.986 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.89 63.11 0.54 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.764 -0.731 . . . . 15.0 112.55 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.56 ' HB1' ' CB ' ' A' ' 73' ' ' GLN . . . -172.98 164.64 4.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.835 0.35 . . . . 15.0 111.024 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.534 ' HB ' HG13 ' A' ' 26' ' ' VAL . 5.9 p -93.26 -172.89 3.08 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.067 0.46 . . . . 15.0 111.118 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' HIS . . . . . 0.744 ' CD2' ' HA ' ' A' ' 23' ' ' THR . 0.0 OUTLIER -62.35 -61.34 2.52 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.733 -0.667 . . . . 15.0 110.212 179.985 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 22.4 ttpp -52.85 -35.68 57.77 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.789 -0.641 . . . . 15.0 110.345 179.358 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.56 ' CB ' ' HB1' ' A' ' 69' ' ' ALA . 4.8 mt-30 -59.68 -48.31 82.19 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.432 -0.581 . . . . 15.0 109.432 179.137 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.494 ' HB3' HG13 ' A' ' 35' ' ' ILE . . . -66.79 -47.87 70.75 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 115.789 -0.641 . . . . 15.0 109.441 178.361 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.619 HG23 ' CG2' ' A' ' 22' ' ' VAL . 0.5 OUTLIER -41.66 -40.26 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.271 0 N-CA-C 108.827 -0.805 . . . . 15.0 108.827 178.203 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.476 ' O ' ' HB2' ' A' ' 80' ' ' ASN . 1.5 mm-40 -67.2 -47.02 72.13 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.734 -1.121 . . . . 15.0 110.509 178.542 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.734 ' O ' HG11 ' A' ' 61' ' ' VAL . 16.5 p -64.08 -53.06 55.69 Favored 'General case' 0 N--CA 1.461 0.117 0 C-N-CA 120.913 -0.315 . . . . 15.0 111.469 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.743 HD23 HG21 ' A' ' 61' ' ' VAL . 3.6 mt -53.44 -47.43 69.68 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.174 0.511 . . . . 15.0 110.047 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.447 ' HB2' ' O ' ' A' ' 75' ' ' VAL . 0.0 OUTLIER -68.64 -57.9 5.03 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.571 -0.741 . . . . 15.0 110.657 179.331 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.476 ' HB2' ' O ' ' A' ' 76' ' ' GLU . 11.9 m-80 -65.92 63.05 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.163 -0.472 . . . . 15.0 111.966 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.661 HG22 ' OD1' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -94.0 -71.95 0.64 Allowed 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 110.096 -0.335 . . . . 15.0 110.096 179.103 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 122.06 -105.22 0.96 Allowed Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.774 -0.727 . . . . 15.0 113.124 179.235 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.415 ' O ' ' HB3' ' A' ' 13' ' ' LYS . 0.1 OUTLIER -64.8 -82.86 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 111.885 0.328 . . . . 15.0 111.885 -179.16 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.453 HG12 ' N ' ' A' ' 85' ' ' VAL . 72.9 t -109.64 159.85 8.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.921 0.391 . . . . 15.0 110.869 -179.508 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.713 HG23 ' CB ' ' A' ' 13' ' ' LYS . 14.9 t -97.76 80.83 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.054 0.454 . . . . 15.0 110.593 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -102.84 85.09 2.48 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.765 -0.652 . . . . 15.0 110.44 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.834 ' HB3' HD21 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -102.42 119.9 39.6 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.948 -0.569 . . . . 15.0 111.742 -179.207 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.759 HD12 ' HB2' ' A' ' 8' ' ' GLU . 4.3 mp -94.52 100.66 12.6 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.773 -0.454 . . . . 15.0 109.773 178.923 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.834 HD21 ' HB3' ' A' ' 87' ' ' LEU . 0.1 OUTLIER -105.81 -163.53 0.95 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.517 0.675 . . . . 15.0 112.173 -178.531 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.45 ' HB2' HG13 ' A' ' 6' ' ' ILE . 3.4 tt0 -141.36 140.15 33.67 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 114.824 -1.08 . . . . 15.0 109.505 179.02 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 2.7 tptp -55.98 96.66 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.025 0.441 . . . . 15.0 111.014 -179.613 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.518 0.254 0 CA-C-N 115.732 -0.667 . . . . 15.0 113.188 -179.677 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.419 ' CD1' ' HB2' ' A' ' 90' ' ' GLU . 1.2 mp . . . . . 0 N--CA 1.45 -0.458 0 CA-C-O 120.897 0.38 . . . . 15.0 111.244 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.79 ' CZ ' HD12 ' A' ' 89' ' ' LEU . 2.1 p90 -140.28 164.32 30.4 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.012 -0.54 . . . . 15.0 110.253 178.912 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.719 ' CB ' HD12 ' A' ' 88' ' ' LEU . 10.0 pt-20 -130.06 143.96 51.08 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.254 0.55 . . . . 15.0 111.701 -179.33 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.501 ' CG1' HD11 ' A' ' 89' ' ' LEU . 0.3 OUTLIER -101.5 116.99 46.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.327 -0.851 . . . . 15.0 109.815 178.895 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -106.01 70.97 0.87 Allowed 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.278 -0.419 . . . . 15.0 111.854 -179.331 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.819 HD13 ' CG ' ' A' ' 51' ' ' ARG . 6.0 tp -87.83 164.75 15.75 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.124 -0.489 . . . . 15.0 109.853 179.088 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -95.91 94.03 7.38 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.993 0.425 . . . . 15.0 111.346 -179.696 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.687 ' CB ' HG23 ' A' ' 85' ' ' VAL . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.367 0 CA-C-N 115.904 -0.589 . . . . 15.0 110.881 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.658 ' N ' HD22 ' A' ' 18' ' ' LEU . 1.3 mm? . . . . . 0 N--CA 1.453 -0.304 0 CA-C-O 121.019 0.438 . . . . 15.0 110.66 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.601 ' O ' ' HB ' ' A' ' 41' ' ' ILE . . . -165.78 31.46 0.22 Allowed Glycine 0 C--O 1.224 -0.529 0 N-CA-C 111.336 -0.706 . . . . 15.0 111.336 -179.677 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.708 HG13 HG12 ' A' ' 40' ' ' VAL . 0.0 OUTLIER -114.07 140.87 32.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 112.314 0.487 . . . . 15.0 112.314 -179.497 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.746 ' HB3' HD11 ' A' ' 41' ' ' ILE . 1.7 t -96.43 106.32 18.54 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 107.962 -1.125 . . . . 15.0 107.962 176.705 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.961 HG21 HG23 ' A' ' 75' ' ' VAL . 21.1 m -93.59 149.59 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 N-CA-C 112.947 0.721 . . . . 15.0 112.947 -177.246 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.537 HG22 ' HB2' ' A' ' 38' ' ' LYS . 8.8 t -150.37 -179.96 7.63 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.357 -0.838 . . . . 15.0 110.887 179.266 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.662 ' O ' HG22 ' A' ' 26' ' ' VAL . . . 74.11 -114.83 4.68 Favored Glycine 0 C--N 1.334 0.467 0 C-N-CA 120.973 -0.632 . . . . 15.0 112.526 179.773 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.539 ' HA3' ' N ' ' A' ' 71' ' ' HIS . . . 63.88 -65.3 0.05 OUTLIER Glycine 0 C--N 1.331 0.251 0 C-N-CA 121.093 -0.575 . . . . 15.0 113.885 179.082 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.662 HG22 ' O ' ' A' ' 24' ' ' GLY . 0.0 OUTLIER -28.68 141.81 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 N-CA-C 112.329 0.492 . . . . 15.0 112.329 -179.159 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.44 ' ND2' ' O ' ' A' ' 27' ' ' ASN . 2.2 p-10 -75.53 62.24 1.38 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.965 -0.561 . . . . 15.0 111.001 -179.797 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 9.7 m -151.71 -65.34 0.18 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.258 -0.428 . . . . 15.0 111.011 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -69.52 -48.92 58.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.118 -0.492 . . . . 15.0 111.087 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.554 HG22 ' O ' ' A' ' 26' ' ' VAL . 34.8 m -72.69 -174.51 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.217 -0.447 . . . . 15.0 111.247 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.45 -74.56 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.184 -0.462 . . . . 15.0 111.258 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 8.8 p-80 -132.52 -45.71 0.9 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.35 -0.386 . . . . 15.0 111.179 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -168.39 24.05 0.11 Allowed Glycine 0 N--CA 1.453 -0.19 0 C-N-CA 120.8 -0.714 . . . . 15.0 112.732 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -90.31 153.71 22.99 Favored Glycine 0 N--CA 1.449 -0.448 0 N-CA-C 110.836 -0.906 . . . . 15.0 110.836 178.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.91 HG22 HG22 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -92.21 154.11 3.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.504 0.669 . . . . 15.0 111.888 -179.335 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.51 ' CZ ' ' HG2' ' A' ' 57' ' ' ARG . 24.1 m-85 -139.49 110.97 7.07 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.857 -1.065 . . . . 15.0 109.136 178.846 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.794 HG22 ' N ' ' A' ' 55' ' ' GLY . 0.8 OUTLIER -56.44 156.42 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.46 0.648 . . . . 15.0 110.953 -178.762 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.537 ' HB2' HG22 ' A' ' 23' ' ' THR . 0.0 OUTLIER -90.39 -46.85 8.11 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 108.281 -1.007 . . . . 15.0 108.281 178.667 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.532 ' O ' HG12 ' A' ' 20' ' ' ILE . . . -172.84 166.74 5.23 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.088 -0.96 . . . . 15.0 110.566 178.326 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.708 HG12 HG13 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -97.24 119.94 45.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.789 0.328 . . . . 15.0 110.493 179.75 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.746 HD11 ' HB3' ' A' ' 21' ' ' SER . 1.4 mm -78.31 109.28 9.8 Favored Pre-proline 0 N--CA 1.466 0.358 0 N-CA-C 113.028 0.751 . . . . 15.0 113.028 -178.394 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.453 ' HA ' ' OE1' ' A' ' 47' ' ' GLU . 41.0 Cg_endo -66.54 64.42 0.53 Allowed 'Trans proline' 0 C--N 1.352 0.753 0 C-N-CA 122.846 2.364 . . . . 15.0 112.28 179.474 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 11.5 mt-30 -159.37 -45.91 0.05 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.362 -0.835 . . . . 15.0 109.436 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.508 ' HA3' ' HA3' ' A' ' 19' ' ' GLY . . . -87.4 151.6 23.56 Favored Glycine 0 N--CA 1.446 -0.678 0 CA-C-N 115.611 -0.722 . . . . 15.0 112.222 179.232 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.502 ' O ' HD21 ' A' ' 11' ' ' LEU . . . -40.59 -18.28 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 113.367 0.877 . . . . 15.0 113.367 -179.435 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.465 ' N ' ' O ' ' A' ' 44' ' ' GLY . . . -71.66 -71.64 0.26 Allowed 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.893 -0.323 . . . . 15.0 111.267 -179.593 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.56 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 9.4 tm-20 -58.16 -37.79 75.36 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.832 0.348 . . . . 15.0 110.341 179.578 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 16.0 m -53.92 -66.4 0.4 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.1 -0.5 . . . . 15.0 110.47 179.676 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.643 ' CB ' HD11 ' A' ' 11' ' ' LEU . 2.1 t0 -63.3 -37.64 88.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.103 -0.499 . . . . 15.0 109.922 179.152 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.55 43.68 8.32 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.928 -0.653 . . . . 15.0 112.523 179.63 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.819 ' CG ' HD13 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -80.13 -51.72 8.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.75 0.309 . . . . 15.0 110.724 179.943 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.734 HG21 HG11 ' A' ' 37' ' ' VAL . 1.2 mm -91.24 163.41 2.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.973 0.416 . . . . 15.0 111.15 179.736 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' HIS . . . . . 0.614 ' N ' HG22 ' A' ' 52' ' ' ILE . 47.6 m80 -139.39 153.29 47.62 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-O 121.368 0.604 . . . . 15.0 110.485 179.463 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.506 ' HA ' ' CG2' ' A' ' 37' ' ' VAL . 0.6 OUTLIER -35.21 132.96 0.35 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.747 -1.115 . . . . 15.0 112.354 -178.459 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.794 ' N ' HG22 ' A' ' 37' ' ' VAL . . . 52.11 35.57 41.9 Favored Glycine 0 C--N 1.332 0.31 0 CA-C-N 115.892 -0.594 . . . . 15.0 114.01 179.644 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -66.16 130.57 43.68 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 117.676 0.738 . . . . 15.0 110.561 179.205 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.51 ' HG2' ' CZ ' ' A' ' 36' ' ' TYR . 26.4 mtt-85 -81.63 91.55 6.43 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.462 -0.335 . . . . 15.0 110.586 179.735 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.91 HG22 HG22 ' A' ' 35' ' ' ILE . 1.1 m -85.86 116.29 28.67 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 CA-C-O 121.178 0.513 . . . . 15.0 111.384 -179.645 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -107.26 -10.59 15.78 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 115.589 -0.732 . . . . 15.0 112.248 -179.602 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.698 ' HB3' ' HB2' ' A' ' 88' ' ' LEU . . . -152.01 145.16 24.6 Favored 'General case' 0 N--CA 1.462 0.17 0 N-CA-C 112.301 0.482 . . . . 15.0 112.301 -178.936 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.831 HG21 HD23 ' A' ' 78' ' ' LEU . 59.7 t -138.94 101.41 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.57 -0.741 . . . . 15.0 109.264 178.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.647 ' OD1' HG22 ' A' ' 81' ' ' THR . 2.7 m120 64.96 16.04 10.31 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.02 0.438 . . . . 15.0 109.919 -178.286 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 107.06 4.76 35.68 Favored Glycine 0 C--N 1.336 0.578 0 CA-C-N 115.932 -0.577 . . . . 15.0 113.376 179.588 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.644 HG13 ' O ' ' A' ' 64' ' ' VAL . 5.2 p -93.85 107.54 19.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 117.084 0.442 . . . . 15.0 110.857 179.529 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.6 m -56.82 130.74 46.97 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.3 -0.409 . . . . 15.0 111.111 -179.677 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.471 HD13 ' HB3' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -90.76 -22.03 21.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.04 -0.527 . . . . 15.0 110.95 179.975 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -46.6 96.68 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.889 0.376 . . . . 15.0 111.047 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.76 66.45 0.58 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.801 -0.714 . . . . 15.0 112.428 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.512 ' HB1' ' HB3' ' A' ' 73' ' ' GLN . . . -173.09 162.77 4.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.838 0.351 . . . . 15.0 111.052 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.424 HG22 ' HA ' ' A' ' 26' ' ' VAL . 15.0 p -93.12 -174.1 3.45 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.016 0.436 . . . . 15.0 111.106 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' HIS . . . . . 0.765 ' NE2' HG23 ' A' ' 22' ' ' VAL . 0.2 OUTLIER -63.95 -59.7 4.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.841 -0.618 . . . . 15.0 110.296 179.946 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.467 ' O ' HG12 ' A' ' 75' ' ' VAL . 30.4 ttmt -52.69 -33.52 47.89 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.153 -0.476 . . . . 15.0 110.235 178.858 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.512 ' HB3' ' HB1' ' A' ' 69' ' ' ALA . 0.0 OUTLIER -59.39 -51.25 70.73 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.565 -0.532 . . . . 15.0 109.565 179.258 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.633 ' HB3' HG13 ' A' ' 35' ' ' ILE . . . -66.91 -43.87 82.22 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-N 116.041 -0.527 . . . . 15.0 109.711 178.425 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.961 HG23 HG21 ' A' ' 22' ' ' VAL . 0.5 OUTLIER -42.83 -41.91 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.23 0 N-CA-C 108.896 -0.779 . . . . 15.0 108.896 178.395 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.418 ' HG3' ' O ' ' A' ' 72' ' ' LYS . 17.2 mt-10 -67.32 -45.15 77.31 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.794 -1.093 . . . . 15.0 110.078 178.275 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.653 ' O ' HG11 ' A' ' 61' ' ' VAL . 82.1 p -64.17 -54.58 31.47 Favored 'General case' 0 N--CA 1.461 0.114 0 CA-C-N 116.612 -0.267 . . . . 15.0 111.436 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.831 HD23 HG21 ' A' ' 61' ' ' VAL . 4.2 mt -53.51 -48.17 69.24 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 121.145 0.498 . . . . 15.0 110.141 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.408 ' HB2' ' O ' ' A' ' 75' ' ' VAL . 0.0 OUTLIER -68.52 -59.02 3.45 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.561 -0.745 . . . . 15.0 110.564 179.478 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 74.6 m-20 -66.04 59.4 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.933 -0.576 . . . . 15.0 112.43 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.647 HG22 ' OD1' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -95.73 -71.97 0.65 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.889 -0.412 . . . . 15.0 109.889 178.855 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 122.13 -105.16 0.96 Allowed Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.72 -0.752 . . . . 15.0 113.451 178.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.406 ' O ' ' HB3' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -64.56 -83.0 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.071 0.397 . . . . 15.0 112.071 -178.815 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.443 HG12 ' N ' ' A' ' 85' ' ' VAL . 76.2 t -109.64 158.84 9.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.077 0.465 . . . . 15.0 111.167 -179.199 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.687 HG23 ' CB ' ' A' ' 13' ' ' LYS . 9.1 t -97.86 81.23 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.011 -0.54 . . . . 15.0 110.499 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -99.06 85.54 3.26 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.76 -0.655 . . . . 15.0 110.344 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.732 ' HB3' HD21 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -104.02 126.52 51.2 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.041 -0.527 . . . . 15.0 111.917 -179.16 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.719 HD12 ' CB ' ' A' ' 8' ' ' GLU . 5.0 mp -102.41 99.96 10.06 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.751 -0.463 . . . . 15.0 109.751 178.695 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.79 HD12 ' CZ ' ' A' ' 7' ' ' PHE . 0.1 OUTLIER -105.85 -162.56 0.87 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.646 0.736 . . . . 15.0 112.29 -178.633 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.419 ' HB2' ' CD1' ' A' ' 6' ' ' ILE . 3.3 tt0 -137.68 138.64 39.6 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 114.639 -1.164 . . . . 15.0 109.48 178.86 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.3 tppt? -49.49 107.35 0.14 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.947 0.403 . . . . 15.0 111.151 -179.549 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.272 0 C-N-CA 120.928 -0.653 . . . . 15.0 112.935 -179.707 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.452 HG13 ' HB2' ' A' ' 90' ' ' GLU . 1.3 mp . . . . . 0 N--CA 1.452 -0.366 0 CA-C-O 120.665 0.269 . . . . 15.0 110.709 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.513 ' CZ ' HD12 ' A' ' 89' ' ' LEU . 2.5 p90 -144.8 165.14 28.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.793 0.33 . . . . 15.0 110.686 179.177 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.732 ' CB ' HD12 ' A' ' 88' ' ' LEU . 9.7 pt-20 -130.18 143.91 51.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.22 0.534 . . . . 15.0 111.426 -179.472 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.56 ' CG1' HD11 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -101.38 115.3 42.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.434 -0.803 . . . . 15.0 109.521 178.905 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -106.02 72.03 0.92 Allowed 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.524 0.565 . . . . 15.0 112.524 -178.602 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.652 HD13 ' HG3' ' A' ' 51' ' ' ARG . 5.7 tp -88.2 166.3 14.46 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.448 -0.575 . . . . 15.0 109.448 178.462 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -96.18 92.15 6.26 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.897 0.379 . . . . 15.0 111.203 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.7 ' CB ' HG23 ' A' ' 85' ' ' VAL . 0.2 OUTLIER . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 115.914 -0.584 . . . . 15.0 111.018 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.65 ' N ' HD22 ' A' ' 18' ' ' LEU . 1.9 mm? . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.878 0.37 . . . . 15.0 110.748 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.782 ' O ' ' HB ' ' A' ' 41' ' ' ILE . . . -163.63 44.32 0.32 Allowed Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 121.053 -0.594 . . . . 15.0 111.871 -179.751 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.672 HG12 ' O ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -112.88 135.58 51.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 121.012 0.434 . . . . 15.0 111.876 -179.353 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 29.9 t -89.81 104.4 16.97 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 107.668 -1.234 . . . . 15.0 107.668 177.366 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 1.001 HG21 HG23 ' A' ' 75' ' ' VAL . 14.1 m -93.44 151.91 3.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 112.953 0.723 . . . . 15.0 112.953 -176.825 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -149.57 -177.72 6.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 114.977 -1.01 . . . . 15.0 110.678 -179.685 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.58 ' O ' HG22 ' A' ' 26' ' ' VAL . . . 73.26 -120.52 7.16 Favored Glycine 0 C--N 1.331 0.256 0 C-N-CA 120.675 -0.774 . . . . 15.0 112.381 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.524 ' HA3' ' N ' ' A' ' 71' ' ' HIS . . . 66.94 -65.57 0.19 Allowed Glycine 0 C--N 1.33 0.214 0 C-N-CA 120.943 -0.646 . . . . 15.0 113.565 179.31 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.58 HG22 ' O ' ' A' ' 24' ' ' GLY . 0.0 OUTLIER -25.87 133.08 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 N-CA-C 112.621 0.6 . . . . 15.0 112.621 -179.298 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -75.65 63.17 1.54 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.784 -0.644 . . . . 15.0 111.018 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.4 m -151.67 -47.27 0.11 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.287 -0.415 . . . . 15.0 111.0 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 12.5 t -90.28 -41.65 11.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 15.0 111.001 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.484 HG22 ' O ' ' A' ' 26' ' ' VAL . 33.9 m -71.99 -176.3 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.471 . . . . 15.0 111.166 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.0 -51.32 69.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.218 -0.446 . . . . 15.0 110.983 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 73.2 m-70 -151.21 -51.98 0.13 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.28 -0.418 . . . . 15.0 111.012 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -168.1 27.42 0.14 Allowed Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.803 -0.713 . . . . 15.0 112.5 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -91.13 149.14 19.71 Favored Glycine 0 N--CA 1.45 -0.411 0 N-CA-C 111.037 -0.825 . . . . 15.0 111.037 179.134 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.769 HG22 HG22 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -88.18 154.78 3.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.388 0.613 . . . . 15.0 111.719 -179.299 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.532 ' CZ ' ' HG2' ' A' ' 57' ' ' ARG . 51.2 m-85 -141.35 106.91 5.06 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.008 -0.996 . . . . 15.0 109.737 179.272 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.767 HG22 ' N ' ' A' ' 55' ' ' GLY . 0.8 OUTLIER -56.16 148.11 4.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.021 0.438 . . . . 15.0 111.317 -179.193 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.493 ' O ' ' HG2' ' A' ' 54' ' ' LYS . 0.4 OUTLIER -80.37 -46.46 16.01 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.49 -0.93 . . . . 15.0 108.49 178.248 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.672 ' O ' HG12 ' A' ' 20' ' ' ILE . . . -172.1 172.58 4.59 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.594 -0.73 . . . . 15.0 110.508 178.626 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.56 ' HA ' HG12 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -96.87 111.42 26.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 109.545 -0.539 . . . . 15.0 109.545 179.248 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.782 ' HB ' ' O ' ' A' ' 19' ' ' GLY . 0.4 OUTLIER -78.47 117.05 64.02 Favored Pre-proline 0 C--N 1.329 -0.324 0 N-CA-C 113.273 0.842 . . . . 15.0 113.273 -177.422 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.621 ' HA ' ' CG ' ' A' ' 47' ' ' GLU . 37.9 Cg_endo -65.29 59.76 0.34 Allowed 'Trans proline' 0 C--N 1.356 0.924 0 C-N-CA 123.437 2.758 . . . . 15.0 112.785 179.734 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.526 ' N ' ' HG2' ' A' ' 47' ' ' GLU . 0.5 OUTLIER -147.47 -46.32 0.17 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.517 -0.31 . . . . 15.0 111.296 -179.996 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.71 ' HA3' ' HA3' ' A' ' 19' ' ' GLY . . . -87.77 168.02 37.3 Favored Glycine 0 C--N 1.331 0.269 0 C-N-CA 120.332 -0.937 . . . . 15.0 113.722 -179.258 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -57.83 -14.35 5.85 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.862 0.69 . . . . 15.0 112.862 -179.473 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.14 -55.86 6.57 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.935 -0.306 . . . . 15.0 110.932 -179.69 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.621 ' CG ' ' HA ' ' A' ' 42' ' ' PRO . 2.9 pp20? -57.36 -43.02 83.15 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.923 -0.58 . . . . 15.0 110.231 179.196 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.5 m -53.84 -69.89 0.11 Allowed 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 115.882 -0.599 . . . . 15.0 110.483 -179.63 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.533 ' CB ' HD11 ' A' ' 11' ' ' LEU . 1.1 t0 -58.07 -41.74 84.01 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.072 -0.714 . . . . 15.0 109.072 178.785 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.75 40.03 12.97 Favored Glycine 0 N--CA 1.446 -0.648 0 CA-C-N 115.293 -0.867 . . . . 15.0 111.711 179.33 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.652 ' HG3' HD13 ' A' ' 11' ' ' LEU . 0.2 OUTLIER -79.79 -50.07 11.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.895 0.378 . . . . 15.0 110.599 -179.362 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.649 ' CG1' HD12 ' A' ' 20' ' ' ILE . 8.7 tp -81.12 161.44 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 CA-C-N 116.075 -0.511 . . . . 15.0 110.367 179.571 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' HIS . . . . . 0.471 ' O ' ' HB2' ' A' ' 56' ' ' ASP . 78.3 m80 -146.27 158.78 43.91 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-O 121.635 0.731 . . . . 15.0 112.16 -179.192 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.556 ' HA ' ' CG2' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -43.12 133.97 3.71 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 114.382 -1.281 . . . . 15.0 112.645 -178.752 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.767 ' N ' HG22 ' A' ' 37' ' ' VAL . . . 49.97 34.0 22.37 Favored Glycine 0 C--N 1.333 0.414 0 CA-C-N 115.841 -0.618 . . . . 15.0 113.354 179.403 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.471 ' HB2' ' O ' ' A' ' 53' ' ' HIS . 0.3 OUTLIER -65.96 131.9 47.33 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.635 -0.426 . . . . 15.0 110.618 179.525 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.64 ' HD2' HD21 ' A' ' 59' ' ' LEU . 0.0 OUTLIER -85.32 90.89 8.03 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.169 -0.468 . . . . 15.0 110.403 179.553 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.769 HG22 HG22 ' A' ' 35' ' ' ILE . 1.5 m -83.57 112.95 21.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.079 0.466 . . . . 15.0 111.207 -179.524 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.64 HD21 ' HD2' ' A' ' 57' ' ' ARG . 3.5 mm? -107.32 -16.54 14.37 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 115.764 -0.653 . . . . 15.0 112.615 -179.099 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.791 ' HB3' ' HB2' ' A' ' 88' ' ' LEU . . . -147.5 150.21 34.12 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 112.518 0.562 . . . . 15.0 112.518 -178.454 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.691 HG21 ' HB ' ' A' ' 77' ' ' THR . 3.3 t -139.07 101.66 1.62 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.267 0 CA-C-N 115.311 -0.859 . . . . 15.0 109.281 178.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.647 ' OD1' HG22 ' A' ' 81' ' ' THR . 3.8 m120 64.96 15.59 10.05 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.64 -0.504 . . . . 15.0 109.64 -178.112 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 105.95 6.71 36.93 Favored Glycine 0 C--N 1.336 0.54 0 CA-C-N 115.816 -0.629 . . . . 15.0 113.126 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.664 HG13 ' O ' ' A' ' 64' ' ' VAL . 7.2 p -93.76 105.32 16.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.118 0.485 . . . . 15.0 110.727 179.283 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -59.3 116.35 3.85 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.127 -0.488 . . . . 15.0 110.733 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.704 HD21 ' HA ' ' A' ' 74' ' ' ALA . 1.2 mt -87.59 -12.07 46.75 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.826 -0.624 . . . . 15.0 111.295 -179.835 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -46.29 102.51 0.03 OUTLIER 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.827 0.346 . . . . 15.0 110.936 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.86 64.25 0.55 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.8 -0.714 . . . . 15.0 112.264 -179.608 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.721 ' HB1' ' CB ' ' A' ' 73' ' ' GLN . . . -172.91 148.44 1.79 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.9 0.381 . . . . 15.0 110.855 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.444 ' CB ' ' HA ' ' A' ' 26' ' ' VAL . 11.8 p -72.83 -173.75 1.29 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.198 -0.456 . . . . 15.0 111.157 -179.65 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' HIS . . . . . 0.674 ' CE1' HG23 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -61.89 -59.46 5.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.882 -0.599 . . . . 15.0 110.572 -179.847 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 25.0 ttpt -52.34 -35.51 51.14 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.84 -0.618 . . . . 15.0 110.689 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.721 ' CB ' ' HB1' ' A' ' 69' ' ' ALA . 3.5 mt-30 -59.31 -46.22 89.16 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.647 -0.501 . . . . 15.0 109.647 179.232 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.704 ' HA ' HD21 ' A' ' 66' ' ' LEU . . . -66.96 -50.34 62.61 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 109.472 -0.566 . . . . 15.0 109.472 178.195 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 1.001 HG23 HG21 ' A' ' 22' ' ' VAL . 0.6 OUTLIER -40.85 -43.58 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.192 0 CA-C-N 115.237 -0.892 . . . . 15.0 109.614 178.567 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.439 ' N ' HG12 ' A' ' 75' ' ' VAL . 41.4 mt-10 -67.37 -43.85 80.39 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.01 -0.996 . . . . 15.0 110.663 179.156 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.691 ' HB ' HG21 ' A' ' 61' ' ' VAL . 0.6 OUTLIER -64.68 -55.78 17.92 Favored 'General case' 0 C--O 1.23 0.075 0 C-N-CA 120.796 -0.362 . . . . 15.0 111.272 179.937 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.752 HD22 HD21 ' A' ' 87' ' ' LEU . 3.2 mt -53.43 -46.03 69.65 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 121.116 0.484 . . . . 15.0 110.132 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.22 -55.06 13.6 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.612 -0.722 . . . . 15.0 110.359 179.4 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 8.1 m-20 -66.26 57.81 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 115.919 -0.582 . . . . 15.0 112.01 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.647 HG22 ' OD1' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -95.66 -70.54 0.71 Allowed 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 110.203 -0.295 . . . . 15.0 110.203 179.332 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 115.25 -98.15 0.84 Allowed Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.691 -0.766 . . . . 15.0 113.412 178.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.427 ' O ' ' HB3' ' A' ' 13' ' ' LYS . 0.5 OUTLIER -64.39 -86.24 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.063 0.394 . . . . 15.0 112.063 -178.827 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.452 HG12 ' N ' ' A' ' 85' ' ' VAL . 77.7 t -109.73 159.76 9.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.924 0.392 . . . . 15.0 110.978 -179.397 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.7 HG23 ' CB ' ' A' ' 13' ' ' LYS . 13.4 t -97.99 79.4 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.145 0.497 . . . . 15.0 110.466 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -101.41 84.14 2.56 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.746 -0.661 . . . . 15.0 110.495 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.789 ' HB3' HD21 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -101.02 128.64 46.97 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.014 -0.539 . . . . 15.0 111.54 -179.302 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.791 ' HB2' ' HB3' ' A' ' 60' ' ' ALA . 4.8 mp -102.2 99.67 9.8 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.737 -0.468 . . . . 15.0 109.737 178.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.789 HD21 ' HB3' ' A' ' 87' ' ' LEU . 0.1 OUTLIER -105.73 -160.86 0.77 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.394 0.616 . . . . 15.0 112.011 -178.677 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.452 ' HB2' HG13 ' A' ' 6' ' ' ILE . 3.6 tt0 -141.77 132.69 25.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.051 -0.977 . . . . 15.0 109.897 179.136 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 3.6 tmtp? -49.26 95.51 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.378 -0.374 . . . . 15.0 111.146 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.365 0 C-N-CA 120.85 -0.691 . . . . 15.0 112.639 -179.964 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.411 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 1.2 mp . . . . . 0 N--CA 1.451 -0.409 0 CA-C-O 120.921 0.391 . . . . 15.0 111.335 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.513 ' CZ ' HD12 ' A' ' 89' ' ' LEU . 1.8 p90 -140.54 153.91 46.33 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.026 -0.533 . . . . 15.0 110.407 178.899 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.748 ' HB2' HD12 ' A' ' 88' ' ' LEU . 0.1 OUTLIER -121.37 143.61 49.11 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.369 0.604 . . . . 15.0 111.759 -179.192 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.585 ' CG1' HD11 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -101.43 116.02 44.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.063 -0.971 . . . . 15.0 109.628 178.956 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -106.24 72.59 0.94 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.239 -0.437 . . . . 15.0 112.145 -178.899 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.615 HD13 ' HG3' ' A' ' 51' ' ' ARG . 7.1 tp -88.3 161.69 17.01 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.319 -0.4 . . . . 15.0 110.007 178.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -97.1 94.67 7.28 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.654 0.264 . . . . 15.0 111.686 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.853 ' HB2' HG23 ' A' ' 85' ' ' VAL . 0.6 OUTLIER . . . . . 0 N--CA 1.466 0.325 0 N-CA-C 112.738 0.644 . . . . 15.0 112.738 179.623 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.492 HD12 ' HE3' ' A' ' 13' ' ' LYS . 4.5 mp . . . . . 0 N--CA 1.452 -0.341 0 CA-C-O 120.729 0.3 . . . . 15.0 110.357 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.686 ' O ' ' HB ' ' A' ' 41' ' ' ILE . . . -160.61 38.88 0.44 Allowed Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.901 -0.666 . . . . 15.0 111.719 -179.728 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.643 HG12 ' O ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -112.9 138.4 42.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 120.998 0.428 . . . . 15.0 111.805 -179.53 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.42 ' O ' ' HB3' ' A' ' 38' ' ' LYS . 28.9 t -95.78 100.92 12.57 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 107.801 -1.185 . . . . 15.0 107.801 177.395 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.616 HG22 HG23 ' A' ' 75' ' ' VAL . 1.0 OUTLIER -93.66 154.82 3.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.162 0.506 . . . . 15.0 112.299 -177.151 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.679 ' HA ' ' CD2' ' A' ' 71' ' ' HIS . 14.5 t -149.34 -176.19 5.28 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.421 -0.809 . . . . 15.0 110.516 179.647 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.712 ' O ' HG22 ' A' ' 26' ' ' VAL . . . 77.1 -112.07 3.42 Favored Glycine 0 C--N 1.331 0.287 0 C-N-CA 120.555 -0.831 . . . . 15.0 112.253 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.56 ' HA3' ' N ' ' A' ' 71' ' ' HIS . . . 62.8 -65.89 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 121.037 -0.601 . . . . 15.0 113.812 179.133 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.718 ' O ' HG22 ' A' ' 30' ' ' VAL . 0.0 OUTLIER -30.27 145.01 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 N-CA-C 112.47 0.544 . . . . 15.0 112.47 -179.068 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -80.28 56.26 2.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.863 -0.608 . . . . 15.0 110.967 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -151.04 -65.38 0.19 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.212 -0.449 . . . . 15.0 110.585 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.09 -47.11 75.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 15.0 110.251 179.57 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.718 HG22 ' O ' ' A' ' 26' ' ' VAL . 33.7 m -88.07 -170.3 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.923 -0.581 . . . . 15.0 110.567 179.475 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -95.83 128.49 42.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.933 0.396 . . . . 15.0 111.152 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 25.6 m80 59.47 -83.35 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.947 -0.57 . . . . 15.0 111.464 179.645 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.407 ' O ' ' O ' ' A' ' 69' ' ' ALA . . . -170.36 30.61 0.14 Allowed Glycine 0 C--N 1.33 0.244 0 C-N-CA 121.056 -0.592 . . . . 15.0 112.026 -179.548 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.49 ' O ' HG21 ' A' ' 30' ' ' VAL . . . -89.96 151.88 21.95 Favored Glycine 0 N--CA 1.447 -0.583 0 N-CA-C 110.667 -0.973 . . . . 15.0 110.667 178.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.883 HG22 HG22 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -94.25 152.6 3.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.546 0.689 . . . . 15.0 112.149 -179.034 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -136.76 108.14 6.88 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.661 -1.154 . . . . 15.0 109.39 179.517 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.785 HG22 ' N ' ' A' ' 55' ' ' GLY . 0.8 OUTLIER -55.32 152.19 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.123 0.487 . . . . 15.0 111.563 -178.622 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.451 ' O ' ' HG2' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -84.51 -46.33 11.72 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.457 -0.942 . . . . 15.0 108.457 178.088 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.643 ' O ' HG12 ' A' ' 20' ' ' ILE . . . -172.35 173.17 4.23 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 115.75 -0.659 . . . . 15.0 110.448 178.438 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.565 ' HA ' HG12 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -96.96 111.52 27.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 109.519 -0.548 . . . . 15.0 109.519 179.196 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.686 ' HB ' ' O ' ' A' ' 19' ' ' GLY . 0.4 OUTLIER -78.39 117.01 63.7 Favored Pre-proline 0 C--N 1.33 -0.264 0 N-CA-C 113.408 0.892 . . . . 15.0 113.408 -177.306 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.612 ' HA ' ' CG ' ' A' ' 47' ' ' GLU . 27.1 Cg_exo -62.86 59.79 0.15 Allowed 'Trans proline' 0 C--N 1.357 0.989 0 C-N-CA 123.651 2.9 . . . . 15.0 113.001 179.637 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.521 ' N ' ' HG2' ' A' ' 47' ' ' GLU . 3.9 tt0 -147.51 -47.06 0.17 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.582 0.229 . . . . 15.0 111.394 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.623 ' HA3' ' HA3' ' A' ' 19' ' ' GLY . . . -87.82 167.8 36.98 Favored Glycine 0 CA--C 1.518 0.24 0 C-N-CA 120.368 -0.92 . . . . 15.0 113.884 -179.051 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -57.34 -14.45 4.61 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.722 0.638 . . . . 15.0 112.722 -179.616 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.17 -56.59 5.31 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.662 0.267 . . . . 15.0 110.934 -179.592 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.612 ' CG ' ' HA ' ' A' ' 42' ' ' PRO . 3.0 pp20? -57.45 -42.69 82.98 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.965 -0.561 . . . . 15.0 110.287 179.309 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -53.77 -70.76 0.09 Allowed 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 115.845 -0.616 . . . . 15.0 110.535 -179.433 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.579 ' CB ' HD11 ' A' ' 11' ' ' LEU . 0.1 OUTLIER -58.43 -41.3 84.73 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.154 -0.684 . . . . 15.0 109.154 178.829 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.75 41.2 11.14 Favored Glycine 0 N--CA 1.445 -0.702 0 CA-C-N 115.361 -0.836 . . . . 15.0 111.718 179.464 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.615 ' HG3' HD13 ' A' ' 11' ' ' LEU . 0.5 OUTLIER -79.7 -50.3 10.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.883 0.373 . . . . 15.0 110.655 -179.363 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.637 ' CG1' HD12 ' A' ' 20' ' ' ILE . 7.9 tp -81.04 163.3 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 CA-C-N 116.062 -0.517 . . . . 15.0 110.282 179.439 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' HIS . . . . . 0.476 ' O ' ' HB2' ' A' ' 56' ' ' ASP . 64.0 m80 -147.37 160.82 42.1 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-O 121.687 0.756 . . . . 15.0 112.252 -179.087 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.546 ' HA ' ' CG2' ' A' ' 37' ' ' VAL . 6.1 mtpt -43.82 134.11 4.55 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.309 -1.314 . . . . 15.0 112.576 -178.817 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.785 ' N ' HG22 ' A' ' 37' ' ' VAL . . . 49.88 33.12 19.83 Favored Glycine 0 C--N 1.333 0.369 0 CA-C-N 115.914 -0.585 . . . . 15.0 113.589 179.324 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.476 ' HB2' ' O ' ' A' ' 53' ' ' HIS . 0.3 OUTLIER -65.93 130.5 43.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 117.16 0.48 . . . . 15.0 110.598 179.38 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.432 ' HA ' ' O ' ' A' ' 35' ' ' ILE . 35.4 ttt180 -82.74 87.91 6.76 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.794 0.331 . . . . 15.0 110.313 179.485 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.883 HG22 HG22 ' A' ' 35' ' ' ILE . 2.3 m -79.32 112.45 17.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.148 0.499 . . . . 15.0 111.063 -179.388 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 44.5 mt -107.21 -11.85 15.5 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 115.645 -0.707 . . . . 15.0 112.625 -179.047 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.718 ' HB3' ' HB2' ' A' ' 88' ' ' LEU . . . -151.35 146.41 25.98 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 112.693 0.627 . . . . 15.0 112.693 -178.775 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.884 HG11 ' O ' ' A' ' 77' ' ' THR . 40.0 t -139.59 93.53 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.192 -0.913 . . . . 15.0 109.459 178.847 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.491 HD21 HG22 ' A' ' 81' ' ' THR . 7.5 m120 69.92 17.68 7.45 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.086 -0.507 . . . . 15.0 109.98 -178.305 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 107.27 4.72 35.2 Favored Glycine 0 C--N 1.334 0.456 0 CA-C-N 115.841 -0.618 . . . . 15.0 113.482 179.466 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.673 HG13 ' O ' ' A' ' 64' ' ' VAL . 5.1 p -93.72 103.25 14.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.207 0.527 . . . . 15.0 110.645 179.198 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 24.3 m -56.89 133.62 54.74 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.995 -0.548 . . . . 15.0 111.117 -179.384 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.703 HD11 ' HB2' ' A' ' 74' ' ' ALA . 0.1 OUTLIER -88.09 -19.35 27.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.036 -0.529 . . . . 15.0 110.935 179.841 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -47.47 95.86 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 120.91 0.386 . . . . 15.0 110.897 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.73 65.17 0.57 Allowed Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.783 -0.722 . . . . 15.0 112.271 -179.676 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.65 ' HB1' ' CB ' ' A' ' 73' ' ' GLN . . . -172.76 156.89 3.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.94 0.4 . . . . 15.0 110.859 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.478 ' HB ' HG13 ' A' ' 26' ' ' VAL . 11.3 p -93.07 -171.11 2.59 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.104 0.478 . . . . 15.0 111.336 -179.572 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' HIS . . . . . 0.679 ' CD2' ' HA ' ' A' ' 23' ' ' THR . 0.0 OUTLIER -59.61 -60.99 2.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.621 -0.718 . . . . 15.0 110.158 179.737 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 20.0 ttpp -52.79 -35.93 57.52 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.519 -0.764 . . . . 15.0 110.806 179.647 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.65 ' CB ' ' HB1' ' A' ' 69' ' ' ALA . 7.9 mt-30 -59.6 -54.43 46.55 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.298 -0.41 . . . . 15.0 109.935 179.606 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.74 ' HB3' HD12 ' A' ' 35' ' ' ILE . . . -65.17 -43.88 90.32 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.1 -0.5 . . . . 15.0 109.721 178.728 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.616 HG23 HG22 ' A' ' 22' ' ' VAL . 0.5 OUTLIER -43.38 -42.39 1.42 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.223 0 N-CA-C 108.987 -0.745 . . . . 15.0 108.987 178.289 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.401 ' N ' HG12 ' A' ' 75' ' ' VAL . 1.8 mt-10 -67.41 -43.28 81.63 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 114.9 -1.046 . . . . 15.0 110.323 178.522 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.884 ' O ' HG11 ' A' ' 61' ' ' VAL . 70.4 p -63.94 -56.87 12.04 Favored 'General case' 0 N--CA 1.461 0.116 0 CA-C-O 120.615 0.245 . . . . 15.0 111.521 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.666 HD21 HG21 ' A' ' 58' ' ' VAL . 4.0 mt -53.31 -46.86 69.58 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-O 121.118 0.485 . . . . 15.0 110.185 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.5 -58.2 4.67 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.644 -0.707 . . . . 15.0 110.708 179.467 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 68.7 m-20 -65.85 63.03 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.053 -0.521 . . . . 15.0 111.956 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.491 HG22 HD21 ' A' ' 62' ' ' ASN . 0.0 OUTLIER -92.93 -78.31 0.42 Allowed 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 110.073 -0.343 . . . . 15.0 110.073 179.233 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 122.34 -107.89 1.21 Allowed Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.807 -0.711 . . . . 15.0 112.965 179.223 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -65.23 -80.23 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.665 0.269 . . . . 15.0 111.415 -179.318 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.472 HG12 ' N ' ' A' ' 85' ' ' VAL . 75.9 t -110.19 159.47 9.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.054 0.454 . . . . 15.0 111.179 -179.646 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.853 HG23 ' HB2' ' A' ' 13' ' ' LYS . 6.4 t -97.9 80.88 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.015 -0.539 . . . . 15.0 110.225 179.528 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 11.2 t60 -97.07 80.39 2.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.846 -0.615 . . . . 15.0 110.403 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.827 ' HB3' HD21 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -103.78 120.93 41.98 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.884 -0.598 . . . . 15.0 111.818 -179.118 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.748 HD12 ' HB2' ' A' ' 8' ' ' GLU . 4.0 mp -98.87 101.92 13.48 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.49 -0.559 . . . . 15.0 109.49 178.645 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.827 HD21 ' HB3' ' A' ' 87' ' ' LEU . 0.1 OUTLIER -105.64 -162.37 0.87 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.488 0.661 . . . . 15.0 112.061 -178.334 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.411 ' HA ' ' HA ' ' A' ' 6' ' ' ILE . 2.1 tt0 -140.67 139.39 34.79 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 114.73 -1.123 . . . . 15.0 109.736 179.124 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 2.0 tptp -52.08 105.65 0.12 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.91 0.386 . . . . 15.0 111.069 -179.658 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.289 0 C-N-CA 120.814 -0.708 . . . . 15.0 112.544 -179.888 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.452 HG13 ' HB2' ' A' ' 90' ' ' GLU . 1.3 mp . . . . . 0 N--CA 1.45 -0.463 0 CA-C-O 120.711 0.291 . . . . 15.0 110.96 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.544 ' CZ ' HD12 ' A' ' 89' ' ' LEU . 4.0 p90 -141.05 165.22 28.15 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.298 -0.41 . . . . 15.0 110.555 178.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.723 ' CB ' HD12 ' A' ' 88' ' ' LEU . 9.7 pt-20 -130.15 144.27 51.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.243 0.544 . . . . 15.0 111.543 -179.352 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.712 ' CG1' HD11 ' A' ' 89' ' ' LEU . 0.5 OUTLIER -101.34 114.13 39.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.31 -0.859 . . . . 15.0 109.539 178.948 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -106.03 71.12 0.88 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.152 -0.476 . . . . 15.0 111.922 -178.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.619 HD11 ' CB ' ' A' ' 49' ' ' ASP . 7.5 tp -88.28 165.04 15.29 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.08 -0.509 . . . . 15.0 109.914 178.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -95.3 93.29 7.19 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.983 0.421 . . . . 15.0 111.041 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.642 ' CB ' HG23 ' A' ' 85' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 115.913 -0.585 . . . . 15.0 111.033 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.2 mp . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.884 0.373 . . . . 15.0 110.749 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.777 ' O ' ' HB ' ' A' ' 41' ' ' ILE . . . -161.05 45.08 0.4 Allowed Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 121.152 -0.547 . . . . 15.0 111.935 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.703 HG12 ' O ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -112.77 139.69 36.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 120.974 0.416 . . . . 15.0 111.77 -179.549 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 45.0 t -94.98 104.05 15.91 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.084 -1.08 . . . . 15.0 108.084 177.65 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.949 HG21 HG23 ' A' ' 75' ' ' VAL . 10.6 m -93.73 153.9 3.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 113.124 0.787 . . . . 15.0 113.124 -177.037 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.33 -179.66 7.23 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 114.981 -1.009 . . . . 15.0 110.391 179.632 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.448 ' O ' ' CB ' ' A' ' 71' ' ' HIS . . . 76.71 -121.77 6.1 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.562 -0.828 . . . . 15.0 112.563 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.556 ' HA3' ' N ' ' A' ' 71' ' ' HIS . . . 68.2 -66.27 0.37 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.831 -0.699 . . . . 15.0 113.388 179.437 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.529 ' O ' HG22 ' A' ' 30' ' ' VAL . 1.6 m -28.34 138.76 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 N-CA-C 112.39 0.515 . . . . 15.0 112.39 -179.208 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.453 ' ND2' ' O ' ' A' ' 32' ' ' HIS . 8.3 m120 -76.25 60.08 1.46 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.951 -0.568 . . . . 15.0 111.041 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -151.78 -55.71 0.14 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.331 -0.395 . . . . 15.0 110.956 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.4 m -78.15 -46.23 21.16 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.17 -0.468 . . . . 15.0 111.019 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.529 HG22 ' O ' ' A' ' 26' ' ' VAL . 21.9 m -71.36 -173.72 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.244 -0.435 . . . . 15.0 111.192 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 6.1 mtp85 -57.34 -54.59 45.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.281 -0.418 . . . . 15.0 111.078 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' HIS . . . . . 0.453 ' O ' ' ND2' ' A' ' 27' ' ' ASN . 48.6 p-80 -151.8 -44.69 0.11 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.363 -0.38 . . . . 15.0 111.174 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -169.59 23.6 0.1 OUTLIER Glycine 0 CA--C 1.518 0.223 0 C-N-CA 120.816 -0.707 . . . . 15.0 112.615 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.502 ' O ' HG11 ' A' ' 30' ' ' VAL . . . -93.88 153.93 21.39 Favored Glycine 0 N--CA 1.449 -0.499 0 N-CA-C 110.429 -1.068 . . . . 15.0 110.429 178.747 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.911 HG22 HG22 ' A' ' 58' ' ' VAL . 0.1 OUTLIER -96.67 153.36 3.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 C-N-CA 119.601 -0.84 . . . . 15.0 112.371 -179.078 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.454 ' CE2' ' HG2' ' A' ' 57' ' ' ARG . 32.5 m-85 -135.67 106.96 6.79 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.63 -1.168 . . . . 15.0 109.27 179.289 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.785 HG22 ' N ' ' A' ' 55' ' ' GLY . 0.7 OUTLIER -55.03 149.36 2.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.147 0.499 . . . . 15.0 111.357 -178.554 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.485 ' O ' ' HG2' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -80.16 -50.46 10.25 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.628 -0.879 . . . . 15.0 108.628 178.739 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.703 ' O ' HG12 ' A' ' 20' ' ' ILE . . . -172.3 173.27 4.24 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 115.72 -0.673 . . . . 15.0 110.081 178.702 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.543 ' HA ' HG12 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -96.76 112.8 29.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 108.983 -0.747 . . . . 15.0 108.983 178.778 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.777 ' HB ' ' O ' ' A' ' 19' ' ' GLY . 0.4 OUTLIER -77.96 118.07 69.84 Favored Pre-proline 0 C--N 1.328 -0.338 0 N-CA-C 113.231 0.826 . . . . 15.0 113.231 -176.978 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.61 ' HA ' ' HG2' ' A' ' 47' ' ' GLU . 37.3 Cg_endo -64.88 61.67 0.29 Allowed 'Trans proline' 0 C--N 1.357 0.974 0 C-N-CA 123.457 2.771 . . . . 15.0 112.745 179.704 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.5 ' N ' ' HG2' ' A' ' 47' ' ' GLU . 4.3 mm-40 -151.51 -46.35 0.11 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.536 -0.302 . . . . 15.0 111.489 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.715 ' HA3' ' HA3' ' A' ' 19' ' ' GLY . . . -87.68 166.87 36.29 Favored Glycine 0 C--N 1.33 0.222 0 C-N-CA 120.312 -0.947 . . . . 15.0 113.618 -179.259 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -56.95 -13.91 3.09 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.616 0.599 . . . . 15.0 112.616 -179.613 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.04 -57.19 4.48 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.734 0.302 . . . . 15.0 110.782 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.61 ' HG2' ' HA ' ' A' ' 42' ' ' PRO . 2.8 pp20? -57.21 -42.93 82.25 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.19 -0.459 . . . . 15.0 110.397 179.383 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 22.9 t -53.95 -71.47 0.07 Allowed 'General case' 0 CA--C 1.52 -0.176 0 CA-C-N 115.976 -0.556 . . . . 15.0 110.626 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.619 ' CB ' HD11 ' A' ' 11' ' ' LEU . 0.4 OUTLIER -58.63 -40.78 84.33 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.391 -0.596 . . . . 15.0 109.391 178.901 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.93 45.02 7.89 Favored Glycine 0 N--CA 1.446 -0.65 0 CA-C-N 115.393 -0.822 . . . . 15.0 111.67 179.596 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.613 ' HB2' HD13 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -79.43 -54.36 6.0 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.892 0.377 . . . . 15.0 110.477 -179.325 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.623 ' CG1' HD12 ' A' ' 20' ' ' ILE . 8.3 tp -81.08 164.29 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 CA-C-N 115.991 -0.55 . . . . 15.0 110.362 179.55 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' HIS . . . . . 0.441 ' N ' ' OD2' ' A' ' 56' ' ' ASP . 74.5 m80 -146.34 157.13 43.76 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-O 121.659 0.742 . . . . 15.0 112.135 -179.063 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.563 ' HA ' ' CG2' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -44.13 133.52 5.19 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.229 -1.351 . . . . 15.0 112.975 -178.605 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.785 ' N ' HG22 ' A' ' 37' ' ' VAL . . . 49.99 31.28 17.61 Favored Glycine 0 C--N 1.336 0.538 0 CA-C-N 115.809 -0.632 . . . . 15.0 113.268 179.206 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.477 ' OD2' HD12 ' A' ' 52' ' ' ILE . 5.3 m-20 -65.72 129.31 39.32 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.887 -0.325 . . . . 15.0 110.733 179.691 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.454 ' HG2' ' CE2' ' A' ' 36' ' ' TYR . 50.6 mtt180 -80.74 88.32 5.79 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.233 -0.439 . . . . 15.0 110.313 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.911 HG22 HG22 ' A' ' 35' ' ' ILE . 1.4 m -79.45 112.05 17.01 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 CA-C-O 121.158 0.504 . . . . 15.0 111.058 -179.62 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 33.3 mt -107.49 -15.27 14.65 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 115.441 -0.8 . . . . 15.0 112.47 -179.137 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.781 ' HB3' ' HB2' ' A' ' 88' ' ' LEU . . . -149.49 148.28 29.22 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 112.765 0.654 . . . . 15.0 112.765 -178.673 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.744 HG11 ' O ' ' A' ' 77' ' ' THR . 15.4 t -139.11 99.87 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.263 -0.88 . . . . 15.0 109.083 178.733 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.552 ' OD1' HG22 ' A' ' 81' ' ' THR . 7.0 m120 65.19 16.42 10.54 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.28 -0.418 . . . . 15.0 109.881 -177.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 107.23 4.79 35.29 Favored Glycine 0 C--N 1.336 0.56 0 CA-C-N 115.924 -0.58 . . . . 15.0 113.531 179.658 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.644 HG13 ' O ' ' A' ' 64' ' ' VAL . 5.3 p -93.78 107.46 19.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 117.175 0.488 . . . . 15.0 110.882 179.511 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -56.57 135.6 54.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.211 -0.449 . . . . 15.0 111.163 -179.603 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.65 HD11 ' HB2' ' A' ' 74' ' ' ALA . 0.1 OUTLIER -97.16 -21.35 17.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.988 -0.551 . . . . 15.0 110.915 179.9 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -46.7 98.71 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.399 -0.364 . . . . 15.0 110.93 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.83 63.08 0.54 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.804 -0.713 . . . . 15.0 112.139 -179.545 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.704 ' HB1' ' CB ' ' A' ' 73' ' ' GLN . . . -173.0 143.18 1.14 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.841 0.353 . . . . 15.0 110.865 -179.812 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.465 ' HA ' ' N ' ' A' ' 26' ' ' VAL . 12.2 p -72.99 -173.16 1.18 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.255 -0.43 . . . . 15.0 111.208 -179.717 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' HIS . . . . . 0.614 ' CE1' HG23 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -61.93 -59.69 4.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.89 -0.596 . . . . 15.0 110.514 -179.987 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 20.4 ttmt -52.64 -33.69 48.03 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.849 -0.614 . . . . 15.0 110.632 179.405 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.704 ' CB ' ' HB1' ' A' ' 69' ' ' ALA . 4.7 mt-30 -59.5 -52.66 64.64 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.784 -0.45 . . . . 15.0 109.784 179.447 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.864 ' HB3' HD12 ' A' ' 35' ' ' ILE . . . -66.86 -44.24 81.48 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.704 -0.48 . . . . 15.0 109.704 178.516 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.949 HG23 HG21 ' A' ' 22' ' ' VAL . 0.5 OUTLIER -43.01 -40.79 1.08 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.262 0 N-CA-C 109.012 -0.736 . . . . 15.0 109.012 178.412 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.406 ' O ' ' CB ' ' A' ' 80' ' ' ASN . 46.3 mt-10 -67.39 -44.65 78.35 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 114.789 -1.096 . . . . 15.0 110.369 178.533 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.744 ' O ' HG11 ' A' ' 61' ' ' VAL . 40.9 p -64.14 -54.52 32.5 Favored 'General case' 0 N--CA 1.462 0.151 0 C-N-CA 120.99 -0.284 . . . . 15.0 111.414 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.601 HD21 HG21 ' A' ' 58' ' ' VAL . 5.7 mt -53.56 -47.93 69.61 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-O 121.211 0.529 . . . . 15.0 110.012 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.41 ' HB2' ' O ' ' A' ' 75' ' ' VAL . 1.9 ttt-85 -68.35 -59.47 3.16 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.429 -0.805 . . . . 15.0 110.397 179.375 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.406 ' CB ' ' O ' ' A' ' 76' ' ' GLU . 14.2 m-20 -65.99 62.03 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.933 -0.576 . . . . 15.0 111.94 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.552 HG22 ' OD1' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -93.23 -71.36 0.66 Allowed 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 110.043 -0.355 . . . . 15.0 110.043 179.234 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 122.0 -108.02 1.25 Allowed Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.939 -0.648 . . . . 15.0 112.993 179.207 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.414 ' O ' ' HB3' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -65.17 -79.69 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.917 0.389 . . . . 15.0 111.623 -179.359 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.444 HG12 ' N ' ' A' ' 85' ' ' VAL . 77.6 t -110.21 158.25 10.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.952 -0.567 . . . . 15.0 111.087 -179.319 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.672 ' O ' HG12 ' A' ' 85' ' ' VAL . 6.8 t -97.93 82.35 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.056 -0.52 . . . . 15.0 110.46 179.753 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -101.91 85.02 2.62 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.793 -0.639 . . . . 15.0 110.379 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.849 ' HB3' HD21 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -103.86 122.94 46.19 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.925 -0.58 . . . . 15.0 111.808 -179.136 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.781 ' HB2' ' HB3' ' A' ' 60' ' ' ALA . 4.4 mp -97.69 101.37 12.86 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.586 -0.524 . . . . 15.0 109.586 178.802 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.849 HD21 ' HB3' ' A' ' 87' ' ' LEU . 0.1 OUTLIER -105.93 -161.8 0.82 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.456 0.646 . . . . 15.0 111.961 -178.46 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.452 ' HB2' HG13 ' A' ' 6' ' ' ILE . 4.6 tt0 -143.27 133.56 24.59 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 114.948 -1.024 . . . . 15.0 109.77 179.174 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -46.95 106.14 0.08 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.994 0.426 . . . . 15.0 111.174 -179.669 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.318 0 C-N-CA 120.868 -0.682 . . . . 15.0 112.759 -179.663 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.461 HG13 ' HB2' ' A' ' 90' ' ' GLU . 1.2 mp . . . . . 0 N--CA 1.447 -0.593 0 CA-C-O 120.821 0.343 . . . . 15.0 111.034 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.605 ' CE1' HD12 ' A' ' 89' ' ' LEU . 3.4 p90 -140.19 163.87 31.59 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.224 -0.444 . . . . 15.0 110.261 178.838 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.732 ' HB3' HD12 ' A' ' 88' ' ' LEU . 4.9 pt-20 -130.17 143.24 50.67 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.295 0.569 . . . . 15.0 111.848 -178.88 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.511 HG23 ' HB3' ' A' ' 51' ' ' ARG . 0.2 OUTLIER -101.61 115.34 43.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.23 -0.895 . . . . 15.0 109.696 178.74 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -105.84 72.54 0.96 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.243 -0.435 . . . . 15.0 112.121 -178.839 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.536 HD11 ' CB ' ' A' ' 49' ' ' ASP . 6.3 tp -88.12 165.6 15.0 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.561 -0.533 . . . . 15.0 109.561 178.719 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -96.13 92.7 6.54 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.993 0.425 . . . . 15.0 111.331 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.711 ' CB ' HG23 ' A' ' 85' ' ' VAL . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.354 0 CA-C-N 115.892 -0.595 . . . . 15.0 111.061 179.824 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.666 ' N ' HD22 ' A' ' 18' ' ' LEU . 1.4 mm? . . . . . 0 N--CA 1.453 -0.317 0 CA-C-O 120.914 0.388 . . . . 15.0 110.726 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.654 ' O ' ' HB ' ' A' ' 41' ' ' ILE . . . -162.84 33.75 0.31 Allowed Glycine 0 N--CA 1.449 -0.465 0 CA-C-N 115.91 -0.586 . . . . 15.0 111.717 -179.678 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.635 HD12 ' CG1' ' A' ' 52' ' ' ILE . 0.0 OUTLIER -112.72 139.96 35.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 121.131 0.491 . . . . 15.0 112.033 -179.261 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.463 ' O ' ' HB3' ' A' ' 38' ' ' LYS . 43.2 t -96.33 100.96 12.53 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 107.396 -1.335 . . . . 15.0 107.396 176.912 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.629 HG12 ' CG2' ' A' ' 20' ' ' ILE . 1.1 m -93.62 153.82 3.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 112.769 0.655 . . . . 15.0 112.769 -176.777 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.681 ' HA ' ' CD2' ' A' ' 71' ' ' HIS . 11.1 t -149.6 -173.48 4.42 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.223 -0.899 . . . . 15.0 110.369 179.317 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.683 ' O ' HG22 ' A' ' 26' ' ' VAL . . . 75.88 -113.94 4.05 Favored Glycine 0 C--N 1.33 0.23 0 C-N-CA 120.517 -0.849 . . . . 15.0 112.347 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.582 ' HA3' ' N ' ' A' ' 71' ' ' HIS . . . 63.59 -65.84 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 121.06 -0.591 . . . . 15.0 113.724 179.175 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.683 HG22 ' O ' ' A' ' 24' ' ' GLY . 0.0 OUTLIER -26.07 139.55 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 N-CA-C 112.51 0.559 . . . . 15.0 112.51 -179.015 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 17.5 m-20 -75.64 61.21 1.33 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.806 -0.634 . . . . 15.0 111.046 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -151.75 -66.49 0.18 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.317 -0.402 . . . . 15.0 111.095 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.8 m -67.79 -34.26 76.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.129 -0.487 . . . . 15.0 111.061 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.559 HG22 ' O ' ' A' ' 26' ' ' VAL . 21.0 m -85.67 -174.33 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.302 -0.408 . . . . 15.0 111.171 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 8.9 mtp180 -57.78 -61.26 2.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.251 -0.431 . . . . 15.0 111.033 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 9.2 p80 -143.25 -45.95 0.29 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.253 -0.43 . . . . 15.0 111.018 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -169.18 25.7 0.11 Allowed Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.901 -0.666 . . . . 15.0 112.491 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.459 ' O ' HG11 ' A' ' 30' ' ' VAL . . . -90.9 151.31 21.1 Favored Glycine 0 N--CA 1.447 -0.588 0 N-CA-C 110.519 -1.032 . . . . 15.0 110.519 178.809 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.919 HG22 HG22 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -94.74 152.87 3.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 C-N-CA 119.9 -0.72 . . . . 15.0 112.238 -179.112 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.466 ' CZ ' ' HG2' ' A' ' 57' ' ' ARG . 18.9 m-85 -135.29 107.4 7.17 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.652 -1.158 . . . . 15.0 109.364 179.396 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.788 HG22 ' N ' ' A' ' 55' ' ' GLY . 0.8 OUTLIER -55.14 149.42 2.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 116.102 -0.499 . . . . 15.0 111.462 -178.581 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.482 ' HB2' HG22 ' A' ' 23' ' ' THR . 0.0 OUTLIER -81.19 -48.03 12.64 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.668 -0.864 . . . . 15.0 108.668 178.266 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.582 ' O ' HG12 ' A' ' 20' ' ' ILE . . . -172.29 170.77 4.99 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 115.757 -0.656 . . . . 15.0 110.234 178.5 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.562 ' HA ' HG12 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -97.18 111.81 27.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.055 0.455 . . . . 15.0 110.344 179.575 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.654 ' HB ' ' O ' ' A' ' 19' ' ' GLY . 0.4 OUTLIER -78.56 109.14 9.58 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 115.74 -0.663 . . . . 15.0 112.238 -178.428 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.451 ' N ' ' HG2' ' A' ' 47' ' ' GLU . 30.2 Cg_endo -63.12 65.54 0.16 Allowed 'Trans proline' 0 C--N 1.356 0.944 0 C-N-CA 123.192 2.595 . . . . 15.0 112.591 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.449 ' N ' ' O ' ' A' ' 41' ' ' ILE . 42.2 tt0 -147.44 -53.37 0.21 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.392 -0.822 . . . . 15.0 109.317 179.418 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.552 ' HA3' ' HA3' ' A' ' 19' ' ' GLY . . . -88.02 157.32 28.21 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.684 -0.769 . . . . 15.0 112.528 179.147 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -41.73 -16.73 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 113.51 0.93 . . . . 15.0 113.51 -179.64 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.442 ' N ' ' O ' ' A' ' 44' ' ' GLY . . . -71.5 -71.38 0.27 Allowed 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.768 -0.373 . . . . 15.0 111.159 -179.464 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.501 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 4.3 tp10 -58.59 -40.51 83.39 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-O 120.958 0.409 . . . . 15.0 110.312 179.364 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.7 t -55.51 -63.98 0.99 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.976 -0.556 . . . . 15.0 110.278 179.379 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.536 ' CB ' HD11 ' A' ' 11' ' ' LEU . 5.6 t0 -62.69 -39.08 92.88 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.146 0.498 . . . . 15.0 109.89 179.053 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.55 36.81 18.95 Favored Glycine 0 N--CA 1.448 -0.512 0 CA-C-N 115.58 -0.736 . . . . 15.0 112.651 179.53 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.513 ' HG3' HD13 ' A' ' 11' ' ' LEU . 1.7 mmt85 -83.69 -53.44 5.64 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.928 0.394 . . . . 15.0 110.607 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.635 ' CG1' HD12 ' A' ' 20' ' ' ILE . 11.0 tp -81.15 157.85 4.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.977 -0.556 . . . . 15.0 110.183 179.581 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 78.5 m-70 -139.75 160.37 40.03 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-O 121.832 0.825 . . . . 15.0 113.097 -178.554 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.6 ' HA ' ' CG2' ' A' ' 37' ' ' VAL . 1.0 OUTLIER -45.28 135.13 6.08 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 113.821 -1.536 . . . . 15.0 112.742 -178.865 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.788 ' N ' HG22 ' A' ' 37' ' ' VAL . . . 49.69 32.75 17.67 Favored Glycine 0 C--N 1.335 0.499 0 CA-C-N 116.031 -0.531 . . . . 15.0 113.116 179.146 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.461 ' OD2' HD12 ' A' ' 52' ' ' ILE . 3.5 m-20 -65.72 130.65 44.02 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.95 -0.3 . . . . 15.0 110.821 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.763 ' CD ' HD21 ' A' ' 59' ' ' LEU . 0.0 OUTLIER -84.4 86.37 7.28 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.11 -0.495 . . . . 15.0 110.345 179.579 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.919 HG22 HG22 ' A' ' 35' ' ' ILE . 1.5 m -79.39 113.44 18.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 CA-C-N 116.162 -0.472 . . . . 15.0 111.17 -179.466 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.763 HD21 ' CD ' ' A' ' 57' ' ' ARG . 19.2 mt -107.26 -13.06 15.22 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.819 -0.628 . . . . 15.0 112.41 -179.332 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.572 ' O ' HD23 ' A' ' 87' ' ' LEU . . . -150.62 147.35 27.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.192 0.52 . . . . 15.0 112.313 -178.825 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.841 HG21 HD23 ' A' ' 78' ' ' LEU . 60.6 t -138.72 102.88 1.97 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.275 0 CA-C-N 115.484 -0.78 . . . . 15.0 109.047 178.811 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.596 ' OD1' HG22 ' A' ' 81' ' ' THR . 2.7 m120 64.94 16.32 10.46 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.71 -0.478 . . . . 15.0 109.71 -178.089 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 105.32 5.17 40.4 Favored Glycine 0 C--N 1.337 0.617 0 CA-C-N 115.82 -0.627 . . . . 15.0 113.23 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.653 HG13 ' O ' ' A' ' 64' ' ' VAL . 6.7 p -93.85 107.53 19.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.006 0.432 . . . . 15.0 111.046 179.6 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.2 m -55.8 133.08 50.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.269 -0.423 . . . . 15.0 111.083 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.593 HD11 ' HB2' ' A' ' 74' ' ' ALA . 0.1 OUTLIER -91.59 -21.68 20.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.001 -0.545 . . . . 15.0 111.026 179.992 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -43.85 97.41 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 120.905 0.383 . . . . 15.0 110.978 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.85 64.26 0.56 Allowed Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.866 -0.683 . . . . 15.0 112.058 -179.534 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.785 ' HB1' ' HB3' ' A' ' 73' ' ' GLN . . . -172.98 135.68 0.62 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.895 0.379 . . . . 15.0 110.982 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.431 ' HA ' ' N ' ' A' ' 26' ' ' VAL . 10.2 p -72.9 -171.45 0.87 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.112 0.482 . . . . 15.0 111.31 -179.66 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' HIS . . . . . 0.681 ' CD2' ' HA ' ' A' ' 23' ' ' THR . 0.0 OUTLIER -58.33 -63.08 1.4 Allowed 'General case' 0 CA--C 1.517 -0.315 0 CA-C-N 115.721 -0.672 . . . . 15.0 109.814 179.812 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 13.5 ttpp -53.23 -36.12 60.71 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.316 -0.856 . . . . 15.0 110.574 179.189 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.785 ' HB3' ' HB1' ' A' ' 69' ' ' ALA . 5.8 mt-30 -59.32 -50.75 72.79 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 116.149 -0.478 . . . . 15.0 109.715 179.475 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.801 ' HB3' HD12 ' A' ' 35' ' ' ILE . . . -66.96 -47.39 71.75 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.059 -0.519 . . . . 15.0 109.665 178.495 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.615 HG23 ' CG2' ' A' ' 22' ' ' VAL . 0.5 OUTLIER -40.84 -41.19 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.23 0 CA-C-N 115.522 -0.763 . . . . 15.0 109.472 178.643 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -67.18 -46.05 75.1 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 114.884 -1.053 . . . . 15.0 110.781 179.092 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.656 ' O ' HG11 ' A' ' 61' ' ' VAL . 2.5 p -64.6 -53.28 50.17 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 120.79 -0.364 . . . . 15.0 111.529 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.841 HD23 HG21 ' A' ' 61' ' ' VAL . 3.8 mt -53.4 -48.41 68.71 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-O 121.185 0.517 . . . . 15.0 110.07 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.4 ' O ' ' N ' ' A' ' 81' ' ' THR . 4.1 ttt85 -68.46 -57.4 5.89 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.575 -0.739 . . . . 15.0 110.492 179.282 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 63.3 m-20 -66.0 62.77 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.879 -0.6 . . . . 15.0 111.948 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.596 HG22 ' OD1' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -95.37 -71.71 0.66 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.769 0.318 . . . . 15.0 110.22 179.221 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 122.04 -104.05 0.89 Allowed Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.744 -0.741 . . . . 15.0 113.185 179.244 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.418 ' O ' ' HB3' ' A' ' 13' ' ' LYS . 0.4 OUTLIER -64.59 -84.49 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 111.975 0.361 . . . . 15.0 111.975 -179.072 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.461 HG12 ' N ' ' A' ' 85' ' ' VAL . 74.1 t -109.65 160.17 8.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.873 0.368 . . . . 15.0 110.897 -179.528 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.711 HG23 ' CB ' ' A' ' 13' ' ' LYS . 12.9 t -97.83 81.23 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.118 0.485 . . . . 15.0 110.56 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -101.15 84.69 2.69 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.778 -0.646 . . . . 15.0 110.429 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.742 ' HB3' HD21 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -103.19 121.06 41.89 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.06 -0.518 . . . . 15.0 111.743 -179.226 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.732 HD12 ' HB3' ' A' ' 8' ' ' GLU . 0.2 OUTLIER -97.52 101.53 13.08 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.374 -0.602 . . . . 15.0 109.374 178.636 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.742 HD21 ' HB3' ' A' ' 87' ' ' LEU . 0.1 OUTLIER -105.89 -161.89 0.83 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.598 0.713 . . . . 15.0 112.347 -178.451 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.461 ' HB2' HG13 ' A' ' 6' ' ' ILE . 3.4 tt0 -142.17 132.66 25.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 114.609 -1.178 . . . . 15.0 109.059 178.842 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.54 100.13 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.003 0.43 . . . . 15.0 111.19 -179.393 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.404 0 CA-C-N 115.766 -0.652 . . . . 15.0 112.703 -179.737 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.419 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 1.4 mp . . . . . 0 N--CA 1.449 -0.49 0 CA-C-O 120.705 0.288 . . . . 15.0 110.883 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.589 ' CE1' HD12 ' A' ' 89' ' ' LEU . 4.2 p90 -140.61 165.74 26.64 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.378 -0.374 . . . . 15.0 110.446 178.946 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.718 ' CB ' HD12 ' A' ' 88' ' ' LEU . 10.7 pt-20 -130.11 143.09 50.59 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.295 0.569 . . . . 15.0 111.55 -179.32 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.578 ' CG1' HD11 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -101.54 115.44 43.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.203 -0.908 . . . . 15.0 109.548 178.84 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -106.0 72.28 0.94 Allowed 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.193 0.442 . . . . 15.0 112.193 -178.708 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.598 HD13 ' HG3' ' A' ' 51' ' ' ARG . 5.8 tp -88.33 166.55 14.21 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 109.685 -0.487 . . . . 15.0 109.685 178.636 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -95.73 95.31 8.23 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.006 0.431 . . . . 15.0 111.167 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.689 ' CB ' HG23 ' A' ' 85' ' ' VAL . 0.2 OUTLIER . . . . . 0 C--N 1.327 -0.401 0 CA-C-N 115.803 -0.635 . . . . 15.0 111.225 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.662 ' N ' HD22 ' A' ' 18' ' ' LEU . 1.0 OUTLIER . . . . . 0 N--CA 1.453 -0.309 0 CA-C-O 120.931 0.396 . . . . 15.0 110.775 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.748 ' O ' ' HB ' ' A' ' 41' ' ' ILE . . . -162.38 44.1 0.36 Allowed Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.966 -0.635 . . . . 15.0 111.932 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.641 HG12 ' O ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -112.67 140.27 33.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 120.979 0.419 . . . . 15.0 111.622 -179.571 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.5 t -94.59 102.41 14.33 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 107.613 -1.255 . . . . 15.0 107.613 177.415 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.877 HG21 HG23 ' A' ' 75' ' ' VAL . 3.8 m -93.63 148.95 4.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 113.212 0.819 . . . . 15.0 113.212 -176.629 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.559 ' O ' ' O ' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -149.62 158.02 43.78 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 115.335 -0.848 . . . . 15.0 111.026 179.996 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.414 ' O ' HG12 ' A' ' 35' ' ' ILE . . . 67.7 116.5 0.02 OUTLIER Glycine 0 N--CA 1.453 -0.182 0 C-N-CA 120.589 -0.815 . . . . 15.0 113.421 178.664 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.514 ' HA3' ' N ' ' A' ' 71' ' ' HIS . . . -164.65 -39.05 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.964 -0.636 . . . . 15.0 112.501 179.225 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.504 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 0.2 OUTLIER -39.86 160.09 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-O 120.803 0.335 . . . . 15.0 111.736 179.791 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -85.45 52.18 2.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.314 -0.403 . . . . 15.0 111.024 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -151.8 -63.03 0.17 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.156 -0.475 . . . . 15.0 110.767 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.83 -51.8 51.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.216 -0.447 . . . . 15.0 110.689 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.461 HG22 ' O ' ' A' ' 26' ' ' VAL . 17.7 m -88.06 -177.8 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.107 -0.497 . . . . 15.0 110.76 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.41 ' O ' ' N ' ' A' ' 33' ' ' GLY . 0.2 OUTLIER -85.48 134.28 34.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.974 0.416 . . . . 15.0 111.062 -179.926 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 54.26 -85.42 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.657 -0.701 . . . . 15.0 111.578 179.635 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 31' ' ' ARG . . . -172.46 31.78 0.12 Allowed Glycine 0 C--N 1.331 0.272 0 C-N-CA 120.977 -0.63 . . . . 15.0 112.196 -179.498 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -95.25 158.67 22.37 Favored Glycine 0 N--CA 1.449 -0.446 0 N-CA-C 110.807 -0.917 . . . . 15.0 110.807 179.151 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 1.043 HG22 HG22 ' A' ' 58' ' ' VAL . 0.1 OUTLIER -98.31 154.99 3.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 C-N-CA 119.996 -0.682 . . . . 15.0 111.993 -179.355 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.559 ' O ' ' O ' ' A' ' 23' ' ' THR . 14.1 m-85 -135.16 108.94 8.04 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.365 -0.834 . . . . 15.0 109.767 179.498 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.762 HG22 ' N ' ' A' ' 55' ' ' GLY . 0.8 OUTLIER -54.8 149.54 2.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 121.262 0.553 . . . . 15.0 111.626 -178.45 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.508 ' O ' ' HG2' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -80.17 -47.46 14.67 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.32 -0.992 . . . . 15.0 108.32 178.516 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.641 ' O ' HG12 ' A' ' 20' ' ' ILE . . . -172.51 174.16 3.86 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.349 -0.841 . . . . 15.0 110.114 178.614 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.556 ' HA ' HG12 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -96.81 110.09 24.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 108.938 -0.764 . . . . 15.0 108.938 178.741 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.748 ' HB ' ' O ' ' A' ' 19' ' ' GLY . 0.7 OUTLIER -78.12 116.43 58.75 Favored Pre-proline 0 C--N 1.328 -0.365 0 N-CA-C 113.488 0.922 . . . . 15.0 113.488 -176.916 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.609 ' HA ' ' CG ' ' A' ' 47' ' ' GLU . 39.1 Cg_exo -61.33 61.39 0.1 Allowed 'Trans proline' 0 C--N 1.358 1.074 0 C-N-CA 123.752 2.968 . . . . 15.0 112.969 179.725 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.519 ' H ' ' HG2' ' A' ' 47' ' ' GLU . 2.9 mm-40 -149.83 -48.63 0.13 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.619 0.247 . . . . 15.0 111.554 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.74 ' HA3' ' HA3' ' A' ' 19' ' ' GLY . . . -87.79 168.69 37.95 Favored Glycine 0 CA--C 1.517 0.195 0 C-N-CA 120.362 -0.923 . . . . 15.0 113.905 -179.116 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -57.72 -12.35 2.89 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.549 0.574 . . . . 15.0 112.549 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.425 ' HB1' HG22 ' A' ' 52' ' ' ILE . . . -71.78 -58.5 3.41 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.854 0.359 . . . . 15.0 110.435 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.609 ' CG ' ' HA ' ' A' ' 42' ' ' PRO . 2.9 pp20? -57.67 -43.43 85.02 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.686 -0.688 . . . . 15.0 110.473 179.159 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -53.78 -71.31 0.08 Allowed 'General case' 0 CA--C 1.519 -0.225 0 CA-C-N 115.87 -0.604 . . . . 15.0 110.581 -179.398 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.548 ' CB ' HD11 ' A' ' 11' ' ' LEU . 0.7 OUTLIER -58.13 -41.24 83.22 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.141 -0.688 . . . . 15.0 109.141 178.778 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.79 39.57 13.61 Favored Glycine 0 N--CA 1.445 -0.702 0 CA-C-N 115.319 -0.855 . . . . 15.0 111.665 179.379 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.598 ' HG3' HD13 ' A' ' 11' ' ' LEU . 0.8 OUTLIER -79.72 -49.44 12.07 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.873 0.368 . . . . 15.0 110.573 -179.3 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.593 ' CG1' HD12 ' A' ' 20' ' ' ILE . 9.3 tp -81.01 160.6 3.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 116.037 -0.528 . . . . 15.0 110.181 179.411 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' HIS . . . . . 0.471 ' O ' ' HB2' ' A' ' 56' ' ' ASP . 63.5 m80 -144.31 158.68 43.61 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-O 121.644 0.735 . . . . 15.0 112.146 -179.13 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.553 ' HA ' ' CG2' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -43.81 134.01 4.57 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.437 -1.256 . . . . 15.0 112.607 -178.734 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.762 ' N ' HG22 ' A' ' 37' ' ' VAL . . . 49.98 34.34 23.1 Favored Glycine 0 C--N 1.333 0.394 0 CA-C-N 115.827 -0.624 . . . . 15.0 113.44 179.397 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.471 ' HB2' ' O ' ' A' ' 53' ' ' HIS . 0.4 OUTLIER -65.99 130.37 43.01 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.584 -0.446 . . . . 15.0 110.561 179.481 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.423 ' HE ' HD21 ' A' ' 59' ' ' LEU . 39.0 ttt180 -84.58 87.65 7.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.175 -0.466 . . . . 15.0 110.12 179.502 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 1.043 HG22 HG22 ' A' ' 35' ' ' ILE . 1.5 m -79.26 113.01 18.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 CA-C-O 121.187 0.518 . . . . 15.0 111.032 -179.413 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.423 HD21 ' HE ' ' A' ' 57' ' ' ARG . 23.7 mt -107.34 -11.77 15.48 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 115.424 -0.807 . . . . 15.0 112.304 -179.179 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.847 ' HB3' ' HB2' ' A' ' 88' ' ' LEU . . . -150.81 144.48 25.1 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.165 0.507 . . . . 15.0 112.323 -178.855 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.796 HG21 ' OG1' ' A' ' 77' ' ' THR . 14.8 t -139.24 102.21 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.487 -0.779 . . . . 15.0 109.569 178.848 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.716 ' OD1' HG22 ' A' ' 81' ' ' THR . 2.7 m120 64.71 15.39 9.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.017 0.437 . . . . 15.0 109.83 -178.377 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 107.15 6.03 34.43 Favored Glycine 0 C--N 1.336 0.554 0 CA-C-N 115.903 -0.589 . . . . 15.0 113.409 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.659 HG13 ' O ' ' A' ' 64' ' ' VAL . 6.4 p -93.77 105.41 16.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 117.213 0.506 . . . . 15.0 110.907 179.413 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -58.76 127.91 34.57 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.099 -0.501 . . . . 15.0 110.986 -179.692 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -87.66 -20.01 26.89 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.029 -0.532 . . . . 15.0 110.864 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -47.77 97.91 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.896 0.379 . . . . 15.0 110.768 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.8 64.48 0.56 Allowed Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.738 -0.744 . . . . 15.0 112.022 -179.508 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.713 ' HB1' ' CG ' ' A' ' 73' ' ' GLN . . . -172.68 166.76 5.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.882 0.373 . . . . 15.0 110.949 -179.655 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.504 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 11.5 p -93.38 -174.42 3.51 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.064 0.459 . . . . 15.0 111.506 -179.461 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' HIS . . . . . 0.569 ' CE1' HG23 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -62.95 -60.36 3.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.745 -0.661 . . . . 15.0 110.51 -179.862 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.428 ' O ' ' HG3' ' A' ' 76' ' ' GLU . 8.3 ttpp -52.37 -29.5 24.25 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.88 -0.6 . . . . 15.0 110.343 179.511 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.713 ' CG ' ' HB1' ' A' ' 69' ' ' ALA . 0.4 OUTLIER -59.31 -50.24 74.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.138 -0.483 . . . . 15.0 109.842 179.371 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.47 ' O ' ' N ' ' A' ' 77' ' ' THR . . . -67.09 -47.46 71.16 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 109.597 -0.52 . . . . 15.0 109.597 178.572 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.877 HG23 HG21 ' A' ' 22' ' ' VAL . 0.5 OUTLIER -41.44 -41.05 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.251 0 N-CA-C 108.95 -0.759 . . . . 15.0 108.95 178.202 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.45 ' O ' ' N ' ' A' ' 80' ' ' ASN . 62.0 mt-10 -67.64 -46.49 72.33 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 114.711 -1.131 . . . . 15.0 110.317 178.434 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.796 ' OG1' HG21 ' A' ' 61' ' ' VAL . 32.6 p -64.34 -51.4 63.59 Favored 'General case' 0 C--O 1.231 0.119 0 C-N-CA 120.851 -0.34 . . . . 15.0 111.193 179.708 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.584 HD21 HG21 ' A' ' 58' ' ' VAL . 5.3 mt -53.67 -50.55 65.57 Favored 'General case' 0 CA--C 1.521 -0.168 0 CA-C-O 121.249 0.547 . . . . 15.0 109.801 179.798 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 21.8 ttt180 -68.46 -61.9 1.63 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.31 -0.859 . . . . 15.0 110.472 179.359 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.45 ' N ' ' O ' ' A' ' 76' ' ' GLU . 9.5 m-20 -66.04 61.68 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.878 -0.601 . . . . 15.0 111.997 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.716 HG22 ' OD1' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -94.16 -67.18 0.87 Allowed 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 110.062 -0.348 . . . . 15.0 110.062 179.193 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 122.28 -108.96 1.34 Allowed Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.864 -0.684 . . . . 15.0 113.118 179.153 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -65.39 -79.17 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.772 0.32 . . . . 15.0 111.696 -179.157 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.45 HG12 ' N ' ' A' ' 85' ' ' VAL . 63.8 t -109.94 159.2 9.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.023 0.44 . . . . 15.0 111.034 -179.337 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.689 HG23 ' CB ' ' A' ' 13' ' ' LYS . 9.4 t -97.86 81.26 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.095 -0.502 . . . . 15.0 110.402 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -100.78 85.0 2.8 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.748 -0.66 . . . . 15.0 110.28 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.792 ' HB3' HD21 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -103.32 119.61 39.21 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.009 -0.541 . . . . 15.0 111.893 -179.003 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.847 ' HB2' ' HB3' ' A' ' 60' ' ' ALA . 4.6 mp -94.59 101.64 13.52 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.451 -0.574 . . . . 15.0 109.451 178.564 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.792 HD21 ' HB3' ' A' ' 87' ' ' LEU . 0.2 OUTLIER -105.64 -163.48 0.94 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.346 0.594 . . . . 15.0 111.982 -178.55 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.419 ' HA ' ' HA ' ' A' ' 6' ' ' ILE . 2.6 tt0 -140.97 131.77 25.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.01 -0.996 . . . . 15.0 109.796 179.143 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.62 94.92 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.863 0.363 . . . . 15.0 111.122 -179.63 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.357 0 C-N-CA 120.945 -0.645 . . . . 15.0 112.729 -179.73 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.502 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 1.4 mp . . . . . 0 N--CA 1.452 -0.373 0 CA-C-O 120.984 0.421 . . . . 15.0 111.529 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.722 ' CE1' HD12 ' A' ' 89' ' ' LEU . 7.6 p90 -144.71 164.22 31.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.913 -0.585 . . . . 15.0 110.048 178.958 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.729 ' HB3' HD12 ' A' ' 88' ' ' LEU . 5.6 pt-20 -130.26 142.54 50.55 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.369 0.604 . . . . 15.0 111.907 -179.289 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.525 ' CG1' HD11 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -101.65 114.4 40.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.117 -0.947 . . . . 15.0 109.638 178.85 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -106.15 72.74 0.95 Allowed 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 112.351 0.501 . . . . 15.0 112.351 -178.77 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.676 HD13 ' HG3' ' A' ' 51' ' ' ARG . 6.0 tp -88.36 165.91 14.63 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.668 -0.493 . . . . 15.0 109.668 178.609 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -96.15 94.43 7.52 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.003 0.43 . . . . 15.0 111.149 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.688 ' CB ' HG23 ' A' ' 85' ' ' VAL . 0.1 OUTLIER . . . . . 0 C--N 1.327 -0.404 0 CA-C-N 115.764 -0.653 . . . . 15.0 111.315 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.678 ' N ' HD22 ' A' ' 18' ' ' LEU . 0.4 OUTLIER . . . . . 0 N--CA 1.456 -0.173 0 CA-C-O 120.813 0.34 . . . . 15.0 110.689 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.789 ' O ' ' HB ' ' A' ' 41' ' ' ILE . . . -173.2 44.68 0.16 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.921 -0.657 . . . . 15.0 111.913 -179.747 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.731 HG12 ' O ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -112.61 137.29 46.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 120.996 0.427 . . . . 15.0 111.579 -179.611 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.41 ' H ' HD13 ' A' ' 41' ' ' ILE . 29.1 t -88.86 105.5 17.78 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 107.865 -1.161 . . . . 15.0 107.865 177.516 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 1.014 HG21 HG23 ' A' ' 75' ' ' VAL . 34.8 m -93.37 152.5 3.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 112.618 0.599 . . . . 15.0 112.618 -177.155 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.424 ' OG1' ' CB ' ' A' ' 38' ' ' LYS . 0.8 OUTLIER -149.14 -178.62 6.48 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.245 -0.889 . . . . 15.0 110.807 -179.565 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.608 ' O ' HG22 ' A' ' 26' ' ' VAL . . . 70.16 -119.36 8.67 Favored Glycine 0 C--N 1.333 0.372 0 C-N-CA 120.856 -0.688 . . . . 15.0 112.421 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.518 ' HA3' ' N ' ' A' ' 71' ' ' HIS . . . 66.61 -65.62 0.17 Allowed Glycine 0 C--N 1.331 0.259 0 C-N-CA 121.013 -0.613 . . . . 15.0 113.61 179.402 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.608 HG22 ' O ' ' A' ' 24' ' ' GLY . 0.0 OUTLIER -28.14 140.33 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 N-CA-C 112.457 0.54 . . . . 15.0 112.457 -179.353 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.412 ' HA ' ' O ' ' A' ' 32' ' ' HIS . 59.5 t-20 -77.33 58.07 1.59 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.904 -0.589 . . . . 15.0 111.075 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.0 m -151.83 -48.28 0.11 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.283 -0.417 . . . . 15.0 110.935 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 21.6 m -83.2 -46.68 12.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 15.0 111.053 -179.836 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.523 HG22 ' O ' ' A' ' 26' ' ' VAL . 33.2 m -69.95 -174.62 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.262 -0.426 . . . . 15.0 111.169 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 10.0 mmp_? -67.59 -44.85 77.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.242 -0.436 . . . . 15.0 111.052 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' HIS . . . . . 0.412 ' O ' ' HA ' ' A' ' 27' ' ' ASN . 43.3 m80 -143.28 -68.41 0.34 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.306 -0.406 . . . . 15.0 111.004 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -161.43 19.52 0.19 Allowed Glycine 0 CA--C 1.517 0.189 0 C-N-CA 120.892 -0.671 . . . . 15.0 112.559 -179.836 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -83.64 150.67 27.06 Favored Glycine 0 N--CA 1.449 -0.493 0 N-CA-C 110.767 -0.933 . . . . 15.0 110.767 178.848 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.893 HG22 HG22 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -85.79 154.94 3.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 C-N-CA 120.031 -0.667 . . . . 15.0 111.745 -179.294 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.516 ' CE2' ' HG2' ' A' ' 57' ' ' ARG . 30.4 m-85 -139.2 106.8 5.59 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.041 -0.981 . . . . 15.0 109.736 178.878 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.793 HG22 ' N ' ' A' ' 55' ' ' GLY . 0.7 OUTLIER -55.17 146.11 4.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 116.041 -0.527 . . . . 15.0 111.025 -179.072 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.477 ' HG3' ' N ' ' A' ' 39' ' ' ALA . 0.2 OUTLIER -80.23 -46.24 16.61 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.502 -0.925 . . . . 15.0 108.502 178.616 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.731 ' O ' HG12 ' A' ' 20' ' ' ILE . . . -172.07 171.45 4.97 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 115.764 -0.653 . . . . 15.0 110.242 178.471 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.548 ' HA ' ' CG1' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -96.63 109.49 23.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 109.118 -0.697 . . . . 15.0 109.118 179.135 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.789 ' HB ' ' O ' ' A' ' 19' ' ' GLY . 0.5 OUTLIER -78.16 118.31 71.43 Favored Pre-proline 0 C--N 1.326 -0.44 0 N-CA-C 113.261 0.837 . . . . 15.0 113.261 -177.106 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.625 ' HA ' ' CG ' ' A' ' 47' ' ' GLU . 36.9 Cg_endo -64.71 60.46 0.28 Allowed 'Trans proline' 0 C--N 1.357 0.992 0 C-N-CA 123.539 2.826 . . . . 15.0 112.793 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.517 ' N ' ' HG2' ' A' ' 47' ' ' GLU . 11.2 tt0 -147.41 -46.75 0.17 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.52 -0.309 . . . . 15.0 111.244 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.777 ' HA3' ' HA3' ' A' ' 19' ' ' GLY . . . -87.87 169.33 38.53 Favored Glycine 0 C--N 1.33 0.229 0 C-N-CA 120.36 -0.924 . . . . 15.0 113.851 -179.285 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -59.36 -13.3 7.81 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.465 0.542 . . . . 15.0 112.465 -179.783 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.532 ' HB1' HG22 ' A' ' 52' ' ' ILE . . . -71.94 -56.15 6.2 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.934 -0.306 . . . . 15.0 110.578 -179.793 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.625 ' CG ' ' HA ' ' A' ' 42' ' ' PRO . 2.8 pp20? -57.61 -43.89 85.08 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 115.988 -0.551 . . . . 15.0 110.354 179.001 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 50.1 m -53.84 -70.55 0.09 Allowed 'General case' 0 CA--C 1.519 -0.225 0 CA-C-N 115.825 -0.625 . . . . 15.0 110.583 -179.477 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.487 ' CB ' HD11 ' A' ' 11' ' ' LEU . 4.4 t0 -58.1 -41.24 83.08 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.058 -0.719 . . . . 15.0 109.058 178.862 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.63 39.06 15.07 Favored Glycine 0 N--CA 1.446 -0.672 0 CA-C-N 115.295 -0.866 . . . . 15.0 111.771 179.285 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.676 ' HG3' HD13 ' A' ' 11' ' ' LEU . 0.5 OUTLIER -79.67 -51.05 9.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.976 0.417 . . . . 15.0 110.571 -179.388 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.601 ' CG2' HD12 ' A' ' 20' ' ' ILE . 10.8 tp -81.12 158.36 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 CA-C-N 115.93 -0.577 . . . . 15.0 110.106 179.465 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' HIS . . . . . 0.453 ' N ' ' OD2' ' A' ' 56' ' ' ASP . 80.4 m80 -145.54 159.27 43.36 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-O 121.591 0.71 . . . . 15.0 112.36 -178.812 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.572 ' HA ' ' CG2' ' A' ' 37' ' ' VAL . 5.0 mtpt -42.13 132.63 3.24 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.213 -1.358 . . . . 15.0 113.01 -178.595 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.793 ' N ' HG22 ' A' ' 37' ' ' VAL . . . 49.9 31.28 16.9 Favored Glycine 0 C--N 1.334 0.455 0 CA-C-N 115.697 -0.683 . . . . 15.0 113.279 179.187 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.453 ' OD2' ' N ' ' A' ' 53' ' ' HIS . 6.2 m-20 -65.7 129.39 39.6 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.726 -0.39 . . . . 15.0 110.526 179.531 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.516 ' HG2' ' CE2' ' A' ' 36' ' ' TYR . 0.5 OUTLIER -82.57 95.96 7.92 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.222 -0.445 . . . . 15.0 110.677 -179.921 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.893 HG22 HG22 ' A' ' 35' ' ' ILE . 1.4 m -86.63 117.06 30.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 CA-C-O 120.927 0.394 . . . . 15.0 110.873 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.532 HD22 ' N ' ' A' ' 59' ' ' LEU . 3.1 mm? -107.0 -17.0 14.3 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.915 -0.584 . . . . 15.0 112.482 -179.064 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.45 ' O ' HD23 ' A' ' 87' ' ' LEU . . . -149.05 148.73 30.05 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.199 0.524 . . . . 15.0 112.411 -178.83 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.643 HG22 HD21 ' A' ' 87' ' ' LEU . 17.5 t -139.13 101.36 1.55 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.26 0 CA-C-N 115.446 -0.797 . . . . 15.0 109.409 178.853 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.667 ' OD1' HG22 ' A' ' 81' ' ' THR . 2.7 m120 64.79 15.5 9.86 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.658 -0.497 . . . . 15.0 109.658 -178.066 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 107.06 4.82 35.66 Favored Glycine 0 C--N 1.337 0.613 0 CA-C-N 115.832 -0.622 . . . . 15.0 113.331 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.636 HG13 ' O ' ' A' ' 64' ' ' VAL . 4.5 p -93.87 107.83 19.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.022 0.439 . . . . 15.0 110.886 179.487 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 67.2 m -56.5 133.7 53.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.21 -0.45 . . . . 15.0 111.079 -179.566 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.663 HD11 ' HB2' ' A' ' 74' ' ' ALA . 0.2 OUTLIER -94.76 -26.23 16.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.016 -0.538 . . . . 15.0 110.902 179.924 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 14.3 tt0 -46.03 104.12 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.308 -0.406 . . . . 15.0 111.048 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.75 60.13 0.54 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.79 -0.719 . . . . 15.0 112.464 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.609 ' HB1' ' CB ' ' A' ' 73' ' ' GLN . . . -173.04 166.94 5.02 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.959 0.409 . . . . 15.0 111.148 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.471 ' CB ' ' HA ' ' A' ' 26' ' ' VAL . 9.1 p -93.18 -172.3 2.92 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.125 -0.489 . . . . 15.0 111.053 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' HIS . . . . . 0.791 ' CE1' HG23 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -63.86 -58.91 5.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.787 -0.642 . . . . 15.0 110.583 179.868 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.422 ' O ' ' HG3' ' A' ' 76' ' ' GLU . 18.0 ttpp -52.59 -34.06 48.95 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.003 -0.544 . . . . 15.0 110.557 179.396 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.609 ' CB ' ' HB1' ' A' ' 69' ' ' ALA . 9.5 mt-30 -59.36 -49.35 78.16 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.613 -0.514 . . . . 15.0 109.613 179.241 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.778 ' HB3' HG13 ' A' ' 35' ' ' ILE . . . -67.06 -44.75 79.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.932 -0.577 . . . . 15.0 109.512 178.431 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 1.014 HG23 HG21 ' A' ' 22' ' ' VAL . 0.5 OUTLIER -43.96 -40.88 1.63 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.27 0 N-CA-C 108.797 -0.816 . . . . 15.0 108.797 178.202 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.422 ' HG3' ' O ' ' A' ' 72' ' ' LYS . 9.0 mt-10 -67.42 -44.08 79.64 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 114.744 -1.117 . . . . 15.0 110.19 178.462 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.622 ' O ' HG11 ' A' ' 61' ' ' VAL . 42.5 p -64.13 -55.48 21.65 Favored 'General case' 0 C--O 1.231 0.131 0 C-N-CA 121.056 -0.258 . . . . 15.0 111.509 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.528 HD23 HG21 ' A' ' 61' ' ' VAL . 4.6 mt -53.38 -47.26 69.64 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 121.127 0.489 . . . . 15.0 109.9 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.405 ' HB2' ' O ' ' A' ' 75' ' ' VAL . 0.0 OUTLIER -68.53 -59.49 3.11 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.518 -0.765 . . . . 15.0 110.529 179.29 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 68.5 m-20 -66.06 60.27 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.931 -0.577 . . . . 15.0 112.154 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.667 HG22 ' OD1' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -95.76 -73.02 0.61 Allowed 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 110.127 -0.323 . . . . 15.0 110.127 179.1 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 122.01 -103.71 0.87 Allowed Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.702 -0.761 . . . . 15.0 113.439 179.029 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -64.53 -84.43 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 111.965 0.357 . . . . 15.0 111.965 -178.884 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.469 HG12 ' N ' ' A' ' 85' ' ' VAL . 69.9 t -109.72 160.02 8.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.946 0.403 . . . . 15.0 110.873 -179.398 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.688 HG23 ' CB ' ' A' ' 13' ' ' LYS . 8.7 t -97.81 81.65 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.156 0.503 . . . . 15.0 110.457 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.423 ' NE2' HD11 ' A' ' 88' ' ' LEU . 20.5 t60 -101.13 83.87 2.56 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.72 -0.673 . . . . 15.0 110.33 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.778 ' HB3' HD21 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -103.85 115.58 30.72 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.921 -0.581 . . . . 15.0 111.873 -179.115 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.729 HD12 ' HB3' ' A' ' 8' ' ' GLU . 0.2 OUTLIER -92.15 100.49 13.1 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.327 -0.62 . . . . 15.0 109.327 178.573 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.778 HD21 ' HB3' ' A' ' 87' ' ' LEU . 0.1 OUTLIER -104.04 -159.46 0.72 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.26 0.553 . . . . 15.0 111.725 -178.658 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.502 ' HA ' ' HA ' ' A' ' 6' ' ' ILE . 5.3 tt0 -140.57 143.7 35.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.35 -0.841 . . . . 15.0 110.32 179.322 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 7.9 tppt? -55.48 105.89 0.21 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.227 -0.442 . . . . 15.0 110.954 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.336 0 C-N-CA 120.869 -0.681 . . . . 15.0 112.616 -179.899 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.488 HD11 ' OE1' ' A' ' 90' ' ' GLU . 1.3 mp . . . . . 0 N--CA 1.451 -0.379 0 CA-C-O 120.829 0.347 . . . . 15.0 110.944 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.607 ' CZ ' HD12 ' A' ' 89' ' ' LEU . 2.9 p90 -140.82 164.96 28.82 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.214 -0.448 . . . . 15.0 110.415 178.896 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.715 ' HB3' HD12 ' A' ' 88' ' ' LEU . 1.9 pt-20 -130.17 143.85 51.02 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.234 0.54 . . . . 15.0 111.6 -179.438 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.667 ' CG1' HD11 ' A' ' 89' ' ' LEU . 0.3 OUTLIER -101.26 114.52 40.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.277 -0.874 . . . . 15.0 109.706 179.111 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -106.04 69.88 0.83 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.076 -0.511 . . . . 15.0 111.772 -179.063 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.65 HD11 ' CB ' ' A' ' 49' ' ' ASP . 8.5 tp -88.19 161.89 16.99 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.006 -0.543 . . . . 15.0 110.316 179.223 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -96.69 98.6 10.3 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.537 -0.301 . . . . 15.0 111.151 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.889 ' HB2' HG23 ' A' ' 85' ' ' VAL . 0.3 OUTLIER . . . . . 0 CA--C 1.533 0.312 0 N-CA-C 112.706 0.632 . . . . 15.0 112.706 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.413 HD22 ' HE3' ' A' ' 13' ' ' LYS . 2.5 mm? . . . . . 0 N--CA 1.453 -0.312 0 CA-C-O 120.986 0.422 . . . . 15.0 110.74 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.705 ' O ' ' HB ' ' A' ' 41' ' ' ILE . . . -160.8 40.07 0.43 Allowed Glycine 0 N--CA 1.448 -0.532 0 N-CA-C 111.439 -0.664 . . . . 15.0 111.439 -179.818 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.653 HG12 ' O ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -112.7 139.08 39.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 120.907 0.384 . . . . 15.0 111.876 -179.227 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 30.3 t -96.03 104.96 16.93 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 107.924 -1.139 . . . . 15.0 107.924 177.371 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.978 HG21 HG23 ' A' ' 75' ' ' VAL . 32.6 m -93.63 156.84 3.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 113.09 0.774 . . . . 15.0 113.09 -177.091 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.31 -175.03 4.83 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.128 -0.942 . . . . 15.0 110.703 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.585 ' O ' HG22 ' A' ' 26' ' ' VAL . . . 68.71 -119.52 10.09 Favored Glycine 0 C--N 1.332 0.309 0 C-N-CA 120.831 -0.699 . . . . 15.0 112.542 179.794 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.526 ' HA3' ' N ' ' A' ' 71' ' ' HIS . . . 67.1 -66.65 0.21 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.922 -0.656 . . . . 15.0 113.336 179.563 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.585 HG22 ' O ' ' A' ' 24' ' ' GLY . 0.0 OUTLIER -32.62 142.48 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 N-CA-C 112.063 0.394 . . . . 15.0 112.063 -179.492 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -75.63 59.6 1.17 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.065 -0.516 . . . . 15.0 110.857 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.5 m -151.6 -66.3 0.18 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.231 -0.44 . . . . 15.0 110.566 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 29.5 t -65.44 -51.25 61.51 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.111 -0.495 . . . . 15.0 110.424 179.562 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.472 HG11 ' CD1' ' A' ' 36' ' ' TYR . 27.0 m -88.07 -175.35 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.02 -0.536 . . . . 15.0 110.689 179.601 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 38.1 ttm180 -90.4 137.63 32.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.969 0.414 . . . . 15.0 111.096 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 42.1 m170 55.53 -86.36 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.756 -0.656 . . . . 15.0 111.345 179.822 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.411 ' O ' ' O ' ' A' ' 69' ' ' ALA . . . -171.94 27.79 0.1 OUTLIER Glycine 0 C--N 1.33 0.24 0 C-N-CA 120.922 -0.656 . . . . 15.0 112.48 -179.709 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.432 ' O ' HG21 ' A' ' 30' ' ' VAL . . . -81.7 151.79 31.13 Favored Glycine 0 N--CA 1.451 -0.363 0 N-CA-C 110.857 -0.897 . . . . 15.0 110.857 179.029 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.925 HG22 HG22 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -88.94 154.1 3.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 119.99 -0.684 . . . . 15.0 111.704 -179.346 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.494 ' CZ ' ' HG2' ' A' ' 57' ' ' ARG . 29.4 m-85 -141.73 107.52 5.13 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.154 -0.93 . . . . 15.0 110.008 179.114 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.781 HG22 ' N ' ' A' ' 55' ' ' GLY . 0.7 OUTLIER -55.81 153.16 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.191 0.52 . . . . 15.0 111.295 -179.131 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.514 ' O ' ' HG2' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -85.72 -48.33 8.93 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.379 -0.971 . . . . 15.0 108.379 178.33 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.653 ' O ' HG12 ' A' ' 20' ' ' ILE . . . -172.39 173.78 4.04 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 115.354 -0.839 . . . . 15.0 110.145 178.722 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.622 ' HA ' HG12 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -96.97 112.16 28.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 109.436 -0.579 . . . . 15.0 109.436 179.125 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.705 ' HB ' ' O ' ' A' ' 19' ' ' GLY . 0.4 OUTLIER -78.36 118.72 73.96 Favored Pre-proline 0 C--N 1.329 -0.298 0 N-CA-C 113.349 0.87 . . . . 15.0 113.349 -177.245 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.613 ' HA ' ' HG2' ' A' ' 47' ' ' GLU . 36.9 Cg_endo -64.36 61.66 0.25 Allowed 'Trans proline' 0 C--N 1.357 0.998 0 C-N-CA 123.509 2.806 . . . . 15.0 112.918 179.706 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.514 ' H ' ' HG2' ' A' ' 47' ' ' GLU . 2.2 mm-40 -150.8 -46.6 0.12 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.611 -0.268 . . . . 15.0 111.618 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.651 ' HA3' ' HA3' ' A' ' 19' ' ' GLY . . . -87.82 166.65 35.89 Favored Glycine 0 C--N 1.331 0.268 0 C-N-CA 120.311 -0.947 . . . . 15.0 113.879 -179.142 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -55.96 -14.83 2.76 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.703 0.631 . . . . 15.0 112.703 -179.612 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.16 -57.5 4.2 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.707 0.289 . . . . 15.0 111.109 -179.504 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.613 ' HG2' ' HA ' ' A' ' 42' ' ' PRO . 2.9 pp20? -57.11 -41.91 79.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 15.0 110.478 179.545 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 40.1 t -53.7 -70.37 0.1 Allowed 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 115.896 -0.593 . . . . 15.0 110.668 -179.508 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.65 ' CB ' HD11 ' A' ' 11' ' ' LEU . 1.5 m-20 -61.1 -39.57 90.48 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.219 0.533 . . . . 15.0 109.575 179.049 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.01 44.21 8.32 Favored Glycine 0 N--CA 1.447 -0.599 0 CA-C-N 115.439 -0.801 . . . . 15.0 111.835 179.668 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.652 ' CG ' HG23 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -79.5 -53.4 6.91 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.962 0.411 . . . . 15.0 110.647 -179.397 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.625 ' CG1' HD12 ' A' ' 20' ' ' ILE . 10.3 tp -81.08 163.1 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 CA-C-N 115.936 -0.575 . . . . 15.0 110.442 179.695 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' HIS . . . . . 0.424 ' N ' ' OD2' ' A' ' 56' ' ' ASP . 65.0 m-70 -146.57 158.82 43.97 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-O 121.606 0.717 . . . . 15.0 112.126 -179.072 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.564 ' HA ' ' CG2' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -43.15 133.33 3.95 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.246 -1.343 . . . . 15.0 112.928 -178.58 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.781 ' N ' HG22 ' A' ' 37' ' ' VAL . . . 49.84 32.14 17.83 Favored Glycine 0 C--N 1.336 0.545 0 CA-C-N 115.841 -0.618 . . . . 15.0 113.053 179.275 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.512 ' OD2' HD12 ' A' ' 52' ' ' ILE . 4.6 m-20 -65.47 124.75 23.11 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.706 -0.397 . . . . 15.0 110.216 179.498 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.861 ' HD2' HD21 ' A' ' 59' ' ' LEU . 0.0 OUTLIER -81.82 92.85 6.74 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.203 -0.453 . . . . 15.0 110.505 -179.959 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.925 HG22 HG22 ' A' ' 35' ' ' ILE . 1.3 m -84.76 120.85 36.04 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 CA-C-N 116.195 -0.457 . . . . 15.0 111.383 -179.372 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.861 HD21 ' HD2' ' A' ' 57' ' ' ARG . 3.4 mm? -107.24 -20.88 13.15 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 115.73 -0.668 . . . . 15.0 112.455 -179.36 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.494 ' O ' HD23 ' A' ' 87' ' ' LEU . . . -147.75 153.74 39.64 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.33 0.586 . . . . 15.0 112.569 -178.585 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.83 HG11 ' O ' ' A' ' 77' ' ' THR . 25.9 t -138.97 99.56 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.331 0 CA-C-N 115.231 -0.895 . . . . 15.0 109.048 178.788 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.439 ' OD1' HG22 ' A' ' 81' ' ' THR . 2.7 m120 65.37 16.36 10.49 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.535 -0.543 . . . . 15.0 109.535 -177.806 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 107.07 5.59 35.02 Favored Glycine 0 C--N 1.337 0.633 0 CA-C-N 115.689 -0.687 . . . . 15.0 113.63 179.404 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.664 HG13 ' O ' ' A' ' 64' ' ' VAL . 5.9 p -93.88 105.34 16.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 117.339 0.57 . . . . 15.0 110.809 179.306 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -55.58 130.73 44.13 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.053 -0.521 . . . . 15.0 111.11 -179.57 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.735 HD21 ' HA ' ' A' ' 74' ' ' ALA . 0.1 OUTLIER -97.76 -24.16 15.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.97 -0.559 . . . . 15.0 111.036 179.925 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -45.41 106.23 0.07 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.426 -0.352 . . . . 15.0 110.999 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.85 58.95 0.53 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.785 -0.721 . . . . 15.0 112.289 -179.655 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.579 ' HB1' ' CD ' ' A' ' 73' ' ' GLN . . . -172.98 171.75 4.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.848 0.356 . . . . 15.0 110.945 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.567 ' HB ' HG13 ' A' ' 26' ' ' VAL . 13.5 p -93.37 -172.64 2.99 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.092 0.472 . . . . 15.0 111.376 -179.749 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' HIS . . . . . 0.679 ' CE1' HG23 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -64.24 -59.58 4.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.654 -0.703 . . . . 15.0 110.668 -179.975 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.406 ' N ' ' CG ' ' A' ' 71' ' ' HIS . 29.9 ttpt -52.44 -32.78 41.13 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.895 -0.593 . . . . 15.0 110.643 179.777 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.579 ' CD ' ' HB1' ' A' ' 69' ' ' ALA . 10.4 mt-30 -59.45 -51.76 68.49 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.542 -0.54 . . . . 15.0 109.542 179.264 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.735 ' HA ' HD21 ' A' ' 66' ' ' LEU . . . -67.23 -44.49 79.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.008 -0.542 . . . . 15.0 110.033 178.511 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.978 HG23 HG21 ' A' ' 22' ' ' VAL . 0.5 OUTLIER -41.9 -41.76 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.239 0 N-CA-C 109.249 -0.649 . . . . 15.0 109.249 178.688 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.463 ' O ' ' HB2' ' A' ' 80' ' ' ASN . 54.0 mt-10 -67.3 -44.88 78.12 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 114.882 -1.054 . . . . 15.0 110.453 178.639 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.83 ' O ' HG11 ' A' ' 61' ' ' VAL . 37.2 p -64.05 -55.1 24.64 Favored 'General case' 0 N--CA 1.461 0.122 0 C-N-CA 121.159 -0.216 . . . . 15.0 111.555 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.757 HD21 HG21 ' A' ' 58' ' ' VAL . 6.5 mt -53.31 -45.98 69.23 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-O 121.237 0.542 . . . . 15.0 109.997 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.403 ' HB2' ' O ' ' A' ' 75' ' ' VAL . 0.0 OUTLIER -68.35 -58.91 3.65 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.334 -0.848 . . . . 15.0 110.643 179.493 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.463 ' HB2' ' O ' ' A' ' 76' ' ' GLU . 11.2 m-80 -66.08 62.71 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.074 -0.512 . . . . 15.0 111.928 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.439 HG22 ' OD1' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -92.74 -76.26 0.47 Allowed 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 110.155 -0.313 . . . . 15.0 110.155 179.284 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 122.2 -105.17 0.95 Allowed Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.728 -0.749 . . . . 15.0 113.052 179.165 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.429 ' O ' ' HB3' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -64.87 -84.07 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.753 0.311 . . . . 15.0 111.209 -179.42 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.453 HG12 ' N ' ' A' ' 85' ' ' VAL . 79.0 t -110.17 158.61 10.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.021 0.439 . . . . 15.0 111.083 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.889 HG23 ' HB2' ' A' ' 13' ' ' LYS . 3.3 t -97.68 83.15 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.176 0.513 . . . . 15.0 110.213 179.68 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -100.09 82.08 2.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.736 -0.666 . . . . 15.0 110.242 179.778 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.789 ' HB3' HD21 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -103.98 127.04 51.52 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.914 -0.584 . . . . 15.0 111.85 -179.022 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.715 HD12 ' HB3' ' A' ' 8' ' ' GLU . 0.2 OUTLIER -102.17 100.54 10.76 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.292 -0.633 . . . . 15.0 109.292 178.433 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.789 HD21 ' HB3' ' A' ' 87' ' ' LEU . 0.1 OUTLIER -104.85 -161.49 0.82 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.405 0.621 . . . . 15.0 111.795 -178.582 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.488 ' OE1' HD11 ' A' ' 6' ' ' ILE . 3.2 tt0 -141.5 135.55 30.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.064 -0.971 . . . . 15.0 109.876 179.232 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.1 105.56 0.07 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.951 0.405 . . . . 15.0 111.169 -179.663 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.342 0 C-N-CA 120.938 -0.648 . . . . 15.0 112.641 -179.794 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.618 HD11 ' OE1' ' A' ' 90' ' ' GLU . 1.4 mp . . . . . 0 N--CA 1.45 -0.438 0 CA-C-O 120.799 0.333 . . . . 15.0 111.097 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.514 ' CZ ' HD12 ' A' ' 89' ' ' LEU . 3.0 p90 -140.65 166.37 24.93 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.274 -0.421 . . . . 15.0 110.569 178.647 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.732 ' CB ' HD12 ' A' ' 88' ' ' LEU . 9.5 pt-20 -129.43 143.87 51.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.196 0.522 . . . . 15.0 111.432 -179.336 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.639 ' CG1' HD11 ' A' ' 89' ' ' LEU . 0.3 OUTLIER -101.37 117.26 46.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.424 -0.807 . . . . 15.0 109.382 178.82 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 55.1 tt0 -105.97 75.71 1.13 Allowed 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.456 0.539 . . . . 15.0 112.456 -178.534 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.596 ' HB3' ' HB ' ' A' ' 85' ' ' VAL . 6.4 tp -87.93 161.21 17.58 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.24 -0.652 . . . . 15.0 109.24 178.179 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -96.8 94.55 7.32 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 120.816 -0.354 . . . . 15.0 111.819 -179.516 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.615 ' CB ' HG23 ' A' ' 85' ' ' VAL . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.319 0 CA-C-O 121.334 0.588 . . . . 15.0 111.203 179.283 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.472 ' N ' HD22 ' A' ' 18' ' ' LEU . 3.1 mm? . . . . . 0 N--CA 1.45 -0.449 0 CA-C-O 121.165 0.507 . . . . 15.0 111.066 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.618 ' O ' ' HB ' ' A' ' 41' ' ' ILE . . . -162.87 31.85 0.29 Allowed Glycine 0 CA--C 1.505 -0.561 0 N-CA-C 110.931 -0.868 . . . . 15.0 110.931 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.741 HD13 ' HB ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -112.5 143.65 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 CA-C-O 121.104 0.478 . . . . 15.0 112.146 -178.709 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 27.1 t -96.07 102.47 14.27 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 107.014 -1.476 . . . . 15.0 107.014 176.616 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.977 HG21 HG23 ' A' ' 75' ' ' VAL . 32.8 m -93.36 155.28 3.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 113.439 0.903 . . . . 15.0 113.439 -176.23 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.3 -175.44 4.99 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 114.8 -1.091 . . . . 15.0 110.609 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.425 ' O ' ' HB3' ' A' ' 71' ' ' HIS . . . 68.73 -120.23 10.84 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 120.823 -0.703 . . . . 15.0 112.602 179.725 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.543 ' HA3' ' N ' ' A' ' 71' ' ' HIS . . . 69.07 -66.38 0.49 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.795 -0.717 . . . . 15.0 113.431 179.449 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.505 ' O ' HG22 ' A' ' 30' ' ' VAL . 1.0 OUTLIER -27.66 140.25 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 N-CA-C 112.471 0.545 . . . . 15.0 112.471 -179.271 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -76.61 60.14 1.61 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.983 -0.553 . . . . 15.0 111.034 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -151.72 -50.45 0.11 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.373 -0.376 . . . . 15.0 111.01 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.8 t -84.21 -37.58 21.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.202 -0.453 . . . . 15.0 111.071 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.505 HG22 ' O ' ' A' ' 26' ' ' VAL . 21.7 m -80.75 -174.75 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.306 -0.406 . . . . 15.0 111.238 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 2.8 mtt-85 -58.8 -54.17 50.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.449 . . . . 15.0 111.022 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 24.8 m80 -146.37 -50.47 0.22 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.264 -0.426 . . . . 15.0 111.043 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -169.28 26.24 0.11 Allowed Glycine 0 N--CA 1.453 -0.19 0 C-N-CA 120.825 -0.702 . . . . 15.0 112.512 -179.765 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.481 ' O ' HG11 ' A' ' 30' ' ' VAL . . . -90.58 149.18 19.95 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.684 -0.769 . . . . 15.0 111.197 179.101 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.82 HG22 HG22 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -87.68 154.69 3.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 117.341 0.571 . . . . 15.0 111.568 -179.39 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.427 ' CZ ' ' HG3' ' A' ' 57' ' ' ARG . 26.6 m-85 -140.76 106.83 5.19 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.241 -0.891 . . . . 15.0 109.829 179.312 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.783 HG22 ' N ' ' A' ' 55' ' ' GLY . 0.8 OUTLIER -55.58 148.25 3.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.18 0.514 . . . . 15.0 111.553 -178.938 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.41 ' O ' ' HG2' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -80.41 -47.7 14.01 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.316 -0.994 . . . . 15.0 108.316 178.2 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.626 ' O ' HG12 ' A' ' 20' ' ' ILE . . . -172.02 172.76 4.59 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 115.254 -0.885 . . . . 15.0 110.291 178.606 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.665 ' HA ' HG12 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -97.42 107.84 20.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.936 0.398 . . . . 15.0 110.889 179.946 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.618 ' HB ' ' O ' ' A' ' 19' ' ' GLY . 0.6 OUTLIER -78.86 108.03 7.28 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 115.789 -0.641 . . . . 15.0 112.611 -178.671 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.477 ' N ' ' HG2' ' A' ' 47' ' ' GLU . 30.7 Cg_endo -62.93 69.67 0.13 Allowed 'Trans proline' 0 C--N 1.355 0.904 0 C-N-CA 123.139 2.559 . . . . 15.0 112.535 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.463 ' HB2' HG22 ' A' ' 41' ' ' ILE . 0.7 OUTLIER -151.79 -52.93 0.12 Allowed 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.365 -0.834 . . . . 15.0 109.675 179.501 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.521 ' HA3' ' CA ' ' A' ' 19' ' ' GLY . . . -87.93 155.99 27.07 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.611 -0.804 . . . . 15.0 112.402 179.254 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -39.11 -18.81 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 113.638 0.977 . . . . 15.0 113.638 -179.693 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.478 ' N ' ' O ' ' A' ' 44' ' ' GLY . . . -71.68 -71.89 0.25 Allowed 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 111.783 0.29 . . . . 15.0 111.783 -179.31 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.508 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 3.9 tp10 -58.22 -40.4 81.57 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 120.423 -0.511 . . . . 15.0 110.379 179.827 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 16.5 m -54.27 -59.18 5.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.974 -0.557 . . . . 15.0 110.463 179.439 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.569 ' CB ' HD11 ' A' ' 11' ' ' LEU . 3.6 t70 -68.46 -38.37 81.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.155 -0.475 . . . . 15.0 110.107 179.303 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.81 42.8 8.7 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.695 -0.684 . . . . 15.0 112.988 179.491 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.488 ' HG3' HD13 ' A' ' 11' ' ' LEU . 2.8 mmp_? -90.2 -50.68 5.85 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.877 0.37 . . . . 15.0 110.521 179.475 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.632 ' CG1' HD12 ' A' ' 20' ' ' ILE . 10.1 tp -81.22 158.9 4.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.048 -0.524 . . . . 15.0 110.773 179.69 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' HIS . . . . . 0.424 ' O ' ' HB2' ' A' ' 56' ' ' ASP . 72.8 m80 -141.0 158.24 44.22 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-O 121.645 0.736 . . . . 15.0 112.244 -179.407 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.573 ' HA ' ' CG2' ' A' ' 37' ' ' VAL . 2.3 mtpt -42.25 134.12 2.96 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.407 -1.269 . . . . 15.0 112.794 -178.704 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.783 ' N ' HG22 ' A' ' 37' ' ' VAL . . . 49.76 33.41 19.46 Favored Glycine 0 C--N 1.334 0.444 0 CA-C-N 115.815 -0.63 . . . . 15.0 113.616 179.157 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.424 ' HB2' ' O ' ' A' ' 53' ' ' HIS . 0.2 OUTLIER -66.01 133.17 50.25 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 117.169 0.485 . . . . 15.0 110.679 179.529 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.427 ' HG3' ' CZ ' ' A' ' 36' ' ' TYR . 6.2 ttt85 -86.47 88.42 7.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.193 -0.458 . . . . 15.0 110.363 179.604 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.82 HG22 HG22 ' A' ' 35' ' ' ILE . 1.7 m -79.43 114.77 20.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.057 0.456 . . . . 15.0 111.003 -179.558 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.416 ' HA ' ' HB2' ' A' ' 66' ' ' LEU . 32.0 mt -107.09 -16.71 14.36 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.762 -0.654 . . . . 15.0 112.46 -179.244 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.636 ' HB3' ' HB2' ' A' ' 88' ' ' LEU . . . -147.88 146.46 29.08 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 112.563 0.579 . . . . 15.0 112.563 -178.746 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.879 HG11 ' O ' ' A' ' 77' ' ' THR . 57.3 t -139.02 102.77 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.368 -0.833 . . . . 15.0 109.098 178.674 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.616 ' OD1' HG22 ' A' ' 81' ' ' THR . 2.4 m120 64.9 14.94 9.61 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.87 -0.419 . . . . 15.0 109.87 -178.163 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 107.0 5.47 35.29 Favored Glycine 0 C--N 1.336 0.552 0 CA-C-N 115.989 -0.55 . . . . 15.0 113.361 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.644 HG13 ' O ' ' A' ' 64' ' ' VAL . 6.1 p -93.87 107.59 19.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 117.077 0.439 . . . . 15.0 111.192 179.645 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 44.2 m -58.48 133.04 55.44 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.294 -0.412 . . . . 15.0 110.798 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.496 HD11 ' HA ' ' A' ' 74' ' ' ALA . 1.2 mm? -91.1 -21.86 21.0 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.07 -0.514 . . . . 15.0 111.185 -179.699 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -43.55 98.06 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 120.912 0.387 . . . . 15.0 111.149 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.87 63.28 0.55 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.817 -0.706 . . . . 15.0 112.333 -179.748 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.664 ' HB1' ' CB ' ' A' ' 73' ' ' GLN . . . -173.13 150.65 1.97 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.907 0.384 . . . . 15.0 111.098 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.434 ' HA ' ' N ' ' A' ' 26' ' ' VAL . 2.9 p -81.05 -171.96 3.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 15.0 111.015 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' HIS . . . . . 0.726 ' CE1' HG23 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -62.08 -59.68 4.71 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.847 -0.615 . . . . 15.0 110.537 -179.953 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 13.3 ttpp -52.65 -34.64 52.45 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.685 -0.689 . . . . 15.0 111.046 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.664 ' CB ' ' HB1' ' A' ' 69' ' ' ALA . 2.8 mt-30 -59.31 -49.97 75.78 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.71 -0.478 . . . . 15.0 109.71 179.526 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.608 ' HB3' HG13 ' A' ' 35' ' ' ILE . . . -66.2 -45.68 79.93 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.929 -0.578 . . . . 15.0 109.532 178.423 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.977 HG23 HG21 ' A' ' 22' ' ' VAL . 0.5 OUTLIER -43.59 -40.81 1.41 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.209 0 N-CA-C 108.853 -0.795 . . . . 15.0 108.853 178.158 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -67.28 -44.87 78.23 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 114.845 -1.071 . . . . 15.0 110.126 178.365 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.879 ' O ' HG11 ' A' ' 61' ' ' VAL . 61.3 p -64.19 -54.24 36.76 Favored 'General case' 0 N--CA 1.461 0.08 0 CA-C-N 116.621 -0.263 . . . . 15.0 111.349 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.821 HD23 HG21 ' A' ' 61' ' ' VAL . 4.4 mt -53.43 -48.59 68.62 Favored 'General case' 0 CA--C 1.521 -0.146 0 CA-C-O 121.099 0.476 . . . . 15.0 110.138 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.405 ' O ' ' N ' ' A' ' 81' ' ' THR . 0.3 OUTLIER -68.54 -58.16 4.71 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.559 -0.746 . . . . 15.0 110.748 179.558 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -65.88 63.53 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.089 -0.505 . . . . 15.0 111.952 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.616 HG22 ' OD1' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -94.99 -73.53 0.58 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.65 0.262 . . . . 15.0 110.468 179.362 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 122.2 -105.22 0.96 Allowed Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.828 -0.701 . . . . 15.0 113.132 179.4 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.468 ' O ' ' HB3' ' A' ' 13' ' ' LYS . 0.4 OUTLIER -64.67 -82.17 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.705 0.288 . . . . 15.0 111.484 -179.279 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.434 HG12 ' N ' ' A' ' 85' ' ' VAL . 50.0 t -109.76 158.05 10.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.904 0.383 . . . . 15.0 110.423 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.615 HG23 ' CB ' ' A' ' 13' ' ' LYS . 50.7 t -98.23 77.85 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.231 -0.441 . . . . 15.0 110.627 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -98.63 88.37 4.06 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.021 -0.536 . . . . 15.0 110.893 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.803 ' HB3' HD21 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -103.89 125.84 50.59 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.104 -0.498 . . . . 15.0 111.633 -179.474 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.732 HD12 ' CB ' ' A' ' 8' ' ' GLU . 4.6 mp -101.59 101.85 12.47 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.428 -0.582 . . . . 15.0 109.428 178.657 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.803 HD21 ' HB3' ' A' ' 87' ' ' LEU . 0.1 OUTLIER -105.83 -163.62 0.95 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.536 0.684 . . . . 15.0 112.119 -178.325 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.618 ' OE1' HD11 ' A' ' 6' ' ' ILE . 2.2 tt0 -142.47 137.62 30.42 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 114.803 -1.09 . . . . 15.0 109.758 179.063 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.95 106.85 0.13 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.942 0.401 . . . . 15.0 111.05 -179.687 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.267 0 C-N-CA 120.955 -0.64 . . . . 15.0 112.765 -179.641 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.425 HG13 ' HB2' ' A' ' 90' ' ' GLU . 1.4 mp . . . . . 0 N--CA 1.452 -0.349 0 CA-C-O 120.734 0.302 . . . . 15.0 111.088 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.831 ' CZ ' HD12 ' A' ' 89' ' ' LEU . 3.9 p90 -140.65 165.53 27.22 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.327 -0.397 . . . . 15.0 110.729 178.911 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.737 ' HB2' HD12 ' A' ' 88' ' ' LEU . 11.0 pt-20 -130.14 143.52 50.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.117 0.484 . . . . 15.0 111.467 -179.642 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.58 HG11 ' CD1' ' A' ' 52' ' ' ILE . 0.5 OUTLIER -101.55 117.45 46.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.582 -0.735 . . . . 15.0 109.998 179.115 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -106.43 71.81 0.89 Allowed 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 112.243 0.46 . . . . 15.0 112.243 -179.221 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.548 ' HB3' ' HB ' ' A' ' 85' ' ' VAL . 7.9 tp -88.0 164.25 15.89 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.538 -0.542 . . . . 15.0 109.538 178.697 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -96.09 93.02 6.72 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.025 0.441 . . . . 15.0 111.297 -179.792 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.731 ' CB ' HG23 ' A' ' 85' ' ' VAL . 0.1 OUTLIER . . . . . 0 C--N 1.327 -0.376 0 CA-C-N 115.857 -0.61 . . . . 15.0 110.935 179.769 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.679 ' N ' HD22 ' A' ' 18' ' ' LEU . 0.4 OUTLIER . . . . . 0 N--CA 1.456 -0.161 0 CA-C-O 120.826 0.346 . . . . 15.0 110.702 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.633 ' O ' ' HB ' ' A' ' 41' ' ' ILE . . . -166.77 34.09 0.22 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 121.09 -0.576 . . . . 15.0 112.183 -179.665 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.674 HG13 HG12 ' A' ' 40' ' ' VAL . 0.1 OUTLIER -112.63 140.65 31.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 121.023 0.439 . . . . 15.0 111.892 -179.464 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.456 ' HB3' HD11 ' A' ' 41' ' ' ILE . 31.3 t -96.3 107.16 19.48 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 107.735 -1.209 . . . . 15.0 107.735 177.221 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 1.025 HG21 HG23 ' A' ' 75' ' ' VAL . 30.4 m -93.31 152.5 3.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 N-CA-C 113.061 0.763 . . . . 15.0 113.061 -176.807 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.419 HG23 ' HB3' ' A' ' 38' ' ' LYS . 35.4 p -149.42 178.68 8.58 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 115.036 -0.984 . . . . 15.0 110.874 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.551 ' O ' HG22 ' A' ' 26' ' ' VAL . . . 71.83 -118.69 7.14 Favored Glycine 0 C--N 1.332 0.345 0 C-N-CA 120.987 -0.625 . . . . 15.0 112.697 179.813 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.536 ' HA3' ' N ' ' A' ' 71' ' ' HIS . . . 68.21 -66.28 0.37 Allowed Glycine 0 C--N 1.331 0.254 0 C-N-CA 120.874 -0.679 . . . . 15.0 113.585 179.563 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.551 HG22 ' O ' ' A' ' 24' ' ' GLY . 0.0 OUTLIER -29.64 137.89 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 N-CA-C 112.247 0.462 . . . . 15.0 112.247 -179.355 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -75.46 63.5 1.48 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.905 -0.589 . . . . 15.0 111.038 -179.701 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 29.5 m -151.71 -50.3 0.11 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.247 -0.433 . . . . 15.0 111.067 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 11.0 t -88.04 -29.27 20.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.231 -0.441 . . . . 15.0 111.146 -179.822 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.49 HG22 ' O ' ' A' ' 26' ' ' VAL . 34.4 m -85.4 -176.85 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.367 -0.379 . . . . 15.0 111.312 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -61.47 -46.95 87.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.14 -0.482 . . . . 15.0 111.101 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 74.6 m-70 -148.29 -61.94 0.25 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.405 -0.361 . . . . 15.0 111.226 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.4 ' O ' ' O ' ' A' ' 69' ' ' ALA . . . -163.67 24.98 0.19 Allowed Glycine 0 N--CA 1.453 -0.205 0 C-N-CA 120.853 -0.689 . . . . 15.0 112.586 -179.642 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -89.61 156.97 26.14 Favored Glycine 0 N--CA 1.449 -0.462 0 N-CA-C 110.626 -0.99 . . . . 15.0 110.626 178.849 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.966 HG22 HG22 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -93.69 151.5 3.69 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.388 0 CA-C-N 117.66 0.73 . . . . 15.0 112.013 -179.366 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.515 ' CZ ' ' HG2' ' A' ' 57' ' ' ARG . 49.9 m-85 -133.46 107.65 8.17 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.718 -1.128 . . . . 15.0 109.162 178.707 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.822 HG22 ' N ' ' A' ' 55' ' ' GLY . 0.6 OUTLIER -54.85 152.91 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 121.261 0.553 . . . . 15.0 110.723 -178.575 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.651 ' HG3' ' N ' ' A' ' 39' ' ' ALA . 1.4 ppmt? -88.17 -47.32 8.55 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 108.795 -0.817 . . . . 15.0 108.795 179.313 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.651 ' N ' ' HG3' ' A' ' 38' ' ' LYS . . . -173.06 167.14 4.98 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.669 -0.696 . . . . 15.0 110.202 178.305 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.674 HG12 HG13 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -96.84 111.87 27.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.647 -0.501 . . . . 15.0 109.647 179.14 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.633 ' HB ' ' O ' ' A' ' 19' ' ' GLY . 0.3 OUTLIER -78.39 111.37 18.36 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 115.728 -0.669 . . . . 15.0 112.664 -177.676 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.442 ' HD2' ' HA ' ' A' ' 41' ' ' ILE . 37.1 Cg_endo -65.23 65.35 0.33 Allowed 'Trans proline' 0 C--N 1.355 0.899 0 C-N-CA 123.07 2.514 . . . . 15.0 112.763 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.507 ' HB2' HG22 ' A' ' 41' ' ' ILE . 5.5 mt-30 -149.52 -52.03 0.15 Allowed 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.402 -0.817 . . . . 15.0 109.196 179.293 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.543 ' HA3' ' HA3' ' A' ' 19' ' ' GLY . . . -88.03 154.34 25.42 Favored Glycine 0 N--CA 1.445 -0.719 0 CA-C-N 115.443 -0.799 . . . . 15.0 112.516 179.109 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -40.61 -17.73 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 113.804 1.038 . . . . 15.0 113.804 -179.528 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.446 ' N ' ' O ' ' A' ' 44' ' ' GLY . . . -71.67 -70.54 0.32 Allowed 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.707 -0.397 . . . . 15.0 111.477 -179.247 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.518 ' HG2' ' HB ' ' A' ' 40' ' ' VAL . 6.8 tm-20 -58.08 -37.17 73.98 Favored 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 120.678 -0.409 . . . . 15.0 110.039 179.508 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 37.4 m -56.25 -65.76 0.55 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.021 -0.536 . . . . 15.0 110.335 179.265 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.458 ' CB ' HD11 ' A' ' 11' ' ' LEU . 18.6 m-20 -62.55 -38.4 89.86 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.123 0.487 . . . . 15.0 109.931 179.135 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.51 43.56 8.42 Favored Glycine 0 N--CA 1.449 -0.493 0 CA-C-N 115.59 -0.732 . . . . 15.0 112.446 179.721 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.568 ' CG ' HG23 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -79.8 -58.26 3.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.867 0.365 . . . . 15.0 110.616 -179.982 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.58 ' CD1' HG11 ' A' ' 9' ' ' VAL . 1.4 mm -86.13 163.41 2.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.114 -0.494 . . . . 15.0 110.887 179.809 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' HIS . . . . . 0.563 ' N ' HG22 ' A' ' 52' ' ' ILE . 43.2 m80 -139.37 154.67 47.88 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-O 121.61 0.719 . . . . 15.0 111.415 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.543 ' HA ' ' CG2' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -36.07 133.93 0.43 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.368 -1.287 . . . . 15.0 113.016 -178.549 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.822 ' N ' HG22 ' A' ' 37' ' ' VAL . . . 50.74 34.16 28.45 Favored Glycine 0 C--N 1.334 0.468 0 CA-C-N 115.806 -0.633 . . . . 15.0 113.929 179.091 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.457 ' H ' HG13 ' A' ' 37' ' ' VAL . 1.9 m-20 -65.4 130.62 43.99 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 117.296 0.548 . . . . 15.0 110.525 179.203 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.575 ' CD ' HD21 ' A' ' 59' ' ' LEU . 0.0 OUTLIER -82.34 85.73 6.82 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.002 -0.545 . . . . 15.0 110.543 179.818 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.966 HG22 HG22 ' A' ' 35' ' ' ILE . 1.0 OUTLIER -81.67 114.33 22.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.15 0.5 . . . . 15.0 111.266 -179.549 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.575 HD21 ' CD ' ' A' ' 57' ' ' ARG . 18.6 mt -107.23 -15.74 14.58 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.702 -0.681 . . . . 15.0 112.142 -179.563 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.559 ' O ' HD23 ' A' ' 87' ' ' LEU . . . -147.58 151.01 35.55 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.292 0.567 . . . . 15.0 112.337 -178.767 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.583 HG21 ' HB ' ' A' ' 77' ' ' THR . 10.7 t -139.04 102.83 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.257 -0.883 . . . . 15.0 109.105 178.909 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.535 ' OD1' HG22 ' A' ' 81' ' ' THR . 2.6 m120 65.0 14.73 9.54 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.575 -0.528 . . . . 15.0 109.575 -177.817 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 106.49 6.57 35.63 Favored Glycine 0 C--N 1.337 0.606 0 CA-C-N 115.824 -0.626 . . . . 15.0 113.336 179.77 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.656 HG13 ' O ' ' A' ' 64' ' ' VAL . 8.9 p -93.86 106.64 18.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.098 0.475 . . . . 15.0 111.066 179.54 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 49.1 m -58.8 124.62 20.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.187 -0.46 . . . . 15.0 110.716 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.544 HD13 HG23 ' A' ' 58' ' ' VAL . 0.2 OUTLIER -92.05 -14.58 29.09 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.169 -0.469 . . . . 15.0 111.467 -179.654 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -45.23 103.77 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.89 0.376 . . . . 15.0 111.183 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.85 63.82 0.55 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.793 -0.717 . . . . 15.0 112.525 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.659 ' HB1' ' CB ' ' A' ' 73' ' ' GLN . . . -173.13 166.86 4.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.837 0.351 . . . . 15.0 111.077 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.475 ' HB ' HG13 ' A' ' 26' ' ' VAL . 2.6 p -93.23 -170.49 2.41 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.023 0.44 . . . . 15.0 110.943 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' HIS . . . . . 0.672 ' CD2' HG23 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -63.96 -58.37 6.94 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.782 -0.645 . . . . 15.0 110.613 179.979 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.421 ' O ' ' HG3' ' A' ' 76' ' ' GLU . 28.9 ttmt -52.84 -35.51 57.47 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.095 -0.502 . . . . 15.0 110.823 179.392 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.659 ' CB ' ' HB1' ' A' ' 69' ' ' ALA . 3.6 mt-30 -59.21 -46.88 87.29 Favored 'General case' 0 CA--C 1.518 -0.287 0 N-CA-C 109.497 -0.557 . . . . 15.0 109.497 179.277 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.583 ' HB3' HG13 ' A' ' 35' ' ' ILE . . . -66.88 -47.8 70.72 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.596 -0.729 . . . . 15.0 109.717 178.458 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 1.025 HG23 HG21 ' A' ' 22' ' ' VAL . 0.5 OUTLIER -41.75 -42.03 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.254 0 CA-C-O 121.62 0.724 . . . . 15.0 109.182 178.575 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.421 ' HG3' ' O ' ' A' ' 72' ' ' LYS . 20.8 mt-10 -67.35 -44.02 80.07 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.644 -1.162 . . . . 15.0 110.884 179.006 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.583 ' HB ' HG21 ' A' ' 61' ' ' VAL . 4.9 p -64.42 -56.33 14.98 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 120.845 -0.342 . . . . 15.0 111.606 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.591 HD21 HG21 ' A' ' 58' ' ' VAL . 5.2 mt -53.28 -45.49 68.9 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-O 121.177 0.513 . . . . 15.0 109.931 -179.745 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -68.37 -58.32 4.55 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.462 -0.79 . . . . 15.0 110.232 179.345 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 32.9 m-20 -66.14 58.51 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.845 -0.616 . . . . 15.0 112.196 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.535 HG22 ' OD1' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -95.7 -72.82 0.61 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.742 0.306 . . . . 15.0 110.234 179.249 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 122.15 -103.36 0.84 Allowed Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.72 -0.752 . . . . 15.0 113.332 179.141 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.403 ' O ' ' HB3' ' A' ' 13' ' ' LYS . 0.4 OUTLIER -64.54 -84.66 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.105 0.409 . . . . 15.0 112.105 -178.857 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.454 HG12 ' N ' ' A' ' 85' ' ' VAL . 78.5 t -109.6 158.98 9.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.937 0.399 . . . . 15.0 110.976 -179.322 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.731 HG23 ' CB ' ' A' ' 13' ' ' LYS . 9.4 t -98.04 80.65 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.231 0.538 . . . . 15.0 110.596 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -99.71 86.96 3.43 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.73 -0.668 . . . . 15.0 110.038 179.603 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.725 ' HB3' HD21 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -103.86 121.19 42.56 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.926 -0.579 . . . . 15.0 111.983 -178.873 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.737 HD12 ' HB2' ' A' ' 8' ' ' GLU . 4.6 mp -97.19 101.25 12.77 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.421 -0.585 . . . . 15.0 109.421 178.488 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.831 HD12 ' CZ ' ' A' ' 7' ' ' PHE . 0.1 OUTLIER -105.61 -162.14 0.85 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.488 0.661 . . . . 15.0 111.964 -178.649 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.425 ' HB2' HG13 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -142.01 136.9 30.72 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 114.836 -1.075 . . . . 15.0 109.34 178.874 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -46.69 105.03 0.06 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.03 0.443 . . . . 15.0 111.114 -179.486 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.333 0 CA-C-N 115.738 -0.664 . . . . 15.0 112.849 -179.462 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.445 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 1.2 mp . . . . . 0 N--CA 1.449 -0.522 0 CA-C-O 120.908 0.385 . . . . 15.0 110.797 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.606 ' CZ ' HD12 ' A' ' 89' ' ' LEU . 0.3 OUTLIER -146.91 158.35 43.9 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.024 -0.535 . . . . 15.0 110.305 179.479 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.708 ' HB3' HD12 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -126.64 142.85 51.41 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.348 0.594 . . . . 15.0 111.937 -178.955 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.541 ' CG1' HD11 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -101.45 114.97 42.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.083 -0.962 . . . . 15.0 109.397 178.79 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -105.8 73.08 0.99 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.198 -0.455 . . . . 15.0 112.183 -178.544 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.592 HD13 ' HG3' ' A' ' 51' ' ' ARG . 5.7 tp -88.36 166.14 14.48 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.714 -0.476 . . . . 15.0 109.714 178.707 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -95.39 94.2 7.69 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.048 0.452 . . . . 15.0 111.266 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.648 ' CB ' HG23 ' A' ' 85' ' ' VAL . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.364 0 CA-C-N 115.807 -0.633 . . . . 15.0 111.114 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.652 ' N ' HD22 ' A' ' 18' ' ' LEU . 1.6 mm? . . . . . 0 N--CA 1.453 -0.29 0 CA-C-O 120.937 0.399 . . . . 15.0 110.779 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.701 ' HA3' ' HA3' ' A' ' 44' ' ' GLY . . . -160.89 42.83 0.41 Allowed Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.924 -0.655 . . . . 15.0 111.915 -179.772 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.638 HG12 ' O ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -112.74 141.29 28.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 120.915 0.388 . . . . 15.0 111.768 -179.471 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.403 ' H ' HD13 ' A' ' 41' ' ' ILE . 43.0 t -96.18 103.44 15.34 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 107.721 -1.214 . . . . 15.0 107.721 177.29 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.948 HG21 HG23 ' A' ' 75' ' ' VAL . 27.3 m -93.51 155.39 3.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 113.339 0.866 . . . . 15.0 113.339 -176.714 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.33 -178.4 6.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 114.811 -1.086 . . . . 15.0 110.19 179.498 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.448 ' O ' ' CB ' ' A' ' 71' ' ' HIS . . . 73.0 -120.58 7.32 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.486 -0.864 . . . . 15.0 112.523 179.724 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.569 ' HA3' ' N ' ' A' ' 71' ' ' HIS . . . 68.3 -63.69 0.4 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.945 -0.645 . . . . 15.0 113.522 179.361 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.674 ' O ' HG22 ' A' ' 30' ' ' VAL . 1.7 m -32.32 146.96 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 N-CA-C 112.233 0.457 . . . . 15.0 112.233 -179.123 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.412 ' CB ' ' O ' ' A' ' 32' ' ' HIS . 15.1 m-20 -79.84 57.85 2.68 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.951 -0.568 . . . . 15.0 111.195 -179.714 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -151.76 -61.43 0.17 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.832 0.349 . . . . 15.0 111.238 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.4 m -71.93 -35.22 69.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 15.0 111.347 -179.633 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.674 HG22 ' O ' ' A' ' 26' ' ' VAL . 24.7 m -84.77 -173.78 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.895 0.379 . . . . 15.0 111.445 -179.613 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 41.4 ttt85 -57.08 -39.67 75.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.082 -0.508 . . . . 15.0 111.486 -179.617 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' HIS . . . . . 0.418 ' H ' HG23 ' A' ' 30' ' ' VAL . 1.6 p-80 -174.63 -35.7 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.592 -0.276 . . . . 15.0 111.656 -179.784 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -173.77 20.62 0.06 OUTLIER Glycine 0 CA--C 1.519 0.324 0 C-N-CA 120.594 -0.813 . . . . 15.0 113.104 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.52 ' O ' HG11 ' A' ' 30' ' ' VAL . . . -97.31 152.06 19.92 Favored Glycine 0 N--CA 1.448 -0.516 0 N-CA-C 110.294 -1.122 . . . . 15.0 110.294 178.623 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.934 HD12 ' HB3' ' A' ' 74' ' ' ALA . 0.1 OUTLIER -95.35 154.18 3.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 119.668 -0.813 . . . . 15.0 112.382 -178.962 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 31.8 m-85 -136.06 107.51 6.9 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.649 -1.16 . . . . 15.0 109.206 179.224 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.792 HG22 ' N ' ' A' ' 55' ' ' GLY . 0.6 OUTLIER -55.05 148.1 3.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.035 -0.529 . . . . 15.0 111.557 -178.446 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.459 ' O ' ' HG2' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -80.26 -49.6 11.37 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.452 -0.944 . . . . 15.0 108.452 178.397 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.638 ' O ' HG12 ' A' ' 20' ' ' ILE . . . -172.27 173.11 4.31 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-N 115.661 -0.7 . . . . 15.0 110.338 178.687 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.578 ' HA ' HG12 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -96.96 112.01 28.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 109.388 -0.597 . . . . 15.0 109.388 179.041 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.695 ' HB ' ' O ' ' A' ' 19' ' ' GLY . 0.5 OUTLIER -78.28 118.81 74.52 Favored Pre-proline 0 C--N 1.328 -0.328 0 N-CA-C 113.18 0.808 . . . . 15.0 113.18 -177.301 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.605 ' HA ' ' CG ' ' A' ' 47' ' ' GLU . 36.2 Cg_endo -64.09 62.38 0.23 Allowed 'Trans proline' 0 C--N 1.357 1.012 0 C-N-CA 123.592 2.861 . . . . 15.0 112.874 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.526 ' H ' ' HG2' ' A' ' 47' ' ' GLU . 9.8 mt-30 -152.03 -47.14 0.11 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.524 -0.307 . . . . 15.0 111.596 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.701 ' HA3' ' HA3' ' A' ' 19' ' ' GLY . . . -87.9 167.47 36.52 Favored Glycine 0 C--N 1.331 0.258 0 C-N-CA 120.354 -0.927 . . . . 15.0 113.825 -179.191 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -56.99 -12.68 2.16 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.634 0.605 . . . . 15.0 112.634 -179.762 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.79 -58.56 3.36 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 120.762 0.315 . . . . 15.0 110.406 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.605 ' CG ' ' HA ' ' A' ' 42' ' ' PRO . 2.6 pp20? -57.68 -43.16 84.88 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.763 -0.653 . . . . 15.0 110.525 179.079 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 66.7 m -53.65 -70.96 0.08 Allowed 'General case' 0 CA--C 1.518 -0.265 0 CA-C-N 115.931 -0.577 . . . . 15.0 110.574 -179.411 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.524 ' CB ' HD11 ' A' ' 11' ' ' LEU . 1.6 t0 -58.13 -41.51 83.8 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.128 -0.693 . . . . 15.0 109.128 178.736 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.67 40.12 13.03 Favored Glycine 0 N--CA 1.446 -0.645 0 CA-C-N 115.31 -0.859 . . . . 15.0 111.632 179.378 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.592 ' HG3' HD13 ' A' ' 11' ' ' LEU . 0.2 OUTLIER -79.76 -50.63 10.28 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.935 0.398 . . . . 15.0 110.723 -179.252 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.607 ' CG1' HD12 ' A' ' 20' ' ' ILE . 9.3 tp -81.07 162.34 3.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.043 -0.526 . . . . 15.0 110.249 179.433 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' HIS . . . . . 0.474 ' N ' ' OD2' ' A' ' 56' ' ' ASP . 76.1 m80 -147.54 158.71 44.11 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-O 121.644 0.735 . . . . 15.0 112.281 -178.962 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.567 ' HA ' ' CG2' ' A' ' 37' ' ' VAL . 8.1 mtpt -43.09 133.28 3.89 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 114.13 -1.396 . . . . 15.0 112.956 -178.68 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.792 ' N ' HG22 ' A' ' 37' ' ' VAL . . . 50.06 29.44 14.78 Favored Glycine 0 C--N 1.332 0.34 0 CA-C-N 115.587 -0.733 . . . . 15.0 113.364 179.206 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.474 ' OD2' ' N ' ' A' ' 53' ' ' HIS . 17.4 m-20 -65.86 130.29 42.74 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.759 -0.376 . . . . 15.0 110.605 179.568 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.451 ' HE ' HD21 ' A' ' 59' ' ' LEU . 8.9 ttt180 -80.85 94.97 6.56 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.307 -0.406 . . . . 15.0 111.123 -179.767 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.914 HG22 HG22 ' A' ' 35' ' ' ILE . 1.4 m -84.44 112.72 22.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 CA-C-N 116.315 -0.402 . . . . 15.0 110.621 179.743 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.451 HD21 ' HE ' ' A' ' 57' ' ' ARG . 30.5 mt -107.4 -13.18 15.16 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 112.628 0.603 . . . . 15.0 112.628 -179.116 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.462 ' O ' HD23 ' A' ' 87' ' ' LEU . . . -151.77 148.15 27.52 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.511 0.56 . . . . 15.0 112.511 -178.806 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.726 HG11 ' O ' ' A' ' 77' ' ' THR . 19.0 t -139.2 101.6 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.24 -0.891 . . . . 15.0 109.409 178.896 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.688 ' OD1' HG22 ' A' ' 81' ' ' THR . 2.7 m120 64.9 15.32 9.84 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.667 -0.494 . . . . 15.0 109.667 -178.141 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 107.22 6.17 34.15 Favored Glycine 0 C--N 1.336 0.575 0 CA-C-N 115.867 -0.606 . . . . 15.0 113.46 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.676 HG13 ' O ' ' A' ' 64' ' ' VAL . 6.3 p -93.83 103.94 15.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 117.25 0.525 . . . . 15.0 110.786 179.313 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -55.8 132.29 49.0 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.055 -0.52 . . . . 15.0 111.22 -179.561 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.593 HD13 ' HB3' ' A' ' 69' ' ' ALA . 0.2 OUTLIER -87.64 -20.33 26.48 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.971 -0.559 . . . . 15.0 110.714 179.679 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -43.39 96.1 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.295 -0.411 . . . . 15.0 111.131 179.833 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 104.36 69.65 0.78 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.802 -0.713 . . . . 15.0 112.216 -179.68 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.593 ' HB3' HD13 ' A' ' 66' ' ' LEU . . . -173.02 159.35 3.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.787 0.327 . . . . 15.0 111.038 -179.764 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.472 ' HA ' ' N ' ' A' ' 26' ' ' VAL . 15.9 p -93.04 -173.96 3.43 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.219 -0.446 . . . . 15.0 111.275 -179.799 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' HIS . . . . . 0.696 ' CE1' HG23 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -61.22 -60.79 3.2 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.862 -0.608 . . . . 15.0 110.438 -179.978 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -52.65 -31.96 39.6 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.717 -0.674 . . . . 15.0 110.473 179.449 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.578 ' HB3' ' HB1' ' A' ' 69' ' ' ALA . 1.5 tt0 -59.56 -53.93 52.44 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.007 -0.542 . . . . 15.0 109.955 179.424 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.934 ' HB3' HD12 ' A' ' 35' ' ' ILE . . . -64.89 -44.78 88.52 Favored 'General case' 0 CA--C 1.518 -0.267 0 N-CA-C 109.432 -0.581 . . . . 15.0 109.432 178.581 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.948 HG23 HG21 ' A' ' 22' ' ' VAL . 0.5 OUTLIER -44.04 -40.6 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.21 0 N-CA-C 108.68 -0.859 . . . . 15.0 108.68 178.021 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.405 ' O ' ' CB ' ' A' ' 80' ' ' ASN . 1.8 mm-40 -67.36 -45.03 77.53 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 114.835 -1.075 . . . . 15.0 109.828 178.093 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.726 ' O ' HG11 ' A' ' 61' ' ' VAL . 80.3 p -64.13 -53.81 43.71 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 116.616 -0.265 . . . . 15.0 111.398 179.751 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.568 HD22 HD11 ' A' ' 87' ' ' LEU . 5.4 mt -53.37 -48.84 68.23 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-O 121.237 0.541 . . . . 15.0 109.851 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 16.2 ttt180 -68.57 -60.67 2.25 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.356 -0.838 . . . . 15.0 110.636 179.224 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.405 ' CB ' ' O ' ' A' ' 76' ' ' GLU . 36.6 m-20 -65.97 61.47 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.93 -0.577 . . . . 15.0 112.133 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.688 HG22 ' OD1' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -95.56 -68.77 0.78 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.779 0.323 . . . . 15.0 110.174 179.178 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 121.92 -105.9 1.03 Allowed Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.883 -0.675 . . . . 15.0 112.889 179.224 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.413 ' O ' ' HB3' ' A' ' 13' ' ' LYS . 0.2 OUTLIER -64.81 -83.05 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 111.943 0.349 . . . . 15.0 111.943 -179.241 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.476 HG12 ' N ' ' A' ' 85' ' ' VAL . 78.1 t -109.78 160.31 8.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.979 0.418 . . . . 15.0 110.944 -179.475 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.656 ' O ' HG12 ' A' ' 85' ' ' VAL . 8.7 t -97.65 82.24 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.109 0.48 . . . . 15.0 110.402 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.48 ' CE1' HD11 ' A' ' 88' ' ' LEU . 2.8 t60 -101.01 82.26 2.35 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.769 -0.65 . . . . 15.0 110.624 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.814 ' HB3' HD21 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -100.56 120.24 39.73 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.919 -0.582 . . . . 15.0 111.679 -179.332 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.708 HD12 ' HB3' ' A' ' 8' ' ' GLU . 0.2 OUTLIER -97.11 101.48 13.06 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.464 -0.569 . . . . 15.0 109.464 178.794 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.814 HD21 ' HB3' ' A' ' 87' ' ' LEU . 0.1 OUTLIER -105.86 -162.99 0.9 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.694 0.759 . . . . 15.0 112.388 -178.392 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.445 ' HA ' ' HA ' ' A' ' 6' ' ' ILE . 7.4 tt0 -139.58 120.91 14.94 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 114.475 -1.239 . . . . 15.0 109.116 178.731 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -46.86 101.92 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.005 0.431 . . . . 15.0 111.398 -179.094 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.401 0 C-N-CA 120.946 -0.645 . . . . 15.0 112.499 -179.89 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.431 HG13 ' HB2' ' A' ' 90' ' ' GLU . 1.2 mp . . . . . 0 N--CA 1.453 -0.312 0 CA-C-O 120.685 0.278 . . . . 15.0 110.791 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.792 ' CE1' HD12 ' A' ' 89' ' ' LEU . 5.8 p90 -140.69 156.77 46.13 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.413 -0.358 . . . . 15.0 110.678 179.102 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.711 ' CB ' HD12 ' A' ' 88' ' ' LEU . 10.2 pt-20 -124.22 142.84 50.91 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.339 0.59 . . . . 15.0 111.551 -179.399 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.53 ' CG1' HD11 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -101.54 116.47 45.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.132 -0.94 . . . . 15.0 109.716 178.978 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -106.21 73.53 0.99 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.292 -0.413 . . . . 15.0 112.101 -179.017 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.689 HD13 ' HG3' ' A' ' 51' ' ' ARG . 9.7 tp -88.25 160.28 17.75 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.219 -0.446 . . . . 15.0 109.867 178.809 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -96.94 95.0 7.53 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.683 0.277 . . . . 15.0 111.716 -179.62 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.889 ' HB2' HG23 ' A' ' 85' ' ' VAL . 0.6 OUTLIER . . . . . 0 CA--C 1.533 0.304 0 N-CA-C 112.619 0.6 . . . . 15.0 112.619 179.565 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 51.2 mt . . . . . 0 N--CA 1.451 -0.391 0 CA-C-O 120.734 0.302 . . . . 15.0 110.699 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.793 ' HA3' ' HA3' ' A' ' 44' ' ' GLY . . . -170.86 45.33 0.19 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.729 -0.748 . . . . 15.0 112.347 -179.72 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.744 HG12 ' O ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -112.52 139.12 38.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 120.827 0.346 . . . . 15.0 111.231 -179.913 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.414 ' H ' HD13 ' A' ' 41' ' ' ILE . 13.0 t -90.28 103.32 16.01 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.419 -0.956 . . . . 15.0 108.419 177.959 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 1.006 HG21 HG23 ' A' ' 75' ' ' VAL . 34.7 m -93.94 155.81 3.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 112.645 0.609 . . . . 15.0 112.645 -177.443 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.36 -177.08 5.64 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.31 -0.859 . . . . 15.0 110.779 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.445 ' O ' ' HB3' ' A' ' 71' ' ' HIS . . . 68.83 -119.46 9.87 Favored Glycine 0 C--N 1.332 0.336 0 C-N-CA 120.84 -0.695 . . . . 15.0 112.532 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.531 ' HA3' ' N ' ' A' ' 71' ' ' HIS . . . 68.11 -66.26 0.36 Allowed Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.833 -0.698 . . . . 15.0 113.492 179.466 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.548 ' O ' HG22 ' A' ' 30' ' ' VAL . 1.7 m -30.36 144.74 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 N-CA-C 112.384 0.513 . . . . 15.0 112.384 -179.322 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 49.5 t-20 -75.68 61.08 1.33 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.964 -0.562 . . . . 15.0 110.935 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.4 m -151.73 -66.37 0.18 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.204 -0.453 . . . . 15.0 111.028 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.8 m -68.43 -42.59 78.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.213 -0.449 . . . . 15.0 111.084 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.548 HG22 ' O ' ' A' ' 26' ' ' VAL . 16.6 m -75.12 -173.01 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.269 -0.423 . . . . 15.0 111.202 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.02 -58.36 6.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.204 -0.453 . . . . 15.0 110.934 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 93.0 m-70 -137.12 -54.56 0.7 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.23 -0.441 . . . . 15.0 111.061 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -167.76 22.05 0.1 Allowed Glycine 0 CA--C 1.517 0.215 0 C-N-CA 120.807 -0.711 . . . . 15.0 112.756 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.422 ' O ' HG11 ' A' ' 30' ' ' VAL . . . -85.63 152.86 26.71 Favored Glycine 0 N--CA 1.449 -0.453 0 N-CA-C 110.882 -0.887 . . . . 15.0 110.882 178.945 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.949 HG22 HG22 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -89.73 154.39 3.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 117.522 0.661 . . . . 15.0 111.929 -179.357 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.44 ' CE2' ' HG2' ' A' ' 57' ' ' ARG . 35.3 m-85 -139.28 107.86 5.88 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.98 -1.009 . . . . 15.0 109.998 178.917 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.819 HG22 ' N ' ' A' ' 55' ' ' GLY . 0.6 OUTLIER -55.29 156.22 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.857 -0.61 . . . . 15.0 111.037 -179.097 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.551 ' O ' ' HG2' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -91.09 -47.24 7.66 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.344 -0.984 . . . . 15.0 108.344 178.526 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.744 ' O ' HG12 ' A' ' 20' ' ' ILE . . . -172.48 171.96 4.49 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.329 -0.85 . . . . 15.0 110.062 178.611 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.56 ' HA ' ' CG1' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -96.45 108.41 21.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 109.178 -0.675 . . . . 15.0 109.178 179.191 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.756 ' HB ' ' O ' ' A' ' 19' ' ' GLY . 0.7 OUTLIER -77.99 118.43 72.11 Favored Pre-proline 0 C--N 1.328 -0.362 0 N-CA-C 113.528 0.936 . . . . 15.0 113.528 -176.904 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.597 ' HA ' ' CG ' ' A' ' 47' ' ' GLU . 36.8 Cg_endo -64.31 61.81 0.25 Allowed 'Trans proline' 0 C--N 1.356 0.971 0 C-N-CA 123.602 2.868 . . . . 15.0 112.907 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.508 ' H ' ' HG2' ' A' ' 47' ' ' GLU . 5.4 mm100 -149.42 -46.42 0.14 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.513 -0.312 . . . . 15.0 111.398 179.779 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.793 ' HA3' ' HA3' ' A' ' 19' ' ' GLY . . . -87.88 167.74 36.82 Favored Glycine 0 C--N 1.33 0.204 0 C-N-CA 120.443 -0.884 . . . . 15.0 113.825 -179.249 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -59.61 -13.53 9.85 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.168 -0.516 . . . . 15.0 112.244 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.22 -55.99 6.28 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 120.701 0.286 . . . . 15.0 110.79 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.597 ' CG ' ' HA ' ' A' ' 42' ' ' PRO . 2.9 pp20? -57.73 -42.48 83.95 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-N 115.973 -0.558 . . . . 15.0 110.45 179.144 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 32.8 t -53.51 -69.44 0.12 Allowed 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 115.804 -0.635 . . . . 15.0 110.459 -179.244 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.563 ' HB2' HD11 ' A' ' 11' ' ' LEU . 0.4 OUTLIER -59.42 -42.04 90.92 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.07 -0.715 . . . . 15.0 109.07 178.729 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.75 43.02 9.34 Favored Glycine 0 N--CA 1.447 -0.622 0 CA-C-N 115.36 -0.836 . . . . 15.0 111.645 179.42 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.689 ' HG3' HD13 ' A' ' 11' ' ' LEU . 0.7 OUTLIER -79.89 -41.63 25.79 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.712 0.291 . . . . 15.0 111.071 -179.111 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.56 ' CG2' HG11 ' A' ' 37' ' ' VAL . 5.9 mm -91.25 161.49 2.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 120.921 0.391 . . . . 15.0 110.922 179.702 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' HIS . . . . . 0.552 ' N ' HG22 ' A' ' 52' ' ' ILE . 75.8 m80 -142.38 154.91 45.03 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-O 121.447 0.641 . . . . 15.0 111.083 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.551 ' HG2' ' O ' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -37.68 133.13 0.83 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.552 -1.203 . . . . 15.0 112.934 -178.552 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.819 ' N ' HG22 ' A' ' 37' ' ' VAL . . . 50.05 33.48 21.87 Favored Glycine 0 C--N 1.335 0.489 0 CA-C-N 115.822 -0.626 . . . . 15.0 113.716 179.243 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.431 ' H ' HG13 ' A' ' 37' ' ' VAL . 2.8 m-20 -65.34 130.71 44.3 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 117.178 0.489 . . . . 15.0 110.181 179.16 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.44 ' HG2' ' CE2' ' A' ' 36' ' ' TYR . 30.9 mtt180 -83.28 94.83 8.0 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.341 -0.39 . . . . 15.0 110.522 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.949 HG22 HG22 ' A' ' 35' ' ' ILE . 1.1 m -87.87 117.22 31.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 121.039 0.447 . . . . 15.0 111.055 -179.713 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.555 HD12 ' HG3' ' A' ' 67' ' ' GLU . 2.9 mm? -107.17 -14.23 14.96 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 115.797 -0.638 . . . . 15.0 112.567 -179.129 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.576 ' HB3' ' HB2' ' A' ' 88' ' ' LEU . . . -149.98 146.56 27.08 Favored 'General case' 0 N--CA 1.462 0.162 0 N-CA-C 112.591 0.589 . . . . 15.0 112.591 -178.819 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.82 HG11 ' O ' ' A' ' 77' ' ' THR . 45.9 t -139.25 100.26 1.37 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.224 0 CA-C-N 115.32 -0.854 . . . . 15.0 109.385 178.751 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.637 ' OD1' HG22 ' A' ' 81' ' ' THR . 2.6 m120 65.05 16.57 10.64 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.086 -0.507 . . . . 15.0 109.937 -178.157 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 107.05 4.39 35.83 Favored Glycine 0 C--N 1.336 0.531 0 CA-C-N 115.848 -0.614 . . . . 15.0 113.387 179.601 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.626 HG13 ' O ' ' A' ' 64' ' ' VAL . 4.3 p -93.79 107.04 18.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 121.087 0.47 . . . . 15.0 110.78 179.499 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -57.55 130.73 47.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 15.0 111.049 -179.526 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.937 HD11 ' HB2' ' A' ' 74' ' ' ALA . 0.2 OUTLIER -87.69 -27.06 22.65 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.067 -0.515 . . . . 15.0 110.811 179.98 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.555 ' HG3' HD12 ' A' ' 59' ' ' LEU . 82.2 mt-10 -47.39 103.49 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.338 -0.392 . . . . 15.0 111.019 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.8 58.73 0.54 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.756 -0.735 . . . . 15.0 112.425 -179.734 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.562 ' HB1' ' CB ' ' A' ' 73' ' ' GLN . . . -173.1 165.61 4.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.901 0.382 . . . . 15.0 111.07 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.497 HG22 ' HA ' ' A' ' 26' ' ' VAL . 17.3 p -93.13 -172.93 3.11 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.095 -0.502 . . . . 15.0 111.046 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' HIS . . . . . 0.74 ' CE1' HG23 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -63.07 -59.7 4.43 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.797 -0.638 . . . . 15.0 110.563 -179.924 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.41 ' HA ' ' HB ' ' A' ' 75' ' ' VAL . 7.6 ttpt -52.56 -33.77 47.28 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.838 -0.619 . . . . 15.0 110.807 179.719 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.562 ' CB ' ' HB1' ' A' ' 69' ' ' ALA . 7.0 mt-30 -59.5 -50.79 72.57 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.688 -0.486 . . . . 15.0 109.688 179.339 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.937 ' HB2' HD11 ' A' ' 66' ' ' LEU . . . -66.97 -43.82 82.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.95 -0.568 . . . . 15.0 109.697 178.416 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 1.006 HG23 HG21 ' A' ' 22' ' ' VAL . 0.5 OUTLIER -43.34 -41.76 1.35 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.289 0 N-CA-C 108.878 -0.786 . . . . 15.0 108.878 178.319 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.407 ' O ' ' CB ' ' A' ' 80' ' ' ASN . 2.0 mt-10 -67.17 -44.3 80.07 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 114.822 -1.081 . . . . 15.0 110.022 178.323 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.82 ' O ' HG11 ' A' ' 61' ' ' VAL . 59.4 p -64.06 -54.38 34.96 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-N 116.665 -0.243 . . . . 15.0 111.596 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.717 HD21 HG21 ' A' ' 58' ' ' VAL . 8.8 mt -53.45 -48.98 68.35 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.317 0.58 . . . . 15.0 110.03 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.417 ' HB2' ' O ' ' A' ' 75' ' ' VAL . 0.0 OUTLIER -68.44 -59.15 3.38 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.251 -0.886 . . . . 15.0 110.723 179.722 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.407 ' CB ' ' O ' ' A' ' 76' ' ' GLU . 14.6 m120 -65.97 62.87 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.1 -0.5 . . . . 15.0 111.909 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.637 HG22 ' OD1' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -95.46 -73.66 0.58 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 110.146 -0.316 . . . . 15.0 110.146 179.205 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 122.15 -105.4 0.98 Allowed Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.696 -0.764 . . . . 15.0 113.268 179.048 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.404 ' O ' ' HB3' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -64.88 -83.64 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.761 0.315 . . . . 15.0 111.18 -179.39 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.476 HG12 ' N ' ' A' ' 85' ' ' VAL . 79.7 t -109.82 160.18 8.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.257 -0.428 . . . . 15.0 110.864 -179.755 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.889 HG23 ' HB2' ' A' ' 13' ' ' LYS . 3.6 t -97.63 81.64 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.137 0.494 . . . . 15.0 110.18 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -96.41 80.23 3.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.727 -0.669 . . . . 15.0 110.391 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.67 ' HB3' HD21 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -102.12 124.68 48.15 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.063 -0.517 . . . . 15.0 111.649 -179.269 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.711 HD12 ' CB ' ' A' ' 8' ' ' GLU . 4.7 mp -102.01 99.01 9.13 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.658 -0.497 . . . . 15.0 109.658 178.825 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.792 HD12 ' CE1' ' A' ' 7' ' ' PHE . 0.1 OUTLIER -102.93 -161.42 0.84 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.383 0.611 . . . . 15.0 111.841 -178.772 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.431 ' HB2' HG13 ' A' ' 6' ' ' ILE . 3.1 tt0 -140.93 144.01 34.92 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.059 -0.973 . . . . 15.0 109.772 179.108 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 7.1 tptp -55.17 104.95 0.14 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.877 0.37 . . . . 15.0 110.961 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.36 0 C-N-CA 120.845 -0.693 . . . . 15.0 112.6 -179.897 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.467 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 1.3 mp . . . . . 0 N--CA 1.45 -0.462 0 CA-C-O 120.893 0.377 . . . . 15.0 111.176 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.645 ' CE1' HD12 ' A' ' 89' ' ' LEU . 6.8 p90 -140.64 164.31 30.53 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.063 -0.517 . . . . 15.0 110.203 178.924 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.753 ' HB2' HD12 ' A' ' 88' ' ' LEU . 0.3 OUTLIER -130.2 143.24 50.66 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.284 0.564 . . . . 15.0 111.66 -179.506 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.575 ' CG1' HD11 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -101.42 114.35 40.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.184 -0.916 . . . . 15.0 109.397 178.859 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -106.01 72.25 0.93 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.213 -0.449 . . . . 15.0 112.137 -178.715 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.629 HD13 ' HG3' ' A' ' 51' ' ' ARG . 5.4 tp -88.21 166.39 14.39 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.429 -0.582 . . . . 15.0 109.429 178.61 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -96.02 97.66 9.77 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.05 0.453 . . . . 15.0 111.262 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.74 ' CB ' HG23 ' A' ' 85' ' ' VAL . 0.1 OUTLIER . . . . . 0 C--N 1.327 -0.37 0 CA-C-N 115.735 -0.666 . . . . 15.0 111.42 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.4 mp . . . . . 0 N--CA 1.455 -0.204 0 CA-C-O 120.955 0.407 . . . . 15.0 110.715 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.808 ' O ' ' HB ' ' A' ' 41' ' ' ILE . . . -161.12 46.07 0.39 Allowed Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 121.034 -0.603 . . . . 15.0 111.794 -179.791 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.757 HG12 ' O ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -112.77 136.67 48.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 120.927 0.394 . . . . 15.0 111.581 -179.609 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 37.4 t -88.65 103.13 15.64 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.285 -1.006 . . . . 15.0 108.285 177.857 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.887 HG21 HG23 ' A' ' 75' ' ' VAL . 8.0 m -93.6 149.11 4.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 112.643 0.609 . . . . 15.0 112.643 -177.433 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.489 ' HA ' ' ND1' ' A' ' 71' ' ' HIS . 5.4 t -150.02 179.24 8.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.39 -0.823 . . . . 15.0 110.468 179.185 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.696 ' O ' HG22 ' A' ' 26' ' ' VAL . . . 82.78 -117.32 4.38 Favored Glycine 0 C--N 1.331 0.298 0 C-N-CA 120.542 -0.837 . . . . 15.0 112.649 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.579 ' HA3' ' N ' ' A' ' 71' ' ' HIS . . . 63.34 -65.87 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 121.084 -0.579 . . . . 15.0 113.742 179.184 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.696 HG22 ' O ' ' A' ' 24' ' ' GLY . 0.0 OUTLIER -26.57 139.86 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 N-CA-C 112.633 0.605 . . . . 15.0 112.633 -178.994 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.425 ' HA ' ' O ' ' A' ' 32' ' ' HIS . 54.2 t-20 -77.62 57.67 1.65 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.768 -0.651 . . . . 15.0 110.927 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 5.9 m -151.69 -61.18 0.17 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.24 -0.437 . . . . 15.0 110.767 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.64 -34.77 77.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.15 -0.477 . . . . 15.0 110.692 179.755 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.642 HG22 ' O ' ' A' ' 26' ' ' VAL . 33.2 m -88.02 -174.34 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.064 -0.516 . . . . 15.0 111.003 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -70.53 -51.5 28.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.394 -0.367 . . . . 15.0 111.241 -179.764 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' HIS . . . . . 0.425 ' O ' ' HA ' ' A' ' 27' ' ' ASN . 76.8 m80 -132.52 -70.97 0.54 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.401 -0.363 . . . . 15.0 111.255 -179.745 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -162.75 24.84 0.21 Allowed Glycine 0 C--O 1.23 -0.145 0 C-N-CA 120.904 -0.665 . . . . 15.0 112.388 -179.733 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -86.89 148.19 21.5 Favored Glycine 0 N--CA 1.448 -0.522 0 N-CA-C 110.171 -1.172 . . . . 15.0 110.171 178.658 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 1.056 HD12 ' HB3' ' A' ' 74' ' ' ALA . 0.3 OUTLIER -88.68 153.78 3.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 C-N-CA 119.574 -0.85 . . . . 15.0 112.297 -178.894 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.477 ' CE2' ' CG ' ' A' ' 57' ' ' ARG . 32.4 m-85 -134.16 107.89 7.97 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.644 -1.162 . . . . 15.0 109.056 179.321 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.797 HG22 ' N ' ' A' ' 55' ' ' GLY . 0.7 OUTLIER -54.96 148.02 3.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.144 0.497 . . . . 15.0 111.189 -178.479 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.445 ' O ' ' HG2' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -80.05 -49.06 12.31 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.882 -0.784 . . . . 15.0 108.882 178.91 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.757 ' O ' HG12 ' A' ' 20' ' ' ILE . . . -172.33 172.45 4.46 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 115.999 -0.546 . . . . 15.0 110.184 178.439 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.556 ' HA ' ' CG1' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -96.72 110.01 24.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 108.957 -0.757 . . . . 15.0 108.957 178.905 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.808 ' HB ' ' O ' ' A' ' 19' ' ' GLY . 0.5 OUTLIER -78.0 115.25 48.98 Favored Pre-proline 0 C--N 1.326 -0.433 0 N-CA-C 113.275 0.843 . . . . 15.0 113.275 -177.053 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.617 ' HA ' ' CG ' ' A' ' 47' ' ' GLU . 30.3 Cg_exo -62.56 59.49 0.14 Allowed 'Trans proline' 0 C--N 1.358 1.07 0 C-N-CA 123.612 2.875 . . . . 15.0 112.95 179.706 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.528 ' N ' ' HG2' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -147.45 -47.38 0.17 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.594 0.235 . . . . 15.0 111.341 -179.985 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.739 ' HA3' ' HA3' ' A' ' 19' ' ' GLY . . . -87.67 168.89 38.37 Favored Glycine 0 C--N 1.33 0.217 0 C-N-CA 120.398 -0.906 . . . . 15.0 113.801 -179.136 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -58.12 -13.78 5.52 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.702 0.63 . . . . 15.0 112.702 -179.673 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.03 -56.46 5.59 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.97 -0.292 . . . . 15.0 110.69 -179.688 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.617 ' CG ' ' HA ' ' A' ' 42' ' ' PRO . 2.8 pp20? -57.61 -43.33 84.68 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.997 -0.547 . . . . 15.0 110.434 179.172 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -53.81 -70.21 0.1 Allowed 'General case' 0 CA--C 1.518 -0.256 0 CA-C-N 115.902 -0.59 . . . . 15.0 110.523 -179.473 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.539 ' CB ' HD11 ' A' ' 11' ' ' LEU . 0.1 OUTLIER -58.13 -41.59 83.99 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.137 -0.69 . . . . 15.0 109.137 178.786 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.72 40.49 12.26 Favored Glycine 0 N--CA 1.445 -0.702 0 CA-C-N 115.305 -0.861 . . . . 15.0 111.676 179.309 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.629 ' HG3' HD13 ' A' ' 11' ' ' LEU . 0.1 OUTLIER -79.74 -49.9 11.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.891 0.376 . . . . 15.0 110.65 -179.351 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.611 ' CG1' HD12 ' A' ' 20' ' ' ILE . 8.8 tp -81.14 161.21 3.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.02 -0.536 . . . . 15.0 110.241 179.464 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' HIS . . . . . 0.444 ' N ' ' OD2' ' A' ' 56' ' ' ASP . 75.2 m80 -146.07 156.77 43.69 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-O 121.581 0.705 . . . . 15.0 112.258 -179.047 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.557 ' HA ' ' CG2' ' A' ' 37' ' ' VAL . 0.6 OUTLIER -43.28 132.51 4.37 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.3 -1.318 . . . . 15.0 112.902 -178.666 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.797 ' N ' HG22 ' A' ' 37' ' ' VAL . . . 50.98 29.87 21.34 Favored Glycine 0 C--N 1.335 0.475 0 CA-C-N 115.785 -0.643 . . . . 15.0 113.456 179.137 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.444 ' OD2' ' N ' ' A' ' 53' ' ' HIS . 6.4 m-20 -65.76 128.81 37.46 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.827 -0.349 . . . . 15.0 110.51 179.516 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.477 ' CG ' ' CE2' ' A' ' 36' ' ' TYR . 2.3 mtp85 -80.62 95.45 6.56 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.476 -0.329 . . . . 15.0 110.663 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.953 HG22 HG22 ' A' ' 35' ' ' ILE . 1.5 m -85.76 113.42 23.91 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-O 121.094 0.474 . . . . 15.0 111.177 -179.654 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.502 HD22 ' N ' ' A' ' 59' ' ' LEU . 3.6 mm? -107.35 -12.08 15.41 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 115.677 -0.692 . . . . 15.0 112.505 -179.288 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.819 ' HB3' ' HB2' ' A' ' 88' ' ' LEU . . . -150.71 148.25 28.33 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 112.762 0.653 . . . . 15.0 112.762 -178.709 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.685 HG11 ' O ' ' A' ' 77' ' ' THR . 15.4 t -139.12 99.51 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.231 -0.895 . . . . 15.0 109.107 178.741 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.73 ' OD1' HG22 ' A' ' 81' ' ' THR . 9.2 m120 65.22 16.41 10.53 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.871 -0.418 . . . . 15.0 109.871 -177.987 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 107.2 4.93 35.3 Favored Glycine 0 C--N 1.336 0.544 0 CA-C-N 116.039 -0.528 . . . . 15.0 113.465 179.631 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.663 HG13 ' O ' ' A' ' 64' ' ' VAL . 5.2 p -93.8 106.37 17.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 117.168 0.484 . . . . 15.0 110.783 179.506 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.2 m -56.33 130.15 43.38 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.171 -0.468 . . . . 15.0 111.051 -179.609 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.551 HD21 ' OG1' ' A' ' 77' ' ' THR . 0.2 OUTLIER -89.44 -21.38 23.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.075 -0.511 . . . . 15.0 110.997 179.946 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -45.76 101.5 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.869 0.366 . . . . 15.0 111.062 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.78 63.11 0.55 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.791 -0.718 . . . . 15.0 112.4 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.733 ' HB1' ' CB ' ' A' ' 73' ' ' GLN . . . -173.02 160.59 4.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.89 0.376 . . . . 15.0 111.035 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.453 ' HB ' ' HA ' ' A' ' 26' ' ' VAL . 3.0 p -93.17 -170.54 2.43 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.084 0.468 . . . . 15.0 111.055 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' HIS . . . . . 0.715 ' CD2' HG23 ' A' ' 22' ' ' VAL . 0.2 OUTLIER -60.75 -61.02 2.89 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.691 -0.686 . . . . 15.0 110.13 179.908 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.556 ' O ' HG12 ' A' ' 75' ' ' VAL . 12.7 ttpp -53.21 -34.79 58.55 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.716 -0.674 . . . . 15.0 110.863 179.234 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.733 ' CB ' ' HB1' ' A' ' 69' ' ' ALA . 3.3 mt-30 -59.42 -54.9 41.37 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.645 -0.502 . . . . 15.0 109.645 179.575 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 1.056 ' HB3' HD12 ' A' ' 35' ' ' ILE . . . -63.9 -43.55 95.65 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.823 -0.626 . . . . 15.0 109.536 178.458 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.887 HG23 HG21 ' A' ' 22' ' ' VAL . 0.5 OUTLIER -44.25 -40.06 1.68 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.296 0 N-CA-C 108.771 -0.825 . . . . 15.0 108.771 178.176 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.522 ' O ' ' HB2' ' A' ' 80' ' ' ASN . 3.6 mm-40 -67.42 -45.01 77.39 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 114.793 -1.094 . . . . 15.0 110.302 178.377 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.685 ' O ' HG11 ' A' ' 61' ' ' VAL . 32.9 p -64.02 -54.64 31.08 Favored 'General case' 0 C--O 1.231 0.124 0 C-N-CA 121.055 -0.258 . . . . 15.0 111.509 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.559 HD21 HG21 ' A' ' 58' ' ' VAL . 6.5 mt -53.37 -46.6 69.68 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-O 121.262 0.553 . . . . 15.0 109.8 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.425 ' HB2' ' O ' ' A' ' 75' ' ' VAL . 8.9 tpp180 -68.49 -59.81 2.88 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.266 -0.879 . . . . 15.0 110.5 179.284 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.522 ' HB2' ' O ' ' A' ' 76' ' ' GLU . 10.9 m-80 -66.12 62.11 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.98 -0.554 . . . . 15.0 111.833 179.801 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.73 HG22 ' OD1' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -93.74 -74.16 0.54 Allowed 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.804 -0.443 . . . . 15.0 109.804 179.182 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 122.03 -106.15 1.05 Allowed Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.802 -0.713 . . . . 15.0 113.195 179.019 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -64.7 -82.13 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 111.984 0.365 . . . . 15.0 111.984 -179.067 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.436 HG12 ' N ' ' A' ' 85' ' ' VAL . 62.4 t -109.87 158.29 10.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.06 0.457 . . . . 15.0 110.87 -179.335 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.74 HG23 ' CB ' ' A' ' 13' ' ' LYS . 14.0 t -97.93 80.96 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 116.084 -0.507 . . . . 15.0 110.569 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -103.13 83.39 2.2 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.901 -0.591 . . . . 15.0 110.265 179.718 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.805 ' HB3' HD21 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -99.93 118.32 36.11 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.952 -0.567 . . . . 15.0 111.756 -179.088 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.819 ' HB2' ' HB3' ' A' ' 60' ' ' ALA . 4.3 mp -92.14 101.1 13.62 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.757 -0.46 . . . . 15.0 109.757 178.914 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.805 HD21 ' HB3' ' A' ' 87' ' ' LEU . 0.2 OUTLIER -105.65 -159.71 0.72 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.303 0.573 . . . . 15.0 111.66 -178.836 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.467 ' HA ' ' HA ' ' A' ' 6' ' ' ILE . 3.1 tt0 -140.58 145.23 36.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.311 -0.859 . . . . 15.0 110.195 179.243 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.85 106.87 0.34 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.249 -0.432 . . . . 15.0 110.977 -179.837 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.379 0 C-N-CA 120.842 -0.695 . . . . 15.0 112.581 -179.849 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.531 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 1.5 mp . . . . . 0 N--CA 1.45 -0.425 0 CA-C-O 120.893 0.378 . . . . 15.0 111.301 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.579 ' CE1' HD12 ' A' ' 89' ' ' LEU . 3.8 p90 -144.56 165.03 29.15 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.061 -0.518 . . . . 15.0 110.415 178.799 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.727 ' CB ' HD12 ' A' ' 88' ' ' LEU . 10.7 pt-20 -130.19 143.84 51.01 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.201 0.524 . . . . 15.0 111.6 -179.05 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.454 HG23 ' HB3' ' A' ' 51' ' ' ARG . 0.2 OUTLIER -101.64 117.13 46.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.441 -0.799 . . . . 15.0 109.542 178.615 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 -106.14 74.86 1.06 Allowed 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 112.33 0.493 . . . . 15.0 112.33 -178.833 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.559 HD11 ' CB ' ' A' ' 49' ' ' ASP . 6.8 tp -88.19 166.34 14.44 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.389 -0.597 . . . . 15.0 109.389 178.43 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -96.2 95.76 8.35 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.041 0.448 . . . . 15.0 111.28 -179.797 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.662 ' CB ' HG23 ' A' ' 85' ' ' VAL . 0.2 OUTLIER . . . . . 0 C--N 1.327 -0.396 0 CA-C-N 115.73 -0.668 . . . . 15.0 111.195 179.869 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.0 mp . . . . . 0 N--CA 1.454 -0.231 0 CA-C-O 120.826 0.346 . . . . 15.0 110.561 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.649 ' O ' ' HB ' ' A' ' 41' ' ' ILE . . . -160.99 36.86 0.42 Allowed Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 121.136 -0.554 . . . . 15.0 111.782 -179.636 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.616 HD13 ' HB ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -112.66 141.68 27.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 120.996 0.427 . . . . 15.0 112.027 -179.291 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 31.4 t -96.24 102.69 14.52 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 107.301 -1.37 . . . . 15.0 107.301 176.86 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.998 HG21 HG23 ' A' ' 75' ' ' VAL . 14.1 m -93.33 148.26 4.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 113.536 0.939 . . . . 15.0 113.536 -176.293 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.533 ' O ' ' O ' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -149.86 157.92 43.66 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.005 -0.998 . . . . 15.0 110.699 179.586 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.412 ' O ' HG12 ' A' ' 35' ' ' ILE . . . 67.71 112.67 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.444 -0.884 . . . . 15.0 113.42 178.653 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.508 ' HA3' ' N ' ' A' ' 71' ' ' HIS . . . -163.74 -38.97 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 121.112 -0.566 . . . . 15.0 112.301 179.244 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.508 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 0.2 OUTLIER -40.78 162.58 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-O 120.868 0.366 . . . . 15.0 111.823 179.935 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -87.91 51.72 2.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.454 . . . . 15.0 110.887 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -151.63 -62.15 0.17 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.094 -0.503 . . . . 15.0 110.663 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.75 -52.34 51.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.192 -0.458 . . . . 15.0 110.609 179.753 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.441 HG22 ' O ' ' A' ' 26' ' ' VAL . 16.4 m -87.98 -177.68 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.137 -0.483 . . . . 15.0 110.771 179.726 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 5.1 ppt_? -88.41 127.1 35.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.851 0.358 . . . . 15.0 111.184 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 57.1 m80 62.76 -82.14 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.005 -0.543 . . . . 15.0 111.424 179.709 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -177.25 33.08 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.721 -0.752 . . . . 15.0 112.661 -179.525 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -93.52 156.35 22.58 Favored Glycine 0 N--CA 1.45 -0.388 0 N-CA-C 110.846 -0.902 . . . . 15.0 110.846 179.079 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.955 HG22 HG22 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -97.64 153.6 3.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 119.854 -0.738 . . . . 15.0 111.997 -179.29 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.533 ' O ' ' O ' ' A' ' 23' ' ' THR . 26.8 m-85 -134.17 106.82 7.37 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.963 -1.017 . . . . 15.0 109.7 179.225 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.806 HG22 ' N ' ' A' ' 55' ' ' GLY . 0.7 OUTLIER -54.63 146.64 3.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.106 0.479 . . . . 15.0 111.282 -178.593 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.475 ' HB3' ' OG1' ' A' ' 23' ' ' THR . 0.0 OUTLIER -79.94 -48.87 12.71 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.319 -0.993 . . . . 15.0 108.319 178.78 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.597 ' O ' HG12 ' A' ' 20' ' ' ILE . . . -172.23 171.07 4.95 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.285 -0.87 . . . . 15.0 110.119 178.612 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.567 ' HA ' HG12 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -97.1 110.26 24.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.085 0.469 . . . . 15.0 110.182 179.558 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.649 ' HB ' ' O ' ' A' ' 19' ' ' GLY . 0.4 OUTLIER -78.47 109.58 10.99 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 115.701 -0.682 . . . . 15.0 112.32 -178.326 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.466 ' N ' ' HG2' ' A' ' 47' ' ' GLU . 31.4 Cg_endo -63.45 65.88 0.18 Allowed 'Trans proline' 0 C--N 1.355 0.919 0 C-N-CA 123.159 2.572 . . . . 15.0 112.568 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.424 ' N ' ' O ' ' A' ' 41' ' ' ILE . 5.2 tp60 -147.32 -53.34 0.21 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.322 -0.854 . . . . 15.0 109.112 179.469 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.57 ' HA3' ' HA3' ' A' ' 19' ' ' GLY . . . -87.93 157.18 28.19 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.667 -0.778 . . . . 15.0 112.51 179.175 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -41.58 -17.38 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 113.588 0.958 . . . . 15.0 113.588 -179.531 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.43 ' N ' ' O ' ' A' ' 44' ' ' GLY . . . -71.65 -70.72 0.31 Allowed 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.75 -0.38 . . . . 15.0 111.345 -179.409 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.501 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 4.3 tp10 -58.54 -40.6 83.43 Favored 'General case' 0 N--CA 1.463 0.179 0 C-N-CA 120.587 -0.445 . . . . 15.0 110.436 179.546 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.8 m -54.15 -63.56 1.11 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.997 -0.547 . . . . 15.0 110.338 179.355 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.559 ' CB ' HD11 ' A' ' 11' ' ' LEU . 1.9 t70 -63.5 -40.05 96.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.108 -0.496 . . . . 15.0 109.899 179.081 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.58 43.37 8.49 Favored Glycine 0 N--CA 1.449 -0.437 0 CA-C-N 115.678 -0.692 . . . . 15.0 112.836 179.472 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.541 ' HG3' HD13 ' A' ' 11' ' ' LEU . 1.1 mmt-85 -89.34 -52.81 4.85 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.938 0.399 . . . . 15.0 110.557 179.696 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.568 ' CG1' HD12 ' A' ' 20' ' ' ILE . 9.7 tp -81.0 159.16 4.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.036 -0.529 . . . . 15.0 110.398 179.546 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' HIS . . . . . 0.41 ' O ' ' HB2' ' A' ' 56' ' ' ASP . 80.3 m80 -139.69 160.88 38.87 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-O 121.794 0.807 . . . . 15.0 112.758 -178.871 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.574 ' HA ' ' CG2' ' A' ' 37' ' ' VAL . 0.2 OUTLIER -44.67 134.29 5.53 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.002 -1.453 . . . . 15.0 113.1 -178.657 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.806 ' N ' HG22 ' A' ' 37' ' ' VAL . . . 49.66 31.8 15.97 Favored Glycine 0 C--N 1.334 0.442 0 CA-C-N 115.738 -0.664 . . . . 15.0 113.636 178.802 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.41 ' HB2' ' O ' ' A' ' 53' ' ' HIS . 0.3 OUTLIER -65.97 131.71 46.88 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.506 -0.478 . . . . 15.0 110.683 179.442 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.491 ' HG2' ' CE2' ' A' ' 36' ' ' TYR . 6.6 mtp85 -82.65 87.41 6.73 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.351 -0.386 . . . . 15.0 110.113 179.411 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.955 HG22 HG22 ' A' ' 35' ' ' ILE . 1.3 m -79.31 113.25 18.4 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 CA-C-O 121.158 0.504 . . . . 15.0 111.087 -179.379 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 21.3 mt -107.56 -14.48 14.82 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 115.472 -0.786 . . . . 15.0 112.493 -179.173 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.714 ' HB3' ' HB2' ' A' ' 88' ' ' LEU . . . -147.5 150.41 34.51 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.604 0.594 . . . . 15.0 112.604 -178.414 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.781 HG11 ' O ' ' A' ' 77' ' ' THR . 80.9 t -139.05 102.72 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.175 -0.92 . . . . 15.0 109.018 178.746 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.665 ' OD1' HG22 ' A' ' 81' ' ' THR . 2.4 m120 65.11 14.89 9.68 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.723 -0.473 . . . . 15.0 109.723 -177.901 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 106.4 6.71 35.72 Favored Glycine 0 C--N 1.336 0.566 0 CA-C-N 115.839 -0.619 . . . . 15.0 113.366 179.64 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.68 HG13 ' O ' ' A' ' 64' ' ' VAL . 6.5 p -93.79 104.96 16.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 117.17 0.485 . . . . 15.0 110.874 179.486 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 50.8 m -58.47 121.3 10.55 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.148 -0.478 . . . . 15.0 110.733 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.47 HD13 HG23 ' A' ' 58' ' ' VAL . 0.5 OUTLIER -87.56 -10.04 52.7 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.031 -0.532 . . . . 15.0 111.185 -179.879 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -46.12 98.48 0.01 OUTLIER 'General case' 0 C--N 1.334 -0.105 0 CA-C-O 120.916 0.389 . . . . 15.0 110.799 179.734 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.94 68.66 0.62 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.75 -0.738 . . . . 15.0 112.193 -179.515 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.454 ' HB1' ' CB ' ' A' ' 73' ' ' GLN . . . -172.87 167.7 5.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.783 0.325 . . . . 15.0 110.863 -179.892 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.508 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 7.0 p -92.98 -175.05 3.76 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.238 -0.437 . . . . 15.0 111.335 -179.604 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' HIS . . . . . 0.681 ' CD2' HG23 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -63.32 -61.2 2.51 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.928 -0.578 . . . . 15.0 110.283 -179.873 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.401 ' HA ' ' HB ' ' A' ' 75' ' ' VAL . 3.0 ttpp -52.7 -33.06 45.92 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.772 -0.649 . . . . 15.0 110.732 179.568 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.454 ' CB ' ' HB1' ' A' ' 69' ' ' ALA . 5.9 mt-30 -59.41 -48.25 82.36 Favored 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 109.403 -0.591 . . . . 15.0 109.403 179.236 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.461 ' HA ' ' OG1' ' A' ' 77' ' ' THR . . . -65.37 -47.99 74.5 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.719 -0.673 . . . . 15.0 109.214 178.307 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.998 HG23 HG21 ' A' ' 22' ' ' VAL . 0.5 OUTLIER -43.39 -39.42 1.17 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.242 0 N-CA-C 108.74 -0.837 . . . . 15.0 108.74 178.07 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -67.31 -45.92 75.06 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 114.739 -1.119 . . . . 15.0 110.349 178.468 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.781 ' O ' HG11 ' A' ' 61' ' ' VAL . 10.0 p -64.37 -53.18 52.6 Favored 'General case' 0 C--O 1.231 0.129 0 C-N-CA 120.893 -0.323 . . . . 15.0 111.309 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.696 HD23 HG21 ' A' ' 61' ' ' VAL . 5.7 mt -53.36 -48.28 68.69 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-O 121.219 0.533 . . . . 15.0 109.944 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -68.4 -59.04 3.47 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.353 -0.84 . . . . 15.0 110.351 179.357 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -66.02 61.47 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.846 -0.615 . . . . 15.0 111.911 179.739 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.665 HG22 ' OD1' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -95.72 -71.01 0.69 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.693 0.282 . . . . 15.0 110.51 179.519 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 122.15 -104.42 0.91 Allowed Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.824 -0.703 . . . . 15.0 113.186 179.345 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.426 ' O ' ' HB3' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -64.64 -83.41 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 111.965 0.357 . . . . 15.0 111.965 -179.066 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.439 HG12 ' N ' ' A' ' 85' ' ' VAL . 53.9 t -109.46 159.91 8.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.94 0.4 . . . . 15.0 110.839 -179.543 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.662 HG23 ' CB ' ' A' ' 13' ' ' LYS . 24.5 t -97.87 79.59 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.161 -0.472 . . . . 15.0 110.52 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -100.63 85.39 2.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.856 -0.611 . . . . 15.0 110.594 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.713 ' HB3' HD21 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -99.57 123.11 43.53 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.083 -0.508 . . . . 15.0 111.513 -179.468 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.727 HD12 ' CB ' ' A' ' 8' ' ' GLU . 4.7 mp -98.5 100.74 12.02 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.891 -0.411 . . . . 15.0 109.891 179.014 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.713 HD21 ' HB3' ' A' ' 87' ' ' LEU . 0.1 OUTLIER -105.93 -162.29 0.85 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.428 0.632 . . . . 15.0 111.903 -178.87 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.531 ' HA ' ' HA ' ' A' ' 6' ' ' ILE . 3.1 tt0 -138.25 142.26 39.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 114.977 -1.01 . . . . 15.0 109.952 178.88 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 4.2 tptt -54.25 103.32 0.08 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.36 -0.382 . . . . 15.0 111.129 -179.58 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.37 0 C-N-CA 120.862 -0.685 . . . . 15.0 112.522 -179.971 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.427 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 1.4 mp . . . . . 0 N--CA 1.45 -0.425 0 CA-C-O 120.86 0.362 . . . . 15.0 111.181 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.536 ' CZ ' HD12 ' A' ' 89' ' ' LEU . 2.3 p90 -140.66 158.17 44.37 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.122 -0.49 . . . . 15.0 110.456 178.794 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.771 ' HB2' HD12 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -123.96 143.6 50.3 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.289 0.566 . . . . 15.0 111.566 -179.37 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.695 ' CG1' HD11 ' A' ' 89' ' ' LEU . 0.5 OUTLIER -101.31 114.6 41.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.295 -0.866 . . . . 15.0 109.6 179.08 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -106.24 70.38 0.84 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.261 -0.427 . . . . 15.0 112.021 -178.963 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.648 HD11 ' CB ' ' A' ' 49' ' ' ASP . 8.6 tp -88.26 162.1 16.82 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.137 -0.483 . . . . 15.0 110.007 179.069 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -96.58 99.28 10.92 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.703 0.287 . . . . 15.0 111.042 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.908 ' HB2' HG23 ' A' ' 85' ' ' VAL . 0.3 OUTLIER . . . . . 0 CA--C 1.533 0.324 0 N-CA-C 112.651 0.611 . . . . 15.0 112.651 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.475 HD12 ' HE3' ' A' ' 13' ' ' LYS . 3.9 mp . . . . . 0 N--CA 1.451 -0.391 0 CA-C-O 120.847 0.356 . . . . 15.0 110.581 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.639 ' O ' ' HB ' ' A' ' 41' ' ' ILE . . . -160.78 38.42 0.43 Allowed Glycine 0 N--CA 1.449 -0.48 0 N-CA-C 111.527 -0.629 . . . . 15.0 111.527 -179.774 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.719 HG12 ' O ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -112.62 140.78 30.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-O 120.937 0.399 . . . . 15.0 111.835 -179.363 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.452 ' HB3' HD11 ' A' ' 41' ' ' ILE . 30.8 t -96.09 105.92 18.03 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 107.79 -1.189 . . . . 15.0 107.79 177.491 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.887 HG21 HG23 ' A' ' 75' ' ' VAL . 14.5 m -93.67 151.91 3.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 113.087 0.773 . . . . 15.0 113.087 -176.957 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -149.46 174.02 12.94 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 114.752 -1.113 . . . . 15.0 110.489 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.584 ' O ' HG22 ' A' ' 26' ' ' VAL . . . 80.94 -118.54 4.65 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.491 -0.861 . . . . 15.0 112.356 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.544 ' HA3' ' N ' ' A' ' 71' ' ' HIS . . . 66.66 -65.72 0.18 Allowed Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.967 -0.635 . . . . 15.0 113.497 179.268 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.584 HG22 ' O ' ' A' ' 24' ' ' GLY . 0.0 OUTLIER -28.43 139.78 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 N-CA-C 112.38 0.511 . . . . 15.0 112.38 -179.188 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.433 ' ND2' ' O ' ' A' ' 32' ' ' HIS . 8.4 m120 -75.53 61.3 1.29 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.913 -0.585 . . . . 15.0 111.024 -179.84 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -151.7 -64.46 0.18 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.28 -0.418 . . . . 15.0 110.927 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 59.7 p -69.1 -49.13 59.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.176 -0.465 . . . . 15.0 110.954 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.525 HG22 ' O ' ' A' ' 26' ' ' VAL . 23.1 m -70.6 -173.56 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.159 -0.473 . . . . 15.0 111.114 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.69 -67.13 0.31 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.291 -0.413 . . . . 15.0 111.055 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' HIS . . . . . 0.433 ' O ' ' ND2' ' A' ' 27' ' ' ASN . 10.1 p-80 -139.32 -45.3 0.46 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.315 -0.402 . . . . 15.0 111.052 -179.83 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -168.38 25.54 0.12 Allowed Glycine 0 N--CA 1.453 -0.212 0 C-N-CA 120.894 -0.669 . . . . 15.0 112.508 -179.834 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.406 ' O ' HG11 ' A' ' 30' ' ' VAL . . . -94.47 152.53 20.64 Favored Glycine 0 N--CA 1.448 -0.509 0 N-CA-C 110.443 -1.063 . . . . 15.0 110.443 178.747 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.918 HG22 HG22 ' A' ' 58' ' ' VAL . 0.1 OUTLIER -95.79 153.22 3.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 C-N-CA 119.731 -0.787 . . . . 15.0 112.329 -179.021 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.464 ' CZ ' ' HG2' ' A' ' 57' ' ' ARG . 29.3 m-85 -135.04 106.55 6.86 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.699 -1.137 . . . . 15.0 109.158 179.117 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.801 HG22 ' N ' ' A' ' 55' ' ' GLY . 0.8 OUTLIER -55.22 148.05 3.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.127 0.489 . . . . 15.0 111.571 -178.392 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.424 ' O ' ' HG2' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -80.37 -49.59 11.29 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.509 -0.923 . . . . 15.0 108.509 178.3 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.719 ' O ' HG12 ' A' ' 20' ' ' ILE . . . -172.17 172.71 4.5 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.963 -0.562 . . . . 15.0 110.879 178.808 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.55 ' HA ' HG12 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -96.81 112.72 29.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 N-CA-C 109.598 -0.519 . . . . 15.0 109.598 179.296 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.639 ' HB ' ' O ' ' A' ' 19' ' ' GLY . 0.3 OUTLIER -78.45 119.33 76.92 Favored Pre-proline 0 C--N 1.328 -0.327 0 N-CA-C 113.334 0.864 . . . . 15.0 113.334 -177.403 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.606 ' HA ' ' CG ' ' A' ' 47' ' ' GLU . 38.0 Cg_endo -65.15 61.1 0.32 Allowed 'Trans proline' 0 C--N 1.356 0.966 0 C-N-CA 123.448 2.766 . . . . 15.0 112.944 179.676 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.509 ' H ' ' HG2' ' A' ' 47' ' ' GLU . 0.1 OUTLIER -151.32 -44.75 0.11 Allowed 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 111.663 0.246 . . . . 15.0 111.663 179.903 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.599 ' HA3' ' HA3' ' A' ' 19' ' ' GLY . . . -87.71 165.54 35.16 Favored Glycine 0 CA--C 1.518 0.255 0 C-N-CA 120.328 -0.939 . . . . 15.0 113.719 -179.159 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -55.47 -15.88 3.19 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.796 0.665 . . . . 15.0 112.796 -179.543 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.2 -57.11 4.51 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.648 0.261 . . . . 15.0 111.204 -179.485 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.606 ' CG ' ' HA ' ' A' ' 42' ' ' PRO . 2.6 pp20? -56.93 -41.72 78.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.913 0.387 . . . . 15.0 110.386 179.711 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -53.91 -68.82 0.15 Allowed 'General case' 0 CA--C 1.52 -0.182 0 CA-C-N 115.91 -0.587 . . . . 15.0 110.851 -179.393 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.648 ' CB ' HD11 ' A' ' 11' ' ' LEU . 11.8 t0 -63.2 -39.13 93.75 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.57 -0.529 . . . . 15.0 109.57 179.13 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.07 45.55 7.52 Favored Glycine 0 N--CA 1.447 -0.595 0 CA-C-N 115.452 -0.795 . . . . 15.0 111.758 179.67 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.589 ' CG ' HG23 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -79.41 -53.15 7.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.966 0.413 . . . . 15.0 110.578 -179.377 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.659 ' CG1' HD12 ' A' ' 20' ' ' ILE . 7.9 tp -82.34 164.97 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 CA-C-N 115.947 -0.569 . . . . 15.0 110.392 179.676 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' HIS . . . . . 0.451 ' O ' ' HB2' ' A' ' 56' ' ' ASP . 76.3 m80 -147.68 158.01 43.81 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-O 121.674 0.75 . . . . 15.0 112.285 -179.147 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.552 ' HA ' ' CG2' ' A' ' 37' ' ' VAL . 8.5 mtpt -43.4 134.08 4.03 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.302 -1.317 . . . . 15.0 112.94 -178.617 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.801 ' N ' HG22 ' A' ' 37' ' ' VAL . . . 49.9 31.12 16.63 Favored Glycine 0 C--N 1.334 0.432 0 CA-C-N 115.692 -0.686 . . . . 15.0 113.659 179.051 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.451 ' HB2' ' O ' ' A' ' 53' ' ' HIS . 0.4 OUTLIER -66.09 129.94 41.52 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 117.094 0.447 . . . . 15.0 110.786 179.563 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.862 ' HD2' HD21 ' A' ' 59' ' ' LEU . 0.0 OUTLIER -81.33 89.96 6.12 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.299 -0.41 . . . . 15.0 110.138 179.371 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.918 HG22 HG22 ' A' ' 35' ' ' ILE . 1.4 m -82.8 114.17 23.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 CA-C-O 121.073 0.463 . . . . 15.0 111.584 -179.146 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.862 HD21 ' HD2' ' A' ' 57' ' ' ARG . 3.4 mm? -107.69 -12.84 15.16 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 115.614 -0.721 . . . . 15.0 112.501 -179.498 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.674 ' HB3' ' HB2' ' A' ' 88' ' ' LEU . . . -149.72 149.0 29.91 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 112.659 0.614 . . . . 15.0 112.659 -178.527 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.85 HG11 ' O ' ' A' ' 77' ' ' THR . 23.1 t -142.29 99.04 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.27 0 CA-C-N 115.304 -0.862 . . . . 15.0 109.441 178.842 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.467 ' OD1' HG22 ' A' ' 81' ' ' THR . 2.7 m120 65.05 16.67 10.69 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.155 -0.475 . . . . 15.0 109.896 -178.282 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 107.17 6.04 34.36 Favored Glycine 0 C--N 1.336 0.536 0 CA-C-N 115.813 -0.631 . . . . 15.0 113.564 179.48 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.663 HG13 ' O ' ' A' ' 64' ' ' VAL . 4.6 p -93.75 103.71 14.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 117.292 0.546 . . . . 15.0 110.628 179.155 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -57.91 127.69 33.35 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.134 -0.484 . . . . 15.0 111.071 -179.417 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.668 HD13 ' HB3' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -87.69 -15.86 35.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.021 -0.536 . . . . 15.0 111.063 179.962 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -45.24 95.32 0.01 OUTLIER 'General case' 0 N--CA 1.461 0.114 0 CA-C-O 120.871 0.367 . . . . 15.0 111.008 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 103.75 69.35 0.79 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.79 -0.719 . . . . 15.0 112.238 -179.679 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.706 ' HB1' ' CB ' ' A' ' 73' ' ' GLN . . . -173.03 142.73 1.09 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.901 0.381 . . . . 15.0 111.049 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.429 ' CB ' ' HA ' ' A' ' 26' ' ' VAL . 13.7 p -74.3 -172.5 1.45 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.162 -0.472 . . . . 15.0 111.241 -179.774 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' HIS . . . . . 0.63 ' CE1' HG23 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -62.19 -59.49 4.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.914 -0.584 . . . . 15.0 110.475 179.99 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.453 ' O ' HG12 ' A' ' 75' ' ' VAL . 6.6 ttmt -52.81 -33.8 50.77 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.871 -0.604 . . . . 15.0 110.623 179.399 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.706 ' CB ' ' HB1' ' A' ' 69' ' ' ALA . 5.2 mt-30 -59.54 -52.93 63.45 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.708 -0.478 . . . . 15.0 109.708 179.313 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.868 ' HB3' HD12 ' A' ' 35' ' ' ILE . . . -67.08 -42.4 84.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.099 -0.501 . . . . 15.0 109.725 178.48 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.887 HG23 HG21 ' A' ' 22' ' ' VAL . 0.5 OUTLIER -44.31 -39.51 1.63 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.221 0 N-CA-C 108.985 -0.746 . . . . 15.0 108.985 178.528 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -67.3 -44.17 79.88 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.751 -1.113 . . . . 15.0 110.314 178.586 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.85 ' O ' HG11 ' A' ' 61' ' ' VAL . 27.6 p -64.04 -56.15 17.11 Favored 'General case' 0 N--CA 1.462 0.151 0 C-N-CA 121.047 -0.261 . . . . 15.0 111.375 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.588 HD23 HG21 ' A' ' 61' ' ' VAL . 4.6 mt -53.49 -46.94 70.22 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 121.179 0.514 . . . . 15.0 109.958 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 3.3 tmt_? -68.49 -60.27 2.55 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.434 -0.803 . . . . 15.0 110.739 179.53 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 15.2 m-20 -65.96 60.83 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.846 -0.615 . . . . 15.0 112.222 -179.76 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.467 HG22 ' OD1' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -95.57 -76.08 0.51 Allowed 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.744 -0.465 . . . . 15.0 109.744 178.91 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 112.75 -98.51 0.96 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.634 -0.793 . . . . 15.0 113.58 178.63 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.46 ' O ' ' HB3' ' A' ' 13' ' ' LYS . 0.5 OUTLIER -63.92 -87.92 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 111.682 0.252 . . . . 15.0 111.682 -178.907 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.453 HG12 ' N ' ' A' ' 85' ' ' VAL . 72.0 t -110.06 158.23 10.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.066 0.46 . . . . 15.0 110.925 -179.738 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.908 HG23 ' HB2' ' A' ' 13' ' ' LYS . 3.8 t -97.87 81.92 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.094 -0.503 . . . . 15.0 110.256 179.698 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 15.3 t-160 -100.7 82.81 2.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.766 -0.652 . . . . 15.0 109.99 179.585 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.852 ' HB3' HD21 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -103.79 115.97 31.44 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.799 -0.637 . . . . 15.0 112.05 -178.745 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.771 HD12 ' HB2' ' A' ' 8' ' ' GLU . 4.0 mp -92.21 102.13 14.64 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.451 -0.574 . . . . 15.0 109.451 178.576 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.852 HD21 ' HB3' ' A' ' 87' ' ' LEU . 0.1 OUTLIER -105.81 -161.74 0.82 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.487 0.661 . . . . 15.0 112.102 -178.317 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.427 ' HA ' ' HA ' ' A' ' 6' ' ' ILE . 3.5 tt0 -143.98 135.38 25.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 114.879 -1.055 . . . . 15.0 109.621 179.148 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.08 103.56 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.005 0.431 . . . . 15.0 111.087 -179.566 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.299 0 C-N-CA 120.944 -0.646 . . . . 15.0 112.706 -179.706 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.519 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 1.2 mp . . . . . 0 N--CA 1.45 -0.426 0 CA-C-O 120.508 0.194 . . . . 15.0 110.624 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.879 ' CE1' HD12 ' A' ' 89' ' ' LEU . 3.0 p90 -141.93 141.32 32.96 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.035 0.445 . . . . 15.0 111.206 179.418 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.79 ' HB2' HD12 ' A' ' 88' ' ' LEU . 5.6 pm0 -113.53 141.8 46.71 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.804 -0.635 . . . . 15.0 111.15 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.489 ' N ' ' O ' ' A' ' 87' ' ' LEU . 0.2 OUTLIER -101.41 114.02 39.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.45 -0.796 . . . . 15.0 109.839 179.335 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -105.96 71.16 0.88 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.033 -0.53 . . . . 15.0 111.896 -178.904 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.489 HD11 ' CB ' ' A' ' 49' ' ' ASP . 5.4 tp -88.65 166.83 13.84 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.155 -0.475 . . . . 15.0 109.949 179.016 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -96.08 96.88 9.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.028 0.442 . . . . 15.0 111.163 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.768 ' CB ' HG23 ' A' ' 85' ' ' VAL . 0.1 OUTLIER . . . . . 0 C--N 1.327 -0.393 0 CA-C-N 115.725 -0.671 . . . . 15.0 111.442 -179.721 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 9.8 mt . . . . . 0 N--CA 1.455 -0.188 0 CA-C-O 120.968 0.413 . . . . 15.0 110.794 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.663 ' O ' ' HB ' ' A' ' 41' ' ' ILE . . . -161.13 38.59 0.42 Allowed Glycine 0 N--CA 1.449 -0.459 0 CA-C-N 115.867 -0.606 . . . . 15.0 111.752 -179.831 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.725 HG12 ' O ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -112.69 140.75 30.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 121.02 0.438 . . . . 15.0 111.94 -179.358 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.409 ' HB3' HD11 ' A' ' 41' ' ' ILE . 41.0 t -96.11 106.18 18.32 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 107.837 -1.171 . . . . 15.0 107.837 177.296 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.999 HG21 HG23 ' A' ' 75' ' ' VAL . 31.2 m -93.54 152.5 3.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 113.083 0.771 . . . . 15.0 113.083 -177.0 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.415 ' OG1' ' HB2' ' A' ' 38' ' ' LYS . 0.3 OUTLIER -149.46 179.27 8.09 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 114.863 -1.062 . . . . 15.0 110.728 -179.962 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.431 ' O ' ' CB ' ' A' ' 71' ' ' HIS . . . 74.22 -120.23 6.56 Favored Glycine 0 C--N 1.33 0.24 0 C-N-CA 120.672 -0.775 . . . . 15.0 112.327 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.537 ' HA3' ' N ' ' A' ' 71' ' ' HIS . . . 67.52 -65.69 0.27 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.848 -0.691 . . . . 15.0 113.631 179.31 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.569 ' O ' HG22 ' A' ' 30' ' ' VAL . 2.0 m -31.22 140.84 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 N-CA-C 112.328 0.492 . . . . 15.0 112.328 -179.17 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 14.2 p-10 -75.47 64.62 1.62 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.944 -0.571 . . . . 15.0 111.035 -179.818 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.5 m -151.67 -61.52 0.17 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.263 -0.426 . . . . 15.0 111.075 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 91.3 p -76.45 -42.88 42.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.18 -0.464 . . . . 15.0 111.155 -179.805 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.569 HG22 ' O ' ' A' ' 26' ' ' VAL . 35.3 m -73.78 -176.17 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.274 -0.421 . . . . 15.0 111.275 -179.858 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.14 -59.96 4.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.118 -0.492 . . . . 15.0 111.078 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 10.5 m80 -143.55 -47.93 0.3 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.306 -0.407 . . . . 15.0 111.149 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -169.44 22.56 0.09 OUTLIER Glycine 0 CA--C 1.519 0.292 0 C-N-CA 120.668 -0.777 . . . . 15.0 112.888 -179.701 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -87.55 154.46 26.02 Favored Glycine 0 N--CA 1.451 -0.354 0 N-CA-C 110.788 -0.925 . . . . 15.0 110.788 178.825 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.685 HG22 HG13 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -92.5 152.02 3.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 C-N-CA 119.895 -0.722 . . . . 15.0 111.906 -179.242 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.515 ' CZ ' ' HG2' ' A' ' 57' ' ' ARG . 53.8 m-85 -137.3 106.64 6.08 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.835 -1.075 . . . . 15.0 109.892 179.333 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.869 HG22 ' N ' ' A' ' 55' ' ' GLY . 0.6 OUTLIER -57.46 146.0 7.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.977 -0.556 . . . . 15.0 111.144 -179.089 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.485 ' O ' ' HG2' ' A' ' 54' ' ' LYS . 0.6 OUTLIER -80.33 -48.87 12.32 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.947 -0.76 . . . . 15.0 108.947 178.837 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.725 ' O ' HG12 ' A' ' 20' ' ' ILE . . . -172.07 172.6 4.61 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.906 -0.588 . . . . 15.0 110.736 178.811 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.533 ' HA ' HG12 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -96.86 112.93 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 N-CA-C 109.781 -0.451 . . . . 15.0 109.781 179.433 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.663 ' HB ' ' O ' ' A' ' 19' ' ' GLY . 0.3 OUTLIER -78.56 118.49 72.65 Favored Pre-proline 0 C--N 1.328 -0.331 0 N-CA-C 113.021 0.749 . . . . 15.0 113.021 -177.764 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.612 ' HA ' ' CG ' ' A' ' 47' ' ' GLU . 37.2 Cg_endo -64.8 60.63 0.29 Allowed 'Trans proline' 0 C--N 1.356 0.935 0 C-N-CA 123.416 2.744 . . . . 15.0 112.91 179.842 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.527 ' N ' ' HG2' ' A' ' 47' ' ' GLU . 41.1 tt0 -149.87 -46.26 0.13 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.632 -0.258 . . . . 15.0 111.511 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.608 ' HA3' ' HA3' ' A' ' 19' ' ' GLY . . . -87.8 166.91 36.12 Favored Glycine 0 CA--C 1.519 0.314 0 C-N-CA 120.417 -0.897 . . . . 15.0 114.008 -178.965 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -55.29 -15.43 2.45 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.911 0.708 . . . . 15.0 112.911 -179.677 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.429 ' HB1' HG22 ' A' ' 52' ' ' ILE . . . -71.97 -57.4 4.33 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 121.005 -0.278 . . . . 15.0 111.051 -179.418 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.612 ' CG ' ' HA ' ' A' ' 42' ' ' PRO . 2.9 pp20? -57.05 -42.99 81.57 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.035 -0.529 . . . . 15.0 110.378 179.358 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -53.88 -70.47 0.1 Allowed 'General case' 0 CA--C 1.52 -0.194 0 CA-C-N 115.893 -0.594 . . . . 15.0 110.498 -179.623 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.489 ' CB ' HD11 ' A' ' 11' ' ' LEU . 14.4 t0 -58.21 -39.92 80.26 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.349 -0.611 . . . . 15.0 109.349 178.87 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.76 35.02 26.24 Favored Glycine 0 N--CA 1.447 -0.631 0 CA-C-N 115.384 -0.825 . . . . 15.0 111.595 179.676 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.488 ' HG3' HD13 ' A' ' 11' ' ' LEU . 0.3 OUTLIER -79.73 -46.5 16.94 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.05 0.452 . . . . 15.0 110.524 -179.431 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.685 ' CG1' HD12 ' A' ' 20' ' ' ILE . 7.0 tp -80.94 149.95 4.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.697 -0.683 . . . . 15.0 109.616 179.371 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' HIS . . . . . 0.456 ' O ' HG21 ' A' ' 37' ' ' VAL . 80.4 m80 -139.7 156.94 46.52 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 113.14 0.793 . . . . 15.0 113.14 -178.269 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.564 ' HA ' ' CG2' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -45.31 133.28 7.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 113.784 -1.553 . . . . 15.0 112.961 -178.897 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.869 ' N ' HG22 ' A' ' 37' ' ' VAL . . . 49.04 27.25 6.66 Favored Glycine 0 C--N 1.335 0.486 0 CA-C-N 115.766 -0.652 . . . . 15.0 113.784 178.918 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.801 ' CG ' HD13 ' A' ' 89' ' ' LEU . 1.2 p30 -66.32 133.23 50.11 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 119.485 -0.886 . . . . 15.0 110.077 179.512 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.529 ' HD2' HD21 ' A' ' 59' ' ' LEU . 0.0 OUTLIER -80.76 97.58 7.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 15.0 110.434 -179.845 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.685 HG13 HG22 ' A' ' 35' ' ' ILE . 1.3 m -82.24 112.74 20.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.265 -0.425 . . . . 15.0 110.392 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.529 HD21 ' HD2' ' A' ' 57' ' ' ARG . 3.5 mm? -107.26 -21.62 12.89 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 115.826 -0.625 . . . . 15.0 112.384 -179.041 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.607 ' O ' HD23 ' A' ' 87' ' ' LEU . . . -147.45 150.47 34.67 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.251 0.548 . . . . 15.0 112.365 -178.56 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.745 HG21 HD23 ' A' ' 78' ' ' LEU . 60.4 t -138.92 102.46 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.264 -0.88 . . . . 15.0 109.022 178.846 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.634 ' OD1' HG22 ' A' ' 81' ' ' THR . 3.0 m120 65.09 15.62 10.1 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.706 -0.479 . . . . 15.0 109.706 -177.955 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 105.69 6.46 37.92 Favored Glycine 0 C--N 1.336 0.539 0 CA-C-N 115.785 -0.643 . . . . 15.0 113.349 179.659 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.667 HG13 ' O ' ' A' ' 64' ' ' VAL . 6.1 p -93.76 105.69 17.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 121.124 0.488 . . . . 15.0 110.843 179.398 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -58.78 115.45 3.09 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.148 -0.478 . . . . 15.0 110.726 -179.748 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.619 HD21 ' HA ' ' A' ' 74' ' ' ALA . 3.1 mt -89.45 -16.44 30.86 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.718 -0.674 . . . . 15.0 111.339 -179.619 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -45.79 105.44 0.06 Allowed 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.878 0.371 . . . . 15.0 111.017 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.96 66.15 0.57 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.814 -0.707 . . . . 15.0 112.433 -179.719 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.555 ' HB1' ' CG ' ' A' ' 73' ' ' GLN . . . -172.9 172.71 3.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.807 0.337 . . . . 15.0 110.851 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.481 HG22 ' HA ' ' A' ' 26' ' ' VAL . 19.3 p -93.16 -175.83 3.97 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.961 0.41 . . . . 15.0 111.091 -179.768 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' HIS . . . . . 0.734 ' CE1' HG23 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -62.42 -60.98 2.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.969 -0.559 . . . . 15.0 110.428 -179.994 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 7.3 ttmt -52.49 -33.68 45.9 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.773 -0.649 . . . . 15.0 110.497 179.455 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.555 ' CG ' ' HB1' ' A' ' 69' ' ' ALA . 0.5 OUTLIER -59.4 -49.01 79.46 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.567 -0.531 . . . . 15.0 109.567 179.194 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.619 ' HA ' HD21 ' A' ' 66' ' ' LEU . . . -66.96 -48.57 68.16 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 116.009 -0.541 . . . . 15.0 109.658 178.392 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.999 HG23 HG21 ' A' ' 22' ' ' VAL . 0.5 OUTLIER -40.39 -42.1 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.212 0 CA-C-N 115.476 -0.784 . . . . 15.0 109.444 178.48 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.404 ' N ' HG12 ' A' ' 75' ' ' VAL . 21.9 mt-10 -67.4 -46.07 74.33 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 114.843 -1.071 . . . . 15.0 110.45 178.795 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.592 ' O ' HG11 ' A' ' 61' ' ' VAL . 2.0 p -64.64 -53.08 53.18 Favored 'General case' 0 C--O 1.231 0.099 0 C-N-CA 120.918 -0.313 . . . . 15.0 111.378 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.745 HD23 HG21 ' A' ' 61' ' ' VAL . 4.4 mt -53.66 -48.38 69.48 Favored 'General case' 0 CA--C 1.52 -0.18 0 CA-C-O 121.135 0.493 . . . . 15.0 110.15 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.415 ' O ' ' N ' ' A' ' 81' ' ' THR . 3.0 ttm-85 -68.34 -56.65 7.81 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.558 -0.747 . . . . 15.0 110.493 179.511 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -66.0 62.51 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.017 -0.538 . . . . 15.0 111.752 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.634 HG22 ' OD1' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -95.55 -71.94 0.65 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.783 0.325 . . . . 15.0 110.438 179.426 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 122.17 -103.82 0.87 Allowed Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.753 -0.737 . . . . 15.0 113.157 179.272 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.58 -83.66 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 111.866 0.321 . . . . 15.0 111.866 -179.089 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.424 HG12 ' N ' ' A' ' 85' ' ' VAL . 67.3 t -109.47 157.59 9.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.105 0.478 . . . . 15.0 111.082 -179.416 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.768 HG23 ' CB ' ' A' ' 13' ' ' LYS . 10.6 t -97.81 81.86 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.011 -0.54 . . . . 15.0 110.559 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 59.6 t60 -104.96 86.54 2.47 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.747 -0.66 . . . . 15.0 110.892 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.658 HD22 HD21 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -103.81 129.75 51.28 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.996 -0.547 . . . . 15.0 111.537 -179.601 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.79 HD12 ' HB2' ' A' ' 8' ' ' GLU . 5.2 mp -102.33 101.3 11.54 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.928 -0.397 . . . . 15.0 109.928 178.976 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.879 HD12 ' CE1' ' A' ' 7' ' ' PHE . 0.4 OUTLIER -105.84 -161.94 0.83 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.3 0.572 . . . . 15.0 111.939 -178.699 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.519 ' HA ' ' HA ' ' A' ' 6' ' ' ILE . 26.0 tt0 -146.28 134.91 22.18 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.159 -0.928 . . . . 15.0 109.951 179.238 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 4.7 tptt -46.83 111.86 0.44 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.311 -0.404 . . . . 15.0 111.096 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.369 0 C-N-CA 120.785 -0.721 . . . . 15.0 112.614 -179.631 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.507 HG13 ' HB2' ' A' ' 90' ' ' GLU . 1.3 mp . . . . . 0 N--CA 1.45 -0.439 0 CA-C-O 120.657 0.265 . . . . 15.0 110.62 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.63 ' CE1' HD12 ' A' ' 89' ' ' LEU . 4.9 p90 -140.65 165.51 27.28 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.594 -0.275 . . . . 15.0 110.544 178.912 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.721 ' CB ' HD12 ' A' ' 88' ' ' LEU . 4.9 pt-20 -130.07 142.62 50.59 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.381 0.61 . . . . 15.0 111.417 -179.546 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.582 ' CG1' HD11 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -101.44 114.97 42.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.073 -0.967 . . . . 15.0 109.718 179.143 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -105.89 71.46 0.9 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.118 -0.492 . . . . 15.0 111.874 -178.976 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.662 HD13 ' HG3' ' A' ' 51' ' ' ARG . 6.2 tp -88.05 167.99 13.2 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.942 -0.572 . . . . 15.0 110.007 179.121 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -94.64 98.84 11.09 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.98 0.419 . . . . 15.0 110.867 179.88 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.601 ' CA ' HG23 ' A' ' 85' ' ' VAL . 0.2 OUTLIER . . . . . 0 C--N 1.328 -0.365 0 CA-C-N 115.899 -0.592 . . . . 15.0 111.13 -179.827 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.423 ' O ' ' HA3' ' A' ' 44' ' ' GLY . 3.9 mm? . . . . . 0 N--CA 1.449 -0.48 0 N-CA-C 110.627 -0.138 . . . . 15.0 110.627 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.742 ' O ' ' HB ' ' A' ' 41' ' ' ILE . . . -160.56 21.44 0.24 Allowed Glycine 0 C--O 1.226 -0.378 0 C-N-CA 120.4 -0.905 . . . . 15.0 113.395 -179.495 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.937 HG21 HG21 ' A' ' 52' ' ' ILE . 2.9 pt -113.13 139.16 39.82 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.382 0 CA-C-N 117.394 0.597 . . . . 15.0 111.709 178.738 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.514 ' O ' ' HB3' ' A' ' 38' ' ' LYS . 6.2 t -84.98 116.09 23.18 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 105.167 -2.16 . . . . 15.0 105.167 174.841 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 1.016 HG21 HG23 ' A' ' 75' ' ' VAL . 35.6 m -93.74 152.35 3.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 113.58 0.955 . . . . 15.0 113.58 -175.521 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.57 -179.18 6.89 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 114.782 -1.099 . . . . 15.0 110.564 179.642 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.591 ' O ' HG22 ' A' ' 26' ' ' VAL . . . 71.4 -121.03 8.68 Favored Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.814 -0.708 . . . . 15.0 112.613 179.658 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.52 ' HA3' ' N ' ' A' ' 71' ' ' HIS . . . 66.82 -65.71 0.19 Allowed Glycine 0 C--N 1.331 0.251 0 C-N-CA 121.028 -0.606 . . . . 15.0 113.576 179.43 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.643 ' O ' HG22 ' A' ' 30' ' ' VAL . 0.0 OUTLIER -32.83 137.78 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 N-CA-C 112.375 0.509 . . . . 15.0 112.375 -179.208 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.406 ' CB ' ' O ' ' A' ' 32' ' ' HIS . 1.6 m-20 -76.58 59.64 1.53 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.826 -0.625 . . . . 15.0 111.103 -179.856 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -151.74 -48.48 0.11 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.373 -0.376 . . . . 15.0 110.884 179.972 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 22.0 t -87.12 -31.84 20.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.203 -0.453 . . . . 15.0 110.962 -179.929 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.643 HG22 ' O ' ' A' ' 26' ' ' VAL . 33.4 m -87.9 -175.62 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.459 . . . . 15.0 111.223 -179.965 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 3.4 ttt85 -58.11 -60.81 3.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.23 -0.441 . . . . 15.0 111.102 -179.86 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 32' ' ' HIS . . . . . 0.406 ' O ' ' CB ' ' A' ' 27' ' ' ASN . 22.9 m80 -136.3 -58.45 0.74 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.371 -0.377 . . . . 15.0 111.163 -179.87 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -166.72 26.11 0.15 Allowed Glycine 0 N--CA 1.453 -0.223 0 C-N-CA 120.806 -0.711 . . . . 15.0 112.599 -179.723 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -90.69 153.25 22.41 Favored Glycine 0 N--CA 1.449 -0.488 0 N-CA-C 110.828 -0.909 . . . . 15.0 110.828 179.024 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.833 HG22 HG22 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -90.72 153.6 3.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 C-N-CA 120.028 -0.669 . . . . 15.0 111.648 -179.358 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.413 ' CE2' ' HG2' ' A' ' 57' ' ' ARG . 47.5 m-85 -134.43 108.39 8.12 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 114.98 -1.009 . . . . 15.0 109.534 179.4 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.784 HG22 ' N ' ' A' ' 55' ' ' GLY . 0.6 OUTLIER -54.94 148.45 2.89 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.45 0 CA-C-O 121.105 0.479 . . . . 15.0 110.731 -178.835 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.514 ' HB3' ' O ' ' A' ' 21' ' ' SER . 0.1 OUTLIER -86.17 -45.66 11.13 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 108.37 -0.974 . . . . 15.0 108.37 178.167 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.624 ' O ' ' HB ' ' A' ' 20' ' ' ILE . . . -173.76 171.37 3.78 Favored 'General case' 0 C--O 1.226 -0.157 0 C-N-CA 120.512 -0.475 . . . . 15.0 112.214 178.762 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.754 ' HA ' HG22 ' A' ' 20' ' ' ILE . 0.1 OUTLIER -97.32 81.57 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.291 0.567 . . . . 15.0 109.75 178.889 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.742 ' HB ' ' O ' ' A' ' 19' ' ' GLY . 27.2 mm -47.95 120.79 8.19 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 115.263 -0.88 . . . . 15.0 113.039 -178.351 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.602 ' HA ' ' HG2' ' A' ' 47' ' ' GLU . 40.8 Cg_endo -66.16 60.94 0.48 Allowed 'Trans proline' 0 C--N 1.354 0.831 0 C-N-CA 123.336 2.691 . . . . 15.0 112.762 179.682 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.534 ' N ' ' HG2' ' A' ' 47' ' ' GLU . 4.6 mt-30 -158.85 -41.08 0.06 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.646 0.26 . . . . 15.0 111.63 179.878 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.502 ' HA3' ' CA ' ' A' ' 19' ' ' GLY . . . -87.29 163.0 33.95 Favored Glycine 0 CA--C 1.519 0.318 0 C-N-CA 120.629 -0.796 . . . . 15.0 113.652 -179.151 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.561 ' O ' HD21 ' A' ' 11' ' ' LEU . . . -53.28 -15.21 0.88 Allowed 'General case' 0 N--CA 1.462 0.166 0 N-CA-C 112.708 0.633 . . . . 15.0 112.708 -179.721 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.99 -59.35 2.79 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.651 0.262 . . . . 15.0 110.946 -179.554 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.602 ' HG2' ' HA ' ' A' ' 42' ' ' PRO . 2.6 pp20? -56.97 -42.82 80.88 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.109 -0.496 . . . . 15.0 110.824 179.557 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.3 m -53.69 -70.77 0.09 Allowed 'General case' 0 CA--C 1.519 -0.22 0 CA-C-N 115.965 -0.561 . . . . 15.0 110.597 -179.333 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.559 ' CB ' HD11 ' A' ' 11' ' ' LEU . 1.9 t0 -61.19 -39.43 90.17 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.472 -0.566 . . . . 15.0 109.472 178.981 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.92 38.66 15.15 Favored Glycine 0 N--CA 1.447 -0.571 0 CA-C-N 115.438 -0.801 . . . . 15.0 111.638 179.802 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.662 ' HG3' HD13 ' A' ' 11' ' ' LEU . 21.7 mmt-85 -79.71 -33.71 40.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.872 0.368 . . . . 15.0 111.106 -179.18 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.937 HG21 HG21 ' A' ' 20' ' ' ILE . 21.2 mm -91.21 159.12 2.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.091 -0.504 . . . . 15.0 111.181 -179.737 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 53' ' ' HIS . . . . . 0.48 ' N ' ' CG2' ' A' ' 52' ' ' ILE . 29.2 m80 -141.69 138.5 32.49 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-N 115.69 -0.686 . . . . 15.0 110.663 179.394 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.532 ' HA ' ' CG2' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -35.59 131.11 0.51 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.479 -1.237 . . . . 15.0 113.039 -178.373 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.784 ' N ' HG22 ' A' ' 37' ' ' VAL . . . 56.28 29.08 55.99 Favored Glycine 0 C--N 1.332 0.353 0 CA-C-N 115.665 -0.698 . . . . 15.0 113.629 179.176 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.447 ' OD2' ' N ' ' A' ' 53' ' ' HIS . 0.4 OUTLIER -65.34 130.48 43.49 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.941 -0.304 . . . . 15.0 110.597 179.346 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.413 ' HG2' ' CE2' ' A' ' 36' ' ' TYR . 2.2 mtt180 -80.63 90.04 5.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.436 -0.347 . . . . 15.0 110.672 179.934 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.833 HG22 HG22 ' A' ' 35' ' ' ILE . 1.4 m -79.37 116.82 23.98 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 CA-C-O 121.017 0.437 . . . . 15.0 110.613 -179.875 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 29.1 mt -107.04 -15.09 14.77 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.785 -0.643 . . . . 15.0 112.559 -178.946 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.888 ' HB3' ' HB2' ' A' ' 88' ' ' LEU . . . -149.11 148.49 29.74 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 112.595 0.591 . . . . 15.0 112.595 -178.8 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.762 HG21 ' OG1' ' A' ' 77' ' ' THR . 20.8 t -139.18 100.5 1.42 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.251 0 CA-C-N 115.115 -0.948 . . . . 15.0 109.115 178.795 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.675 ' OD1' HG22 ' A' ' 81' ' ' THR . 2.8 m120 65.03 16.08 10.36 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.76 -0.459 . . . . 15.0 109.76 -178.096 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 107.21 5.24 35.05 Favored Glycine 0 C--N 1.336 0.566 0 CA-C-N 115.925 -0.58 . . . . 15.0 113.558 179.666 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.66 HG13 ' O ' ' A' ' 64' ' ' VAL . 5.7 p -93.84 106.34 17.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 117.275 0.538 . . . . 15.0 110.988 179.417 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -56.59 136.33 54.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.201 -0.454 . . . . 15.0 110.914 -179.808 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.516 HD11 ' HB2' ' A' ' 74' ' ' ALA . 0.6 OUTLIER -95.55 -20.16 19.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.06 -0.518 . . . . 15.0 111.065 -179.964 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -46.53 99.96 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.876 0.369 . . . . 15.0 111.082 179.984 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 104.88 66.4 0.69 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.767 -0.73 . . . . 15.0 112.207 -179.799 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.564 ' HB1' ' HB3' ' A' ' 73' ' ' GLN . . . -173.09 162.02 4.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.841 0.353 . . . . 15.0 111.117 -179.771 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.465 ' HB ' HG13 ' A' ' 26' ' ' VAL . 15.6 p -93.22 -173.75 3.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.002 0.429 . . . . 15.0 111.019 -179.873 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 71' ' ' HIS . . . . . 0.684 ' CD2' HG23 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -62.59 -58.79 6.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.907 -0.588 . . . . 15.0 110.329 179.841 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.422 ' HA ' ' HB ' ' A' ' 75' ' ' VAL . 28.4 ttmt -52.56 -33.9 47.82 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.017 -0.538 . . . . 15.0 110.534 179.117 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.564 ' HB3' ' HB1' ' A' ' 69' ' ' ALA . 1.1 tt0 -59.45 -50.04 75.45 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.5 -0.555 . . . . 15.0 109.5 179.32 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.516 ' HB2' HD11 ' A' ' 66' ' ' LEU . . . -66.86 -44.48 80.88 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 109.531 -0.544 . . . . 15.0 109.531 178.313 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 1.016 HG23 HG21 ' A' ' 22' ' ' VAL . 0.5 OUTLIER -43.57 -39.4 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.363 0 N-CA-C 108.732 -0.84 . . . . 15.0 108.732 178.099 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.518 ' O ' ' HB2' ' A' ' 80' ' ' ASN . 1.5 mm-40 -67.06 -46.32 74.68 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.573 -1.194 . . . . 15.0 110.381 178.577 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.762 ' OG1' HG21 ' A' ' 61' ' ' VAL . 31.4 p -64.09 -53.24 52.77 Favored 'General case' 0 N--CA 1.462 0.161 0 C-N-CA 120.951 -0.3 . . . . 15.0 111.575 -179.969 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.6 HD22 HD11 ' A' ' 87' ' ' LEU . 6.0 mt -53.49 -48.15 69.19 Favored 'General case' 0 CA--C 1.52 -0.18 0 CA-C-O 121.261 0.553 . . . . 15.0 109.866 179.929 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.411 ' HB2' ' O ' ' A' ' 75' ' ' VAL . 18.1 ttp180 -68.64 -60.77 2.17 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.318 -0.855 . . . . 15.0 110.833 179.505 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.518 ' HB2' ' O ' ' A' ' 76' ' ' GLU . 15.1 m-80 -66.11 58.23 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 112.476 0.547 . . . . 15.0 112.476 -179.677 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.675 HG22 ' OD1' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -95.67 -69.28 0.76 Allowed 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.809 -0.441 . . . . 15.0 109.809 178.804 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 118.37 -104.42 1.12 Allowed Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.817 -0.706 . . . . 15.0 113.386 178.891 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.452 ' O ' ' HB3' ' A' ' 13' ' ' LYS . 0.4 OUTLIER -64.93 -80.95 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 112.525 0.565 . . . . 15.0 112.525 -178.724 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.426 HG12 ' N ' ' A' ' 85' ' ' VAL . 55.1 t -110.07 158.11 10.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.113 0.482 . . . . 15.0 111.298 -178.89 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.671 ' O ' HG12 ' A' ' 85' ' ' VAL . 8.0 t -97.99 81.15 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.986 -0.552 . . . . 15.0 110.426 179.867 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.473 ' NE2' HD11 ' A' ' 88' ' ' LEU . 78.9 t60 -100.42 84.66 2.82 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.754 -0.657 . . . . 15.0 110.362 179.79 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.792 ' HB3' HD21 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -103.52 119.44 38.9 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.949 -0.568 . . . . 15.0 111.986 -179.008 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.888 ' HB2' ' HB3' ' A' ' 60' ' ' ALA . 4.3 mp -92.87 103.23 15.58 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.52 -0.548 . . . . 15.0 109.52 178.673 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.792 HD21 ' HB3' ' A' ' 87' ' ' LEU . 0.2 OUTLIER -105.48 -163.32 0.94 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.273 0.559 . . . . 15.0 111.635 -178.69 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.507 ' HB2' HG13 ' A' ' 6' ' ' ILE . 8.3 tt0 -145.27 134.58 22.96 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.385 -0.825 . . . . 15.0 110.354 179.476 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 4.0 tptt -48.04 104.04 0.05 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.106 -0.497 . . . . 15.0 111.009 -179.92 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.341 0 C-N-CA 120.919 -0.658 . . . . 15.0 112.68 -179.647 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.548 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 1.4 mp . . . . . 0 N--CA 1.449 -0.48 0 CA-C-O 120.811 0.339 . . . . 15.0 111.375 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.826 ' CE1' HD12 ' A' ' 89' ' ' LEU . 3.6 p90 -140.62 165.67 26.84 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.123 -0.49 . . . . 15.0 110.112 178.514 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.72 ' HB3' HD12 ' A' ' 88' ' ' LEU . 4.8 pt-20 -130.13 144.38 51.32 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.427 0.632 . . . . 15.0 111.842 -178.93 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.516 ' CG2' ' HB3' ' A' ' 51' ' ' ARG . 0.2 OUTLIER -101.42 115.25 42.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.034 -0.984 . . . . 15.0 109.354 178.75 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -105.92 72.72 0.96 Allowed 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 112.4 0.518 . . . . 15.0 112.4 -178.523 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.673 HD13 ' HG3' ' A' ' 51' ' ' ARG . 5.2 tp -88.06 162.56 16.72 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.465 -0.569 . . . . 15.0 109.465 178.467 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -96.52 93.31 6.72 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.947 0.403 . . . . 15.0 111.343 -179.868 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.627 ' CB ' HG23 ' A' ' 85' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.43 0 CA-C-N 115.957 -0.565 . . . . 15.0 110.714 179.644 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.641 ' N ' HD22 ' A' ' 18' ' ' LEU . 2.1 mm? . . . . . 0 N--CA 1.45 -0.448 0 CA-C-O 120.961 0.41 . . . . 15.0 110.714 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.775 ' HA3' ' HA3' ' A' ' 44' ' ' GLY . . . -160.88 45.61 0.4 Allowed Glycine 0 N--CA 1.449 -0.499 0 N-CA-C 111.481 -0.648 . . . . 15.0 111.481 -179.771 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.663 HG12 ' O ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -112.53 139.19 38.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 120.843 0.354 . . . . 15.0 111.4 -179.326 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.4 ' H ' HD13 ' A' ' 41' ' ' ILE . 8.1 t -91.78 102.64 15.25 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 107.999 -1.111 . . . . 15.0 107.999 177.723 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.961 HG21 HG23 ' A' ' 75' ' ' VAL . 35.5 m -93.8 155.27 3.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 113.033 0.753 . . . . 15.0 113.033 -176.995 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.22 -176.39 5.35 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.174 -0.921 . . . . 15.0 110.92 -179.69 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.474 ' O ' ' HB3' ' A' ' 71' ' ' HIS . . . 68.73 -119.46 9.99 Favored Glycine 0 C--N 1.333 0.389 0 C-N-CA 120.951 -0.642 . . . . 15.0 112.611 179.834 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.572 ' HA2' ' HA ' ' A' ' 35' ' ' ILE . . . 68.6 -66.53 0.42 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.823 -0.703 . . . . 15.0 113.612 179.468 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.448 ' O ' HG22 ' A' ' 30' ' ' VAL . 1.3 m -29.38 141.82 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 N-CA-C 112.087 0.403 . . . . 15.0 112.087 -179.262 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -75.45 61.59 1.28 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.122 -0.49 . . . . 15.0 111.074 -179.602 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.6 m -151.73 -51.86 0.12 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.26 -0.427 . . . . 15.0 111.11 179.942 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -85.36 -44.39 12.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.446 . . . . 15.0 111.204 -179.793 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.539 HG11 ' O ' ' A' ' 34' ' ' GLY . 17.5 m -70.33 -173.77 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.333 -0.394 . . . . 15.0 111.258 -179.875 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -57.98 -51.73 68.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 15.0 111.073 -179.892 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 19.6 p-80 -153.31 -46.88 0.09 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.343 -0.389 . . . . 15.0 111.058 -179.865 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -167.44 19.24 0.09 OUTLIER Glycine 0 CA--C 1.519 0.291 0 C-N-CA 120.739 -0.743 . . . . 15.0 112.881 -179.767 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.539 ' O ' HG11 ' A' ' 30' ' ' VAL . . . -90.12 152.3 22.13 Favored Glycine 0 N--CA 1.449 -0.468 0 N-CA-C 110.249 -1.14 . . . . 15.0 110.249 178.493 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.919 ' CG2' HG22 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -97.58 147.38 6.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 117.893 0.847 . . . . 15.0 111.658 -179.263 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.509 ' N ' HD13 ' A' ' 35' ' ' ILE . 2.9 m-85 -130.96 113.59 14.19 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.563 -0.744 . . . . 15.0 109.755 -179.313 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.748 HG22 ' N ' ' A' ' 55' ' ' GLY . 0.8 OUTLIER -55.16 161.16 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-O 121.308 0.575 . . . . 15.0 111.238 -179.216 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.531 ' O ' ' HG2' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -91.6 -46.21 8.07 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.456 -0.942 . . . . 15.0 108.456 178.388 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.663 ' O ' HG12 ' A' ' 20' ' ' ILE . . . -172.27 173.71 4.14 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 115.302 -0.863 . . . . 15.0 110.193 178.772 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.61 ' HA ' HG12 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -96.81 108.75 21.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 109.472 -0.566 . . . . 15.0 109.472 179.268 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.75 ' HB ' ' O ' ' A' ' 19' ' ' GLY . 0.7 OUTLIER -78.28 116.33 58.16 Favored Pre-proline 0 C--N 1.328 -0.369 0 N-CA-C 113.482 0.919 . . . . 15.0 113.482 -177.245 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.618 ' HA ' ' CG ' ' A' ' 47' ' ' GLU . 36.0 Cg_exo -61.78 60.02 0.12 Allowed 'Trans proline' 0 C--N 1.358 1.045 0 C-N-CA 123.707 2.938 . . . . 15.0 113.271 179.821 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.533 ' N ' ' HG2' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -147.44 -46.97 0.17 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.649 0.261 . . . . 15.0 111.484 179.769 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.775 ' HA3' ' HA3' ' A' ' 19' ' ' GLY . . . -87.87 169.06 38.18 Favored Glycine 0 C--N 1.331 0.264 0 C-N-CA 120.386 -0.911 . . . . 15.0 114.007 -179.124 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -58.1 -14.88 7.64 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.023 -0.588 . . . . 15.0 112.499 -179.765 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.499 ' HB1' HG22 ' A' ' 52' ' ' ILE . . . -72.22 -56.26 5.85 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.587 0.232 . . . . 15.0 110.996 -179.656 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.618 ' CG ' ' HA ' ' A' ' 42' ' ' PRO . 2.9 pp20? -57.41 -42.91 83.19 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.222 -0.445 . . . . 15.0 110.309 179.256 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -53.71 -71.12 0.08 Allowed 'General case' 0 CA--C 1.519 -0.221 0 CA-C-N 115.801 -0.636 . . . . 15.0 110.488 -179.457 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.584 ' HB2' HD11 ' A' ' 11' ' ' LEU . 0.2 OUTLIER -58.34 -40.07 81.18 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.286 -0.635 . . . . 15.0 109.286 178.826 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.83 37.79 18.27 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 115.359 -0.837 . . . . 15.0 111.756 179.415 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.673 ' HG3' HD13 ' A' ' 11' ' ' LEU . 2.8 mmp_? -79.85 -48.09 14.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.861 0.362 . . . . 15.0 110.775 -179.447 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.556 ' CG1' HD12 ' A' ' 20' ' ' ILE . 10.5 tp -81.04 155.7 4.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.104 -0.498 . . . . 15.0 110.391 179.62 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 53' ' ' HIS . . . . . 0.525 ' O ' ' HB2' ' A' ' 56' ' ' ASP . 53.1 m80 -142.33 161.49 37.91 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-O 121.694 0.759 . . . . 15.0 112.345 -179.032 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.531 ' HG2' ' O ' ' A' ' 38' ' ' LYS . 0.8 OUTLIER -44.27 133.33 5.47 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.445 -1.252 . . . . 15.0 112.561 -178.707 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.748 ' N ' HG22 ' A' ' 37' ' ' VAL . . . 49.59 36.62 25.05 Favored Glycine 0 C--N 1.334 0.441 0 C-N-CA 121.009 -0.615 . . . . 15.0 113.101 179.45 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.525 ' HB2' ' O ' ' A' ' 53' ' ' HIS . 1.4 t0 -65.46 125.11 24.12 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.816 -0.353 . . . . 15.0 110.261 179.539 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.428 ' NE ' ' HG2' ' A' ' 90' ' ' GLU . 1.3 mtt180 -83.15 81.69 8.58 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.321 -0.4 . . . . 15.0 110.05 179.614 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.924 HG12 HD22 ' A' ' 89' ' ' LEU . 1.1 m -79.23 119.77 29.16 Favored 'Isoleucine or valine' 0 C--O 1.24 0.556 0 CA-C-O 121.276 0.56 . . . . 15.0 110.747 -179.502 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -107.64 -13.63 15.0 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 115.236 -0.893 . . . . 15.0 112.516 -179.091 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.485 ' O ' HD23 ' A' ' 87' ' ' LEU . . . -149.63 151.25 33.45 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 112.82 0.674 . . . . 15.0 112.82 -178.543 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.856 HG11 ' O ' ' A' ' 77' ' ' THR . 20.8 t -140.7 100.76 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.171 -0.922 . . . . 15.0 109.198 178.71 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.627 ' OD1' HG22 ' A' ' 81' ' ' THR . 12.1 m120 64.87 15.29 9.8 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.779 -0.452 . . . . 15.0 109.779 -177.968 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 107.19 6.64 33.77 Favored Glycine 0 C--N 1.336 0.561 0 CA-C-N 115.926 -0.579 . . . . 15.0 113.476 179.602 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.674 HG13 ' O ' ' A' ' 64' ' ' VAL . 5.7 p -93.76 104.08 15.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 117.273 0.537 . . . . 15.0 110.588 179.206 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -56.07 134.16 52.44 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.099 -0.5 . . . . 15.0 111.318 -179.336 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.513 HD21 ' HA ' ' A' ' 74' ' ' ALA . 0.1 OUTLIER -97.78 -21.23 17.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.881 -0.6 . . . . 15.0 110.81 179.887 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -44.35 99.27 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 116.339 -0.392 . . . . 15.0 111.219 179.988 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.49 64.74 0.57 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.798 -0.715 . . . . 15.0 112.328 -179.774 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.456 ' HB1' ' CB ' ' A' ' 73' ' ' GLN . . . -173.03 169.03 4.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.89 0.376 . . . . 15.0 111.185 -179.774 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.443 ' HA ' ' N ' ' A' ' 26' ' ' VAL . 5.7 p -93.28 -171.7 2.73 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.184 -0.462 . . . . 15.0 111.27 -179.855 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 71' ' ' HIS . . . . . 0.741 ' CE1' HG23 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -65.69 -59.61 3.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.737 -0.665 . . . . 15.0 110.866 -179.859 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.439 ' N ' ' CG ' ' A' ' 71' ' ' HIS . 16.7 ttmt -52.4 -32.27 38.06 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.804 -0.634 . . . . 15.0 110.647 179.952 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.456 ' CB ' ' HB1' ' A' ' 69' ' ' ALA . 8.4 mt-30 -59.23 -49.85 76.26 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.778 -0.453 . . . . 15.0 109.778 179.432 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.655 ' CB ' HG21 ' A' ' 35' ' ' ILE . . . -67.39 -46.42 73.33 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 109.615 -0.513 . . . . 15.0 109.615 178.302 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.961 HG23 HG21 ' A' ' 22' ' ' VAL . 0.5 OUTLIER -40.97 -40.3 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.283 0 N-CA-C 108.97 -0.752 . . . . 15.0 108.97 178.324 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.459 ' O ' ' HB2' ' A' ' 80' ' ' ASN . 46.9 mt-10 -67.36 -47.48 70.29 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 114.666 -1.152 . . . . 15.0 110.541 178.659 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.856 ' O ' HG11 ' A' ' 61' ' ' VAL . 67.4 p -64.2 -52.45 58.82 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 121.045 -0.262 . . . . 15.0 111.511 179.974 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.789 HD21 HG21 ' A' ' 58' ' ' VAL . 5.0 mt -53.4 -47.68 69.35 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-O 121.193 0.521 . . . . 15.0 109.761 179.959 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.414 ' HB2' ' O ' ' A' ' 75' ' ' VAL . 5.2 ttm180 -68.62 -62.37 1.42 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.375 -0.829 . . . . 15.0 110.42 179.112 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.459 ' HB2' ' O ' ' A' ' 76' ' ' GLU . 15.8 m-80 -66.01 62.35 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.02 -0.537 . . . . 15.0 111.78 179.766 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.627 HG22 ' OD1' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -88.11 -70.4 0.64 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.865 0.364 . . . . 15.0 110.213 179.442 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 121.99 -107.85 1.23 Allowed Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 121.047 -0.597 . . . . 15.0 112.686 179.54 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.497 ' O ' ' HB3' ' A' ' 13' ' ' LYS . 0.4 OUTLIER -65.0 -82.99 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.773 0.32 . . . . 15.0 111.664 -179.567 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.469 HG12 ' N ' ' A' ' 85' ' ' VAL . 63.1 t -110.2 160.61 9.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.327 -0.397 . . . . 15.0 110.436 179.999 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.627 HG23 ' CB ' ' A' ' 13' ' ' LYS . 19.9 t -98.01 80.89 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.127 0.489 . . . . 15.0 110.503 179.83 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 7.1 t60 -100.45 82.05 2.43 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 115.762 -0.654 . . . . 15.0 110.241 179.832 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.539 HD11 ' HA ' ' A' ' 78' ' ' LEU . 0.1 OUTLIER -102.0 126.26 48.89 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.777 -0.647 . . . . 15.0 111.909 -178.961 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.72 HD12 ' HB3' ' A' ' 8' ' ' GLU . 0.2 OUTLIER -102.3 103.44 13.91 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.648 -0.501 . . . . 15.0 109.648 178.813 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.924 HD22 HG12 ' A' ' 58' ' ' VAL . 0.1 OUTLIER -105.76 -163.82 0.97 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.366 0.603 . . . . 15.0 111.782 -178.955 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.548 ' HA ' ' HA ' ' A' ' 6' ' ' ILE . 3.6 tt0 -138.11 134.2 34.35 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.052 -0.976 . . . . 15.0 109.676 178.996 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.413 ' HD2' ' HA ' ' A' ' 91' ' ' LYS . 0.0 OUTLIER -46.67 97.99 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.316 -0.402 . . . . 15.0 111.414 -179.356 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.287 0 C-N-CA 120.944 -0.646 . . . . 15.0 112.579 179.988 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.422 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 1.4 mp . . . . . 0 N--CA 1.45 -0.434 0 CA-C-O 120.871 0.367 . . . . 15.0 111.27 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.644 ' CZ ' HD12 ' A' ' 89' ' ' LEU . 4.0 p90 -140.91 166.39 24.9 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.098 -0.501 . . . . 15.0 110.465 178.797 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.713 ' CB ' HD12 ' A' ' 88' ' ' LEU . 9.4 pt-20 -130.07 144.95 51.62 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.235 0.54 . . . . 15.0 111.613 -179.287 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.681 HG23 ' HG2' ' A' ' 51' ' ' ARG . 0.4 OUTLIER -101.57 116.18 44.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.395 -0.82 . . . . 15.0 109.93 179.019 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -106.56 69.14 0.77 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.236 -0.438 . . . . 15.0 111.807 -179.448 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.645 HD11 ' CB ' ' A' ' 49' ' ' ASP . 6.1 tp -88.07 160.75 17.69 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.298 -0.41 . . . . 15.0 109.961 179.058 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -97.1 95.71 7.96 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.292 0.479 . . . . 15.0 112.292 -179.177 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.881 ' HB2' HG23 ' A' ' 85' ' ' VAL . 3.5 tppt? . . . . . 0 CA--C 1.537 0.453 0 N-CA-C 112.131 0.419 . . . . 15.0 112.131 178.894 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.634 HD22 ' HZ1' ' A' ' 13' ' ' LYS . 0.3 OUTLIER . . . . . 0 N--CA 1.451 -0.414 0 CA-C-O 120.821 0.344 . . . . 15.0 110.841 . . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.714 ' O ' ' HB ' ' A' ' 41' ' ' ILE . . . -161.05 36.27 0.41 Allowed Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.968 -0.634 . . . . 15.0 112.279 -179.703 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.759 HD12 ' HB ' ' A' ' 52' ' ' ILE . 0.0 OUTLIER -112.82 136.95 47.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 120.993 0.425 . . . . 15.0 111.719 -179.676 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.429 ' O ' ' HB3' ' A' ' 38' ' ' LYS . 27.5 t -95.96 100.41 12.09 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 107.845 -1.168 . . . . 15.0 107.845 177.294 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.652 HG12 ' CG2' ' A' ' 20' ' ' ILE . 1.0 OUTLIER -93.78 155.74 3.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 112.334 0.494 . . . . 15.0 112.334 -177.226 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.624 ' HA ' ' CD2' ' A' ' 71' ' ' HIS . 6.0 t -149.82 176.02 11.1 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.47 -0.787 . . . . 15.0 110.472 179.429 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.721 ' O ' HG22 ' A' ' 26' ' ' VAL . . . 86.95 -112.03 3.74 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.558 -0.829 . . . . 15.0 112.505 179.849 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.591 ' HA3' ' N ' ' A' ' 71' ' ' HIS . . . 62.58 -66.2 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 121.067 -0.587 . . . . 15.0 113.653 179.199 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.721 HG22 ' O ' ' A' ' 24' ' ' GLY . 0.0 OUTLIER -28.94 143.12 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 N-CA-C 112.528 0.566 . . . . 15.0 112.528 -179.038 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.402 ' CB ' ' O ' ' A' ' 32' ' ' HIS . 0.6 OUTLIER -75.67 61.87 1.41 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.738 -0.664 . . . . 15.0 110.968 -179.844 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -151.65 -66.97 0.18 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.376 -0.375 . . . . 15.0 111.045 179.994 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 72.4 m -65.4 -49.76 68.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.183 -0.462 . . . . 15.0 110.877 -179.939 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.521 HG21 ' O ' ' A' ' 34' ' ' GLY . 34.5 m -75.95 -174.1 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.185 -0.462 . . . . 15.0 111.119 -179.966 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.81 -78.89 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.337 -0.392 . . . . 15.0 111.258 -179.755 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 32' ' ' HIS . . . . . 0.402 ' O ' ' CB ' ' A' ' 27' ' ' ASN . 34.4 p-80 -126.92 -42.85 1.72 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.431 -0.35 . . . . 15.0 111.223 -179.818 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -170.06 26.62 0.11 Allowed Glycine 0 N--CA 1.453 -0.2 0 C-N-CA 120.745 -0.74 . . . . 15.0 112.554 -179.772 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.521 ' O ' HG21 ' A' ' 30' ' ' VAL . . . -92.61 154.75 22.3 Favored Glycine 0 N--CA 1.448 -0.521 0 N-CA-C 110.33 -1.108 . . . . 15.0 110.33 178.723 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 1.0 HG22 HG22 ' A' ' 58' ' ' VAL . 0.2 OUTLIER -98.86 152.82 4.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 119.768 -0.773 . . . . 15.0 112.318 -179.154 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.41 ' CZ ' ' HG3' ' A' ' 57' ' ' ARG . 14.7 m-85 -137.19 111.21 8.31 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.65 -1.159 . . . . 15.0 109.087 179.406 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.769 HG22 ' N ' ' A' ' 55' ' ' GLY . 0.8 OUTLIER -55.37 168.69 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.42 0.628 . . . . 15.0 111.572 -178.315 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.523 ' O ' ' HG2' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -99.75 -45.12 5.85 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.374 -0.973 . . . . 15.0 108.374 178.189 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.58 ' O ' HG12 ' A' ' 20' ' ' ILE . . . -172.66 171.45 4.48 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 115.437 -0.801 . . . . 15.0 110.363 178.466 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.466 ' HA ' HG12 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -96.76 110.68 25.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 108.803 -0.814 . . . . 15.0 108.803 178.877 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.714 ' HB ' ' O ' ' A' ' 19' ' ' GLY . 0.4 OUTLIER -77.55 115.66 51.51 Favored Pre-proline 0 C--N 1.329 -0.288 0 N-CA-C 113.597 0.962 . . . . 15.0 113.597 -176.693 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.616 ' HA ' ' HG2' ' A' ' 47' ' ' GLU . 38.9 Cg_exo -61.55 61.14 0.11 Allowed 'Trans proline' 0 C--N 1.358 1.073 0 C-N-CA 123.726 2.951 . . . . 15.0 113.003 179.578 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.517 ' H ' ' HG2' ' A' ' 47' ' ' GLU . 3.5 mt-30 -150.57 -47.93 0.12 Allowed 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 111.738 0.273 . . . . 15.0 111.738 179.957 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.609 ' HA3' ' HA3' ' A' ' 19' ' ' GLY . . . -87.81 166.66 35.91 Favored Glycine 0 CA--C 1.519 0.303 0 C-N-CA 120.356 -0.926 . . . . 15.0 113.79 -179.082 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -55.48 -14.87 2.22 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.66 0.615 . . . . 15.0 112.66 -179.817 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.93 -57.95 3.87 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.702 0.287 . . . . 15.0 110.945 -179.397 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.616 ' HG2' ' HA ' ' A' ' 42' ' ' PRO . 2.8 pp20? -56.94 -42.2 79.64 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.989 0.423 . . . . 15.0 110.391 179.415 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -53.82 -72.25 0.06 Allowed 'General case' 0 CA--C 1.519 -0.214 0 CA-C-N 115.883 -0.598 . . . . 15.0 110.466 -179.636 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.645 ' CB ' HD11 ' A' ' 11' ' ' LEU . 0.5 OUTLIER -58.68 -40.4 83.46 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.456 -0.572 . . . . 15.0 109.456 179.01 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.93 50.03 5.38 Favored Glycine 0 N--CA 1.447 -0.584 0 CA-C-N 115.388 -0.824 . . . . 15.0 111.766 179.604 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.681 ' HG2' HG23 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -79.49 -51.59 9.13 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.764 0.316 . . . . 15.0 110.775 -179.34 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.759 ' HB ' HD12 ' A' ' 20' ' ' ILE . 3.1 mm -91.45 162.72 2.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.993 0.425 . . . . 15.0 111.083 179.694 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 53' ' ' HIS . . . . . 0.596 ' N ' HG22 ' A' ' 52' ' ' ILE . 52.0 m80 -141.5 157.6 44.93 Favored 'General case' 0 CA--C 1.513 -0.466 0 CA-C-N 115.797 -0.638 . . . . 15.0 110.616 179.718 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.523 ' HG2' ' O ' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -35.61 132.58 0.44 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.848 -1.069 . . . . 15.0 112.647 -178.501 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.769 ' N ' HG22 ' A' ' 37' ' ' VAL . . . 49.71 38.02 28.58 Favored Glycine 0 C--N 1.332 0.338 0 CA-C-N 115.923 -0.58 . . . . 15.0 113.64 179.524 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -65.88 128.59 36.62 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 117.499 0.65 . . . . 15.0 110.523 179.388 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.439 ' HA ' ' O ' ' A' ' 35' ' ' ILE . 56.3 ttt180 -83.25 88.02 6.94 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.429 -0.35 . . . . 15.0 110.537 179.808 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 1.0 HG22 HG22 ' A' ' 35' ' ' ILE . 1.8 m -82.94 112.53 20.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.17 0.509 . . . . 15.0 111.353 -179.44 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.4 ' HA ' ' HB2' ' A' ' 66' ' ' LEU . 35.6 mt -107.27 -9.47 16.06 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 115.685 -0.689 . . . . 15.0 112.654 -179.306 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.55 ' HB3' ' HB2' ' A' ' 88' ' ' LEU . . . -151.25 144.81 24.94 Favored 'General case' 0 N--CA 1.463 0.194 0 N-CA-C 112.565 0.58 . . . . 15.0 112.565 -178.857 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.881 HG11 ' O ' ' A' ' 77' ' ' THR . 32.7 t -139.07 98.96 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.258 0 CA-C-N 115.497 -0.774 . . . . 15.0 109.452 178.878 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.518 ' OD1' HG22 ' A' ' 81' ' ' THR . 2.9 m120 65.06 17.76 11.2 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.066 -0.516 . . . . 15.0 109.874 -178.415 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 107.24 4.57 35.33 Favored Glycine 0 C--N 1.336 0.536 0 CA-C-N 115.836 -0.62 . . . . 15.0 113.676 179.488 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.664 HG13 ' O ' ' A' ' 64' ' ' VAL . 4.9 p -93.87 105.28 16.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 117.323 0.562 . . . . 15.0 110.818 179.319 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -56.87 134.59 55.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.142 -0.481 . . . . 15.0 110.983 -179.692 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.59 HD13 ' HB3' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -87.64 -19.35 27.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.121 -0.49 . . . . 15.0 111.034 -179.998 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -46.92 95.56 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 120.892 0.377 . . . . 15.0 110.888 179.943 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.77 66.75 0.59 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.785 -0.721 . . . . 15.0 112.217 -179.588 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.65 ' HB1' ' CB ' ' A' ' 73' ' ' GLN . . . -172.95 154.36 2.82 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.859 0.362 . . . . 15.0 110.976 -179.867 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.427 ' HA ' ' C ' ' A' ' 25' ' ' GLY . 13.7 p -93.04 -170.91 2.54 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.114 -0.494 . . . . 15.0 111.396 -179.626 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 71' ' ' HIS . . . . . 0.624 ' CD2' ' HA ' ' A' ' 23' ' ' THR . 0.1 OUTLIER -58.12 -62.17 2.02 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.618 -0.719 . . . . 15.0 110.063 179.75 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 3.4 ttpt -53.02 -36.23 60.3 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.236 -0.893 . . . . 15.0 111.051 179.483 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.65 ' CB ' ' HB1' ' A' ' 69' ' ' ALA . 7.0 mt-30 -59.41 -57.31 13.53 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.304 -0.407 . . . . 15.0 110.163 179.88 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.894 ' HB3' HD12 ' A' ' 35' ' ' ILE . . . -63.27 -43.63 97.4 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.715 -0.476 . . . . 15.0 109.715 178.835 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.588 HG23 ' CG2' ' A' ' 22' ' ' VAL . 0.5 OUTLIER -43.66 -42.74 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.223 0 N-CA-C 108.807 -0.812 . . . . 15.0 108.807 178.176 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.41 ' N ' HG12 ' A' ' 75' ' ' VAL . 21.7 mt-10 -67.45 -42.91 82.3 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 114.856 -1.066 . . . . 15.0 110.535 178.556 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.881 ' O ' HG11 ' A' ' 61' ' ' VAL . 69.9 p -63.9 -56.18 17.22 Favored 'General case' 0 N--CA 1.462 0.135 0 C-N-CA 120.997 -0.281 . . . . 15.0 111.5 -179.924 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.811 HD21 HG21 ' A' ' 58' ' ' VAL . 5.6 mt -53.37 -47.14 69.71 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-O 121.197 0.523 . . . . 15.0 110.007 179.953 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.409 ' O ' ' N ' ' A' ' 81' ' ' THR . 7.1 tpp85 -68.53 -59.12 3.37 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.395 -0.82 . . . . 15.0 110.691 179.489 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.408 ' CB ' ' O ' ' A' ' 76' ' ' GLU . 2.9 m-20 -65.92 63.0 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.035 -0.53 . . . . 15.0 111.848 179.909 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.518 HG22 ' OD1' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -91.79 -73.55 0.54 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.728 0.299 . . . . 15.0 110.33 179.322 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.434 ' O ' ' HG3' ' A' ' 13' ' ' LYS . . . 120.98 -103.43 0.9 Allowed Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.773 -0.727 . . . . 15.0 112.672 179.431 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -64.85 -87.03 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.723 0.297 . . . . 15.0 111.05 -179.841 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.507 HG12 ' N ' ' A' ' 85' ' ' VAL . 93.7 t -110.07 161.9 8.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.881 0.372 . . . . 15.0 110.625 179.956 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.881 HG23 ' HB2' ' A' ' 13' ' ' LYS . 3.3 t -97.43 84.54 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.176 0.512 . . . . 15.0 110.368 179.825 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 10.9 t60 -101.28 82.63 2.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.59 -0.732 . . . . 15.0 110.001 179.493 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.695 ' HB3' HD21 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -103.92 126.36 50.98 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.818 -0.628 . . . . 15.0 112.01 -178.907 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.713 HD12 ' CB ' ' A' ' 8' ' ' GLU . 4.9 mp -102.38 100.48 10.63 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.4 -0.593 . . . . 15.0 109.4 178.487 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.695 HD21 ' HB3' ' A' ' 87' ' ' LEU . 0.1 OUTLIER -105.57 -162.24 0.86 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.611 0.719 . . . . 15.0 112.027 -178.566 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.422 ' HA ' ' HA ' ' A' ' 6' ' ' ILE . 1.3 tt0 -139.89 133.88 30.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 114.73 -1.123 . . . . 15.0 109.485 178.856 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.15 93.81 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.89 0.376 . . . . 15.0 111.069 -179.562 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.322 0 C-N-CA 120.959 -0.639 . . . . 15.0 112.738 -179.769 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.471 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 1.1 mp . . . . . 0 N--CA 1.451 -0.405 0 CA-C-O 120.859 0.362 . . . . 15.0 111.125 . . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.658 ' CZ ' HD12 ' A' ' 89' ' ' LEU . 2.3 p90 -140.41 151.3 44.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.171 -0.468 . . . . 15.0 110.611 179.119 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.656 ' CB ' HD12 ' A' ' 88' ' ' LEU . 13.7 pt-20 -116.9 143.08 46.12 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.206 0.527 . . . . 15.0 111.402 -179.467 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.678 ' CG1' HD11 ' A' ' 89' ' ' LEU . 0.4 OUTLIER -101.46 116.92 45.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.401 -0.818 . . . . 15.0 109.766 179.056 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -106.0 72.25 0.93 Allowed 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.198 0.444 . . . . 15.0 112.198 -178.932 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.738 HD13 ' HB2' ' A' ' 51' ' ' ARG . 6.7 tp -88.23 165.41 15.07 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.035 -0.53 . . . . 15.0 109.592 178.699 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -96.03 96.33 8.8 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.004 0.431 . . . . 15.0 110.991 179.952 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.737 ' CB ' HG23 ' A' ' 85' ' ' VAL . 0.1 OUTLIER . . . . . 0 C--N 1.327 -0.395 0 CA-C-N 115.785 -0.643 . . . . 15.0 111.261 -179.863 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.675 ' N ' HD22 ' A' ' 18' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.455 -0.196 0 CA-C-O 121.051 0.453 . . . . 15.0 110.721 . . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.595 ' O ' ' HB ' ' A' ' 41' ' ' ILE . . . -169.73 34.87 0.18 Allowed Glycine 0 CA--C 1.506 -0.53 0 N-CA-C 111.102 -0.799 . . . . 15.0 111.102 -179.673 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.652 HD12 HG12 ' A' ' 52' ' ' ILE . 0.0 OUTLIER -114.23 142.11 28.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 112.652 0.612 . . . . 15.0 112.652 -179.188 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.704 ' CB ' HD11 ' A' ' 41' ' ' ILE . 2.3 t -96.86 104.1 16.08 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 107.903 -1.147 . . . . 15.0 107.903 176.315 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.984 HG21 HG23 ' A' ' 75' ' ' VAL . 27.5 m -93.63 147.36 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 N-CA-C 112.981 0.734 . . . . 15.0 112.981 -177.248 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.549 ' HA ' ' CE1' ' A' ' 71' ' ' HIS . 6.4 t -150.04 -177.46 5.93 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 115.553 -0.749 . . . . 15.0 111.327 179.205 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.641 ' O ' HG22 ' A' ' 26' ' ' VAL . . . 73.58 -115.95 5.23 Favored Glycine 0 C--N 1.336 0.565 0 C-N-CA 121.067 -0.587 . . . . 15.0 112.457 179.86 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.563 ' HA3' ' N ' ' A' ' 71' ' ' HIS . . . 64.18 -65.22 0.05 OUTLIER Glycine 0 C--N 1.33 0.233 0 C-N-CA 121.091 -0.576 . . . . 15.0 114.05 178.977 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.641 HG22 ' O ' ' A' ' 24' ' ' GLY . 0.0 OUTLIER -30.11 144.0 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 N-CA-C 112.145 0.424 . . . . 15.0 112.145 -179.121 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -75.51 58.21 1.01 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.137 -0.483 . . . . 15.0 110.974 -179.644 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 5.3 m -151.92 -60.7 0.16 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.243 -0.435 . . . . 15.0 110.792 179.965 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 9.0 t -70.31 -46.67 63.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.069 -0.514 . . . . 15.0 110.914 -179.927 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.498 HG22 ' O ' ' A' ' 26' ' ' VAL . 14.2 m -77.05 -170.03 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.237 -0.438 . . . . 15.0 111.093 -179.959 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 5.2 mmt180 -57.42 -71.47 0.1 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.273 -0.421 . . . . 15.0 111.009 -179.997 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 32' ' ' HIS . . . . . 0.442 ' CD2' ' N ' ' A' ' 33' ' ' GLY . 8.5 p-80 -134.93 -42.3 0.74 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.318 -0.401 . . . . 15.0 111.37 -179.817 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.442 ' N ' ' CD2' ' A' ' 32' ' ' HIS . . . -170.16 22.49 0.09 OUTLIER Glycine 0 CA--C 1.52 0.344 0 C-N-CA 120.504 -0.855 . . . . 15.0 113.086 -179.66 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.438 ' O ' HG21 ' A' ' 30' ' ' VAL . . . -92.58 154.25 22.06 Favored Glycine 0 N--CA 1.451 -0.33 0 N-CA-C 110.163 -1.175 . . . . 15.0 110.163 178.405 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.987 HG22 HG22 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -101.34 147.33 8.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 118.181 0.99 . . . . 15.0 111.795 -179.209 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.736 ' N ' HD13 ' A' ' 35' ' ' ILE . 13.5 m-85 -131.28 113.18 13.49 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-N 115.433 -0.803 . . . . 15.0 109.537 -179.61 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.797 HG22 ' N ' ' A' ' 55' ' ' GLY . 0.7 OUTLIER -54.87 148.68 2.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 115.471 -0.786 . . . . 15.0 111.363 -178.736 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.484 ' O ' ' HG2' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -81.08 -48.39 12.24 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.775 -0.824 . . . . 15.0 108.775 178.654 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.501 ' O ' HG12 ' A' ' 20' ' ' ILE . . . -172.5 169.04 5.27 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.567 -0.742 . . . . 15.0 110.766 178.572 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.647 HG12 HG13 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -97.49 122.08 48.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.793 0.33 . . . . 15.0 110.526 179.676 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.704 HD11 ' CB ' ' A' ' 21' ' ' SER . 1.5 mm -78.5 109.26 9.93 Favored Pre-proline 0 N--CA 1.464 0.229 0 N-CA-C 112.956 0.724 . . . . 15.0 112.956 -178.627 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.474 ' HA ' ' OE1' ' A' ' 47' ' ' GLU . 38.2 Cg_endo -65.72 65.46 0.4 Allowed 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 122.828 2.352 . . . . 15.0 112.246 179.49 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -162.55 -44.94 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.434 -0.803 . . . . 15.0 109.508 179.816 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.556 ' HA3' ' HA3' ' A' ' 19' ' ' GLY . . . -87.43 151.35 23.31 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.774 -0.727 . . . . 15.0 112.338 179.351 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -40.19 -19.6 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 113.465 0.913 . . . . 15.0 113.465 -179.312 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.445 ' N ' ' O ' ' A' ' 44' ' ' GLY . . . -71.58 -71.13 0.28 Allowed 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.809 -0.356 . . . . 15.0 111.076 -179.654 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.56 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 9.0 tm-20 -58.22 -36.58 73.35 Favored 'General case' 0 N--CA 1.462 0.153 0 C-N-CA 120.81 -0.356 . . . . 15.0 110.284 179.36 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 53.6 m -56.16 -67.69 0.27 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.173 -0.467 . . . . 15.0 110.395 179.464 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.558 ' CB ' HD11 ' A' ' 11' ' ' LEU . 2.6 m-20 -62.11 -37.64 85.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.129 -0.487 . . . . 15.0 109.932 179.179 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.32 38.19 15.63 Favored Glycine 0 N--CA 1.448 -0.521 0 CA-C-N 115.694 -0.684 . . . . 15.0 112.028 179.943 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.738 ' HB2' HD13 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -79.69 -53.58 6.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.124 0.487 . . . . 15.0 110.286 -179.846 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.652 HG12 HD12 ' A' ' 20' ' ' ILE . 11.0 tp -87.82 158.04 3.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.587 -0.733 . . . . 15.0 110.158 179.477 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 67.6 m80 -139.78 160.52 39.71 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-O 121.777 0.799 . . . . 15.0 112.898 -178.705 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.592 ' HA ' ' CG2' ' A' ' 37' ' ' VAL . 1.1 mtpt -43.97 134.7 4.49 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 114.007 -1.451 . . . . 15.0 112.702 -178.843 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.797 ' N ' HG22 ' A' ' 37' ' ' VAL . . . 49.75 31.95 16.87 Favored Glycine 0 C--N 1.333 0.408 0 CA-C-N 115.945 -0.571 . . . . 15.0 113.284 179.282 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -65.56 122.59 17.57 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.629 -0.428 . . . . 15.0 109.874 179.15 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.503 ' NE ' HD21 ' A' ' 59' ' ' LEU . 36.9 ttt85 -80.98 85.44 6.26 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.429 -0.35 . . . . 15.0 110.421 -179.859 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.987 HG22 HG22 ' A' ' 35' ' ' ILE . 1.3 m -79.67 121.76 33.58 Favored 'Isoleucine or valine' 0 C--O 1.24 0.601 0 CA-C-O 121.211 0.529 . . . . 15.0 111.559 -179.365 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.503 HD21 ' NE ' ' A' ' 57' ' ' ARG . 3.8 mm? -107.91 -15.63 14.5 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 115.09 -0.959 . . . . 15.0 111.984 -179.861 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.641 ' HB3' ' HB2' ' A' ' 88' ' ' LEU . . . -147.91 148.16 30.51 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.113 0.483 . . . . 15.0 112.263 -178.565 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.688 HG11 ' O ' ' A' ' 77' ' ' THR . 39.6 t -139.02 102.69 1.8 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.249 0 CA-C-N 115.577 -0.738 . . . . 15.0 109.451 178.825 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.65 ' OD1' HG22 ' A' ' 81' ' ' THR . 2.4 m120 64.83 14.46 9.21 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.763 -0.458 . . . . 15.0 109.763 -178.195 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 107.01 6.49 34.3 Favored Glycine 0 C--N 1.336 0.573 0 CA-C-N 115.863 -0.608 . . . . 15.0 113.244 179.828 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.666 HG13 ' O ' ' A' ' 64' ' ' VAL . 6.3 p -93.67 105.22 16.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 121.098 0.475 . . . . 15.0 110.579 179.216 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -58.46 123.67 16.98 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.145 -0.479 . . . . 15.0 111.142 -179.442 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.847 HD13 HG23 ' A' ' 58' ' ' VAL . 0.2 OUTLIER -92.07 -16.96 25.69 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.918 -0.583 . . . . 15.0 111.096 179.877 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -43.43 95.26 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.874 0.369 . . . . 15.0 111.239 -179.994 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 107.83 71.42 0.74 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.799 -0.715 . . . . 15.0 112.301 -179.73 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.597 ' HB1' ' CG ' ' A' ' 73' ' ' GLN . . . -173.02 169.46 4.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.831 0.348 . . . . 15.0 111.107 -179.778 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 15.6 p -93.42 -175.21 3.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.927 0.394 . . . . 15.0 111.27 -179.749 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 71' ' ' HIS . . . . . 0.772 ' NE2' HG23 ' A' ' 22' ' ' VAL . 0.1 OUTLIER -65.78 -58.56 5.35 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.882 -0.599 . . . . 15.0 110.623 -179.902 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.442 ' O ' ' HG3' ' A' ' 76' ' ' GLU . 23.3 ttpp -52.21 -31.03 30.09 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.747 -0.464 . . . . 15.0 109.747 178.925 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.597 ' CG ' ' HB1' ' A' ' 69' ' ' ALA . 1.1 tt0 -59.5 -49.19 78.73 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.916 -0.584 . . . . 15.0 109.609 178.813 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.626 ' CB ' HG21 ' A' ' 35' ' ' ILE . . . -67.11 -45.79 76.15 Favored 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 109.568 -0.53 . . . . 15.0 109.568 178.512 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.984 HG23 HG21 ' A' ' 22' ' ' VAL . 0.5 OUTLIER -42.2 -42.12 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.27 0 N-CA-C 108.792 -0.818 . . . . 15.0 108.792 178.257 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.499 ' O ' ' HB2' ' A' ' 80' ' ' ASN . 8.9 mt-10 -67.3 -45.28 77.01 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 114.651 -1.159 . . . . 15.0 110.361 178.477 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.688 ' O ' HG11 ' A' ' 61' ' ' VAL . 72.9 p -64.1 -54.54 32.42 Favored 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 111.545 0.202 . . . . 15.0 111.545 -179.949 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.597 HD21 HG21 ' A' ' 58' ' ' VAL . 8.3 mt -53.47 -46.35 69.92 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 121.308 0.575 . . . . 15.0 109.881 -179.989 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.451 ' HB2' ' O ' ' A' ' 75' ' ' VAL . 0.2 OUTLIER -68.51 -58.89 3.63 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.204 -0.907 . . . . 15.0 110.805 179.677 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.499 ' HB2' ' O ' ' A' ' 76' ' ' GLU . 6.5 m-80 -66.23 56.98 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 112.393 0.516 . . . . 15.0 112.393 -179.86 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.65 HG22 ' OD1' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -95.69 -75.02 0.53 Allowed 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.94 -0.393 . . . . 15.0 109.94 178.853 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 122.06 -104.02 0.89 Allowed Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.641 -0.79 . . . . 15.0 113.537 178.804 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -63.08 -84.9 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.06 0.393 . . . . 15.0 112.06 -178.699 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.453 HG12 ' N ' ' A' ' 85' ' ' VAL . 55.4 t -109.46 160.18 8.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.891 0.377 . . . . 15.0 110.706 -179.408 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.737 HG23 ' CB ' ' A' ' 13' ' ' LYS . 9.3 t -97.8 81.42 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-O 121.118 0.485 . . . . 15.0 110.382 -179.926 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 5.0 t-160 -99.66 86.29 3.3 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.736 -0.665 . . . . 15.0 110.229 179.863 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.822 ' HB3' HD21 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -103.82 127.33 51.33 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.882 -0.599 . . . . 15.0 111.718 -179.018 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.656 HD12 ' CB ' ' A' ' 8' ' ' GLU . 4.4 mp -102.18 99.44 9.57 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.552 -0.536 . . . . 15.0 109.552 178.742 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.822 HD21 ' HB3' ' A' ' 87' ' ' LEU . 0.1 OUTLIER -105.88 -162.66 0.88 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.56 0.695 . . . . 15.0 112.406 -178.317 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.471 ' HA ' ' HA ' ' A' ' 6' ' ' ILE . 1.9 tt0 -138.37 142.27 39.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 114.617 -1.174 . . . . 15.0 109.288 178.669 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -53.79 100.75 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.002 0.429 . . . . 15.0 111.107 -179.522 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.323 0 C-N-CA 120.956 -0.64 . . . . 15.0 112.604 -179.768 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.411 HG13 ' HB2' ' A' ' 90' ' ' GLU . 1.2 mp . . . . . 0 N--CA 1.45 -0.456 0 CA-C-O 120.704 0.288 . . . . 15.0 110.651 . . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.612 ' CZ ' HD12 ' A' ' 89' ' ' LEU . 2.0 p90 -140.67 160.25 40.44 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.438 -0.346 . . . . 15.0 110.532 179.085 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.713 ' CB ' HD12 ' A' ' 88' ' ' LEU . 9.5 pt-20 -126.46 144.95 50.68 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.249 0.547 . . . . 15.0 111.48 -179.338 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.703 ' CG1' HD11 ' A' ' 89' ' ' LEU . 0.5 OUTLIER -101.29 115.07 42.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.331 -0.85 . . . . 15.0 109.722 179.157 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -106.13 69.56 0.81 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.107 -0.497 . . . . 15.0 111.643 -179.302 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.646 HD11 ' CB ' ' A' ' 49' ' ' ASP . 7.0 tp -88.15 161.68 17.14 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.013 -0.54 . . . . 15.0 110.082 179.213 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -96.63 101.0 12.53 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.717 0.294 . . . . 15.0 111.113 179.918 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.883 ' HB2' HG23 ' A' ' 85' ' ' VAL . 0.4 OUTLIER . . . . . 0 CA--C 1.534 0.365 0 N-CA-C 112.511 0.56 . . . . 15.0 112.511 179.882 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.7 mm? . . . . . 0 N--CA 1.45 -0.461 0 CA-C-O 120.889 0.376 . . . . 15.0 110.709 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.631 ' O ' ' HB ' ' A' ' 41' ' ' ILE . . . -160.85 35.64 0.42 Allowed Glycine 0 CA--C 1.506 -0.513 0 N-CA-C 111.308 -0.717 . . . . 15.0 111.308 179.987 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.669 HG12 ' O ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -112.61 140.13 33.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.011 0.434 . . . . 15.0 111.948 -179.169 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.455 ' HB3' HD11 ' A' ' 41' ' ' ILE . 33.2 t -96.01 105.82 17.91 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 107.696 -1.224 . . . . 15.0 107.696 177.275 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.989 HG21 HG23 ' A' ' 75' ' ' VAL . 33.2 m -93.57 152.77 3.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 112.984 0.735 . . . . 15.0 112.984 -176.908 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -149.42 -178.8 6.62 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 115.014 -0.994 . . . . 15.0 110.823 -179.736 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.437 ' O ' ' HB3' ' A' ' 71' ' ' HIS . . . 71.17 -119.19 7.81 Favored Glycine 0 C--N 1.332 0.308 0 C-N-CA 120.744 -0.741 . . . . 15.0 112.319 -179.95 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.536 ' HA3' ' N ' ' A' ' 71' ' ' HIS . . . 68.47 -66.46 0.41 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.784 -0.722 . . . . 15.0 113.448 179.338 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.525 ' O ' HG22 ' A' ' 30' ' ' VAL . 0.9 OUTLIER -26.27 138.69 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 N-CA-C 112.5 0.555 . . . . 15.0 112.5 -179.297 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 8.1 p-10 -76.72 57.47 1.28 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.97 -0.559 . . . . 15.0 111.093 -179.929 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.2 m -151.85 -51.84 0.12 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.332 -0.395 . . . . 15.0 110.895 179.971 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 6.0 m -80.53 -41.18 24.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.108 -0.496 . . . . 15.0 110.934 -179.918 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.525 HG22 ' O ' ' A' ' 26' ' ' VAL . 13.9 m -79.21 -169.96 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.284 -0.416 . . . . 15.0 111.095 -179.948 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.59 -62.94 1.5 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.284 -0.416 . . . . 15.0 111.05 -179.853 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 32' ' ' HIS . . . . . 0.446 ' CD2' ' HG3' ' A' ' 67' ' ' GLU . 11.0 p-80 -139.22 -51.51 0.53 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.356 -0.384 . . . . 15.0 111.257 -179.764 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -168.28 24.75 0.11 Allowed Glycine 0 CA--C 1.518 0.241 0 C-N-CA 120.791 -0.719 . . . . 15.0 112.628 -179.872 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -91.43 154.08 22.55 Favored Glycine 0 N--CA 1.45 -0.398 0 N-CA-C 110.681 -0.967 . . . . 15.0 110.681 178.891 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.943 HG22 HG22 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -92.55 154.72 3.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 117.685 0.742 . . . . 15.0 111.928 -179.265 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.419 ' CE2' ' HG2' ' A' ' 57' ' ' ARG . 30.4 m-85 -139.19 106.07 5.41 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.042 -0.981 . . . . 15.0 109.691 178.849 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.804 HG22 ' N ' ' A' ' 55' ' ' GLY . 0.7 OUTLIER -55.39 146.4 4.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.929 -0.578 . . . . 15.0 111.335 -178.873 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.426 ' O ' ' HG2' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -80.32 -48.51 12.88 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.475 -0.935 . . . . 15.0 108.475 178.356 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.669 ' O ' HG12 ' A' ' 20' ' ' ILE . . . -172.16 172.36 4.62 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.667 -0.697 . . . . 15.0 110.703 178.68 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.606 ' HA ' HG12 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -96.9 113.07 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 N-CA-C 109.712 -0.477 . . . . 15.0 109.712 179.397 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.631 ' HB ' ' O ' ' A' ' 19' ' ' GLY . 0.3 OUTLIER -78.6 119.34 76.92 Favored Pre-proline 0 C--N 1.33 -0.268 0 N-CA-C 113.281 0.845 . . . . 15.0 113.281 -177.411 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.609 ' HA ' ' CG ' ' A' ' 47' ' ' GLU . 38.3 Cg_endo -65.27 61.2 0.34 Allowed 'Trans proline' 0 C--N 1.355 0.904 0 C-N-CA 123.512 2.808 . . . . 15.0 112.958 179.713 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.528 ' H ' ' HG2' ' A' ' 47' ' ' GLU . 1.8 mm-40 -152.11 -44.63 0.11 Allowed 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 111.767 0.284 . . . . 15.0 111.767 179.81 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.578 ' HA3' ' HA3' ' A' ' 19' ' ' GLY . . . -87.77 164.77 34.47 Favored Glycine 0 CA--C 1.519 0.299 0 C-N-CA 120.347 -0.93 . . . . 15.0 113.828 -179.049 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -53.95 -16.34 1.83 Allowed 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 112.847 0.684 . . . . 15.0 112.847 -179.559 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.29 -57.85 3.88 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.609 0.243 . . . . 15.0 111.27 -179.35 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.609 ' CG ' ' HA ' ' A' ' 42' ' ' PRO . 2.9 pp20? -56.74 -40.84 76.47 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.03 0.443 . . . . 15.0 110.312 179.552 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 33.4 t -53.85 -69.79 0.11 Allowed 'General case' 0 CA--C 1.52 -0.182 0 CA-C-N 115.818 -0.628 . . . . 15.0 110.753 -179.449 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.646 ' CB ' HD11 ' A' ' 11' ' ' LEU . 2.0 m-20 -62.61 -38.42 90.11 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.598 -0.519 . . . . 15.0 109.598 179.257 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.03 44.53 8.11 Favored Glycine 0 N--CA 1.447 -0.611 0 CA-C-N 115.573 -0.739 . . . . 15.0 111.703 179.851 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.643 ' HB2' HD13 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -79.43 -53.46 6.88 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.884 0.373 . . . . 15.0 110.832 -179.273 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.66 ' CG1' HD12 ' A' ' 20' ' ' ILE . 8.4 tp -81.93 164.55 2.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.996 -0.547 . . . . 15.0 110.482 179.72 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 53' ' ' HIS . . . . . 0.439 ' O ' ' HB2' ' A' ' 56' ' ' ASP . 78.8 m80 -147.44 156.98 43.38 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.701 0.762 . . . . 15.0 112.181 -179.142 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.57 ' HA ' ' CG2' ' A' ' 37' ' ' VAL . 6.1 mtpt -42.31 133.73 3.11 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.31 -1.314 . . . . 15.0 112.99 -178.646 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.804 ' N ' HG22 ' A' ' 37' ' ' VAL . . . 49.81 31.87 17.19 Favored Glycine 0 C--N 1.334 0.449 0 CA-C-N 115.635 -0.711 . . . . 15.0 113.644 179.061 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.439 ' HB2' ' O ' ' A' ' 53' ' ' HIS . 0.3 OUTLIER -65.9 130.5 43.47 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 117.179 0.49 . . . . 15.0 110.493 179.413 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.419 ' HG2' ' CE2' ' A' ' 36' ' ' TYR . 40.3 mtt180 -83.9 87.23 7.09 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.242 -0.435 . . . . 15.0 110.17 179.62 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.943 HG22 HG22 ' A' ' 35' ' ' ILE . 1.3 m -79.66 117.93 26.27 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 CA-C-O 121.086 0.469 . . . . 15.0 111.566 -179.12 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.438 ' O ' ' N ' ' A' ' 66' ' ' LEU . 27.7 mt -107.48 -18.84 13.75 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 115.504 -0.771 . . . . 15.0 112.493 -179.423 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.766 ' HB3' ' HB2' ' A' ' 88' ' ' LEU . . . -148.79 148.52 30.04 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 112.946 0.721 . . . . 15.0 112.946 -178.575 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.822 HG11 ' O ' ' A' ' 77' ' ' THR . 56.7 t -139.2 94.53 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 CA-C-N 115.101 -0.954 . . . . 15.0 109.076 178.892 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.497 ' OD1' HG22 ' A' ' 81' ' ' THR . 6.0 m120 70.5 16.6 6.98 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.047 -0.524 . . . . 15.0 109.87 -178.101 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 107.17 4.75 35.44 Favored Glycine 0 C--N 1.336 0.549 0 CA-C-N 115.851 -0.613 . . . . 15.0 113.429 179.559 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.655 HG13 ' O ' ' A' ' 64' ' ' VAL . 5.9 p -93.82 105.58 17.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.131 0.491 . . . . 15.0 110.845 179.446 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.6 t -55.71 139.4 45.09 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.057 -0.52 . . . . 15.0 111.206 -179.518 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.963 HD11 ' HB2' ' A' ' 74' ' ' ALA . 0.2 OUTLIER -97.43 -22.97 16.28 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.966 -0.561 . . . . 15.0 110.78 179.875 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.446 ' HG3' ' CD2' ' A' ' 32' ' ' HIS . 1.6 tt0 -46.38 103.36 0.04 OUTLIER 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.237 -0.438 . . . . 15.0 111.125 -179.952 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 102.89 61.63 0.71 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.759 -0.734 . . . . 15.0 112.309 -179.865 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.745 ' HB1' ' CB ' ' A' ' 73' ' ' GLN . . . -173.09 142.57 1.06 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.874 0.368 . . . . 15.0 111.079 -179.823 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.451 ' CB ' ' HA ' ' A' ' 26' ' ' VAL . 2.3 p -72.87 -171.85 0.93 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.252 -0.431 . . . . 15.0 110.953 -179.959 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 71' ' ' HIS . . . . . 0.695 ' CE1' HG23 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -62.95 -58.43 7.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.95 -0.568 . . . . 15.0 110.447 179.827 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.462 ' O ' HG12 ' A' ' 75' ' ' VAL . 1.8 ttpp -52.5 -33.91 47.05 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.826 -0.625 . . . . 15.0 110.855 179.691 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.745 ' CB ' ' HB1' ' A' ' 69' ' ' ALA . 2.0 mt-30 -59.31 -51.47 69.82 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.35 -0.611 . . . . 15.0 109.35 179.32 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.963 ' HB2' HD11 ' A' ' 66' ' ' LEU . . . -66.86 -43.96 82.22 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.804 -0.634 . . . . 15.0 109.797 178.532 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.989 HG23 HG21 ' A' ' 22' ' ' VAL . 0.5 OUTLIER -43.35 -39.94 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.236 0 N-CA-C 109.029 -0.73 . . . . 15.0 109.029 178.419 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -67.22 -45.83 75.61 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 114.778 -1.101 . . . . 15.0 110.048 178.342 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.822 ' O ' HG11 ' A' ' 61' ' ' VAL . 35.4 p -64.28 -53.48 48.26 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-N 116.526 -0.306 . . . . 15.0 111.454 179.848 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.678 HD23 HG21 ' A' ' 61' ' ' VAL . 4.5 mt -53.88 -48.53 69.99 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 121.205 0.526 . . . . 15.0 110.102 179.914 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.406 ' O ' ' N ' ' A' ' 81' ' ' THR . 0.0 OUTLIER -68.34 -57.68 5.55 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.405 -0.816 . . . . 15.0 110.737 179.655 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 64.8 m-20 -65.84 62.49 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.961 -0.563 . . . . 15.0 112.088 -179.86 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.497 HG22 ' OD1' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -95.41 -73.99 0.57 Allowed 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.798 -0.445 . . . . 15.0 109.798 179.015 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 114.87 -101.11 1.04 Allowed Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.744 -0.741 . . . . 15.0 113.263 178.781 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.48 ' O ' ' HB3' ' A' ' 13' ' ' LYS . 0.1 OUTLIER -64.63 -86.27 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.612 0.244 . . . . 15.0 111.527 -179.208 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.461 HG12 ' N ' ' A' ' 85' ' ' VAL . 79.0 t -110.3 159.52 10.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.98 0.419 . . . . 15.0 110.738 -179.893 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.883 HG23 ' HB2' ' A' ' 13' ' ' LYS . 3.6 t -97.62 83.66 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.146 0.498 . . . . 15.0 110.228 179.648 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -101.75 83.89 2.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.707 -0.679 . . . . 15.0 110.238 179.727 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.834 ' HB3' HD21 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -103.92 128.18 51.43 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.87 -0.605 . . . . 15.0 111.827 -179.106 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.766 ' HB2' ' HB3' ' A' ' 60' ' ' ALA . 4.6 mp -102.28 100.86 11.08 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.629 -0.508 . . . . 15.0 109.629 178.805 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.834 HD21 ' HB3' ' A' ' 87' ' ' LEU . 0.1 OUTLIER -105.64 -161.78 0.83 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.388 0.613 . . . . 15.0 111.848 -178.552 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.411 ' HB2' HG13 ' A' ' 6' ' ' ILE . 3.1 tt0 -142.23 135.38 28.8 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.052 -0.976 . . . . 15.0 109.878 179.21 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 2.8 tptt -47.47 103.95 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.919 0.39 . . . . 15.0 111.188 -179.681 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.295 0 C-N-CA 120.785 -0.721 . . . . 15.0 112.5 -179.943 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.514 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 1.4 mp . . . . . 0 N--CA 1.451 -0.377 0 CA-C-O 120.77 0.319 . . . . 15.0 111.215 . . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.968 ' CE1' HD12 ' A' ' 89' ' ' LEU . 10.8 p90 -141.82 143.59 33.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.264 -0.425 . . . . 15.0 110.882 178.874 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.795 ' HB2' HD12 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -109.96 142.42 41.36 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.339 0.59 . . . . 15.0 111.534 -179.404 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.683 HG12 HD11 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -101.55 114.89 42.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.117 -0.947 . . . . 15.0 109.831 179.124 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -105.95 71.45 0.9 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.015 -0.539 . . . . 15.0 111.931 -178.988 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.651 HD13 ' HG3' ' A' ' 51' ' ' ARG . 5.6 tp -87.98 165.76 14.98 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.151 -0.477 . . . . 15.0 109.727 178.972 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -94.71 94.2 7.98 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.916 0.389 . . . . 15.0 111.057 -179.995 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.654 ' CB ' HG23 ' A' ' 85' ' ' VAL . 0.2 OUTLIER . . . . . 0 C--N 1.328 -0.358 0 CA-C-N 115.977 -0.556 . . . . 15.0 110.885 179.924 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.588 ' N ' HD22 ' A' ' 18' ' ' LEU . 1.1 mm? . . . . . 0 N--CA 1.452 -0.352 0 CA-C-O 120.877 0.37 . . . . 15.0 110.779 . . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.624 ' HA3' ' HA3' ' A' ' 44' ' ' GLY . . . -160.98 39.44 0.42 Allowed Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 121.043 -0.599 . . . . 15.0 112.024 -179.794 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.661 HD12 ' CG2' ' A' ' 52' ' ' ILE . 0.0 OUTLIER -112.51 144.71 19.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 121.06 0.457 . . . . 15.0 111.686 -179.493 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 55.0 p -96.06 101.49 13.16 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.267 -1.012 . . . . 15.0 108.267 177.958 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 1.024 HG21 HG23 ' A' ' 75' ' ' VAL . 33.8 m -93.77 145.61 7.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 113.092 0.775 . . . . 15.0 113.092 -177.273 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.555 ' HA ' ' ND1' ' A' ' 71' ' ' HIS . 0.9 OUTLIER -149.49 -177.65 5.98 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 115.384 -0.826 . . . . 15.0 110.773 178.74 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.477 ' O ' ' HB3' ' A' ' 71' ' ' HIS . . . 76.32 -118.19 5.23 Favored Glycine 0 C--N 1.333 0.401 0 C-N-CA 120.87 -0.681 . . . . 15.0 112.361 -179.753 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.528 ' HA3' ' N ' ' A' ' 71' ' ' HIS . . . 64.42 -64.66 0.06 OUTLIER Glycine 0 CA--C 1.519 0.31 0 C-N-CA 121.139 -0.553 . . . . 15.0 114.116 178.956 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.609 ' O ' HG22 ' A' ' 30' ' ' VAL . 1.5 m -25.97 142.18 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 N-CA-C 112.892 0.701 . . . . 15.0 112.892 -178.999 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 44.4 t-20 -78.4 55.41 1.57 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.681 -0.69 . . . . 15.0 110.934 179.856 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 15.0 m -152.03 -63.92 0.17 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.915 0.388 . . . . 15.0 110.938 -179.933 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 47.7 t -68.86 -49.99 53.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.029 -0.532 . . . . 15.0 110.885 -179.892 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.609 HG22 ' O ' ' A' ' 26' ' ' VAL . 35.8 m -84.4 -176.74 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.25 -0.432 . . . . 15.0 111.027 179.912 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -89.09 121.86 31.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.956 0.408 . . . . 15.0 111.158 -179.867 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 65.08 -91.36 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.951 -0.568 . . . . 15.0 111.384 179.722 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.456 ' O ' ' O ' ' A' ' 69' ' ' ALA . . . -164.85 27.97 0.2 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.78 -0.724 . . . . 15.0 112.131 -179.717 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -84.81 149.47 24.37 Favored Glycine 0 N--CA 1.449 -0.47 0 N-CA-C 110.523 -1.031 . . . . 15.0 110.523 178.845 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 1.028 HG22 HG22 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -90.13 150.92 3.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 119.923 -0.711 . . . . 15.0 111.78 -179.215 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.453 ' CZ ' ' HG3' ' A' ' 57' ' ' ARG . 44.1 m-85 -136.49 108.54 7.19 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 114.904 -1.044 . . . . 15.0 109.124 178.942 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.785 HG22 ' N ' ' A' ' 55' ' ' GLY . 0.8 OUTLIER -55.17 153.72 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 121.269 0.557 . . . . 15.0 111.266 -178.567 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.576 ' O ' ' HG2' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -86.34 -46.05 10.65 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.745 -0.835 . . . . 15.0 108.745 178.848 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.624 ' O ' HG12 ' A' ' 20' ' ' ILE . . . -172.34 169.34 5.34 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.804 -0.635 . . . . 15.0 110.683 178.527 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.529 ' HA ' HG12 ' A' ' 20' ' ' ILE . 0.1 OUTLIER -96.73 109.86 23.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 N-CA-C 109.288 -0.634 . . . . 15.0 109.288 179.049 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.595 ' HB ' ' O ' ' A' ' 19' ' ' GLY . 0.3 OUTLIER -78.36 118.48 72.54 Favored Pre-proline 0 C--N 1.328 -0.348 0 N-CA-C 113.522 0.934 . . . . 15.0 113.522 -176.967 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.626 ' HA ' ' CG ' ' A' ' 47' ' ' GLU . 36.9 Cg_endo -64.48 61.59 0.26 Allowed 'Trans proline' 0 C--N 1.358 1.042 0 C-N-CA 123.536 2.824 . . . . 15.0 112.991 179.865 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.51 ' N ' ' HG2' ' A' ' 47' ' ' GLU . 41.8 mt-30 -149.88 -46.72 0.13 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.597 -0.274 . . . . 15.0 111.54 179.763 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.624 ' HA3' ' HA3' ' A' ' 19' ' ' GLY . . . -88.03 167.59 36.41 Favored Glycine 0 CA--C 1.518 0.27 0 C-N-CA 120.332 -0.937 . . . . 15.0 113.946 -179.212 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -56.6 -13.48 2.44 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.678 0.622 . . . . 15.0 112.678 -179.852 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.444 ' HB1' HG22 ' A' ' 52' ' ' ILE . . . -71.95 -58.23 3.63 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-O 120.773 0.321 . . . . 15.0 110.868 -179.618 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.626 ' CG ' ' HA ' ' A' ' 42' ' ' PRO . 2.6 pp20? -57.38 -42.0 81.33 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.732 -0.667 . . . . 15.0 110.423 179.285 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -53.78 -71.28 0.08 Allowed 'General case' 0 CA--C 1.519 -0.22 0 CA-C-N 115.783 -0.644 . . . . 15.0 110.549 -179.359 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.594 ' CB ' HD11 ' A' ' 11' ' ' LEU . 0.1 OUTLIER -58.24 -40.71 82.47 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.137 -0.69 . . . . 15.0 109.137 178.838 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.416 ' O ' ' CE1' ' A' ' 53' ' ' HIS . . . 80.98 39.54 13.02 Favored Glycine 0 N--CA 1.446 -0.683 0 CA-C-N 115.197 -0.91 . . . . 15.0 112.011 179.212 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.651 ' HG3' HD13 ' A' ' 11' ' ' LEU . 3.0 mmt-85 -80.07 -59.31 2.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.963 0.411 . . . . 15.0 110.386 -179.773 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.661 ' CG2' HD12 ' A' ' 20' ' ' ILE . 6.6 tp -80.86 146.18 7.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.86 -0.609 . . . . 15.0 109.568 179.115 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 53' ' ' HIS . . . . . 0.514 ' O ' ' HB2' ' A' ' 56' ' ' ASP . 57.4 m80 -139.47 167.37 22.24 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-O 121.77 0.795 . . . . 15.0 112.762 -178.253 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.58 ' HA ' ' CG2' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -40.29 132.72 1.94 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.109 -1.405 . . . . 15.0 113.27 -178.353 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.785 ' N ' HG22 ' A' ' 37' ' ' VAL . . . 49.7 36.23 25.0 Favored Glycine 0 C--N 1.335 0.511 0 CA-C-N 115.613 -0.721 . . . . 15.0 113.566 179.115 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.514 ' HB2' ' O ' ' A' ' 53' ' ' HIS . 1.7 t0 -65.66 132.32 48.51 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.99 0.395 . . . . 15.0 110.34 179.206 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.453 ' HG3' ' CZ ' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -85.11 77.25 10.11 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.983 -0.553 . . . . 15.0 110.134 179.545 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 1.028 HG22 HG22 ' A' ' 35' ' ' ILE . 0.8 OUTLIER -79.23 115.62 21.82 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 CA-C-O 121.293 0.568 . . . . 15.0 111.027 -179.25 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 35.0 mt -107.32 -14.12 14.96 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 115.555 -0.748 . . . . 15.0 112.522 -178.967 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.698 ' HB3' ' HB2' ' A' ' 88' ' ' LEU . . . -147.56 149.9 33.46 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 112.642 0.608 . . . . 15.0 112.642 -178.51 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.644 HG11 ' O ' ' A' ' 77' ' ' THR . 15.6 t -139.12 101.54 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.27 0 CA-C-N 115.255 -0.884 . . . . 15.0 109.139 178.741 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.669 ' OD1' HG22 ' A' ' 81' ' ' THR . 2.9 m120 65.04 15.54 10.05 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.668 -0.493 . . . . 15.0 109.668 -177.901 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 106.82 4.9 36.29 Favored Glycine 0 C--N 1.337 0.614 0 CA-C-N 115.822 -0.626 . . . . 15.0 113.286 179.77 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.643 HG13 ' O ' ' A' ' 64' ' ' VAL . 5.8 p -93.83 108.67 20.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 117.017 0.408 . . . . 15.0 111.046 179.616 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -57.11 137.98 55.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.259 -0.428 . . . . 15.0 111.064 -179.741 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.927 HD11 ' HB2' ' A' ' 74' ' ' ALA . 0.2 OUTLIER -97.74 -23.08 16.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.076 -0.511 . . . . 15.0 111.003 179.96 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -47.57 104.0 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.389 -0.369 . . . . 15.0 111.091 179.937 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.76 54.87 0.58 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.744 -0.741 . . . . 15.0 112.288 -179.871 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.678 ' HB1' ' CB ' ' A' ' 73' ' ' GLN . . . -173.07 146.85 1.53 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.857 0.36 . . . . 15.0 111.012 -179.953 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.462 HG22 ' HA ' ' A' ' 26' ' ' VAL . 11.3 p -72.94 -172.33 1.02 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.146 0.498 . . . . 15.0 111.097 -179.771 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 71' ' ' HIS . . . . . 0.742 ' NE2' HG23 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -65.29 -57.83 7.44 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.636 -0.711 . . . . 15.0 110.751 -179.806 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.49 ' O ' HG12 ' A' ' 75' ' ' VAL . 5.4 ttpp -52.5 -32.91 42.52 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.352 -0.385 . . . . 15.0 110.285 179.316 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.678 ' CB ' ' HB1' ' A' ' 69' ' ' ALA . 4.9 mt-30 -59.56 -48.93 79.74 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.32 -0.622 . . . . 15.0 109.32 178.843 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.927 ' HB2' HD11 ' A' ' 66' ' ' LEU . . . -67.16 -44.12 80.56 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-N 115.944 -0.571 . . . . 15.0 109.582 178.24 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 1.024 HG23 HG21 ' A' ' 22' ' ' VAL . 0.5 OUTLIER -44.03 -39.28 1.47 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.26 0 N-CA-C 108.706 -0.85 . . . . 15.0 108.706 178.312 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -67.17 -45.3 77.41 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 114.668 -1.151 . . . . 15.0 110.132 178.249 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.644 ' O ' HG11 ' A' ' 61' ' ' VAL . 39.0 p -64.12 -54.79 28.43 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.634 -0.257 . . . . 15.0 111.599 179.851 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.59 HD21 HG21 ' A' ' 58' ' ' VAL . 5.9 mt -53.33 -47.68 69.12 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-O 121.215 0.531 . . . . 15.0 109.851 -179.853 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.4 ' HB2' ' O ' ' A' ' 75' ' ' VAL . 0.0 OUTLIER -68.49 -59.09 3.41 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.423 -0.808 . . . . 15.0 110.551 179.403 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -66.15 59.71 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.947 -0.57 . . . . 15.0 112.411 -179.903 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.669 HG22 ' OD1' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -95.63 -71.51 0.67 Allowed 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 110.006 -0.368 . . . . 15.0 110.006 178.917 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 121.97 -105.39 0.98 Allowed Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.833 -0.699 . . . . 15.0 113.157 179.118 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.75 -81.62 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 112.151 0.426 . . . . 15.0 112.151 -179.06 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.45 HG12 ' N ' ' A' ' 85' ' ' VAL . 72.2 t -109.97 159.1 9.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.136 0.493 . . . . 15.0 111.21 -179.136 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.678 ' O ' HG12 ' A' ' 85' ' ' VAL . 6.8 t -97.82 81.56 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.909 -0.587 . . . . 15.0 110.553 179.935 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -100.45 84.34 2.76 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.729 -0.668 . . . . 15.0 110.419 179.786 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.642 ' HB3' HD21 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -103.55 118.62 37.15 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.985 -0.552 . . . . 15.0 111.916 -179.102 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.795 HD12 ' HB2' ' A' ' 8' ' ' GLU . 3.8 mp -92.01 103.65 16.14 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.17 -0.678 . . . . 15.0 109.17 178.445 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.968 HD12 ' CE1' ' A' ' 7' ' ' PHE . 0.1 OUTLIER -105.61 -164.91 1.06 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.615 0.721 . . . . 15.0 112.352 -178.035 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.514 ' HA ' ' HA ' ' A' ' 6' ' ' ILE . 0.7 OUTLIER -144.93 135.86 24.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 114.626 -1.17 . . . . 15.0 109.487 179.146 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -46.81 98.65 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.942 0.401 . . . . 15.0 111.253 -179.497 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.364 0 C-N-CA 120.869 -0.681 . . . . 15.0 112.641 -179.83 . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.525 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 1.2 mp . . . . . 0 N--CA 1.451 -0.402 0 CA-C-O 120.786 0.327 . . . . 15.0 111.129 . . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.637 ' CE1' HD12 ' A' ' 89' ' ' LEU . 2.3 p90 -140.44 153.79 46.41 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.234 -0.439 . . . . 15.0 110.557 178.949 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.605 ' CB ' HD12 ' A' ' 88' ' ' LEU . 13.3 pt-20 -119.86 143.12 48.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.29 0.567 . . . . 15.0 111.748 -179.164 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.544 HG23 ' HB3' ' A' ' 51' ' ' ARG . 0.2 OUTLIER -101.67 117.79 47.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.277 -0.874 . . . . 15.0 109.72 178.817 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 51.5 tt0 -106.2 73.38 0.98 Allowed 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.094 0.405 . . . . 15.0 112.094 -179.165 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.532 HD11 ' CB ' ' A' ' 49' ' ' ASP . 9.5 tp -88.43 160.69 17.43 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.245 -0.434 . . . . 15.0 109.975 178.9 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -97.0 94.69 7.32 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 111.853 0.316 . . . . 15.0 111.853 -179.615 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.896 ' HB2' HG23 ' A' ' 85' ' ' VAL . 0.5 OUTLIER . . . . . 0 N--CA 1.466 0.337 0 N-CA-C 112.522 0.564 . . . . 15.0 112.522 179.476 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.2 mm? . . . . . 0 N--CA 1.453 -0.307 0 CA-C-O 121.066 0.46 . . . . 15.0 110.865 . . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.614 ' O ' ' HB ' ' A' ' 41' ' ' ILE . . . -161.0 33.68 0.39 Allowed Glycine 0 C--O 1.223 -0.55 0 N-CA-C 110.84 -0.904 . . . . 15.0 110.84 -179.815 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.662 HG13 HG12 ' A' ' 40' ' ' VAL . 0.0 OUTLIER -114.0 139.94 37.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 112.445 0.535 . . . . 15.0 112.445 -179.217 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.668 ' CB ' HD11 ' A' ' 41' ' ' ILE . 4.3 t -96.17 105.47 17.53 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 107.882 -1.155 . . . . 15.0 107.882 176.492 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 1.02 HG21 HG23 ' A' ' 75' ' ' VAL . 6.8 m -93.69 154.91 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 N-CA-C 113.28 0.844 . . . . 15.0 113.28 -176.952 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.52 -178.74 6.6 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.191 -0.913 . . . . 15.0 111.032 179.852 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.538 ' O ' HG22 ' A' ' 26' ' ' VAL . . . 69.04 -119.07 9.29 Favored Glycine 0 C--N 1.333 0.364 0 C-N-CA 120.968 -0.634 . . . . 15.0 112.531 179.719 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.559 ' HA3' ' N ' ' A' ' 71' ' ' HIS . . . 68.11 -65.79 0.36 Allowed Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.919 -0.658 . . . . 15.0 113.615 179.339 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.538 HG22 ' O ' ' A' ' 24' ' ' GLY . 0.0 OUTLIER -27.36 139.29 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 N-CA-C 112.209 0.448 . . . . 15.0 112.209 -179.337 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 7.8 p-10 -75.22 61.99 1.2 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.08 -0.509 . . . . 15.0 111.006 -179.59 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.5 m -151.75 -59.68 0.16 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.274 -0.421 . . . . 15.0 111.055 179.957 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 91.4 p -74.86 -47.65 29.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.118 -0.492 . . . . 15.0 111.168 -179.779 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.517 HG22 ' O ' ' A' ' 26' ' ' VAL . 35.1 m -70.12 -174.14 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.328 -0.396 . . . . 15.0 111.154 -179.89 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 6.8 mmp_? -54.5 -59.1 5.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.227 -0.442 . . . . 15.0 111.217 -179.792 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 1.7 p-80 -149.92 -44.83 0.13 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.44 -0.346 . . . . 15.0 111.325 -179.782 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.402 ' O ' ' O ' ' A' ' 69' ' ' ALA . . . -167.53 24.45 0.12 Allowed Glycine 0 CA--C 1.517 0.179 0 C-N-CA 120.605 -0.807 . . . . 15.0 112.894 -179.689 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -91.92 154.04 22.28 Favored Glycine 0 N--CA 1.45 -0.406 0 N-CA-C 110.074 -1.21 . . . . 15.0 110.074 178.341 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 1.053 HG22 HG22 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -101.39 147.13 8.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 118.184 0.992 . . . . 15.0 111.767 -179.249 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.769 ' N ' HD13 ' A' ' 35' ' ' ILE . 15.9 m-85 -130.94 109.2 10.36 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-N 115.307 -0.861 . . . . 15.0 109.539 -179.634 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.763 HG22 ' N ' ' A' ' 55' ' ' GLY . 0.7 OUTLIER -55.46 167.11 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.916 -0.583 . . . . 15.0 110.739 -179.27 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.42 -48.14 4.66 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.059 -0.719 . . . . 15.0 109.059 178.77 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.58 ' O ' HG12 ' A' ' 20' ' ' ILE . . . -171.5 169.18 6.22 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.269 -0.878 . . . . 15.0 110.463 179.341 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.662 HG12 HG13 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -97.24 123.57 49.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.727 0.298 . . . . 15.0 110.838 -179.908 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.716 ' O ' ' HB3' ' A' ' 47' ' ' GLU . 1.7 mm -78.68 108.14 7.37 Favored Pre-proline 0 N--CA 1.468 0.443 0 N-CA-C 113.199 0.815 . . . . 15.0 113.199 -178.651 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.458 ' HD3' ' O ' ' A' ' 40' ' ' VAL . 25.8 Cg_exo -62.35 72.52 0.11 Allowed 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 122.99 2.46 . . . . 15.0 112.264 179.341 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.422 ' N ' ' O ' ' A' ' 41' ' ' ILE . 0.6 OUTLIER -174.32 -41.66 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.687 -0.688 . . . . 15.0 110.245 179.926 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.595 ' HA3' ' HA3' ' A' ' 19' ' ' GLY . . . -87.3 150.63 22.85 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.651 -0.785 . . . . 15.0 112.409 179.613 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -39.5 -22.73 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 113.191 0.811 . . . . 15.0 113.191 -179.369 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.427 ' N ' ' O ' ' A' ' 44' ' ' GLY . . . -71.82 -70.2 0.34 Allowed 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.937 -0.305 . . . . 15.0 111.294 -179.625 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.716 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 4.3 tp10 -58.03 -38.94 77.17 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.904 0.383 . . . . 15.0 110.657 179.653 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -53.82 -60.6 3.11 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.092 -0.504 . . . . 15.0 110.358 179.867 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.532 ' CB ' HD11 ' A' ' 11' ' ' LEU . 0.7 OUTLIER -66.71 -38.73 87.32 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.142 -0.481 . . . . 15.0 109.982 179.07 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.48 41.05 10.3 Favored Glycine 0 N--CA 1.449 -0.486 0 CA-C-N 115.699 -0.682 . . . . 15.0 112.486 179.664 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.544 ' HB3' HG23 ' A' ' 9' ' ' VAL . 5.3 mmp_? -86.3 -55.91 3.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.906 0.384 . . . . 15.0 110.74 179.858 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.564 ' CG1' HD12 ' A' ' 20' ' ' ILE . 9.0 tp -81.12 160.63 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 CA-C-N 116.037 -0.529 . . . . 15.0 110.71 179.808 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 53' ' ' HIS . . . . . 0.462 ' O ' ' HB2' ' A' ' 56' ' ' ASP . 62.2 m80 -141.17 160.54 39.88 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-O 121.73 0.776 . . . . 15.0 112.575 -179.077 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.625 ' HA ' ' CG2' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -45.77 137.45 5.44 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.398 -1.274 . . . . 15.0 112.497 -178.671 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.763 ' N ' HG22 ' A' ' 37' ' ' VAL . . . 49.73 32.7 17.88 Favored Glycine 0 C--N 1.334 0.452 0 CA-C-N 115.874 -0.603 . . . . 15.0 113.467 179.676 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.475 ' CB ' HD11 ' A' ' 52' ' ' ILE . 0.3 OUTLIER -66.06 127.59 32.72 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.314 -0.554 . . . . 15.0 110.205 179.09 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.538 ' HE ' HD21 ' A' ' 59' ' ' LEU . 5.8 ttt180 -83.17 83.32 7.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.277 -0.42 . . . . 15.0 110.097 179.713 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 1.053 HG22 HG22 ' A' ' 35' ' ' ILE . 1.0 OUTLIER -79.47 123.6 36.59 Favored 'Isoleucine or valine' 0 C--O 1.241 0.646 0 CA-C-O 121.089 0.471 . . . . 15.0 111.329 -179.259 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.581 HD12 ' HG2' ' A' ' 67' ' ' GLU . 3.4 mm? -107.62 -18.78 13.75 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.189 -0.914 . . . . 15.0 112.491 -179.461 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.482 ' O ' HD23 ' A' ' 87' ' ' LEU . . . -147.87 149.1 31.64 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 112.799 0.666 . . . . 15.0 112.799 -178.35 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.796 HG11 ' O ' ' A' ' 77' ' ' THR . 43.7 t -139.33 100.6 1.4 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.225 0 CA-C-N 115.297 -0.865 . . . . 15.0 109.281 178.596 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.672 ' OD1' HG22 ' A' ' 81' ' ' THR . 2.4 m120 65.46 15.9 10.25 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.135 -0.484 . . . . 15.0 109.833 -178.149 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 106.79 5.47 35.89 Favored Glycine 0 C--N 1.336 0.559 0 CA-C-N 115.868 -0.605 . . . . 15.0 113.321 179.615 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.646 HG13 ' O ' ' A' ' 64' ' ' VAL . 5.4 p -93.8 106.17 17.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.092 0.473 . . . . 15.0 110.713 179.405 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -57.66 127.84 34.03 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.159 -0.473 . . . . 15.0 111.147 -179.472 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.568 HD13 ' HB3' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -88.87 -23.96 22.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.986 -0.552 . . . . 15.0 110.741 179.81 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.581 ' HG2' HD12 ' A' ' 59' ' ' LEU . 4.4 mm-40 -45.25 97.16 0.01 OUTLIER 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 116.374 -0.375 . . . . 15.0 110.928 179.863 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.79 62.6 0.54 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.791 -0.718 . . . . 15.0 112.073 -179.544 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.651 ' HB1' ' CB ' ' A' ' 73' ' ' GLN . . . -172.93 146.22 1.51 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.897 0.379 . . . . 15.0 110.86 -179.789 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.42 ' CB ' ' HA ' ' A' ' 26' ' ' VAL . 6.8 p -72.81 -171.85 0.92 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.072 0.463 . . . . 15.0 111.304 -179.62 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 71' ' ' HIS . . . . . 0.642 ' NE2' HG23 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -65.39 -58.47 5.81 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.753 -0.658 . . . . 15.0 110.724 -179.91 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.413 ' HA ' ' HB ' ' A' ' 75' ' ' VAL . 15.6 ttpp -52.52 -31.46 35.54 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.018 -0.537 . . . . 15.0 110.52 179.725 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.651 ' CB ' ' HB1' ' A' ' 69' ' ' ALA . 4.1 mt-30 -59.59 -49.03 79.34 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.651 -0.5 . . . . 15.0 109.651 179.239 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.558 ' HA ' HD21 ' A' ' 66' ' ' LEU . . . -67.2 -45.16 77.72 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 109.495 -0.557 . . . . 15.0 109.495 178.404 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 1.02 HG23 HG21 ' A' ' 22' ' ' VAL . 0.5 OUTLIER -43.06 -41.92 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.272 0 N-CA-C 108.888 -0.782 . . . . 15.0 108.888 178.305 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.503 ' O ' ' HB2' ' A' ' 80' ' ' ASN . 1.6 mt-10 -67.17 -44.59 79.33 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 114.861 -1.063 . . . . 15.0 110.073 178.212 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.796 ' O ' HG11 ' A' ' 61' ' ' VAL . 68.7 p -64.08 -54.4 34.67 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-N 116.566 -0.288 . . . . 15.0 111.577 179.93 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.585 HD21 HG21 ' A' ' 58' ' ' VAL . 8.6 mt -53.56 -47.02 70.44 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.351 0.596 . . . . 15.0 109.903 179.855 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.427 ' HB2' ' O ' ' A' ' 75' ' ' VAL . 0.1 OUTLIER -68.44 -59.49 3.13 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.194 -0.912 . . . . 15.0 110.837 179.728 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.503 ' HB2' ' O ' ' A' ' 76' ' ' GLU . 12.0 m-80 -66.09 61.06 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.161 -0.472 . . . . 15.0 112.131 -179.859 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.672 HG22 ' OD1' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -95.7 -71.46 0.67 Allowed 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 110.0 -0.37 . . . . 15.0 110.0 179.02 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 116.85 -102.02 1.0 Allowed Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.838 -0.696 . . . . 15.0 112.979 179.055 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.81 -87.51 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.632 0.253 . . . . 15.0 111.437 -179.456 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.494 HG12 ' N ' ' A' ' 85' ' ' VAL . 84.1 t -109.85 160.69 8.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.951 0.405 . . . . 15.0 110.873 -179.816 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.896 HG23 ' HB2' ' A' ' 13' ' ' LYS . 3.3 t -97.71 81.43 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 121.258 0.551 . . . . 15.0 110.143 179.804 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -96.03 81.32 3.37 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.668 -0.697 . . . . 15.0 110.107 179.827 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.618 ' HB3' HD21 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -103.21 124.38 48.51 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.963 -0.562 . . . . 15.0 111.891 -178.947 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.661 ' N ' HD13 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -102.34 101.98 12.29 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.371 -0.603 . . . . 15.0 109.371 178.548 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.637 HD12 ' CE1' ' A' ' 7' ' ' PHE . 0.1 OUTLIER -105.65 -163.57 0.95 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.553 0.692 . . . . 15.0 112.09 -178.581 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.525 ' HA ' ' HA ' ' A' ' 6' ' ' ILE . 0.9 OUTLIER -138.79 134.87 34.01 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.731 -1.122 . . . . 15.0 109.433 178.845 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.87 105.15 0.06 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.857 0.36 . . . . 15.0 111.379 -179.219 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.39 0 C-N-CA 120.777 -0.725 . . . . 15.0 112.581 -179.912 . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.438 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 1.1 mp . . . . . 0 N--CA 1.451 -0.414 0 CA-C-O 120.825 0.345 . . . . 15.0 111.0 . . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.812 ' CZ ' HD12 ' A' ' 89' ' ' LEU . 4.0 p90 -140.65 157.71 45.05 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.191 -0.459 . . . . 15.0 110.58 179.087 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.723 ' HB2' HD12 ' A' ' 88' ' ' LEU . 11.3 pt-20 -124.71 141.83 51.83 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.226 0.536 . . . . 15.0 111.362 -179.557 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.566 HG23 ' HB3' ' A' ' 51' ' ' ARG . 0.2 OUTLIER -101.56 117.98 47.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.38 -0.827 . . . . 15.0 109.771 178.984 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -106.22 75.47 1.09 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.29 -0.414 . . . . 15.0 112.115 -179.064 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.566 ' HB3' ' HB ' ' A' ' 85' ' ' VAL . 11.4 tp -88.45 159.98 17.74 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.615 -0.513 . . . . 15.0 109.615 178.728 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -96.9 94.26 7.12 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 112.043 0.386 . . . . 15.0 112.043 -179.393 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.91 ' HB2' HG23 ' A' ' 85' ' ' VAL . 0.6 OUTLIER . . . . . 0 CA--C 1.534 0.352 0 N-CA-C 112.435 0.531 . . . . 15.0 112.435 179.312 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.595 ' N ' HD22 ' A' ' 18' ' ' LEU . 2.2 mm? . . . . . 0 N--CA 1.451 -0.405 0 CA-C-O 121.109 0.48 . . . . 15.0 110.722 . . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.596 ' O ' ' HB ' ' A' ' 41' ' ' ILE . . . -162.96 33.4 0.3 Allowed Glycine 0 C--O 1.223 -0.572 0 N-CA-C 110.83 -0.908 . . . . 15.0 110.83 -179.766 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.663 HD13 ' HB ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -113.87 143.26 23.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 112.243 0.46 . . . . 15.0 112.243 -179.159 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.742 ' CB ' HD11 ' A' ' 41' ' ' ILE . 1.7 t -96.41 103.45 15.36 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 107.745 -1.206 . . . . 15.0 107.745 176.676 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 1.028 HG21 HG23 ' A' ' 75' ' ' VAL . 29.6 m -93.5 149.82 4.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.368 0.604 . . . . 15.0 112.612 -177.367 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -149.51 -178.46 6.44 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.167 -0.924 . . . . 15.0 110.949 -179.411 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.556 ' O ' HG22 ' A' ' 26' ' ' VAL . . . 69.52 -117.64 7.86 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 120.802 -0.713 . . . . 15.0 112.251 -179.973 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.51 ' HA3' ' N ' ' A' ' 71' ' ' HIS . . . 67.2 -64.25 0.23 Allowed Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.904 -0.665 . . . . 15.0 113.668 179.362 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.556 HG22 ' O ' ' A' ' 24' ' ' GLY . 0.0 OUTLIER -28.99 137.51 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 N-CA-C 112.459 0.54 . . . . 15.0 112.459 -179.255 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 11.5 m-80 -75.56 61.3 1.3 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.802 -0.635 . . . . 15.0 111.016 -179.729 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -151.74 -53.76 0.13 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.341 -0.39 . . . . 15.0 111.074 179.971 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.6 m -81.92 -45.64 15.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.155 -0.475 . . . . 15.0 111.133 -179.812 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.555 HG22 ' O ' ' A' ' 26' ' ' VAL . 34.8 m -72.15 -175.23 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.22 -0.445 . . . . 15.0 111.271 -179.838 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.5 -60.55 3.16 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.204 -0.453 . . . . 15.0 111.202 -179.942 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 5.4 p-80 -146.62 -46.81 0.19 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.357 -0.383 . . . . 15.0 111.235 -179.847 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -169.2 25.81 0.11 Allowed Glycine 0 N--CA 1.453 -0.2 0 C-N-CA 120.749 -0.738 . . . . 15.0 112.686 -179.73 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -94.28 153.41 21.05 Favored Glycine 0 N--CA 1.449 -0.47 0 N-CA-C 110.629 -0.989 . . . . 15.0 110.629 178.838 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.952 HG22 HG22 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -94.18 152.77 3.52 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.321 0 CA-C-N 117.727 0.764 . . . . 15.0 112.073 -179.252 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.51 ' CZ ' ' HG2' ' A' ' 57' ' ' ARG . 44.5 m-85 -136.04 106.29 6.39 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.84 -1.073 . . . . 15.0 109.613 178.849 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.817 HG22 ' N ' ' A' ' 55' ' ' GLY . 0.6 OUTLIER -55.22 145.74 5.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.911 -0.586 . . . . 15.0 111.491 -178.846 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.458 ' O ' ' HG2' ' A' ' 54' ' ' LYS . 1.2 ttpt -81.91 -47.45 12.74 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.342 -0.984 . . . . 15.0 108.342 178.213 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.545 ' O ' HG12 ' A' ' 20' ' ' ILE . . . -172.2 169.79 5.35 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.625 -0.716 . . . . 15.0 111.366 178.679 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.577 HG12 HG13 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -97.5 121.04 47.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-N 116.254 -0.43 . . . . 15.0 111.131 -179.871 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.742 HD11 ' CB ' ' A' ' 21' ' ' SER . 1.5 mm -78.98 110.33 14.16 Favored Pre-proline 0 N--CA 1.466 0.368 0 N-CA-C 113.135 0.791 . . . . 15.0 113.135 -178.919 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.524 ' HA ' ' OE1' ' A' ' 47' ' ' GLU . 17.8 Cg_exo -65.8 63.68 0.42 Allowed 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 122.858 2.372 . . . . 15.0 112.213 179.243 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 1.9 mm-40 -159.48 -45.81 0.05 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.654 -0.703 . . . . 15.0 109.85 179.873 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.513 ' HA3' ' HA3' ' A' ' 19' ' ' GLY . . . -87.42 151.51 23.47 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.68 -0.772 . . . . 15.0 112.374 179.518 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -39.96 -19.58 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 113.494 0.924 . . . . 15.0 113.494 -179.326 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.448 ' N ' ' O ' ' A' ' 44' ' ' GLY . . . -71.72 -70.95 0.29 Allowed 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.829 -0.348 . . . . 15.0 111.426 -179.453 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.592 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 9.9 tm-20 -58.2 -38.25 76.37 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.823 0.344 . . . . 15.0 110.336 179.599 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.3 m -53.9 -64.97 0.66 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.164 -0.471 . . . . 15.0 110.449 179.821 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.491 ' CB ' HD11 ' A' ' 11' ' ' LEU . 0.4 OUTLIER -63.21 -37.51 87.54 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.151 -0.477 . . . . 15.0 109.979 179.112 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.49 37.46 17.31 Favored Glycine 0 N--CA 1.449 -0.439 0 CA-C-N 115.726 -0.67 . . . . 15.0 112.377 179.695 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.566 ' HB3' HG23 ' A' ' 9' ' ' VAL . 0.9 OUTLIER -82.8 -54.65 4.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.938 0.399 . . . . 15.0 110.543 179.91 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.656 HG12 HD12 ' A' ' 20' ' ' ILE . 11.4 tp -81.18 159.07 4.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.979 -0.555 . . . . 15.0 110.177 179.458 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 53' ' ' HIS . . . . . 0.4 ' N ' ' OD2' ' A' ' 56' ' ' ASP . 76.1 m80 -142.16 160.67 39.76 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 121.766 0.793 . . . . 15.0 112.813 -178.784 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.585 ' HA ' ' CG2' ' A' ' 37' ' ' VAL . 1.2 mtpt -44.01 134.73 4.53 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 113.93 -1.486 . . . . 15.0 112.762 -178.788 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.817 ' N ' HG22 ' A' ' 37' ' ' VAL . . . 49.75 29.82 13.54 Favored Glycine 0 C--N 1.334 0.428 0 CA-C-N 115.791 -0.64 . . . . 15.0 113.448 179.261 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.4 ' OD2' ' N ' ' A' ' 53' ' ' HIS . 6.2 m-20 -65.78 128.75 37.26 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.761 -0.376 . . . . 15.0 110.413 179.359 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.612 ' HD2' HD21 ' A' ' 59' ' ' LEU . 0.0 OUTLIER -82.08 93.49 7.02 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.362 -0.381 . . . . 15.0 110.54 -179.988 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.952 HG22 HG22 ' A' ' 35' ' ' ILE . 1.2 m -86.26 115.7 27.86 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 CA-C-O 121.112 0.482 . . . . 15.0 111.586 -179.32 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.612 HD21 ' HD2' ' A' ' 57' ' ' ARG . 4.5 mm? -107.68 -14.67 14.76 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 115.633 -0.712 . . . . 15.0 112.542 -179.496 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.587 ' HB3' ' HB2' ' A' ' 88' ' ' LEU . . . -147.56 150.33 34.27 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 112.743 0.646 . . . . 15.0 112.743 -178.394 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.9 HG11 ' O ' ' A' ' 77' ' ' THR . 98.2 t -139.21 103.01 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.202 -0.908 . . . . 15.0 109.066 178.808 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.547 ' OD1' HG22 ' A' ' 81' ' ' THR . 2.1 m120 65.23 16.9 10.79 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.516 -0.55 . . . . 15.0 109.516 -178.038 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.0 6.97 44.98 Favored Glycine 0 C--N 1.335 0.49 0 CA-C-N 115.789 -0.641 . . . . 15.0 113.135 179.814 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.658 HG13 ' O ' ' A' ' 64' ' ' VAL . 6.0 p -93.86 106.56 18.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.062 0.458 . . . . 15.0 110.724 179.394 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -58.3 122.98 14.56 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.179 -0.464 . . . . 15.0 110.955 -179.488 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.493 HD11 ' OG1' ' A' ' 77' ' ' THR . 3.7 mt -94.38 -12.53 27.73 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.836 -0.62 . . . . 15.0 111.286 -179.92 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -44.65 98.05 0.01 OUTLIER 'General case' 0 N--CA 1.461 0.1 0 CA-C-O 120.865 0.364 . . . . 15.0 110.894 179.855 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.85 67.53 0.6 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.838 -0.696 . . . . 15.0 112.102 -179.46 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.614 ' HB1' ' CB ' ' A' ' 73' ' ' GLN . . . -172.91 148.16 1.76 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.78 0.324 . . . . 15.0 110.837 -179.683 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.468 ' HB ' ' HA ' ' A' ' 26' ' ' VAL . 1.4 p -72.86 -174.2 1.41 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.019 0.438 . . . . 15.0 111.041 -179.731 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 71' ' ' HIS . . . . . 0.736 ' CE1' HG23 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -63.51 -59.03 5.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.885 -0.598 . . . . 15.0 110.658 -179.822 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.413 ' HA ' ' HB ' ' A' ' 75' ' ' VAL . 18.1 ttpp -52.44 -33.19 43.09 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.987 -0.551 . . . . 15.0 110.75 179.669 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.614 ' CB ' ' HB1' ' A' ' 69' ' ' ALA . 3.0 mt-30 -59.57 -49.98 75.65 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.428 -0.582 . . . . 15.0 109.428 179.123 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.458 ' HA ' ' OG1' ' A' ' 77' ' ' THR . . . -67.05 -45.93 75.93 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.743 -0.662 . . . . 15.0 109.836 178.482 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 1.028 HG23 HG21 ' A' ' 22' ' ' VAL . 0.5 OUTLIER -41.87 -41.49 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.27 0 CA-C-O 121.524 0.678 . . . . 15.0 109.218 178.553 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -67.33 -44.93 77.88 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.762 -1.108 . . . . 15.0 110.681 178.941 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.9 ' O ' HG11 ' A' ' 61' ' ' VAL . 15.3 p -64.38 -54.9 25.61 Favored 'General case' 0 N--CA 1.463 0.184 0 C-N-CA 121.028 -0.269 . . . . 15.0 111.599 -179.96 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.739 HD23 HG21 ' A' ' 61' ' ' VAL . 6.5 mt -53.43 -47.79 69.32 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-O 121.122 0.487 . . . . 15.0 110.188 -179.752 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.424 ' HB2' ' O ' ' A' ' 75' ' ' VAL . 3.1 ttp180 -68.32 -57.48 5.87 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.554 -0.748 . . . . 15.0 110.479 179.521 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -66.11 61.69 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.016 -0.538 . . . . 15.0 111.906 179.859 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.547 HG22 ' OD1' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -95.57 -74.97 0.54 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.719 0.295 . . . . 15.0 110.234 179.236 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.401 ' O ' ' HG3' ' A' ' 13' ' ' LYS . . . 120.36 -102.33 0.86 Allowed Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.775 -0.726 . . . . 15.0 112.88 179.381 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -64.7 -86.02 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.609 0.242 . . . . 15.0 111.209 -179.627 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.491 HG12 ' N ' ' A' ' 85' ' ' VAL . 86.8 t -109.77 160.36 8.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.886 0.374 . . . . 15.0 110.778 -179.924 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.91 HG23 ' HB2' ' A' ' 13' ' ' LYS . 3.1 t -97.66 81.86 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.214 0.53 . . . . 15.0 110.195 179.868 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -96.08 82.29 3.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.687 -0.688 . . . . 15.0 110.344 179.895 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.756 ' HB3' HD21 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -101.95 121.83 42.89 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.933 -0.576 . . . . 15.0 111.719 -179.281 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.723 HD12 ' HB2' ' A' ' 8' ' ' GLU . 4.7 mp -99.4 100.76 11.86 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.521 -0.548 . . . . 15.0 109.521 178.745 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.812 HD12 ' CZ ' ' A' ' 7' ' ' PHE . 0.1 OUTLIER -105.52 -161.52 0.81 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.456 0.646 . . . . 15.0 112.031 -178.501 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.438 ' HA ' ' HA ' ' A' ' 6' ' ' ILE . 1.1 tt0 -138.88 142.58 38.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 114.862 -1.063 . . . . 15.0 109.629 178.969 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 2.5 tppp? -54.48 106.04 0.18 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.978 0.418 . . . . 15.0 111.242 -179.421 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.382 0 C-N-CA 120.971 -0.633 . . . . 15.0 112.438 179.914 . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.443 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 1.4 mp . . . . . 0 N--CA 1.449 -0.516 0 CA-C-O 120.818 0.342 . . . . 15.0 111.034 . . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.519 ' CE1' HD12 ' A' ' 89' ' ' LEU . 4.8 p90 -140.45 166.81 23.71 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.182 -0.463 . . . . 15.0 110.37 178.871 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.725 ' HB3' HD12 ' A' ' 88' ' ' LEU . 4.2 pt-20 -130.22 142.87 50.53 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.269 0.557 . . . . 15.0 111.88 -179.21 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.676 ' CG1' HD11 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -101.38 115.93 44.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.237 -0.892 . . . . 15.0 109.332 178.805 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.406 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 4.1 tt0 -105.96 76.37 1.17 Allowed 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 112.696 0.628 . . . . 15.0 112.696 -178.394 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.512 ' HB3' ' HB ' ' A' ' 85' ' ' VAL . 6.9 tp -88.16 162.03 16.93 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.018 -0.734 . . . . 15.0 109.018 177.995 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -96.92 89.98 5.05 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 112.431 0.53 . . . . 15.0 112.431 -179.185 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.689 ' HB2' HG23 ' A' ' 85' ' ' VAL . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.033 -0.531 . . . . 15.0 111.552 178.9 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.587 ' N ' HD22 ' A' ' 18' ' ' LEU . 2.4 mm? . . . . . 0 N--CA 1.45 -0.425 0 CA-C-O 120.811 0.338 . . . . 15.0 110.457 . . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.663 ' O ' ' HB ' ' A' ' 41' ' ' ILE . . . -167.51 37.1 0.22 Allowed Glycine 0 CA--C 1.506 -0.52 0 N-CA-C 111.566 -0.614 . . . . 15.0 111.566 -179.609 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.681 HD13 ' HB ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -112.5 142.28 25.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 112.216 0.45 . . . . 15.0 112.216 -179.04 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.435 ' H ' HD13 ' A' ' 41' ' ' ILE . 30.9 t -95.46 101.66 13.4 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 107.079 -1.452 . . . . 15.0 107.079 176.657 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.965 HG21 HG23 ' A' ' 75' ' ' VAL . 35.5 m -93.26 156.7 3.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 113.236 0.828 . . . . 15.0 113.236 -176.364 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.25 -175.03 4.82 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 114.966 -1.016 . . . . 15.0 110.647 -179.694 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.553 ' O ' HG22 ' A' ' 26' ' ' VAL . . . 68.79 -121.38 12.15 Favored Glycine 0 C--N 1.332 0.32 0 C-N-CA 120.868 -0.682 . . . . 15.0 112.469 179.8 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.521 ' HA3' ' N ' ' A' ' 71' ' ' HIS . . . 66.76 -64.42 0.18 Allowed Glycine 0 CA--C 1.518 0.269 0 C-N-CA 120.997 -0.621 . . . . 15.0 113.679 179.285 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.553 HG22 ' O ' ' A' ' 24' ' ' GLY . 0.0 OUTLIER -30.46 146.97 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 N-CA-C 112.591 0.589 . . . . 15.0 112.591 -179.204 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -75.75 56.31 0.92 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.872 -0.604 . . . . 15.0 111.066 -179.946 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.3 m -151.96 -63.61 0.17 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.914 0.388 . . . . 15.0 111.202 -179.986 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 30.9 t -67.07 -50.43 61.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.046 -0.524 . . . . 15.0 111.325 -179.575 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.532 HG11 ' O ' ' A' ' 34' ' ' GLY . 19.6 m -69.45 -175.94 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.378 -0.374 . . . . 15.0 111.415 -179.644 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.405 ' HD3' ' NH2' ' A' ' 57' ' ' ARG . 46.2 mtp85 -62.4 -53.06 60.53 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.162 -0.472 . . . . 15.0 111.089 -179.859 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 32' ' ' HIS . . . . . 0.418 ' CD2' ' HG2' ' A' ' 67' ' ' GLU . 42.1 p-80 -142.24 -52.79 0.41 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.449 -0.341 . . . . 15.0 111.201 179.939 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -169.18 19.01 0.08 OUTLIER Glycine 0 CA--C 1.519 0.328 0 C-N-CA 120.522 -0.847 . . . . 15.0 113.097 -179.802 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.532 ' O ' HG11 ' A' ' 30' ' ' VAL . . . -85.27 152.92 27.21 Favored Glycine 0 N--CA 1.45 -0.401 0 N-CA-C 110.797 -0.921 . . . . 15.0 110.797 178.89 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.944 HG22 HG22 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -90.54 154.97 3.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 117.642 0.721 . . . . 15.0 111.851 -179.352 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 30.4 m-85 -141.8 107.34 5.06 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.028 -0.987 . . . . 15.0 109.737 178.918 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.776 HG22 ' N ' ' A' ' 55' ' ' GLY . 0.8 OUTLIER -55.3 150.83 2.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.035 -0.53 . . . . 15.0 111.315 -178.9 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.496 ' O ' ' HG2' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -82.37 -47.04 12.78 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.416 -0.957 . . . . 15.0 108.416 178.412 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.588 ' O ' HG12 ' A' ' 20' ' ' ILE . . . -172.17 173.37 4.3 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.361 -0.836 . . . . 15.0 110.231 178.569 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.629 ' HA ' HG12 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -97.36 108.69 22.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.892 0.377 . . . . 15.0 110.349 179.647 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.663 ' HB ' ' O ' ' A' ' 19' ' ' GLY . 0.8 OUTLIER -78.96 110.53 14.86 Favored Pre-proline 0 C--O 1.234 0.245 0 N-CA-C 113.046 0.758 . . . . 15.0 113.046 -178.322 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.563 ' HA ' ' OE1' ' A' ' 47' ' ' GLU . 22.7 Cg_exo -64.28 66.58 0.24 Allowed 'Trans proline' 0 C--N 1.356 0.96 0 C-N-CA 123.177 2.585 . . . . 15.0 112.721 179.771 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.536 ' HB2' HG22 ' A' ' 41' ' ' ILE . 12.8 mt-30 -148.42 -52.88 0.18 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.483 -0.781 . . . . 15.0 109.258 179.233 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.644 ' HA3' ' HA3' ' A' ' 19' ' ' GLY . . . -88.24 156.19 26.91 Favored Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.612 -0.804 . . . . 15.0 112.474 179.044 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -42.5 -16.46 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 113.432 0.901 . . . . 15.0 113.432 -179.696 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.437 ' N ' ' O ' ' A' ' 44' ' ' GLY . . . -71.57 -70.27 0.33 Allowed 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.92 -0.312 . . . . 15.0 111.474 -179.258 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.563 ' OE1' ' HA ' ' A' ' 42' ' ' PRO . 10.2 tm-20 -58.31 -36.13 72.89 Favored 'General case' 0 N--CA 1.463 0.211 0 C-N-CA 120.504 -0.479 . . . . 15.0 110.064 179.408 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 48.8 m -57.57 -66.99 0.37 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.925 -0.58 . . . . 15.0 110.186 179.411 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.454 ' CB ' HD11 ' A' ' 11' ' ' LEU . 0.8 OUTLIER -60.55 -37.65 81.94 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.096 0.475 . . . . 15.0 109.881 179.004 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.44 37.43 17.54 Favored Glycine 0 N--CA 1.449 -0.461 0 CA-C-N 115.58 -0.736 . . . . 15.0 112.504 179.585 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.556 ' HB3' HG23 ' A' ' 9' ' ' VAL . 14.3 mmt180 -84.77 -49.75 8.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.94 0.4 . . . . 15.0 110.621 179.999 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.649 HG12 HD12 ' A' ' 20' ' ' ILE . 11.1 tp -81.19 157.22 4.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.016 -0.538 . . . . 15.0 110.347 179.537 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 76.6 m80 -139.65 158.1 44.67 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-O 121.753 0.787 . . . . 15.0 112.71 -179.006 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.599 ' HA ' ' CG2' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -44.25 134.95 4.72 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.137 -1.392 . . . . 15.0 112.477 -178.893 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.776 ' N ' HG22 ' A' ' 37' ' ' VAL . . . 49.7 34.32 21.0 Favored Glycine 0 C--N 1.334 0.456 0 C-N-CA 121.135 -0.555 . . . . 15.0 112.907 179.569 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.43 ' OD2' HD12 ' A' ' 52' ' ' ILE . 1.1 m-20 -65.5 130.64 44.04 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 121.003 -0.279 . . . . 15.0 110.439 179.636 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.405 ' NH2' ' HD3' ' A' ' 31' ' ' ARG . 59.7 ttt180 -86.33 86.45 7.34 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.112 -0.494 . . . . 15.0 110.432 179.792 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.944 HG22 HG22 ' A' ' 35' ' ' ILE . 1.3 m -79.41 116.68 23.79 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 CA-C-O 121.095 0.474 . . . . 15.0 110.948 -179.618 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 20.0 mt -107.19 -18.71 13.81 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.563 -0.744 . . . . 15.0 112.254 -179.323 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.424 ' HA ' ' O ' ' A' ' 64' ' ' VAL . . . -148.29 148.79 30.83 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 112.479 0.548 . . . . 15.0 112.479 -178.898 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.791 HG11 ' O ' ' A' ' 77' ' ' THR . 26.1 t -139.16 102.18 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.339 -0.846 . . . . 15.0 109.173 178.878 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.593 ' OD1' HG22 ' A' ' 81' ' ' THR . 2.6 m120 64.8 15.03 9.58 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.699 -0.482 . . . . 15.0 109.699 -177.966 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 107.1 5.76 34.79 Favored Glycine 0 C--N 1.337 0.606 0 CA-C-N 115.86 -0.609 . . . . 15.0 113.425 179.727 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.657 HG13 ' O ' ' A' ' 64' ' ' VAL . 6.2 p -93.92 106.83 18.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 117.181 0.49 . . . . 15.0 111.083 179.474 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.99 134.24 55.6 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.217 -0.447 . . . . 15.0 110.995 -179.877 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.611 HD21 ' HA ' ' A' ' 74' ' ' ALA . 0.1 OUTLIER -95.5 -22.78 17.44 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.024 -0.535 . . . . 15.0 111.015 -179.958 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.418 ' HG2' ' CD2' ' A' ' 32' ' ' HIS . 1.8 tt0 -46.27 100.42 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.899 0.38 . . . . 15.0 111.064 179.942 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.73 63.67 0.55 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.814 -0.708 . . . . 15.0 112.222 -179.719 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.59 ' HB1' ' CG ' ' A' ' 73' ' ' GLN . . . -173.03 167.12 5.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.829 0.347 . . . . 15.0 111.117 -179.798 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.437 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 16.2 p -93.23 -175.11 3.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.227 -0.442 . . . . 15.0 111.095 -179.883 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 71' ' ' HIS . . . . . 0.739 ' CE1' HG23 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -62.17 -60.49 3.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.918 -0.583 . . . . 15.0 110.447 179.977 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.425 ' N ' ' CG ' ' A' ' 71' ' ' HIS . 8.0 ttpp -52.41 -31.12 32.66 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.814 -0.63 . . . . 15.0 110.517 179.448 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.59 ' CG ' ' HB1' ' A' ' 69' ' ' ALA . 0.3 OUTLIER -59.32 -52.02 67.42 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.64 -0.504 . . . . 15.0 109.64 179.335 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.611 ' HA ' HD21 ' A' ' 66' ' ' LEU . . . -66.95 -45.96 76.18 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.092 -0.504 . . . . 15.0 109.706 178.495 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.965 HG23 HG21 ' A' ' 22' ' ' VAL . 0.5 OUTLIER -41.43 -40.04 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.221 0 N-CA-C 109.123 -0.695 . . . . 15.0 109.123 178.43 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.421 ' HG3' ' O ' ' A' ' 72' ' ' LYS . 22.5 mt-10 -67.47 -46.72 72.18 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 114.731 -1.122 . . . . 15.0 110.244 178.488 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.791 ' O ' HG11 ' A' ' 61' ' ' VAL . 44.8 p -64.33 -51.9 61.14 Favored 'General case' 0 N--CA 1.461 0.102 0 C-N-CA 120.991 -0.283 . . . . 15.0 111.24 179.637 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.617 HD21 HG21 ' A' ' 58' ' ' VAL . 5.6 mt -53.53 -49.98 66.44 Favored 'General case' 0 CA--C 1.521 -0.168 0 CA-C-O 121.22 0.533 . . . . 15.0 109.878 179.934 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.46 -61.45 1.83 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.357 -0.838 . . . . 15.0 110.467 179.387 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -65.92 62.71 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.926 -0.579 . . . . 15.0 111.792 179.844 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.593 HG22 ' OD1' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -91.85 -69.81 0.72 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.648 0.261 . . . . 15.0 110.443 179.52 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 122.32 -107.19 1.13 Allowed Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.872 -0.68 . . . . 15.0 112.939 179.441 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.81 -83.56 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.775 0.321 . . . . 15.0 111.545 -179.45 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.474 HG12 ' N ' ' A' ' 85' ' ' VAL . 62.7 t -109.82 159.92 9.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.855 0.36 . . . . 15.0 110.335 179.999 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.689 HG23 ' HB2' ' A' ' 13' ' ' LYS . 24.4 t -97.85 80.16 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-O 121.016 0.436 . . . . 15.0 110.687 -179.943 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -98.46 81.89 2.79 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.893 -0.594 . . . . 15.0 110.447 179.865 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.772 ' HB3' HD21 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -101.15 118.03 36.19 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.045 -0.525 . . . . 15.0 111.742 -179.229 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.725 HD12 ' HB3' ' A' ' 8' ' ' GLU . 0.2 OUTLIER -94.99 101.47 13.23 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.302 -0.629 . . . . 15.0 109.302 178.657 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.772 HD21 ' HB3' ' A' ' 87' ' ' LEU . 0.2 OUTLIER -104.6 -162.29 0.88 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.417 0.627 . . . . 15.0 111.752 -178.629 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.443 ' HA ' ' HA ' ' A' ' 6' ' ' ILE . 2.2 tt0 -139.86 143.1 36.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.085 -0.961 . . . . 15.0 109.888 179.062 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -54.03 102.99 0.07 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.904 0.383 . . . . 15.0 110.96 -179.642 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.294 0 C-N-CA 120.84 -0.695 . . . . 15.0 112.65 -179.757 . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.461 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 1.3 mp . . . . . 0 N--CA 1.451 -0.395 0 CA-C-O 121.024 0.44 . . . . 15.0 111.655 . . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.554 ' CZ ' HD12 ' A' ' 89' ' ' LEU . 3.3 p90 -141.68 165.06 28.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.884 -0.598 . . . . 15.0 110.263 178.759 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.774 ' HB2' HD12 ' A' ' 88' ' ' LEU . 0.2 OUTLIER -130.16 142.21 50.6 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.272 0.558 . . . . 15.0 111.615 -179.442 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.655 ' CG1' HD11 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -101.49 117.29 46.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.327 -0.851 . . . . 15.0 109.819 178.958 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -106.24 74.44 1.03 Allowed 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 112.166 0.432 . . . . 15.0 112.166 -179.031 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.585 HD13 ' CG ' ' A' ' 51' ' ' ARG . 8.7 tp -88.42 165.64 14.78 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.847 -0.427 . . . . 15.0 109.847 178.778 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -94.75 94.7 8.25 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.039 0.447 . . . . 15.0 111.186 -179.945 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.516 ' CB ' HG23 ' A' ' 85' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.363 0 CA-C-N 115.797 -0.638 . . . . 15.0 111.2 179.945 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.507 ' N ' HD22 ' A' ' 18' ' ' LEU . 1.4 mm? . . . . . 0 N--CA 1.452 -0.373 0 CA-C-O 120.915 0.388 . . . . 15.0 110.449 . . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.643 ' O ' ' HB ' ' A' ' 41' ' ' ILE . . . -161.57 31.02 0.32 Allowed Glycine 0 CA--C 1.507 -0.431 0 N-CA-C 111.535 -0.626 . . . . 15.0 111.535 -179.835 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.64 HD12 ' CG1' ' A' ' 52' ' ' ILE . 0.0 OUTLIER -112.62 139.76 35.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 121.061 0.458 . . . . 15.0 111.936 -179.206 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.468 ' O ' ' HB3' ' A' ' 38' ' ' LYS . 42.4 t -96.25 100.22 11.87 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 107.587 -1.264 . . . . 15.0 107.587 176.951 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.621 HG12 ' CG2' ' A' ' 20' ' ' ILE . 1.3 m -93.68 152.01 3.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 112.622 0.601 . . . . 15.0 112.622 -176.971 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.708 ' HA ' ' CD2' ' A' ' 71' ' ' HIS . 15.3 t -149.47 177.52 9.64 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.393 -0.822 . . . . 15.0 110.689 179.632 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.66 ' O ' HG22 ' A' ' 26' ' ' VAL . . . 83.05 -115.07 3.95 Favored Glycine 0 C--N 1.332 0.353 0 C-N-CA 120.723 -0.751 . . . . 15.0 112.136 -179.779 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.563 ' HA3' ' N ' ' A' ' 71' ' ' HIS . . . 63.79 -65.24 0.04 OUTLIER Glycine 0 C--N 1.331 0.266 0 C-N-CA 121.002 -0.618 . . . . 15.0 113.781 178.933 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.66 HG22 ' O ' ' A' ' 24' ' ' GLY . 0.0 OUTLIER -30.73 143.13 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 N-CA-C 112.234 0.457 . . . . 15.0 112.234 -179.116 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.409 ' CB ' ' O ' ' A' ' 32' ' ' HIS . 14.3 p-10 -75.59 62.26 1.41 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.956 -0.565 . . . . 15.0 111.0 -179.692 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 40.9 m -151.73 -67.13 0.17 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.308 -0.405 . . . . 15.0 111.088 -179.96 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -68.98 -32.45 72.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.137 -0.483 . . . . 15.0 111.071 -179.8 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.587 HG22 ' O ' ' A' ' 26' ' ' VAL . 19.8 m -88.09 -172.85 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.239 -0.437 . . . . 15.0 111.269 -179.895 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -61.94 -63.14 1.35 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.138 -0.483 . . . . 15.0 111.031 -179.984 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 32' ' ' HIS . . . . . 0.409 ' O ' ' CB ' ' A' ' 27' ' ' ASN . 90.8 m-70 -136.26 -49.72 0.68 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.294 -0.412 . . . . 15.0 111.103 -179.853 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -171.13 26.13 0.1 OUTLIER Glycine 0 C--N 1.329 0.155 0 C-N-CA 120.789 -0.72 . . . . 15.0 112.595 -179.755 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -89.51 154.43 24.13 Favored Glycine 0 N--CA 1.449 -0.472 0 N-CA-C 110.749 -0.94 . . . . 15.0 110.749 178.836 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.832 HG22 HG22 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -93.6 153.82 3.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 117.648 0.724 . . . . 15.0 111.828 -179.265 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.511 ' CE2' ' CG ' ' A' ' 57' ' ' ARG . 42.7 m-85 -138.39 106.28 5.67 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.957 -1.02 . . . . 15.0 109.859 179.69 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.818 HG22 ' N ' ' A' ' 55' ' ' GLY . 0.7 OUTLIER -55.27 145.29 5.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.164 -0.471 . . . . 15.0 111.002 -179.179 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.538 ' HB2' HG22 ' A' ' 23' ' ' THR . 0.2 OUTLIER -80.13 -47.57 14.55 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.661 -0.866 . . . . 15.0 108.661 178.512 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.567 ' O ' HG12 ' A' ' 20' ' ' ILE . . . -172.23 170.45 5.14 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 115.698 -0.683 . . . . 15.0 110.309 178.397 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.595 ' HA ' HG12 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -97.07 111.7 27.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.928 0.394 . . . . 15.0 110.264 179.638 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.643 ' HB ' ' O ' ' A' ' 19' ' ' GLY . 0.4 OUTLIER -78.65 109.99 12.57 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 115.781 -0.645 . . . . 15.0 112.632 -178.293 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.45 ' N ' ' HG2' ' A' ' 47' ' ' GLU . 24.5 Cg_exo -62.47 68.55 0.12 Allowed 'Trans proline' 0 C--N 1.356 0.935 0 C-N-CA 123.211 2.607 . . . . 15.0 112.507 179.828 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.478 ' HB2' HG22 ' A' ' 41' ' ' ILE . 8.1 mm-40 -153.43 -52.93 0.1 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.628 -0.715 . . . . 15.0 109.825 179.638 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.499 ' HA3' ' HA3' ' A' ' 19' ' ' GLY . . . -87.78 155.9 27.15 Favored Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.66 -0.781 . . . . 15.0 112.481 179.393 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -41.05 -16.8 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 113.517 0.932 . . . . 15.0 113.517 -179.546 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.463 ' N ' ' O ' ' A' ' 44' ' ' GLY . . . -71.68 -71.76 0.26 Allowed 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.819 -0.353 . . . . 15.0 111.155 -179.739 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.542 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 4.1 tp10 -58.27 -39.78 80.13 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 121.033 0.445 . . . . 15.0 110.402 179.569 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.2 m -53.98 -64.5 0.81 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.904 -0.589 . . . . 15.0 110.434 179.537 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.526 ' CB ' HD11 ' A' ' 11' ' ' LEU . 3.7 m-20 -64.79 -37.62 88.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.163 -0.471 . . . . 15.0 110.175 179.273 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.62 38.22 14.85 Favored Glycine 0 N--CA 1.45 -0.41 0 CA-C-N 115.744 -0.662 . . . . 15.0 112.571 179.581 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.585 ' CG ' HD13 ' A' ' 11' ' ' LEU . 0.2 OUTLIER -82.33 -54.47 5.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.968 0.413 . . . . 15.0 110.614 179.864 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.64 ' CG1' HD12 ' A' ' 20' ' ' ILE . 9.6 tp -81.09 159.72 4.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.873 -0.603 . . . . 15.0 110.379 179.705 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 53' ' ' HIS . . . . . 0.421 ' O ' ' HB2' ' A' ' 56' ' ' ASP . 53.2 m80 -140.74 159.47 42.14 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-O 121.742 0.782 . . . . 15.0 112.728 -178.875 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.595 ' HA ' ' CG2' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -44.14 134.45 4.8 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.054 -1.43 . . . . 15.0 113.057 -178.728 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.818 ' N ' HG22 ' A' ' 37' ' ' VAL . . . 49.83 31.4 16.58 Favored Glycine 0 C--N 1.335 0.483 0 CA-C-N 115.779 -0.646 . . . . 15.0 113.618 178.934 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.421 ' HB2' ' O ' ' A' ' 53' ' ' HIS . 0.4 OUTLIER -65.92 130.22 42.51 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.628 -0.429 . . . . 15.0 110.655 179.504 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.511 ' CG ' ' CE2' ' A' ' 36' ' ' TYR . 3.5 mtt180 -82.08 88.35 6.44 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.177 -0.465 . . . . 15.0 110.407 179.564 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.832 HG22 HG22 ' A' ' 35' ' ' ILE . 1.5 m -79.45 111.93 16.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 CA-C-O 121.199 0.523 . . . . 15.0 111.061 -179.554 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.414 HD22 ' N ' ' A' ' 59' ' ' LEU . 4.0 mm? -107.38 -15.14 14.7 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 115.558 -0.746 . . . . 15.0 112.33 -179.224 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.783 ' HB3' ' HB2' ' A' ' 88' ' ' LEU . . . -147.91 145.68 28.72 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.099 0.476 . . . . 15.0 112.217 -178.782 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.836 HG23 HD11 ' A' ' 66' ' ' LEU . 47.1 t -138.93 103.48 2.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.624 -0.716 . . . . 15.0 109.378 178.918 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.728 ' OD1' HG22 ' A' ' 81' ' ' THR . 2.4 m120 64.97 16.43 10.55 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.727 -0.471 . . . . 15.0 109.727 -178.114 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.99 5.81 43.61 Favored Glycine 0 C--N 1.336 0.545 0 CA-C-N 115.744 -0.662 . . . . 15.0 113.103 179.958 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.649 HG13 ' O ' ' A' ' 64' ' ' VAL . 5.7 p -93.78 108.33 20.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 121.007 0.432 . . . . 15.0 110.915 179.573 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 13.7 m -58.74 124.41 19.67 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.178 0.514 . . . . 15.0 110.796 -179.781 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.836 HD11 HG23 ' A' ' 61' ' ' VAL . 0.2 OUTLIER -89.11 -18.7 26.69 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.489 -0.778 . . . . 15.0 111.21 -179.652 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -46.66 101.84 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 120.832 0.349 . . . . 15.0 110.985 179.88 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.75 66.38 0.58 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.788 -0.72 . . . . 15.0 112.291 -179.707 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.641 ' HB1' ' HB3' ' A' ' 73' ' ' GLN . . . -173.03 164.21 4.88 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.849 0.357 . . . . 15.0 111.031 -179.821 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.445 ' HB ' HG13 ' A' ' 26' ' ' VAL . 18.5 p -93.24 -174.66 3.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.998 0.428 . . . . 15.0 111.232 -179.831 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 71' ' ' HIS . . . . . 0.708 ' CD2' ' HA ' ' A' ' 23' ' ' THR . 0.0 OUTLIER -61.53 -61.88 2.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.85 -0.614 . . . . 15.0 109.826 179.774 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 16.1 ttpt -52.88 -35.61 58.09 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.876 -0.602 . . . . 15.0 110.085 179.005 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.641 ' HB3' ' HB1' ' A' ' 69' ' ' ALA . 3.5 tt0 -59.64 -48.96 79.62 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.944 -0.571 . . . . 15.0 109.501 179.035 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.467 ' HA ' ' OG1' ' A' ' 77' ' ' THR . . . -66.93 -46.71 73.94 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-N 115.92 -0.582 . . . . 15.0 109.491 178.344 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.59 HG23 ' CG2' ' A' ' 22' ' ' VAL . 0.5 OUTLIER -42.54 -39.72 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.27 0 N-CA-C 108.814 -0.81 . . . . 15.0 108.814 178.218 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.462 ' O ' ' HB2' ' A' ' 80' ' ' ASN . 1.0 OUTLIER -67.29 -46.34 73.9 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 114.663 -1.153 . . . . 15.0 110.57 178.59 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.622 ' O ' HG11 ' A' ' 61' ' ' VAL . 6.9 p -64.07 -53.74 44.98 Favored 'General case' 0 N--CA 1.462 0.16 0 C-N-CA 120.974 -0.29 . . . . 15.0 111.636 -179.87 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.696 HD23 HG21 ' A' ' 61' ' ' VAL . 6.9 mt -53.31 -46.8 69.55 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-O 121.259 0.552 . . . . 15.0 110.017 179.982 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.448 ' HB2' ' O ' ' A' ' 75' ' ' VAL . 0.0 OUTLIER -68.45 -57.41 5.89 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.344 -0.844 . . . . 15.0 110.784 179.576 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.462 ' HB2' ' O ' ' A' ' 76' ' ' GLU . 9.3 m-80 -66.14 61.53 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.103 -0.499 . . . . 15.0 112.155 -179.882 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.728 HG22 ' OD1' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -95.67 -68.44 0.8 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.836 0.35 . . . . 15.0 110.158 179.098 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 122.14 -108.33 1.28 Allowed Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 121.004 -0.617 . . . . 15.0 112.957 179.396 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.443 ' O ' ' HB3' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -65.26 -79.08 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.912 0.387 . . . . 15.0 111.773 -179.326 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.464 HG12 ' N ' ' A' ' 85' ' ' VAL . 75.6 t -109.88 159.42 9.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.942 -0.572 . . . . 15.0 111.035 -179.219 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.678 ' O ' HG12 ' A' ' 85' ' ' VAL . 5.9 t -97.9 81.14 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.122 0.486 . . . . 15.0 110.485 179.96 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 13.7 t60 -97.94 82.83 3.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.784 -0.644 . . . . 15.0 110.297 179.67 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.813 ' HB3' HD21 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -101.2 119.72 39.17 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.928 -0.578 . . . . 15.0 111.857 -179.132 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.783 ' HB2' ' HB3' ' A' ' 60' ' ' ALA . 4.0 mp -96.05 100.71 12.34 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.557 -0.535 . . . . 15.0 109.557 178.841 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.813 HD21 ' HB3' ' A' ' 87' ' ' LEU . 0.1 OUTLIER -105.61 -160.86 0.77 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.42 0.629 . . . . 15.0 111.974 -178.589 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.461 ' HA ' ' HA ' ' A' ' 6' ' ' ILE . 3.5 tt0 -138.91 139.89 38.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 114.978 -1.01 . . . . 15.0 109.979 179.107 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 14.0 tppt? -51.17 106.71 0.14 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.312 -0.404 . . . . 15.0 111.003 -179.913 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.328 0 C-N-CA 120.872 -0.68 . . . . 15.0 112.714 -179.789 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo . . . . . 0 N--CA 1.489 1.222 0 CA-C-O 120.953 0.314 . . . . 15.0 111.688 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 11.4 pttp -155.24 150.69 21.32 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.146 -0.479 . . . . 15.0 110.849 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -63.89 -162.78 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.552 2.168 . . . . 15.0 112.136 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 88.32 -20.5 29.9 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.516 -0.85 . . . . 15.0 112.44 -179.678 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -62.12 144.45 55.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.194 0.521 . . . . 15.0 110.727 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.467 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 1.4 mp -104.33 143.13 16.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.335 -0.848 . . . . 15.0 111.243 -179.192 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.545 ' CE1' HD12 ' A' ' 89' ' ' LEU . 2.8 p90 -140.43 164.95 28.76 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.088 -0.506 . . . . 15.0 110.261 178.621 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.727 ' HB3' HD12 ' A' ' 88' ' ' LEU . 6.3 pt-20 -130.09 142.09 50.64 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.362 0.601 . . . . 15.0 111.867 -179.047 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.593 ' CG1' HD11 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -101.56 114.74 41.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.037 -0.983 . . . . 15.0 109.728 178.915 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -105.87 72.11 0.93 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.156 -0.475 . . . . 15.0 111.916 -178.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.594 HD13 ' HG3' ' A' ' 51' ' ' ARG . 6.3 tp -88.33 165.67 14.82 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.098 -0.501 . . . . 15.0 110.061 179.056 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -95.57 92.26 6.55 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.93 0.395 . . . . 15.0 111.138 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.611 ' CB ' HG23 ' A' ' 85' ' ' VAL . 0.0 OUTLIER -54.42 -32.11 56.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.982 -0.554 . . . . 15.0 110.977 179.96 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.474 ' O ' ' CB ' ' A' ' 15' ' ' ASP . 12.5 t-20 -84.8 138.37 32.63 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.233 -0.439 . . . . 15.0 110.7 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.474 ' CB ' ' O ' ' A' ' 14' ' ' ASN . 9.8 t70 88.67 -27.91 0.05 Allowed 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.944 -0.571 . . . . 15.0 111.218 -179.588 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.491 ' HB3' ' HB2' ' A' ' 45' ' ' ALA . 16.0 m120 -161.86 133.89 5.64 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.827 0.346 . . . . 15.0 110.816 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.807 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 0.0 OUTLIER -86.04 -162.76 0.78 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.259 -0.428 . . . . 15.0 110.665 179.856 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.652 ' N ' HD22 ' A' ' 18' ' ' LEU . 1.3 mm? -93.27 -171.64 2.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.896 0.379 . . . . 15.0 110.653 179.664 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.735 ' O ' ' HB ' ' A' ' 41' ' ' ILE . . . -161.0 40.16 0.42 Allowed Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.908 -0.663 . . . . 15.0 111.973 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.703 HG12 ' O ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -112.83 139.77 36.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 120.961 0.41 . . . . 15.0 111.998 -179.414 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 21.8 t -96.04 105.76 17.84 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.132 -1.062 . . . . 15.0 108.132 177.505 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.919 HG21 HG23 ' A' ' 75' ' ' VAL . 18.5 m -93.84 156.0 3.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 113.435 0.902 . . . . 15.0 113.435 -176.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.5 -172.76 4.22 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 114.981 -1.009 . . . . 15.0 110.437 179.438 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.418 ' O ' ' CB ' ' A' ' 71' ' ' HIS . . . 68.65 -120.2 10.93 Favored Glycine 0 C--N 1.331 0.251 0 C-N-CA 120.773 -0.727 . . . . 15.0 112.72 179.594 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.561 ' HA3' ' N ' ' A' ' 71' ' ' HIS . . . 68.48 -66.59 0.41 Allowed Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.82 -0.705 . . . . 15.0 113.367 179.651 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.599 ' O ' HG22 ' A' ' 30' ' ' VAL . 2.1 m -33.13 144.33 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 N-CA-C 112.024 0.379 . . . . 15.0 112.024 -179.374 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 13.0 p-10 -75.57 62.67 1.44 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.059 -0.518 . . . . 15.0 111.008 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -151.71 -67.68 0.17 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.219 -0.446 . . . . 15.0 110.945 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 21.1 m -67.21 -33.33 75.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.129 -0.487 . . . . 15.0 110.949 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.599 HG22 ' O ' ' A' ' 26' ' ' VAL . 29.5 m -88.02 -174.01 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 15.0 111.209 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -64.26 -60.53 3.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.181 -0.463 . . . . 15.0 111.146 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 52.2 m80 -132.88 -57.36 0.93 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.388 -0.369 . . . . 15.0 111.225 -179.647 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -167.13 21.45 0.1 Allowed Glycine 0 CA--C 1.518 0.246 0 C-N-CA 120.816 -0.707 . . . . 15.0 112.718 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -83.74 152.77 29.16 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.467 -0.873 . . . . 15.0 110.921 178.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.815 HG22 HG22 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -89.12 153.7 3.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 117.482 0.641 . . . . 15.0 111.633 -179.357 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.424 ' CZ ' ' HG2' ' A' ' 57' ' ' ARG . 25.3 m-85 -141.35 108.26 5.42 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.084 -0.962 . . . . 15.0 109.661 179.324 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.763 HG22 ' N ' ' A' ' 55' ' ' GLY . 0.8 OUTLIER -56.09 154.85 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.18 0.514 . . . . 15.0 111.573 -178.939 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.47 ' O ' ' HG2' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -85.45 -47.94 9.46 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.379 -0.971 . . . . 15.0 108.379 178.239 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.703 ' O ' HG12 ' A' ' 20' ' ' ILE . . . -172.39 172.99 4.25 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 115.349 -0.841 . . . . 15.0 110.224 178.693 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.529 ' HA ' ' CG1' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -96.76 110.91 25.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 109.273 -0.64 . . . . 15.0 109.273 179.125 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.735 ' HB ' ' O ' ' A' ' 19' ' ' GLY . 0.4 OUTLIER -78.24 116.57 60.0 Favored Pre-proline 0 C--N 1.328 -0.364 0 N-CA-C 113.4 0.889 . . . . 15.0 113.4 -177.11 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.604 ' HA ' ' CG ' ' A' ' 47' ' ' GLU . 37.8 Cg_exo -61.56 61.56 0.11 Allowed 'Trans proline' 0 C--N 1.358 1.054 0 C-N-CA 123.76 2.973 . . . . 15.0 113.1 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.533 ' H ' ' HG2' ' A' ' 47' ' ' GLU . 3.0 mt-30 -149.93 -47.94 0.13 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.609 0.242 . . . . 15.0 111.592 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.67 ' HA3' ' HA3' ' A' ' 19' ' ' GLY . . . -87.79 168.04 37.28 Favored Glycine 0 C--N 1.329 0.176 0 C-N-CA 120.324 -0.941 . . . . 15.0 113.781 -179.167 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.807 ' HB3' ' O ' ' A' ' 17' ' ' SER . . . -57.51 -13.23 3.4 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.721 0.637 . . . . 15.0 112.721 -179.644 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.0 -57.56 4.19 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 120.988 -0.285 . . . . 15.0 110.663 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.604 ' CG ' ' HA ' ' A' ' 42' ' ' PRO . 2.7 pp20? -57.55 -42.84 83.79 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.97 -0.559 . . . . 15.0 110.379 179.097 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 69.4 m -53.64 -71.12 0.08 Allowed 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 115.806 -0.634 . . . . 15.0 110.571 -179.429 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.569 ' HB2' HD11 ' A' ' 11' ' ' LEU . 0.3 OUTLIER -58.13 -41.14 83.02 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.12 -0.696 . . . . 15.0 109.12 178.872 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.57 40.19 13.21 Favored Glycine 0 N--CA 1.446 -0.7 0 CA-C-N 115.357 -0.838 . . . . 15.0 111.631 179.411 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.594 ' HG3' HD13 ' A' ' 11' ' ' LEU . 1.2 mmp_? -79.71 -50.07 11.15 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.867 0.365 . . . . 15.0 110.658 -179.253 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.62 ' CG1' HD12 ' A' ' 20' ' ' ILE . 8.4 tp -80.91 162.54 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 CA-C-N 116.021 -0.536 . . . . 15.0 110.198 179.457 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' HIS . . . . . 0.464 ' O ' ' HB2' ' A' ' 56' ' ' ASP . 79.6 m80 -146.88 159.88 42.99 Favored 'General case' 0 CA--C 1.514 -0.432 0 CA-C-O 121.641 0.734 . . . . 15.0 112.241 -179.067 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.53 ' HA ' ' CG2' ' A' ' 37' ' ' VAL . 0.1 OUTLIER -43.49 133.43 4.38 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.407 -1.269 . . . . 15.0 112.526 -178.77 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.763 ' N ' HG22 ' A' ' 37' ' ' VAL . . . 49.91 35.12 24.17 Favored Glycine 0 C--N 1.333 0.381 0 CA-C-N 115.927 -0.579 . . . . 15.0 113.377 179.328 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.464 ' HB2' ' O ' ' A' ' 53' ' ' HIS . 0.4 OUTLIER -65.92 132.5 48.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 117.08 0.44 . . . . 15.0 110.682 179.632 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.737 ' CD ' HD21 ' A' ' 59' ' ' LEU . 0.0 OUTLIER -85.5 85.9 7.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.04 -0.527 . . . . 15.0 110.618 179.799 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.815 HG22 HG22 ' A' ' 35' ' ' ILE . 1.4 m -79.49 116.33 23.31 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 CA-C-O 120.998 0.428 . . . . 15.0 110.955 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.737 HD21 ' CD ' ' A' ' 57' ' ' ARG . 18.7 mt -107.01 -18.11 14.0 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.809 -0.632 . . . . 15.0 112.329 -179.146 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.483 ' O ' HD23 ' A' ' 87' ' ' LEU . . . -147.84 149.67 32.73 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.246 0.546 . . . . 15.0 112.389 -178.858 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.663 HG11 ' O ' ' A' ' 77' ' ' THR . 17.6 t -138.93 101.67 1.66 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.31 0 CA-C-N 115.312 -0.858 . . . . 15.0 109.138 178.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.638 ' OD1' HG22 ' A' ' 81' ' ' THR . 2.9 m120 64.95 15.51 10.0 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.637 -0.505 . . . . 15.0 109.637 -177.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 107.04 5.46 35.22 Favored Glycine 0 C--N 1.338 0.642 0 CA-C-N 115.811 -0.631 . . . . 15.0 113.471 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.653 HG13 ' O ' ' A' ' 64' ' ' VAL . 6.3 p -93.91 107.18 18.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 117.085 0.442 . . . . 15.0 111.059 179.549 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.3 m -56.96 134.67 55.86 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.216 -0.447 . . . . 15.0 111.07 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.675 HD21 ' HA ' ' A' ' 74' ' ' ALA . 0.2 OUTLIER -97.83 -20.59 17.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.009 -0.542 . . . . 15.0 111.173 -179.994 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -45.64 110.91 0.29 Allowed 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.384 -0.371 . . . . 15.0 111.123 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 97.62 64.25 0.89 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.781 -0.723 . . . . 15.0 112.251 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.606 ' HB1' ' CG ' ' A' ' 73' ' ' GLN . . . -173.03 166.85 5.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.916 0.389 . . . . 15.0 111.148 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.435 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 15.3 p -93.49 -172.63 2.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.18 -0.463 . . . . 15.0 111.301 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.621 ' CE1' HG23 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -63.57 -59.07 5.09 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.72 -0.673 . . . . 15.0 110.557 179.816 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 9.4 ttpp -52.36 -31.2 32.53 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.868 -0.606 . . . . 15.0 110.627 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.606 ' CG ' ' HB1' ' A' ' 69' ' ' ALA . 0.0 OUTLIER -59.3 -53.77 54.42 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.239 -0.437 . . . . 15.0 109.932 179.444 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.675 ' HA ' HD21 ' A' ' 66' ' ' LEU . . . -66.78 -43.91 82.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.173 -0.467 . . . . 15.0 109.86 178.734 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.919 HG23 HG21 ' A' ' 22' ' ' VAL . 0.5 OUTLIER -42.37 -41.79 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.225 0 N-CA-C 109.129 -0.693 . . . . 15.0 109.129 178.376 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -67.46 -44.54 78.36 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 114.875 -1.057 . . . . 15.0 110.289 178.458 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.663 ' O ' HG11 ' A' ' 61' ' ' VAL . 69.0 p -64.09 -54.27 36.58 Favored 'General case' 0 N--CA 1.461 0.117 0 C-N-CA 121.161 -0.215 . . . . 15.0 111.508 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.562 HD21 HG21 ' A' ' 58' ' ' VAL . 7.6 mt -53.55 -47.88 69.61 Favored 'General case' 0 CA--C 1.518 -0.25 0 CA-C-O 121.313 0.578 . . . . 15.0 109.867 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.404 ' HB2' ' O ' ' A' ' 75' ' ' VAL . 11.1 ttp85 -68.42 -59.95 2.79 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.242 -0.89 . . . . 15.0 110.651 179.484 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -66.06 58.52 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.865 -0.607 . . . . 15.0 112.498 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.638 HG22 ' OD1' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -95.57 -71.46 0.67 Allowed 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.89 -0.411 . . . . 15.0 109.89 178.872 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 121.11 -104.15 0.94 Allowed Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.703 -0.76 . . . . 15.0 113.344 178.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.401 ' O ' ' HB3' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -64.67 -82.77 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 112.104 0.409 . . . . 15.0 112.104 -178.943 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.441 HG12 ' N ' ' A' ' 85' ' ' VAL . 75.6 t -109.79 158.66 9.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.107 0.479 . . . . 15.0 111.232 -179.114 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.675 ' O ' HG12 ' A' ' 85' ' ' VAL . 6.7 t -97.79 82.03 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.992 -0.549 . . . . 15.0 110.498 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -99.06 82.18 2.7 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.76 -0.655 . . . . 15.0 110.291 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.812 ' HB3' HD21 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -103.97 118.74 37.4 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.046 -0.524 . . . . 15.0 112.061 -178.988 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.727 HD12 ' HB3' ' A' ' 8' ' ' GLU . 0.2 OUTLIER -95.46 101.4 13.11 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.111 -0.7 . . . . 15.0 109.111 178.252 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.812 HD21 ' HB3' ' A' ' 87' ' ' LEU . 0.2 OUTLIER -104.11 -164.91 1.1 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.439 0.638 . . . . 15.0 112.094 -178.312 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.467 ' HA ' ' HA ' ' A' ' 6' ' ' ILE . 2.3 tt0 -139.37 139.84 37.31 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.999 -1.0 . . . . 15.0 109.817 179.205 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 6.7 tptt -52.11 102.04 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.009 0.433 . . . . 15.0 111.06 -179.665 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -72.17 135.54 22.76 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.973 -0.632 . . . . 15.0 112.784 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -86.38 176.01 8.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.801 0.334 . . . . 15.0 110.787 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -90.18 165.48 23.73 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.205 -0.452 . . . . 15.0 110.9 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_exo -51.43 -58.6 1.53 Allowed 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.583 2.189 . . . . 15.0 112.269 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.7 t . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.195 -0.907 . . . . 15.0 110.912 179.959 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo . . . . . 0 N--CA 1.488 1.168 0 CA-C-O 120.941 0.309 . . . . 15.0 111.821 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -155.27 146.4 16.58 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.16 -0.473 . . . . 15.0 110.795 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -69.06 -166.77 0.17 Allowed 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.431 2.087 . . . . 15.0 112.162 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 84.67 -15.34 42.35 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.452 -0.88 . . . . 15.0 112.344 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -62.04 151.34 35.62 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 121.111 0.481 . . . . 15.0 110.518 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.455 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 1.1 mp -104.34 146.07 12.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.672 -0.694 . . . . 15.0 111.324 -179.226 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.749 ' CE1' HD12 ' A' ' 89' ' ' LEU . 6.0 p90 -140.29 152.02 45.55 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.902 -0.59 . . . . 15.0 110.193 178.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.741 ' HB2' HD12 ' A' ' 88' ' ' LEU . 1.4 pm0 -120.93 143.06 49.17 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.373 0.606 . . . . 15.0 111.713 -179.22 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.559 ' CG1' HD11 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -101.47 115.51 43.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.119 -0.946 . . . . 15.0 109.558 178.948 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -106.18 74.33 1.03 Allowed 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 112.321 0.489 . . . . 15.0 112.321 -178.68 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.66 HD13 ' HG3' ' A' ' 51' ' ' ARG . 6.7 tp -88.11 164.84 15.51 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.339 -0.615 . . . . 15.0 109.339 178.466 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -96.33 97.72 9.71 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.047 0.451 . . . . 15.0 111.379 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.607 ' CB ' HG23 ' A' ' 85' ' ' VAL . 0.0 OUTLIER -64.23 -34.08 77.29 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.77 -0.65 . . . . 15.0 111.064 179.948 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.455 ' N ' ' O ' ' A' ' 83' ' ' GLN . 2.1 t30 -84.94 62.57 7.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.194 -0.457 . . . . 15.0 110.813 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 13.0 t0 179.81 -38.27 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.721 -0.672 . . . . 15.0 110.199 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.494 ' HB3' ' HB2' ' A' ' 45' ' ' ALA . 11.1 t30 -164.93 149.73 9.32 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.628 -0.714 . . . . 15.0 110.291 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.743 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 0.5 OUTLIER -85.85 -171.47 3.6 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.422 -0.354 . . . . 15.0 110.573 179.966 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.64 ' N ' HD22 ' A' ' 18' ' ' LEU . 1.9 mm? -88.67 -174.65 4.63 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.225 -0.443 . . . . 15.0 110.612 179.479 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.761 ' O ' ' HB ' ' A' ' 41' ' ' ILE . . . -160.88 43.53 0.41 Allowed Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.939 -0.648 . . . . 15.0 111.698 -179.825 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.687 HG12 ' O ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -112.78 138.46 41.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 120.948 0.404 . . . . 15.0 111.615 -179.453 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.441 ' H ' HD13 ' A' ' 41' ' ' ILE . 31.4 t -91.73 103.5 16.06 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 107.813 -1.18 . . . . 15.0 107.813 177.443 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.978 HG21 HG23 ' A' ' 75' ' ' VAL . 32.8 m -93.72 154.42 3.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 113.079 0.77 . . . . 15.0 113.079 -177.012 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.29 -175.22 4.9 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.132 -0.94 . . . . 15.0 110.72 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.533 ' O ' HG22 ' A' ' 26' ' ' VAL . . . 68.67 -119.88 10.54 Favored Glycine 0 C--N 1.332 0.306 0 C-N-CA 120.829 -0.701 . . . . 15.0 112.424 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.533 ' HA3' ' N ' ' A' ' 71' ' ' HIS . . . 68.12 -64.21 0.37 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.876 -0.678 . . . . 15.0 113.525 179.4 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.533 HG22 ' O ' ' A' ' 24' ' ' GLY . 0.0 OUTLIER -30.63 138.58 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 N-CA-C 112.337 0.495 . . . . 15.0 112.337 -179.323 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 28.3 p30 -75.55 62.72 1.44 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.897 -0.592 . . . . 15.0 111.012 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.0 m -151.7 -50.76 0.12 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.277 -0.42 . . . . 15.0 111.106 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -87.65 -40.54 14.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.232 -0.44 . . . . 15.0 111.192 -179.703 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.506 HG22 ' O ' ' A' ' 26' ' ' VAL . 31.1 m -72.62 -174.9 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.317 -0.402 . . . . 15.0 111.366 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 2.1 ttm180 -60.31 -40.78 91.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.2 -0.455 . . . . 15.0 111.239 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -163.9 -46.76 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.688 -0.233 . . . . 15.0 111.515 179.799 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -170.22 19.96 0.07 OUTLIER Glycine 0 CA--C 1.519 0.288 0 C-N-CA 120.649 -0.786 . . . . 15.0 112.979 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.405 ' O ' HG11 ' A' ' 30' ' ' VAL . . . -89.76 153.85 23.48 Favored Glycine 0 N--CA 1.45 -0.385 0 N-CA-C 111.005 -0.838 . . . . 15.0 111.005 179.018 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.831 HG22 HG22 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -89.13 155.62 3.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 117.478 0.639 . . . . 15.0 111.773 -179.396 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.47 ' CE2' ' HG2' ' A' ' 57' ' ' ARG . 29.5 m-85 -140.19 106.75 5.32 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.082 -0.963 . . . . 15.0 109.804 179.023 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.793 HG22 ' N ' ' A' ' 55' ' ' GLY . 0.6 OUTLIER -55.35 147.05 4.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.913 -0.585 . . . . 15.0 111.361 -178.956 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.459 ' O ' ' HG2' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -80.35 -48.61 12.68 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.449 -0.945 . . . . 15.0 108.449 178.379 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.687 ' O ' HG12 ' A' ' 20' ' ' ILE . . . -172.2 173.95 4.12 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 115.416 -0.811 . . . . 15.0 110.142 178.704 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.575 ' HA ' HG12 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -97.03 110.09 24.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 109.657 -0.498 . . . . 15.0 109.657 179.295 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.761 ' HB ' ' O ' ' A' ' 19' ' ' GLY . 0.6 OUTLIER -78.4 116.48 59.57 Favored Pre-proline 0 C--N 1.328 -0.333 0 N-CA-C 113.39 0.885 . . . . 15.0 113.39 -177.518 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.621 ' HA ' ' CG ' ' A' ' 47' ' ' GLU . 35.2 Cg_exo -62.01 59.94 0.13 Allowed 'Trans proline' 0 C--N 1.357 1.02 0 C-N-CA 123.663 2.909 . . . . 15.0 113.064 179.728 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.538 ' N ' ' HG2' ' A' ' 47' ' ' GLU . 0.6 OUTLIER -147.53 -47.69 0.17 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.642 0.258 . . . . 15.0 111.579 179.913 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.725 ' HA3' ' HA3' ' A' ' 19' ' ' GLY . . . -87.86 168.81 37.94 Favored Glycine 0 C--N 1.331 0.279 0 C-N-CA 120.393 -0.908 . . . . 15.0 114.047 -179.022 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.743 ' HB3' ' O ' ' A' ' 17' ' ' SER . . . -57.51 -13.72 4.09 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.592 0.59 . . . . 15.0 112.592 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.11 -57.72 4.03 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.712 0.291 . . . . 15.0 110.797 -179.714 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.621 ' CG ' ' HA ' ' A' ' 42' ' ' PRO . 2.9 pp20? -57.57 -42.37 82.96 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.77 -0.65 . . . . 15.0 110.381 179.276 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -53.76 -71.49 0.07 Allowed 'General case' 0 CA--C 1.519 -0.241 0 CA-C-N 115.814 -0.63 . . . . 15.0 110.486 -179.404 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.581 ' HB2' HD11 ' A' ' 11' ' ' LEU . 0.2 OUTLIER -58.36 -41.15 84.09 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.125 -0.694 . . . . 15.0 109.125 178.801 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.78 40.46 12.15 Favored Glycine 0 N--CA 1.446 -0.643 0 CA-C-N 115.416 -0.811 . . . . 15.0 111.726 179.365 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.66 ' HG3' HD13 ' A' ' 11' ' ' LEU . 0.6 OUTLIER -79.92 -48.19 13.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.907 0.384 . . . . 15.0 110.726 -179.402 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.595 ' CG1' HD12 ' A' ' 20' ' ' ILE . 9.4 tp -81.11 162.07 3.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.037 -0.528 . . . . 15.0 110.275 179.56 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' HIS . . . . . 0.475 ' N ' ' OD2' ' A' ' 56' ' ' ASP . 78.8 m80 -147.51 157.63 43.65 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-O 121.61 0.719 . . . . 15.0 112.021 -179.073 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.558 ' HA ' ' CG2' ' A' ' 37' ' ' VAL . 0.1 OUTLIER -42.4 132.2 3.55 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.327 -1.306 . . . . 15.0 113.027 -178.564 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.793 ' N ' HG22 ' A' ' 37' ' ' VAL . . . 50.35 30.31 18.29 Favored Glycine 0 C--N 1.333 0.416 0 CA-C-N 115.672 -0.694 . . . . 15.0 113.4 179.235 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.475 ' OD2' ' N ' ' A' ' 53' ' ' HIS . 16.8 m-20 -65.87 129.59 40.33 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.716 -0.394 . . . . 15.0 110.58 179.521 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.47 ' HG2' ' CE2' ' A' ' 36' ' ' TYR . 15.8 mtt-85 -80.85 96.84 7.13 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.229 -0.441 . . . . 15.0 110.846 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.831 HG22 HG22 ' A' ' 35' ' ' ILE . 1.4 m -86.96 114.02 25.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.079 0.466 . . . . 15.0 110.749 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 21.5 mt -107.02 -16.42 14.44 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.799 -0.637 . . . . 15.0 112.397 -179.05 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.79 ' HB3' ' HB2' ' A' ' 88' ' ' LEU . . . -148.13 147.67 29.75 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.509 0.559 . . . . 15.0 112.509 -178.887 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.863 HG11 ' O ' ' A' ' 77' ' ' THR . 21.4 t -139.03 101.12 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.316 -0.856 . . . . 15.0 109.16 178.826 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.535 ' OD1' HG22 ' A' ' 81' ' ' THR . 2.5 m120 65.14 15.98 10.3 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.72 -0.474 . . . . 15.0 109.72 -177.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 107.07 4.58 35.73 Favored Glycine 0 C--N 1.337 0.598 0 CA-C-N 115.969 -0.56 . . . . 15.0 113.469 179.672 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.644 HG13 ' O ' ' A' ' 64' ' ' VAL . 5.4 p -93.9 108.4 20.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 117.122 0.461 . . . . 15.0 111.164 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 61.5 m -56.87 138.14 54.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.296 -0.411 . . . . 15.0 110.996 -179.812 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.912 HD11 ' HB2' ' A' ' 74' ' ' ALA . 0.2 OUTLIER -97.75 -21.88 16.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.063 -0.517 . . . . 15.0 111.085 -179.903 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -46.53 106.17 0.08 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.361 -0.381 . . . . 15.0 111.21 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 104.33 62.16 0.67 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.808 -0.711 . . . . 15.0 112.453 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.666 ' HB1' ' CB ' ' A' ' 73' ' ' GLN . . . -173.18 163.48 4.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.86 0.362 . . . . 15.0 111.086 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.46 ' HB ' HG13 ' A' ' 26' ' ' VAL . 1.7 p -92.33 -171.96 2.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.457 . . . . 15.0 110.983 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.732 ' CE1' HG23 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -62.19 -59.45 5.03 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.844 -0.616 . . . . 15.0 110.458 179.949 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.41 ' O ' HG12 ' A' ' 75' ' ' VAL . 24.9 ttpp -52.68 -34.29 51.23 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.768 -0.651 . . . . 15.0 110.836 179.612 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.666 ' CB ' ' HB1' ' A' ' 69' ' ' ALA . 3.2 mt-30 -59.28 -50.77 72.7 Favored 'General case' 0 CA--C 1.518 -0.272 0 N-CA-C 109.527 -0.546 . . . . 15.0 109.527 179.35 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.912 ' HB2' HD11 ' A' ' 66' ' ' LEU . . . -66.29 -45.42 80.47 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.69 -0.687 . . . . 15.0 109.672 178.519 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.978 HG23 HG21 ' A' ' 22' ' ' VAL . 0.5 OUTLIER -43.15 -40.51 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.243 0 N-CA-C 108.976 -0.749 . . . . 15.0 108.976 178.243 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -67.26 -44.96 78.08 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 114.871 -1.058 . . . . 15.0 110.076 178.405 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.863 ' O ' HG11 ' A' ' 61' ' ' VAL . 41.2 p -64.3 -53.41 49.29 Favored 'General case' 0 N--CA 1.461 0.098 0 CA-C-O 120.572 0.225 . . . . 15.0 111.318 179.606 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.718 HD21 HG21 ' A' ' 58' ' ' VAL . 6.1 mt -53.42 -48.86 68.35 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 121.245 0.545 . . . . 15.0 109.97 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.413 ' O ' ' N ' ' A' ' 81' ' ' THR . 0.2 OUTLIER -68.38 -59.05 3.46 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.317 -0.856 . . . . 15.0 110.665 179.502 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -65.88 62.9 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.946 -0.57 . . . . 15.0 111.931 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.535 HG22 ' OD1' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -91.7 -70.87 0.67 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.785 0.326 . . . . 15.0 110.302 179.425 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 122.28 -109.97 1.52 Allowed Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.978 -0.63 . . . . 15.0 112.852 179.377 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.455 ' O ' ' N ' ' A' ' 14' ' ' ASN . 0.8 OUTLIER -65.25 -77.88 0.06 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.884 0.373 . . . . 15.0 111.438 -179.437 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.44 HG12 ' N ' ' A' ' 85' ' ' VAL . 51.0 t -110.26 159.07 10.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.198 -0.455 . . . . 15.0 110.678 -179.729 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.655 ' O ' HG12 ' A' ' 85' ' ' VAL . 19.7 t -98.12 79.92 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.051 0.453 . . . . 15.0 110.429 179.648 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 3.0 t60 -100.51 84.22 2.73 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.842 -0.617 . . . . 15.0 110.426 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.794 ' HB3' HD21 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -101.45 117.53 35.13 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.003 -0.544 . . . . 15.0 111.655 -179.325 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.79 ' HB2' ' HB3' ' A' ' 60' ' ' ALA . 4.3 mp -92.87 100.23 12.74 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.807 -0.442 . . . . 15.0 109.807 179.038 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.794 HD21 ' HB3' ' A' ' 87' ' ' LEU . 0.2 OUTLIER -103.88 -162.83 0.93 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.92 -0.582 . . . . 15.0 111.655 -178.871 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.455 ' HA ' ' HA ' ' A' ' 6' ' ' ILE . 3.8 tt0 -139.09 148.18 42.97 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.259 -0.882 . . . . 15.0 110.056 179.285 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.04 113.41 1.69 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.298 -0.41 . . . . 15.0 111.136 -179.637 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -71.34 88.31 0.42 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.879 -0.677 . . . . 15.0 112.722 -179.741 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -86.42 139.93 30.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.773 0.32 . . . . 15.0 110.748 179.789 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -60.19 136.13 91.14 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.276 -0.42 . . . . 15.0 110.887 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -53.47 109.19 0.33 Allowed 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.467 2.111 . . . . 15.0 112.274 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 39.6 p . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.259 -0.877 . . . . 15.0 110.941 179.969 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_endo . . . . . 0 N--CA 1.488 1.158 0 CA-C-O 120.809 0.254 . . . . 15.0 111.78 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.11 144.2 16.51 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.225 -0.443 . . . . 15.0 110.901 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.73 -161.78 0.09 OUTLIER 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.584 2.189 . . . . 15.0 112.305 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 90.57 -23.67 21.21 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.612 -0.804 . . . . 15.0 112.27 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 58.7 m-20 -62.18 145.64 52.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.241 0.543 . . . . 15.0 110.827 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.459 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 1.4 mp -104.38 142.52 17.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.281 -0.872 . . . . 15.0 111.101 -179.356 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.682 ' CZ ' HD12 ' A' ' 89' ' ' LEU . 3.4 p90 -140.66 163.33 33.18 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.185 -0.461 . . . . 15.0 110.574 178.741 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.737 ' HB2' HD12 ' A' ' 88' ' ' LEU . 10.2 pt-20 -129.04 143.6 50.92 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.204 0.526 . . . . 15.0 111.466 -179.364 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.499 ' CG1' HD11 ' A' ' 89' ' ' LEU . 0.3 OUTLIER -101.54 115.7 43.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.335 -0.848 . . . . 15.0 109.818 178.969 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -105.98 70.54 0.86 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.154 -0.475 . . . . 15.0 111.727 -179.202 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.77 HD13 ' CG ' ' A' ' 51' ' ' ARG . 4.9 tp -88.05 165.74 14.94 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.117 -0.492 . . . . 15.0 110.064 179.167 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -95.71 94.43 7.69 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.919 0.39 . . . . 15.0 111.125 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.674 ' CB ' HG23 ' A' ' 85' ' ' VAL . 0.2 OUTLIER -54.08 -28.22 37.79 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.96 -0.564 . . . . 15.0 111.095 179.962 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.449 ' O ' ' CB ' ' A' ' 15' ' ' ASP . 25.0 m-20 -84.5 154.96 22.39 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.252 -0.431 . . . . 15.0 110.596 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.449 ' CB ' ' O ' ' A' ' 14' ' ' ASN . 10.0 t0 84.02 -42.93 0.08 Allowed 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.217 -0.447 . . . . 15.0 110.794 -179.343 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.513 ' HB3' ' HB2' ' A' ' 45' ' ' ALA . 1.0 OUTLIER -155.09 145.34 21.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.326 -0.397 . . . . 15.0 110.37 179.687 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.762 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 0.0 OUTLIER -86.04 -164.41 1.03 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.369 -0.378 . . . . 15.0 110.873 -179.677 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.649 ' N ' HD22 ' A' ' 18' ' ' LEU . 1.3 mm? -93.3 -170.64 2.44 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.167 -0.47 . . . . 15.0 110.736 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.773 ' O ' ' HB ' ' A' ' 41' ' ' ILE . . . -169.02 43.67 0.22 Allowed Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.72 -0.752 . . . . 15.0 112.314 -179.709 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.707 HD12 ' HB ' ' A' ' 52' ' ' ILE . 0.0 OUTLIER -112.72 139.39 37.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 120.928 0.394 . . . . 15.0 111.516 -179.806 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.401 ' HB3' HD11 ' A' ' 41' ' ' ILE . 18.3 t -96.23 105.41 17.46 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.572 -0.899 . . . . 15.0 108.572 178.004 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.804 ' CG2' HG23 ' A' ' 75' ' ' VAL . 5.7 m -93.94 155.21 3.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 112.722 0.638 . . . . 15.0 112.722 -177.511 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.657 ' O ' ' O ' ' A' ' 36' ' ' TYR . 0.2 OUTLIER -149.68 153.28 36.72 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.627 -0.715 . . . . 15.0 111.463 -179.7 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.418 ' O ' HG12 ' A' ' 35' ' ' ILE . . . 67.5 121.53 0.02 OUTLIER Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.484 -0.865 . . . . 15.0 113.351 178.648 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.523 ' HA3' ' N ' ' A' ' 71' ' ' HIS . . . -166.3 -39.3 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.962 -0.637 . . . . 15.0 112.455 179.27 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.553 ' O ' HG22 ' A' ' 30' ' ' VAL . 0.1 OUTLIER -40.46 161.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 CA-C-O 120.849 0.357 . . . . 15.0 111.645 179.87 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.434 ' ND2' ' O ' ' A' ' 32' ' ' HIS . 6.6 m120 -85.84 52.51 2.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.22 -0.445 . . . . 15.0 110.952 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.4 m -151.71 -58.23 0.15 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.195 -0.457 . . . . 15.0 110.8 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.4 m -68.91 -51.76 36.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 15.0 110.847 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.673 HG21 ' O ' ' A' ' 34' ' ' GLY . 17.5 m -87.99 -169.08 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.166 -0.47 . . . . 15.0 110.934 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 4.3 mmt180 -93.41 125.67 38.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.937 0.399 . . . . 15.0 111.073 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' HIS . . . . . 0.434 ' O ' ' ND2' ' A' ' 27' ' ' ASN . 74.6 m80 61.67 -80.61 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.945 -0.571 . . . . 15.0 111.52 179.605 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -175.25 34.59 0.1 OUTLIER Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.9 -0.667 . . . . 15.0 112.422 -179.472 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.673 ' O ' HG21 ' A' ' 30' ' ' VAL . . . -95.15 158.24 22.3 Favored Glycine 0 N--CA 1.449 -0.487 0 N-CA-C 110.659 -0.976 . . . . 15.0 110.659 179.027 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 1.051 HG22 HG22 ' A' ' 58' ' ' VAL . 0.1 OUTLIER -101.12 153.11 4.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 C-N-CA 119.852 -0.739 . . . . 15.0 112.058 -179.326 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.657 ' O ' ' O ' ' A' ' 23' ' ' THR . 11.7 m-85 -133.22 108.29 8.68 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.13 -0.941 . . . . 15.0 109.308 179.343 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.705 HG22 ' N ' ' A' ' 55' ' ' GLY . 0.7 OUTLIER -54.84 169.61 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 C-N-CA 120.359 -0.536 . . . . 15.0 111.113 -178.33 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.77 -49.22 4.23 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.806 -0.813 . . . . 15.0 108.806 178.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.707 ' O ' HG12 ' A' ' 20' ' ' ILE . . . -171.96 173.13 4.52 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 115.523 -0.762 . . . . 15.0 110.054 179.03 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.533 ' HA ' ' CG1' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -96.42 103.3 14.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 109.244 -0.65 . . . . 15.0 109.244 179.15 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.773 ' HB ' ' O ' ' A' ' 19' ' ' GLY . 0.6 OUTLIER -69.13 115.74 34.88 Favored Pre-proline 0 C--N 1.328 -0.353 0 N-CA-C 113.376 0.88 . . . . 15.0 113.376 -177.066 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.591 ' HA ' ' HG2' ' A' ' 47' ' ' GLU . 37.5 Cg_exo -61.16 62.01 0.1 OUTLIER 'Trans proline' 0 C--N 1.358 1.038 0 C-N-CA 123.655 2.903 . . . . 15.0 112.951 179.72 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.515 ' HB2' HG22 ' A' ' 41' ' ' ILE . 7.3 mt-30 -150.55 -48.6 0.13 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.635 0.255 . . . . 15.0 111.524 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.751 ' HA3' ' HA3' ' A' ' 19' ' ' GLY . . . -87.73 167.82 37.16 Favored Glycine 0 C--N 1.33 0.232 0 C-N-CA 120.387 -0.911 . . . . 15.0 113.861 -179.128 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.762 ' HB3' ' O ' ' A' ' 17' ' ' SER . . . -58.5 -13.52 5.77 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.087 -0.556 . . . . 15.0 112.43 -179.797 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.16 -56.74 5.06 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.696 0.284 . . . . 15.0 110.784 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.591 ' HG2' ' HA ' ' A' ' 42' ' ' PRO . 2.8 pp20? -57.59 -41.99 82.3 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.059 -0.519 . . . . 15.0 110.502 179.239 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -53.55 -69.54 0.12 Allowed 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 115.769 -0.651 . . . . 15.0 110.567 -179.25 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.665 ' CB ' HD11 ' A' ' 11' ' ' LEU . 0.1 OUTLIER -60.25 -41.25 92.81 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.149 -0.685 . . . . 15.0 109.149 178.867 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.8 46.47 7.18 Favored Glycine 0 N--CA 1.446 -0.663 0 CA-C-N 115.436 -0.802 . . . . 15.0 111.866 179.395 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.77 ' CG ' HD13 ' A' ' 11' ' ' LEU . 0.9 OUTLIER -79.78 -44.77 20.03 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.695 0.283 . . . . 15.0 110.969 -179.285 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.707 ' HB ' HD12 ' A' ' 20' ' ' ILE . 3.5 mm -91.42 160.92 2.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.055 0.455 . . . . 15.0 111.187 179.838 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' HIS . . . . . 0.57 ' N ' HG22 ' A' ' 52' ' ' ILE . 75.9 m80 -140.52 148.92 41.78 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-N 115.741 -0.663 . . . . 15.0 110.438 179.52 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.568 ' HA ' ' CG2' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -36.23 133.76 0.47 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.935 -1.03 . . . . 15.0 112.575 -178.237 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.705 ' N ' HG22 ' A' ' 37' ' ' VAL . . . 55.14 33.0 57.3 Favored Glycine 0 N--CA 1.453 -0.2 0 CA-C-N 115.309 -0.86 . . . . 15.0 113.707 179.5 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -66.13 127.75 33.36 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 117.603 0.701 . . . . 15.0 110.541 179.217 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.572 ' NH1' HD11 ' A' ' 59' ' ' LEU . 50.8 ttt-85 -80.71 86.6 5.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.464 -0.335 . . . . 15.0 110.529 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 1.051 HG22 HG22 ' A' ' 35' ' ' ILE . 1.3 m -79.95 115.3 22.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 CA-C-O 121.174 0.512 . . . . 15.0 111.173 -179.588 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.572 HD11 ' NH1' ' A' ' 57' ' ' ARG . 20.4 mt -107.43 -12.73 15.25 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 115.432 -0.804 . . . . 15.0 112.165 -179.41 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.864 ' HB3' ' HB2' ' A' ' 88' ' ' LEU . . . -150.06 144.6 25.87 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.202 0.525 . . . . 15.0 112.388 -178.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.832 HG11 ' O ' ' A' ' 77' ' ' THR . 44.9 t -139.04 101.73 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.452 -0.795 . . . . 15.0 109.457 178.864 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.71 ' OD1' HG22 ' A' ' 81' ' ' THR . 2.4 m120 64.87 15.87 10.15 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.822 -0.436 . . . . 15.0 109.822 -178.327 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 107.08 5.75 34.87 Favored Glycine 0 C--N 1.335 0.512 0 CA-C-N 115.956 -0.566 . . . . 15.0 113.469 179.683 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.654 HG13 ' O ' ' A' ' 64' ' ' VAL . 5.8 p -93.85 105.49 16.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 117.275 0.537 . . . . 15.0 110.949 179.405 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 72.3 m -58.41 131.75 51.65 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.122 -0.49 . . . . 15.0 110.936 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.464 HD11 ' HB2' ' A' ' 74' ' ' ALA . 0.2 OUTLIER -87.65 -18.93 28.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.015 -0.539 . . . . 15.0 110.91 179.942 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -48.23 95.07 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.876 0.37 . . . . 15.0 110.858 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.66 66.82 0.59 Allowed Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.81 -0.709 . . . . 15.0 111.96 -179.458 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.615 ' HB1' ' CG ' ' A' ' 73' ' ' GLN . . . -172.73 161.9 4.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.915 0.388 . . . . 15.0 110.9 -179.646 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.489 ' HB ' HG13 ' A' ' 26' ' ' VAL . 8.3 p -93.19 -173.68 3.32 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.188 -0.46 . . . . 15.0 111.436 -179.562 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.585 ' CE1' HG23 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -62.38 -60.76 3.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.832 -0.622 . . . . 15.0 110.39 -179.967 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.418 ' O ' ' HG3' ' A' ' 76' ' ' GLU . 17.7 ttpp -52.54 -30.69 31.94 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.746 -0.661 . . . . 15.0 110.442 179.36 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.615 ' CG ' ' HB1' ' A' ' 69' ' ' ALA . 0.9 OUTLIER -59.39 -51.43 69.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.072 -0.513 . . . . 15.0 110.075 179.567 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.479 ' O ' ' HG ' ' A' ' 78' ' ' LEU . . . -66.94 -45.23 78.44 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 109.717 -0.475 . . . . 15.0 109.717 178.773 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.804 HG23 ' CG2' ' A' ' 22' ' ' VAL . 0.5 OUTLIER -42.65 -43.14 1.11 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.269 0 N-CA-C 108.946 -0.761 . . . . 15.0 108.946 178.167 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.418 ' HG3' ' O ' ' A' ' 72' ' ' LYS . 24.3 mt-10 -67.42 -44.02 79.79 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 114.925 -1.034 . . . . 15.0 110.005 178.267 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.832 ' O ' HG11 ' A' ' 61' ' ' VAL . 72.0 p -64.2 -54.18 37.58 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 116.744 -0.207 . . . . 15.0 111.397 179.718 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.776 HD21 HG21 ' A' ' 58' ' ' VAL . 6.6 mt -53.28 -49.03 67.79 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-O 121.277 0.56 . . . . 15.0 109.947 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.407 ' O ' ' N ' ' A' ' 81' ' ' THR . 4.3 ttp180 -68.51 -59.87 2.84 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.322 -0.854 . . . . 15.0 110.699 179.508 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.412 ' CB ' ' O ' ' A' ' 76' ' ' GLU . 43.4 m-20 -66.0 62.28 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.024 -0.535 . . . . 15.0 112.057 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.71 HG22 ' OD1' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -93.8 -68.68 0.79 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.83 0.348 . . . . 15.0 110.077 179.044 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 122.09 -109.85 1.51 Allowed Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 120.957 -0.64 . . . . 15.0 112.874 179.211 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -65.47 -77.26 0.06 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.52 -0.34 . . . . 15.0 111.701 -179.314 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.433 HG12 ' N ' ' A' ' 85' ' ' VAL . 55.8 t -110.17 157.68 10.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.174 -0.466 . . . . 15.0 111.295 -179.4 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.676 ' O ' HG12 ' A' ' 85' ' ' VAL . 8.6 t -98.0 81.16 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.026 -0.534 . . . . 15.0 110.48 179.772 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -100.43 86.08 3.1 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.796 -0.638 . . . . 15.0 110.506 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.731 ' HB3' HD21 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -103.86 126.03 50.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.058 -0.519 . . . . 15.0 111.807 -179.265 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.864 ' HB2' ' HB3' ' A' ' 60' ' ' ALA . 4.9 mp -101.64 101.59 12.15 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.305 -0.628 . . . . 15.0 109.305 178.536 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.731 HD21 ' HB3' ' A' ' 87' ' ' LEU . 0.1 OUTLIER -105.66 -165.19 1.09 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.502 0.667 . . . . 15.0 112.089 -178.448 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.459 ' HA ' ' HA ' ' A' ' 6' ' ' ILE . 1.0 OUTLIER -140.12 136.23 33.33 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.873 -1.058 . . . . 15.0 109.619 178.97 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 10.2 tppt? -46.89 103.63 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.93 0.395 . . . . 15.0 111.293 -179.545 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -64.06 151.65 49.56 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.866 -0.683 . . . . 15.0 112.565 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -86.19 99.2 11.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.752 0.311 . . . . 15.0 110.842 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -89.37 162.82 35.84 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.211 -0.45 . . . . 15.0 110.878 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_exo -51.45 -26.77 22.46 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.535 2.157 . . . . 15.0 112.368 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 21.6 p . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.238 -0.886 . . . . 15.0 110.86 179.987 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_endo . . . . . 0 N--CA 1.488 1.192 0 CA-C-O 120.878 0.282 . . . . 15.0 111.816 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 3.3 mtmp? -155.17 89.26 3.07 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.183 -0.462 . . . . 15.0 110.935 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.44 ' HD2' ' CB ' ' A' ' 93' ' ' GLN . 71.6 Cg_exo -49.19 -62.03 0.49 Allowed 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.632 2.221 . . . . 15.0 112.457 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 88.19 -20.67 28.44 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.502 -0.856 . . . . 15.0 112.677 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -61.88 155.1 24.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.299 0.571 . . . . 15.0 110.934 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.45 HG13 ' HB2' ' A' ' 90' ' ' GLU . 1.4 mp -103.03 144.47 13.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.185 -0.916 . . . . 15.0 111.099 -179.257 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.524 ' CZ ' HD12 ' A' ' 89' ' ' LEU . 2.2 p90 -140.59 163.75 32.03 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.318 -0.401 . . . . 15.0 110.561 178.81 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.759 ' HB2' HD12 ' A' ' 88' ' ' LEU . 11.0 pt-20 -128.97 143.05 50.76 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.257 0.551 . . . . 15.0 111.424 -179.453 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.489 ' CG1' HD11 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -101.44 114.6 41.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.227 -0.897 . . . . 15.0 109.572 178.924 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -106.09 72.42 0.94 Allowed 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 112.397 0.518 . . . . 15.0 112.397 -178.647 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.938 HD13 ' HG3' ' A' ' 51' ' ' ARG . 6.5 tp -88.35 166.7 14.1 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.517 -0.549 . . . . 15.0 109.517 178.554 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -95.97 94.0 7.34 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.961 0.41 . . . . 15.0 111.305 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.713 ' CB ' HG23 ' A' ' 85' ' ' VAL . 0.2 OUTLIER -58.4 -26.38 63.16 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.884 -0.598 . . . . 15.0 111.057 179.838 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -84.06 -34.84 24.13 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.296 -0.411 . . . . 15.0 110.893 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -70.84 -42.76 69.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.005 0.431 . . . . 15.0 110.326 179.507 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.524 ' HB3' ' HB2' ' A' ' 45' ' ' ALA . 0.6 OUTLIER -165.47 163.27 19.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.857 -0.61 . . . . 15.0 110.632 179.789 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.912 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 0.3 OUTLIER -85.87 -162.75 0.77 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.362 -0.381 . . . . 15.0 110.236 179.664 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 9.6 mt -101.14 -168.68 1.59 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.939 0.4 . . . . 15.0 110.763 179.486 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.757 ' O ' ' HB ' ' A' ' 41' ' ' ILE . . . -164.71 40.72 0.3 Allowed Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 121.01 -0.614 . . . . 15.0 111.826 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.625 HD12 ' CG1' ' A' ' 52' ' ' ILE . 0.0 OUTLIER -112.7 138.86 40.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 121.004 0.43 . . . . 15.0 111.773 -179.441 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.455 ' O ' ' HB3' ' A' ' 38' ' ' LYS . 21.1 t -94.49 100.4 12.4 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 107.704 -1.221 . . . . 15.0 107.704 177.282 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.619 ' CG2' HG23 ' A' ' 75' ' ' VAL . 1.4 m -93.79 152.69 3.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 112.463 0.542 . . . . 15.0 112.463 -177.076 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.744 ' HA ' ' CD2' ' A' ' 71' ' ' HIS . 14.8 t -149.29 -174.64 4.71 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.444 -0.798 . . . . 15.0 110.71 179.564 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.652 ' O ' HG22 ' A' ' 26' ' ' VAL . . . 75.18 -115.51 4.66 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 120.721 -0.752 . . . . 15.0 112.153 -179.713 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.544 ' HA3' ' N ' ' A' ' 71' ' ' HIS . . . 64.33 -65.34 0.06 OUTLIER Glycine 0 N--CA 1.453 -0.215 0 C-N-CA 121.015 -0.612 . . . . 15.0 113.841 179.024 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.652 HG22 ' O ' ' A' ' 24' ' ' GLY . 0.0 OUTLIER -30.54 145.13 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 N-CA-C 112.362 0.504 . . . . 15.0 112.362 -179.143 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.446 ' ND2' ' O ' ' A' ' 32' ' ' HIS . 4.8 m120 -79.63 56.25 2.18 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.961 -0.563 . . . . 15.0 111.031 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -151.69 -64.96 0.18 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.234 -0.439 . . . . 15.0 110.641 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.63 -48.23 70.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.11 -0.495 . . . . 15.0 110.559 179.7 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.643 HG22 ' O ' ' A' ' 26' ' ' VAL . 34.5 m -88.09 -171.15 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.024 -0.534 . . . . 15.0 110.77 179.711 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -92.4 127.17 37.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.91 0.386 . . . . 15.0 111.155 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' HIS . . . . . 0.446 ' O ' ' ND2' ' A' ' 27' ' ' ASN . 34.4 m80 58.18 -84.71 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.937 -0.574 . . . . 15.0 111.464 179.683 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -167.7 26.18 0.14 Allowed Glycine 0 C--N 1.331 0.263 0 C-N-CA 120.977 -0.63 . . . . 15.0 112.274 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.41 ' O ' HG21 ' A' ' 30' ' ' VAL . . . -83.83 149.16 25.28 Favored Glycine 0 N--CA 1.448 -0.529 0 N-CA-C 110.769 -0.932 . . . . 15.0 110.769 178.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.8 HG22 HG22 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -88.29 153.45 3.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 117.537 0.669 . . . . 15.0 111.777 -179.165 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.49 ' CZ ' ' HG2' ' A' ' 57' ' ' ARG . 30.7 m-85 -139.76 107.94 5.78 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.026 -0.988 . . . . 15.0 109.732 179.571 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.763 HG22 ' N ' ' A' ' 55' ' ' GLY . 0.8 OUTLIER -55.99 151.29 2.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.046 0.45 . . . . 15.0 111.284 -179.111 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.457 ' O ' ' HG2' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -83.8 -45.3 13.46 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.493 -0.928 . . . . 15.0 108.493 178.29 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.613 ' O ' HG12 ' A' ' 20' ' ' ILE . . . -172.28 172.43 4.5 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 115.853 -0.612 . . . . 15.0 110.32 178.333 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.591 ' HA ' HG12 ' A' ' 20' ' ' ILE . 0.1 OUTLIER -96.86 109.71 23.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.205 -0.665 . . . . 15.0 109.205 179.04 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.757 ' HB ' ' O ' ' A' ' 19' ' ' GLY . 0.5 OUTLIER -78.24 115.29 49.76 Favored Pre-proline 0 C--N 1.327 -0.371 0 N-CA-C 113.51 0.93 . . . . 15.0 113.51 -177.148 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.631 ' HA ' ' CG ' ' A' ' 47' ' ' GLU . 32.8 Cg_exo -62.0 60.58 0.13 Allowed 'Trans proline' 0 C--N 1.357 1.01 0 C-N-CA 123.619 2.879 . . . . 15.0 112.949 179.619 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.528 ' N ' ' HG2' ' A' ' 47' ' ' GLU . 6.0 tt0 -147.33 -48.38 0.18 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.62 0.248 . . . . 15.0 111.345 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.703 ' HA3' ' HA3' ' A' ' 19' ' ' GLY . . . -87.86 169.02 38.16 Favored Glycine 0 C--N 1.33 0.217 0 C-N-CA 120.403 -0.903 . . . . 15.0 113.807 -179.192 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.912 ' HB3' ' O ' ' A' ' 17' ' ' SER . . . -57.91 -13.84 5.17 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.749 0.648 . . . . 15.0 112.749 -179.624 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.9 -56.47 5.64 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.936 -0.306 . . . . 15.0 110.711 -179.59 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.631 ' CG ' ' HA ' ' A' ' 42' ' ' PRO . 2.9 pp20? -57.57 -42.96 84.1 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.992 -0.549 . . . . 15.0 110.322 179.009 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -53.86 -70.75 0.09 Allowed 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 115.828 -0.624 . . . . 15.0 110.567 -179.497 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.426 ' CB ' HD11 ' A' ' 11' ' ' LEU . 0.5 OUTLIER -58.11 -41.18 83.01 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.046 -0.724 . . . . 15.0 109.046 178.872 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.73 40.56 12.12 Favored Glycine 0 N--CA 1.446 -0.655 0 CA-C-N 115.345 -0.843 . . . . 15.0 111.779 179.241 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.938 ' HG3' HD13 ' A' ' 11' ' ' LEU . 2.7 mmp_? -79.78 -50.49 10.48 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.931 0.396 . . . . 15.0 110.644 -179.438 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.625 ' CG1' HD12 ' A' ' 20' ' ' ILE . 9.4 tp -81.1 160.1 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 CA-C-N 115.989 -0.55 . . . . 15.0 110.378 179.543 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' HIS . . . . . 0.459 ' O ' ' HB2' ' A' ' 56' ' ' ASP . 75.7 m80 -145.31 159.01 43.69 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-O 121.599 0.714 . . . . 15.0 112.083 -179.217 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.534 ' HA ' ' CG2' ' A' ' 37' ' ' VAL . 0.1 OUTLIER -42.21 132.91 3.25 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.512 -1.222 . . . . 15.0 112.642 -178.687 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.763 ' N ' HG22 ' A' ' 37' ' ' VAL . . . 49.98 34.24 22.89 Favored Glycine 0 C--N 1.333 0.395 0 CA-C-N 115.761 -0.654 . . . . 15.0 113.425 179.277 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.459 ' HB2' ' O ' ' A' ' 53' ' ' HIS . 0.3 OUTLIER -65.84 132.66 49.21 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.538 -0.465 . . . . 15.0 110.617 179.475 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.797 ' HD2' HD21 ' A' ' 59' ' ' LEU . 0.0 OUTLIER -85.73 92.13 8.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.321 -0.4 . . . . 15.0 110.499 179.664 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.8 HG22 HG22 ' A' ' 35' ' ' ILE . 2.0 m -83.14 114.43 23.9 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 CA-C-O 120.988 0.423 . . . . 15.0 111.143 -179.566 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.797 HD21 ' HD2' ' A' ' 57' ' ' ARG . 3.4 mm? -107.15 -16.39 14.43 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 115.747 -0.66 . . . . 15.0 112.494 -179.236 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.711 ' HB3' ' HB2' ' A' ' 88' ' ' LEU . . . -147.78 146.91 29.35 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.112 0.482 . . . . 15.0 112.222 -178.76 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.902 HG23 HD11 ' A' ' 66' ' ' LEU . 61.5 t -138.78 102.18 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.578 -0.737 . . . . 15.0 109.194 178.869 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.661 ' OD1' HG22 ' A' ' 81' ' ' THR . 2.5 m120 65.07 16.1 10.37 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.103 -0.499 . . . . 15.0 109.763 -178.096 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 105.83 5.18 38.94 Favored Glycine 0 C--N 1.336 0.564 0 CA-C-N 115.821 -0.627 . . . . 15.0 113.247 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.646 HG13 ' O ' ' A' ' 64' ' ' VAL . 5.5 p -93.84 108.3 20.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.983 0.392 . . . . 15.0 110.979 179.6 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 21.4 m -57.99 124.89 20.83 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.204 0.526 . . . . 15.0 110.777 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.902 HD11 HG23 ' A' ' 61' ' ' VAL . 0.3 OUTLIER -87.72 -21.06 25.41 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.444 -0.798 . . . . 15.0 111.327 -179.499 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -46.7 103.6 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.843 0.354 . . . . 15.0 110.986 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.89 63.11 0.54 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.764 -0.731 . . . . 15.0 112.55 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.56 ' HB1' ' CB ' ' A' ' 73' ' ' GLN . . . -172.98 164.64 4.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.835 0.35 . . . . 15.0 111.024 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.534 ' HB ' HG13 ' A' ' 26' ' ' VAL . 5.9 p -93.26 -172.89 3.08 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.067 0.46 . . . . 15.0 111.118 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.744 ' CD2' ' HA ' ' A' ' 23' ' ' THR . 0.0 OUTLIER -62.35 -61.34 2.52 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.733 -0.667 . . . . 15.0 110.212 179.985 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 22.4 ttpp -52.85 -35.68 57.77 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.789 -0.641 . . . . 15.0 110.345 179.358 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.56 ' CB ' ' HB1' ' A' ' 69' ' ' ALA . 4.8 mt-30 -59.68 -48.31 82.19 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.432 -0.581 . . . . 15.0 109.432 179.137 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.494 ' HB3' HG13 ' A' ' 35' ' ' ILE . . . -66.79 -47.87 70.75 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 115.789 -0.641 . . . . 15.0 109.441 178.361 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.619 HG23 ' CG2' ' A' ' 22' ' ' VAL . 0.5 OUTLIER -41.66 -40.26 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.271 0 N-CA-C 108.827 -0.805 . . . . 15.0 108.827 178.203 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.476 ' O ' ' HB2' ' A' ' 80' ' ' ASN . 1.5 mm-40 -67.2 -47.02 72.13 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.734 -1.121 . . . . 15.0 110.509 178.542 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.734 ' O ' HG11 ' A' ' 61' ' ' VAL . 16.5 p -64.08 -53.06 55.69 Favored 'General case' 0 N--CA 1.461 0.117 0 C-N-CA 120.913 -0.315 . . . . 15.0 111.469 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.743 HD23 HG21 ' A' ' 61' ' ' VAL . 3.6 mt -53.44 -47.43 69.68 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.174 0.511 . . . . 15.0 110.047 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.447 ' HB2' ' O ' ' A' ' 75' ' ' VAL . 0.0 OUTLIER -68.64 -57.9 5.03 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.571 -0.741 . . . . 15.0 110.657 179.331 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.476 ' HB2' ' O ' ' A' ' 76' ' ' GLU . 11.9 m-80 -65.92 63.05 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.163 -0.472 . . . . 15.0 111.966 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.661 HG22 ' OD1' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -94.0 -71.95 0.64 Allowed 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 110.096 -0.335 . . . . 15.0 110.096 179.103 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 122.06 -105.22 0.96 Allowed Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.774 -0.727 . . . . 15.0 113.124 179.235 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.415 ' O ' ' HB3' ' A' ' 13' ' ' LYS . 0.1 OUTLIER -64.8 -82.86 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 111.885 0.328 . . . . 15.0 111.885 -179.16 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.453 HG12 ' N ' ' A' ' 85' ' ' VAL . 72.9 t -109.64 159.85 8.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.921 0.391 . . . . 15.0 110.869 -179.508 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.713 HG23 ' CB ' ' A' ' 13' ' ' LYS . 14.9 t -97.76 80.83 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.054 0.454 . . . . 15.0 110.593 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -102.84 85.09 2.48 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.765 -0.652 . . . . 15.0 110.44 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.834 ' HB3' HD21 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -102.42 119.9 39.6 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.948 -0.569 . . . . 15.0 111.742 -179.207 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.759 HD12 ' HB2' ' A' ' 8' ' ' GLU . 4.3 mp -94.52 100.66 12.6 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.773 -0.454 . . . . 15.0 109.773 178.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.834 HD21 ' HB3' ' A' ' 87' ' ' LEU . 0.1 OUTLIER -105.81 -163.53 0.95 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.517 0.675 . . . . 15.0 112.173 -178.531 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.45 ' HB2' HG13 ' A' ' 6' ' ' ILE . 3.4 tt0 -141.36 140.15 33.67 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 114.824 -1.08 . . . . 15.0 109.505 179.02 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 2.7 tptp -55.98 96.66 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.025 0.441 . . . . 15.0 111.014 -179.613 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -72.65 56.04 1.68 Allowed Glycine 0 CA--C 1.518 0.254 0 CA-C-N 115.732 -0.667 . . . . 15.0 113.188 -179.677 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.44 ' CB ' ' HD2' ' A' ' 3' ' ' PRO . 0.0 OUTLIER -86.67 129.9 34.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.749 0.309 . . . . 15.0 110.93 179.754 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -87.4 164.34 35.74 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.298 -0.41 . . . . 15.0 110.78 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -49.82 -25.85 12.61 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.548 2.165 . . . . 15.0 112.3 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.247 -0.882 . . . . 15.0 110.888 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo . . . . . 0 N--CA 1.488 1.179 0 CA-C-O 120.815 0.256 . . . . 15.0 111.689 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 20.9 mtmt -151.35 160.72 31.42 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.161 -0.472 . . . . 15.0 110.912 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -52.85 148.92 27.44 Favored 'Trans proline' 0 CA--C 1.518 -0.3 0 C-N-CA 122.556 2.171 . . . . 15.0 112.487 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 82.39 -25.15 4.5 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.157 -1.02 . . . . 15.0 111.019 -179.52 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -61.96 164.27 6.76 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.268 0.556 . . . . 15.0 110.691 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.419 ' CD1' ' HB2' ' A' ' 90' ' ' GLU . 1.2 mp -102.02 147.54 8.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.344 -0.844 . . . . 15.0 111.244 -179.149 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.79 ' CZ ' HD12 ' A' ' 89' ' ' LEU . 2.1 p90 -140.28 164.32 30.4 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.012 -0.54 . . . . 15.0 110.253 178.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.719 ' CB ' HD12 ' A' ' 88' ' ' LEU . 10.0 pt-20 -130.06 143.96 51.08 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.254 0.55 . . . . 15.0 111.701 -179.33 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.501 ' CG1' HD11 ' A' ' 89' ' ' LEU . 0.3 OUTLIER -101.5 116.99 46.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.327 -0.851 . . . . 15.0 109.815 178.895 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -106.01 70.97 0.87 Allowed 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.278 -0.419 . . . . 15.0 111.854 -179.331 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.819 HD13 ' CG ' ' A' ' 51' ' ' ARG . 6.0 tp -87.83 164.75 15.75 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.124 -0.489 . . . . 15.0 109.853 179.088 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -95.91 94.03 7.38 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.993 0.425 . . . . 15.0 111.346 -179.696 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.687 ' CB ' HG23 ' A' ' 85' ' ' VAL . 0.1 OUTLIER -57.27 -31.96 66.11 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.904 -0.589 . . . . 15.0 110.881 179.872 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.41 ' O ' ' CB ' ' A' ' 15' ' ' ASP . 10.1 t-20 -84.7 140.45 31.28 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.19 -0.459 . . . . 15.0 110.75 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.41 ' CB ' ' O ' ' A' ' 14' ' ' ASN . 4.1 m-20 80.77 -12.53 1.02 Allowed 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.021 -0.536 . . . . 15.0 111.507 -179.715 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.498 ' HB3' ' HB2' ' A' ' 45' ' ' ALA . 5.5 m120 -165.55 136.11 3.71 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.767 0.318 . . . . 15.0 110.677 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.844 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 0.2 OUTLIER -85.97 -159.41 0.46 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.236 -0.438 . . . . 15.0 110.461 179.815 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.658 ' N ' HD22 ' A' ' 18' ' ' LEU . 1.3 mm? -92.67 -168.93 2.07 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 121.019 0.438 . . . . 15.0 110.66 179.55 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.601 ' O ' ' HB ' ' A' ' 41' ' ' ILE . . . -165.78 31.46 0.22 Allowed Glycine 0 C--O 1.224 -0.529 0 N-CA-C 111.336 -0.706 . . . . 15.0 111.336 -179.677 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.708 HG13 HG12 ' A' ' 40' ' ' VAL . 0.0 OUTLIER -114.07 140.87 32.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 112.314 0.487 . . . . 15.0 112.314 -179.497 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.746 ' HB3' HD11 ' A' ' 41' ' ' ILE . 1.7 t -96.43 106.32 18.54 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 107.962 -1.125 . . . . 15.0 107.962 176.705 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.961 HG21 HG23 ' A' ' 75' ' ' VAL . 21.1 m -93.59 149.59 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 N-CA-C 112.947 0.721 . . . . 15.0 112.947 -177.246 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.537 HG22 ' HB2' ' A' ' 38' ' ' LYS . 8.8 t -150.37 -179.96 7.63 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.357 -0.838 . . . . 15.0 110.887 179.266 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.662 ' O ' HG22 ' A' ' 26' ' ' VAL . . . 74.11 -114.83 4.68 Favored Glycine 0 C--N 1.334 0.467 0 C-N-CA 120.973 -0.632 . . . . 15.0 112.526 179.773 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.539 ' HA3' ' N ' ' A' ' 71' ' ' HIS . . . 63.88 -65.3 0.05 OUTLIER Glycine 0 C--N 1.331 0.251 0 C-N-CA 121.093 -0.575 . . . . 15.0 113.885 179.082 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.662 HG22 ' O ' ' A' ' 24' ' ' GLY . 0.0 OUTLIER -28.68 141.81 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 N-CA-C 112.329 0.492 . . . . 15.0 112.329 -179.159 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.44 ' ND2' ' O ' ' A' ' 27' ' ' ASN . 2.2 p-10 -75.53 62.24 1.38 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.965 -0.561 . . . . 15.0 111.001 -179.797 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 9.7 m -151.71 -65.34 0.18 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.258 -0.428 . . . . 15.0 111.011 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -69.52 -48.92 58.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.118 -0.492 . . . . 15.0 111.087 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.554 HG22 ' O ' ' A' ' 26' ' ' VAL . 34.8 m -72.69 -174.51 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.217 -0.447 . . . . 15.0 111.247 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.402 ' HG2' HG21 ' A' ' 96' ' ' THR . 0.0 OUTLIER -52.45 -74.56 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.184 -0.462 . . . . 15.0 111.258 -179.923 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 8.8 p-80 -132.52 -45.71 0.9 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.35 -0.386 . . . . 15.0 111.179 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -168.39 24.05 0.11 Allowed Glycine 0 N--CA 1.453 -0.19 0 C-N-CA 120.8 -0.714 . . . . 15.0 112.732 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -90.31 153.71 22.99 Favored Glycine 0 N--CA 1.449 -0.448 0 N-CA-C 110.836 -0.906 . . . . 15.0 110.836 178.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.91 HG22 HG22 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -92.21 154.11 3.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.504 0.669 . . . . 15.0 111.888 -179.335 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.51 ' CZ ' ' HG2' ' A' ' 57' ' ' ARG . 24.1 m-85 -139.49 110.97 7.07 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.857 -1.065 . . . . 15.0 109.136 178.846 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.794 HG22 ' N ' ' A' ' 55' ' ' GLY . 0.8 OUTLIER -56.44 156.42 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.46 0.648 . . . . 15.0 110.953 -178.762 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.537 ' HB2' HG22 ' A' ' 23' ' ' THR . 0.0 OUTLIER -90.39 -46.85 8.11 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 108.281 -1.007 . . . . 15.0 108.281 178.667 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.532 ' O ' HG12 ' A' ' 20' ' ' ILE . . . -172.84 166.74 5.23 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.088 -0.96 . . . . 15.0 110.566 178.326 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.708 HG12 HG13 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -97.24 119.94 45.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.789 0.328 . . . . 15.0 110.493 179.75 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.746 HD11 ' HB3' ' A' ' 21' ' ' SER . 1.4 mm -78.31 109.28 9.8 Favored Pre-proline 0 N--CA 1.466 0.358 0 N-CA-C 113.028 0.751 . . . . 15.0 113.028 -178.394 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.453 ' HA ' ' OE1' ' A' ' 47' ' ' GLU . 41.0 Cg_endo -66.54 64.42 0.53 Allowed 'Trans proline' 0 C--N 1.352 0.753 0 C-N-CA 122.846 2.364 . . . . 15.0 112.28 179.474 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 11.5 mt-30 -159.37 -45.91 0.05 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.362 -0.835 . . . . 15.0 109.436 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.508 ' HA3' ' HA3' ' A' ' 19' ' ' GLY . . . -87.4 151.6 23.56 Favored Glycine 0 N--CA 1.446 -0.678 0 CA-C-N 115.611 -0.722 . . . . 15.0 112.222 179.232 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.844 ' HB3' ' O ' ' A' ' 17' ' ' SER . . . -40.59 -18.28 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 113.367 0.877 . . . . 15.0 113.367 -179.435 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.465 ' N ' ' O ' ' A' ' 44' ' ' GLY . . . -71.66 -71.64 0.26 Allowed 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.893 -0.323 . . . . 15.0 111.267 -179.593 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.56 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 9.4 tm-20 -58.16 -37.79 75.36 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.832 0.348 . . . . 15.0 110.341 179.578 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 16.0 m -53.92 -66.4 0.4 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.1 -0.5 . . . . 15.0 110.47 179.676 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.643 ' CB ' HD11 ' A' ' 11' ' ' LEU . 2.1 t0 -63.3 -37.64 88.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.103 -0.499 . . . . 15.0 109.922 179.152 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.55 43.68 8.32 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.928 -0.653 . . . . 15.0 112.523 179.63 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.819 ' CG ' HD13 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -80.13 -51.72 8.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.75 0.309 . . . . 15.0 110.724 179.943 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.734 HG21 HG11 ' A' ' 37' ' ' VAL . 1.2 mm -91.24 163.41 2.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.973 0.416 . . . . 15.0 111.15 179.736 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' HIS . . . . . 0.614 ' N ' HG22 ' A' ' 52' ' ' ILE . 47.6 m80 -139.39 153.29 47.62 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-O 121.368 0.604 . . . . 15.0 110.485 179.463 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.506 ' HA ' ' CG2' ' A' ' 37' ' ' VAL . 0.6 OUTLIER -35.21 132.96 0.35 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.747 -1.115 . . . . 15.0 112.354 -178.459 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.794 ' N ' HG22 ' A' ' 37' ' ' VAL . . . 52.11 35.57 41.9 Favored Glycine 0 C--N 1.332 0.31 0 CA-C-N 115.892 -0.594 . . . . 15.0 114.01 179.644 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -66.16 130.57 43.68 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 117.676 0.738 . . . . 15.0 110.561 179.205 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.51 ' HG2' ' CZ ' ' A' ' 36' ' ' TYR . 26.4 mtt-85 -81.63 91.55 6.43 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.462 -0.335 . . . . 15.0 110.586 179.735 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.91 HG22 HG22 ' A' ' 35' ' ' ILE . 1.1 m -85.86 116.29 28.67 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 CA-C-O 121.178 0.513 . . . . 15.0 111.384 -179.645 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -107.26 -10.59 15.78 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 115.589 -0.732 . . . . 15.0 112.248 -179.602 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.698 ' HB3' ' HB2' ' A' ' 88' ' ' LEU . . . -152.01 145.16 24.6 Favored 'General case' 0 N--CA 1.462 0.17 0 N-CA-C 112.301 0.482 . . . . 15.0 112.301 -178.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.831 HG21 HD23 ' A' ' 78' ' ' LEU . 59.7 t -138.94 101.41 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.57 -0.741 . . . . 15.0 109.264 178.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.647 ' OD1' HG22 ' A' ' 81' ' ' THR . 2.7 m120 64.96 16.04 10.31 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.02 0.438 . . . . 15.0 109.919 -178.286 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 107.06 4.76 35.68 Favored Glycine 0 C--N 1.336 0.578 0 CA-C-N 115.932 -0.577 . . . . 15.0 113.376 179.588 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.644 HG13 ' O ' ' A' ' 64' ' ' VAL . 5.2 p -93.85 107.54 19.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 117.084 0.442 . . . . 15.0 110.857 179.529 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.6 m -56.82 130.74 46.97 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.3 -0.409 . . . . 15.0 111.111 -179.677 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.471 HD13 ' HB3' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -90.76 -22.03 21.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.04 -0.527 . . . . 15.0 110.95 179.975 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -46.6 96.68 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.889 0.376 . . . . 15.0 111.047 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.76 66.45 0.58 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.801 -0.714 . . . . 15.0 112.428 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.512 ' HB1' ' HB3' ' A' ' 73' ' ' GLN . . . -173.09 162.77 4.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.838 0.351 . . . . 15.0 111.052 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.424 HG22 ' HA ' ' A' ' 26' ' ' VAL . 15.0 p -93.12 -174.1 3.45 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.016 0.436 . . . . 15.0 111.106 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.765 ' NE2' HG23 ' A' ' 22' ' ' VAL . 0.2 OUTLIER -63.95 -59.7 4.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.841 -0.618 . . . . 15.0 110.296 179.946 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.467 ' O ' HG12 ' A' ' 75' ' ' VAL . 30.4 ttmt -52.69 -33.52 47.89 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.153 -0.476 . . . . 15.0 110.235 178.858 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.512 ' HB3' ' HB1' ' A' ' 69' ' ' ALA . 0.0 OUTLIER -59.39 -51.25 70.73 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.565 -0.532 . . . . 15.0 109.565 179.258 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.633 ' HB3' HG13 ' A' ' 35' ' ' ILE . . . -66.91 -43.87 82.22 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-N 116.041 -0.527 . . . . 15.0 109.711 178.425 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.961 HG23 HG21 ' A' ' 22' ' ' VAL . 0.5 OUTLIER -42.83 -41.91 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.23 0 N-CA-C 108.896 -0.779 . . . . 15.0 108.896 178.395 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.418 ' HG3' ' O ' ' A' ' 72' ' ' LYS . 17.2 mt-10 -67.32 -45.15 77.31 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.794 -1.093 . . . . 15.0 110.078 178.275 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.653 ' O ' HG11 ' A' ' 61' ' ' VAL . 82.1 p -64.17 -54.58 31.47 Favored 'General case' 0 N--CA 1.461 0.114 0 CA-C-N 116.612 -0.267 . . . . 15.0 111.436 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.831 HD23 HG21 ' A' ' 61' ' ' VAL . 4.2 mt -53.51 -48.17 69.24 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 121.145 0.498 . . . . 15.0 110.141 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.408 ' HB2' ' O ' ' A' ' 75' ' ' VAL . 0.0 OUTLIER -68.52 -59.02 3.45 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.561 -0.745 . . . . 15.0 110.564 179.478 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 74.6 m-20 -66.04 59.4 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.933 -0.576 . . . . 15.0 112.43 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.647 HG22 ' OD1' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -95.73 -71.97 0.65 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.889 -0.412 . . . . 15.0 109.889 178.855 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 122.13 -105.16 0.96 Allowed Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.72 -0.752 . . . . 15.0 113.451 178.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.406 ' O ' ' HB3' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -64.56 -83.0 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.071 0.397 . . . . 15.0 112.071 -178.815 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.443 HG12 ' N ' ' A' ' 85' ' ' VAL . 76.2 t -109.64 158.84 9.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.077 0.465 . . . . 15.0 111.167 -179.199 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.687 HG23 ' CB ' ' A' ' 13' ' ' LYS . 9.1 t -97.86 81.23 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.011 -0.54 . . . . 15.0 110.499 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -99.06 85.54 3.26 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.76 -0.655 . . . . 15.0 110.344 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.732 ' HB3' HD21 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -104.02 126.52 51.2 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.041 -0.527 . . . . 15.0 111.917 -179.16 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.719 HD12 ' CB ' ' A' ' 8' ' ' GLU . 5.0 mp -102.41 99.96 10.06 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.751 -0.463 . . . . 15.0 109.751 178.695 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.79 HD12 ' CZ ' ' A' ' 7' ' ' PHE . 0.1 OUTLIER -105.85 -162.56 0.87 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.646 0.736 . . . . 15.0 112.29 -178.633 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.419 ' HB2' ' CD1' ' A' ' 6' ' ' ILE . 3.3 tt0 -137.68 138.64 39.6 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 114.639 -1.164 . . . . 15.0 109.48 178.86 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.3 tppt? -49.49 107.35 0.14 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.947 0.403 . . . . 15.0 111.151 -179.549 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -61.97 100.13 0.27 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.928 -0.653 . . . . 15.0 112.935 -179.707 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.34 -165.58 1.3 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.77 0.319 . . . . 15.0 110.709 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.4 m -61.03 148.57 83.98 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.345 -0.389 . . . . 15.0 110.734 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -50.6 139.46 38.48 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.556 2.171 . . . . 15.0 112.369 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.402 HG21 ' HG2' ' A' ' 31' ' ' ARG . 7.0 t . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.253 -0.88 . . . . 15.0 110.861 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo . . . . . 0 N--CA 1.489 1.249 0 CA-C-O 120.937 0.307 . . . . 15.0 111.828 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 4.2 tttt -146.66 84.4 7.68 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.177 -0.465 . . . . 15.0 110.555 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -68.61 -90.32 0.0 OUTLIER 'Trans proline' 0 CA--C 1.531 0.373 0 C-N-CA 122.423 2.082 . . . . 15.0 112.256 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 86.22 -44.0 3.3 Favored Glycine 0 C--N 1.333 0.401 0 C-N-CA 120.596 -0.811 . . . . 15.0 112.957 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -62.09 139.67 58.43 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.501 0.667 . . . . 15.0 111.505 -179.651 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.452 HG13 ' HB2' ' A' ' 90' ' ' GLU . 1.3 mp -77.25 151.67 5.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 114.829 -1.078 . . . . 15.0 110.709 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.513 ' CZ ' HD12 ' A' ' 89' ' ' LEU . 2.5 p90 -144.8 165.14 28.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.793 0.33 . . . . 15.0 110.686 179.177 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.732 ' CB ' HD12 ' A' ' 88' ' ' LEU . 9.7 pt-20 -130.18 143.91 51.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.22 0.534 . . . . 15.0 111.426 -179.472 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.56 ' CG1' HD11 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -101.38 115.3 42.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.434 -0.803 . . . . 15.0 109.521 178.905 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -106.02 72.03 0.92 Allowed 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.524 0.565 . . . . 15.0 112.524 -178.602 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.652 HD13 ' HG3' ' A' ' 51' ' ' ARG . 5.7 tp -88.2 166.3 14.46 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.448 -0.575 . . . . 15.0 109.448 178.462 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.451 ' HB1' ' HB2' ' A' ' 15' ' ' ASP . . . -96.18 92.15 6.26 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.897 0.379 . . . . 15.0 111.203 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.7 ' CB ' HG23 ' A' ' 85' ' ' VAL . 0.2 OUTLIER -54.18 -27.87 36.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.914 -0.584 . . . . 15.0 111.018 179.879 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -84.32 -47.04 11.15 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.16 -0.473 . . . . 15.0 110.671 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.451 ' HB2' ' HB1' ' A' ' 12' ' ' ALA . 1.0 OUTLIER -63.71 -37.8 88.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 15.0 110.634 179.903 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.551 ' HB2' ' HB2' ' A' ' 45' ' ' ALA . 26.3 p30 -165.46 156.34 13.85 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.264 -0.425 . . . . 15.0 111.135 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.974 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 0.8 OUTLIER -86.08 -149.16 0.13 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.141 -0.482 . . . . 15.0 110.254 179.526 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.65 ' N ' HD22 ' A' ' 18' ' ' LEU . 1.9 mm? -119.52 -171.87 2.21 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.878 0.37 . . . . 15.0 110.748 179.589 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.782 ' O ' ' HB ' ' A' ' 41' ' ' ILE . . . -163.63 44.32 0.32 Allowed Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 121.053 -0.594 . . . . 15.0 111.871 -179.751 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.672 HG12 ' O ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -112.88 135.58 51.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 121.012 0.434 . . . . 15.0 111.876 -179.353 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 29.9 t -89.81 104.4 16.97 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 107.668 -1.234 . . . . 15.0 107.668 177.366 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 1.001 HG21 HG23 ' A' ' 75' ' ' VAL . 14.1 m -93.44 151.91 3.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 112.953 0.723 . . . . 15.0 112.953 -176.825 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -149.57 -177.72 6.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 114.977 -1.01 . . . . 15.0 110.678 -179.685 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.58 ' O ' HG22 ' A' ' 26' ' ' VAL . . . 73.26 -120.52 7.16 Favored Glycine 0 C--N 1.331 0.256 0 C-N-CA 120.675 -0.774 . . . . 15.0 112.381 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.524 ' HA3' ' N ' ' A' ' 71' ' ' HIS . . . 66.94 -65.57 0.19 Allowed Glycine 0 C--N 1.33 0.214 0 C-N-CA 120.943 -0.646 . . . . 15.0 113.565 179.31 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.58 HG22 ' O ' ' A' ' 24' ' ' GLY . 0.0 OUTLIER -25.87 133.08 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 N-CA-C 112.621 0.6 . . . . 15.0 112.621 -179.298 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -75.65 63.17 1.54 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.784 -0.644 . . . . 15.0 111.018 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.4 m -151.67 -47.27 0.11 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.287 -0.415 . . . . 15.0 111.0 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 12.5 t -90.28 -41.65 11.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 15.0 111.001 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.484 HG22 ' O ' ' A' ' 26' ' ' VAL . 33.9 m -71.99 -176.3 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.471 . . . . 15.0 111.166 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.0 -51.32 69.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.218 -0.446 . . . . 15.0 110.983 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 73.2 m-70 -151.21 -51.98 0.13 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.28 -0.418 . . . . 15.0 111.012 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -168.1 27.42 0.14 Allowed Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.803 -0.713 . . . . 15.0 112.5 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -91.13 149.14 19.71 Favored Glycine 0 N--CA 1.45 -0.411 0 N-CA-C 111.037 -0.825 . . . . 15.0 111.037 179.134 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.769 HG22 HG22 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -88.18 154.78 3.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.388 0.613 . . . . 15.0 111.719 -179.299 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.532 ' CZ ' ' HG2' ' A' ' 57' ' ' ARG . 51.2 m-85 -141.35 106.91 5.06 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.008 -0.996 . . . . 15.0 109.737 179.272 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.767 HG22 ' N ' ' A' ' 55' ' ' GLY . 0.8 OUTLIER -56.16 148.11 4.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.021 0.438 . . . . 15.0 111.317 -179.193 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.493 ' O ' ' HG2' ' A' ' 54' ' ' LYS . 0.4 OUTLIER -80.37 -46.46 16.01 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.49 -0.93 . . . . 15.0 108.49 178.248 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.672 ' O ' HG12 ' A' ' 20' ' ' ILE . . . -172.1 172.58 4.59 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.594 -0.73 . . . . 15.0 110.508 178.626 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.56 ' HA ' HG12 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -96.87 111.42 26.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 109.545 -0.539 . . . . 15.0 109.545 179.248 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.782 ' HB ' ' O ' ' A' ' 19' ' ' GLY . 0.4 OUTLIER -78.47 117.05 64.02 Favored Pre-proline 0 C--N 1.329 -0.324 0 N-CA-C 113.273 0.842 . . . . 15.0 113.273 -177.422 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.621 ' HA ' ' CG ' ' A' ' 47' ' ' GLU . 37.9 Cg_endo -65.29 59.76 0.34 Allowed 'Trans proline' 0 C--N 1.356 0.924 0 C-N-CA 123.437 2.758 . . . . 15.0 112.785 179.734 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.526 ' N ' ' HG2' ' A' ' 47' ' ' GLU . 0.5 OUTLIER -147.47 -46.32 0.17 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.517 -0.31 . . . . 15.0 111.296 -179.996 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.71 ' HA3' ' HA3' ' A' ' 19' ' ' GLY . . . -87.77 168.02 37.3 Favored Glycine 0 C--N 1.331 0.269 0 C-N-CA 120.332 -0.937 . . . . 15.0 113.722 -179.258 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.974 ' HB3' ' O ' ' A' ' 17' ' ' SER . . . -57.83 -14.35 5.85 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.862 0.69 . . . . 15.0 112.862 -179.473 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.14 -55.86 6.57 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.935 -0.306 . . . . 15.0 110.932 -179.69 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.621 ' CG ' ' HA ' ' A' ' 42' ' ' PRO . 2.9 pp20? -57.36 -43.02 83.15 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.923 -0.58 . . . . 15.0 110.231 179.196 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.5 m -53.84 -69.89 0.11 Allowed 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 115.882 -0.599 . . . . 15.0 110.483 -179.63 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.533 ' CB ' HD11 ' A' ' 11' ' ' LEU . 1.1 t0 -58.07 -41.74 84.01 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.072 -0.714 . . . . 15.0 109.072 178.785 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.75 40.03 12.97 Favored Glycine 0 N--CA 1.446 -0.648 0 CA-C-N 115.293 -0.867 . . . . 15.0 111.711 179.33 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.652 ' HG3' HD13 ' A' ' 11' ' ' LEU . 0.2 OUTLIER -79.79 -50.07 11.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.895 0.378 . . . . 15.0 110.599 -179.362 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.649 ' CG1' HD12 ' A' ' 20' ' ' ILE . 8.7 tp -81.12 161.44 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 CA-C-N 116.075 -0.511 . . . . 15.0 110.367 179.571 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' HIS . . . . . 0.471 ' O ' ' HB2' ' A' ' 56' ' ' ASP . 78.3 m80 -146.27 158.78 43.91 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-O 121.635 0.731 . . . . 15.0 112.16 -179.192 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.556 ' HA ' ' CG2' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -43.12 133.97 3.71 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 114.382 -1.281 . . . . 15.0 112.645 -178.752 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.767 ' N ' HG22 ' A' ' 37' ' ' VAL . . . 49.97 34.0 22.37 Favored Glycine 0 C--N 1.333 0.414 0 CA-C-N 115.841 -0.618 . . . . 15.0 113.354 179.403 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.471 ' HB2' ' O ' ' A' ' 53' ' ' HIS . 0.3 OUTLIER -65.96 131.9 47.33 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.635 -0.426 . . . . 15.0 110.618 179.525 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.64 ' HD2' HD21 ' A' ' 59' ' ' LEU . 0.0 OUTLIER -85.32 90.89 8.03 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.169 -0.468 . . . . 15.0 110.403 179.553 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.769 HG22 HG22 ' A' ' 35' ' ' ILE . 1.5 m -83.57 112.95 21.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.079 0.466 . . . . 15.0 111.207 -179.524 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.64 HD21 ' HD2' ' A' ' 57' ' ' ARG . 3.5 mm? -107.32 -16.54 14.37 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 115.764 -0.653 . . . . 15.0 112.615 -179.099 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.791 ' HB3' ' HB2' ' A' ' 88' ' ' LEU . . . -147.5 150.21 34.12 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 112.518 0.562 . . . . 15.0 112.518 -178.454 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.691 HG21 ' HB ' ' A' ' 77' ' ' THR . 3.3 t -139.07 101.66 1.62 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.267 0 CA-C-N 115.311 -0.859 . . . . 15.0 109.281 178.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.647 ' OD1' HG22 ' A' ' 81' ' ' THR . 3.8 m120 64.96 15.59 10.05 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.64 -0.504 . . . . 15.0 109.64 -178.112 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 105.95 6.71 36.93 Favored Glycine 0 C--N 1.336 0.54 0 CA-C-N 115.816 -0.629 . . . . 15.0 113.126 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.664 HG13 ' O ' ' A' ' 64' ' ' VAL . 7.2 p -93.76 105.32 16.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.118 0.485 . . . . 15.0 110.727 179.283 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -59.3 116.35 3.85 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.127 -0.488 . . . . 15.0 110.733 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.704 HD21 ' HA ' ' A' ' 74' ' ' ALA . 1.2 mt -87.59 -12.07 46.75 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.826 -0.624 . . . . 15.0 111.295 -179.835 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -46.29 102.51 0.03 OUTLIER 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.827 0.346 . . . . 15.0 110.936 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.86 64.25 0.55 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.8 -0.714 . . . . 15.0 112.264 -179.608 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.721 ' HB1' ' CB ' ' A' ' 73' ' ' GLN . . . -172.91 148.44 1.79 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.9 0.381 . . . . 15.0 110.855 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.444 ' CB ' ' HA ' ' A' ' 26' ' ' VAL . 11.8 p -72.83 -173.75 1.29 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.198 -0.456 . . . . 15.0 111.157 -179.65 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.674 ' CE1' HG23 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -61.89 -59.46 5.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.882 -0.599 . . . . 15.0 110.572 -179.847 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 25.0 ttpt -52.34 -35.51 51.14 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.84 -0.618 . . . . 15.0 110.689 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.721 ' CB ' ' HB1' ' A' ' 69' ' ' ALA . 3.5 mt-30 -59.31 -46.22 89.16 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.647 -0.501 . . . . 15.0 109.647 179.232 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.704 ' HA ' HD21 ' A' ' 66' ' ' LEU . . . -66.96 -50.34 62.61 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 109.472 -0.566 . . . . 15.0 109.472 178.195 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 1.001 HG23 HG21 ' A' ' 22' ' ' VAL . 0.6 OUTLIER -40.85 -43.58 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.192 0 CA-C-N 115.237 -0.892 . . . . 15.0 109.614 178.567 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.439 ' N ' HG12 ' A' ' 75' ' ' VAL . 41.4 mt-10 -67.37 -43.85 80.39 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.01 -0.996 . . . . 15.0 110.663 179.156 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.691 ' HB ' HG21 ' A' ' 61' ' ' VAL . 0.6 OUTLIER -64.68 -55.78 17.92 Favored 'General case' 0 C--O 1.23 0.075 0 C-N-CA 120.796 -0.362 . . . . 15.0 111.272 179.937 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.752 HD22 HD21 ' A' ' 87' ' ' LEU . 3.2 mt -53.43 -46.03 69.65 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 121.116 0.484 . . . . 15.0 110.132 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.22 -55.06 13.6 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.612 -0.722 . . . . 15.0 110.359 179.4 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 8.1 m-20 -66.26 57.81 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 115.919 -0.582 . . . . 15.0 112.01 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.647 HG22 ' OD1' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -95.66 -70.54 0.71 Allowed 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 110.203 -0.295 . . . . 15.0 110.203 179.332 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 115.25 -98.15 0.84 Allowed Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.691 -0.766 . . . . 15.0 113.412 178.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.427 ' O ' ' HB3' ' A' ' 13' ' ' LYS . 0.5 OUTLIER -64.39 -86.24 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.063 0.394 . . . . 15.0 112.063 -178.827 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.452 HG12 ' N ' ' A' ' 85' ' ' VAL . 77.7 t -109.73 159.76 9.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.924 0.392 . . . . 15.0 110.978 -179.397 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.7 HG23 ' CB ' ' A' ' 13' ' ' LYS . 13.4 t -97.99 79.4 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.145 0.497 . . . . 15.0 110.466 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -101.41 84.14 2.56 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.746 -0.661 . . . . 15.0 110.495 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.789 ' HB3' HD21 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -101.02 128.64 46.97 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.014 -0.539 . . . . 15.0 111.54 -179.302 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.791 ' HB2' ' HB3' ' A' ' 60' ' ' ALA . 4.8 mp -102.2 99.67 9.8 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.737 -0.468 . . . . 15.0 109.737 178.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.789 HD21 ' HB3' ' A' ' 87' ' ' LEU . 0.1 OUTLIER -105.73 -160.86 0.77 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.394 0.616 . . . . 15.0 112.011 -178.677 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.452 ' HB2' HG13 ' A' ' 6' ' ' ILE . 3.6 tt0 -141.77 132.69 25.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.051 -0.977 . . . . 15.0 109.897 179.136 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 3.6 tmtp? -49.26 95.51 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.378 -0.374 . . . . 15.0 111.146 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -68.3 131.12 27.11 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.85 -0.691 . . . . 15.0 112.639 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -86.39 130.68 34.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.828 0.347 . . . . 15.0 110.874 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 15.2 p -69.46 164.65 47.68 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.221 -0.445 . . . . 15.0 110.916 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_exo -51.73 -54.12 5.86 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.59 2.193 . . . . 15.0 112.267 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 28.7 m . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.242 -0.885 . . . . 15.0 110.933 -179.984 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo . . . . . 0 N--CA 1.488 1.173 0 CA-C-O 120.852 0.271 . . . . 15.0 111.757 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.488 ' CB ' ' HD3' ' A' ' 3' ' ' PRO . 7.0 mttp -155.38 -63.89 0.02 OUTLIER Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.146 -0.479 . . . . 15.0 111.057 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.488 ' HD3' ' CB ' ' A' ' 2' ' ' LYS . 88.4 Cg_exo -42.95 92.14 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.633 2.222 . . . . 15.0 112.707 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 88.35 -21.68 23.8 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.488 -0.863 . . . . 15.0 112.209 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -61.86 151.12 35.4 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 121.193 0.52 . . . . 15.0 110.668 179.723 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.411 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 1.2 mp -98.45 145.44 9.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.473 -0.785 . . . . 15.0 111.335 -179.179 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.513 ' CZ ' HD12 ' A' ' 89' ' ' LEU . 1.8 p90 -140.54 153.91 46.33 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.026 -0.533 . . . . 15.0 110.407 178.899 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.748 ' HB2' HD12 ' A' ' 88' ' ' LEU . 0.1 OUTLIER -121.37 143.61 49.11 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.369 0.604 . . . . 15.0 111.759 -179.192 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.585 ' CG1' HD11 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -101.43 116.02 44.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.063 -0.971 . . . . 15.0 109.628 178.956 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -106.24 72.59 0.94 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.239 -0.437 . . . . 15.0 112.145 -178.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.615 HD13 ' HG3' ' A' ' 51' ' ' ARG . 7.1 tp -88.3 161.69 17.01 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.319 -0.4 . . . . 15.0 110.007 178.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.497 ' C ' ' H ' ' A' ' 14' ' ' ASN . . . -97.1 94.67 7.28 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.654 0.264 . . . . 15.0 111.686 -179.713 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.853 ' HB2' HG23 ' A' ' 85' ' ' VAL . 0.6 OUTLIER -65.84 32.37 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 112.738 0.644 . . . . 15.0 112.738 179.623 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.497 ' H ' ' C ' ' A' ' 12' ' ' ALA . 0.6 OUTLIER -108.8 -68.56 0.91 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.79 0.329 . . . . 15.0 111.289 -179.57 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -46.68 -42.58 16.73 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.286 -0.415 . . . . 15.0 111.128 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -165.42 174.15 10.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 15.0 110.876 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.711 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 0.0 OUTLIER -86.07 -165.52 1.27 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.242 -0.435 . . . . 15.0 110.355 179.636 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.492 HD12 ' HE3' ' A' ' 13' ' ' LYS . 4.5 mp -84.14 -170.2 2.97 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.357 -0.383 . . . . 15.0 110.357 179.447 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.686 ' O ' ' HB ' ' A' ' 41' ' ' ILE . . . -160.61 38.88 0.44 Allowed Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.901 -0.666 . . . . 15.0 111.719 -179.728 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.643 HG12 ' O ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -112.9 138.4 42.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 120.998 0.428 . . . . 15.0 111.805 -179.53 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.42 ' O ' ' HB3' ' A' ' 38' ' ' LYS . 28.9 t -95.78 100.92 12.57 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 107.801 -1.185 . . . . 15.0 107.801 177.395 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.616 HG22 HG23 ' A' ' 75' ' ' VAL . 1.0 OUTLIER -93.66 154.82 3.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.162 0.506 . . . . 15.0 112.299 -177.151 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.679 ' HA ' ' CD2' ' A' ' 71' ' ' HIS . 14.5 t -149.34 -176.19 5.28 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.421 -0.809 . . . . 15.0 110.516 179.647 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.712 ' O ' HG22 ' A' ' 26' ' ' VAL . . . 77.1 -112.07 3.42 Favored Glycine 0 C--N 1.331 0.287 0 C-N-CA 120.555 -0.831 . . . . 15.0 112.253 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.56 ' HA3' ' N ' ' A' ' 71' ' ' HIS . . . 62.8 -65.89 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 121.037 -0.601 . . . . 15.0 113.812 179.133 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.718 ' O ' HG22 ' A' ' 30' ' ' VAL . 0.0 OUTLIER -30.27 145.01 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 N-CA-C 112.47 0.544 . . . . 15.0 112.47 -179.068 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -80.28 56.26 2.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.863 -0.608 . . . . 15.0 110.967 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -151.04 -65.38 0.19 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.212 -0.449 . . . . 15.0 110.585 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.09 -47.11 75.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 15.0 110.251 179.57 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.718 HG22 ' O ' ' A' ' 26' ' ' VAL . 33.7 m -88.07 -170.3 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.923 -0.581 . . . . 15.0 110.567 179.475 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -95.83 128.49 42.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.933 0.396 . . . . 15.0 111.152 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 25.6 m80 59.47 -83.35 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.947 -0.57 . . . . 15.0 111.464 179.645 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.407 ' O ' ' O ' ' A' ' 69' ' ' ALA . . . -170.36 30.61 0.14 Allowed Glycine 0 C--N 1.33 0.244 0 C-N-CA 121.056 -0.592 . . . . 15.0 112.026 -179.548 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.49 ' O ' HG21 ' A' ' 30' ' ' VAL . . . -89.96 151.88 21.95 Favored Glycine 0 N--CA 1.447 -0.583 0 N-CA-C 110.667 -0.973 . . . . 15.0 110.667 178.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.883 HG22 HG22 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -94.25 152.6 3.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.546 0.689 . . . . 15.0 112.149 -179.034 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -136.76 108.14 6.88 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.661 -1.154 . . . . 15.0 109.39 179.517 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.785 HG22 ' N ' ' A' ' 55' ' ' GLY . 0.8 OUTLIER -55.32 152.19 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.123 0.487 . . . . 15.0 111.563 -178.622 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.451 ' O ' ' HG2' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -84.51 -46.33 11.72 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.457 -0.942 . . . . 15.0 108.457 178.088 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.643 ' O ' HG12 ' A' ' 20' ' ' ILE . . . -172.35 173.17 4.23 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 115.75 -0.659 . . . . 15.0 110.448 178.438 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.565 ' HA ' HG12 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -96.96 111.52 27.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 109.519 -0.548 . . . . 15.0 109.519 179.196 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.686 ' HB ' ' O ' ' A' ' 19' ' ' GLY . 0.4 OUTLIER -78.39 117.01 63.7 Favored Pre-proline 0 C--N 1.33 -0.264 0 N-CA-C 113.408 0.892 . . . . 15.0 113.408 -177.306 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.612 ' HA ' ' CG ' ' A' ' 47' ' ' GLU . 27.1 Cg_exo -62.86 59.79 0.15 Allowed 'Trans proline' 0 C--N 1.357 0.989 0 C-N-CA 123.651 2.9 . . . . 15.0 113.001 179.637 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.521 ' N ' ' HG2' ' A' ' 47' ' ' GLU . 3.9 tt0 -147.51 -47.06 0.17 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.582 0.229 . . . . 15.0 111.394 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.623 ' HA3' ' HA3' ' A' ' 19' ' ' GLY . . . -87.82 167.8 36.98 Favored Glycine 0 CA--C 1.518 0.24 0 C-N-CA 120.368 -0.92 . . . . 15.0 113.884 -179.051 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.711 ' HB3' ' O ' ' A' ' 17' ' ' SER . . . -57.34 -14.45 4.61 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.722 0.638 . . . . 15.0 112.722 -179.616 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.17 -56.59 5.31 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.662 0.267 . . . . 15.0 110.934 -179.592 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.612 ' CG ' ' HA ' ' A' ' 42' ' ' PRO . 3.0 pp20? -57.45 -42.69 82.98 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.965 -0.561 . . . . 15.0 110.287 179.309 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -53.77 -70.76 0.09 Allowed 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 115.845 -0.616 . . . . 15.0 110.535 -179.433 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.579 ' CB ' HD11 ' A' ' 11' ' ' LEU . 0.1 OUTLIER -58.43 -41.3 84.73 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.154 -0.684 . . . . 15.0 109.154 178.829 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.75 41.2 11.14 Favored Glycine 0 N--CA 1.445 -0.702 0 CA-C-N 115.361 -0.836 . . . . 15.0 111.718 179.464 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.615 ' HG3' HD13 ' A' ' 11' ' ' LEU . 0.5 OUTLIER -79.7 -50.3 10.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.883 0.373 . . . . 15.0 110.655 -179.363 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.637 ' CG1' HD12 ' A' ' 20' ' ' ILE . 7.9 tp -81.04 163.3 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 CA-C-N 116.062 -0.517 . . . . 15.0 110.282 179.439 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' HIS . . . . . 0.476 ' O ' ' HB2' ' A' ' 56' ' ' ASP . 64.0 m80 -147.37 160.82 42.1 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-O 121.687 0.756 . . . . 15.0 112.252 -179.087 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.546 ' HA ' ' CG2' ' A' ' 37' ' ' VAL . 6.1 mtpt -43.82 134.11 4.55 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.309 -1.314 . . . . 15.0 112.576 -178.817 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.785 ' N ' HG22 ' A' ' 37' ' ' VAL . . . 49.88 33.12 19.83 Favored Glycine 0 C--N 1.333 0.369 0 CA-C-N 115.914 -0.585 . . . . 15.0 113.589 179.324 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.476 ' HB2' ' O ' ' A' ' 53' ' ' HIS . 0.3 OUTLIER -65.93 130.5 43.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 117.16 0.48 . . . . 15.0 110.598 179.38 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.432 ' HA ' ' O ' ' A' ' 35' ' ' ILE . 35.4 ttt180 -82.74 87.91 6.76 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.794 0.331 . . . . 15.0 110.313 179.485 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.883 HG22 HG22 ' A' ' 35' ' ' ILE . 2.3 m -79.32 112.45 17.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.148 0.499 . . . . 15.0 111.063 -179.388 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 44.5 mt -107.21 -11.85 15.5 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 115.645 -0.707 . . . . 15.0 112.625 -179.047 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.718 ' HB3' ' HB2' ' A' ' 88' ' ' LEU . . . -151.35 146.41 25.98 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 112.693 0.627 . . . . 15.0 112.693 -178.775 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.884 HG11 ' O ' ' A' ' 77' ' ' THR . 40.0 t -139.59 93.53 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.192 -0.913 . . . . 15.0 109.459 178.847 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.491 HD21 HG22 ' A' ' 81' ' ' THR . 7.5 m120 69.92 17.68 7.45 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.086 -0.507 . . . . 15.0 109.98 -178.305 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 107.27 4.72 35.2 Favored Glycine 0 C--N 1.334 0.456 0 CA-C-N 115.841 -0.618 . . . . 15.0 113.482 179.466 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.673 HG13 ' O ' ' A' ' 64' ' ' VAL . 5.1 p -93.72 103.25 14.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.207 0.527 . . . . 15.0 110.645 179.198 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 24.3 m -56.89 133.62 54.74 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.995 -0.548 . . . . 15.0 111.117 -179.384 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.703 HD11 ' HB2' ' A' ' 74' ' ' ALA . 0.1 OUTLIER -88.09 -19.35 27.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.036 -0.529 . . . . 15.0 110.935 179.841 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -47.47 95.86 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 120.91 0.386 . . . . 15.0 110.897 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.73 65.17 0.57 Allowed Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.783 -0.722 . . . . 15.0 112.271 -179.676 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.65 ' HB1' ' CB ' ' A' ' 73' ' ' GLN . . . -172.76 156.89 3.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.94 0.4 . . . . 15.0 110.859 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.478 ' HB ' HG13 ' A' ' 26' ' ' VAL . 11.3 p -93.07 -171.11 2.59 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.104 0.478 . . . . 15.0 111.336 -179.572 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.679 ' CD2' ' HA ' ' A' ' 23' ' ' THR . 0.0 OUTLIER -59.61 -60.99 2.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.621 -0.718 . . . . 15.0 110.158 179.737 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 20.0 ttpp -52.79 -35.93 57.52 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.519 -0.764 . . . . 15.0 110.806 179.647 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.65 ' CB ' ' HB1' ' A' ' 69' ' ' ALA . 7.9 mt-30 -59.6 -54.43 46.55 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.298 -0.41 . . . . 15.0 109.935 179.606 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.74 ' HB3' HD12 ' A' ' 35' ' ' ILE . . . -65.17 -43.88 90.32 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.1 -0.5 . . . . 15.0 109.721 178.728 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.616 HG23 HG22 ' A' ' 22' ' ' VAL . 0.5 OUTLIER -43.38 -42.39 1.42 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.223 0 N-CA-C 108.987 -0.745 . . . . 15.0 108.987 178.289 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.401 ' N ' HG12 ' A' ' 75' ' ' VAL . 1.8 mt-10 -67.41 -43.28 81.63 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 114.9 -1.046 . . . . 15.0 110.323 178.522 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.884 ' O ' HG11 ' A' ' 61' ' ' VAL . 70.4 p -63.94 -56.87 12.04 Favored 'General case' 0 N--CA 1.461 0.116 0 CA-C-O 120.615 0.245 . . . . 15.0 111.521 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.666 HD21 HG21 ' A' ' 58' ' ' VAL . 4.0 mt -53.31 -46.86 69.58 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-O 121.118 0.485 . . . . 15.0 110.185 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.5 -58.2 4.67 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.644 -0.707 . . . . 15.0 110.708 179.467 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 68.7 m-20 -65.85 63.03 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.053 -0.521 . . . . 15.0 111.956 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.491 HG22 HD21 ' A' ' 62' ' ' ASN . 0.0 OUTLIER -92.93 -78.31 0.42 Allowed 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 110.073 -0.343 . . . . 15.0 110.073 179.233 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 122.34 -107.89 1.21 Allowed Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.807 -0.711 . . . . 15.0 112.965 179.223 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -65.23 -80.23 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.665 0.269 . . . . 15.0 111.415 -179.318 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.472 HG12 ' N ' ' A' ' 85' ' ' VAL . 75.9 t -110.19 159.47 9.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.054 0.454 . . . . 15.0 111.179 -179.646 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.853 HG23 ' HB2' ' A' ' 13' ' ' LYS . 6.4 t -97.9 80.88 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.015 -0.539 . . . . 15.0 110.225 179.528 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 11.2 t60 -97.07 80.39 2.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.846 -0.615 . . . . 15.0 110.403 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.827 ' HB3' HD21 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -103.78 120.93 41.98 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.884 -0.598 . . . . 15.0 111.818 -179.118 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.748 HD12 ' HB2' ' A' ' 8' ' ' GLU . 4.0 mp -98.87 101.92 13.48 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.49 -0.559 . . . . 15.0 109.49 178.645 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.827 HD21 ' HB3' ' A' ' 87' ' ' LEU . 0.1 OUTLIER -105.64 -162.37 0.87 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.488 0.661 . . . . 15.0 112.061 -178.334 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.411 ' HA ' ' HA ' ' A' ' 6' ' ' ILE . 2.1 tt0 -140.67 139.39 34.79 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 114.73 -1.123 . . . . 15.0 109.736 179.124 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 2.0 tptp -52.08 105.65 0.12 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.91 0.386 . . . . 15.0 111.069 -179.658 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -69.44 129.72 22.91 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.814 -0.708 . . . . 15.0 112.544 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -86.25 87.75 7.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.817 0.341 . . . . 15.0 110.831 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 4.0 t -67.34 147.88 98.81 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.121 -0.491 . . . . 15.0 110.937 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -52.17 -36.82 68.12 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.575 2.183 . . . . 15.0 112.317 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 76.6 p . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.186 -0.912 . . . . 15.0 110.867 -179.986 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_endo . . . . . 0 N--CA 1.488 1.152 0 CA-C-O 120.88 0.283 . . . . 15.0 111.761 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -145.07 118.37 5.46 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.117 -0.492 . . . . 15.0 110.41 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.403 ' CG ' ' HG2' ' A' ' 91' ' ' LYS . 31.7 Cg_endo -63.78 -86.22 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.412 2.075 . . . . 15.0 112.481 -179.777 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 93.13 -30.26 7.32 Favored Glycine 0 C--N 1.332 0.328 0 C-N-CA 120.612 -0.804 . . . . 15.0 112.507 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.21 164.82 6.46 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-O 121.422 0.63 . . . . 15.0 111.181 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.452 HG13 ' HB2' ' A' ' 90' ' ' GLU . 1.3 mp -104.34 146.28 11.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.067 -0.97 . . . . 15.0 110.96 -179.282 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.544 ' CZ ' HD12 ' A' ' 89' ' ' LEU . 4.0 p90 -141.05 165.22 28.15 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.298 -0.41 . . . . 15.0 110.555 178.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.723 ' CB ' HD12 ' A' ' 88' ' ' LEU . 9.7 pt-20 -130.15 144.27 51.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.243 0.544 . . . . 15.0 111.543 -179.352 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.712 ' CG1' HD11 ' A' ' 89' ' ' LEU . 0.5 OUTLIER -101.34 114.13 39.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.31 -0.859 . . . . 15.0 109.539 178.948 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -106.03 71.12 0.88 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.152 -0.476 . . . . 15.0 111.922 -178.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.619 HD11 ' CB ' ' A' ' 49' ' ' ASP . 7.5 tp -88.28 165.04 15.29 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.08 -0.509 . . . . 15.0 109.914 178.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -95.3 93.29 7.19 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.983 0.421 . . . . 15.0 111.041 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.642 ' CB ' HG23 ' A' ' 85' ' ' VAL . 0.0 OUTLIER -54.34 -30.63 52.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.913 -0.585 . . . . 15.0 111.033 179.911 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.478 ' O ' ' CB ' ' A' ' 15' ' ' ASP . 39.5 t30 -84.62 137.58 33.2 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.224 -0.444 . . . . 15.0 110.816 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.478 ' CB ' ' O ' ' A' ' 14' ' ' ASN . 4.7 t70 89.47 -24.25 0.09 Allowed 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.902 -0.59 . . . . 15.0 111.305 -179.787 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.522 ' HB2' ' HB2' ' A' ' 45' ' ' ALA . 0.9 OUTLIER -165.39 136.12 3.81 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.868 0.366 . . . . 15.0 111.097 179.908 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.935 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 0.5 OUTLIER -86.09 -156.17 0.28 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.141 -0.481 . . . . 15.0 110.205 179.547 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.2 mp -104.78 -172.11 2.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.884 0.373 . . . . 15.0 110.749 179.591 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.777 ' O ' ' HB ' ' A' ' 41' ' ' ILE . . . -161.05 45.08 0.4 Allowed Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 121.152 -0.547 . . . . 15.0 111.935 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.703 HG12 ' O ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -112.77 139.69 36.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 120.974 0.416 . . . . 15.0 111.77 -179.549 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 45.0 t -94.98 104.05 15.91 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.084 -1.08 . . . . 15.0 108.084 177.65 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.949 HG21 HG23 ' A' ' 75' ' ' VAL . 10.6 m -93.73 153.9 3.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 113.124 0.787 . . . . 15.0 113.124 -177.037 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.33 -179.66 7.23 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 114.981 -1.009 . . . . 15.0 110.391 179.632 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.448 ' O ' ' CB ' ' A' ' 71' ' ' HIS . . . 76.71 -121.77 6.1 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.562 -0.828 . . . . 15.0 112.563 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.556 ' HA3' ' N ' ' A' ' 71' ' ' HIS . . . 68.2 -66.27 0.37 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.831 -0.699 . . . . 15.0 113.388 179.437 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.529 ' O ' HG22 ' A' ' 30' ' ' VAL . 1.6 m -28.34 138.76 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 N-CA-C 112.39 0.515 . . . . 15.0 112.39 -179.208 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.453 ' ND2' ' O ' ' A' ' 32' ' ' HIS . 8.3 m120 -76.25 60.08 1.46 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.951 -0.568 . . . . 15.0 111.041 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -151.78 -55.71 0.14 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.331 -0.395 . . . . 15.0 110.956 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.4 m -78.15 -46.23 21.16 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.17 -0.468 . . . . 15.0 111.019 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.529 HG22 ' O ' ' A' ' 26' ' ' VAL . 21.9 m -71.36 -173.72 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.244 -0.435 . . . . 15.0 111.192 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 6.1 mtp85 -57.34 -54.59 45.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.281 -0.418 . . . . 15.0 111.078 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' HIS . . . . . 0.453 ' O ' ' ND2' ' A' ' 27' ' ' ASN . 48.6 p-80 -151.8 -44.69 0.11 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.363 -0.38 . . . . 15.0 111.174 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -169.59 23.6 0.1 OUTLIER Glycine 0 CA--C 1.518 0.223 0 C-N-CA 120.816 -0.707 . . . . 15.0 112.615 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.502 ' O ' HG11 ' A' ' 30' ' ' VAL . . . -93.88 153.93 21.39 Favored Glycine 0 N--CA 1.449 -0.499 0 N-CA-C 110.429 -1.068 . . . . 15.0 110.429 178.747 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.911 HG22 HG22 ' A' ' 58' ' ' VAL . 0.1 OUTLIER -96.67 153.36 3.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 C-N-CA 119.601 -0.84 . . . . 15.0 112.371 -179.078 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.454 ' CE2' ' HG2' ' A' ' 57' ' ' ARG . 32.5 m-85 -135.67 106.96 6.79 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.63 -1.168 . . . . 15.0 109.27 179.289 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.785 HG22 ' N ' ' A' ' 55' ' ' GLY . 0.7 OUTLIER -55.03 149.36 2.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.147 0.499 . . . . 15.0 111.357 -178.554 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.485 ' O ' ' HG2' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -80.16 -50.46 10.25 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.628 -0.879 . . . . 15.0 108.628 178.739 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.703 ' O ' HG12 ' A' ' 20' ' ' ILE . . . -172.3 173.27 4.24 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 115.72 -0.673 . . . . 15.0 110.081 178.702 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.543 ' HA ' HG12 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -96.76 112.8 29.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 108.983 -0.747 . . . . 15.0 108.983 178.778 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.777 ' HB ' ' O ' ' A' ' 19' ' ' GLY . 0.4 OUTLIER -77.96 118.07 69.84 Favored Pre-proline 0 C--N 1.328 -0.338 0 N-CA-C 113.231 0.826 . . . . 15.0 113.231 -176.978 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.61 ' HA ' ' HG2' ' A' ' 47' ' ' GLU . 37.3 Cg_endo -64.88 61.67 0.29 Allowed 'Trans proline' 0 C--N 1.357 0.974 0 C-N-CA 123.457 2.771 . . . . 15.0 112.745 179.704 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.5 ' N ' ' HG2' ' A' ' 47' ' ' GLU . 4.3 mm-40 -151.51 -46.35 0.11 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.536 -0.302 . . . . 15.0 111.489 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.715 ' HA3' ' HA3' ' A' ' 19' ' ' GLY . . . -87.68 166.87 36.29 Favored Glycine 0 C--N 1.33 0.222 0 C-N-CA 120.312 -0.947 . . . . 15.0 113.618 -179.259 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.935 ' HB3' ' O ' ' A' ' 17' ' ' SER . . . -56.95 -13.91 3.09 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.616 0.599 . . . . 15.0 112.616 -179.613 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.04 -57.19 4.48 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.734 0.302 . . . . 15.0 110.782 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.61 ' HG2' ' HA ' ' A' ' 42' ' ' PRO . 2.8 pp20? -57.21 -42.93 82.25 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.19 -0.459 . . . . 15.0 110.397 179.383 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 22.9 t -53.95 -71.47 0.07 Allowed 'General case' 0 CA--C 1.52 -0.176 0 CA-C-N 115.976 -0.556 . . . . 15.0 110.626 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.619 ' CB ' HD11 ' A' ' 11' ' ' LEU . 0.4 OUTLIER -58.63 -40.78 84.33 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.391 -0.596 . . . . 15.0 109.391 178.901 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.93 45.02 7.89 Favored Glycine 0 N--CA 1.446 -0.65 0 CA-C-N 115.393 -0.822 . . . . 15.0 111.67 179.596 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.613 ' HB2' HD13 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -79.43 -54.36 6.0 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.892 0.377 . . . . 15.0 110.477 -179.325 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.623 ' CG1' HD12 ' A' ' 20' ' ' ILE . 8.3 tp -81.08 164.29 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 CA-C-N 115.991 -0.55 . . . . 15.0 110.362 179.55 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' HIS . . . . . 0.441 ' N ' ' OD2' ' A' ' 56' ' ' ASP . 74.5 m80 -146.34 157.13 43.76 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-O 121.659 0.742 . . . . 15.0 112.135 -179.063 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.563 ' HA ' ' CG2' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -44.13 133.52 5.19 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.229 -1.351 . . . . 15.0 112.975 -178.605 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.785 ' N ' HG22 ' A' ' 37' ' ' VAL . . . 49.99 31.28 17.61 Favored Glycine 0 C--N 1.336 0.538 0 CA-C-N 115.809 -0.632 . . . . 15.0 113.268 179.206 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.477 ' OD2' HD12 ' A' ' 52' ' ' ILE . 5.3 m-20 -65.72 129.31 39.32 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.887 -0.325 . . . . 15.0 110.733 179.691 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.454 ' HG2' ' CE2' ' A' ' 36' ' ' TYR . 50.6 mtt180 -80.74 88.32 5.79 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.233 -0.439 . . . . 15.0 110.313 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.911 HG22 HG22 ' A' ' 35' ' ' ILE . 1.4 m -79.45 112.05 17.01 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 CA-C-O 121.158 0.504 . . . . 15.0 111.058 -179.62 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 33.3 mt -107.49 -15.27 14.65 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 115.441 -0.8 . . . . 15.0 112.47 -179.137 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.781 ' HB3' ' HB2' ' A' ' 88' ' ' LEU . . . -149.49 148.28 29.22 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 112.765 0.654 . . . . 15.0 112.765 -178.673 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.744 HG11 ' O ' ' A' ' 77' ' ' THR . 15.4 t -139.11 99.87 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.263 -0.88 . . . . 15.0 109.083 178.733 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.552 ' OD1' HG22 ' A' ' 81' ' ' THR . 7.0 m120 65.19 16.42 10.54 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.28 -0.418 . . . . 15.0 109.881 -177.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 107.23 4.79 35.29 Favored Glycine 0 C--N 1.336 0.56 0 CA-C-N 115.924 -0.58 . . . . 15.0 113.531 179.658 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.644 HG13 ' O ' ' A' ' 64' ' ' VAL . 5.3 p -93.78 107.46 19.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 117.175 0.488 . . . . 15.0 110.882 179.511 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -56.57 135.6 54.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.211 -0.449 . . . . 15.0 111.163 -179.603 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.65 HD11 ' HB2' ' A' ' 74' ' ' ALA . 0.1 OUTLIER -97.16 -21.35 17.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.988 -0.551 . . . . 15.0 110.915 179.9 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -46.7 98.71 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.399 -0.364 . . . . 15.0 110.93 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.83 63.08 0.54 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.804 -0.713 . . . . 15.0 112.139 -179.545 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.704 ' HB1' ' CB ' ' A' ' 73' ' ' GLN . . . -173.0 143.18 1.14 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.841 0.353 . . . . 15.0 110.865 -179.812 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.465 ' HA ' ' N ' ' A' ' 26' ' ' VAL . 12.2 p -72.99 -173.16 1.18 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.255 -0.43 . . . . 15.0 111.208 -179.717 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.614 ' CE1' HG23 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -61.93 -59.69 4.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.89 -0.596 . . . . 15.0 110.514 -179.987 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 20.4 ttmt -52.64 -33.69 48.03 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.849 -0.614 . . . . 15.0 110.632 179.405 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.704 ' CB ' ' HB1' ' A' ' 69' ' ' ALA . 4.7 mt-30 -59.5 -52.66 64.64 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.784 -0.45 . . . . 15.0 109.784 179.447 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.864 ' HB3' HD12 ' A' ' 35' ' ' ILE . . . -66.86 -44.24 81.48 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.704 -0.48 . . . . 15.0 109.704 178.516 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.949 HG23 HG21 ' A' ' 22' ' ' VAL . 0.5 OUTLIER -43.01 -40.79 1.08 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.262 0 N-CA-C 109.012 -0.736 . . . . 15.0 109.012 178.412 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.406 ' O ' ' CB ' ' A' ' 80' ' ' ASN . 46.3 mt-10 -67.39 -44.65 78.35 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 114.789 -1.096 . . . . 15.0 110.369 178.533 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.744 ' O ' HG11 ' A' ' 61' ' ' VAL . 40.9 p -64.14 -54.52 32.5 Favored 'General case' 0 N--CA 1.462 0.151 0 C-N-CA 120.99 -0.284 . . . . 15.0 111.414 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.601 HD21 HG21 ' A' ' 58' ' ' VAL . 5.7 mt -53.56 -47.93 69.61 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-O 121.211 0.529 . . . . 15.0 110.012 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.41 ' HB2' ' O ' ' A' ' 75' ' ' VAL . 1.9 ttt-85 -68.35 -59.47 3.16 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.429 -0.805 . . . . 15.0 110.397 179.375 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.406 ' CB ' ' O ' ' A' ' 76' ' ' GLU . 14.2 m-20 -65.99 62.03 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.933 -0.576 . . . . 15.0 111.94 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.552 HG22 ' OD1' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -93.23 -71.36 0.66 Allowed 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 110.043 -0.355 . . . . 15.0 110.043 179.234 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 122.0 -108.02 1.25 Allowed Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.939 -0.648 . . . . 15.0 112.993 179.207 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.414 ' O ' ' HB3' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -65.17 -79.69 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.917 0.389 . . . . 15.0 111.623 -179.359 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.444 HG12 ' N ' ' A' ' 85' ' ' VAL . 77.6 t -110.21 158.25 10.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.952 -0.567 . . . . 15.0 111.087 -179.319 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.672 ' O ' HG12 ' A' ' 85' ' ' VAL . 6.8 t -97.93 82.35 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.056 -0.52 . . . . 15.0 110.46 179.753 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -101.91 85.02 2.62 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.793 -0.639 . . . . 15.0 110.379 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.849 ' HB3' HD21 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -103.86 122.94 46.19 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.925 -0.58 . . . . 15.0 111.808 -179.136 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.781 ' HB2' ' HB3' ' A' ' 60' ' ' ALA . 4.4 mp -97.69 101.37 12.86 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.586 -0.524 . . . . 15.0 109.586 178.802 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.849 HD21 ' HB3' ' A' ' 87' ' ' LEU . 0.1 OUTLIER -105.93 -161.8 0.82 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.456 0.646 . . . . 15.0 111.961 -178.46 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.452 ' HB2' HG13 ' A' ' 6' ' ' ILE . 4.6 tt0 -143.27 133.56 24.59 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 114.948 -1.024 . . . . 15.0 109.77 179.174 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.403 ' HG2' ' CG ' ' A' ' 3' ' ' PRO . 0.6 OUTLIER -46.95 106.14 0.08 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.994 0.426 . . . . 15.0 111.174 -179.669 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -70.61 -162.43 4.29 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.868 -0.682 . . . . 15.0 112.759 -179.663 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -76.26 152.35 36.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.847 0.356 . . . . 15.0 110.906 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -90.22 121.57 68.47 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.196 -0.457 . . . . 15.0 110.803 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_exo -51.53 -47.49 25.92 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.49 2.127 . . . . 15.0 112.27 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 2.9 p . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.233 -0.889 . . . . 15.0 110.887 179.98 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo . . . . . 0 N--CA 1.487 1.133 0 CA-C-O 120.799 0.25 . . . . 15.0 111.717 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.411 ' HA ' ' HD2' ' A' ' 3' ' ' PRO . 2.1 ptpt -145.37 107.6 4.46 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.207 -0.452 . . . . 15.0 110.855 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.506 ' HG2' ' HG2' ' A' ' 91' ' ' LYS . 21.2 Cg_endo -61.63 -73.79 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.407 2.071 . . . . 15.0 112.488 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 93.54 -28.56 9.79 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.513 -0.851 . . . . 15.0 112.011 -179.671 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -61.96 155.86 22.55 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-O 121.607 0.718 . . . . 15.0 110.874 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.461 HG13 ' HB2' ' A' ' 90' ' ' GLU . 1.2 mp -78.56 146.51 7.98 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 114.652 -1.158 . . . . 15.0 111.034 -179.58 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.605 ' CE1' HD12 ' A' ' 89' ' ' LEU . 3.4 p90 -140.19 163.87 31.59 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.224 -0.444 . . . . 15.0 110.261 178.838 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.732 ' HB3' HD12 ' A' ' 88' ' ' LEU . 4.9 pt-20 -130.17 143.24 50.67 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.295 0.569 . . . . 15.0 111.848 -178.88 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.511 HG23 ' HB3' ' A' ' 51' ' ' ARG . 0.2 OUTLIER -101.61 115.34 43.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.23 -0.895 . . . . 15.0 109.696 178.74 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -105.84 72.54 0.96 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.243 -0.435 . . . . 15.0 112.121 -178.839 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.536 HD11 ' CB ' ' A' ' 49' ' ' ASP . 6.3 tp -88.12 165.6 15.0 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.561 -0.533 . . . . 15.0 109.561 178.719 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -96.13 92.7 6.54 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.993 0.425 . . . . 15.0 111.331 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.711 ' CB ' HG23 ' A' ' 85' ' ' VAL . 0.1 OUTLIER -56.84 -26.61 58.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.892 -0.595 . . . . 15.0 111.061 179.824 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -83.95 -48.81 9.58 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.238 -0.437 . . . . 15.0 110.776 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -58.48 -38.68 78.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.995 0.426 . . . . 15.0 110.301 179.615 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -165.52 162.76 19.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.841 -0.618 . . . . 15.0 110.671 179.718 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.834 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 0.1 OUTLIER -86.03 -161.37 0.63 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.432 -0.349 . . . . 15.0 110.292 179.653 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.666 ' N ' HD22 ' A' ' 18' ' ' LEU . 1.4 mm? -94.54 -172.29 2.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.914 0.388 . . . . 15.0 110.726 179.556 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.654 ' O ' ' HB ' ' A' ' 41' ' ' ILE . . . -162.84 33.75 0.31 Allowed Glycine 0 N--CA 1.449 -0.465 0 CA-C-N 115.91 -0.586 . . . . 15.0 111.717 -179.678 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.635 HD12 ' CG1' ' A' ' 52' ' ' ILE . 0.0 OUTLIER -112.72 139.96 35.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 121.131 0.491 . . . . 15.0 112.033 -179.261 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.463 ' O ' ' HB3' ' A' ' 38' ' ' LYS . 43.2 t -96.33 100.96 12.53 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 107.396 -1.335 . . . . 15.0 107.396 176.912 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.629 HG12 ' CG2' ' A' ' 20' ' ' ILE . 1.1 m -93.62 153.82 3.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 112.769 0.655 . . . . 15.0 112.769 -176.777 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.681 ' HA ' ' CD2' ' A' ' 71' ' ' HIS . 11.1 t -149.6 -173.48 4.42 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.223 -0.899 . . . . 15.0 110.369 179.317 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.683 ' O ' HG22 ' A' ' 26' ' ' VAL . . . 75.88 -113.94 4.05 Favored Glycine 0 C--N 1.33 0.23 0 C-N-CA 120.517 -0.849 . . . . 15.0 112.347 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.582 ' HA3' ' N ' ' A' ' 71' ' ' HIS . . . 63.59 -65.84 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 121.06 -0.591 . . . . 15.0 113.724 179.175 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.683 HG22 ' O ' ' A' ' 24' ' ' GLY . 0.0 OUTLIER -26.07 139.55 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 N-CA-C 112.51 0.559 . . . . 15.0 112.51 -179.015 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 17.5 m-20 -75.64 61.21 1.33 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.806 -0.634 . . . . 15.0 111.046 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -151.75 -66.49 0.18 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.317 -0.402 . . . . 15.0 111.095 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.8 m -67.79 -34.26 76.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.129 -0.487 . . . . 15.0 111.061 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.559 HG22 ' O ' ' A' ' 26' ' ' VAL . 21.0 m -85.67 -174.33 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.302 -0.408 . . . . 15.0 111.171 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 8.9 mtp180 -57.78 -61.26 2.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.251 -0.431 . . . . 15.0 111.033 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 9.2 p80 -143.25 -45.95 0.29 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.253 -0.43 . . . . 15.0 111.018 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -169.18 25.7 0.11 Allowed Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.901 -0.666 . . . . 15.0 112.491 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.459 ' O ' HG11 ' A' ' 30' ' ' VAL . . . -90.9 151.31 21.1 Favored Glycine 0 N--CA 1.447 -0.588 0 N-CA-C 110.519 -1.032 . . . . 15.0 110.519 178.809 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.919 HG22 HG22 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -94.74 152.87 3.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 C-N-CA 119.9 -0.72 . . . . 15.0 112.238 -179.112 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.466 ' CZ ' ' HG2' ' A' ' 57' ' ' ARG . 18.9 m-85 -135.29 107.4 7.17 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.652 -1.158 . . . . 15.0 109.364 179.396 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.788 HG22 ' N ' ' A' ' 55' ' ' GLY . 0.8 OUTLIER -55.14 149.42 2.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 116.102 -0.499 . . . . 15.0 111.462 -178.581 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.482 ' HB2' HG22 ' A' ' 23' ' ' THR . 0.0 OUTLIER -81.19 -48.03 12.64 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.668 -0.864 . . . . 15.0 108.668 178.266 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.582 ' O ' HG12 ' A' ' 20' ' ' ILE . . . -172.29 170.77 4.99 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 115.757 -0.656 . . . . 15.0 110.234 178.5 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.562 ' HA ' HG12 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -97.18 111.81 27.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.055 0.455 . . . . 15.0 110.344 179.575 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.654 ' HB ' ' O ' ' A' ' 19' ' ' GLY . 0.4 OUTLIER -78.56 109.14 9.58 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 115.74 -0.663 . . . . 15.0 112.238 -178.428 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.451 ' N ' ' HG2' ' A' ' 47' ' ' GLU . 30.2 Cg_endo -63.12 65.54 0.16 Allowed 'Trans proline' 0 C--N 1.356 0.944 0 C-N-CA 123.192 2.595 . . . . 15.0 112.591 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.449 ' N ' ' O ' ' A' ' 41' ' ' ILE . 42.2 tt0 -147.44 -53.37 0.21 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.392 -0.822 . . . . 15.0 109.317 179.418 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.552 ' HA3' ' HA3' ' A' ' 19' ' ' GLY . . . -88.02 157.32 28.21 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.684 -0.769 . . . . 15.0 112.528 179.147 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.834 ' HB3' ' O ' ' A' ' 17' ' ' SER . . . -41.73 -16.73 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 113.51 0.93 . . . . 15.0 113.51 -179.64 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.442 ' N ' ' O ' ' A' ' 44' ' ' GLY . . . -71.5 -71.38 0.27 Allowed 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.768 -0.373 . . . . 15.0 111.159 -179.464 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.501 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 4.3 tp10 -58.59 -40.51 83.39 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-O 120.958 0.409 . . . . 15.0 110.312 179.364 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.7 t -55.51 -63.98 0.99 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.976 -0.556 . . . . 15.0 110.278 179.379 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.536 ' CB ' HD11 ' A' ' 11' ' ' LEU . 5.6 t0 -62.69 -39.08 92.88 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.146 0.498 . . . . 15.0 109.89 179.053 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.55 36.81 18.95 Favored Glycine 0 N--CA 1.448 -0.512 0 CA-C-N 115.58 -0.736 . . . . 15.0 112.651 179.53 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.513 ' HG3' HD13 ' A' ' 11' ' ' LEU . 1.7 mmt85 -83.69 -53.44 5.64 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.928 0.394 . . . . 15.0 110.607 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.635 ' CG1' HD12 ' A' ' 20' ' ' ILE . 11.0 tp -81.15 157.85 4.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.977 -0.556 . . . . 15.0 110.183 179.581 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 78.5 m-70 -139.75 160.37 40.03 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-O 121.832 0.825 . . . . 15.0 113.097 -178.554 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.6 ' HA ' ' CG2' ' A' ' 37' ' ' VAL . 1.0 OUTLIER -45.28 135.13 6.08 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 113.821 -1.536 . . . . 15.0 112.742 -178.865 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.788 ' N ' HG22 ' A' ' 37' ' ' VAL . . . 49.69 32.75 17.67 Favored Glycine 0 C--N 1.335 0.499 0 CA-C-N 116.031 -0.531 . . . . 15.0 113.116 179.146 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.461 ' OD2' HD12 ' A' ' 52' ' ' ILE . 3.5 m-20 -65.72 130.65 44.02 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.95 -0.3 . . . . 15.0 110.821 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.763 ' CD ' HD21 ' A' ' 59' ' ' LEU . 0.0 OUTLIER -84.4 86.37 7.28 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.11 -0.495 . . . . 15.0 110.345 179.579 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.919 HG22 HG22 ' A' ' 35' ' ' ILE . 1.5 m -79.39 113.44 18.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 CA-C-N 116.162 -0.472 . . . . 15.0 111.17 -179.466 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.763 HD21 ' CD ' ' A' ' 57' ' ' ARG . 19.2 mt -107.26 -13.06 15.22 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.819 -0.628 . . . . 15.0 112.41 -179.332 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.572 ' O ' HD23 ' A' ' 87' ' ' LEU . . . -150.62 147.35 27.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.192 0.52 . . . . 15.0 112.313 -178.825 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.841 HG21 HD23 ' A' ' 78' ' ' LEU . 60.6 t -138.72 102.88 1.97 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.275 0 CA-C-N 115.484 -0.78 . . . . 15.0 109.047 178.811 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.596 ' OD1' HG22 ' A' ' 81' ' ' THR . 2.7 m120 64.94 16.32 10.46 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.71 -0.478 . . . . 15.0 109.71 -178.089 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 105.32 5.17 40.4 Favored Glycine 0 C--N 1.337 0.617 0 CA-C-N 115.82 -0.627 . . . . 15.0 113.23 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.653 HG13 ' O ' ' A' ' 64' ' ' VAL . 6.7 p -93.85 107.53 19.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.006 0.432 . . . . 15.0 111.046 179.6 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.2 m -55.8 133.08 50.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.269 -0.423 . . . . 15.0 111.083 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.593 HD11 ' HB2' ' A' ' 74' ' ' ALA . 0.1 OUTLIER -91.59 -21.68 20.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.001 -0.545 . . . . 15.0 111.026 179.992 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -43.85 97.41 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 120.905 0.383 . . . . 15.0 110.978 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.85 64.26 0.56 Allowed Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.866 -0.683 . . . . 15.0 112.058 -179.534 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.785 ' HB1' ' HB3' ' A' ' 73' ' ' GLN . . . -172.98 135.68 0.62 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.895 0.379 . . . . 15.0 110.982 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.431 ' HA ' ' N ' ' A' ' 26' ' ' VAL . 10.2 p -72.9 -171.45 0.87 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.112 0.482 . . . . 15.0 111.31 -179.66 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.681 ' CD2' ' HA ' ' A' ' 23' ' ' THR . 0.0 OUTLIER -58.33 -63.08 1.4 Allowed 'General case' 0 CA--C 1.517 -0.315 0 CA-C-N 115.721 -0.672 . . . . 15.0 109.814 179.812 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 13.5 ttpp -53.23 -36.12 60.71 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.316 -0.856 . . . . 15.0 110.574 179.189 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.785 ' HB3' ' HB1' ' A' ' 69' ' ' ALA . 5.8 mt-30 -59.32 -50.75 72.79 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 116.149 -0.478 . . . . 15.0 109.715 179.475 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.801 ' HB3' HD12 ' A' ' 35' ' ' ILE . . . -66.96 -47.39 71.75 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.059 -0.519 . . . . 15.0 109.665 178.495 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.615 HG23 ' CG2' ' A' ' 22' ' ' VAL . 0.5 OUTLIER -40.84 -41.19 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.23 0 CA-C-N 115.522 -0.763 . . . . 15.0 109.472 178.643 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -67.18 -46.05 75.1 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 114.884 -1.053 . . . . 15.0 110.781 179.092 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.656 ' O ' HG11 ' A' ' 61' ' ' VAL . 2.5 p -64.6 -53.28 50.17 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 120.79 -0.364 . . . . 15.0 111.529 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.841 HD23 HG21 ' A' ' 61' ' ' VAL . 3.8 mt -53.4 -48.41 68.71 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-O 121.185 0.517 . . . . 15.0 110.07 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.4 ' O ' ' N ' ' A' ' 81' ' ' THR . 4.1 ttt85 -68.46 -57.4 5.89 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.575 -0.739 . . . . 15.0 110.492 179.282 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 63.3 m-20 -66.0 62.77 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.879 -0.6 . . . . 15.0 111.948 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.596 HG22 ' OD1' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -95.37 -71.71 0.66 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.769 0.318 . . . . 15.0 110.22 179.221 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 122.04 -104.05 0.89 Allowed Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.744 -0.741 . . . . 15.0 113.185 179.244 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.418 ' O ' ' HB3' ' A' ' 13' ' ' LYS . 0.4 OUTLIER -64.59 -84.49 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 111.975 0.361 . . . . 15.0 111.975 -179.072 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.461 HG12 ' N ' ' A' ' 85' ' ' VAL . 74.1 t -109.65 160.17 8.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.873 0.368 . . . . 15.0 110.897 -179.528 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.711 HG23 ' CB ' ' A' ' 13' ' ' LYS . 12.9 t -97.83 81.23 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.118 0.485 . . . . 15.0 110.56 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -101.15 84.69 2.69 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.778 -0.646 . . . . 15.0 110.429 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.742 ' HB3' HD21 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -103.19 121.06 41.89 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.06 -0.518 . . . . 15.0 111.743 -179.226 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.732 HD12 ' HB3' ' A' ' 8' ' ' GLU . 0.2 OUTLIER -97.52 101.53 13.08 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.374 -0.602 . . . . 15.0 109.374 178.636 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.742 HD21 ' HB3' ' A' ' 87' ' ' LEU . 0.1 OUTLIER -105.89 -161.89 0.83 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.598 0.713 . . . . 15.0 112.347 -178.451 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.461 ' HB2' HG13 ' A' ' 6' ' ' ILE . 3.4 tt0 -142.17 132.66 25.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 114.609 -1.178 . . . . 15.0 109.059 178.842 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.506 ' HG2' ' HG2' ' A' ' 3' ' ' PRO . 0.0 OUTLIER -49.54 100.13 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.003 0.43 . . . . 15.0 111.19 -179.393 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -65.36 -129.74 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.404 0 CA-C-N 115.766 -0.652 . . . . 15.0 112.703 -179.737 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -76.15 111.65 11.78 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.834 0.349 . . . . 15.0 110.951 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -74.74 152.52 87.1 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.172 -0.467 . . . . 15.0 110.906 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_exo -51.28 175.52 0.05 OUTLIER 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.607 2.205 . . . . 15.0 112.295 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 3.5 t . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.209 -0.901 . . . . 15.0 110.85 -179.969 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_endo . . . . . 0 N--CA 1.488 1.192 0 CA-C-O 120.861 0.275 . . . . 15.0 111.778 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.97 66.94 9.86 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.162 -0.472 . . . . 15.0 110.827 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -65.09 -169.31 0.13 Allowed 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.411 2.074 . . . . 15.0 112.51 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 86.09 -19.8 24.39 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.768 -0.729 . . . . 15.0 112.003 -179.407 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -72.55 162.8 29.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.293 0.568 . . . . 15.0 111.04 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.419 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 1.4 mp -104.39 144.08 15.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.185 -0.916 . . . . 15.0 110.883 -179.655 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.589 ' CE1' HD12 ' A' ' 89' ' ' LEU . 4.2 p90 -140.61 165.74 26.64 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.378 -0.374 . . . . 15.0 110.446 178.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.718 ' CB ' HD12 ' A' ' 88' ' ' LEU . 10.7 pt-20 -130.11 143.09 50.59 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.295 0.569 . . . . 15.0 111.55 -179.32 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.578 ' CG1' HD11 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -101.54 115.44 43.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.203 -0.908 . . . . 15.0 109.548 178.84 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -106.0 72.28 0.94 Allowed 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.193 0.442 . . . . 15.0 112.193 -178.708 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.598 HD13 ' HG3' ' A' ' 51' ' ' ARG . 5.8 tp -88.33 166.55 14.21 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 109.685 -0.487 . . . . 15.0 109.685 178.636 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -95.73 95.31 8.23 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.006 0.431 . . . . 15.0 111.167 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.689 ' CB ' HG23 ' A' ' 85' ' ' VAL . 0.2 OUTLIER -58.64 -26.3 63.6 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.803 -0.635 . . . . 15.0 111.225 -179.972 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -83.95 -49.44 8.97 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.373 -0.376 . . . . 15.0 111.045 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -56.06 -41.52 75.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.972 0.415 . . . . 15.0 110.453 179.616 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.51 ' HB3' ' HB2' ' A' ' 45' ' ' ALA . 1.9 t-20 -165.57 159.25 16.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.842 -0.617 . . . . 15.0 110.632 179.717 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.823 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 0.6 OUTLIER -85.94 -168.31 2.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.404 -0.362 . . . . 15.0 110.358 179.657 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.662 ' N ' HD22 ' A' ' 18' ' ' LEU . 1.0 OUTLIER -96.12 -174.31 3.06 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.931 0.396 . . . . 15.0 110.775 179.539 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.748 ' O ' ' HB ' ' A' ' 41' ' ' ILE . . . -162.38 44.1 0.36 Allowed Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.966 -0.635 . . . . 15.0 111.932 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.641 HG12 ' O ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -112.67 140.27 33.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 120.979 0.419 . . . . 15.0 111.622 -179.571 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.5 t -94.59 102.41 14.33 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 107.613 -1.255 . . . . 15.0 107.613 177.415 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.877 HG21 HG23 ' A' ' 75' ' ' VAL . 3.8 m -93.63 148.95 4.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 113.212 0.819 . . . . 15.0 113.212 -176.629 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.559 ' O ' ' O ' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -149.62 158.02 43.78 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 115.335 -0.848 . . . . 15.0 111.026 179.996 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.414 ' O ' HG12 ' A' ' 35' ' ' ILE . . . 67.7 116.5 0.02 OUTLIER Glycine 0 N--CA 1.453 -0.182 0 C-N-CA 120.589 -0.815 . . . . 15.0 113.421 178.664 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.514 ' HA3' ' N ' ' A' ' 71' ' ' HIS . . . -164.65 -39.05 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.964 -0.636 . . . . 15.0 112.501 179.225 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.504 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 0.2 OUTLIER -39.86 160.09 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-O 120.803 0.335 . . . . 15.0 111.736 179.791 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -85.45 52.18 2.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.314 -0.403 . . . . 15.0 111.024 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -151.8 -63.03 0.17 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.156 -0.475 . . . . 15.0 110.767 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.83 -51.8 51.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.216 -0.447 . . . . 15.0 110.689 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.461 HG22 ' O ' ' A' ' 26' ' ' VAL . 17.7 m -88.06 -177.8 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.107 -0.497 . . . . 15.0 110.76 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.41 ' O ' ' N ' ' A' ' 33' ' ' GLY . 0.2 OUTLIER -85.48 134.28 34.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.974 0.416 . . . . 15.0 111.062 -179.926 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 54.26 -85.42 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.657 -0.701 . . . . 15.0 111.578 179.635 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 31' ' ' ARG . . . -172.46 31.78 0.12 Allowed Glycine 0 C--N 1.331 0.272 0 C-N-CA 120.977 -0.63 . . . . 15.0 112.196 -179.498 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -95.25 158.67 22.37 Favored Glycine 0 N--CA 1.449 -0.446 0 N-CA-C 110.807 -0.917 . . . . 15.0 110.807 179.151 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 1.043 HG22 HG22 ' A' ' 58' ' ' VAL . 0.1 OUTLIER -98.31 154.99 3.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 C-N-CA 119.996 -0.682 . . . . 15.0 111.993 -179.355 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.559 ' O ' ' O ' ' A' ' 23' ' ' THR . 14.1 m-85 -135.16 108.94 8.04 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.365 -0.834 . . . . 15.0 109.767 179.498 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.762 HG22 ' N ' ' A' ' 55' ' ' GLY . 0.8 OUTLIER -54.8 149.54 2.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 121.262 0.553 . . . . 15.0 111.626 -178.45 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.508 ' O ' ' HG2' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -80.17 -47.46 14.67 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.32 -0.992 . . . . 15.0 108.32 178.516 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.641 ' O ' HG12 ' A' ' 20' ' ' ILE . . . -172.51 174.16 3.86 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.349 -0.841 . . . . 15.0 110.114 178.614 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.556 ' HA ' HG12 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -96.81 110.09 24.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 108.938 -0.764 . . . . 15.0 108.938 178.741 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.748 ' HB ' ' O ' ' A' ' 19' ' ' GLY . 0.7 OUTLIER -78.12 116.43 58.75 Favored Pre-proline 0 C--N 1.328 -0.365 0 N-CA-C 113.488 0.922 . . . . 15.0 113.488 -176.916 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.609 ' HA ' ' CG ' ' A' ' 47' ' ' GLU . 39.1 Cg_exo -61.33 61.39 0.1 Allowed 'Trans proline' 0 C--N 1.358 1.074 0 C-N-CA 123.752 2.968 . . . . 15.0 112.969 179.725 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.519 ' H ' ' HG2' ' A' ' 47' ' ' GLU . 2.9 mm-40 -149.83 -48.63 0.13 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.619 0.247 . . . . 15.0 111.554 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.74 ' HA3' ' HA3' ' A' ' 19' ' ' GLY . . . -87.79 168.69 37.95 Favored Glycine 0 CA--C 1.517 0.195 0 C-N-CA 120.362 -0.923 . . . . 15.0 113.905 -179.116 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.823 ' HB3' ' O ' ' A' ' 17' ' ' SER . . . -57.72 -12.35 2.89 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.549 0.574 . . . . 15.0 112.549 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.425 ' HB1' HG22 ' A' ' 52' ' ' ILE . . . -71.78 -58.5 3.41 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.854 0.359 . . . . 15.0 110.435 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.609 ' CG ' ' HA ' ' A' ' 42' ' ' PRO . 2.9 pp20? -57.67 -43.43 85.02 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.686 -0.688 . . . . 15.0 110.473 179.159 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -53.78 -71.31 0.08 Allowed 'General case' 0 CA--C 1.519 -0.225 0 CA-C-N 115.87 -0.604 . . . . 15.0 110.581 -179.398 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.548 ' CB ' HD11 ' A' ' 11' ' ' LEU . 0.7 OUTLIER -58.13 -41.24 83.22 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.141 -0.688 . . . . 15.0 109.141 178.778 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.79 39.57 13.61 Favored Glycine 0 N--CA 1.445 -0.702 0 CA-C-N 115.319 -0.855 . . . . 15.0 111.665 179.379 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.598 ' HG3' HD13 ' A' ' 11' ' ' LEU . 0.8 OUTLIER -79.72 -49.44 12.07 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.873 0.368 . . . . 15.0 110.573 -179.3 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.593 ' CG1' HD12 ' A' ' 20' ' ' ILE . 9.3 tp -81.01 160.6 3.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 116.037 -0.528 . . . . 15.0 110.181 179.411 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' HIS . . . . . 0.471 ' O ' ' HB2' ' A' ' 56' ' ' ASP . 63.5 m80 -144.31 158.68 43.61 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-O 121.644 0.735 . . . . 15.0 112.146 -179.13 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.553 ' HA ' ' CG2' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -43.81 134.01 4.57 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.437 -1.256 . . . . 15.0 112.607 -178.734 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.762 ' N ' HG22 ' A' ' 37' ' ' VAL . . . 49.98 34.34 23.1 Favored Glycine 0 C--N 1.333 0.394 0 CA-C-N 115.827 -0.624 . . . . 15.0 113.44 179.397 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.471 ' HB2' ' O ' ' A' ' 53' ' ' HIS . 0.4 OUTLIER -65.99 130.37 43.01 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.584 -0.446 . . . . 15.0 110.561 179.481 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.423 ' HE ' HD21 ' A' ' 59' ' ' LEU . 39.0 ttt180 -84.58 87.65 7.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.175 -0.466 . . . . 15.0 110.12 179.502 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 1.043 HG22 HG22 ' A' ' 35' ' ' ILE . 1.5 m -79.26 113.01 18.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 CA-C-O 121.187 0.518 . . . . 15.0 111.032 -179.413 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.423 HD21 ' HE ' ' A' ' 57' ' ' ARG . 23.7 mt -107.34 -11.77 15.48 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 115.424 -0.807 . . . . 15.0 112.304 -179.179 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.847 ' HB3' ' HB2' ' A' ' 88' ' ' LEU . . . -150.81 144.48 25.1 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.165 0.507 . . . . 15.0 112.323 -178.855 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.796 HG21 ' OG1' ' A' ' 77' ' ' THR . 14.8 t -139.24 102.21 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.487 -0.779 . . . . 15.0 109.569 178.848 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.716 ' OD1' HG22 ' A' ' 81' ' ' THR . 2.7 m120 64.71 15.39 9.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.017 0.437 . . . . 15.0 109.83 -178.377 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 107.15 6.03 34.43 Favored Glycine 0 C--N 1.336 0.554 0 CA-C-N 115.903 -0.589 . . . . 15.0 113.409 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.659 HG13 ' O ' ' A' ' 64' ' ' VAL . 6.4 p -93.77 105.41 16.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 117.213 0.506 . . . . 15.0 110.907 179.413 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -58.76 127.91 34.57 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.099 -0.501 . . . . 15.0 110.986 -179.692 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -87.66 -20.01 26.89 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.029 -0.532 . . . . 15.0 110.864 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -47.77 97.91 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.896 0.379 . . . . 15.0 110.768 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.8 64.48 0.56 Allowed Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.738 -0.744 . . . . 15.0 112.022 -179.508 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.713 ' HB1' ' CG ' ' A' ' 73' ' ' GLN . . . -172.68 166.76 5.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.882 0.373 . . . . 15.0 110.949 -179.655 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.504 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 11.5 p -93.38 -174.42 3.51 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.064 0.459 . . . . 15.0 111.506 -179.461 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.569 ' CE1' HG23 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -62.95 -60.36 3.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.745 -0.661 . . . . 15.0 110.51 -179.862 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.428 ' O ' ' HG3' ' A' ' 76' ' ' GLU . 8.3 ttpp -52.37 -29.5 24.25 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.88 -0.6 . . . . 15.0 110.343 179.511 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.713 ' CG ' ' HB1' ' A' ' 69' ' ' ALA . 0.4 OUTLIER -59.31 -50.24 74.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.138 -0.483 . . . . 15.0 109.842 179.371 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.47 ' O ' ' N ' ' A' ' 77' ' ' THR . . . -67.09 -47.46 71.16 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 109.597 -0.52 . . . . 15.0 109.597 178.572 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.877 HG23 HG21 ' A' ' 22' ' ' VAL . 0.5 OUTLIER -41.44 -41.05 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.251 0 N-CA-C 108.95 -0.759 . . . . 15.0 108.95 178.202 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.45 ' O ' ' N ' ' A' ' 80' ' ' ASN . 62.0 mt-10 -67.64 -46.49 72.33 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 114.711 -1.131 . . . . 15.0 110.317 178.434 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.796 ' OG1' HG21 ' A' ' 61' ' ' VAL . 32.6 p -64.34 -51.4 63.59 Favored 'General case' 0 C--O 1.231 0.119 0 C-N-CA 120.851 -0.34 . . . . 15.0 111.193 179.708 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.584 HD21 HG21 ' A' ' 58' ' ' VAL . 5.3 mt -53.67 -50.55 65.57 Favored 'General case' 0 CA--C 1.521 -0.168 0 CA-C-O 121.249 0.547 . . . . 15.0 109.801 179.798 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 21.8 ttt180 -68.46 -61.9 1.63 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.31 -0.859 . . . . 15.0 110.472 179.359 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.45 ' N ' ' O ' ' A' ' 76' ' ' GLU . 9.5 m-20 -66.04 61.68 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.878 -0.601 . . . . 15.0 111.997 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.716 HG22 ' OD1' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -94.16 -67.18 0.87 Allowed 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 110.062 -0.348 . . . . 15.0 110.062 179.193 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 122.28 -108.96 1.34 Allowed Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.864 -0.684 . . . . 15.0 113.118 179.153 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -65.39 -79.17 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.772 0.32 . . . . 15.0 111.696 -179.157 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.45 HG12 ' N ' ' A' ' 85' ' ' VAL . 63.8 t -109.94 159.2 9.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.023 0.44 . . . . 15.0 111.034 -179.337 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.689 HG23 ' CB ' ' A' ' 13' ' ' LYS . 9.4 t -97.86 81.26 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.095 -0.502 . . . . 15.0 110.402 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -100.78 85.0 2.8 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.748 -0.66 . . . . 15.0 110.28 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.792 ' HB3' HD21 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -103.32 119.61 39.21 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.009 -0.541 . . . . 15.0 111.893 -179.003 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.847 ' HB2' ' HB3' ' A' ' 60' ' ' ALA . 4.6 mp -94.59 101.64 13.52 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.451 -0.574 . . . . 15.0 109.451 178.564 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.792 HD21 ' HB3' ' A' ' 87' ' ' LEU . 0.2 OUTLIER -105.64 -163.48 0.94 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.346 0.594 . . . . 15.0 111.982 -178.55 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.419 ' HA ' ' HA ' ' A' ' 6' ' ' ILE . 2.6 tt0 -140.97 131.77 25.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.01 -0.996 . . . . 15.0 109.796 179.143 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.62 94.92 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.863 0.363 . . . . 15.0 111.122 -179.63 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -63.71 164.03 31.57 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.945 -0.645 . . . . 15.0 112.729 -179.73 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 8.4 mm100 -86.31 122.3 30.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.825 0.345 . . . . 15.0 110.747 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 36.4 m -89.59 144.01 31.33 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.22 -0.445 . . . . 15.0 110.87 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -52.81 -62.07 0.4 Allowed 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.533 2.155 . . . . 15.0 112.271 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 7.7 p . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.262 -0.875 . . . . 15.0 110.833 -179.988 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo . . . . . 0 N--CA 1.487 1.127 0 CA-C-O 120.839 0.266 . . . . 15.0 111.871 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.54 ' HB3' ' HD3' ' A' ' 3' ' ' PRO . 1.5 tttm -155.19 -63.14 0.02 OUTLIER Pre-proline 0 CA--C 1.534 0.327 0 CA-C-N 116.168 -0.469 . . . . 15.0 110.851 -179.781 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.54 ' HD3' ' HB3' ' A' ' 2' ' ' LYS . 74.1 Cg_exo -41.58 109.82 0.12 Allowed 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.694 2.262 . . . . 15.0 113.107 179.769 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 83.11 -23.46 6.04 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.433 -0.889 . . . . 15.0 112.728 179.611 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.413 ' HB2' ' O ' ' A' ' 2' ' ' LYS . 0.7 OUTLIER -61.56 150.8 34.97 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-O 121.473 0.654 . . . . 15.0 110.823 -179.921 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.502 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 1.4 mp -89.62 149.7 3.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 114.949 -1.023 . . . . 15.0 111.529 -178.838 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.722 ' CE1' HD12 ' A' ' 89' ' ' LEU . 7.6 p90 -144.71 164.22 31.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.913 -0.585 . . . . 15.0 110.048 178.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.729 ' HB3' HD12 ' A' ' 88' ' ' LEU . 5.6 pt-20 -130.26 142.54 50.55 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.369 0.604 . . . . 15.0 111.907 -179.289 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.525 ' CG1' HD11 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -101.65 114.4 40.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.117 -0.947 . . . . 15.0 109.638 178.85 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -106.15 72.74 0.95 Allowed 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 112.351 0.501 . . . . 15.0 112.351 -178.77 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.676 HD13 ' HG3' ' A' ' 51' ' ' ARG . 6.0 tp -88.36 165.91 14.63 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.668 -0.493 . . . . 15.0 109.668 178.609 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.555 ' HB1' ' HB2' ' A' ' 15' ' ' ASP . . . -96.15 94.43 7.52 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.003 0.43 . . . . 15.0 111.149 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.688 ' CB ' HG23 ' A' ' 85' ' ' VAL . 0.1 OUTLIER -60.18 -30.84 69.61 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.764 -0.653 . . . . 15.0 111.315 -179.927 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.403 ' N ' ' O ' ' A' ' 83' ' ' GLN . 1.5 t30 -84.44 -30.48 25.26 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.322 -0.399 . . . . 15.0 110.964 -179.616 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.555 ' HB2' ' HB1' ' A' ' 12' ' ' ALA . 1.1 t70 -78.0 -36.59 48.62 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.013 0.435 . . . . 15.0 110.12 179.255 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.483 ' HB3' ' HB2' ' A' ' 45' ' ' ALA . 1.1 m-20 -165.49 156.71 14.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.806 -0.634 . . . . 15.0 110.625 179.634 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.918 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 0.3 OUTLIER -86.02 -158.27 0.39 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.353 -0.385 . . . . 15.0 110.297 179.695 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.678 ' N ' HD22 ' A' ' 18' ' ' LEU . 0.4 OUTLIER -109.66 -166.14 1.07 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.813 0.34 . . . . 15.0 110.689 179.603 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.789 ' O ' ' HB ' ' A' ' 41' ' ' ILE . . . -173.2 44.68 0.16 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.921 -0.657 . . . . 15.0 111.913 -179.747 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.731 HG12 ' O ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -112.61 137.29 46.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 120.996 0.427 . . . . 15.0 111.579 -179.611 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.41 ' H ' HD13 ' A' ' 41' ' ' ILE . 29.1 t -88.86 105.5 17.78 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 107.865 -1.161 . . . . 15.0 107.865 177.516 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 1.014 HG21 HG23 ' A' ' 75' ' ' VAL . 34.8 m -93.37 152.5 3.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 112.618 0.599 . . . . 15.0 112.618 -177.155 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.424 ' OG1' ' CB ' ' A' ' 38' ' ' LYS . 0.8 OUTLIER -149.14 -178.62 6.48 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.245 -0.889 . . . . 15.0 110.807 -179.565 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.608 ' O ' HG22 ' A' ' 26' ' ' VAL . . . 70.16 -119.36 8.67 Favored Glycine 0 C--N 1.333 0.372 0 C-N-CA 120.856 -0.688 . . . . 15.0 112.421 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.518 ' HA3' ' N ' ' A' ' 71' ' ' HIS . . . 66.61 -65.62 0.17 Allowed Glycine 0 C--N 1.331 0.259 0 C-N-CA 121.013 -0.613 . . . . 15.0 113.61 179.402 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.608 HG22 ' O ' ' A' ' 24' ' ' GLY . 0.0 OUTLIER -28.14 140.33 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 N-CA-C 112.457 0.54 . . . . 15.0 112.457 -179.353 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.412 ' HA ' ' O ' ' A' ' 32' ' ' HIS . 59.5 t-20 -77.33 58.07 1.59 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.904 -0.589 . . . . 15.0 111.075 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.0 m -151.83 -48.28 0.11 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.283 -0.417 . . . . 15.0 110.935 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 21.6 m -83.2 -46.68 12.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 15.0 111.053 -179.836 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.523 HG22 ' O ' ' A' ' 26' ' ' VAL . 33.2 m -69.95 -174.62 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.262 -0.426 . . . . 15.0 111.169 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 10.0 mmp_? -67.59 -44.85 77.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.242 -0.436 . . . . 15.0 111.052 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' HIS . . . . . 0.412 ' O ' ' HA ' ' A' ' 27' ' ' ASN . 43.3 m80 -143.28 -68.41 0.34 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.306 -0.406 . . . . 15.0 111.004 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -161.43 19.52 0.19 Allowed Glycine 0 CA--C 1.517 0.189 0 C-N-CA 120.892 -0.671 . . . . 15.0 112.559 -179.836 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -83.64 150.67 27.06 Favored Glycine 0 N--CA 1.449 -0.493 0 N-CA-C 110.767 -0.933 . . . . 15.0 110.767 178.848 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.893 HG22 HG22 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -85.79 154.94 3.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 C-N-CA 120.031 -0.667 . . . . 15.0 111.745 -179.294 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.516 ' CE2' ' HG2' ' A' ' 57' ' ' ARG . 30.4 m-85 -139.2 106.8 5.59 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.041 -0.981 . . . . 15.0 109.736 178.878 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.793 HG22 ' N ' ' A' ' 55' ' ' GLY . 0.7 OUTLIER -55.17 146.11 4.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 116.041 -0.527 . . . . 15.0 111.025 -179.072 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.477 ' HG3' ' N ' ' A' ' 39' ' ' ALA . 0.2 OUTLIER -80.23 -46.24 16.61 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.502 -0.925 . . . . 15.0 108.502 178.616 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.731 ' O ' HG12 ' A' ' 20' ' ' ILE . . . -172.07 171.45 4.97 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 115.764 -0.653 . . . . 15.0 110.242 178.471 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.548 ' HA ' ' CG1' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -96.63 109.49 23.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 109.118 -0.697 . . . . 15.0 109.118 179.135 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.789 ' HB ' ' O ' ' A' ' 19' ' ' GLY . 0.5 OUTLIER -78.16 118.31 71.43 Favored Pre-proline 0 C--N 1.326 -0.44 0 N-CA-C 113.261 0.837 . . . . 15.0 113.261 -177.106 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.625 ' HA ' ' CG ' ' A' ' 47' ' ' GLU . 36.9 Cg_endo -64.71 60.46 0.28 Allowed 'Trans proline' 0 C--N 1.357 0.992 0 C-N-CA 123.539 2.826 . . . . 15.0 112.793 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.517 ' N ' ' HG2' ' A' ' 47' ' ' GLU . 11.2 tt0 -147.41 -46.75 0.17 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.52 -0.309 . . . . 15.0 111.244 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.777 ' HA3' ' HA3' ' A' ' 19' ' ' GLY . . . -87.87 169.33 38.53 Favored Glycine 0 C--N 1.33 0.229 0 C-N-CA 120.36 -0.924 . . . . 15.0 113.851 -179.285 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.918 ' HB3' ' O ' ' A' ' 17' ' ' SER . . . -59.36 -13.3 7.81 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.465 0.542 . . . . 15.0 112.465 -179.783 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.532 ' HB1' HG22 ' A' ' 52' ' ' ILE . . . -71.94 -56.15 6.2 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.934 -0.306 . . . . 15.0 110.578 -179.793 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.625 ' CG ' ' HA ' ' A' ' 42' ' ' PRO . 2.8 pp20? -57.61 -43.89 85.08 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 115.988 -0.551 . . . . 15.0 110.354 179.001 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 50.1 m -53.84 -70.55 0.09 Allowed 'General case' 0 CA--C 1.519 -0.225 0 CA-C-N 115.825 -0.625 . . . . 15.0 110.583 -179.477 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.487 ' CB ' HD11 ' A' ' 11' ' ' LEU . 4.4 t0 -58.1 -41.24 83.08 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.058 -0.719 . . . . 15.0 109.058 178.862 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.63 39.06 15.07 Favored Glycine 0 N--CA 1.446 -0.672 0 CA-C-N 115.295 -0.866 . . . . 15.0 111.771 179.285 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.676 ' HG3' HD13 ' A' ' 11' ' ' LEU . 0.5 OUTLIER -79.67 -51.05 9.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.976 0.417 . . . . 15.0 110.571 -179.388 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.601 ' CG2' HD12 ' A' ' 20' ' ' ILE . 10.8 tp -81.12 158.36 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 CA-C-N 115.93 -0.577 . . . . 15.0 110.106 179.465 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' HIS . . . . . 0.453 ' N ' ' OD2' ' A' ' 56' ' ' ASP . 80.4 m80 -145.54 159.27 43.36 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-O 121.591 0.71 . . . . 15.0 112.36 -178.812 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.572 ' HA ' ' CG2' ' A' ' 37' ' ' VAL . 5.0 mtpt -42.13 132.63 3.24 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.213 -1.358 . . . . 15.0 113.01 -178.595 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.793 ' N ' HG22 ' A' ' 37' ' ' VAL . . . 49.9 31.28 16.9 Favored Glycine 0 C--N 1.334 0.455 0 CA-C-N 115.697 -0.683 . . . . 15.0 113.279 179.187 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.453 ' OD2' ' N ' ' A' ' 53' ' ' HIS . 6.2 m-20 -65.7 129.39 39.6 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.726 -0.39 . . . . 15.0 110.526 179.531 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.516 ' HG2' ' CE2' ' A' ' 36' ' ' TYR . 0.5 OUTLIER -82.57 95.96 7.92 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.222 -0.445 . . . . 15.0 110.677 -179.921 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.893 HG22 HG22 ' A' ' 35' ' ' ILE . 1.4 m -86.63 117.06 30.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 CA-C-O 120.927 0.394 . . . . 15.0 110.873 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.532 HD22 ' N ' ' A' ' 59' ' ' LEU . 3.1 mm? -107.0 -17.0 14.3 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.915 -0.584 . . . . 15.0 112.482 -179.064 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.45 ' O ' HD23 ' A' ' 87' ' ' LEU . . . -149.05 148.73 30.05 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.199 0.524 . . . . 15.0 112.411 -178.83 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.643 HG22 HD21 ' A' ' 87' ' ' LEU . 17.5 t -139.13 101.36 1.55 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.26 0 CA-C-N 115.446 -0.797 . . . . 15.0 109.409 178.853 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.667 ' OD1' HG22 ' A' ' 81' ' ' THR . 2.7 m120 64.79 15.5 9.86 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.658 -0.497 . . . . 15.0 109.658 -178.066 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 107.06 4.82 35.66 Favored Glycine 0 C--N 1.337 0.613 0 CA-C-N 115.832 -0.622 . . . . 15.0 113.331 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.636 HG13 ' O ' ' A' ' 64' ' ' VAL . 4.5 p -93.87 107.83 19.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.022 0.439 . . . . 15.0 110.886 179.487 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 67.2 m -56.5 133.7 53.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.21 -0.45 . . . . 15.0 111.079 -179.566 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.663 HD11 ' HB2' ' A' ' 74' ' ' ALA . 0.2 OUTLIER -94.76 -26.23 16.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.016 -0.538 . . . . 15.0 110.902 179.924 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 14.3 tt0 -46.03 104.12 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.308 -0.406 . . . . 15.0 111.048 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.75 60.13 0.54 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.79 -0.719 . . . . 15.0 112.464 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.609 ' HB1' ' CB ' ' A' ' 73' ' ' GLN . . . -173.04 166.94 5.02 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.959 0.409 . . . . 15.0 111.148 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.471 ' CB ' ' HA ' ' A' ' 26' ' ' VAL . 9.1 p -93.18 -172.3 2.92 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.125 -0.489 . . . . 15.0 111.053 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.791 ' CE1' HG23 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -63.86 -58.91 5.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.787 -0.642 . . . . 15.0 110.583 179.868 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.422 ' O ' ' HG3' ' A' ' 76' ' ' GLU . 18.0 ttpp -52.59 -34.06 48.95 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.003 -0.544 . . . . 15.0 110.557 179.396 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.609 ' CB ' ' HB1' ' A' ' 69' ' ' ALA . 9.5 mt-30 -59.36 -49.35 78.16 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.613 -0.514 . . . . 15.0 109.613 179.241 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.778 ' HB3' HG13 ' A' ' 35' ' ' ILE . . . -67.06 -44.75 79.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.932 -0.577 . . . . 15.0 109.512 178.431 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 1.014 HG23 HG21 ' A' ' 22' ' ' VAL . 0.5 OUTLIER -43.96 -40.88 1.63 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.27 0 N-CA-C 108.797 -0.816 . . . . 15.0 108.797 178.202 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.422 ' HG3' ' O ' ' A' ' 72' ' ' LYS . 9.0 mt-10 -67.42 -44.08 79.64 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 114.744 -1.117 . . . . 15.0 110.19 178.462 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.622 ' O ' HG11 ' A' ' 61' ' ' VAL . 42.5 p -64.13 -55.48 21.65 Favored 'General case' 0 C--O 1.231 0.131 0 C-N-CA 121.056 -0.258 . . . . 15.0 111.509 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.528 HD23 HG21 ' A' ' 61' ' ' VAL . 4.6 mt -53.38 -47.26 69.64 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 121.127 0.489 . . . . 15.0 109.9 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.405 ' HB2' ' O ' ' A' ' 75' ' ' VAL . 0.0 OUTLIER -68.53 -59.49 3.11 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.518 -0.765 . . . . 15.0 110.529 179.29 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 68.5 m-20 -66.06 60.27 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.931 -0.577 . . . . 15.0 112.154 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.667 HG22 ' OD1' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -95.76 -73.02 0.61 Allowed 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 110.127 -0.323 . . . . 15.0 110.127 179.1 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 122.01 -103.71 0.87 Allowed Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.702 -0.761 . . . . 15.0 113.439 179.029 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.403 ' O ' ' N ' ' A' ' 14' ' ' ASN . 0.3 OUTLIER -64.53 -84.43 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 111.965 0.357 . . . . 15.0 111.965 -178.884 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.469 HG12 ' N ' ' A' ' 85' ' ' VAL . 69.9 t -109.72 160.02 8.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.946 0.403 . . . . 15.0 110.873 -179.398 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.688 HG23 ' CB ' ' A' ' 13' ' ' LYS . 8.7 t -97.81 81.65 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.156 0.503 . . . . 15.0 110.457 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.423 ' NE2' HD11 ' A' ' 88' ' ' LEU . 20.5 t60 -101.13 83.87 2.56 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.72 -0.673 . . . . 15.0 110.33 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.778 ' HB3' HD21 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -103.85 115.58 30.72 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.921 -0.581 . . . . 15.0 111.873 -179.115 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.729 HD12 ' HB3' ' A' ' 8' ' ' GLU . 0.2 OUTLIER -92.15 100.49 13.1 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.327 -0.62 . . . . 15.0 109.327 178.573 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.778 HD21 ' HB3' ' A' ' 87' ' ' LEU . 0.1 OUTLIER -104.04 -159.46 0.72 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.26 0.553 . . . . 15.0 111.725 -178.658 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.502 ' HA ' ' HA ' ' A' ' 6' ' ' ILE . 5.3 tt0 -140.57 143.7 35.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.35 -0.841 . . . . 15.0 110.32 179.322 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 7.9 tppt? -55.48 105.89 0.21 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.227 -0.442 . . . . 15.0 110.954 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -66.1 150.1 51.72 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.869 -0.681 . . . . 15.0 112.616 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -86.1 124.19 32.24 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.837 0.351 . . . . 15.0 110.857 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.6 m -82.77 163.4 51.64 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.149 -0.478 . . . . 15.0 110.92 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_exo -51.27 -57.61 2.12 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.594 2.196 . . . . 15.0 112.329 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 5.8 p . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.221 -0.895 . . . . 15.0 110.893 179.973 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo . . . . . 0 N--CA 1.488 1.189 0 CA-C-O 120.876 0.282 . . . . 15.0 111.805 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.414 ' HA ' ' HD2' ' A' ' 3' ' ' PRO . 4.7 mttp -150.75 100.86 3.08 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.45 . . . . 15.0 110.811 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.414 ' HD2' ' HA ' ' A' ' 2' ' ' LYS . 24.6 Cg_endo -62.15 -82.95 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.391 2.06 . . . . 15.0 112.422 -179.821 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 92.91 -34.77 4.36 Favored Glycine 0 C--N 1.332 0.311 0 C-N-CA 120.68 -0.772 . . . . 15.0 112.599 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -62.16 159.09 15.41 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.345 0.593 . . . . 15.0 111.126 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.488 HD11 ' OE1' ' A' ' 90' ' ' GLU . 1.3 mp -104.4 147.31 10.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.195 -0.912 . . . . 15.0 110.944 -179.429 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.607 ' CZ ' HD12 ' A' ' 89' ' ' LEU . 2.9 p90 -140.82 164.96 28.82 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.214 -0.448 . . . . 15.0 110.415 178.896 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.715 ' HB3' HD12 ' A' ' 88' ' ' LEU . 1.9 pt-20 -130.17 143.85 51.02 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.234 0.54 . . . . 15.0 111.6 -179.438 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.667 ' CG1' HD11 ' A' ' 89' ' ' LEU . 0.3 OUTLIER -101.26 114.52 40.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.277 -0.874 . . . . 15.0 109.706 179.111 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -106.04 69.88 0.83 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.076 -0.511 . . . . 15.0 111.772 -179.063 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.65 HD11 ' CB ' ' A' ' 49' ' ' ASP . 8.5 tp -88.19 161.89 16.99 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.006 -0.543 . . . . 15.0 110.316 179.223 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.523 ' C ' ' H ' ' A' ' 14' ' ' ASN . . . -96.69 98.6 10.3 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.537 -0.301 . . . . 15.0 111.151 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.889 ' HB2' HG23 ' A' ' 85' ' ' VAL . 0.3 OUTLIER -65.38 26.46 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 112.706 0.632 . . . . 15.0 112.706 -179.995 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.523 ' H ' ' C ' ' A' ' 12' ' ' ALA . 15.6 m-20 -112.82 148.15 35.46 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.665 0.269 . . . . 15.0 110.579 179.765 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.431 ' CB ' ' O ' ' A' ' 14' ' ' ASN . 1.0 OUTLIER 82.29 -45.45 0.16 Allowed 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.267 -0.424 . . . . 15.0 111.293 -179.832 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -155.07 156.44 35.87 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.861 0.363 . . . . 15.0 110.819 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.742 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 0.2 OUTLIER -86.07 -159.71 0.49 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.134 -0.484 . . . . 15.0 110.652 179.976 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.413 HD22 ' HE3' ' A' ' 13' ' ' LYS . 2.5 mm? -83.41 -169.37 2.51 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 120.986 0.422 . . . . 15.0 110.74 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.705 ' O ' ' HB ' ' A' ' 41' ' ' ILE . . . -160.8 40.07 0.43 Allowed Glycine 0 N--CA 1.448 -0.532 0 N-CA-C 111.439 -0.664 . . . . 15.0 111.439 -179.818 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.653 HG12 ' O ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -112.7 139.08 39.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 120.907 0.384 . . . . 15.0 111.876 -179.227 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 30.3 t -96.03 104.96 16.93 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 107.924 -1.139 . . . . 15.0 107.924 177.371 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.978 HG21 HG23 ' A' ' 75' ' ' VAL . 32.6 m -93.63 156.84 3.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 113.09 0.774 . . . . 15.0 113.09 -177.091 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.31 -175.03 4.83 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.128 -0.942 . . . . 15.0 110.703 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.585 ' O ' HG22 ' A' ' 26' ' ' VAL . . . 68.71 -119.52 10.09 Favored Glycine 0 C--N 1.332 0.309 0 C-N-CA 120.831 -0.699 . . . . 15.0 112.542 179.794 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.526 ' HA3' ' N ' ' A' ' 71' ' ' HIS . . . 67.1 -66.65 0.21 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.922 -0.656 . . . . 15.0 113.336 179.563 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.585 HG22 ' O ' ' A' ' 24' ' ' GLY . 0.0 OUTLIER -32.62 142.48 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 N-CA-C 112.063 0.394 . . . . 15.0 112.063 -179.492 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -75.63 59.6 1.17 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.065 -0.516 . . . . 15.0 110.857 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.5 m -151.6 -66.3 0.18 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.231 -0.44 . . . . 15.0 110.566 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 29.5 t -65.44 -51.25 61.51 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.111 -0.495 . . . . 15.0 110.424 179.562 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.472 HG11 ' CD1' ' A' ' 36' ' ' TYR . 27.0 m -88.07 -175.35 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.02 -0.536 . . . . 15.0 110.689 179.601 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 38.1 ttm180 -90.4 137.63 32.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.969 0.414 . . . . 15.0 111.096 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 42.1 m170 55.53 -86.36 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.756 -0.656 . . . . 15.0 111.345 179.822 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.411 ' O ' ' O ' ' A' ' 69' ' ' ALA . . . -171.94 27.79 0.1 OUTLIER Glycine 0 C--N 1.33 0.24 0 C-N-CA 120.922 -0.656 . . . . 15.0 112.48 -179.709 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.432 ' O ' HG21 ' A' ' 30' ' ' VAL . . . -81.7 151.79 31.13 Favored Glycine 0 N--CA 1.451 -0.363 0 N-CA-C 110.857 -0.897 . . . . 15.0 110.857 179.029 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.925 HG22 HG22 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -88.94 154.1 3.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 119.99 -0.684 . . . . 15.0 111.704 -179.346 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.494 ' CZ ' ' HG2' ' A' ' 57' ' ' ARG . 29.4 m-85 -141.73 107.52 5.13 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.154 -0.93 . . . . 15.0 110.008 179.114 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.781 HG22 ' N ' ' A' ' 55' ' ' GLY . 0.7 OUTLIER -55.81 153.16 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.191 0.52 . . . . 15.0 111.295 -179.131 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.514 ' O ' ' HG2' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -85.72 -48.33 8.93 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.379 -0.971 . . . . 15.0 108.379 178.33 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.653 ' O ' HG12 ' A' ' 20' ' ' ILE . . . -172.39 173.78 4.04 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 115.354 -0.839 . . . . 15.0 110.145 178.722 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.622 ' HA ' HG12 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -96.97 112.16 28.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 109.436 -0.579 . . . . 15.0 109.436 179.125 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.705 ' HB ' ' O ' ' A' ' 19' ' ' GLY . 0.4 OUTLIER -78.36 118.72 73.96 Favored Pre-proline 0 C--N 1.329 -0.298 0 N-CA-C 113.349 0.87 . . . . 15.0 113.349 -177.245 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.613 ' HA ' ' HG2' ' A' ' 47' ' ' GLU . 36.9 Cg_endo -64.36 61.66 0.25 Allowed 'Trans proline' 0 C--N 1.357 0.998 0 C-N-CA 123.509 2.806 . . . . 15.0 112.918 179.706 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.514 ' H ' ' HG2' ' A' ' 47' ' ' GLU . 2.2 mm-40 -150.8 -46.6 0.12 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.611 -0.268 . . . . 15.0 111.618 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.651 ' HA3' ' HA3' ' A' ' 19' ' ' GLY . . . -87.82 166.65 35.89 Favored Glycine 0 C--N 1.331 0.268 0 C-N-CA 120.311 -0.947 . . . . 15.0 113.879 -179.142 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.742 ' HB3' ' O ' ' A' ' 17' ' ' SER . . . -55.96 -14.83 2.76 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.703 0.631 . . . . 15.0 112.703 -179.612 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.16 -57.5 4.2 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.707 0.289 . . . . 15.0 111.109 -179.504 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.613 ' HG2' ' HA ' ' A' ' 42' ' ' PRO . 2.9 pp20? -57.11 -41.91 79.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 15.0 110.478 179.545 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 40.1 t -53.7 -70.37 0.1 Allowed 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 115.896 -0.593 . . . . 15.0 110.668 -179.508 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.65 ' CB ' HD11 ' A' ' 11' ' ' LEU . 1.5 m-20 -61.1 -39.57 90.48 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.219 0.533 . . . . 15.0 109.575 179.049 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.01 44.21 8.32 Favored Glycine 0 N--CA 1.447 -0.599 0 CA-C-N 115.439 -0.801 . . . . 15.0 111.835 179.668 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.652 ' CG ' HG23 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -79.5 -53.4 6.91 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.962 0.411 . . . . 15.0 110.647 -179.397 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.625 ' CG1' HD12 ' A' ' 20' ' ' ILE . 10.3 tp -81.08 163.1 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 CA-C-N 115.936 -0.575 . . . . 15.0 110.442 179.695 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' HIS . . . . . 0.424 ' N ' ' OD2' ' A' ' 56' ' ' ASP . 65.0 m-70 -146.57 158.82 43.97 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-O 121.606 0.717 . . . . 15.0 112.126 -179.072 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.564 ' HA ' ' CG2' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -43.15 133.33 3.95 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.246 -1.343 . . . . 15.0 112.928 -178.58 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.781 ' N ' HG22 ' A' ' 37' ' ' VAL . . . 49.84 32.14 17.83 Favored Glycine 0 C--N 1.336 0.545 0 CA-C-N 115.841 -0.618 . . . . 15.0 113.053 179.275 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.512 ' OD2' HD12 ' A' ' 52' ' ' ILE . 4.6 m-20 -65.47 124.75 23.11 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.706 -0.397 . . . . 15.0 110.216 179.498 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.861 ' HD2' HD21 ' A' ' 59' ' ' LEU . 0.0 OUTLIER -81.82 92.85 6.74 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.203 -0.453 . . . . 15.0 110.505 -179.959 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.925 HG22 HG22 ' A' ' 35' ' ' ILE . 1.3 m -84.76 120.85 36.04 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 CA-C-N 116.195 -0.457 . . . . 15.0 111.383 -179.372 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.861 HD21 ' HD2' ' A' ' 57' ' ' ARG . 3.4 mm? -107.24 -20.88 13.15 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 115.73 -0.668 . . . . 15.0 112.455 -179.36 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.494 ' O ' HD23 ' A' ' 87' ' ' LEU . . . -147.75 153.74 39.64 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.33 0.586 . . . . 15.0 112.569 -178.585 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.83 HG11 ' O ' ' A' ' 77' ' ' THR . 25.9 t -138.97 99.56 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.331 0 CA-C-N 115.231 -0.895 . . . . 15.0 109.048 178.788 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.439 ' OD1' HG22 ' A' ' 81' ' ' THR . 2.7 m120 65.37 16.36 10.49 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.535 -0.543 . . . . 15.0 109.535 -177.806 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 107.07 5.59 35.02 Favored Glycine 0 C--N 1.337 0.633 0 CA-C-N 115.689 -0.687 . . . . 15.0 113.63 179.404 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.664 HG13 ' O ' ' A' ' 64' ' ' VAL . 5.9 p -93.88 105.34 16.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 117.339 0.57 . . . . 15.0 110.809 179.306 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -55.58 130.73 44.13 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.053 -0.521 . . . . 15.0 111.11 -179.57 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.735 HD21 ' HA ' ' A' ' 74' ' ' ALA . 0.1 OUTLIER -97.76 -24.16 15.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.97 -0.559 . . . . 15.0 111.036 179.925 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -45.41 106.23 0.07 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.426 -0.352 . . . . 15.0 110.999 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.85 58.95 0.53 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.785 -0.721 . . . . 15.0 112.289 -179.655 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.579 ' HB1' ' CD ' ' A' ' 73' ' ' GLN . . . -172.98 171.75 4.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.848 0.356 . . . . 15.0 110.945 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.567 ' HB ' HG13 ' A' ' 26' ' ' VAL . 13.5 p -93.37 -172.64 2.99 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.092 0.472 . . . . 15.0 111.376 -179.749 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.679 ' CE1' HG23 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -64.24 -59.58 4.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.654 -0.703 . . . . 15.0 110.668 -179.975 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.406 ' N ' ' CG ' ' A' ' 71' ' ' HIS . 29.9 ttpt -52.44 -32.78 41.13 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.895 -0.593 . . . . 15.0 110.643 179.777 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.579 ' CD ' ' HB1' ' A' ' 69' ' ' ALA . 10.4 mt-30 -59.45 -51.76 68.49 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.542 -0.54 . . . . 15.0 109.542 179.264 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.735 ' HA ' HD21 ' A' ' 66' ' ' LEU . . . -67.23 -44.49 79.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.008 -0.542 . . . . 15.0 110.033 178.511 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.978 HG23 HG21 ' A' ' 22' ' ' VAL . 0.5 OUTLIER -41.9 -41.76 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.239 0 N-CA-C 109.249 -0.649 . . . . 15.0 109.249 178.688 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.463 ' O ' ' HB2' ' A' ' 80' ' ' ASN . 54.0 mt-10 -67.3 -44.88 78.12 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 114.882 -1.054 . . . . 15.0 110.453 178.639 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.83 ' O ' HG11 ' A' ' 61' ' ' VAL . 37.2 p -64.05 -55.1 24.64 Favored 'General case' 0 N--CA 1.461 0.122 0 C-N-CA 121.159 -0.216 . . . . 15.0 111.555 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.757 HD21 HG21 ' A' ' 58' ' ' VAL . 6.5 mt -53.31 -45.98 69.23 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-O 121.237 0.542 . . . . 15.0 109.997 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.403 ' HB2' ' O ' ' A' ' 75' ' ' VAL . 0.0 OUTLIER -68.35 -58.91 3.65 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.334 -0.848 . . . . 15.0 110.643 179.493 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.463 ' HB2' ' O ' ' A' ' 76' ' ' GLU . 11.2 m-80 -66.08 62.71 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.074 -0.512 . . . . 15.0 111.928 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.439 HG22 ' OD1' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -92.74 -76.26 0.47 Allowed 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 110.155 -0.313 . . . . 15.0 110.155 179.284 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 122.2 -105.17 0.95 Allowed Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.728 -0.749 . . . . 15.0 113.052 179.165 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.429 ' O ' ' HB3' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -64.87 -84.07 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.753 0.311 . . . . 15.0 111.209 -179.42 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.453 HG12 ' N ' ' A' ' 85' ' ' VAL . 79.0 t -110.17 158.61 10.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.021 0.439 . . . . 15.0 111.083 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.889 HG23 ' HB2' ' A' ' 13' ' ' LYS . 3.3 t -97.68 83.15 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.176 0.513 . . . . 15.0 110.213 179.68 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -100.09 82.08 2.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.736 -0.666 . . . . 15.0 110.242 179.778 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.789 ' HB3' HD21 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -103.98 127.04 51.52 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.914 -0.584 . . . . 15.0 111.85 -179.022 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.715 HD12 ' HB3' ' A' ' 8' ' ' GLU . 0.2 OUTLIER -102.17 100.54 10.76 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.292 -0.633 . . . . 15.0 109.292 178.433 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.789 HD21 ' HB3' ' A' ' 87' ' ' LEU . 0.1 OUTLIER -104.85 -161.49 0.82 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.405 0.621 . . . . 15.0 111.795 -178.582 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.488 ' OE1' HD11 ' A' ' 6' ' ' ILE . 3.2 tt0 -141.5 135.55 30.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.064 -0.971 . . . . 15.0 109.876 179.232 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.1 105.56 0.07 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.951 0.405 . . . . 15.0 111.169 -179.663 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -72.11 -160.29 4.68 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.938 -0.648 . . . . 15.0 112.641 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -76.4 125.47 29.25 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.846 0.355 . . . . 15.0 110.862 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 94.2 p -79.37 160.28 70.65 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 15.0 110.876 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_exo -51.19 148.63 17.81 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.609 2.206 . . . . 15.0 112.299 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 6.3 t . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.237 -0.887 . . . . 15.0 110.858 -179.985 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_endo . . . . . 0 N--CA 1.489 1.225 0 CA-C-O 120.812 0.255 . . . . 15.0 111.759 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.476 ' CB ' ' CD ' ' A' ' 3' ' ' PRO . 7.8 mttt -155.28 -66.42 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.198 -0.455 . . . . 15.0 111.138 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.476 ' CD ' ' CB ' ' A' ' 2' ' ' LYS . 13.4 Cg_endo -55.97 -80.77 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.388 2.059 . . . . 15.0 112.242 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 88.81 -22.95 19.09 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.58 -0.819 . . . . 15.0 112.763 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -62.08 145.75 52.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.36 0.6 . . . . 15.0 110.962 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.618 HD11 ' OE1' ' A' ' 90' ' ' GLU . 1.4 mp -104.38 141.22 20.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.149 -0.932 . . . . 15.0 111.097 -179.352 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.514 ' CZ ' HD12 ' A' ' 89' ' ' LEU . 3.0 p90 -140.65 166.37 24.93 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.274 -0.421 . . . . 15.0 110.569 178.647 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.732 ' CB ' HD12 ' A' ' 88' ' ' LEU . 9.5 pt-20 -129.43 143.87 51.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.196 0.522 . . . . 15.0 111.432 -179.336 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.639 ' CG1' HD11 ' A' ' 89' ' ' LEU . 0.3 OUTLIER -101.37 117.26 46.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.424 -0.807 . . . . 15.0 109.382 178.82 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 55.1 tt0 -105.97 75.71 1.13 Allowed 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.456 0.539 . . . . 15.0 112.456 -178.534 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.596 ' HB3' ' HB ' ' A' ' 85' ' ' VAL . 6.4 tp -87.93 161.21 17.58 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.24 -0.652 . . . . 15.0 109.24 178.179 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.474 ' O ' ' N ' ' A' ' 14' ' ' ASN . . . -96.8 94.55 7.32 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 120.816 -0.354 . . . . 15.0 111.819 -179.516 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.615 ' CB ' HG23 ' A' ' 85' ' ' VAL . 0.3 OUTLIER -65.09 61.82 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.334 0.588 . . . . 15.0 111.203 179.283 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.474 ' N ' ' O ' ' A' ' 12' ' ' ALA . 9.4 m-20 -116.16 -80.25 0.6 Allowed 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.799 -0.637 . . . . 15.0 111.585 -179.655 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.28 -24.62 59.28 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.112 -0.495 . . . . 15.0 111.721 -179.206 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -155.15 162.94 40.84 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.881 0.372 . . . . 15.0 111.219 -179.711 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.827 ' C ' HD22 ' A' ' 18' ' ' LEU . 0.5 OUTLIER -93.66 -79.04 0.42 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.043 -0.526 . . . . 15.0 111.019 -179.904 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.827 HD22 ' C ' ' A' ' 17' ' ' SER . 3.1 mm? -139.11 -168.44 2.44 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 121.165 0.507 . . . . 15.0 111.066 -179.533 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.618 ' O ' ' HB ' ' A' ' 41' ' ' ILE . . . -162.87 31.85 0.29 Allowed Glycine 0 CA--C 1.505 -0.561 0 N-CA-C 110.931 -0.868 . . . . 15.0 110.931 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.741 HD13 ' HB ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -112.5 143.65 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 CA-C-O 121.104 0.478 . . . . 15.0 112.146 -178.709 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 27.1 t -96.07 102.47 14.27 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 107.014 -1.476 . . . . 15.0 107.014 176.616 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.977 HG21 HG23 ' A' ' 75' ' ' VAL . 32.8 m -93.36 155.28 3.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 113.439 0.903 . . . . 15.0 113.439 -176.23 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.3 -175.44 4.99 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 114.8 -1.091 . . . . 15.0 110.609 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.425 ' O ' ' HB3' ' A' ' 71' ' ' HIS . . . 68.73 -120.23 10.84 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 120.823 -0.703 . . . . 15.0 112.602 179.725 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.543 ' HA3' ' N ' ' A' ' 71' ' ' HIS . . . 69.07 -66.38 0.49 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.795 -0.717 . . . . 15.0 113.431 179.449 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.505 ' O ' HG22 ' A' ' 30' ' ' VAL . 1.0 OUTLIER -27.66 140.25 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 N-CA-C 112.471 0.545 . . . . 15.0 112.471 -179.271 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -76.61 60.14 1.61 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.983 -0.553 . . . . 15.0 111.034 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -151.72 -50.45 0.11 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.373 -0.376 . . . . 15.0 111.01 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.8 t -84.21 -37.58 21.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.202 -0.453 . . . . 15.0 111.071 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.505 HG22 ' O ' ' A' ' 26' ' ' VAL . 21.7 m -80.75 -174.75 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.306 -0.406 . . . . 15.0 111.238 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 2.8 mtt-85 -58.8 -54.17 50.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.449 . . . . 15.0 111.022 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 24.8 m80 -146.37 -50.47 0.22 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.264 -0.426 . . . . 15.0 111.043 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -169.28 26.24 0.11 Allowed Glycine 0 N--CA 1.453 -0.19 0 C-N-CA 120.825 -0.702 . . . . 15.0 112.512 -179.765 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.481 ' O ' HG11 ' A' ' 30' ' ' VAL . . . -90.58 149.18 19.95 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.684 -0.769 . . . . 15.0 111.197 179.101 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.82 HG22 HG22 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -87.68 154.69 3.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 117.341 0.571 . . . . 15.0 111.568 -179.39 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.427 ' CZ ' ' HG3' ' A' ' 57' ' ' ARG . 26.6 m-85 -140.76 106.83 5.19 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.241 -0.891 . . . . 15.0 109.829 179.312 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.783 HG22 ' N ' ' A' ' 55' ' ' GLY . 0.8 OUTLIER -55.58 148.25 3.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.18 0.514 . . . . 15.0 111.553 -178.938 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.41 ' O ' ' HG2' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -80.41 -47.7 14.01 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.316 -0.994 . . . . 15.0 108.316 178.2 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.626 ' O ' HG12 ' A' ' 20' ' ' ILE . . . -172.02 172.76 4.59 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 115.254 -0.885 . . . . 15.0 110.291 178.606 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.665 ' HA ' HG12 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -97.42 107.84 20.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.936 0.398 . . . . 15.0 110.889 179.946 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.618 ' HB ' ' O ' ' A' ' 19' ' ' GLY . 0.6 OUTLIER -78.86 108.03 7.28 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 115.789 -0.641 . . . . 15.0 112.611 -178.671 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.477 ' N ' ' HG2' ' A' ' 47' ' ' GLU . 30.7 Cg_endo -62.93 69.67 0.13 Allowed 'Trans proline' 0 C--N 1.355 0.904 0 C-N-CA 123.139 2.559 . . . . 15.0 112.535 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.463 ' HB2' HG22 ' A' ' 41' ' ' ILE . 0.7 OUTLIER -151.79 -52.93 0.12 Allowed 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.365 -0.834 . . . . 15.0 109.675 179.501 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.521 ' HA3' ' CA ' ' A' ' 19' ' ' GLY . . . -87.93 155.99 27.07 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.611 -0.804 . . . . 15.0 112.402 179.254 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -39.11 -18.81 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 113.638 0.977 . . . . 15.0 113.638 -179.693 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.478 ' N ' ' O ' ' A' ' 44' ' ' GLY . . . -71.68 -71.89 0.25 Allowed 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 111.783 0.29 . . . . 15.0 111.783 -179.31 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.508 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 3.9 tp10 -58.22 -40.4 81.57 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 120.423 -0.511 . . . . 15.0 110.379 179.827 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 16.5 m -54.27 -59.18 5.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.974 -0.557 . . . . 15.0 110.463 179.439 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.569 ' CB ' HD11 ' A' ' 11' ' ' LEU . 3.6 t70 -68.46 -38.37 81.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.155 -0.475 . . . . 15.0 110.107 179.303 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.81 42.8 8.7 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.695 -0.684 . . . . 15.0 112.988 179.491 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.488 ' HG3' HD13 ' A' ' 11' ' ' LEU . 2.8 mmp_? -90.2 -50.68 5.85 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.877 0.37 . . . . 15.0 110.521 179.475 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.632 ' CG1' HD12 ' A' ' 20' ' ' ILE . 10.1 tp -81.22 158.9 4.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.048 -0.524 . . . . 15.0 110.773 179.69 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' HIS . . . . . 0.424 ' O ' ' HB2' ' A' ' 56' ' ' ASP . 72.8 m80 -141.0 158.24 44.22 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-O 121.645 0.736 . . . . 15.0 112.244 -179.407 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.573 ' HA ' ' CG2' ' A' ' 37' ' ' VAL . 2.3 mtpt -42.25 134.12 2.96 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.407 -1.269 . . . . 15.0 112.794 -178.704 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.783 ' N ' HG22 ' A' ' 37' ' ' VAL . . . 49.76 33.41 19.46 Favored Glycine 0 C--N 1.334 0.444 0 CA-C-N 115.815 -0.63 . . . . 15.0 113.616 179.157 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.424 ' HB2' ' O ' ' A' ' 53' ' ' HIS . 0.2 OUTLIER -66.01 133.17 50.25 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 117.169 0.485 . . . . 15.0 110.679 179.529 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.427 ' HG3' ' CZ ' ' A' ' 36' ' ' TYR . 6.2 ttt85 -86.47 88.42 7.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.193 -0.458 . . . . 15.0 110.363 179.604 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.82 HG22 HG22 ' A' ' 35' ' ' ILE . 1.7 m -79.43 114.77 20.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.057 0.456 . . . . 15.0 111.003 -179.558 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.416 ' HA ' ' HB2' ' A' ' 66' ' ' LEU . 32.0 mt -107.09 -16.71 14.36 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.762 -0.654 . . . . 15.0 112.46 -179.244 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.636 ' HB3' ' HB2' ' A' ' 88' ' ' LEU . . . -147.88 146.46 29.08 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 112.563 0.579 . . . . 15.0 112.563 -178.746 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.879 HG11 ' O ' ' A' ' 77' ' ' THR . 57.3 t -139.02 102.77 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.368 -0.833 . . . . 15.0 109.098 178.674 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.616 ' OD1' HG22 ' A' ' 81' ' ' THR . 2.4 m120 64.9 14.94 9.61 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.87 -0.419 . . . . 15.0 109.87 -178.163 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 107.0 5.47 35.29 Favored Glycine 0 C--N 1.336 0.552 0 CA-C-N 115.989 -0.55 . . . . 15.0 113.361 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.644 HG13 ' O ' ' A' ' 64' ' ' VAL . 6.1 p -93.87 107.59 19.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 117.077 0.439 . . . . 15.0 111.192 179.645 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 44.2 m -58.48 133.04 55.44 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.294 -0.412 . . . . 15.0 110.798 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.496 HD11 ' HA ' ' A' ' 74' ' ' ALA . 1.2 mm? -91.1 -21.86 21.0 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.07 -0.514 . . . . 15.0 111.185 -179.699 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -43.55 98.06 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 120.912 0.387 . . . . 15.0 111.149 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.87 63.28 0.55 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.817 -0.706 . . . . 15.0 112.333 -179.748 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.664 ' HB1' ' CB ' ' A' ' 73' ' ' GLN . . . -173.13 150.65 1.97 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.907 0.384 . . . . 15.0 111.098 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.434 ' HA ' ' N ' ' A' ' 26' ' ' VAL . 2.9 p -81.05 -171.96 3.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 15.0 111.015 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.726 ' CE1' HG23 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -62.08 -59.68 4.71 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.847 -0.615 . . . . 15.0 110.537 -179.953 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 13.3 ttpp -52.65 -34.64 52.45 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.685 -0.689 . . . . 15.0 111.046 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.664 ' CB ' ' HB1' ' A' ' 69' ' ' ALA . 2.8 mt-30 -59.31 -49.97 75.78 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.71 -0.478 . . . . 15.0 109.71 179.526 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.608 ' HB3' HG13 ' A' ' 35' ' ' ILE . . . -66.2 -45.68 79.93 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.929 -0.578 . . . . 15.0 109.532 178.423 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.977 HG23 HG21 ' A' ' 22' ' ' VAL . 0.5 OUTLIER -43.59 -40.81 1.41 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.209 0 N-CA-C 108.853 -0.795 . . . . 15.0 108.853 178.158 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -67.28 -44.87 78.23 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 114.845 -1.071 . . . . 15.0 110.126 178.365 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.879 ' O ' HG11 ' A' ' 61' ' ' VAL . 61.3 p -64.19 -54.24 36.76 Favored 'General case' 0 N--CA 1.461 0.08 0 CA-C-N 116.621 -0.263 . . . . 15.0 111.349 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.821 HD23 HG21 ' A' ' 61' ' ' VAL . 4.4 mt -53.43 -48.59 68.62 Favored 'General case' 0 CA--C 1.521 -0.146 0 CA-C-O 121.099 0.476 . . . . 15.0 110.138 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.405 ' O ' ' N ' ' A' ' 81' ' ' THR . 0.3 OUTLIER -68.54 -58.16 4.71 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.559 -0.746 . . . . 15.0 110.748 179.558 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -65.88 63.53 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.089 -0.505 . . . . 15.0 111.952 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.616 HG22 ' OD1' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -94.99 -73.53 0.58 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.65 0.262 . . . . 15.0 110.468 179.362 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 122.2 -105.22 0.96 Allowed Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.828 -0.701 . . . . 15.0 113.132 179.4 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.468 ' O ' ' HB3' ' A' ' 13' ' ' LYS . 0.4 OUTLIER -64.67 -82.17 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.705 0.288 . . . . 15.0 111.484 -179.279 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.434 HG12 ' N ' ' A' ' 85' ' ' VAL . 50.0 t -109.76 158.05 10.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.904 0.383 . . . . 15.0 110.423 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.615 HG23 ' CB ' ' A' ' 13' ' ' LYS . 50.7 t -98.23 77.85 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.231 -0.441 . . . . 15.0 110.627 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -98.63 88.37 4.06 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.021 -0.536 . . . . 15.0 110.893 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.803 ' HB3' HD21 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -103.89 125.84 50.59 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.104 -0.498 . . . . 15.0 111.633 -179.474 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.732 HD12 ' CB ' ' A' ' 8' ' ' GLU . 4.6 mp -101.59 101.85 12.47 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.428 -0.582 . . . . 15.0 109.428 178.657 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.803 HD21 ' HB3' ' A' ' 87' ' ' LEU . 0.1 OUTLIER -105.83 -163.62 0.95 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.536 0.684 . . . . 15.0 112.119 -178.325 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.618 ' OE1' HD11 ' A' ' 6' ' ' ILE . 2.2 tt0 -142.47 137.62 30.42 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 114.803 -1.09 . . . . 15.0 109.758 179.063 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.95 106.85 0.13 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.942 0.401 . . . . 15.0 111.05 -179.687 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -68.02 170.94 36.33 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.955 -0.64 . . . . 15.0 112.765 -179.641 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -86.27 61.96 7.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.855 0.36 . . . . 15.0 110.832 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 4.7 m -74.78 113.06 20.79 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.236 -0.438 . . . . 15.0 110.938 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -53.95 -26.71 41.45 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.445 2.096 . . . . 15.0 112.254 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 32.2 p . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.163 -0.922 . . . . 15.0 110.913 179.969 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_endo . . . . . 0 N--CA 1.489 1.214 0 CA-C-O 120.801 0.25 . . . . 15.0 111.805 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.18 137.56 13.42 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 15.0 110.835 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.402 ' CB ' ' HG2' ' A' ' 91' ' ' LYS . 20.6 Cg_endo -61.69 -78.03 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.477 2.118 . . . . 15.0 112.411 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 94.53 -33.52 5.27 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.699 -0.762 . . . . 15.0 112.622 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -63.8 147.2 52.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.353 0.597 . . . . 15.0 111.143 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.425 HG13 ' HB2' ' A' ' 90' ' ' GLU . 1.4 mp -104.41 144.18 14.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.135 -0.939 . . . . 15.0 111.088 -179.553 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.831 ' CZ ' HD12 ' A' ' 89' ' ' LEU . 3.9 p90 -140.65 165.53 27.22 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.327 -0.397 . . . . 15.0 110.729 178.911 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.737 ' HB2' HD12 ' A' ' 88' ' ' LEU . 11.0 pt-20 -130.14 143.52 50.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.117 0.484 . . . . 15.0 111.467 -179.642 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.58 HG11 ' CD1' ' A' ' 52' ' ' ILE . 0.5 OUTLIER -101.55 117.45 46.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.582 -0.735 . . . . 15.0 109.998 179.115 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -106.43 71.81 0.89 Allowed 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 112.243 0.46 . . . . 15.0 112.243 -179.221 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.548 ' HB3' ' HB ' ' A' ' 85' ' ' VAL . 7.9 tp -88.0 164.25 15.89 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.538 -0.542 . . . . 15.0 109.538 178.697 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -96.09 93.02 6.72 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.025 0.441 . . . . 15.0 111.297 -179.792 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.731 ' CB ' HG23 ' A' ' 85' ' ' VAL . 0.1 OUTLIER -57.74 -26.13 61.4 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.857 -0.61 . . . . 15.0 110.935 179.769 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -83.94 -44.69 13.97 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.189 -0.46 . . . . 15.0 110.926 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -54.72 -41.66 70.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.989 0.423 . . . . 15.0 110.544 179.717 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -165.53 175.65 8.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.93 -0.577 . . . . 15.0 110.757 179.691 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.878 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 0.3 OUTLIER -86.09 -158.71 0.42 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.27 -0.423 . . . . 15.0 110.299 179.647 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.679 ' N ' HD22 ' A' ' 18' ' ' LEU . 0.4 OUTLIER -102.32 -170.81 1.86 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.826 0.346 . . . . 15.0 110.702 179.57 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.633 ' O ' ' HB ' ' A' ' 41' ' ' ILE . . . -166.77 34.09 0.22 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 121.09 -0.576 . . . . 15.0 112.183 -179.665 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.674 HG13 HG12 ' A' ' 40' ' ' VAL . 0.1 OUTLIER -112.63 140.65 31.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 121.023 0.439 . . . . 15.0 111.892 -179.464 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.456 ' HB3' HD11 ' A' ' 41' ' ' ILE . 31.3 t -96.3 107.16 19.48 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 107.735 -1.209 . . . . 15.0 107.735 177.221 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 1.025 HG21 HG23 ' A' ' 75' ' ' VAL . 30.4 m -93.31 152.5 3.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 N-CA-C 113.061 0.763 . . . . 15.0 113.061 -176.807 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.419 HG23 ' HB3' ' A' ' 38' ' ' LYS . 35.4 p -149.42 178.68 8.58 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 115.036 -0.984 . . . . 15.0 110.874 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.551 ' O ' HG22 ' A' ' 26' ' ' VAL . . . 71.83 -118.69 7.14 Favored Glycine 0 C--N 1.332 0.345 0 C-N-CA 120.987 -0.625 . . . . 15.0 112.697 179.813 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.536 ' HA3' ' N ' ' A' ' 71' ' ' HIS . . . 68.21 -66.28 0.37 Allowed Glycine 0 C--N 1.331 0.254 0 C-N-CA 120.874 -0.679 . . . . 15.0 113.585 179.563 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.551 HG22 ' O ' ' A' ' 24' ' ' GLY . 0.0 OUTLIER -29.64 137.89 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 N-CA-C 112.247 0.462 . . . . 15.0 112.247 -179.355 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -75.46 63.5 1.48 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.905 -0.589 . . . . 15.0 111.038 -179.701 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 29.5 m -151.71 -50.3 0.11 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.247 -0.433 . . . . 15.0 111.067 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 11.0 t -88.04 -29.27 20.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.231 -0.441 . . . . 15.0 111.146 -179.822 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.49 HG22 ' O ' ' A' ' 26' ' ' VAL . 34.4 m -85.4 -176.85 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.367 -0.379 . . . . 15.0 111.312 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -61.47 -46.95 87.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.14 -0.482 . . . . 15.0 111.101 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 74.6 m-70 -148.29 -61.94 0.25 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.405 -0.361 . . . . 15.0 111.226 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.4 ' O ' ' O ' ' A' ' 69' ' ' ALA . . . -163.67 24.98 0.19 Allowed Glycine 0 N--CA 1.453 -0.205 0 C-N-CA 120.853 -0.689 . . . . 15.0 112.586 -179.642 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -89.61 156.97 26.14 Favored Glycine 0 N--CA 1.449 -0.462 0 N-CA-C 110.626 -0.99 . . . . 15.0 110.626 178.849 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.966 HG22 HG22 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -93.69 151.5 3.69 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.388 0 CA-C-N 117.66 0.73 . . . . 15.0 112.013 -179.366 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.515 ' CZ ' ' HG2' ' A' ' 57' ' ' ARG . 49.9 m-85 -133.46 107.65 8.17 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.718 -1.128 . . . . 15.0 109.162 178.707 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.822 HG22 ' N ' ' A' ' 55' ' ' GLY . 0.6 OUTLIER -54.85 152.91 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 121.261 0.553 . . . . 15.0 110.723 -178.575 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.651 ' HG3' ' N ' ' A' ' 39' ' ' ALA . 1.4 ppmt? -88.17 -47.32 8.55 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 108.795 -0.817 . . . . 15.0 108.795 179.313 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.651 ' N ' ' HG3' ' A' ' 38' ' ' LYS . . . -173.06 167.14 4.98 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.669 -0.696 . . . . 15.0 110.202 178.305 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.674 HG12 HG13 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -96.84 111.87 27.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.647 -0.501 . . . . 15.0 109.647 179.14 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.633 ' HB ' ' O ' ' A' ' 19' ' ' GLY . 0.3 OUTLIER -78.39 111.37 18.36 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 115.728 -0.669 . . . . 15.0 112.664 -177.676 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.442 ' HD2' ' HA ' ' A' ' 41' ' ' ILE . 37.1 Cg_endo -65.23 65.35 0.33 Allowed 'Trans proline' 0 C--N 1.355 0.899 0 C-N-CA 123.07 2.514 . . . . 15.0 112.763 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.507 ' HB2' HG22 ' A' ' 41' ' ' ILE . 5.5 mt-30 -149.52 -52.03 0.15 Allowed 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.402 -0.817 . . . . 15.0 109.196 179.293 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.543 ' HA3' ' HA3' ' A' ' 19' ' ' GLY . . . -88.03 154.34 25.42 Favored Glycine 0 N--CA 1.445 -0.719 0 CA-C-N 115.443 -0.799 . . . . 15.0 112.516 179.109 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.878 ' HB3' ' O ' ' A' ' 17' ' ' SER . . . -40.61 -17.73 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 113.804 1.038 . . . . 15.0 113.804 -179.528 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.446 ' N ' ' O ' ' A' ' 44' ' ' GLY . . . -71.67 -70.54 0.32 Allowed 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.707 -0.397 . . . . 15.0 111.477 -179.247 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.518 ' HG2' ' HB ' ' A' ' 40' ' ' VAL . 6.8 tm-20 -58.08 -37.17 73.98 Favored 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 120.678 -0.409 . . . . 15.0 110.039 179.508 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 37.4 m -56.25 -65.76 0.55 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.021 -0.536 . . . . 15.0 110.335 179.265 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.458 ' CB ' HD11 ' A' ' 11' ' ' LEU . 18.6 m-20 -62.55 -38.4 89.86 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.123 0.487 . . . . 15.0 109.931 179.135 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.51 43.56 8.42 Favored Glycine 0 N--CA 1.449 -0.493 0 CA-C-N 115.59 -0.732 . . . . 15.0 112.446 179.721 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.568 ' CG ' HG23 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -79.8 -58.26 3.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.867 0.365 . . . . 15.0 110.616 -179.982 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.58 ' CD1' HG11 ' A' ' 9' ' ' VAL . 1.4 mm -86.13 163.41 2.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.114 -0.494 . . . . 15.0 110.887 179.809 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' HIS . . . . . 0.563 ' N ' HG22 ' A' ' 52' ' ' ILE . 43.2 m80 -139.37 154.67 47.88 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-O 121.61 0.719 . . . . 15.0 111.415 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.543 ' HA ' ' CG2' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -36.07 133.93 0.43 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.368 -1.287 . . . . 15.0 113.016 -178.549 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.822 ' N ' HG22 ' A' ' 37' ' ' VAL . . . 50.74 34.16 28.45 Favored Glycine 0 C--N 1.334 0.468 0 CA-C-N 115.806 -0.633 . . . . 15.0 113.929 179.091 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.457 ' H ' HG13 ' A' ' 37' ' ' VAL . 1.9 m-20 -65.4 130.62 43.99 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 117.296 0.548 . . . . 15.0 110.525 179.203 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.575 ' CD ' HD21 ' A' ' 59' ' ' LEU . 0.0 OUTLIER -82.34 85.73 6.82 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.002 -0.545 . . . . 15.0 110.543 179.818 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.966 HG22 HG22 ' A' ' 35' ' ' ILE . 1.0 OUTLIER -81.67 114.33 22.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.15 0.5 . . . . 15.0 111.266 -179.549 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.575 HD21 ' CD ' ' A' ' 57' ' ' ARG . 18.6 mt -107.23 -15.74 14.58 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.702 -0.681 . . . . 15.0 112.142 -179.563 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.559 ' O ' HD23 ' A' ' 87' ' ' LEU . . . -147.58 151.01 35.55 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.292 0.567 . . . . 15.0 112.337 -178.767 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.583 HG21 ' HB ' ' A' ' 77' ' ' THR . 10.7 t -139.04 102.83 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.257 -0.883 . . . . 15.0 109.105 178.909 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.535 ' OD1' HG22 ' A' ' 81' ' ' THR . 2.6 m120 65.0 14.73 9.54 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.575 -0.528 . . . . 15.0 109.575 -177.817 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 106.49 6.57 35.63 Favored Glycine 0 C--N 1.337 0.606 0 CA-C-N 115.824 -0.626 . . . . 15.0 113.336 179.77 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.656 HG13 ' O ' ' A' ' 64' ' ' VAL . 8.9 p -93.86 106.64 18.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.098 0.475 . . . . 15.0 111.066 179.54 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 49.1 m -58.8 124.62 20.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.187 -0.46 . . . . 15.0 110.716 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.544 HD13 HG23 ' A' ' 58' ' ' VAL . 0.2 OUTLIER -92.05 -14.58 29.09 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.169 -0.469 . . . . 15.0 111.467 -179.654 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -45.23 103.77 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.89 0.376 . . . . 15.0 111.183 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.85 63.82 0.55 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.793 -0.717 . . . . 15.0 112.525 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.659 ' HB1' ' CB ' ' A' ' 73' ' ' GLN . . . -173.13 166.86 4.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.837 0.351 . . . . 15.0 111.077 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.475 ' HB ' HG13 ' A' ' 26' ' ' VAL . 2.6 p -93.23 -170.49 2.41 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.023 0.44 . . . . 15.0 110.943 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.672 ' CD2' HG23 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -63.96 -58.37 6.94 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.782 -0.645 . . . . 15.0 110.613 179.979 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.421 ' O ' ' HG3' ' A' ' 76' ' ' GLU . 28.9 ttmt -52.84 -35.51 57.47 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.095 -0.502 . . . . 15.0 110.823 179.392 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.659 ' CB ' ' HB1' ' A' ' 69' ' ' ALA . 3.6 mt-30 -59.21 -46.88 87.29 Favored 'General case' 0 CA--C 1.518 -0.287 0 N-CA-C 109.497 -0.557 . . . . 15.0 109.497 179.277 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.583 ' HB3' HG13 ' A' ' 35' ' ' ILE . . . -66.88 -47.8 70.72 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.596 -0.729 . . . . 15.0 109.717 178.458 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 1.025 HG23 HG21 ' A' ' 22' ' ' VAL . 0.5 OUTLIER -41.75 -42.03 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.254 0 CA-C-O 121.62 0.724 . . . . 15.0 109.182 178.575 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.421 ' HG3' ' O ' ' A' ' 72' ' ' LYS . 20.8 mt-10 -67.35 -44.02 80.07 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.644 -1.162 . . . . 15.0 110.884 179.006 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.583 ' HB ' HG21 ' A' ' 61' ' ' VAL . 4.9 p -64.42 -56.33 14.98 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 120.845 -0.342 . . . . 15.0 111.606 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.591 HD21 HG21 ' A' ' 58' ' ' VAL . 5.2 mt -53.28 -45.49 68.9 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-O 121.177 0.513 . . . . 15.0 109.931 -179.745 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -68.37 -58.32 4.55 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.462 -0.79 . . . . 15.0 110.232 179.345 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 32.9 m-20 -66.14 58.51 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.845 -0.616 . . . . 15.0 112.196 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.535 HG22 ' OD1' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -95.7 -72.82 0.61 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.742 0.306 . . . . 15.0 110.234 179.249 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 122.15 -103.36 0.84 Allowed Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.72 -0.752 . . . . 15.0 113.332 179.141 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.403 ' O ' ' HB3' ' A' ' 13' ' ' LYS . 0.4 OUTLIER -64.54 -84.66 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.105 0.409 . . . . 15.0 112.105 -178.857 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.454 HG12 ' N ' ' A' ' 85' ' ' VAL . 78.5 t -109.6 158.98 9.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.937 0.399 . . . . 15.0 110.976 -179.322 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.731 HG23 ' CB ' ' A' ' 13' ' ' LYS . 9.4 t -98.04 80.65 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.231 0.538 . . . . 15.0 110.596 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -99.71 86.96 3.43 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.73 -0.668 . . . . 15.0 110.038 179.603 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.725 ' HB3' HD21 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -103.86 121.19 42.56 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.926 -0.579 . . . . 15.0 111.983 -178.873 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.737 HD12 ' HB2' ' A' ' 8' ' ' GLU . 4.6 mp -97.19 101.25 12.77 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.421 -0.585 . . . . 15.0 109.421 178.488 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.831 HD12 ' CZ ' ' A' ' 7' ' ' PHE . 0.1 OUTLIER -105.61 -162.14 0.85 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.488 0.661 . . . . 15.0 111.964 -178.649 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.425 ' HB2' HG13 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -142.01 136.9 30.72 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 114.836 -1.075 . . . . 15.0 109.34 178.874 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.402 ' HG2' ' CB ' ' A' ' 3' ' ' PRO . 0.3 OUTLIER -46.69 105.03 0.06 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.03 0.443 . . . . 15.0 111.114 -179.486 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -70.02 -162.09 3.59 Favored Glycine 0 N--CA 1.451 -0.333 0 CA-C-N 115.738 -0.664 . . . . 15.0 112.849 -179.462 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -76.22 120.17 21.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.817 0.341 . . . . 15.0 110.888 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.4 m -88.38 145.48 35.76 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.249 -0.432 . . . . 15.0 110.8 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -52.25 -175.53 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.51 2.14 . . . . 15.0 112.327 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 69.1 p . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.222 -0.894 . . . . 15.0 110.863 179.985 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_endo . . . . . 0 N--CA 1.489 1.218 0 CA-C-O 120.776 0.24 . . . . 15.0 111.727 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.5 ' CB ' ' HD3' ' A' ' 3' ' ' PRO . 1.3 mtpp -155.31 -58.85 0.02 OUTLIER Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.264 -0.425 . . . . 15.0 111.369 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.5 ' HD3' ' CB ' ' A' ' 2' ' ' LYS . 41.7 Cg_exo -56.96 -163.11 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.166 1.91 . . . . 15.0 112.419 -179.794 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 90.37 -23.51 21.45 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.658 -0.782 . . . . 15.0 112.041 -179.531 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -72.19 143.55 48.85 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 121.334 0.588 . . . . 15.0 110.646 179.64 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.445 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 1.2 mp -74.09 150.99 7.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.18 -0.918 . . . . 15.0 110.797 -179.641 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.606 ' CZ ' HD12 ' A' ' 89' ' ' LEU . 0.3 OUTLIER -146.91 158.35 43.9 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.024 -0.535 . . . . 15.0 110.305 179.479 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.708 ' HB3' HD12 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -126.64 142.85 51.41 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.348 0.594 . . . . 15.0 111.937 -178.955 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.541 ' CG1' HD11 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -101.45 114.97 42.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.083 -0.962 . . . . 15.0 109.397 178.79 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -105.8 73.08 0.99 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.198 -0.455 . . . . 15.0 112.183 -178.544 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.592 HD13 ' HG3' ' A' ' 51' ' ' ARG . 5.7 tp -88.36 166.14 14.48 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.714 -0.476 . . . . 15.0 109.714 178.707 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -95.39 94.2 7.69 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.048 0.452 . . . . 15.0 111.266 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.648 ' CB ' HG23 ' A' ' 85' ' ' VAL . 0.1 OUTLIER -57.2 -27.1 61.68 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.807 -0.633 . . . . 15.0 111.114 179.901 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 99.8 m-20 -83.99 -45.09 13.49 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.3 -0.409 . . . . 15.0 110.875 -179.725 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -58.77 -43.32 90.34 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.041 0.448 . . . . 15.0 110.411 179.573 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.509 ' HB3' ' HB2' ' A' ' 45' ' ' ALA . 9.9 t-20 -165.58 163.57 19.33 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.837 -0.62 . . . . 15.0 110.642 179.719 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.87 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 0.5 OUTLIER -85.9 -166.94 1.67 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.379 -0.373 . . . . 15.0 110.176 179.595 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.652 ' N ' HD22 ' A' ' 18' ' ' LEU . 1.6 mm? -96.77 -173.53 2.75 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.937 0.399 . . . . 15.0 110.779 179.473 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.701 ' HA3' ' HA3' ' A' ' 44' ' ' GLY . . . -160.89 42.83 0.41 Allowed Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.924 -0.655 . . . . 15.0 111.915 -179.772 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.638 HG12 ' O ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -112.74 141.29 28.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 120.915 0.388 . . . . 15.0 111.768 -179.471 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.403 ' H ' HD13 ' A' ' 41' ' ' ILE . 43.0 t -96.18 103.44 15.34 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 107.721 -1.214 . . . . 15.0 107.721 177.29 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.948 HG21 HG23 ' A' ' 75' ' ' VAL . 27.3 m -93.51 155.39 3.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 113.339 0.866 . . . . 15.0 113.339 -176.714 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.33 -178.4 6.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 114.811 -1.086 . . . . 15.0 110.19 179.498 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.448 ' O ' ' CB ' ' A' ' 71' ' ' HIS . . . 73.0 -120.58 7.32 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.486 -0.864 . . . . 15.0 112.523 179.724 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.569 ' HA3' ' N ' ' A' ' 71' ' ' HIS . . . 68.3 -63.69 0.4 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.945 -0.645 . . . . 15.0 113.522 179.361 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.674 ' O ' HG22 ' A' ' 30' ' ' VAL . 1.7 m -32.32 146.96 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 N-CA-C 112.233 0.457 . . . . 15.0 112.233 -179.123 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.412 ' CB ' ' O ' ' A' ' 32' ' ' HIS . 15.1 m-20 -79.84 57.85 2.68 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.951 -0.568 . . . . 15.0 111.195 -179.714 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -151.76 -61.43 0.17 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.832 0.349 . . . . 15.0 111.238 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.4 m -71.93 -35.22 69.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 15.0 111.347 -179.633 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.674 HG22 ' O ' ' A' ' 26' ' ' VAL . 24.7 m -84.77 -173.78 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.895 0.379 . . . . 15.0 111.445 -179.613 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 41.4 ttt85 -57.08 -39.67 75.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.082 -0.508 . . . . 15.0 111.486 -179.617 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' HIS . . . . . 0.418 ' H ' HG23 ' A' ' 30' ' ' VAL . 1.6 p-80 -174.63 -35.7 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.592 -0.276 . . . . 15.0 111.656 -179.784 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -173.77 20.62 0.06 OUTLIER Glycine 0 CA--C 1.519 0.324 0 C-N-CA 120.594 -0.813 . . . . 15.0 113.104 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.52 ' O ' HG11 ' A' ' 30' ' ' VAL . . . -97.31 152.06 19.92 Favored Glycine 0 N--CA 1.448 -0.516 0 N-CA-C 110.294 -1.122 . . . . 15.0 110.294 178.623 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.934 HD12 ' HB3' ' A' ' 74' ' ' ALA . 0.1 OUTLIER -95.35 154.18 3.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 119.668 -0.813 . . . . 15.0 112.382 -178.962 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 31.8 m-85 -136.06 107.51 6.9 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.649 -1.16 . . . . 15.0 109.206 179.224 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.792 HG22 ' N ' ' A' ' 55' ' ' GLY . 0.6 OUTLIER -55.05 148.1 3.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.035 -0.529 . . . . 15.0 111.557 -178.446 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.459 ' O ' ' HG2' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -80.26 -49.6 11.37 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.452 -0.944 . . . . 15.0 108.452 178.397 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.638 ' O ' HG12 ' A' ' 20' ' ' ILE . . . -172.27 173.11 4.31 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-N 115.661 -0.7 . . . . 15.0 110.338 178.687 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.578 ' HA ' HG12 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -96.96 112.01 28.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 109.388 -0.597 . . . . 15.0 109.388 179.041 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.695 ' HB ' ' O ' ' A' ' 19' ' ' GLY . 0.5 OUTLIER -78.28 118.81 74.52 Favored Pre-proline 0 C--N 1.328 -0.328 0 N-CA-C 113.18 0.808 . . . . 15.0 113.18 -177.301 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.605 ' HA ' ' CG ' ' A' ' 47' ' ' GLU . 36.2 Cg_endo -64.09 62.38 0.23 Allowed 'Trans proline' 0 C--N 1.357 1.012 0 C-N-CA 123.592 2.861 . . . . 15.0 112.874 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.526 ' H ' ' HG2' ' A' ' 47' ' ' GLU . 9.8 mt-30 -152.03 -47.14 0.11 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.524 -0.307 . . . . 15.0 111.596 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.701 ' HA3' ' HA3' ' A' ' 19' ' ' GLY . . . -87.9 167.47 36.52 Favored Glycine 0 C--N 1.331 0.258 0 C-N-CA 120.354 -0.927 . . . . 15.0 113.825 -179.191 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.87 ' HB3' ' O ' ' A' ' 17' ' ' SER . . . -56.99 -12.68 2.16 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.634 0.605 . . . . 15.0 112.634 -179.762 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.79 -58.56 3.36 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 120.762 0.315 . . . . 15.0 110.406 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.605 ' CG ' ' HA ' ' A' ' 42' ' ' PRO . 2.6 pp20? -57.68 -43.16 84.88 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.763 -0.653 . . . . 15.0 110.525 179.079 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 66.7 m -53.65 -70.96 0.08 Allowed 'General case' 0 CA--C 1.518 -0.265 0 CA-C-N 115.931 -0.577 . . . . 15.0 110.574 -179.411 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.524 ' CB ' HD11 ' A' ' 11' ' ' LEU . 1.6 t0 -58.13 -41.51 83.8 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.128 -0.693 . . . . 15.0 109.128 178.736 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.67 40.12 13.03 Favored Glycine 0 N--CA 1.446 -0.645 0 CA-C-N 115.31 -0.859 . . . . 15.0 111.632 179.378 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.592 ' HG3' HD13 ' A' ' 11' ' ' LEU . 0.2 OUTLIER -79.76 -50.63 10.28 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.935 0.398 . . . . 15.0 110.723 -179.252 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.607 ' CG1' HD12 ' A' ' 20' ' ' ILE . 9.3 tp -81.07 162.34 3.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.043 -0.526 . . . . 15.0 110.249 179.433 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' HIS . . . . . 0.474 ' N ' ' OD2' ' A' ' 56' ' ' ASP . 76.1 m80 -147.54 158.71 44.11 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-O 121.644 0.735 . . . . 15.0 112.281 -178.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.567 ' HA ' ' CG2' ' A' ' 37' ' ' VAL . 8.1 mtpt -43.09 133.28 3.89 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 114.13 -1.396 . . . . 15.0 112.956 -178.68 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.792 ' N ' HG22 ' A' ' 37' ' ' VAL . . . 50.06 29.44 14.78 Favored Glycine 0 C--N 1.332 0.34 0 CA-C-N 115.587 -0.733 . . . . 15.0 113.364 179.206 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.474 ' OD2' ' N ' ' A' ' 53' ' ' HIS . 17.4 m-20 -65.86 130.29 42.74 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.759 -0.376 . . . . 15.0 110.605 179.568 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.451 ' HE ' HD21 ' A' ' 59' ' ' LEU . 8.9 ttt180 -80.85 94.97 6.56 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.307 -0.406 . . . . 15.0 111.123 -179.767 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.914 HG22 HG22 ' A' ' 35' ' ' ILE . 1.4 m -84.44 112.72 22.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 CA-C-N 116.315 -0.402 . . . . 15.0 110.621 179.743 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.451 HD21 ' HE ' ' A' ' 57' ' ' ARG . 30.5 mt -107.4 -13.18 15.16 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 112.628 0.603 . . . . 15.0 112.628 -179.116 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.462 ' O ' HD23 ' A' ' 87' ' ' LEU . . . -151.77 148.15 27.52 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.511 0.56 . . . . 15.0 112.511 -178.806 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.726 HG11 ' O ' ' A' ' 77' ' ' THR . 19.0 t -139.2 101.6 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.24 -0.891 . . . . 15.0 109.409 178.896 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.688 ' OD1' HG22 ' A' ' 81' ' ' THR . 2.7 m120 64.9 15.32 9.84 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.667 -0.494 . . . . 15.0 109.667 -178.141 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 107.22 6.17 34.15 Favored Glycine 0 C--N 1.336 0.575 0 CA-C-N 115.867 -0.606 . . . . 15.0 113.46 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.676 HG13 ' O ' ' A' ' 64' ' ' VAL . 6.3 p -93.83 103.94 15.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 117.25 0.525 . . . . 15.0 110.786 179.313 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -55.8 132.29 49.0 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.055 -0.52 . . . . 15.0 111.22 -179.561 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.593 HD13 ' HB3' ' A' ' 69' ' ' ALA . 0.2 OUTLIER -87.64 -20.33 26.48 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.971 -0.559 . . . . 15.0 110.714 179.679 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -43.39 96.1 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.295 -0.411 . . . . 15.0 111.131 179.833 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 104.36 69.65 0.78 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.802 -0.713 . . . . 15.0 112.216 -179.68 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.593 ' HB3' HD13 ' A' ' 66' ' ' LEU . . . -173.02 159.35 3.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.787 0.327 . . . . 15.0 111.038 -179.764 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.472 ' HA ' ' N ' ' A' ' 26' ' ' VAL . 15.9 p -93.04 -173.96 3.43 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.219 -0.446 . . . . 15.0 111.275 -179.799 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.696 ' CE1' HG23 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -61.22 -60.79 3.2 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.862 -0.608 . . . . 15.0 110.438 -179.978 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -52.65 -31.96 39.6 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.717 -0.674 . . . . 15.0 110.473 179.449 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.578 ' HB3' ' HB1' ' A' ' 69' ' ' ALA . 1.5 tt0 -59.56 -53.93 52.44 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.007 -0.542 . . . . 15.0 109.955 179.424 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.934 ' HB3' HD12 ' A' ' 35' ' ' ILE . . . -64.89 -44.78 88.52 Favored 'General case' 0 CA--C 1.518 -0.267 0 N-CA-C 109.432 -0.581 . . . . 15.0 109.432 178.581 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.948 HG23 HG21 ' A' ' 22' ' ' VAL . 0.5 OUTLIER -44.04 -40.6 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.21 0 N-CA-C 108.68 -0.859 . . . . 15.0 108.68 178.021 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.405 ' O ' ' CB ' ' A' ' 80' ' ' ASN . 1.8 mm-40 -67.36 -45.03 77.53 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 114.835 -1.075 . . . . 15.0 109.828 178.093 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.726 ' O ' HG11 ' A' ' 61' ' ' VAL . 80.3 p -64.13 -53.81 43.71 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 116.616 -0.265 . . . . 15.0 111.398 179.751 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.568 HD22 HD11 ' A' ' 87' ' ' LEU . 5.4 mt -53.37 -48.84 68.23 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-O 121.237 0.541 . . . . 15.0 109.851 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 16.2 ttt180 -68.57 -60.67 2.25 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.356 -0.838 . . . . 15.0 110.636 179.224 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.405 ' CB ' ' O ' ' A' ' 76' ' ' GLU . 36.6 m-20 -65.97 61.47 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.93 -0.577 . . . . 15.0 112.133 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.688 HG22 ' OD1' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -95.56 -68.77 0.78 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.779 0.323 . . . . 15.0 110.174 179.178 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 121.92 -105.9 1.03 Allowed Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.883 -0.675 . . . . 15.0 112.889 179.224 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.413 ' O ' ' HB3' ' A' ' 13' ' ' LYS . 0.2 OUTLIER -64.81 -83.05 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 111.943 0.349 . . . . 15.0 111.943 -179.241 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.476 HG12 ' N ' ' A' ' 85' ' ' VAL . 78.1 t -109.78 160.31 8.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.979 0.418 . . . . 15.0 110.944 -179.475 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.656 ' O ' HG12 ' A' ' 85' ' ' VAL . 8.7 t -97.65 82.24 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.109 0.48 . . . . 15.0 110.402 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.48 ' CE1' HD11 ' A' ' 88' ' ' LEU . 2.8 t60 -101.01 82.26 2.35 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.769 -0.65 . . . . 15.0 110.624 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.814 ' HB3' HD21 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -100.56 120.24 39.73 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.919 -0.582 . . . . 15.0 111.679 -179.332 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.708 HD12 ' HB3' ' A' ' 8' ' ' GLU . 0.2 OUTLIER -97.11 101.48 13.06 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.464 -0.569 . . . . 15.0 109.464 178.794 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.814 HD21 ' HB3' ' A' ' 87' ' ' LEU . 0.1 OUTLIER -105.86 -162.99 0.9 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.694 0.759 . . . . 15.0 112.388 -178.392 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.445 ' HA ' ' HA ' ' A' ' 6' ' ' ILE . 7.4 tt0 -139.58 120.91 14.94 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 114.475 -1.239 . . . . 15.0 109.116 178.731 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -46.86 101.92 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.005 0.431 . . . . 15.0 111.398 -179.094 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -62.04 137.28 45.89 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.946 -0.645 . . . . 15.0 112.499 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -85.25 134.44 34.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.836 0.35 . . . . 15.0 110.904 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -90.19 169.95 11.24 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 15.0 110.872 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -52.77 -49.83 16.18 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.563 2.175 . . . . 15.0 112.301 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 3.1 p . . . . . 0 C--O 1.25 1.089 0 CA-C-O 118.214 -0.898 . . . . 15.0 110.892 179.983 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo . . . . . 0 N--CA 1.486 1.08 0 CA-C-O 120.811 0.254 . . . . 15.0 111.698 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.465 ' CB ' ' CD ' ' A' ' 3' ' ' PRO . 1.2 mtpt -155.24 -66.56 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.25 -0.432 . . . . 15.0 111.198 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.465 ' CD ' ' CB ' ' A' ' 2' ' ' LYS . 59.1 Cg_endo -71.0 -94.88 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.206 1.937 . . . . 15.0 112.266 -179.839 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 87.1 -39.44 3.1 Favored Glycine 0 C--N 1.334 0.443 0 C-N-CA 120.527 -0.844 . . . . 15.0 112.865 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -62.07 163.32 8.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.31 0.576 . . . . 15.0 111.349 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.431 HG13 ' HB2' ' A' ' 90' ' ' GLU . 1.2 mp -104.39 150.17 7.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.135 -0.939 . . . . 15.0 110.791 -179.494 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.792 ' CE1' HD12 ' A' ' 89' ' ' LEU . 5.8 p90 -140.69 156.77 46.13 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.413 -0.358 . . . . 15.0 110.678 179.102 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.711 ' CB ' HD12 ' A' ' 88' ' ' LEU . 10.2 pt-20 -124.22 142.84 50.91 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.339 0.59 . . . . 15.0 111.551 -179.399 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.53 ' CG1' HD11 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -101.54 116.47 45.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.132 -0.94 . . . . 15.0 109.716 178.978 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -106.21 73.53 0.99 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.292 -0.413 . . . . 15.0 112.101 -179.017 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.689 HD13 ' HG3' ' A' ' 51' ' ' ARG . 9.7 tp -88.25 160.28 17.75 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.219 -0.446 . . . . 15.0 109.867 178.809 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.517 ' C ' ' H ' ' A' ' 14' ' ' ASN . . . -96.94 95.0 7.53 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.683 0.277 . . . . 15.0 111.716 -179.62 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.889 ' HB2' HG23 ' A' ' 85' ' ' VAL . 0.6 OUTLIER -65.82 28.53 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 112.619 0.6 . . . . 15.0 112.619 179.565 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.517 ' H ' ' C ' ' A' ' 12' ' ' ALA . 76.7 m-20 -109.97 -62.64 1.48 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.744 0.307 . . . . 15.0 111.154 -179.658 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -48.83 -43.77 38.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.272 -0.422 . . . . 15.0 111.05 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 7.9 m-80 -165.41 172.2 12.49 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.14 -0.482 . . . . 15.0 110.811 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.654 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 0.6 OUTLIER -86.07 -168.85 2.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 15.0 110.696 179.834 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 51.2 mt -86.54 -170.26 3.0 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 116.153 -0.476 . . . . 15.0 110.699 179.469 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.793 ' HA3' ' HA3' ' A' ' 44' ' ' GLY . . . -170.86 45.33 0.19 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.729 -0.748 . . . . 15.0 112.347 -179.72 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.744 HG12 ' O ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -112.52 139.12 38.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 120.827 0.346 . . . . 15.0 111.231 -179.913 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.414 ' H ' HD13 ' A' ' 41' ' ' ILE . 13.0 t -90.28 103.32 16.01 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.419 -0.956 . . . . 15.0 108.419 177.959 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 1.006 HG21 HG23 ' A' ' 75' ' ' VAL . 34.7 m -93.94 155.81 3.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 112.645 0.609 . . . . 15.0 112.645 -177.443 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.36 -177.08 5.64 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.31 -0.859 . . . . 15.0 110.779 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.445 ' O ' ' HB3' ' A' ' 71' ' ' HIS . . . 68.83 -119.46 9.87 Favored Glycine 0 C--N 1.332 0.336 0 C-N-CA 120.84 -0.695 . . . . 15.0 112.532 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.531 ' HA3' ' N ' ' A' ' 71' ' ' HIS . . . 68.11 -66.26 0.36 Allowed Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.833 -0.698 . . . . 15.0 113.492 179.466 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.548 ' O ' HG22 ' A' ' 30' ' ' VAL . 1.7 m -30.36 144.74 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 N-CA-C 112.384 0.513 . . . . 15.0 112.384 -179.322 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 49.5 t-20 -75.68 61.08 1.33 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.964 -0.562 . . . . 15.0 110.935 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.4 m -151.73 -66.37 0.18 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.204 -0.453 . . . . 15.0 111.028 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.8 m -68.43 -42.59 78.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.213 -0.449 . . . . 15.0 111.084 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.548 HG22 ' O ' ' A' ' 26' ' ' VAL . 16.6 m -75.12 -173.01 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.269 -0.423 . . . . 15.0 111.202 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.02 -58.36 6.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.204 -0.453 . . . . 15.0 110.934 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 93.0 m-70 -137.12 -54.56 0.7 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.23 -0.441 . . . . 15.0 111.061 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -167.76 22.05 0.1 Allowed Glycine 0 CA--C 1.517 0.215 0 C-N-CA 120.807 -0.711 . . . . 15.0 112.756 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.422 ' O ' HG11 ' A' ' 30' ' ' VAL . . . -85.63 152.86 26.71 Favored Glycine 0 N--CA 1.449 -0.453 0 N-CA-C 110.882 -0.887 . . . . 15.0 110.882 178.945 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.949 HG22 HG22 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -89.73 154.39 3.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 117.522 0.661 . . . . 15.0 111.929 -179.357 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.44 ' CE2' ' HG2' ' A' ' 57' ' ' ARG . 35.3 m-85 -139.28 107.86 5.88 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.98 -1.009 . . . . 15.0 109.998 178.917 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.819 HG22 ' N ' ' A' ' 55' ' ' GLY . 0.6 OUTLIER -55.29 156.22 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.857 -0.61 . . . . 15.0 111.037 -179.097 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.551 ' O ' ' HG2' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -91.09 -47.24 7.66 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.344 -0.984 . . . . 15.0 108.344 178.526 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.744 ' O ' HG12 ' A' ' 20' ' ' ILE . . . -172.48 171.96 4.49 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.329 -0.85 . . . . 15.0 110.062 178.611 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.56 ' HA ' ' CG1' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -96.45 108.41 21.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 109.178 -0.675 . . . . 15.0 109.178 179.191 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.756 ' HB ' ' O ' ' A' ' 19' ' ' GLY . 0.7 OUTLIER -77.99 118.43 72.11 Favored Pre-proline 0 C--N 1.328 -0.362 0 N-CA-C 113.528 0.936 . . . . 15.0 113.528 -176.904 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.597 ' HA ' ' CG ' ' A' ' 47' ' ' GLU . 36.8 Cg_endo -64.31 61.81 0.25 Allowed 'Trans proline' 0 C--N 1.356 0.971 0 C-N-CA 123.602 2.868 . . . . 15.0 112.907 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.508 ' H ' ' HG2' ' A' ' 47' ' ' GLU . 5.4 mm100 -149.42 -46.42 0.14 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.513 -0.312 . . . . 15.0 111.398 179.779 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.793 ' HA3' ' HA3' ' A' ' 19' ' ' GLY . . . -87.88 167.74 36.82 Favored Glycine 0 C--N 1.33 0.204 0 C-N-CA 120.443 -0.884 . . . . 15.0 113.825 -179.249 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.654 ' HB3' ' O ' ' A' ' 17' ' ' SER . . . -59.61 -13.53 9.85 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.168 -0.516 . . . . 15.0 112.244 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.22 -55.99 6.28 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 120.701 0.286 . . . . 15.0 110.79 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.597 ' CG ' ' HA ' ' A' ' 42' ' ' PRO . 2.9 pp20? -57.73 -42.48 83.95 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-N 115.973 -0.558 . . . . 15.0 110.45 179.144 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 32.8 t -53.51 -69.44 0.12 Allowed 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 115.804 -0.635 . . . . 15.0 110.459 -179.244 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.563 ' HB2' HD11 ' A' ' 11' ' ' LEU . 0.4 OUTLIER -59.42 -42.04 90.92 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.07 -0.715 . . . . 15.0 109.07 178.729 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.75 43.02 9.34 Favored Glycine 0 N--CA 1.447 -0.622 0 CA-C-N 115.36 -0.836 . . . . 15.0 111.645 179.42 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.689 ' HG3' HD13 ' A' ' 11' ' ' LEU . 0.7 OUTLIER -79.89 -41.63 25.79 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.712 0.291 . . . . 15.0 111.071 -179.111 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.56 ' CG2' HG11 ' A' ' 37' ' ' VAL . 5.9 mm -91.25 161.49 2.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 120.921 0.391 . . . . 15.0 110.922 179.702 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' HIS . . . . . 0.552 ' N ' HG22 ' A' ' 52' ' ' ILE . 75.8 m80 -142.38 154.91 45.03 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-O 121.447 0.641 . . . . 15.0 111.083 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.551 ' HG2' ' O ' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -37.68 133.13 0.83 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.552 -1.203 . . . . 15.0 112.934 -178.552 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.819 ' N ' HG22 ' A' ' 37' ' ' VAL . . . 50.05 33.48 21.87 Favored Glycine 0 C--N 1.335 0.489 0 CA-C-N 115.822 -0.626 . . . . 15.0 113.716 179.243 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.431 ' H ' HG13 ' A' ' 37' ' ' VAL . 2.8 m-20 -65.34 130.71 44.3 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 117.178 0.489 . . . . 15.0 110.181 179.16 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.44 ' HG2' ' CE2' ' A' ' 36' ' ' TYR . 30.9 mtt180 -83.28 94.83 8.0 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.341 -0.39 . . . . 15.0 110.522 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.949 HG22 HG22 ' A' ' 35' ' ' ILE . 1.1 m -87.87 117.22 31.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 121.039 0.447 . . . . 15.0 111.055 -179.713 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.555 HD12 ' HG3' ' A' ' 67' ' ' GLU . 2.9 mm? -107.17 -14.23 14.96 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 115.797 -0.638 . . . . 15.0 112.567 -179.129 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.576 ' HB3' ' HB2' ' A' ' 88' ' ' LEU . . . -149.98 146.56 27.08 Favored 'General case' 0 N--CA 1.462 0.162 0 N-CA-C 112.591 0.589 . . . . 15.0 112.591 -178.819 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.82 HG11 ' O ' ' A' ' 77' ' ' THR . 45.9 t -139.25 100.26 1.37 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.224 0 CA-C-N 115.32 -0.854 . . . . 15.0 109.385 178.751 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.637 ' OD1' HG22 ' A' ' 81' ' ' THR . 2.6 m120 65.05 16.57 10.64 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.086 -0.507 . . . . 15.0 109.937 -178.157 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 107.05 4.39 35.83 Favored Glycine 0 C--N 1.336 0.531 0 CA-C-N 115.848 -0.614 . . . . 15.0 113.387 179.601 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.626 HG13 ' O ' ' A' ' 64' ' ' VAL . 4.3 p -93.79 107.04 18.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 121.087 0.47 . . . . 15.0 110.78 179.499 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -57.55 130.73 47.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 15.0 111.049 -179.526 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.937 HD11 ' HB2' ' A' ' 74' ' ' ALA . 0.2 OUTLIER -87.69 -27.06 22.65 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.067 -0.515 . . . . 15.0 110.811 179.98 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.555 ' HG3' HD12 ' A' ' 59' ' ' LEU . 82.2 mt-10 -47.39 103.49 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.338 -0.392 . . . . 15.0 111.019 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.8 58.73 0.54 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.756 -0.735 . . . . 15.0 112.425 -179.734 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.562 ' HB1' ' CB ' ' A' ' 73' ' ' GLN . . . -173.1 165.61 4.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.901 0.382 . . . . 15.0 111.07 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.497 HG22 ' HA ' ' A' ' 26' ' ' VAL . 17.3 p -93.13 -172.93 3.11 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.095 -0.502 . . . . 15.0 111.046 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.74 ' CE1' HG23 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -63.07 -59.7 4.43 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.797 -0.638 . . . . 15.0 110.563 -179.924 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.41 ' HA ' ' HB ' ' A' ' 75' ' ' VAL . 7.6 ttpt -52.56 -33.77 47.28 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.838 -0.619 . . . . 15.0 110.807 179.719 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.562 ' CB ' ' HB1' ' A' ' 69' ' ' ALA . 7.0 mt-30 -59.5 -50.79 72.57 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.688 -0.486 . . . . 15.0 109.688 179.339 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.937 ' HB2' HD11 ' A' ' 66' ' ' LEU . . . -66.97 -43.82 82.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.95 -0.568 . . . . 15.0 109.697 178.416 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 1.006 HG23 HG21 ' A' ' 22' ' ' VAL . 0.5 OUTLIER -43.34 -41.76 1.35 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.289 0 N-CA-C 108.878 -0.786 . . . . 15.0 108.878 178.319 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.407 ' O ' ' CB ' ' A' ' 80' ' ' ASN . 2.0 mt-10 -67.17 -44.3 80.07 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 114.822 -1.081 . . . . 15.0 110.022 178.323 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.82 ' O ' HG11 ' A' ' 61' ' ' VAL . 59.4 p -64.06 -54.38 34.96 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-N 116.665 -0.243 . . . . 15.0 111.596 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.717 HD21 HG21 ' A' ' 58' ' ' VAL . 8.8 mt -53.45 -48.98 68.35 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.317 0.58 . . . . 15.0 110.03 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.417 ' HB2' ' O ' ' A' ' 75' ' ' VAL . 0.0 OUTLIER -68.44 -59.15 3.38 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.251 -0.886 . . . . 15.0 110.723 179.722 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.407 ' CB ' ' O ' ' A' ' 76' ' ' GLU . 14.6 m120 -65.97 62.87 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.1 -0.5 . . . . 15.0 111.909 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.637 HG22 ' OD1' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -95.46 -73.66 0.58 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 110.146 -0.316 . . . . 15.0 110.146 179.205 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 122.15 -105.4 0.98 Allowed Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.696 -0.764 . . . . 15.0 113.268 179.048 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.404 ' O ' ' HB3' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -64.88 -83.64 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.761 0.315 . . . . 15.0 111.18 -179.39 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.476 HG12 ' N ' ' A' ' 85' ' ' VAL . 79.7 t -109.82 160.18 8.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.257 -0.428 . . . . 15.0 110.864 -179.755 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.889 HG23 ' HB2' ' A' ' 13' ' ' LYS . 3.6 t -97.63 81.64 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.137 0.494 . . . . 15.0 110.18 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -96.41 80.23 3.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.727 -0.669 . . . . 15.0 110.391 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.67 ' HB3' HD21 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -102.12 124.68 48.15 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.063 -0.517 . . . . 15.0 111.649 -179.269 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.711 HD12 ' CB ' ' A' ' 8' ' ' GLU . 4.7 mp -102.01 99.01 9.13 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.658 -0.497 . . . . 15.0 109.658 178.825 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.792 HD12 ' CE1' ' A' ' 7' ' ' PHE . 0.1 OUTLIER -102.93 -161.42 0.84 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.383 0.611 . . . . 15.0 111.841 -178.772 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.431 ' HB2' HG13 ' A' ' 6' ' ' ILE . 3.1 tt0 -140.93 144.01 34.92 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.059 -0.973 . . . . 15.0 109.772 179.108 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 7.1 tptp -55.17 104.95 0.14 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.877 0.37 . . . . 15.0 110.961 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -62.42 105.91 1.1 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.845 -0.693 . . . . 15.0 112.6 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -84.21 108.83 17.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.855 0.36 . . . . 15.0 110.849 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -86.55 139.43 33.6 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.19 -0.459 . . . . 15.0 110.911 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -53.28 -46.92 30.41 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.501 2.134 . . . . 15.0 112.267 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 17.1 m . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.217 -0.897 . . . . 15.0 110.915 179.971 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo . . . . . 0 N--CA 1.487 1.138 0 CA-C-O 120.852 0.272 . . . . 15.0 111.745 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -155.18 159.36 31.83 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.149 -0.478 . . . . 15.0 110.782 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -56.46 -164.05 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.585 2.19 . . . . 15.0 112.19 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 85.69 -17.24 36.47 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.533 -0.841 . . . . 15.0 112.505 -179.716 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -62.01 162.88 8.59 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-O 121.226 0.536 . . . . 15.0 110.941 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.467 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 1.3 mp -104.38 146.2 12.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.318 -0.856 . . . . 15.0 111.176 -179.226 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.645 ' CE1' HD12 ' A' ' 89' ' ' LEU . 6.8 p90 -140.64 164.31 30.53 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.063 -0.517 . . . . 15.0 110.203 178.924 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.753 ' HB2' HD12 ' A' ' 88' ' ' LEU . 0.3 OUTLIER -130.2 143.24 50.66 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.284 0.564 . . . . 15.0 111.66 -179.506 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.575 ' CG1' HD11 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -101.42 114.35 40.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.184 -0.916 . . . . 15.0 109.397 178.859 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -106.01 72.25 0.93 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.213 -0.449 . . . . 15.0 112.137 -178.715 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.629 HD13 ' HG3' ' A' ' 51' ' ' ARG . 5.4 tp -88.21 166.39 14.39 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.429 -0.582 . . . . 15.0 109.429 178.61 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.501 ' HB3' ' HB2' ' A' ' 15' ' ' ASP . . . -96.02 97.66 9.77 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.05 0.453 . . . . 15.0 111.262 -179.834 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.74 ' CB ' HG23 ' A' ' 85' ' ' VAL . 0.1 OUTLIER -63.88 -29.44 70.62 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.735 -0.666 . . . . 15.0 111.42 -179.861 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 22.9 t30 -84.3 -30.9 25.21 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.426 -0.352 . . . . 15.0 111.039 -179.524 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.501 ' HB2' ' HB3' ' A' ' 12' ' ' ALA . 0.8 OUTLIER -77.59 -37.01 51.36 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.03 0.443 . . . . 15.0 110.132 179.319 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.516 ' HB3' ' HB2' ' A' ' 45' ' ' ALA . 2.4 m120 -165.6 156.12 13.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.802 -0.635 . . . . 15.0 110.702 179.769 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.931 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 0.3 OUTLIER -85.86 -162.83 0.78 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.421 -0.354 . . . . 15.0 110.163 179.589 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.4 mp -108.2 -175.72 2.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.955 0.407 . . . . 15.0 110.715 179.452 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.808 ' O ' ' HB ' ' A' ' 41' ' ' ILE . . . -161.12 46.07 0.39 Allowed Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 121.034 -0.603 . . . . 15.0 111.794 -179.791 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.757 HG12 ' O ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -112.77 136.67 48.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 120.927 0.394 . . . . 15.0 111.581 -179.609 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 37.4 t -88.65 103.13 15.64 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.285 -1.006 . . . . 15.0 108.285 177.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.887 HG21 HG23 ' A' ' 75' ' ' VAL . 8.0 m -93.6 149.11 4.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 112.643 0.609 . . . . 15.0 112.643 -177.433 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.489 ' HA ' ' ND1' ' A' ' 71' ' ' HIS . 5.4 t -150.02 179.24 8.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.39 -0.823 . . . . 15.0 110.468 179.185 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.696 ' O ' HG22 ' A' ' 26' ' ' VAL . . . 82.78 -117.32 4.38 Favored Glycine 0 C--N 1.331 0.298 0 C-N-CA 120.542 -0.837 . . . . 15.0 112.649 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.579 ' HA3' ' N ' ' A' ' 71' ' ' HIS . . . 63.34 -65.87 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 121.084 -0.579 . . . . 15.0 113.742 179.184 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.696 HG22 ' O ' ' A' ' 24' ' ' GLY . 0.0 OUTLIER -26.57 139.86 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 N-CA-C 112.633 0.605 . . . . 15.0 112.633 -178.994 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.425 ' HA ' ' O ' ' A' ' 32' ' ' HIS . 54.2 t-20 -77.62 57.67 1.65 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.768 -0.651 . . . . 15.0 110.927 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 5.9 m -151.69 -61.18 0.17 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.24 -0.437 . . . . 15.0 110.767 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.64 -34.77 77.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.15 -0.477 . . . . 15.0 110.692 179.755 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.642 HG22 ' O ' ' A' ' 26' ' ' VAL . 33.2 m -88.02 -174.34 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.064 -0.516 . . . . 15.0 111.003 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -70.53 -51.5 28.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.394 -0.367 . . . . 15.0 111.241 -179.764 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' HIS . . . . . 0.425 ' O ' ' HA ' ' A' ' 27' ' ' ASN . 76.8 m80 -132.52 -70.97 0.54 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.401 -0.363 . . . . 15.0 111.255 -179.745 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -162.75 24.84 0.21 Allowed Glycine 0 C--O 1.23 -0.145 0 C-N-CA 120.904 -0.665 . . . . 15.0 112.388 -179.733 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -86.89 148.19 21.5 Favored Glycine 0 N--CA 1.448 -0.522 0 N-CA-C 110.171 -1.172 . . . . 15.0 110.171 178.658 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 1.056 HD12 ' HB3' ' A' ' 74' ' ' ALA . 0.3 OUTLIER -88.68 153.78 3.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 C-N-CA 119.574 -0.85 . . . . 15.0 112.297 -178.894 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.477 ' CE2' ' CG ' ' A' ' 57' ' ' ARG . 32.4 m-85 -134.16 107.89 7.97 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.644 -1.162 . . . . 15.0 109.056 179.321 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.797 HG22 ' N ' ' A' ' 55' ' ' GLY . 0.7 OUTLIER -54.96 148.02 3.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.144 0.497 . . . . 15.0 111.189 -178.479 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.445 ' O ' ' HG2' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -80.05 -49.06 12.31 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.882 -0.784 . . . . 15.0 108.882 178.91 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.757 ' O ' HG12 ' A' ' 20' ' ' ILE . . . -172.33 172.45 4.46 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 115.999 -0.546 . . . . 15.0 110.184 178.439 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.556 ' HA ' ' CG1' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -96.72 110.01 24.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 108.957 -0.757 . . . . 15.0 108.957 178.905 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.808 ' HB ' ' O ' ' A' ' 19' ' ' GLY . 0.5 OUTLIER -78.0 115.25 48.98 Favored Pre-proline 0 C--N 1.326 -0.433 0 N-CA-C 113.275 0.843 . . . . 15.0 113.275 -177.053 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.617 ' HA ' ' CG ' ' A' ' 47' ' ' GLU . 30.3 Cg_exo -62.56 59.49 0.14 Allowed 'Trans proline' 0 C--N 1.358 1.07 0 C-N-CA 123.612 2.875 . . . . 15.0 112.95 179.706 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.528 ' N ' ' HG2' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -147.45 -47.38 0.17 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.594 0.235 . . . . 15.0 111.341 -179.985 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.739 ' HA3' ' HA3' ' A' ' 19' ' ' GLY . . . -87.67 168.89 38.37 Favored Glycine 0 C--N 1.33 0.217 0 C-N-CA 120.398 -0.906 . . . . 15.0 113.801 -179.136 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.931 ' HB3' ' O ' ' A' ' 17' ' ' SER . . . -58.12 -13.78 5.52 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.702 0.63 . . . . 15.0 112.702 -179.673 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.03 -56.46 5.59 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.97 -0.292 . . . . 15.0 110.69 -179.688 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.617 ' CG ' ' HA ' ' A' ' 42' ' ' PRO . 2.8 pp20? -57.61 -43.33 84.68 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.997 -0.547 . . . . 15.0 110.434 179.172 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -53.81 -70.21 0.1 Allowed 'General case' 0 CA--C 1.518 -0.256 0 CA-C-N 115.902 -0.59 . . . . 15.0 110.523 -179.473 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.539 ' CB ' HD11 ' A' ' 11' ' ' LEU . 0.1 OUTLIER -58.13 -41.59 83.99 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.137 -0.69 . . . . 15.0 109.137 178.786 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.72 40.49 12.26 Favored Glycine 0 N--CA 1.445 -0.702 0 CA-C-N 115.305 -0.861 . . . . 15.0 111.676 179.309 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.629 ' HG3' HD13 ' A' ' 11' ' ' LEU . 0.1 OUTLIER -79.74 -49.9 11.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.891 0.376 . . . . 15.0 110.65 -179.351 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.611 ' CG1' HD12 ' A' ' 20' ' ' ILE . 8.8 tp -81.14 161.21 3.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.02 -0.536 . . . . 15.0 110.241 179.464 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' HIS . . . . . 0.444 ' N ' ' OD2' ' A' ' 56' ' ' ASP . 75.2 m80 -146.07 156.77 43.69 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-O 121.581 0.705 . . . . 15.0 112.258 -179.047 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.557 ' HA ' ' CG2' ' A' ' 37' ' ' VAL . 0.6 OUTLIER -43.28 132.51 4.37 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.3 -1.318 . . . . 15.0 112.902 -178.666 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.797 ' N ' HG22 ' A' ' 37' ' ' VAL . . . 50.98 29.87 21.34 Favored Glycine 0 C--N 1.335 0.475 0 CA-C-N 115.785 -0.643 . . . . 15.0 113.456 179.137 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.444 ' OD2' ' N ' ' A' ' 53' ' ' HIS . 6.4 m-20 -65.76 128.81 37.46 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.827 -0.349 . . . . 15.0 110.51 179.516 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.477 ' CG ' ' CE2' ' A' ' 36' ' ' TYR . 2.3 mtp85 -80.62 95.45 6.56 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.476 -0.329 . . . . 15.0 110.663 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.953 HG22 HG22 ' A' ' 35' ' ' ILE . 1.5 m -85.76 113.42 23.91 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-O 121.094 0.474 . . . . 15.0 111.177 -179.654 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.502 HD22 ' N ' ' A' ' 59' ' ' LEU . 3.6 mm? -107.35 -12.08 15.41 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 115.677 -0.692 . . . . 15.0 112.505 -179.288 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.819 ' HB3' ' HB2' ' A' ' 88' ' ' LEU . . . -150.71 148.25 28.33 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 112.762 0.653 . . . . 15.0 112.762 -178.709 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.685 HG11 ' O ' ' A' ' 77' ' ' THR . 15.4 t -139.12 99.51 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.231 -0.895 . . . . 15.0 109.107 178.741 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.73 ' OD1' HG22 ' A' ' 81' ' ' THR . 9.2 m120 65.22 16.41 10.53 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.871 -0.418 . . . . 15.0 109.871 -177.987 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 107.2 4.93 35.3 Favored Glycine 0 C--N 1.336 0.544 0 CA-C-N 116.039 -0.528 . . . . 15.0 113.465 179.631 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.663 HG13 ' O ' ' A' ' 64' ' ' VAL . 5.2 p -93.8 106.37 17.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 117.168 0.484 . . . . 15.0 110.783 179.506 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.2 m -56.33 130.15 43.38 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.171 -0.468 . . . . 15.0 111.051 -179.609 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.551 HD21 ' OG1' ' A' ' 77' ' ' THR . 0.2 OUTLIER -89.44 -21.38 23.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.075 -0.511 . . . . 15.0 110.997 179.946 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -45.76 101.5 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.869 0.366 . . . . 15.0 111.062 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.78 63.11 0.55 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.791 -0.718 . . . . 15.0 112.4 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.733 ' HB1' ' CB ' ' A' ' 73' ' ' GLN . . . -173.02 160.59 4.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.89 0.376 . . . . 15.0 111.035 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.453 ' HB ' ' HA ' ' A' ' 26' ' ' VAL . 3.0 p -93.17 -170.54 2.43 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.084 0.468 . . . . 15.0 111.055 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.715 ' CD2' HG23 ' A' ' 22' ' ' VAL . 0.2 OUTLIER -60.75 -61.02 2.89 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.691 -0.686 . . . . 15.0 110.13 179.908 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.556 ' O ' HG12 ' A' ' 75' ' ' VAL . 12.7 ttpp -53.21 -34.79 58.55 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.716 -0.674 . . . . 15.0 110.863 179.234 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.733 ' CB ' ' HB1' ' A' ' 69' ' ' ALA . 3.3 mt-30 -59.42 -54.9 41.37 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.645 -0.502 . . . . 15.0 109.645 179.575 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 1.056 ' HB3' HD12 ' A' ' 35' ' ' ILE . . . -63.9 -43.55 95.65 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.823 -0.626 . . . . 15.0 109.536 178.458 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.887 HG23 HG21 ' A' ' 22' ' ' VAL . 0.5 OUTLIER -44.25 -40.06 1.68 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.296 0 N-CA-C 108.771 -0.825 . . . . 15.0 108.771 178.176 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.522 ' O ' ' HB2' ' A' ' 80' ' ' ASN . 3.6 mm-40 -67.42 -45.01 77.39 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 114.793 -1.094 . . . . 15.0 110.302 178.377 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.685 ' O ' HG11 ' A' ' 61' ' ' VAL . 32.9 p -64.02 -54.64 31.08 Favored 'General case' 0 C--O 1.231 0.124 0 C-N-CA 121.055 -0.258 . . . . 15.0 111.509 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.559 HD21 HG21 ' A' ' 58' ' ' VAL . 6.5 mt -53.37 -46.6 69.68 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-O 121.262 0.553 . . . . 15.0 109.8 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.425 ' HB2' ' O ' ' A' ' 75' ' ' VAL . 8.9 tpp180 -68.49 -59.81 2.88 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.266 -0.879 . . . . 15.0 110.5 179.284 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.522 ' HB2' ' O ' ' A' ' 76' ' ' GLU . 10.9 m-80 -66.12 62.11 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.98 -0.554 . . . . 15.0 111.833 179.801 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.73 HG22 ' OD1' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -93.74 -74.16 0.54 Allowed 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.804 -0.443 . . . . 15.0 109.804 179.182 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 122.03 -106.15 1.05 Allowed Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.802 -0.713 . . . . 15.0 113.195 179.019 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -64.7 -82.13 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 111.984 0.365 . . . . 15.0 111.984 -179.067 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.436 HG12 ' N ' ' A' ' 85' ' ' VAL . 62.4 t -109.87 158.29 10.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.06 0.457 . . . . 15.0 110.87 -179.335 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.74 HG23 ' CB ' ' A' ' 13' ' ' LYS . 14.0 t -97.93 80.96 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 116.084 -0.507 . . . . 15.0 110.569 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -103.13 83.39 2.2 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.901 -0.591 . . . . 15.0 110.265 179.718 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.805 ' HB3' HD21 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -99.93 118.32 36.11 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.952 -0.567 . . . . 15.0 111.756 -179.088 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.819 ' HB2' ' HB3' ' A' ' 60' ' ' ALA . 4.3 mp -92.14 101.1 13.62 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.757 -0.46 . . . . 15.0 109.757 178.914 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.805 HD21 ' HB3' ' A' ' 87' ' ' LEU . 0.2 OUTLIER -105.65 -159.71 0.72 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.303 0.573 . . . . 15.0 111.66 -178.836 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.467 ' HA ' ' HA ' ' A' ' 6' ' ' ILE . 3.1 tt0 -140.58 145.23 36.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.311 -0.859 . . . . 15.0 110.195 179.243 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.85 106.87 0.34 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.249 -0.432 . . . . 15.0 110.977 -179.837 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -69.59 167.03 48.2 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.842 -0.695 . . . . 15.0 112.581 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -86.2 142.77 28.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.783 0.325 . . . . 15.0 110.896 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -81.76 150.63 66.41 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.224 -0.444 . . . . 15.0 110.884 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_exo -51.47 -53.25 7.4 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.594 2.196 . . . . 15.0 112.34 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 23.3 m . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.206 -0.902 . . . . 15.0 110.861 -179.996 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_endo . . . . . 0 N--CA 1.488 1.187 0 CA-C-O 120.857 0.274 . . . . 15.0 111.81 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 13.9 pttp -149.49 129.08 6.43 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 15.0 110.867 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.9 -160.26 0.07 OUTLIER 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.491 2.127 . . . . 15.0 112.222 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 92.18 -25.94 15.37 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.622 -0.799 . . . . 15.0 112.18 -179.678 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -62.33 133.88 55.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.271 0.558 . . . . 15.0 110.633 179.783 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.531 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 1.5 mp -104.46 144.98 13.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.342 -0.844 . . . . 15.0 111.301 -179.188 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.579 ' CE1' HD12 ' A' ' 89' ' ' LEU . 3.8 p90 -144.56 165.03 29.15 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.061 -0.518 . . . . 15.0 110.415 178.799 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.727 ' CB ' HD12 ' A' ' 88' ' ' LEU . 10.7 pt-20 -130.19 143.84 51.01 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.201 0.524 . . . . 15.0 111.6 -179.05 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.454 HG23 ' HB3' ' A' ' 51' ' ' ARG . 0.2 OUTLIER -101.64 117.13 46.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.441 -0.799 . . . . 15.0 109.542 178.615 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 -106.14 74.86 1.06 Allowed 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 112.33 0.493 . . . . 15.0 112.33 -178.833 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.559 HD11 ' CB ' ' A' ' 49' ' ' ASP . 6.8 tp -88.19 166.34 14.44 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.389 -0.597 . . . . 15.0 109.389 178.43 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -96.2 95.76 8.35 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.041 0.448 . . . . 15.0 111.28 -179.797 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.662 ' CB ' HG23 ' A' ' 85' ' ' VAL . 0.2 OUTLIER -60.47 -26.03 66.48 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.73 -0.668 . . . . 15.0 111.195 179.869 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 54.1 m-20 -83.81 -39.69 19.67 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.322 -0.399 . . . . 15.0 110.641 -179.792 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -69.98 -37.68 75.8 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.078 0.466 . . . . 15.0 109.994 179.243 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.679 ' HB3' ' HB2' ' A' ' 45' ' ' ALA . 8.4 m-80 -165.52 163.21 19.5 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.73 -0.668 . . . . 15.0 110.673 179.572 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.601 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 1.5 m -85.97 -137.73 0.08 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.333 -0.394 . . . . 15.0 110.052 179.651 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.0 mp -116.87 -174.54 2.6 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 120.826 0.346 . . . . 15.0 110.561 179.318 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.649 ' O ' ' HB ' ' A' ' 41' ' ' ILE . . . -160.99 36.86 0.42 Allowed Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 121.136 -0.554 . . . . 15.0 111.782 -179.636 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.616 HD13 ' HB ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -112.66 141.68 27.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 120.996 0.427 . . . . 15.0 112.027 -179.291 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 31.4 t -96.24 102.69 14.52 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 107.301 -1.37 . . . . 15.0 107.301 176.86 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.998 HG21 HG23 ' A' ' 75' ' ' VAL . 14.1 m -93.33 148.26 4.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 113.536 0.939 . . . . 15.0 113.536 -176.293 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.533 ' O ' ' O ' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -149.86 157.92 43.66 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.005 -0.998 . . . . 15.0 110.699 179.586 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.412 ' O ' HG12 ' A' ' 35' ' ' ILE . . . 67.71 112.67 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.444 -0.884 . . . . 15.0 113.42 178.653 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.508 ' HA3' ' N ' ' A' ' 71' ' ' HIS . . . -163.74 -38.97 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 121.112 -0.566 . . . . 15.0 112.301 179.244 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.508 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 0.2 OUTLIER -40.78 162.58 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-O 120.868 0.366 . . . . 15.0 111.823 179.935 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -87.91 51.72 2.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.454 . . . . 15.0 110.887 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -151.63 -62.15 0.17 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.094 -0.503 . . . . 15.0 110.663 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.75 -52.34 51.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.192 -0.458 . . . . 15.0 110.609 179.753 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.441 HG22 ' O ' ' A' ' 26' ' ' VAL . 16.4 m -87.98 -177.68 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.137 -0.483 . . . . 15.0 110.771 179.726 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 5.1 ppt_? -88.41 127.1 35.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.851 0.358 . . . . 15.0 111.184 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 57.1 m80 62.76 -82.14 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.005 -0.543 . . . . 15.0 111.424 179.709 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -177.25 33.08 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.721 -0.752 . . . . 15.0 112.661 -179.525 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -93.52 156.35 22.58 Favored Glycine 0 N--CA 1.45 -0.388 0 N-CA-C 110.846 -0.902 . . . . 15.0 110.846 179.079 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.955 HG22 HG22 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -97.64 153.6 3.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 119.854 -0.738 . . . . 15.0 111.997 -179.29 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.533 ' O ' ' O ' ' A' ' 23' ' ' THR . 26.8 m-85 -134.17 106.82 7.37 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.963 -1.017 . . . . 15.0 109.7 179.225 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.806 HG22 ' N ' ' A' ' 55' ' ' GLY . 0.7 OUTLIER -54.63 146.64 3.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.106 0.479 . . . . 15.0 111.282 -178.593 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.475 ' HB3' ' OG1' ' A' ' 23' ' ' THR . 0.0 OUTLIER -79.94 -48.87 12.71 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.319 -0.993 . . . . 15.0 108.319 178.78 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.597 ' O ' HG12 ' A' ' 20' ' ' ILE . . . -172.23 171.07 4.95 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.285 -0.87 . . . . 15.0 110.119 178.612 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.567 ' HA ' HG12 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -97.1 110.26 24.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.085 0.469 . . . . 15.0 110.182 179.558 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.649 ' HB ' ' O ' ' A' ' 19' ' ' GLY . 0.4 OUTLIER -78.47 109.58 10.99 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 115.701 -0.682 . . . . 15.0 112.32 -178.326 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.466 ' N ' ' HG2' ' A' ' 47' ' ' GLU . 31.4 Cg_endo -63.45 65.88 0.18 Allowed 'Trans proline' 0 C--N 1.355 0.919 0 C-N-CA 123.159 2.572 . . . . 15.0 112.568 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.424 ' N ' ' O ' ' A' ' 41' ' ' ILE . 5.2 tp60 -147.32 -53.34 0.21 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.322 -0.854 . . . . 15.0 109.112 179.469 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.57 ' HA3' ' HA3' ' A' ' 19' ' ' GLY . . . -87.93 157.18 28.19 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.667 -0.778 . . . . 15.0 112.51 179.175 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.679 ' HB2' ' HB3' ' A' ' 16' ' ' ASN . . . -41.58 -17.38 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 113.588 0.958 . . . . 15.0 113.588 -179.531 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.43 ' N ' ' O ' ' A' ' 44' ' ' GLY . . . -71.65 -70.72 0.31 Allowed 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.75 -0.38 . . . . 15.0 111.345 -179.409 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.501 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 4.3 tp10 -58.54 -40.6 83.43 Favored 'General case' 0 N--CA 1.463 0.179 0 C-N-CA 120.587 -0.445 . . . . 15.0 110.436 179.546 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.8 m -54.15 -63.56 1.11 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.997 -0.547 . . . . 15.0 110.338 179.355 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.559 ' CB ' HD11 ' A' ' 11' ' ' LEU . 1.9 t70 -63.5 -40.05 96.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.108 -0.496 . . . . 15.0 109.899 179.081 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.58 43.37 8.49 Favored Glycine 0 N--CA 1.449 -0.437 0 CA-C-N 115.678 -0.692 . . . . 15.0 112.836 179.472 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.541 ' HG3' HD13 ' A' ' 11' ' ' LEU . 1.1 mmt-85 -89.34 -52.81 4.85 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.938 0.399 . . . . 15.0 110.557 179.696 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.568 ' CG1' HD12 ' A' ' 20' ' ' ILE . 9.7 tp -81.0 159.16 4.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.036 -0.529 . . . . 15.0 110.398 179.546 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' HIS . . . . . 0.41 ' O ' ' HB2' ' A' ' 56' ' ' ASP . 80.3 m80 -139.69 160.88 38.87 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-O 121.794 0.807 . . . . 15.0 112.758 -178.871 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.574 ' HA ' ' CG2' ' A' ' 37' ' ' VAL . 0.2 OUTLIER -44.67 134.29 5.53 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.002 -1.453 . . . . 15.0 113.1 -178.657 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.806 ' N ' HG22 ' A' ' 37' ' ' VAL . . . 49.66 31.8 15.97 Favored Glycine 0 C--N 1.334 0.442 0 CA-C-N 115.738 -0.664 . . . . 15.0 113.636 178.802 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.41 ' HB2' ' O ' ' A' ' 53' ' ' HIS . 0.3 OUTLIER -65.97 131.71 46.88 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.506 -0.478 . . . . 15.0 110.683 179.442 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.491 ' HG2' ' CE2' ' A' ' 36' ' ' TYR . 6.6 mtp85 -82.65 87.41 6.73 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.351 -0.386 . . . . 15.0 110.113 179.411 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.955 HG22 HG22 ' A' ' 35' ' ' ILE . 1.3 m -79.31 113.25 18.4 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 CA-C-O 121.158 0.504 . . . . 15.0 111.087 -179.379 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 21.3 mt -107.56 -14.48 14.82 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 115.472 -0.786 . . . . 15.0 112.493 -179.173 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.714 ' HB3' ' HB2' ' A' ' 88' ' ' LEU . . . -147.5 150.41 34.51 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.604 0.594 . . . . 15.0 112.604 -178.414 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.781 HG11 ' O ' ' A' ' 77' ' ' THR . 80.9 t -139.05 102.72 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.175 -0.92 . . . . 15.0 109.018 178.746 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.665 ' OD1' HG22 ' A' ' 81' ' ' THR . 2.4 m120 65.11 14.89 9.68 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.723 -0.473 . . . . 15.0 109.723 -177.901 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 106.4 6.71 35.72 Favored Glycine 0 C--N 1.336 0.566 0 CA-C-N 115.839 -0.619 . . . . 15.0 113.366 179.64 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.68 HG13 ' O ' ' A' ' 64' ' ' VAL . 6.5 p -93.79 104.96 16.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 117.17 0.485 . . . . 15.0 110.874 179.486 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 50.8 m -58.47 121.3 10.55 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.148 -0.478 . . . . 15.0 110.733 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.47 HD13 HG23 ' A' ' 58' ' ' VAL . 0.5 OUTLIER -87.56 -10.04 52.7 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.031 -0.532 . . . . 15.0 111.185 -179.879 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -46.12 98.48 0.01 OUTLIER 'General case' 0 C--N 1.334 -0.105 0 CA-C-O 120.916 0.389 . . . . 15.0 110.799 179.734 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.94 68.66 0.62 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.75 -0.738 . . . . 15.0 112.193 -179.515 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.454 ' HB1' ' CB ' ' A' ' 73' ' ' GLN . . . -172.87 167.7 5.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.783 0.325 . . . . 15.0 110.863 -179.892 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.508 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 7.0 p -92.98 -175.05 3.76 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.238 -0.437 . . . . 15.0 111.335 -179.604 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.681 ' CD2' HG23 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -63.32 -61.2 2.51 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.928 -0.578 . . . . 15.0 110.283 -179.873 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.401 ' HA ' ' HB ' ' A' ' 75' ' ' VAL . 3.0 ttpp -52.7 -33.06 45.92 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.772 -0.649 . . . . 15.0 110.732 179.568 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.454 ' CB ' ' HB1' ' A' ' 69' ' ' ALA . 5.9 mt-30 -59.41 -48.25 82.36 Favored 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 109.403 -0.591 . . . . 15.0 109.403 179.236 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.461 ' HA ' ' OG1' ' A' ' 77' ' ' THR . . . -65.37 -47.99 74.5 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.719 -0.673 . . . . 15.0 109.214 178.307 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.998 HG23 HG21 ' A' ' 22' ' ' VAL . 0.5 OUTLIER -43.39 -39.42 1.17 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.242 0 N-CA-C 108.74 -0.837 . . . . 15.0 108.74 178.07 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -67.31 -45.92 75.06 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 114.739 -1.119 . . . . 15.0 110.349 178.468 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.781 ' O ' HG11 ' A' ' 61' ' ' VAL . 10.0 p -64.37 -53.18 52.6 Favored 'General case' 0 C--O 1.231 0.129 0 C-N-CA 120.893 -0.323 . . . . 15.0 111.309 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.696 HD23 HG21 ' A' ' 61' ' ' VAL . 5.7 mt -53.36 -48.28 68.69 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-O 121.219 0.533 . . . . 15.0 109.944 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -68.4 -59.04 3.47 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.353 -0.84 . . . . 15.0 110.351 179.357 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -66.02 61.47 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.846 -0.615 . . . . 15.0 111.911 179.739 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.665 HG22 ' OD1' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -95.72 -71.01 0.69 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.693 0.282 . . . . 15.0 110.51 179.519 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 122.15 -104.42 0.91 Allowed Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.824 -0.703 . . . . 15.0 113.186 179.345 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.426 ' O ' ' HB3' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -64.64 -83.41 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 111.965 0.357 . . . . 15.0 111.965 -179.066 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.439 HG12 ' N ' ' A' ' 85' ' ' VAL . 53.9 t -109.46 159.91 8.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.94 0.4 . . . . 15.0 110.839 -179.543 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.662 HG23 ' CB ' ' A' ' 13' ' ' LYS . 24.5 t -97.87 79.59 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.161 -0.472 . . . . 15.0 110.52 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -100.63 85.39 2.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.856 -0.611 . . . . 15.0 110.594 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.713 ' HB3' HD21 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -99.57 123.11 43.53 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.083 -0.508 . . . . 15.0 111.513 -179.468 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.727 HD12 ' CB ' ' A' ' 8' ' ' GLU . 4.7 mp -98.5 100.74 12.02 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.891 -0.411 . . . . 15.0 109.891 179.014 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.713 HD21 ' HB3' ' A' ' 87' ' ' LEU . 0.1 OUTLIER -105.93 -162.29 0.85 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.428 0.632 . . . . 15.0 111.903 -178.87 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.531 ' HA ' ' HA ' ' A' ' 6' ' ' ILE . 3.1 tt0 -138.25 142.26 39.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 114.977 -1.01 . . . . 15.0 109.952 178.88 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 4.2 tptt -54.25 103.32 0.08 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.36 -0.382 . . . . 15.0 111.129 -179.58 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -72.09 145.44 37.93 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.862 -0.685 . . . . 15.0 112.522 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 15.1 tt0 -81.18 144.49 31.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.847 0.356 . . . . 15.0 110.892 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.25 111.76 48.83 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.161 -0.472 . . . . 15.0 110.972 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -58.44 149.67 73.1 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.48 2.12 . . . . 15.0 112.163 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.427 ' OXT' HG23 ' A' ' 96' ' ' THR . 2.2 t . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.284 -0.865 . . . . 15.0 110.882 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo . . . . . 0 N--CA 1.487 1.12 0 CA-C-O 120.828 0.262 . . . . 15.0 111.709 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.509 ' CB ' ' HD3' ' A' ' 3' ' ' PRO . 22.3 mttt -155.33 -58.85 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.144 -0.48 . . . . 15.0 111.147 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.509 ' HD3' ' CB ' ' A' ' 2' ' ' LYS . 35.0 Cg_exo -57.65 -161.25 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.197 1.931 . . . . 15.0 112.17 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 87.15 -19.5 30.57 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.619 -0.801 . . . . 15.0 112.559 -179.758 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.0 160.1 13.06 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-O 121.341 0.591 . . . . 15.0 110.855 179.858 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.427 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 1.4 mp -104.58 142.66 17.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.168 -0.924 . . . . 15.0 111.181 -179.224 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.536 ' CZ ' HD12 ' A' ' 89' ' ' LEU . 2.3 p90 -140.66 158.17 44.37 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.122 -0.49 . . . . 15.0 110.456 178.794 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.771 ' HB2' HD12 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -123.96 143.6 50.3 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.289 0.566 . . . . 15.0 111.566 -179.37 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.695 ' CG1' HD11 ' A' ' 89' ' ' LEU . 0.5 OUTLIER -101.31 114.6 41.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.295 -0.866 . . . . 15.0 109.6 179.08 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -106.24 70.38 0.84 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.261 -0.427 . . . . 15.0 112.021 -178.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.648 HD11 ' CB ' ' A' ' 49' ' ' ASP . 8.6 tp -88.26 162.1 16.82 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.137 -0.483 . . . . 15.0 110.007 179.069 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.525 ' C ' ' H ' ' A' ' 14' ' ' ASN . . . -96.58 99.28 10.92 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.703 0.287 . . . . 15.0 111.042 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.908 ' HB2' HG23 ' A' ' 85' ' ' VAL . 0.3 OUTLIER -65.45 27.04 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 112.651 0.611 . . . . 15.0 112.651 -179.892 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.525 ' H ' ' C ' ' A' ' 12' ' ' ALA . 1.0 OUTLIER -109.69 150.26 28.55 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.672 0.272 . . . . 15.0 110.673 179.86 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.412 ' CB ' ' O ' ' A' ' 14' ' ' ASN . 5.9 t0 80.79 -46.48 0.26 Allowed 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.311 -0.404 . . . . 15.0 111.105 -179.811 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -154.94 158.53 39.38 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.775 0.322 . . . . 15.0 110.69 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.639 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 0.0 OUTLIER -85.97 -163.0 0.8 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.342 -0.39 . . . . 15.0 110.845 -179.888 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.475 HD12 ' HE3' ' A' ' 13' ' ' LYS . 3.9 mp -77.41 -168.35 1.13 Allowed 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 116.163 -0.471 . . . . 15.0 110.581 179.745 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.639 ' O ' ' HB ' ' A' ' 41' ' ' ILE . . . -160.78 38.42 0.43 Allowed Glycine 0 N--CA 1.449 -0.48 0 N-CA-C 111.527 -0.629 . . . . 15.0 111.527 -179.774 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.719 HG12 ' O ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -112.62 140.78 30.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-O 120.937 0.399 . . . . 15.0 111.835 -179.363 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.452 ' HB3' HD11 ' A' ' 41' ' ' ILE . 30.8 t -96.09 105.92 18.03 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 107.79 -1.189 . . . . 15.0 107.79 177.491 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.887 HG21 HG23 ' A' ' 75' ' ' VAL . 14.5 m -93.67 151.91 3.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 113.087 0.773 . . . . 15.0 113.087 -176.957 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -149.46 174.02 12.94 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 114.752 -1.113 . . . . 15.0 110.489 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.584 ' O ' HG22 ' A' ' 26' ' ' VAL . . . 80.94 -118.54 4.65 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.491 -0.861 . . . . 15.0 112.356 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.544 ' HA3' ' N ' ' A' ' 71' ' ' HIS . . . 66.66 -65.72 0.18 Allowed Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.967 -0.635 . . . . 15.0 113.497 179.268 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.584 HG22 ' O ' ' A' ' 24' ' ' GLY . 0.0 OUTLIER -28.43 139.78 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 N-CA-C 112.38 0.511 . . . . 15.0 112.38 -179.188 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.433 ' ND2' ' O ' ' A' ' 32' ' ' HIS . 8.4 m120 -75.53 61.3 1.29 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.913 -0.585 . . . . 15.0 111.024 -179.84 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -151.7 -64.46 0.18 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.28 -0.418 . . . . 15.0 110.927 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 59.7 p -69.1 -49.13 59.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.176 -0.465 . . . . 15.0 110.954 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.525 HG22 ' O ' ' A' ' 26' ' ' VAL . 23.1 m -70.6 -173.56 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.159 -0.473 . . . . 15.0 111.114 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.69 -67.13 0.31 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.291 -0.413 . . . . 15.0 111.055 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' HIS . . . . . 0.433 ' O ' ' ND2' ' A' ' 27' ' ' ASN . 10.1 p-80 -139.32 -45.3 0.46 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.315 -0.402 . . . . 15.0 111.052 -179.83 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -168.38 25.54 0.12 Allowed Glycine 0 N--CA 1.453 -0.212 0 C-N-CA 120.894 -0.669 . . . . 15.0 112.508 -179.834 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.406 ' O ' HG11 ' A' ' 30' ' ' VAL . . . -94.47 152.53 20.64 Favored Glycine 0 N--CA 1.448 -0.509 0 N-CA-C 110.443 -1.063 . . . . 15.0 110.443 178.747 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.918 HG22 HG22 ' A' ' 58' ' ' VAL . 0.1 OUTLIER -95.79 153.22 3.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 C-N-CA 119.731 -0.787 . . . . 15.0 112.329 -179.021 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.464 ' CZ ' ' HG2' ' A' ' 57' ' ' ARG . 29.3 m-85 -135.04 106.55 6.86 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.699 -1.137 . . . . 15.0 109.158 179.117 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.801 HG22 ' N ' ' A' ' 55' ' ' GLY . 0.8 OUTLIER -55.22 148.05 3.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.127 0.489 . . . . 15.0 111.571 -178.392 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.424 ' O ' ' HG2' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -80.37 -49.59 11.29 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.509 -0.923 . . . . 15.0 108.509 178.3 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.719 ' O ' HG12 ' A' ' 20' ' ' ILE . . . -172.17 172.71 4.5 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.963 -0.562 . . . . 15.0 110.879 178.808 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.55 ' HA ' HG12 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -96.81 112.72 29.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 N-CA-C 109.598 -0.519 . . . . 15.0 109.598 179.296 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.639 ' HB ' ' O ' ' A' ' 19' ' ' GLY . 0.3 OUTLIER -78.45 119.33 76.92 Favored Pre-proline 0 C--N 1.328 -0.327 0 N-CA-C 113.334 0.864 . . . . 15.0 113.334 -177.403 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.606 ' HA ' ' CG ' ' A' ' 47' ' ' GLU . 38.0 Cg_endo -65.15 61.1 0.32 Allowed 'Trans proline' 0 C--N 1.356 0.966 0 C-N-CA 123.448 2.766 . . . . 15.0 112.944 179.676 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.509 ' H ' ' HG2' ' A' ' 47' ' ' GLU . 0.1 OUTLIER -151.32 -44.75 0.11 Allowed 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 111.663 0.246 . . . . 15.0 111.663 179.903 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.599 ' HA3' ' HA3' ' A' ' 19' ' ' GLY . . . -87.71 165.54 35.16 Favored Glycine 0 CA--C 1.518 0.255 0 C-N-CA 120.328 -0.939 . . . . 15.0 113.719 -179.159 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.639 ' HB3' ' O ' ' A' ' 17' ' ' SER . . . -55.47 -15.88 3.19 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.796 0.665 . . . . 15.0 112.796 -179.543 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.2 -57.11 4.51 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.648 0.261 . . . . 15.0 111.204 -179.485 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.606 ' CG ' ' HA ' ' A' ' 42' ' ' PRO . 2.6 pp20? -56.93 -41.72 78.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.913 0.387 . . . . 15.0 110.386 179.711 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -53.91 -68.82 0.15 Allowed 'General case' 0 CA--C 1.52 -0.182 0 CA-C-N 115.91 -0.587 . . . . 15.0 110.851 -179.393 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.648 ' CB ' HD11 ' A' ' 11' ' ' LEU . 11.8 t0 -63.2 -39.13 93.75 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.57 -0.529 . . . . 15.0 109.57 179.13 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.07 45.55 7.52 Favored Glycine 0 N--CA 1.447 -0.595 0 CA-C-N 115.452 -0.795 . . . . 15.0 111.758 179.67 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.589 ' CG ' HG23 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -79.41 -53.15 7.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.966 0.413 . . . . 15.0 110.578 -179.377 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.659 ' CG1' HD12 ' A' ' 20' ' ' ILE . 7.9 tp -82.34 164.97 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 CA-C-N 115.947 -0.569 . . . . 15.0 110.392 179.676 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' HIS . . . . . 0.451 ' O ' ' HB2' ' A' ' 56' ' ' ASP . 76.3 m80 -147.68 158.01 43.81 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-O 121.674 0.75 . . . . 15.0 112.285 -179.147 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.552 ' HA ' ' CG2' ' A' ' 37' ' ' VAL . 8.5 mtpt -43.4 134.08 4.03 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.302 -1.317 . . . . 15.0 112.94 -178.617 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.801 ' N ' HG22 ' A' ' 37' ' ' VAL . . . 49.9 31.12 16.63 Favored Glycine 0 C--N 1.334 0.432 0 CA-C-N 115.692 -0.686 . . . . 15.0 113.659 179.051 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.451 ' HB2' ' O ' ' A' ' 53' ' ' HIS . 0.4 OUTLIER -66.09 129.94 41.52 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 117.094 0.447 . . . . 15.0 110.786 179.563 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.862 ' HD2' HD21 ' A' ' 59' ' ' LEU . 0.0 OUTLIER -81.33 89.96 6.12 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.299 -0.41 . . . . 15.0 110.138 179.371 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.918 HG22 HG22 ' A' ' 35' ' ' ILE . 1.4 m -82.8 114.17 23.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 CA-C-O 121.073 0.463 . . . . 15.0 111.584 -179.146 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.862 HD21 ' HD2' ' A' ' 57' ' ' ARG . 3.4 mm? -107.69 -12.84 15.16 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 115.614 -0.721 . . . . 15.0 112.501 -179.498 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.674 ' HB3' ' HB2' ' A' ' 88' ' ' LEU . . . -149.72 149.0 29.91 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 112.659 0.614 . . . . 15.0 112.659 -178.527 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.85 HG11 ' O ' ' A' ' 77' ' ' THR . 23.1 t -142.29 99.04 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.27 0 CA-C-N 115.304 -0.862 . . . . 15.0 109.441 178.842 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.467 ' OD1' HG22 ' A' ' 81' ' ' THR . 2.7 m120 65.05 16.67 10.69 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.155 -0.475 . . . . 15.0 109.896 -178.282 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 107.17 6.04 34.36 Favored Glycine 0 C--N 1.336 0.536 0 CA-C-N 115.813 -0.631 . . . . 15.0 113.564 179.48 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.663 HG13 ' O ' ' A' ' 64' ' ' VAL . 4.6 p -93.75 103.71 14.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 117.292 0.546 . . . . 15.0 110.628 179.155 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -57.91 127.69 33.35 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.134 -0.484 . . . . 15.0 111.071 -179.417 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.668 HD13 ' HB3' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -87.69 -15.86 35.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.021 -0.536 . . . . 15.0 111.063 179.962 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -45.24 95.32 0.01 OUTLIER 'General case' 0 N--CA 1.461 0.114 0 CA-C-O 120.871 0.367 . . . . 15.0 111.008 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 103.75 69.35 0.79 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.79 -0.719 . . . . 15.0 112.238 -179.679 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.706 ' HB1' ' CB ' ' A' ' 73' ' ' GLN . . . -173.03 142.73 1.09 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.901 0.381 . . . . 15.0 111.049 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.429 ' CB ' ' HA ' ' A' ' 26' ' ' VAL . 13.7 p -74.3 -172.5 1.45 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.162 -0.472 . . . . 15.0 111.241 -179.774 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.63 ' CE1' HG23 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -62.19 -59.49 4.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.914 -0.584 . . . . 15.0 110.475 179.99 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.453 ' O ' HG12 ' A' ' 75' ' ' VAL . 6.6 ttmt -52.81 -33.8 50.77 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.871 -0.604 . . . . 15.0 110.623 179.399 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.706 ' CB ' ' HB1' ' A' ' 69' ' ' ALA . 5.2 mt-30 -59.54 -52.93 63.45 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.708 -0.478 . . . . 15.0 109.708 179.313 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.868 ' HB3' HD12 ' A' ' 35' ' ' ILE . . . -67.08 -42.4 84.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.099 -0.501 . . . . 15.0 109.725 178.48 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.887 HG23 HG21 ' A' ' 22' ' ' VAL . 0.5 OUTLIER -44.31 -39.51 1.63 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.221 0 N-CA-C 108.985 -0.746 . . . . 15.0 108.985 178.528 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -67.3 -44.17 79.88 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.751 -1.113 . . . . 15.0 110.314 178.586 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.85 ' O ' HG11 ' A' ' 61' ' ' VAL . 27.6 p -64.04 -56.15 17.11 Favored 'General case' 0 N--CA 1.462 0.151 0 C-N-CA 121.047 -0.261 . . . . 15.0 111.375 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.588 HD23 HG21 ' A' ' 61' ' ' VAL . 4.6 mt -53.49 -46.94 70.22 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 121.179 0.514 . . . . 15.0 109.958 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 3.3 tmt_? -68.49 -60.27 2.55 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.434 -0.803 . . . . 15.0 110.739 179.53 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 15.2 m-20 -65.96 60.83 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.846 -0.615 . . . . 15.0 112.222 -179.76 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.467 HG22 ' OD1' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -95.57 -76.08 0.51 Allowed 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.744 -0.465 . . . . 15.0 109.744 178.91 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 112.75 -98.51 0.96 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.634 -0.793 . . . . 15.0 113.58 178.63 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.46 ' O ' ' HB3' ' A' ' 13' ' ' LYS . 0.5 OUTLIER -63.92 -87.92 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 111.682 0.252 . . . . 15.0 111.682 -178.907 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.453 HG12 ' N ' ' A' ' 85' ' ' VAL . 72.0 t -110.06 158.23 10.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.066 0.46 . . . . 15.0 110.925 -179.738 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.908 HG23 ' HB2' ' A' ' 13' ' ' LYS . 3.8 t -97.87 81.92 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.094 -0.503 . . . . 15.0 110.256 179.698 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 15.3 t-160 -100.7 82.81 2.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.766 -0.652 . . . . 15.0 109.99 179.585 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.852 ' HB3' HD21 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -103.79 115.97 31.44 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.799 -0.637 . . . . 15.0 112.05 -178.745 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.771 HD12 ' HB2' ' A' ' 8' ' ' GLU . 4.0 mp -92.21 102.13 14.64 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.451 -0.574 . . . . 15.0 109.451 178.576 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.852 HD21 ' HB3' ' A' ' 87' ' ' LEU . 0.1 OUTLIER -105.81 -161.74 0.82 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.487 0.661 . . . . 15.0 112.102 -178.317 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.427 ' HA ' ' HA ' ' A' ' 6' ' ' ILE . 3.5 tt0 -143.98 135.38 25.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 114.879 -1.055 . . . . 15.0 109.621 179.148 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.08 103.56 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.005 0.431 . . . . 15.0 111.087 -179.566 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -63.12 137.59 43.48 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.944 -0.646 . . . . 15.0 112.706 -179.706 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -86.38 91.67 8.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.794 0.33 . . . . 15.0 110.818 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -72.88 148.08 89.21 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.231 -0.441 . . . . 15.0 110.871 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -52.25 -34.98 61.9 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.596 2.197 . . . . 15.0 112.307 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 70.2 p . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.232 -0.889 . . . . 15.0 110.911 179.972 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo . . . . . 0 N--CA 1.488 1.2 0 CA-C-O 120.788 0.245 . . . . 15.0 111.812 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.19 110.97 4.68 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.218 -0.446 . . . . 15.0 110.859 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -67.42 -165.42 0.11 Allowed 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.403 2.069 . . . . 15.0 112.477 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 87.02 -19.34 30.87 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.781 -0.723 . . . . 15.0 112.328 -179.665 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -72.3 161.83 30.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.317 0.58 . . . . 15.0 111.216 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.519 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 1.2 mp -97.88 145.78 8.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.177 -0.919 . . . . 15.0 110.624 -179.73 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.879 ' CE1' HD12 ' A' ' 89' ' ' LEU . 3.0 p90 -141.93 141.32 32.96 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.035 0.445 . . . . 15.0 111.206 179.418 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.79 ' HB2' HD12 ' A' ' 88' ' ' LEU . 5.6 pm0 -113.53 141.8 46.71 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.804 -0.635 . . . . 15.0 111.15 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.489 ' N ' ' O ' ' A' ' 87' ' ' LEU . 0.2 OUTLIER -101.41 114.02 39.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.45 -0.796 . . . . 15.0 109.839 179.335 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -105.96 71.16 0.88 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.033 -0.53 . . . . 15.0 111.896 -178.904 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.489 HD11 ' CB ' ' A' ' 49' ' ' ASP . 5.4 tp -88.65 166.83 13.84 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.155 -0.475 . . . . 15.0 109.949 179.016 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.445 ' CB ' ' HB2' ' A' ' 15' ' ' ASP . . . -96.08 96.88 9.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.028 0.442 . . . . 15.0 111.163 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.768 ' CB ' HG23 ' A' ' 85' ' ' VAL . 0.1 OUTLIER -63.46 -28.43 69.96 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.725 -0.671 . . . . 15.0 111.442 -179.721 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -84.32 -19.06 34.36 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.466 -0.334 . . . . 15.0 111.524 -179.37 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.445 ' HB2' ' CB ' ' A' ' 12' ' ' ALA . 0.3 OUTLIER -92.18 -36.71 13.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.879 0.371 . . . . 15.0 110.462 179.538 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.495 ' HB3' ' HB2' ' A' ' 45' ' ' ALA . 1.1 t30 -165.45 161.23 18.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.006 -0.543 . . . . 15.0 110.74 179.757 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.893 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 0.3 OUTLIER -85.95 -157.5 0.34 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.266 -0.425 . . . . 15.0 110.234 179.675 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 9.8 mt -105.49 -169.69 1.63 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.968 0.413 . . . . 15.0 110.794 179.598 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.663 ' O ' ' HB ' ' A' ' 41' ' ' ILE . . . -161.13 38.59 0.42 Allowed Glycine 0 N--CA 1.449 -0.459 0 CA-C-N 115.867 -0.606 . . . . 15.0 111.752 -179.831 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.725 HG12 ' O ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -112.69 140.75 30.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 121.02 0.438 . . . . 15.0 111.94 -179.358 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.409 ' HB3' HD11 ' A' ' 41' ' ' ILE . 41.0 t -96.11 106.18 18.32 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 107.837 -1.171 . . . . 15.0 107.837 177.296 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.999 HG21 HG23 ' A' ' 75' ' ' VAL . 31.2 m -93.54 152.5 3.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 113.083 0.771 . . . . 15.0 113.083 -177.0 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.415 ' OG1' ' HB2' ' A' ' 38' ' ' LYS . 0.3 OUTLIER -149.46 179.27 8.09 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 114.863 -1.062 . . . . 15.0 110.728 -179.962 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.431 ' O ' ' CB ' ' A' ' 71' ' ' HIS . . . 74.22 -120.23 6.56 Favored Glycine 0 C--N 1.33 0.24 0 C-N-CA 120.672 -0.775 . . . . 15.0 112.327 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.537 ' HA3' ' N ' ' A' ' 71' ' ' HIS . . . 67.52 -65.69 0.27 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.848 -0.691 . . . . 15.0 113.631 179.31 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.569 ' O ' HG22 ' A' ' 30' ' ' VAL . 2.0 m -31.22 140.84 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 N-CA-C 112.328 0.492 . . . . 15.0 112.328 -179.17 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 14.2 p-10 -75.47 64.62 1.62 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.944 -0.571 . . . . 15.0 111.035 -179.818 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.5 m -151.67 -61.52 0.17 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.263 -0.426 . . . . 15.0 111.075 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 91.3 p -76.45 -42.88 42.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.18 -0.464 . . . . 15.0 111.155 -179.805 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.569 HG22 ' O ' ' A' ' 26' ' ' VAL . 35.3 m -73.78 -176.17 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.274 -0.421 . . . . 15.0 111.275 -179.858 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.14 -59.96 4.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.118 -0.492 . . . . 15.0 111.078 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 10.5 m80 -143.55 -47.93 0.3 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.306 -0.407 . . . . 15.0 111.149 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -169.44 22.56 0.09 OUTLIER Glycine 0 CA--C 1.519 0.292 0 C-N-CA 120.668 -0.777 . . . . 15.0 112.888 -179.701 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -87.55 154.46 26.02 Favored Glycine 0 N--CA 1.451 -0.354 0 N-CA-C 110.788 -0.925 . . . . 15.0 110.788 178.825 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.685 HG22 HG13 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -92.5 152.02 3.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 C-N-CA 119.895 -0.722 . . . . 15.0 111.906 -179.242 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.515 ' CZ ' ' HG2' ' A' ' 57' ' ' ARG . 53.8 m-85 -137.3 106.64 6.08 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.835 -1.075 . . . . 15.0 109.892 179.333 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.869 HG22 ' N ' ' A' ' 55' ' ' GLY . 0.6 OUTLIER -57.46 146.0 7.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.977 -0.556 . . . . 15.0 111.144 -179.089 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.485 ' O ' ' HG2' ' A' ' 54' ' ' LYS . 0.6 OUTLIER -80.33 -48.87 12.32 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.947 -0.76 . . . . 15.0 108.947 178.837 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.725 ' O ' HG12 ' A' ' 20' ' ' ILE . . . -172.07 172.6 4.61 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.906 -0.588 . . . . 15.0 110.736 178.811 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.533 ' HA ' HG12 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -96.86 112.93 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 N-CA-C 109.781 -0.451 . . . . 15.0 109.781 179.433 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.663 ' HB ' ' O ' ' A' ' 19' ' ' GLY . 0.3 OUTLIER -78.56 118.49 72.65 Favored Pre-proline 0 C--N 1.328 -0.331 0 N-CA-C 113.021 0.749 . . . . 15.0 113.021 -177.764 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.612 ' HA ' ' CG ' ' A' ' 47' ' ' GLU . 37.2 Cg_endo -64.8 60.63 0.29 Allowed 'Trans proline' 0 C--N 1.356 0.935 0 C-N-CA 123.416 2.744 . . . . 15.0 112.91 179.842 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.527 ' N ' ' HG2' ' A' ' 47' ' ' GLU . 41.1 tt0 -149.87 -46.26 0.13 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.632 -0.258 . . . . 15.0 111.511 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.608 ' HA3' ' HA3' ' A' ' 19' ' ' GLY . . . -87.8 166.91 36.12 Favored Glycine 0 CA--C 1.519 0.314 0 C-N-CA 120.417 -0.897 . . . . 15.0 114.008 -178.965 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.893 ' HB3' ' O ' ' A' ' 17' ' ' SER . . . -55.29 -15.43 2.45 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.911 0.708 . . . . 15.0 112.911 -179.677 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.429 ' HB1' HG22 ' A' ' 52' ' ' ILE . . . -71.97 -57.4 4.33 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 121.005 -0.278 . . . . 15.0 111.051 -179.418 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.612 ' CG ' ' HA ' ' A' ' 42' ' ' PRO . 2.9 pp20? -57.05 -42.99 81.57 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.035 -0.529 . . . . 15.0 110.378 179.358 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -53.88 -70.47 0.1 Allowed 'General case' 0 CA--C 1.52 -0.194 0 CA-C-N 115.893 -0.594 . . . . 15.0 110.498 -179.623 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.489 ' CB ' HD11 ' A' ' 11' ' ' LEU . 14.4 t0 -58.21 -39.92 80.26 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.349 -0.611 . . . . 15.0 109.349 178.87 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.76 35.02 26.24 Favored Glycine 0 N--CA 1.447 -0.631 0 CA-C-N 115.384 -0.825 . . . . 15.0 111.595 179.676 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.488 ' HG3' HD13 ' A' ' 11' ' ' LEU . 0.3 OUTLIER -79.73 -46.5 16.94 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.05 0.452 . . . . 15.0 110.524 -179.431 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.685 ' CG1' HD12 ' A' ' 20' ' ' ILE . 7.0 tp -80.94 149.95 4.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.697 -0.683 . . . . 15.0 109.616 179.371 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' HIS . . . . . 0.456 ' O ' HG21 ' A' ' 37' ' ' VAL . 80.4 m80 -139.7 156.94 46.52 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 113.14 0.793 . . . . 15.0 113.14 -178.269 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.564 ' HA ' ' CG2' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -45.31 133.28 7.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 113.784 -1.553 . . . . 15.0 112.961 -178.897 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.869 ' N ' HG22 ' A' ' 37' ' ' VAL . . . 49.04 27.25 6.66 Favored Glycine 0 C--N 1.335 0.486 0 CA-C-N 115.766 -0.652 . . . . 15.0 113.784 178.918 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.801 ' CG ' HD13 ' A' ' 89' ' ' LEU . 1.2 p30 -66.32 133.23 50.11 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 119.485 -0.886 . . . . 15.0 110.077 179.512 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.529 ' HD2' HD21 ' A' ' 59' ' ' LEU . 0.0 OUTLIER -80.76 97.58 7.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 15.0 110.434 -179.845 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.685 HG13 HG22 ' A' ' 35' ' ' ILE . 1.3 m -82.24 112.74 20.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.265 -0.425 . . . . 15.0 110.392 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.529 HD21 ' HD2' ' A' ' 57' ' ' ARG . 3.5 mm? -107.26 -21.62 12.89 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 115.826 -0.625 . . . . 15.0 112.384 -179.041 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.607 ' O ' HD23 ' A' ' 87' ' ' LEU . . . -147.45 150.47 34.67 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.251 0.548 . . . . 15.0 112.365 -178.56 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.745 HG21 HD23 ' A' ' 78' ' ' LEU . 60.4 t -138.92 102.46 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.264 -0.88 . . . . 15.0 109.022 178.846 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.634 ' OD1' HG22 ' A' ' 81' ' ' THR . 3.0 m120 65.09 15.62 10.1 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.706 -0.479 . . . . 15.0 109.706 -177.955 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 105.69 6.46 37.92 Favored Glycine 0 C--N 1.336 0.539 0 CA-C-N 115.785 -0.643 . . . . 15.0 113.349 179.659 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.667 HG13 ' O ' ' A' ' 64' ' ' VAL . 6.1 p -93.76 105.69 17.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 121.124 0.488 . . . . 15.0 110.843 179.398 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -58.78 115.45 3.09 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.148 -0.478 . . . . 15.0 110.726 -179.748 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.619 HD21 ' HA ' ' A' ' 74' ' ' ALA . 3.1 mt -89.45 -16.44 30.86 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.718 -0.674 . . . . 15.0 111.339 -179.619 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -45.79 105.44 0.06 Allowed 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.878 0.371 . . . . 15.0 111.017 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.96 66.15 0.57 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.814 -0.707 . . . . 15.0 112.433 -179.719 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.555 ' HB1' ' CG ' ' A' ' 73' ' ' GLN . . . -172.9 172.71 3.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.807 0.337 . . . . 15.0 110.851 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.481 HG22 ' HA ' ' A' ' 26' ' ' VAL . 19.3 p -93.16 -175.83 3.97 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.961 0.41 . . . . 15.0 111.091 -179.768 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.734 ' CE1' HG23 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -62.42 -60.98 2.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.969 -0.559 . . . . 15.0 110.428 -179.994 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 7.3 ttmt -52.49 -33.68 45.9 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.773 -0.649 . . . . 15.0 110.497 179.455 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.555 ' CG ' ' HB1' ' A' ' 69' ' ' ALA . 0.5 OUTLIER -59.4 -49.01 79.46 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.567 -0.531 . . . . 15.0 109.567 179.194 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.619 ' HA ' HD21 ' A' ' 66' ' ' LEU . . . -66.96 -48.57 68.16 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 116.009 -0.541 . . . . 15.0 109.658 178.392 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.999 HG23 HG21 ' A' ' 22' ' ' VAL . 0.5 OUTLIER -40.39 -42.1 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.212 0 CA-C-N 115.476 -0.784 . . . . 15.0 109.444 178.48 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.404 ' N ' HG12 ' A' ' 75' ' ' VAL . 21.9 mt-10 -67.4 -46.07 74.33 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 114.843 -1.071 . . . . 15.0 110.45 178.795 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.592 ' O ' HG11 ' A' ' 61' ' ' VAL . 2.0 p -64.64 -53.08 53.18 Favored 'General case' 0 C--O 1.231 0.099 0 C-N-CA 120.918 -0.313 . . . . 15.0 111.378 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.745 HD23 HG21 ' A' ' 61' ' ' VAL . 4.4 mt -53.66 -48.38 69.48 Favored 'General case' 0 CA--C 1.52 -0.18 0 CA-C-O 121.135 0.493 . . . . 15.0 110.15 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.415 ' O ' ' N ' ' A' ' 81' ' ' THR . 3.0 ttm-85 -68.34 -56.65 7.81 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.558 -0.747 . . . . 15.0 110.493 179.511 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -66.0 62.51 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.017 -0.538 . . . . 15.0 111.752 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.634 HG22 ' OD1' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -95.55 -71.94 0.65 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.783 0.325 . . . . 15.0 110.438 179.426 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 122.17 -103.82 0.87 Allowed Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.753 -0.737 . . . . 15.0 113.157 179.272 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.58 -83.66 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 111.866 0.321 . . . . 15.0 111.866 -179.089 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.424 HG12 ' N ' ' A' ' 85' ' ' VAL . 67.3 t -109.47 157.59 9.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.105 0.478 . . . . 15.0 111.082 -179.416 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.768 HG23 ' CB ' ' A' ' 13' ' ' LYS . 10.6 t -97.81 81.86 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.011 -0.54 . . . . 15.0 110.559 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 59.6 t60 -104.96 86.54 2.47 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.747 -0.66 . . . . 15.0 110.892 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.658 HD22 HD21 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -103.81 129.75 51.28 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.996 -0.547 . . . . 15.0 111.537 -179.601 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.79 HD12 ' HB2' ' A' ' 8' ' ' GLU . 5.2 mp -102.33 101.3 11.54 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.928 -0.397 . . . . 15.0 109.928 178.976 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.879 HD12 ' CE1' ' A' ' 7' ' ' PHE . 0.4 OUTLIER -105.84 -161.94 0.83 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.3 0.572 . . . . 15.0 111.939 -178.699 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.519 ' HA ' ' HA ' ' A' ' 6' ' ' ILE . 26.0 tt0 -146.28 134.91 22.18 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.159 -0.928 . . . . 15.0 109.951 179.238 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 4.7 tptt -46.83 111.86 0.44 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.311 -0.404 . . . . 15.0 111.096 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -61.91 151.74 44.08 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.785 -0.721 . . . . 15.0 112.614 -179.631 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -76.33 119.44 20.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.859 0.361 . . . . 15.0 110.973 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -85.64 168.46 19.73 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.099 -0.5 . . . . 15.0 110.843 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_exo -51.12 -33.63 44.46 Favored 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 122.592 2.195 . . . . 15.0 112.236 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.22 -0.895 . . . . 15.0 110.9 179.929 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_endo . . . . . 0 N--CA 1.488 1.155 0 CA-C-O 120.836 0.265 . . . . 15.0 111.831 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 11.3 mttt -145.15 127.99 8.27 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.113 -0.494 . . . . 15.0 110.687 179.946 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_exo -56.23 -165.59 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.342 2.028 . . . . 15.0 112.505 -179.822 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 87.32 -20.3 27.08 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.8 -0.714 . . . . 15.0 112.253 -179.625 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -72.55 158.86 34.89 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.381 0.61 . . . . 15.0 111.273 -179.979 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.507 HG13 ' HB2' ' A' ' 90' ' ' GLU . 1.3 mp -104.33 144.11 14.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.051 -0.977 . . . . 15.0 110.62 -179.714 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.63 ' CE1' HD12 ' A' ' 89' ' ' LEU . 4.9 p90 -140.65 165.51 27.28 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.594 -0.275 . . . . 15.0 110.544 178.912 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.721 ' CB ' HD12 ' A' ' 88' ' ' LEU . 4.9 pt-20 -130.07 142.62 50.59 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.381 0.61 . . . . 15.0 111.417 -179.546 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.582 ' CG1' HD11 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -101.44 114.97 42.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.073 -0.967 . . . . 15.0 109.718 179.143 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -105.89 71.46 0.9 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.118 -0.492 . . . . 15.0 111.874 -178.976 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.662 HD13 ' HG3' ' A' ' 51' ' ' ARG . 6.2 tp -88.05 167.99 13.2 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.942 -0.572 . . . . 15.0 110.007 179.121 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -94.64 98.84 11.09 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.98 0.419 . . . . 15.0 110.867 179.88 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.601 ' CA ' HG23 ' A' ' 85' ' ' VAL . 0.2 OUTLIER -54.05 -27.2 30.85 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.899 -0.592 . . . . 15.0 111.13 -179.827 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.433 ' O ' ' CB ' ' A' ' 15' ' ' ASP . 2.9 m-80 -84.64 154.19 22.69 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.357 -0.383 . . . . 15.0 110.551 179.692 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.433 ' CB ' ' O ' ' A' ' 14' ' ' ASN . 5.9 t70 82.82 -48.1 0.16 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.219 -0.446 . . . . 15.0 110.884 -179.356 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -155.11 147.46 23.94 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.402 -0.363 . . . . 15.0 110.582 179.768 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.612 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 0.4 OUTLIER -86.17 -169.17 2.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.054 0.454 . . . . 15.0 111.311 -179.642 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.423 ' O ' ' HA3' ' A' ' 44' ' ' GLY . 3.9 mm? -62.79 -163.62 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.745 -0.661 . . . . 15.0 110.627 179.581 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.742 ' O ' ' HB ' ' A' ' 41' ' ' ILE . . . -160.56 21.44 0.24 Allowed Glycine 0 C--O 1.226 -0.378 0 C-N-CA 120.4 -0.905 . . . . 15.0 113.395 -179.495 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.937 HG21 HG21 ' A' ' 52' ' ' ILE . 2.9 pt -113.13 139.16 39.82 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.382 0 CA-C-N 117.394 0.597 . . . . 15.0 111.709 178.738 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.514 ' O ' ' HB3' ' A' ' 38' ' ' LYS . 6.2 t -84.98 116.09 23.18 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 105.167 -2.16 . . . . 15.0 105.167 174.841 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 1.016 HG21 HG23 ' A' ' 75' ' ' VAL . 35.6 m -93.74 152.35 3.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 113.58 0.955 . . . . 15.0 113.58 -175.521 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.57 -179.18 6.89 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 114.782 -1.099 . . . . 15.0 110.564 179.642 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.591 ' O ' HG22 ' A' ' 26' ' ' VAL . . . 71.4 -121.03 8.68 Favored Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.814 -0.708 . . . . 15.0 112.613 179.658 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.52 ' HA3' ' N ' ' A' ' 71' ' ' HIS . . . 66.82 -65.71 0.19 Allowed Glycine 0 C--N 1.331 0.251 0 C-N-CA 121.028 -0.606 . . . . 15.0 113.576 179.43 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.643 ' O ' HG22 ' A' ' 30' ' ' VAL . 0.0 OUTLIER -32.83 137.78 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 N-CA-C 112.375 0.509 . . . . 15.0 112.375 -179.208 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.406 ' CB ' ' O ' ' A' ' 32' ' ' HIS . 1.6 m-20 -76.58 59.64 1.53 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.826 -0.625 . . . . 15.0 111.103 -179.856 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -151.74 -48.48 0.11 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.373 -0.376 . . . . 15.0 110.884 179.972 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 22.0 t -87.12 -31.84 20.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.203 -0.453 . . . . 15.0 110.962 -179.929 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.643 HG22 ' O ' ' A' ' 26' ' ' VAL . 33.4 m -87.9 -175.62 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.459 . . . . 15.0 111.223 -179.965 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 3.4 ttt85 -58.11 -60.81 3.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.23 -0.441 . . . . 15.0 111.102 -179.86 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 32' ' ' HIS . . . . . 0.406 ' O ' ' CB ' ' A' ' 27' ' ' ASN . 22.9 m80 -136.3 -58.45 0.74 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.371 -0.377 . . . . 15.0 111.163 -179.87 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -166.72 26.11 0.15 Allowed Glycine 0 N--CA 1.453 -0.223 0 C-N-CA 120.806 -0.711 . . . . 15.0 112.599 -179.723 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -90.69 153.25 22.41 Favored Glycine 0 N--CA 1.449 -0.488 0 N-CA-C 110.828 -0.909 . . . . 15.0 110.828 179.024 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.833 HG22 HG22 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -90.72 153.6 3.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 C-N-CA 120.028 -0.669 . . . . 15.0 111.648 -179.358 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.413 ' CE2' ' HG2' ' A' ' 57' ' ' ARG . 47.5 m-85 -134.43 108.39 8.12 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 114.98 -1.009 . . . . 15.0 109.534 179.4 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.784 HG22 ' N ' ' A' ' 55' ' ' GLY . 0.6 OUTLIER -54.94 148.45 2.89 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.45 0 CA-C-O 121.105 0.479 . . . . 15.0 110.731 -178.835 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.514 ' HB3' ' O ' ' A' ' 21' ' ' SER . 0.1 OUTLIER -86.17 -45.66 11.13 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 108.37 -0.974 . . . . 15.0 108.37 178.167 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.624 ' O ' ' HB ' ' A' ' 20' ' ' ILE . . . -173.76 171.37 3.78 Favored 'General case' 0 C--O 1.226 -0.157 0 C-N-CA 120.512 -0.475 . . . . 15.0 112.214 178.762 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.754 ' HA ' HG22 ' A' ' 20' ' ' ILE . 0.1 OUTLIER -97.32 81.57 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.291 0.567 . . . . 15.0 109.75 178.889 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.742 ' HB ' ' O ' ' A' ' 19' ' ' GLY . 27.2 mm -47.95 120.79 8.19 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 115.263 -0.88 . . . . 15.0 113.039 -178.351 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.602 ' HA ' ' HG2' ' A' ' 47' ' ' GLU . 40.8 Cg_endo -66.16 60.94 0.48 Allowed 'Trans proline' 0 C--N 1.354 0.831 0 C-N-CA 123.336 2.691 . . . . 15.0 112.762 179.682 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.534 ' N ' ' HG2' ' A' ' 47' ' ' GLU . 4.6 mt-30 -158.85 -41.08 0.06 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.646 0.26 . . . . 15.0 111.63 179.878 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.502 ' HA3' ' CA ' ' A' ' 19' ' ' GLY . . . -87.29 163.0 33.95 Favored Glycine 0 CA--C 1.519 0.318 0 C-N-CA 120.629 -0.796 . . . . 15.0 113.652 -179.151 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.612 ' HB3' ' O ' ' A' ' 17' ' ' SER . . . -53.28 -15.21 0.88 Allowed 'General case' 0 N--CA 1.462 0.166 0 N-CA-C 112.708 0.633 . . . . 15.0 112.708 -179.721 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.99 -59.35 2.79 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.651 0.262 . . . . 15.0 110.946 -179.554 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.602 ' HG2' ' HA ' ' A' ' 42' ' ' PRO . 2.6 pp20? -56.97 -42.82 80.88 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.109 -0.496 . . . . 15.0 110.824 179.557 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.3 m -53.69 -70.77 0.09 Allowed 'General case' 0 CA--C 1.519 -0.22 0 CA-C-N 115.965 -0.561 . . . . 15.0 110.597 -179.333 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.559 ' CB ' HD11 ' A' ' 11' ' ' LEU . 1.9 t0 -61.19 -39.43 90.17 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.472 -0.566 . . . . 15.0 109.472 178.981 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.92 38.66 15.15 Favored Glycine 0 N--CA 1.447 -0.571 0 CA-C-N 115.438 -0.801 . . . . 15.0 111.638 179.802 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.662 ' HG3' HD13 ' A' ' 11' ' ' LEU . 21.7 mmt-85 -79.71 -33.71 40.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.872 0.368 . . . . 15.0 111.106 -179.18 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.937 HG21 HG21 ' A' ' 20' ' ' ILE . 21.2 mm -91.21 159.12 2.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.091 -0.504 . . . . 15.0 111.181 -179.737 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 53' ' ' HIS . . . . . 0.48 ' N ' ' CG2' ' A' ' 52' ' ' ILE . 29.2 m80 -141.69 138.5 32.49 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-N 115.69 -0.686 . . . . 15.0 110.663 179.394 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.532 ' HA ' ' CG2' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -35.59 131.11 0.51 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.479 -1.237 . . . . 15.0 113.039 -178.373 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.784 ' N ' HG22 ' A' ' 37' ' ' VAL . . . 56.28 29.08 55.99 Favored Glycine 0 C--N 1.332 0.353 0 CA-C-N 115.665 -0.698 . . . . 15.0 113.629 179.176 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.447 ' OD2' ' N ' ' A' ' 53' ' ' HIS . 0.4 OUTLIER -65.34 130.48 43.49 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.941 -0.304 . . . . 15.0 110.597 179.346 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.413 ' HG2' ' CE2' ' A' ' 36' ' ' TYR . 2.2 mtt180 -80.63 90.04 5.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.436 -0.347 . . . . 15.0 110.672 179.934 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.833 HG22 HG22 ' A' ' 35' ' ' ILE . 1.4 m -79.37 116.82 23.98 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 CA-C-O 121.017 0.437 . . . . 15.0 110.613 -179.875 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 29.1 mt -107.04 -15.09 14.77 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.785 -0.643 . . . . 15.0 112.559 -178.946 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.888 ' HB3' ' HB2' ' A' ' 88' ' ' LEU . . . -149.11 148.49 29.74 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 112.595 0.591 . . . . 15.0 112.595 -178.8 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.762 HG21 ' OG1' ' A' ' 77' ' ' THR . 20.8 t -139.18 100.5 1.42 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.251 0 CA-C-N 115.115 -0.948 . . . . 15.0 109.115 178.795 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.675 ' OD1' HG22 ' A' ' 81' ' ' THR . 2.8 m120 65.03 16.08 10.36 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.76 -0.459 . . . . 15.0 109.76 -178.096 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 107.21 5.24 35.05 Favored Glycine 0 C--N 1.336 0.566 0 CA-C-N 115.925 -0.58 . . . . 15.0 113.558 179.666 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.66 HG13 ' O ' ' A' ' 64' ' ' VAL . 5.7 p -93.84 106.34 17.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 117.275 0.538 . . . . 15.0 110.988 179.417 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -56.59 136.33 54.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.201 -0.454 . . . . 15.0 110.914 -179.808 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.516 HD11 ' HB2' ' A' ' 74' ' ' ALA . 0.6 OUTLIER -95.55 -20.16 19.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.06 -0.518 . . . . 15.0 111.065 -179.964 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -46.53 99.96 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.876 0.369 . . . . 15.0 111.082 179.984 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 104.88 66.4 0.69 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.767 -0.73 . . . . 15.0 112.207 -179.799 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.564 ' HB1' ' HB3' ' A' ' 73' ' ' GLN . . . -173.09 162.02 4.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.841 0.353 . . . . 15.0 111.117 -179.771 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.465 ' HB ' HG13 ' A' ' 26' ' ' VAL . 15.6 p -93.22 -173.75 3.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.002 0.429 . . . . 15.0 111.019 -179.873 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.684 ' CD2' HG23 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -62.59 -58.79 6.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.907 -0.588 . . . . 15.0 110.329 179.841 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.422 ' HA ' ' HB ' ' A' ' 75' ' ' VAL . 28.4 ttmt -52.56 -33.9 47.82 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.017 -0.538 . . . . 15.0 110.534 179.117 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.564 ' HB3' ' HB1' ' A' ' 69' ' ' ALA . 1.1 tt0 -59.45 -50.04 75.45 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.5 -0.555 . . . . 15.0 109.5 179.32 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.516 ' HB2' HD11 ' A' ' 66' ' ' LEU . . . -66.86 -44.48 80.88 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 109.531 -0.544 . . . . 15.0 109.531 178.313 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 1.016 HG23 HG21 ' A' ' 22' ' ' VAL . 0.5 OUTLIER -43.57 -39.4 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.363 0 N-CA-C 108.732 -0.84 . . . . 15.0 108.732 178.099 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.518 ' O ' ' HB2' ' A' ' 80' ' ' ASN . 1.5 mm-40 -67.06 -46.32 74.68 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.573 -1.194 . . . . 15.0 110.381 178.577 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.762 ' OG1' HG21 ' A' ' 61' ' ' VAL . 31.4 p -64.09 -53.24 52.77 Favored 'General case' 0 N--CA 1.462 0.161 0 C-N-CA 120.951 -0.3 . . . . 15.0 111.575 -179.969 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.6 HD22 HD11 ' A' ' 87' ' ' LEU . 6.0 mt -53.49 -48.15 69.19 Favored 'General case' 0 CA--C 1.52 -0.18 0 CA-C-O 121.261 0.553 . . . . 15.0 109.866 179.929 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.411 ' HB2' ' O ' ' A' ' 75' ' ' VAL . 18.1 ttp180 -68.64 -60.77 2.17 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.318 -0.855 . . . . 15.0 110.833 179.505 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.518 ' HB2' ' O ' ' A' ' 76' ' ' GLU . 15.1 m-80 -66.11 58.23 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 112.476 0.547 . . . . 15.0 112.476 -179.677 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.675 HG22 ' OD1' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -95.67 -69.28 0.76 Allowed 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.809 -0.441 . . . . 15.0 109.809 178.804 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 118.37 -104.42 1.12 Allowed Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.817 -0.706 . . . . 15.0 113.386 178.891 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.452 ' O ' ' HB3' ' A' ' 13' ' ' LYS . 0.4 OUTLIER -64.93 -80.95 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 112.525 0.565 . . . . 15.0 112.525 -178.724 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.426 HG12 ' N ' ' A' ' 85' ' ' VAL . 55.1 t -110.07 158.11 10.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.113 0.482 . . . . 15.0 111.298 -178.89 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.671 ' O ' HG12 ' A' ' 85' ' ' VAL . 8.0 t -97.99 81.15 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.986 -0.552 . . . . 15.0 110.426 179.867 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.473 ' NE2' HD11 ' A' ' 88' ' ' LEU . 78.9 t60 -100.42 84.66 2.82 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.754 -0.657 . . . . 15.0 110.362 179.79 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.792 ' HB3' HD21 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -103.52 119.44 38.9 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.949 -0.568 . . . . 15.0 111.986 -179.008 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.888 ' HB2' ' HB3' ' A' ' 60' ' ' ALA . 4.3 mp -92.87 103.23 15.58 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.52 -0.548 . . . . 15.0 109.52 178.673 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.792 HD21 ' HB3' ' A' ' 87' ' ' LEU . 0.2 OUTLIER -105.48 -163.32 0.94 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.273 0.559 . . . . 15.0 111.635 -178.69 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.507 ' HB2' HG13 ' A' ' 6' ' ' ILE . 8.3 tt0 -145.27 134.58 22.96 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.385 -0.825 . . . . 15.0 110.354 179.476 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 4.0 tptt -48.04 104.04 0.05 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.106 -0.497 . . . . 15.0 111.009 -179.92 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -62.06 162.21 27.72 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.919 -0.658 . . . . 15.0 112.68 -179.647 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -84.93 107.62 17.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.807 0.337 . . . . 15.0 110.85 179.975 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.2 m -61.7 130.62 92.39 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.22 -0.445 . . . . 15.0 110.851 179.977 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -53.1 -31.09 52.78 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.479 2.119 . . . . 15.0 112.259 -179.973 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.179 -0.915 . . . . 15.0 110.878 -179.969 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo . . . . . 0 N--CA 1.487 1.108 0 CA-C-O 120.835 0.264 . . . . 15.0 111.668 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.59 154.45 38.05 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.152 -0.476 . . . . 15.0 110.737 179.974 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -61.99 -164.57 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.488 2.126 . . . . 15.0 112.266 179.958 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 89.21 -22.43 23.13 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.676 -0.773 . . . . 15.0 112.202 -179.578 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -72.33 145.25 47.93 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-O 121.24 0.543 . . . . 15.0 110.849 179.763 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.548 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 1.4 mp -104.53 141.42 20.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.425 -0.807 . . . . 15.0 111.375 -179.379 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.826 ' CE1' HD12 ' A' ' 89' ' ' LEU . 3.6 p90 -140.62 165.67 26.84 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.123 -0.49 . . . . 15.0 110.112 178.514 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.72 ' HB3' HD12 ' A' ' 88' ' ' LEU . 4.8 pt-20 -130.13 144.38 51.32 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.427 0.632 . . . . 15.0 111.842 -178.93 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.516 ' CG2' ' HB3' ' A' ' 51' ' ' ARG . 0.2 OUTLIER -101.42 115.25 42.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.034 -0.984 . . . . 15.0 109.354 178.75 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -105.92 72.72 0.96 Allowed 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 112.4 0.518 . . . . 15.0 112.4 -178.523 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.673 HD13 ' HG3' ' A' ' 51' ' ' ARG . 5.2 tp -88.06 162.56 16.72 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.465 -0.569 . . . . 15.0 109.465 178.467 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -96.52 93.31 6.72 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.947 0.403 . . . . 15.0 111.343 -179.868 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.627 ' CB ' HG23 ' A' ' 85' ' ' VAL . 0.0 OUTLIER -58.15 -28.8 65.04 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.957 -0.565 . . . . 15.0 110.714 179.644 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -84.27 67.77 9.92 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.032 -0.531 . . . . 15.0 110.83 179.932 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 171.18 -39.88 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.076 -0.511 . . . . 15.0 110.414 179.912 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.479 ' HB3' ' HB2' ' A' ' 45' ' ' ALA . 2.4 t-20 -165.42 149.31 8.37 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.788 -0.642 . . . . 15.0 110.487 179.802 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.716 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 0.5 OUTLIER -85.94 -168.4 2.22 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.356 -0.384 . . . . 15.0 110.518 179.908 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.641 ' N ' HD22 ' A' ' 18' ' ' LEU . 2.1 mm? -89.14 -175.57 4.84 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 116.171 -0.468 . . . . 15.0 110.714 179.432 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.775 ' HA3' ' HA3' ' A' ' 44' ' ' GLY . . . -160.88 45.61 0.4 Allowed Glycine 0 N--CA 1.449 -0.499 0 N-CA-C 111.481 -0.648 . . . . 15.0 111.481 -179.771 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.663 HG12 ' O ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -112.53 139.19 38.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 120.843 0.354 . . . . 15.0 111.4 -179.326 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.4 ' H ' HD13 ' A' ' 41' ' ' ILE . 8.1 t -91.78 102.64 15.25 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 107.999 -1.111 . . . . 15.0 107.999 177.723 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.961 HG21 HG23 ' A' ' 75' ' ' VAL . 35.5 m -93.8 155.27 3.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 113.033 0.753 . . . . 15.0 113.033 -176.995 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.22 -176.39 5.35 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.174 -0.921 . . . . 15.0 110.92 -179.69 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.474 ' O ' ' HB3' ' A' ' 71' ' ' HIS . . . 68.73 -119.46 9.99 Favored Glycine 0 C--N 1.333 0.389 0 C-N-CA 120.951 -0.642 . . . . 15.0 112.611 179.834 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.572 ' HA2' ' HA ' ' A' ' 35' ' ' ILE . . . 68.6 -66.53 0.42 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.823 -0.703 . . . . 15.0 113.612 179.468 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.448 ' O ' HG22 ' A' ' 30' ' ' VAL . 1.3 m -29.38 141.82 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 N-CA-C 112.087 0.403 . . . . 15.0 112.087 -179.262 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -75.45 61.59 1.28 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.122 -0.49 . . . . 15.0 111.074 -179.602 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.6 m -151.73 -51.86 0.12 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.26 -0.427 . . . . 15.0 111.11 179.942 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -85.36 -44.39 12.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.446 . . . . 15.0 111.204 -179.793 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.539 HG11 ' O ' ' A' ' 34' ' ' GLY . 17.5 m -70.33 -173.77 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.333 -0.394 . . . . 15.0 111.258 -179.875 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -57.98 -51.73 68.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 15.0 111.073 -179.892 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 19.6 p-80 -153.31 -46.88 0.09 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.343 -0.389 . . . . 15.0 111.058 -179.865 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -167.44 19.24 0.09 OUTLIER Glycine 0 CA--C 1.519 0.291 0 C-N-CA 120.739 -0.743 . . . . 15.0 112.881 -179.767 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.539 ' O ' HG11 ' A' ' 30' ' ' VAL . . . -90.12 152.3 22.13 Favored Glycine 0 N--CA 1.449 -0.468 0 N-CA-C 110.249 -1.14 . . . . 15.0 110.249 178.493 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.919 ' CG2' HG22 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -97.58 147.38 6.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 117.893 0.847 . . . . 15.0 111.658 -179.263 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.509 ' N ' HD13 ' A' ' 35' ' ' ILE . 2.9 m-85 -130.96 113.59 14.19 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.563 -0.744 . . . . 15.0 109.755 -179.313 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.748 HG22 ' N ' ' A' ' 55' ' ' GLY . 0.8 OUTLIER -55.16 161.16 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-O 121.308 0.575 . . . . 15.0 111.238 -179.216 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.531 ' O ' ' HG2' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -91.6 -46.21 8.07 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.456 -0.942 . . . . 15.0 108.456 178.388 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.663 ' O ' HG12 ' A' ' 20' ' ' ILE . . . -172.27 173.71 4.14 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 115.302 -0.863 . . . . 15.0 110.193 178.772 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.61 ' HA ' HG12 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -96.81 108.75 21.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 109.472 -0.566 . . . . 15.0 109.472 179.268 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.75 ' HB ' ' O ' ' A' ' 19' ' ' GLY . 0.7 OUTLIER -78.28 116.33 58.16 Favored Pre-proline 0 C--N 1.328 -0.369 0 N-CA-C 113.482 0.919 . . . . 15.0 113.482 -177.245 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.618 ' HA ' ' CG ' ' A' ' 47' ' ' GLU . 36.0 Cg_exo -61.78 60.02 0.12 Allowed 'Trans proline' 0 C--N 1.358 1.045 0 C-N-CA 123.707 2.938 . . . . 15.0 113.271 179.821 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.533 ' N ' ' HG2' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -147.44 -46.97 0.17 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.649 0.261 . . . . 15.0 111.484 179.769 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.775 ' HA3' ' HA3' ' A' ' 19' ' ' GLY . . . -87.87 169.06 38.18 Favored Glycine 0 C--N 1.331 0.264 0 C-N-CA 120.386 -0.911 . . . . 15.0 114.007 -179.124 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.716 ' HB3' ' O ' ' A' ' 17' ' ' SER . . . -58.1 -14.88 7.64 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.023 -0.588 . . . . 15.0 112.499 -179.765 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.499 ' HB1' HG22 ' A' ' 52' ' ' ILE . . . -72.22 -56.26 5.85 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.587 0.232 . . . . 15.0 110.996 -179.656 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.618 ' CG ' ' HA ' ' A' ' 42' ' ' PRO . 2.9 pp20? -57.41 -42.91 83.19 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.222 -0.445 . . . . 15.0 110.309 179.256 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -53.71 -71.12 0.08 Allowed 'General case' 0 CA--C 1.519 -0.221 0 CA-C-N 115.801 -0.636 . . . . 15.0 110.488 -179.457 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.584 ' HB2' HD11 ' A' ' 11' ' ' LEU . 0.2 OUTLIER -58.34 -40.07 81.18 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.286 -0.635 . . . . 15.0 109.286 178.826 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.83 37.79 18.27 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 115.359 -0.837 . . . . 15.0 111.756 179.415 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.673 ' HG3' HD13 ' A' ' 11' ' ' LEU . 2.8 mmp_? -79.85 -48.09 14.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.861 0.362 . . . . 15.0 110.775 -179.447 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.556 ' CG1' HD12 ' A' ' 20' ' ' ILE . 10.5 tp -81.04 155.7 4.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.104 -0.498 . . . . 15.0 110.391 179.62 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 53' ' ' HIS . . . . . 0.525 ' O ' ' HB2' ' A' ' 56' ' ' ASP . 53.1 m80 -142.33 161.49 37.91 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-O 121.694 0.759 . . . . 15.0 112.345 -179.032 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.531 ' HG2' ' O ' ' A' ' 38' ' ' LYS . 0.8 OUTLIER -44.27 133.33 5.47 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.445 -1.252 . . . . 15.0 112.561 -178.707 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.748 ' N ' HG22 ' A' ' 37' ' ' VAL . . . 49.59 36.62 25.05 Favored Glycine 0 C--N 1.334 0.441 0 C-N-CA 121.009 -0.615 . . . . 15.0 113.101 179.45 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.525 ' HB2' ' O ' ' A' ' 53' ' ' HIS . 1.4 t0 -65.46 125.11 24.12 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.816 -0.353 . . . . 15.0 110.261 179.539 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.428 ' NE ' ' HG2' ' A' ' 90' ' ' GLU . 1.3 mtt180 -83.15 81.69 8.58 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.321 -0.4 . . . . 15.0 110.05 179.614 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.924 HG12 HD22 ' A' ' 89' ' ' LEU . 1.1 m -79.23 119.77 29.16 Favored 'Isoleucine or valine' 0 C--O 1.24 0.556 0 CA-C-O 121.276 0.56 . . . . 15.0 110.747 -179.502 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -107.64 -13.63 15.0 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 115.236 -0.893 . . . . 15.0 112.516 -179.091 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.485 ' O ' HD23 ' A' ' 87' ' ' LEU . . . -149.63 151.25 33.45 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 112.82 0.674 . . . . 15.0 112.82 -178.543 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.856 HG11 ' O ' ' A' ' 77' ' ' THR . 20.8 t -140.7 100.76 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.171 -0.922 . . . . 15.0 109.198 178.71 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.627 ' OD1' HG22 ' A' ' 81' ' ' THR . 12.1 m120 64.87 15.29 9.8 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.779 -0.452 . . . . 15.0 109.779 -177.968 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 107.19 6.64 33.77 Favored Glycine 0 C--N 1.336 0.561 0 CA-C-N 115.926 -0.579 . . . . 15.0 113.476 179.602 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.674 HG13 ' O ' ' A' ' 64' ' ' VAL . 5.7 p -93.76 104.08 15.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 117.273 0.537 . . . . 15.0 110.588 179.206 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -56.07 134.16 52.44 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.099 -0.5 . . . . 15.0 111.318 -179.336 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.513 HD21 ' HA ' ' A' ' 74' ' ' ALA . 0.1 OUTLIER -97.78 -21.23 17.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.881 -0.6 . . . . 15.0 110.81 179.887 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -44.35 99.27 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 116.339 -0.392 . . . . 15.0 111.219 179.988 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.49 64.74 0.57 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.798 -0.715 . . . . 15.0 112.328 -179.774 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.456 ' HB1' ' CB ' ' A' ' 73' ' ' GLN . . . -173.03 169.03 4.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.89 0.376 . . . . 15.0 111.185 -179.774 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.443 ' HA ' ' N ' ' A' ' 26' ' ' VAL . 5.7 p -93.28 -171.7 2.73 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.184 -0.462 . . . . 15.0 111.27 -179.855 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.741 ' CE1' HG23 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -65.69 -59.61 3.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.737 -0.665 . . . . 15.0 110.866 -179.859 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.439 ' N ' ' CG ' ' A' ' 71' ' ' HIS . 16.7 ttmt -52.4 -32.27 38.06 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.804 -0.634 . . . . 15.0 110.647 179.952 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.456 ' CB ' ' HB1' ' A' ' 69' ' ' ALA . 8.4 mt-30 -59.23 -49.85 76.26 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.778 -0.453 . . . . 15.0 109.778 179.432 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.655 ' CB ' HG21 ' A' ' 35' ' ' ILE . . . -67.39 -46.42 73.33 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 109.615 -0.513 . . . . 15.0 109.615 178.302 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.961 HG23 HG21 ' A' ' 22' ' ' VAL . 0.5 OUTLIER -40.97 -40.3 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.283 0 N-CA-C 108.97 -0.752 . . . . 15.0 108.97 178.324 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.459 ' O ' ' HB2' ' A' ' 80' ' ' ASN . 46.9 mt-10 -67.36 -47.48 70.29 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 114.666 -1.152 . . . . 15.0 110.541 178.659 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.856 ' O ' HG11 ' A' ' 61' ' ' VAL . 67.4 p -64.2 -52.45 58.82 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 121.045 -0.262 . . . . 15.0 111.511 179.974 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.789 HD21 HG21 ' A' ' 58' ' ' VAL . 5.0 mt -53.4 -47.68 69.35 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-O 121.193 0.521 . . . . 15.0 109.761 179.959 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.414 ' HB2' ' O ' ' A' ' 75' ' ' VAL . 5.2 ttm180 -68.62 -62.37 1.42 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.375 -0.829 . . . . 15.0 110.42 179.112 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.459 ' HB2' ' O ' ' A' ' 76' ' ' GLU . 15.8 m-80 -66.01 62.35 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.02 -0.537 . . . . 15.0 111.78 179.766 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.627 HG22 ' OD1' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -88.11 -70.4 0.64 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.865 0.364 . . . . 15.0 110.213 179.442 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 121.99 -107.85 1.23 Allowed Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 121.047 -0.597 . . . . 15.0 112.686 179.54 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.497 ' O ' ' HB3' ' A' ' 13' ' ' LYS . 0.4 OUTLIER -65.0 -82.99 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.773 0.32 . . . . 15.0 111.664 -179.567 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.469 HG12 ' N ' ' A' ' 85' ' ' VAL . 63.1 t -110.2 160.61 9.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.327 -0.397 . . . . 15.0 110.436 179.999 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.627 HG23 ' CB ' ' A' ' 13' ' ' LYS . 19.9 t -98.01 80.89 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.127 0.489 . . . . 15.0 110.503 179.83 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 7.1 t60 -100.45 82.05 2.43 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 115.762 -0.654 . . . . 15.0 110.241 179.832 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.539 HD11 ' HA ' ' A' ' 78' ' ' LEU . 0.1 OUTLIER -102.0 126.26 48.89 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.777 -0.647 . . . . 15.0 111.909 -178.961 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.72 HD12 ' HB3' ' A' ' 8' ' ' GLU . 0.2 OUTLIER -102.3 103.44 13.91 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.648 -0.501 . . . . 15.0 109.648 178.813 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.924 HD22 HG12 ' A' ' 58' ' ' VAL . 0.1 OUTLIER -105.76 -163.82 0.97 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.366 0.603 . . . . 15.0 111.782 -178.955 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.548 ' HA ' ' HA ' ' A' ' 6' ' ' ILE . 3.6 tt0 -138.11 134.2 34.35 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.052 -0.976 . . . . 15.0 109.676 178.996 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.413 ' HD2' ' HA ' ' A' ' 91' ' ' LYS . 0.0 OUTLIER -46.67 97.99 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.316 -0.402 . . . . 15.0 111.414 -179.356 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -66.49 -161.8 1.15 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.944 -0.646 . . . . 15.0 112.579 179.988 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -76.3 100.64 5.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.783 0.325 . . . . 15.0 110.819 179.994 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 79.2 p -90.04 153.74 47.1 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.214 -0.448 . . . . 15.0 111.002 179.997 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_exo -51.82 126.66 20.53 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.61 2.207 . . . . 15.0 112.277 179.939 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 59.4 p . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.242 -0.885 . . . . 15.0 110.901 179.974 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo . . . . . 0 N--CA 1.488 1.19 0 CA-C-O 120.87 0.279 . . . . 15.0 111.809 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.517 ' CB ' ' HD3' ' A' ' 3' ' ' PRO . 2.5 mtmm -155.21 -62.77 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.464 . . . . 15.0 111.068 179.884 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.517 ' HD3' ' CB ' ' A' ' 2' ' ' LYS . 89.1 Cg_exo -47.65 89.16 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.546 2.164 . . . . 15.0 112.577 179.818 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 2' ' ' LYS . . . 88.88 -23.24 18.06 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.538 -0.839 . . . . 15.0 112.435 -179.783 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -61.88 143.22 56.72 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-O 121.412 0.625 . . . . 15.0 110.749 179.859 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.422 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 1.4 mp -88.44 144.85 8.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.069 -0.969 . . . . 15.0 111.27 -179.289 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.644 ' CZ ' HD12 ' A' ' 89' ' ' LEU . 4.0 p90 -140.91 166.39 24.9 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.098 -0.501 . . . . 15.0 110.465 178.797 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.713 ' CB ' HD12 ' A' ' 88' ' ' LEU . 9.4 pt-20 -130.07 144.95 51.62 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.235 0.54 . . . . 15.0 111.613 -179.287 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.681 HG23 ' HG2' ' A' ' 51' ' ' ARG . 0.4 OUTLIER -101.57 116.18 44.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.395 -0.82 . . . . 15.0 109.93 179.019 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -106.56 69.14 0.77 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.236 -0.438 . . . . 15.0 111.807 -179.448 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.645 HD11 ' CB ' ' A' ' 49' ' ' ASP . 6.1 tp -88.07 160.75 17.69 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.298 -0.41 . . . . 15.0 109.961 179.058 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.534 ' C ' ' H ' ' A' ' 14' ' ' ASN . . . -97.1 95.71 7.96 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.292 0.479 . . . . 15.0 112.292 -179.177 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.881 ' HB2' HG23 ' A' ' 85' ' ' VAL . 3.5 tppt? -65.82 26.72 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 112.131 0.419 . . . . 15.0 112.131 178.894 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.534 ' H ' ' C ' ' A' ' 12' ' ' ALA . 7.5 m120 -115.58 123.64 48.95 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.947 0.403 . . . . 15.0 111.58 -179.425 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 65.04 11.3 7.0 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.929 -0.578 . . . . 15.0 111.89 179.4 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.469 ' HB3' ' HB2' ' A' ' 45' ' ' ALA . 35.8 m-80 -165.39 120.21 1.28 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.804 0.335 . . . . 15.0 110.891 179.771 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.849 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 0.4 OUTLIER -85.86 -166.84 1.65 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.229 -0.441 . . . . 15.0 110.16 179.552 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.606 HD22 ' HZ1' ' A' ' 13' ' ' LYS . 0.3 OUTLIER -90.18 -172.58 3.53 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.717 -0.393 . . . . 15.0 110.841 179.579 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.714 ' O ' ' HB ' ' A' ' 41' ' ' ILE . . . -161.05 36.27 0.41 Allowed Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.968 -0.634 . . . . 15.0 112.279 -179.703 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.759 HD12 ' HB ' ' A' ' 52' ' ' ILE . 0.0 OUTLIER -112.82 136.95 47.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 120.993 0.425 . . . . 15.0 111.719 -179.676 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.429 ' O ' ' HB3' ' A' ' 38' ' ' LYS . 27.5 t -95.96 100.41 12.09 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 107.845 -1.168 . . . . 15.0 107.845 177.294 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.652 HG12 ' CG2' ' A' ' 20' ' ' ILE . 1.0 OUTLIER -93.78 155.74 3.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 112.334 0.494 . . . . 15.0 112.334 -177.226 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.624 ' HA ' ' CD2' ' A' ' 71' ' ' HIS . 6.0 t -149.82 176.02 11.1 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.47 -0.787 . . . . 15.0 110.472 179.429 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.721 ' O ' HG22 ' A' ' 26' ' ' VAL . . . 86.95 -112.03 3.74 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.558 -0.829 . . . . 15.0 112.505 179.849 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.591 ' HA3' ' N ' ' A' ' 71' ' ' HIS . . . 62.58 -66.2 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 121.067 -0.587 . . . . 15.0 113.653 179.199 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.721 HG22 ' O ' ' A' ' 24' ' ' GLY . 0.0 OUTLIER -28.94 143.12 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 N-CA-C 112.528 0.566 . . . . 15.0 112.528 -179.038 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.402 ' CB ' ' O ' ' A' ' 32' ' ' HIS . 0.6 OUTLIER -75.67 61.87 1.41 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.738 -0.664 . . . . 15.0 110.968 -179.844 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -151.65 -66.97 0.18 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.376 -0.375 . . . . 15.0 111.045 179.994 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 72.4 m -65.4 -49.76 68.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.183 -0.462 . . . . 15.0 110.877 -179.939 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.521 HG21 ' O ' ' A' ' 34' ' ' GLY . 34.5 m -75.95 -174.1 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.185 -0.462 . . . . 15.0 111.119 -179.966 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.81 -78.89 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.337 -0.392 . . . . 15.0 111.258 -179.755 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 32' ' ' HIS . . . . . 0.402 ' O ' ' CB ' ' A' ' 27' ' ' ASN . 34.4 p-80 -126.92 -42.85 1.72 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.431 -0.35 . . . . 15.0 111.223 -179.818 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -170.06 26.62 0.11 Allowed Glycine 0 N--CA 1.453 -0.2 0 C-N-CA 120.745 -0.74 . . . . 15.0 112.554 -179.772 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.521 ' O ' HG21 ' A' ' 30' ' ' VAL . . . -92.61 154.75 22.3 Favored Glycine 0 N--CA 1.448 -0.521 0 N-CA-C 110.33 -1.108 . . . . 15.0 110.33 178.723 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 1.0 HG22 HG22 ' A' ' 58' ' ' VAL . 0.2 OUTLIER -98.86 152.82 4.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 119.768 -0.773 . . . . 15.0 112.318 -179.154 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.41 ' CZ ' ' HG3' ' A' ' 57' ' ' ARG . 14.7 m-85 -137.19 111.21 8.31 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.65 -1.159 . . . . 15.0 109.087 179.406 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.769 HG22 ' N ' ' A' ' 55' ' ' GLY . 0.8 OUTLIER -55.37 168.69 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.42 0.628 . . . . 15.0 111.572 -178.315 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.523 ' O ' ' HG2' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -99.75 -45.12 5.85 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.374 -0.973 . . . . 15.0 108.374 178.189 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.58 ' O ' HG12 ' A' ' 20' ' ' ILE . . . -172.66 171.45 4.48 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 115.437 -0.801 . . . . 15.0 110.363 178.466 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.466 ' HA ' HG12 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -96.76 110.68 25.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 108.803 -0.814 . . . . 15.0 108.803 178.877 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.714 ' HB ' ' O ' ' A' ' 19' ' ' GLY . 0.4 OUTLIER -77.55 115.66 51.51 Favored Pre-proline 0 C--N 1.329 -0.288 0 N-CA-C 113.597 0.962 . . . . 15.0 113.597 -176.693 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.616 ' HA ' ' HG2' ' A' ' 47' ' ' GLU . 38.9 Cg_exo -61.55 61.14 0.11 Allowed 'Trans proline' 0 C--N 1.358 1.073 0 C-N-CA 123.726 2.951 . . . . 15.0 113.003 179.578 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.517 ' H ' ' HG2' ' A' ' 47' ' ' GLU . 3.5 mt-30 -150.57 -47.93 0.12 Allowed 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 111.738 0.273 . . . . 15.0 111.738 179.957 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.609 ' HA3' ' HA3' ' A' ' 19' ' ' GLY . . . -87.81 166.66 35.91 Favored Glycine 0 CA--C 1.519 0.303 0 C-N-CA 120.356 -0.926 . . . . 15.0 113.79 -179.082 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.849 ' HB3' ' O ' ' A' ' 17' ' ' SER . . . -55.48 -14.87 2.22 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.66 0.615 . . . . 15.0 112.66 -179.817 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.93 -57.95 3.87 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.702 0.287 . . . . 15.0 110.945 -179.397 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.616 ' HG2' ' HA ' ' A' ' 42' ' ' PRO . 2.8 pp20? -56.94 -42.2 79.64 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.989 0.423 . . . . 15.0 110.391 179.415 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -53.82 -72.25 0.06 Allowed 'General case' 0 CA--C 1.519 -0.214 0 CA-C-N 115.883 -0.598 . . . . 15.0 110.466 -179.636 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.645 ' CB ' HD11 ' A' ' 11' ' ' LEU . 0.5 OUTLIER -58.68 -40.4 83.46 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.456 -0.572 . . . . 15.0 109.456 179.01 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.93 50.03 5.38 Favored Glycine 0 N--CA 1.447 -0.584 0 CA-C-N 115.388 -0.824 . . . . 15.0 111.766 179.604 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.681 ' HG2' HG23 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -79.49 -51.59 9.13 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.764 0.316 . . . . 15.0 110.775 -179.34 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.759 ' HB ' HD12 ' A' ' 20' ' ' ILE . 3.1 mm -91.45 162.72 2.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.993 0.425 . . . . 15.0 111.083 179.694 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 53' ' ' HIS . . . . . 0.596 ' N ' HG22 ' A' ' 52' ' ' ILE . 52.0 m80 -141.5 157.6 44.93 Favored 'General case' 0 CA--C 1.513 -0.466 0 CA-C-N 115.797 -0.638 . . . . 15.0 110.616 179.718 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.523 ' HG2' ' O ' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -35.61 132.58 0.44 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.848 -1.069 . . . . 15.0 112.647 -178.501 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.769 ' N ' HG22 ' A' ' 37' ' ' VAL . . . 49.71 38.02 28.58 Favored Glycine 0 C--N 1.332 0.338 0 CA-C-N 115.923 -0.58 . . . . 15.0 113.64 179.524 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -65.88 128.59 36.62 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 117.499 0.65 . . . . 15.0 110.523 179.388 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.439 ' HA ' ' O ' ' A' ' 35' ' ' ILE . 56.3 ttt180 -83.25 88.02 6.94 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.429 -0.35 . . . . 15.0 110.537 179.808 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 1.0 HG22 HG22 ' A' ' 35' ' ' ILE . 1.8 m -82.94 112.53 20.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.17 0.509 . . . . 15.0 111.353 -179.44 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.4 ' HA ' ' HB2' ' A' ' 66' ' ' LEU . 35.6 mt -107.27 -9.47 16.06 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 115.685 -0.689 . . . . 15.0 112.654 -179.306 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.55 ' HB3' ' HB2' ' A' ' 88' ' ' LEU . . . -151.25 144.81 24.94 Favored 'General case' 0 N--CA 1.463 0.194 0 N-CA-C 112.565 0.58 . . . . 15.0 112.565 -178.857 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.881 HG11 ' O ' ' A' ' 77' ' ' THR . 32.7 t -139.07 98.96 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.258 0 CA-C-N 115.497 -0.774 . . . . 15.0 109.452 178.878 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.518 ' OD1' HG22 ' A' ' 81' ' ' THR . 2.9 m120 65.06 17.76 11.2 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.066 -0.516 . . . . 15.0 109.874 -178.415 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 107.24 4.57 35.33 Favored Glycine 0 C--N 1.336 0.536 0 CA-C-N 115.836 -0.62 . . . . 15.0 113.676 179.488 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.664 HG13 ' O ' ' A' ' 64' ' ' VAL . 4.9 p -93.87 105.28 16.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 117.323 0.562 . . . . 15.0 110.818 179.319 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -56.87 134.59 55.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.142 -0.481 . . . . 15.0 110.983 -179.692 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.59 HD13 ' HB3' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -87.64 -19.35 27.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.121 -0.49 . . . . 15.0 111.034 -179.998 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -46.92 95.56 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 120.892 0.377 . . . . 15.0 110.888 179.943 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.77 66.75 0.59 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.785 -0.721 . . . . 15.0 112.217 -179.588 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.65 ' HB1' ' CB ' ' A' ' 73' ' ' GLN . . . -172.95 154.36 2.82 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.859 0.362 . . . . 15.0 110.976 -179.867 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.427 ' HA ' ' C ' ' A' ' 25' ' ' GLY . 13.7 p -93.04 -170.91 2.54 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.114 -0.494 . . . . 15.0 111.396 -179.626 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.624 ' CD2' ' HA ' ' A' ' 23' ' ' THR . 0.1 OUTLIER -58.12 -62.17 2.02 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.618 -0.719 . . . . 15.0 110.063 179.75 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 3.4 ttpt -53.02 -36.23 60.3 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.236 -0.893 . . . . 15.0 111.051 179.483 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.65 ' CB ' ' HB1' ' A' ' 69' ' ' ALA . 7.0 mt-30 -59.41 -57.31 13.53 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.304 -0.407 . . . . 15.0 110.163 179.88 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.894 ' HB3' HD12 ' A' ' 35' ' ' ILE . . . -63.27 -43.63 97.4 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.715 -0.476 . . . . 15.0 109.715 178.835 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.588 HG23 ' CG2' ' A' ' 22' ' ' VAL . 0.5 OUTLIER -43.66 -42.74 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.223 0 N-CA-C 108.807 -0.812 . . . . 15.0 108.807 178.176 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.41 ' N ' HG12 ' A' ' 75' ' ' VAL . 21.7 mt-10 -67.45 -42.91 82.3 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 114.856 -1.066 . . . . 15.0 110.535 178.556 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.881 ' O ' HG11 ' A' ' 61' ' ' VAL . 69.9 p -63.9 -56.18 17.22 Favored 'General case' 0 N--CA 1.462 0.135 0 C-N-CA 120.997 -0.281 . . . . 15.0 111.5 -179.924 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.811 HD21 HG21 ' A' ' 58' ' ' VAL . 5.6 mt -53.37 -47.14 69.71 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-O 121.197 0.523 . . . . 15.0 110.007 179.953 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.409 ' O ' ' N ' ' A' ' 81' ' ' THR . 7.1 tpp85 -68.53 -59.12 3.37 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.395 -0.82 . . . . 15.0 110.691 179.489 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.408 ' CB ' ' O ' ' A' ' 76' ' ' GLU . 2.9 m-20 -65.92 63.0 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.035 -0.53 . . . . 15.0 111.848 179.909 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.518 HG22 ' OD1' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -91.79 -73.55 0.54 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.728 0.299 . . . . 15.0 110.33 179.322 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.434 ' O ' ' HG3' ' A' ' 13' ' ' LYS . . . 120.98 -103.43 0.9 Allowed Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.773 -0.727 . . . . 15.0 112.672 179.431 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -64.85 -87.03 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.723 0.297 . . . . 15.0 111.05 -179.841 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.507 HG12 ' N ' ' A' ' 85' ' ' VAL . 93.7 t -110.07 161.9 8.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.881 0.372 . . . . 15.0 110.625 179.956 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.881 HG23 ' HB2' ' A' ' 13' ' ' LYS . 3.3 t -97.43 84.54 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.176 0.512 . . . . 15.0 110.368 179.825 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 10.9 t60 -101.28 82.63 2.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.59 -0.732 . . . . 15.0 110.001 179.493 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.695 ' HB3' HD21 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -103.92 126.36 50.98 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.818 -0.628 . . . . 15.0 112.01 -178.907 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.713 HD12 ' CB ' ' A' ' 8' ' ' GLU . 4.9 mp -102.38 100.48 10.63 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.4 -0.593 . . . . 15.0 109.4 178.487 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.695 HD21 ' HB3' ' A' ' 87' ' ' LEU . 0.1 OUTLIER -105.57 -162.24 0.86 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.611 0.719 . . . . 15.0 112.027 -178.566 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.422 ' HA ' ' HA ' ' A' ' 6' ' ' ILE . 1.3 tt0 -139.89 133.88 30.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 114.73 -1.123 . . . . 15.0 109.485 178.856 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.15 93.81 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.89 0.376 . . . . 15.0 111.069 -179.562 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -72.09 75.92 0.76 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.959 -0.639 . . . . 15.0 112.738 -179.769 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.46 99.63 11.79 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.829 0.347 . . . . 15.0 110.796 179.898 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 99.1 p -71.86 155.29 92.25 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.203 -0.453 . . . . 15.0 110.992 -179.963 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -52.48 -36.98 72.21 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.648 2.232 . . . . 15.0 112.287 179.987 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.3 m . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.29 -0.862 . . . . 15.0 110.915 -179.982 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_endo . . . . . 0 N--CA 1.489 1.211 0 CA-C-O 120.79 0.246 . . . . 15.0 111.768 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.469 ' HB3' ' CD ' ' A' ' 3' ' ' PRO . 45.6 tptt -155.06 -66.5 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.21 -0.45 . . . . 15.0 110.797 179.81 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.469 ' CD ' ' HB3' ' A' ' 2' ' ' LYS . 55.3 Cg_endo -69.62 -167.99 0.25 Allowed 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.146 1.897 . . . . 15.0 112.209 179.772 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 84.55 -15.35 41.66 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.538 -0.839 . . . . 15.0 112.246 -179.704 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -62.12 159.18 15.11 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-O 121.102 0.477 . . . . 15.0 110.673 179.837 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.471 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 1.1 mp -104.3 144.44 14.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.593 -0.73 . . . . 15.0 111.125 -179.274 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.658 ' CZ ' HD12 ' A' ' 89' ' ' LEU . 2.3 p90 -140.41 151.3 44.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.171 -0.468 . . . . 15.0 110.611 179.119 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.656 ' CB ' HD12 ' A' ' 88' ' ' LEU . 13.7 pt-20 -116.9 143.08 46.12 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.206 0.527 . . . . 15.0 111.402 -179.467 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.678 ' CG1' HD11 ' A' ' 89' ' ' LEU . 0.4 OUTLIER -101.46 116.92 45.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.401 -0.818 . . . . 15.0 109.766 179.056 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -106.0 72.25 0.93 Allowed 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.198 0.444 . . . . 15.0 112.198 -178.932 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.738 HD13 ' HB2' ' A' ' 51' ' ' ARG . 6.7 tp -88.23 165.41 15.07 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.035 -0.53 . . . . 15.0 109.592 178.699 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.567 ' HB1' ' HB2' ' A' ' 15' ' ' ASP . . . -96.03 96.33 8.8 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.004 0.431 . . . . 15.0 110.991 179.952 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.737 ' CB ' HG23 ' A' ' 85' ' ' VAL . 0.1 OUTLIER -63.29 -29.78 71.04 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.785 -0.643 . . . . 15.0 111.261 -179.863 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.403 ' N ' ' O ' ' A' ' 83' ' ' GLN . 55.1 t30 -84.44 -37.07 21.87 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.228 -0.442 . . . . 15.0 110.96 -179.639 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.567 ' HB2' ' HB1' ' A' ' 12' ' ' ALA . 2.6 t0 -64.75 -36.16 83.39 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.03 0.443 . . . . 15.0 110.283 179.454 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.552 ' HB3' ' HB2' ' A' ' 45' ' ' ALA . 11.8 m-20 -165.5 171.11 13.63 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.881 -0.6 . . . . 15.0 110.776 179.68 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.908 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 0.5 OUTLIER -86.0 -155.27 0.24 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.251 -0.431 . . . . 15.0 110.142 179.637 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.675 ' N ' HD22 ' A' ' 18' ' ' LEU . 0.3 OUTLIER -105.05 -167.42 1.34 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.051 0.453 . . . . 15.0 110.721 179.413 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.595 ' O ' ' HB ' ' A' ' 41' ' ' ILE . . . -169.73 34.87 0.18 Allowed Glycine 0 CA--C 1.506 -0.53 0 N-CA-C 111.102 -0.799 . . . . 15.0 111.102 -179.673 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.652 HD12 HG12 ' A' ' 52' ' ' ILE . 0.0 OUTLIER -114.23 142.11 28.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 112.652 0.612 . . . . 15.0 112.652 -179.188 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.704 ' CB ' HD11 ' A' ' 41' ' ' ILE . 2.3 t -96.86 104.1 16.08 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 107.903 -1.147 . . . . 15.0 107.903 176.315 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.984 HG21 HG23 ' A' ' 75' ' ' VAL . 27.5 m -93.63 147.36 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 N-CA-C 112.981 0.734 . . . . 15.0 112.981 -177.248 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.549 ' HA ' ' CE1' ' A' ' 71' ' ' HIS . 6.4 t -150.04 -177.46 5.93 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 115.553 -0.749 . . . . 15.0 111.327 179.205 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.641 ' O ' HG22 ' A' ' 26' ' ' VAL . . . 73.58 -115.95 5.23 Favored Glycine 0 C--N 1.336 0.565 0 C-N-CA 121.067 -0.587 . . . . 15.0 112.457 179.86 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.563 ' HA3' ' N ' ' A' ' 71' ' ' HIS . . . 64.18 -65.22 0.05 OUTLIER Glycine 0 C--N 1.33 0.233 0 C-N-CA 121.091 -0.576 . . . . 15.0 114.05 178.977 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.641 HG22 ' O ' ' A' ' 24' ' ' GLY . 0.0 OUTLIER -30.11 144.0 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 N-CA-C 112.145 0.424 . . . . 15.0 112.145 -179.121 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -75.51 58.21 1.01 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.137 -0.483 . . . . 15.0 110.974 -179.644 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 5.3 m -151.92 -60.7 0.16 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.243 -0.435 . . . . 15.0 110.792 179.965 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 9.0 t -70.31 -46.67 63.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.069 -0.514 . . . . 15.0 110.914 -179.927 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.498 HG22 ' O ' ' A' ' 26' ' ' VAL . 14.2 m -77.05 -170.03 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.237 -0.438 . . . . 15.0 111.093 -179.959 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 5.2 mmt180 -57.42 -71.47 0.1 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.273 -0.421 . . . . 15.0 111.009 -179.997 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 32' ' ' HIS . . . . . 0.442 ' CD2' ' N ' ' A' ' 33' ' ' GLY . 8.5 p-80 -134.93 -42.3 0.74 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.318 -0.401 . . . . 15.0 111.37 -179.817 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.442 ' N ' ' CD2' ' A' ' 32' ' ' HIS . . . -170.16 22.49 0.09 OUTLIER Glycine 0 CA--C 1.52 0.344 0 C-N-CA 120.504 -0.855 . . . . 15.0 113.086 -179.66 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.438 ' O ' HG21 ' A' ' 30' ' ' VAL . . . -92.58 154.25 22.06 Favored Glycine 0 N--CA 1.451 -0.33 0 N-CA-C 110.163 -1.175 . . . . 15.0 110.163 178.405 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.987 HG22 HG22 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -101.34 147.33 8.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 118.181 0.99 . . . . 15.0 111.795 -179.209 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.736 ' N ' HD13 ' A' ' 35' ' ' ILE . 13.5 m-85 -131.28 113.18 13.49 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-N 115.433 -0.803 . . . . 15.0 109.537 -179.61 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.797 HG22 ' N ' ' A' ' 55' ' ' GLY . 0.7 OUTLIER -54.87 148.68 2.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 115.471 -0.786 . . . . 15.0 111.363 -178.736 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.484 ' O ' ' HG2' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -81.08 -48.39 12.24 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.775 -0.824 . . . . 15.0 108.775 178.654 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.501 ' O ' HG12 ' A' ' 20' ' ' ILE . . . -172.5 169.04 5.27 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.567 -0.742 . . . . 15.0 110.766 178.572 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.647 HG12 HG13 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -97.49 122.08 48.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.793 0.33 . . . . 15.0 110.526 179.676 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.704 HD11 ' CB ' ' A' ' 21' ' ' SER . 1.5 mm -78.5 109.26 9.93 Favored Pre-proline 0 N--CA 1.464 0.229 0 N-CA-C 112.956 0.724 . . . . 15.0 112.956 -178.627 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.474 ' HA ' ' OE1' ' A' ' 47' ' ' GLU . 38.2 Cg_endo -65.72 65.46 0.4 Allowed 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 122.828 2.352 . . . . 15.0 112.246 179.49 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -162.55 -44.94 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.434 -0.803 . . . . 15.0 109.508 179.816 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.556 ' HA3' ' HA3' ' A' ' 19' ' ' GLY . . . -87.43 151.35 23.31 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.774 -0.727 . . . . 15.0 112.338 179.351 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.908 ' HB3' ' O ' ' A' ' 17' ' ' SER . . . -40.19 -19.6 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 113.465 0.913 . . . . 15.0 113.465 -179.312 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.445 ' N ' ' O ' ' A' ' 44' ' ' GLY . . . -71.58 -71.13 0.28 Allowed 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.809 -0.356 . . . . 15.0 111.076 -179.654 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.56 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 9.0 tm-20 -58.22 -36.58 73.35 Favored 'General case' 0 N--CA 1.462 0.153 0 C-N-CA 120.81 -0.356 . . . . 15.0 110.284 179.36 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 53.6 m -56.16 -67.69 0.27 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.173 -0.467 . . . . 15.0 110.395 179.464 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.558 ' CB ' HD11 ' A' ' 11' ' ' LEU . 2.6 m-20 -62.11 -37.64 85.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.129 -0.487 . . . . 15.0 109.932 179.179 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.32 38.19 15.63 Favored Glycine 0 N--CA 1.448 -0.521 0 CA-C-N 115.694 -0.684 . . . . 15.0 112.028 179.943 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.738 ' HB2' HD13 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -79.69 -53.58 6.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.124 0.487 . . . . 15.0 110.286 -179.846 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.652 HG12 HD12 ' A' ' 20' ' ' ILE . 11.0 tp -87.82 158.04 3.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.587 -0.733 . . . . 15.0 110.158 179.477 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 67.6 m80 -139.78 160.52 39.71 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-O 121.777 0.799 . . . . 15.0 112.898 -178.705 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.592 ' HA ' ' CG2' ' A' ' 37' ' ' VAL . 1.1 mtpt -43.97 134.7 4.49 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 114.007 -1.451 . . . . 15.0 112.702 -178.843 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.797 ' N ' HG22 ' A' ' 37' ' ' VAL . . . 49.75 31.95 16.87 Favored Glycine 0 C--N 1.333 0.408 0 CA-C-N 115.945 -0.571 . . . . 15.0 113.284 179.282 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -65.56 122.59 17.57 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.629 -0.428 . . . . 15.0 109.874 179.15 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.503 ' NE ' HD21 ' A' ' 59' ' ' LEU . 36.9 ttt85 -80.98 85.44 6.26 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.429 -0.35 . . . . 15.0 110.421 -179.859 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.987 HG22 HG22 ' A' ' 35' ' ' ILE . 1.3 m -79.67 121.76 33.58 Favored 'Isoleucine or valine' 0 C--O 1.24 0.601 0 CA-C-O 121.211 0.529 . . . . 15.0 111.559 -179.365 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.503 HD21 ' NE ' ' A' ' 57' ' ' ARG . 3.8 mm? -107.91 -15.63 14.5 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 115.09 -0.959 . . . . 15.0 111.984 -179.861 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.641 ' HB3' ' HB2' ' A' ' 88' ' ' LEU . . . -147.91 148.16 30.51 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.113 0.483 . . . . 15.0 112.263 -178.565 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.688 HG11 ' O ' ' A' ' 77' ' ' THR . 39.6 t -139.02 102.69 1.8 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.249 0 CA-C-N 115.577 -0.738 . . . . 15.0 109.451 178.825 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.65 ' OD1' HG22 ' A' ' 81' ' ' THR . 2.4 m120 64.83 14.46 9.21 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.763 -0.458 . . . . 15.0 109.763 -178.195 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 107.01 6.49 34.3 Favored Glycine 0 C--N 1.336 0.573 0 CA-C-N 115.863 -0.608 . . . . 15.0 113.244 179.828 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.666 HG13 ' O ' ' A' ' 64' ' ' VAL . 6.3 p -93.67 105.22 16.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 121.098 0.475 . . . . 15.0 110.579 179.216 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -58.46 123.67 16.98 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.145 -0.479 . . . . 15.0 111.142 -179.442 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.847 HD13 HG23 ' A' ' 58' ' ' VAL . 0.2 OUTLIER -92.07 -16.96 25.69 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.918 -0.583 . . . . 15.0 111.096 179.877 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -43.43 95.26 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.874 0.369 . . . . 15.0 111.239 -179.994 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 107.83 71.42 0.74 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.799 -0.715 . . . . 15.0 112.301 -179.73 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.597 ' HB1' ' CG ' ' A' ' 73' ' ' GLN . . . -173.02 169.46 4.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.831 0.348 . . . . 15.0 111.107 -179.778 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 15.6 p -93.42 -175.21 3.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.927 0.394 . . . . 15.0 111.27 -179.749 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.772 ' NE2' HG23 ' A' ' 22' ' ' VAL . 0.1 OUTLIER -65.78 -58.56 5.35 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.882 -0.599 . . . . 15.0 110.623 -179.902 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.442 ' O ' ' HG3' ' A' ' 76' ' ' GLU . 23.3 ttpp -52.21 -31.03 30.09 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.747 -0.464 . . . . 15.0 109.747 178.925 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.597 ' CG ' ' HB1' ' A' ' 69' ' ' ALA . 1.1 tt0 -59.5 -49.19 78.73 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.916 -0.584 . . . . 15.0 109.609 178.813 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.626 ' CB ' HG21 ' A' ' 35' ' ' ILE . . . -67.11 -45.79 76.15 Favored 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 109.568 -0.53 . . . . 15.0 109.568 178.512 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.984 HG23 HG21 ' A' ' 22' ' ' VAL . 0.5 OUTLIER -42.2 -42.12 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.27 0 N-CA-C 108.792 -0.818 . . . . 15.0 108.792 178.257 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.499 ' O ' ' HB2' ' A' ' 80' ' ' ASN . 8.9 mt-10 -67.3 -45.28 77.01 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 114.651 -1.159 . . . . 15.0 110.361 178.477 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.688 ' O ' HG11 ' A' ' 61' ' ' VAL . 72.9 p -64.1 -54.54 32.42 Favored 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 111.545 0.202 . . . . 15.0 111.545 -179.949 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.597 HD21 HG21 ' A' ' 58' ' ' VAL . 8.3 mt -53.47 -46.35 69.92 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 121.308 0.575 . . . . 15.0 109.881 -179.989 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.451 ' HB2' ' O ' ' A' ' 75' ' ' VAL . 0.2 OUTLIER -68.51 -58.89 3.63 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.204 -0.907 . . . . 15.0 110.805 179.677 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.499 ' HB2' ' O ' ' A' ' 76' ' ' GLU . 6.5 m-80 -66.23 56.98 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 112.393 0.516 . . . . 15.0 112.393 -179.86 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.65 HG22 ' OD1' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -95.69 -75.02 0.53 Allowed 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.94 -0.393 . . . . 15.0 109.94 178.853 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 122.06 -104.02 0.89 Allowed Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.641 -0.79 . . . . 15.0 113.537 178.804 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.403 ' O ' ' N ' ' A' ' 14' ' ' ASN . 0.2 OUTLIER -63.08 -84.9 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.06 0.393 . . . . 15.0 112.06 -178.699 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.453 HG12 ' N ' ' A' ' 85' ' ' VAL . 55.4 t -109.46 160.18 8.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.891 0.377 . . . . 15.0 110.706 -179.408 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.737 HG23 ' CB ' ' A' ' 13' ' ' LYS . 9.3 t -97.8 81.42 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-O 121.118 0.485 . . . . 15.0 110.382 -179.926 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 5.0 t-160 -99.66 86.29 3.3 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.736 -0.665 . . . . 15.0 110.229 179.863 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.822 ' HB3' HD21 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -103.82 127.33 51.33 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.882 -0.599 . . . . 15.0 111.718 -179.018 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.656 HD12 ' CB ' ' A' ' 8' ' ' GLU . 4.4 mp -102.18 99.44 9.57 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.552 -0.536 . . . . 15.0 109.552 178.742 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.822 HD21 ' HB3' ' A' ' 87' ' ' LEU . 0.1 OUTLIER -105.88 -162.66 0.88 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.56 0.695 . . . . 15.0 112.406 -178.317 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.471 ' HA ' ' HA ' ' A' ' 6' ' ' ILE . 1.9 tt0 -138.37 142.27 39.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 114.617 -1.174 . . . . 15.0 109.288 178.669 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -53.79 100.75 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.002 0.429 . . . . 15.0 111.107 -179.522 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -62.06 97.17 0.15 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.956 -0.64 . . . . 15.0 112.604 -179.768 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.36 112.31 21.32 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.826 0.346 . . . . 15.0 110.86 179.935 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -84.41 146.43 47.48 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.163 -0.471 . . . . 15.0 110.923 -179.964 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -52.87 -36.06 72.87 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.595 2.197 . . . . 15.0 112.25 179.994 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 2.4 t . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.223 -0.894 . . . . 15.0 110.89 -179.957 . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo . . . . . 0 N--CA 1.487 1.099 0 CA-C-O 120.864 0.277 . . . . 15.0 111.848 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 10.5 mttt -145.14 99.35 4.61 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.114 -0.494 . . . . 15.0 110.687 179.993 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -55.16 -167.49 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.458 2.105 . . . . 15.0 112.661 -179.735 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 87.46 -21.49 21.39 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.812 -0.709 . . . . 15.0 112.033 -179.473 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -72.72 143.27 48.08 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 121.439 0.638 . . . . 15.0 111.142 179.851 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.411 HG13 ' HB2' ' A' ' 90' ' ' GLU . 1.2 mp -74.76 147.56 8.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 115.002 -0.999 . . . . 15.0 110.651 179.799 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.612 ' CZ ' HD12 ' A' ' 89' ' ' LEU . 2.0 p90 -140.67 160.25 40.44 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.438 -0.346 . . . . 15.0 110.532 179.085 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.713 ' CB ' HD12 ' A' ' 88' ' ' LEU . 9.5 pt-20 -126.46 144.95 50.68 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.249 0.547 . . . . 15.0 111.48 -179.338 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.703 ' CG1' HD11 ' A' ' 89' ' ' LEU . 0.5 OUTLIER -101.29 115.07 42.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.331 -0.85 . . . . 15.0 109.722 179.157 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -106.13 69.56 0.81 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.107 -0.497 . . . . 15.0 111.643 -179.302 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.646 HD11 ' CB ' ' A' ' 49' ' ' ASP . 7.0 tp -88.15 161.68 17.14 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.013 -0.54 . . . . 15.0 110.082 179.213 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.53 ' C ' ' H ' ' A' ' 14' ' ' ASN . . . -96.63 101.0 12.53 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.717 0.294 . . . . 15.0 111.113 179.918 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.883 ' HB2' HG23 ' A' ' 85' ' ' VAL . 0.4 OUTLIER -65.49 26.59 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 112.511 0.56 . . . . 15.0 112.511 179.882 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.53 ' H ' ' C ' ' A' ' 12' ' ' ALA . 49.5 t30 -109.49 152.53 25.3 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.672 0.272 . . . . 15.0 110.541 179.665 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.407 ' CB ' ' O ' ' A' ' 14' ' ' ASN . 6.3 t70 80.69 -49.21 0.3 Allowed 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.323 -0.399 . . . . 15.0 111.26 -179.91 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -154.99 162.18 41.16 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.855 0.359 . . . . 15.0 110.988 -179.912 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.576 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 0.6 OUTLIER -86.03 -166.02 1.41 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.179 -0.464 . . . . 15.0 110.892 179.955 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.41 ' H ' HD22 ' A' ' 18' ' ' LEU . 2.7 mm? -72.25 -167.83 0.35 Allowed 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 116.12 -0.491 . . . . 15.0 110.709 179.698 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.631 ' O ' ' HB ' ' A' ' 41' ' ' ILE . . . -160.85 35.64 0.42 Allowed Glycine 0 CA--C 1.506 -0.513 0 N-CA-C 111.308 -0.717 . . . . 15.0 111.308 179.987 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.669 HG12 ' O ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -112.61 140.13 33.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.011 0.434 . . . . 15.0 111.948 -179.169 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.455 ' HB3' HD11 ' A' ' 41' ' ' ILE . 33.2 t -96.01 105.82 17.91 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 107.696 -1.224 . . . . 15.0 107.696 177.275 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.989 HG21 HG23 ' A' ' 75' ' ' VAL . 33.2 m -93.57 152.77 3.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 112.984 0.735 . . . . 15.0 112.984 -176.908 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -149.42 -178.8 6.62 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 115.014 -0.994 . . . . 15.0 110.823 -179.736 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.437 ' O ' ' HB3' ' A' ' 71' ' ' HIS . . . 71.17 -119.19 7.81 Favored Glycine 0 C--N 1.332 0.308 0 C-N-CA 120.744 -0.741 . . . . 15.0 112.319 -179.95 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.536 ' HA3' ' N ' ' A' ' 71' ' ' HIS . . . 68.47 -66.46 0.41 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.784 -0.722 . . . . 15.0 113.448 179.338 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.525 ' O ' HG22 ' A' ' 30' ' ' VAL . 0.9 OUTLIER -26.27 138.69 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 N-CA-C 112.5 0.555 . . . . 15.0 112.5 -179.297 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 8.1 p-10 -76.72 57.47 1.28 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.97 -0.559 . . . . 15.0 111.093 -179.929 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.2 m -151.85 -51.84 0.12 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.332 -0.395 . . . . 15.0 110.895 179.971 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 6.0 m -80.53 -41.18 24.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.108 -0.496 . . . . 15.0 110.934 -179.918 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.525 HG22 ' O ' ' A' ' 26' ' ' VAL . 13.9 m -79.21 -169.96 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.284 -0.416 . . . . 15.0 111.095 -179.948 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.59 -62.94 1.5 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.284 -0.416 . . . . 15.0 111.05 -179.853 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 32' ' ' HIS . . . . . 0.446 ' CD2' ' HG3' ' A' ' 67' ' ' GLU . 11.0 p-80 -139.22 -51.51 0.53 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.356 -0.384 . . . . 15.0 111.257 -179.764 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -168.28 24.75 0.11 Allowed Glycine 0 CA--C 1.518 0.241 0 C-N-CA 120.791 -0.719 . . . . 15.0 112.628 -179.872 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -91.43 154.08 22.55 Favored Glycine 0 N--CA 1.45 -0.398 0 N-CA-C 110.681 -0.967 . . . . 15.0 110.681 178.891 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.943 HG22 HG22 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -92.55 154.72 3.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 117.685 0.742 . . . . 15.0 111.928 -179.265 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.419 ' CE2' ' HG2' ' A' ' 57' ' ' ARG . 30.4 m-85 -139.19 106.07 5.41 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.042 -0.981 . . . . 15.0 109.691 178.849 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.804 HG22 ' N ' ' A' ' 55' ' ' GLY . 0.7 OUTLIER -55.39 146.4 4.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.929 -0.578 . . . . 15.0 111.335 -178.873 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.426 ' O ' ' HG2' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -80.32 -48.51 12.88 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.475 -0.935 . . . . 15.0 108.475 178.356 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.669 ' O ' HG12 ' A' ' 20' ' ' ILE . . . -172.16 172.36 4.62 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.667 -0.697 . . . . 15.0 110.703 178.68 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.606 ' HA ' HG12 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -96.9 113.07 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 N-CA-C 109.712 -0.477 . . . . 15.0 109.712 179.397 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.631 ' HB ' ' O ' ' A' ' 19' ' ' GLY . 0.3 OUTLIER -78.6 119.34 76.92 Favored Pre-proline 0 C--N 1.33 -0.268 0 N-CA-C 113.281 0.845 . . . . 15.0 113.281 -177.411 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.609 ' HA ' ' CG ' ' A' ' 47' ' ' GLU . 38.3 Cg_endo -65.27 61.2 0.34 Allowed 'Trans proline' 0 C--N 1.355 0.904 0 C-N-CA 123.512 2.808 . . . . 15.0 112.958 179.713 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.528 ' H ' ' HG2' ' A' ' 47' ' ' GLU . 1.8 mm-40 -152.11 -44.63 0.11 Allowed 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 111.767 0.284 . . . . 15.0 111.767 179.81 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.578 ' HA3' ' HA3' ' A' ' 19' ' ' GLY . . . -87.77 164.77 34.47 Favored Glycine 0 CA--C 1.519 0.299 0 C-N-CA 120.347 -0.93 . . . . 15.0 113.828 -179.049 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.576 ' HB3' ' O ' ' A' ' 17' ' ' SER . . . -53.95 -16.34 1.83 Allowed 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 112.847 0.684 . . . . 15.0 112.847 -179.559 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.29 -57.85 3.88 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.609 0.243 . . . . 15.0 111.27 -179.35 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.609 ' CG ' ' HA ' ' A' ' 42' ' ' PRO . 2.9 pp20? -56.74 -40.84 76.47 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.03 0.443 . . . . 15.0 110.312 179.552 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 33.4 t -53.85 -69.79 0.11 Allowed 'General case' 0 CA--C 1.52 -0.182 0 CA-C-N 115.818 -0.628 . . . . 15.0 110.753 -179.449 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.646 ' CB ' HD11 ' A' ' 11' ' ' LEU . 2.0 m-20 -62.61 -38.42 90.11 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.598 -0.519 . . . . 15.0 109.598 179.257 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.03 44.53 8.11 Favored Glycine 0 N--CA 1.447 -0.611 0 CA-C-N 115.573 -0.739 . . . . 15.0 111.703 179.851 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.643 ' HB2' HD13 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -79.43 -53.46 6.88 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.884 0.373 . . . . 15.0 110.832 -179.273 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.66 ' CG1' HD12 ' A' ' 20' ' ' ILE . 8.4 tp -81.93 164.55 2.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.996 -0.547 . . . . 15.0 110.482 179.72 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 53' ' ' HIS . . . . . 0.439 ' O ' ' HB2' ' A' ' 56' ' ' ASP . 78.8 m80 -147.44 156.98 43.38 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.701 0.762 . . . . 15.0 112.181 -179.142 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.57 ' HA ' ' CG2' ' A' ' 37' ' ' VAL . 6.1 mtpt -42.31 133.73 3.11 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.31 -1.314 . . . . 15.0 112.99 -178.646 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.804 ' N ' HG22 ' A' ' 37' ' ' VAL . . . 49.81 31.87 17.19 Favored Glycine 0 C--N 1.334 0.449 0 CA-C-N 115.635 -0.711 . . . . 15.0 113.644 179.061 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.439 ' HB2' ' O ' ' A' ' 53' ' ' HIS . 0.3 OUTLIER -65.9 130.5 43.47 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 117.179 0.49 . . . . 15.0 110.493 179.413 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.419 ' HG2' ' CE2' ' A' ' 36' ' ' TYR . 40.3 mtt180 -83.9 87.23 7.09 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.242 -0.435 . . . . 15.0 110.17 179.62 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.943 HG22 HG22 ' A' ' 35' ' ' ILE . 1.3 m -79.66 117.93 26.27 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 CA-C-O 121.086 0.469 . . . . 15.0 111.566 -179.12 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.438 ' O ' ' N ' ' A' ' 66' ' ' LEU . 27.7 mt -107.48 -18.84 13.75 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 115.504 -0.771 . . . . 15.0 112.493 -179.423 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.766 ' HB3' ' HB2' ' A' ' 88' ' ' LEU . . . -148.79 148.52 30.04 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 112.946 0.721 . . . . 15.0 112.946 -178.575 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.822 HG11 ' O ' ' A' ' 77' ' ' THR . 56.7 t -139.2 94.53 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 CA-C-N 115.101 -0.954 . . . . 15.0 109.076 178.892 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.497 ' OD1' HG22 ' A' ' 81' ' ' THR . 6.0 m120 70.5 16.6 6.98 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.047 -0.524 . . . . 15.0 109.87 -178.101 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 107.17 4.75 35.44 Favored Glycine 0 C--N 1.336 0.549 0 CA-C-N 115.851 -0.613 . . . . 15.0 113.429 179.559 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.655 HG13 ' O ' ' A' ' 64' ' ' VAL . 5.9 p -93.82 105.58 17.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.131 0.491 . . . . 15.0 110.845 179.446 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.6 t -55.71 139.4 45.09 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.057 -0.52 . . . . 15.0 111.206 -179.518 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.963 HD11 ' HB2' ' A' ' 74' ' ' ALA . 0.2 OUTLIER -97.43 -22.97 16.28 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.966 -0.561 . . . . 15.0 110.78 179.875 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.446 ' HG3' ' CD2' ' A' ' 32' ' ' HIS . 1.6 tt0 -46.38 103.36 0.04 OUTLIER 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.237 -0.438 . . . . 15.0 111.125 -179.952 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 102.89 61.63 0.71 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.759 -0.734 . . . . 15.0 112.309 -179.865 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.745 ' HB1' ' CB ' ' A' ' 73' ' ' GLN . . . -173.09 142.57 1.06 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.874 0.368 . . . . 15.0 111.079 -179.823 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.451 ' CB ' ' HA ' ' A' ' 26' ' ' VAL . 2.3 p -72.87 -171.85 0.93 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.252 -0.431 . . . . 15.0 110.953 -179.959 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.695 ' CE1' HG23 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -62.95 -58.43 7.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.95 -0.568 . . . . 15.0 110.447 179.827 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.462 ' O ' HG12 ' A' ' 75' ' ' VAL . 1.8 ttpp -52.5 -33.91 47.05 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.826 -0.625 . . . . 15.0 110.855 179.691 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.745 ' CB ' ' HB1' ' A' ' 69' ' ' ALA . 2.0 mt-30 -59.31 -51.47 69.82 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.35 -0.611 . . . . 15.0 109.35 179.32 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.963 ' HB2' HD11 ' A' ' 66' ' ' LEU . . . -66.86 -43.96 82.22 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.804 -0.634 . . . . 15.0 109.797 178.532 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.989 HG23 HG21 ' A' ' 22' ' ' VAL . 0.5 OUTLIER -43.35 -39.94 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.236 0 N-CA-C 109.029 -0.73 . . . . 15.0 109.029 178.419 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -67.22 -45.83 75.61 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 114.778 -1.101 . . . . 15.0 110.048 178.342 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.822 ' O ' HG11 ' A' ' 61' ' ' VAL . 35.4 p -64.28 -53.48 48.26 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-N 116.526 -0.306 . . . . 15.0 111.454 179.848 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.678 HD23 HG21 ' A' ' 61' ' ' VAL . 4.5 mt -53.88 -48.53 69.99 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 121.205 0.526 . . . . 15.0 110.102 179.914 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.406 ' O ' ' N ' ' A' ' 81' ' ' THR . 0.0 OUTLIER -68.34 -57.68 5.55 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.405 -0.816 . . . . 15.0 110.737 179.655 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 64.8 m-20 -65.84 62.49 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.961 -0.563 . . . . 15.0 112.088 -179.86 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.497 HG22 ' OD1' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -95.41 -73.99 0.57 Allowed 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.798 -0.445 . . . . 15.0 109.798 179.015 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 114.87 -101.11 1.04 Allowed Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.744 -0.741 . . . . 15.0 113.263 178.781 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.48 ' O ' ' HB3' ' A' ' 13' ' ' LYS . 0.1 OUTLIER -64.63 -86.27 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.612 0.244 . . . . 15.0 111.527 -179.208 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.461 HG12 ' N ' ' A' ' 85' ' ' VAL . 79.0 t -110.3 159.52 10.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.98 0.419 . . . . 15.0 110.738 -179.893 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.883 HG23 ' HB2' ' A' ' 13' ' ' LYS . 3.6 t -97.62 83.66 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.146 0.498 . . . . 15.0 110.228 179.648 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -101.75 83.89 2.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.707 -0.679 . . . . 15.0 110.238 179.727 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.834 ' HB3' HD21 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -103.92 128.18 51.43 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.87 -0.605 . . . . 15.0 111.827 -179.106 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.766 ' HB2' ' HB3' ' A' ' 60' ' ' ALA . 4.6 mp -102.28 100.86 11.08 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.629 -0.508 . . . . 15.0 109.629 178.805 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.834 HD21 ' HB3' ' A' ' 87' ' ' LEU . 0.1 OUTLIER -105.64 -161.78 0.83 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.388 0.613 . . . . 15.0 111.848 -178.552 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.411 ' HB2' HG13 ' A' ' 6' ' ' ILE . 3.1 tt0 -142.23 135.38 28.8 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.052 -0.976 . . . . 15.0 109.878 179.21 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 2.8 tptt -47.47 103.95 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.919 0.39 . . . . 15.0 111.188 -179.681 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -70.38 76.4 0.49 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.785 -0.721 . . . . 15.0 112.5 -179.943 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -80.48 120.66 24.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.78 0.324 . . . . 15.0 110.872 179.957 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.2 t -77.74 150.02 78.28 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.241 -0.436 . . . . 15.0 110.987 179.968 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_exo -51.27 -26.51 20.57 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.582 2.188 . . . . 15.0 112.312 179.932 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 62.2 p . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.209 -0.9 . . . . 15.0 110.887 -179.989 . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo . . . . . 0 N--CA 1.487 1.127 0 CA-C-O 120.818 0.257 . . . . 15.0 111.688 . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 39.0 mtmt -146.32 153.91 48.82 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.454 . . . . 15.0 110.941 -179.954 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -65.5 -161.51 0.05 OUTLIER 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.636 2.224 . . . . 15.0 112.364 179.975 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 90.69 -23.73 21.26 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.676 -0.773 . . . . 15.0 112.28 -179.711 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -62.22 136.19 57.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.236 0.541 . . . . 15.0 110.729 179.839 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.514 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 1.4 mp -104.38 138.51 28.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.405 -0.816 . . . . 15.0 111.215 -179.415 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.968 ' CE1' HD12 ' A' ' 89' ' ' LEU . 10.8 p90 -141.82 143.59 33.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.264 -0.425 . . . . 15.0 110.882 178.874 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.795 ' HB2' HD12 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -109.96 142.42 41.36 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.339 0.59 . . . . 15.0 111.534 -179.404 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.683 HG12 HD11 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -101.55 114.89 42.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.117 -0.947 . . . . 15.0 109.831 179.124 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -105.95 71.45 0.9 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.015 -0.539 . . . . 15.0 111.931 -178.988 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.651 HD13 ' HG3' ' A' ' 51' ' ' ARG . 5.6 tp -87.98 165.76 14.98 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.151 -0.477 . . . . 15.0 109.727 178.972 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -94.71 94.2 7.98 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.916 0.389 . . . . 15.0 111.057 -179.995 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.654 ' CB ' HG23 ' A' ' 85' ' ' VAL . 0.2 OUTLIER -54.11 -28.97 43.0 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.977 -0.556 . . . . 15.0 110.885 179.924 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.409 ' O ' ' CB ' ' A' ' 15' ' ' ASP . 41.7 m-20 -84.78 145.76 27.72 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.197 -0.456 . . . . 15.0 110.839 179.799 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.409 ' CB ' ' O ' ' A' ' 14' ' ' ASN . 4.9 m-20 81.69 -23.32 0.22 Allowed 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.096 -0.502 . . . . 15.0 112.0 179.711 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.465 ' HB2' ' HB2' ' A' ' 45' ' ' ALA . 4.9 p30 -165.36 138.38 4.45 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.873 0.368 . . . . 15.0 111.134 -179.917 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.759 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 0.3 OUTLIER -86.11 -163.3 0.86 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.122 -0.49 . . . . 15.0 110.541 179.693 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.588 ' N ' HD22 ' A' ' 18' ' ' LEU . 1.1 mm? -91.91 -172.46 3.18 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 116.383 -0.372 . . . . 15.0 110.779 179.503 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.624 ' HA3' ' HA3' ' A' ' 44' ' ' GLY . . . -160.98 39.44 0.42 Allowed Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 121.043 -0.599 . . . . 15.0 112.024 -179.794 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.661 HD12 ' CG2' ' A' ' 52' ' ' ILE . 0.0 OUTLIER -112.51 144.71 19.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 121.06 0.457 . . . . 15.0 111.686 -179.493 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 55.0 p -96.06 101.49 13.16 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.267 -1.012 . . . . 15.0 108.267 177.958 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 1.024 HG21 HG23 ' A' ' 75' ' ' VAL . 33.8 m -93.77 145.61 7.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 113.092 0.775 . . . . 15.0 113.092 -177.273 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.555 ' HA ' ' ND1' ' A' ' 71' ' ' HIS . 0.9 OUTLIER -149.49 -177.65 5.98 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 115.384 -0.826 . . . . 15.0 110.773 178.74 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.477 ' O ' ' HB3' ' A' ' 71' ' ' HIS . . . 76.32 -118.19 5.23 Favored Glycine 0 C--N 1.333 0.401 0 C-N-CA 120.87 -0.681 . . . . 15.0 112.361 -179.753 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.528 ' HA3' ' N ' ' A' ' 71' ' ' HIS . . . 64.42 -64.66 0.06 OUTLIER Glycine 0 CA--C 1.519 0.31 0 C-N-CA 121.139 -0.553 . . . . 15.0 114.116 178.956 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.609 ' O ' HG22 ' A' ' 30' ' ' VAL . 1.5 m -25.97 142.18 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 N-CA-C 112.892 0.701 . . . . 15.0 112.892 -178.999 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 44.4 t-20 -78.4 55.41 1.57 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.681 -0.69 . . . . 15.0 110.934 179.856 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 15.0 m -152.03 -63.92 0.17 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.915 0.388 . . . . 15.0 110.938 -179.933 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 47.7 t -68.86 -49.99 53.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.029 -0.532 . . . . 15.0 110.885 -179.892 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.609 HG22 ' O ' ' A' ' 26' ' ' VAL . 35.8 m -84.4 -176.74 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.25 -0.432 . . . . 15.0 111.027 179.912 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -89.09 121.86 31.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.956 0.408 . . . . 15.0 111.158 -179.867 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 65.08 -91.36 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.951 -0.568 . . . . 15.0 111.384 179.722 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.456 ' O ' ' O ' ' A' ' 69' ' ' ALA . . . -164.85 27.97 0.2 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.78 -0.724 . . . . 15.0 112.131 -179.717 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -84.81 149.47 24.37 Favored Glycine 0 N--CA 1.449 -0.47 0 N-CA-C 110.523 -1.031 . . . . 15.0 110.523 178.845 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 1.028 HG22 HG22 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -90.13 150.92 3.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 119.923 -0.711 . . . . 15.0 111.78 -179.215 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.453 ' CZ ' ' HG3' ' A' ' 57' ' ' ARG . 44.1 m-85 -136.49 108.54 7.19 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 114.904 -1.044 . . . . 15.0 109.124 178.942 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.785 HG22 ' N ' ' A' ' 55' ' ' GLY . 0.8 OUTLIER -55.17 153.72 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 121.269 0.557 . . . . 15.0 111.266 -178.567 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.576 ' O ' ' HG2' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -86.34 -46.05 10.65 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.745 -0.835 . . . . 15.0 108.745 178.848 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.624 ' O ' HG12 ' A' ' 20' ' ' ILE . . . -172.34 169.34 5.34 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.804 -0.635 . . . . 15.0 110.683 178.527 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.529 ' HA ' HG12 ' A' ' 20' ' ' ILE . 0.1 OUTLIER -96.73 109.86 23.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 N-CA-C 109.288 -0.634 . . . . 15.0 109.288 179.049 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.595 ' HB ' ' O ' ' A' ' 19' ' ' GLY . 0.3 OUTLIER -78.36 118.48 72.54 Favored Pre-proline 0 C--N 1.328 -0.348 0 N-CA-C 113.522 0.934 . . . . 15.0 113.522 -176.967 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.626 ' HA ' ' CG ' ' A' ' 47' ' ' GLU . 36.9 Cg_endo -64.48 61.59 0.26 Allowed 'Trans proline' 0 C--N 1.358 1.042 0 C-N-CA 123.536 2.824 . . . . 15.0 112.991 179.865 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.51 ' N ' ' HG2' ' A' ' 47' ' ' GLU . 41.8 mt-30 -149.88 -46.72 0.13 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.597 -0.274 . . . . 15.0 111.54 179.763 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.624 ' HA3' ' HA3' ' A' ' 19' ' ' GLY . . . -88.03 167.59 36.41 Favored Glycine 0 CA--C 1.518 0.27 0 C-N-CA 120.332 -0.937 . . . . 15.0 113.946 -179.212 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.759 ' HB3' ' O ' ' A' ' 17' ' ' SER . . . -56.6 -13.48 2.44 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.678 0.622 . . . . 15.0 112.678 -179.852 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.444 ' HB1' HG22 ' A' ' 52' ' ' ILE . . . -71.95 -58.23 3.63 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-O 120.773 0.321 . . . . 15.0 110.868 -179.618 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.626 ' CG ' ' HA ' ' A' ' 42' ' ' PRO . 2.6 pp20? -57.38 -42.0 81.33 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.732 -0.667 . . . . 15.0 110.423 179.285 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -53.78 -71.28 0.08 Allowed 'General case' 0 CA--C 1.519 -0.22 0 CA-C-N 115.783 -0.644 . . . . 15.0 110.549 -179.359 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.594 ' CB ' HD11 ' A' ' 11' ' ' LEU . 0.1 OUTLIER -58.24 -40.71 82.47 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.137 -0.69 . . . . 15.0 109.137 178.838 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.416 ' O ' ' CE1' ' A' ' 53' ' ' HIS . . . 80.98 39.54 13.02 Favored Glycine 0 N--CA 1.446 -0.683 0 CA-C-N 115.197 -0.91 . . . . 15.0 112.011 179.212 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.651 ' HG3' HD13 ' A' ' 11' ' ' LEU . 3.0 mmt-85 -80.07 -59.31 2.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.963 0.411 . . . . 15.0 110.386 -179.773 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.661 ' CG2' HD12 ' A' ' 20' ' ' ILE . 6.6 tp -80.86 146.18 7.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.86 -0.609 . . . . 15.0 109.568 179.115 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 53' ' ' HIS . . . . . 0.514 ' O ' ' HB2' ' A' ' 56' ' ' ASP . 57.4 m80 -139.47 167.37 22.24 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-O 121.77 0.795 . . . . 15.0 112.762 -178.253 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.58 ' HA ' ' CG2' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -40.29 132.72 1.94 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.109 -1.405 . . . . 15.0 113.27 -178.353 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.785 ' N ' HG22 ' A' ' 37' ' ' VAL . . . 49.7 36.23 25.0 Favored Glycine 0 C--N 1.335 0.511 0 CA-C-N 115.613 -0.721 . . . . 15.0 113.566 179.115 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.514 ' HB2' ' O ' ' A' ' 53' ' ' HIS . 1.7 t0 -65.66 132.32 48.51 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.99 0.395 . . . . 15.0 110.34 179.206 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.453 ' HG3' ' CZ ' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -85.11 77.25 10.11 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.983 -0.553 . . . . 15.0 110.134 179.545 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 1.028 HG22 HG22 ' A' ' 35' ' ' ILE . 0.8 OUTLIER -79.23 115.62 21.82 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 CA-C-O 121.293 0.568 . . . . 15.0 111.027 -179.25 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 35.0 mt -107.32 -14.12 14.96 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 115.555 -0.748 . . . . 15.0 112.522 -178.967 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.698 ' HB3' ' HB2' ' A' ' 88' ' ' LEU . . . -147.56 149.9 33.46 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 112.642 0.608 . . . . 15.0 112.642 -178.51 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.644 HG11 ' O ' ' A' ' 77' ' ' THR . 15.6 t -139.12 101.54 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.27 0 CA-C-N 115.255 -0.884 . . . . 15.0 109.139 178.741 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.669 ' OD1' HG22 ' A' ' 81' ' ' THR . 2.9 m120 65.04 15.54 10.05 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.668 -0.493 . . . . 15.0 109.668 -177.901 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 106.82 4.9 36.29 Favored Glycine 0 C--N 1.337 0.614 0 CA-C-N 115.822 -0.626 . . . . 15.0 113.286 179.77 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.643 HG13 ' O ' ' A' ' 64' ' ' VAL . 5.8 p -93.83 108.67 20.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 117.017 0.408 . . . . 15.0 111.046 179.616 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -57.11 137.98 55.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.259 -0.428 . . . . 15.0 111.064 -179.741 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.927 HD11 ' HB2' ' A' ' 74' ' ' ALA . 0.2 OUTLIER -97.74 -23.08 16.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.076 -0.511 . . . . 15.0 111.003 179.96 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -47.57 104.0 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.389 -0.369 . . . . 15.0 111.091 179.937 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.76 54.87 0.58 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.744 -0.741 . . . . 15.0 112.288 -179.871 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.678 ' HB1' ' CB ' ' A' ' 73' ' ' GLN . . . -173.07 146.85 1.53 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.857 0.36 . . . . 15.0 111.012 -179.953 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.462 HG22 ' HA ' ' A' ' 26' ' ' VAL . 11.3 p -72.94 -172.33 1.02 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.146 0.498 . . . . 15.0 111.097 -179.771 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.742 ' NE2' HG23 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -65.29 -57.83 7.44 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.636 -0.711 . . . . 15.0 110.751 -179.806 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.49 ' O ' HG12 ' A' ' 75' ' ' VAL . 5.4 ttpp -52.5 -32.91 42.52 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.352 -0.385 . . . . 15.0 110.285 179.316 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.678 ' CB ' ' HB1' ' A' ' 69' ' ' ALA . 4.9 mt-30 -59.56 -48.93 79.74 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.32 -0.622 . . . . 15.0 109.32 178.843 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.927 ' HB2' HD11 ' A' ' 66' ' ' LEU . . . -67.16 -44.12 80.56 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-N 115.944 -0.571 . . . . 15.0 109.582 178.24 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 1.024 HG23 HG21 ' A' ' 22' ' ' VAL . 0.5 OUTLIER -44.03 -39.28 1.47 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.26 0 N-CA-C 108.706 -0.85 . . . . 15.0 108.706 178.312 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -67.17 -45.3 77.41 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 114.668 -1.151 . . . . 15.0 110.132 178.249 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.644 ' O ' HG11 ' A' ' 61' ' ' VAL . 39.0 p -64.12 -54.79 28.43 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.634 -0.257 . . . . 15.0 111.599 179.851 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.59 HD21 HG21 ' A' ' 58' ' ' VAL . 5.9 mt -53.33 -47.68 69.12 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-O 121.215 0.531 . . . . 15.0 109.851 -179.853 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.4 ' HB2' ' O ' ' A' ' 75' ' ' VAL . 0.0 OUTLIER -68.49 -59.09 3.41 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.423 -0.808 . . . . 15.0 110.551 179.403 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -66.15 59.71 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.947 -0.57 . . . . 15.0 112.411 -179.903 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.669 HG22 ' OD1' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -95.63 -71.51 0.67 Allowed 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 110.006 -0.368 . . . . 15.0 110.006 178.917 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 121.97 -105.39 0.98 Allowed Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.833 -0.699 . . . . 15.0 113.157 179.118 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.75 -81.62 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 112.151 0.426 . . . . 15.0 112.151 -179.06 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.45 HG12 ' N ' ' A' ' 85' ' ' VAL . 72.2 t -109.97 159.1 9.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.136 0.493 . . . . 15.0 111.21 -179.136 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.678 ' O ' HG12 ' A' ' 85' ' ' VAL . 6.8 t -97.82 81.56 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.909 -0.587 . . . . 15.0 110.553 179.935 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -100.45 84.34 2.76 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.729 -0.668 . . . . 15.0 110.419 179.786 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.642 ' HB3' HD21 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -103.55 118.62 37.15 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.985 -0.552 . . . . 15.0 111.916 -179.102 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.795 HD12 ' HB2' ' A' ' 8' ' ' GLU . 3.8 mp -92.01 103.65 16.14 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.17 -0.678 . . . . 15.0 109.17 178.445 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.968 HD12 ' CE1' ' A' ' 7' ' ' PHE . 0.1 OUTLIER -105.61 -164.91 1.06 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.615 0.721 . . . . 15.0 112.352 -178.035 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.514 ' HA ' ' HA ' ' A' ' 6' ' ' ILE . 0.7 OUTLIER -144.93 135.86 24.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 114.626 -1.17 . . . . 15.0 109.487 179.146 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -46.81 98.65 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.942 0.401 . . . . 15.0 111.253 -179.497 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -61.99 -165.01 0.38 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.869 -0.681 . . . . 15.0 112.641 -179.83 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 12.0 mt-30 -76.43 134.88 39.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.829 0.347 . . . . 15.0 110.945 -179.961 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -90.18 111.59 47.75 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 15.0 110.887 179.933 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -55.25 129.64 36.32 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.441 2.094 . . . . 15.0 112.278 -179.981 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 11.7 t . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.234 -0.889 . . . . 15.0 110.856 -179.989 . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo . . . . . 0 N--CA 1.487 1.142 0 CA-C-O 120.799 0.25 . . . . 15.0 111.666 . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.11 91.98 5.4 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 15.0 110.897 -179.973 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_exo -56.4 -163.04 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.573 2.182 . . . . 15.0 112.218 -179.944 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 87.68 -19.98 30.14 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.591 -0.814 . . . . 15.0 112.339 -179.712 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -62.16 154.04 28.44 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.169 0.509 . . . . 15.0 110.844 179.855 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.525 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 1.2 mp -104.35 141.34 20.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.496 -0.775 . . . . 15.0 111.129 -179.376 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.637 ' CE1' HD12 ' A' ' 89' ' ' LEU . 2.3 p90 -140.44 153.79 46.41 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.234 -0.439 . . . . 15.0 110.557 178.949 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.605 ' CB ' HD12 ' A' ' 88' ' ' LEU . 13.3 pt-20 -119.86 143.12 48.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.29 0.567 . . . . 15.0 111.748 -179.164 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.544 HG23 ' HB3' ' A' ' 51' ' ' ARG . 0.2 OUTLIER -101.67 117.79 47.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.277 -0.874 . . . . 15.0 109.72 178.817 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 51.5 tt0 -106.2 73.38 0.98 Allowed 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.094 0.405 . . . . 15.0 112.094 -179.165 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.532 HD11 ' CB ' ' A' ' 49' ' ' ASP . 9.5 tp -88.43 160.69 17.43 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.245 -0.434 . . . . 15.0 109.975 178.9 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.518 ' C ' ' H ' ' A' ' 14' ' ' ASN . . . -97.0 94.69 7.32 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 111.853 0.316 . . . . 15.0 111.853 -179.615 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.896 ' HB2' HG23 ' A' ' 85' ' ' VAL . 0.5 OUTLIER -65.74 27.56 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 112.522 0.564 . . . . 15.0 112.522 179.476 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.518 ' H ' ' C ' ' A' ' 12' ' ' ALA . 33.3 m-20 -115.41 126.51 54.46 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.944 0.402 . . . . 15.0 111.569 -179.45 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.3 t70 75.85 -1.89 2.88 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.989 -0.55 . . . . 15.0 112.107 179.381 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.412 ' HB2' ' HB2' ' A' ' 45' ' ' ALA . 8.0 p30 -165.52 138.96 4.49 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.943 0.401 . . . . 15.0 111.281 179.993 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.832 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 0.8 OUTLIER -88.04 -151.79 0.2 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.953 -0.567 . . . . 15.0 110.345 179.569 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -91.83 -170.69 2.64 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 121.066 0.46 . . . . 15.0 110.865 179.716 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.614 ' O ' ' HB ' ' A' ' 41' ' ' ILE . . . -161.0 33.68 0.39 Allowed Glycine 0 C--O 1.223 -0.55 0 N-CA-C 110.84 -0.904 . . . . 15.0 110.84 -179.815 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.662 HG13 HG12 ' A' ' 40' ' ' VAL . 0.0 OUTLIER -114.0 139.94 37.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 112.445 0.535 . . . . 15.0 112.445 -179.217 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.668 ' CB ' HD11 ' A' ' 41' ' ' ILE . 4.3 t -96.17 105.47 17.53 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 107.882 -1.155 . . . . 15.0 107.882 176.492 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 1.02 HG21 HG23 ' A' ' 75' ' ' VAL . 6.8 m -93.69 154.91 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 N-CA-C 113.28 0.844 . . . . 15.0 113.28 -176.952 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.52 -178.74 6.6 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.191 -0.913 . . . . 15.0 111.032 179.852 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.538 ' O ' HG22 ' A' ' 26' ' ' VAL . . . 69.04 -119.07 9.29 Favored Glycine 0 C--N 1.333 0.364 0 C-N-CA 120.968 -0.634 . . . . 15.0 112.531 179.719 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.559 ' HA3' ' N ' ' A' ' 71' ' ' HIS . . . 68.11 -65.79 0.36 Allowed Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.919 -0.658 . . . . 15.0 113.615 179.339 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.538 HG22 ' O ' ' A' ' 24' ' ' GLY . 0.0 OUTLIER -27.36 139.29 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 N-CA-C 112.209 0.448 . . . . 15.0 112.209 -179.337 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 7.8 p-10 -75.22 61.99 1.2 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.08 -0.509 . . . . 15.0 111.006 -179.59 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.5 m -151.75 -59.68 0.16 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.274 -0.421 . . . . 15.0 111.055 179.957 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 91.4 p -74.86 -47.65 29.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.118 -0.492 . . . . 15.0 111.168 -179.779 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.517 HG22 ' O ' ' A' ' 26' ' ' VAL . 35.1 m -70.12 -174.14 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.328 -0.396 . . . . 15.0 111.154 -179.89 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 6.8 mmp_? -54.5 -59.1 5.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.227 -0.442 . . . . 15.0 111.217 -179.792 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 1.7 p-80 -149.92 -44.83 0.13 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.44 -0.346 . . . . 15.0 111.325 -179.782 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.402 ' O ' ' O ' ' A' ' 69' ' ' ALA . . . -167.53 24.45 0.12 Allowed Glycine 0 CA--C 1.517 0.179 0 C-N-CA 120.605 -0.807 . . . . 15.0 112.894 -179.689 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -91.92 154.04 22.28 Favored Glycine 0 N--CA 1.45 -0.406 0 N-CA-C 110.074 -1.21 . . . . 15.0 110.074 178.341 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 1.053 HG22 HG22 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -101.39 147.13 8.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 118.184 0.992 . . . . 15.0 111.767 -179.249 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.769 ' N ' HD13 ' A' ' 35' ' ' ILE . 15.9 m-85 -130.94 109.2 10.36 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-N 115.307 -0.861 . . . . 15.0 109.539 -179.634 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.763 HG22 ' N ' ' A' ' 55' ' ' GLY . 0.7 OUTLIER -55.46 167.11 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.916 -0.583 . . . . 15.0 110.739 -179.27 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.42 -48.14 4.66 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.059 -0.719 . . . . 15.0 109.059 178.77 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.58 ' O ' HG12 ' A' ' 20' ' ' ILE . . . -171.5 169.18 6.22 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.269 -0.878 . . . . 15.0 110.463 179.341 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.662 HG12 HG13 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -97.24 123.57 49.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.727 0.298 . . . . 15.0 110.838 -179.908 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.716 ' O ' ' HB3' ' A' ' 47' ' ' GLU . 1.7 mm -78.68 108.14 7.37 Favored Pre-proline 0 N--CA 1.468 0.443 0 N-CA-C 113.199 0.815 . . . . 15.0 113.199 -178.651 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.458 ' HD3' ' O ' ' A' ' 40' ' ' VAL . 25.8 Cg_exo -62.35 72.52 0.11 Allowed 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 122.99 2.46 . . . . 15.0 112.264 179.341 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.422 ' N ' ' O ' ' A' ' 41' ' ' ILE . 0.6 OUTLIER -174.32 -41.66 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.687 -0.688 . . . . 15.0 110.245 179.926 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.595 ' HA3' ' HA3' ' A' ' 19' ' ' GLY . . . -87.3 150.63 22.85 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.651 -0.785 . . . . 15.0 112.409 179.613 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.832 ' HB3' ' O ' ' A' ' 17' ' ' SER . . . -39.5 -22.73 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 113.191 0.811 . . . . 15.0 113.191 -179.369 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.427 ' N ' ' O ' ' A' ' 44' ' ' GLY . . . -71.82 -70.2 0.34 Allowed 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.937 -0.305 . . . . 15.0 111.294 -179.625 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.716 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 4.3 tp10 -58.03 -38.94 77.17 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.904 0.383 . . . . 15.0 110.657 179.653 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -53.82 -60.6 3.11 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.092 -0.504 . . . . 15.0 110.358 179.867 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.532 ' CB ' HD11 ' A' ' 11' ' ' LEU . 0.7 OUTLIER -66.71 -38.73 87.32 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.142 -0.481 . . . . 15.0 109.982 179.07 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.48 41.05 10.3 Favored Glycine 0 N--CA 1.449 -0.486 0 CA-C-N 115.699 -0.682 . . . . 15.0 112.486 179.664 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.544 ' HB3' HG23 ' A' ' 9' ' ' VAL . 5.3 mmp_? -86.3 -55.91 3.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.906 0.384 . . . . 15.0 110.74 179.858 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.564 ' CG1' HD12 ' A' ' 20' ' ' ILE . 9.0 tp -81.12 160.63 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 CA-C-N 116.037 -0.529 . . . . 15.0 110.71 179.808 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 53' ' ' HIS . . . . . 0.462 ' O ' ' HB2' ' A' ' 56' ' ' ASP . 62.2 m80 -141.17 160.54 39.88 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-O 121.73 0.776 . . . . 15.0 112.575 -179.077 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.625 ' HA ' ' CG2' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -45.77 137.45 5.44 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.398 -1.274 . . . . 15.0 112.497 -178.671 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.763 ' N ' HG22 ' A' ' 37' ' ' VAL . . . 49.73 32.7 17.88 Favored Glycine 0 C--N 1.334 0.452 0 CA-C-N 115.874 -0.603 . . . . 15.0 113.467 179.676 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.475 ' CB ' HD11 ' A' ' 52' ' ' ILE . 0.3 OUTLIER -66.06 127.59 32.72 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.314 -0.554 . . . . 15.0 110.205 179.09 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.538 ' HE ' HD21 ' A' ' 59' ' ' LEU . 5.8 ttt180 -83.17 83.32 7.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.277 -0.42 . . . . 15.0 110.097 179.713 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 1.053 HG22 HG22 ' A' ' 35' ' ' ILE . 1.0 OUTLIER -79.47 123.6 36.59 Favored 'Isoleucine or valine' 0 C--O 1.241 0.646 0 CA-C-O 121.089 0.471 . . . . 15.0 111.329 -179.259 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.581 HD12 ' HG2' ' A' ' 67' ' ' GLU . 3.4 mm? -107.62 -18.78 13.75 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.189 -0.914 . . . . 15.0 112.491 -179.461 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.482 ' O ' HD23 ' A' ' 87' ' ' LEU . . . -147.87 149.1 31.64 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 112.799 0.666 . . . . 15.0 112.799 -178.35 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.796 HG11 ' O ' ' A' ' 77' ' ' THR . 43.7 t -139.33 100.6 1.4 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.225 0 CA-C-N 115.297 -0.865 . . . . 15.0 109.281 178.596 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.672 ' OD1' HG22 ' A' ' 81' ' ' THR . 2.4 m120 65.46 15.9 10.25 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.135 -0.484 . . . . 15.0 109.833 -178.149 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 106.79 5.47 35.89 Favored Glycine 0 C--N 1.336 0.559 0 CA-C-N 115.868 -0.605 . . . . 15.0 113.321 179.615 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.646 HG13 ' O ' ' A' ' 64' ' ' VAL . 5.4 p -93.8 106.17 17.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.092 0.473 . . . . 15.0 110.713 179.405 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -57.66 127.84 34.03 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.159 -0.473 . . . . 15.0 111.147 -179.472 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.568 HD13 ' HB3' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -88.87 -23.96 22.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.986 -0.552 . . . . 15.0 110.741 179.81 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.581 ' HG2' HD12 ' A' ' 59' ' ' LEU . 4.4 mm-40 -45.25 97.16 0.01 OUTLIER 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 116.374 -0.375 . . . . 15.0 110.928 179.863 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.79 62.6 0.54 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.791 -0.718 . . . . 15.0 112.073 -179.544 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.651 ' HB1' ' CB ' ' A' ' 73' ' ' GLN . . . -172.93 146.22 1.51 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.897 0.379 . . . . 15.0 110.86 -179.789 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.42 ' CB ' ' HA ' ' A' ' 26' ' ' VAL . 6.8 p -72.81 -171.85 0.92 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.072 0.463 . . . . 15.0 111.304 -179.62 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.642 ' NE2' HG23 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -65.39 -58.47 5.81 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.753 -0.658 . . . . 15.0 110.724 -179.91 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.413 ' HA ' ' HB ' ' A' ' 75' ' ' VAL . 15.6 ttpp -52.52 -31.46 35.54 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.018 -0.537 . . . . 15.0 110.52 179.725 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.651 ' CB ' ' HB1' ' A' ' 69' ' ' ALA . 4.1 mt-30 -59.59 -49.03 79.34 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.651 -0.5 . . . . 15.0 109.651 179.239 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.558 ' HA ' HD21 ' A' ' 66' ' ' LEU . . . -67.2 -45.16 77.72 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 109.495 -0.557 . . . . 15.0 109.495 178.404 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 1.02 HG23 HG21 ' A' ' 22' ' ' VAL . 0.5 OUTLIER -43.06 -41.92 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.272 0 N-CA-C 108.888 -0.782 . . . . 15.0 108.888 178.305 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.503 ' O ' ' HB2' ' A' ' 80' ' ' ASN . 1.6 mt-10 -67.17 -44.59 79.33 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 114.861 -1.063 . . . . 15.0 110.073 178.212 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.796 ' O ' HG11 ' A' ' 61' ' ' VAL . 68.7 p -64.08 -54.4 34.67 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-N 116.566 -0.288 . . . . 15.0 111.577 179.93 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.585 HD21 HG21 ' A' ' 58' ' ' VAL . 8.6 mt -53.56 -47.02 70.44 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.351 0.596 . . . . 15.0 109.903 179.855 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.427 ' HB2' ' O ' ' A' ' 75' ' ' VAL . 0.1 OUTLIER -68.44 -59.49 3.13 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.194 -0.912 . . . . 15.0 110.837 179.728 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.503 ' HB2' ' O ' ' A' ' 76' ' ' GLU . 12.0 m-80 -66.09 61.06 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.161 -0.472 . . . . 15.0 112.131 -179.859 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.672 HG22 ' OD1' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -95.7 -71.46 0.67 Allowed 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 110.0 -0.37 . . . . 15.0 110.0 179.02 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 116.85 -102.02 1.0 Allowed Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.838 -0.696 . . . . 15.0 112.979 179.055 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.81 -87.51 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.632 0.253 . . . . 15.0 111.437 -179.456 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.494 HG12 ' N ' ' A' ' 85' ' ' VAL . 84.1 t -109.85 160.69 8.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.951 0.405 . . . . 15.0 110.873 -179.816 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.896 HG23 ' HB2' ' A' ' 13' ' ' LYS . 3.3 t -97.71 81.43 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 121.258 0.551 . . . . 15.0 110.143 179.804 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -96.03 81.32 3.37 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.668 -0.697 . . . . 15.0 110.107 179.827 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.618 ' HB3' HD21 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -103.21 124.38 48.51 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.963 -0.562 . . . . 15.0 111.891 -178.947 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.661 ' N ' HD13 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -102.34 101.98 12.29 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.371 -0.603 . . . . 15.0 109.371 178.548 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.637 HD12 ' CE1' ' A' ' 7' ' ' PHE . 0.1 OUTLIER -105.65 -163.57 0.95 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.553 0.692 . . . . 15.0 112.09 -178.581 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.525 ' HA ' ' HA ' ' A' ' 6' ' ' ILE . 0.9 OUTLIER -138.79 134.87 34.01 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.731 -1.122 . . . . 15.0 109.433 178.845 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.87 105.15 0.06 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.857 0.36 . . . . 15.0 111.379 -179.219 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -63.0 144.36 49.44 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.777 -0.725 . . . . 15.0 112.581 -179.912 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -84.06 146.48 27.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.802 0.334 . . . . 15.0 110.91 179.972 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -83.31 143.83 45.63 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.234 -0.439 . . . . 15.0 110.89 -179.947 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -53.24 -48.02 24.32 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.554 2.169 . . . . 15.0 112.301 179.987 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 3.1 m . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.246 -0.883 . . . . 15.0 110.891 -179.943 . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_endo . . . . . 0 N--CA 1.488 1.168 0 CA-C-O 120.806 0.253 . . . . 15.0 111.868 . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.461 ' HB2' ' HD3' ' A' ' 3' ' ' PRO . 0.0 OUTLIER -147.41 -66.48 0.02 OUTLIER Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.227 -0.442 . . . . 15.0 110.991 179.809 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.461 ' HD3' ' HB2' ' A' ' 2' ' ' LYS . 72.2 Cg_endo -76.34 -169.14 0.65 Allowed 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.19 1.927 . . . . 15.0 112.371 179.908 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 83.15 -14.27 40.05 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.676 -0.773 . . . . 15.0 112.409 -179.764 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -72.36 134.24 45.36 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.31 0.576 . . . . 15.0 110.932 179.962 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.438 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 1.1 mp -81.96 147.3 6.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.217 -0.901 . . . . 15.0 111.0 -179.728 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.812 ' CZ ' HD12 ' A' ' 89' ' ' LEU . 4.0 p90 -140.65 157.71 45.05 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.191 -0.459 . . . . 15.0 110.58 179.087 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.723 ' HB2' HD12 ' A' ' 88' ' ' LEU . 11.3 pt-20 -124.71 141.83 51.83 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.226 0.536 . . . . 15.0 111.362 -179.557 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.566 HG23 ' HB3' ' A' ' 51' ' ' ARG . 0.2 OUTLIER -101.56 117.98 47.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.38 -0.827 . . . . 15.0 109.771 178.984 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -106.22 75.47 1.09 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.29 -0.414 . . . . 15.0 112.115 -179.064 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.566 ' HB3' ' HB ' ' A' ' 85' ' ' VAL . 11.4 tp -88.45 159.98 17.74 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.615 -0.513 . . . . 15.0 109.615 178.728 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.512 ' C ' ' H ' ' A' ' 14' ' ' ASN . . . -96.9 94.26 7.12 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 112.043 0.386 . . . . 15.0 112.043 -179.393 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.91 ' HB2' HG23 ' A' ' 85' ' ' VAL . 0.6 OUTLIER -65.82 29.21 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 112.435 0.531 . . . . 15.0 112.435 179.312 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.512 ' H ' ' C ' ' A' ' 12' ' ' ALA . 37.9 t30 -110.45 123.89 50.74 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.951 0.405 . . . . 15.0 111.68 -179.346 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.5 t0 64.78 11.24 6.71 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.864 -0.607 . . . . 15.0 112.039 179.333 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.456 ' ND2' ' O ' ' A' ' 12' ' ' ALA . 0.6 OUTLIER -165.63 133.05 2.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.969 0.414 . . . . 15.0 111.323 179.78 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.752 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 0.4 OUTLIER -89.78 -162.57 0.9 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.899 -0.592 . . . . 15.0 110.386 179.503 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.595 ' N ' HD22 ' A' ' 18' ' ' LEU . 2.2 mm? -81.99 -169.97 2.64 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 121.109 0.48 . . . . 15.0 110.722 179.476 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.596 ' O ' ' HB ' ' A' ' 41' ' ' ILE . . . -162.96 33.4 0.3 Allowed Glycine 0 C--O 1.223 -0.572 0 N-CA-C 110.83 -0.908 . . . . 15.0 110.83 -179.766 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.663 HD13 ' HB ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -113.87 143.26 23.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 112.243 0.46 . . . . 15.0 112.243 -179.159 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.742 ' CB ' HD11 ' A' ' 41' ' ' ILE . 1.7 t -96.41 103.45 15.36 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 107.745 -1.206 . . . . 15.0 107.745 176.676 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 1.028 HG21 HG23 ' A' ' 75' ' ' VAL . 29.6 m -93.5 149.82 4.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.368 0.604 . . . . 15.0 112.612 -177.367 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -149.51 -178.46 6.44 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.167 -0.924 . . . . 15.0 110.949 -179.411 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.556 ' O ' HG22 ' A' ' 26' ' ' VAL . . . 69.52 -117.64 7.86 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 120.802 -0.713 . . . . 15.0 112.251 -179.973 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.51 ' HA3' ' N ' ' A' ' 71' ' ' HIS . . . 67.2 -64.25 0.23 Allowed Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.904 -0.665 . . . . 15.0 113.668 179.362 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.556 HG22 ' O ' ' A' ' 24' ' ' GLY . 0.0 OUTLIER -28.99 137.51 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 N-CA-C 112.459 0.54 . . . . 15.0 112.459 -179.255 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 11.5 m-80 -75.56 61.3 1.3 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.802 -0.635 . . . . 15.0 111.016 -179.729 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -151.74 -53.76 0.13 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.341 -0.39 . . . . 15.0 111.074 179.971 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.6 m -81.92 -45.64 15.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.155 -0.475 . . . . 15.0 111.133 -179.812 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.555 HG22 ' O ' ' A' ' 26' ' ' VAL . 34.8 m -72.15 -175.23 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.22 -0.445 . . . . 15.0 111.271 -179.838 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.5 -60.55 3.16 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.204 -0.453 . . . . 15.0 111.202 -179.942 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 5.4 p-80 -146.62 -46.81 0.19 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.357 -0.383 . . . . 15.0 111.235 -179.847 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -169.2 25.81 0.11 Allowed Glycine 0 N--CA 1.453 -0.2 0 C-N-CA 120.749 -0.738 . . . . 15.0 112.686 -179.73 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -94.28 153.41 21.05 Favored Glycine 0 N--CA 1.449 -0.47 0 N-CA-C 110.629 -0.989 . . . . 15.0 110.629 178.838 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.952 HG22 HG22 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -94.18 152.77 3.52 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.321 0 CA-C-N 117.727 0.764 . . . . 15.0 112.073 -179.252 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.51 ' CZ ' ' HG2' ' A' ' 57' ' ' ARG . 44.5 m-85 -136.04 106.29 6.39 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.84 -1.073 . . . . 15.0 109.613 178.849 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.817 HG22 ' N ' ' A' ' 55' ' ' GLY . 0.6 OUTLIER -55.22 145.74 5.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.911 -0.586 . . . . 15.0 111.491 -178.846 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.458 ' O ' ' HG2' ' A' ' 54' ' ' LYS . 1.2 ttpt -81.91 -47.45 12.74 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.342 -0.984 . . . . 15.0 108.342 178.213 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.545 ' O ' HG12 ' A' ' 20' ' ' ILE . . . -172.2 169.79 5.35 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.625 -0.716 . . . . 15.0 111.366 178.679 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.577 HG12 HG13 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -97.5 121.04 47.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-N 116.254 -0.43 . . . . 15.0 111.131 -179.871 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.742 HD11 ' CB ' ' A' ' 21' ' ' SER . 1.5 mm -78.98 110.33 14.16 Favored Pre-proline 0 N--CA 1.466 0.368 0 N-CA-C 113.135 0.791 . . . . 15.0 113.135 -178.919 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.524 ' HA ' ' OE1' ' A' ' 47' ' ' GLU . 17.8 Cg_exo -65.8 63.68 0.42 Allowed 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 122.858 2.372 . . . . 15.0 112.213 179.243 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 1.9 mm-40 -159.48 -45.81 0.05 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.654 -0.703 . . . . 15.0 109.85 179.873 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.513 ' HA3' ' HA3' ' A' ' 19' ' ' GLY . . . -87.42 151.51 23.47 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.68 -0.772 . . . . 15.0 112.374 179.518 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.752 ' HB3' ' O ' ' A' ' 17' ' ' SER . . . -39.96 -19.58 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 113.494 0.924 . . . . 15.0 113.494 -179.326 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.448 ' N ' ' O ' ' A' ' 44' ' ' GLY . . . -71.72 -70.95 0.29 Allowed 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.829 -0.348 . . . . 15.0 111.426 -179.453 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.592 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 9.9 tm-20 -58.2 -38.25 76.37 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.823 0.344 . . . . 15.0 110.336 179.599 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.3 m -53.9 -64.97 0.66 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.164 -0.471 . . . . 15.0 110.449 179.821 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.491 ' CB ' HD11 ' A' ' 11' ' ' LEU . 0.4 OUTLIER -63.21 -37.51 87.54 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.151 -0.477 . . . . 15.0 109.979 179.112 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.49 37.46 17.31 Favored Glycine 0 N--CA 1.449 -0.439 0 CA-C-N 115.726 -0.67 . . . . 15.0 112.377 179.695 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.566 ' HB3' HG23 ' A' ' 9' ' ' VAL . 0.9 OUTLIER -82.8 -54.65 4.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.938 0.399 . . . . 15.0 110.543 179.91 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.656 HG12 HD12 ' A' ' 20' ' ' ILE . 11.4 tp -81.18 159.07 4.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.979 -0.555 . . . . 15.0 110.177 179.458 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 53' ' ' HIS . . . . . 0.4 ' N ' ' OD2' ' A' ' 56' ' ' ASP . 76.1 m80 -142.16 160.67 39.76 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 121.766 0.793 . . . . 15.0 112.813 -178.784 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.585 ' HA ' ' CG2' ' A' ' 37' ' ' VAL . 1.2 mtpt -44.01 134.73 4.53 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 113.93 -1.486 . . . . 15.0 112.762 -178.788 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.817 ' N ' HG22 ' A' ' 37' ' ' VAL . . . 49.75 29.82 13.54 Favored Glycine 0 C--N 1.334 0.428 0 CA-C-N 115.791 -0.64 . . . . 15.0 113.448 179.261 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.4 ' OD2' ' N ' ' A' ' 53' ' ' HIS . 6.2 m-20 -65.78 128.75 37.26 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.761 -0.376 . . . . 15.0 110.413 179.359 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.612 ' HD2' HD21 ' A' ' 59' ' ' LEU . 0.0 OUTLIER -82.08 93.49 7.02 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.362 -0.381 . . . . 15.0 110.54 -179.988 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.952 HG22 HG22 ' A' ' 35' ' ' ILE . 1.2 m -86.26 115.7 27.86 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 CA-C-O 121.112 0.482 . . . . 15.0 111.586 -179.32 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.612 HD21 ' HD2' ' A' ' 57' ' ' ARG . 4.5 mm? -107.68 -14.67 14.76 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 115.633 -0.712 . . . . 15.0 112.542 -179.496 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.587 ' HB3' ' HB2' ' A' ' 88' ' ' LEU . . . -147.56 150.33 34.27 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 112.743 0.646 . . . . 15.0 112.743 -178.394 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.9 HG11 ' O ' ' A' ' 77' ' ' THR . 98.2 t -139.21 103.01 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.202 -0.908 . . . . 15.0 109.066 178.808 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.547 ' OD1' HG22 ' A' ' 81' ' ' THR . 2.1 m120 65.23 16.9 10.79 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.516 -0.55 . . . . 15.0 109.516 -178.038 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.0 6.97 44.98 Favored Glycine 0 C--N 1.335 0.49 0 CA-C-N 115.789 -0.641 . . . . 15.0 113.135 179.814 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.658 HG13 ' O ' ' A' ' 64' ' ' VAL . 6.0 p -93.86 106.56 18.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.062 0.458 . . . . 15.0 110.724 179.394 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -58.3 122.98 14.56 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.179 -0.464 . . . . 15.0 110.955 -179.488 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.493 HD11 ' OG1' ' A' ' 77' ' ' THR . 3.7 mt -94.38 -12.53 27.73 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.836 -0.62 . . . . 15.0 111.286 -179.92 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -44.65 98.05 0.01 OUTLIER 'General case' 0 N--CA 1.461 0.1 0 CA-C-O 120.865 0.364 . . . . 15.0 110.894 179.855 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.85 67.53 0.6 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.838 -0.696 . . . . 15.0 112.102 -179.46 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.614 ' HB1' ' CB ' ' A' ' 73' ' ' GLN . . . -172.91 148.16 1.76 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.78 0.324 . . . . 15.0 110.837 -179.683 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.468 ' HB ' ' HA ' ' A' ' 26' ' ' VAL . 1.4 p -72.86 -174.2 1.41 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.019 0.438 . . . . 15.0 111.041 -179.731 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.736 ' CE1' HG23 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -63.51 -59.03 5.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.885 -0.598 . . . . 15.0 110.658 -179.822 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.413 ' HA ' ' HB ' ' A' ' 75' ' ' VAL . 18.1 ttpp -52.44 -33.19 43.09 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.987 -0.551 . . . . 15.0 110.75 179.669 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.614 ' CB ' ' HB1' ' A' ' 69' ' ' ALA . 3.0 mt-30 -59.57 -49.98 75.65 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.428 -0.582 . . . . 15.0 109.428 179.123 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.458 ' HA ' ' OG1' ' A' ' 77' ' ' THR . . . -67.05 -45.93 75.93 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.743 -0.662 . . . . 15.0 109.836 178.482 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 1.028 HG23 HG21 ' A' ' 22' ' ' VAL . 0.5 OUTLIER -41.87 -41.49 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.27 0 CA-C-O 121.524 0.678 . . . . 15.0 109.218 178.553 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -67.33 -44.93 77.88 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.762 -1.108 . . . . 15.0 110.681 178.941 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.9 ' O ' HG11 ' A' ' 61' ' ' VAL . 15.3 p -64.38 -54.9 25.61 Favored 'General case' 0 N--CA 1.463 0.184 0 C-N-CA 121.028 -0.269 . . . . 15.0 111.599 -179.96 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.739 HD23 HG21 ' A' ' 61' ' ' VAL . 6.5 mt -53.43 -47.79 69.32 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-O 121.122 0.487 . . . . 15.0 110.188 -179.752 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.424 ' HB2' ' O ' ' A' ' 75' ' ' VAL . 3.1 ttp180 -68.32 -57.48 5.87 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.554 -0.748 . . . . 15.0 110.479 179.521 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -66.11 61.69 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.016 -0.538 . . . . 15.0 111.906 179.859 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.547 HG22 ' OD1' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -95.57 -74.97 0.54 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.719 0.295 . . . . 15.0 110.234 179.236 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.401 ' O ' ' HG3' ' A' ' 13' ' ' LYS . . . 120.36 -102.33 0.86 Allowed Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.775 -0.726 . . . . 15.0 112.88 179.381 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -64.7 -86.02 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.609 0.242 . . . . 15.0 111.209 -179.627 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.491 HG12 ' N ' ' A' ' 85' ' ' VAL . 86.8 t -109.77 160.36 8.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.886 0.374 . . . . 15.0 110.778 -179.924 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.91 HG23 ' HB2' ' A' ' 13' ' ' LYS . 3.1 t -97.66 81.86 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.214 0.53 . . . . 15.0 110.195 179.868 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -96.08 82.29 3.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.687 -0.688 . . . . 15.0 110.344 179.895 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.756 ' HB3' HD21 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -101.95 121.83 42.89 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.933 -0.576 . . . . 15.0 111.719 -179.281 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.723 HD12 ' HB2' ' A' ' 8' ' ' GLU . 4.7 mp -99.4 100.76 11.86 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.521 -0.548 . . . . 15.0 109.521 178.745 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.812 HD12 ' CZ ' ' A' ' 7' ' ' PHE . 0.1 OUTLIER -105.52 -161.52 0.81 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.456 0.646 . . . . 15.0 112.031 -178.501 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.438 ' HA ' ' HA ' ' A' ' 6' ' ' ILE . 1.1 tt0 -138.88 142.58 38.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 114.862 -1.063 . . . . 15.0 109.629 178.969 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 2.5 tppp? -54.48 106.04 0.18 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.978 0.418 . . . . 15.0 111.242 -179.421 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -72.32 66.55 1.25 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.971 -0.633 . . . . 15.0 112.438 179.914 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -76.35 122.69 24.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.876 0.369 . . . . 15.0 110.976 -179.935 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.7 m -78.56 163.45 61.23 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.164 -0.471 . . . . 15.0 110.904 179.941 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -53.46 -62.44 0.33 Allowed 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.601 2.201 . . . . 15.0 112.297 -179.97 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 3.1 m . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.261 -0.876 . . . . 15.0 110.934 179.972 . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_endo . . . . . 0 N--CA 1.488 1.199 0 CA-C-O 120.922 0.301 . . . . 15.0 111.81 . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.17 149.3 19.32 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.087 -0.506 . . . . 15.0 110.803 179.946 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -55.09 -168.18 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.438 2.092 . . . . 15.0 112.31 -179.975 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 83.27 -14.02 42.14 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.583 -0.818 . . . . 15.0 112.332 -179.616 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -69.4 155.94 39.64 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-O 121.268 0.556 . . . . 15.0 110.867 179.884 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.443 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 1.4 mp -104.32 143.85 15.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.257 -0.883 . . . . 15.0 111.034 -179.441 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.519 ' CE1' HD12 ' A' ' 89' ' ' LEU . 4.8 p90 -140.45 166.81 23.71 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.182 -0.463 . . . . 15.0 110.37 178.871 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.725 ' HB3' HD12 ' A' ' 88' ' ' LEU . 4.2 pt-20 -130.22 142.87 50.53 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.269 0.557 . . . . 15.0 111.88 -179.21 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.676 ' CG1' HD11 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -101.38 115.93 44.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.237 -0.892 . . . . 15.0 109.332 178.805 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.406 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 4.1 tt0 -105.96 76.37 1.17 Allowed 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 112.696 0.628 . . . . 15.0 112.696 -178.394 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.512 ' HB3' ' HB ' ' A' ' 85' ' ' VAL . 6.9 tp -88.16 162.03 16.93 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.018 -0.734 . . . . 15.0 109.018 177.995 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.441 ' O ' ' N ' ' A' ' 14' ' ' ASN . . . -96.92 89.98 5.05 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 112.431 0.53 . . . . 15.0 112.431 -179.185 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.689 ' HB2' HG23 ' A' ' 85' ' ' VAL . 0.1 OUTLIER -65.58 54.67 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.033 -0.531 . . . . 15.0 111.552 178.9 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.441 ' N ' ' O ' ' A' ' 12' ' ' ALA . 42.6 t-20 -108.98 -87.53 0.5 Allowed 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 111.734 0.272 . . . . 15.0 111.734 -179.347 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -101.35 24.29 9.79 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.666 0.27 . . . . 15.0 111.373 -179.462 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.491 ' HB2' ' HB2' ' A' ' 45' ' ' ALA . 1.0 OUTLIER -165.41 128.86 2.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.95 0.405 . . . . 15.0 111.113 179.897 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.802 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 0.0 OUTLIER -89.73 -162.63 0.9 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.928 -0.578 . . . . 15.0 110.545 179.615 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.587 ' N ' HD22 ' A' ' 18' ' ' LEU . 2.4 mm? -80.15 -166.43 1.04 Allowed 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 116.359 -0.382 . . . . 15.0 110.457 179.595 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.663 ' O ' ' HB ' ' A' ' 41' ' ' ILE . . . -167.51 37.1 0.22 Allowed Glycine 0 CA--C 1.506 -0.52 0 N-CA-C 111.566 -0.614 . . . . 15.0 111.566 -179.609 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.681 HD13 ' HB ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -112.5 142.28 25.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 112.216 0.45 . . . . 15.0 112.216 -179.04 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.435 ' H ' HD13 ' A' ' 41' ' ' ILE . 30.9 t -95.46 101.66 13.4 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 107.079 -1.452 . . . . 15.0 107.079 176.657 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.965 HG21 HG23 ' A' ' 75' ' ' VAL . 35.5 m -93.26 156.7 3.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 113.236 0.828 . . . . 15.0 113.236 -176.364 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.25 -175.03 4.82 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 114.966 -1.016 . . . . 15.0 110.647 -179.694 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.553 ' O ' HG22 ' A' ' 26' ' ' VAL . . . 68.79 -121.38 12.15 Favored Glycine 0 C--N 1.332 0.32 0 C-N-CA 120.868 -0.682 . . . . 15.0 112.469 179.8 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.521 ' HA3' ' N ' ' A' ' 71' ' ' HIS . . . 66.76 -64.42 0.18 Allowed Glycine 0 CA--C 1.518 0.269 0 C-N-CA 120.997 -0.621 . . . . 15.0 113.679 179.285 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.553 HG22 ' O ' ' A' ' 24' ' ' GLY . 0.0 OUTLIER -30.46 146.97 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 N-CA-C 112.591 0.589 . . . . 15.0 112.591 -179.204 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -75.75 56.31 0.92 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.872 -0.604 . . . . 15.0 111.066 -179.946 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.3 m -151.96 -63.61 0.17 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.914 0.388 . . . . 15.0 111.202 -179.986 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 30.9 t -67.07 -50.43 61.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.046 -0.524 . . . . 15.0 111.325 -179.575 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.532 HG11 ' O ' ' A' ' 34' ' ' GLY . 19.6 m -69.45 -175.94 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.378 -0.374 . . . . 15.0 111.415 -179.644 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.405 ' HD3' ' NH2' ' A' ' 57' ' ' ARG . 46.2 mtp85 -62.4 -53.06 60.53 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.162 -0.472 . . . . 15.0 111.089 -179.859 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 32' ' ' HIS . . . . . 0.418 ' CD2' ' HG2' ' A' ' 67' ' ' GLU . 42.1 p-80 -142.24 -52.79 0.41 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.449 -0.341 . . . . 15.0 111.201 179.939 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -169.18 19.01 0.08 OUTLIER Glycine 0 CA--C 1.519 0.328 0 C-N-CA 120.522 -0.847 . . . . 15.0 113.097 -179.802 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.532 ' O ' HG11 ' A' ' 30' ' ' VAL . . . -85.27 152.92 27.21 Favored Glycine 0 N--CA 1.45 -0.401 0 N-CA-C 110.797 -0.921 . . . . 15.0 110.797 178.89 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.944 HG22 HG22 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -90.54 154.97 3.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 117.642 0.721 . . . . 15.0 111.851 -179.352 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 30.4 m-85 -141.8 107.34 5.06 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.028 -0.987 . . . . 15.0 109.737 178.918 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.776 HG22 ' N ' ' A' ' 55' ' ' GLY . 0.8 OUTLIER -55.3 150.83 2.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.035 -0.53 . . . . 15.0 111.315 -178.9 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.496 ' O ' ' HG2' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -82.37 -47.04 12.78 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.416 -0.957 . . . . 15.0 108.416 178.412 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.588 ' O ' HG12 ' A' ' 20' ' ' ILE . . . -172.17 173.37 4.3 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.361 -0.836 . . . . 15.0 110.231 178.569 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.629 ' HA ' HG12 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -97.36 108.69 22.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.892 0.377 . . . . 15.0 110.349 179.647 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.663 ' HB ' ' O ' ' A' ' 19' ' ' GLY . 0.8 OUTLIER -78.96 110.53 14.86 Favored Pre-proline 0 C--O 1.234 0.245 0 N-CA-C 113.046 0.758 . . . . 15.0 113.046 -178.322 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.563 ' HA ' ' OE1' ' A' ' 47' ' ' GLU . 22.7 Cg_exo -64.28 66.58 0.24 Allowed 'Trans proline' 0 C--N 1.356 0.96 0 C-N-CA 123.177 2.585 . . . . 15.0 112.721 179.771 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.536 ' HB2' HG22 ' A' ' 41' ' ' ILE . 12.8 mt-30 -148.42 -52.88 0.18 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.483 -0.781 . . . . 15.0 109.258 179.233 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.644 ' HA3' ' HA3' ' A' ' 19' ' ' GLY . . . -88.24 156.19 26.91 Favored Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.612 -0.804 . . . . 15.0 112.474 179.044 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.802 ' HB3' ' O ' ' A' ' 17' ' ' SER . . . -42.5 -16.46 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 113.432 0.901 . . . . 15.0 113.432 -179.696 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.437 ' N ' ' O ' ' A' ' 44' ' ' GLY . . . -71.57 -70.27 0.33 Allowed 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.92 -0.312 . . . . 15.0 111.474 -179.258 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.563 ' OE1' ' HA ' ' A' ' 42' ' ' PRO . 10.2 tm-20 -58.31 -36.13 72.89 Favored 'General case' 0 N--CA 1.463 0.211 0 C-N-CA 120.504 -0.479 . . . . 15.0 110.064 179.408 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 48.8 m -57.57 -66.99 0.37 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.925 -0.58 . . . . 15.0 110.186 179.411 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.454 ' CB ' HD11 ' A' ' 11' ' ' LEU . 0.8 OUTLIER -60.55 -37.65 81.94 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.096 0.475 . . . . 15.0 109.881 179.004 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.44 37.43 17.54 Favored Glycine 0 N--CA 1.449 -0.461 0 CA-C-N 115.58 -0.736 . . . . 15.0 112.504 179.585 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.556 ' HB3' HG23 ' A' ' 9' ' ' VAL . 14.3 mmt180 -84.77 -49.75 8.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.94 0.4 . . . . 15.0 110.621 179.999 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.649 HG12 HD12 ' A' ' 20' ' ' ILE . 11.1 tp -81.19 157.22 4.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.016 -0.538 . . . . 15.0 110.347 179.537 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 76.6 m80 -139.65 158.1 44.67 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-O 121.753 0.787 . . . . 15.0 112.71 -179.006 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.599 ' HA ' ' CG2' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -44.25 134.95 4.72 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.137 -1.392 . . . . 15.0 112.477 -178.893 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.776 ' N ' HG22 ' A' ' 37' ' ' VAL . . . 49.7 34.32 21.0 Favored Glycine 0 C--N 1.334 0.456 0 C-N-CA 121.135 -0.555 . . . . 15.0 112.907 179.569 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.43 ' OD2' HD12 ' A' ' 52' ' ' ILE . 1.1 m-20 -65.5 130.64 44.04 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 121.003 -0.279 . . . . 15.0 110.439 179.636 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.405 ' NH2' ' HD3' ' A' ' 31' ' ' ARG . 59.7 ttt180 -86.33 86.45 7.34 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.112 -0.494 . . . . 15.0 110.432 179.792 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.944 HG22 HG22 ' A' ' 35' ' ' ILE . 1.3 m -79.41 116.68 23.79 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 CA-C-O 121.095 0.474 . . . . 15.0 110.948 -179.618 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 20.0 mt -107.19 -18.71 13.81 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.563 -0.744 . . . . 15.0 112.254 -179.323 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.424 ' HA ' ' O ' ' A' ' 64' ' ' VAL . . . -148.29 148.79 30.83 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 112.479 0.548 . . . . 15.0 112.479 -178.898 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.791 HG11 ' O ' ' A' ' 77' ' ' THR . 26.1 t -139.16 102.18 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.339 -0.846 . . . . 15.0 109.173 178.878 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.593 ' OD1' HG22 ' A' ' 81' ' ' THR . 2.6 m120 64.8 15.03 9.58 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.699 -0.482 . . . . 15.0 109.699 -177.966 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 107.1 5.76 34.79 Favored Glycine 0 C--N 1.337 0.606 0 CA-C-N 115.86 -0.609 . . . . 15.0 113.425 179.727 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.657 HG13 ' O ' ' A' ' 64' ' ' VAL . 6.2 p -93.92 106.83 18.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 117.181 0.49 . . . . 15.0 111.083 179.474 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.99 134.24 55.6 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.217 -0.447 . . . . 15.0 110.995 -179.877 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.611 HD21 ' HA ' ' A' ' 74' ' ' ALA . 0.1 OUTLIER -95.5 -22.78 17.44 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.024 -0.535 . . . . 15.0 111.015 -179.958 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.418 ' HG2' ' CD2' ' A' ' 32' ' ' HIS . 1.8 tt0 -46.27 100.42 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.899 0.38 . . . . 15.0 111.064 179.942 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.73 63.67 0.55 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.814 -0.708 . . . . 15.0 112.222 -179.719 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.59 ' HB1' ' CG ' ' A' ' 73' ' ' GLN . . . -173.03 167.12 5.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.829 0.347 . . . . 15.0 111.117 -179.798 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.437 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 16.2 p -93.23 -175.11 3.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.227 -0.442 . . . . 15.0 111.095 -179.883 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.739 ' CE1' HG23 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -62.17 -60.49 3.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.918 -0.583 . . . . 15.0 110.447 179.977 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.425 ' N ' ' CG ' ' A' ' 71' ' ' HIS . 8.0 ttpp -52.41 -31.12 32.66 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.814 -0.63 . . . . 15.0 110.517 179.448 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.59 ' CG ' ' HB1' ' A' ' 69' ' ' ALA . 0.3 OUTLIER -59.32 -52.02 67.42 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.64 -0.504 . . . . 15.0 109.64 179.335 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.611 ' HA ' HD21 ' A' ' 66' ' ' LEU . . . -66.95 -45.96 76.18 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.092 -0.504 . . . . 15.0 109.706 178.495 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.965 HG23 HG21 ' A' ' 22' ' ' VAL . 0.5 OUTLIER -41.43 -40.04 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.221 0 N-CA-C 109.123 -0.695 . . . . 15.0 109.123 178.43 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.421 ' HG3' ' O ' ' A' ' 72' ' ' LYS . 22.5 mt-10 -67.47 -46.72 72.18 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 114.731 -1.122 . . . . 15.0 110.244 178.488 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.791 ' O ' HG11 ' A' ' 61' ' ' VAL . 44.8 p -64.33 -51.9 61.14 Favored 'General case' 0 N--CA 1.461 0.102 0 C-N-CA 120.991 -0.283 . . . . 15.0 111.24 179.637 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.617 HD21 HG21 ' A' ' 58' ' ' VAL . 5.6 mt -53.53 -49.98 66.44 Favored 'General case' 0 CA--C 1.521 -0.168 0 CA-C-O 121.22 0.533 . . . . 15.0 109.878 179.934 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.46 -61.45 1.83 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.357 -0.838 . . . . 15.0 110.467 179.387 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -65.92 62.71 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.926 -0.579 . . . . 15.0 111.792 179.844 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.593 HG22 ' OD1' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -91.85 -69.81 0.72 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.648 0.261 . . . . 15.0 110.443 179.52 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 122.32 -107.19 1.13 Allowed Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.872 -0.68 . . . . 15.0 112.939 179.441 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.81 -83.56 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.775 0.321 . . . . 15.0 111.545 -179.45 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.474 HG12 ' N ' ' A' ' 85' ' ' VAL . 62.7 t -109.82 159.92 9.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.855 0.36 . . . . 15.0 110.335 179.999 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.689 HG23 ' HB2' ' A' ' 13' ' ' LYS . 24.4 t -97.85 80.16 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-O 121.016 0.436 . . . . 15.0 110.687 -179.943 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -98.46 81.89 2.79 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.893 -0.594 . . . . 15.0 110.447 179.865 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.772 ' HB3' HD21 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -101.15 118.03 36.19 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.045 -0.525 . . . . 15.0 111.742 -179.229 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.725 HD12 ' HB3' ' A' ' 8' ' ' GLU . 0.2 OUTLIER -94.99 101.47 13.23 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.302 -0.629 . . . . 15.0 109.302 178.657 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.772 HD21 ' HB3' ' A' ' 87' ' ' LEU . 0.2 OUTLIER -104.6 -162.29 0.88 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.417 0.627 . . . . 15.0 111.752 -178.629 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.443 ' HA ' ' HA ' ' A' ' 6' ' ' ILE . 2.2 tt0 -139.86 143.1 36.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.085 -0.961 . . . . 15.0 109.888 179.062 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -54.03 102.99 0.07 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.904 0.383 . . . . 15.0 110.96 -179.642 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -69.11 -169.32 6.1 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.84 -0.695 . . . . 15.0 112.65 -179.757 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 7.9 mm-40 -82.48 122.2 27.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.833 0.349 . . . . 15.0 110.895 -179.956 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 33.6 m -87.54 161.61 44.79 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.162 -0.472 . . . . 15.0 110.849 179.948 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -50.16 -33.76 36.81 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.529 2.153 . . . . 15.0 112.344 -179.976 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.22 -0.895 . . . . 15.0 110.878 179.94 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo . . . . . 0 N--CA 1.488 1.183 0 CA-C-O 120.892 0.288 . . . . 15.0 111.793 . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.499 ' HB3' ' HD3' ' A' ' 3' ' ' PRO . 0.0 OUTLIER -155.43 -64.82 0.02 OUTLIER Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.13 -0.487 . . . . 15.0 110.739 179.893 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.499 ' HD3' ' HB3' ' A' ' 2' ' ' LYS . 72.9 Cg_exo -40.96 120.66 1.11 Allowed 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.717 2.278 . . . . 15.0 113.017 179.621 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 82.9 -24.12 5.44 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.27 -0.967 . . . . 15.0 112.295 179.651 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.403 ' HB2' ' O ' ' A' ' 2' ' ' LYS . 1.5 m-20 -61.43 141.63 57.53 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-O 121.457 0.646 . . . . 15.0 110.853 -179.926 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.461 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 1.3 mp -74.19 147.32 9.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 114.894 -1.048 . . . . 15.0 111.655 -179.112 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.554 ' CZ ' HD12 ' A' ' 89' ' ' LEU . 3.3 p90 -141.68 165.06 28.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.884 -0.598 . . . . 15.0 110.263 178.759 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.774 ' HB2' HD12 ' A' ' 88' ' ' LEU . 0.2 OUTLIER -130.16 142.21 50.6 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.272 0.558 . . . . 15.0 111.615 -179.442 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.655 ' CG1' HD11 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -101.49 117.29 46.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.327 -0.851 . . . . 15.0 109.819 178.958 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -106.24 74.44 1.03 Allowed 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 112.166 0.432 . . . . 15.0 112.166 -179.031 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.585 HD13 ' CG ' ' A' ' 51' ' ' ARG . 8.7 tp -88.42 165.64 14.78 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.847 -0.427 . . . . 15.0 109.847 178.778 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -94.75 94.7 8.25 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.039 0.447 . . . . 15.0 111.186 -179.945 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.516 ' CB ' HG23 ' A' ' 85' ' ' VAL . 0.0 OUTLIER -54.56 -29.89 52.45 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.797 -0.638 . . . . 15.0 111.2 179.945 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.457 ' O ' ' CB ' ' A' ' 15' ' ' ASP . 93.0 m-20 -84.51 147.46 27.04 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.239 -0.437 . . . . 15.0 110.617 179.908 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.457 ' CB ' ' O ' ' A' ' 14' ' ' ASN . 1.8 t0 86.03 -39.01 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.054 -0.521 . . . . 15.0 111.157 -179.617 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 34.6 m-20 -155.31 145.5 21.78 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.818 0.342 . . . . 15.0 110.973 179.938 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.686 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 0.4 OUTLIER -86.09 -163.77 0.93 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.128 -0.487 . . . . 15.0 110.698 179.908 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.576 ' H ' HD22 ' A' ' 18' ' ' LEU . 1.4 mm? -80.48 -170.27 2.5 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 116.245 -0.434 . . . . 15.0 110.449 179.35 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.643 ' O ' ' HB ' ' A' ' 41' ' ' ILE . . . -161.57 31.02 0.32 Allowed Glycine 0 CA--C 1.507 -0.431 0 N-CA-C 111.535 -0.626 . . . . 15.0 111.535 -179.835 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.64 HD12 ' CG1' ' A' ' 52' ' ' ILE . 0.0 OUTLIER -112.62 139.76 35.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 121.061 0.458 . . . . 15.0 111.936 -179.206 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.468 ' O ' ' HB3' ' A' ' 38' ' ' LYS . 42.4 t -96.25 100.22 11.87 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 107.587 -1.264 . . . . 15.0 107.587 176.951 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.621 HG12 ' CG2' ' A' ' 20' ' ' ILE . 1.3 m -93.68 152.01 3.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 112.622 0.601 . . . . 15.0 112.622 -176.971 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.708 ' HA ' ' CD2' ' A' ' 71' ' ' HIS . 15.3 t -149.47 177.52 9.64 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.393 -0.822 . . . . 15.0 110.689 179.632 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.66 ' O ' HG22 ' A' ' 26' ' ' VAL . . . 83.05 -115.07 3.95 Favored Glycine 0 C--N 1.332 0.353 0 C-N-CA 120.723 -0.751 . . . . 15.0 112.136 -179.779 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.563 ' HA3' ' N ' ' A' ' 71' ' ' HIS . . . 63.79 -65.24 0.04 OUTLIER Glycine 0 C--N 1.331 0.266 0 C-N-CA 121.002 -0.618 . . . . 15.0 113.781 178.933 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.66 HG22 ' O ' ' A' ' 24' ' ' GLY . 0.0 OUTLIER -30.73 143.13 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 N-CA-C 112.234 0.457 . . . . 15.0 112.234 -179.116 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.409 ' CB ' ' O ' ' A' ' 32' ' ' HIS . 14.3 p-10 -75.59 62.26 1.41 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.956 -0.565 . . . . 15.0 111.0 -179.692 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 40.9 m -151.73 -67.13 0.17 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.308 -0.405 . . . . 15.0 111.088 -179.96 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -68.98 -32.45 72.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.137 -0.483 . . . . 15.0 111.071 -179.8 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.587 HG22 ' O ' ' A' ' 26' ' ' VAL . 19.8 m -88.09 -172.85 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.239 -0.437 . . . . 15.0 111.269 -179.895 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -61.94 -63.14 1.35 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.138 -0.483 . . . . 15.0 111.031 -179.984 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 32' ' ' HIS . . . . . 0.409 ' O ' ' CB ' ' A' ' 27' ' ' ASN . 90.8 m-70 -136.26 -49.72 0.68 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.294 -0.412 . . . . 15.0 111.103 -179.853 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -171.13 26.13 0.1 OUTLIER Glycine 0 C--N 1.329 0.155 0 C-N-CA 120.789 -0.72 . . . . 15.0 112.595 -179.755 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -89.51 154.43 24.13 Favored Glycine 0 N--CA 1.449 -0.472 0 N-CA-C 110.749 -0.94 . . . . 15.0 110.749 178.836 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.832 HG22 HG22 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -93.6 153.82 3.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 117.648 0.724 . . . . 15.0 111.828 -179.265 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.511 ' CE2' ' CG ' ' A' ' 57' ' ' ARG . 42.7 m-85 -138.39 106.28 5.67 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.957 -1.02 . . . . 15.0 109.859 179.69 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.818 HG22 ' N ' ' A' ' 55' ' ' GLY . 0.7 OUTLIER -55.27 145.29 5.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.164 -0.471 . . . . 15.0 111.002 -179.179 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.538 ' HB2' HG22 ' A' ' 23' ' ' THR . 0.2 OUTLIER -80.13 -47.57 14.55 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.661 -0.866 . . . . 15.0 108.661 178.512 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.567 ' O ' HG12 ' A' ' 20' ' ' ILE . . . -172.23 170.45 5.14 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 115.698 -0.683 . . . . 15.0 110.309 178.397 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.595 ' HA ' HG12 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -97.07 111.7 27.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.928 0.394 . . . . 15.0 110.264 179.638 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.643 ' HB ' ' O ' ' A' ' 19' ' ' GLY . 0.4 OUTLIER -78.65 109.99 12.57 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 115.781 -0.645 . . . . 15.0 112.632 -178.293 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.45 ' N ' ' HG2' ' A' ' 47' ' ' GLU . 24.5 Cg_exo -62.47 68.55 0.12 Allowed 'Trans proline' 0 C--N 1.356 0.935 0 C-N-CA 123.211 2.607 . . . . 15.0 112.507 179.828 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.478 ' HB2' HG22 ' A' ' 41' ' ' ILE . 8.1 mm-40 -153.43 -52.93 0.1 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.628 -0.715 . . . . 15.0 109.825 179.638 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.499 ' HA3' ' HA3' ' A' ' 19' ' ' GLY . . . -87.78 155.9 27.15 Favored Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.66 -0.781 . . . . 15.0 112.481 179.393 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.686 ' HB3' ' O ' ' A' ' 17' ' ' SER . . . -41.05 -16.8 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 113.517 0.932 . . . . 15.0 113.517 -179.546 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.463 ' N ' ' O ' ' A' ' 44' ' ' GLY . . . -71.68 -71.76 0.26 Allowed 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.819 -0.353 . . . . 15.0 111.155 -179.739 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.542 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 4.1 tp10 -58.27 -39.78 80.13 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 121.033 0.445 . . . . 15.0 110.402 179.569 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.2 m -53.98 -64.5 0.81 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.904 -0.589 . . . . 15.0 110.434 179.537 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.526 ' CB ' HD11 ' A' ' 11' ' ' LEU . 3.7 m-20 -64.79 -37.62 88.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.163 -0.471 . . . . 15.0 110.175 179.273 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.62 38.22 14.85 Favored Glycine 0 N--CA 1.45 -0.41 0 CA-C-N 115.744 -0.662 . . . . 15.0 112.571 179.581 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.585 ' CG ' HD13 ' A' ' 11' ' ' LEU . 0.2 OUTLIER -82.33 -54.47 5.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.968 0.413 . . . . 15.0 110.614 179.864 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.64 ' CG1' HD12 ' A' ' 20' ' ' ILE . 9.6 tp -81.09 159.72 4.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.873 -0.603 . . . . 15.0 110.379 179.705 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 53' ' ' HIS . . . . . 0.421 ' O ' ' HB2' ' A' ' 56' ' ' ASP . 53.2 m80 -140.74 159.47 42.14 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-O 121.742 0.782 . . . . 15.0 112.728 -178.875 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.595 ' HA ' ' CG2' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -44.14 134.45 4.8 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.054 -1.43 . . . . 15.0 113.057 -178.728 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.818 ' N ' HG22 ' A' ' 37' ' ' VAL . . . 49.83 31.4 16.58 Favored Glycine 0 C--N 1.335 0.483 0 CA-C-N 115.779 -0.646 . . . . 15.0 113.618 178.934 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.421 ' HB2' ' O ' ' A' ' 53' ' ' HIS . 0.4 OUTLIER -65.92 130.22 42.51 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.628 -0.429 . . . . 15.0 110.655 179.504 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.511 ' CG ' ' CE2' ' A' ' 36' ' ' TYR . 3.5 mtt180 -82.08 88.35 6.44 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.177 -0.465 . . . . 15.0 110.407 179.564 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.832 HG22 HG22 ' A' ' 35' ' ' ILE . 1.5 m -79.45 111.93 16.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 CA-C-O 121.199 0.523 . . . . 15.0 111.061 -179.554 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.414 HD22 ' N ' ' A' ' 59' ' ' LEU . 4.0 mm? -107.38 -15.14 14.7 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 115.558 -0.746 . . . . 15.0 112.33 -179.224 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.783 ' HB3' ' HB2' ' A' ' 88' ' ' LEU . . . -147.91 145.68 28.72 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.099 0.476 . . . . 15.0 112.217 -178.782 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.836 HG23 HD11 ' A' ' 66' ' ' LEU . 47.1 t -138.93 103.48 2.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.624 -0.716 . . . . 15.0 109.378 178.918 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.728 ' OD1' HG22 ' A' ' 81' ' ' THR . 2.4 m120 64.97 16.43 10.55 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.727 -0.471 . . . . 15.0 109.727 -178.114 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.99 5.81 43.61 Favored Glycine 0 C--N 1.336 0.545 0 CA-C-N 115.744 -0.662 . . . . 15.0 113.103 179.958 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.649 HG13 ' O ' ' A' ' 64' ' ' VAL . 5.7 p -93.78 108.33 20.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 121.007 0.432 . . . . 15.0 110.915 179.573 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 13.7 m -58.74 124.41 19.67 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.178 0.514 . . . . 15.0 110.796 -179.781 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.836 HD11 HG23 ' A' ' 61' ' ' VAL . 0.2 OUTLIER -89.11 -18.7 26.69 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.489 -0.778 . . . . 15.0 111.21 -179.652 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -46.66 101.84 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 120.832 0.349 . . . . 15.0 110.985 179.88 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.75 66.38 0.58 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.788 -0.72 . . . . 15.0 112.291 -179.707 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.641 ' HB1' ' HB3' ' A' ' 73' ' ' GLN . . . -173.03 164.21 4.88 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.849 0.357 . . . . 15.0 111.031 -179.821 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.445 ' HB ' HG13 ' A' ' 26' ' ' VAL . 18.5 p -93.24 -174.66 3.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.998 0.428 . . . . 15.0 111.232 -179.831 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.708 ' CD2' ' HA ' ' A' ' 23' ' ' THR . 0.0 OUTLIER -61.53 -61.88 2.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.85 -0.614 . . . . 15.0 109.826 179.774 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 16.1 ttpt -52.88 -35.61 58.09 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.876 -0.602 . . . . 15.0 110.085 179.005 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.641 ' HB3' ' HB1' ' A' ' 69' ' ' ALA . 3.5 tt0 -59.64 -48.96 79.62 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.944 -0.571 . . . . 15.0 109.501 179.035 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.467 ' HA ' ' OG1' ' A' ' 77' ' ' THR . . . -66.93 -46.71 73.94 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-N 115.92 -0.582 . . . . 15.0 109.491 178.344 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.59 HG23 ' CG2' ' A' ' 22' ' ' VAL . 0.5 OUTLIER -42.54 -39.72 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.27 0 N-CA-C 108.814 -0.81 . . . . 15.0 108.814 178.218 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.462 ' O ' ' HB2' ' A' ' 80' ' ' ASN . 1.0 OUTLIER -67.29 -46.34 73.9 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 114.663 -1.153 . . . . 15.0 110.57 178.59 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.622 ' O ' HG11 ' A' ' 61' ' ' VAL . 6.9 p -64.07 -53.74 44.98 Favored 'General case' 0 N--CA 1.462 0.16 0 C-N-CA 120.974 -0.29 . . . . 15.0 111.636 -179.87 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.696 HD23 HG21 ' A' ' 61' ' ' VAL . 6.9 mt -53.31 -46.8 69.55 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-O 121.259 0.552 . . . . 15.0 110.017 179.982 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.448 ' HB2' ' O ' ' A' ' 75' ' ' VAL . 0.0 OUTLIER -68.45 -57.41 5.89 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.344 -0.844 . . . . 15.0 110.784 179.576 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.462 ' HB2' ' O ' ' A' ' 76' ' ' GLU . 9.3 m-80 -66.14 61.53 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.103 -0.499 . . . . 15.0 112.155 -179.882 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.728 HG22 ' OD1' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -95.67 -68.44 0.8 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.836 0.35 . . . . 15.0 110.158 179.098 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 122.14 -108.33 1.28 Allowed Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 121.004 -0.617 . . . . 15.0 112.957 179.396 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.443 ' O ' ' HB3' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -65.26 -79.08 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.912 0.387 . . . . 15.0 111.773 -179.326 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.464 HG12 ' N ' ' A' ' 85' ' ' VAL . 75.6 t -109.88 159.42 9.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.942 -0.572 . . . . 15.0 111.035 -179.219 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.678 ' O ' HG12 ' A' ' 85' ' ' VAL . 5.9 t -97.9 81.14 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.122 0.486 . . . . 15.0 110.485 179.96 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 13.7 t60 -97.94 82.83 3.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.784 -0.644 . . . . 15.0 110.297 179.67 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.813 ' HB3' HD21 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -101.2 119.72 39.17 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.928 -0.578 . . . . 15.0 111.857 -179.132 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.783 ' HB2' ' HB3' ' A' ' 60' ' ' ALA . 4.0 mp -96.05 100.71 12.34 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.557 -0.535 . . . . 15.0 109.557 178.841 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.813 HD21 ' HB3' ' A' ' 87' ' ' LEU . 0.1 OUTLIER -105.61 -160.86 0.77 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.42 0.629 . . . . 15.0 111.974 -178.589 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.461 ' HA ' ' HA ' ' A' ' 6' ' ' ILE . 3.5 tt0 -138.91 139.89 38.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 114.978 -1.01 . . . . 15.0 109.979 179.107 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 14.0 tppt? -51.17 106.71 0.14 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.312 -0.404 . . . . 15.0 111.003 -179.913 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -68.1 146.03 45.6 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.872 -0.68 . . . . 15.0 112.714 -179.789 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 41.2 tt0 -86.37 123.2 31.34 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.791 0.329 . . . . 15.0 110.819 179.845 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -77.3 140.27 65.11 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.284 -0.416 . . . . 15.0 110.98 -179.877 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -53.44 -61.3 0.47 Allowed 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.561 2.174 . . . . 15.0 112.227 179.969 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 5.0 m . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.255 -0.879 . . . . 15.0 110.941 -179.996 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.467 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 1.4 mp . . . . . 0 N--CA 1.451 -0.413 0 CA-C-O 120.872 0.368 . . . . 15.0 111.243 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.545 ' CE1' HD12 ' A' ' 89' ' ' LEU . 2.8 p90 -140.43 164.95 28.76 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.088 -0.506 . . . . 15.0 110.261 178.621 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.727 ' HB3' HD12 ' A' ' 88' ' ' LEU . 6.3 pt-20 -130.09 142.09 50.64 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.362 0.601 . . . . 15.0 111.867 -179.047 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.593 ' CG1' HD11 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -101.56 114.74 41.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.037 -0.983 . . . . 15.0 109.728 178.915 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -105.87 72.11 0.93 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.156 -0.475 . . . . 15.0 111.916 -178.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.594 HD13 ' HG3' ' A' ' 51' ' ' ARG . 6.3 tp -88.33 165.67 14.82 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.098 -0.501 . . . . 15.0 110.061 179.056 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -95.57 92.26 6.55 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.93 0.395 . . . . 15.0 111.138 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.611 ' CB ' HG23 ' A' ' 85' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 115.982 -0.554 . . . . 15.0 110.977 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.652 ' N ' HD22 ' A' ' 18' ' ' LEU . 1.3 mm? . . . . . 0 N--CA 1.454 -0.236 0 CA-C-O 120.896 0.379 . . . . 15.0 110.653 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.735 ' O ' ' HB ' ' A' ' 41' ' ' ILE . . . -161.0 40.16 0.42 Allowed Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.908 -0.663 . . . . 15.0 111.973 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.703 HG12 ' O ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -112.83 139.77 36.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 120.961 0.41 . . . . 15.0 111.998 -179.414 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 21.8 t -96.04 105.76 17.84 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.132 -1.062 . . . . 15.0 108.132 177.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.919 HG21 HG23 ' A' ' 75' ' ' VAL . 18.5 m -93.84 156.0 3.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 113.435 0.902 . . . . 15.0 113.435 -176.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.5 -172.76 4.22 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 114.981 -1.009 . . . . 15.0 110.437 179.438 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.418 ' O ' ' CB ' ' A' ' 71' ' ' HIS . . . 68.65 -120.2 10.93 Favored Glycine 0 C--N 1.331 0.251 0 C-N-CA 120.773 -0.727 . . . . 15.0 112.72 179.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.561 ' HA3' ' N ' ' A' ' 71' ' ' HIS . . . 68.48 -66.59 0.41 Allowed Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.82 -0.705 . . . . 15.0 113.367 179.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.599 ' O ' HG22 ' A' ' 30' ' ' VAL . 2.1 m -33.13 144.33 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 N-CA-C 112.024 0.379 . . . . 15.0 112.024 -179.374 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 13.0 p-10 -75.57 62.67 1.44 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.059 -0.518 . . . . 15.0 111.008 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -151.71 -67.68 0.17 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.219 -0.446 . . . . 15.0 110.945 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 21.1 m -67.21 -33.33 75.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.129 -0.487 . . . . 15.0 110.949 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.599 HG22 ' O ' ' A' ' 26' ' ' VAL . 29.5 m -88.02 -174.01 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 15.0 111.209 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -64.26 -60.53 3.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.181 -0.463 . . . . 15.0 111.146 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 52.2 m80 -132.88 -57.36 0.93 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.388 -0.369 . . . . 15.0 111.225 -179.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -167.13 21.45 0.1 Allowed Glycine 0 CA--C 1.518 0.246 0 C-N-CA 120.816 -0.707 . . . . 15.0 112.718 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -83.74 152.77 29.16 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.467 -0.873 . . . . 15.0 110.921 178.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.815 HG22 HG22 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -89.12 153.7 3.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 117.482 0.641 . . . . 15.0 111.633 -179.357 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.424 ' CZ ' ' HG2' ' A' ' 57' ' ' ARG . 25.3 m-85 -141.35 108.26 5.42 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.084 -0.962 . . . . 15.0 109.661 179.324 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.763 HG22 ' N ' ' A' ' 55' ' ' GLY . 0.8 OUTLIER -56.09 154.85 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.18 0.514 . . . . 15.0 111.573 -178.939 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.47 ' O ' ' HG2' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -85.45 -47.94 9.46 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.379 -0.971 . . . . 15.0 108.379 178.239 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.703 ' O ' HG12 ' A' ' 20' ' ' ILE . . . -172.39 172.99 4.25 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 115.349 -0.841 . . . . 15.0 110.224 178.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.529 ' HA ' ' CG1' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -96.76 110.91 25.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 109.273 -0.64 . . . . 15.0 109.273 179.125 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.735 ' HB ' ' O ' ' A' ' 19' ' ' GLY . 0.4 OUTLIER -78.24 116.57 60.0 Favored Pre-proline 0 C--N 1.328 -0.364 0 N-CA-C 113.4 0.889 . . . . 15.0 113.4 -177.11 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.604 ' HA ' ' CG ' ' A' ' 47' ' ' GLU . 37.8 Cg_exo -61.56 61.56 0.11 Allowed 'Trans proline' 0 C--N 1.358 1.054 0 C-N-CA 123.76 2.973 . . . . 15.0 113.1 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.533 ' H ' ' HG2' ' A' ' 47' ' ' GLU . 3.0 mt-30 -149.93 -47.94 0.13 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.609 0.242 . . . . 15.0 111.592 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.67 ' HA3' ' HA3' ' A' ' 19' ' ' GLY . . . -87.79 168.04 37.28 Favored Glycine 0 C--N 1.329 0.176 0 C-N-CA 120.324 -0.941 . . . . 15.0 113.781 -179.167 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -57.51 -13.23 3.4 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.721 0.637 . . . . 15.0 112.721 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.0 -57.56 4.19 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 120.988 -0.285 . . . . 15.0 110.663 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.604 ' CG ' ' HA ' ' A' ' 42' ' ' PRO . 2.7 pp20? -57.55 -42.84 83.79 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.97 -0.559 . . . . 15.0 110.379 179.097 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 69.4 m -53.64 -71.12 0.08 Allowed 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 115.806 -0.634 . . . . 15.0 110.571 -179.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.569 ' HB2' HD11 ' A' ' 11' ' ' LEU . 0.3 OUTLIER -58.13 -41.14 83.02 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.12 -0.696 . . . . 15.0 109.12 178.872 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.57 40.19 13.21 Favored Glycine 0 N--CA 1.446 -0.7 0 CA-C-N 115.357 -0.838 . . . . 15.0 111.631 179.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.594 ' HG3' HD13 ' A' ' 11' ' ' LEU . 1.2 mmp_? -79.71 -50.07 11.15 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.867 0.365 . . . . 15.0 110.658 -179.253 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.62 ' CG1' HD12 ' A' ' 20' ' ' ILE . 8.4 tp -80.91 162.54 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 CA-C-N 116.021 -0.536 . . . . 15.0 110.198 179.457 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . 0.464 ' O ' ' HB2' ' A' ' 56' ' ' ASP . 79.6 m80 -146.88 159.88 42.99 Favored 'General case' 0 CA--C 1.514 -0.432 0 CA-C-O 121.641 0.734 . . . . 15.0 112.241 -179.067 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.53 ' HA ' ' CG2' ' A' ' 37' ' ' VAL . 0.1 OUTLIER -43.49 133.43 4.38 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.407 -1.269 . . . . 15.0 112.526 -178.77 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.763 ' N ' HG22 ' A' ' 37' ' ' VAL . . . 49.91 35.12 24.17 Favored Glycine 0 C--N 1.333 0.381 0 CA-C-N 115.927 -0.579 . . . . 15.0 113.377 179.328 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.464 ' HB2' ' O ' ' A' ' 53' ' ' HIS . 0.4 OUTLIER -65.92 132.5 48.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 117.08 0.44 . . . . 15.0 110.682 179.632 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.737 ' CD ' HD21 ' A' ' 59' ' ' LEU . 0.0 OUTLIER -85.5 85.9 7.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.04 -0.527 . . . . 15.0 110.618 179.799 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.815 HG22 HG22 ' A' ' 35' ' ' ILE . 1.4 m -79.49 116.33 23.31 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 CA-C-O 120.998 0.428 . . . . 15.0 110.955 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.737 HD21 ' CD ' ' A' ' 57' ' ' ARG . 18.7 mt -107.01 -18.11 14.0 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.809 -0.632 . . . . 15.0 112.329 -179.146 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.483 ' O ' HD23 ' A' ' 87' ' ' LEU . . . -147.84 149.67 32.73 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.246 0.546 . . . . 15.0 112.389 -178.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.663 HG11 ' O ' ' A' ' 77' ' ' THR . 17.6 t -138.93 101.67 1.66 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.31 0 CA-C-N 115.312 -0.858 . . . . 15.0 109.138 178.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.793 ' ND2' HG22 ' A' ' 81' ' ' THR . 1.7 m-80 64.95 15.51 10.0 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.637 -0.505 . . . . 15.0 109.637 -177.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 107.04 5.46 35.22 Favored Glycine 0 C--N 1.338 0.642 0 CA-C-N 115.811 -0.631 . . . . 15.0 113.471 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.653 ' O ' HG13 ' A' ' 64' ' ' VAL . 6.3 p -93.91 107.18 18.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 117.085 0.442 . . . . 15.0 111.059 179.549 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.3 m -56.96 134.67 55.86 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.216 -0.447 . . . . 15.0 111.07 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.675 HD21 ' HA ' ' A' ' 74' ' ' ALA . 0.2 OUTLIER -97.83 -20.59 17.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.009 -0.542 . . . . 15.0 111.173 -179.994 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -45.64 110.91 0.29 Allowed 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.384 -0.371 . . . . 15.0 111.123 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 97.62 64.25 0.89 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.781 -0.723 . . . . 15.0 112.251 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.606 ' HB1' ' CG ' ' A' ' 73' ' ' GLN . . . -173.03 166.85 5.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.916 0.389 . . . . 15.0 111.148 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.435 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 15.3 p -93.49 -172.63 2.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.18 -0.463 . . . . 15.0 111.301 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . 0.767 ' CD2' HG23 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -63.57 -59.07 5.09 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.72 -0.673 . . . . 15.0 110.557 179.816 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 9.4 ttpp -52.36 -31.2 32.53 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.868 -0.606 . . . . 15.0 110.627 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.606 ' CG ' ' HB1' ' A' ' 69' ' ' ALA . 0.0 OUTLIER -59.3 -53.77 54.42 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.239 -0.437 . . . . 15.0 109.932 179.444 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.675 ' HA ' HD21 ' A' ' 66' ' ' LEU . . . -66.78 -43.91 82.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.173 -0.467 . . . . 15.0 109.86 178.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.919 HG23 HG21 ' A' ' 22' ' ' VAL . 0.5 OUTLIER -42.37 -41.79 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.225 0 N-CA-C 109.129 -0.693 . . . . 15.0 109.129 178.376 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -67.46 -44.54 78.36 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 114.875 -1.057 . . . . 15.0 110.289 178.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.663 ' O ' HG11 ' A' ' 61' ' ' VAL . 69.0 p -64.09 -54.27 36.58 Favored 'General case' 0 N--CA 1.461 0.117 0 C-N-CA 121.161 -0.215 . . . . 15.0 111.508 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.562 HD21 HG21 ' A' ' 58' ' ' VAL . 7.6 mt -53.55 -47.88 69.61 Favored 'General case' 0 CA--C 1.518 -0.25 0 CA-C-O 121.313 0.578 . . . . 15.0 109.867 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.404 ' HB2' ' O ' ' A' ' 75' ' ' VAL . 11.1 ttp85 -68.42 -59.95 2.79 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.242 -0.89 . . . . 15.0 110.651 179.484 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 68.6 m-20 -66.06 58.52 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.865 -0.607 . . . . 15.0 112.498 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.793 HG22 ' ND2' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -95.57 -71.46 0.67 Allowed 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.89 -0.411 . . . . 15.0 109.89 178.872 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 121.11 -104.15 0.94 Allowed Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.703 -0.76 . . . . 15.0 113.344 178.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.401 ' O ' ' HB3' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -64.67 -82.77 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 112.104 0.409 . . . . 15.0 112.104 -178.943 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.441 HG12 ' N ' ' A' ' 85' ' ' VAL . 75.6 t -109.79 158.66 9.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.107 0.479 . . . . 15.0 111.232 -179.114 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.675 HG12 ' O ' ' A' ' 85' ' ' VAL . 6.7 t -97.79 82.03 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.992 -0.549 . . . . 15.0 110.498 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -99.06 82.18 2.7 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.76 -0.655 . . . . 15.0 110.291 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.812 ' HB3' HD21 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -103.97 118.74 37.4 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.046 -0.524 . . . . 15.0 112.061 -178.988 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.727 HD12 ' HB3' ' A' ' 8' ' ' GLU . 0.2 OUTLIER -95.46 101.4 13.11 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.111 -0.7 . . . . 15.0 109.111 178.252 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.812 HD21 ' HB3' ' A' ' 87' ' ' LEU . 0.2 OUTLIER -104.11 -164.91 1.1 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.439 0.638 . . . . 15.0 112.094 -178.312 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.467 ' HA ' ' HA ' ' A' ' 6' ' ' ILE . 2.3 tt0 -139.37 139.84 37.31 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.999 -1.0 . . . . 15.0 109.817 179.205 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 6.7 tptt -52.11 102.04 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.009 0.433 . . . . 15.0 111.06 -179.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.363 0 C-N-CA 120.973 -0.632 . . . . 15.0 112.784 -179.658 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.455 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 1.1 mp . . . . . 0 N--CA 1.451 -0.419 0 CA-C-O 120.977 0.418 . . . . 15.0 111.324 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.749 ' CE1' HD12 ' A' ' 89' ' ' LEU . 6.0 p90 -140.29 152.02 45.55 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.902 -0.59 . . . . 15.0 110.193 178.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.741 ' HB2' HD12 ' A' ' 88' ' ' LEU . 1.4 pm0 -120.93 143.06 49.17 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.373 0.606 . . . . 15.0 111.713 -179.22 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.559 ' CG1' HD11 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -101.47 115.51 43.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.119 -0.946 . . . . 15.0 109.558 178.948 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -106.18 74.33 1.03 Allowed 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 112.321 0.489 . . . . 15.0 112.321 -178.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.66 HD13 ' HG3' ' A' ' 51' ' ' ARG . 6.7 tp -88.11 164.84 15.51 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.339 -0.615 . . . . 15.0 109.339 178.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -96.33 97.72 9.71 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.047 0.451 . . . . 15.0 111.379 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.607 ' CB ' HG23 ' A' ' 85' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.423 0 CA-C-N 115.77 -0.65 . . . . 15.0 111.064 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.64 ' N ' HD22 ' A' ' 18' ' ' LEU . 1.9 mm? . . . . . 0 N--CA 1.451 -0.402 0 CA-C-O 120.95 0.405 . . . . 15.0 110.612 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.761 ' O ' ' HB ' ' A' ' 41' ' ' ILE . . . -160.88 43.53 0.41 Allowed Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.939 -0.648 . . . . 15.0 111.698 -179.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.687 HG12 ' O ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -112.78 138.46 41.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 120.948 0.404 . . . . 15.0 111.615 -179.453 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.441 ' H ' HD13 ' A' ' 41' ' ' ILE . 31.4 t -91.73 103.5 16.06 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 107.813 -1.18 . . . . 15.0 107.813 177.443 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.978 HG21 HG23 ' A' ' 75' ' ' VAL . 32.8 m -93.72 154.42 3.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 113.079 0.77 . . . . 15.0 113.079 -177.012 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.29 -175.22 4.9 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.132 -0.94 . . . . 15.0 110.72 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.533 ' O ' HG22 ' A' ' 26' ' ' VAL . . . 68.67 -119.88 10.54 Favored Glycine 0 C--N 1.332 0.306 0 C-N-CA 120.829 -0.701 . . . . 15.0 112.424 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.533 ' HA3' ' N ' ' A' ' 71' ' ' HIS . . . 68.12 -64.21 0.37 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.876 -0.678 . . . . 15.0 113.525 179.4 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.533 HG22 ' O ' ' A' ' 24' ' ' GLY . 0.0 OUTLIER -30.63 138.58 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 N-CA-C 112.337 0.495 . . . . 15.0 112.337 -179.323 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 28.3 p30 -75.55 62.72 1.44 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.897 -0.592 . . . . 15.0 111.012 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.0 m -151.7 -50.76 0.12 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.277 -0.42 . . . . 15.0 111.106 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -87.65 -40.54 14.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.232 -0.44 . . . . 15.0 111.192 -179.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.506 HG22 ' O ' ' A' ' 26' ' ' VAL . 31.1 m -72.62 -174.9 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.317 -0.402 . . . . 15.0 111.366 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 2.1 ttm180 -60.31 -40.78 91.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.2 -0.455 . . . . 15.0 111.239 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . 0.454 ' CD2' ' N ' ' A' ' 32' ' ' HIS . 0.1 OUTLIER -163.9 -46.76 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.688 -0.233 . . . . 15.0 111.515 179.799 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -170.22 19.96 0.07 OUTLIER Glycine 0 CA--C 1.519 0.288 0 C-N-CA 120.649 -0.786 . . . . 15.0 112.979 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.405 ' O ' HG11 ' A' ' 30' ' ' VAL . . . -89.76 153.85 23.48 Favored Glycine 0 N--CA 1.45 -0.385 0 N-CA-C 111.005 -0.838 . . . . 15.0 111.005 179.018 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.831 HG22 HG22 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -89.13 155.62 3.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 117.478 0.639 . . . . 15.0 111.773 -179.396 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.47 ' CE2' ' HG2' ' A' ' 57' ' ' ARG . 29.5 m-85 -140.19 106.75 5.32 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.082 -0.963 . . . . 15.0 109.804 179.023 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.793 HG22 ' N ' ' A' ' 55' ' ' GLY . 0.6 OUTLIER -55.35 147.05 4.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.913 -0.585 . . . . 15.0 111.361 -178.956 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.459 ' O ' ' HG2' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -80.35 -48.61 12.68 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.449 -0.945 . . . . 15.0 108.449 178.379 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.687 ' O ' HG12 ' A' ' 20' ' ' ILE . . . -172.2 173.95 4.12 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 115.416 -0.811 . . . . 15.0 110.142 178.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.575 ' HA ' HG12 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -97.03 110.09 24.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 109.657 -0.498 . . . . 15.0 109.657 179.295 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.761 ' HB ' ' O ' ' A' ' 19' ' ' GLY . 0.6 OUTLIER -78.4 116.48 59.57 Favored Pre-proline 0 C--N 1.328 -0.333 0 N-CA-C 113.39 0.885 . . . . 15.0 113.39 -177.518 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.621 ' HA ' ' CG ' ' A' ' 47' ' ' GLU . 35.2 Cg_exo -62.01 59.94 0.13 Allowed 'Trans proline' 0 C--N 1.357 1.02 0 C-N-CA 123.663 2.909 . . . . 15.0 113.064 179.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.538 ' N ' ' HG2' ' A' ' 47' ' ' GLU . 0.6 OUTLIER -147.53 -47.69 0.17 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.642 0.258 . . . . 15.0 111.579 179.913 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.725 ' HA3' ' HA3' ' A' ' 19' ' ' GLY . . . -87.86 168.81 37.94 Favored Glycine 0 C--N 1.331 0.279 0 C-N-CA 120.393 -0.908 . . . . 15.0 114.047 -179.022 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -57.51 -13.72 4.09 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.592 0.59 . . . . 15.0 112.592 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.11 -57.72 4.03 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.712 0.291 . . . . 15.0 110.797 -179.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.621 ' CG ' ' HA ' ' A' ' 42' ' ' PRO . 2.9 pp20? -57.57 -42.37 82.96 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.77 -0.65 . . . . 15.0 110.381 179.276 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -53.76 -71.49 0.07 Allowed 'General case' 0 CA--C 1.519 -0.241 0 CA-C-N 115.814 -0.63 . . . . 15.0 110.486 -179.404 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.581 ' HB2' HD11 ' A' ' 11' ' ' LEU . 0.2 OUTLIER -58.36 -41.15 84.09 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.125 -0.694 . . . . 15.0 109.125 178.801 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.78 40.46 12.15 Favored Glycine 0 N--CA 1.446 -0.643 0 CA-C-N 115.416 -0.811 . . . . 15.0 111.726 179.365 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.66 ' HG3' HD13 ' A' ' 11' ' ' LEU . 0.6 OUTLIER -79.92 -48.19 13.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.907 0.384 . . . . 15.0 110.726 -179.402 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.595 ' CG1' HD12 ' A' ' 20' ' ' ILE . 9.4 tp -81.11 162.07 3.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.037 -0.528 . . . . 15.0 110.275 179.56 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . 0.475 ' N ' ' OD2' ' A' ' 56' ' ' ASP . 78.8 m80 -147.51 157.63 43.65 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-O 121.61 0.719 . . . . 15.0 112.021 -179.073 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.558 ' HA ' ' CG2' ' A' ' 37' ' ' VAL . 0.1 OUTLIER -42.4 132.2 3.55 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.327 -1.306 . . . . 15.0 113.027 -178.564 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.793 ' N ' HG22 ' A' ' 37' ' ' VAL . . . 50.35 30.31 18.29 Favored Glycine 0 C--N 1.333 0.416 0 CA-C-N 115.672 -0.694 . . . . 15.0 113.4 179.235 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.475 ' OD2' ' N ' ' A' ' 53' ' ' HIS . 16.8 m-20 -65.87 129.59 40.33 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.716 -0.394 . . . . 15.0 110.58 179.521 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.47 ' HG2' ' CE2' ' A' ' 36' ' ' TYR . 15.8 mtt-85 -80.85 96.84 7.13 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.229 -0.441 . . . . 15.0 110.846 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.831 HG22 HG22 ' A' ' 35' ' ' ILE . 1.4 m -86.96 114.02 25.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.079 0.466 . . . . 15.0 110.749 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 21.5 mt -107.02 -16.42 14.44 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.799 -0.637 . . . . 15.0 112.397 -179.05 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.79 ' HB3' ' HB2' ' A' ' 88' ' ' LEU . . . -148.13 147.67 29.75 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.509 0.559 . . . . 15.0 112.509 -178.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.863 HG11 ' O ' ' A' ' 77' ' ' THR . 21.4 t -139.03 101.12 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.316 -0.856 . . . . 15.0 109.16 178.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.682 ' ND2' HG22 ' A' ' 81' ' ' THR . 1.7 m-80 65.14 15.98 10.3 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.72 -0.474 . . . . 15.0 109.72 -177.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 107.07 4.58 35.73 Favored Glycine 0 C--N 1.337 0.598 0 CA-C-N 115.969 -0.56 . . . . 15.0 113.469 179.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.644 ' O ' HG13 ' A' ' 64' ' ' VAL . 5.4 p -93.9 108.4 20.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 117.122 0.461 . . . . 15.0 111.164 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 61.5 m -56.87 138.14 54.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.296 -0.411 . . . . 15.0 110.996 -179.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.912 HD11 ' HB2' ' A' ' 74' ' ' ALA . 0.2 OUTLIER -97.75 -21.88 16.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.063 -0.517 . . . . 15.0 111.085 -179.903 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -46.53 106.17 0.08 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.361 -0.381 . . . . 15.0 111.21 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 104.33 62.16 0.67 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.808 -0.711 . . . . 15.0 112.453 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.666 ' HB1' ' CB ' ' A' ' 73' ' ' GLN . . . -173.18 163.48 4.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.86 0.362 . . . . 15.0 111.086 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.46 ' HB ' HG13 ' A' ' 26' ' ' VAL . 1.7 p -92.33 -171.96 2.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.457 . . . . 15.0 110.983 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . 0.777 ' CD2' HG23 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -62.19 -59.45 5.03 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.844 -0.616 . . . . 15.0 110.458 179.949 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.41 ' O ' HG12 ' A' ' 75' ' ' VAL . 24.9 ttpp -52.68 -34.29 51.23 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.768 -0.651 . . . . 15.0 110.836 179.612 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.666 ' CB ' ' HB1' ' A' ' 69' ' ' ALA . 3.2 mt-30 -59.28 -50.77 72.7 Favored 'General case' 0 CA--C 1.518 -0.272 0 N-CA-C 109.527 -0.546 . . . . 15.0 109.527 179.35 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.912 ' HB2' HD11 ' A' ' 66' ' ' LEU . . . -66.29 -45.42 80.47 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.69 -0.687 . . . . 15.0 109.672 178.519 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.978 HG23 HG21 ' A' ' 22' ' ' VAL . 0.5 OUTLIER -43.15 -40.51 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.243 0 N-CA-C 108.976 -0.749 . . . . 15.0 108.976 178.243 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -67.26 -44.96 78.08 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 114.871 -1.058 . . . . 15.0 110.076 178.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.863 ' O ' HG11 ' A' ' 61' ' ' VAL . 41.2 p -64.3 -53.41 49.29 Favored 'General case' 0 N--CA 1.461 0.098 0 CA-C-O 120.572 0.225 . . . . 15.0 111.318 179.606 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.718 HD21 HG21 ' A' ' 58' ' ' VAL . 6.1 mt -53.42 -48.86 68.35 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 121.245 0.545 . . . . 15.0 109.97 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.413 ' O ' ' N ' ' A' ' 81' ' ' THR . 0.2 OUTLIER -68.38 -59.05 3.46 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.317 -0.856 . . . . 15.0 110.665 179.502 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -65.88 62.9 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.946 -0.57 . . . . 15.0 111.931 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.682 HG22 ' ND2' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -91.7 -70.87 0.67 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.785 0.326 . . . . 15.0 110.302 179.425 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 122.28 -109.97 1.52 Allowed Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.978 -0.63 . . . . 15.0 112.852 179.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.4 ' O ' ' HB3' ' A' ' 13' ' ' LYS . 0.8 OUTLIER -65.25 -77.88 0.06 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.884 0.373 . . . . 15.0 111.438 -179.437 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.44 HG12 ' N ' ' A' ' 85' ' ' VAL . 51.0 t -110.26 159.07 10.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.198 -0.455 . . . . 15.0 110.678 -179.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.655 HG12 ' O ' ' A' ' 85' ' ' VAL . 19.7 t -98.12 79.92 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.051 0.453 . . . . 15.0 110.429 179.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 3.0 t60 -100.51 84.22 2.73 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.842 -0.617 . . . . 15.0 110.426 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.794 ' HB3' HD21 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -101.45 117.53 35.13 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.003 -0.544 . . . . 15.0 111.655 -179.325 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.79 ' HB2' ' HB3' ' A' ' 60' ' ' ALA . 4.3 mp -92.87 100.23 12.74 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.807 -0.442 . . . . 15.0 109.807 179.038 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.794 HD21 ' HB3' ' A' ' 87' ' ' LEU . 0.2 OUTLIER -103.88 -162.83 0.93 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.92 -0.582 . . . . 15.0 111.655 -178.871 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.455 ' HA ' ' HA ' ' A' ' 6' ' ' ILE . 3.8 tt0 -139.09 148.18 42.97 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.259 -0.882 . . . . 15.0 110.056 179.285 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.04 113.41 1.69 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.298 -0.41 . . . . 15.0 111.136 -179.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.27 0 C-N-CA 120.879 -0.677 . . . . 15.0 112.722 -179.741 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.459 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 1.4 mp . . . . . 0 N--CA 1.45 -0.435 0 CA-C-O 120.8 0.334 . . . . 15.0 111.101 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.682 ' CZ ' HD12 ' A' ' 89' ' ' LEU . 3.4 p90 -140.66 163.33 33.18 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.185 -0.461 . . . . 15.0 110.574 178.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.737 ' HB2' HD12 ' A' ' 88' ' ' LEU . 10.2 pt-20 -129.04 143.6 50.92 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.204 0.526 . . . . 15.0 111.466 -179.364 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.499 ' CG1' HD11 ' A' ' 89' ' ' LEU . 0.3 OUTLIER -101.54 115.7 43.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.335 -0.848 . . . . 15.0 109.818 178.969 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -105.98 70.54 0.86 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.154 -0.475 . . . . 15.0 111.727 -179.202 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.77 HD13 ' CG ' ' A' ' 51' ' ' ARG . 4.9 tp -88.05 165.74 14.94 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.117 -0.492 . . . . 15.0 110.064 179.167 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -95.71 94.43 7.69 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.919 0.39 . . . . 15.0 111.125 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.674 ' CB ' HG23 ' A' ' 85' ' ' VAL . 0.2 OUTLIER . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 115.96 -0.564 . . . . 15.0 111.095 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.649 ' N ' HD22 ' A' ' 18' ' ' LEU . 1.3 mm? . . . . . 0 N--CA 1.453 -0.321 0 CA-C-O 120.773 0.321 . . . . 15.0 110.736 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.773 ' O ' ' HB ' ' A' ' 41' ' ' ILE . . . -169.02 43.67 0.22 Allowed Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.72 -0.752 . . . . 15.0 112.314 -179.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.707 HD12 ' HB ' ' A' ' 52' ' ' ILE . 0.0 OUTLIER -112.72 139.39 37.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 120.928 0.394 . . . . 15.0 111.516 -179.806 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.401 ' HB3' HD11 ' A' ' 41' ' ' ILE . 18.3 t -96.23 105.41 17.46 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.572 -0.899 . . . . 15.0 108.572 178.004 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.804 ' CG2' HG23 ' A' ' 75' ' ' VAL . 5.7 m -93.94 155.21 3.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 112.722 0.638 . . . . 15.0 112.722 -177.511 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.657 ' O ' ' O ' ' A' ' 36' ' ' TYR . 0.2 OUTLIER -149.68 153.28 36.72 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.627 -0.715 . . . . 15.0 111.463 -179.7 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.418 ' O ' HG12 ' A' ' 35' ' ' ILE . . . 67.5 121.53 0.02 OUTLIER Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.484 -0.865 . . . . 15.0 113.351 178.648 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.523 ' HA3' ' N ' ' A' ' 71' ' ' HIS . . . -166.3 -39.3 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.962 -0.637 . . . . 15.0 112.455 179.27 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.553 ' O ' HG22 ' A' ' 30' ' ' VAL . 0.1 OUTLIER -40.46 161.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 CA-C-O 120.849 0.357 . . . . 15.0 111.645 179.87 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 6.8 m-80 -85.84 52.51 2.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.22 -0.445 . . . . 15.0 110.952 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.4 m -151.71 -58.23 0.15 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.195 -0.457 . . . . 15.0 110.8 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.4 m -68.91 -51.76 36.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 15.0 110.847 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.673 HG21 ' O ' ' A' ' 34' ' ' GLY . 17.5 m -87.99 -169.08 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.166 -0.47 . . . . 15.0 110.934 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 4.3 mmt180 -93.41 125.67 38.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.937 0.399 . . . . 15.0 111.073 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 74.6 m80 61.67 -80.61 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.945 -0.571 . . . . 15.0 111.52 179.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -175.25 34.59 0.1 OUTLIER Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.9 -0.667 . . . . 15.0 112.422 -179.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.673 ' O ' HG21 ' A' ' 30' ' ' VAL . . . -95.15 158.24 22.3 Favored Glycine 0 N--CA 1.449 -0.487 0 N-CA-C 110.659 -0.976 . . . . 15.0 110.659 179.027 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 1.051 HG22 HG22 ' A' ' 58' ' ' VAL . 0.1 OUTLIER -101.12 153.11 4.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 C-N-CA 119.852 -0.739 . . . . 15.0 112.058 -179.326 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.657 ' O ' ' O ' ' A' ' 23' ' ' THR . 11.7 m-85 -133.22 108.29 8.68 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.13 -0.941 . . . . 15.0 109.308 179.343 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.705 HG22 ' N ' ' A' ' 55' ' ' GLY . 0.7 OUTLIER -54.84 169.61 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 C-N-CA 120.359 -0.536 . . . . 15.0 111.113 -178.33 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.77 -49.22 4.23 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.806 -0.813 . . . . 15.0 108.806 178.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.707 ' O ' HG12 ' A' ' 20' ' ' ILE . . . -171.96 173.13 4.52 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 115.523 -0.762 . . . . 15.0 110.054 179.03 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.533 ' HA ' ' CG1' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -96.42 103.3 14.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 109.244 -0.65 . . . . 15.0 109.244 179.15 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.773 ' HB ' ' O ' ' A' ' 19' ' ' GLY . 0.6 OUTLIER -69.13 115.74 34.88 Favored Pre-proline 0 C--N 1.328 -0.353 0 N-CA-C 113.376 0.88 . . . . 15.0 113.376 -177.066 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.591 ' HA ' ' HG2' ' A' ' 47' ' ' GLU . 37.5 Cg_exo -61.16 62.01 0.1 OUTLIER 'Trans proline' 0 C--N 1.358 1.038 0 C-N-CA 123.655 2.903 . . . . 15.0 112.951 179.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.515 ' HB2' HG22 ' A' ' 41' ' ' ILE . 7.3 mt-30 -150.55 -48.6 0.13 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.635 0.255 . . . . 15.0 111.524 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.751 ' HA3' ' HA3' ' A' ' 19' ' ' GLY . . . -87.73 167.82 37.16 Favored Glycine 0 C--N 1.33 0.232 0 C-N-CA 120.387 -0.911 . . . . 15.0 113.861 -179.128 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -58.5 -13.52 5.77 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.087 -0.556 . . . . 15.0 112.43 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.16 -56.74 5.06 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.696 0.284 . . . . 15.0 110.784 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.591 ' HG2' ' HA ' ' A' ' 42' ' ' PRO . 2.8 pp20? -57.59 -41.99 82.3 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.059 -0.519 . . . . 15.0 110.502 179.239 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -53.55 -69.54 0.12 Allowed 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 115.769 -0.651 . . . . 15.0 110.567 -179.25 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.665 ' CB ' HD11 ' A' ' 11' ' ' LEU . 0.1 OUTLIER -60.25 -41.25 92.81 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.149 -0.685 . . . . 15.0 109.149 178.867 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.8 46.47 7.18 Favored Glycine 0 N--CA 1.446 -0.663 0 CA-C-N 115.436 -0.802 . . . . 15.0 111.866 179.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.77 ' CG ' HD13 ' A' ' 11' ' ' LEU . 0.9 OUTLIER -79.78 -44.77 20.03 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.695 0.283 . . . . 15.0 110.969 -179.285 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.707 ' HB ' HD12 ' A' ' 20' ' ' ILE . 3.5 mm -91.42 160.92 2.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.055 0.455 . . . . 15.0 111.187 179.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . 0.57 ' N ' HG22 ' A' ' 52' ' ' ILE . 75.9 m80 -140.52 148.92 41.78 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-N 115.741 -0.663 . . . . 15.0 110.438 179.52 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.568 ' HA ' ' CG2' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -36.23 133.76 0.47 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.935 -1.03 . . . . 15.0 112.575 -178.237 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.705 ' N ' HG22 ' A' ' 37' ' ' VAL . . . 55.14 33.0 57.3 Favored Glycine 0 N--CA 1.453 -0.2 0 CA-C-N 115.309 -0.86 . . . . 15.0 113.707 179.5 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -66.13 127.75 33.36 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 117.603 0.701 . . . . 15.0 110.541 179.217 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.572 ' NH1' HD11 ' A' ' 59' ' ' LEU . 50.8 ttt-85 -80.71 86.6 5.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.464 -0.335 . . . . 15.0 110.529 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 1.051 HG22 HG22 ' A' ' 35' ' ' ILE . 1.3 m -79.95 115.3 22.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 CA-C-O 121.174 0.512 . . . . 15.0 111.173 -179.588 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.572 HD11 ' NH1' ' A' ' 57' ' ' ARG . 20.4 mt -107.43 -12.73 15.25 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 115.432 -0.804 . . . . 15.0 112.165 -179.41 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.864 ' HB3' ' HB2' ' A' ' 88' ' ' LEU . . . -150.06 144.6 25.87 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.202 0.525 . . . . 15.0 112.388 -178.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.832 HG11 ' O ' ' A' ' 77' ' ' THR . 44.9 t -139.04 101.73 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.452 -0.795 . . . . 15.0 109.457 178.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.86 ' ND2' HG22 ' A' ' 81' ' ' THR . 1.5 m-80 64.87 15.87 10.15 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.822 -0.436 . . . . 15.0 109.822 -178.327 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 107.08 5.75 34.87 Favored Glycine 0 C--N 1.335 0.512 0 CA-C-N 115.956 -0.566 . . . . 15.0 113.469 179.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.654 ' O ' HG13 ' A' ' 64' ' ' VAL . 5.8 p -93.85 105.49 16.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 117.275 0.537 . . . . 15.0 110.949 179.405 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 72.3 m -58.41 131.75 51.65 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.122 -0.49 . . . . 15.0 110.936 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.464 HD11 ' HB2' ' A' ' 74' ' ' ALA . 0.2 OUTLIER -87.65 -18.93 28.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.015 -0.539 . . . . 15.0 110.91 179.942 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -48.23 95.07 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.876 0.37 . . . . 15.0 110.858 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.66 66.82 0.59 Allowed Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.81 -0.709 . . . . 15.0 111.96 -179.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.615 ' HB1' ' CG ' ' A' ' 73' ' ' GLN . . . -172.73 161.9 4.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.915 0.388 . . . . 15.0 110.9 -179.646 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.489 ' HB ' HG13 ' A' ' 26' ' ' VAL . 8.3 p -93.19 -173.68 3.32 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.188 -0.46 . . . . 15.0 111.436 -179.562 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . 0.664 ' CD2' HG23 ' A' ' 22' ' ' VAL . 0.1 OUTLIER -62.38 -60.76 3.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.832 -0.622 . . . . 15.0 110.39 -179.967 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.418 ' O ' ' HG3' ' A' ' 76' ' ' GLU . 17.7 ttpp -52.54 -30.69 31.94 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.746 -0.661 . . . . 15.0 110.442 179.36 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.615 ' CG ' ' HB1' ' A' ' 69' ' ' ALA . 0.9 OUTLIER -59.39 -51.43 69.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.072 -0.513 . . . . 15.0 110.075 179.567 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.479 ' O ' ' HG ' ' A' ' 78' ' ' LEU . . . -66.94 -45.23 78.44 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 109.717 -0.475 . . . . 15.0 109.717 178.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.804 HG23 ' CG2' ' A' ' 22' ' ' VAL . 0.5 OUTLIER -42.65 -43.14 1.11 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.269 0 N-CA-C 108.946 -0.761 . . . . 15.0 108.946 178.167 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.418 ' HG3' ' O ' ' A' ' 72' ' ' LYS . 24.3 mt-10 -67.42 -44.02 79.79 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 114.925 -1.034 . . . . 15.0 110.005 178.267 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.832 ' O ' HG11 ' A' ' 61' ' ' VAL . 72.0 p -64.2 -54.18 37.58 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 116.744 -0.207 . . . . 15.0 111.397 179.718 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.776 HD21 HG21 ' A' ' 58' ' ' VAL . 6.6 mt -53.28 -49.03 67.79 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-O 121.277 0.56 . . . . 15.0 109.947 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.407 ' O ' ' N ' ' A' ' 81' ' ' THR . 4.3 ttp180 -68.51 -59.87 2.84 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.322 -0.854 . . . . 15.0 110.699 179.508 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.412 ' CB ' ' O ' ' A' ' 76' ' ' GLU . 43.4 m-20 -66.0 62.28 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.024 -0.535 . . . . 15.0 112.057 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.86 HG22 ' ND2' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -93.8 -68.68 0.79 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.83 0.348 . . . . 15.0 110.077 179.044 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 122.09 -109.85 1.51 Allowed Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 120.957 -0.64 . . . . 15.0 112.874 179.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -65.47 -77.26 0.06 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.52 -0.34 . . . . 15.0 111.701 -179.314 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.433 HG12 ' N ' ' A' ' 85' ' ' VAL . 55.8 t -110.17 157.68 10.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.174 -0.466 . . . . 15.0 111.295 -179.4 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.676 HG12 ' O ' ' A' ' 85' ' ' VAL . 8.6 t -98.0 81.16 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.026 -0.534 . . . . 15.0 110.48 179.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -100.43 86.08 3.1 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.796 -0.638 . . . . 15.0 110.506 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.731 ' HB3' HD21 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -103.86 126.03 50.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.058 -0.519 . . . . 15.0 111.807 -179.265 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.864 ' HB2' ' HB3' ' A' ' 60' ' ' ALA . 4.9 mp -101.64 101.59 12.15 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.305 -0.628 . . . . 15.0 109.305 178.536 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.731 HD21 ' HB3' ' A' ' 87' ' ' LEU . 0.1 OUTLIER -105.66 -165.19 1.09 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.502 0.667 . . . . 15.0 112.089 -178.448 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.459 ' HA ' ' HA ' ' A' ' 6' ' ' ILE . 1.0 OUTLIER -140.12 136.23 33.33 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.873 -1.058 . . . . 15.0 109.619 178.97 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 10.2 tppt? -46.89 103.63 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.93 0.395 . . . . 15.0 111.293 -179.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.399 0 C-N-CA 120.866 -0.683 . . . . 15.0 112.565 -179.878 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.45 HG13 ' HB2' ' A' ' 90' ' ' GLU . 1.4 mp . . . . . 0 N--CA 1.45 -0.449 0 CA-C-O 120.714 0.292 . . . . 15.0 111.099 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.524 ' CZ ' HD12 ' A' ' 89' ' ' LEU . 2.2 p90 -140.59 163.75 32.03 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.318 -0.401 . . . . 15.0 110.561 178.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.759 ' HB2' HD12 ' A' ' 88' ' ' LEU . 11.0 pt-20 -128.97 143.05 50.76 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.257 0.551 . . . . 15.0 111.424 -179.453 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.489 ' CG1' HD11 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -101.44 114.6 41.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.227 -0.897 . . . . 15.0 109.572 178.924 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -106.09 72.42 0.94 Allowed 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 112.397 0.518 . . . . 15.0 112.397 -178.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.938 HD13 ' HG3' ' A' ' 51' ' ' ARG . 6.5 tp -88.35 166.7 14.1 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.517 -0.549 . . . . 15.0 109.517 178.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -95.97 94.0 7.34 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.961 0.41 . . . . 15.0 111.305 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.713 ' CB ' HG23 ' A' ' 85' ' ' VAL . 0.2 OUTLIER . . . . . 0 C--N 1.328 -0.361 0 CA-C-N 115.884 -0.598 . . . . 15.0 111.057 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 9.6 mt . . . . . 0 N--CA 1.454 -0.235 0 CA-C-O 120.939 0.4 . . . . 15.0 110.763 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.757 ' O ' ' HB ' ' A' ' 41' ' ' ILE . . . -164.71 40.72 0.3 Allowed Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 121.01 -0.614 . . . . 15.0 111.826 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.625 HD12 ' CG1' ' A' ' 52' ' ' ILE . 0.0 OUTLIER -112.7 138.86 40.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 121.004 0.43 . . . . 15.0 111.773 -179.441 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.455 ' O ' ' HB3' ' A' ' 38' ' ' LYS . 21.1 t -94.49 100.4 12.4 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 107.704 -1.221 . . . . 15.0 107.704 177.282 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.751 HG23 ' CD2' ' A' ' 71' ' ' HIS . 1.4 m -93.79 152.69 3.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 112.463 0.542 . . . . 15.0 112.463 -177.076 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.544 ' HA ' ' ND1' ' A' ' 71' ' ' HIS . 14.8 t -149.29 -174.64 4.71 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.444 -0.798 . . . . 15.0 110.71 179.564 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.652 ' O ' HG22 ' A' ' 26' ' ' VAL . . . 75.18 -115.51 4.66 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 120.721 -0.752 . . . . 15.0 112.153 -179.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.544 ' HA3' ' N ' ' A' ' 71' ' ' HIS . . . 64.33 -65.34 0.06 OUTLIER Glycine 0 N--CA 1.453 -0.215 0 C-N-CA 121.015 -0.612 . . . . 15.0 113.841 179.024 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.652 HG22 ' O ' ' A' ' 24' ' ' GLY . 0.0 OUTLIER -30.54 145.13 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 N-CA-C 112.362 0.504 . . . . 15.0 112.362 -179.143 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -79.63 56.25 2.18 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.961 -0.563 . . . . 15.0 111.031 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -151.69 -64.96 0.18 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.234 -0.439 . . . . 15.0 110.641 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.63 -48.23 70.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.11 -0.495 . . . . 15.0 110.559 179.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.643 HG22 ' O ' ' A' ' 26' ' ' VAL . 34.5 m -88.09 -171.15 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.024 -0.534 . . . . 15.0 110.77 179.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -92.4 127.17 37.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.91 0.386 . . . . 15.0 111.155 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 34.4 m80 58.18 -84.71 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.937 -0.574 . . . . 15.0 111.464 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -167.7 26.18 0.14 Allowed Glycine 0 C--N 1.331 0.263 0 C-N-CA 120.977 -0.63 . . . . 15.0 112.274 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.41 ' O ' HG21 ' A' ' 30' ' ' VAL . . . -83.83 149.16 25.28 Favored Glycine 0 N--CA 1.448 -0.529 0 N-CA-C 110.769 -0.932 . . . . 15.0 110.769 178.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.8 HG22 HG22 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -88.29 153.45 3.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 117.537 0.669 . . . . 15.0 111.777 -179.165 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.49 ' CZ ' ' HG2' ' A' ' 57' ' ' ARG . 30.7 m-85 -139.76 107.94 5.78 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.026 -0.988 . . . . 15.0 109.732 179.571 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.763 HG22 ' N ' ' A' ' 55' ' ' GLY . 0.8 OUTLIER -55.99 151.29 2.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.046 0.45 . . . . 15.0 111.284 -179.111 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.457 ' O ' ' HG2' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -83.8 -45.3 13.46 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.493 -0.928 . . . . 15.0 108.493 178.29 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.613 ' O ' HG12 ' A' ' 20' ' ' ILE . . . -172.28 172.43 4.5 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 115.853 -0.612 . . . . 15.0 110.32 178.333 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.591 ' HA ' HG12 ' A' ' 20' ' ' ILE . 0.1 OUTLIER -96.86 109.71 23.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.205 -0.665 . . . . 15.0 109.205 179.04 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.757 ' HB ' ' O ' ' A' ' 19' ' ' GLY . 0.5 OUTLIER -78.24 115.29 49.76 Favored Pre-proline 0 C--N 1.327 -0.371 0 N-CA-C 113.51 0.93 . . . . 15.0 113.51 -177.148 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.631 ' HA ' ' CG ' ' A' ' 47' ' ' GLU . 32.8 Cg_exo -62.0 60.58 0.13 Allowed 'Trans proline' 0 C--N 1.357 1.01 0 C-N-CA 123.619 2.879 . . . . 15.0 112.949 179.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.528 ' N ' ' HG2' ' A' ' 47' ' ' GLU . 6.0 tt0 -147.33 -48.38 0.18 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.62 0.248 . . . . 15.0 111.345 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.703 ' HA3' ' HA3' ' A' ' 19' ' ' GLY . . . -87.86 169.02 38.16 Favored Glycine 0 C--N 1.33 0.217 0 C-N-CA 120.403 -0.903 . . . . 15.0 113.807 -179.192 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -57.91 -13.84 5.17 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.749 0.648 . . . . 15.0 112.749 -179.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.9 -56.47 5.64 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.936 -0.306 . . . . 15.0 110.711 -179.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.631 ' CG ' ' HA ' ' A' ' 42' ' ' PRO . 2.9 pp20? -57.57 -42.96 84.1 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.992 -0.549 . . . . 15.0 110.322 179.009 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -53.86 -70.75 0.09 Allowed 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 115.828 -0.624 . . . . 15.0 110.567 -179.497 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.426 ' CB ' HD11 ' A' ' 11' ' ' LEU . 0.5 OUTLIER -58.11 -41.18 83.01 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.046 -0.724 . . . . 15.0 109.046 178.872 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.73 40.56 12.12 Favored Glycine 0 N--CA 1.446 -0.655 0 CA-C-N 115.345 -0.843 . . . . 15.0 111.779 179.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.938 ' HG3' HD13 ' A' ' 11' ' ' LEU . 2.7 mmp_? -79.78 -50.49 10.48 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.931 0.396 . . . . 15.0 110.644 -179.438 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.625 ' CG1' HD12 ' A' ' 20' ' ' ILE . 9.4 tp -81.1 160.1 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 CA-C-N 115.989 -0.55 . . . . 15.0 110.378 179.543 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . 0.459 ' O ' ' HB2' ' A' ' 56' ' ' ASP . 75.7 m80 -145.31 159.01 43.69 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-O 121.599 0.714 . . . . 15.0 112.083 -179.217 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.534 ' HA ' ' CG2' ' A' ' 37' ' ' VAL . 0.1 OUTLIER -42.21 132.91 3.25 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.512 -1.222 . . . . 15.0 112.642 -178.687 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.763 ' N ' HG22 ' A' ' 37' ' ' VAL . . . 49.98 34.24 22.89 Favored Glycine 0 C--N 1.333 0.395 0 CA-C-N 115.761 -0.654 . . . . 15.0 113.425 179.277 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.459 ' HB2' ' O ' ' A' ' 53' ' ' HIS . 0.3 OUTLIER -65.84 132.66 49.21 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.538 -0.465 . . . . 15.0 110.617 179.475 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.797 ' HD2' HD21 ' A' ' 59' ' ' LEU . 0.0 OUTLIER -85.73 92.13 8.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.321 -0.4 . . . . 15.0 110.499 179.664 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.8 HG22 HG22 ' A' ' 35' ' ' ILE . 2.0 m -83.14 114.43 23.9 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 CA-C-O 120.988 0.423 . . . . 15.0 111.143 -179.566 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.797 HD21 ' HD2' ' A' ' 57' ' ' ARG . 3.4 mm? -107.15 -16.39 14.43 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 115.747 -0.66 . . . . 15.0 112.494 -179.236 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.711 ' HB3' ' HB2' ' A' ' 88' ' ' LEU . . . -147.78 146.91 29.35 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.112 0.482 . . . . 15.0 112.222 -178.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.902 HG23 HD11 ' A' ' 66' ' ' LEU . 61.5 t -138.78 102.18 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.578 -0.737 . . . . 15.0 109.194 178.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.815 ' ND2' HG22 ' A' ' 81' ' ' THR . 1.3 m-80 65.07 16.1 10.37 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.103 -0.499 . . . . 15.0 109.763 -178.096 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 105.83 5.18 38.94 Favored Glycine 0 C--N 1.336 0.564 0 CA-C-N 115.821 -0.627 . . . . 15.0 113.247 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.646 ' O ' HG13 ' A' ' 64' ' ' VAL . 5.5 p -93.84 108.3 20.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.983 0.392 . . . . 15.0 110.979 179.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 21.4 m -57.99 124.89 20.83 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.204 0.526 . . . . 15.0 110.777 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.902 HD11 HG23 ' A' ' 61' ' ' VAL . 0.3 OUTLIER -87.72 -21.06 25.41 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.444 -0.798 . . . . 15.0 111.327 -179.499 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -46.7 103.6 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.843 0.354 . . . . 15.0 110.986 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.89 63.11 0.54 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.764 -0.731 . . . . 15.0 112.55 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.56 ' HB1' ' CB ' ' A' ' 73' ' ' GLN . . . -172.98 164.64 4.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.835 0.35 . . . . 15.0 111.024 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.534 ' HB ' HG13 ' A' ' 26' ' ' VAL . 5.9 p -93.26 -172.89 3.08 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.067 0.46 . . . . 15.0 111.118 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . 0.751 ' CD2' HG23 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -62.35 -61.34 2.52 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.733 -0.667 . . . . 15.0 110.212 179.985 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 22.4 ttpp -52.85 -35.68 57.77 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.789 -0.641 . . . . 15.0 110.345 179.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.56 ' CB ' ' HB1' ' A' ' 69' ' ' ALA . 4.8 mt-30 -59.68 -48.31 82.19 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.432 -0.581 . . . . 15.0 109.432 179.137 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.494 ' HB3' HG13 ' A' ' 35' ' ' ILE . . . -66.79 -47.87 70.75 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 115.789 -0.641 . . . . 15.0 109.441 178.361 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.619 HG23 ' CG2' ' A' ' 22' ' ' VAL . 0.5 OUTLIER -41.66 -40.26 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.271 0 N-CA-C 108.827 -0.805 . . . . 15.0 108.827 178.203 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.476 ' O ' ' HB2' ' A' ' 80' ' ' ASN . 1.5 mm-40 -67.2 -47.02 72.13 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.734 -1.121 . . . . 15.0 110.509 178.542 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.734 ' O ' HG11 ' A' ' 61' ' ' VAL . 16.5 p -64.08 -53.06 55.69 Favored 'General case' 0 N--CA 1.461 0.117 0 C-N-CA 120.913 -0.315 . . . . 15.0 111.469 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.743 HD23 HG21 ' A' ' 61' ' ' VAL . 3.6 mt -53.44 -47.43 69.68 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.174 0.511 . . . . 15.0 110.047 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.447 ' HB2' ' O ' ' A' ' 75' ' ' VAL . 0.0 OUTLIER -68.64 -57.9 5.03 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.571 -0.741 . . . . 15.0 110.657 179.331 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.476 ' HB2' ' O ' ' A' ' 76' ' ' GLU . 11.9 m-80 -65.92 63.05 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.163 -0.472 . . . . 15.0 111.966 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.815 HG22 ' ND2' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -94.0 -71.95 0.64 Allowed 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 110.096 -0.335 . . . . 15.0 110.096 179.103 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 122.06 -105.22 0.96 Allowed Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.774 -0.727 . . . . 15.0 113.124 179.235 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.415 ' O ' ' HB3' ' A' ' 13' ' ' LYS . 0.1 OUTLIER -64.8 -82.86 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 111.885 0.328 . . . . 15.0 111.885 -179.16 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.453 HG12 ' N ' ' A' ' 85' ' ' VAL . 72.9 t -109.64 159.85 8.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.921 0.391 . . . . 15.0 110.869 -179.508 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.713 HG23 ' CB ' ' A' ' 13' ' ' LYS . 14.9 t -97.76 80.83 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.054 0.454 . . . . 15.0 110.593 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -102.84 85.09 2.48 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.765 -0.652 . . . . 15.0 110.44 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.834 ' HB3' HD21 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -102.42 119.9 39.6 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.948 -0.569 . . . . 15.0 111.742 -179.207 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.759 HD12 ' HB2' ' A' ' 8' ' ' GLU . 4.3 mp -94.52 100.66 12.6 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.773 -0.454 . . . . 15.0 109.773 178.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.834 HD21 ' HB3' ' A' ' 87' ' ' LEU . 0.1 OUTLIER -105.81 -163.53 0.95 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.517 0.675 . . . . 15.0 112.173 -178.531 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.45 ' HB2' HG13 ' A' ' 6' ' ' ILE . 3.4 tt0 -141.36 140.15 33.67 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 114.824 -1.08 . . . . 15.0 109.505 179.02 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 2.7 tptp -55.98 96.66 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.025 0.441 . . . . 15.0 111.014 -179.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.518 0.254 0 CA-C-N 115.732 -0.667 . . . . 15.0 113.188 -179.677 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.419 ' CD1' ' HB2' ' A' ' 90' ' ' GLU . 1.2 mp . . . . . 0 N--CA 1.45 -0.458 0 CA-C-O 120.897 0.38 . . . . 15.0 111.244 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.79 ' CZ ' HD12 ' A' ' 89' ' ' LEU . 2.1 p90 -140.28 164.32 30.4 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.012 -0.54 . . . . 15.0 110.253 178.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.719 ' CB ' HD12 ' A' ' 88' ' ' LEU . 10.0 pt-20 -130.06 143.96 51.08 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.254 0.55 . . . . 15.0 111.701 -179.33 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.501 ' CG2' ' HB3' ' A' ' 51' ' ' ARG . 0.3 OUTLIER -101.5 116.99 46.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.327 -0.851 . . . . 15.0 109.815 178.895 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -106.01 70.97 0.87 Allowed 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.278 -0.419 . . . . 15.0 111.854 -179.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.819 HD13 ' CG ' ' A' ' 51' ' ' ARG . 6.0 tp -87.83 164.75 15.75 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.124 -0.489 . . . . 15.0 109.853 179.088 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -95.91 94.03 7.38 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.993 0.425 . . . . 15.0 111.346 -179.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.687 ' CB ' HG23 ' A' ' 85' ' ' VAL . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.367 0 CA-C-N 115.904 -0.589 . . . . 15.0 110.881 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.658 ' N ' HD22 ' A' ' 18' ' ' LEU . 1.3 mm? . . . . . 0 N--CA 1.453 -0.304 0 CA-C-O 121.019 0.438 . . . . 15.0 110.66 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.601 ' O ' ' HB ' ' A' ' 41' ' ' ILE . . . -165.78 31.46 0.22 Allowed Glycine 0 C--O 1.224 -0.529 0 N-CA-C 111.336 -0.706 . . . . 15.0 111.336 -179.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.708 HG13 HG12 ' A' ' 40' ' ' VAL . 0.0 OUTLIER -114.07 140.87 32.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 112.314 0.487 . . . . 15.0 112.314 -179.497 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.746 ' HB3' HD11 ' A' ' 41' ' ' ILE . 1.7 t -96.43 106.32 18.54 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 107.962 -1.125 . . . . 15.0 107.962 176.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.961 HG21 HG23 ' A' ' 75' ' ' VAL . 21.1 m -93.59 149.59 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 N-CA-C 112.947 0.721 . . . . 15.0 112.947 -177.246 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.537 HG22 ' HB2' ' A' ' 38' ' ' LYS . 8.8 t -150.37 -179.96 7.63 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.357 -0.838 . . . . 15.0 110.887 179.266 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.662 ' O ' HG22 ' A' ' 26' ' ' VAL . . . 74.11 -114.83 4.68 Favored Glycine 0 C--N 1.334 0.467 0 C-N-CA 120.973 -0.632 . . . . 15.0 112.526 179.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.539 ' HA3' ' N ' ' A' ' 71' ' ' HIS . . . 63.88 -65.3 0.05 OUTLIER Glycine 0 C--N 1.331 0.251 0 C-N-CA 121.093 -0.575 . . . . 15.0 113.885 179.082 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.662 HG22 ' O ' ' A' ' 24' ' ' GLY . 0.0 OUTLIER -28.68 141.81 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 N-CA-C 112.329 0.492 . . . . 15.0 112.329 -179.159 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -75.53 62.24 1.38 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.965 -0.561 . . . . 15.0 111.001 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 9.7 m -151.71 -65.34 0.18 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.258 -0.428 . . . . 15.0 111.011 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -69.52 -48.92 58.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.118 -0.492 . . . . 15.0 111.087 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.554 HG22 ' O ' ' A' ' 26' ' ' VAL . 34.8 m -72.69 -174.51 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.217 -0.447 . . . . 15.0 111.247 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.45 -74.56 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.184 -0.462 . . . . 15.0 111.258 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 8.8 p-80 -132.52 -45.71 0.9 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.35 -0.386 . . . . 15.0 111.179 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -168.39 24.05 0.11 Allowed Glycine 0 N--CA 1.453 -0.19 0 C-N-CA 120.8 -0.714 . . . . 15.0 112.732 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -90.31 153.71 22.99 Favored Glycine 0 N--CA 1.449 -0.448 0 N-CA-C 110.836 -0.906 . . . . 15.0 110.836 178.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.91 HG22 HG22 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -92.21 154.11 3.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.504 0.669 . . . . 15.0 111.888 -179.335 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.51 ' CZ ' ' HG2' ' A' ' 57' ' ' ARG . 24.1 m-85 -139.49 110.97 7.07 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.857 -1.065 . . . . 15.0 109.136 178.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.794 HG22 ' N ' ' A' ' 55' ' ' GLY . 0.8 OUTLIER -56.44 156.42 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.46 0.648 . . . . 15.0 110.953 -178.762 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.537 ' HB2' HG22 ' A' ' 23' ' ' THR . 0.0 OUTLIER -90.39 -46.85 8.11 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 108.281 -1.007 . . . . 15.0 108.281 178.667 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.532 ' O ' HG12 ' A' ' 20' ' ' ILE . . . -172.84 166.74 5.23 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.088 -0.96 . . . . 15.0 110.566 178.326 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.708 HG12 HG13 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -97.24 119.94 45.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.789 0.328 . . . . 15.0 110.493 179.75 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.746 HD11 ' HB3' ' A' ' 21' ' ' SER . 1.4 mm -78.31 109.28 9.8 Favored Pre-proline 0 N--CA 1.466 0.358 0 N-CA-C 113.028 0.751 . . . . 15.0 113.028 -178.394 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.453 ' HA ' ' OE1' ' A' ' 47' ' ' GLU . 41.0 Cg_endo -66.54 64.42 0.53 Allowed 'Trans proline' 0 C--N 1.352 0.753 0 C-N-CA 122.846 2.364 . . . . 15.0 112.28 179.474 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 11.5 mt-30 -159.37 -45.91 0.05 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.362 -0.835 . . . . 15.0 109.436 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.508 ' HA3' ' HA3' ' A' ' 19' ' ' GLY . . . -87.4 151.6 23.56 Favored Glycine 0 N--CA 1.446 -0.678 0 CA-C-N 115.611 -0.722 . . . . 15.0 112.222 179.232 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.502 ' O ' HD21 ' A' ' 11' ' ' LEU . . . -40.59 -18.28 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 113.367 0.877 . . . . 15.0 113.367 -179.435 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.465 ' N ' ' O ' ' A' ' 44' ' ' GLY . . . -71.66 -71.64 0.26 Allowed 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.893 -0.323 . . . . 15.0 111.267 -179.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.56 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 9.4 tm-20 -58.16 -37.79 75.36 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.832 0.348 . . . . 15.0 110.341 179.578 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 16.0 m -53.92 -66.4 0.4 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.1 -0.5 . . . . 15.0 110.47 179.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.643 ' CB ' HD11 ' A' ' 11' ' ' LEU . 2.1 t0 -63.3 -37.64 88.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.103 -0.499 . . . . 15.0 109.922 179.152 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.55 43.68 8.32 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.928 -0.653 . . . . 15.0 112.523 179.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.819 ' CG ' HD13 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -80.13 -51.72 8.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.75 0.309 . . . . 15.0 110.724 179.943 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.734 HG21 HG11 ' A' ' 37' ' ' VAL . 1.2 mm -91.24 163.41 2.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.973 0.416 . . . . 15.0 111.15 179.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . 0.614 ' N ' HG22 ' A' ' 52' ' ' ILE . 47.6 m80 -139.39 153.29 47.62 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-O 121.368 0.604 . . . . 15.0 110.485 179.463 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.506 ' HA ' ' CG2' ' A' ' 37' ' ' VAL . 0.6 OUTLIER -35.21 132.96 0.35 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.747 -1.115 . . . . 15.0 112.354 -178.459 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.794 ' N ' HG22 ' A' ' 37' ' ' VAL . . . 52.11 35.57 41.9 Favored Glycine 0 C--N 1.332 0.31 0 CA-C-N 115.892 -0.594 . . . . 15.0 114.01 179.644 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -66.16 130.57 43.68 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 117.676 0.738 . . . . 15.0 110.561 179.205 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.51 ' HG2' ' CZ ' ' A' ' 36' ' ' TYR . 26.4 mtt-85 -81.63 91.55 6.43 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.462 -0.335 . . . . 15.0 110.586 179.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.91 HG22 HG22 ' A' ' 35' ' ' ILE . 1.1 m -85.86 116.29 28.67 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 CA-C-O 121.178 0.513 . . . . 15.0 111.384 -179.645 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -107.26 -10.59 15.78 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 115.589 -0.732 . . . . 15.0 112.248 -179.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.698 ' HB3' ' HB2' ' A' ' 88' ' ' LEU . . . -152.01 145.16 24.6 Favored 'General case' 0 N--CA 1.462 0.17 0 N-CA-C 112.301 0.482 . . . . 15.0 112.301 -178.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.831 HG21 HD23 ' A' ' 78' ' ' LEU . 59.7 t -138.94 101.41 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.57 -0.741 . . . . 15.0 109.264 178.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.806 ' ND2' HG22 ' A' ' 81' ' ' THR . 1.1 m-80 64.96 16.04 10.31 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.02 0.438 . . . . 15.0 109.919 -178.286 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 107.06 4.76 35.68 Favored Glycine 0 C--N 1.336 0.578 0 CA-C-N 115.932 -0.577 . . . . 15.0 113.376 179.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.644 ' O ' HG13 ' A' ' 64' ' ' VAL . 5.2 p -93.85 107.54 19.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 117.084 0.442 . . . . 15.0 110.857 179.529 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.6 m -56.82 130.74 46.97 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.3 -0.409 . . . . 15.0 111.111 -179.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.471 HD13 ' HB3' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -90.76 -22.03 21.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.04 -0.527 . . . . 15.0 110.95 179.975 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -46.6 96.68 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.889 0.376 . . . . 15.0 111.047 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.76 66.45 0.58 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.801 -0.714 . . . . 15.0 112.428 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.512 ' HB1' ' HB3' ' A' ' 73' ' ' GLN . . . -173.09 162.77 4.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.838 0.351 . . . . 15.0 111.052 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.424 HG22 ' HA ' ' A' ' 26' ' ' VAL . 15.0 p -93.12 -174.1 3.45 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.016 0.436 . . . . 15.0 111.106 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . 0.765 ' NE2' HG23 ' A' ' 22' ' ' VAL . 0.2 OUTLIER -63.95 -59.7 4.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.841 -0.618 . . . . 15.0 110.296 179.946 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.467 ' O ' HG12 ' A' ' 75' ' ' VAL . 30.4 ttmt -52.69 -33.52 47.89 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.153 -0.476 . . . . 15.0 110.235 178.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.512 ' HB3' ' HB1' ' A' ' 69' ' ' ALA . 0.0 OUTLIER -59.39 -51.25 70.73 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.565 -0.532 . . . . 15.0 109.565 179.258 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.633 ' HB3' HG13 ' A' ' 35' ' ' ILE . . . -66.91 -43.87 82.22 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-N 116.041 -0.527 . . . . 15.0 109.711 178.425 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.961 HG23 HG21 ' A' ' 22' ' ' VAL . 0.5 OUTLIER -42.83 -41.91 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.23 0 N-CA-C 108.896 -0.779 . . . . 15.0 108.896 178.395 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.418 ' HG3' ' O ' ' A' ' 72' ' ' LYS . 17.2 mt-10 -67.32 -45.15 77.31 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.794 -1.093 . . . . 15.0 110.078 178.275 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.653 ' O ' HG11 ' A' ' 61' ' ' VAL . 82.1 p -64.17 -54.58 31.47 Favored 'General case' 0 N--CA 1.461 0.114 0 CA-C-N 116.612 -0.267 . . . . 15.0 111.436 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.831 HD23 HG21 ' A' ' 61' ' ' VAL . 4.2 mt -53.51 -48.17 69.24 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 121.145 0.498 . . . . 15.0 110.141 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.408 ' HB2' ' O ' ' A' ' 75' ' ' VAL . 0.0 OUTLIER -68.52 -59.02 3.45 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.561 -0.745 . . . . 15.0 110.564 179.478 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 74.6 m-20 -66.04 59.4 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.933 -0.576 . . . . 15.0 112.43 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.806 HG22 ' ND2' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -95.73 -71.97 0.65 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.889 -0.412 . . . . 15.0 109.889 178.855 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 122.13 -105.16 0.96 Allowed Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.72 -0.752 . . . . 15.0 113.451 178.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.406 ' O ' ' HB3' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -64.56 -83.0 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.071 0.397 . . . . 15.0 112.071 -178.815 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.443 HG12 ' N ' ' A' ' 85' ' ' VAL . 76.2 t -109.64 158.84 9.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.077 0.465 . . . . 15.0 111.167 -179.199 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.687 HG23 ' CB ' ' A' ' 13' ' ' LYS . 9.1 t -97.86 81.23 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.011 -0.54 . . . . 15.0 110.499 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -99.06 85.54 3.26 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.76 -0.655 . . . . 15.0 110.344 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.732 ' HB3' HD21 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -104.02 126.52 51.2 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.041 -0.527 . . . . 15.0 111.917 -179.16 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.719 HD12 ' CB ' ' A' ' 8' ' ' GLU . 5.0 mp -102.41 99.96 10.06 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.751 -0.463 . . . . 15.0 109.751 178.695 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.79 HD12 ' CZ ' ' A' ' 7' ' ' PHE . 0.1 OUTLIER -105.85 -162.56 0.87 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.646 0.736 . . . . 15.0 112.29 -178.633 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.419 ' HB2' ' CD1' ' A' ' 6' ' ' ILE . 3.3 tt0 -137.68 138.64 39.6 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 114.639 -1.164 . . . . 15.0 109.48 178.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.3 tppt? -49.49 107.35 0.14 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.947 0.403 . . . . 15.0 111.151 -179.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.272 0 C-N-CA 120.928 -0.653 . . . . 15.0 112.935 -179.707 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.452 HG13 ' HB2' ' A' ' 90' ' ' GLU . 1.3 mp . . . . . 0 N--CA 1.452 -0.366 0 CA-C-O 120.665 0.269 . . . . 15.0 110.709 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.513 ' CZ ' HD12 ' A' ' 89' ' ' LEU . 2.5 p90 -144.8 165.14 28.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.793 0.33 . . . . 15.0 110.686 179.177 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.732 ' CB ' HD12 ' A' ' 88' ' ' LEU . 9.7 pt-20 -130.18 143.91 51.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.22 0.534 . . . . 15.0 111.426 -179.472 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.56 ' CG1' HD11 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -101.38 115.3 42.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.434 -0.803 . . . . 15.0 109.521 178.905 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -106.02 72.03 0.92 Allowed 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.524 0.565 . . . . 15.0 112.524 -178.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.652 HD13 ' HG3' ' A' ' 51' ' ' ARG . 5.7 tp -88.2 166.3 14.46 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.448 -0.575 . . . . 15.0 109.448 178.462 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -96.18 92.15 6.26 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.897 0.379 . . . . 15.0 111.203 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.7 ' CB ' HG23 ' A' ' 85' ' ' VAL . 0.2 OUTLIER . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 115.914 -0.584 . . . . 15.0 111.018 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.65 ' N ' HD22 ' A' ' 18' ' ' LEU . 1.9 mm? . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.878 0.37 . . . . 15.0 110.748 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.782 ' O ' ' HB ' ' A' ' 41' ' ' ILE . . . -163.63 44.32 0.32 Allowed Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 121.053 -0.594 . . . . 15.0 111.871 -179.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.672 HG12 ' O ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -112.88 135.58 51.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 121.012 0.434 . . . . 15.0 111.876 -179.353 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 29.9 t -89.81 104.4 16.97 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 107.668 -1.234 . . . . 15.0 107.668 177.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 1.001 HG21 HG23 ' A' ' 75' ' ' VAL . 14.1 m -93.44 151.91 3.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 112.953 0.723 . . . . 15.0 112.953 -176.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -149.57 -177.72 6.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 114.977 -1.01 . . . . 15.0 110.678 -179.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.58 ' O ' HG22 ' A' ' 26' ' ' VAL . . . 73.26 -120.52 7.16 Favored Glycine 0 C--N 1.331 0.256 0 C-N-CA 120.675 -0.774 . . . . 15.0 112.381 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.524 ' HA3' ' N ' ' A' ' 71' ' ' HIS . . . 66.94 -65.57 0.19 Allowed Glycine 0 C--N 1.33 0.214 0 C-N-CA 120.943 -0.646 . . . . 15.0 113.565 179.31 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.58 HG22 ' O ' ' A' ' 24' ' ' GLY . 0.0 OUTLIER -25.87 133.08 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 N-CA-C 112.621 0.6 . . . . 15.0 112.621 -179.298 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -75.65 63.17 1.54 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.784 -0.644 . . . . 15.0 111.018 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.4 m -151.67 -47.27 0.11 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.287 -0.415 . . . . 15.0 111.0 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 12.5 t -90.28 -41.65 11.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 15.0 111.001 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.484 HG22 ' O ' ' A' ' 26' ' ' VAL . 33.9 m -71.99 -176.3 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.471 . . . . 15.0 111.166 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.412 ' O ' ' CD2' ' A' ' 32' ' ' HIS . 0.0 OUTLIER -57.0 -51.32 69.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.218 -0.446 . . . . 15.0 110.983 -179.995 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . 0.412 ' CD2' ' O ' ' A' ' 31' ' ' ARG . 27.0 m80 -151.21 -51.98 0.13 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.28 -0.418 . . . . 15.0 111.012 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -168.1 27.42 0.14 Allowed Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.803 -0.713 . . . . 15.0 112.5 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -91.13 149.14 19.71 Favored Glycine 0 N--CA 1.45 -0.411 0 N-CA-C 111.037 -0.825 . . . . 15.0 111.037 179.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.769 HG22 HG22 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -88.18 154.78 3.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.388 0.613 . . . . 15.0 111.719 -179.299 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.532 ' CZ ' ' HG2' ' A' ' 57' ' ' ARG . 51.2 m-85 -141.35 106.91 5.06 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.008 -0.996 . . . . 15.0 109.737 179.272 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.767 HG22 ' N ' ' A' ' 55' ' ' GLY . 0.8 OUTLIER -56.16 148.11 4.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.021 0.438 . . . . 15.0 111.317 -179.193 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.493 ' O ' ' HG2' ' A' ' 54' ' ' LYS . 0.4 OUTLIER -80.37 -46.46 16.01 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.49 -0.93 . . . . 15.0 108.49 178.248 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.672 ' O ' HG12 ' A' ' 20' ' ' ILE . . . -172.1 172.58 4.59 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.594 -0.73 . . . . 15.0 110.508 178.626 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.56 ' HA ' HG12 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -96.87 111.42 26.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 109.545 -0.539 . . . . 15.0 109.545 179.248 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.782 ' HB ' ' O ' ' A' ' 19' ' ' GLY . 0.4 OUTLIER -78.47 117.05 64.02 Favored Pre-proline 0 C--N 1.329 -0.324 0 N-CA-C 113.273 0.842 . . . . 15.0 113.273 -177.422 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.621 ' HA ' ' CG ' ' A' ' 47' ' ' GLU . 37.9 Cg_endo -65.29 59.76 0.34 Allowed 'Trans proline' 0 C--N 1.356 0.924 0 C-N-CA 123.437 2.758 . . . . 15.0 112.785 179.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.526 ' N ' ' HG2' ' A' ' 47' ' ' GLU . 0.5 OUTLIER -147.47 -46.32 0.17 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.517 -0.31 . . . . 15.0 111.296 -179.996 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.71 ' HA3' ' HA3' ' A' ' 19' ' ' GLY . . . -87.77 168.02 37.3 Favored Glycine 0 C--N 1.331 0.269 0 C-N-CA 120.332 -0.937 . . . . 15.0 113.722 -179.258 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -57.83 -14.35 5.85 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.862 0.69 . . . . 15.0 112.862 -179.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.14 -55.86 6.57 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.935 -0.306 . . . . 15.0 110.932 -179.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.621 ' CG ' ' HA ' ' A' ' 42' ' ' PRO . 2.9 pp20? -57.36 -43.02 83.15 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.923 -0.58 . . . . 15.0 110.231 179.196 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.5 m -53.84 -69.89 0.11 Allowed 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 115.882 -0.599 . . . . 15.0 110.483 -179.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.533 ' CB ' HD11 ' A' ' 11' ' ' LEU . 1.1 t0 -58.07 -41.74 84.01 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.072 -0.714 . . . . 15.0 109.072 178.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.75 40.03 12.97 Favored Glycine 0 N--CA 1.446 -0.648 0 CA-C-N 115.293 -0.867 . . . . 15.0 111.711 179.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.652 ' HG3' HD13 ' A' ' 11' ' ' LEU . 0.2 OUTLIER -79.79 -50.07 11.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.895 0.378 . . . . 15.0 110.599 -179.362 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.649 ' CG1' HD12 ' A' ' 20' ' ' ILE . 8.7 tp -81.12 161.44 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 CA-C-N 116.075 -0.511 . . . . 15.0 110.367 179.571 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . 0.471 ' O ' ' HB2' ' A' ' 56' ' ' ASP . 78.3 m80 -146.27 158.78 43.91 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-O 121.635 0.731 . . . . 15.0 112.16 -179.192 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.556 ' HA ' ' CG2' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -43.12 133.97 3.71 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 114.382 -1.281 . . . . 15.0 112.645 -178.752 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.767 ' N ' HG22 ' A' ' 37' ' ' VAL . . . 49.97 34.0 22.37 Favored Glycine 0 C--N 1.333 0.414 0 CA-C-N 115.841 -0.618 . . . . 15.0 113.354 179.403 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.471 ' HB2' ' O ' ' A' ' 53' ' ' HIS . 0.3 OUTLIER -65.96 131.9 47.33 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.635 -0.426 . . . . 15.0 110.618 179.525 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.64 ' HD2' HD21 ' A' ' 59' ' ' LEU . 0.0 OUTLIER -85.32 90.89 8.03 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.169 -0.468 . . . . 15.0 110.403 179.553 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.769 HG22 HG22 ' A' ' 35' ' ' ILE . 1.5 m -83.57 112.95 21.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.079 0.466 . . . . 15.0 111.207 -179.524 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.64 HD21 ' HD2' ' A' ' 57' ' ' ARG . 3.5 mm? -107.32 -16.54 14.37 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 115.764 -0.653 . . . . 15.0 112.615 -179.099 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.791 ' HB3' ' HB2' ' A' ' 88' ' ' LEU . . . -147.5 150.21 34.12 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 112.518 0.562 . . . . 15.0 112.518 -178.454 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.691 HG21 ' HB ' ' A' ' 77' ' ' THR . 3.3 t -139.07 101.66 1.62 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.267 0 CA-C-N 115.311 -0.859 . . . . 15.0 109.281 178.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.792 ' ND2' HG22 ' A' ' 81' ' ' THR . 2.3 m-80 64.96 15.59 10.05 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.64 -0.504 . . . . 15.0 109.64 -178.112 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 105.95 6.71 36.93 Favored Glycine 0 C--N 1.336 0.54 0 CA-C-N 115.816 -0.629 . . . . 15.0 113.126 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.664 ' O ' HG13 ' A' ' 64' ' ' VAL . 7.2 p -93.76 105.32 16.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.118 0.485 . . . . 15.0 110.727 179.283 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -59.3 116.35 3.85 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.127 -0.488 . . . . 15.0 110.733 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.704 HD21 ' HA ' ' A' ' 74' ' ' ALA . 1.2 mt -87.59 -12.07 46.75 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.826 -0.624 . . . . 15.0 111.295 -179.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -46.29 102.51 0.03 OUTLIER 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.827 0.346 . . . . 15.0 110.936 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.86 64.25 0.55 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.8 -0.714 . . . . 15.0 112.264 -179.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.721 ' HB1' ' CB ' ' A' ' 73' ' ' GLN . . . -172.91 148.44 1.79 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.9 0.381 . . . . 15.0 110.855 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.444 ' CB ' ' HA ' ' A' ' 26' ' ' VAL . 11.8 p -72.83 -173.75 1.29 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.198 -0.456 . . . . 15.0 111.157 -179.65 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . 0.789 ' CD2' HG23 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -61.89 -59.46 5.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.882 -0.599 . . . . 15.0 110.572 -179.847 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 25.0 ttpt -52.34 -35.51 51.14 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.84 -0.618 . . . . 15.0 110.689 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.721 ' CB ' ' HB1' ' A' ' 69' ' ' ALA . 3.5 mt-30 -59.31 -46.22 89.16 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.647 -0.501 . . . . 15.0 109.647 179.232 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.704 ' HA ' HD21 ' A' ' 66' ' ' LEU . . . -66.96 -50.34 62.61 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 109.472 -0.566 . . . . 15.0 109.472 178.195 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 1.001 HG23 HG21 ' A' ' 22' ' ' VAL . 0.6 OUTLIER -40.85 -43.58 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.192 0 CA-C-N 115.237 -0.892 . . . . 15.0 109.614 178.567 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.439 ' N ' HG12 ' A' ' 75' ' ' VAL . 41.4 mt-10 -67.37 -43.85 80.39 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.01 -0.996 . . . . 15.0 110.663 179.156 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.691 ' HB ' HG21 ' A' ' 61' ' ' VAL . 0.6 OUTLIER -64.68 -55.78 17.92 Favored 'General case' 0 C--O 1.23 0.075 0 C-N-CA 120.796 -0.362 . . . . 15.0 111.272 179.937 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.752 HD22 HD21 ' A' ' 87' ' ' LEU . 3.2 mt -53.43 -46.03 69.65 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 121.116 0.484 . . . . 15.0 110.132 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.22 -55.06 13.6 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.612 -0.722 . . . . 15.0 110.359 179.4 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 8.1 m-20 -66.26 57.81 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 115.919 -0.582 . . . . 15.0 112.01 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.792 HG22 ' ND2' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -95.66 -70.54 0.71 Allowed 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 110.203 -0.295 . . . . 15.0 110.203 179.332 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 115.25 -98.15 0.84 Allowed Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.691 -0.766 . . . . 15.0 113.412 178.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.427 ' O ' ' HB3' ' A' ' 13' ' ' LYS . 0.5 OUTLIER -64.39 -86.24 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.063 0.394 . . . . 15.0 112.063 -178.827 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.452 HG12 ' N ' ' A' ' 85' ' ' VAL . 77.7 t -109.73 159.76 9.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.924 0.392 . . . . 15.0 110.978 -179.397 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.7 HG23 ' CB ' ' A' ' 13' ' ' LYS . 13.4 t -97.99 79.4 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.145 0.497 . . . . 15.0 110.466 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -101.41 84.14 2.56 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.746 -0.661 . . . . 15.0 110.495 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.789 ' HB3' HD21 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -101.02 128.64 46.97 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.014 -0.539 . . . . 15.0 111.54 -179.302 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.791 ' HB2' ' HB3' ' A' ' 60' ' ' ALA . 4.8 mp -102.2 99.67 9.8 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.737 -0.468 . . . . 15.0 109.737 178.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.789 HD21 ' HB3' ' A' ' 87' ' ' LEU . 0.1 OUTLIER -105.73 -160.86 0.77 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.394 0.616 . . . . 15.0 112.011 -178.677 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.452 ' HB2' HG13 ' A' ' 6' ' ' ILE . 3.6 tt0 -141.77 132.69 25.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.051 -0.977 . . . . 15.0 109.897 179.136 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 3.6 tmtp? -49.26 95.51 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.378 -0.374 . . . . 15.0 111.146 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.365 0 C-N-CA 120.85 -0.691 . . . . 15.0 112.639 -179.964 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.411 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 1.2 mp . . . . . 0 N--CA 1.451 -0.409 0 CA-C-O 120.921 0.391 . . . . 15.0 111.335 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.513 ' CZ ' HD12 ' A' ' 89' ' ' LEU . 1.8 p90 -140.54 153.91 46.33 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.026 -0.533 . . . . 15.0 110.407 178.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.748 ' HB2' HD12 ' A' ' 88' ' ' LEU . 0.1 OUTLIER -121.37 143.61 49.11 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.369 0.604 . . . . 15.0 111.759 -179.192 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.585 ' CG1' HD11 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -101.43 116.02 44.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.063 -0.971 . . . . 15.0 109.628 178.956 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -106.24 72.59 0.94 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.239 -0.437 . . . . 15.0 112.145 -178.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.615 HD13 ' HG3' ' A' ' 51' ' ' ARG . 7.1 tp -88.3 161.69 17.01 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.319 -0.4 . . . . 15.0 110.007 178.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -97.1 94.67 7.28 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.654 0.264 . . . . 15.0 111.686 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.853 ' HB2' HG23 ' A' ' 85' ' ' VAL . 0.6 OUTLIER . . . . . 0 N--CA 1.466 0.325 0 N-CA-C 112.738 0.644 . . . . 15.0 112.738 179.623 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.492 HD12 ' HE3' ' A' ' 13' ' ' LYS . 4.5 mp . . . . . 0 N--CA 1.452 -0.341 0 CA-C-O 120.729 0.3 . . . . 15.0 110.357 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.686 ' O ' ' HB ' ' A' ' 41' ' ' ILE . . . -160.61 38.88 0.44 Allowed Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.901 -0.666 . . . . 15.0 111.719 -179.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.643 HG12 ' O ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -112.9 138.4 42.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 120.998 0.428 . . . . 15.0 111.805 -179.53 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.42 ' O ' ' HB3' ' A' ' 38' ' ' LYS . 28.9 t -95.78 100.92 12.57 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 107.801 -1.185 . . . . 15.0 107.801 177.395 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.616 HG22 HG23 ' A' ' 75' ' ' VAL . 1.0 OUTLIER -93.66 154.82 3.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.162 0.506 . . . . 15.0 112.299 -177.151 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.479 ' HA ' ' ND1' ' A' ' 71' ' ' HIS . 14.5 t -149.34 -176.19 5.28 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.421 -0.809 . . . . 15.0 110.516 179.647 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.712 ' O ' HG22 ' A' ' 26' ' ' VAL . . . 77.1 -112.07 3.42 Favored Glycine 0 C--N 1.331 0.287 0 C-N-CA 120.555 -0.831 . . . . 15.0 112.253 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.56 ' HA3' ' N ' ' A' ' 71' ' ' HIS . . . 62.8 -65.89 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 121.037 -0.601 . . . . 15.0 113.812 179.133 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.718 ' O ' HG22 ' A' ' 30' ' ' VAL . 0.0 OUTLIER -30.27 145.01 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 N-CA-C 112.47 0.544 . . . . 15.0 112.47 -179.068 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -80.28 56.26 2.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.863 -0.608 . . . . 15.0 110.967 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -151.04 -65.38 0.19 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.212 -0.449 . . . . 15.0 110.585 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.09 -47.11 75.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 15.0 110.251 179.57 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.718 HG22 ' O ' ' A' ' 26' ' ' VAL . 33.7 m -88.07 -170.3 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.923 -0.581 . . . . 15.0 110.567 179.475 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -95.83 128.49 42.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.933 0.396 . . . . 15.0 111.152 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 25.6 m80 59.47 -83.35 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.947 -0.57 . . . . 15.0 111.464 179.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.407 ' O ' ' O ' ' A' ' 69' ' ' ALA . . . -170.36 30.61 0.14 Allowed Glycine 0 C--N 1.33 0.244 0 C-N-CA 121.056 -0.592 . . . . 15.0 112.026 -179.548 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.49 ' O ' HG21 ' A' ' 30' ' ' VAL . . . -89.96 151.88 21.95 Favored Glycine 0 N--CA 1.447 -0.583 0 N-CA-C 110.667 -0.973 . . . . 15.0 110.667 178.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.883 HG22 HG22 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -94.25 152.6 3.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.546 0.689 . . . . 15.0 112.149 -179.034 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -136.76 108.14 6.88 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.661 -1.154 . . . . 15.0 109.39 179.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.785 HG22 ' N ' ' A' ' 55' ' ' GLY . 0.8 OUTLIER -55.32 152.19 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.123 0.487 . . . . 15.0 111.563 -178.622 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.451 ' O ' ' HG2' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -84.51 -46.33 11.72 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.457 -0.942 . . . . 15.0 108.457 178.088 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.643 ' O ' HG12 ' A' ' 20' ' ' ILE . . . -172.35 173.17 4.23 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 115.75 -0.659 . . . . 15.0 110.448 178.438 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.565 ' HA ' HG12 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -96.96 111.52 27.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 109.519 -0.548 . . . . 15.0 109.519 179.196 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.686 ' HB ' ' O ' ' A' ' 19' ' ' GLY . 0.4 OUTLIER -78.39 117.01 63.7 Favored Pre-proline 0 C--N 1.33 -0.264 0 N-CA-C 113.408 0.892 . . . . 15.0 113.408 -177.306 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.612 ' HA ' ' CG ' ' A' ' 47' ' ' GLU . 27.1 Cg_exo -62.86 59.79 0.15 Allowed 'Trans proline' 0 C--N 1.357 0.989 0 C-N-CA 123.651 2.9 . . . . 15.0 113.001 179.637 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.521 ' N ' ' HG2' ' A' ' 47' ' ' GLU . 3.9 tt0 -147.51 -47.06 0.17 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.582 0.229 . . . . 15.0 111.394 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.623 ' HA3' ' HA3' ' A' ' 19' ' ' GLY . . . -87.82 167.8 36.98 Favored Glycine 0 CA--C 1.518 0.24 0 C-N-CA 120.368 -0.92 . . . . 15.0 113.884 -179.051 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -57.34 -14.45 4.61 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.722 0.638 . . . . 15.0 112.722 -179.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.17 -56.59 5.31 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.662 0.267 . . . . 15.0 110.934 -179.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.612 ' CG ' ' HA ' ' A' ' 42' ' ' PRO . 3.0 pp20? -57.45 -42.69 82.98 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.965 -0.561 . . . . 15.0 110.287 179.309 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -53.77 -70.76 0.09 Allowed 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 115.845 -0.616 . . . . 15.0 110.535 -179.433 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.579 ' CB ' HD11 ' A' ' 11' ' ' LEU . 0.1 OUTLIER -58.43 -41.3 84.73 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.154 -0.684 . . . . 15.0 109.154 178.829 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.75 41.2 11.14 Favored Glycine 0 N--CA 1.445 -0.702 0 CA-C-N 115.361 -0.836 . . . . 15.0 111.718 179.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.615 ' HG3' HD13 ' A' ' 11' ' ' LEU . 0.5 OUTLIER -79.7 -50.3 10.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.883 0.373 . . . . 15.0 110.655 -179.363 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.637 ' CG1' HD12 ' A' ' 20' ' ' ILE . 7.9 tp -81.04 163.3 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 CA-C-N 116.062 -0.517 . . . . 15.0 110.282 179.439 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . 0.476 ' O ' ' HB2' ' A' ' 56' ' ' ASP . 64.0 m80 -147.37 160.82 42.1 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-O 121.687 0.756 . . . . 15.0 112.252 -179.087 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.546 ' HA ' ' CG2' ' A' ' 37' ' ' VAL . 6.1 mtpt -43.82 134.11 4.55 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.309 -1.314 . . . . 15.0 112.576 -178.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.785 ' N ' HG22 ' A' ' 37' ' ' VAL . . . 49.88 33.12 19.83 Favored Glycine 0 C--N 1.333 0.369 0 CA-C-N 115.914 -0.585 . . . . 15.0 113.589 179.324 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.476 ' HB2' ' O ' ' A' ' 53' ' ' HIS . 0.3 OUTLIER -65.93 130.5 43.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 117.16 0.48 . . . . 15.0 110.598 179.38 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.432 ' HA ' ' O ' ' A' ' 35' ' ' ILE . 35.4 ttt180 -82.74 87.91 6.76 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.794 0.331 . . . . 15.0 110.313 179.485 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.883 HG22 HG22 ' A' ' 35' ' ' ILE . 2.3 m -79.32 112.45 17.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.148 0.499 . . . . 15.0 111.063 -179.388 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 44.5 mt -107.21 -11.85 15.5 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 115.645 -0.707 . . . . 15.0 112.625 -179.047 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.718 ' HB3' ' HB2' ' A' ' 88' ' ' LEU . . . -151.35 146.41 25.98 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 112.693 0.627 . . . . 15.0 112.693 -178.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.884 HG11 ' O ' ' A' ' 77' ' ' THR . 40.0 t -139.59 93.53 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.192 -0.913 . . . . 15.0 109.459 178.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.491 HD21 HG22 ' A' ' 81' ' ' THR . 7.5 m120 69.92 17.68 7.45 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.086 -0.507 . . . . 15.0 109.98 -178.305 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 107.27 4.72 35.2 Favored Glycine 0 C--N 1.334 0.456 0 CA-C-N 115.841 -0.618 . . . . 15.0 113.482 179.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.673 ' O ' HG13 ' A' ' 64' ' ' VAL . 5.1 p -93.72 103.25 14.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.207 0.527 . . . . 15.0 110.645 179.198 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 24.3 m -56.89 133.62 54.74 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.995 -0.548 . . . . 15.0 111.117 -179.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.703 HD11 ' HB2' ' A' ' 74' ' ' ALA . 0.1 OUTLIER -88.09 -19.35 27.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.036 -0.529 . . . . 15.0 110.935 179.841 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -47.47 95.86 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 120.91 0.386 . . . . 15.0 110.897 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.73 65.17 0.57 Allowed Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.783 -0.722 . . . . 15.0 112.271 -179.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.65 ' HB1' ' CB ' ' A' ' 73' ' ' GLN . . . -172.76 156.89 3.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.94 0.4 . . . . 15.0 110.859 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.478 ' HB ' HG13 ' A' ' 26' ' ' VAL . 11.3 p -93.07 -171.11 2.59 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.104 0.478 . . . . 15.0 111.336 -179.572 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . 0.615 ' CD2' HG23 ' A' ' 22' ' ' VAL . 0.4 OUTLIER -59.61 -60.99 2.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.621 -0.718 . . . . 15.0 110.158 179.737 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 20.0 ttpp -52.79 -35.93 57.52 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.519 -0.764 . . . . 15.0 110.806 179.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.65 ' CB ' ' HB1' ' A' ' 69' ' ' ALA . 7.9 mt-30 -59.6 -54.43 46.55 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.298 -0.41 . . . . 15.0 109.935 179.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.74 ' HB3' HD12 ' A' ' 35' ' ' ILE . . . -65.17 -43.88 90.32 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.1 -0.5 . . . . 15.0 109.721 178.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.616 HG23 HG22 ' A' ' 22' ' ' VAL . 0.5 OUTLIER -43.38 -42.39 1.42 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.223 0 N-CA-C 108.987 -0.745 . . . . 15.0 108.987 178.289 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.401 ' N ' HG12 ' A' ' 75' ' ' VAL . 1.8 mt-10 -67.41 -43.28 81.63 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 114.9 -1.046 . . . . 15.0 110.323 178.522 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.884 ' O ' HG11 ' A' ' 61' ' ' VAL . 70.4 p -63.94 -56.87 12.04 Favored 'General case' 0 N--CA 1.461 0.116 0 CA-C-O 120.615 0.245 . . . . 15.0 111.521 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.666 HD21 HG21 ' A' ' 58' ' ' VAL . 4.0 mt -53.31 -46.86 69.58 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-O 121.118 0.485 . . . . 15.0 110.185 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.5 -58.2 4.67 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.644 -0.707 . . . . 15.0 110.708 179.467 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 68.7 m-20 -65.85 63.03 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.053 -0.521 . . . . 15.0 111.956 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.491 HG22 HD21 ' A' ' 62' ' ' ASN . 0.0 OUTLIER -92.93 -78.31 0.42 Allowed 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 110.073 -0.343 . . . . 15.0 110.073 179.233 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 122.34 -107.89 1.21 Allowed Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.807 -0.711 . . . . 15.0 112.965 179.223 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -65.23 -80.23 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.665 0.269 . . . . 15.0 111.415 -179.318 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.472 HG12 ' N ' ' A' ' 85' ' ' VAL . 75.9 t -110.19 159.47 9.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.054 0.454 . . . . 15.0 111.179 -179.646 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.853 HG23 ' HB2' ' A' ' 13' ' ' LYS . 6.4 t -97.9 80.88 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.015 -0.539 . . . . 15.0 110.225 179.528 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 11.2 t60 -97.07 80.39 2.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.846 -0.615 . . . . 15.0 110.403 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.827 ' HB3' HD21 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -103.78 120.93 41.98 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.884 -0.598 . . . . 15.0 111.818 -179.118 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.748 HD12 ' HB2' ' A' ' 8' ' ' GLU . 4.0 mp -98.87 101.92 13.48 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.49 -0.559 . . . . 15.0 109.49 178.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.827 HD21 ' HB3' ' A' ' 87' ' ' LEU . 0.1 OUTLIER -105.64 -162.37 0.87 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.488 0.661 . . . . 15.0 112.061 -178.334 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.411 ' HA ' ' HA ' ' A' ' 6' ' ' ILE . 2.1 tt0 -140.67 139.39 34.79 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 114.73 -1.123 . . . . 15.0 109.736 179.124 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 2.0 tptp -52.08 105.65 0.12 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.91 0.386 . . . . 15.0 111.069 -179.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.289 0 C-N-CA 120.814 -0.708 . . . . 15.0 112.544 -179.888 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.452 HG13 ' HB2' ' A' ' 90' ' ' GLU . 1.3 mp . . . . . 0 N--CA 1.45 -0.463 0 CA-C-O 120.711 0.291 . . . . 15.0 110.96 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.544 ' CZ ' HD12 ' A' ' 89' ' ' LEU . 4.0 p90 -141.05 165.22 28.15 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.298 -0.41 . . . . 15.0 110.555 178.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.723 ' CB ' HD12 ' A' ' 88' ' ' LEU . 9.7 pt-20 -130.15 144.27 51.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.243 0.544 . . . . 15.0 111.543 -179.352 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.712 ' CG1' HD11 ' A' ' 89' ' ' LEU . 0.5 OUTLIER -101.34 114.13 39.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.31 -0.859 . . . . 15.0 109.539 178.948 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -106.03 71.12 0.88 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.152 -0.476 . . . . 15.0 111.922 -178.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.619 HD11 ' CB ' ' A' ' 49' ' ' ASP . 7.5 tp -88.28 165.04 15.29 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.08 -0.509 . . . . 15.0 109.914 178.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -95.3 93.29 7.19 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.983 0.421 . . . . 15.0 111.041 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.642 ' CB ' HG23 ' A' ' 85' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 115.913 -0.585 . . . . 15.0 111.033 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.2 mp . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.884 0.373 . . . . 15.0 110.749 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.777 ' O ' ' HB ' ' A' ' 41' ' ' ILE . . . -161.05 45.08 0.4 Allowed Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 121.152 -0.547 . . . . 15.0 111.935 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.703 HG12 ' O ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -112.77 139.69 36.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 120.974 0.416 . . . . 15.0 111.77 -179.549 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 45.0 t -94.98 104.05 15.91 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.084 -1.08 . . . . 15.0 108.084 177.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.949 HG21 HG23 ' A' ' 75' ' ' VAL . 10.6 m -93.73 153.9 3.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 113.124 0.787 . . . . 15.0 113.124 -177.037 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.33 -179.66 7.23 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 114.981 -1.009 . . . . 15.0 110.391 179.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.448 ' O ' ' CB ' ' A' ' 71' ' ' HIS . . . 76.71 -121.77 6.1 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.562 -0.828 . . . . 15.0 112.563 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.556 ' HA3' ' N ' ' A' ' 71' ' ' HIS . . . 68.2 -66.27 0.37 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.831 -0.699 . . . . 15.0 113.388 179.437 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.529 ' O ' HG22 ' A' ' 30' ' ' VAL . 1.6 m -28.34 138.76 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 N-CA-C 112.39 0.515 . . . . 15.0 112.39 -179.208 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 10.9 m-80 -76.25 60.08 1.46 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.951 -0.568 . . . . 15.0 111.041 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -151.78 -55.71 0.14 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.331 -0.395 . . . . 15.0 110.956 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.4 m -78.15 -46.23 21.16 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.17 -0.468 . . . . 15.0 111.019 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.529 HG22 ' O ' ' A' ' 26' ' ' VAL . 21.9 m -71.36 -173.72 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.244 -0.435 . . . . 15.0 111.192 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 6.1 mtp85 -57.34 -54.59 45.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.281 -0.418 . . . . 15.0 111.078 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 48.6 p-80 -151.8 -44.69 0.11 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.363 -0.38 . . . . 15.0 111.174 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -169.59 23.6 0.1 OUTLIER Glycine 0 CA--C 1.518 0.223 0 C-N-CA 120.816 -0.707 . . . . 15.0 112.615 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.502 ' O ' HG11 ' A' ' 30' ' ' VAL . . . -93.88 153.93 21.39 Favored Glycine 0 N--CA 1.449 -0.499 0 N-CA-C 110.429 -1.068 . . . . 15.0 110.429 178.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.911 HG22 HG22 ' A' ' 58' ' ' VAL . 0.1 OUTLIER -96.67 153.36 3.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 C-N-CA 119.601 -0.84 . . . . 15.0 112.371 -179.078 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.454 ' CE2' ' HG2' ' A' ' 57' ' ' ARG . 32.5 m-85 -135.67 106.96 6.79 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.63 -1.168 . . . . 15.0 109.27 179.289 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.785 HG22 ' N ' ' A' ' 55' ' ' GLY . 0.7 OUTLIER -55.03 149.36 2.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.147 0.499 . . . . 15.0 111.357 -178.554 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.485 ' O ' ' HG2' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -80.16 -50.46 10.25 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.628 -0.879 . . . . 15.0 108.628 178.739 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.703 ' O ' HG12 ' A' ' 20' ' ' ILE . . . -172.3 173.27 4.24 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 115.72 -0.673 . . . . 15.0 110.081 178.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.543 ' HA ' HG12 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -96.76 112.8 29.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 108.983 -0.747 . . . . 15.0 108.983 178.778 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.777 ' HB ' ' O ' ' A' ' 19' ' ' GLY . 0.4 OUTLIER -77.96 118.07 69.84 Favored Pre-proline 0 C--N 1.328 -0.338 0 N-CA-C 113.231 0.826 . . . . 15.0 113.231 -176.978 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.61 ' HA ' ' HG2' ' A' ' 47' ' ' GLU . 37.3 Cg_endo -64.88 61.67 0.29 Allowed 'Trans proline' 0 C--N 1.357 0.974 0 C-N-CA 123.457 2.771 . . . . 15.0 112.745 179.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.5 ' N ' ' HG2' ' A' ' 47' ' ' GLU . 4.3 mm-40 -151.51 -46.35 0.11 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.536 -0.302 . . . . 15.0 111.489 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.715 ' HA3' ' HA3' ' A' ' 19' ' ' GLY . . . -87.68 166.87 36.29 Favored Glycine 0 C--N 1.33 0.222 0 C-N-CA 120.312 -0.947 . . . . 15.0 113.618 -179.259 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -56.95 -13.91 3.09 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.616 0.599 . . . . 15.0 112.616 -179.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.04 -57.19 4.48 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.734 0.302 . . . . 15.0 110.782 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.61 ' HG2' ' HA ' ' A' ' 42' ' ' PRO . 2.8 pp20? -57.21 -42.93 82.25 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.19 -0.459 . . . . 15.0 110.397 179.383 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 22.9 t -53.95 -71.47 0.07 Allowed 'General case' 0 CA--C 1.52 -0.176 0 CA-C-N 115.976 -0.556 . . . . 15.0 110.626 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.619 ' CB ' HD11 ' A' ' 11' ' ' LEU . 0.4 OUTLIER -58.63 -40.78 84.33 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.391 -0.596 . . . . 15.0 109.391 178.901 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.93 45.02 7.89 Favored Glycine 0 N--CA 1.446 -0.65 0 CA-C-N 115.393 -0.822 . . . . 15.0 111.67 179.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.613 ' HB2' HD13 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -79.43 -54.36 6.0 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.892 0.377 . . . . 15.0 110.477 -179.325 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.623 ' CG1' HD12 ' A' ' 20' ' ' ILE . 8.3 tp -81.08 164.29 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 CA-C-N 115.991 -0.55 . . . . 15.0 110.362 179.55 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . 0.441 ' N ' ' OD2' ' A' ' 56' ' ' ASP . 74.5 m80 -146.34 157.13 43.76 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-O 121.659 0.742 . . . . 15.0 112.135 -179.063 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.563 ' HA ' ' CG2' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -44.13 133.52 5.19 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.229 -1.351 . . . . 15.0 112.975 -178.605 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.785 ' N ' HG22 ' A' ' 37' ' ' VAL . . . 49.99 31.28 17.61 Favored Glycine 0 C--N 1.336 0.538 0 CA-C-N 115.809 -0.632 . . . . 15.0 113.268 179.206 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.477 ' OD2' HD12 ' A' ' 52' ' ' ILE . 5.3 m-20 -65.72 129.31 39.32 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.887 -0.325 . . . . 15.0 110.733 179.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.454 ' HG2' ' CE2' ' A' ' 36' ' ' TYR . 50.6 mtt180 -80.74 88.32 5.79 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.233 -0.439 . . . . 15.0 110.313 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.911 HG22 HG22 ' A' ' 35' ' ' ILE . 1.4 m -79.45 112.05 17.01 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 CA-C-O 121.158 0.504 . . . . 15.0 111.058 -179.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 33.3 mt -107.49 -15.27 14.65 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 115.441 -0.8 . . . . 15.0 112.47 -179.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.781 ' HB3' ' HB2' ' A' ' 88' ' ' LEU . . . -149.49 148.28 29.22 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 112.765 0.654 . . . . 15.0 112.765 -178.673 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.744 HG11 ' O ' ' A' ' 77' ' ' THR . 15.4 t -139.11 99.87 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.263 -0.88 . . . . 15.0 109.083 178.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.552 ' OD1' HG22 ' A' ' 81' ' ' THR . 7.0 m120 65.19 16.42 10.54 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.28 -0.418 . . . . 15.0 109.881 -177.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 107.23 4.79 35.29 Favored Glycine 0 C--N 1.336 0.56 0 CA-C-N 115.924 -0.58 . . . . 15.0 113.531 179.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.644 ' O ' HG13 ' A' ' 64' ' ' VAL . 5.3 p -93.78 107.46 19.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 117.175 0.488 . . . . 15.0 110.882 179.511 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -56.57 135.6 54.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.211 -0.449 . . . . 15.0 111.163 -179.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.65 HD11 ' HB2' ' A' ' 74' ' ' ALA . 0.1 OUTLIER -97.16 -21.35 17.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.988 -0.551 . . . . 15.0 110.915 179.9 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -46.7 98.71 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.399 -0.364 . . . . 15.0 110.93 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.83 63.08 0.54 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.804 -0.713 . . . . 15.0 112.139 -179.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.704 ' HB1' ' CB ' ' A' ' 73' ' ' GLN . . . -173.0 143.18 1.14 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.841 0.353 . . . . 15.0 110.865 -179.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.465 ' HA ' ' N ' ' A' ' 26' ' ' VAL . 12.2 p -72.99 -173.16 1.18 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.255 -0.43 . . . . 15.0 111.208 -179.717 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . 0.778 ' CD2' HG23 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -61.93 -59.69 4.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.89 -0.596 . . . . 15.0 110.514 -179.987 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 20.4 ttmt -52.64 -33.69 48.03 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.849 -0.614 . . . . 15.0 110.632 179.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.704 ' CB ' ' HB1' ' A' ' 69' ' ' ALA . 4.7 mt-30 -59.5 -52.66 64.64 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.784 -0.45 . . . . 15.0 109.784 179.447 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.864 ' HB3' HD12 ' A' ' 35' ' ' ILE . . . -66.86 -44.24 81.48 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.704 -0.48 . . . . 15.0 109.704 178.516 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.949 HG23 HG21 ' A' ' 22' ' ' VAL . 0.5 OUTLIER -43.01 -40.79 1.08 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.262 0 N-CA-C 109.012 -0.736 . . . . 15.0 109.012 178.412 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.406 ' O ' ' CB ' ' A' ' 80' ' ' ASN . 46.3 mt-10 -67.39 -44.65 78.35 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 114.789 -1.096 . . . . 15.0 110.369 178.533 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.744 ' O ' HG11 ' A' ' 61' ' ' VAL . 40.9 p -64.14 -54.52 32.5 Favored 'General case' 0 N--CA 1.462 0.151 0 C-N-CA 120.99 -0.284 . . . . 15.0 111.414 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.601 HD21 HG21 ' A' ' 58' ' ' VAL . 5.7 mt -53.56 -47.93 69.61 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-O 121.211 0.529 . . . . 15.0 110.012 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.41 ' HB2' ' O ' ' A' ' 75' ' ' VAL . 1.9 ttt-85 -68.35 -59.47 3.16 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.429 -0.805 . . . . 15.0 110.397 179.375 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.406 ' CB ' ' O ' ' A' ' 76' ' ' GLU . 14.2 m-20 -65.99 62.03 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.933 -0.576 . . . . 15.0 111.94 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.552 HG22 ' OD1' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -93.23 -71.36 0.66 Allowed 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 110.043 -0.355 . . . . 15.0 110.043 179.234 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 122.0 -108.02 1.25 Allowed Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.939 -0.648 . . . . 15.0 112.993 179.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.414 ' O ' ' HB3' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -65.17 -79.69 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.917 0.389 . . . . 15.0 111.623 -179.359 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.444 HG12 ' N ' ' A' ' 85' ' ' VAL . 77.6 t -110.21 158.25 10.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.952 -0.567 . . . . 15.0 111.087 -179.319 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.672 HG12 ' O ' ' A' ' 85' ' ' VAL . 6.8 t -97.93 82.35 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.056 -0.52 . . . . 15.0 110.46 179.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -101.91 85.02 2.62 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.793 -0.639 . . . . 15.0 110.379 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.849 ' HB3' HD21 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -103.86 122.94 46.19 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.925 -0.58 . . . . 15.0 111.808 -179.136 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.781 ' HB2' ' HB3' ' A' ' 60' ' ' ALA . 4.4 mp -97.69 101.37 12.86 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.586 -0.524 . . . . 15.0 109.586 178.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.849 HD21 ' HB3' ' A' ' 87' ' ' LEU . 0.1 OUTLIER -105.93 -161.8 0.82 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.456 0.646 . . . . 15.0 111.961 -178.46 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.452 ' HB2' HG13 ' A' ' 6' ' ' ILE . 4.6 tt0 -143.27 133.56 24.59 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 114.948 -1.024 . . . . 15.0 109.77 179.174 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -46.95 106.14 0.08 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.994 0.426 . . . . 15.0 111.174 -179.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.318 0 C-N-CA 120.868 -0.682 . . . . 15.0 112.759 -179.663 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.461 HG13 ' HB2' ' A' ' 90' ' ' GLU . 1.2 mp . . . . . 0 N--CA 1.447 -0.593 0 CA-C-O 120.821 0.343 . . . . 15.0 111.034 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.605 ' CE1' HD12 ' A' ' 89' ' ' LEU . 3.4 p90 -140.19 163.87 31.59 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.224 -0.444 . . . . 15.0 110.261 178.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.732 ' HB3' HD12 ' A' ' 88' ' ' LEU . 4.9 pt-20 -130.17 143.24 50.67 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.295 0.569 . . . . 15.0 111.848 -178.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.511 HG23 ' HB3' ' A' ' 51' ' ' ARG . 0.2 OUTLIER -101.61 115.34 43.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.23 -0.895 . . . . 15.0 109.696 178.74 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -105.84 72.54 0.96 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.243 -0.435 . . . . 15.0 112.121 -178.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.536 HD11 ' CB ' ' A' ' 49' ' ' ASP . 6.3 tp -88.12 165.6 15.0 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.561 -0.533 . . . . 15.0 109.561 178.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -96.13 92.7 6.54 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.993 0.425 . . . . 15.0 111.331 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.711 ' CB ' HG23 ' A' ' 85' ' ' VAL . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.354 0 CA-C-N 115.892 -0.595 . . . . 15.0 111.061 179.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.666 ' N ' HD22 ' A' ' 18' ' ' LEU . 1.4 mm? . . . . . 0 N--CA 1.453 -0.317 0 CA-C-O 120.914 0.388 . . . . 15.0 110.726 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.654 ' O ' ' HB ' ' A' ' 41' ' ' ILE . . . -162.84 33.75 0.31 Allowed Glycine 0 N--CA 1.449 -0.465 0 CA-C-N 115.91 -0.586 . . . . 15.0 111.717 -179.678 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.635 HD12 ' CG1' ' A' ' 52' ' ' ILE . 0.0 OUTLIER -112.72 139.96 35.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 121.131 0.491 . . . . 15.0 112.033 -179.261 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.463 ' O ' ' HB3' ' A' ' 38' ' ' LYS . 43.2 t -96.33 100.96 12.53 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 107.396 -1.335 . . . . 15.0 107.396 176.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.673 HG23 ' CD2' ' A' ' 71' ' ' HIS . 1.1 m -93.62 153.82 3.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 112.769 0.655 . . . . 15.0 112.769 -176.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.482 HG22 ' HB2' ' A' ' 38' ' ' LYS . 11.1 t -149.6 -173.48 4.42 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.223 -0.899 . . . . 15.0 110.369 179.317 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.683 ' O ' HG22 ' A' ' 26' ' ' VAL . . . 75.88 -113.94 4.05 Favored Glycine 0 C--N 1.33 0.23 0 C-N-CA 120.517 -0.849 . . . . 15.0 112.347 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.582 ' HA3' ' N ' ' A' ' 71' ' ' HIS . . . 63.59 -65.84 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 121.06 -0.591 . . . . 15.0 113.724 179.175 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.683 HG22 ' O ' ' A' ' 24' ' ' GLY . 0.0 OUTLIER -26.07 139.55 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 N-CA-C 112.51 0.559 . . . . 15.0 112.51 -179.015 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 17.5 m-20 -75.64 61.21 1.33 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.806 -0.634 . . . . 15.0 111.046 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -151.75 -66.49 0.18 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.317 -0.402 . . . . 15.0 111.095 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.8 m -67.79 -34.26 76.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.129 -0.487 . . . . 15.0 111.061 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.559 HG22 ' O ' ' A' ' 26' ' ' VAL . 21.0 m -85.67 -174.33 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.302 -0.408 . . . . 15.0 111.171 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 8.9 mtp180 -57.78 -61.26 2.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.251 -0.431 . . . . 15.0 111.033 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 11.0 p-80 -143.25 -45.95 0.29 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.253 -0.43 . . . . 15.0 111.018 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -169.18 25.7 0.11 Allowed Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.901 -0.666 . . . . 15.0 112.491 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.459 ' O ' HG11 ' A' ' 30' ' ' VAL . . . -90.9 151.31 21.1 Favored Glycine 0 N--CA 1.447 -0.588 0 N-CA-C 110.519 -1.032 . . . . 15.0 110.519 178.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.919 HG22 HG22 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -94.74 152.87 3.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 C-N-CA 119.9 -0.72 . . . . 15.0 112.238 -179.112 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.466 ' CZ ' ' HG2' ' A' ' 57' ' ' ARG . 18.9 m-85 -135.29 107.4 7.17 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.652 -1.158 . . . . 15.0 109.364 179.396 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.788 HG22 ' N ' ' A' ' 55' ' ' GLY . 0.8 OUTLIER -55.14 149.42 2.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 116.102 -0.499 . . . . 15.0 111.462 -178.581 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.482 ' HB2' HG22 ' A' ' 23' ' ' THR . 0.0 OUTLIER -81.19 -48.03 12.64 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.668 -0.864 . . . . 15.0 108.668 178.266 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.582 ' O ' HG12 ' A' ' 20' ' ' ILE . . . -172.29 170.77 4.99 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 115.757 -0.656 . . . . 15.0 110.234 178.5 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.562 ' HA ' HG12 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -97.18 111.81 27.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.055 0.455 . . . . 15.0 110.344 179.575 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.654 ' HB ' ' O ' ' A' ' 19' ' ' GLY . 0.4 OUTLIER -78.56 109.14 9.58 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 115.74 -0.663 . . . . 15.0 112.238 -178.428 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.451 ' N ' ' HG2' ' A' ' 47' ' ' GLU . 30.2 Cg_endo -63.12 65.54 0.16 Allowed 'Trans proline' 0 C--N 1.356 0.944 0 C-N-CA 123.192 2.595 . . . . 15.0 112.591 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.449 ' N ' ' O ' ' A' ' 41' ' ' ILE . 42.2 tt0 -147.44 -53.37 0.21 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.392 -0.822 . . . . 15.0 109.317 179.418 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.552 ' HA3' ' HA3' ' A' ' 19' ' ' GLY . . . -88.02 157.32 28.21 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.684 -0.769 . . . . 15.0 112.528 179.147 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -41.73 -16.73 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 113.51 0.93 . . . . 15.0 113.51 -179.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.442 ' N ' ' O ' ' A' ' 44' ' ' GLY . . . -71.5 -71.38 0.27 Allowed 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.768 -0.373 . . . . 15.0 111.159 -179.464 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.501 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 4.3 tp10 -58.59 -40.51 83.39 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-O 120.958 0.409 . . . . 15.0 110.312 179.364 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.7 t -55.51 -63.98 0.99 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.976 -0.556 . . . . 15.0 110.278 179.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.536 ' CB ' HD11 ' A' ' 11' ' ' LEU . 5.6 t0 -62.69 -39.08 92.88 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.146 0.498 . . . . 15.0 109.89 179.053 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.55 36.81 18.95 Favored Glycine 0 N--CA 1.448 -0.512 0 CA-C-N 115.58 -0.736 . . . . 15.0 112.651 179.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.513 ' HG3' HD13 ' A' ' 11' ' ' LEU . 1.7 mmt85 -83.69 -53.44 5.64 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.928 0.394 . . . . 15.0 110.607 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.635 ' CG1' HD12 ' A' ' 20' ' ' ILE . 11.0 tp -81.15 157.85 4.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.977 -0.556 . . . . 15.0 110.183 179.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 53.1 m80 -139.75 160.37 40.03 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-O 121.832 0.825 . . . . 15.0 113.097 -178.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.6 ' HA ' ' CG2' ' A' ' 37' ' ' VAL . 1.0 OUTLIER -45.28 135.13 6.08 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 113.821 -1.536 . . . . 15.0 112.742 -178.865 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.788 ' N ' HG22 ' A' ' 37' ' ' VAL . . . 49.69 32.75 17.67 Favored Glycine 0 C--N 1.335 0.499 0 CA-C-N 116.031 -0.531 . . . . 15.0 113.116 179.146 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.461 ' OD2' HD12 ' A' ' 52' ' ' ILE . 3.5 m-20 -65.72 130.65 44.02 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.95 -0.3 . . . . 15.0 110.821 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.763 ' CD ' HD21 ' A' ' 59' ' ' LEU . 0.0 OUTLIER -84.4 86.37 7.28 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.11 -0.495 . . . . 15.0 110.345 179.579 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.919 HG22 HG22 ' A' ' 35' ' ' ILE . 1.5 m -79.39 113.44 18.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 CA-C-N 116.162 -0.472 . . . . 15.0 111.17 -179.466 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.763 HD21 ' CD ' ' A' ' 57' ' ' ARG . 19.2 mt -107.26 -13.06 15.22 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.819 -0.628 . . . . 15.0 112.41 -179.332 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.572 ' O ' HD23 ' A' ' 87' ' ' LEU . . . -150.62 147.35 27.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.192 0.52 . . . . 15.0 112.313 -178.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.841 HG21 HD23 ' A' ' 78' ' ' LEU . 60.6 t -138.72 102.88 1.97 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.275 0 CA-C-N 115.484 -0.78 . . . . 15.0 109.047 178.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.738 ' ND2' HG22 ' A' ' 81' ' ' THR . 1.5 m-80 64.94 16.32 10.46 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.71 -0.478 . . . . 15.0 109.71 -178.089 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 105.32 5.17 40.4 Favored Glycine 0 C--N 1.337 0.617 0 CA-C-N 115.82 -0.627 . . . . 15.0 113.23 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.653 ' O ' HG13 ' A' ' 64' ' ' VAL . 6.7 p -93.85 107.53 19.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.006 0.432 . . . . 15.0 111.046 179.6 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.2 m -55.8 133.08 50.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.269 -0.423 . . . . 15.0 111.083 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.593 HD11 ' HB2' ' A' ' 74' ' ' ALA . 0.1 OUTLIER -91.59 -21.68 20.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.001 -0.545 . . . . 15.0 111.026 179.992 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -43.85 97.41 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 120.905 0.383 . . . . 15.0 110.978 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.85 64.26 0.56 Allowed Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.866 -0.683 . . . . 15.0 112.058 -179.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.785 ' HB1' ' HB3' ' A' ' 73' ' ' GLN . . . -172.98 135.68 0.62 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.895 0.379 . . . . 15.0 110.982 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.431 ' HA ' ' N ' ' A' ' 26' ' ' VAL . 10.2 p -72.9 -171.45 0.87 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.112 0.482 . . . . 15.0 111.31 -179.66 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . 0.673 ' CD2' HG23 ' A' ' 22' ' ' VAL . 0.4 OUTLIER -58.33 -63.08 1.4 Allowed 'General case' 0 CA--C 1.517 -0.315 0 CA-C-N 115.721 -0.672 . . . . 15.0 109.814 179.812 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 13.5 ttpp -53.23 -36.12 60.71 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.316 -0.856 . . . . 15.0 110.574 179.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.785 ' HB3' ' HB1' ' A' ' 69' ' ' ALA . 5.8 mt-30 -59.32 -50.75 72.79 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 116.149 -0.478 . . . . 15.0 109.715 179.475 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.801 ' HB3' HD12 ' A' ' 35' ' ' ILE . . . -66.96 -47.39 71.75 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.059 -0.519 . . . . 15.0 109.665 178.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.615 HG23 ' CG2' ' A' ' 22' ' ' VAL . 0.5 OUTLIER -40.84 -41.19 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.23 0 CA-C-N 115.522 -0.763 . . . . 15.0 109.472 178.643 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -67.18 -46.05 75.1 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 114.884 -1.053 . . . . 15.0 110.781 179.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.656 ' O ' HG11 ' A' ' 61' ' ' VAL . 2.5 p -64.6 -53.28 50.17 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 120.79 -0.364 . . . . 15.0 111.529 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.841 HD23 HG21 ' A' ' 61' ' ' VAL . 3.8 mt -53.4 -48.41 68.71 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-O 121.185 0.517 . . . . 15.0 110.07 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.4 ' O ' ' N ' ' A' ' 81' ' ' THR . 4.1 ttt85 -68.46 -57.4 5.89 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.575 -0.739 . . . . 15.0 110.492 179.282 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 63.3 m-20 -66.0 62.77 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.879 -0.6 . . . . 15.0 111.948 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.738 HG22 ' ND2' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -95.37 -71.71 0.66 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.769 0.318 . . . . 15.0 110.22 179.221 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 122.04 -104.05 0.89 Allowed Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.744 -0.741 . . . . 15.0 113.185 179.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.418 ' O ' ' HB3' ' A' ' 13' ' ' LYS . 0.4 OUTLIER -64.59 -84.49 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 111.975 0.361 . . . . 15.0 111.975 -179.072 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.461 HG12 ' N ' ' A' ' 85' ' ' VAL . 74.1 t -109.65 160.17 8.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.873 0.368 . . . . 15.0 110.897 -179.528 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.711 HG23 ' CB ' ' A' ' 13' ' ' LYS . 12.9 t -97.83 81.23 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.118 0.485 . . . . 15.0 110.56 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -101.15 84.69 2.69 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.778 -0.646 . . . . 15.0 110.429 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.742 ' HB3' HD21 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -103.19 121.06 41.89 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.06 -0.518 . . . . 15.0 111.743 -179.226 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.732 HD12 ' HB3' ' A' ' 8' ' ' GLU . 0.2 OUTLIER -97.52 101.53 13.08 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.374 -0.602 . . . . 15.0 109.374 178.636 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.742 HD21 ' HB3' ' A' ' 87' ' ' LEU . 0.1 OUTLIER -105.89 -161.89 0.83 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.598 0.713 . . . . 15.0 112.347 -178.451 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.461 ' HB2' HG13 ' A' ' 6' ' ' ILE . 3.4 tt0 -142.17 132.66 25.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 114.609 -1.178 . . . . 15.0 109.059 178.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.54 100.13 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.003 0.43 . . . . 15.0 111.19 -179.393 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.404 0 CA-C-N 115.766 -0.652 . . . . 15.0 112.703 -179.737 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.419 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 1.4 mp . . . . . 0 N--CA 1.449 -0.49 0 CA-C-O 120.705 0.288 . . . . 15.0 110.883 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.589 ' CE1' HD12 ' A' ' 89' ' ' LEU . 4.2 p90 -140.61 165.74 26.64 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.378 -0.374 . . . . 15.0 110.446 178.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.718 ' CB ' HD12 ' A' ' 88' ' ' LEU . 10.7 pt-20 -130.11 143.09 50.59 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.295 0.569 . . . . 15.0 111.55 -179.32 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.578 ' CG1' HD11 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -101.54 115.44 43.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.203 -0.908 . . . . 15.0 109.548 178.84 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -106.0 72.28 0.94 Allowed 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.193 0.442 . . . . 15.0 112.193 -178.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.598 HD13 ' HG3' ' A' ' 51' ' ' ARG . 5.8 tp -88.33 166.55 14.21 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 109.685 -0.487 . . . . 15.0 109.685 178.636 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -95.73 95.31 8.23 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.006 0.431 . . . . 15.0 111.167 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.689 ' CB ' HG23 ' A' ' 85' ' ' VAL . 0.2 OUTLIER . . . . . 0 C--N 1.327 -0.401 0 CA-C-N 115.803 -0.635 . . . . 15.0 111.225 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.662 ' N ' HD22 ' A' ' 18' ' ' LEU . 1.0 OUTLIER . . . . . 0 N--CA 1.453 -0.309 0 CA-C-O 120.931 0.396 . . . . 15.0 110.775 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.748 ' O ' ' HB ' ' A' ' 41' ' ' ILE . . . -162.38 44.1 0.36 Allowed Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.966 -0.635 . . . . 15.0 111.932 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.641 HG12 ' O ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -112.67 140.27 33.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 120.979 0.419 . . . . 15.0 111.622 -179.571 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.5 t -94.59 102.41 14.33 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 107.613 -1.255 . . . . 15.0 107.613 177.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.877 HG21 HG23 ' A' ' 75' ' ' VAL . 3.8 m -93.63 148.95 4.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 113.212 0.819 . . . . 15.0 113.212 -176.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.559 ' O ' ' O ' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -149.62 158.02 43.78 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 115.335 -0.848 . . . . 15.0 111.026 179.996 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.414 ' O ' HG12 ' A' ' 35' ' ' ILE . . . 67.7 116.5 0.02 OUTLIER Glycine 0 N--CA 1.453 -0.182 0 C-N-CA 120.589 -0.815 . . . . 15.0 113.421 178.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.514 ' HA3' ' N ' ' A' ' 71' ' ' HIS . . . -164.65 -39.05 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.964 -0.636 . . . . 15.0 112.501 179.225 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.504 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 0.2 OUTLIER -39.86 160.09 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-O 120.803 0.335 . . . . 15.0 111.736 179.791 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -85.45 52.18 2.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.314 -0.403 . . . . 15.0 111.024 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -151.8 -63.03 0.17 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.156 -0.475 . . . . 15.0 110.767 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.83 -51.8 51.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.216 -0.447 . . . . 15.0 110.689 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.461 HG22 ' O ' ' A' ' 26' ' ' VAL . 17.7 m -88.06 -177.8 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.107 -0.497 . . . . 15.0 110.76 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.41 ' O ' ' N ' ' A' ' 33' ' ' GLY . 0.2 OUTLIER -85.48 134.28 34.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.974 0.416 . . . . 15.0 111.062 -179.926 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 54.26 -85.42 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.657 -0.701 . . . . 15.0 111.578 179.635 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 31' ' ' ARG . . . -172.46 31.78 0.12 Allowed Glycine 0 C--N 1.331 0.272 0 C-N-CA 120.977 -0.63 . . . . 15.0 112.196 -179.498 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -95.25 158.67 22.37 Favored Glycine 0 N--CA 1.449 -0.446 0 N-CA-C 110.807 -0.917 . . . . 15.0 110.807 179.151 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 1.043 HG22 HG22 ' A' ' 58' ' ' VAL . 0.1 OUTLIER -98.31 154.99 3.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 C-N-CA 119.996 -0.682 . . . . 15.0 111.993 -179.355 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.559 ' O ' ' O ' ' A' ' 23' ' ' THR . 14.1 m-85 -135.16 108.94 8.04 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.365 -0.834 . . . . 15.0 109.767 179.498 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.762 HG22 ' N ' ' A' ' 55' ' ' GLY . 0.8 OUTLIER -54.8 149.54 2.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 121.262 0.553 . . . . 15.0 111.626 -178.45 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.508 ' O ' ' HG2' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -80.17 -47.46 14.67 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.32 -0.992 . . . . 15.0 108.32 178.516 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.641 ' O ' HG12 ' A' ' 20' ' ' ILE . . . -172.51 174.16 3.86 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.349 -0.841 . . . . 15.0 110.114 178.614 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.556 ' HA ' HG12 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -96.81 110.09 24.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 108.938 -0.764 . . . . 15.0 108.938 178.741 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.748 ' HB ' ' O ' ' A' ' 19' ' ' GLY . 0.7 OUTLIER -78.12 116.43 58.75 Favored Pre-proline 0 C--N 1.328 -0.365 0 N-CA-C 113.488 0.922 . . . . 15.0 113.488 -176.916 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.609 ' HA ' ' CG ' ' A' ' 47' ' ' GLU . 39.1 Cg_exo -61.33 61.39 0.1 Allowed 'Trans proline' 0 C--N 1.358 1.074 0 C-N-CA 123.752 2.968 . . . . 15.0 112.969 179.725 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.519 ' H ' ' HG2' ' A' ' 47' ' ' GLU . 2.9 mm-40 -149.83 -48.63 0.13 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.619 0.247 . . . . 15.0 111.554 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.74 ' HA3' ' HA3' ' A' ' 19' ' ' GLY . . . -87.79 168.69 37.95 Favored Glycine 0 CA--C 1.517 0.195 0 C-N-CA 120.362 -0.923 . . . . 15.0 113.905 -179.116 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -57.72 -12.35 2.89 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.549 0.574 . . . . 15.0 112.549 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.425 ' HB1' HG22 ' A' ' 52' ' ' ILE . . . -71.78 -58.5 3.41 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.854 0.359 . . . . 15.0 110.435 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.609 ' CG ' ' HA ' ' A' ' 42' ' ' PRO . 2.9 pp20? -57.67 -43.43 85.02 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.686 -0.688 . . . . 15.0 110.473 179.159 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -53.78 -71.31 0.08 Allowed 'General case' 0 CA--C 1.519 -0.225 0 CA-C-N 115.87 -0.604 . . . . 15.0 110.581 -179.398 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.548 ' CB ' HD11 ' A' ' 11' ' ' LEU . 0.7 OUTLIER -58.13 -41.24 83.22 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.141 -0.688 . . . . 15.0 109.141 178.778 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.79 39.57 13.61 Favored Glycine 0 N--CA 1.445 -0.702 0 CA-C-N 115.319 -0.855 . . . . 15.0 111.665 179.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.598 ' HG3' HD13 ' A' ' 11' ' ' LEU . 0.8 OUTLIER -79.72 -49.44 12.07 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.873 0.368 . . . . 15.0 110.573 -179.3 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.593 ' CG1' HD12 ' A' ' 20' ' ' ILE . 9.3 tp -81.01 160.6 3.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 116.037 -0.528 . . . . 15.0 110.181 179.411 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . 0.471 ' O ' ' HB2' ' A' ' 56' ' ' ASP . 63.5 m80 -144.31 158.68 43.61 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-O 121.644 0.735 . . . . 15.0 112.146 -179.13 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.553 ' HA ' ' CG2' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -43.81 134.01 4.57 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.437 -1.256 . . . . 15.0 112.607 -178.734 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.762 ' N ' HG22 ' A' ' 37' ' ' VAL . . . 49.98 34.34 23.1 Favored Glycine 0 C--N 1.333 0.394 0 CA-C-N 115.827 -0.624 . . . . 15.0 113.44 179.397 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.471 ' HB2' ' O ' ' A' ' 53' ' ' HIS . 0.4 OUTLIER -65.99 130.37 43.01 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.584 -0.446 . . . . 15.0 110.561 179.481 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.423 ' HE ' HD21 ' A' ' 59' ' ' LEU . 39.0 ttt180 -84.58 87.65 7.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.175 -0.466 . . . . 15.0 110.12 179.502 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 1.043 HG22 HG22 ' A' ' 35' ' ' ILE . 1.5 m -79.26 113.01 18.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 CA-C-O 121.187 0.518 . . . . 15.0 111.032 -179.413 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.423 HD21 ' HE ' ' A' ' 57' ' ' ARG . 23.7 mt -107.34 -11.77 15.48 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 115.424 -0.807 . . . . 15.0 112.304 -179.179 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.847 ' HB3' ' HB2' ' A' ' 88' ' ' LEU . . . -150.81 144.48 25.1 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.165 0.507 . . . . 15.0 112.323 -178.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.796 HG21 ' OG1' ' A' ' 77' ' ' THR . 14.8 t -139.24 102.21 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.487 -0.779 . . . . 15.0 109.569 178.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.867 ' ND2' HG22 ' A' ' 81' ' ' THR . 1.7 m-80 64.71 15.39 9.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.017 0.437 . . . . 15.0 109.83 -178.377 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 107.15 6.03 34.43 Favored Glycine 0 C--N 1.336 0.554 0 CA-C-N 115.903 -0.589 . . . . 15.0 113.409 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.659 ' O ' HG13 ' A' ' 64' ' ' VAL . 6.4 p -93.77 105.41 16.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 117.213 0.506 . . . . 15.0 110.907 179.413 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -58.76 127.91 34.57 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.099 -0.501 . . . . 15.0 110.986 -179.692 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -87.66 -20.01 26.89 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.029 -0.532 . . . . 15.0 110.864 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -47.77 97.91 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.896 0.379 . . . . 15.0 110.768 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.8 64.48 0.56 Allowed Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.738 -0.744 . . . . 15.0 112.022 -179.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.713 ' HB1' ' CG ' ' A' ' 73' ' ' GLN . . . -172.68 166.76 5.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.882 0.373 . . . . 15.0 110.949 -179.655 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.504 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 11.5 p -93.38 -174.42 3.51 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.064 0.459 . . . . 15.0 111.506 -179.461 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . 0.653 ' CD2' HG23 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -62.95 -60.36 3.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.745 -0.661 . . . . 15.0 110.51 -179.862 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.428 ' O ' ' HG3' ' A' ' 76' ' ' GLU . 8.3 ttpp -52.37 -29.5 24.25 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.88 -0.6 . . . . 15.0 110.343 179.511 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.713 ' CG ' ' HB1' ' A' ' 69' ' ' ALA . 0.4 OUTLIER -59.31 -50.24 74.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.138 -0.483 . . . . 15.0 109.842 179.371 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.47 ' O ' ' N ' ' A' ' 77' ' ' THR . . . -67.09 -47.46 71.16 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 109.597 -0.52 . . . . 15.0 109.597 178.572 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.877 HG23 HG21 ' A' ' 22' ' ' VAL . 0.5 OUTLIER -41.44 -41.05 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.251 0 N-CA-C 108.95 -0.759 . . . . 15.0 108.95 178.202 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.45 ' O ' ' N ' ' A' ' 80' ' ' ASN . 62.0 mt-10 -67.64 -46.49 72.33 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 114.711 -1.131 . . . . 15.0 110.317 178.434 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.796 ' OG1' HG21 ' A' ' 61' ' ' VAL . 32.6 p -64.34 -51.4 63.59 Favored 'General case' 0 C--O 1.231 0.119 0 C-N-CA 120.851 -0.34 . . . . 15.0 111.193 179.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.584 HD21 HG21 ' A' ' 58' ' ' VAL . 5.3 mt -53.67 -50.55 65.57 Favored 'General case' 0 CA--C 1.521 -0.168 0 CA-C-O 121.249 0.547 . . . . 15.0 109.801 179.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 21.8 ttt180 -68.46 -61.9 1.63 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.31 -0.859 . . . . 15.0 110.472 179.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.45 ' N ' ' O ' ' A' ' 76' ' ' GLU . 9.5 m-20 -66.04 61.68 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.878 -0.601 . . . . 15.0 111.997 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.867 HG22 ' ND2' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -94.16 -67.18 0.87 Allowed 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 110.062 -0.348 . . . . 15.0 110.062 179.193 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 122.28 -108.96 1.34 Allowed Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.864 -0.684 . . . . 15.0 113.118 179.153 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -65.39 -79.17 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.772 0.32 . . . . 15.0 111.696 -179.157 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.45 HG12 ' N ' ' A' ' 85' ' ' VAL . 63.8 t -109.94 159.2 9.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.023 0.44 . . . . 15.0 111.034 -179.337 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.689 HG23 ' CB ' ' A' ' 13' ' ' LYS . 9.4 t -97.86 81.26 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.095 -0.502 . . . . 15.0 110.402 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -100.78 85.0 2.8 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.748 -0.66 . . . . 15.0 110.28 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.792 ' HB3' HD21 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -103.32 119.61 39.21 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.009 -0.541 . . . . 15.0 111.893 -179.003 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.847 ' HB2' ' HB3' ' A' ' 60' ' ' ALA . 4.6 mp -94.59 101.64 13.52 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.451 -0.574 . . . . 15.0 109.451 178.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.792 HD21 ' HB3' ' A' ' 87' ' ' LEU . 0.2 OUTLIER -105.64 -163.48 0.94 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.346 0.594 . . . . 15.0 111.982 -178.55 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.419 ' HA ' ' HA ' ' A' ' 6' ' ' ILE . 2.6 tt0 -140.97 131.77 25.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.01 -0.996 . . . . 15.0 109.796 179.143 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.62 94.92 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.863 0.363 . . . . 15.0 111.122 -179.63 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.357 0 C-N-CA 120.945 -0.645 . . . . 15.0 112.729 -179.73 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.502 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 1.4 mp . . . . . 0 N--CA 1.452 -0.373 0 CA-C-O 120.984 0.421 . . . . 15.0 111.529 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.722 ' CE1' HD12 ' A' ' 89' ' ' LEU . 7.6 p90 -144.71 164.22 31.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.913 -0.585 . . . . 15.0 110.048 178.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.729 ' HB3' HD12 ' A' ' 88' ' ' LEU . 5.6 pt-20 -130.26 142.54 50.55 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.369 0.604 . . . . 15.0 111.907 -179.289 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.525 ' CG1' HD11 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -101.65 114.4 40.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.117 -0.947 . . . . 15.0 109.638 178.85 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -106.15 72.74 0.95 Allowed 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 112.351 0.501 . . . . 15.0 112.351 -178.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.676 HD13 ' HG3' ' A' ' 51' ' ' ARG . 6.0 tp -88.36 165.91 14.63 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.668 -0.493 . . . . 15.0 109.668 178.609 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -96.15 94.43 7.52 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.003 0.43 . . . . 15.0 111.149 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.688 ' CB ' HG23 ' A' ' 85' ' ' VAL . 0.1 OUTLIER . . . . . 0 C--N 1.327 -0.404 0 CA-C-N 115.764 -0.653 . . . . 15.0 111.315 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.678 ' N ' HD22 ' A' ' 18' ' ' LEU . 0.4 OUTLIER . . . . . 0 N--CA 1.456 -0.173 0 CA-C-O 120.813 0.34 . . . . 15.0 110.689 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.789 ' O ' ' HB ' ' A' ' 41' ' ' ILE . . . -173.2 44.68 0.16 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.921 -0.657 . . . . 15.0 111.913 -179.747 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.731 HG12 ' O ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -112.61 137.29 46.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 120.996 0.427 . . . . 15.0 111.579 -179.611 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.41 ' H ' HD13 ' A' ' 41' ' ' ILE . 29.1 t -88.86 105.5 17.78 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 107.865 -1.161 . . . . 15.0 107.865 177.516 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 1.014 HG21 HG23 ' A' ' 75' ' ' VAL . 34.8 m -93.37 152.5 3.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 112.618 0.599 . . . . 15.0 112.618 -177.155 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.424 ' OG1' ' CB ' ' A' ' 38' ' ' LYS . 0.8 OUTLIER -149.14 -178.62 6.48 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.245 -0.889 . . . . 15.0 110.807 -179.565 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.608 ' O ' HG22 ' A' ' 26' ' ' VAL . . . 70.16 -119.36 8.67 Favored Glycine 0 C--N 1.333 0.372 0 C-N-CA 120.856 -0.688 . . . . 15.0 112.421 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.518 ' HA3' ' N ' ' A' ' 71' ' ' HIS . . . 66.61 -65.62 0.17 Allowed Glycine 0 C--N 1.331 0.259 0 C-N-CA 121.013 -0.613 . . . . 15.0 113.61 179.402 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.608 HG22 ' O ' ' A' ' 24' ' ' GLY . 0.0 OUTLIER -28.14 140.33 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 N-CA-C 112.457 0.54 . . . . 15.0 112.457 -179.353 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.412 ' HA ' ' O ' ' A' ' 32' ' ' HIS . 59.5 t-20 -77.33 58.07 1.59 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.904 -0.589 . . . . 15.0 111.075 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.0 m -151.83 -48.28 0.11 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.283 -0.417 . . . . 15.0 110.935 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 21.6 m -83.2 -46.68 12.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 15.0 111.053 -179.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.523 HG22 ' O ' ' A' ' 26' ' ' VAL . 33.2 m -69.95 -174.62 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.262 -0.426 . . . . 15.0 111.169 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 10.0 mmp_? -67.59 -44.85 77.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.242 -0.436 . . . . 15.0 111.052 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . 0.412 ' O ' ' HA ' ' A' ' 27' ' ' ASN . 43.3 m80 -143.28 -68.41 0.34 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.306 -0.406 . . . . 15.0 111.004 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -161.43 19.52 0.19 Allowed Glycine 0 CA--C 1.517 0.189 0 C-N-CA 120.892 -0.671 . . . . 15.0 112.559 -179.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -83.64 150.67 27.06 Favored Glycine 0 N--CA 1.449 -0.493 0 N-CA-C 110.767 -0.933 . . . . 15.0 110.767 178.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.893 HG22 HG22 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -85.79 154.94 3.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 C-N-CA 120.031 -0.667 . . . . 15.0 111.745 -179.294 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.516 ' CE2' ' HG2' ' A' ' 57' ' ' ARG . 30.4 m-85 -139.2 106.8 5.59 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.041 -0.981 . . . . 15.0 109.736 178.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.793 HG22 ' N ' ' A' ' 55' ' ' GLY . 0.7 OUTLIER -55.17 146.11 4.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 116.041 -0.527 . . . . 15.0 111.025 -179.072 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.477 ' HG3' ' N ' ' A' ' 39' ' ' ALA . 0.2 OUTLIER -80.23 -46.24 16.61 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.502 -0.925 . . . . 15.0 108.502 178.616 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.731 ' O ' HG12 ' A' ' 20' ' ' ILE . . . -172.07 171.45 4.97 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 115.764 -0.653 . . . . 15.0 110.242 178.471 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.548 ' HA ' ' CG1' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -96.63 109.49 23.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 109.118 -0.697 . . . . 15.0 109.118 179.135 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.789 ' HB ' ' O ' ' A' ' 19' ' ' GLY . 0.5 OUTLIER -78.16 118.31 71.43 Favored Pre-proline 0 C--N 1.326 -0.44 0 N-CA-C 113.261 0.837 . . . . 15.0 113.261 -177.106 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.625 ' HA ' ' CG ' ' A' ' 47' ' ' GLU . 36.9 Cg_endo -64.71 60.46 0.28 Allowed 'Trans proline' 0 C--N 1.357 0.992 0 C-N-CA 123.539 2.826 . . . . 15.0 112.793 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.517 ' N ' ' HG2' ' A' ' 47' ' ' GLU . 11.2 tt0 -147.41 -46.75 0.17 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.52 -0.309 . . . . 15.0 111.244 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.777 ' HA3' ' HA3' ' A' ' 19' ' ' GLY . . . -87.87 169.33 38.53 Favored Glycine 0 C--N 1.33 0.229 0 C-N-CA 120.36 -0.924 . . . . 15.0 113.851 -179.285 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -59.36 -13.3 7.81 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.465 0.542 . . . . 15.0 112.465 -179.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.532 ' HB1' HG22 ' A' ' 52' ' ' ILE . . . -71.94 -56.15 6.2 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.934 -0.306 . . . . 15.0 110.578 -179.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.625 ' CG ' ' HA ' ' A' ' 42' ' ' PRO . 2.8 pp20? -57.61 -43.89 85.08 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 115.988 -0.551 . . . . 15.0 110.354 179.001 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 50.1 m -53.84 -70.55 0.09 Allowed 'General case' 0 CA--C 1.519 -0.225 0 CA-C-N 115.825 -0.625 . . . . 15.0 110.583 -179.477 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.487 ' CB ' HD11 ' A' ' 11' ' ' LEU . 4.4 t0 -58.1 -41.24 83.08 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.058 -0.719 . . . . 15.0 109.058 178.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.63 39.06 15.07 Favored Glycine 0 N--CA 1.446 -0.672 0 CA-C-N 115.295 -0.866 . . . . 15.0 111.771 179.285 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.676 ' HG3' HD13 ' A' ' 11' ' ' LEU . 0.5 OUTLIER -79.67 -51.05 9.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.976 0.417 . . . . 15.0 110.571 -179.388 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.601 ' CG2' HD12 ' A' ' 20' ' ' ILE . 10.8 tp -81.12 158.36 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 CA-C-N 115.93 -0.577 . . . . 15.0 110.106 179.465 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . 0.453 ' N ' ' OD2' ' A' ' 56' ' ' ASP . 80.4 m80 -145.54 159.27 43.36 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-O 121.591 0.71 . . . . 15.0 112.36 -178.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.572 ' HA ' ' CG2' ' A' ' 37' ' ' VAL . 5.0 mtpt -42.13 132.63 3.24 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.213 -1.358 . . . . 15.0 113.01 -178.595 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.793 ' N ' HG22 ' A' ' 37' ' ' VAL . . . 49.9 31.28 16.9 Favored Glycine 0 C--N 1.334 0.455 0 CA-C-N 115.697 -0.683 . . . . 15.0 113.279 179.187 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.453 ' OD2' ' N ' ' A' ' 53' ' ' HIS . 6.2 m-20 -65.7 129.39 39.6 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.726 -0.39 . . . . 15.0 110.526 179.531 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.516 ' HG2' ' CE2' ' A' ' 36' ' ' TYR . 0.5 OUTLIER -82.57 95.96 7.92 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.222 -0.445 . . . . 15.0 110.677 -179.921 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.893 HG22 HG22 ' A' ' 35' ' ' ILE . 1.4 m -86.63 117.06 30.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 CA-C-O 120.927 0.394 . . . . 15.0 110.873 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.532 ' N ' HD22 ' A' ' 59' ' ' LEU . 3.1 mm? -107.0 -17.0 14.3 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.915 -0.584 . . . . 15.0 112.482 -179.064 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.45 ' O ' HD23 ' A' ' 87' ' ' LEU . . . -149.05 148.73 30.05 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.199 0.524 . . . . 15.0 112.411 -178.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.643 HG22 HD21 ' A' ' 87' ' ' LEU . 17.5 t -139.13 101.36 1.55 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.26 0 CA-C-N 115.446 -0.797 . . . . 15.0 109.409 178.853 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.812 ' ND2' HG22 ' A' ' 81' ' ' THR . 1.6 m-80 64.79 15.5 9.86 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.658 -0.497 . . . . 15.0 109.658 -178.066 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 107.06 4.82 35.66 Favored Glycine 0 C--N 1.337 0.613 0 CA-C-N 115.832 -0.622 . . . . 15.0 113.331 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.636 ' O ' HG13 ' A' ' 64' ' ' VAL . 4.5 p -93.87 107.83 19.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.022 0.439 . . . . 15.0 110.886 179.487 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 67.2 m -56.5 133.7 53.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.21 -0.45 . . . . 15.0 111.079 -179.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.663 HD11 ' HB2' ' A' ' 74' ' ' ALA . 0.2 OUTLIER -94.76 -26.23 16.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.016 -0.538 . . . . 15.0 110.902 179.924 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 14.3 tt0 -46.03 104.12 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.308 -0.406 . . . . 15.0 111.048 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.75 60.13 0.54 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.79 -0.719 . . . . 15.0 112.464 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.609 ' HB1' ' CB ' ' A' ' 73' ' ' GLN . . . -173.04 166.94 5.02 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.959 0.409 . . . . 15.0 111.148 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.471 ' CB ' ' HA ' ' A' ' 26' ' ' VAL . 9.1 p -93.18 -172.3 2.92 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.125 -0.489 . . . . 15.0 111.053 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . 0.76 ' CD2' HG23 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -63.86 -58.91 5.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.787 -0.642 . . . . 15.0 110.583 179.868 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.422 ' O ' ' HG3' ' A' ' 76' ' ' GLU . 18.0 ttpp -52.59 -34.06 48.95 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.003 -0.544 . . . . 15.0 110.557 179.396 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.609 ' CB ' ' HB1' ' A' ' 69' ' ' ALA . 9.5 mt-30 -59.36 -49.35 78.16 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.613 -0.514 . . . . 15.0 109.613 179.241 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.778 ' HB3' HG13 ' A' ' 35' ' ' ILE . . . -67.06 -44.75 79.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.932 -0.577 . . . . 15.0 109.512 178.431 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 1.014 HG23 HG21 ' A' ' 22' ' ' VAL . 0.5 OUTLIER -43.96 -40.88 1.63 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.27 0 N-CA-C 108.797 -0.816 . . . . 15.0 108.797 178.202 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.422 ' HG3' ' O ' ' A' ' 72' ' ' LYS . 9.0 mt-10 -67.42 -44.08 79.64 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 114.744 -1.117 . . . . 15.0 110.19 178.462 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.622 ' O ' HG11 ' A' ' 61' ' ' VAL . 42.5 p -64.13 -55.48 21.65 Favored 'General case' 0 C--O 1.231 0.131 0 C-N-CA 121.056 -0.258 . . . . 15.0 111.509 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.528 HD23 HG21 ' A' ' 61' ' ' VAL . 4.6 mt -53.38 -47.26 69.64 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 121.127 0.489 . . . . 15.0 109.9 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.405 ' HB2' ' O ' ' A' ' 75' ' ' VAL . 0.0 OUTLIER -68.53 -59.49 3.11 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.518 -0.765 . . . . 15.0 110.529 179.29 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 68.5 m-20 -66.06 60.27 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.931 -0.577 . . . . 15.0 112.154 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.812 HG22 ' ND2' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -95.76 -73.02 0.61 Allowed 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 110.127 -0.323 . . . . 15.0 110.127 179.1 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 122.01 -103.71 0.87 Allowed Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.702 -0.761 . . . . 15.0 113.439 179.029 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -64.53 -84.43 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 111.965 0.357 . . . . 15.0 111.965 -178.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.469 HG12 ' N ' ' A' ' 85' ' ' VAL . 69.9 t -109.72 160.02 8.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.946 0.403 . . . . 15.0 110.873 -179.398 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.688 HG23 ' CB ' ' A' ' 13' ' ' LYS . 8.7 t -97.81 81.65 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.156 0.503 . . . . 15.0 110.457 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.423 ' NE2' HD11 ' A' ' 88' ' ' LEU . 20.5 t60 -101.13 83.87 2.56 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.72 -0.673 . . . . 15.0 110.33 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.778 ' HB3' HD21 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -103.85 115.58 30.72 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.921 -0.581 . . . . 15.0 111.873 -179.115 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.729 HD12 ' HB3' ' A' ' 8' ' ' GLU . 0.2 OUTLIER -92.15 100.49 13.1 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.327 -0.62 . . . . 15.0 109.327 178.573 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.778 HD21 ' HB3' ' A' ' 87' ' ' LEU . 0.1 OUTLIER -104.04 -159.46 0.72 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.26 0.553 . . . . 15.0 111.725 -178.658 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.502 ' HA ' ' HA ' ' A' ' 6' ' ' ILE . 5.3 tt0 -140.57 143.7 35.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.35 -0.841 . . . . 15.0 110.32 179.322 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 7.9 tppt? -55.48 105.89 0.21 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.227 -0.442 . . . . 15.0 110.954 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.336 0 C-N-CA 120.869 -0.681 . . . . 15.0 112.616 -179.899 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.488 HD11 ' OE1' ' A' ' 90' ' ' GLU . 1.3 mp . . . . . 0 N--CA 1.451 -0.379 0 CA-C-O 120.829 0.347 . . . . 15.0 110.944 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.607 ' CZ ' HD12 ' A' ' 89' ' ' LEU . 2.9 p90 -140.82 164.96 28.82 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.214 -0.448 . . . . 15.0 110.415 178.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.715 ' HB3' HD12 ' A' ' 88' ' ' LEU . 1.9 pt-20 -130.17 143.85 51.02 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.234 0.54 . . . . 15.0 111.6 -179.438 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.667 ' CG1' HD11 ' A' ' 89' ' ' LEU . 0.3 OUTLIER -101.26 114.52 40.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.277 -0.874 . . . . 15.0 109.706 179.111 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -106.04 69.88 0.83 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.076 -0.511 . . . . 15.0 111.772 -179.063 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.65 HD11 ' CB ' ' A' ' 49' ' ' ASP . 8.5 tp -88.19 161.89 16.99 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.006 -0.543 . . . . 15.0 110.316 179.223 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -96.69 98.6 10.3 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.537 -0.301 . . . . 15.0 111.151 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.889 ' HB2' HG23 ' A' ' 85' ' ' VAL . 0.3 OUTLIER . . . . . 0 CA--C 1.533 0.312 0 N-CA-C 112.706 0.632 . . . . 15.0 112.706 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.413 HD22 ' HE3' ' A' ' 13' ' ' LYS . 2.5 mm? . . . . . 0 N--CA 1.453 -0.312 0 CA-C-O 120.986 0.422 . . . . 15.0 110.74 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.705 ' O ' ' HB ' ' A' ' 41' ' ' ILE . . . -160.8 40.07 0.43 Allowed Glycine 0 N--CA 1.448 -0.532 0 N-CA-C 111.439 -0.664 . . . . 15.0 111.439 -179.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.653 HG12 ' O ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -112.7 139.08 39.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 120.907 0.384 . . . . 15.0 111.876 -179.227 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 30.3 t -96.03 104.96 16.93 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 107.924 -1.139 . . . . 15.0 107.924 177.371 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.978 HG21 HG23 ' A' ' 75' ' ' VAL . 32.6 m -93.63 156.84 3.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 113.09 0.774 . . . . 15.0 113.09 -177.091 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.31 -175.03 4.83 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.128 -0.942 . . . . 15.0 110.703 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.585 ' O ' HG22 ' A' ' 26' ' ' VAL . . . 68.71 -119.52 10.09 Favored Glycine 0 C--N 1.332 0.309 0 C-N-CA 120.831 -0.699 . . . . 15.0 112.542 179.794 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.526 ' HA3' ' N ' ' A' ' 71' ' ' HIS . . . 67.1 -66.65 0.21 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.922 -0.656 . . . . 15.0 113.336 179.563 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.585 HG22 ' O ' ' A' ' 24' ' ' GLY . 0.0 OUTLIER -32.62 142.48 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 N-CA-C 112.063 0.394 . . . . 15.0 112.063 -179.492 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -75.63 59.6 1.17 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.065 -0.516 . . . . 15.0 110.857 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.5 m -151.6 -66.3 0.18 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.231 -0.44 . . . . 15.0 110.566 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 29.5 t -65.44 -51.25 61.51 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.111 -0.495 . . . . 15.0 110.424 179.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.472 HG11 ' CD1' ' A' ' 36' ' ' TYR . 27.0 m -88.07 -175.35 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.02 -0.536 . . . . 15.0 110.689 179.601 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 38.1 ttm180 -90.4 137.63 32.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.969 0.414 . . . . 15.0 111.096 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 42.1 m170 55.53 -86.36 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.756 -0.656 . . . . 15.0 111.345 179.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.411 ' O ' ' O ' ' A' ' 69' ' ' ALA . . . -171.94 27.79 0.1 OUTLIER Glycine 0 C--N 1.33 0.24 0 C-N-CA 120.922 -0.656 . . . . 15.0 112.48 -179.709 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.432 ' O ' HG21 ' A' ' 30' ' ' VAL . . . -81.7 151.79 31.13 Favored Glycine 0 N--CA 1.451 -0.363 0 N-CA-C 110.857 -0.897 . . . . 15.0 110.857 179.029 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.925 HG22 HG22 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -88.94 154.1 3.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 119.99 -0.684 . . . . 15.0 111.704 -179.346 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.494 ' CZ ' ' HG2' ' A' ' 57' ' ' ARG . 29.4 m-85 -141.73 107.52 5.13 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.154 -0.93 . . . . 15.0 110.008 179.114 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.781 HG22 ' N ' ' A' ' 55' ' ' GLY . 0.7 OUTLIER -55.81 153.16 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.191 0.52 . . . . 15.0 111.295 -179.131 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.514 ' O ' ' HG2' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -85.72 -48.33 8.93 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.379 -0.971 . . . . 15.0 108.379 178.33 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.653 ' O ' HG12 ' A' ' 20' ' ' ILE . . . -172.39 173.78 4.04 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 115.354 -0.839 . . . . 15.0 110.145 178.722 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.622 ' HA ' HG12 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -96.97 112.16 28.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 109.436 -0.579 . . . . 15.0 109.436 179.125 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.705 ' HB ' ' O ' ' A' ' 19' ' ' GLY . 0.4 OUTLIER -78.36 118.72 73.96 Favored Pre-proline 0 C--N 1.329 -0.298 0 N-CA-C 113.349 0.87 . . . . 15.0 113.349 -177.245 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.613 ' HA ' ' HG2' ' A' ' 47' ' ' GLU . 36.9 Cg_endo -64.36 61.66 0.25 Allowed 'Trans proline' 0 C--N 1.357 0.998 0 C-N-CA 123.509 2.806 . . . . 15.0 112.918 179.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.514 ' H ' ' HG2' ' A' ' 47' ' ' GLU . 2.2 mm-40 -150.8 -46.6 0.12 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.611 -0.268 . . . . 15.0 111.618 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.651 ' HA3' ' HA3' ' A' ' 19' ' ' GLY . . . -87.82 166.65 35.89 Favored Glycine 0 C--N 1.331 0.268 0 C-N-CA 120.311 -0.947 . . . . 15.0 113.879 -179.142 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -55.96 -14.83 2.76 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.703 0.631 . . . . 15.0 112.703 -179.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.16 -57.5 4.2 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.707 0.289 . . . . 15.0 111.109 -179.504 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.613 ' HG2' ' HA ' ' A' ' 42' ' ' PRO . 2.9 pp20? -57.11 -41.91 79.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 15.0 110.478 179.545 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 40.1 t -53.7 -70.37 0.1 Allowed 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 115.896 -0.593 . . . . 15.0 110.668 -179.508 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.65 ' CB ' HD11 ' A' ' 11' ' ' LEU . 1.5 m-20 -61.1 -39.57 90.48 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.219 0.533 . . . . 15.0 109.575 179.049 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.01 44.21 8.32 Favored Glycine 0 N--CA 1.447 -0.599 0 CA-C-N 115.439 -0.801 . . . . 15.0 111.835 179.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.652 ' CG ' HG23 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -79.5 -53.4 6.91 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.962 0.411 . . . . 15.0 110.647 -179.397 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.625 ' CG1' HD12 ' A' ' 20' ' ' ILE . 10.3 tp -81.08 163.1 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 CA-C-N 115.936 -0.575 . . . . 15.0 110.442 179.695 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . 0.424 ' N ' ' OD2' ' A' ' 56' ' ' ASP . 42.3 m80 -146.57 158.82 43.97 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-O 121.606 0.717 . . . . 15.0 112.126 -179.072 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.564 ' HA ' ' CG2' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -43.15 133.33 3.95 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.246 -1.343 . . . . 15.0 112.928 -178.58 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.781 ' N ' HG22 ' A' ' 37' ' ' VAL . . . 49.84 32.14 17.83 Favored Glycine 0 C--N 1.336 0.545 0 CA-C-N 115.841 -0.618 . . . . 15.0 113.053 179.275 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.512 ' OD2' HD12 ' A' ' 52' ' ' ILE . 4.6 m-20 -65.47 124.75 23.11 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.706 -0.397 . . . . 15.0 110.216 179.498 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.861 ' HD2' HD21 ' A' ' 59' ' ' LEU . 0.0 OUTLIER -81.82 92.85 6.74 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.203 -0.453 . . . . 15.0 110.505 -179.959 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.925 HG22 HG22 ' A' ' 35' ' ' ILE . 1.3 m -84.76 120.85 36.04 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 CA-C-N 116.195 -0.457 . . . . 15.0 111.383 -179.372 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.861 HD21 ' HD2' ' A' ' 57' ' ' ARG . 3.4 mm? -107.24 -20.88 13.15 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 115.73 -0.668 . . . . 15.0 112.455 -179.36 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.494 ' O ' HD23 ' A' ' 87' ' ' LEU . . . -147.75 153.74 39.64 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.33 0.586 . . . . 15.0 112.569 -178.585 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.83 HG11 ' O ' ' A' ' 77' ' ' THR . 25.9 t -138.97 99.56 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.331 0 CA-C-N 115.231 -0.895 . . . . 15.0 109.048 178.788 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.593 ' ND2' HG22 ' A' ' 81' ' ' THR . 1.6 m-80 65.37 16.36 10.49 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.535 -0.543 . . . . 15.0 109.535 -177.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 107.07 5.59 35.02 Favored Glycine 0 C--N 1.337 0.633 0 CA-C-N 115.689 -0.687 . . . . 15.0 113.63 179.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.664 ' O ' HG13 ' A' ' 64' ' ' VAL . 5.9 p -93.88 105.34 16.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 117.339 0.57 . . . . 15.0 110.809 179.306 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -55.58 130.73 44.13 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.053 -0.521 . . . . 15.0 111.11 -179.57 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.735 HD21 ' HA ' ' A' ' 74' ' ' ALA . 0.1 OUTLIER -97.76 -24.16 15.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.97 -0.559 . . . . 15.0 111.036 179.925 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -45.41 106.23 0.07 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.426 -0.352 . . . . 15.0 110.999 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.85 58.95 0.53 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.785 -0.721 . . . . 15.0 112.289 -179.655 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.579 ' HB1' ' CD ' ' A' ' 73' ' ' GLN . . . -172.98 171.75 4.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.848 0.356 . . . . 15.0 110.945 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.567 ' HB ' HG13 ' A' ' 26' ' ' VAL . 13.5 p -93.37 -172.64 2.99 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.092 0.472 . . . . 15.0 111.376 -179.749 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . 0.783 ' CD2' HG23 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -64.24 -59.58 4.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.654 -0.703 . . . . 15.0 110.668 -179.975 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.406 ' N ' ' CG ' ' A' ' 71' ' ' HIS . 29.9 ttpt -52.44 -32.78 41.13 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.895 -0.593 . . . . 15.0 110.643 179.777 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.579 ' CD ' ' HB1' ' A' ' 69' ' ' ALA . 10.4 mt-30 -59.45 -51.76 68.49 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.542 -0.54 . . . . 15.0 109.542 179.264 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.735 ' HA ' HD21 ' A' ' 66' ' ' LEU . . . -67.23 -44.49 79.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.008 -0.542 . . . . 15.0 110.033 178.511 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.978 HG23 HG21 ' A' ' 22' ' ' VAL . 0.5 OUTLIER -41.9 -41.76 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.239 0 N-CA-C 109.249 -0.649 . . . . 15.0 109.249 178.688 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.463 ' O ' ' HB2' ' A' ' 80' ' ' ASN . 54.0 mt-10 -67.3 -44.88 78.12 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 114.882 -1.054 . . . . 15.0 110.453 178.639 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.83 ' O ' HG11 ' A' ' 61' ' ' VAL . 37.2 p -64.05 -55.1 24.64 Favored 'General case' 0 N--CA 1.461 0.122 0 C-N-CA 121.159 -0.216 . . . . 15.0 111.555 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.757 HD21 HG21 ' A' ' 58' ' ' VAL . 6.5 mt -53.31 -45.98 69.23 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-O 121.237 0.542 . . . . 15.0 109.997 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.403 ' HB2' ' O ' ' A' ' 75' ' ' VAL . 0.0 OUTLIER -68.35 -58.91 3.65 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.334 -0.848 . . . . 15.0 110.643 179.493 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.463 ' HB2' ' O ' ' A' ' 76' ' ' GLU . 11.2 m-80 -66.08 62.71 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.074 -0.512 . . . . 15.0 111.928 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.593 HG22 ' ND2' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -92.74 -76.26 0.47 Allowed 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 110.155 -0.313 . . . . 15.0 110.155 179.284 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 122.2 -105.17 0.95 Allowed Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.728 -0.749 . . . . 15.0 113.052 179.165 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.429 ' O ' ' HB3' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -64.87 -84.07 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.753 0.311 . . . . 15.0 111.209 -179.42 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.453 HG12 ' N ' ' A' ' 85' ' ' VAL . 79.0 t -110.17 158.61 10.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.021 0.439 . . . . 15.0 111.083 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.889 HG23 ' HB2' ' A' ' 13' ' ' LYS . 3.3 t -97.68 83.15 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.176 0.513 . . . . 15.0 110.213 179.68 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -100.09 82.08 2.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.736 -0.666 . . . . 15.0 110.242 179.778 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.789 ' HB3' HD21 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -103.98 127.04 51.52 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.914 -0.584 . . . . 15.0 111.85 -179.022 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.715 HD12 ' HB3' ' A' ' 8' ' ' GLU . 0.2 OUTLIER -102.17 100.54 10.76 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.292 -0.633 . . . . 15.0 109.292 178.433 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.789 HD21 ' HB3' ' A' ' 87' ' ' LEU . 0.1 OUTLIER -104.85 -161.49 0.82 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.405 0.621 . . . . 15.0 111.795 -178.582 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.488 ' OE1' HD11 ' A' ' 6' ' ' ILE . 3.2 tt0 -141.5 135.55 30.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.064 -0.971 . . . . 15.0 109.876 179.232 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.1 105.56 0.07 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.951 0.405 . . . . 15.0 111.169 -179.663 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.342 0 C-N-CA 120.938 -0.648 . . . . 15.0 112.641 -179.794 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.618 HD11 ' OE1' ' A' ' 90' ' ' GLU . 1.4 mp . . . . . 0 N--CA 1.45 -0.438 0 CA-C-O 120.799 0.333 . . . . 15.0 111.097 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.514 ' CZ ' HD12 ' A' ' 89' ' ' LEU . 3.0 p90 -140.65 166.37 24.93 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.274 -0.421 . . . . 15.0 110.569 178.647 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.732 ' CB ' HD12 ' A' ' 88' ' ' LEU . 9.5 pt-20 -129.43 143.87 51.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.196 0.522 . . . . 15.0 111.432 -179.336 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.639 ' CG1' HD11 ' A' ' 89' ' ' LEU . 0.3 OUTLIER -101.37 117.26 46.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.424 -0.807 . . . . 15.0 109.382 178.82 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 55.1 tt0 -105.97 75.71 1.13 Allowed 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.456 0.539 . . . . 15.0 112.456 -178.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.596 ' HB3' ' HB ' ' A' ' 85' ' ' VAL . 6.4 tp -87.93 161.21 17.58 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.24 -0.652 . . . . 15.0 109.24 178.179 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -96.8 94.55 7.32 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 120.816 -0.354 . . . . 15.0 111.819 -179.516 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.615 ' CB ' HG23 ' A' ' 85' ' ' VAL . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.319 0 CA-C-O 121.334 0.588 . . . . 15.0 111.203 179.283 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.472 ' N ' HD22 ' A' ' 18' ' ' LEU . 3.1 mm? . . . . . 0 N--CA 1.45 -0.449 0 CA-C-O 121.165 0.507 . . . . 15.0 111.066 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.618 ' O ' ' HB ' ' A' ' 41' ' ' ILE . . . -162.87 31.85 0.29 Allowed Glycine 0 CA--C 1.505 -0.561 0 N-CA-C 110.931 -0.868 . . . . 15.0 110.931 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.741 HD13 ' HB ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -112.5 143.65 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 CA-C-O 121.104 0.478 . . . . 15.0 112.146 -178.709 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 27.1 t -96.07 102.47 14.27 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 107.014 -1.476 . . . . 15.0 107.014 176.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.977 HG21 HG23 ' A' ' 75' ' ' VAL . 32.8 m -93.36 155.28 3.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 113.439 0.903 . . . . 15.0 113.439 -176.23 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.3 -175.44 4.99 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 114.8 -1.091 . . . . 15.0 110.609 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.425 ' O ' ' HB3' ' A' ' 71' ' ' HIS . . . 68.73 -120.23 10.84 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 120.823 -0.703 . . . . 15.0 112.602 179.725 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.543 ' HA3' ' N ' ' A' ' 71' ' ' HIS . . . 69.07 -66.38 0.49 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.795 -0.717 . . . . 15.0 113.431 179.449 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.505 ' O ' HG22 ' A' ' 30' ' ' VAL . 1.0 OUTLIER -27.66 140.25 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 N-CA-C 112.471 0.545 . . . . 15.0 112.471 -179.271 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -76.61 60.14 1.61 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.983 -0.553 . . . . 15.0 111.034 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -151.72 -50.45 0.11 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.373 -0.376 . . . . 15.0 111.01 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.8 t -84.21 -37.58 21.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.202 -0.453 . . . . 15.0 111.071 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.505 HG22 ' O ' ' A' ' 26' ' ' VAL . 21.7 m -80.75 -174.75 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.306 -0.406 . . . . 15.0 111.238 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.437 ' HB3' ' CD2' ' A' ' 32' ' ' HIS . 2.8 mtt-85 -58.8 -54.17 50.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.449 . . . . 15.0 111.022 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . 0.437 ' CD2' ' HB3' ' A' ' 31' ' ' ARG . 47.6 m-70 -146.37 -50.47 0.22 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.264 -0.426 . . . . 15.0 111.043 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -169.28 26.24 0.11 Allowed Glycine 0 N--CA 1.453 -0.19 0 C-N-CA 120.825 -0.702 . . . . 15.0 112.512 -179.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.481 ' O ' HG11 ' A' ' 30' ' ' VAL . . . -90.58 149.18 19.95 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.684 -0.769 . . . . 15.0 111.197 179.101 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.82 HG22 HG22 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -87.68 154.69 3.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 117.341 0.571 . . . . 15.0 111.568 -179.39 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.427 ' CZ ' ' HG3' ' A' ' 57' ' ' ARG . 26.6 m-85 -140.76 106.83 5.19 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.241 -0.891 . . . . 15.0 109.829 179.312 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.783 HG22 ' N ' ' A' ' 55' ' ' GLY . 0.8 OUTLIER -55.58 148.25 3.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.18 0.514 . . . . 15.0 111.553 -178.938 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.41 ' O ' ' HG2' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -80.41 -47.7 14.01 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.316 -0.994 . . . . 15.0 108.316 178.2 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.626 ' O ' HG12 ' A' ' 20' ' ' ILE . . . -172.02 172.76 4.59 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 115.254 -0.885 . . . . 15.0 110.291 178.606 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.665 ' HA ' HG12 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -97.42 107.84 20.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.936 0.398 . . . . 15.0 110.889 179.946 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.618 ' HB ' ' O ' ' A' ' 19' ' ' GLY . 0.6 OUTLIER -78.86 108.03 7.28 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 115.789 -0.641 . . . . 15.0 112.611 -178.671 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.477 ' N ' ' HG2' ' A' ' 47' ' ' GLU . 30.7 Cg_endo -62.93 69.67 0.13 Allowed 'Trans proline' 0 C--N 1.355 0.904 0 C-N-CA 123.139 2.559 . . . . 15.0 112.535 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.463 ' HB2' HG22 ' A' ' 41' ' ' ILE . 0.7 OUTLIER -151.79 -52.93 0.12 Allowed 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.365 -0.834 . . . . 15.0 109.675 179.501 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.521 ' HA3' ' CA ' ' A' ' 19' ' ' GLY . . . -87.93 155.99 27.07 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.611 -0.804 . . . . 15.0 112.402 179.254 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -39.11 -18.81 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 113.638 0.977 . . . . 15.0 113.638 -179.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.478 ' N ' ' O ' ' A' ' 44' ' ' GLY . . . -71.68 -71.89 0.25 Allowed 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 111.783 0.29 . . . . 15.0 111.783 -179.31 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.508 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 3.9 tp10 -58.22 -40.4 81.57 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 120.423 -0.511 . . . . 15.0 110.379 179.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 16.5 m -54.27 -59.18 5.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.974 -0.557 . . . . 15.0 110.463 179.439 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.569 ' CB ' HD11 ' A' ' 11' ' ' LEU . 3.6 t70 -68.46 -38.37 81.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.155 -0.475 . . . . 15.0 110.107 179.303 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.81 42.8 8.7 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.695 -0.684 . . . . 15.0 112.988 179.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.488 ' HG3' HD13 ' A' ' 11' ' ' LEU . 2.8 mmp_? -90.2 -50.68 5.85 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.877 0.37 . . . . 15.0 110.521 179.475 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.632 ' CG1' HD12 ' A' ' 20' ' ' ILE . 10.1 tp -81.22 158.9 4.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.048 -0.524 . . . . 15.0 110.773 179.69 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . 0.424 ' O ' ' HB2' ' A' ' 56' ' ' ASP . 72.8 m80 -141.0 158.24 44.22 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-O 121.645 0.736 . . . . 15.0 112.244 -179.407 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.573 ' HA ' ' CG2' ' A' ' 37' ' ' VAL . 2.3 mtpt -42.25 134.12 2.96 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.407 -1.269 . . . . 15.0 112.794 -178.704 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.783 ' N ' HG22 ' A' ' 37' ' ' VAL . . . 49.76 33.41 19.46 Favored Glycine 0 C--N 1.334 0.444 0 CA-C-N 115.815 -0.63 . . . . 15.0 113.616 179.157 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.424 ' HB2' ' O ' ' A' ' 53' ' ' HIS . 0.2 OUTLIER -66.01 133.17 50.25 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 117.169 0.485 . . . . 15.0 110.679 179.529 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.427 ' HG3' ' CZ ' ' A' ' 36' ' ' TYR . 6.2 ttt85 -86.47 88.42 7.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.193 -0.458 . . . . 15.0 110.363 179.604 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.82 HG22 HG22 ' A' ' 35' ' ' ILE . 1.7 m -79.43 114.77 20.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.057 0.456 . . . . 15.0 111.003 -179.558 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.416 ' HA ' ' HB2' ' A' ' 66' ' ' LEU . 32.0 mt -107.09 -16.71 14.36 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.762 -0.654 . . . . 15.0 112.46 -179.244 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.636 ' HB3' ' HB2' ' A' ' 88' ' ' LEU . . . -147.88 146.46 29.08 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 112.563 0.579 . . . . 15.0 112.563 -178.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.879 HG11 ' O ' ' A' ' 77' ' ' THR . 57.3 t -139.02 102.77 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.368 -0.833 . . . . 15.0 109.098 178.674 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.76 ' ND2' HG22 ' A' ' 81' ' ' THR . 1.3 m-80 64.9 14.94 9.61 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.87 -0.419 . . . . 15.0 109.87 -178.163 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 107.0 5.47 35.29 Favored Glycine 0 C--N 1.336 0.552 0 CA-C-N 115.989 -0.55 . . . . 15.0 113.361 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.644 ' O ' HG13 ' A' ' 64' ' ' VAL . 6.1 p -93.87 107.59 19.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 117.077 0.439 . . . . 15.0 111.192 179.645 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 44.2 m -58.48 133.04 55.44 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.294 -0.412 . . . . 15.0 110.798 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.496 HD11 ' HA ' ' A' ' 74' ' ' ALA . 1.2 mm? -91.1 -21.86 21.0 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.07 -0.514 . . . . 15.0 111.185 -179.699 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -43.55 98.06 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 120.912 0.387 . . . . 15.0 111.149 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.87 63.28 0.55 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.817 -0.706 . . . . 15.0 112.333 -179.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.664 ' HB1' ' CB ' ' A' ' 73' ' ' GLN . . . -173.13 150.65 1.97 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.907 0.384 . . . . 15.0 111.098 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.434 ' HA ' ' N ' ' A' ' 26' ' ' VAL . 2.9 p -81.05 -171.96 3.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 15.0 111.015 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . 0.769 ' CD2' HG23 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -62.08 -59.68 4.71 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.847 -0.615 . . . . 15.0 110.537 -179.953 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 13.3 ttpp -52.65 -34.64 52.45 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.685 -0.689 . . . . 15.0 111.046 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.664 ' CB ' ' HB1' ' A' ' 69' ' ' ALA . 2.8 mt-30 -59.31 -49.97 75.78 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.71 -0.478 . . . . 15.0 109.71 179.526 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.608 ' HB3' HG13 ' A' ' 35' ' ' ILE . . . -66.2 -45.68 79.93 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.929 -0.578 . . . . 15.0 109.532 178.423 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.977 HG23 HG21 ' A' ' 22' ' ' VAL . 0.5 OUTLIER -43.59 -40.81 1.41 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.209 0 N-CA-C 108.853 -0.795 . . . . 15.0 108.853 178.158 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -67.28 -44.87 78.23 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 114.845 -1.071 . . . . 15.0 110.126 178.365 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.879 ' O ' HG11 ' A' ' 61' ' ' VAL . 61.3 p -64.19 -54.24 36.76 Favored 'General case' 0 N--CA 1.461 0.08 0 CA-C-N 116.621 -0.263 . . . . 15.0 111.349 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.821 HD23 HG21 ' A' ' 61' ' ' VAL . 4.4 mt -53.43 -48.59 68.62 Favored 'General case' 0 CA--C 1.521 -0.146 0 CA-C-O 121.099 0.476 . . . . 15.0 110.138 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.405 ' O ' ' N ' ' A' ' 81' ' ' THR . 0.3 OUTLIER -68.54 -58.16 4.71 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.559 -0.746 . . . . 15.0 110.748 179.558 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -65.88 63.53 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.089 -0.505 . . . . 15.0 111.952 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.76 HG22 ' ND2' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -94.99 -73.53 0.58 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.65 0.262 . . . . 15.0 110.468 179.362 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 122.2 -105.22 0.96 Allowed Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.828 -0.701 . . . . 15.0 113.132 179.4 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.468 ' O ' ' HB3' ' A' ' 13' ' ' LYS . 0.4 OUTLIER -64.67 -82.17 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.705 0.288 . . . . 15.0 111.484 -179.279 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.434 HG12 ' N ' ' A' ' 85' ' ' VAL . 50.0 t -109.76 158.05 10.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.904 0.383 . . . . 15.0 110.423 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.615 HG23 ' CB ' ' A' ' 13' ' ' LYS . 50.7 t -98.23 77.85 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.231 -0.441 . . . . 15.0 110.627 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -98.63 88.37 4.06 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.021 -0.536 . . . . 15.0 110.893 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.803 ' HB3' HD21 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -103.89 125.84 50.59 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.104 -0.498 . . . . 15.0 111.633 -179.474 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.732 HD12 ' CB ' ' A' ' 8' ' ' GLU . 4.6 mp -101.59 101.85 12.47 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.428 -0.582 . . . . 15.0 109.428 178.657 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.803 HD21 ' HB3' ' A' ' 87' ' ' LEU . 0.1 OUTLIER -105.83 -163.62 0.95 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.536 0.684 . . . . 15.0 112.119 -178.325 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.618 ' OE1' HD11 ' A' ' 6' ' ' ILE . 2.2 tt0 -142.47 137.62 30.42 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 114.803 -1.09 . . . . 15.0 109.758 179.063 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.95 106.85 0.13 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.942 0.401 . . . . 15.0 111.05 -179.687 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.267 0 C-N-CA 120.955 -0.64 . . . . 15.0 112.765 -179.641 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.425 HG13 ' HB2' ' A' ' 90' ' ' GLU . 1.4 mp . . . . . 0 N--CA 1.452 -0.349 0 CA-C-O 120.734 0.302 . . . . 15.0 111.088 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.831 ' CZ ' HD12 ' A' ' 89' ' ' LEU . 3.9 p90 -140.65 165.53 27.22 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.327 -0.397 . . . . 15.0 110.729 178.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.737 ' HB2' HD12 ' A' ' 88' ' ' LEU . 11.0 pt-20 -130.14 143.52 50.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.117 0.484 . . . . 15.0 111.467 -179.642 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.58 HG11 ' CD1' ' A' ' 52' ' ' ILE . 0.5 OUTLIER -101.55 117.45 46.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.582 -0.735 . . . . 15.0 109.998 179.115 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -106.43 71.81 0.89 Allowed 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 112.243 0.46 . . . . 15.0 112.243 -179.221 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.548 ' HB3' ' HB ' ' A' ' 85' ' ' VAL . 7.9 tp -88.0 164.25 15.89 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.538 -0.542 . . . . 15.0 109.538 178.697 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -96.09 93.02 6.72 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.025 0.441 . . . . 15.0 111.297 -179.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.731 ' CB ' HG23 ' A' ' 85' ' ' VAL . 0.1 OUTLIER . . . . . 0 C--N 1.327 -0.376 0 CA-C-N 115.857 -0.61 . . . . 15.0 110.935 179.769 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.679 ' N ' HD22 ' A' ' 18' ' ' LEU . 0.4 OUTLIER . . . . . 0 N--CA 1.456 -0.161 0 CA-C-O 120.826 0.346 . . . . 15.0 110.702 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.633 ' O ' ' HB ' ' A' ' 41' ' ' ILE . . . -166.77 34.09 0.22 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 121.09 -0.576 . . . . 15.0 112.183 -179.665 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.674 HG13 HG12 ' A' ' 40' ' ' VAL . 0.1 OUTLIER -112.63 140.65 31.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 121.023 0.439 . . . . 15.0 111.892 -179.464 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.456 ' HB3' HD11 ' A' ' 41' ' ' ILE . 31.3 t -96.3 107.16 19.48 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 107.735 -1.209 . . . . 15.0 107.735 177.221 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 1.025 HG21 HG23 ' A' ' 75' ' ' VAL . 30.4 m -93.31 152.5 3.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 N-CA-C 113.061 0.763 . . . . 15.0 113.061 -176.807 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.419 HG23 ' HB3' ' A' ' 38' ' ' LYS . 35.4 p -149.42 178.68 8.58 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 115.036 -0.984 . . . . 15.0 110.874 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.551 ' O ' HG22 ' A' ' 26' ' ' VAL . . . 71.83 -118.69 7.14 Favored Glycine 0 C--N 1.332 0.345 0 C-N-CA 120.987 -0.625 . . . . 15.0 112.697 179.813 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.536 ' HA3' ' N ' ' A' ' 71' ' ' HIS . . . 68.21 -66.28 0.37 Allowed Glycine 0 C--N 1.331 0.254 0 C-N-CA 120.874 -0.679 . . . . 15.0 113.585 179.563 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.551 HG22 ' O ' ' A' ' 24' ' ' GLY . 0.0 OUTLIER -29.64 137.89 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 N-CA-C 112.247 0.462 . . . . 15.0 112.247 -179.355 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -75.46 63.5 1.48 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.905 -0.589 . . . . 15.0 111.038 -179.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 29.5 m -151.71 -50.3 0.11 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.247 -0.433 . . . . 15.0 111.067 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 11.0 t -88.04 -29.27 20.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.231 -0.441 . . . . 15.0 111.146 -179.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.49 HG22 ' O ' ' A' ' 26' ' ' VAL . 34.4 m -85.4 -176.85 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.367 -0.379 . . . . 15.0 111.312 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -61.47 -46.95 87.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.14 -0.482 . . . . 15.0 111.101 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 74.6 m-70 -148.29 -61.94 0.25 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.405 -0.361 . . . . 15.0 111.226 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.4 ' O ' ' O ' ' A' ' 69' ' ' ALA . . . -163.67 24.98 0.19 Allowed Glycine 0 N--CA 1.453 -0.205 0 C-N-CA 120.853 -0.689 . . . . 15.0 112.586 -179.642 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -89.61 156.97 26.14 Favored Glycine 0 N--CA 1.449 -0.462 0 N-CA-C 110.626 -0.99 . . . . 15.0 110.626 178.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.966 HG22 HG22 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -93.69 151.5 3.69 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.388 0 CA-C-N 117.66 0.73 . . . . 15.0 112.013 -179.366 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.515 ' CZ ' ' HG2' ' A' ' 57' ' ' ARG . 49.9 m-85 -133.46 107.65 8.17 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.718 -1.128 . . . . 15.0 109.162 178.707 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.822 HG22 ' N ' ' A' ' 55' ' ' GLY . 0.6 OUTLIER -54.85 152.91 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 121.261 0.553 . . . . 15.0 110.723 -178.575 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.651 ' HG3' ' N ' ' A' ' 39' ' ' ALA . 1.4 ppmt? -88.17 -47.32 8.55 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 108.795 -0.817 . . . . 15.0 108.795 179.313 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.651 ' N ' ' HG3' ' A' ' 38' ' ' LYS . . . -173.06 167.14 4.98 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.669 -0.696 . . . . 15.0 110.202 178.305 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.674 HG12 HG13 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -96.84 111.87 27.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.647 -0.501 . . . . 15.0 109.647 179.14 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.633 ' HB ' ' O ' ' A' ' 19' ' ' GLY . 0.3 OUTLIER -78.39 111.37 18.36 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 115.728 -0.669 . . . . 15.0 112.664 -177.676 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.442 ' HD2' ' HA ' ' A' ' 41' ' ' ILE . 37.1 Cg_endo -65.23 65.35 0.33 Allowed 'Trans proline' 0 C--N 1.355 0.899 0 C-N-CA 123.07 2.514 . . . . 15.0 112.763 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.507 ' HB2' HG22 ' A' ' 41' ' ' ILE . 5.5 mt-30 -149.52 -52.03 0.15 Allowed 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.402 -0.817 . . . . 15.0 109.196 179.293 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.543 ' HA3' ' HA3' ' A' ' 19' ' ' GLY . . . -88.03 154.34 25.42 Favored Glycine 0 N--CA 1.445 -0.719 0 CA-C-N 115.443 -0.799 . . . . 15.0 112.516 179.109 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -40.61 -17.73 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 113.804 1.038 . . . . 15.0 113.804 -179.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.446 ' N ' ' O ' ' A' ' 44' ' ' GLY . . . -71.67 -70.54 0.32 Allowed 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.707 -0.397 . . . . 15.0 111.477 -179.247 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.518 ' HG2' ' HB ' ' A' ' 40' ' ' VAL . 6.8 tm-20 -58.08 -37.17 73.98 Favored 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 120.678 -0.409 . . . . 15.0 110.039 179.508 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 37.4 m -56.25 -65.76 0.55 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.021 -0.536 . . . . 15.0 110.335 179.265 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.458 ' CB ' HD11 ' A' ' 11' ' ' LEU . 18.6 m-20 -62.55 -38.4 89.86 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.123 0.487 . . . . 15.0 109.931 179.135 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.51 43.56 8.42 Favored Glycine 0 N--CA 1.449 -0.493 0 CA-C-N 115.59 -0.732 . . . . 15.0 112.446 179.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.568 ' CG ' HG23 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -79.8 -58.26 3.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.867 0.365 . . . . 15.0 110.616 -179.982 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.58 ' CD1' HG11 ' A' ' 9' ' ' VAL . 1.4 mm -86.13 163.41 2.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.114 -0.494 . . . . 15.0 110.887 179.809 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . 0.563 ' N ' HG22 ' A' ' 52' ' ' ILE . 43.2 m80 -139.37 154.67 47.88 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-O 121.61 0.719 . . . . 15.0 111.415 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.543 ' HA ' ' CG2' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -36.07 133.93 0.43 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.368 -1.287 . . . . 15.0 113.016 -178.549 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.822 ' N ' HG22 ' A' ' 37' ' ' VAL . . . 50.74 34.16 28.45 Favored Glycine 0 C--N 1.334 0.468 0 CA-C-N 115.806 -0.633 . . . . 15.0 113.929 179.091 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.457 ' H ' HG13 ' A' ' 37' ' ' VAL . 1.9 m-20 -65.4 130.62 43.99 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 117.296 0.548 . . . . 15.0 110.525 179.203 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.575 ' CD ' HD21 ' A' ' 59' ' ' LEU . 0.0 OUTLIER -82.34 85.73 6.82 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.002 -0.545 . . . . 15.0 110.543 179.818 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.966 HG22 HG22 ' A' ' 35' ' ' ILE . 1.0 OUTLIER -81.67 114.33 22.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.15 0.5 . . . . 15.0 111.266 -179.549 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.575 HD21 ' CD ' ' A' ' 57' ' ' ARG . 18.6 mt -107.23 -15.74 14.58 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.702 -0.681 . . . . 15.0 112.142 -179.563 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.559 ' O ' HD23 ' A' ' 87' ' ' LEU . . . -147.58 151.01 35.55 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.292 0.567 . . . . 15.0 112.337 -178.767 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.583 HG21 ' HB ' ' A' ' 77' ' ' THR . 10.7 t -139.04 102.83 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.257 -0.883 . . . . 15.0 109.105 178.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.683 ' ND2' HG22 ' A' ' 81' ' ' THR . 1.5 m-80 65.0 14.73 9.54 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.575 -0.528 . . . . 15.0 109.575 -177.817 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 106.49 6.57 35.63 Favored Glycine 0 C--N 1.337 0.606 0 CA-C-N 115.824 -0.626 . . . . 15.0 113.336 179.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.656 ' O ' HG13 ' A' ' 64' ' ' VAL . 8.9 p -93.86 106.64 18.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.098 0.475 . . . . 15.0 111.066 179.54 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 49.1 m -58.8 124.62 20.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.187 -0.46 . . . . 15.0 110.716 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.544 HD13 HG23 ' A' ' 58' ' ' VAL . 0.2 OUTLIER -92.05 -14.58 29.09 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.169 -0.469 . . . . 15.0 111.467 -179.654 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -45.23 103.77 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.89 0.376 . . . . 15.0 111.183 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.85 63.82 0.55 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.793 -0.717 . . . . 15.0 112.525 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.659 ' HB1' ' CB ' ' A' ' 73' ' ' GLN . . . -173.13 166.86 4.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.837 0.351 . . . . 15.0 111.077 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.475 ' HB ' HG13 ' A' ' 26' ' ' VAL . 2.6 p -93.23 -170.49 2.41 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.023 0.44 . . . . 15.0 110.943 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . 0.672 ' CD2' HG23 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -63.96 -58.37 6.94 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.782 -0.645 . . . . 15.0 110.613 179.979 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.421 ' O ' ' HG3' ' A' ' 76' ' ' GLU . 28.9 ttmt -52.84 -35.51 57.47 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.095 -0.502 . . . . 15.0 110.823 179.392 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.659 ' CB ' ' HB1' ' A' ' 69' ' ' ALA . 3.6 mt-30 -59.21 -46.88 87.29 Favored 'General case' 0 CA--C 1.518 -0.287 0 N-CA-C 109.497 -0.557 . . . . 15.0 109.497 179.277 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.583 ' HB3' HG13 ' A' ' 35' ' ' ILE . . . -66.88 -47.8 70.72 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.596 -0.729 . . . . 15.0 109.717 178.458 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 1.025 HG23 HG21 ' A' ' 22' ' ' VAL . 0.5 OUTLIER -41.75 -42.03 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.254 0 CA-C-O 121.62 0.724 . . . . 15.0 109.182 178.575 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.421 ' HG3' ' O ' ' A' ' 72' ' ' LYS . 20.8 mt-10 -67.35 -44.02 80.07 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.644 -1.162 . . . . 15.0 110.884 179.006 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.583 ' HB ' HG21 ' A' ' 61' ' ' VAL . 4.9 p -64.42 -56.33 14.98 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 120.845 -0.342 . . . . 15.0 111.606 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.591 HD21 HG21 ' A' ' 58' ' ' VAL . 5.2 mt -53.28 -45.49 68.9 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-O 121.177 0.513 . . . . 15.0 109.931 -179.745 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -68.37 -58.32 4.55 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.462 -0.79 . . . . 15.0 110.232 179.345 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 32.9 m-20 -66.14 58.51 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.845 -0.616 . . . . 15.0 112.196 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.683 HG22 ' ND2' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -95.7 -72.82 0.61 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.742 0.306 . . . . 15.0 110.234 179.249 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 122.15 -103.36 0.84 Allowed Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.72 -0.752 . . . . 15.0 113.332 179.141 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.403 ' O ' ' HB3' ' A' ' 13' ' ' LYS . 0.4 OUTLIER -64.54 -84.66 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.105 0.409 . . . . 15.0 112.105 -178.857 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.454 HG12 ' N ' ' A' ' 85' ' ' VAL . 78.5 t -109.6 158.98 9.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.937 0.399 . . . . 15.0 110.976 -179.322 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.731 HG23 ' CB ' ' A' ' 13' ' ' LYS . 9.4 t -98.04 80.65 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.231 0.538 . . . . 15.0 110.596 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -99.71 86.96 3.43 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.73 -0.668 . . . . 15.0 110.038 179.603 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.725 ' HB3' HD21 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -103.86 121.19 42.56 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.926 -0.579 . . . . 15.0 111.983 -178.873 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.737 HD12 ' HB2' ' A' ' 8' ' ' GLU . 4.6 mp -97.19 101.25 12.77 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.421 -0.585 . . . . 15.0 109.421 178.488 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.831 HD12 ' CZ ' ' A' ' 7' ' ' PHE . 0.1 OUTLIER -105.61 -162.14 0.85 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.488 0.661 . . . . 15.0 111.964 -178.649 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.425 ' HB2' HG13 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -142.01 136.9 30.72 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 114.836 -1.075 . . . . 15.0 109.34 178.874 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -46.69 105.03 0.06 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.03 0.443 . . . . 15.0 111.114 -179.486 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.333 0 CA-C-N 115.738 -0.664 . . . . 15.0 112.849 -179.462 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.445 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 1.2 mp . . . . . 0 N--CA 1.449 -0.522 0 CA-C-O 120.908 0.385 . . . . 15.0 110.797 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.606 ' CZ ' HD12 ' A' ' 89' ' ' LEU . 0.3 OUTLIER -146.91 158.35 43.9 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.024 -0.535 . . . . 15.0 110.305 179.479 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.708 ' HB3' HD12 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -126.64 142.85 51.41 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.348 0.594 . . . . 15.0 111.937 -178.955 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.541 ' CG1' HD11 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -101.45 114.97 42.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.083 -0.962 . . . . 15.0 109.397 178.79 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -105.8 73.08 0.99 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.198 -0.455 . . . . 15.0 112.183 -178.544 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.592 HD13 ' HG3' ' A' ' 51' ' ' ARG . 5.7 tp -88.36 166.14 14.48 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.714 -0.476 . . . . 15.0 109.714 178.707 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -95.39 94.2 7.69 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.048 0.452 . . . . 15.0 111.266 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.648 ' CB ' HG23 ' A' ' 85' ' ' VAL . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.364 0 CA-C-N 115.807 -0.633 . . . . 15.0 111.114 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.652 ' N ' HD22 ' A' ' 18' ' ' LEU . 1.6 mm? . . . . . 0 N--CA 1.453 -0.29 0 CA-C-O 120.937 0.399 . . . . 15.0 110.779 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.701 ' HA3' ' HA3' ' A' ' 44' ' ' GLY . . . -160.89 42.83 0.41 Allowed Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.924 -0.655 . . . . 15.0 111.915 -179.772 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.638 HG12 ' O ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -112.74 141.29 28.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 120.915 0.388 . . . . 15.0 111.768 -179.471 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.403 ' H ' HD13 ' A' ' 41' ' ' ILE . 43.0 t -96.18 103.44 15.34 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 107.721 -1.214 . . . . 15.0 107.721 177.29 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.948 HG21 HG23 ' A' ' 75' ' ' VAL . 27.3 m -93.51 155.39 3.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 113.339 0.866 . . . . 15.0 113.339 -176.714 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.33 -178.4 6.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 114.811 -1.086 . . . . 15.0 110.19 179.498 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.448 ' O ' ' CB ' ' A' ' 71' ' ' HIS . . . 73.0 -120.58 7.32 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.486 -0.864 . . . . 15.0 112.523 179.724 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.569 ' HA3' ' N ' ' A' ' 71' ' ' HIS . . . 68.3 -63.69 0.4 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.945 -0.645 . . . . 15.0 113.522 179.361 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.674 ' O ' HG22 ' A' ' 30' ' ' VAL . 1.7 m -32.32 146.96 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 N-CA-C 112.233 0.457 . . . . 15.0 112.233 -179.123 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.412 ' CB ' ' O ' ' A' ' 32' ' ' HIS . 15.1 m-20 -79.84 57.85 2.68 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.951 -0.568 . . . . 15.0 111.195 -179.714 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -151.76 -61.43 0.17 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.832 0.349 . . . . 15.0 111.238 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.4 m -71.93 -35.22 69.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 15.0 111.347 -179.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.674 HG22 ' O ' ' A' ' 26' ' ' VAL . 24.7 m -84.77 -173.78 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.895 0.379 . . . . 15.0 111.445 -179.613 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 41.4 ttt85 -57.08 -39.67 75.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.082 -0.508 . . . . 15.0 111.486 -179.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . 0.418 ' H ' HG23 ' A' ' 30' ' ' VAL . 1.6 p-80 -174.63 -35.7 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.592 -0.276 . . . . 15.0 111.656 -179.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -173.77 20.62 0.06 OUTLIER Glycine 0 CA--C 1.519 0.324 0 C-N-CA 120.594 -0.813 . . . . 15.0 113.104 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.52 ' O ' HG11 ' A' ' 30' ' ' VAL . . . -97.31 152.06 19.92 Favored Glycine 0 N--CA 1.448 -0.516 0 N-CA-C 110.294 -1.122 . . . . 15.0 110.294 178.623 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.934 HD12 ' HB3' ' A' ' 74' ' ' ALA . 0.1 OUTLIER -95.35 154.18 3.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 119.668 -0.813 . . . . 15.0 112.382 -178.962 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 31.8 m-85 -136.06 107.51 6.9 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.649 -1.16 . . . . 15.0 109.206 179.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.792 HG22 ' N ' ' A' ' 55' ' ' GLY . 0.6 OUTLIER -55.05 148.1 3.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.035 -0.529 . . . . 15.0 111.557 -178.446 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.459 ' O ' ' HG2' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -80.26 -49.6 11.37 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.452 -0.944 . . . . 15.0 108.452 178.397 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.638 ' O ' HG12 ' A' ' 20' ' ' ILE . . . -172.27 173.11 4.31 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-N 115.661 -0.7 . . . . 15.0 110.338 178.687 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.578 ' HA ' HG12 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -96.96 112.01 28.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 109.388 -0.597 . . . . 15.0 109.388 179.041 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.695 ' HB ' ' O ' ' A' ' 19' ' ' GLY . 0.5 OUTLIER -78.28 118.81 74.52 Favored Pre-proline 0 C--N 1.328 -0.328 0 N-CA-C 113.18 0.808 . . . . 15.0 113.18 -177.301 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.605 ' HA ' ' CG ' ' A' ' 47' ' ' GLU . 36.2 Cg_endo -64.09 62.38 0.23 Allowed 'Trans proline' 0 C--N 1.357 1.012 0 C-N-CA 123.592 2.861 . . . . 15.0 112.874 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.526 ' H ' ' HG2' ' A' ' 47' ' ' GLU . 9.8 mt-30 -152.03 -47.14 0.11 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.524 -0.307 . . . . 15.0 111.596 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.701 ' HA3' ' HA3' ' A' ' 19' ' ' GLY . . . -87.9 167.47 36.52 Favored Glycine 0 C--N 1.331 0.258 0 C-N-CA 120.354 -0.927 . . . . 15.0 113.825 -179.191 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -56.99 -12.68 2.16 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.634 0.605 . . . . 15.0 112.634 -179.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.79 -58.56 3.36 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 120.762 0.315 . . . . 15.0 110.406 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.605 ' CG ' ' HA ' ' A' ' 42' ' ' PRO . 2.6 pp20? -57.68 -43.16 84.88 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.763 -0.653 . . . . 15.0 110.525 179.079 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 66.7 m -53.65 -70.96 0.08 Allowed 'General case' 0 CA--C 1.518 -0.265 0 CA-C-N 115.931 -0.577 . . . . 15.0 110.574 -179.411 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.524 ' CB ' HD11 ' A' ' 11' ' ' LEU . 1.6 t0 -58.13 -41.51 83.8 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.128 -0.693 . . . . 15.0 109.128 178.736 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.67 40.12 13.03 Favored Glycine 0 N--CA 1.446 -0.645 0 CA-C-N 115.31 -0.859 . . . . 15.0 111.632 179.378 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.592 ' HG3' HD13 ' A' ' 11' ' ' LEU . 0.2 OUTLIER -79.76 -50.63 10.28 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.935 0.398 . . . . 15.0 110.723 -179.252 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.607 ' CG1' HD12 ' A' ' 20' ' ' ILE . 9.3 tp -81.07 162.34 3.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.043 -0.526 . . . . 15.0 110.249 179.433 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . 0.474 ' N ' ' OD2' ' A' ' 56' ' ' ASP . 76.1 m80 -147.54 158.71 44.11 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-O 121.644 0.735 . . . . 15.0 112.281 -178.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.567 ' HA ' ' CG2' ' A' ' 37' ' ' VAL . 8.1 mtpt -43.09 133.28 3.89 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 114.13 -1.396 . . . . 15.0 112.956 -178.68 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.792 ' N ' HG22 ' A' ' 37' ' ' VAL . . . 50.06 29.44 14.78 Favored Glycine 0 C--N 1.332 0.34 0 CA-C-N 115.587 -0.733 . . . . 15.0 113.364 179.206 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.474 ' OD2' ' N ' ' A' ' 53' ' ' HIS . 17.4 m-20 -65.86 130.29 42.74 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.759 -0.376 . . . . 15.0 110.605 179.568 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.451 ' HE ' HD21 ' A' ' 59' ' ' LEU . 8.9 ttt180 -80.85 94.97 6.56 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.307 -0.406 . . . . 15.0 111.123 -179.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.914 HG22 HG22 ' A' ' 35' ' ' ILE . 1.4 m -84.44 112.72 22.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 CA-C-N 116.315 -0.402 . . . . 15.0 110.621 179.743 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.451 HD21 ' HE ' ' A' ' 57' ' ' ARG . 30.5 mt -107.4 -13.18 15.16 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 112.628 0.603 . . . . 15.0 112.628 -179.116 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.462 ' O ' HD23 ' A' ' 87' ' ' LEU . . . -151.77 148.15 27.52 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.511 0.56 . . . . 15.0 112.511 -178.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.726 HG11 ' O ' ' A' ' 77' ' ' THR . 19.0 t -139.2 101.6 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.24 -0.891 . . . . 15.0 109.409 178.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.824 ' ND2' HG22 ' A' ' 81' ' ' THR . 1.6 m-80 64.9 15.32 9.84 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.667 -0.494 . . . . 15.0 109.667 -178.141 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 107.22 6.17 34.15 Favored Glycine 0 C--N 1.336 0.575 0 CA-C-N 115.867 -0.606 . . . . 15.0 113.46 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.676 ' O ' HG13 ' A' ' 64' ' ' VAL . 6.3 p -93.83 103.94 15.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 117.25 0.525 . . . . 15.0 110.786 179.313 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -55.8 132.29 49.0 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.055 -0.52 . . . . 15.0 111.22 -179.561 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.593 HD13 ' HB3' ' A' ' 69' ' ' ALA . 0.2 OUTLIER -87.64 -20.33 26.48 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.971 -0.559 . . . . 15.0 110.714 179.679 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -43.39 96.1 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.295 -0.411 . . . . 15.0 111.131 179.833 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 104.36 69.65 0.78 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.802 -0.713 . . . . 15.0 112.216 -179.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.593 ' HB3' HD13 ' A' ' 66' ' ' LEU . . . -173.02 159.35 3.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.787 0.327 . . . . 15.0 111.038 -179.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.472 ' HA ' ' N ' ' A' ' 26' ' ' VAL . 15.9 p -93.04 -173.96 3.43 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.219 -0.446 . . . . 15.0 111.275 -179.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . 0.768 ' CD2' HG23 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -61.22 -60.79 3.2 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.862 -0.608 . . . . 15.0 110.438 -179.978 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -52.65 -31.96 39.6 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.717 -0.674 . . . . 15.0 110.473 179.449 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.578 ' HB3' ' HB1' ' A' ' 69' ' ' ALA . 1.5 tt0 -59.56 -53.93 52.44 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.007 -0.542 . . . . 15.0 109.955 179.424 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.934 ' HB3' HD12 ' A' ' 35' ' ' ILE . . . -64.89 -44.78 88.52 Favored 'General case' 0 CA--C 1.518 -0.267 0 N-CA-C 109.432 -0.581 . . . . 15.0 109.432 178.581 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.948 HG23 HG21 ' A' ' 22' ' ' VAL . 0.5 OUTLIER -44.04 -40.6 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.21 0 N-CA-C 108.68 -0.859 . . . . 15.0 108.68 178.021 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.405 ' O ' ' CB ' ' A' ' 80' ' ' ASN . 1.8 mm-40 -67.36 -45.03 77.53 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 114.835 -1.075 . . . . 15.0 109.828 178.093 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.726 ' O ' HG11 ' A' ' 61' ' ' VAL . 80.3 p -64.13 -53.81 43.71 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 116.616 -0.265 . . . . 15.0 111.398 179.751 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.568 HD22 HD11 ' A' ' 87' ' ' LEU . 5.4 mt -53.37 -48.84 68.23 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-O 121.237 0.541 . . . . 15.0 109.851 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 16.2 ttt180 -68.57 -60.67 2.25 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.356 -0.838 . . . . 15.0 110.636 179.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.405 ' CB ' ' O ' ' A' ' 76' ' ' GLU . 36.6 m-20 -65.97 61.47 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.93 -0.577 . . . . 15.0 112.133 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.824 HG22 ' ND2' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -95.56 -68.77 0.78 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.779 0.323 . . . . 15.0 110.174 179.178 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 121.92 -105.9 1.03 Allowed Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.883 -0.675 . . . . 15.0 112.889 179.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.413 ' O ' ' HB3' ' A' ' 13' ' ' LYS . 0.2 OUTLIER -64.81 -83.05 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 111.943 0.349 . . . . 15.0 111.943 -179.241 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.476 HG12 ' N ' ' A' ' 85' ' ' VAL . 78.1 t -109.78 160.31 8.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.979 0.418 . . . . 15.0 110.944 -179.475 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.656 HG12 ' O ' ' A' ' 85' ' ' VAL . 8.7 t -97.65 82.24 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.109 0.48 . . . . 15.0 110.402 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.48 ' CE1' HD11 ' A' ' 88' ' ' LEU . 2.8 t60 -101.01 82.26 2.35 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.769 -0.65 . . . . 15.0 110.624 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.814 ' HB3' HD21 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -100.56 120.24 39.73 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.919 -0.582 . . . . 15.0 111.679 -179.332 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.708 HD12 ' HB3' ' A' ' 8' ' ' GLU . 0.2 OUTLIER -97.11 101.48 13.06 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.464 -0.569 . . . . 15.0 109.464 178.794 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.814 HD21 ' HB3' ' A' ' 87' ' ' LEU . 0.1 OUTLIER -105.86 -162.99 0.9 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.694 0.759 . . . . 15.0 112.388 -178.392 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.445 ' HA ' ' HA ' ' A' ' 6' ' ' ILE . 7.4 tt0 -139.58 120.91 14.94 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 114.475 -1.239 . . . . 15.0 109.116 178.731 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -46.86 101.92 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.005 0.431 . . . . 15.0 111.398 -179.094 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.401 0 C-N-CA 120.946 -0.645 . . . . 15.0 112.499 -179.89 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.431 HG13 ' HB2' ' A' ' 90' ' ' GLU . 1.2 mp . . . . . 0 N--CA 1.453 -0.312 0 CA-C-O 120.685 0.278 . . . . 15.0 110.791 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.792 ' CE1' HD12 ' A' ' 89' ' ' LEU . 5.8 p90 -140.69 156.77 46.13 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.413 -0.358 . . . . 15.0 110.678 179.102 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.711 ' CB ' HD12 ' A' ' 88' ' ' LEU . 10.2 pt-20 -124.22 142.84 50.91 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.339 0.59 . . . . 15.0 111.551 -179.399 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.53 ' CG1' HD11 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -101.54 116.47 45.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.132 -0.94 . . . . 15.0 109.716 178.978 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -106.21 73.53 0.99 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.292 -0.413 . . . . 15.0 112.101 -179.017 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.689 HD13 ' HG3' ' A' ' 51' ' ' ARG . 9.7 tp -88.25 160.28 17.75 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.219 -0.446 . . . . 15.0 109.867 178.809 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -96.94 95.0 7.53 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.683 0.277 . . . . 15.0 111.716 -179.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.889 ' HB2' HG23 ' A' ' 85' ' ' VAL . 0.6 OUTLIER . . . . . 0 CA--C 1.533 0.304 0 N-CA-C 112.619 0.6 . . . . 15.0 112.619 179.565 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 51.2 mt . . . . . 0 N--CA 1.451 -0.391 0 CA-C-O 120.734 0.302 . . . . 15.0 110.699 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.793 ' HA3' ' HA3' ' A' ' 44' ' ' GLY . . . -170.86 45.33 0.19 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.729 -0.748 . . . . 15.0 112.347 -179.72 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.744 HG12 ' O ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -112.52 139.12 38.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 120.827 0.346 . . . . 15.0 111.231 -179.913 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.414 ' H ' HD13 ' A' ' 41' ' ' ILE . 13.0 t -90.28 103.32 16.01 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.419 -0.956 . . . . 15.0 108.419 177.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 1.006 HG21 HG23 ' A' ' 75' ' ' VAL . 34.7 m -93.94 155.81 3.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 112.645 0.609 . . . . 15.0 112.645 -177.443 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.36 -177.08 5.64 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.31 -0.859 . . . . 15.0 110.779 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.445 ' O ' ' HB3' ' A' ' 71' ' ' HIS . . . 68.83 -119.46 9.87 Favored Glycine 0 C--N 1.332 0.336 0 C-N-CA 120.84 -0.695 . . . . 15.0 112.532 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.531 ' HA3' ' N ' ' A' ' 71' ' ' HIS . . . 68.11 -66.26 0.36 Allowed Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.833 -0.698 . . . . 15.0 113.492 179.466 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.548 ' O ' HG22 ' A' ' 30' ' ' VAL . 1.7 m -30.36 144.74 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 N-CA-C 112.384 0.513 . . . . 15.0 112.384 -179.322 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 49.5 t-20 -75.68 61.08 1.33 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.964 -0.562 . . . . 15.0 110.935 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.4 m -151.73 -66.37 0.18 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.204 -0.453 . . . . 15.0 111.028 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.8 m -68.43 -42.59 78.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.213 -0.449 . . . . 15.0 111.084 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.548 HG22 ' O ' ' A' ' 26' ' ' VAL . 16.6 m -75.12 -173.01 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.269 -0.423 . . . . 15.0 111.202 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.02 -58.36 6.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.204 -0.453 . . . . 15.0 110.934 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 93.0 m-70 -137.12 -54.56 0.7 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.23 -0.441 . . . . 15.0 111.061 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -167.76 22.05 0.1 Allowed Glycine 0 CA--C 1.517 0.215 0 C-N-CA 120.807 -0.711 . . . . 15.0 112.756 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.422 ' O ' HG11 ' A' ' 30' ' ' VAL . . . -85.63 152.86 26.71 Favored Glycine 0 N--CA 1.449 -0.453 0 N-CA-C 110.882 -0.887 . . . . 15.0 110.882 178.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.949 HG22 HG22 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -89.73 154.39 3.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 117.522 0.661 . . . . 15.0 111.929 -179.357 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.44 ' CE2' ' HG2' ' A' ' 57' ' ' ARG . 35.3 m-85 -139.28 107.86 5.88 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.98 -1.009 . . . . 15.0 109.998 178.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.819 HG22 ' N ' ' A' ' 55' ' ' GLY . 0.6 OUTLIER -55.29 156.22 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.857 -0.61 . . . . 15.0 111.037 -179.097 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.551 ' O ' ' HG2' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -91.09 -47.24 7.66 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.344 -0.984 . . . . 15.0 108.344 178.526 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.744 ' O ' HG12 ' A' ' 20' ' ' ILE . . . -172.48 171.96 4.49 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.329 -0.85 . . . . 15.0 110.062 178.611 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.56 ' HA ' ' CG1' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -96.45 108.41 21.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 109.178 -0.675 . . . . 15.0 109.178 179.191 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.756 ' HB ' ' O ' ' A' ' 19' ' ' GLY . 0.7 OUTLIER -77.99 118.43 72.11 Favored Pre-proline 0 C--N 1.328 -0.362 0 N-CA-C 113.528 0.936 . . . . 15.0 113.528 -176.904 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.597 ' HA ' ' CG ' ' A' ' 47' ' ' GLU . 36.8 Cg_endo -64.31 61.81 0.25 Allowed 'Trans proline' 0 C--N 1.356 0.971 0 C-N-CA 123.602 2.868 . . . . 15.0 112.907 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.508 ' H ' ' HG2' ' A' ' 47' ' ' GLU . 5.4 mm100 -149.42 -46.42 0.14 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.513 -0.312 . . . . 15.0 111.398 179.779 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.793 ' HA3' ' HA3' ' A' ' 19' ' ' GLY . . . -87.88 167.74 36.82 Favored Glycine 0 C--N 1.33 0.204 0 C-N-CA 120.443 -0.884 . . . . 15.0 113.825 -179.249 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -59.61 -13.53 9.85 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.168 -0.516 . . . . 15.0 112.244 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.22 -55.99 6.28 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 120.701 0.286 . . . . 15.0 110.79 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.597 ' CG ' ' HA ' ' A' ' 42' ' ' PRO . 2.9 pp20? -57.73 -42.48 83.95 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-N 115.973 -0.558 . . . . 15.0 110.45 179.144 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 32.8 t -53.51 -69.44 0.12 Allowed 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 115.804 -0.635 . . . . 15.0 110.459 -179.244 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.563 ' HB2' HD11 ' A' ' 11' ' ' LEU . 0.4 OUTLIER -59.42 -42.04 90.92 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.07 -0.715 . . . . 15.0 109.07 178.729 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.75 43.02 9.34 Favored Glycine 0 N--CA 1.447 -0.622 0 CA-C-N 115.36 -0.836 . . . . 15.0 111.645 179.42 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.689 ' HG3' HD13 ' A' ' 11' ' ' LEU . 0.7 OUTLIER -79.89 -41.63 25.79 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.712 0.291 . . . . 15.0 111.071 -179.111 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.56 ' CG2' HG11 ' A' ' 37' ' ' VAL . 5.9 mm -91.25 161.49 2.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 120.921 0.391 . . . . 15.0 110.922 179.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . 0.552 ' N ' HG22 ' A' ' 52' ' ' ILE . 75.8 m80 -142.38 154.91 45.03 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-O 121.447 0.641 . . . . 15.0 111.083 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.551 ' HG2' ' O ' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -37.68 133.13 0.83 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.552 -1.203 . . . . 15.0 112.934 -178.552 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.819 ' N ' HG22 ' A' ' 37' ' ' VAL . . . 50.05 33.48 21.87 Favored Glycine 0 C--N 1.335 0.489 0 CA-C-N 115.822 -0.626 . . . . 15.0 113.716 179.243 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.431 ' H ' HG13 ' A' ' 37' ' ' VAL . 2.8 m-20 -65.34 130.71 44.3 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 117.178 0.489 . . . . 15.0 110.181 179.16 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.44 ' HG2' ' CE2' ' A' ' 36' ' ' TYR . 30.9 mtt180 -83.28 94.83 8.0 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.341 -0.39 . . . . 15.0 110.522 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.949 HG22 HG22 ' A' ' 35' ' ' ILE . 1.1 m -87.87 117.22 31.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 121.039 0.447 . . . . 15.0 111.055 -179.713 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.555 HD12 ' HG3' ' A' ' 67' ' ' GLU . 2.9 mm? -107.17 -14.23 14.96 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 115.797 -0.638 . . . . 15.0 112.567 -179.129 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.576 ' HB3' ' HB2' ' A' ' 88' ' ' LEU . . . -149.98 146.56 27.08 Favored 'General case' 0 N--CA 1.462 0.162 0 N-CA-C 112.591 0.589 . . . . 15.0 112.591 -178.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.82 HG11 ' O ' ' A' ' 77' ' ' THR . 45.9 t -139.25 100.26 1.37 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.224 0 CA-C-N 115.32 -0.854 . . . . 15.0 109.385 178.751 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.787 ' ND2' HG22 ' A' ' 81' ' ' THR . 1.4 m-80 65.05 16.57 10.64 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.086 -0.507 . . . . 15.0 109.937 -178.157 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 107.05 4.39 35.83 Favored Glycine 0 C--N 1.336 0.531 0 CA-C-N 115.848 -0.614 . . . . 15.0 113.387 179.601 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.626 ' O ' HG13 ' A' ' 64' ' ' VAL . 4.3 p -93.79 107.04 18.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 121.087 0.47 . . . . 15.0 110.78 179.499 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -57.55 130.73 47.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 15.0 111.049 -179.526 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.937 HD11 ' HB2' ' A' ' 74' ' ' ALA . 0.2 OUTLIER -87.69 -27.06 22.65 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.067 -0.515 . . . . 15.0 110.811 179.98 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.555 ' HG3' HD12 ' A' ' 59' ' ' LEU . 82.2 mt-10 -47.39 103.49 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.338 -0.392 . . . . 15.0 111.019 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.8 58.73 0.54 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.756 -0.735 . . . . 15.0 112.425 -179.734 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.562 ' HB1' ' CB ' ' A' ' 73' ' ' GLN . . . -173.1 165.61 4.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.901 0.382 . . . . 15.0 111.07 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.497 HG22 ' HA ' ' A' ' 26' ' ' VAL . 17.3 p -93.13 -172.93 3.11 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.095 -0.502 . . . . 15.0 111.046 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . 0.776 ' CD2' HG23 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -63.07 -59.7 4.43 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.797 -0.638 . . . . 15.0 110.563 -179.924 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.41 ' HA ' ' HB ' ' A' ' 75' ' ' VAL . 7.6 ttpt -52.56 -33.77 47.28 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.838 -0.619 . . . . 15.0 110.807 179.719 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.562 ' CB ' ' HB1' ' A' ' 69' ' ' ALA . 7.0 mt-30 -59.5 -50.79 72.57 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.688 -0.486 . . . . 15.0 109.688 179.339 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.937 ' HB2' HD11 ' A' ' 66' ' ' LEU . . . -66.97 -43.82 82.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.95 -0.568 . . . . 15.0 109.697 178.416 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 1.006 HG23 HG21 ' A' ' 22' ' ' VAL . 0.5 OUTLIER -43.34 -41.76 1.35 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.289 0 N-CA-C 108.878 -0.786 . . . . 15.0 108.878 178.319 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.407 ' O ' ' CB ' ' A' ' 80' ' ' ASN . 2.0 mt-10 -67.17 -44.3 80.07 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 114.822 -1.081 . . . . 15.0 110.022 178.323 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.82 ' O ' HG11 ' A' ' 61' ' ' VAL . 59.4 p -64.06 -54.38 34.96 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-N 116.665 -0.243 . . . . 15.0 111.596 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.717 HD21 HG21 ' A' ' 58' ' ' VAL . 8.8 mt -53.45 -48.98 68.35 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.317 0.58 . . . . 15.0 110.03 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.417 ' HB2' ' O ' ' A' ' 75' ' ' VAL . 0.0 OUTLIER -68.44 -59.15 3.38 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.251 -0.886 . . . . 15.0 110.723 179.722 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.407 ' CB ' ' O ' ' A' ' 76' ' ' GLU . 71.4 m-20 -65.97 62.87 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.1 -0.5 . . . . 15.0 111.909 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.787 HG22 ' ND2' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -95.46 -73.66 0.58 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 110.146 -0.316 . . . . 15.0 110.146 179.205 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 122.15 -105.4 0.98 Allowed Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.696 -0.764 . . . . 15.0 113.268 179.048 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.404 ' O ' ' HB3' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -64.88 -83.64 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.761 0.315 . . . . 15.0 111.18 -179.39 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.476 HG12 ' N ' ' A' ' 85' ' ' VAL . 79.7 t -109.82 160.18 8.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.257 -0.428 . . . . 15.0 110.864 -179.755 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.889 HG23 ' HB2' ' A' ' 13' ' ' LYS . 3.6 t -97.63 81.64 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.137 0.494 . . . . 15.0 110.18 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -96.41 80.23 3.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.727 -0.669 . . . . 15.0 110.391 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.67 ' HB3' HD21 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -102.12 124.68 48.15 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.063 -0.517 . . . . 15.0 111.649 -179.269 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.711 HD12 ' CB ' ' A' ' 8' ' ' GLU . 4.7 mp -102.01 99.01 9.13 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.658 -0.497 . . . . 15.0 109.658 178.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.792 HD12 ' CE1' ' A' ' 7' ' ' PHE . 0.1 OUTLIER -102.93 -161.42 0.84 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.383 0.611 . . . . 15.0 111.841 -178.772 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.431 ' HB2' HG13 ' A' ' 6' ' ' ILE . 3.1 tt0 -140.93 144.01 34.92 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.059 -0.973 . . . . 15.0 109.772 179.108 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 7.1 tptp -55.17 104.95 0.14 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.877 0.37 . . . . 15.0 110.961 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.36 0 C-N-CA 120.845 -0.693 . . . . 15.0 112.6 -179.897 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.467 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 1.3 mp . . . . . 0 N--CA 1.45 -0.462 0 CA-C-O 120.893 0.377 . . . . 15.0 111.176 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.645 ' CE1' HD12 ' A' ' 89' ' ' LEU . 6.8 p90 -140.64 164.31 30.53 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.063 -0.517 . . . . 15.0 110.203 178.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.753 ' HB2' HD12 ' A' ' 88' ' ' LEU . 0.3 OUTLIER -130.2 143.24 50.66 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.284 0.564 . . . . 15.0 111.66 -179.506 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.575 ' CG1' HD11 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -101.42 114.35 40.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.184 -0.916 . . . . 15.0 109.397 178.859 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -106.01 72.25 0.93 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.213 -0.449 . . . . 15.0 112.137 -178.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.629 HD13 ' HG3' ' A' ' 51' ' ' ARG . 5.4 tp -88.21 166.39 14.39 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.429 -0.582 . . . . 15.0 109.429 178.61 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -96.02 97.66 9.77 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.05 0.453 . . . . 15.0 111.262 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.74 ' CB ' HG23 ' A' ' 85' ' ' VAL . 0.1 OUTLIER . . . . . 0 C--N 1.327 -0.37 0 CA-C-N 115.735 -0.666 . . . . 15.0 111.42 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.4 mp . . . . . 0 N--CA 1.455 -0.204 0 CA-C-O 120.955 0.407 . . . . 15.0 110.715 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.808 ' O ' ' HB ' ' A' ' 41' ' ' ILE . . . -161.12 46.07 0.39 Allowed Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 121.034 -0.603 . . . . 15.0 111.794 -179.791 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.757 HG12 ' O ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -112.77 136.67 48.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 120.927 0.394 . . . . 15.0 111.581 -179.609 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 37.4 t -88.65 103.13 15.64 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.285 -1.006 . . . . 15.0 108.285 177.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.887 HG21 HG23 ' A' ' 75' ' ' VAL . 8.0 m -93.6 149.11 4.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 112.643 0.609 . . . . 15.0 112.643 -177.433 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.489 ' HA ' ' ND1' ' A' ' 71' ' ' HIS . 5.4 t -150.02 179.24 8.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.39 -0.823 . . . . 15.0 110.468 179.185 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.696 ' O ' HG22 ' A' ' 26' ' ' VAL . . . 82.78 -117.32 4.38 Favored Glycine 0 C--N 1.331 0.298 0 C-N-CA 120.542 -0.837 . . . . 15.0 112.649 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.579 ' HA3' ' N ' ' A' ' 71' ' ' HIS . . . 63.34 -65.87 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 121.084 -0.579 . . . . 15.0 113.742 179.184 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.696 HG22 ' O ' ' A' ' 24' ' ' GLY . 0.0 OUTLIER -26.57 139.86 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 N-CA-C 112.633 0.605 . . . . 15.0 112.633 -178.994 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.425 ' HA ' ' O ' ' A' ' 32' ' ' HIS . 54.2 t-20 -77.62 57.67 1.65 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.768 -0.651 . . . . 15.0 110.927 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 5.9 m -151.69 -61.18 0.17 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.24 -0.437 . . . . 15.0 110.767 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.64 -34.77 77.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.15 -0.477 . . . . 15.0 110.692 179.755 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.642 HG22 ' O ' ' A' ' 26' ' ' VAL . 33.2 m -88.02 -174.34 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.064 -0.516 . . . . 15.0 111.003 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -70.53 -51.5 28.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.394 -0.367 . . . . 15.0 111.241 -179.764 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . 0.425 ' O ' ' HA ' ' A' ' 27' ' ' ASN . 86.4 m-70 -132.52 -70.97 0.54 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.401 -0.363 . . . . 15.0 111.255 -179.745 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -162.75 24.84 0.21 Allowed Glycine 0 C--O 1.23 -0.145 0 C-N-CA 120.904 -0.665 . . . . 15.0 112.388 -179.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -86.89 148.19 21.5 Favored Glycine 0 N--CA 1.448 -0.522 0 N-CA-C 110.171 -1.172 . . . . 15.0 110.171 178.658 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 1.056 HD12 ' HB3' ' A' ' 74' ' ' ALA . 0.3 OUTLIER -88.68 153.78 3.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 C-N-CA 119.574 -0.85 . . . . 15.0 112.297 -178.894 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.477 ' CE2' ' CG ' ' A' ' 57' ' ' ARG . 32.4 m-85 -134.16 107.89 7.97 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.644 -1.162 . . . . 15.0 109.056 179.321 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.797 HG22 ' N ' ' A' ' 55' ' ' GLY . 0.7 OUTLIER -54.96 148.02 3.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.144 0.497 . . . . 15.0 111.189 -178.479 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.445 ' O ' ' HG2' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -80.05 -49.06 12.31 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.882 -0.784 . . . . 15.0 108.882 178.91 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.757 ' O ' HG12 ' A' ' 20' ' ' ILE . . . -172.33 172.45 4.46 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 115.999 -0.546 . . . . 15.0 110.184 178.439 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.556 ' HA ' ' CG1' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -96.72 110.01 24.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 108.957 -0.757 . . . . 15.0 108.957 178.905 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.808 ' HB ' ' O ' ' A' ' 19' ' ' GLY . 0.5 OUTLIER -78.0 115.25 48.98 Favored Pre-proline 0 C--N 1.326 -0.433 0 N-CA-C 113.275 0.843 . . . . 15.0 113.275 -177.053 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.617 ' HA ' ' CG ' ' A' ' 47' ' ' GLU . 30.3 Cg_exo -62.56 59.49 0.14 Allowed 'Trans proline' 0 C--N 1.358 1.07 0 C-N-CA 123.612 2.875 . . . . 15.0 112.95 179.706 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.528 ' N ' ' HG2' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -147.45 -47.38 0.17 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.594 0.235 . . . . 15.0 111.341 -179.985 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.739 ' HA3' ' HA3' ' A' ' 19' ' ' GLY . . . -87.67 168.89 38.37 Favored Glycine 0 C--N 1.33 0.217 0 C-N-CA 120.398 -0.906 . . . . 15.0 113.801 -179.136 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -58.12 -13.78 5.52 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.702 0.63 . . . . 15.0 112.702 -179.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.03 -56.46 5.59 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.97 -0.292 . . . . 15.0 110.69 -179.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.617 ' CG ' ' HA ' ' A' ' 42' ' ' PRO . 2.8 pp20? -57.61 -43.33 84.68 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.997 -0.547 . . . . 15.0 110.434 179.172 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -53.81 -70.21 0.1 Allowed 'General case' 0 CA--C 1.518 -0.256 0 CA-C-N 115.902 -0.59 . . . . 15.0 110.523 -179.473 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.539 ' CB ' HD11 ' A' ' 11' ' ' LEU . 0.1 OUTLIER -58.13 -41.59 83.99 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.137 -0.69 . . . . 15.0 109.137 178.786 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.72 40.49 12.26 Favored Glycine 0 N--CA 1.445 -0.702 0 CA-C-N 115.305 -0.861 . . . . 15.0 111.676 179.309 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.629 ' HG3' HD13 ' A' ' 11' ' ' LEU . 0.1 OUTLIER -79.74 -49.9 11.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.891 0.376 . . . . 15.0 110.65 -179.351 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.611 ' CG1' HD12 ' A' ' 20' ' ' ILE . 8.8 tp -81.14 161.21 3.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.02 -0.536 . . . . 15.0 110.241 179.464 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . 0.444 ' N ' ' OD2' ' A' ' 56' ' ' ASP . 75.2 m80 -146.07 156.77 43.69 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-O 121.581 0.705 . . . . 15.0 112.258 -179.047 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.557 ' HA ' ' CG2' ' A' ' 37' ' ' VAL . 0.6 OUTLIER -43.28 132.51 4.37 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.3 -1.318 . . . . 15.0 112.902 -178.666 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.797 ' N ' HG22 ' A' ' 37' ' ' VAL . . . 50.98 29.87 21.34 Favored Glycine 0 C--N 1.335 0.475 0 CA-C-N 115.785 -0.643 . . . . 15.0 113.456 179.137 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.444 ' OD2' ' N ' ' A' ' 53' ' ' HIS . 6.4 m-20 -65.76 128.81 37.46 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.827 -0.349 . . . . 15.0 110.51 179.516 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.477 ' CG ' ' CE2' ' A' ' 36' ' ' TYR . 2.3 mtp85 -80.62 95.45 6.56 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.476 -0.329 . . . . 15.0 110.663 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.953 HG22 HG22 ' A' ' 35' ' ' ILE . 1.5 m -85.76 113.42 23.91 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-O 121.094 0.474 . . . . 15.0 111.177 -179.654 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.502 ' N ' HD22 ' A' ' 59' ' ' LEU . 3.6 mm? -107.35 -12.08 15.41 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 115.677 -0.692 . . . . 15.0 112.505 -179.288 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.819 ' HB3' ' HB2' ' A' ' 88' ' ' LEU . . . -150.71 148.25 28.33 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 112.762 0.653 . . . . 15.0 112.762 -178.709 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.685 HG11 ' O ' ' A' ' 77' ' ' THR . 15.4 t -139.12 99.51 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.231 -0.895 . . . . 15.0 109.107 178.741 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.73 ' OD1' HG22 ' A' ' 81' ' ' THR . 9.2 m120 65.22 16.41 10.53 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.871 -0.418 . . . . 15.0 109.871 -177.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 107.2 4.93 35.3 Favored Glycine 0 C--N 1.336 0.544 0 CA-C-N 116.039 -0.528 . . . . 15.0 113.465 179.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.663 ' O ' HG13 ' A' ' 64' ' ' VAL . 5.2 p -93.8 106.37 17.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 117.168 0.484 . . . . 15.0 110.783 179.506 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.2 m -56.33 130.15 43.38 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.171 -0.468 . . . . 15.0 111.051 -179.609 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.551 HD21 ' OG1' ' A' ' 77' ' ' THR . 0.2 OUTLIER -89.44 -21.38 23.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.075 -0.511 . . . . 15.0 110.997 179.946 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -45.76 101.5 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.869 0.366 . . . . 15.0 111.062 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.78 63.11 0.55 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.791 -0.718 . . . . 15.0 112.4 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.733 ' HB1' ' CB ' ' A' ' 73' ' ' GLN . . . -173.02 160.59 4.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.89 0.376 . . . . 15.0 111.035 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.453 ' HB ' ' HA ' ' A' ' 26' ' ' VAL . 3.0 p -93.17 -170.54 2.43 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.084 0.468 . . . . 15.0 111.055 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . 0.715 ' CD2' HG23 ' A' ' 22' ' ' VAL . 0.2 OUTLIER -60.75 -61.02 2.89 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.691 -0.686 . . . . 15.0 110.13 179.908 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.556 ' O ' HG12 ' A' ' 75' ' ' VAL . 12.7 ttpp -53.21 -34.79 58.55 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.716 -0.674 . . . . 15.0 110.863 179.234 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.733 ' CB ' ' HB1' ' A' ' 69' ' ' ALA . 3.3 mt-30 -59.42 -54.9 41.37 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.645 -0.502 . . . . 15.0 109.645 179.575 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 1.056 ' HB3' HD12 ' A' ' 35' ' ' ILE . . . -63.9 -43.55 95.65 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.823 -0.626 . . . . 15.0 109.536 178.458 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.887 HG23 HG21 ' A' ' 22' ' ' VAL . 0.5 OUTLIER -44.25 -40.06 1.68 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.296 0 N-CA-C 108.771 -0.825 . . . . 15.0 108.771 178.176 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.522 ' O ' ' HB2' ' A' ' 80' ' ' ASN . 3.6 mm-40 -67.42 -45.01 77.39 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 114.793 -1.094 . . . . 15.0 110.302 178.377 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.685 ' O ' HG11 ' A' ' 61' ' ' VAL . 32.9 p -64.02 -54.64 31.08 Favored 'General case' 0 C--O 1.231 0.124 0 C-N-CA 121.055 -0.258 . . . . 15.0 111.509 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.559 HD21 HG21 ' A' ' 58' ' ' VAL . 6.5 mt -53.37 -46.6 69.68 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-O 121.262 0.553 . . . . 15.0 109.8 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.425 ' HB2' ' O ' ' A' ' 75' ' ' VAL . 8.9 tpp180 -68.49 -59.81 2.88 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.266 -0.879 . . . . 15.0 110.5 179.284 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.522 ' HB2' ' O ' ' A' ' 76' ' ' GLU . 10.9 m-80 -66.12 62.11 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.98 -0.554 . . . . 15.0 111.833 179.801 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.73 HG22 ' OD1' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -93.74 -74.16 0.54 Allowed 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.804 -0.443 . . . . 15.0 109.804 179.182 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 122.03 -106.15 1.05 Allowed Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.802 -0.713 . . . . 15.0 113.195 179.019 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -64.7 -82.13 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 111.984 0.365 . . . . 15.0 111.984 -179.067 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.436 HG12 ' N ' ' A' ' 85' ' ' VAL . 62.4 t -109.87 158.29 10.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.06 0.457 . . . . 15.0 110.87 -179.335 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.74 HG23 ' CB ' ' A' ' 13' ' ' LYS . 14.0 t -97.93 80.96 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 116.084 -0.507 . . . . 15.0 110.569 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -103.13 83.39 2.2 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.901 -0.591 . . . . 15.0 110.265 179.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.805 ' HB3' HD21 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -99.93 118.32 36.11 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.952 -0.567 . . . . 15.0 111.756 -179.088 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.819 ' HB2' ' HB3' ' A' ' 60' ' ' ALA . 4.3 mp -92.14 101.1 13.62 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.757 -0.46 . . . . 15.0 109.757 178.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.805 HD21 ' HB3' ' A' ' 87' ' ' LEU . 0.2 OUTLIER -105.65 -159.71 0.72 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.303 0.573 . . . . 15.0 111.66 -178.836 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.467 ' HA ' ' HA ' ' A' ' 6' ' ' ILE . 3.1 tt0 -140.58 145.23 36.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.311 -0.859 . . . . 15.0 110.195 179.243 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.85 106.87 0.34 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.249 -0.432 . . . . 15.0 110.977 -179.837 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.379 0 C-N-CA 120.842 -0.695 . . . . 15.0 112.581 -179.849 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.531 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 1.5 mp . . . . . 0 N--CA 1.45 -0.425 0 CA-C-O 120.893 0.378 . . . . 15.0 111.301 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.579 ' CE1' HD12 ' A' ' 89' ' ' LEU . 3.8 p90 -144.56 165.03 29.15 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.061 -0.518 . . . . 15.0 110.415 178.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.727 ' CB ' HD12 ' A' ' 88' ' ' LEU . 10.7 pt-20 -130.19 143.84 51.01 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.201 0.524 . . . . 15.0 111.6 -179.05 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.454 HG23 ' HB3' ' A' ' 51' ' ' ARG . 0.2 OUTLIER -101.64 117.13 46.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.441 -0.799 . . . . 15.0 109.542 178.615 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 -106.14 74.86 1.06 Allowed 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 112.33 0.493 . . . . 15.0 112.33 -178.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.559 HD11 ' CB ' ' A' ' 49' ' ' ASP . 6.8 tp -88.19 166.34 14.44 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.389 -0.597 . . . . 15.0 109.389 178.43 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -96.2 95.76 8.35 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.041 0.448 . . . . 15.0 111.28 -179.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.662 ' CB ' HG23 ' A' ' 85' ' ' VAL . 0.2 OUTLIER . . . . . 0 C--N 1.327 -0.396 0 CA-C-N 115.73 -0.668 . . . . 15.0 111.195 179.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.0 mp . . . . . 0 N--CA 1.454 -0.231 0 CA-C-O 120.826 0.346 . . . . 15.0 110.561 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.649 ' O ' ' HB ' ' A' ' 41' ' ' ILE . . . -160.99 36.86 0.42 Allowed Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 121.136 -0.554 . . . . 15.0 111.782 -179.636 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.616 HD13 ' HB ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -112.66 141.68 27.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 120.996 0.427 . . . . 15.0 112.027 -179.291 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 31.4 t -96.24 102.69 14.52 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 107.301 -1.37 . . . . 15.0 107.301 176.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.998 HG21 HG23 ' A' ' 75' ' ' VAL . 14.1 m -93.33 148.26 4.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 113.536 0.939 . . . . 15.0 113.536 -176.293 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.533 ' O ' ' O ' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -149.86 157.92 43.66 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.005 -0.998 . . . . 15.0 110.699 179.586 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.412 ' O ' HG12 ' A' ' 35' ' ' ILE . . . 67.71 112.67 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.444 -0.884 . . . . 15.0 113.42 178.653 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.508 ' HA3' ' N ' ' A' ' 71' ' ' HIS . . . -163.74 -38.97 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 121.112 -0.566 . . . . 15.0 112.301 179.244 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.508 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 0.2 OUTLIER -40.78 162.58 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-O 120.868 0.366 . . . . 15.0 111.823 179.935 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -87.91 51.72 2.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.454 . . . . 15.0 110.887 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -151.63 -62.15 0.17 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.094 -0.503 . . . . 15.0 110.663 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.75 -52.34 51.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.192 -0.458 . . . . 15.0 110.609 179.753 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.441 HG22 ' O ' ' A' ' 26' ' ' VAL . 16.4 m -87.98 -177.68 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.137 -0.483 . . . . 15.0 110.771 179.726 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 5.1 ppt_? -88.41 127.1 35.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.851 0.358 . . . . 15.0 111.184 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 57.1 m80 62.76 -82.14 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.005 -0.543 . . . . 15.0 111.424 179.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -177.25 33.08 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.721 -0.752 . . . . 15.0 112.661 -179.525 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -93.52 156.35 22.58 Favored Glycine 0 N--CA 1.45 -0.388 0 N-CA-C 110.846 -0.902 . . . . 15.0 110.846 179.079 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.955 HG22 HG22 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -97.64 153.6 3.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 119.854 -0.738 . . . . 15.0 111.997 -179.29 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.533 ' O ' ' O ' ' A' ' 23' ' ' THR . 26.8 m-85 -134.17 106.82 7.37 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.963 -1.017 . . . . 15.0 109.7 179.225 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.806 HG22 ' N ' ' A' ' 55' ' ' GLY . 0.7 OUTLIER -54.63 146.64 3.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.106 0.479 . . . . 15.0 111.282 -178.593 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.475 ' HB3' ' OG1' ' A' ' 23' ' ' THR . 0.0 OUTLIER -79.94 -48.87 12.71 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.319 -0.993 . . . . 15.0 108.319 178.78 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.597 ' O ' HG12 ' A' ' 20' ' ' ILE . . . -172.23 171.07 4.95 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.285 -0.87 . . . . 15.0 110.119 178.612 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.567 ' HA ' HG12 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -97.1 110.26 24.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.085 0.469 . . . . 15.0 110.182 179.558 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.649 ' HB ' ' O ' ' A' ' 19' ' ' GLY . 0.4 OUTLIER -78.47 109.58 10.99 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 115.701 -0.682 . . . . 15.0 112.32 -178.326 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.466 ' N ' ' HG2' ' A' ' 47' ' ' GLU . 31.4 Cg_endo -63.45 65.88 0.18 Allowed 'Trans proline' 0 C--N 1.355 0.919 0 C-N-CA 123.159 2.572 . . . . 15.0 112.568 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.424 ' N ' ' O ' ' A' ' 41' ' ' ILE . 5.2 tp60 -147.32 -53.34 0.21 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.322 -0.854 . . . . 15.0 109.112 179.469 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.57 ' HA3' ' HA3' ' A' ' 19' ' ' GLY . . . -87.93 157.18 28.19 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.667 -0.778 . . . . 15.0 112.51 179.175 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -41.58 -17.38 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 113.588 0.958 . . . . 15.0 113.588 -179.531 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.43 ' N ' ' O ' ' A' ' 44' ' ' GLY . . . -71.65 -70.72 0.31 Allowed 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.75 -0.38 . . . . 15.0 111.345 -179.409 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.501 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 4.3 tp10 -58.54 -40.6 83.43 Favored 'General case' 0 N--CA 1.463 0.179 0 C-N-CA 120.587 -0.445 . . . . 15.0 110.436 179.546 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.8 m -54.15 -63.56 1.11 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.997 -0.547 . . . . 15.0 110.338 179.355 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.559 ' CB ' HD11 ' A' ' 11' ' ' LEU . 1.9 t70 -63.5 -40.05 96.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.108 -0.496 . . . . 15.0 109.899 179.081 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.58 43.37 8.49 Favored Glycine 0 N--CA 1.449 -0.437 0 CA-C-N 115.678 -0.692 . . . . 15.0 112.836 179.472 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.541 ' HG3' HD13 ' A' ' 11' ' ' LEU . 1.1 mmt-85 -89.34 -52.81 4.85 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.938 0.399 . . . . 15.0 110.557 179.696 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.568 ' CG1' HD12 ' A' ' 20' ' ' ILE . 9.7 tp -81.0 159.16 4.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.036 -0.529 . . . . 15.0 110.398 179.546 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . 0.41 ' O ' ' HB2' ' A' ' 56' ' ' ASP . 80.3 m80 -139.69 160.88 38.87 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-O 121.794 0.807 . . . . 15.0 112.758 -178.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.574 ' HA ' ' CG2' ' A' ' 37' ' ' VAL . 0.2 OUTLIER -44.67 134.29 5.53 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.002 -1.453 . . . . 15.0 113.1 -178.657 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.806 ' N ' HG22 ' A' ' 37' ' ' VAL . . . 49.66 31.8 15.97 Favored Glycine 0 C--N 1.334 0.442 0 CA-C-N 115.738 -0.664 . . . . 15.0 113.636 178.802 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.41 ' HB2' ' O ' ' A' ' 53' ' ' HIS . 0.3 OUTLIER -65.97 131.71 46.88 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.506 -0.478 . . . . 15.0 110.683 179.442 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.491 ' HG2' ' CE2' ' A' ' 36' ' ' TYR . 6.6 mtp85 -82.65 87.41 6.73 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.351 -0.386 . . . . 15.0 110.113 179.411 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.955 HG22 HG22 ' A' ' 35' ' ' ILE . 1.3 m -79.31 113.25 18.4 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 CA-C-O 121.158 0.504 . . . . 15.0 111.087 -179.379 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 21.3 mt -107.56 -14.48 14.82 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 115.472 -0.786 . . . . 15.0 112.493 -179.173 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.714 ' HB3' ' HB2' ' A' ' 88' ' ' LEU . . . -147.5 150.41 34.51 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.604 0.594 . . . . 15.0 112.604 -178.414 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.781 HG11 ' O ' ' A' ' 77' ' ' THR . 80.9 t -139.05 102.72 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.175 -0.92 . . . . 15.0 109.018 178.746 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.815 ' ND2' HG22 ' A' ' 81' ' ' THR . 1.7 m-80 65.11 14.89 9.68 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.723 -0.473 . . . . 15.0 109.723 -177.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 106.4 6.71 35.72 Favored Glycine 0 C--N 1.336 0.566 0 CA-C-N 115.839 -0.619 . . . . 15.0 113.366 179.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.68 ' O ' HG13 ' A' ' 64' ' ' VAL . 6.5 p -93.79 104.96 16.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 117.17 0.485 . . . . 15.0 110.874 179.486 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 50.8 m -58.47 121.3 10.55 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.148 -0.478 . . . . 15.0 110.733 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.47 HD13 HG23 ' A' ' 58' ' ' VAL . 0.5 OUTLIER -87.56 -10.04 52.7 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.031 -0.532 . . . . 15.0 111.185 -179.879 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -46.12 98.48 0.01 OUTLIER 'General case' 0 C--N 1.334 -0.105 0 CA-C-O 120.916 0.389 . . . . 15.0 110.799 179.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.94 68.66 0.62 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.75 -0.738 . . . . 15.0 112.193 -179.515 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.454 ' HB1' ' CB ' ' A' ' 73' ' ' GLN . . . -172.87 167.7 5.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.783 0.325 . . . . 15.0 110.863 -179.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.508 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 7.0 p -92.98 -175.05 3.76 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.238 -0.437 . . . . 15.0 111.335 -179.604 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . 0.681 ' CD2' HG23 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -63.32 -61.2 2.51 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.928 -0.578 . . . . 15.0 110.283 -179.873 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.401 ' HA ' ' HB ' ' A' ' 75' ' ' VAL . 3.0 ttpp -52.7 -33.06 45.92 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.772 -0.649 . . . . 15.0 110.732 179.568 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.454 ' CB ' ' HB1' ' A' ' 69' ' ' ALA . 5.9 mt-30 -59.41 -48.25 82.36 Favored 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 109.403 -0.591 . . . . 15.0 109.403 179.236 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.461 ' HA ' ' OG1' ' A' ' 77' ' ' THR . . . -65.37 -47.99 74.5 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.719 -0.673 . . . . 15.0 109.214 178.307 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.998 HG23 HG21 ' A' ' 22' ' ' VAL . 0.5 OUTLIER -43.39 -39.42 1.17 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.242 0 N-CA-C 108.74 -0.837 . . . . 15.0 108.74 178.07 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -67.31 -45.92 75.06 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 114.739 -1.119 . . . . 15.0 110.349 178.468 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.781 ' O ' HG11 ' A' ' 61' ' ' VAL . 10.0 p -64.37 -53.18 52.6 Favored 'General case' 0 C--O 1.231 0.129 0 C-N-CA 120.893 -0.323 . . . . 15.0 111.309 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.696 HD23 HG21 ' A' ' 61' ' ' VAL . 5.7 mt -53.36 -48.28 68.69 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-O 121.219 0.533 . . . . 15.0 109.944 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -68.4 -59.04 3.47 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.353 -0.84 . . . . 15.0 110.351 179.357 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 75.1 m-20 -66.02 61.47 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.846 -0.615 . . . . 15.0 111.911 179.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.815 HG22 ' ND2' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -95.72 -71.01 0.69 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.693 0.282 . . . . 15.0 110.51 179.519 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 122.15 -104.42 0.91 Allowed Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.824 -0.703 . . . . 15.0 113.186 179.345 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.426 ' O ' ' HB3' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -64.64 -83.41 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 111.965 0.357 . . . . 15.0 111.965 -179.066 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.439 HG12 ' N ' ' A' ' 85' ' ' VAL . 53.9 t -109.46 159.91 8.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.94 0.4 . . . . 15.0 110.839 -179.543 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.662 HG23 ' CB ' ' A' ' 13' ' ' LYS . 24.5 t -97.87 79.59 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.161 -0.472 . . . . 15.0 110.52 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -100.63 85.39 2.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.856 -0.611 . . . . 15.0 110.594 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.713 ' HB3' HD21 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -99.57 123.11 43.53 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.083 -0.508 . . . . 15.0 111.513 -179.468 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.727 HD12 ' CB ' ' A' ' 8' ' ' GLU . 4.7 mp -98.5 100.74 12.02 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.891 -0.411 . . . . 15.0 109.891 179.014 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.713 HD21 ' HB3' ' A' ' 87' ' ' LEU . 0.1 OUTLIER -105.93 -162.29 0.85 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.428 0.632 . . . . 15.0 111.903 -178.87 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.531 ' HA ' ' HA ' ' A' ' 6' ' ' ILE . 3.1 tt0 -138.25 142.26 39.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 114.977 -1.01 . . . . 15.0 109.952 178.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 4.2 tptt -54.25 103.32 0.08 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.36 -0.382 . . . . 15.0 111.129 -179.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.37 0 C-N-CA 120.862 -0.685 . . . . 15.0 112.522 -179.971 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.427 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 1.4 mp . . . . . 0 N--CA 1.45 -0.425 0 CA-C-O 120.86 0.362 . . . . 15.0 111.181 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.536 ' CZ ' HD12 ' A' ' 89' ' ' LEU . 2.3 p90 -140.66 158.17 44.37 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.122 -0.49 . . . . 15.0 110.456 178.794 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.771 ' HB2' HD12 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -123.96 143.6 50.3 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.289 0.566 . . . . 15.0 111.566 -179.37 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.695 ' CG1' HD11 ' A' ' 89' ' ' LEU . 0.5 OUTLIER -101.31 114.6 41.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.295 -0.866 . . . . 15.0 109.6 179.08 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -106.24 70.38 0.84 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.261 -0.427 . . . . 15.0 112.021 -178.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.648 HD11 ' CB ' ' A' ' 49' ' ' ASP . 8.6 tp -88.26 162.1 16.82 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.137 -0.483 . . . . 15.0 110.007 179.069 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -96.58 99.28 10.92 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.703 0.287 . . . . 15.0 111.042 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.908 ' HB2' HG23 ' A' ' 85' ' ' VAL . 0.3 OUTLIER . . . . . 0 CA--C 1.533 0.324 0 N-CA-C 112.651 0.611 . . . . 15.0 112.651 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.475 HD12 ' HE3' ' A' ' 13' ' ' LYS . 3.9 mp . . . . . 0 N--CA 1.451 -0.391 0 CA-C-O 120.847 0.356 . . . . 15.0 110.581 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.639 ' O ' ' HB ' ' A' ' 41' ' ' ILE . . . -160.78 38.42 0.43 Allowed Glycine 0 N--CA 1.449 -0.48 0 N-CA-C 111.527 -0.629 . . . . 15.0 111.527 -179.774 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.719 HG12 ' O ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -112.62 140.78 30.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-O 120.937 0.399 . . . . 15.0 111.835 -179.363 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.452 ' HB3' HD11 ' A' ' 41' ' ' ILE . 30.8 t -96.09 105.92 18.03 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 107.79 -1.189 . . . . 15.0 107.79 177.491 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.887 HG21 HG23 ' A' ' 75' ' ' VAL . 14.5 m -93.67 151.91 3.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 113.087 0.773 . . . . 15.0 113.087 -176.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -149.46 174.02 12.94 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 114.752 -1.113 . . . . 15.0 110.489 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.584 ' O ' HG22 ' A' ' 26' ' ' VAL . . . 80.94 -118.54 4.65 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.491 -0.861 . . . . 15.0 112.356 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.544 ' HA3' ' N ' ' A' ' 71' ' ' HIS . . . 66.66 -65.72 0.18 Allowed Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.967 -0.635 . . . . 15.0 113.497 179.268 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.584 HG22 ' O ' ' A' ' 24' ' ' GLY . 0.0 OUTLIER -28.43 139.78 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 N-CA-C 112.38 0.511 . . . . 15.0 112.38 -179.188 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 11.2 m-80 -75.53 61.3 1.29 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.913 -0.585 . . . . 15.0 111.024 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -151.7 -64.46 0.18 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.28 -0.418 . . . . 15.0 110.927 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 59.7 p -69.1 -49.13 59.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.176 -0.465 . . . . 15.0 110.954 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.525 HG22 ' O ' ' A' ' 26' ' ' VAL . 23.1 m -70.6 -173.56 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.159 -0.473 . . . . 15.0 111.114 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.69 -67.13 0.31 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.291 -0.413 . . . . 15.0 111.055 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 10.1 p-80 -139.32 -45.3 0.46 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.315 -0.402 . . . . 15.0 111.052 -179.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -168.38 25.54 0.12 Allowed Glycine 0 N--CA 1.453 -0.212 0 C-N-CA 120.894 -0.669 . . . . 15.0 112.508 -179.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.406 ' O ' HG11 ' A' ' 30' ' ' VAL . . . -94.47 152.53 20.64 Favored Glycine 0 N--CA 1.448 -0.509 0 N-CA-C 110.443 -1.063 . . . . 15.0 110.443 178.747 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.918 HG22 HG22 ' A' ' 58' ' ' VAL . 0.1 OUTLIER -95.79 153.22 3.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 C-N-CA 119.731 -0.787 . . . . 15.0 112.329 -179.021 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.464 ' CZ ' ' HG2' ' A' ' 57' ' ' ARG . 29.3 m-85 -135.04 106.55 6.86 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.699 -1.137 . . . . 15.0 109.158 179.117 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.801 HG22 ' N ' ' A' ' 55' ' ' GLY . 0.8 OUTLIER -55.22 148.05 3.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.127 0.489 . . . . 15.0 111.571 -178.392 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.424 ' O ' ' HG2' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -80.37 -49.59 11.29 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.509 -0.923 . . . . 15.0 108.509 178.3 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.719 ' O ' HG12 ' A' ' 20' ' ' ILE . . . -172.17 172.71 4.5 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.963 -0.562 . . . . 15.0 110.879 178.808 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.55 ' HA ' HG12 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -96.81 112.72 29.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 N-CA-C 109.598 -0.519 . . . . 15.0 109.598 179.296 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.639 ' HB ' ' O ' ' A' ' 19' ' ' GLY . 0.3 OUTLIER -78.45 119.33 76.92 Favored Pre-proline 0 C--N 1.328 -0.327 0 N-CA-C 113.334 0.864 . . . . 15.0 113.334 -177.403 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.606 ' HA ' ' CG ' ' A' ' 47' ' ' GLU . 38.0 Cg_endo -65.15 61.1 0.32 Allowed 'Trans proline' 0 C--N 1.356 0.966 0 C-N-CA 123.448 2.766 . . . . 15.0 112.944 179.676 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.509 ' H ' ' HG2' ' A' ' 47' ' ' GLU . 0.1 OUTLIER -151.32 -44.75 0.11 Allowed 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 111.663 0.246 . . . . 15.0 111.663 179.903 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.599 ' HA3' ' HA3' ' A' ' 19' ' ' GLY . . . -87.71 165.54 35.16 Favored Glycine 0 CA--C 1.518 0.255 0 C-N-CA 120.328 -0.939 . . . . 15.0 113.719 -179.159 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -55.47 -15.88 3.19 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.796 0.665 . . . . 15.0 112.796 -179.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.2 -57.11 4.51 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.648 0.261 . . . . 15.0 111.204 -179.485 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.606 ' CG ' ' HA ' ' A' ' 42' ' ' PRO . 2.6 pp20? -56.93 -41.72 78.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.913 0.387 . . . . 15.0 110.386 179.711 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -53.91 -68.82 0.15 Allowed 'General case' 0 CA--C 1.52 -0.182 0 CA-C-N 115.91 -0.587 . . . . 15.0 110.851 -179.393 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.648 ' CB ' HD11 ' A' ' 11' ' ' LEU . 11.8 t0 -63.2 -39.13 93.75 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.57 -0.529 . . . . 15.0 109.57 179.13 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.07 45.55 7.52 Favored Glycine 0 N--CA 1.447 -0.595 0 CA-C-N 115.452 -0.795 . . . . 15.0 111.758 179.67 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.589 ' CG ' HG23 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -79.41 -53.15 7.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.966 0.413 . . . . 15.0 110.578 -179.377 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.659 ' CG1' HD12 ' A' ' 20' ' ' ILE . 7.9 tp -82.34 164.97 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 CA-C-N 115.947 -0.569 . . . . 15.0 110.392 179.676 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . 0.451 ' O ' ' HB2' ' A' ' 56' ' ' ASP . 76.3 m80 -147.68 158.01 43.81 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-O 121.674 0.75 . . . . 15.0 112.285 -179.147 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.552 ' HA ' ' CG2' ' A' ' 37' ' ' VAL . 8.5 mtpt -43.4 134.08 4.03 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.302 -1.317 . . . . 15.0 112.94 -178.617 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.801 ' N ' HG22 ' A' ' 37' ' ' VAL . . . 49.9 31.12 16.63 Favored Glycine 0 C--N 1.334 0.432 0 CA-C-N 115.692 -0.686 . . . . 15.0 113.659 179.051 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.451 ' HB2' ' O ' ' A' ' 53' ' ' HIS . 0.4 OUTLIER -66.09 129.94 41.52 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 117.094 0.447 . . . . 15.0 110.786 179.563 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.862 ' HD2' HD21 ' A' ' 59' ' ' LEU . 0.0 OUTLIER -81.33 89.96 6.12 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.299 -0.41 . . . . 15.0 110.138 179.371 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.918 HG22 HG22 ' A' ' 35' ' ' ILE . 1.4 m -82.8 114.17 23.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 CA-C-O 121.073 0.463 . . . . 15.0 111.584 -179.146 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.862 HD21 ' HD2' ' A' ' 57' ' ' ARG . 3.4 mm? -107.69 -12.84 15.16 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 115.614 -0.721 . . . . 15.0 112.501 -179.498 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.674 ' HB3' ' HB2' ' A' ' 88' ' ' LEU . . . -149.72 149.0 29.91 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 112.659 0.614 . . . . 15.0 112.659 -178.527 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.85 HG11 ' O ' ' A' ' 77' ' ' THR . 23.1 t -142.29 99.04 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.27 0 CA-C-N 115.304 -0.862 . . . . 15.0 109.441 178.842 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.617 ' ND2' HG22 ' A' ' 81' ' ' THR . 1.6 m-80 65.05 16.67 10.69 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.155 -0.475 . . . . 15.0 109.896 -178.282 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 107.17 6.04 34.36 Favored Glycine 0 C--N 1.336 0.536 0 CA-C-N 115.813 -0.631 . . . . 15.0 113.564 179.48 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.663 ' O ' HG13 ' A' ' 64' ' ' VAL . 4.6 p -93.75 103.71 14.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 117.292 0.546 . . . . 15.0 110.628 179.155 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -57.91 127.69 33.35 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.134 -0.484 . . . . 15.0 111.071 -179.417 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.668 HD13 ' HB3' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -87.69 -15.86 35.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.021 -0.536 . . . . 15.0 111.063 179.962 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -45.24 95.32 0.01 OUTLIER 'General case' 0 N--CA 1.461 0.114 0 CA-C-O 120.871 0.367 . . . . 15.0 111.008 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 103.75 69.35 0.79 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.79 -0.719 . . . . 15.0 112.238 -179.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.706 ' HB1' ' CB ' ' A' ' 73' ' ' GLN . . . -173.03 142.73 1.09 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.901 0.381 . . . . 15.0 111.049 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.429 ' CB ' ' HA ' ' A' ' 26' ' ' VAL . 13.7 p -74.3 -172.5 1.45 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.162 -0.472 . . . . 15.0 111.241 -179.774 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . 0.761 ' CD2' HG23 ' A' ' 22' ' ' VAL . 0.1 OUTLIER -62.19 -59.49 4.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.914 -0.584 . . . . 15.0 110.475 179.99 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.453 ' O ' HG12 ' A' ' 75' ' ' VAL . 6.6 ttmt -52.81 -33.8 50.77 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.871 -0.604 . . . . 15.0 110.623 179.399 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.706 ' CB ' ' HB1' ' A' ' 69' ' ' ALA . 5.2 mt-30 -59.54 -52.93 63.45 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.708 -0.478 . . . . 15.0 109.708 179.313 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.868 ' HB3' HD12 ' A' ' 35' ' ' ILE . . . -67.08 -42.4 84.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.099 -0.501 . . . . 15.0 109.725 178.48 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.887 HG23 HG21 ' A' ' 22' ' ' VAL . 0.5 OUTLIER -44.31 -39.51 1.63 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.221 0 N-CA-C 108.985 -0.746 . . . . 15.0 108.985 178.528 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -67.3 -44.17 79.88 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.751 -1.113 . . . . 15.0 110.314 178.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.85 ' O ' HG11 ' A' ' 61' ' ' VAL . 27.6 p -64.04 -56.15 17.11 Favored 'General case' 0 N--CA 1.462 0.151 0 C-N-CA 121.047 -0.261 . . . . 15.0 111.375 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.588 HD23 HG21 ' A' ' 61' ' ' VAL . 4.6 mt -53.49 -46.94 70.22 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 121.179 0.514 . . . . 15.0 109.958 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 3.3 tmt_? -68.49 -60.27 2.55 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.434 -0.803 . . . . 15.0 110.739 179.53 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 15.2 m-20 -65.96 60.83 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.846 -0.615 . . . . 15.0 112.222 -179.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.617 HG22 ' ND2' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -95.57 -76.08 0.51 Allowed 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.744 -0.465 . . . . 15.0 109.744 178.91 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 112.75 -98.51 0.96 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.634 -0.793 . . . . 15.0 113.58 178.63 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.46 ' O ' ' HB3' ' A' ' 13' ' ' LYS . 0.5 OUTLIER -63.92 -87.92 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 111.682 0.252 . . . . 15.0 111.682 -178.907 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.453 HG12 ' N ' ' A' ' 85' ' ' VAL . 72.0 t -110.06 158.23 10.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.066 0.46 . . . . 15.0 110.925 -179.738 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.908 HG23 ' HB2' ' A' ' 13' ' ' LYS . 3.8 t -97.87 81.92 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.094 -0.503 . . . . 15.0 110.256 179.698 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.452 ' CE1' HD11 ' A' ' 88' ' ' LEU . 1.4 t60 -100.7 82.81 2.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.766 -0.652 . . . . 15.0 109.99 179.585 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.852 ' HB3' HD21 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -103.79 115.97 31.44 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.799 -0.637 . . . . 15.0 112.05 -178.745 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.771 HD12 ' HB2' ' A' ' 8' ' ' GLU . 4.0 mp -92.21 102.13 14.64 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.451 -0.574 . . . . 15.0 109.451 178.576 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.852 HD21 ' HB3' ' A' ' 87' ' ' LEU . 0.1 OUTLIER -105.81 -161.74 0.82 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.487 0.661 . . . . 15.0 112.102 -178.317 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.427 ' HA ' ' HA ' ' A' ' 6' ' ' ILE . 3.5 tt0 -143.98 135.38 25.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 114.879 -1.055 . . . . 15.0 109.621 179.148 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.08 103.56 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.005 0.431 . . . . 15.0 111.087 -179.566 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.299 0 C-N-CA 120.944 -0.646 . . . . 15.0 112.706 -179.706 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.519 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 1.2 mp . . . . . 0 N--CA 1.45 -0.426 0 CA-C-O 120.508 0.194 . . . . 15.0 110.624 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.879 ' CE1' HD12 ' A' ' 89' ' ' LEU . 3.0 p90 -141.93 141.32 32.96 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.035 0.445 . . . . 15.0 111.206 179.418 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.79 ' HB2' HD12 ' A' ' 88' ' ' LEU . 5.6 pm0 -113.53 141.8 46.71 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.804 -0.635 . . . . 15.0 111.15 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.489 ' N ' ' O ' ' A' ' 87' ' ' LEU . 0.2 OUTLIER -101.41 114.02 39.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.45 -0.796 . . . . 15.0 109.839 179.335 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -105.96 71.16 0.88 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.033 -0.53 . . . . 15.0 111.896 -178.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.489 HD11 ' CB ' ' A' ' 49' ' ' ASP . 5.4 tp -88.65 166.83 13.84 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.155 -0.475 . . . . 15.0 109.949 179.016 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -96.08 96.88 9.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.028 0.442 . . . . 15.0 111.163 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.768 ' CB ' HG23 ' A' ' 85' ' ' VAL . 0.1 OUTLIER . . . . . 0 C--N 1.327 -0.393 0 CA-C-N 115.725 -0.671 . . . . 15.0 111.442 -179.721 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 9.8 mt . . . . . 0 N--CA 1.455 -0.188 0 CA-C-O 120.968 0.413 . . . . 15.0 110.794 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.663 ' O ' ' HB ' ' A' ' 41' ' ' ILE . . . -161.13 38.59 0.42 Allowed Glycine 0 N--CA 1.449 -0.459 0 CA-C-N 115.867 -0.606 . . . . 15.0 111.752 -179.831 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.725 HG12 ' O ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -112.69 140.75 30.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 121.02 0.438 . . . . 15.0 111.94 -179.358 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.409 ' HB3' HD11 ' A' ' 41' ' ' ILE . 41.0 t -96.11 106.18 18.32 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 107.837 -1.171 . . . . 15.0 107.837 177.296 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.999 HG21 HG23 ' A' ' 75' ' ' VAL . 31.2 m -93.54 152.5 3.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 113.083 0.771 . . . . 15.0 113.083 -177.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.415 ' OG1' ' HB2' ' A' ' 38' ' ' LYS . 0.3 OUTLIER -149.46 179.27 8.09 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 114.863 -1.062 . . . . 15.0 110.728 -179.962 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.431 ' O ' ' CB ' ' A' ' 71' ' ' HIS . . . 74.22 -120.23 6.56 Favored Glycine 0 C--N 1.33 0.24 0 C-N-CA 120.672 -0.775 . . . . 15.0 112.327 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.537 ' HA3' ' N ' ' A' ' 71' ' ' HIS . . . 67.52 -65.69 0.27 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.848 -0.691 . . . . 15.0 113.631 179.31 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.569 ' O ' HG22 ' A' ' 30' ' ' VAL . 2.0 m -31.22 140.84 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 N-CA-C 112.328 0.492 . . . . 15.0 112.328 -179.17 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 14.2 p-10 -75.47 64.62 1.62 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.944 -0.571 . . . . 15.0 111.035 -179.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.5 m -151.67 -61.52 0.17 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.263 -0.426 . . . . 15.0 111.075 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 91.3 p -76.45 -42.88 42.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.18 -0.464 . . . . 15.0 111.155 -179.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.569 HG22 ' O ' ' A' ' 26' ' ' VAL . 35.3 m -73.78 -176.17 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.274 -0.421 . . . . 15.0 111.275 -179.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.14 -59.96 4.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.118 -0.492 . . . . 15.0 111.078 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 10.5 m80 -143.55 -47.93 0.3 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.306 -0.407 . . . . 15.0 111.149 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -169.44 22.56 0.09 OUTLIER Glycine 0 CA--C 1.519 0.292 0 C-N-CA 120.668 -0.777 . . . . 15.0 112.888 -179.701 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -87.55 154.46 26.02 Favored Glycine 0 N--CA 1.451 -0.354 0 N-CA-C 110.788 -0.925 . . . . 15.0 110.788 178.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.685 HG22 HG13 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -92.5 152.02 3.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 C-N-CA 119.895 -0.722 . . . . 15.0 111.906 -179.242 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.515 ' CZ ' ' HG2' ' A' ' 57' ' ' ARG . 53.8 m-85 -137.3 106.64 6.08 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.835 -1.075 . . . . 15.0 109.892 179.333 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.869 HG22 ' N ' ' A' ' 55' ' ' GLY . 0.6 OUTLIER -57.46 146.0 7.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.977 -0.556 . . . . 15.0 111.144 -179.089 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.485 ' O ' ' HG2' ' A' ' 54' ' ' LYS . 0.6 OUTLIER -80.33 -48.87 12.32 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.947 -0.76 . . . . 15.0 108.947 178.837 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.725 ' O ' HG12 ' A' ' 20' ' ' ILE . . . -172.07 172.6 4.61 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.906 -0.588 . . . . 15.0 110.736 178.811 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.533 ' HA ' HG12 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -96.86 112.93 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 N-CA-C 109.781 -0.451 . . . . 15.0 109.781 179.433 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.663 ' HB ' ' O ' ' A' ' 19' ' ' GLY . 0.3 OUTLIER -78.56 118.49 72.65 Favored Pre-proline 0 C--N 1.328 -0.331 0 N-CA-C 113.021 0.749 . . . . 15.0 113.021 -177.764 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.612 ' HA ' ' CG ' ' A' ' 47' ' ' GLU . 37.2 Cg_endo -64.8 60.63 0.29 Allowed 'Trans proline' 0 C--N 1.356 0.935 0 C-N-CA 123.416 2.744 . . . . 15.0 112.91 179.842 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.527 ' N ' ' HG2' ' A' ' 47' ' ' GLU . 41.1 tt0 -149.87 -46.26 0.13 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.632 -0.258 . . . . 15.0 111.511 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.608 ' HA3' ' HA3' ' A' ' 19' ' ' GLY . . . -87.8 166.91 36.12 Favored Glycine 0 CA--C 1.519 0.314 0 C-N-CA 120.417 -0.897 . . . . 15.0 114.008 -178.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -55.29 -15.43 2.45 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.911 0.708 . . . . 15.0 112.911 -179.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.429 ' HB1' HG22 ' A' ' 52' ' ' ILE . . . -71.97 -57.4 4.33 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 121.005 -0.278 . . . . 15.0 111.051 -179.418 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.612 ' CG ' ' HA ' ' A' ' 42' ' ' PRO . 2.9 pp20? -57.05 -42.99 81.57 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.035 -0.529 . . . . 15.0 110.378 179.358 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -53.88 -70.47 0.1 Allowed 'General case' 0 CA--C 1.52 -0.194 0 CA-C-N 115.893 -0.594 . . . . 15.0 110.498 -179.623 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.489 ' CB ' HD11 ' A' ' 11' ' ' LEU . 14.4 t0 -58.21 -39.92 80.26 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.349 -0.611 . . . . 15.0 109.349 178.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.76 35.02 26.24 Favored Glycine 0 N--CA 1.447 -0.631 0 CA-C-N 115.384 -0.825 . . . . 15.0 111.595 179.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.488 ' HG3' HD13 ' A' ' 11' ' ' LEU . 0.3 OUTLIER -79.73 -46.5 16.94 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.05 0.452 . . . . 15.0 110.524 -179.431 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.685 ' CG1' HD12 ' A' ' 20' ' ' ILE . 7.0 tp -80.94 149.95 4.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.697 -0.683 . . . . 15.0 109.616 179.371 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . 0.456 ' O ' HG21 ' A' ' 37' ' ' VAL . 80.4 m80 -139.7 156.94 46.52 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 113.14 0.793 . . . . 15.0 113.14 -178.269 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.564 ' HA ' ' CG2' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -45.31 133.28 7.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 113.784 -1.553 . . . . 15.0 112.961 -178.897 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.869 ' N ' HG22 ' A' ' 37' ' ' VAL . . . 49.04 27.25 6.66 Favored Glycine 0 C--N 1.335 0.486 0 CA-C-N 115.766 -0.652 . . . . 15.0 113.784 178.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.801 ' CG ' HD13 ' A' ' 89' ' ' LEU . 1.2 p30 -66.32 133.23 50.11 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 119.485 -0.886 . . . . 15.0 110.077 179.512 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.529 ' HD2' HD21 ' A' ' 59' ' ' LEU . 0.0 OUTLIER -80.76 97.58 7.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 15.0 110.434 -179.845 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.685 HG13 HG22 ' A' ' 35' ' ' ILE . 1.3 m -82.24 112.74 20.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.265 -0.425 . . . . 15.0 110.392 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.529 HD21 ' HD2' ' A' ' 57' ' ' ARG . 3.5 mm? -107.26 -21.62 12.89 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 115.826 -0.625 . . . . 15.0 112.384 -179.041 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.607 ' O ' HD23 ' A' ' 87' ' ' LEU . . . -147.45 150.47 34.67 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.251 0.548 . . . . 15.0 112.365 -178.56 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.745 HG21 HD23 ' A' ' 78' ' ' LEU . 60.4 t -138.92 102.46 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.264 -0.88 . . . . 15.0 109.022 178.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.781 ' ND2' HG22 ' A' ' 81' ' ' THR . 1.8 m-80 65.09 15.62 10.1 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.706 -0.479 . . . . 15.0 109.706 -177.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 105.69 6.46 37.92 Favored Glycine 0 C--N 1.336 0.539 0 CA-C-N 115.785 -0.643 . . . . 15.0 113.349 179.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.667 ' O ' HG13 ' A' ' 64' ' ' VAL . 6.1 p -93.76 105.69 17.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 121.124 0.488 . . . . 15.0 110.843 179.398 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -58.78 115.45 3.09 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.148 -0.478 . . . . 15.0 110.726 -179.748 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.619 HD21 ' HA ' ' A' ' 74' ' ' ALA . 3.1 mt -89.45 -16.44 30.86 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.718 -0.674 . . . . 15.0 111.339 -179.619 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -45.79 105.44 0.06 Allowed 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.878 0.371 . . . . 15.0 111.017 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.96 66.15 0.57 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.814 -0.707 . . . . 15.0 112.433 -179.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.555 ' HB1' ' CG ' ' A' ' 73' ' ' GLN . . . -172.9 172.71 3.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.807 0.337 . . . . 15.0 110.851 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.481 HG22 ' HA ' ' A' ' 26' ' ' VAL . 19.3 p -93.16 -175.83 3.97 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.961 0.41 . . . . 15.0 111.091 -179.768 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . 0.771 ' CD2' HG23 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -62.42 -60.98 2.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.969 -0.559 . . . . 15.0 110.428 -179.994 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 7.3 ttmt -52.49 -33.68 45.9 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.773 -0.649 . . . . 15.0 110.497 179.455 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.555 ' CG ' ' HB1' ' A' ' 69' ' ' ALA . 0.5 OUTLIER -59.4 -49.01 79.46 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.567 -0.531 . . . . 15.0 109.567 179.194 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.619 ' HA ' HD21 ' A' ' 66' ' ' LEU . . . -66.96 -48.57 68.16 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 116.009 -0.541 . . . . 15.0 109.658 178.392 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.999 HG23 HG21 ' A' ' 22' ' ' VAL . 0.5 OUTLIER -40.39 -42.1 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.212 0 CA-C-N 115.476 -0.784 . . . . 15.0 109.444 178.48 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.404 ' N ' HG12 ' A' ' 75' ' ' VAL . 21.9 mt-10 -67.4 -46.07 74.33 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 114.843 -1.071 . . . . 15.0 110.45 178.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.592 ' O ' HG11 ' A' ' 61' ' ' VAL . 2.0 p -64.64 -53.08 53.18 Favored 'General case' 0 C--O 1.231 0.099 0 C-N-CA 120.918 -0.313 . . . . 15.0 111.378 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.745 HD23 HG21 ' A' ' 61' ' ' VAL . 4.4 mt -53.66 -48.38 69.48 Favored 'General case' 0 CA--C 1.52 -0.18 0 CA-C-O 121.135 0.493 . . . . 15.0 110.15 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.415 ' O ' ' N ' ' A' ' 81' ' ' THR . 3.0 ttm-85 -68.34 -56.65 7.81 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.558 -0.747 . . . . 15.0 110.493 179.511 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -66.0 62.51 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.017 -0.538 . . . . 15.0 111.752 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.781 HG22 ' ND2' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -95.55 -71.94 0.65 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.783 0.325 . . . . 15.0 110.438 179.426 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 122.17 -103.82 0.87 Allowed Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.753 -0.737 . . . . 15.0 113.157 179.272 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.58 -83.66 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 111.866 0.321 . . . . 15.0 111.866 -179.089 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.424 HG12 ' N ' ' A' ' 85' ' ' VAL . 67.3 t -109.47 157.59 9.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.105 0.478 . . . . 15.0 111.082 -179.416 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.768 HG23 ' CB ' ' A' ' 13' ' ' LYS . 10.6 t -97.81 81.86 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.011 -0.54 . . . . 15.0 110.559 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 59.6 t60 -104.96 86.54 2.47 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.747 -0.66 . . . . 15.0 110.892 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.658 HD22 HD21 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -103.81 129.75 51.28 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.996 -0.547 . . . . 15.0 111.537 -179.601 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.79 HD12 ' HB2' ' A' ' 8' ' ' GLU . 5.2 mp -102.33 101.3 11.54 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.928 -0.397 . . . . 15.0 109.928 178.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.879 HD12 ' CE1' ' A' ' 7' ' ' PHE . 0.4 OUTLIER -105.84 -161.94 0.83 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.3 0.572 . . . . 15.0 111.939 -178.699 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.519 ' HA ' ' HA ' ' A' ' 6' ' ' ILE . 26.0 tt0 -146.28 134.91 22.18 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.159 -0.928 . . . . 15.0 109.951 179.238 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 4.7 tptt -46.83 111.86 0.44 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.311 -0.404 . . . . 15.0 111.096 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.369 0 C-N-CA 120.785 -0.721 . . . . 15.0 112.614 -179.631 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.507 HG13 ' HB2' ' A' ' 90' ' ' GLU . 1.3 mp . . . . . 0 N--CA 1.45 -0.439 0 CA-C-O 120.657 0.265 . . . . 15.0 110.62 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.63 ' CE1' HD12 ' A' ' 89' ' ' LEU . 4.9 p90 -140.65 165.51 27.28 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.594 -0.275 . . . . 15.0 110.544 178.912 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.721 ' CB ' HD12 ' A' ' 88' ' ' LEU . 4.9 pt-20 -130.07 142.62 50.59 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.381 0.61 . . . . 15.0 111.417 -179.546 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.582 ' CG1' HD11 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -101.44 114.97 42.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.073 -0.967 . . . . 15.0 109.718 179.143 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -105.89 71.46 0.9 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.118 -0.492 . . . . 15.0 111.874 -178.976 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.662 HD13 ' HG3' ' A' ' 51' ' ' ARG . 6.2 tp -88.05 167.99 13.2 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.942 -0.572 . . . . 15.0 110.007 179.121 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -94.64 98.84 11.09 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.98 0.419 . . . . 15.0 110.867 179.88 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.601 ' CA ' HG23 ' A' ' 85' ' ' VAL . 0.2 OUTLIER . . . . . 0 C--N 1.328 -0.365 0 CA-C-N 115.899 -0.592 . . . . 15.0 111.13 -179.827 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.423 ' O ' ' HA3' ' A' ' 44' ' ' GLY . 3.9 mm? . . . . . 0 N--CA 1.449 -0.48 0 N-CA-C 110.627 -0.138 . . . . 15.0 110.627 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.742 ' O ' ' HB ' ' A' ' 41' ' ' ILE . . . -160.56 21.44 0.24 Allowed Glycine 0 C--O 1.226 -0.378 0 C-N-CA 120.4 -0.905 . . . . 15.0 113.395 -179.495 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.937 HG21 HG21 ' A' ' 52' ' ' ILE . 2.9 pt -113.13 139.16 39.82 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.382 0 CA-C-N 117.394 0.597 . . . . 15.0 111.709 178.738 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.514 ' O ' ' HB3' ' A' ' 38' ' ' LYS . 6.2 t -84.98 116.09 23.18 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 105.167 -2.16 . . . . 15.0 105.167 174.841 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 1.016 HG21 HG23 ' A' ' 75' ' ' VAL . 35.6 m -93.74 152.35 3.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 113.58 0.955 . . . . 15.0 113.58 -175.521 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.57 -179.18 6.89 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 114.782 -1.099 . . . . 15.0 110.564 179.642 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.591 ' O ' HG22 ' A' ' 26' ' ' VAL . . . 71.4 -121.03 8.68 Favored Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.814 -0.708 . . . . 15.0 112.613 179.658 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.52 ' HA3' ' N ' ' A' ' 71' ' ' HIS . . . 66.82 -65.71 0.19 Allowed Glycine 0 C--N 1.331 0.251 0 C-N-CA 121.028 -0.606 . . . . 15.0 113.576 179.43 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.643 ' O ' HG22 ' A' ' 30' ' ' VAL . 0.0 OUTLIER -32.83 137.78 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 N-CA-C 112.375 0.509 . . . . 15.0 112.375 -179.208 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.406 ' CB ' ' O ' ' A' ' 32' ' ' HIS . 1.6 m-20 -76.58 59.64 1.53 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.826 -0.625 . . . . 15.0 111.103 -179.856 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -151.74 -48.48 0.11 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.373 -0.376 . . . . 15.0 110.884 179.972 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 22.0 t -87.12 -31.84 20.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.203 -0.453 . . . . 15.0 110.962 -179.929 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.643 HG22 ' O ' ' A' ' 26' ' ' VAL . 33.4 m -87.9 -175.62 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.459 . . . . 15.0 111.223 -179.965 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 3.4 ttt85 -58.11 -60.81 3.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.23 -0.441 . . . . 15.0 111.102 -179.86 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . 0.406 ' O ' ' CB ' ' A' ' 27' ' ' ASN . 22.9 m80 -136.3 -58.45 0.74 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.371 -0.377 . . . . 15.0 111.163 -179.87 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -166.72 26.11 0.15 Allowed Glycine 0 N--CA 1.453 -0.223 0 C-N-CA 120.806 -0.711 . . . . 15.0 112.599 -179.723 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -90.69 153.25 22.41 Favored Glycine 0 N--CA 1.449 -0.488 0 N-CA-C 110.828 -0.909 . . . . 15.0 110.828 179.024 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.833 HG22 HG22 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -90.72 153.6 3.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 C-N-CA 120.028 -0.669 . . . . 15.0 111.648 -179.358 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.413 ' CE2' ' HG2' ' A' ' 57' ' ' ARG . 47.5 m-85 -134.43 108.39 8.12 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 114.98 -1.009 . . . . 15.0 109.534 179.4 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.784 HG22 ' N ' ' A' ' 55' ' ' GLY . 0.6 OUTLIER -54.94 148.45 2.89 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.45 0 CA-C-O 121.105 0.479 . . . . 15.0 110.731 -178.835 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.514 ' HB3' ' O ' ' A' ' 21' ' ' SER . 0.1 OUTLIER -86.17 -45.66 11.13 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 108.37 -0.974 . . . . 15.0 108.37 178.167 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.624 ' O ' ' HB ' ' A' ' 20' ' ' ILE . . . -173.76 171.37 3.78 Favored 'General case' 0 C--O 1.226 -0.157 0 C-N-CA 120.512 -0.475 . . . . 15.0 112.214 178.762 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.754 ' HA ' HG22 ' A' ' 20' ' ' ILE . 0.1 OUTLIER -97.32 81.57 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.291 0.567 . . . . 15.0 109.75 178.889 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.742 ' HB ' ' O ' ' A' ' 19' ' ' GLY . 27.2 mm -47.95 120.79 8.19 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 115.263 -0.88 . . . . 15.0 113.039 -178.351 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.602 ' HA ' ' HG2' ' A' ' 47' ' ' GLU . 40.8 Cg_endo -66.16 60.94 0.48 Allowed 'Trans proline' 0 C--N 1.354 0.831 0 C-N-CA 123.336 2.691 . . . . 15.0 112.762 179.682 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.534 ' N ' ' HG2' ' A' ' 47' ' ' GLU . 4.6 mt-30 -158.85 -41.08 0.06 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.646 0.26 . . . . 15.0 111.63 179.878 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.502 ' HA3' ' CA ' ' A' ' 19' ' ' GLY . . . -87.29 163.0 33.95 Favored Glycine 0 CA--C 1.519 0.318 0 C-N-CA 120.629 -0.796 . . . . 15.0 113.652 -179.151 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.561 ' O ' HD21 ' A' ' 11' ' ' LEU . . . -53.28 -15.21 0.88 Allowed 'General case' 0 N--CA 1.462 0.166 0 N-CA-C 112.708 0.633 . . . . 15.0 112.708 -179.721 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.99 -59.35 2.79 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.651 0.262 . . . . 15.0 110.946 -179.554 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.602 ' HG2' ' HA ' ' A' ' 42' ' ' PRO . 2.6 pp20? -56.97 -42.82 80.88 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.109 -0.496 . . . . 15.0 110.824 179.557 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.3 m -53.69 -70.77 0.09 Allowed 'General case' 0 CA--C 1.519 -0.22 0 CA-C-N 115.965 -0.561 . . . . 15.0 110.597 -179.333 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.559 ' CB ' HD11 ' A' ' 11' ' ' LEU . 1.9 t0 -61.19 -39.43 90.17 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.472 -0.566 . . . . 15.0 109.472 178.981 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.92 38.66 15.15 Favored Glycine 0 N--CA 1.447 -0.571 0 CA-C-N 115.438 -0.801 . . . . 15.0 111.638 179.802 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.662 ' HG3' HD13 ' A' ' 11' ' ' LEU . 21.7 mmt-85 -79.71 -33.71 40.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.872 0.368 . . . . 15.0 111.106 -179.18 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.937 HG21 HG21 ' A' ' 20' ' ' ILE . 21.2 mm -91.21 159.12 2.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.091 -0.504 . . . . 15.0 111.181 -179.737 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . 0.48 ' N ' ' CG2' ' A' ' 52' ' ' ILE . 29.2 m80 -141.69 138.5 32.49 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-N 115.69 -0.686 . . . . 15.0 110.663 179.394 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.532 ' HA ' ' CG2' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -35.59 131.11 0.51 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.479 -1.237 . . . . 15.0 113.039 -178.373 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.784 ' N ' HG22 ' A' ' 37' ' ' VAL . . . 56.28 29.08 55.99 Favored Glycine 0 C--N 1.332 0.353 0 CA-C-N 115.665 -0.698 . . . . 15.0 113.629 179.176 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.447 ' OD2' ' N ' ' A' ' 53' ' ' HIS . 0.4 OUTLIER -65.34 130.48 43.49 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.941 -0.304 . . . . 15.0 110.597 179.346 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.413 ' HG2' ' CE2' ' A' ' 36' ' ' TYR . 2.2 mtt180 -80.63 90.04 5.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.436 -0.347 . . . . 15.0 110.672 179.934 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.833 HG22 HG22 ' A' ' 35' ' ' ILE . 1.4 m -79.37 116.82 23.98 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 CA-C-O 121.017 0.437 . . . . 15.0 110.613 -179.875 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 29.1 mt -107.04 -15.09 14.77 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.785 -0.643 . . . . 15.0 112.559 -178.946 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.888 ' HB3' ' HB2' ' A' ' 88' ' ' LEU . . . -149.11 148.49 29.74 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 112.595 0.591 . . . . 15.0 112.595 -178.8 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.762 HG21 ' OG1' ' A' ' 77' ' ' THR . 20.8 t -139.18 100.5 1.42 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.251 0 CA-C-N 115.115 -0.948 . . . . 15.0 109.115 178.795 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.819 ' ND2' HG22 ' A' ' 81' ' ' THR . 1.7 m-80 65.03 16.08 10.36 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.76 -0.459 . . . . 15.0 109.76 -178.096 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 107.21 5.24 35.05 Favored Glycine 0 C--N 1.336 0.566 0 CA-C-N 115.925 -0.58 . . . . 15.0 113.558 179.666 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.66 ' O ' HG13 ' A' ' 64' ' ' VAL . 5.7 p -93.84 106.34 17.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 117.275 0.538 . . . . 15.0 110.988 179.417 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -56.59 136.33 54.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.201 -0.454 . . . . 15.0 110.914 -179.808 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.516 HD11 ' HB2' ' A' ' 74' ' ' ALA . 0.6 OUTLIER -95.55 -20.16 19.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.06 -0.518 . . . . 15.0 111.065 -179.964 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -46.53 99.96 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.876 0.369 . . . . 15.0 111.082 179.984 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 104.88 66.4 0.69 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.767 -0.73 . . . . 15.0 112.207 -179.799 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.564 ' HB1' ' HB3' ' A' ' 73' ' ' GLN . . . -173.09 162.02 4.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.841 0.353 . . . . 15.0 111.117 -179.771 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.465 ' HB ' HG13 ' A' ' 26' ' ' VAL . 15.6 p -93.22 -173.75 3.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.002 0.429 . . . . 15.0 111.019 -179.873 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . 0.684 ' CD2' HG23 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -62.59 -58.79 6.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.907 -0.588 . . . . 15.0 110.329 179.841 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.422 ' HA ' ' HB ' ' A' ' 75' ' ' VAL . 28.4 ttmt -52.56 -33.9 47.82 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.017 -0.538 . . . . 15.0 110.534 179.117 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.564 ' HB3' ' HB1' ' A' ' 69' ' ' ALA . 1.1 tt0 -59.45 -50.04 75.45 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.5 -0.555 . . . . 15.0 109.5 179.32 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.516 ' HB2' HD11 ' A' ' 66' ' ' LEU . . . -66.86 -44.48 80.88 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 109.531 -0.544 . . . . 15.0 109.531 178.313 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 1.016 HG23 HG21 ' A' ' 22' ' ' VAL . 0.5 OUTLIER -43.57 -39.4 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.363 0 N-CA-C 108.732 -0.84 . . . . 15.0 108.732 178.099 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.518 ' O ' ' HB2' ' A' ' 80' ' ' ASN . 1.5 mm-40 -67.06 -46.32 74.68 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.573 -1.194 . . . . 15.0 110.381 178.577 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.762 ' OG1' HG21 ' A' ' 61' ' ' VAL . 31.4 p -64.09 -53.24 52.77 Favored 'General case' 0 N--CA 1.462 0.161 0 C-N-CA 120.951 -0.3 . . . . 15.0 111.575 -179.969 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.6 HD22 HD11 ' A' ' 87' ' ' LEU . 6.0 mt -53.49 -48.15 69.19 Favored 'General case' 0 CA--C 1.52 -0.18 0 CA-C-O 121.261 0.553 . . . . 15.0 109.866 179.929 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.411 ' HB2' ' O ' ' A' ' 75' ' ' VAL . 18.1 ttp180 -68.64 -60.77 2.17 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.318 -0.855 . . . . 15.0 110.833 179.505 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.518 ' HB2' ' O ' ' A' ' 76' ' ' GLU . 15.1 m-80 -66.11 58.23 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 112.476 0.547 . . . . 15.0 112.476 -179.677 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.819 HG22 ' ND2' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -95.67 -69.28 0.76 Allowed 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.809 -0.441 . . . . 15.0 109.809 178.804 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 118.37 -104.42 1.12 Allowed Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.817 -0.706 . . . . 15.0 113.386 178.891 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.452 ' O ' ' HB3' ' A' ' 13' ' ' LYS . 0.4 OUTLIER -64.93 -80.95 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 112.525 0.565 . . . . 15.0 112.525 -178.724 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.426 HG12 ' N ' ' A' ' 85' ' ' VAL . 55.1 t -110.07 158.11 10.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.113 0.482 . . . . 15.0 111.298 -178.89 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.671 HG12 ' O ' ' A' ' 85' ' ' VAL . 8.0 t -97.99 81.15 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.986 -0.552 . . . . 15.0 110.426 179.867 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.473 ' NE2' HD11 ' A' ' 88' ' ' LEU . 78.9 t60 -100.42 84.66 2.82 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.754 -0.657 . . . . 15.0 110.362 179.79 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.792 ' HB3' HD21 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -103.52 119.44 38.9 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.949 -0.568 . . . . 15.0 111.986 -179.008 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.888 ' HB2' ' HB3' ' A' ' 60' ' ' ALA . 4.3 mp -92.87 103.23 15.58 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.52 -0.548 . . . . 15.0 109.52 178.673 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.792 HD21 ' HB3' ' A' ' 87' ' ' LEU . 0.2 OUTLIER -105.48 -163.32 0.94 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.273 0.559 . . . . 15.0 111.635 -178.69 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.507 ' HB2' HG13 ' A' ' 6' ' ' ILE . 8.3 tt0 -145.27 134.58 22.96 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.385 -0.825 . . . . 15.0 110.354 179.476 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 4.0 tptt -48.04 104.04 0.05 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.106 -0.497 . . . . 15.0 111.009 -179.92 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.341 0 C-N-CA 120.919 -0.658 . . . . 15.0 112.68 -179.647 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.548 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 1.4 mp . . . . . 0 N--CA 1.449 -0.48 0 CA-C-O 120.811 0.339 . . . . 15.0 111.375 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.826 ' CE1' HD12 ' A' ' 89' ' ' LEU . 3.6 p90 -140.62 165.67 26.84 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.123 -0.49 . . . . 15.0 110.112 178.514 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.72 ' HB3' HD12 ' A' ' 88' ' ' LEU . 4.8 pt-20 -130.13 144.38 51.32 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.427 0.632 . . . . 15.0 111.842 -178.93 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.516 ' CG2' ' HB3' ' A' ' 51' ' ' ARG . 0.2 OUTLIER -101.42 115.25 42.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.034 -0.984 . . . . 15.0 109.354 178.75 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -105.92 72.72 0.96 Allowed 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 112.4 0.518 . . . . 15.0 112.4 -178.523 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.673 HD13 ' HG3' ' A' ' 51' ' ' ARG . 5.2 tp -88.06 162.56 16.72 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.465 -0.569 . . . . 15.0 109.465 178.467 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -96.52 93.31 6.72 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.947 0.403 . . . . 15.0 111.343 -179.868 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.627 ' CB ' HG23 ' A' ' 85' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.43 0 CA-C-N 115.957 -0.565 . . . . 15.0 110.714 179.644 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.641 ' N ' HD22 ' A' ' 18' ' ' LEU . 2.1 mm? . . . . . 0 N--CA 1.45 -0.448 0 CA-C-O 120.961 0.41 . . . . 15.0 110.714 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.775 ' HA3' ' HA3' ' A' ' 44' ' ' GLY . . . -160.88 45.61 0.4 Allowed Glycine 0 N--CA 1.449 -0.499 0 N-CA-C 111.481 -0.648 . . . . 15.0 111.481 -179.771 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.663 HG12 ' O ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -112.53 139.19 38.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 120.843 0.354 . . . . 15.0 111.4 -179.326 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.4 ' H ' HD13 ' A' ' 41' ' ' ILE . 8.1 t -91.78 102.64 15.25 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 107.999 -1.111 . . . . 15.0 107.999 177.723 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.961 HG21 HG23 ' A' ' 75' ' ' VAL . 35.5 m -93.8 155.27 3.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 113.033 0.753 . . . . 15.0 113.033 -176.995 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.22 -176.39 5.35 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.174 -0.921 . . . . 15.0 110.92 -179.69 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.474 ' O ' ' HB3' ' A' ' 71' ' ' HIS . . . 68.73 -119.46 9.99 Favored Glycine 0 C--N 1.333 0.389 0 C-N-CA 120.951 -0.642 . . . . 15.0 112.611 179.834 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.572 ' HA2' ' HA ' ' A' ' 35' ' ' ILE . . . 68.6 -66.53 0.42 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.823 -0.703 . . . . 15.0 113.612 179.468 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.448 ' O ' HG22 ' A' ' 30' ' ' VAL . 1.3 m -29.38 141.82 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 N-CA-C 112.087 0.403 . . . . 15.0 112.087 -179.262 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -75.45 61.59 1.28 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.122 -0.49 . . . . 15.0 111.074 -179.602 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.6 m -151.73 -51.86 0.12 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.26 -0.427 . . . . 15.0 111.11 179.942 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -85.36 -44.39 12.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.446 . . . . 15.0 111.204 -179.793 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.539 HG11 ' O ' ' A' ' 34' ' ' GLY . 17.5 m -70.33 -173.77 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.333 -0.394 . . . . 15.0 111.258 -179.875 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -57.98 -51.73 68.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 15.0 111.073 -179.892 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 19.6 p-80 -153.31 -46.88 0.09 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.343 -0.389 . . . . 15.0 111.058 -179.865 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -167.44 19.24 0.09 OUTLIER Glycine 0 CA--C 1.519 0.291 0 C-N-CA 120.739 -0.743 . . . . 15.0 112.881 -179.767 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.539 ' O ' HG11 ' A' ' 30' ' ' VAL . . . -90.12 152.3 22.13 Favored Glycine 0 N--CA 1.449 -0.468 0 N-CA-C 110.249 -1.14 . . . . 15.0 110.249 178.493 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.919 ' CG2' HG22 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -97.58 147.38 6.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 117.893 0.847 . . . . 15.0 111.658 -179.263 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.509 ' N ' HD13 ' A' ' 35' ' ' ILE . 2.9 m-85 -130.96 113.59 14.19 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.563 -0.744 . . . . 15.0 109.755 -179.313 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.748 HG22 ' N ' ' A' ' 55' ' ' GLY . 0.8 OUTLIER -55.16 161.16 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-O 121.308 0.575 . . . . 15.0 111.238 -179.216 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.531 ' O ' ' HG2' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -91.6 -46.21 8.07 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.456 -0.942 . . . . 15.0 108.456 178.388 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.663 ' O ' HG12 ' A' ' 20' ' ' ILE . . . -172.27 173.71 4.14 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 115.302 -0.863 . . . . 15.0 110.193 178.772 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.61 ' HA ' HG12 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -96.81 108.75 21.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 109.472 -0.566 . . . . 15.0 109.472 179.268 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.75 ' HB ' ' O ' ' A' ' 19' ' ' GLY . 0.7 OUTLIER -78.28 116.33 58.16 Favored Pre-proline 0 C--N 1.328 -0.369 0 N-CA-C 113.482 0.919 . . . . 15.0 113.482 -177.245 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.618 ' HA ' ' CG ' ' A' ' 47' ' ' GLU . 36.0 Cg_exo -61.78 60.02 0.12 Allowed 'Trans proline' 0 C--N 1.358 1.045 0 C-N-CA 123.707 2.938 . . . . 15.0 113.271 179.821 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.533 ' N ' ' HG2' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -147.44 -46.97 0.17 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.649 0.261 . . . . 15.0 111.484 179.769 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.775 ' HA3' ' HA3' ' A' ' 19' ' ' GLY . . . -87.87 169.06 38.18 Favored Glycine 0 C--N 1.331 0.264 0 C-N-CA 120.386 -0.911 . . . . 15.0 114.007 -179.124 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -58.1 -14.88 7.64 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.023 -0.588 . . . . 15.0 112.499 -179.765 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.499 ' HB1' HG22 ' A' ' 52' ' ' ILE . . . -72.22 -56.26 5.85 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.587 0.232 . . . . 15.0 110.996 -179.656 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.618 ' CG ' ' HA ' ' A' ' 42' ' ' PRO . 2.9 pp20? -57.41 -42.91 83.19 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.222 -0.445 . . . . 15.0 110.309 179.256 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -53.71 -71.12 0.08 Allowed 'General case' 0 CA--C 1.519 -0.221 0 CA-C-N 115.801 -0.636 . . . . 15.0 110.488 -179.457 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.584 ' HB2' HD11 ' A' ' 11' ' ' LEU . 0.2 OUTLIER -58.34 -40.07 81.18 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.286 -0.635 . . . . 15.0 109.286 178.826 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.83 37.79 18.27 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 115.359 -0.837 . . . . 15.0 111.756 179.415 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.673 ' HG3' HD13 ' A' ' 11' ' ' LEU . 2.8 mmp_? -79.85 -48.09 14.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.861 0.362 . . . . 15.0 110.775 -179.447 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.556 ' CG1' HD12 ' A' ' 20' ' ' ILE . 10.5 tp -81.04 155.7 4.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.104 -0.498 . . . . 15.0 110.391 179.62 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . 0.525 ' O ' ' HB2' ' A' ' 56' ' ' ASP . 53.1 m80 -142.33 161.49 37.91 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-O 121.694 0.759 . . . . 15.0 112.345 -179.032 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.531 ' HG2' ' O ' ' A' ' 38' ' ' LYS . 0.8 OUTLIER -44.27 133.33 5.47 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.445 -1.252 . . . . 15.0 112.561 -178.707 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.748 ' N ' HG22 ' A' ' 37' ' ' VAL . . . 49.59 36.62 25.05 Favored Glycine 0 C--N 1.334 0.441 0 C-N-CA 121.009 -0.615 . . . . 15.0 113.101 179.45 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.525 ' HB2' ' O ' ' A' ' 53' ' ' HIS . 1.4 t0 -65.46 125.11 24.12 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.816 -0.353 . . . . 15.0 110.261 179.539 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.428 ' NE ' ' HG2' ' A' ' 90' ' ' GLU . 1.3 mtt180 -83.15 81.69 8.58 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.321 -0.4 . . . . 15.0 110.05 179.614 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.924 HG12 HD22 ' A' ' 89' ' ' LEU . 1.1 m -79.23 119.77 29.16 Favored 'Isoleucine or valine' 0 C--O 1.24 0.556 0 CA-C-O 121.276 0.56 . . . . 15.0 110.747 -179.502 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -107.64 -13.63 15.0 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 115.236 -0.893 . . . . 15.0 112.516 -179.091 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.485 ' O ' HD23 ' A' ' 87' ' ' LEU . . . -149.63 151.25 33.45 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 112.82 0.674 . . . . 15.0 112.82 -178.543 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.856 HG11 ' O ' ' A' ' 77' ' ' THR . 20.8 t -140.7 100.76 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.171 -0.922 . . . . 15.0 109.198 178.71 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.627 ' OD1' HG22 ' A' ' 81' ' ' THR . 12.1 m120 64.87 15.29 9.8 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.779 -0.452 . . . . 15.0 109.779 -177.968 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 107.19 6.64 33.77 Favored Glycine 0 C--N 1.336 0.561 0 CA-C-N 115.926 -0.579 . . . . 15.0 113.476 179.602 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.674 ' O ' HG13 ' A' ' 64' ' ' VAL . 5.7 p -93.76 104.08 15.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 117.273 0.537 . . . . 15.0 110.588 179.206 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -56.07 134.16 52.44 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.099 -0.5 . . . . 15.0 111.318 -179.336 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.513 HD21 ' HA ' ' A' ' 74' ' ' ALA . 0.1 OUTLIER -97.78 -21.23 17.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.881 -0.6 . . . . 15.0 110.81 179.887 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -44.35 99.27 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 116.339 -0.392 . . . . 15.0 111.219 179.988 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.49 64.74 0.57 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.798 -0.715 . . . . 15.0 112.328 -179.774 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.456 ' HB1' ' CB ' ' A' ' 73' ' ' GLN . . . -173.03 169.03 4.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.89 0.376 . . . . 15.0 111.185 -179.774 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.443 ' HA ' ' N ' ' A' ' 26' ' ' VAL . 5.7 p -93.28 -171.7 2.73 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.184 -0.462 . . . . 15.0 111.27 -179.855 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . 0.776 ' CD2' HG23 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -65.69 -59.61 3.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.737 -0.665 . . . . 15.0 110.866 -179.859 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.439 ' N ' ' CG ' ' A' ' 71' ' ' HIS . 16.7 ttmt -52.4 -32.27 38.06 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.804 -0.634 . . . . 15.0 110.647 179.952 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.456 ' CB ' ' HB1' ' A' ' 69' ' ' ALA . 8.4 mt-30 -59.23 -49.85 76.26 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.778 -0.453 . . . . 15.0 109.778 179.432 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.655 ' CB ' HG21 ' A' ' 35' ' ' ILE . . . -67.39 -46.42 73.33 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 109.615 -0.513 . . . . 15.0 109.615 178.302 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.961 HG23 HG21 ' A' ' 22' ' ' VAL . 0.5 OUTLIER -40.97 -40.3 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.283 0 N-CA-C 108.97 -0.752 . . . . 15.0 108.97 178.324 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.459 ' O ' ' HB2' ' A' ' 80' ' ' ASN . 46.9 mt-10 -67.36 -47.48 70.29 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 114.666 -1.152 . . . . 15.0 110.541 178.659 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.856 ' O ' HG11 ' A' ' 61' ' ' VAL . 67.4 p -64.2 -52.45 58.82 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 121.045 -0.262 . . . . 15.0 111.511 179.974 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.789 HD21 HG21 ' A' ' 58' ' ' VAL . 5.0 mt -53.4 -47.68 69.35 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-O 121.193 0.521 . . . . 15.0 109.761 179.959 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.414 ' HB2' ' O ' ' A' ' 75' ' ' VAL . 5.2 ttm180 -68.62 -62.37 1.42 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.375 -0.829 . . . . 15.0 110.42 179.112 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.459 ' HB2' ' O ' ' A' ' 76' ' ' GLU . 15.8 m-80 -66.01 62.35 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.02 -0.537 . . . . 15.0 111.78 179.766 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.627 HG22 ' OD1' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -88.11 -70.4 0.64 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.865 0.364 . . . . 15.0 110.213 179.442 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 121.99 -107.85 1.23 Allowed Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 121.047 -0.597 . . . . 15.0 112.686 179.54 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.497 ' O ' ' HB3' ' A' ' 13' ' ' LYS . 0.4 OUTLIER -65.0 -82.99 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.773 0.32 . . . . 15.0 111.664 -179.567 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.469 HG12 ' N ' ' A' ' 85' ' ' VAL . 63.1 t -110.2 160.61 9.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.327 -0.397 . . . . 15.0 110.436 179.999 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.627 HG23 ' CB ' ' A' ' 13' ' ' LYS . 19.9 t -98.01 80.89 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.127 0.489 . . . . 15.0 110.503 179.83 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 7.1 t60 -100.45 82.05 2.43 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 115.762 -0.654 . . . . 15.0 110.241 179.832 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.539 HD11 ' HA ' ' A' ' 78' ' ' LEU . 0.1 OUTLIER -102.0 126.26 48.89 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.777 -0.647 . . . . 15.0 111.909 -178.961 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.72 HD12 ' HB3' ' A' ' 8' ' ' GLU . 0.2 OUTLIER -102.3 103.44 13.91 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.648 -0.501 . . . . 15.0 109.648 178.813 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.924 HD22 HG12 ' A' ' 58' ' ' VAL . 0.1 OUTLIER -105.76 -163.82 0.97 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.366 0.603 . . . . 15.0 111.782 -178.955 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.548 ' HA ' ' HA ' ' A' ' 6' ' ' ILE . 3.6 tt0 -138.11 134.2 34.35 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.052 -0.976 . . . . 15.0 109.676 178.996 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.413 ' HD2' ' HA ' ' A' ' 91' ' ' LYS . 0.0 OUTLIER -46.67 97.99 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.316 -0.402 . . . . 15.0 111.414 -179.356 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.287 0 C-N-CA 120.944 -0.646 . . . . 15.0 112.579 179.988 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.422 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 1.4 mp . . . . . 0 N--CA 1.45 -0.434 0 CA-C-O 120.871 0.367 . . . . 15.0 111.27 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.644 ' CZ ' HD12 ' A' ' 89' ' ' LEU . 4.0 p90 -140.91 166.39 24.9 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.098 -0.501 . . . . 15.0 110.465 178.797 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.713 ' CB ' HD12 ' A' ' 88' ' ' LEU . 9.4 pt-20 -130.07 144.95 51.62 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.235 0.54 . . . . 15.0 111.613 -179.287 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.681 HG23 ' HG2' ' A' ' 51' ' ' ARG . 0.4 OUTLIER -101.57 116.18 44.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.395 -0.82 . . . . 15.0 109.93 179.019 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -106.56 69.14 0.77 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.236 -0.438 . . . . 15.0 111.807 -179.448 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.645 HD11 ' CB ' ' A' ' 49' ' ' ASP . 6.1 tp -88.07 160.75 17.69 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.298 -0.41 . . . . 15.0 109.961 179.058 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -97.1 95.71 7.96 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.292 0.479 . . . . 15.0 112.292 -179.177 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.881 ' HB2' HG23 ' A' ' 85' ' ' VAL . 3.5 tppt? . . . . . 0 CA--C 1.537 0.453 0 N-CA-C 112.131 0.419 . . . . 15.0 112.131 178.894 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.634 HD22 ' HZ1' ' A' ' 13' ' ' LYS . 0.3 OUTLIER . . . . . 0 N--CA 1.451 -0.414 0 CA-C-O 120.821 0.344 . . . . 15.0 110.841 . . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.714 ' O ' ' HB ' ' A' ' 41' ' ' ILE . . . -161.05 36.27 0.41 Allowed Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.968 -0.634 . . . . 15.0 112.279 -179.703 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.759 HD12 ' HB ' ' A' ' 52' ' ' ILE . 0.0 OUTLIER -112.82 136.95 47.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 120.993 0.425 . . . . 15.0 111.719 -179.676 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.429 ' O ' ' HB3' ' A' ' 38' ' ' LYS . 27.5 t -95.96 100.41 12.09 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 107.845 -1.168 . . . . 15.0 107.845 177.294 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.652 HG12 ' CG2' ' A' ' 20' ' ' ILE . 1.0 OUTLIER -93.78 155.74 3.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 112.334 0.494 . . . . 15.0 112.334 -177.226 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.465 ' HA ' ' CE1' ' A' ' 71' ' ' HIS . 6.0 t -149.82 176.02 11.1 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.47 -0.787 . . . . 15.0 110.472 179.429 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.721 ' O ' HG22 ' A' ' 26' ' ' VAL . . . 86.95 -112.03 3.74 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.558 -0.829 . . . . 15.0 112.505 179.849 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.591 ' HA3' ' N ' ' A' ' 71' ' ' HIS . . . 62.58 -66.2 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 121.067 -0.587 . . . . 15.0 113.653 179.199 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.721 HG22 ' O ' ' A' ' 24' ' ' GLY . 0.0 OUTLIER -28.94 143.12 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 N-CA-C 112.528 0.566 . . . . 15.0 112.528 -179.038 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.402 ' CB ' ' O ' ' A' ' 32' ' ' HIS . 13.4 p30 -75.67 61.87 1.41 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.738 -0.664 . . . . 15.0 110.968 -179.844 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -151.65 -66.97 0.18 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.376 -0.375 . . . . 15.0 111.045 179.994 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 72.4 m -65.4 -49.76 68.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.183 -0.462 . . . . 15.0 110.877 -179.939 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.521 HG21 ' O ' ' A' ' 34' ' ' GLY . 34.5 m -75.95 -174.1 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.185 -0.462 . . . . 15.0 111.119 -179.966 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.81 -78.89 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.337 -0.392 . . . . 15.0 111.258 -179.755 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . 0.402 ' O ' ' CB ' ' A' ' 27' ' ' ASN . 34.4 p-80 -126.92 -42.85 1.72 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.431 -0.35 . . . . 15.0 111.223 -179.818 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -170.06 26.62 0.11 Allowed Glycine 0 N--CA 1.453 -0.2 0 C-N-CA 120.745 -0.74 . . . . 15.0 112.554 -179.772 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.521 ' O ' HG21 ' A' ' 30' ' ' VAL . . . -92.61 154.75 22.3 Favored Glycine 0 N--CA 1.448 -0.521 0 N-CA-C 110.33 -1.108 . . . . 15.0 110.33 178.723 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 1.0 HG22 HG22 ' A' ' 58' ' ' VAL . 0.2 OUTLIER -98.86 152.82 4.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 119.768 -0.773 . . . . 15.0 112.318 -179.154 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.41 ' CZ ' ' HG3' ' A' ' 57' ' ' ARG . 14.7 m-85 -137.19 111.21 8.31 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.65 -1.159 . . . . 15.0 109.087 179.406 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.769 HG22 ' N ' ' A' ' 55' ' ' GLY . 0.8 OUTLIER -55.37 168.69 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.42 0.628 . . . . 15.0 111.572 -178.315 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.523 ' O ' ' HG2' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -99.75 -45.12 5.85 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.374 -0.973 . . . . 15.0 108.374 178.189 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.58 ' O ' HG12 ' A' ' 20' ' ' ILE . . . -172.66 171.45 4.48 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 115.437 -0.801 . . . . 15.0 110.363 178.466 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.466 ' HA ' HG12 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -96.76 110.68 25.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 108.803 -0.814 . . . . 15.0 108.803 178.877 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.714 ' HB ' ' O ' ' A' ' 19' ' ' GLY . 0.4 OUTLIER -77.55 115.66 51.51 Favored Pre-proline 0 C--N 1.329 -0.288 0 N-CA-C 113.597 0.962 . . . . 15.0 113.597 -176.693 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.616 ' HA ' ' HG2' ' A' ' 47' ' ' GLU . 38.9 Cg_exo -61.55 61.14 0.11 Allowed 'Trans proline' 0 C--N 1.358 1.073 0 C-N-CA 123.726 2.951 . . . . 15.0 113.003 179.578 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.517 ' H ' ' HG2' ' A' ' 47' ' ' GLU . 3.5 mt-30 -150.57 -47.93 0.12 Allowed 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 111.738 0.273 . . . . 15.0 111.738 179.957 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.609 ' HA3' ' HA3' ' A' ' 19' ' ' GLY . . . -87.81 166.66 35.91 Favored Glycine 0 CA--C 1.519 0.303 0 C-N-CA 120.356 -0.926 . . . . 15.0 113.79 -179.082 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -55.48 -14.87 2.22 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.66 0.615 . . . . 15.0 112.66 -179.817 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.93 -57.95 3.87 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.702 0.287 . . . . 15.0 110.945 -179.397 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.616 ' HG2' ' HA ' ' A' ' 42' ' ' PRO . 2.8 pp20? -56.94 -42.2 79.64 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.989 0.423 . . . . 15.0 110.391 179.415 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -53.82 -72.25 0.06 Allowed 'General case' 0 CA--C 1.519 -0.214 0 CA-C-N 115.883 -0.598 . . . . 15.0 110.466 -179.636 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.645 ' CB ' HD11 ' A' ' 11' ' ' LEU . 0.5 OUTLIER -58.68 -40.4 83.46 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.456 -0.572 . . . . 15.0 109.456 179.01 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.93 50.03 5.38 Favored Glycine 0 N--CA 1.447 -0.584 0 CA-C-N 115.388 -0.824 . . . . 15.0 111.766 179.604 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.681 ' HG2' HG23 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -79.49 -51.59 9.13 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.764 0.316 . . . . 15.0 110.775 -179.34 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.759 ' HB ' HD12 ' A' ' 20' ' ' ILE . 3.1 mm -91.45 162.72 2.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.993 0.425 . . . . 15.0 111.083 179.694 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . 0.596 ' N ' HG22 ' A' ' 52' ' ' ILE . 52.0 m80 -141.5 157.6 44.93 Favored 'General case' 0 CA--C 1.513 -0.466 0 CA-C-N 115.797 -0.638 . . . . 15.0 110.616 179.718 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.523 ' HG2' ' O ' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -35.61 132.58 0.44 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.848 -1.069 . . . . 15.0 112.647 -178.501 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.769 ' N ' HG22 ' A' ' 37' ' ' VAL . . . 49.71 38.02 28.58 Favored Glycine 0 C--N 1.332 0.338 0 CA-C-N 115.923 -0.58 . . . . 15.0 113.64 179.524 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -65.88 128.59 36.62 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 117.499 0.65 . . . . 15.0 110.523 179.388 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.439 ' HA ' ' O ' ' A' ' 35' ' ' ILE . 56.3 ttt180 -83.25 88.02 6.94 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.429 -0.35 . . . . 15.0 110.537 179.808 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 1.0 HG22 HG22 ' A' ' 35' ' ' ILE . 1.8 m -82.94 112.53 20.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.17 0.509 . . . . 15.0 111.353 -179.44 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.4 ' HA ' ' HB2' ' A' ' 66' ' ' LEU . 35.6 mt -107.27 -9.47 16.06 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 115.685 -0.689 . . . . 15.0 112.654 -179.306 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.55 ' HB3' ' HB2' ' A' ' 88' ' ' LEU . . . -151.25 144.81 24.94 Favored 'General case' 0 N--CA 1.463 0.194 0 N-CA-C 112.565 0.58 . . . . 15.0 112.565 -178.857 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.881 HG11 ' O ' ' A' ' 77' ' ' THR . 32.7 t -139.07 98.96 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.258 0 CA-C-N 115.497 -0.774 . . . . 15.0 109.452 178.878 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.667 ' ND2' HG22 ' A' ' 81' ' ' THR . 1.7 m-80 65.06 17.76 11.2 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.066 -0.516 . . . . 15.0 109.874 -178.415 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 107.24 4.57 35.33 Favored Glycine 0 C--N 1.336 0.536 0 CA-C-N 115.836 -0.62 . . . . 15.0 113.676 179.488 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.664 ' O ' HG13 ' A' ' 64' ' ' VAL . 4.9 p -93.87 105.28 16.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 117.323 0.562 . . . . 15.0 110.818 179.319 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -56.87 134.59 55.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.142 -0.481 . . . . 15.0 110.983 -179.692 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.59 HD13 ' HB3' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -87.64 -19.35 27.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.121 -0.49 . . . . 15.0 111.034 -179.998 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -46.92 95.56 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 120.892 0.377 . . . . 15.0 110.888 179.943 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.77 66.75 0.59 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.785 -0.721 . . . . 15.0 112.217 -179.588 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.65 ' HB1' ' CB ' ' A' ' 73' ' ' GLN . . . -172.95 154.36 2.82 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.859 0.362 . . . . 15.0 110.976 -179.867 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.427 ' HA ' ' C ' ' A' ' 25' ' ' GLY . 13.7 p -93.04 -170.91 2.54 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.114 -0.494 . . . . 15.0 111.396 -179.626 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . 0.591 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 1.5 t-160 -58.12 -62.17 2.02 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.618 -0.719 . . . . 15.0 110.063 179.75 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 3.4 ttpt -53.02 -36.23 60.3 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.236 -0.893 . . . . 15.0 111.051 179.483 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.65 ' CB ' ' HB1' ' A' ' 69' ' ' ALA . 7.0 mt-30 -59.41 -57.31 13.53 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.304 -0.407 . . . . 15.0 110.163 179.88 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.894 ' HB3' HD12 ' A' ' 35' ' ' ILE . . . -63.27 -43.63 97.4 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.715 -0.476 . . . . 15.0 109.715 178.835 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.588 HG23 ' CG2' ' A' ' 22' ' ' VAL . 0.5 OUTLIER -43.66 -42.74 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.223 0 N-CA-C 108.807 -0.812 . . . . 15.0 108.807 178.176 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.41 ' N ' HG12 ' A' ' 75' ' ' VAL . 21.7 mt-10 -67.45 -42.91 82.3 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 114.856 -1.066 . . . . 15.0 110.535 178.556 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.881 ' O ' HG11 ' A' ' 61' ' ' VAL . 69.9 p -63.9 -56.18 17.22 Favored 'General case' 0 N--CA 1.462 0.135 0 C-N-CA 120.997 -0.281 . . . . 15.0 111.5 -179.924 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.811 HD21 HG21 ' A' ' 58' ' ' VAL . 5.6 mt -53.37 -47.14 69.71 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-O 121.197 0.523 . . . . 15.0 110.007 179.953 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.409 ' O ' ' N ' ' A' ' 81' ' ' THR . 7.1 tpp85 -68.53 -59.12 3.37 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.395 -0.82 . . . . 15.0 110.691 179.489 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.408 ' CB ' ' O ' ' A' ' 76' ' ' GLU . 2.9 m-20 -65.92 63.0 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.035 -0.53 . . . . 15.0 111.848 179.909 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.667 HG22 ' ND2' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -91.79 -73.55 0.54 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.728 0.299 . . . . 15.0 110.33 179.322 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.434 ' O ' ' HG3' ' A' ' 13' ' ' LYS . . . 120.98 -103.43 0.9 Allowed Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.773 -0.727 . . . . 15.0 112.672 179.431 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -64.85 -87.03 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.723 0.297 . . . . 15.0 111.05 -179.841 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.507 HG12 ' N ' ' A' ' 85' ' ' VAL . 93.7 t -110.07 161.9 8.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.881 0.372 . . . . 15.0 110.625 179.956 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.881 HG23 ' HB2' ' A' ' 13' ' ' LYS . 3.3 t -97.43 84.54 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.176 0.512 . . . . 15.0 110.368 179.825 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 10.9 t60 -101.28 82.63 2.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.59 -0.732 . . . . 15.0 110.001 179.493 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.695 ' HB3' HD21 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -103.92 126.36 50.98 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.818 -0.628 . . . . 15.0 112.01 -178.907 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.713 HD12 ' CB ' ' A' ' 8' ' ' GLU . 4.9 mp -102.38 100.48 10.63 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.4 -0.593 . . . . 15.0 109.4 178.487 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.695 HD21 ' HB3' ' A' ' 87' ' ' LEU . 0.1 OUTLIER -105.57 -162.24 0.86 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.611 0.719 . . . . 15.0 112.027 -178.566 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.422 ' HA ' ' HA ' ' A' ' 6' ' ' ILE . 1.3 tt0 -139.89 133.88 30.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 114.73 -1.123 . . . . 15.0 109.485 178.856 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.15 93.81 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.89 0.376 . . . . 15.0 111.069 -179.562 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.322 0 C-N-CA 120.959 -0.639 . . . . 15.0 112.738 -179.769 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.471 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 1.1 mp . . . . . 0 N--CA 1.451 -0.405 0 CA-C-O 120.859 0.362 . . . . 15.0 111.125 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.658 ' CZ ' HD12 ' A' ' 89' ' ' LEU . 2.3 p90 -140.41 151.3 44.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.171 -0.468 . . . . 15.0 110.611 179.119 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.656 ' CB ' HD12 ' A' ' 88' ' ' LEU . 13.7 pt-20 -116.9 143.08 46.12 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.206 0.527 . . . . 15.0 111.402 -179.467 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.678 ' CG1' HD11 ' A' ' 89' ' ' LEU . 0.4 OUTLIER -101.46 116.92 45.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.401 -0.818 . . . . 15.0 109.766 179.056 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.404 ' OE1' ' CE1' ' A' ' 86' ' ' HIS . 3.8 tp10 -106.0 72.25 0.93 Allowed 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.198 0.444 . . . . 15.0 112.198 -178.932 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.738 HD13 ' HB2' ' A' ' 51' ' ' ARG . 6.7 tp -88.23 165.41 15.07 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.035 -0.53 . . . . 15.0 109.592 178.699 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -96.03 96.33 8.8 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.004 0.431 . . . . 15.0 110.991 179.952 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.737 ' CB ' HG23 ' A' ' 85' ' ' VAL . 0.1 OUTLIER . . . . . 0 C--N 1.327 -0.395 0 CA-C-N 115.785 -0.643 . . . . 15.0 111.261 -179.863 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.675 ' N ' HD22 ' A' ' 18' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.455 -0.196 0 CA-C-O 121.051 0.453 . . . . 15.0 110.721 . . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.595 ' O ' ' HB ' ' A' ' 41' ' ' ILE . . . -169.73 34.87 0.18 Allowed Glycine 0 CA--C 1.506 -0.53 0 N-CA-C 111.102 -0.799 . . . . 15.0 111.102 -179.673 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.652 HD12 HG12 ' A' ' 52' ' ' ILE . 0.0 OUTLIER -114.23 142.11 28.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 112.652 0.612 . . . . 15.0 112.652 -179.188 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.704 ' CB ' HD11 ' A' ' 41' ' ' ILE . 2.3 t -96.86 104.1 16.08 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 107.903 -1.147 . . . . 15.0 107.903 176.315 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.984 HG21 HG23 ' A' ' 75' ' ' VAL . 27.5 m -93.63 147.36 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 N-CA-C 112.981 0.734 . . . . 15.0 112.981 -177.248 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.549 ' HA ' ' CE1' ' A' ' 71' ' ' HIS . 6.4 t -150.04 -177.46 5.93 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 115.553 -0.749 . . . . 15.0 111.327 179.205 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.641 ' O ' HG22 ' A' ' 26' ' ' VAL . . . 73.58 -115.95 5.23 Favored Glycine 0 C--N 1.336 0.565 0 C-N-CA 121.067 -0.587 . . . . 15.0 112.457 179.86 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.563 ' HA3' ' N ' ' A' ' 71' ' ' HIS . . . 64.18 -65.22 0.05 OUTLIER Glycine 0 C--N 1.33 0.233 0 C-N-CA 121.091 -0.576 . . . . 15.0 114.05 178.977 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.641 HG22 ' O ' ' A' ' 24' ' ' GLY . 0.0 OUTLIER -30.11 144.0 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 N-CA-C 112.145 0.424 . . . . 15.0 112.145 -179.121 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -75.51 58.21 1.01 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.137 -0.483 . . . . 15.0 110.974 -179.644 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 5.3 m -151.92 -60.7 0.16 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.243 -0.435 . . . . 15.0 110.792 179.965 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 9.0 t -70.31 -46.67 63.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.069 -0.514 . . . . 15.0 110.914 -179.927 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.498 HG22 ' O ' ' A' ' 26' ' ' VAL . 14.2 m -77.05 -170.03 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.237 -0.438 . . . . 15.0 111.093 -179.959 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 5.2 mmt180 -57.42 -71.47 0.1 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.273 -0.421 . . . . 15.0 111.009 -179.997 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . 0.442 ' CD2' ' N ' ' A' ' 33' ' ' GLY . 8.5 p-80 -134.93 -42.3 0.74 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.318 -0.401 . . . . 15.0 111.37 -179.817 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.442 ' N ' ' CD2' ' A' ' 32' ' ' HIS . . . -170.16 22.49 0.09 OUTLIER Glycine 0 CA--C 1.52 0.344 0 C-N-CA 120.504 -0.855 . . . . 15.0 113.086 -179.66 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.438 ' O ' HG21 ' A' ' 30' ' ' VAL . . . -92.58 154.25 22.06 Favored Glycine 0 N--CA 1.451 -0.33 0 N-CA-C 110.163 -1.175 . . . . 15.0 110.163 178.405 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.987 HG22 HG22 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -101.34 147.33 8.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 118.181 0.99 . . . . 15.0 111.795 -179.209 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.736 ' N ' HD13 ' A' ' 35' ' ' ILE . 13.5 m-85 -131.28 113.18 13.49 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-N 115.433 -0.803 . . . . 15.0 109.537 -179.61 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.797 HG22 ' N ' ' A' ' 55' ' ' GLY . 0.7 OUTLIER -54.87 148.68 2.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 115.471 -0.786 . . . . 15.0 111.363 -178.736 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.484 ' O ' ' HG2' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -81.08 -48.39 12.24 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.775 -0.824 . . . . 15.0 108.775 178.654 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.501 ' O ' HG12 ' A' ' 20' ' ' ILE . . . -172.5 169.04 5.27 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.567 -0.742 . . . . 15.0 110.766 178.572 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.647 HG12 HG13 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -97.49 122.08 48.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.793 0.33 . . . . 15.0 110.526 179.676 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.704 HD11 ' CB ' ' A' ' 21' ' ' SER . 1.5 mm -78.5 109.26 9.93 Favored Pre-proline 0 N--CA 1.464 0.229 0 N-CA-C 112.956 0.724 . . . . 15.0 112.956 -178.627 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.474 ' HA ' ' OE1' ' A' ' 47' ' ' GLU . 38.2 Cg_endo -65.72 65.46 0.4 Allowed 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 122.828 2.352 . . . . 15.0 112.246 179.49 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -162.55 -44.94 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.434 -0.803 . . . . 15.0 109.508 179.816 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.556 ' HA3' ' HA3' ' A' ' 19' ' ' GLY . . . -87.43 151.35 23.31 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.774 -0.727 . . . . 15.0 112.338 179.351 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -40.19 -19.6 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 113.465 0.913 . . . . 15.0 113.465 -179.312 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.445 ' N ' ' O ' ' A' ' 44' ' ' GLY . . . -71.58 -71.13 0.28 Allowed 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.809 -0.356 . . . . 15.0 111.076 -179.654 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.56 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 9.0 tm-20 -58.22 -36.58 73.35 Favored 'General case' 0 N--CA 1.462 0.153 0 C-N-CA 120.81 -0.356 . . . . 15.0 110.284 179.36 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 53.6 m -56.16 -67.69 0.27 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.173 -0.467 . . . . 15.0 110.395 179.464 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.558 ' CB ' HD11 ' A' ' 11' ' ' LEU . 2.6 m-20 -62.11 -37.64 85.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.129 -0.487 . . . . 15.0 109.932 179.179 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.32 38.19 15.63 Favored Glycine 0 N--CA 1.448 -0.521 0 CA-C-N 115.694 -0.684 . . . . 15.0 112.028 179.943 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.738 ' HB2' HD13 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -79.69 -53.58 6.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.124 0.487 . . . . 15.0 110.286 -179.846 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.652 HG12 HD12 ' A' ' 20' ' ' ILE . 11.0 tp -87.82 158.04 3.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.587 -0.733 . . . . 15.0 110.158 179.477 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 67.6 m80 -139.78 160.52 39.71 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-O 121.777 0.799 . . . . 15.0 112.898 -178.705 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.592 ' HA ' ' CG2' ' A' ' 37' ' ' VAL . 1.1 mtpt -43.97 134.7 4.49 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 114.007 -1.451 . . . . 15.0 112.702 -178.843 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.797 ' N ' HG22 ' A' ' 37' ' ' VAL . . . 49.75 31.95 16.87 Favored Glycine 0 C--N 1.333 0.408 0 CA-C-N 115.945 -0.571 . . . . 15.0 113.284 179.282 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -65.56 122.59 17.57 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.629 -0.428 . . . . 15.0 109.874 179.15 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.503 ' NE ' HD21 ' A' ' 59' ' ' LEU . 36.9 ttt85 -80.98 85.44 6.26 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.429 -0.35 . . . . 15.0 110.421 -179.859 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.987 HG22 HG22 ' A' ' 35' ' ' ILE . 1.3 m -79.67 121.76 33.58 Favored 'Isoleucine or valine' 0 C--O 1.24 0.601 0 CA-C-O 121.211 0.529 . . . . 15.0 111.559 -179.365 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.503 HD21 ' NE ' ' A' ' 57' ' ' ARG . 3.8 mm? -107.91 -15.63 14.5 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 115.09 -0.959 . . . . 15.0 111.984 -179.861 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.641 ' HB3' ' HB2' ' A' ' 88' ' ' LEU . . . -147.91 148.16 30.51 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.113 0.483 . . . . 15.0 112.263 -178.565 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.688 HG11 ' O ' ' A' ' 77' ' ' THR . 39.6 t -139.02 102.69 1.8 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.249 0 CA-C-N 115.577 -0.738 . . . . 15.0 109.451 178.825 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.797 ' ND2' HG22 ' A' ' 81' ' ' THR . 1.1 m-80 64.83 14.46 9.21 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.763 -0.458 . . . . 15.0 109.763 -178.195 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 107.01 6.49 34.3 Favored Glycine 0 C--N 1.336 0.573 0 CA-C-N 115.863 -0.608 . . . . 15.0 113.244 179.828 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.666 ' O ' HG13 ' A' ' 64' ' ' VAL . 6.3 p -93.67 105.22 16.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 121.098 0.475 . . . . 15.0 110.579 179.216 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -58.46 123.67 16.98 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.145 -0.479 . . . . 15.0 111.142 -179.442 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.847 HD13 HG23 ' A' ' 58' ' ' VAL . 0.2 OUTLIER -92.07 -16.96 25.69 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.918 -0.583 . . . . 15.0 111.096 179.877 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -43.43 95.26 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.874 0.369 . . . . 15.0 111.239 -179.994 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 107.83 71.42 0.74 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.799 -0.715 . . . . 15.0 112.301 -179.73 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.597 ' HB1' ' CG ' ' A' ' 73' ' ' GLN . . . -173.02 169.46 4.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.831 0.348 . . . . 15.0 111.107 -179.778 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 15.6 p -93.42 -175.21 3.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.927 0.394 . . . . 15.0 111.27 -179.749 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . 0.772 ' NE2' HG23 ' A' ' 22' ' ' VAL . 0.1 OUTLIER -65.78 -58.56 5.35 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.882 -0.599 . . . . 15.0 110.623 -179.902 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.442 ' O ' ' HG3' ' A' ' 76' ' ' GLU . 23.3 ttpp -52.21 -31.03 30.09 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.747 -0.464 . . . . 15.0 109.747 178.925 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.597 ' CG ' ' HB1' ' A' ' 69' ' ' ALA . 1.1 tt0 -59.5 -49.19 78.73 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.916 -0.584 . . . . 15.0 109.609 178.813 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.626 ' CB ' HG21 ' A' ' 35' ' ' ILE . . . -67.11 -45.79 76.15 Favored 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 109.568 -0.53 . . . . 15.0 109.568 178.512 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.984 HG23 HG21 ' A' ' 22' ' ' VAL . 0.5 OUTLIER -42.2 -42.12 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.27 0 N-CA-C 108.792 -0.818 . . . . 15.0 108.792 178.257 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.499 ' O ' ' HB2' ' A' ' 80' ' ' ASN . 8.9 mt-10 -67.3 -45.28 77.01 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 114.651 -1.159 . . . . 15.0 110.361 178.477 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.688 ' O ' HG11 ' A' ' 61' ' ' VAL . 72.9 p -64.1 -54.54 32.42 Favored 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 111.545 0.202 . . . . 15.0 111.545 -179.949 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.597 HD21 HG21 ' A' ' 58' ' ' VAL . 8.3 mt -53.47 -46.35 69.92 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 121.308 0.575 . . . . 15.0 109.881 -179.989 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.451 ' HB2' ' O ' ' A' ' 75' ' ' VAL . 0.2 OUTLIER -68.51 -58.89 3.63 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.204 -0.907 . . . . 15.0 110.805 179.677 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.499 ' HB2' ' O ' ' A' ' 76' ' ' GLU . 6.5 m-80 -66.23 56.98 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 112.393 0.516 . . . . 15.0 112.393 -179.86 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.797 HG22 ' ND2' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -95.69 -75.02 0.53 Allowed 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.94 -0.393 . . . . 15.0 109.94 178.853 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 122.06 -104.02 0.89 Allowed Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.641 -0.79 . . . . 15.0 113.537 178.804 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -63.08 -84.9 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.06 0.393 . . . . 15.0 112.06 -178.699 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.453 HG12 ' N ' ' A' ' 85' ' ' VAL . 55.4 t -109.46 160.18 8.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.891 0.377 . . . . 15.0 110.706 -179.408 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.737 HG23 ' CB ' ' A' ' 13' ' ' LYS . 9.3 t -97.8 81.42 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-O 121.118 0.485 . . . . 15.0 110.382 -179.926 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.404 ' CE1' ' OE1' ' A' ' 10' ' ' GLU . 0.5 OUTLIER -99.66 86.29 3.3 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.736 -0.665 . . . . 15.0 110.229 179.863 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.822 ' HB3' HD21 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -103.82 127.33 51.33 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.882 -0.599 . . . . 15.0 111.718 -179.018 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.656 HD12 ' CB ' ' A' ' 8' ' ' GLU . 4.4 mp -102.18 99.44 9.57 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.552 -0.536 . . . . 15.0 109.552 178.742 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.822 HD21 ' HB3' ' A' ' 87' ' ' LEU . 0.1 OUTLIER -105.88 -162.66 0.88 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.56 0.695 . . . . 15.0 112.406 -178.317 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.471 ' HA ' ' HA ' ' A' ' 6' ' ' ILE . 1.9 tt0 -138.37 142.27 39.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 114.617 -1.174 . . . . 15.0 109.288 178.669 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -53.79 100.75 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.002 0.429 . . . . 15.0 111.107 -179.522 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.323 0 C-N-CA 120.956 -0.64 . . . . 15.0 112.604 -179.768 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.411 HG13 ' HB2' ' A' ' 90' ' ' GLU . 1.2 mp . . . . . 0 N--CA 1.45 -0.456 0 CA-C-O 120.704 0.288 . . . . 15.0 110.651 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.612 ' CZ ' HD12 ' A' ' 89' ' ' LEU . 2.0 p90 -140.67 160.25 40.44 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.438 -0.346 . . . . 15.0 110.532 179.085 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.713 ' CB ' HD12 ' A' ' 88' ' ' LEU . 9.5 pt-20 -126.46 144.95 50.68 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.249 0.547 . . . . 15.0 111.48 -179.338 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.703 ' CG1' HD11 ' A' ' 89' ' ' LEU . 0.5 OUTLIER -101.29 115.07 42.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.331 -0.85 . . . . 15.0 109.722 179.157 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -106.13 69.56 0.81 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.107 -0.497 . . . . 15.0 111.643 -179.302 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.646 HD11 ' CB ' ' A' ' 49' ' ' ASP . 7.0 tp -88.15 161.68 17.14 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.013 -0.54 . . . . 15.0 110.082 179.213 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -96.63 101.0 12.53 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.717 0.294 . . . . 15.0 111.113 179.918 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.883 ' HB2' HG23 ' A' ' 85' ' ' VAL . 0.4 OUTLIER . . . . . 0 CA--C 1.534 0.365 0 N-CA-C 112.511 0.56 . . . . 15.0 112.511 179.882 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.7 mm? . . . . . 0 N--CA 1.45 -0.461 0 CA-C-O 120.889 0.376 . . . . 15.0 110.709 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.631 ' O ' ' HB ' ' A' ' 41' ' ' ILE . . . -160.85 35.64 0.42 Allowed Glycine 0 CA--C 1.506 -0.513 0 N-CA-C 111.308 -0.717 . . . . 15.0 111.308 179.987 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.669 HG12 ' O ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -112.61 140.13 33.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.011 0.434 . . . . 15.0 111.948 -179.169 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.455 ' HB3' HD11 ' A' ' 41' ' ' ILE . 33.2 t -96.01 105.82 17.91 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 107.696 -1.224 . . . . 15.0 107.696 177.275 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.989 HG21 HG23 ' A' ' 75' ' ' VAL . 33.2 m -93.57 152.77 3.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 112.984 0.735 . . . . 15.0 112.984 -176.908 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -149.42 -178.8 6.62 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 115.014 -0.994 . . . . 15.0 110.823 -179.736 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.437 ' O ' ' HB3' ' A' ' 71' ' ' HIS . . . 71.17 -119.19 7.81 Favored Glycine 0 C--N 1.332 0.308 0 C-N-CA 120.744 -0.741 . . . . 15.0 112.319 -179.95 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.536 ' HA3' ' N ' ' A' ' 71' ' ' HIS . . . 68.47 -66.46 0.41 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.784 -0.722 . . . . 15.0 113.448 179.338 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.525 ' O ' HG22 ' A' ' 30' ' ' VAL . 0.9 OUTLIER -26.27 138.69 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 N-CA-C 112.5 0.555 . . . . 15.0 112.5 -179.297 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 8.1 p-10 -76.72 57.47 1.28 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.97 -0.559 . . . . 15.0 111.093 -179.929 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.2 m -151.85 -51.84 0.12 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.332 -0.395 . . . . 15.0 110.895 179.971 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 6.0 m -80.53 -41.18 24.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.108 -0.496 . . . . 15.0 110.934 -179.918 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.525 HG22 ' O ' ' A' ' 26' ' ' VAL . 13.9 m -79.21 -169.96 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.284 -0.416 . . . . 15.0 111.095 -179.948 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.59 -62.94 1.5 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.284 -0.416 . . . . 15.0 111.05 -179.853 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . 0.446 ' CD2' ' HG3' ' A' ' 67' ' ' GLU . 11.0 p-80 -139.22 -51.51 0.53 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.356 -0.384 . . . . 15.0 111.257 -179.764 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -168.28 24.75 0.11 Allowed Glycine 0 CA--C 1.518 0.241 0 C-N-CA 120.791 -0.719 . . . . 15.0 112.628 -179.872 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -91.43 154.08 22.55 Favored Glycine 0 N--CA 1.45 -0.398 0 N-CA-C 110.681 -0.967 . . . . 15.0 110.681 178.891 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.943 HG22 HG22 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -92.55 154.72 3.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 117.685 0.742 . . . . 15.0 111.928 -179.265 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.419 ' CE2' ' HG2' ' A' ' 57' ' ' ARG . 30.4 m-85 -139.19 106.07 5.41 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.042 -0.981 . . . . 15.0 109.691 178.849 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.804 HG22 ' N ' ' A' ' 55' ' ' GLY . 0.7 OUTLIER -55.39 146.4 4.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.929 -0.578 . . . . 15.0 111.335 -178.873 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.426 ' O ' ' HG2' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -80.32 -48.51 12.88 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.475 -0.935 . . . . 15.0 108.475 178.356 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.669 ' O ' HG12 ' A' ' 20' ' ' ILE . . . -172.16 172.36 4.62 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.667 -0.697 . . . . 15.0 110.703 178.68 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.606 ' HA ' HG12 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -96.9 113.07 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 N-CA-C 109.712 -0.477 . . . . 15.0 109.712 179.397 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.631 ' HB ' ' O ' ' A' ' 19' ' ' GLY . 0.3 OUTLIER -78.6 119.34 76.92 Favored Pre-proline 0 C--N 1.33 -0.268 0 N-CA-C 113.281 0.845 . . . . 15.0 113.281 -177.411 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.609 ' HA ' ' CG ' ' A' ' 47' ' ' GLU . 38.3 Cg_endo -65.27 61.2 0.34 Allowed 'Trans proline' 0 C--N 1.355 0.904 0 C-N-CA 123.512 2.808 . . . . 15.0 112.958 179.713 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.528 ' H ' ' HG2' ' A' ' 47' ' ' GLU . 1.8 mm-40 -152.11 -44.63 0.11 Allowed 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 111.767 0.284 . . . . 15.0 111.767 179.81 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.578 ' HA3' ' HA3' ' A' ' 19' ' ' GLY . . . -87.77 164.77 34.47 Favored Glycine 0 CA--C 1.519 0.299 0 C-N-CA 120.347 -0.93 . . . . 15.0 113.828 -179.049 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -53.95 -16.34 1.83 Allowed 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 112.847 0.684 . . . . 15.0 112.847 -179.559 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.29 -57.85 3.88 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.609 0.243 . . . . 15.0 111.27 -179.35 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.609 ' CG ' ' HA ' ' A' ' 42' ' ' PRO . 2.9 pp20? -56.74 -40.84 76.47 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.03 0.443 . . . . 15.0 110.312 179.552 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 33.4 t -53.85 -69.79 0.11 Allowed 'General case' 0 CA--C 1.52 -0.182 0 CA-C-N 115.818 -0.628 . . . . 15.0 110.753 -179.449 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.646 ' CB ' HD11 ' A' ' 11' ' ' LEU . 2.0 m-20 -62.61 -38.42 90.11 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.598 -0.519 . . . . 15.0 109.598 179.257 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.03 44.53 8.11 Favored Glycine 0 N--CA 1.447 -0.611 0 CA-C-N 115.573 -0.739 . . . . 15.0 111.703 179.851 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.643 ' HB2' HD13 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -79.43 -53.46 6.88 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.884 0.373 . . . . 15.0 110.832 -179.273 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.66 ' CG1' HD12 ' A' ' 20' ' ' ILE . 8.4 tp -81.93 164.55 2.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.996 -0.547 . . . . 15.0 110.482 179.72 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . 0.439 ' O ' ' HB2' ' A' ' 56' ' ' ASP . 78.8 m80 -147.44 156.98 43.38 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.701 0.762 . . . . 15.0 112.181 -179.142 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.57 ' HA ' ' CG2' ' A' ' 37' ' ' VAL . 6.1 mtpt -42.31 133.73 3.11 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.31 -1.314 . . . . 15.0 112.99 -178.646 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.804 ' N ' HG22 ' A' ' 37' ' ' VAL . . . 49.81 31.87 17.19 Favored Glycine 0 C--N 1.334 0.449 0 CA-C-N 115.635 -0.711 . . . . 15.0 113.644 179.061 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.439 ' HB2' ' O ' ' A' ' 53' ' ' HIS . 0.3 OUTLIER -65.9 130.5 43.47 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 117.179 0.49 . . . . 15.0 110.493 179.413 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.419 ' HG2' ' CE2' ' A' ' 36' ' ' TYR . 40.3 mtt180 -83.9 87.23 7.09 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.242 -0.435 . . . . 15.0 110.17 179.62 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.943 HG22 HG22 ' A' ' 35' ' ' ILE . 1.3 m -79.66 117.93 26.27 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 CA-C-O 121.086 0.469 . . . . 15.0 111.566 -179.12 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.438 ' O ' ' N ' ' A' ' 66' ' ' LEU . 27.7 mt -107.48 -18.84 13.75 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 115.504 -0.771 . . . . 15.0 112.493 -179.423 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.766 ' HB3' ' HB2' ' A' ' 88' ' ' LEU . . . -148.79 148.52 30.04 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 112.946 0.721 . . . . 15.0 112.946 -178.575 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.822 HG11 ' O ' ' A' ' 77' ' ' THR . 56.7 t -139.2 94.53 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 CA-C-N 115.101 -0.954 . . . . 15.0 109.076 178.892 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.497 ' OD1' HG22 ' A' ' 81' ' ' THR . 6.0 m120 70.5 16.6 6.98 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.047 -0.524 . . . . 15.0 109.87 -178.101 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 107.17 4.75 35.44 Favored Glycine 0 C--N 1.336 0.549 0 CA-C-N 115.851 -0.613 . . . . 15.0 113.429 179.559 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.655 ' O ' HG13 ' A' ' 64' ' ' VAL . 5.9 p -93.82 105.58 17.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.131 0.491 . . . . 15.0 110.845 179.446 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.6 t -55.71 139.4 45.09 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.057 -0.52 . . . . 15.0 111.206 -179.518 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.963 HD11 ' HB2' ' A' ' 74' ' ' ALA . 0.2 OUTLIER -97.43 -22.97 16.28 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.966 -0.561 . . . . 15.0 110.78 179.875 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.446 ' HG3' ' CD2' ' A' ' 32' ' ' HIS . 1.6 tt0 -46.38 103.36 0.04 OUTLIER 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.237 -0.438 . . . . 15.0 111.125 -179.952 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 102.89 61.63 0.71 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.759 -0.734 . . . . 15.0 112.309 -179.865 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.745 ' HB1' ' CB ' ' A' ' 73' ' ' GLN . . . -173.09 142.57 1.06 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.874 0.368 . . . . 15.0 111.079 -179.823 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.451 ' CB ' ' HA ' ' A' ' 26' ' ' VAL . 2.3 p -72.87 -171.85 0.93 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.252 -0.431 . . . . 15.0 110.953 -179.959 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . 0.778 ' CD2' HG23 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -62.95 -58.43 7.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.95 -0.568 . . . . 15.0 110.447 179.827 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.462 ' O ' HG12 ' A' ' 75' ' ' VAL . 1.8 ttpp -52.5 -33.91 47.05 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.826 -0.625 . . . . 15.0 110.855 179.691 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.745 ' CB ' ' HB1' ' A' ' 69' ' ' ALA . 2.0 mt-30 -59.31 -51.47 69.82 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.35 -0.611 . . . . 15.0 109.35 179.32 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.963 ' HB2' HD11 ' A' ' 66' ' ' LEU . . . -66.86 -43.96 82.22 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.804 -0.634 . . . . 15.0 109.797 178.532 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.989 HG23 HG21 ' A' ' 22' ' ' VAL . 0.5 OUTLIER -43.35 -39.94 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.236 0 N-CA-C 109.029 -0.73 . . . . 15.0 109.029 178.419 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -67.22 -45.83 75.61 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 114.778 -1.101 . . . . 15.0 110.048 178.342 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.822 ' O ' HG11 ' A' ' 61' ' ' VAL . 35.4 p -64.28 -53.48 48.26 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-N 116.526 -0.306 . . . . 15.0 111.454 179.848 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.678 HD23 HG21 ' A' ' 61' ' ' VAL . 4.5 mt -53.88 -48.53 69.99 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 121.205 0.526 . . . . 15.0 110.102 179.914 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.406 ' O ' ' N ' ' A' ' 81' ' ' THR . 0.0 OUTLIER -68.34 -57.68 5.55 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.405 -0.816 . . . . 15.0 110.737 179.655 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 64.8 m-20 -65.84 62.49 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.961 -0.563 . . . . 15.0 112.088 -179.86 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.497 HG22 ' OD1' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -95.41 -73.99 0.57 Allowed 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.798 -0.445 . . . . 15.0 109.798 179.015 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 114.87 -101.11 1.04 Allowed Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.744 -0.741 . . . . 15.0 113.263 178.781 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.48 ' O ' ' HB3' ' A' ' 13' ' ' LYS . 0.1 OUTLIER -64.63 -86.27 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.612 0.244 . . . . 15.0 111.527 -179.208 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.461 HG12 ' N ' ' A' ' 85' ' ' VAL . 79.0 t -110.3 159.52 10.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.98 0.419 . . . . 15.0 110.738 -179.893 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.883 HG23 ' HB2' ' A' ' 13' ' ' LYS . 3.6 t -97.62 83.66 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.146 0.498 . . . . 15.0 110.228 179.648 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -101.75 83.89 2.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.707 -0.679 . . . . 15.0 110.238 179.727 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.834 ' HB3' HD21 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -103.92 128.18 51.43 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.87 -0.605 . . . . 15.0 111.827 -179.106 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.766 ' HB2' ' HB3' ' A' ' 60' ' ' ALA . 4.6 mp -102.28 100.86 11.08 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.629 -0.508 . . . . 15.0 109.629 178.805 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.834 HD21 ' HB3' ' A' ' 87' ' ' LEU . 0.1 OUTLIER -105.64 -161.78 0.83 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.388 0.613 . . . . 15.0 111.848 -178.552 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.411 ' HB2' HG13 ' A' ' 6' ' ' ILE . 3.1 tt0 -142.23 135.38 28.8 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.052 -0.976 . . . . 15.0 109.878 179.21 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 2.8 tptt -47.47 103.95 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.919 0.39 . . . . 15.0 111.188 -179.681 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.295 0 C-N-CA 120.785 -0.721 . . . . 15.0 112.5 -179.943 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.514 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 1.4 mp . . . . . 0 N--CA 1.451 -0.377 0 CA-C-O 120.77 0.319 . . . . 15.0 111.215 . . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.968 ' CE1' HD12 ' A' ' 89' ' ' LEU . 10.8 p90 -141.82 143.59 33.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.264 -0.425 . . . . 15.0 110.882 178.874 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.795 ' HB2' HD12 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -109.96 142.42 41.36 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.339 0.59 . . . . 15.0 111.534 -179.404 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.683 HG12 HD11 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -101.55 114.89 42.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.117 -0.947 . . . . 15.0 109.831 179.124 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -105.95 71.45 0.9 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.015 -0.539 . . . . 15.0 111.931 -178.988 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.651 HD13 ' HG3' ' A' ' 51' ' ' ARG . 5.6 tp -87.98 165.76 14.98 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.151 -0.477 . . . . 15.0 109.727 178.972 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -94.71 94.2 7.98 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.916 0.389 . . . . 15.0 111.057 -179.995 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.654 ' CB ' HG23 ' A' ' 85' ' ' VAL . 0.2 OUTLIER . . . . . 0 C--N 1.328 -0.358 0 CA-C-N 115.977 -0.556 . . . . 15.0 110.885 179.924 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.588 ' N ' HD22 ' A' ' 18' ' ' LEU . 1.1 mm? . . . . . 0 N--CA 1.452 -0.352 0 CA-C-O 120.877 0.37 . . . . 15.0 110.779 . . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.624 ' HA3' ' HA3' ' A' ' 44' ' ' GLY . . . -160.98 39.44 0.42 Allowed Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 121.043 -0.599 . . . . 15.0 112.024 -179.794 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.661 HD12 ' CG2' ' A' ' 52' ' ' ILE . 0.0 OUTLIER -112.51 144.71 19.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 121.06 0.457 . . . . 15.0 111.686 -179.493 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 55.0 p -96.06 101.49 13.16 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.267 -1.012 . . . . 15.0 108.267 177.958 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 1.024 HG21 HG23 ' A' ' 75' ' ' VAL . 33.8 m -93.77 145.61 7.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 113.092 0.775 . . . . 15.0 113.092 -177.273 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.555 ' HA ' ' ND1' ' A' ' 71' ' ' HIS . 0.9 OUTLIER -149.49 -177.65 5.98 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 115.384 -0.826 . . . . 15.0 110.773 178.74 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.477 ' O ' ' HB3' ' A' ' 71' ' ' HIS . . . 76.32 -118.19 5.23 Favored Glycine 0 C--N 1.333 0.401 0 C-N-CA 120.87 -0.681 . . . . 15.0 112.361 -179.753 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.528 ' HA3' ' N ' ' A' ' 71' ' ' HIS . . . 64.42 -64.66 0.06 OUTLIER Glycine 0 CA--C 1.519 0.31 0 C-N-CA 121.139 -0.553 . . . . 15.0 114.116 178.956 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.609 ' O ' HG22 ' A' ' 30' ' ' VAL . 1.5 m -25.97 142.18 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 N-CA-C 112.892 0.701 . . . . 15.0 112.892 -178.999 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 44.4 t-20 -78.4 55.41 1.57 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.681 -0.69 . . . . 15.0 110.934 179.856 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 15.0 m -152.03 -63.92 0.17 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.915 0.388 . . . . 15.0 110.938 -179.933 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 47.7 t -68.86 -49.99 53.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.029 -0.532 . . . . 15.0 110.885 -179.892 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.609 HG22 ' O ' ' A' ' 26' ' ' VAL . 35.8 m -84.4 -176.74 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.25 -0.432 . . . . 15.0 111.027 179.912 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -89.09 121.86 31.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.956 0.408 . . . . 15.0 111.158 -179.867 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 65.08 -91.36 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.951 -0.568 . . . . 15.0 111.384 179.722 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.456 ' O ' ' O ' ' A' ' 69' ' ' ALA . . . -164.85 27.97 0.2 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.78 -0.724 . . . . 15.0 112.131 -179.717 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -84.81 149.47 24.37 Favored Glycine 0 N--CA 1.449 -0.47 0 N-CA-C 110.523 -1.031 . . . . 15.0 110.523 178.845 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 1.028 HG22 HG22 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -90.13 150.92 3.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 119.923 -0.711 . . . . 15.0 111.78 -179.215 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.453 ' CZ ' ' HG3' ' A' ' 57' ' ' ARG . 44.1 m-85 -136.49 108.54 7.19 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 114.904 -1.044 . . . . 15.0 109.124 178.942 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.785 HG22 ' N ' ' A' ' 55' ' ' GLY . 0.8 OUTLIER -55.17 153.72 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 121.269 0.557 . . . . 15.0 111.266 -178.567 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.576 ' O ' ' HG2' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -86.34 -46.05 10.65 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.745 -0.835 . . . . 15.0 108.745 178.848 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.624 ' O ' HG12 ' A' ' 20' ' ' ILE . . . -172.34 169.34 5.34 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.804 -0.635 . . . . 15.0 110.683 178.527 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.529 ' HA ' HG12 ' A' ' 20' ' ' ILE . 0.1 OUTLIER -96.73 109.86 23.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 N-CA-C 109.288 -0.634 . . . . 15.0 109.288 179.049 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.595 ' HB ' ' O ' ' A' ' 19' ' ' GLY . 0.3 OUTLIER -78.36 118.48 72.54 Favored Pre-proline 0 C--N 1.328 -0.348 0 N-CA-C 113.522 0.934 . . . . 15.0 113.522 -176.967 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.626 ' HA ' ' CG ' ' A' ' 47' ' ' GLU . 36.9 Cg_endo -64.48 61.59 0.26 Allowed 'Trans proline' 0 C--N 1.358 1.042 0 C-N-CA 123.536 2.824 . . . . 15.0 112.991 179.865 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.51 ' N ' ' HG2' ' A' ' 47' ' ' GLU . 41.8 mt-30 -149.88 -46.72 0.13 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.597 -0.274 . . . . 15.0 111.54 179.763 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.624 ' HA3' ' HA3' ' A' ' 19' ' ' GLY . . . -88.03 167.59 36.41 Favored Glycine 0 CA--C 1.518 0.27 0 C-N-CA 120.332 -0.937 . . . . 15.0 113.946 -179.212 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -56.6 -13.48 2.44 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.678 0.622 . . . . 15.0 112.678 -179.852 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.444 ' HB1' HG22 ' A' ' 52' ' ' ILE . . . -71.95 -58.23 3.63 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-O 120.773 0.321 . . . . 15.0 110.868 -179.618 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.626 ' CG ' ' HA ' ' A' ' 42' ' ' PRO . 2.6 pp20? -57.38 -42.0 81.33 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.732 -0.667 . . . . 15.0 110.423 179.285 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -53.78 -71.28 0.08 Allowed 'General case' 0 CA--C 1.519 -0.22 0 CA-C-N 115.783 -0.644 . . . . 15.0 110.549 -179.359 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.594 ' CB ' HD11 ' A' ' 11' ' ' LEU . 0.1 OUTLIER -58.24 -40.71 82.47 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.137 -0.69 . . . . 15.0 109.137 178.838 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.416 ' O ' ' CE1' ' A' ' 53' ' ' HIS . . . 80.98 39.54 13.02 Favored Glycine 0 N--CA 1.446 -0.683 0 CA-C-N 115.197 -0.91 . . . . 15.0 112.011 179.212 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.651 ' HG3' HD13 ' A' ' 11' ' ' LEU . 3.0 mmt-85 -80.07 -59.31 2.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.963 0.411 . . . . 15.0 110.386 -179.773 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.661 ' CG2' HD12 ' A' ' 20' ' ' ILE . 6.6 tp -80.86 146.18 7.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.86 -0.609 . . . . 15.0 109.568 179.115 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . 0.514 ' O ' ' HB2' ' A' ' 56' ' ' ASP . 57.4 m80 -139.47 167.37 22.24 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-O 121.77 0.795 . . . . 15.0 112.762 -178.253 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.58 ' HA ' ' CG2' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -40.29 132.72 1.94 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.109 -1.405 . . . . 15.0 113.27 -178.353 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.785 ' N ' HG22 ' A' ' 37' ' ' VAL . . . 49.7 36.23 25.0 Favored Glycine 0 C--N 1.335 0.511 0 CA-C-N 115.613 -0.721 . . . . 15.0 113.566 179.115 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.514 ' HB2' ' O ' ' A' ' 53' ' ' HIS . 1.7 t0 -65.66 132.32 48.51 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.99 0.395 . . . . 15.0 110.34 179.206 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.453 ' HG3' ' CZ ' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -85.11 77.25 10.11 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.983 -0.553 . . . . 15.0 110.134 179.545 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 1.028 HG22 HG22 ' A' ' 35' ' ' ILE . 0.8 OUTLIER -79.23 115.62 21.82 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 CA-C-O 121.293 0.568 . . . . 15.0 111.027 -179.25 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 35.0 mt -107.32 -14.12 14.96 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 115.555 -0.748 . . . . 15.0 112.522 -178.967 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.698 ' HB3' ' HB2' ' A' ' 88' ' ' LEU . . . -147.56 149.9 33.46 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 112.642 0.608 . . . . 15.0 112.642 -178.51 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.644 HG11 ' O ' ' A' ' 77' ' ' THR . 15.6 t -139.12 101.54 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.27 0 CA-C-N 115.255 -0.884 . . . . 15.0 109.139 178.741 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.807 ' ND2' HG22 ' A' ' 81' ' ' THR . 1.7 m-80 65.04 15.54 10.05 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.668 -0.493 . . . . 15.0 109.668 -177.901 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 106.82 4.9 36.29 Favored Glycine 0 C--N 1.337 0.614 0 CA-C-N 115.822 -0.626 . . . . 15.0 113.286 179.77 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.643 ' O ' HG13 ' A' ' 64' ' ' VAL . 5.8 p -93.83 108.67 20.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 117.017 0.408 . . . . 15.0 111.046 179.616 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -57.11 137.98 55.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.259 -0.428 . . . . 15.0 111.064 -179.741 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.927 HD11 ' HB2' ' A' ' 74' ' ' ALA . 0.2 OUTLIER -97.74 -23.08 16.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.076 -0.511 . . . . 15.0 111.003 179.96 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -47.57 104.0 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.389 -0.369 . . . . 15.0 111.091 179.937 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.76 54.87 0.58 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.744 -0.741 . . . . 15.0 112.288 -179.871 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.678 ' HB1' ' CB ' ' A' ' 73' ' ' GLN . . . -173.07 146.85 1.53 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.857 0.36 . . . . 15.0 111.012 -179.953 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.462 HG22 ' HA ' ' A' ' 26' ' ' VAL . 11.3 p -72.94 -172.33 1.02 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.146 0.498 . . . . 15.0 111.097 -179.771 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . 0.742 ' NE2' HG23 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -65.29 -57.83 7.44 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.636 -0.711 . . . . 15.0 110.751 -179.806 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.49 ' O ' HG12 ' A' ' 75' ' ' VAL . 5.4 ttpp -52.5 -32.91 42.52 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.352 -0.385 . . . . 15.0 110.285 179.316 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.678 ' CB ' ' HB1' ' A' ' 69' ' ' ALA . 4.9 mt-30 -59.56 -48.93 79.74 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.32 -0.622 . . . . 15.0 109.32 178.843 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.927 ' HB2' HD11 ' A' ' 66' ' ' LEU . . . -67.16 -44.12 80.56 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-N 115.944 -0.571 . . . . 15.0 109.582 178.24 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 1.024 HG23 HG21 ' A' ' 22' ' ' VAL . 0.5 OUTLIER -44.03 -39.28 1.47 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.26 0 N-CA-C 108.706 -0.85 . . . . 15.0 108.706 178.312 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -67.17 -45.3 77.41 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 114.668 -1.151 . . . . 15.0 110.132 178.249 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.644 ' O ' HG11 ' A' ' 61' ' ' VAL . 39.0 p -64.12 -54.79 28.43 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.634 -0.257 . . . . 15.0 111.599 179.851 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.59 HD21 HG21 ' A' ' 58' ' ' VAL . 5.9 mt -53.33 -47.68 69.12 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-O 121.215 0.531 . . . . 15.0 109.851 -179.853 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.4 ' HB2' ' O ' ' A' ' 75' ' ' VAL . 0.0 OUTLIER -68.49 -59.09 3.41 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.423 -0.808 . . . . 15.0 110.551 179.403 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -66.15 59.71 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.947 -0.57 . . . . 15.0 112.411 -179.903 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.807 HG22 ' ND2' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -95.63 -71.51 0.67 Allowed 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 110.006 -0.368 . . . . 15.0 110.006 178.917 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 121.97 -105.39 0.98 Allowed Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.833 -0.699 . . . . 15.0 113.157 179.118 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.75 -81.62 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 112.151 0.426 . . . . 15.0 112.151 -179.06 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.45 HG12 ' N ' ' A' ' 85' ' ' VAL . 72.2 t -109.97 159.1 9.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.136 0.493 . . . . 15.0 111.21 -179.136 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.678 HG12 ' O ' ' A' ' 85' ' ' VAL . 6.8 t -97.82 81.56 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.909 -0.587 . . . . 15.0 110.553 179.935 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -100.45 84.34 2.76 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.729 -0.668 . . . . 15.0 110.419 179.786 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.642 ' HB3' HD21 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -103.55 118.62 37.15 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.985 -0.552 . . . . 15.0 111.916 -179.102 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.795 HD12 ' HB2' ' A' ' 8' ' ' GLU . 3.8 mp -92.01 103.65 16.14 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.17 -0.678 . . . . 15.0 109.17 178.445 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.968 HD12 ' CE1' ' A' ' 7' ' ' PHE . 0.1 OUTLIER -105.61 -164.91 1.06 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.615 0.721 . . . . 15.0 112.352 -178.035 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.514 ' HA ' ' HA ' ' A' ' 6' ' ' ILE . 0.7 OUTLIER -144.93 135.86 24.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 114.626 -1.17 . . . . 15.0 109.487 179.146 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -46.81 98.65 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.942 0.401 . . . . 15.0 111.253 -179.497 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.364 0 C-N-CA 120.869 -0.681 . . . . 15.0 112.641 -179.83 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.525 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 1.2 mp . . . . . 0 N--CA 1.451 -0.402 0 CA-C-O 120.786 0.327 . . . . 15.0 111.129 . . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.637 ' CE1' HD12 ' A' ' 89' ' ' LEU . 2.3 p90 -140.44 153.79 46.41 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.234 -0.439 . . . . 15.0 110.557 178.949 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.605 ' CB ' HD12 ' A' ' 88' ' ' LEU . 13.3 pt-20 -119.86 143.12 48.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.29 0.567 . . . . 15.0 111.748 -179.164 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.544 HG23 ' HB3' ' A' ' 51' ' ' ARG . 0.2 OUTLIER -101.67 117.79 47.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.277 -0.874 . . . . 15.0 109.72 178.817 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 51.5 tt0 -106.2 73.38 0.98 Allowed 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.094 0.405 . . . . 15.0 112.094 -179.165 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.532 HD11 ' CB ' ' A' ' 49' ' ' ASP . 9.5 tp -88.43 160.69 17.43 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.245 -0.434 . . . . 15.0 109.975 178.9 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -97.0 94.69 7.32 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 111.853 0.316 . . . . 15.0 111.853 -179.615 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.896 ' HB2' HG23 ' A' ' 85' ' ' VAL . 0.5 OUTLIER . . . . . 0 N--CA 1.466 0.337 0 N-CA-C 112.522 0.564 . . . . 15.0 112.522 179.476 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.2 mm? . . . . . 0 N--CA 1.453 -0.307 0 CA-C-O 121.066 0.46 . . . . 15.0 110.865 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.614 ' O ' ' HB ' ' A' ' 41' ' ' ILE . . . -161.0 33.68 0.39 Allowed Glycine 0 C--O 1.223 -0.55 0 N-CA-C 110.84 -0.904 . . . . 15.0 110.84 -179.815 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.662 HG13 HG12 ' A' ' 40' ' ' VAL . 0.0 OUTLIER -114.0 139.94 37.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 112.445 0.535 . . . . 15.0 112.445 -179.217 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.668 ' CB ' HD11 ' A' ' 41' ' ' ILE . 4.3 t -96.17 105.47 17.53 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 107.882 -1.155 . . . . 15.0 107.882 176.492 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 1.02 HG21 HG23 ' A' ' 75' ' ' VAL . 6.8 m -93.69 154.91 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 N-CA-C 113.28 0.844 . . . . 15.0 113.28 -176.952 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.52 -178.74 6.6 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.191 -0.913 . . . . 15.0 111.032 179.852 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.538 ' O ' HG22 ' A' ' 26' ' ' VAL . . . 69.04 -119.07 9.29 Favored Glycine 0 C--N 1.333 0.364 0 C-N-CA 120.968 -0.634 . . . . 15.0 112.531 179.719 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.559 ' HA3' ' N ' ' A' ' 71' ' ' HIS . . . 68.11 -65.79 0.36 Allowed Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.919 -0.658 . . . . 15.0 113.615 179.339 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.538 HG22 ' O ' ' A' ' 24' ' ' GLY . 0.0 OUTLIER -27.36 139.29 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 N-CA-C 112.209 0.448 . . . . 15.0 112.209 -179.337 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 7.8 p-10 -75.22 61.99 1.2 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.08 -0.509 . . . . 15.0 111.006 -179.59 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.5 m -151.75 -59.68 0.16 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.274 -0.421 . . . . 15.0 111.055 179.957 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 91.4 p -74.86 -47.65 29.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.118 -0.492 . . . . 15.0 111.168 -179.779 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.517 HG22 ' O ' ' A' ' 26' ' ' VAL . 35.1 m -70.12 -174.14 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.328 -0.396 . . . . 15.0 111.154 -179.89 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 6.8 mmp_? -54.5 -59.1 5.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.227 -0.442 . . . . 15.0 111.217 -179.792 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 1.7 p-80 -149.92 -44.83 0.13 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.44 -0.346 . . . . 15.0 111.325 -179.782 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.402 ' O ' ' O ' ' A' ' 69' ' ' ALA . . . -167.53 24.45 0.12 Allowed Glycine 0 CA--C 1.517 0.179 0 C-N-CA 120.605 -0.807 . . . . 15.0 112.894 -179.689 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -91.92 154.04 22.28 Favored Glycine 0 N--CA 1.45 -0.406 0 N-CA-C 110.074 -1.21 . . . . 15.0 110.074 178.341 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 1.053 HG22 HG22 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -101.39 147.13 8.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 118.184 0.992 . . . . 15.0 111.767 -179.249 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.769 ' N ' HD13 ' A' ' 35' ' ' ILE . 15.9 m-85 -130.94 109.2 10.36 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-N 115.307 -0.861 . . . . 15.0 109.539 -179.634 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.763 HG22 ' N ' ' A' ' 55' ' ' GLY . 0.7 OUTLIER -55.46 167.11 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.916 -0.583 . . . . 15.0 110.739 -179.27 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.42 -48.14 4.66 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.059 -0.719 . . . . 15.0 109.059 178.77 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.58 ' O ' HG12 ' A' ' 20' ' ' ILE . . . -171.5 169.18 6.22 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.269 -0.878 . . . . 15.0 110.463 179.341 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.662 HG12 HG13 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -97.24 123.57 49.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.727 0.298 . . . . 15.0 110.838 -179.908 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.716 ' O ' ' HB3' ' A' ' 47' ' ' GLU . 1.7 mm -78.68 108.14 7.37 Favored Pre-proline 0 N--CA 1.468 0.443 0 N-CA-C 113.199 0.815 . . . . 15.0 113.199 -178.651 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.458 ' HD3' ' O ' ' A' ' 40' ' ' VAL . 25.8 Cg_exo -62.35 72.52 0.11 Allowed 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 122.99 2.46 . . . . 15.0 112.264 179.341 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.422 ' N ' ' O ' ' A' ' 41' ' ' ILE . 0.6 OUTLIER -174.32 -41.66 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.687 -0.688 . . . . 15.0 110.245 179.926 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.595 ' HA3' ' HA3' ' A' ' 19' ' ' GLY . . . -87.3 150.63 22.85 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.651 -0.785 . . . . 15.0 112.409 179.613 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -39.5 -22.73 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 113.191 0.811 . . . . 15.0 113.191 -179.369 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.427 ' N ' ' O ' ' A' ' 44' ' ' GLY . . . -71.82 -70.2 0.34 Allowed 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.937 -0.305 . . . . 15.0 111.294 -179.625 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.716 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 4.3 tp10 -58.03 -38.94 77.17 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.904 0.383 . . . . 15.0 110.657 179.653 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -53.82 -60.6 3.11 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.092 -0.504 . . . . 15.0 110.358 179.867 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.532 ' CB ' HD11 ' A' ' 11' ' ' LEU . 0.7 OUTLIER -66.71 -38.73 87.32 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.142 -0.481 . . . . 15.0 109.982 179.07 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.48 41.05 10.3 Favored Glycine 0 N--CA 1.449 -0.486 0 CA-C-N 115.699 -0.682 . . . . 15.0 112.486 179.664 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.544 ' HB3' HG23 ' A' ' 9' ' ' VAL . 5.3 mmp_? -86.3 -55.91 3.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.906 0.384 . . . . 15.0 110.74 179.858 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.564 ' CG1' HD12 ' A' ' 20' ' ' ILE . 9.0 tp -81.12 160.63 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 CA-C-N 116.037 -0.529 . . . . 15.0 110.71 179.808 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . 0.462 ' O ' ' HB2' ' A' ' 56' ' ' ASP . 62.2 m80 -141.17 160.54 39.88 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-O 121.73 0.776 . . . . 15.0 112.575 -179.077 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.625 ' HA ' ' CG2' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -45.77 137.45 5.44 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.398 -1.274 . . . . 15.0 112.497 -178.671 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.763 ' N ' HG22 ' A' ' 37' ' ' VAL . . . 49.73 32.7 17.88 Favored Glycine 0 C--N 1.334 0.452 0 CA-C-N 115.874 -0.603 . . . . 15.0 113.467 179.676 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.475 ' CB ' HD11 ' A' ' 52' ' ' ILE . 0.3 OUTLIER -66.06 127.59 32.72 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.314 -0.554 . . . . 15.0 110.205 179.09 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.538 ' HE ' HD21 ' A' ' 59' ' ' LEU . 5.8 ttt180 -83.17 83.32 7.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.277 -0.42 . . . . 15.0 110.097 179.713 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 1.053 HG22 HG22 ' A' ' 35' ' ' ILE . 1.0 OUTLIER -79.47 123.6 36.59 Favored 'Isoleucine or valine' 0 C--O 1.241 0.646 0 CA-C-O 121.089 0.471 . . . . 15.0 111.329 -179.259 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.581 HD12 ' HG2' ' A' ' 67' ' ' GLU . 3.4 mm? -107.62 -18.78 13.75 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.189 -0.914 . . . . 15.0 112.491 -179.461 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.482 ' O ' HD23 ' A' ' 87' ' ' LEU . . . -147.87 149.1 31.64 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 112.799 0.666 . . . . 15.0 112.799 -178.35 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.796 HG11 ' O ' ' A' ' 77' ' ' THR . 43.7 t -139.33 100.6 1.4 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.225 0 CA-C-N 115.297 -0.865 . . . . 15.0 109.281 178.596 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.822 ' ND2' HG22 ' A' ' 81' ' ' THR . 1.5 m-80 65.46 15.9 10.25 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.135 -0.484 . . . . 15.0 109.833 -178.149 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 106.79 5.47 35.89 Favored Glycine 0 C--N 1.336 0.559 0 CA-C-N 115.868 -0.605 . . . . 15.0 113.321 179.615 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.646 ' O ' HG13 ' A' ' 64' ' ' VAL . 5.4 p -93.8 106.17 17.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.092 0.473 . . . . 15.0 110.713 179.405 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -57.66 127.84 34.03 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.159 -0.473 . . . . 15.0 111.147 -179.472 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.568 HD13 ' HB3' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -88.87 -23.96 22.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.986 -0.552 . . . . 15.0 110.741 179.81 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.581 ' HG2' HD12 ' A' ' 59' ' ' LEU . 4.4 mm-40 -45.25 97.16 0.01 OUTLIER 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 116.374 -0.375 . . . . 15.0 110.928 179.863 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.79 62.6 0.54 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.791 -0.718 . . . . 15.0 112.073 -179.544 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.651 ' HB1' ' CB ' ' A' ' 73' ' ' GLN . . . -172.93 146.22 1.51 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.897 0.379 . . . . 15.0 110.86 -179.789 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.42 ' CB ' ' HA ' ' A' ' 26' ' ' VAL . 6.8 p -72.81 -171.85 0.92 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.072 0.463 . . . . 15.0 111.304 -179.62 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . 0.642 ' NE2' HG23 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -65.39 -58.47 5.81 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.753 -0.658 . . . . 15.0 110.724 -179.91 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.413 ' HA ' ' HB ' ' A' ' 75' ' ' VAL . 15.6 ttpp -52.52 -31.46 35.54 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.018 -0.537 . . . . 15.0 110.52 179.725 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.651 ' CB ' ' HB1' ' A' ' 69' ' ' ALA . 4.1 mt-30 -59.59 -49.03 79.34 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.651 -0.5 . . . . 15.0 109.651 179.239 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.558 ' HA ' HD21 ' A' ' 66' ' ' LEU . . . -67.2 -45.16 77.72 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 109.495 -0.557 . . . . 15.0 109.495 178.404 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 1.02 HG23 HG21 ' A' ' 22' ' ' VAL . 0.5 OUTLIER -43.06 -41.92 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.272 0 N-CA-C 108.888 -0.782 . . . . 15.0 108.888 178.305 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.503 ' O ' ' HB2' ' A' ' 80' ' ' ASN . 1.6 mt-10 -67.17 -44.59 79.33 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 114.861 -1.063 . . . . 15.0 110.073 178.212 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.796 ' O ' HG11 ' A' ' 61' ' ' VAL . 68.7 p -64.08 -54.4 34.67 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-N 116.566 -0.288 . . . . 15.0 111.577 179.93 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.585 HD21 HG21 ' A' ' 58' ' ' VAL . 8.6 mt -53.56 -47.02 70.44 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.351 0.596 . . . . 15.0 109.903 179.855 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.427 ' HB2' ' O ' ' A' ' 75' ' ' VAL . 0.1 OUTLIER -68.44 -59.49 3.13 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.194 -0.912 . . . . 15.0 110.837 179.728 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.503 ' HB2' ' O ' ' A' ' 76' ' ' GLU . 12.0 m-80 -66.09 61.06 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.161 -0.472 . . . . 15.0 112.131 -179.859 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.822 HG22 ' ND2' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -95.7 -71.46 0.67 Allowed 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 110.0 -0.37 . . . . 15.0 110.0 179.02 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 116.85 -102.02 1.0 Allowed Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.838 -0.696 . . . . 15.0 112.979 179.055 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.81 -87.51 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.632 0.253 . . . . 15.0 111.437 -179.456 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.494 HG12 ' N ' ' A' ' 85' ' ' VAL . 84.1 t -109.85 160.69 8.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.951 0.405 . . . . 15.0 110.873 -179.816 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.896 HG23 ' HB2' ' A' ' 13' ' ' LYS . 3.3 t -97.71 81.43 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 121.258 0.551 . . . . 15.0 110.143 179.804 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -96.03 81.32 3.37 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.668 -0.697 . . . . 15.0 110.107 179.827 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.618 ' HB3' HD21 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -103.21 124.38 48.51 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.963 -0.562 . . . . 15.0 111.891 -178.947 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.661 ' N ' HD13 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -102.34 101.98 12.29 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.371 -0.603 . . . . 15.0 109.371 178.548 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.637 HD12 ' CE1' ' A' ' 7' ' ' PHE . 0.1 OUTLIER -105.65 -163.57 0.95 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.553 0.692 . . . . 15.0 112.09 -178.581 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.525 ' HA ' ' HA ' ' A' ' 6' ' ' ILE . 0.9 OUTLIER -138.79 134.87 34.01 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.731 -1.122 . . . . 15.0 109.433 178.845 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.87 105.15 0.06 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.857 0.36 . . . . 15.0 111.379 -179.219 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.39 0 C-N-CA 120.777 -0.725 . . . . 15.0 112.581 -179.912 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.438 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 1.1 mp . . . . . 0 N--CA 1.451 -0.414 0 CA-C-O 120.825 0.345 . . . . 15.0 111.0 . . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.812 ' CZ ' HD12 ' A' ' 89' ' ' LEU . 4.0 p90 -140.65 157.71 45.05 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.191 -0.459 . . . . 15.0 110.58 179.087 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.723 ' HB2' HD12 ' A' ' 88' ' ' LEU . 11.3 pt-20 -124.71 141.83 51.83 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.226 0.536 . . . . 15.0 111.362 -179.557 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.566 HG23 ' HB3' ' A' ' 51' ' ' ARG . 0.2 OUTLIER -101.56 117.98 47.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.38 -0.827 . . . . 15.0 109.771 178.984 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -106.22 75.47 1.09 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.29 -0.414 . . . . 15.0 112.115 -179.064 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.566 ' HB3' ' HB ' ' A' ' 85' ' ' VAL . 11.4 tp -88.45 159.98 17.74 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.615 -0.513 . . . . 15.0 109.615 178.728 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -96.9 94.26 7.12 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 112.043 0.386 . . . . 15.0 112.043 -179.393 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.91 ' HB2' HG23 ' A' ' 85' ' ' VAL . 0.6 OUTLIER . . . . . 0 CA--C 1.534 0.352 0 N-CA-C 112.435 0.531 . . . . 15.0 112.435 179.312 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.595 ' N ' HD22 ' A' ' 18' ' ' LEU . 2.2 mm? . . . . . 0 N--CA 1.451 -0.405 0 CA-C-O 121.109 0.48 . . . . 15.0 110.722 . . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.596 ' O ' ' HB ' ' A' ' 41' ' ' ILE . . . -162.96 33.4 0.3 Allowed Glycine 0 C--O 1.223 -0.572 0 N-CA-C 110.83 -0.908 . . . . 15.0 110.83 -179.766 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.663 HD13 ' HB ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -113.87 143.26 23.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 112.243 0.46 . . . . 15.0 112.243 -179.159 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.742 ' CB ' HD11 ' A' ' 41' ' ' ILE . 1.7 t -96.41 103.45 15.36 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 107.745 -1.206 . . . . 15.0 107.745 176.676 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 1.028 HG21 HG23 ' A' ' 75' ' ' VAL . 29.6 m -93.5 149.82 4.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.368 0.604 . . . . 15.0 112.612 -177.367 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -149.51 -178.46 6.44 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.167 -0.924 . . . . 15.0 110.949 -179.411 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.556 ' O ' HG22 ' A' ' 26' ' ' VAL . . . 69.52 -117.64 7.86 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 120.802 -0.713 . . . . 15.0 112.251 -179.973 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.51 ' HA3' ' N ' ' A' ' 71' ' ' HIS . . . 67.2 -64.25 0.23 Allowed Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.904 -0.665 . . . . 15.0 113.668 179.362 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.556 HG22 ' O ' ' A' ' 24' ' ' GLY . 0.0 OUTLIER -28.99 137.51 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 N-CA-C 112.459 0.54 . . . . 15.0 112.459 -179.255 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 11.5 m-80 -75.56 61.3 1.3 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.802 -0.635 . . . . 15.0 111.016 -179.729 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -151.74 -53.76 0.13 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.341 -0.39 . . . . 15.0 111.074 179.971 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.6 m -81.92 -45.64 15.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.155 -0.475 . . . . 15.0 111.133 -179.812 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.555 HG22 ' O ' ' A' ' 26' ' ' VAL . 34.8 m -72.15 -175.23 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.22 -0.445 . . . . 15.0 111.271 -179.838 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.5 -60.55 3.16 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.204 -0.453 . . . . 15.0 111.202 -179.942 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 5.4 p-80 -146.62 -46.81 0.19 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.357 -0.383 . . . . 15.0 111.235 -179.847 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -169.2 25.81 0.11 Allowed Glycine 0 N--CA 1.453 -0.2 0 C-N-CA 120.749 -0.738 . . . . 15.0 112.686 -179.73 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -94.28 153.41 21.05 Favored Glycine 0 N--CA 1.449 -0.47 0 N-CA-C 110.629 -0.989 . . . . 15.0 110.629 178.838 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.952 HG22 HG22 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -94.18 152.77 3.52 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.321 0 CA-C-N 117.727 0.764 . . . . 15.0 112.073 -179.252 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.51 ' CZ ' ' HG2' ' A' ' 57' ' ' ARG . 44.5 m-85 -136.04 106.29 6.39 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.84 -1.073 . . . . 15.0 109.613 178.849 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.817 HG22 ' N ' ' A' ' 55' ' ' GLY . 0.6 OUTLIER -55.22 145.74 5.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.911 -0.586 . . . . 15.0 111.491 -178.846 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.458 ' O ' ' HG2' ' A' ' 54' ' ' LYS . 1.2 ttpt -81.91 -47.45 12.74 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.342 -0.984 . . . . 15.0 108.342 178.213 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.545 ' O ' HG12 ' A' ' 20' ' ' ILE . . . -172.2 169.79 5.35 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.625 -0.716 . . . . 15.0 111.366 178.679 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.577 HG12 HG13 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -97.5 121.04 47.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-N 116.254 -0.43 . . . . 15.0 111.131 -179.871 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.742 HD11 ' CB ' ' A' ' 21' ' ' SER . 1.5 mm -78.98 110.33 14.16 Favored Pre-proline 0 N--CA 1.466 0.368 0 N-CA-C 113.135 0.791 . . . . 15.0 113.135 -178.919 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.524 ' HA ' ' OE1' ' A' ' 47' ' ' GLU . 17.8 Cg_exo -65.8 63.68 0.42 Allowed 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 122.858 2.372 . . . . 15.0 112.213 179.243 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 1.9 mm-40 -159.48 -45.81 0.05 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.654 -0.703 . . . . 15.0 109.85 179.873 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.513 ' HA3' ' HA3' ' A' ' 19' ' ' GLY . . . -87.42 151.51 23.47 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.68 -0.772 . . . . 15.0 112.374 179.518 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -39.96 -19.58 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 113.494 0.924 . . . . 15.0 113.494 -179.326 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.448 ' N ' ' O ' ' A' ' 44' ' ' GLY . . . -71.72 -70.95 0.29 Allowed 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.829 -0.348 . . . . 15.0 111.426 -179.453 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.592 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 9.9 tm-20 -58.2 -38.25 76.37 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.823 0.344 . . . . 15.0 110.336 179.599 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.3 m -53.9 -64.97 0.66 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.164 -0.471 . . . . 15.0 110.449 179.821 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.491 ' CB ' HD11 ' A' ' 11' ' ' LEU . 0.4 OUTLIER -63.21 -37.51 87.54 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.151 -0.477 . . . . 15.0 109.979 179.112 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.49 37.46 17.31 Favored Glycine 0 N--CA 1.449 -0.439 0 CA-C-N 115.726 -0.67 . . . . 15.0 112.377 179.695 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.566 ' HB3' HG23 ' A' ' 9' ' ' VAL . 0.9 OUTLIER -82.8 -54.65 4.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.938 0.399 . . . . 15.0 110.543 179.91 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.656 HG12 HD12 ' A' ' 20' ' ' ILE . 11.4 tp -81.18 159.07 4.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.979 -0.555 . . . . 15.0 110.177 179.458 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . 0.4 ' N ' ' OD2' ' A' ' 56' ' ' ASP . 76.1 m80 -142.16 160.67 39.76 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 121.766 0.793 . . . . 15.0 112.813 -178.784 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.585 ' HA ' ' CG2' ' A' ' 37' ' ' VAL . 1.2 mtpt -44.01 134.73 4.53 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 113.93 -1.486 . . . . 15.0 112.762 -178.788 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.817 ' N ' HG22 ' A' ' 37' ' ' VAL . . . 49.75 29.82 13.54 Favored Glycine 0 C--N 1.334 0.428 0 CA-C-N 115.791 -0.64 . . . . 15.0 113.448 179.261 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.4 ' OD2' ' N ' ' A' ' 53' ' ' HIS . 6.2 m-20 -65.78 128.75 37.26 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.761 -0.376 . . . . 15.0 110.413 179.359 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.612 ' HD2' HD21 ' A' ' 59' ' ' LEU . 0.0 OUTLIER -82.08 93.49 7.02 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.362 -0.381 . . . . 15.0 110.54 -179.988 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.952 HG22 HG22 ' A' ' 35' ' ' ILE . 1.2 m -86.26 115.7 27.86 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 CA-C-O 121.112 0.482 . . . . 15.0 111.586 -179.32 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.612 HD21 ' HD2' ' A' ' 57' ' ' ARG . 4.5 mm? -107.68 -14.67 14.76 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 115.633 -0.712 . . . . 15.0 112.542 -179.496 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.587 ' HB3' ' HB2' ' A' ' 88' ' ' LEU . . . -147.56 150.33 34.27 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 112.743 0.646 . . . . 15.0 112.743 -178.394 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.9 HG11 ' O ' ' A' ' 77' ' ' THR . 98.2 t -139.21 103.01 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.202 -0.908 . . . . 15.0 109.066 178.808 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.697 ' ND2' HG22 ' A' ' 81' ' ' THR . 1.2 m-80 65.23 16.9 10.79 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.516 -0.55 . . . . 15.0 109.516 -178.038 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.0 6.97 44.98 Favored Glycine 0 C--N 1.335 0.49 0 CA-C-N 115.789 -0.641 . . . . 15.0 113.135 179.814 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.658 ' O ' HG13 ' A' ' 64' ' ' VAL . 6.0 p -93.86 106.56 18.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.062 0.458 . . . . 15.0 110.724 179.394 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -58.3 122.98 14.56 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.179 -0.464 . . . . 15.0 110.955 -179.488 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.493 HD11 ' OG1' ' A' ' 77' ' ' THR . 3.7 mt -94.38 -12.53 27.73 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.836 -0.62 . . . . 15.0 111.286 -179.92 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -44.65 98.05 0.01 OUTLIER 'General case' 0 N--CA 1.461 0.1 0 CA-C-O 120.865 0.364 . . . . 15.0 110.894 179.855 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.85 67.53 0.6 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.838 -0.696 . . . . 15.0 112.102 -179.46 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.614 ' HB1' ' CB ' ' A' ' 73' ' ' GLN . . . -172.91 148.16 1.76 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.78 0.324 . . . . 15.0 110.837 -179.683 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.468 ' HB ' ' HA ' ' A' ' 26' ' ' VAL . 1.4 p -72.86 -174.2 1.41 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.019 0.438 . . . . 15.0 111.041 -179.731 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . 0.752 ' CD2' HG23 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -63.51 -59.03 5.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.885 -0.598 . . . . 15.0 110.658 -179.822 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.413 ' HA ' ' HB ' ' A' ' 75' ' ' VAL . 18.1 ttpp -52.44 -33.19 43.09 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.987 -0.551 . . . . 15.0 110.75 179.669 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.614 ' CB ' ' HB1' ' A' ' 69' ' ' ALA . 3.0 mt-30 -59.57 -49.98 75.65 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.428 -0.582 . . . . 15.0 109.428 179.123 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.458 ' HA ' ' OG1' ' A' ' 77' ' ' THR . . . -67.05 -45.93 75.93 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.743 -0.662 . . . . 15.0 109.836 178.482 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 1.028 HG23 HG21 ' A' ' 22' ' ' VAL . 0.5 OUTLIER -41.87 -41.49 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.27 0 CA-C-O 121.524 0.678 . . . . 15.0 109.218 178.553 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -67.33 -44.93 77.88 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.762 -1.108 . . . . 15.0 110.681 178.941 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.9 ' O ' HG11 ' A' ' 61' ' ' VAL . 15.3 p -64.38 -54.9 25.61 Favored 'General case' 0 N--CA 1.463 0.184 0 C-N-CA 121.028 -0.269 . . . . 15.0 111.599 -179.96 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.739 HD23 HG21 ' A' ' 61' ' ' VAL . 6.5 mt -53.43 -47.79 69.32 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-O 121.122 0.487 . . . . 15.0 110.188 -179.752 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.424 ' HB2' ' O ' ' A' ' 75' ' ' VAL . 3.1 ttp180 -68.32 -57.48 5.87 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.554 -0.748 . . . . 15.0 110.479 179.521 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -66.11 61.69 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.016 -0.538 . . . . 15.0 111.906 179.859 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.697 HG22 ' ND2' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -95.57 -74.97 0.54 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.719 0.295 . . . . 15.0 110.234 179.236 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.401 ' O ' ' HG3' ' A' ' 13' ' ' LYS . . . 120.36 -102.33 0.86 Allowed Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.775 -0.726 . . . . 15.0 112.88 179.381 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -64.7 -86.02 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.609 0.242 . . . . 15.0 111.209 -179.627 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.491 HG12 ' N ' ' A' ' 85' ' ' VAL . 86.8 t -109.77 160.36 8.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.886 0.374 . . . . 15.0 110.778 -179.924 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.91 HG23 ' HB2' ' A' ' 13' ' ' LYS . 3.1 t -97.66 81.86 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.214 0.53 . . . . 15.0 110.195 179.868 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -96.08 82.29 3.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.687 -0.688 . . . . 15.0 110.344 179.895 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.756 ' HB3' HD21 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -101.95 121.83 42.89 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.933 -0.576 . . . . 15.0 111.719 -179.281 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.723 HD12 ' HB2' ' A' ' 8' ' ' GLU . 4.7 mp -99.4 100.76 11.86 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.521 -0.548 . . . . 15.0 109.521 178.745 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.812 HD12 ' CZ ' ' A' ' 7' ' ' PHE . 0.1 OUTLIER -105.52 -161.52 0.81 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.456 0.646 . . . . 15.0 112.031 -178.501 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.438 ' HA ' ' HA ' ' A' ' 6' ' ' ILE . 1.1 tt0 -138.88 142.58 38.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 114.862 -1.063 . . . . 15.0 109.629 178.969 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 2.5 tppp? -54.48 106.04 0.18 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.978 0.418 . . . . 15.0 111.242 -179.421 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.382 0 C-N-CA 120.971 -0.633 . . . . 15.0 112.438 179.914 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.443 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 1.4 mp . . . . . 0 N--CA 1.449 -0.516 0 CA-C-O 120.818 0.342 . . . . 15.0 111.034 . . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.519 ' CE1' HD12 ' A' ' 89' ' ' LEU . 4.8 p90 -140.45 166.81 23.71 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.182 -0.463 . . . . 15.0 110.37 178.871 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.725 ' HB3' HD12 ' A' ' 88' ' ' LEU . 4.2 pt-20 -130.22 142.87 50.53 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.269 0.557 . . . . 15.0 111.88 -179.21 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.676 ' CG1' HD11 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -101.38 115.93 44.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.237 -0.892 . . . . 15.0 109.332 178.805 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.406 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 4.1 tt0 -105.96 76.37 1.17 Allowed 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 112.696 0.628 . . . . 15.0 112.696 -178.394 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.512 ' HB3' ' HB ' ' A' ' 85' ' ' VAL . 6.9 tp -88.16 162.03 16.93 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.018 -0.734 . . . . 15.0 109.018 177.995 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -96.92 89.98 5.05 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 112.431 0.53 . . . . 15.0 112.431 -179.185 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.689 ' HB2' HG23 ' A' ' 85' ' ' VAL . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.033 -0.531 . . . . 15.0 111.552 178.9 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.587 ' N ' HD22 ' A' ' 18' ' ' LEU . 2.4 mm? . . . . . 0 N--CA 1.45 -0.425 0 CA-C-O 120.811 0.338 . . . . 15.0 110.457 . . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.663 ' O ' ' HB ' ' A' ' 41' ' ' ILE . . . -167.51 37.1 0.22 Allowed Glycine 0 CA--C 1.506 -0.52 0 N-CA-C 111.566 -0.614 . . . . 15.0 111.566 -179.609 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.681 HD13 ' HB ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -112.5 142.28 25.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 112.216 0.45 . . . . 15.0 112.216 -179.04 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.435 ' H ' HD13 ' A' ' 41' ' ' ILE . 30.9 t -95.46 101.66 13.4 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 107.079 -1.452 . . . . 15.0 107.079 176.657 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.965 HG21 HG23 ' A' ' 75' ' ' VAL . 35.5 m -93.26 156.7 3.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 113.236 0.828 . . . . 15.0 113.236 -176.364 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.25 -175.03 4.82 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 114.966 -1.016 . . . . 15.0 110.647 -179.694 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.553 ' O ' HG22 ' A' ' 26' ' ' VAL . . . 68.79 -121.38 12.15 Favored Glycine 0 C--N 1.332 0.32 0 C-N-CA 120.868 -0.682 . . . . 15.0 112.469 179.8 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.521 ' HA3' ' N ' ' A' ' 71' ' ' HIS . . . 66.76 -64.42 0.18 Allowed Glycine 0 CA--C 1.518 0.269 0 C-N-CA 120.997 -0.621 . . . . 15.0 113.679 179.285 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.553 HG22 ' O ' ' A' ' 24' ' ' GLY . 0.0 OUTLIER -30.46 146.97 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 N-CA-C 112.591 0.589 . . . . 15.0 112.591 -179.204 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -75.75 56.31 0.92 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.872 -0.604 . . . . 15.0 111.066 -179.946 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.3 m -151.96 -63.61 0.17 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.914 0.388 . . . . 15.0 111.202 -179.986 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 30.9 t -67.07 -50.43 61.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.046 -0.524 . . . . 15.0 111.325 -179.575 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.532 HG11 ' O ' ' A' ' 34' ' ' GLY . 19.6 m -69.45 -175.94 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.378 -0.374 . . . . 15.0 111.415 -179.644 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.405 ' HD3' ' NH2' ' A' ' 57' ' ' ARG . 46.2 mtp85 -62.4 -53.06 60.53 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.162 -0.472 . . . . 15.0 111.089 -179.859 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . 0.418 ' CD2' ' HG2' ' A' ' 67' ' ' GLU . 42.1 p-80 -142.24 -52.79 0.41 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.449 -0.341 . . . . 15.0 111.201 179.939 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -169.18 19.01 0.08 OUTLIER Glycine 0 CA--C 1.519 0.328 0 C-N-CA 120.522 -0.847 . . . . 15.0 113.097 -179.802 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.532 ' O ' HG11 ' A' ' 30' ' ' VAL . . . -85.27 152.92 27.21 Favored Glycine 0 N--CA 1.45 -0.401 0 N-CA-C 110.797 -0.921 . . . . 15.0 110.797 178.89 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.944 HG22 HG22 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -90.54 154.97 3.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 117.642 0.721 . . . . 15.0 111.851 -179.352 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 30.4 m-85 -141.8 107.34 5.06 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.028 -0.987 . . . . 15.0 109.737 178.918 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.776 HG22 ' N ' ' A' ' 55' ' ' GLY . 0.8 OUTLIER -55.3 150.83 2.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.035 -0.53 . . . . 15.0 111.315 -178.9 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.496 ' O ' ' HG2' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -82.37 -47.04 12.78 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.416 -0.957 . . . . 15.0 108.416 178.412 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.588 ' O ' HG12 ' A' ' 20' ' ' ILE . . . -172.17 173.37 4.3 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.361 -0.836 . . . . 15.0 110.231 178.569 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.629 ' HA ' HG12 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -97.36 108.69 22.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.892 0.377 . . . . 15.0 110.349 179.647 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.663 ' HB ' ' O ' ' A' ' 19' ' ' GLY . 0.8 OUTLIER -78.96 110.53 14.86 Favored Pre-proline 0 C--O 1.234 0.245 0 N-CA-C 113.046 0.758 . . . . 15.0 113.046 -178.322 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.563 ' HA ' ' OE1' ' A' ' 47' ' ' GLU . 22.7 Cg_exo -64.28 66.58 0.24 Allowed 'Trans proline' 0 C--N 1.356 0.96 0 C-N-CA 123.177 2.585 . . . . 15.0 112.721 179.771 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.536 ' HB2' HG22 ' A' ' 41' ' ' ILE . 12.8 mt-30 -148.42 -52.88 0.18 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.483 -0.781 . . . . 15.0 109.258 179.233 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.644 ' HA3' ' HA3' ' A' ' 19' ' ' GLY . . . -88.24 156.19 26.91 Favored Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.612 -0.804 . . . . 15.0 112.474 179.044 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -42.5 -16.46 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 113.432 0.901 . . . . 15.0 113.432 -179.696 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.437 ' N ' ' O ' ' A' ' 44' ' ' GLY . . . -71.57 -70.27 0.33 Allowed 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.92 -0.312 . . . . 15.0 111.474 -179.258 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.563 ' OE1' ' HA ' ' A' ' 42' ' ' PRO . 10.2 tm-20 -58.31 -36.13 72.89 Favored 'General case' 0 N--CA 1.463 0.211 0 C-N-CA 120.504 -0.479 . . . . 15.0 110.064 179.408 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 48.8 m -57.57 -66.99 0.37 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.925 -0.58 . . . . 15.0 110.186 179.411 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.454 ' CB ' HD11 ' A' ' 11' ' ' LEU . 0.8 OUTLIER -60.55 -37.65 81.94 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.096 0.475 . . . . 15.0 109.881 179.004 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.44 37.43 17.54 Favored Glycine 0 N--CA 1.449 -0.461 0 CA-C-N 115.58 -0.736 . . . . 15.0 112.504 179.585 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.556 ' HB3' HG23 ' A' ' 9' ' ' VAL . 14.3 mmt180 -84.77 -49.75 8.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.94 0.4 . . . . 15.0 110.621 179.999 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.649 HG12 HD12 ' A' ' 20' ' ' ILE . 11.1 tp -81.19 157.22 4.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.016 -0.538 . . . . 15.0 110.347 179.537 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 76.6 m80 -139.65 158.1 44.67 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-O 121.753 0.787 . . . . 15.0 112.71 -179.006 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.599 ' HA ' ' CG2' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -44.25 134.95 4.72 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.137 -1.392 . . . . 15.0 112.477 -178.893 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.776 ' N ' HG22 ' A' ' 37' ' ' VAL . . . 49.7 34.32 21.0 Favored Glycine 0 C--N 1.334 0.456 0 C-N-CA 121.135 -0.555 . . . . 15.0 112.907 179.569 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.43 ' OD2' HD12 ' A' ' 52' ' ' ILE . 1.1 m-20 -65.5 130.64 44.04 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 121.003 -0.279 . . . . 15.0 110.439 179.636 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.405 ' NH2' ' HD3' ' A' ' 31' ' ' ARG . 59.7 ttt180 -86.33 86.45 7.34 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.112 -0.494 . . . . 15.0 110.432 179.792 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.944 HG22 HG22 ' A' ' 35' ' ' ILE . 1.3 m -79.41 116.68 23.79 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 CA-C-O 121.095 0.474 . . . . 15.0 110.948 -179.618 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 20.0 mt -107.19 -18.71 13.81 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.563 -0.744 . . . . 15.0 112.254 -179.323 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.424 ' HA ' ' O ' ' A' ' 64' ' ' VAL . . . -148.29 148.79 30.83 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 112.479 0.548 . . . . 15.0 112.479 -178.898 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.791 HG11 ' O ' ' A' ' 77' ' ' THR . 26.1 t -139.16 102.18 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.339 -0.846 . . . . 15.0 109.173 178.878 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.743 ' ND2' HG22 ' A' ' 81' ' ' THR . 1.4 m-80 64.8 15.03 9.58 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.699 -0.482 . . . . 15.0 109.699 -177.966 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 107.1 5.76 34.79 Favored Glycine 0 C--N 1.337 0.606 0 CA-C-N 115.86 -0.609 . . . . 15.0 113.425 179.727 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.657 ' O ' HG13 ' A' ' 64' ' ' VAL . 6.2 p -93.92 106.83 18.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 117.181 0.49 . . . . 15.0 111.083 179.474 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.99 134.24 55.6 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.217 -0.447 . . . . 15.0 110.995 -179.877 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.611 HD21 ' HA ' ' A' ' 74' ' ' ALA . 0.1 OUTLIER -95.5 -22.78 17.44 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.024 -0.535 . . . . 15.0 111.015 -179.958 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.418 ' HG2' ' CD2' ' A' ' 32' ' ' HIS . 1.8 tt0 -46.27 100.42 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.899 0.38 . . . . 15.0 111.064 179.942 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.73 63.67 0.55 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.814 -0.708 . . . . 15.0 112.222 -179.719 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.59 ' HB1' ' CG ' ' A' ' 73' ' ' GLN . . . -173.03 167.12 5.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.829 0.347 . . . . 15.0 111.117 -179.798 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.437 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 16.2 p -93.23 -175.11 3.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.227 -0.442 . . . . 15.0 111.095 -179.883 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . 0.773 ' CD2' HG23 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -62.17 -60.49 3.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.918 -0.583 . . . . 15.0 110.447 179.977 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.425 ' N ' ' CG ' ' A' ' 71' ' ' HIS . 8.0 ttpp -52.41 -31.12 32.66 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.814 -0.63 . . . . 15.0 110.517 179.448 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.59 ' CG ' ' HB1' ' A' ' 69' ' ' ALA . 0.3 OUTLIER -59.32 -52.02 67.42 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.64 -0.504 . . . . 15.0 109.64 179.335 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.611 ' HA ' HD21 ' A' ' 66' ' ' LEU . . . -66.95 -45.96 76.18 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.092 -0.504 . . . . 15.0 109.706 178.495 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.965 HG23 HG21 ' A' ' 22' ' ' VAL . 0.5 OUTLIER -41.43 -40.04 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.221 0 N-CA-C 109.123 -0.695 . . . . 15.0 109.123 178.43 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.421 ' HG3' ' O ' ' A' ' 72' ' ' LYS . 22.5 mt-10 -67.47 -46.72 72.18 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 114.731 -1.122 . . . . 15.0 110.244 178.488 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.791 ' O ' HG11 ' A' ' 61' ' ' VAL . 44.8 p -64.33 -51.9 61.14 Favored 'General case' 0 N--CA 1.461 0.102 0 C-N-CA 120.991 -0.283 . . . . 15.0 111.24 179.637 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.617 HD21 HG21 ' A' ' 58' ' ' VAL . 5.6 mt -53.53 -49.98 66.44 Favored 'General case' 0 CA--C 1.521 -0.168 0 CA-C-O 121.22 0.533 . . . . 15.0 109.878 179.934 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.46 -61.45 1.83 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.357 -0.838 . . . . 15.0 110.467 179.387 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -65.92 62.71 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.926 -0.579 . . . . 15.0 111.792 179.844 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.743 HG22 ' ND2' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -91.85 -69.81 0.72 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.648 0.261 . . . . 15.0 110.443 179.52 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 122.32 -107.19 1.13 Allowed Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.872 -0.68 . . . . 15.0 112.939 179.441 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.81 -83.56 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.775 0.321 . . . . 15.0 111.545 -179.45 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.474 HG12 ' N ' ' A' ' 85' ' ' VAL . 62.7 t -109.82 159.92 9.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.855 0.36 . . . . 15.0 110.335 179.999 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.689 HG23 ' HB2' ' A' ' 13' ' ' LYS . 24.4 t -97.85 80.16 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-O 121.016 0.436 . . . . 15.0 110.687 -179.943 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -98.46 81.89 2.79 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.893 -0.594 . . . . 15.0 110.447 179.865 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.772 ' HB3' HD21 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -101.15 118.03 36.19 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.045 -0.525 . . . . 15.0 111.742 -179.229 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.725 HD12 ' HB3' ' A' ' 8' ' ' GLU . 0.2 OUTLIER -94.99 101.47 13.23 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.302 -0.629 . . . . 15.0 109.302 178.657 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.772 HD21 ' HB3' ' A' ' 87' ' ' LEU . 0.2 OUTLIER -104.6 -162.29 0.88 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.417 0.627 . . . . 15.0 111.752 -178.629 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.443 ' HA ' ' HA ' ' A' ' 6' ' ' ILE . 2.2 tt0 -139.86 143.1 36.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.085 -0.961 . . . . 15.0 109.888 179.062 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -54.03 102.99 0.07 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.904 0.383 . . . . 15.0 110.96 -179.642 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.294 0 C-N-CA 120.84 -0.695 . . . . 15.0 112.65 -179.757 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.461 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 1.3 mp . . . . . 0 N--CA 1.451 -0.395 0 CA-C-O 121.024 0.44 . . . . 15.0 111.655 . . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.554 ' CZ ' HD12 ' A' ' 89' ' ' LEU . 3.3 p90 -141.68 165.06 28.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.884 -0.598 . . . . 15.0 110.263 178.759 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.774 ' HB2' HD12 ' A' ' 88' ' ' LEU . 0.2 OUTLIER -130.16 142.21 50.6 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.272 0.558 . . . . 15.0 111.615 -179.442 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.655 ' CG1' HD11 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -101.49 117.29 46.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.327 -0.851 . . . . 15.0 109.819 178.958 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -106.24 74.44 1.03 Allowed 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 112.166 0.432 . . . . 15.0 112.166 -179.031 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.585 HD13 ' CG ' ' A' ' 51' ' ' ARG . 8.7 tp -88.42 165.64 14.78 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.847 -0.427 . . . . 15.0 109.847 178.778 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -94.75 94.7 8.25 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.039 0.447 . . . . 15.0 111.186 -179.945 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.516 ' CB ' HG23 ' A' ' 85' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.363 0 CA-C-N 115.797 -0.638 . . . . 15.0 111.2 179.945 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.507 ' N ' HD22 ' A' ' 18' ' ' LEU . 1.4 mm? . . . . . 0 N--CA 1.452 -0.373 0 CA-C-O 120.915 0.388 . . . . 15.0 110.449 . . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.643 ' O ' ' HB ' ' A' ' 41' ' ' ILE . . . -161.57 31.02 0.32 Allowed Glycine 0 CA--C 1.507 -0.431 0 N-CA-C 111.535 -0.626 . . . . 15.0 111.535 -179.835 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.64 HD12 ' CG1' ' A' ' 52' ' ' ILE . 0.0 OUTLIER -112.62 139.76 35.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 121.061 0.458 . . . . 15.0 111.936 -179.206 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.468 ' O ' ' HB3' ' A' ' 38' ' ' LYS . 42.4 t -96.25 100.22 11.87 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 107.587 -1.264 . . . . 15.0 107.587 176.951 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.741 HG23 ' CD2' ' A' ' 71' ' ' HIS . 1.3 m -93.68 152.01 3.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 112.622 0.601 . . . . 15.0 112.622 -176.971 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.538 HG22 ' HB2' ' A' ' 38' ' ' LYS . 15.3 t -149.47 177.52 9.64 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.393 -0.822 . . . . 15.0 110.689 179.632 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.66 ' O ' HG22 ' A' ' 26' ' ' VAL . . . 83.05 -115.07 3.95 Favored Glycine 0 C--N 1.332 0.353 0 C-N-CA 120.723 -0.751 . . . . 15.0 112.136 -179.779 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.563 ' HA3' ' N ' ' A' ' 71' ' ' HIS . . . 63.79 -65.24 0.04 OUTLIER Glycine 0 C--N 1.331 0.266 0 C-N-CA 121.002 -0.618 . . . . 15.0 113.781 178.933 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.66 HG22 ' O ' ' A' ' 24' ' ' GLY . 0.0 OUTLIER -30.73 143.13 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 N-CA-C 112.234 0.457 . . . . 15.0 112.234 -179.116 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.409 ' CB ' ' O ' ' A' ' 32' ' ' HIS . 14.3 p-10 -75.59 62.26 1.41 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.956 -0.565 . . . . 15.0 111.0 -179.692 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 40.9 m -151.73 -67.13 0.17 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.308 -0.405 . . . . 15.0 111.088 -179.96 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -68.98 -32.45 72.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.137 -0.483 . . . . 15.0 111.071 -179.8 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.587 HG22 ' O ' ' A' ' 26' ' ' VAL . 19.8 m -88.09 -172.85 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.239 -0.437 . . . . 15.0 111.269 -179.895 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -61.94 -63.14 1.35 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.138 -0.483 . . . . 15.0 111.031 -179.984 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . 0.409 ' O ' ' CB ' ' A' ' 27' ' ' ASN . 90.8 m-70 -136.26 -49.72 0.68 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.294 -0.412 . . . . 15.0 111.103 -179.853 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -171.13 26.13 0.1 OUTLIER Glycine 0 C--N 1.329 0.155 0 C-N-CA 120.789 -0.72 . . . . 15.0 112.595 -179.755 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -89.51 154.43 24.13 Favored Glycine 0 N--CA 1.449 -0.472 0 N-CA-C 110.749 -0.94 . . . . 15.0 110.749 178.836 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.832 HG22 HG22 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -93.6 153.82 3.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 117.648 0.724 . . . . 15.0 111.828 -179.265 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.511 ' CE2' ' CG ' ' A' ' 57' ' ' ARG . 42.7 m-85 -138.39 106.28 5.67 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.957 -1.02 . . . . 15.0 109.859 179.69 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.818 HG22 ' N ' ' A' ' 55' ' ' GLY . 0.7 OUTLIER -55.27 145.29 5.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.164 -0.471 . . . . 15.0 111.002 -179.179 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.538 ' HB2' HG22 ' A' ' 23' ' ' THR . 0.2 OUTLIER -80.13 -47.57 14.55 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.661 -0.866 . . . . 15.0 108.661 178.512 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.567 ' O ' HG12 ' A' ' 20' ' ' ILE . . . -172.23 170.45 5.14 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 115.698 -0.683 . . . . 15.0 110.309 178.397 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.595 ' HA ' HG12 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -97.07 111.7 27.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.928 0.394 . . . . 15.0 110.264 179.638 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.643 ' HB ' ' O ' ' A' ' 19' ' ' GLY . 0.4 OUTLIER -78.65 109.99 12.57 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 115.781 -0.645 . . . . 15.0 112.632 -178.293 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.45 ' N ' ' HG2' ' A' ' 47' ' ' GLU . 24.5 Cg_exo -62.47 68.55 0.12 Allowed 'Trans proline' 0 C--N 1.356 0.935 0 C-N-CA 123.211 2.607 . . . . 15.0 112.507 179.828 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.478 ' HB2' HG22 ' A' ' 41' ' ' ILE . 8.1 mm-40 -153.43 -52.93 0.1 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.628 -0.715 . . . . 15.0 109.825 179.638 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.499 ' HA3' ' HA3' ' A' ' 19' ' ' GLY . . . -87.78 155.9 27.15 Favored Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.66 -0.781 . . . . 15.0 112.481 179.393 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -41.05 -16.8 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 113.517 0.932 . . . . 15.0 113.517 -179.546 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.463 ' N ' ' O ' ' A' ' 44' ' ' GLY . . . -71.68 -71.76 0.26 Allowed 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.819 -0.353 . . . . 15.0 111.155 -179.739 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.542 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 4.1 tp10 -58.27 -39.78 80.13 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 121.033 0.445 . . . . 15.0 110.402 179.569 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.2 m -53.98 -64.5 0.81 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.904 -0.589 . . . . 15.0 110.434 179.537 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.526 ' CB ' HD11 ' A' ' 11' ' ' LEU . 3.7 m-20 -64.79 -37.62 88.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.163 -0.471 . . . . 15.0 110.175 179.273 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.62 38.22 14.85 Favored Glycine 0 N--CA 1.45 -0.41 0 CA-C-N 115.744 -0.662 . . . . 15.0 112.571 179.581 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.585 ' CG ' HD13 ' A' ' 11' ' ' LEU . 0.2 OUTLIER -82.33 -54.47 5.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.968 0.413 . . . . 15.0 110.614 179.864 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.64 ' CG1' HD12 ' A' ' 20' ' ' ILE . 9.6 tp -81.09 159.72 4.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.873 -0.603 . . . . 15.0 110.379 179.705 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . 0.421 ' O ' ' HB2' ' A' ' 56' ' ' ASP . 53.2 m80 -140.74 159.47 42.14 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-O 121.742 0.782 . . . . 15.0 112.728 -178.875 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.595 ' HA ' ' CG2' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -44.14 134.45 4.8 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.054 -1.43 . . . . 15.0 113.057 -178.728 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.818 ' N ' HG22 ' A' ' 37' ' ' VAL . . . 49.83 31.4 16.58 Favored Glycine 0 C--N 1.335 0.483 0 CA-C-N 115.779 -0.646 . . . . 15.0 113.618 178.934 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.421 ' HB2' ' O ' ' A' ' 53' ' ' HIS . 0.4 OUTLIER -65.92 130.22 42.51 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.628 -0.429 . . . . 15.0 110.655 179.504 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.511 ' CG ' ' CE2' ' A' ' 36' ' ' TYR . 3.5 mtt180 -82.08 88.35 6.44 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.177 -0.465 . . . . 15.0 110.407 179.564 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.832 HG22 HG22 ' A' ' 35' ' ' ILE . 1.5 m -79.45 111.93 16.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 CA-C-O 121.199 0.523 . . . . 15.0 111.061 -179.554 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.414 ' N ' HD22 ' A' ' 59' ' ' LEU . 4.0 mm? -107.38 -15.14 14.7 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 115.558 -0.746 . . . . 15.0 112.33 -179.224 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.783 ' HB3' ' HB2' ' A' ' 88' ' ' LEU . . . -147.91 145.68 28.72 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.099 0.476 . . . . 15.0 112.217 -178.782 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.836 HG23 HD11 ' A' ' 66' ' ' LEU . 47.1 t -138.93 103.48 2.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.624 -0.716 . . . . 15.0 109.378 178.918 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.879 ' ND2' HG22 ' A' ' 81' ' ' THR . 1.7 m-80 64.97 16.43 10.55 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.727 -0.471 . . . . 15.0 109.727 -178.114 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.99 5.81 43.61 Favored Glycine 0 C--N 1.336 0.545 0 CA-C-N 115.744 -0.662 . . . . 15.0 113.103 179.958 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.649 ' O ' HG13 ' A' ' 64' ' ' VAL . 5.7 p -93.78 108.33 20.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 121.007 0.432 . . . . 15.0 110.915 179.573 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 13.7 m -58.74 124.41 19.67 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.178 0.514 . . . . 15.0 110.796 -179.781 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.836 HD11 HG23 ' A' ' 61' ' ' VAL . 0.2 OUTLIER -89.11 -18.7 26.69 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.489 -0.778 . . . . 15.0 111.21 -179.652 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -46.66 101.84 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 120.832 0.349 . . . . 15.0 110.985 179.88 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.75 66.38 0.58 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.788 -0.72 . . . . 15.0 112.291 -179.707 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.641 ' HB1' ' HB3' ' A' ' 73' ' ' GLN . . . -173.03 164.21 4.88 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.849 0.357 . . . . 15.0 111.031 -179.821 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.445 ' HB ' HG13 ' A' ' 26' ' ' VAL . 18.5 p -93.24 -174.66 3.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.998 0.428 . . . . 15.0 111.232 -179.831 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . 0.741 ' CD2' HG23 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -61.53 -61.88 2.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.85 -0.614 . . . . 15.0 109.826 179.774 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 16.1 ttpt -52.88 -35.61 58.09 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.876 -0.602 . . . . 15.0 110.085 179.005 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.641 ' HB3' ' HB1' ' A' ' 69' ' ' ALA . 3.5 tt0 -59.64 -48.96 79.62 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.944 -0.571 . . . . 15.0 109.501 179.035 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.467 ' HA ' ' OG1' ' A' ' 77' ' ' THR . . . -66.93 -46.71 73.94 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-N 115.92 -0.582 . . . . 15.0 109.491 178.344 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.59 HG23 ' CG2' ' A' ' 22' ' ' VAL . 0.5 OUTLIER -42.54 -39.72 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.27 0 N-CA-C 108.814 -0.81 . . . . 15.0 108.814 178.218 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.462 ' O ' ' HB2' ' A' ' 80' ' ' ASN . 1.0 OUTLIER -67.29 -46.34 73.9 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 114.663 -1.153 . . . . 15.0 110.57 178.59 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.622 ' O ' HG11 ' A' ' 61' ' ' VAL . 6.9 p -64.07 -53.74 44.98 Favored 'General case' 0 N--CA 1.462 0.16 0 C-N-CA 120.974 -0.29 . . . . 15.0 111.636 -179.87 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.696 HD23 HG21 ' A' ' 61' ' ' VAL . 6.9 mt -53.31 -46.8 69.55 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-O 121.259 0.552 . . . . 15.0 110.017 179.982 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.448 ' HB2' ' O ' ' A' ' 75' ' ' VAL . 0.0 OUTLIER -68.45 -57.41 5.89 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.344 -0.844 . . . . 15.0 110.784 179.576 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.462 ' HB2' ' O ' ' A' ' 76' ' ' GLU . 9.3 m-80 -66.14 61.53 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.103 -0.499 . . . . 15.0 112.155 -179.882 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.879 HG22 ' ND2' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -95.67 -68.44 0.8 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.836 0.35 . . . . 15.0 110.158 179.098 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 122.14 -108.33 1.28 Allowed Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 121.004 -0.617 . . . . 15.0 112.957 179.396 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.443 ' O ' ' HB3' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -65.26 -79.08 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.912 0.387 . . . . 15.0 111.773 -179.326 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.464 HG12 ' N ' ' A' ' 85' ' ' VAL . 75.6 t -109.88 159.42 9.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.942 -0.572 . . . . 15.0 111.035 -179.219 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.678 HG12 ' O ' ' A' ' 85' ' ' VAL . 5.9 t -97.9 81.14 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.122 0.486 . . . . 15.0 110.485 179.96 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 13.7 t60 -97.94 82.83 3.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.784 -0.644 . . . . 15.0 110.297 179.67 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.813 ' HB3' HD21 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -101.2 119.72 39.17 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.928 -0.578 . . . . 15.0 111.857 -179.132 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.783 ' HB2' ' HB3' ' A' ' 60' ' ' ALA . 4.0 mp -96.05 100.71 12.34 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.557 -0.535 . . . . 15.0 109.557 178.841 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.813 HD21 ' HB3' ' A' ' 87' ' ' LEU . 0.1 OUTLIER -105.61 -160.86 0.77 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.42 0.629 . . . . 15.0 111.974 -178.589 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.461 ' HA ' ' HA ' ' A' ' 6' ' ' ILE . 3.5 tt0 -138.91 139.89 38.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 114.978 -1.01 . . . . 15.0 109.979 179.107 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 14.0 tppt? -51.17 106.71 0.14 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.312 -0.404 . . . . 15.0 111.003 -179.913 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.328 0 C-N-CA 120.872 -0.68 . . . . 15.0 112.714 -179.789 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo . . . . . 0 N--CA 1.489 1.222 0 CA-C-O 120.953 0.314 . . . . 15.0 111.688 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 11.4 pttp -155.24 150.69 21.32 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.146 -0.479 . . . . 15.0 110.849 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -63.89 -162.78 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.552 2.168 . . . . 15.0 112.136 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 88.32 -20.5 29.9 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.516 -0.85 . . . . 15.0 112.44 -179.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -62.12 144.45 55.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.194 0.521 . . . . 15.0 110.727 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.467 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 1.4 mp -104.33 143.13 16.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.335 -0.848 . . . . 15.0 111.243 -179.192 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.545 ' CE1' HD12 ' A' ' 89' ' ' LEU . 2.8 p90 -140.43 164.95 28.76 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.088 -0.506 . . . . 15.0 110.261 178.621 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.727 ' HB3' HD12 ' A' ' 88' ' ' LEU . 6.3 pt-20 -130.09 142.09 50.64 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.362 0.601 . . . . 15.0 111.867 -179.047 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.593 ' CG1' HD11 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -101.56 114.74 41.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.037 -0.983 . . . . 15.0 109.728 178.915 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -105.87 72.11 0.93 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.156 -0.475 . . . . 15.0 111.916 -178.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.594 HD13 ' HG3' ' A' ' 51' ' ' ARG . 6.3 tp -88.33 165.67 14.82 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.098 -0.501 . . . . 15.0 110.061 179.056 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -95.57 92.26 6.55 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.93 0.395 . . . . 15.0 111.138 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.611 ' CB ' HG23 ' A' ' 85' ' ' VAL . 0.0 OUTLIER -54.42 -32.11 56.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.982 -0.554 . . . . 15.0 110.977 179.96 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.474 ' O ' ' CB ' ' A' ' 15' ' ' ASP . 0.9 OUTLIER -84.8 138.37 32.63 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.233 -0.439 . . . . 15.0 110.7 179.958 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.474 ' CB ' ' O ' ' A' ' 14' ' ' ASN . 9.8 t70 88.67 -27.91 0.05 Allowed 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.944 -0.571 . . . . 15.0 111.218 -179.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.491 ' HB3' ' HB2' ' A' ' 45' ' ' ALA . 16.0 m120 -161.86 133.89 5.64 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.827 0.346 . . . . 15.0 110.816 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.807 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 0.0 OUTLIER -86.04 -162.76 0.78 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.259 -0.428 . . . . 15.0 110.665 179.856 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.652 ' N ' HD22 ' A' ' 18' ' ' LEU . 1.3 mm? -93.27 -171.64 2.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.896 0.379 . . . . 15.0 110.653 179.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.735 ' O ' ' HB ' ' A' ' 41' ' ' ILE . . . -161.0 40.16 0.42 Allowed Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.908 -0.663 . . . . 15.0 111.973 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.703 HG12 ' O ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -112.83 139.77 36.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 120.961 0.41 . . . . 15.0 111.998 -179.414 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 21.8 t -96.04 105.76 17.84 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.132 -1.062 . . . . 15.0 108.132 177.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.919 HG21 HG23 ' A' ' 75' ' ' VAL . 18.5 m -93.84 156.0 3.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 113.435 0.902 . . . . 15.0 113.435 -176.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.5 -172.76 4.22 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 114.981 -1.009 . . . . 15.0 110.437 179.438 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.418 ' O ' ' CB ' ' A' ' 71' ' ' HIS . . . 68.65 -120.2 10.93 Favored Glycine 0 C--N 1.331 0.251 0 C-N-CA 120.773 -0.727 . . . . 15.0 112.72 179.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.561 ' HA3' ' N ' ' A' ' 71' ' ' HIS . . . 68.48 -66.59 0.41 Allowed Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.82 -0.705 . . . . 15.0 113.367 179.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.599 ' O ' HG22 ' A' ' 30' ' ' VAL . 2.1 m -33.13 144.33 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 N-CA-C 112.024 0.379 . . . . 15.0 112.024 -179.374 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 13.0 p-10 -75.57 62.67 1.44 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.059 -0.518 . . . . 15.0 111.008 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -151.71 -67.68 0.17 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.219 -0.446 . . . . 15.0 110.945 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 21.1 m -67.21 -33.33 75.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.129 -0.487 . . . . 15.0 110.949 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.599 HG22 ' O ' ' A' ' 26' ' ' VAL . 29.5 m -88.02 -174.01 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 15.0 111.209 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -64.26 -60.53 3.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.181 -0.463 . . . . 15.0 111.146 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 52.2 m80 -132.88 -57.36 0.93 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.388 -0.369 . . . . 15.0 111.225 -179.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -167.13 21.45 0.1 Allowed Glycine 0 CA--C 1.518 0.246 0 C-N-CA 120.816 -0.707 . . . . 15.0 112.718 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -83.74 152.77 29.16 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.467 -0.873 . . . . 15.0 110.921 178.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.815 HG22 HG22 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -89.12 153.7 3.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 117.482 0.641 . . . . 15.0 111.633 -179.357 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.424 ' CZ ' ' HG2' ' A' ' 57' ' ' ARG . 25.3 m-85 -141.35 108.26 5.42 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.084 -0.962 . . . . 15.0 109.661 179.324 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.763 HG22 ' N ' ' A' ' 55' ' ' GLY . 0.8 OUTLIER -56.09 154.85 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.18 0.514 . . . . 15.0 111.573 -178.939 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.47 ' O ' ' HG2' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -85.45 -47.94 9.46 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.379 -0.971 . . . . 15.0 108.379 178.239 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.703 ' O ' HG12 ' A' ' 20' ' ' ILE . . . -172.39 172.99 4.25 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 115.349 -0.841 . . . . 15.0 110.224 178.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.529 ' HA ' ' CG1' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -96.76 110.91 25.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 109.273 -0.64 . . . . 15.0 109.273 179.125 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.735 ' HB ' ' O ' ' A' ' 19' ' ' GLY . 0.4 OUTLIER -78.24 116.57 60.0 Favored Pre-proline 0 C--N 1.328 -0.364 0 N-CA-C 113.4 0.889 . . . . 15.0 113.4 -177.11 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.604 ' HA ' ' CG ' ' A' ' 47' ' ' GLU . 37.8 Cg_exo -61.56 61.56 0.11 Allowed 'Trans proline' 0 C--N 1.358 1.054 0 C-N-CA 123.76 2.973 . . . . 15.0 113.1 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.533 ' H ' ' HG2' ' A' ' 47' ' ' GLU . 3.0 mt-30 -149.93 -47.94 0.13 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.609 0.242 . . . . 15.0 111.592 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.67 ' HA3' ' HA3' ' A' ' 19' ' ' GLY . . . -87.79 168.04 37.28 Favored Glycine 0 C--N 1.329 0.176 0 C-N-CA 120.324 -0.941 . . . . 15.0 113.781 -179.167 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.807 ' HB3' ' O ' ' A' ' 17' ' ' SER . . . -57.51 -13.23 3.4 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.721 0.637 . . . . 15.0 112.721 -179.644 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.0 -57.56 4.19 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 120.988 -0.285 . . . . 15.0 110.663 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.604 ' CG ' ' HA ' ' A' ' 42' ' ' PRO . 2.7 pp20? -57.55 -42.84 83.79 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.97 -0.559 . . . . 15.0 110.379 179.097 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 69.4 m -53.64 -71.12 0.08 Allowed 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 115.806 -0.634 . . . . 15.0 110.571 -179.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.569 ' HB2' HD11 ' A' ' 11' ' ' LEU . 0.3 OUTLIER -58.13 -41.14 83.02 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.12 -0.696 . . . . 15.0 109.12 178.872 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.57 40.19 13.21 Favored Glycine 0 N--CA 1.446 -0.7 0 CA-C-N 115.357 -0.838 . . . . 15.0 111.631 179.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.594 ' HG3' HD13 ' A' ' 11' ' ' LEU . 1.2 mmp_? -79.71 -50.07 11.15 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.867 0.365 . . . . 15.0 110.658 -179.253 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.62 ' CG1' HD12 ' A' ' 20' ' ' ILE . 8.4 tp -80.91 162.54 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 CA-C-N 116.021 -0.536 . . . . 15.0 110.198 179.457 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.464 ' O ' ' HB2' ' A' ' 56' ' ' ASP . 79.6 m80 -146.88 159.88 42.99 Favored 'General case' 0 CA--C 1.514 -0.432 0 CA-C-O 121.641 0.734 . . . . 15.0 112.241 -179.067 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.53 ' HA ' ' CG2' ' A' ' 37' ' ' VAL . 0.1 OUTLIER -43.49 133.43 4.38 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.407 -1.269 . . . . 15.0 112.526 -178.77 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.763 ' N ' HG22 ' A' ' 37' ' ' VAL . . . 49.91 35.12 24.17 Favored Glycine 0 C--N 1.333 0.381 0 CA-C-N 115.927 -0.579 . . . . 15.0 113.377 179.328 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.464 ' HB2' ' O ' ' A' ' 53' ' ' HIS . 0.4 OUTLIER -65.92 132.5 48.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 117.08 0.44 . . . . 15.0 110.682 179.632 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.737 ' CD ' HD21 ' A' ' 59' ' ' LEU . 0.0 OUTLIER -85.5 85.9 7.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.04 -0.527 . . . . 15.0 110.618 179.799 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.815 HG22 HG22 ' A' ' 35' ' ' ILE . 1.4 m -79.49 116.33 23.31 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 CA-C-O 120.998 0.428 . . . . 15.0 110.955 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.737 HD21 ' CD ' ' A' ' 57' ' ' ARG . 18.7 mt -107.01 -18.11 14.0 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.809 -0.632 . . . . 15.0 112.329 -179.146 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.483 ' O ' HD23 ' A' ' 87' ' ' LEU . . . -147.84 149.67 32.73 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.246 0.546 . . . . 15.0 112.389 -178.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.663 HG11 ' O ' ' A' ' 77' ' ' THR . 17.6 t -138.93 101.67 1.66 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.31 0 CA-C-N 115.312 -0.858 . . . . 15.0 109.138 178.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.793 ' ND2' HG22 ' A' ' 81' ' ' THR . 1.7 m-80 64.95 15.51 10.0 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.637 -0.505 . . . . 15.0 109.637 -177.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 107.04 5.46 35.22 Favored Glycine 0 C--N 1.338 0.642 0 CA-C-N 115.811 -0.631 . . . . 15.0 113.471 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.653 ' O ' HG13 ' A' ' 64' ' ' VAL . 6.3 p -93.91 107.18 18.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 117.085 0.442 . . . . 15.0 111.059 179.549 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.3 m -56.96 134.67 55.86 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.216 -0.447 . . . . 15.0 111.07 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.675 HD21 ' HA ' ' A' ' 74' ' ' ALA . 0.2 OUTLIER -97.83 -20.59 17.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.009 -0.542 . . . . 15.0 111.173 -179.994 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -45.64 110.91 0.29 Allowed 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.384 -0.371 . . . . 15.0 111.123 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 97.62 64.25 0.89 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.781 -0.723 . . . . 15.0 112.251 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.606 ' HB1' ' CG ' ' A' ' 73' ' ' GLN . . . -173.03 166.85 5.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.916 0.389 . . . . 15.0 111.148 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.435 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 15.3 p -93.49 -172.63 2.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.18 -0.463 . . . . 15.0 111.301 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.767 ' CD2' HG23 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -63.57 -59.07 5.09 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.72 -0.673 . . . . 15.0 110.557 179.816 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 9.4 ttpp -52.36 -31.2 32.53 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.868 -0.606 . . . . 15.0 110.627 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.606 ' CG ' ' HB1' ' A' ' 69' ' ' ALA . 0.0 OUTLIER -59.3 -53.77 54.42 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.239 -0.437 . . . . 15.0 109.932 179.444 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.675 ' HA ' HD21 ' A' ' 66' ' ' LEU . . . -66.78 -43.91 82.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.173 -0.467 . . . . 15.0 109.86 178.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.919 HG23 HG21 ' A' ' 22' ' ' VAL . 0.5 OUTLIER -42.37 -41.79 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.225 0 N-CA-C 109.129 -0.693 . . . . 15.0 109.129 178.376 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -67.46 -44.54 78.36 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 114.875 -1.057 . . . . 15.0 110.289 178.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.663 ' O ' HG11 ' A' ' 61' ' ' VAL . 69.0 p -64.09 -54.27 36.58 Favored 'General case' 0 N--CA 1.461 0.117 0 C-N-CA 121.161 -0.215 . . . . 15.0 111.508 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.562 HD21 HG21 ' A' ' 58' ' ' VAL . 7.6 mt -53.55 -47.88 69.61 Favored 'General case' 0 CA--C 1.518 -0.25 0 CA-C-O 121.313 0.578 . . . . 15.0 109.867 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.404 ' HB2' ' O ' ' A' ' 75' ' ' VAL . 11.1 ttp85 -68.42 -59.95 2.79 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.242 -0.89 . . . . 15.0 110.651 179.484 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 68.6 m-20 -66.06 58.52 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.865 -0.607 . . . . 15.0 112.498 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.793 HG22 ' ND2' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -95.57 -71.46 0.67 Allowed 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.89 -0.411 . . . . 15.0 109.89 178.872 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 121.11 -104.15 0.94 Allowed Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.703 -0.76 . . . . 15.0 113.344 178.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.401 ' O ' ' HB3' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -64.67 -82.77 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 112.104 0.409 . . . . 15.0 112.104 -178.943 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.441 HG12 ' N ' ' A' ' 85' ' ' VAL . 75.6 t -109.79 158.66 9.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.107 0.479 . . . . 15.0 111.232 -179.114 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.675 HG12 ' O ' ' A' ' 85' ' ' VAL . 6.7 t -97.79 82.03 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.992 -0.549 . . . . 15.0 110.498 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -99.06 82.18 2.7 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.76 -0.655 . . . . 15.0 110.291 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.812 ' HB3' HD21 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -103.97 118.74 37.4 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.046 -0.524 . . . . 15.0 112.061 -178.988 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.727 HD12 ' HB3' ' A' ' 8' ' ' GLU . 0.2 OUTLIER -95.46 101.4 13.11 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.111 -0.7 . . . . 15.0 109.111 178.252 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.812 HD21 ' HB3' ' A' ' 87' ' ' LEU . 0.2 OUTLIER -104.11 -164.91 1.1 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.439 0.638 . . . . 15.0 112.094 -178.312 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.467 ' HA ' ' HA ' ' A' ' 6' ' ' ILE . 2.3 tt0 -139.37 139.84 37.31 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.999 -1.0 . . . . 15.0 109.817 179.205 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 6.7 tptt -52.11 102.04 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.009 0.433 . . . . 15.0 111.06 -179.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -72.17 135.54 22.76 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.973 -0.632 . . . . 15.0 112.784 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -86.38 176.01 8.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.801 0.334 . . . . 15.0 110.787 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -90.18 165.48 23.73 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.205 -0.452 . . . . 15.0 110.9 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_exo -51.43 -58.6 1.53 Allowed 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.583 2.189 . . . . 15.0 112.269 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.7 t . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.195 -0.907 . . . . 15.0 110.912 179.959 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo . . . . . 0 N--CA 1.488 1.168 0 CA-C-O 120.941 0.309 . . . . 15.0 111.821 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -155.27 146.4 16.58 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.16 -0.473 . . . . 15.0 110.795 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -69.06 -166.77 0.17 Allowed 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.431 2.087 . . . . 15.0 112.162 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 84.67 -15.34 42.35 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.452 -0.88 . . . . 15.0 112.344 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -62.04 151.34 35.62 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 121.111 0.481 . . . . 15.0 110.518 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.455 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 1.1 mp -104.34 146.07 12.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.672 -0.694 . . . . 15.0 111.324 -179.226 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.749 ' CE1' HD12 ' A' ' 89' ' ' LEU . 6.0 p90 -140.29 152.02 45.55 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.902 -0.59 . . . . 15.0 110.193 178.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.741 ' HB2' HD12 ' A' ' 88' ' ' LEU . 1.4 pm0 -120.93 143.06 49.17 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.373 0.606 . . . . 15.0 111.713 -179.22 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.559 ' CG1' HD11 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -101.47 115.51 43.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.119 -0.946 . . . . 15.0 109.558 178.948 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -106.18 74.33 1.03 Allowed 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 112.321 0.489 . . . . 15.0 112.321 -178.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.66 HD13 ' HG3' ' A' ' 51' ' ' ARG . 6.7 tp -88.11 164.84 15.51 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.339 -0.615 . . . . 15.0 109.339 178.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -96.33 97.72 9.71 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.047 0.451 . . . . 15.0 111.379 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.607 ' CB ' HG23 ' A' ' 85' ' ' VAL . 0.0 OUTLIER -64.23 -34.08 77.29 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.77 -0.65 . . . . 15.0 111.064 179.948 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.455 ' N ' ' O ' ' A' ' 83' ' ' GLN . 2.1 t30 -84.94 62.57 7.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.194 -0.457 . . . . 15.0 110.813 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 13.0 t0 179.81 -38.27 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.721 -0.672 . . . . 15.0 110.199 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.494 ' HB3' ' HB2' ' A' ' 45' ' ' ALA . 11.1 t30 -164.93 149.73 9.32 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.628 -0.714 . . . . 15.0 110.291 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.743 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 0.5 OUTLIER -85.85 -171.47 3.6 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.422 -0.354 . . . . 15.0 110.573 179.966 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.64 ' N ' HD22 ' A' ' 18' ' ' LEU . 1.9 mm? -88.67 -174.65 4.63 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.225 -0.443 . . . . 15.0 110.612 179.479 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.761 ' O ' ' HB ' ' A' ' 41' ' ' ILE . . . -160.88 43.53 0.41 Allowed Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.939 -0.648 . . . . 15.0 111.698 -179.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.687 HG12 ' O ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -112.78 138.46 41.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 120.948 0.404 . . . . 15.0 111.615 -179.453 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.441 ' H ' HD13 ' A' ' 41' ' ' ILE . 31.4 t -91.73 103.5 16.06 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 107.813 -1.18 . . . . 15.0 107.813 177.443 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.978 HG21 HG23 ' A' ' 75' ' ' VAL . 32.8 m -93.72 154.42 3.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 113.079 0.77 . . . . 15.0 113.079 -177.012 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.29 -175.22 4.9 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.132 -0.94 . . . . 15.0 110.72 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.533 ' O ' HG22 ' A' ' 26' ' ' VAL . . . 68.67 -119.88 10.54 Favored Glycine 0 C--N 1.332 0.306 0 C-N-CA 120.829 -0.701 . . . . 15.0 112.424 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.533 ' HA3' ' N ' ' A' ' 71' ' ' HIS . . . 68.12 -64.21 0.37 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.876 -0.678 . . . . 15.0 113.525 179.4 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.533 HG22 ' O ' ' A' ' 24' ' ' GLY . 0.0 OUTLIER -30.63 138.58 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 N-CA-C 112.337 0.495 . . . . 15.0 112.337 -179.323 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 28.3 p30 -75.55 62.72 1.44 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.897 -0.592 . . . . 15.0 111.012 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.0 m -151.7 -50.76 0.12 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.277 -0.42 . . . . 15.0 111.106 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -87.65 -40.54 14.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.232 -0.44 . . . . 15.0 111.192 -179.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.506 HG22 ' O ' ' A' ' 26' ' ' VAL . 31.1 m -72.62 -174.9 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.317 -0.402 . . . . 15.0 111.366 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 2.1 ttm180 -60.31 -40.78 91.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.2 -0.455 . . . . 15.0 111.239 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . 0.454 ' CD2' ' N ' ' A' ' 32' ' ' HIS . 0.1 OUTLIER -163.9 -46.76 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.688 -0.233 . . . . 15.0 111.515 179.799 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -170.22 19.96 0.07 OUTLIER Glycine 0 CA--C 1.519 0.288 0 C-N-CA 120.649 -0.786 . . . . 15.0 112.979 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.405 ' O ' HG11 ' A' ' 30' ' ' VAL . . . -89.76 153.85 23.48 Favored Glycine 0 N--CA 1.45 -0.385 0 N-CA-C 111.005 -0.838 . . . . 15.0 111.005 179.018 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.831 HG22 HG22 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -89.13 155.62 3.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 117.478 0.639 . . . . 15.0 111.773 -179.396 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.47 ' CE2' ' HG2' ' A' ' 57' ' ' ARG . 29.5 m-85 -140.19 106.75 5.32 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.082 -0.963 . . . . 15.0 109.804 179.023 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.793 HG22 ' N ' ' A' ' 55' ' ' GLY . 0.6 OUTLIER -55.35 147.05 4.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.913 -0.585 . . . . 15.0 111.361 -178.956 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.459 ' O ' ' HG2' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -80.35 -48.61 12.68 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.449 -0.945 . . . . 15.0 108.449 178.379 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.687 ' O ' HG12 ' A' ' 20' ' ' ILE . . . -172.2 173.95 4.12 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 115.416 -0.811 . . . . 15.0 110.142 178.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.575 ' HA ' HG12 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -97.03 110.09 24.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 109.657 -0.498 . . . . 15.0 109.657 179.295 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.761 ' HB ' ' O ' ' A' ' 19' ' ' GLY . 0.6 OUTLIER -78.4 116.48 59.57 Favored Pre-proline 0 C--N 1.328 -0.333 0 N-CA-C 113.39 0.885 . . . . 15.0 113.39 -177.518 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.621 ' HA ' ' CG ' ' A' ' 47' ' ' GLU . 35.2 Cg_exo -62.01 59.94 0.13 Allowed 'Trans proline' 0 C--N 1.357 1.02 0 C-N-CA 123.663 2.909 . . . . 15.0 113.064 179.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.538 ' N ' ' HG2' ' A' ' 47' ' ' GLU . 0.6 OUTLIER -147.53 -47.69 0.17 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.642 0.258 . . . . 15.0 111.579 179.913 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.725 ' HA3' ' HA3' ' A' ' 19' ' ' GLY . . . -87.86 168.81 37.94 Favored Glycine 0 C--N 1.331 0.279 0 C-N-CA 120.393 -0.908 . . . . 15.0 114.047 -179.022 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.743 ' HB3' ' O ' ' A' ' 17' ' ' SER . . . -57.51 -13.72 4.09 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.592 0.59 . . . . 15.0 112.592 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.11 -57.72 4.03 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.712 0.291 . . . . 15.0 110.797 -179.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.621 ' CG ' ' HA ' ' A' ' 42' ' ' PRO . 2.9 pp20? -57.57 -42.37 82.96 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.77 -0.65 . . . . 15.0 110.381 179.276 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -53.76 -71.49 0.07 Allowed 'General case' 0 CA--C 1.519 -0.241 0 CA-C-N 115.814 -0.63 . . . . 15.0 110.486 -179.404 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.581 ' HB2' HD11 ' A' ' 11' ' ' LEU . 0.2 OUTLIER -58.36 -41.15 84.09 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.125 -0.694 . . . . 15.0 109.125 178.801 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.78 40.46 12.15 Favored Glycine 0 N--CA 1.446 -0.643 0 CA-C-N 115.416 -0.811 . . . . 15.0 111.726 179.365 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.66 ' HG3' HD13 ' A' ' 11' ' ' LEU . 0.6 OUTLIER -79.92 -48.19 13.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.907 0.384 . . . . 15.0 110.726 -179.402 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.595 ' CG1' HD12 ' A' ' 20' ' ' ILE . 9.4 tp -81.11 162.07 3.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.037 -0.528 . . . . 15.0 110.275 179.56 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.475 ' N ' ' OD2' ' A' ' 56' ' ' ASP . 78.8 m80 -147.51 157.63 43.65 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-O 121.61 0.719 . . . . 15.0 112.021 -179.073 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.558 ' HA ' ' CG2' ' A' ' 37' ' ' VAL . 0.1 OUTLIER -42.4 132.2 3.55 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.327 -1.306 . . . . 15.0 113.027 -178.564 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.793 ' N ' HG22 ' A' ' 37' ' ' VAL . . . 50.35 30.31 18.29 Favored Glycine 0 C--N 1.333 0.416 0 CA-C-N 115.672 -0.694 . . . . 15.0 113.4 179.235 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.475 ' OD2' ' N ' ' A' ' 53' ' ' HIS . 16.8 m-20 -65.87 129.59 40.33 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.716 -0.394 . . . . 15.0 110.58 179.521 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.47 ' HG2' ' CE2' ' A' ' 36' ' ' TYR . 15.8 mtt-85 -80.85 96.84 7.13 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.229 -0.441 . . . . 15.0 110.846 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.831 HG22 HG22 ' A' ' 35' ' ' ILE . 1.4 m -86.96 114.02 25.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.079 0.466 . . . . 15.0 110.749 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 21.5 mt -107.02 -16.42 14.44 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.799 -0.637 . . . . 15.0 112.397 -179.05 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.79 ' HB3' ' HB2' ' A' ' 88' ' ' LEU . . . -148.13 147.67 29.75 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.509 0.559 . . . . 15.0 112.509 -178.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.863 HG11 ' O ' ' A' ' 77' ' ' THR . 21.4 t -139.03 101.12 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.316 -0.856 . . . . 15.0 109.16 178.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.682 ' ND2' HG22 ' A' ' 81' ' ' THR . 1.7 m-80 65.14 15.98 10.3 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.72 -0.474 . . . . 15.0 109.72 -177.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 107.07 4.58 35.73 Favored Glycine 0 C--N 1.337 0.598 0 CA-C-N 115.969 -0.56 . . . . 15.0 113.469 179.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.644 ' O ' HG13 ' A' ' 64' ' ' VAL . 5.4 p -93.9 108.4 20.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 117.122 0.461 . . . . 15.0 111.164 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 61.5 m -56.87 138.14 54.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.296 -0.411 . . . . 15.0 110.996 -179.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.912 HD11 ' HB2' ' A' ' 74' ' ' ALA . 0.2 OUTLIER -97.75 -21.88 16.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.063 -0.517 . . . . 15.0 111.085 -179.903 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -46.53 106.17 0.08 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.361 -0.381 . . . . 15.0 111.21 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 104.33 62.16 0.67 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.808 -0.711 . . . . 15.0 112.453 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.666 ' HB1' ' CB ' ' A' ' 73' ' ' GLN . . . -173.18 163.48 4.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.86 0.362 . . . . 15.0 111.086 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.46 ' HB ' HG13 ' A' ' 26' ' ' VAL . 1.7 p -92.33 -171.96 2.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.457 . . . . 15.0 110.983 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.777 ' CD2' HG23 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -62.19 -59.45 5.03 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.844 -0.616 . . . . 15.0 110.458 179.949 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.41 ' O ' HG12 ' A' ' 75' ' ' VAL . 24.9 ttpp -52.68 -34.29 51.23 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.768 -0.651 . . . . 15.0 110.836 179.612 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.666 ' CB ' ' HB1' ' A' ' 69' ' ' ALA . 3.2 mt-30 -59.28 -50.77 72.7 Favored 'General case' 0 CA--C 1.518 -0.272 0 N-CA-C 109.527 -0.546 . . . . 15.0 109.527 179.35 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.912 ' HB2' HD11 ' A' ' 66' ' ' LEU . . . -66.29 -45.42 80.47 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.69 -0.687 . . . . 15.0 109.672 178.519 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.978 HG23 HG21 ' A' ' 22' ' ' VAL . 0.5 OUTLIER -43.15 -40.51 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.243 0 N-CA-C 108.976 -0.749 . . . . 15.0 108.976 178.243 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -67.26 -44.96 78.08 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 114.871 -1.058 . . . . 15.0 110.076 178.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.863 ' O ' HG11 ' A' ' 61' ' ' VAL . 41.2 p -64.3 -53.41 49.29 Favored 'General case' 0 N--CA 1.461 0.098 0 CA-C-O 120.572 0.225 . . . . 15.0 111.318 179.606 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.718 HD21 HG21 ' A' ' 58' ' ' VAL . 6.1 mt -53.42 -48.86 68.35 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 121.245 0.545 . . . . 15.0 109.97 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.413 ' O ' ' N ' ' A' ' 81' ' ' THR . 0.2 OUTLIER -68.38 -59.05 3.46 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.317 -0.856 . . . . 15.0 110.665 179.502 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -65.88 62.9 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.946 -0.57 . . . . 15.0 111.931 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.682 HG22 ' ND2' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -91.7 -70.87 0.67 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.785 0.326 . . . . 15.0 110.302 179.425 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 122.28 -109.97 1.52 Allowed Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.978 -0.63 . . . . 15.0 112.852 179.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.455 ' O ' ' N ' ' A' ' 14' ' ' ASN . 0.8 OUTLIER -65.25 -77.88 0.06 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.884 0.373 . . . . 15.0 111.438 -179.437 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.44 HG12 ' N ' ' A' ' 85' ' ' VAL . 51.0 t -110.26 159.07 10.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.198 -0.455 . . . . 15.0 110.678 -179.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.655 HG12 ' O ' ' A' ' 85' ' ' VAL . 19.7 t -98.12 79.92 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.051 0.453 . . . . 15.0 110.429 179.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 3.0 t60 -100.51 84.22 2.73 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.842 -0.617 . . . . 15.0 110.426 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.794 ' HB3' HD21 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -101.45 117.53 35.13 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.003 -0.544 . . . . 15.0 111.655 -179.325 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.79 ' HB2' ' HB3' ' A' ' 60' ' ' ALA . 4.3 mp -92.87 100.23 12.74 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.807 -0.442 . . . . 15.0 109.807 179.038 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.794 HD21 ' HB3' ' A' ' 87' ' ' LEU . 0.2 OUTLIER -103.88 -162.83 0.93 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.92 -0.582 . . . . 15.0 111.655 -178.871 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.455 ' HA ' ' HA ' ' A' ' 6' ' ' ILE . 3.8 tt0 -139.09 148.18 42.97 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.259 -0.882 . . . . 15.0 110.056 179.285 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.04 113.41 1.69 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.298 -0.41 . . . . 15.0 111.136 -179.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -71.34 88.31 0.42 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.879 -0.677 . . . . 15.0 112.722 -179.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -86.42 139.93 30.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.773 0.32 . . . . 15.0 110.748 179.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -60.19 136.13 91.14 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.276 -0.42 . . . . 15.0 110.887 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -53.47 109.19 0.33 Allowed 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.467 2.111 . . . . 15.0 112.274 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 39.6 p . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.259 -0.877 . . . . 15.0 110.941 179.969 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_endo . . . . . 0 N--CA 1.488 1.158 0 CA-C-O 120.809 0.254 . . . . 15.0 111.78 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.11 144.2 16.51 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.225 -0.443 . . . . 15.0 110.901 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.73 -161.78 0.09 OUTLIER 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.584 2.189 . . . . 15.0 112.305 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 90.57 -23.67 21.21 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.612 -0.804 . . . . 15.0 112.27 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 58.7 m-20 -62.18 145.64 52.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.241 0.543 . . . . 15.0 110.827 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.459 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 1.4 mp -104.38 142.52 17.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.281 -0.872 . . . . 15.0 111.101 -179.356 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.682 ' CZ ' HD12 ' A' ' 89' ' ' LEU . 3.4 p90 -140.66 163.33 33.18 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.185 -0.461 . . . . 15.0 110.574 178.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.737 ' HB2' HD12 ' A' ' 88' ' ' LEU . 10.2 pt-20 -129.04 143.6 50.92 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.204 0.526 . . . . 15.0 111.466 -179.364 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.499 ' CG1' HD11 ' A' ' 89' ' ' LEU . 0.3 OUTLIER -101.54 115.7 43.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.335 -0.848 . . . . 15.0 109.818 178.969 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -105.98 70.54 0.86 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.154 -0.475 . . . . 15.0 111.727 -179.202 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.77 HD13 ' CG ' ' A' ' 51' ' ' ARG . 4.9 tp -88.05 165.74 14.94 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.117 -0.492 . . . . 15.0 110.064 179.167 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -95.71 94.43 7.69 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.919 0.39 . . . . 15.0 111.125 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.674 ' CB ' HG23 ' A' ' 85' ' ' VAL . 0.2 OUTLIER -54.08 -28.22 37.79 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.96 -0.564 . . . . 15.0 111.095 179.962 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.449 ' O ' ' CB ' ' A' ' 15' ' ' ASP . 25.0 m-20 -84.5 154.96 22.39 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.252 -0.431 . . . . 15.0 110.596 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.449 ' CB ' ' O ' ' A' ' 14' ' ' ASN . 10.0 t0 84.02 -42.93 0.08 Allowed 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.217 -0.447 . . . . 15.0 110.794 -179.343 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.513 ' HB3' ' HB2' ' A' ' 45' ' ' ALA . 1.0 OUTLIER -155.09 145.34 21.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.326 -0.397 . . . . 15.0 110.37 179.687 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.762 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 0.0 OUTLIER -86.04 -164.41 1.03 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.369 -0.378 . . . . 15.0 110.873 -179.677 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.649 ' N ' HD22 ' A' ' 18' ' ' LEU . 1.3 mm? -93.3 -170.64 2.44 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.167 -0.47 . . . . 15.0 110.736 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.773 ' O ' ' HB ' ' A' ' 41' ' ' ILE . . . -169.02 43.67 0.22 Allowed Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.72 -0.752 . . . . 15.0 112.314 -179.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.707 HD12 ' HB ' ' A' ' 52' ' ' ILE . 0.0 OUTLIER -112.72 139.39 37.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 120.928 0.394 . . . . 15.0 111.516 -179.806 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.401 ' HB3' HD11 ' A' ' 41' ' ' ILE . 18.3 t -96.23 105.41 17.46 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.572 -0.899 . . . . 15.0 108.572 178.004 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.804 ' CG2' HG23 ' A' ' 75' ' ' VAL . 5.7 m -93.94 155.21 3.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 112.722 0.638 . . . . 15.0 112.722 -177.511 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.657 ' O ' ' O ' ' A' ' 36' ' ' TYR . 0.2 OUTLIER -149.68 153.28 36.72 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.627 -0.715 . . . . 15.0 111.463 -179.7 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.418 ' O ' HG12 ' A' ' 35' ' ' ILE . . . 67.5 121.53 0.02 OUTLIER Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.484 -0.865 . . . . 15.0 113.351 178.648 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.523 ' HA3' ' N ' ' A' ' 71' ' ' HIS . . . -166.3 -39.3 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.962 -0.637 . . . . 15.0 112.455 179.27 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.553 ' O ' HG22 ' A' ' 30' ' ' VAL . 0.1 OUTLIER -40.46 161.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 CA-C-O 120.849 0.357 . . . . 15.0 111.645 179.87 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 6.8 m-80 -85.84 52.51 2.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.22 -0.445 . . . . 15.0 110.952 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.4 m -151.71 -58.23 0.15 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.195 -0.457 . . . . 15.0 110.8 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.4 m -68.91 -51.76 36.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 15.0 110.847 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.673 HG21 ' O ' ' A' ' 34' ' ' GLY . 17.5 m -87.99 -169.08 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.166 -0.47 . . . . 15.0 110.934 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 4.3 mmt180 -93.41 125.67 38.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.937 0.399 . . . . 15.0 111.073 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 74.6 m80 61.67 -80.61 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.945 -0.571 . . . . 15.0 111.52 179.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -175.25 34.59 0.1 OUTLIER Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.9 -0.667 . . . . 15.0 112.422 -179.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.673 ' O ' HG21 ' A' ' 30' ' ' VAL . . . -95.15 158.24 22.3 Favored Glycine 0 N--CA 1.449 -0.487 0 N-CA-C 110.659 -0.976 . . . . 15.0 110.659 179.027 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 1.051 HG22 HG22 ' A' ' 58' ' ' VAL . 0.1 OUTLIER -101.12 153.11 4.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 C-N-CA 119.852 -0.739 . . . . 15.0 112.058 -179.326 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.657 ' O ' ' O ' ' A' ' 23' ' ' THR . 11.7 m-85 -133.22 108.29 8.68 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.13 -0.941 . . . . 15.0 109.308 179.343 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.705 HG22 ' N ' ' A' ' 55' ' ' GLY . 0.7 OUTLIER -54.84 169.61 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 C-N-CA 120.359 -0.536 . . . . 15.0 111.113 -178.33 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.77 -49.22 4.23 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.806 -0.813 . . . . 15.0 108.806 178.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.707 ' O ' HG12 ' A' ' 20' ' ' ILE . . . -171.96 173.13 4.52 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 115.523 -0.762 . . . . 15.0 110.054 179.03 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.533 ' HA ' ' CG1' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -96.42 103.3 14.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 109.244 -0.65 . . . . 15.0 109.244 179.15 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.773 ' HB ' ' O ' ' A' ' 19' ' ' GLY . 0.6 OUTLIER -69.13 115.74 34.88 Favored Pre-proline 0 C--N 1.328 -0.353 0 N-CA-C 113.376 0.88 . . . . 15.0 113.376 -177.066 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.591 ' HA ' ' HG2' ' A' ' 47' ' ' GLU . 37.5 Cg_exo -61.16 62.01 0.1 OUTLIER 'Trans proline' 0 C--N 1.358 1.038 0 C-N-CA 123.655 2.903 . . . . 15.0 112.951 179.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.515 ' HB2' HG22 ' A' ' 41' ' ' ILE . 7.3 mt-30 -150.55 -48.6 0.13 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.635 0.255 . . . . 15.0 111.524 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.751 ' HA3' ' HA3' ' A' ' 19' ' ' GLY . . . -87.73 167.82 37.16 Favored Glycine 0 C--N 1.33 0.232 0 C-N-CA 120.387 -0.911 . . . . 15.0 113.861 -179.128 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.762 ' HB3' ' O ' ' A' ' 17' ' ' SER . . . -58.5 -13.52 5.77 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.087 -0.556 . . . . 15.0 112.43 -179.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.16 -56.74 5.06 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.696 0.284 . . . . 15.0 110.784 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.591 ' HG2' ' HA ' ' A' ' 42' ' ' PRO . 2.8 pp20? -57.59 -41.99 82.3 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.059 -0.519 . . . . 15.0 110.502 179.239 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -53.55 -69.54 0.12 Allowed 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 115.769 -0.651 . . . . 15.0 110.567 -179.25 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.665 ' CB ' HD11 ' A' ' 11' ' ' LEU . 0.1 OUTLIER -60.25 -41.25 92.81 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.149 -0.685 . . . . 15.0 109.149 178.867 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.8 46.47 7.18 Favored Glycine 0 N--CA 1.446 -0.663 0 CA-C-N 115.436 -0.802 . . . . 15.0 111.866 179.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.77 ' CG ' HD13 ' A' ' 11' ' ' LEU . 0.9 OUTLIER -79.78 -44.77 20.03 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.695 0.283 . . . . 15.0 110.969 -179.285 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.707 ' HB ' HD12 ' A' ' 20' ' ' ILE . 3.5 mm -91.42 160.92 2.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.055 0.455 . . . . 15.0 111.187 179.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.57 ' N ' HG22 ' A' ' 52' ' ' ILE . 75.9 m80 -140.52 148.92 41.78 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-N 115.741 -0.663 . . . . 15.0 110.438 179.52 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.568 ' HA ' ' CG2' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -36.23 133.76 0.47 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.935 -1.03 . . . . 15.0 112.575 -178.237 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.705 ' N ' HG22 ' A' ' 37' ' ' VAL . . . 55.14 33.0 57.3 Favored Glycine 0 N--CA 1.453 -0.2 0 CA-C-N 115.309 -0.86 . . . . 15.0 113.707 179.5 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -66.13 127.75 33.36 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 117.603 0.701 . . . . 15.0 110.541 179.217 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.572 ' NH1' HD11 ' A' ' 59' ' ' LEU . 50.8 ttt-85 -80.71 86.6 5.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.464 -0.335 . . . . 15.0 110.529 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 1.051 HG22 HG22 ' A' ' 35' ' ' ILE . 1.3 m -79.95 115.3 22.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 CA-C-O 121.174 0.512 . . . . 15.0 111.173 -179.588 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.572 HD11 ' NH1' ' A' ' 57' ' ' ARG . 20.4 mt -107.43 -12.73 15.25 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 115.432 -0.804 . . . . 15.0 112.165 -179.41 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.864 ' HB3' ' HB2' ' A' ' 88' ' ' LEU . . . -150.06 144.6 25.87 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.202 0.525 . . . . 15.0 112.388 -178.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.832 HG11 ' O ' ' A' ' 77' ' ' THR . 44.9 t -139.04 101.73 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.452 -0.795 . . . . 15.0 109.457 178.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.86 ' ND2' HG22 ' A' ' 81' ' ' THR . 1.5 m-80 64.87 15.87 10.15 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.822 -0.436 . . . . 15.0 109.822 -178.327 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 107.08 5.75 34.87 Favored Glycine 0 C--N 1.335 0.512 0 CA-C-N 115.956 -0.566 . . . . 15.0 113.469 179.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.654 ' O ' HG13 ' A' ' 64' ' ' VAL . 5.8 p -93.85 105.49 16.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 117.275 0.537 . . . . 15.0 110.949 179.405 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 72.3 m -58.41 131.75 51.65 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.122 -0.49 . . . . 15.0 110.936 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.464 HD11 ' HB2' ' A' ' 74' ' ' ALA . 0.2 OUTLIER -87.65 -18.93 28.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.015 -0.539 . . . . 15.0 110.91 179.942 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -48.23 95.07 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.876 0.37 . . . . 15.0 110.858 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.66 66.82 0.59 Allowed Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.81 -0.709 . . . . 15.0 111.96 -179.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.615 ' HB1' ' CG ' ' A' ' 73' ' ' GLN . . . -172.73 161.9 4.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.915 0.388 . . . . 15.0 110.9 -179.646 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.489 ' HB ' HG13 ' A' ' 26' ' ' VAL . 8.3 p -93.19 -173.68 3.32 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.188 -0.46 . . . . 15.0 111.436 -179.562 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.664 ' CD2' HG23 ' A' ' 22' ' ' VAL . 0.1 OUTLIER -62.38 -60.76 3.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.832 -0.622 . . . . 15.0 110.39 -179.967 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.418 ' O ' ' HG3' ' A' ' 76' ' ' GLU . 17.7 ttpp -52.54 -30.69 31.94 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.746 -0.661 . . . . 15.0 110.442 179.36 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.615 ' CG ' ' HB1' ' A' ' 69' ' ' ALA . 0.9 OUTLIER -59.39 -51.43 69.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.072 -0.513 . . . . 15.0 110.075 179.567 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.479 ' O ' ' HG ' ' A' ' 78' ' ' LEU . . . -66.94 -45.23 78.44 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 109.717 -0.475 . . . . 15.0 109.717 178.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.804 HG23 ' CG2' ' A' ' 22' ' ' VAL . 0.5 OUTLIER -42.65 -43.14 1.11 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.269 0 N-CA-C 108.946 -0.761 . . . . 15.0 108.946 178.167 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.418 ' HG3' ' O ' ' A' ' 72' ' ' LYS . 24.3 mt-10 -67.42 -44.02 79.79 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 114.925 -1.034 . . . . 15.0 110.005 178.267 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.832 ' O ' HG11 ' A' ' 61' ' ' VAL . 72.0 p -64.2 -54.18 37.58 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 116.744 -0.207 . . . . 15.0 111.397 179.718 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.776 HD21 HG21 ' A' ' 58' ' ' VAL . 6.6 mt -53.28 -49.03 67.79 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-O 121.277 0.56 . . . . 15.0 109.947 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.407 ' O ' ' N ' ' A' ' 81' ' ' THR . 4.3 ttp180 -68.51 -59.87 2.84 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.322 -0.854 . . . . 15.0 110.699 179.508 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.412 ' CB ' ' O ' ' A' ' 76' ' ' GLU . 43.4 m-20 -66.0 62.28 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.024 -0.535 . . . . 15.0 112.057 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.86 HG22 ' ND2' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -93.8 -68.68 0.79 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.83 0.348 . . . . 15.0 110.077 179.044 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 122.09 -109.85 1.51 Allowed Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 120.957 -0.64 . . . . 15.0 112.874 179.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -65.47 -77.26 0.06 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.52 -0.34 . . . . 15.0 111.701 -179.314 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.433 HG12 ' N ' ' A' ' 85' ' ' VAL . 55.8 t -110.17 157.68 10.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.174 -0.466 . . . . 15.0 111.295 -179.4 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.676 HG12 ' O ' ' A' ' 85' ' ' VAL . 8.6 t -98.0 81.16 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.026 -0.534 . . . . 15.0 110.48 179.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -100.43 86.08 3.1 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.796 -0.638 . . . . 15.0 110.506 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.731 ' HB3' HD21 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -103.86 126.03 50.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.058 -0.519 . . . . 15.0 111.807 -179.265 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.864 ' HB2' ' HB3' ' A' ' 60' ' ' ALA . 4.9 mp -101.64 101.59 12.15 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.305 -0.628 . . . . 15.0 109.305 178.536 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.731 HD21 ' HB3' ' A' ' 87' ' ' LEU . 0.1 OUTLIER -105.66 -165.19 1.09 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.502 0.667 . . . . 15.0 112.089 -178.448 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.459 ' HA ' ' HA ' ' A' ' 6' ' ' ILE . 1.0 OUTLIER -140.12 136.23 33.33 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.873 -1.058 . . . . 15.0 109.619 178.97 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 10.2 tppt? -46.89 103.63 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.93 0.395 . . . . 15.0 111.293 -179.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -64.06 151.65 49.56 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.866 -0.683 . . . . 15.0 112.565 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -86.19 99.2 11.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.752 0.311 . . . . 15.0 110.842 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -89.37 162.82 35.84 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.211 -0.45 . . . . 15.0 110.878 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_exo -51.45 -26.77 22.46 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.535 2.157 . . . . 15.0 112.368 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 21.6 p . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.238 -0.886 . . . . 15.0 110.86 179.987 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_endo . . . . . 0 N--CA 1.488 1.192 0 CA-C-O 120.878 0.282 . . . . 15.0 111.816 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 3.3 mtmp? -155.17 89.26 3.07 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.183 -0.462 . . . . 15.0 110.935 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.44 ' HD2' ' CB ' ' A' ' 93' ' ' GLN . 71.6 Cg_exo -49.19 -62.03 0.49 Allowed 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.632 2.221 . . . . 15.0 112.457 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 88.19 -20.67 28.44 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.502 -0.856 . . . . 15.0 112.677 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -61.88 155.1 24.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.299 0.571 . . . . 15.0 110.934 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.45 HG13 ' HB2' ' A' ' 90' ' ' GLU . 1.4 mp -103.03 144.47 13.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.185 -0.916 . . . . 15.0 111.099 -179.257 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.524 ' CZ ' HD12 ' A' ' 89' ' ' LEU . 2.2 p90 -140.59 163.75 32.03 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.318 -0.401 . . . . 15.0 110.561 178.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.759 ' HB2' HD12 ' A' ' 88' ' ' LEU . 11.0 pt-20 -128.97 143.05 50.76 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.257 0.551 . . . . 15.0 111.424 -179.453 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.489 ' CG1' HD11 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -101.44 114.6 41.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.227 -0.897 . . . . 15.0 109.572 178.924 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -106.09 72.42 0.94 Allowed 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 112.397 0.518 . . . . 15.0 112.397 -178.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.938 HD13 ' HG3' ' A' ' 51' ' ' ARG . 6.5 tp -88.35 166.7 14.1 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.517 -0.549 . . . . 15.0 109.517 178.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -95.97 94.0 7.34 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.961 0.41 . . . . 15.0 111.305 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.713 ' CB ' HG23 ' A' ' 85' ' ' VAL . 0.2 OUTLIER -58.4 -26.38 63.16 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.884 -0.598 . . . . 15.0 111.057 179.838 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -84.06 -34.84 24.13 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.296 -0.411 . . . . 15.0 110.893 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -70.84 -42.76 69.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.005 0.431 . . . . 15.0 110.326 179.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.524 ' HB3' ' HB2' ' A' ' 45' ' ' ALA . 0.6 OUTLIER -165.47 163.27 19.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.857 -0.61 . . . . 15.0 110.632 179.789 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.912 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 0.3 OUTLIER -85.87 -162.75 0.77 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.362 -0.381 . . . . 15.0 110.236 179.664 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 9.6 mt -101.14 -168.68 1.59 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.939 0.4 . . . . 15.0 110.763 179.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.757 ' O ' ' HB ' ' A' ' 41' ' ' ILE . . . -164.71 40.72 0.3 Allowed Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 121.01 -0.614 . . . . 15.0 111.826 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.625 HD12 ' CG1' ' A' ' 52' ' ' ILE . 0.0 OUTLIER -112.7 138.86 40.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 121.004 0.43 . . . . 15.0 111.773 -179.441 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.455 ' O ' ' HB3' ' A' ' 38' ' ' LYS . 21.1 t -94.49 100.4 12.4 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 107.704 -1.221 . . . . 15.0 107.704 177.282 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.751 HG23 ' CD2' ' A' ' 71' ' ' HIS . 1.4 m -93.79 152.69 3.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 112.463 0.542 . . . . 15.0 112.463 -177.076 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.544 ' HA ' ' ND1' ' A' ' 71' ' ' HIS . 14.8 t -149.29 -174.64 4.71 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.444 -0.798 . . . . 15.0 110.71 179.564 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.652 ' O ' HG22 ' A' ' 26' ' ' VAL . . . 75.18 -115.51 4.66 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 120.721 -0.752 . . . . 15.0 112.153 -179.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.544 ' HA3' ' N ' ' A' ' 71' ' ' HIS . . . 64.33 -65.34 0.06 OUTLIER Glycine 0 N--CA 1.453 -0.215 0 C-N-CA 121.015 -0.612 . . . . 15.0 113.841 179.024 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.652 HG22 ' O ' ' A' ' 24' ' ' GLY . 0.0 OUTLIER -30.54 145.13 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 N-CA-C 112.362 0.504 . . . . 15.0 112.362 -179.143 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -79.63 56.25 2.18 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.961 -0.563 . . . . 15.0 111.031 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -151.69 -64.96 0.18 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.234 -0.439 . . . . 15.0 110.641 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.63 -48.23 70.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.11 -0.495 . . . . 15.0 110.559 179.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.643 HG22 ' O ' ' A' ' 26' ' ' VAL . 34.5 m -88.09 -171.15 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.024 -0.534 . . . . 15.0 110.77 179.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -92.4 127.17 37.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.91 0.386 . . . . 15.0 111.155 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 34.4 m80 58.18 -84.71 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.937 -0.574 . . . . 15.0 111.464 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -167.7 26.18 0.14 Allowed Glycine 0 C--N 1.331 0.263 0 C-N-CA 120.977 -0.63 . . . . 15.0 112.274 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.41 ' O ' HG21 ' A' ' 30' ' ' VAL . . . -83.83 149.16 25.28 Favored Glycine 0 N--CA 1.448 -0.529 0 N-CA-C 110.769 -0.932 . . . . 15.0 110.769 178.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.8 HG22 HG22 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -88.29 153.45 3.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 117.537 0.669 . . . . 15.0 111.777 -179.165 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.49 ' CZ ' ' HG2' ' A' ' 57' ' ' ARG . 30.7 m-85 -139.76 107.94 5.78 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.026 -0.988 . . . . 15.0 109.732 179.571 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.763 HG22 ' N ' ' A' ' 55' ' ' GLY . 0.8 OUTLIER -55.99 151.29 2.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.046 0.45 . . . . 15.0 111.284 -179.111 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.457 ' O ' ' HG2' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -83.8 -45.3 13.46 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.493 -0.928 . . . . 15.0 108.493 178.29 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.613 ' O ' HG12 ' A' ' 20' ' ' ILE . . . -172.28 172.43 4.5 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 115.853 -0.612 . . . . 15.0 110.32 178.333 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.591 ' HA ' HG12 ' A' ' 20' ' ' ILE . 0.1 OUTLIER -96.86 109.71 23.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.205 -0.665 . . . . 15.0 109.205 179.04 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.757 ' HB ' ' O ' ' A' ' 19' ' ' GLY . 0.5 OUTLIER -78.24 115.29 49.76 Favored Pre-proline 0 C--N 1.327 -0.371 0 N-CA-C 113.51 0.93 . . . . 15.0 113.51 -177.148 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.631 ' HA ' ' CG ' ' A' ' 47' ' ' GLU . 32.8 Cg_exo -62.0 60.58 0.13 Allowed 'Trans proline' 0 C--N 1.357 1.01 0 C-N-CA 123.619 2.879 . . . . 15.0 112.949 179.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.528 ' N ' ' HG2' ' A' ' 47' ' ' GLU . 6.0 tt0 -147.33 -48.38 0.18 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.62 0.248 . . . . 15.0 111.345 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.703 ' HA3' ' HA3' ' A' ' 19' ' ' GLY . . . -87.86 169.02 38.16 Favored Glycine 0 C--N 1.33 0.217 0 C-N-CA 120.403 -0.903 . . . . 15.0 113.807 -179.192 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.912 ' HB3' ' O ' ' A' ' 17' ' ' SER . . . -57.91 -13.84 5.17 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.749 0.648 . . . . 15.0 112.749 -179.624 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.9 -56.47 5.64 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.936 -0.306 . . . . 15.0 110.711 -179.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.631 ' CG ' ' HA ' ' A' ' 42' ' ' PRO . 2.9 pp20? -57.57 -42.96 84.1 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.992 -0.549 . . . . 15.0 110.322 179.009 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -53.86 -70.75 0.09 Allowed 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 115.828 -0.624 . . . . 15.0 110.567 -179.497 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.426 ' CB ' HD11 ' A' ' 11' ' ' LEU . 0.5 OUTLIER -58.11 -41.18 83.01 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.046 -0.724 . . . . 15.0 109.046 178.872 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.73 40.56 12.12 Favored Glycine 0 N--CA 1.446 -0.655 0 CA-C-N 115.345 -0.843 . . . . 15.0 111.779 179.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.938 ' HG3' HD13 ' A' ' 11' ' ' LEU . 2.7 mmp_? -79.78 -50.49 10.48 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.931 0.396 . . . . 15.0 110.644 -179.438 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.625 ' CG1' HD12 ' A' ' 20' ' ' ILE . 9.4 tp -81.1 160.1 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 CA-C-N 115.989 -0.55 . . . . 15.0 110.378 179.543 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.459 ' O ' ' HB2' ' A' ' 56' ' ' ASP . 75.7 m80 -145.31 159.01 43.69 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-O 121.599 0.714 . . . . 15.0 112.083 -179.217 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.534 ' HA ' ' CG2' ' A' ' 37' ' ' VAL . 0.1 OUTLIER -42.21 132.91 3.25 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.512 -1.222 . . . . 15.0 112.642 -178.687 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.763 ' N ' HG22 ' A' ' 37' ' ' VAL . . . 49.98 34.24 22.89 Favored Glycine 0 C--N 1.333 0.395 0 CA-C-N 115.761 -0.654 . . . . 15.0 113.425 179.277 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.459 ' HB2' ' O ' ' A' ' 53' ' ' HIS . 0.3 OUTLIER -65.84 132.66 49.21 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.538 -0.465 . . . . 15.0 110.617 179.475 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.797 ' HD2' HD21 ' A' ' 59' ' ' LEU . 0.0 OUTLIER -85.73 92.13 8.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.321 -0.4 . . . . 15.0 110.499 179.664 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.8 HG22 HG22 ' A' ' 35' ' ' ILE . 2.0 m -83.14 114.43 23.9 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 CA-C-O 120.988 0.423 . . . . 15.0 111.143 -179.566 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.797 HD21 ' HD2' ' A' ' 57' ' ' ARG . 3.4 mm? -107.15 -16.39 14.43 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 115.747 -0.66 . . . . 15.0 112.494 -179.236 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.711 ' HB3' ' HB2' ' A' ' 88' ' ' LEU . . . -147.78 146.91 29.35 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.112 0.482 . . . . 15.0 112.222 -178.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.902 HG23 HD11 ' A' ' 66' ' ' LEU . 61.5 t -138.78 102.18 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.578 -0.737 . . . . 15.0 109.194 178.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.815 ' ND2' HG22 ' A' ' 81' ' ' THR . 1.3 m-80 65.07 16.1 10.37 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.103 -0.499 . . . . 15.0 109.763 -178.096 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 105.83 5.18 38.94 Favored Glycine 0 C--N 1.336 0.564 0 CA-C-N 115.821 -0.627 . . . . 15.0 113.247 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.646 ' O ' HG13 ' A' ' 64' ' ' VAL . 5.5 p -93.84 108.3 20.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.983 0.392 . . . . 15.0 110.979 179.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 21.4 m -57.99 124.89 20.83 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.204 0.526 . . . . 15.0 110.777 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.902 HD11 HG23 ' A' ' 61' ' ' VAL . 0.3 OUTLIER -87.72 -21.06 25.41 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.444 -0.798 . . . . 15.0 111.327 -179.499 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -46.7 103.6 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.843 0.354 . . . . 15.0 110.986 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.89 63.11 0.54 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.764 -0.731 . . . . 15.0 112.55 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.56 ' HB1' ' CB ' ' A' ' 73' ' ' GLN . . . -172.98 164.64 4.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.835 0.35 . . . . 15.0 111.024 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.534 ' HB ' HG13 ' A' ' 26' ' ' VAL . 5.9 p -93.26 -172.89 3.08 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.067 0.46 . . . . 15.0 111.118 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.751 ' CD2' HG23 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -62.35 -61.34 2.52 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.733 -0.667 . . . . 15.0 110.212 179.985 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 22.4 ttpp -52.85 -35.68 57.77 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.789 -0.641 . . . . 15.0 110.345 179.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.56 ' CB ' ' HB1' ' A' ' 69' ' ' ALA . 4.8 mt-30 -59.68 -48.31 82.19 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.432 -0.581 . . . . 15.0 109.432 179.137 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.494 ' HB3' HG13 ' A' ' 35' ' ' ILE . . . -66.79 -47.87 70.75 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 115.789 -0.641 . . . . 15.0 109.441 178.361 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.619 HG23 ' CG2' ' A' ' 22' ' ' VAL . 0.5 OUTLIER -41.66 -40.26 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.271 0 N-CA-C 108.827 -0.805 . . . . 15.0 108.827 178.203 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.476 ' O ' ' HB2' ' A' ' 80' ' ' ASN . 1.5 mm-40 -67.2 -47.02 72.13 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.734 -1.121 . . . . 15.0 110.509 178.542 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.734 ' O ' HG11 ' A' ' 61' ' ' VAL . 16.5 p -64.08 -53.06 55.69 Favored 'General case' 0 N--CA 1.461 0.117 0 C-N-CA 120.913 -0.315 . . . . 15.0 111.469 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.743 HD23 HG21 ' A' ' 61' ' ' VAL . 3.6 mt -53.44 -47.43 69.68 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.174 0.511 . . . . 15.0 110.047 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.447 ' HB2' ' O ' ' A' ' 75' ' ' VAL . 0.0 OUTLIER -68.64 -57.9 5.03 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.571 -0.741 . . . . 15.0 110.657 179.331 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.476 ' HB2' ' O ' ' A' ' 76' ' ' GLU . 11.9 m-80 -65.92 63.05 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.163 -0.472 . . . . 15.0 111.966 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.815 HG22 ' ND2' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -94.0 -71.95 0.64 Allowed 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 110.096 -0.335 . . . . 15.0 110.096 179.103 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 122.06 -105.22 0.96 Allowed Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.774 -0.727 . . . . 15.0 113.124 179.235 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.415 ' O ' ' HB3' ' A' ' 13' ' ' LYS . 0.1 OUTLIER -64.8 -82.86 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 111.885 0.328 . . . . 15.0 111.885 -179.16 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.453 HG12 ' N ' ' A' ' 85' ' ' VAL . 72.9 t -109.64 159.85 8.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.921 0.391 . . . . 15.0 110.869 -179.508 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.713 HG23 ' CB ' ' A' ' 13' ' ' LYS . 14.9 t -97.76 80.83 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.054 0.454 . . . . 15.0 110.593 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -102.84 85.09 2.48 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.765 -0.652 . . . . 15.0 110.44 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.834 ' HB3' HD21 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -102.42 119.9 39.6 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.948 -0.569 . . . . 15.0 111.742 -179.207 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.759 HD12 ' HB2' ' A' ' 8' ' ' GLU . 4.3 mp -94.52 100.66 12.6 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.773 -0.454 . . . . 15.0 109.773 178.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.834 HD21 ' HB3' ' A' ' 87' ' ' LEU . 0.1 OUTLIER -105.81 -163.53 0.95 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.517 0.675 . . . . 15.0 112.173 -178.531 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.45 ' HB2' HG13 ' A' ' 6' ' ' ILE . 3.4 tt0 -141.36 140.15 33.67 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 114.824 -1.08 . . . . 15.0 109.505 179.02 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 2.7 tptp -55.98 96.66 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.025 0.441 . . . . 15.0 111.014 -179.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -72.65 56.04 1.68 Allowed Glycine 0 CA--C 1.518 0.254 0 CA-C-N 115.732 -0.667 . . . . 15.0 113.188 -179.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.44 ' CB ' ' HD2' ' A' ' 3' ' ' PRO . 0.0 OUTLIER -86.67 129.9 34.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.749 0.309 . . . . 15.0 110.93 179.754 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -87.4 164.34 35.74 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.298 -0.41 . . . . 15.0 110.78 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -49.82 -25.85 12.61 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.548 2.165 . . . . 15.0 112.3 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.247 -0.882 . . . . 15.0 110.888 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo . . . . . 0 N--CA 1.488 1.179 0 CA-C-O 120.815 0.256 . . . . 15.0 111.689 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 20.9 mtmt -151.35 160.72 31.42 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.161 -0.472 . . . . 15.0 110.912 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -52.85 148.92 27.44 Favored 'Trans proline' 0 CA--C 1.518 -0.3 0 C-N-CA 122.556 2.171 . . . . 15.0 112.487 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 82.39 -25.15 4.5 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.157 -1.02 . . . . 15.0 111.019 -179.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -61.96 164.27 6.76 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.268 0.556 . . . . 15.0 110.691 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.419 ' CD1' ' HB2' ' A' ' 90' ' ' GLU . 1.2 mp -102.02 147.54 8.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.344 -0.844 . . . . 15.0 111.244 -179.149 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.79 ' CZ ' HD12 ' A' ' 89' ' ' LEU . 2.1 p90 -140.28 164.32 30.4 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.012 -0.54 . . . . 15.0 110.253 178.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.719 ' CB ' HD12 ' A' ' 88' ' ' LEU . 10.0 pt-20 -130.06 143.96 51.08 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.254 0.55 . . . . 15.0 111.701 -179.33 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.501 ' CG2' ' HB3' ' A' ' 51' ' ' ARG . 0.3 OUTLIER -101.5 116.99 46.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.327 -0.851 . . . . 15.0 109.815 178.895 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -106.01 70.97 0.87 Allowed 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.278 -0.419 . . . . 15.0 111.854 -179.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.819 HD13 ' CG ' ' A' ' 51' ' ' ARG . 6.0 tp -87.83 164.75 15.75 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.124 -0.489 . . . . 15.0 109.853 179.088 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -95.91 94.03 7.38 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.993 0.425 . . . . 15.0 111.346 -179.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.687 ' CB ' HG23 ' A' ' 85' ' ' VAL . 0.1 OUTLIER -57.27 -31.96 66.11 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.904 -0.589 . . . . 15.0 110.881 179.872 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.41 ' O ' ' CB ' ' A' ' 15' ' ' ASP . 38.2 t30 -84.7 140.45 31.28 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.19 -0.459 . . . . 15.0 110.75 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.41 ' CB ' ' O ' ' A' ' 14' ' ' ASN . 4.1 m-20 80.77 -12.53 1.02 Allowed 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.021 -0.536 . . . . 15.0 111.507 -179.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.498 ' HB3' ' HB2' ' A' ' 45' ' ' ALA . 18.9 m-80 -165.55 136.11 3.71 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.767 0.318 . . . . 15.0 110.677 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.844 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 0.2 OUTLIER -85.97 -159.41 0.46 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.236 -0.438 . . . . 15.0 110.461 179.815 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.658 ' N ' HD22 ' A' ' 18' ' ' LEU . 1.3 mm? -92.67 -168.93 2.07 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 121.019 0.438 . . . . 15.0 110.66 179.55 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.601 ' O ' ' HB ' ' A' ' 41' ' ' ILE . . . -165.78 31.46 0.22 Allowed Glycine 0 C--O 1.224 -0.529 0 N-CA-C 111.336 -0.706 . . . . 15.0 111.336 -179.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.708 HG13 HG12 ' A' ' 40' ' ' VAL . 0.0 OUTLIER -114.07 140.87 32.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 112.314 0.487 . . . . 15.0 112.314 -179.497 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.746 ' HB3' HD11 ' A' ' 41' ' ' ILE . 1.7 t -96.43 106.32 18.54 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 107.962 -1.125 . . . . 15.0 107.962 176.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.961 HG21 HG23 ' A' ' 75' ' ' VAL . 21.1 m -93.59 149.59 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 N-CA-C 112.947 0.721 . . . . 15.0 112.947 -177.246 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.537 HG22 ' HB2' ' A' ' 38' ' ' LYS . 8.8 t -150.37 -179.96 7.63 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.357 -0.838 . . . . 15.0 110.887 179.266 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.662 ' O ' HG22 ' A' ' 26' ' ' VAL . . . 74.11 -114.83 4.68 Favored Glycine 0 C--N 1.334 0.467 0 C-N-CA 120.973 -0.632 . . . . 15.0 112.526 179.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.539 ' HA3' ' N ' ' A' ' 71' ' ' HIS . . . 63.88 -65.3 0.05 OUTLIER Glycine 0 C--N 1.331 0.251 0 C-N-CA 121.093 -0.575 . . . . 15.0 113.885 179.082 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.662 HG22 ' O ' ' A' ' 24' ' ' GLY . 0.0 OUTLIER -28.68 141.81 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 N-CA-C 112.329 0.492 . . . . 15.0 112.329 -179.159 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -75.53 62.24 1.38 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.965 -0.561 . . . . 15.0 111.001 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 9.7 m -151.71 -65.34 0.18 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.258 -0.428 . . . . 15.0 111.011 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -69.52 -48.92 58.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.118 -0.492 . . . . 15.0 111.087 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.554 HG22 ' O ' ' A' ' 26' ' ' VAL . 34.8 m -72.69 -174.51 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.217 -0.447 . . . . 15.0 111.247 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.402 ' HG2' HG21 ' A' ' 96' ' ' THR . 0.0 OUTLIER -52.45 -74.56 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.184 -0.462 . . . . 15.0 111.258 -179.923 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 8.8 p-80 -132.52 -45.71 0.9 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.35 -0.386 . . . . 15.0 111.179 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -168.39 24.05 0.11 Allowed Glycine 0 N--CA 1.453 -0.19 0 C-N-CA 120.8 -0.714 . . . . 15.0 112.732 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -90.31 153.71 22.99 Favored Glycine 0 N--CA 1.449 -0.448 0 N-CA-C 110.836 -0.906 . . . . 15.0 110.836 178.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.91 HG22 HG22 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -92.21 154.11 3.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.504 0.669 . . . . 15.0 111.888 -179.335 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.51 ' CZ ' ' HG2' ' A' ' 57' ' ' ARG . 24.1 m-85 -139.49 110.97 7.07 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.857 -1.065 . . . . 15.0 109.136 178.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.794 HG22 ' N ' ' A' ' 55' ' ' GLY . 0.8 OUTLIER -56.44 156.42 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.46 0.648 . . . . 15.0 110.953 -178.762 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.537 ' HB2' HG22 ' A' ' 23' ' ' THR . 0.0 OUTLIER -90.39 -46.85 8.11 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 108.281 -1.007 . . . . 15.0 108.281 178.667 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.532 ' O ' HG12 ' A' ' 20' ' ' ILE . . . -172.84 166.74 5.23 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.088 -0.96 . . . . 15.0 110.566 178.326 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.708 HG12 HG13 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -97.24 119.94 45.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.789 0.328 . . . . 15.0 110.493 179.75 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.746 HD11 ' HB3' ' A' ' 21' ' ' SER . 1.4 mm -78.31 109.28 9.8 Favored Pre-proline 0 N--CA 1.466 0.358 0 N-CA-C 113.028 0.751 . . . . 15.0 113.028 -178.394 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.453 ' HA ' ' OE1' ' A' ' 47' ' ' GLU . 41.0 Cg_endo -66.54 64.42 0.53 Allowed 'Trans proline' 0 C--N 1.352 0.753 0 C-N-CA 122.846 2.364 . . . . 15.0 112.28 179.474 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 11.5 mt-30 -159.37 -45.91 0.05 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.362 -0.835 . . . . 15.0 109.436 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.508 ' HA3' ' HA3' ' A' ' 19' ' ' GLY . . . -87.4 151.6 23.56 Favored Glycine 0 N--CA 1.446 -0.678 0 CA-C-N 115.611 -0.722 . . . . 15.0 112.222 179.232 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.844 ' HB3' ' O ' ' A' ' 17' ' ' SER . . . -40.59 -18.28 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 113.367 0.877 . . . . 15.0 113.367 -179.435 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.465 ' N ' ' O ' ' A' ' 44' ' ' GLY . . . -71.66 -71.64 0.26 Allowed 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.893 -0.323 . . . . 15.0 111.267 -179.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.56 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 9.4 tm-20 -58.16 -37.79 75.36 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.832 0.348 . . . . 15.0 110.341 179.578 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 16.0 m -53.92 -66.4 0.4 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.1 -0.5 . . . . 15.0 110.47 179.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.643 ' CB ' HD11 ' A' ' 11' ' ' LEU . 2.1 t0 -63.3 -37.64 88.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.103 -0.499 . . . . 15.0 109.922 179.152 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.55 43.68 8.32 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.928 -0.653 . . . . 15.0 112.523 179.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.819 ' CG ' HD13 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -80.13 -51.72 8.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.75 0.309 . . . . 15.0 110.724 179.943 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.734 HG21 HG11 ' A' ' 37' ' ' VAL . 1.2 mm -91.24 163.41 2.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.973 0.416 . . . . 15.0 111.15 179.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.614 ' N ' HG22 ' A' ' 52' ' ' ILE . 47.6 m80 -139.39 153.29 47.62 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-O 121.368 0.604 . . . . 15.0 110.485 179.463 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.506 ' HA ' ' CG2' ' A' ' 37' ' ' VAL . 0.6 OUTLIER -35.21 132.96 0.35 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.747 -1.115 . . . . 15.0 112.354 -178.459 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.794 ' N ' HG22 ' A' ' 37' ' ' VAL . . . 52.11 35.57 41.9 Favored Glycine 0 C--N 1.332 0.31 0 CA-C-N 115.892 -0.594 . . . . 15.0 114.01 179.644 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -66.16 130.57 43.68 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 117.676 0.738 . . . . 15.0 110.561 179.205 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.51 ' HG2' ' CZ ' ' A' ' 36' ' ' TYR . 26.4 mtt-85 -81.63 91.55 6.43 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.462 -0.335 . . . . 15.0 110.586 179.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.91 HG22 HG22 ' A' ' 35' ' ' ILE . 1.1 m -85.86 116.29 28.67 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 CA-C-O 121.178 0.513 . . . . 15.0 111.384 -179.645 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -107.26 -10.59 15.78 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 115.589 -0.732 . . . . 15.0 112.248 -179.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.698 ' HB3' ' HB2' ' A' ' 88' ' ' LEU . . . -152.01 145.16 24.6 Favored 'General case' 0 N--CA 1.462 0.17 0 N-CA-C 112.301 0.482 . . . . 15.0 112.301 -178.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.831 HG21 HD23 ' A' ' 78' ' ' LEU . 59.7 t -138.94 101.41 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.57 -0.741 . . . . 15.0 109.264 178.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.806 ' ND2' HG22 ' A' ' 81' ' ' THR . 1.1 m-80 64.96 16.04 10.31 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.02 0.438 . . . . 15.0 109.919 -178.286 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 107.06 4.76 35.68 Favored Glycine 0 C--N 1.336 0.578 0 CA-C-N 115.932 -0.577 . . . . 15.0 113.376 179.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.644 ' O ' HG13 ' A' ' 64' ' ' VAL . 5.2 p -93.85 107.54 19.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 117.084 0.442 . . . . 15.0 110.857 179.529 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.6 m -56.82 130.74 46.97 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.3 -0.409 . . . . 15.0 111.111 -179.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.471 HD13 ' HB3' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -90.76 -22.03 21.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.04 -0.527 . . . . 15.0 110.95 179.975 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -46.6 96.68 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.889 0.376 . . . . 15.0 111.047 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.76 66.45 0.58 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.801 -0.714 . . . . 15.0 112.428 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.512 ' HB1' ' HB3' ' A' ' 73' ' ' GLN . . . -173.09 162.77 4.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.838 0.351 . . . . 15.0 111.052 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.424 HG22 ' HA ' ' A' ' 26' ' ' VAL . 15.0 p -93.12 -174.1 3.45 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.016 0.436 . . . . 15.0 111.106 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.765 ' NE2' HG23 ' A' ' 22' ' ' VAL . 0.2 OUTLIER -63.95 -59.7 4.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.841 -0.618 . . . . 15.0 110.296 179.946 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.467 ' O ' HG12 ' A' ' 75' ' ' VAL . 30.4 ttmt -52.69 -33.52 47.89 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.153 -0.476 . . . . 15.0 110.235 178.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.512 ' HB3' ' HB1' ' A' ' 69' ' ' ALA . 0.0 OUTLIER -59.39 -51.25 70.73 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.565 -0.532 . . . . 15.0 109.565 179.258 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.633 ' HB3' HG13 ' A' ' 35' ' ' ILE . . . -66.91 -43.87 82.22 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-N 116.041 -0.527 . . . . 15.0 109.711 178.425 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.961 HG23 HG21 ' A' ' 22' ' ' VAL . 0.5 OUTLIER -42.83 -41.91 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.23 0 N-CA-C 108.896 -0.779 . . . . 15.0 108.896 178.395 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.418 ' HG3' ' O ' ' A' ' 72' ' ' LYS . 17.2 mt-10 -67.32 -45.15 77.31 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.794 -1.093 . . . . 15.0 110.078 178.275 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.653 ' O ' HG11 ' A' ' 61' ' ' VAL . 82.1 p -64.17 -54.58 31.47 Favored 'General case' 0 N--CA 1.461 0.114 0 CA-C-N 116.612 -0.267 . . . . 15.0 111.436 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.831 HD23 HG21 ' A' ' 61' ' ' VAL . 4.2 mt -53.51 -48.17 69.24 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 121.145 0.498 . . . . 15.0 110.141 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.408 ' HB2' ' O ' ' A' ' 75' ' ' VAL . 0.0 OUTLIER -68.52 -59.02 3.45 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.561 -0.745 . . . . 15.0 110.564 179.478 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 74.6 m-20 -66.04 59.4 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.933 -0.576 . . . . 15.0 112.43 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.806 HG22 ' ND2' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -95.73 -71.97 0.65 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.889 -0.412 . . . . 15.0 109.889 178.855 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 122.13 -105.16 0.96 Allowed Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.72 -0.752 . . . . 15.0 113.451 178.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.406 ' O ' ' HB3' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -64.56 -83.0 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.071 0.397 . . . . 15.0 112.071 -178.815 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.443 HG12 ' N ' ' A' ' 85' ' ' VAL . 76.2 t -109.64 158.84 9.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.077 0.465 . . . . 15.0 111.167 -179.199 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.687 HG23 ' CB ' ' A' ' 13' ' ' LYS . 9.1 t -97.86 81.23 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.011 -0.54 . . . . 15.0 110.499 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -99.06 85.54 3.26 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.76 -0.655 . . . . 15.0 110.344 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.732 ' HB3' HD21 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -104.02 126.52 51.2 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.041 -0.527 . . . . 15.0 111.917 -179.16 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.719 HD12 ' CB ' ' A' ' 8' ' ' GLU . 5.0 mp -102.41 99.96 10.06 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.751 -0.463 . . . . 15.0 109.751 178.695 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.79 HD12 ' CZ ' ' A' ' 7' ' ' PHE . 0.1 OUTLIER -105.85 -162.56 0.87 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.646 0.736 . . . . 15.0 112.29 -178.633 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.419 ' HB2' ' CD1' ' A' ' 6' ' ' ILE . 3.3 tt0 -137.68 138.64 39.6 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 114.639 -1.164 . . . . 15.0 109.48 178.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.3 tppt? -49.49 107.35 0.14 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.947 0.403 . . . . 15.0 111.151 -179.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -61.97 100.13 0.27 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.928 -0.653 . . . . 15.0 112.935 -179.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.34 -165.58 1.3 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.77 0.319 . . . . 15.0 110.709 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.4 m -61.03 148.57 83.98 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.345 -0.389 . . . . 15.0 110.734 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -50.6 139.46 38.48 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.556 2.171 . . . . 15.0 112.369 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.402 HG21 ' HG2' ' A' ' 31' ' ' ARG . 7.0 t . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.253 -0.88 . . . . 15.0 110.861 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo . . . . . 0 N--CA 1.489 1.249 0 CA-C-O 120.937 0.307 . . . . 15.0 111.828 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 4.2 tttt -146.66 84.4 7.68 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.177 -0.465 . . . . 15.0 110.555 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -68.61 -90.32 0.0 OUTLIER 'Trans proline' 0 CA--C 1.531 0.373 0 C-N-CA 122.423 2.082 . . . . 15.0 112.256 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 86.22 -44.0 3.3 Favored Glycine 0 C--N 1.333 0.401 0 C-N-CA 120.596 -0.811 . . . . 15.0 112.957 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -62.09 139.67 58.43 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.501 0.667 . . . . 15.0 111.505 -179.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.452 HG13 ' HB2' ' A' ' 90' ' ' GLU . 1.3 mp -77.25 151.67 5.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 114.829 -1.078 . . . . 15.0 110.709 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.513 ' CZ ' HD12 ' A' ' 89' ' ' LEU . 2.5 p90 -144.8 165.14 28.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.793 0.33 . . . . 15.0 110.686 179.177 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.732 ' CB ' HD12 ' A' ' 88' ' ' LEU . 9.7 pt-20 -130.18 143.91 51.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.22 0.534 . . . . 15.0 111.426 -179.472 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.56 ' CG1' HD11 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -101.38 115.3 42.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.434 -0.803 . . . . 15.0 109.521 178.905 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -106.02 72.03 0.92 Allowed 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.524 0.565 . . . . 15.0 112.524 -178.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.652 HD13 ' HG3' ' A' ' 51' ' ' ARG . 5.7 tp -88.2 166.3 14.46 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.448 -0.575 . . . . 15.0 109.448 178.462 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.451 ' HB1' ' HB2' ' A' ' 15' ' ' ASP . . . -96.18 92.15 6.26 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.897 0.379 . . . . 15.0 111.203 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.7 ' CB ' HG23 ' A' ' 85' ' ' VAL . 0.2 OUTLIER -54.18 -27.87 36.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.914 -0.584 . . . . 15.0 111.018 179.879 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -84.32 -47.04 11.15 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.16 -0.473 . . . . 15.0 110.671 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.451 ' HB2' ' HB1' ' A' ' 12' ' ' ALA . 1.0 OUTLIER -63.71 -37.8 88.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 15.0 110.634 179.903 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.551 ' HB2' ' HB2' ' A' ' 45' ' ' ALA . 26.3 p30 -165.46 156.34 13.85 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.264 -0.425 . . . . 15.0 111.135 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.974 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 0.8 OUTLIER -86.08 -149.16 0.13 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.141 -0.482 . . . . 15.0 110.254 179.526 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.65 ' N ' HD22 ' A' ' 18' ' ' LEU . 1.9 mm? -119.52 -171.87 2.21 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.878 0.37 . . . . 15.0 110.748 179.589 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.782 ' O ' ' HB ' ' A' ' 41' ' ' ILE . . . -163.63 44.32 0.32 Allowed Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 121.053 -0.594 . . . . 15.0 111.871 -179.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.672 HG12 ' O ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -112.88 135.58 51.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 121.012 0.434 . . . . 15.0 111.876 -179.353 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 29.9 t -89.81 104.4 16.97 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 107.668 -1.234 . . . . 15.0 107.668 177.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 1.001 HG21 HG23 ' A' ' 75' ' ' VAL . 14.1 m -93.44 151.91 3.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 112.953 0.723 . . . . 15.0 112.953 -176.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -149.57 -177.72 6.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 114.977 -1.01 . . . . 15.0 110.678 -179.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.58 ' O ' HG22 ' A' ' 26' ' ' VAL . . . 73.26 -120.52 7.16 Favored Glycine 0 C--N 1.331 0.256 0 C-N-CA 120.675 -0.774 . . . . 15.0 112.381 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.524 ' HA3' ' N ' ' A' ' 71' ' ' HIS . . . 66.94 -65.57 0.19 Allowed Glycine 0 C--N 1.33 0.214 0 C-N-CA 120.943 -0.646 . . . . 15.0 113.565 179.31 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.58 HG22 ' O ' ' A' ' 24' ' ' GLY . 0.0 OUTLIER -25.87 133.08 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 N-CA-C 112.621 0.6 . . . . 15.0 112.621 -179.298 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -75.65 63.17 1.54 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.784 -0.644 . . . . 15.0 111.018 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.4 m -151.67 -47.27 0.11 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.287 -0.415 . . . . 15.0 111.0 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 12.5 t -90.28 -41.65 11.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 15.0 111.001 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.484 HG22 ' O ' ' A' ' 26' ' ' VAL . 33.9 m -71.99 -176.3 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.471 . . . . 15.0 111.166 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.412 ' O ' ' CD2' ' A' ' 32' ' ' HIS . 0.0 OUTLIER -57.0 -51.32 69.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.218 -0.446 . . . . 15.0 110.983 -179.995 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . 0.412 ' CD2' ' O ' ' A' ' 31' ' ' ARG . 27.0 m80 -151.21 -51.98 0.13 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.28 -0.418 . . . . 15.0 111.012 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -168.1 27.42 0.14 Allowed Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.803 -0.713 . . . . 15.0 112.5 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -91.13 149.14 19.71 Favored Glycine 0 N--CA 1.45 -0.411 0 N-CA-C 111.037 -0.825 . . . . 15.0 111.037 179.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.769 HG22 HG22 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -88.18 154.78 3.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.388 0.613 . . . . 15.0 111.719 -179.299 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.532 ' CZ ' ' HG2' ' A' ' 57' ' ' ARG . 51.2 m-85 -141.35 106.91 5.06 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.008 -0.996 . . . . 15.0 109.737 179.272 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.767 HG22 ' N ' ' A' ' 55' ' ' GLY . 0.8 OUTLIER -56.16 148.11 4.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.021 0.438 . . . . 15.0 111.317 -179.193 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.493 ' O ' ' HG2' ' A' ' 54' ' ' LYS . 0.4 OUTLIER -80.37 -46.46 16.01 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.49 -0.93 . . . . 15.0 108.49 178.248 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.672 ' O ' HG12 ' A' ' 20' ' ' ILE . . . -172.1 172.58 4.59 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.594 -0.73 . . . . 15.0 110.508 178.626 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.56 ' HA ' HG12 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -96.87 111.42 26.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 109.545 -0.539 . . . . 15.0 109.545 179.248 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.782 ' HB ' ' O ' ' A' ' 19' ' ' GLY . 0.4 OUTLIER -78.47 117.05 64.02 Favored Pre-proline 0 C--N 1.329 -0.324 0 N-CA-C 113.273 0.842 . . . . 15.0 113.273 -177.422 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.621 ' HA ' ' CG ' ' A' ' 47' ' ' GLU . 37.9 Cg_endo -65.29 59.76 0.34 Allowed 'Trans proline' 0 C--N 1.356 0.924 0 C-N-CA 123.437 2.758 . . . . 15.0 112.785 179.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.526 ' N ' ' HG2' ' A' ' 47' ' ' GLU . 0.5 OUTLIER -147.47 -46.32 0.17 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.517 -0.31 . . . . 15.0 111.296 -179.996 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.71 ' HA3' ' HA3' ' A' ' 19' ' ' GLY . . . -87.77 168.02 37.3 Favored Glycine 0 C--N 1.331 0.269 0 C-N-CA 120.332 -0.937 . . . . 15.0 113.722 -179.258 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.974 ' HB3' ' O ' ' A' ' 17' ' ' SER . . . -57.83 -14.35 5.85 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.862 0.69 . . . . 15.0 112.862 -179.473 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.14 -55.86 6.57 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.935 -0.306 . . . . 15.0 110.932 -179.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.621 ' CG ' ' HA ' ' A' ' 42' ' ' PRO . 2.9 pp20? -57.36 -43.02 83.15 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.923 -0.58 . . . . 15.0 110.231 179.196 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.5 m -53.84 -69.89 0.11 Allowed 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 115.882 -0.599 . . . . 15.0 110.483 -179.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.533 ' CB ' HD11 ' A' ' 11' ' ' LEU . 1.1 t0 -58.07 -41.74 84.01 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.072 -0.714 . . . . 15.0 109.072 178.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.75 40.03 12.97 Favored Glycine 0 N--CA 1.446 -0.648 0 CA-C-N 115.293 -0.867 . . . . 15.0 111.711 179.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.652 ' HG3' HD13 ' A' ' 11' ' ' LEU . 0.2 OUTLIER -79.79 -50.07 11.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.895 0.378 . . . . 15.0 110.599 -179.362 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.649 ' CG1' HD12 ' A' ' 20' ' ' ILE . 8.7 tp -81.12 161.44 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 CA-C-N 116.075 -0.511 . . . . 15.0 110.367 179.571 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.471 ' O ' ' HB2' ' A' ' 56' ' ' ASP . 78.3 m80 -146.27 158.78 43.91 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-O 121.635 0.731 . . . . 15.0 112.16 -179.192 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.556 ' HA ' ' CG2' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -43.12 133.97 3.71 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 114.382 -1.281 . . . . 15.0 112.645 -178.752 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.767 ' N ' HG22 ' A' ' 37' ' ' VAL . . . 49.97 34.0 22.37 Favored Glycine 0 C--N 1.333 0.414 0 CA-C-N 115.841 -0.618 . . . . 15.0 113.354 179.403 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.471 ' HB2' ' O ' ' A' ' 53' ' ' HIS . 0.3 OUTLIER -65.96 131.9 47.33 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.635 -0.426 . . . . 15.0 110.618 179.525 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.64 ' HD2' HD21 ' A' ' 59' ' ' LEU . 0.0 OUTLIER -85.32 90.89 8.03 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.169 -0.468 . . . . 15.0 110.403 179.553 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.769 HG22 HG22 ' A' ' 35' ' ' ILE . 1.5 m -83.57 112.95 21.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.079 0.466 . . . . 15.0 111.207 -179.524 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.64 HD21 ' HD2' ' A' ' 57' ' ' ARG . 3.5 mm? -107.32 -16.54 14.37 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 115.764 -0.653 . . . . 15.0 112.615 -179.099 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.791 ' HB3' ' HB2' ' A' ' 88' ' ' LEU . . . -147.5 150.21 34.12 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 112.518 0.562 . . . . 15.0 112.518 -178.454 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.691 HG21 ' HB ' ' A' ' 77' ' ' THR . 3.3 t -139.07 101.66 1.62 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.267 0 CA-C-N 115.311 -0.859 . . . . 15.0 109.281 178.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.792 ' ND2' HG22 ' A' ' 81' ' ' THR . 2.3 m-80 64.96 15.59 10.05 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.64 -0.504 . . . . 15.0 109.64 -178.112 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 105.95 6.71 36.93 Favored Glycine 0 C--N 1.336 0.54 0 CA-C-N 115.816 -0.629 . . . . 15.0 113.126 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.664 ' O ' HG13 ' A' ' 64' ' ' VAL . 7.2 p -93.76 105.32 16.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.118 0.485 . . . . 15.0 110.727 179.283 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -59.3 116.35 3.85 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.127 -0.488 . . . . 15.0 110.733 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.704 HD21 ' HA ' ' A' ' 74' ' ' ALA . 1.2 mt -87.59 -12.07 46.75 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.826 -0.624 . . . . 15.0 111.295 -179.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -46.29 102.51 0.03 OUTLIER 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.827 0.346 . . . . 15.0 110.936 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.86 64.25 0.55 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.8 -0.714 . . . . 15.0 112.264 -179.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.721 ' HB1' ' CB ' ' A' ' 73' ' ' GLN . . . -172.91 148.44 1.79 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.9 0.381 . . . . 15.0 110.855 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.444 ' CB ' ' HA ' ' A' ' 26' ' ' VAL . 11.8 p -72.83 -173.75 1.29 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.198 -0.456 . . . . 15.0 111.157 -179.65 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.789 ' CD2' HG23 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -61.89 -59.46 5.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.882 -0.599 . . . . 15.0 110.572 -179.847 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 25.0 ttpt -52.34 -35.51 51.14 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.84 -0.618 . . . . 15.0 110.689 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.721 ' CB ' ' HB1' ' A' ' 69' ' ' ALA . 3.5 mt-30 -59.31 -46.22 89.16 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.647 -0.501 . . . . 15.0 109.647 179.232 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.704 ' HA ' HD21 ' A' ' 66' ' ' LEU . . . -66.96 -50.34 62.61 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 109.472 -0.566 . . . . 15.0 109.472 178.195 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 1.001 HG23 HG21 ' A' ' 22' ' ' VAL . 0.6 OUTLIER -40.85 -43.58 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.192 0 CA-C-N 115.237 -0.892 . . . . 15.0 109.614 178.567 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.439 ' N ' HG12 ' A' ' 75' ' ' VAL . 41.4 mt-10 -67.37 -43.85 80.39 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.01 -0.996 . . . . 15.0 110.663 179.156 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.691 ' HB ' HG21 ' A' ' 61' ' ' VAL . 0.6 OUTLIER -64.68 -55.78 17.92 Favored 'General case' 0 C--O 1.23 0.075 0 C-N-CA 120.796 -0.362 . . . . 15.0 111.272 179.937 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.752 HD22 HD21 ' A' ' 87' ' ' LEU . 3.2 mt -53.43 -46.03 69.65 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 121.116 0.484 . . . . 15.0 110.132 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.22 -55.06 13.6 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.612 -0.722 . . . . 15.0 110.359 179.4 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 8.1 m-20 -66.26 57.81 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 115.919 -0.582 . . . . 15.0 112.01 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.792 HG22 ' ND2' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -95.66 -70.54 0.71 Allowed 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 110.203 -0.295 . . . . 15.0 110.203 179.332 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 115.25 -98.15 0.84 Allowed Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.691 -0.766 . . . . 15.0 113.412 178.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.427 ' O ' ' HB3' ' A' ' 13' ' ' LYS . 0.5 OUTLIER -64.39 -86.24 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.063 0.394 . . . . 15.0 112.063 -178.827 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.452 HG12 ' N ' ' A' ' 85' ' ' VAL . 77.7 t -109.73 159.76 9.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.924 0.392 . . . . 15.0 110.978 -179.397 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.7 HG23 ' CB ' ' A' ' 13' ' ' LYS . 13.4 t -97.99 79.4 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.145 0.497 . . . . 15.0 110.466 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -101.41 84.14 2.56 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.746 -0.661 . . . . 15.0 110.495 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.789 ' HB3' HD21 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -101.02 128.64 46.97 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.014 -0.539 . . . . 15.0 111.54 -179.302 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.791 ' HB2' ' HB3' ' A' ' 60' ' ' ALA . 4.8 mp -102.2 99.67 9.8 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.737 -0.468 . . . . 15.0 109.737 178.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.789 HD21 ' HB3' ' A' ' 87' ' ' LEU . 0.1 OUTLIER -105.73 -160.86 0.77 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.394 0.616 . . . . 15.0 112.011 -178.677 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.452 ' HB2' HG13 ' A' ' 6' ' ' ILE . 3.6 tt0 -141.77 132.69 25.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.051 -0.977 . . . . 15.0 109.897 179.136 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 3.6 tmtp? -49.26 95.51 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.378 -0.374 . . . . 15.0 111.146 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -68.3 131.12 27.11 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.85 -0.691 . . . . 15.0 112.639 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -86.39 130.68 34.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.828 0.347 . . . . 15.0 110.874 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 15.2 p -69.46 164.65 47.68 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.221 -0.445 . . . . 15.0 110.916 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_exo -51.73 -54.12 5.86 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.59 2.193 . . . . 15.0 112.267 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 28.7 m . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.242 -0.885 . . . . 15.0 110.933 -179.984 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo . . . . . 0 N--CA 1.488 1.173 0 CA-C-O 120.852 0.271 . . . . 15.0 111.757 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.488 ' CB ' ' HD3' ' A' ' 3' ' ' PRO . 7.0 mttp -155.38 -63.89 0.02 OUTLIER Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.146 -0.479 . . . . 15.0 111.057 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.488 ' HD3' ' CB ' ' A' ' 2' ' ' LYS . 88.4 Cg_exo -42.95 92.14 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.633 2.222 . . . . 15.0 112.707 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 88.35 -21.68 23.8 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.488 -0.863 . . . . 15.0 112.209 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -61.86 151.12 35.4 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 121.193 0.52 . . . . 15.0 110.668 179.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.411 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 1.2 mp -98.45 145.44 9.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.473 -0.785 . . . . 15.0 111.335 -179.179 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.513 ' CZ ' HD12 ' A' ' 89' ' ' LEU . 1.8 p90 -140.54 153.91 46.33 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.026 -0.533 . . . . 15.0 110.407 178.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.748 ' HB2' HD12 ' A' ' 88' ' ' LEU . 0.1 OUTLIER -121.37 143.61 49.11 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.369 0.604 . . . . 15.0 111.759 -179.192 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.585 ' CG1' HD11 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -101.43 116.02 44.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.063 -0.971 . . . . 15.0 109.628 178.956 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -106.24 72.59 0.94 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.239 -0.437 . . . . 15.0 112.145 -178.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.615 HD13 ' HG3' ' A' ' 51' ' ' ARG . 7.1 tp -88.3 161.69 17.01 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.319 -0.4 . . . . 15.0 110.007 178.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.497 ' C ' ' H ' ' A' ' 14' ' ' ASN . . . -97.1 94.67 7.28 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.654 0.264 . . . . 15.0 111.686 -179.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.853 ' HB2' HG23 ' A' ' 85' ' ' VAL . 0.6 OUTLIER -65.84 32.37 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 112.738 0.644 . . . . 15.0 112.738 179.623 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.497 ' H ' ' C ' ' A' ' 12' ' ' ALA . 0.6 OUTLIER -108.8 -68.56 0.91 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.79 0.329 . . . . 15.0 111.289 -179.57 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -46.68 -42.58 16.73 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.286 -0.415 . . . . 15.0 111.128 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -165.42 174.15 10.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 15.0 110.876 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.711 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 0.0 OUTLIER -86.07 -165.52 1.27 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.242 -0.435 . . . . 15.0 110.355 179.636 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.492 HD12 ' HE3' ' A' ' 13' ' ' LYS . 4.5 mp -84.14 -170.2 2.97 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.357 -0.383 . . . . 15.0 110.357 179.447 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.686 ' O ' ' HB ' ' A' ' 41' ' ' ILE . . . -160.61 38.88 0.44 Allowed Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.901 -0.666 . . . . 15.0 111.719 -179.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.643 HG12 ' O ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -112.9 138.4 42.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 120.998 0.428 . . . . 15.0 111.805 -179.53 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.42 ' O ' ' HB3' ' A' ' 38' ' ' LYS . 28.9 t -95.78 100.92 12.57 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 107.801 -1.185 . . . . 15.0 107.801 177.395 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.616 HG22 HG23 ' A' ' 75' ' ' VAL . 1.0 OUTLIER -93.66 154.82 3.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.162 0.506 . . . . 15.0 112.299 -177.151 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.479 ' HA ' ' ND1' ' A' ' 71' ' ' HIS . 14.5 t -149.34 -176.19 5.28 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.421 -0.809 . . . . 15.0 110.516 179.647 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.712 ' O ' HG22 ' A' ' 26' ' ' VAL . . . 77.1 -112.07 3.42 Favored Glycine 0 C--N 1.331 0.287 0 C-N-CA 120.555 -0.831 . . . . 15.0 112.253 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.56 ' HA3' ' N ' ' A' ' 71' ' ' HIS . . . 62.8 -65.89 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 121.037 -0.601 . . . . 15.0 113.812 179.133 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.718 ' O ' HG22 ' A' ' 30' ' ' VAL . 0.0 OUTLIER -30.27 145.01 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 N-CA-C 112.47 0.544 . . . . 15.0 112.47 -179.068 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -80.28 56.26 2.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.863 -0.608 . . . . 15.0 110.967 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -151.04 -65.38 0.19 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.212 -0.449 . . . . 15.0 110.585 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.09 -47.11 75.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 15.0 110.251 179.57 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.718 HG22 ' O ' ' A' ' 26' ' ' VAL . 33.7 m -88.07 -170.3 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.923 -0.581 . . . . 15.0 110.567 179.475 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -95.83 128.49 42.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.933 0.396 . . . . 15.0 111.152 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 25.6 m80 59.47 -83.35 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.947 -0.57 . . . . 15.0 111.464 179.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.407 ' O ' ' O ' ' A' ' 69' ' ' ALA . . . -170.36 30.61 0.14 Allowed Glycine 0 C--N 1.33 0.244 0 C-N-CA 121.056 -0.592 . . . . 15.0 112.026 -179.548 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.49 ' O ' HG21 ' A' ' 30' ' ' VAL . . . -89.96 151.88 21.95 Favored Glycine 0 N--CA 1.447 -0.583 0 N-CA-C 110.667 -0.973 . . . . 15.0 110.667 178.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.883 HG22 HG22 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -94.25 152.6 3.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.546 0.689 . . . . 15.0 112.149 -179.034 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -136.76 108.14 6.88 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.661 -1.154 . . . . 15.0 109.39 179.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.785 HG22 ' N ' ' A' ' 55' ' ' GLY . 0.8 OUTLIER -55.32 152.19 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.123 0.487 . . . . 15.0 111.563 -178.622 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.451 ' O ' ' HG2' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -84.51 -46.33 11.72 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.457 -0.942 . . . . 15.0 108.457 178.088 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.643 ' O ' HG12 ' A' ' 20' ' ' ILE . . . -172.35 173.17 4.23 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 115.75 -0.659 . . . . 15.0 110.448 178.438 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.565 ' HA ' HG12 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -96.96 111.52 27.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 109.519 -0.548 . . . . 15.0 109.519 179.196 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.686 ' HB ' ' O ' ' A' ' 19' ' ' GLY . 0.4 OUTLIER -78.39 117.01 63.7 Favored Pre-proline 0 C--N 1.33 -0.264 0 N-CA-C 113.408 0.892 . . . . 15.0 113.408 -177.306 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.612 ' HA ' ' CG ' ' A' ' 47' ' ' GLU . 27.1 Cg_exo -62.86 59.79 0.15 Allowed 'Trans proline' 0 C--N 1.357 0.989 0 C-N-CA 123.651 2.9 . . . . 15.0 113.001 179.637 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.521 ' N ' ' HG2' ' A' ' 47' ' ' GLU . 3.9 tt0 -147.51 -47.06 0.17 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.582 0.229 . . . . 15.0 111.394 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.623 ' HA3' ' HA3' ' A' ' 19' ' ' GLY . . . -87.82 167.8 36.98 Favored Glycine 0 CA--C 1.518 0.24 0 C-N-CA 120.368 -0.92 . . . . 15.0 113.884 -179.051 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.711 ' HB3' ' O ' ' A' ' 17' ' ' SER . . . -57.34 -14.45 4.61 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.722 0.638 . . . . 15.0 112.722 -179.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.17 -56.59 5.31 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.662 0.267 . . . . 15.0 110.934 -179.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.612 ' CG ' ' HA ' ' A' ' 42' ' ' PRO . 3.0 pp20? -57.45 -42.69 82.98 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.965 -0.561 . . . . 15.0 110.287 179.309 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -53.77 -70.76 0.09 Allowed 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 115.845 -0.616 . . . . 15.0 110.535 -179.433 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.579 ' CB ' HD11 ' A' ' 11' ' ' LEU . 0.1 OUTLIER -58.43 -41.3 84.73 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.154 -0.684 . . . . 15.0 109.154 178.829 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.75 41.2 11.14 Favored Glycine 0 N--CA 1.445 -0.702 0 CA-C-N 115.361 -0.836 . . . . 15.0 111.718 179.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.615 ' HG3' HD13 ' A' ' 11' ' ' LEU . 0.5 OUTLIER -79.7 -50.3 10.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.883 0.373 . . . . 15.0 110.655 -179.363 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.637 ' CG1' HD12 ' A' ' 20' ' ' ILE . 7.9 tp -81.04 163.3 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 CA-C-N 116.062 -0.517 . . . . 15.0 110.282 179.439 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.476 ' O ' ' HB2' ' A' ' 56' ' ' ASP . 64.0 m80 -147.37 160.82 42.1 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-O 121.687 0.756 . . . . 15.0 112.252 -179.087 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.546 ' HA ' ' CG2' ' A' ' 37' ' ' VAL . 6.1 mtpt -43.82 134.11 4.55 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.309 -1.314 . . . . 15.0 112.576 -178.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.785 ' N ' HG22 ' A' ' 37' ' ' VAL . . . 49.88 33.12 19.83 Favored Glycine 0 C--N 1.333 0.369 0 CA-C-N 115.914 -0.585 . . . . 15.0 113.589 179.324 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.476 ' HB2' ' O ' ' A' ' 53' ' ' HIS . 0.3 OUTLIER -65.93 130.5 43.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 117.16 0.48 . . . . 15.0 110.598 179.38 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.432 ' HA ' ' O ' ' A' ' 35' ' ' ILE . 35.4 ttt180 -82.74 87.91 6.76 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.794 0.331 . . . . 15.0 110.313 179.485 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.883 HG22 HG22 ' A' ' 35' ' ' ILE . 2.3 m -79.32 112.45 17.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.148 0.499 . . . . 15.0 111.063 -179.388 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 44.5 mt -107.21 -11.85 15.5 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 115.645 -0.707 . . . . 15.0 112.625 -179.047 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.718 ' HB3' ' HB2' ' A' ' 88' ' ' LEU . . . -151.35 146.41 25.98 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 112.693 0.627 . . . . 15.0 112.693 -178.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.884 HG11 ' O ' ' A' ' 77' ' ' THR . 40.0 t -139.59 93.53 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.192 -0.913 . . . . 15.0 109.459 178.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.491 HD21 HG22 ' A' ' 81' ' ' THR . 7.5 m120 69.92 17.68 7.45 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.086 -0.507 . . . . 15.0 109.98 -178.305 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 107.27 4.72 35.2 Favored Glycine 0 C--N 1.334 0.456 0 CA-C-N 115.841 -0.618 . . . . 15.0 113.482 179.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.673 ' O ' HG13 ' A' ' 64' ' ' VAL . 5.1 p -93.72 103.25 14.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.207 0.527 . . . . 15.0 110.645 179.198 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 24.3 m -56.89 133.62 54.74 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.995 -0.548 . . . . 15.0 111.117 -179.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.703 HD11 ' HB2' ' A' ' 74' ' ' ALA . 0.1 OUTLIER -88.09 -19.35 27.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.036 -0.529 . . . . 15.0 110.935 179.841 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -47.47 95.86 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 120.91 0.386 . . . . 15.0 110.897 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.73 65.17 0.57 Allowed Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.783 -0.722 . . . . 15.0 112.271 -179.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.65 ' HB1' ' CB ' ' A' ' 73' ' ' GLN . . . -172.76 156.89 3.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.94 0.4 . . . . 15.0 110.859 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.478 ' HB ' HG13 ' A' ' 26' ' ' VAL . 11.3 p -93.07 -171.11 2.59 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.104 0.478 . . . . 15.0 111.336 -179.572 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.615 ' CD2' HG23 ' A' ' 22' ' ' VAL . 0.4 OUTLIER -59.61 -60.99 2.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.621 -0.718 . . . . 15.0 110.158 179.737 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 20.0 ttpp -52.79 -35.93 57.52 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.519 -0.764 . . . . 15.0 110.806 179.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.65 ' CB ' ' HB1' ' A' ' 69' ' ' ALA . 7.9 mt-30 -59.6 -54.43 46.55 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.298 -0.41 . . . . 15.0 109.935 179.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.74 ' HB3' HD12 ' A' ' 35' ' ' ILE . . . -65.17 -43.88 90.32 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.1 -0.5 . . . . 15.0 109.721 178.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.616 HG23 HG22 ' A' ' 22' ' ' VAL . 0.5 OUTLIER -43.38 -42.39 1.42 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.223 0 N-CA-C 108.987 -0.745 . . . . 15.0 108.987 178.289 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.401 ' N ' HG12 ' A' ' 75' ' ' VAL . 1.8 mt-10 -67.41 -43.28 81.63 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 114.9 -1.046 . . . . 15.0 110.323 178.522 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.884 ' O ' HG11 ' A' ' 61' ' ' VAL . 70.4 p -63.94 -56.87 12.04 Favored 'General case' 0 N--CA 1.461 0.116 0 CA-C-O 120.615 0.245 . . . . 15.0 111.521 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.666 HD21 HG21 ' A' ' 58' ' ' VAL . 4.0 mt -53.31 -46.86 69.58 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-O 121.118 0.485 . . . . 15.0 110.185 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.5 -58.2 4.67 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.644 -0.707 . . . . 15.0 110.708 179.467 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 68.7 m-20 -65.85 63.03 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.053 -0.521 . . . . 15.0 111.956 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.491 HG22 HD21 ' A' ' 62' ' ' ASN . 0.0 OUTLIER -92.93 -78.31 0.42 Allowed 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 110.073 -0.343 . . . . 15.0 110.073 179.233 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 122.34 -107.89 1.21 Allowed Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.807 -0.711 . . . . 15.0 112.965 179.223 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -65.23 -80.23 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.665 0.269 . . . . 15.0 111.415 -179.318 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.472 HG12 ' N ' ' A' ' 85' ' ' VAL . 75.9 t -110.19 159.47 9.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.054 0.454 . . . . 15.0 111.179 -179.646 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.853 HG23 ' HB2' ' A' ' 13' ' ' LYS . 6.4 t -97.9 80.88 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.015 -0.539 . . . . 15.0 110.225 179.528 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 11.2 t60 -97.07 80.39 2.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.846 -0.615 . . . . 15.0 110.403 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.827 ' HB3' HD21 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -103.78 120.93 41.98 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.884 -0.598 . . . . 15.0 111.818 -179.118 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.748 HD12 ' HB2' ' A' ' 8' ' ' GLU . 4.0 mp -98.87 101.92 13.48 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.49 -0.559 . . . . 15.0 109.49 178.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.827 HD21 ' HB3' ' A' ' 87' ' ' LEU . 0.1 OUTLIER -105.64 -162.37 0.87 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.488 0.661 . . . . 15.0 112.061 -178.334 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.411 ' HA ' ' HA ' ' A' ' 6' ' ' ILE . 2.1 tt0 -140.67 139.39 34.79 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 114.73 -1.123 . . . . 15.0 109.736 179.124 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 2.0 tptp -52.08 105.65 0.12 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.91 0.386 . . . . 15.0 111.069 -179.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -69.44 129.72 22.91 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.814 -0.708 . . . . 15.0 112.544 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -86.25 87.75 7.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.817 0.341 . . . . 15.0 110.831 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 4.0 t -67.34 147.88 98.81 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.121 -0.491 . . . . 15.0 110.937 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -52.17 -36.82 68.12 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.575 2.183 . . . . 15.0 112.317 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 76.6 p . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.186 -0.912 . . . . 15.0 110.867 -179.986 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_endo . . . . . 0 N--CA 1.488 1.152 0 CA-C-O 120.88 0.283 . . . . 15.0 111.761 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -145.07 118.37 5.46 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.117 -0.492 . . . . 15.0 110.41 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.403 ' CG ' ' HG2' ' A' ' 91' ' ' LYS . 31.7 Cg_endo -63.78 -86.22 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.412 2.075 . . . . 15.0 112.481 -179.777 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 93.13 -30.26 7.32 Favored Glycine 0 C--N 1.332 0.328 0 C-N-CA 120.612 -0.804 . . . . 15.0 112.507 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.21 164.82 6.46 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-O 121.422 0.63 . . . . 15.0 111.181 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.452 HG13 ' HB2' ' A' ' 90' ' ' GLU . 1.3 mp -104.34 146.28 11.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.067 -0.97 . . . . 15.0 110.96 -179.282 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.544 ' CZ ' HD12 ' A' ' 89' ' ' LEU . 4.0 p90 -141.05 165.22 28.15 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.298 -0.41 . . . . 15.0 110.555 178.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.723 ' CB ' HD12 ' A' ' 88' ' ' LEU . 9.7 pt-20 -130.15 144.27 51.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.243 0.544 . . . . 15.0 111.543 -179.352 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.712 ' CG1' HD11 ' A' ' 89' ' ' LEU . 0.5 OUTLIER -101.34 114.13 39.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.31 -0.859 . . . . 15.0 109.539 178.948 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -106.03 71.12 0.88 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.152 -0.476 . . . . 15.0 111.922 -178.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.619 HD11 ' CB ' ' A' ' 49' ' ' ASP . 7.5 tp -88.28 165.04 15.29 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.08 -0.509 . . . . 15.0 109.914 178.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -95.3 93.29 7.19 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.983 0.421 . . . . 15.0 111.041 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.642 ' CB ' HG23 ' A' ' 85' ' ' VAL . 0.0 OUTLIER -54.34 -30.63 52.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.913 -0.585 . . . . 15.0 111.033 179.911 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.478 ' O ' ' CB ' ' A' ' 15' ' ' ASP . 39.5 t30 -84.62 137.58 33.2 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.224 -0.444 . . . . 15.0 110.816 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.478 ' CB ' ' O ' ' A' ' 14' ' ' ASN . 4.7 t70 89.47 -24.25 0.09 Allowed 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.902 -0.59 . . . . 15.0 111.305 -179.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.522 ' HB2' ' HB2' ' A' ' 45' ' ' ALA . 0.9 OUTLIER -165.39 136.12 3.81 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.868 0.366 . . . . 15.0 111.097 179.908 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.935 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 0.5 OUTLIER -86.09 -156.17 0.28 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.141 -0.481 . . . . 15.0 110.205 179.547 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.2 mp -104.78 -172.11 2.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.884 0.373 . . . . 15.0 110.749 179.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.777 ' O ' ' HB ' ' A' ' 41' ' ' ILE . . . -161.05 45.08 0.4 Allowed Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 121.152 -0.547 . . . . 15.0 111.935 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.703 HG12 ' O ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -112.77 139.69 36.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 120.974 0.416 . . . . 15.0 111.77 -179.549 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 45.0 t -94.98 104.05 15.91 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.084 -1.08 . . . . 15.0 108.084 177.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.949 HG21 HG23 ' A' ' 75' ' ' VAL . 10.6 m -93.73 153.9 3.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 113.124 0.787 . . . . 15.0 113.124 -177.037 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.33 -179.66 7.23 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 114.981 -1.009 . . . . 15.0 110.391 179.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.448 ' O ' ' CB ' ' A' ' 71' ' ' HIS . . . 76.71 -121.77 6.1 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.562 -0.828 . . . . 15.0 112.563 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.556 ' HA3' ' N ' ' A' ' 71' ' ' HIS . . . 68.2 -66.27 0.37 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.831 -0.699 . . . . 15.0 113.388 179.437 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.529 ' O ' HG22 ' A' ' 30' ' ' VAL . 1.6 m -28.34 138.76 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 N-CA-C 112.39 0.515 . . . . 15.0 112.39 -179.208 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 10.9 m-80 -76.25 60.08 1.46 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.951 -0.568 . . . . 15.0 111.041 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -151.78 -55.71 0.14 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.331 -0.395 . . . . 15.0 110.956 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.4 m -78.15 -46.23 21.16 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.17 -0.468 . . . . 15.0 111.019 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.529 HG22 ' O ' ' A' ' 26' ' ' VAL . 21.9 m -71.36 -173.72 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.244 -0.435 . . . . 15.0 111.192 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 6.1 mtp85 -57.34 -54.59 45.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.281 -0.418 . . . . 15.0 111.078 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 48.6 p-80 -151.8 -44.69 0.11 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.363 -0.38 . . . . 15.0 111.174 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -169.59 23.6 0.1 OUTLIER Glycine 0 CA--C 1.518 0.223 0 C-N-CA 120.816 -0.707 . . . . 15.0 112.615 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.502 ' O ' HG11 ' A' ' 30' ' ' VAL . . . -93.88 153.93 21.39 Favored Glycine 0 N--CA 1.449 -0.499 0 N-CA-C 110.429 -1.068 . . . . 15.0 110.429 178.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.911 HG22 HG22 ' A' ' 58' ' ' VAL . 0.1 OUTLIER -96.67 153.36 3.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 C-N-CA 119.601 -0.84 . . . . 15.0 112.371 -179.078 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.454 ' CE2' ' HG2' ' A' ' 57' ' ' ARG . 32.5 m-85 -135.67 106.96 6.79 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.63 -1.168 . . . . 15.0 109.27 179.289 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.785 HG22 ' N ' ' A' ' 55' ' ' GLY . 0.7 OUTLIER -55.03 149.36 2.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.147 0.499 . . . . 15.0 111.357 -178.554 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.485 ' O ' ' HG2' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -80.16 -50.46 10.25 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.628 -0.879 . . . . 15.0 108.628 178.739 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.703 ' O ' HG12 ' A' ' 20' ' ' ILE . . . -172.3 173.27 4.24 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 115.72 -0.673 . . . . 15.0 110.081 178.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.543 ' HA ' HG12 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -96.76 112.8 29.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 108.983 -0.747 . . . . 15.0 108.983 178.778 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.777 ' HB ' ' O ' ' A' ' 19' ' ' GLY . 0.4 OUTLIER -77.96 118.07 69.84 Favored Pre-proline 0 C--N 1.328 -0.338 0 N-CA-C 113.231 0.826 . . . . 15.0 113.231 -176.978 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.61 ' HA ' ' HG2' ' A' ' 47' ' ' GLU . 37.3 Cg_endo -64.88 61.67 0.29 Allowed 'Trans proline' 0 C--N 1.357 0.974 0 C-N-CA 123.457 2.771 . . . . 15.0 112.745 179.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.5 ' N ' ' HG2' ' A' ' 47' ' ' GLU . 4.3 mm-40 -151.51 -46.35 0.11 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.536 -0.302 . . . . 15.0 111.489 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.715 ' HA3' ' HA3' ' A' ' 19' ' ' GLY . . . -87.68 166.87 36.29 Favored Glycine 0 C--N 1.33 0.222 0 C-N-CA 120.312 -0.947 . . . . 15.0 113.618 -179.259 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.935 ' HB3' ' O ' ' A' ' 17' ' ' SER . . . -56.95 -13.91 3.09 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.616 0.599 . . . . 15.0 112.616 -179.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.04 -57.19 4.48 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.734 0.302 . . . . 15.0 110.782 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.61 ' HG2' ' HA ' ' A' ' 42' ' ' PRO . 2.8 pp20? -57.21 -42.93 82.25 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.19 -0.459 . . . . 15.0 110.397 179.383 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 22.9 t -53.95 -71.47 0.07 Allowed 'General case' 0 CA--C 1.52 -0.176 0 CA-C-N 115.976 -0.556 . . . . 15.0 110.626 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.619 ' CB ' HD11 ' A' ' 11' ' ' LEU . 0.4 OUTLIER -58.63 -40.78 84.33 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.391 -0.596 . . . . 15.0 109.391 178.901 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.93 45.02 7.89 Favored Glycine 0 N--CA 1.446 -0.65 0 CA-C-N 115.393 -0.822 . . . . 15.0 111.67 179.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.613 ' HB2' HD13 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -79.43 -54.36 6.0 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.892 0.377 . . . . 15.0 110.477 -179.325 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.623 ' CG1' HD12 ' A' ' 20' ' ' ILE . 8.3 tp -81.08 164.29 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 CA-C-N 115.991 -0.55 . . . . 15.0 110.362 179.55 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.441 ' N ' ' OD2' ' A' ' 56' ' ' ASP . 74.5 m80 -146.34 157.13 43.76 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-O 121.659 0.742 . . . . 15.0 112.135 -179.063 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.563 ' HA ' ' CG2' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -44.13 133.52 5.19 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.229 -1.351 . . . . 15.0 112.975 -178.605 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.785 ' N ' HG22 ' A' ' 37' ' ' VAL . . . 49.99 31.28 17.61 Favored Glycine 0 C--N 1.336 0.538 0 CA-C-N 115.809 -0.632 . . . . 15.0 113.268 179.206 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.477 ' OD2' HD12 ' A' ' 52' ' ' ILE . 5.3 m-20 -65.72 129.31 39.32 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.887 -0.325 . . . . 15.0 110.733 179.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.454 ' HG2' ' CE2' ' A' ' 36' ' ' TYR . 50.6 mtt180 -80.74 88.32 5.79 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.233 -0.439 . . . . 15.0 110.313 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.911 HG22 HG22 ' A' ' 35' ' ' ILE . 1.4 m -79.45 112.05 17.01 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 CA-C-O 121.158 0.504 . . . . 15.0 111.058 -179.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 33.3 mt -107.49 -15.27 14.65 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 115.441 -0.8 . . . . 15.0 112.47 -179.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.781 ' HB3' ' HB2' ' A' ' 88' ' ' LEU . . . -149.49 148.28 29.22 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 112.765 0.654 . . . . 15.0 112.765 -178.673 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.744 HG11 ' O ' ' A' ' 77' ' ' THR . 15.4 t -139.11 99.87 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.263 -0.88 . . . . 15.0 109.083 178.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.552 ' OD1' HG22 ' A' ' 81' ' ' THR . 7.0 m120 65.19 16.42 10.54 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.28 -0.418 . . . . 15.0 109.881 -177.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 107.23 4.79 35.29 Favored Glycine 0 C--N 1.336 0.56 0 CA-C-N 115.924 -0.58 . . . . 15.0 113.531 179.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.644 ' O ' HG13 ' A' ' 64' ' ' VAL . 5.3 p -93.78 107.46 19.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 117.175 0.488 . . . . 15.0 110.882 179.511 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -56.57 135.6 54.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.211 -0.449 . . . . 15.0 111.163 -179.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.65 HD11 ' HB2' ' A' ' 74' ' ' ALA . 0.1 OUTLIER -97.16 -21.35 17.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.988 -0.551 . . . . 15.0 110.915 179.9 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -46.7 98.71 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.399 -0.364 . . . . 15.0 110.93 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.83 63.08 0.54 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.804 -0.713 . . . . 15.0 112.139 -179.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.704 ' HB1' ' CB ' ' A' ' 73' ' ' GLN . . . -173.0 143.18 1.14 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.841 0.353 . . . . 15.0 110.865 -179.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.465 ' HA ' ' N ' ' A' ' 26' ' ' VAL . 12.2 p -72.99 -173.16 1.18 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.255 -0.43 . . . . 15.0 111.208 -179.717 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.778 ' CD2' HG23 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -61.93 -59.69 4.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.89 -0.596 . . . . 15.0 110.514 -179.987 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 20.4 ttmt -52.64 -33.69 48.03 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.849 -0.614 . . . . 15.0 110.632 179.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.704 ' CB ' ' HB1' ' A' ' 69' ' ' ALA . 4.7 mt-30 -59.5 -52.66 64.64 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.784 -0.45 . . . . 15.0 109.784 179.447 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.864 ' HB3' HD12 ' A' ' 35' ' ' ILE . . . -66.86 -44.24 81.48 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.704 -0.48 . . . . 15.0 109.704 178.516 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.949 HG23 HG21 ' A' ' 22' ' ' VAL . 0.5 OUTLIER -43.01 -40.79 1.08 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.262 0 N-CA-C 109.012 -0.736 . . . . 15.0 109.012 178.412 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.406 ' O ' ' CB ' ' A' ' 80' ' ' ASN . 46.3 mt-10 -67.39 -44.65 78.35 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 114.789 -1.096 . . . . 15.0 110.369 178.533 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.744 ' O ' HG11 ' A' ' 61' ' ' VAL . 40.9 p -64.14 -54.52 32.5 Favored 'General case' 0 N--CA 1.462 0.151 0 C-N-CA 120.99 -0.284 . . . . 15.0 111.414 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.601 HD21 HG21 ' A' ' 58' ' ' VAL . 5.7 mt -53.56 -47.93 69.61 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-O 121.211 0.529 . . . . 15.0 110.012 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.41 ' HB2' ' O ' ' A' ' 75' ' ' VAL . 1.9 ttt-85 -68.35 -59.47 3.16 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.429 -0.805 . . . . 15.0 110.397 179.375 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.406 ' CB ' ' O ' ' A' ' 76' ' ' GLU . 14.2 m-20 -65.99 62.03 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.933 -0.576 . . . . 15.0 111.94 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.552 HG22 ' OD1' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -93.23 -71.36 0.66 Allowed 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 110.043 -0.355 . . . . 15.0 110.043 179.234 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 122.0 -108.02 1.25 Allowed Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.939 -0.648 . . . . 15.0 112.993 179.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.414 ' O ' ' HB3' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -65.17 -79.69 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.917 0.389 . . . . 15.0 111.623 -179.359 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.444 HG12 ' N ' ' A' ' 85' ' ' VAL . 77.6 t -110.21 158.25 10.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.952 -0.567 . . . . 15.0 111.087 -179.319 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.672 HG12 ' O ' ' A' ' 85' ' ' VAL . 6.8 t -97.93 82.35 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.056 -0.52 . . . . 15.0 110.46 179.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -101.91 85.02 2.62 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.793 -0.639 . . . . 15.0 110.379 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.849 ' HB3' HD21 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -103.86 122.94 46.19 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.925 -0.58 . . . . 15.0 111.808 -179.136 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.781 ' HB2' ' HB3' ' A' ' 60' ' ' ALA . 4.4 mp -97.69 101.37 12.86 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.586 -0.524 . . . . 15.0 109.586 178.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.849 HD21 ' HB3' ' A' ' 87' ' ' LEU . 0.1 OUTLIER -105.93 -161.8 0.82 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.456 0.646 . . . . 15.0 111.961 -178.46 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.452 ' HB2' HG13 ' A' ' 6' ' ' ILE . 4.6 tt0 -143.27 133.56 24.59 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 114.948 -1.024 . . . . 15.0 109.77 179.174 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.403 ' HG2' ' CG ' ' A' ' 3' ' ' PRO . 0.6 OUTLIER -46.95 106.14 0.08 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.994 0.426 . . . . 15.0 111.174 -179.669 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -70.61 -162.43 4.29 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.868 -0.682 . . . . 15.0 112.759 -179.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -76.26 152.35 36.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.847 0.356 . . . . 15.0 110.906 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -90.22 121.57 68.47 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.196 -0.457 . . . . 15.0 110.803 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_exo -51.53 -47.49 25.92 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.49 2.127 . . . . 15.0 112.27 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 2.9 p . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.233 -0.889 . . . . 15.0 110.887 179.98 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo . . . . . 0 N--CA 1.487 1.133 0 CA-C-O 120.799 0.25 . . . . 15.0 111.717 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.411 ' HA ' ' HD2' ' A' ' 3' ' ' PRO . 2.1 ptpt -145.37 107.6 4.46 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.207 -0.452 . . . . 15.0 110.855 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.506 ' HG2' ' HG2' ' A' ' 91' ' ' LYS . 21.2 Cg_endo -61.63 -73.79 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.407 2.071 . . . . 15.0 112.488 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 93.54 -28.56 9.79 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.513 -0.851 . . . . 15.0 112.011 -179.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -61.96 155.86 22.55 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-O 121.607 0.718 . . . . 15.0 110.874 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.461 HG13 ' HB2' ' A' ' 90' ' ' GLU . 1.2 mp -78.56 146.51 7.98 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 114.652 -1.158 . . . . 15.0 111.034 -179.58 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.605 ' CE1' HD12 ' A' ' 89' ' ' LEU . 3.4 p90 -140.19 163.87 31.59 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.224 -0.444 . . . . 15.0 110.261 178.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.732 ' HB3' HD12 ' A' ' 88' ' ' LEU . 4.9 pt-20 -130.17 143.24 50.67 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.295 0.569 . . . . 15.0 111.848 -178.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.511 HG23 ' HB3' ' A' ' 51' ' ' ARG . 0.2 OUTLIER -101.61 115.34 43.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.23 -0.895 . . . . 15.0 109.696 178.74 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -105.84 72.54 0.96 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.243 -0.435 . . . . 15.0 112.121 -178.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.536 HD11 ' CB ' ' A' ' 49' ' ' ASP . 6.3 tp -88.12 165.6 15.0 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.561 -0.533 . . . . 15.0 109.561 178.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -96.13 92.7 6.54 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.993 0.425 . . . . 15.0 111.331 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.711 ' CB ' HG23 ' A' ' 85' ' ' VAL . 0.1 OUTLIER -56.84 -26.61 58.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.892 -0.595 . . . . 15.0 111.061 179.824 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -83.95 -48.81 9.58 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.238 -0.437 . . . . 15.0 110.776 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -58.48 -38.68 78.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.995 0.426 . . . . 15.0 110.301 179.615 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -165.52 162.76 19.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.841 -0.618 . . . . 15.0 110.671 179.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.834 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 0.1 OUTLIER -86.03 -161.37 0.63 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.432 -0.349 . . . . 15.0 110.292 179.653 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.666 ' N ' HD22 ' A' ' 18' ' ' LEU . 1.4 mm? -94.54 -172.29 2.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.914 0.388 . . . . 15.0 110.726 179.556 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.654 ' O ' ' HB ' ' A' ' 41' ' ' ILE . . . -162.84 33.75 0.31 Allowed Glycine 0 N--CA 1.449 -0.465 0 CA-C-N 115.91 -0.586 . . . . 15.0 111.717 -179.678 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.635 HD12 ' CG1' ' A' ' 52' ' ' ILE . 0.0 OUTLIER -112.72 139.96 35.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 121.131 0.491 . . . . 15.0 112.033 -179.261 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.463 ' O ' ' HB3' ' A' ' 38' ' ' LYS . 43.2 t -96.33 100.96 12.53 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 107.396 -1.335 . . . . 15.0 107.396 176.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.673 HG23 ' CD2' ' A' ' 71' ' ' HIS . 1.1 m -93.62 153.82 3.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 112.769 0.655 . . . . 15.0 112.769 -176.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.482 HG22 ' HB2' ' A' ' 38' ' ' LYS . 11.1 t -149.6 -173.48 4.42 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.223 -0.899 . . . . 15.0 110.369 179.317 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.683 ' O ' HG22 ' A' ' 26' ' ' VAL . . . 75.88 -113.94 4.05 Favored Glycine 0 C--N 1.33 0.23 0 C-N-CA 120.517 -0.849 . . . . 15.0 112.347 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.582 ' HA3' ' N ' ' A' ' 71' ' ' HIS . . . 63.59 -65.84 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 121.06 -0.591 . . . . 15.0 113.724 179.175 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.683 HG22 ' O ' ' A' ' 24' ' ' GLY . 0.0 OUTLIER -26.07 139.55 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 N-CA-C 112.51 0.559 . . . . 15.0 112.51 -179.015 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 17.5 m-20 -75.64 61.21 1.33 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.806 -0.634 . . . . 15.0 111.046 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -151.75 -66.49 0.18 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.317 -0.402 . . . . 15.0 111.095 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.8 m -67.79 -34.26 76.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.129 -0.487 . . . . 15.0 111.061 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.559 HG22 ' O ' ' A' ' 26' ' ' VAL . 21.0 m -85.67 -174.33 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.302 -0.408 . . . . 15.0 111.171 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 8.9 mtp180 -57.78 -61.26 2.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.251 -0.431 . . . . 15.0 111.033 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 11.0 p-80 -143.25 -45.95 0.29 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.253 -0.43 . . . . 15.0 111.018 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -169.18 25.7 0.11 Allowed Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.901 -0.666 . . . . 15.0 112.491 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.459 ' O ' HG11 ' A' ' 30' ' ' VAL . . . -90.9 151.31 21.1 Favored Glycine 0 N--CA 1.447 -0.588 0 N-CA-C 110.519 -1.032 . . . . 15.0 110.519 178.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.919 HG22 HG22 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -94.74 152.87 3.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 C-N-CA 119.9 -0.72 . . . . 15.0 112.238 -179.112 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.466 ' CZ ' ' HG2' ' A' ' 57' ' ' ARG . 18.9 m-85 -135.29 107.4 7.17 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.652 -1.158 . . . . 15.0 109.364 179.396 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.788 HG22 ' N ' ' A' ' 55' ' ' GLY . 0.8 OUTLIER -55.14 149.42 2.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 116.102 -0.499 . . . . 15.0 111.462 -178.581 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.482 ' HB2' HG22 ' A' ' 23' ' ' THR . 0.0 OUTLIER -81.19 -48.03 12.64 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.668 -0.864 . . . . 15.0 108.668 178.266 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.582 ' O ' HG12 ' A' ' 20' ' ' ILE . . . -172.29 170.77 4.99 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 115.757 -0.656 . . . . 15.0 110.234 178.5 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.562 ' HA ' HG12 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -97.18 111.81 27.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.055 0.455 . . . . 15.0 110.344 179.575 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.654 ' HB ' ' O ' ' A' ' 19' ' ' GLY . 0.4 OUTLIER -78.56 109.14 9.58 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 115.74 -0.663 . . . . 15.0 112.238 -178.428 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.451 ' N ' ' HG2' ' A' ' 47' ' ' GLU . 30.2 Cg_endo -63.12 65.54 0.16 Allowed 'Trans proline' 0 C--N 1.356 0.944 0 C-N-CA 123.192 2.595 . . . . 15.0 112.591 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.449 ' N ' ' O ' ' A' ' 41' ' ' ILE . 42.2 tt0 -147.44 -53.37 0.21 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.392 -0.822 . . . . 15.0 109.317 179.418 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.552 ' HA3' ' HA3' ' A' ' 19' ' ' GLY . . . -88.02 157.32 28.21 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.684 -0.769 . . . . 15.0 112.528 179.147 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.834 ' HB3' ' O ' ' A' ' 17' ' ' SER . . . -41.73 -16.73 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 113.51 0.93 . . . . 15.0 113.51 -179.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.442 ' N ' ' O ' ' A' ' 44' ' ' GLY . . . -71.5 -71.38 0.27 Allowed 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.768 -0.373 . . . . 15.0 111.159 -179.464 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.501 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 4.3 tp10 -58.59 -40.51 83.39 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-O 120.958 0.409 . . . . 15.0 110.312 179.364 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.7 t -55.51 -63.98 0.99 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.976 -0.556 . . . . 15.0 110.278 179.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.536 ' CB ' HD11 ' A' ' 11' ' ' LEU . 5.6 t0 -62.69 -39.08 92.88 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.146 0.498 . . . . 15.0 109.89 179.053 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.55 36.81 18.95 Favored Glycine 0 N--CA 1.448 -0.512 0 CA-C-N 115.58 -0.736 . . . . 15.0 112.651 179.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.513 ' HG3' HD13 ' A' ' 11' ' ' LEU . 1.7 mmt85 -83.69 -53.44 5.64 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.928 0.394 . . . . 15.0 110.607 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.635 ' CG1' HD12 ' A' ' 20' ' ' ILE . 11.0 tp -81.15 157.85 4.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.977 -0.556 . . . . 15.0 110.183 179.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 53.1 m80 -139.75 160.37 40.03 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-O 121.832 0.825 . . . . 15.0 113.097 -178.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.6 ' HA ' ' CG2' ' A' ' 37' ' ' VAL . 1.0 OUTLIER -45.28 135.13 6.08 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 113.821 -1.536 . . . . 15.0 112.742 -178.865 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.788 ' N ' HG22 ' A' ' 37' ' ' VAL . . . 49.69 32.75 17.67 Favored Glycine 0 C--N 1.335 0.499 0 CA-C-N 116.031 -0.531 . . . . 15.0 113.116 179.146 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.461 ' OD2' HD12 ' A' ' 52' ' ' ILE . 3.5 m-20 -65.72 130.65 44.02 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.95 -0.3 . . . . 15.0 110.821 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.763 ' CD ' HD21 ' A' ' 59' ' ' LEU . 0.0 OUTLIER -84.4 86.37 7.28 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.11 -0.495 . . . . 15.0 110.345 179.579 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.919 HG22 HG22 ' A' ' 35' ' ' ILE . 1.5 m -79.39 113.44 18.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 CA-C-N 116.162 -0.472 . . . . 15.0 111.17 -179.466 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.763 HD21 ' CD ' ' A' ' 57' ' ' ARG . 19.2 mt -107.26 -13.06 15.22 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.819 -0.628 . . . . 15.0 112.41 -179.332 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.572 ' O ' HD23 ' A' ' 87' ' ' LEU . . . -150.62 147.35 27.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.192 0.52 . . . . 15.0 112.313 -178.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.841 HG21 HD23 ' A' ' 78' ' ' LEU . 60.6 t -138.72 102.88 1.97 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.275 0 CA-C-N 115.484 -0.78 . . . . 15.0 109.047 178.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.738 ' ND2' HG22 ' A' ' 81' ' ' THR . 1.5 m-80 64.94 16.32 10.46 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.71 -0.478 . . . . 15.0 109.71 -178.089 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 105.32 5.17 40.4 Favored Glycine 0 C--N 1.337 0.617 0 CA-C-N 115.82 -0.627 . . . . 15.0 113.23 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.653 ' O ' HG13 ' A' ' 64' ' ' VAL . 6.7 p -93.85 107.53 19.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.006 0.432 . . . . 15.0 111.046 179.6 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.2 m -55.8 133.08 50.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.269 -0.423 . . . . 15.0 111.083 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.593 HD11 ' HB2' ' A' ' 74' ' ' ALA . 0.1 OUTLIER -91.59 -21.68 20.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.001 -0.545 . . . . 15.0 111.026 179.992 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -43.85 97.41 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 120.905 0.383 . . . . 15.0 110.978 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.85 64.26 0.56 Allowed Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.866 -0.683 . . . . 15.0 112.058 -179.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.785 ' HB1' ' HB3' ' A' ' 73' ' ' GLN . . . -172.98 135.68 0.62 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.895 0.379 . . . . 15.0 110.982 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.431 ' HA ' ' N ' ' A' ' 26' ' ' VAL . 10.2 p -72.9 -171.45 0.87 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.112 0.482 . . . . 15.0 111.31 -179.66 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.673 ' CD2' HG23 ' A' ' 22' ' ' VAL . 0.4 OUTLIER -58.33 -63.08 1.4 Allowed 'General case' 0 CA--C 1.517 -0.315 0 CA-C-N 115.721 -0.672 . . . . 15.0 109.814 179.812 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 13.5 ttpp -53.23 -36.12 60.71 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.316 -0.856 . . . . 15.0 110.574 179.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.785 ' HB3' ' HB1' ' A' ' 69' ' ' ALA . 5.8 mt-30 -59.32 -50.75 72.79 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 116.149 -0.478 . . . . 15.0 109.715 179.475 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.801 ' HB3' HD12 ' A' ' 35' ' ' ILE . . . -66.96 -47.39 71.75 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.059 -0.519 . . . . 15.0 109.665 178.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.615 HG23 ' CG2' ' A' ' 22' ' ' VAL . 0.5 OUTLIER -40.84 -41.19 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.23 0 CA-C-N 115.522 -0.763 . . . . 15.0 109.472 178.643 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -67.18 -46.05 75.1 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 114.884 -1.053 . . . . 15.0 110.781 179.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.656 ' O ' HG11 ' A' ' 61' ' ' VAL . 2.5 p -64.6 -53.28 50.17 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 120.79 -0.364 . . . . 15.0 111.529 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.841 HD23 HG21 ' A' ' 61' ' ' VAL . 3.8 mt -53.4 -48.41 68.71 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-O 121.185 0.517 . . . . 15.0 110.07 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.4 ' O ' ' N ' ' A' ' 81' ' ' THR . 4.1 ttt85 -68.46 -57.4 5.89 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.575 -0.739 . . . . 15.0 110.492 179.282 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 63.3 m-20 -66.0 62.77 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.879 -0.6 . . . . 15.0 111.948 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.738 HG22 ' ND2' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -95.37 -71.71 0.66 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.769 0.318 . . . . 15.0 110.22 179.221 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 122.04 -104.05 0.89 Allowed Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.744 -0.741 . . . . 15.0 113.185 179.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.418 ' O ' ' HB3' ' A' ' 13' ' ' LYS . 0.4 OUTLIER -64.59 -84.49 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 111.975 0.361 . . . . 15.0 111.975 -179.072 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.461 HG12 ' N ' ' A' ' 85' ' ' VAL . 74.1 t -109.65 160.17 8.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.873 0.368 . . . . 15.0 110.897 -179.528 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.711 HG23 ' CB ' ' A' ' 13' ' ' LYS . 12.9 t -97.83 81.23 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.118 0.485 . . . . 15.0 110.56 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -101.15 84.69 2.69 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.778 -0.646 . . . . 15.0 110.429 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.742 ' HB3' HD21 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -103.19 121.06 41.89 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.06 -0.518 . . . . 15.0 111.743 -179.226 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.732 HD12 ' HB3' ' A' ' 8' ' ' GLU . 0.2 OUTLIER -97.52 101.53 13.08 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.374 -0.602 . . . . 15.0 109.374 178.636 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.742 HD21 ' HB3' ' A' ' 87' ' ' LEU . 0.1 OUTLIER -105.89 -161.89 0.83 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.598 0.713 . . . . 15.0 112.347 -178.451 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.461 ' HB2' HG13 ' A' ' 6' ' ' ILE . 3.4 tt0 -142.17 132.66 25.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 114.609 -1.178 . . . . 15.0 109.059 178.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.506 ' HG2' ' HG2' ' A' ' 3' ' ' PRO . 0.0 OUTLIER -49.54 100.13 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.003 0.43 . . . . 15.0 111.19 -179.393 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -65.36 -129.74 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.404 0 CA-C-N 115.766 -0.652 . . . . 15.0 112.703 -179.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -76.15 111.65 11.78 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.834 0.349 . . . . 15.0 110.951 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -74.74 152.52 87.1 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.172 -0.467 . . . . 15.0 110.906 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_exo -51.28 175.52 0.05 OUTLIER 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.607 2.205 . . . . 15.0 112.295 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 3.5 t . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.209 -0.901 . . . . 15.0 110.85 -179.969 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_endo . . . . . 0 N--CA 1.488 1.192 0 CA-C-O 120.861 0.275 . . . . 15.0 111.778 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.97 66.94 9.86 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.162 -0.472 . . . . 15.0 110.827 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -65.09 -169.31 0.13 Allowed 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.411 2.074 . . . . 15.0 112.51 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 86.09 -19.8 24.39 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.768 -0.729 . . . . 15.0 112.003 -179.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -72.55 162.8 29.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.293 0.568 . . . . 15.0 111.04 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.419 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 1.4 mp -104.39 144.08 15.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.185 -0.916 . . . . 15.0 110.883 -179.655 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.589 ' CE1' HD12 ' A' ' 89' ' ' LEU . 4.2 p90 -140.61 165.74 26.64 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.378 -0.374 . . . . 15.0 110.446 178.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.718 ' CB ' HD12 ' A' ' 88' ' ' LEU . 10.7 pt-20 -130.11 143.09 50.59 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.295 0.569 . . . . 15.0 111.55 -179.32 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.578 ' CG1' HD11 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -101.54 115.44 43.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.203 -0.908 . . . . 15.0 109.548 178.84 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -106.0 72.28 0.94 Allowed 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.193 0.442 . . . . 15.0 112.193 -178.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.598 HD13 ' HG3' ' A' ' 51' ' ' ARG . 5.8 tp -88.33 166.55 14.21 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 109.685 -0.487 . . . . 15.0 109.685 178.636 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -95.73 95.31 8.23 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.006 0.431 . . . . 15.0 111.167 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.689 ' CB ' HG23 ' A' ' 85' ' ' VAL . 0.2 OUTLIER -58.64 -26.3 63.6 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.803 -0.635 . . . . 15.0 111.225 -179.972 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -83.95 -49.44 8.97 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.373 -0.376 . . . . 15.0 111.045 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -56.06 -41.52 75.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.972 0.415 . . . . 15.0 110.453 179.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.51 ' HB3' ' HB2' ' A' ' 45' ' ' ALA . 0.9 OUTLIER -165.57 159.25 16.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.842 -0.617 . . . . 15.0 110.632 179.717 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.823 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 0.6 OUTLIER -85.94 -168.31 2.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.404 -0.362 . . . . 15.0 110.358 179.657 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.662 ' N ' HD22 ' A' ' 18' ' ' LEU . 1.0 OUTLIER -96.12 -174.31 3.06 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.931 0.396 . . . . 15.0 110.775 179.539 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.748 ' O ' ' HB ' ' A' ' 41' ' ' ILE . . . -162.38 44.1 0.36 Allowed Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.966 -0.635 . . . . 15.0 111.932 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.641 HG12 ' O ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -112.67 140.27 33.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 120.979 0.419 . . . . 15.0 111.622 -179.571 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.5 t -94.59 102.41 14.33 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 107.613 -1.255 . . . . 15.0 107.613 177.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.877 HG21 HG23 ' A' ' 75' ' ' VAL . 3.8 m -93.63 148.95 4.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 113.212 0.819 . . . . 15.0 113.212 -176.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.559 ' O ' ' O ' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -149.62 158.02 43.78 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 115.335 -0.848 . . . . 15.0 111.026 179.996 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.414 ' O ' HG12 ' A' ' 35' ' ' ILE . . . 67.7 116.5 0.02 OUTLIER Glycine 0 N--CA 1.453 -0.182 0 C-N-CA 120.589 -0.815 . . . . 15.0 113.421 178.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.514 ' HA3' ' N ' ' A' ' 71' ' ' HIS . . . -164.65 -39.05 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.964 -0.636 . . . . 15.0 112.501 179.225 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.504 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 0.2 OUTLIER -39.86 160.09 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-O 120.803 0.335 . . . . 15.0 111.736 179.791 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -85.45 52.18 2.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.314 -0.403 . . . . 15.0 111.024 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -151.8 -63.03 0.17 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.156 -0.475 . . . . 15.0 110.767 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.83 -51.8 51.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.216 -0.447 . . . . 15.0 110.689 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.461 HG22 ' O ' ' A' ' 26' ' ' VAL . 17.7 m -88.06 -177.8 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.107 -0.497 . . . . 15.0 110.76 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.41 ' O ' ' N ' ' A' ' 33' ' ' GLY . 0.2 OUTLIER -85.48 134.28 34.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.974 0.416 . . . . 15.0 111.062 -179.926 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 54.26 -85.42 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.657 -0.701 . . . . 15.0 111.578 179.635 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 31' ' ' ARG . . . -172.46 31.78 0.12 Allowed Glycine 0 C--N 1.331 0.272 0 C-N-CA 120.977 -0.63 . . . . 15.0 112.196 -179.498 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -95.25 158.67 22.37 Favored Glycine 0 N--CA 1.449 -0.446 0 N-CA-C 110.807 -0.917 . . . . 15.0 110.807 179.151 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 1.043 HG22 HG22 ' A' ' 58' ' ' VAL . 0.1 OUTLIER -98.31 154.99 3.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 C-N-CA 119.996 -0.682 . . . . 15.0 111.993 -179.355 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.559 ' O ' ' O ' ' A' ' 23' ' ' THR . 14.1 m-85 -135.16 108.94 8.04 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.365 -0.834 . . . . 15.0 109.767 179.498 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.762 HG22 ' N ' ' A' ' 55' ' ' GLY . 0.8 OUTLIER -54.8 149.54 2.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 121.262 0.553 . . . . 15.0 111.626 -178.45 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.508 ' O ' ' HG2' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -80.17 -47.46 14.67 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.32 -0.992 . . . . 15.0 108.32 178.516 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.641 ' O ' HG12 ' A' ' 20' ' ' ILE . . . -172.51 174.16 3.86 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.349 -0.841 . . . . 15.0 110.114 178.614 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.556 ' HA ' HG12 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -96.81 110.09 24.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 108.938 -0.764 . . . . 15.0 108.938 178.741 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.748 ' HB ' ' O ' ' A' ' 19' ' ' GLY . 0.7 OUTLIER -78.12 116.43 58.75 Favored Pre-proline 0 C--N 1.328 -0.365 0 N-CA-C 113.488 0.922 . . . . 15.0 113.488 -176.916 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.609 ' HA ' ' CG ' ' A' ' 47' ' ' GLU . 39.1 Cg_exo -61.33 61.39 0.1 Allowed 'Trans proline' 0 C--N 1.358 1.074 0 C-N-CA 123.752 2.968 . . . . 15.0 112.969 179.725 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.519 ' H ' ' HG2' ' A' ' 47' ' ' GLU . 2.9 mm-40 -149.83 -48.63 0.13 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.619 0.247 . . . . 15.0 111.554 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.74 ' HA3' ' HA3' ' A' ' 19' ' ' GLY . . . -87.79 168.69 37.95 Favored Glycine 0 CA--C 1.517 0.195 0 C-N-CA 120.362 -0.923 . . . . 15.0 113.905 -179.116 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.823 ' HB3' ' O ' ' A' ' 17' ' ' SER . . . -57.72 -12.35 2.89 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.549 0.574 . . . . 15.0 112.549 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.425 ' HB1' HG22 ' A' ' 52' ' ' ILE . . . -71.78 -58.5 3.41 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.854 0.359 . . . . 15.0 110.435 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.609 ' CG ' ' HA ' ' A' ' 42' ' ' PRO . 2.9 pp20? -57.67 -43.43 85.02 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.686 -0.688 . . . . 15.0 110.473 179.159 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -53.78 -71.31 0.08 Allowed 'General case' 0 CA--C 1.519 -0.225 0 CA-C-N 115.87 -0.604 . . . . 15.0 110.581 -179.398 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.548 ' CB ' HD11 ' A' ' 11' ' ' LEU . 0.7 OUTLIER -58.13 -41.24 83.22 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.141 -0.688 . . . . 15.0 109.141 178.778 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.79 39.57 13.61 Favored Glycine 0 N--CA 1.445 -0.702 0 CA-C-N 115.319 -0.855 . . . . 15.0 111.665 179.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.598 ' HG3' HD13 ' A' ' 11' ' ' LEU . 0.8 OUTLIER -79.72 -49.44 12.07 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.873 0.368 . . . . 15.0 110.573 -179.3 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.593 ' CG1' HD12 ' A' ' 20' ' ' ILE . 9.3 tp -81.01 160.6 3.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 116.037 -0.528 . . . . 15.0 110.181 179.411 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.471 ' O ' ' HB2' ' A' ' 56' ' ' ASP . 63.5 m80 -144.31 158.68 43.61 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-O 121.644 0.735 . . . . 15.0 112.146 -179.13 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.553 ' HA ' ' CG2' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -43.81 134.01 4.57 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.437 -1.256 . . . . 15.0 112.607 -178.734 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.762 ' N ' HG22 ' A' ' 37' ' ' VAL . . . 49.98 34.34 23.1 Favored Glycine 0 C--N 1.333 0.394 0 CA-C-N 115.827 -0.624 . . . . 15.0 113.44 179.397 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.471 ' HB2' ' O ' ' A' ' 53' ' ' HIS . 0.4 OUTLIER -65.99 130.37 43.01 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.584 -0.446 . . . . 15.0 110.561 179.481 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.423 ' HE ' HD21 ' A' ' 59' ' ' LEU . 39.0 ttt180 -84.58 87.65 7.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.175 -0.466 . . . . 15.0 110.12 179.502 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 1.043 HG22 HG22 ' A' ' 35' ' ' ILE . 1.5 m -79.26 113.01 18.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 CA-C-O 121.187 0.518 . . . . 15.0 111.032 -179.413 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.423 HD21 ' HE ' ' A' ' 57' ' ' ARG . 23.7 mt -107.34 -11.77 15.48 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 115.424 -0.807 . . . . 15.0 112.304 -179.179 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.847 ' HB3' ' HB2' ' A' ' 88' ' ' LEU . . . -150.81 144.48 25.1 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.165 0.507 . . . . 15.0 112.323 -178.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.796 HG21 ' OG1' ' A' ' 77' ' ' THR . 14.8 t -139.24 102.21 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.487 -0.779 . . . . 15.0 109.569 178.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.867 ' ND2' HG22 ' A' ' 81' ' ' THR . 1.7 m-80 64.71 15.39 9.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.017 0.437 . . . . 15.0 109.83 -178.377 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 107.15 6.03 34.43 Favored Glycine 0 C--N 1.336 0.554 0 CA-C-N 115.903 -0.589 . . . . 15.0 113.409 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.659 ' O ' HG13 ' A' ' 64' ' ' VAL . 6.4 p -93.77 105.41 16.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 117.213 0.506 . . . . 15.0 110.907 179.413 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -58.76 127.91 34.57 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.099 -0.501 . . . . 15.0 110.986 -179.692 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -87.66 -20.01 26.89 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.029 -0.532 . . . . 15.0 110.864 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -47.77 97.91 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.896 0.379 . . . . 15.0 110.768 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.8 64.48 0.56 Allowed Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.738 -0.744 . . . . 15.0 112.022 -179.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.713 ' HB1' ' CG ' ' A' ' 73' ' ' GLN . . . -172.68 166.76 5.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.882 0.373 . . . . 15.0 110.949 -179.655 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.504 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 11.5 p -93.38 -174.42 3.51 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.064 0.459 . . . . 15.0 111.506 -179.461 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.653 ' CD2' HG23 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -62.95 -60.36 3.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.745 -0.661 . . . . 15.0 110.51 -179.862 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.428 ' O ' ' HG3' ' A' ' 76' ' ' GLU . 8.3 ttpp -52.37 -29.5 24.25 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.88 -0.6 . . . . 15.0 110.343 179.511 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.713 ' CG ' ' HB1' ' A' ' 69' ' ' ALA . 0.4 OUTLIER -59.31 -50.24 74.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.138 -0.483 . . . . 15.0 109.842 179.371 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.47 ' O ' ' N ' ' A' ' 77' ' ' THR . . . -67.09 -47.46 71.16 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 109.597 -0.52 . . . . 15.0 109.597 178.572 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.877 HG23 HG21 ' A' ' 22' ' ' VAL . 0.5 OUTLIER -41.44 -41.05 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.251 0 N-CA-C 108.95 -0.759 . . . . 15.0 108.95 178.202 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.45 ' O ' ' N ' ' A' ' 80' ' ' ASN . 62.0 mt-10 -67.64 -46.49 72.33 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 114.711 -1.131 . . . . 15.0 110.317 178.434 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.796 ' OG1' HG21 ' A' ' 61' ' ' VAL . 32.6 p -64.34 -51.4 63.59 Favored 'General case' 0 C--O 1.231 0.119 0 C-N-CA 120.851 -0.34 . . . . 15.0 111.193 179.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.584 HD21 HG21 ' A' ' 58' ' ' VAL . 5.3 mt -53.67 -50.55 65.57 Favored 'General case' 0 CA--C 1.521 -0.168 0 CA-C-O 121.249 0.547 . . . . 15.0 109.801 179.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 21.8 ttt180 -68.46 -61.9 1.63 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.31 -0.859 . . . . 15.0 110.472 179.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.45 ' N ' ' O ' ' A' ' 76' ' ' GLU . 9.5 m-20 -66.04 61.68 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.878 -0.601 . . . . 15.0 111.997 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.867 HG22 ' ND2' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -94.16 -67.18 0.87 Allowed 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 110.062 -0.348 . . . . 15.0 110.062 179.193 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 122.28 -108.96 1.34 Allowed Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.864 -0.684 . . . . 15.0 113.118 179.153 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -65.39 -79.17 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.772 0.32 . . . . 15.0 111.696 -179.157 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.45 HG12 ' N ' ' A' ' 85' ' ' VAL . 63.8 t -109.94 159.2 9.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.023 0.44 . . . . 15.0 111.034 -179.337 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.689 HG23 ' CB ' ' A' ' 13' ' ' LYS . 9.4 t -97.86 81.26 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.095 -0.502 . . . . 15.0 110.402 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -100.78 85.0 2.8 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.748 -0.66 . . . . 15.0 110.28 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.792 ' HB3' HD21 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -103.32 119.61 39.21 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.009 -0.541 . . . . 15.0 111.893 -179.003 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.847 ' HB2' ' HB3' ' A' ' 60' ' ' ALA . 4.6 mp -94.59 101.64 13.52 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.451 -0.574 . . . . 15.0 109.451 178.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.792 HD21 ' HB3' ' A' ' 87' ' ' LEU . 0.2 OUTLIER -105.64 -163.48 0.94 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.346 0.594 . . . . 15.0 111.982 -178.55 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.419 ' HA ' ' HA ' ' A' ' 6' ' ' ILE . 2.6 tt0 -140.97 131.77 25.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.01 -0.996 . . . . 15.0 109.796 179.143 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.62 94.92 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.863 0.363 . . . . 15.0 111.122 -179.63 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -63.71 164.03 31.57 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.945 -0.645 . . . . 15.0 112.729 -179.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 8.4 mm100 -86.31 122.3 30.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.825 0.345 . . . . 15.0 110.747 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 36.4 m -89.59 144.01 31.33 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.22 -0.445 . . . . 15.0 110.87 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -52.81 -62.07 0.4 Allowed 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.533 2.155 . . . . 15.0 112.271 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 7.7 p . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.262 -0.875 . . . . 15.0 110.833 -179.988 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo . . . . . 0 N--CA 1.487 1.127 0 CA-C-O 120.839 0.266 . . . . 15.0 111.871 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.54 ' HB3' ' HD3' ' A' ' 3' ' ' PRO . 1.5 tttm -155.19 -63.14 0.02 OUTLIER Pre-proline 0 CA--C 1.534 0.327 0 CA-C-N 116.168 -0.469 . . . . 15.0 110.851 -179.781 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.54 ' HD3' ' HB3' ' A' ' 2' ' ' LYS . 74.1 Cg_exo -41.58 109.82 0.12 Allowed 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.694 2.262 . . . . 15.0 113.107 179.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 83.11 -23.46 6.04 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.433 -0.889 . . . . 15.0 112.728 179.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.413 ' HB2' ' O ' ' A' ' 2' ' ' LYS . 0.7 OUTLIER -61.56 150.8 34.97 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-O 121.473 0.654 . . . . 15.0 110.823 -179.921 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.502 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 1.4 mp -89.62 149.7 3.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 114.949 -1.023 . . . . 15.0 111.529 -178.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.722 ' CE1' HD12 ' A' ' 89' ' ' LEU . 7.6 p90 -144.71 164.22 31.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.913 -0.585 . . . . 15.0 110.048 178.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.729 ' HB3' HD12 ' A' ' 88' ' ' LEU . 5.6 pt-20 -130.26 142.54 50.55 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.369 0.604 . . . . 15.0 111.907 -179.289 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.525 ' CG1' HD11 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -101.65 114.4 40.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.117 -0.947 . . . . 15.0 109.638 178.85 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -106.15 72.74 0.95 Allowed 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 112.351 0.501 . . . . 15.0 112.351 -178.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.676 HD13 ' HG3' ' A' ' 51' ' ' ARG . 6.0 tp -88.36 165.91 14.63 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.668 -0.493 . . . . 15.0 109.668 178.609 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.555 ' HB1' ' HB2' ' A' ' 15' ' ' ASP . . . -96.15 94.43 7.52 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.003 0.43 . . . . 15.0 111.149 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.688 ' CB ' HG23 ' A' ' 85' ' ' VAL . 0.1 OUTLIER -60.18 -30.84 69.61 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.764 -0.653 . . . . 15.0 111.315 -179.927 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.403 ' N ' ' O ' ' A' ' 83' ' ' GLN . 1.5 t30 -84.44 -30.48 25.26 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.322 -0.399 . . . . 15.0 110.964 -179.616 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.555 ' HB2' ' HB1' ' A' ' 12' ' ' ALA . 1.1 t70 -78.0 -36.59 48.62 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.013 0.435 . . . . 15.0 110.12 179.255 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.483 ' HB3' ' HB2' ' A' ' 45' ' ' ALA . 1.1 m-20 -165.49 156.71 14.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.806 -0.634 . . . . 15.0 110.625 179.634 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.918 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 0.3 OUTLIER -86.02 -158.27 0.39 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.353 -0.385 . . . . 15.0 110.297 179.695 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.678 ' N ' HD22 ' A' ' 18' ' ' LEU . 0.4 OUTLIER -109.66 -166.14 1.07 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.813 0.34 . . . . 15.0 110.689 179.603 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.789 ' O ' ' HB ' ' A' ' 41' ' ' ILE . . . -173.2 44.68 0.16 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.921 -0.657 . . . . 15.0 111.913 -179.747 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.731 HG12 ' O ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -112.61 137.29 46.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 120.996 0.427 . . . . 15.0 111.579 -179.611 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.41 ' H ' HD13 ' A' ' 41' ' ' ILE . 29.1 t -88.86 105.5 17.78 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 107.865 -1.161 . . . . 15.0 107.865 177.516 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 1.014 HG21 HG23 ' A' ' 75' ' ' VAL . 34.8 m -93.37 152.5 3.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 112.618 0.599 . . . . 15.0 112.618 -177.155 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.424 ' OG1' ' CB ' ' A' ' 38' ' ' LYS . 0.8 OUTLIER -149.14 -178.62 6.48 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.245 -0.889 . . . . 15.0 110.807 -179.565 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.608 ' O ' HG22 ' A' ' 26' ' ' VAL . . . 70.16 -119.36 8.67 Favored Glycine 0 C--N 1.333 0.372 0 C-N-CA 120.856 -0.688 . . . . 15.0 112.421 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.518 ' HA3' ' N ' ' A' ' 71' ' ' HIS . . . 66.61 -65.62 0.17 Allowed Glycine 0 C--N 1.331 0.259 0 C-N-CA 121.013 -0.613 . . . . 15.0 113.61 179.402 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.608 HG22 ' O ' ' A' ' 24' ' ' GLY . 0.0 OUTLIER -28.14 140.33 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 N-CA-C 112.457 0.54 . . . . 15.0 112.457 -179.353 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.412 ' HA ' ' O ' ' A' ' 32' ' ' HIS . 59.5 t-20 -77.33 58.07 1.59 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.904 -0.589 . . . . 15.0 111.075 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.0 m -151.83 -48.28 0.11 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.283 -0.417 . . . . 15.0 110.935 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 21.6 m -83.2 -46.68 12.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 15.0 111.053 -179.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.523 HG22 ' O ' ' A' ' 26' ' ' VAL . 33.2 m -69.95 -174.62 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.262 -0.426 . . . . 15.0 111.169 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 10.0 mmp_? -67.59 -44.85 77.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.242 -0.436 . . . . 15.0 111.052 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . 0.412 ' O ' ' HA ' ' A' ' 27' ' ' ASN . 43.3 m80 -143.28 -68.41 0.34 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.306 -0.406 . . . . 15.0 111.004 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -161.43 19.52 0.19 Allowed Glycine 0 CA--C 1.517 0.189 0 C-N-CA 120.892 -0.671 . . . . 15.0 112.559 -179.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -83.64 150.67 27.06 Favored Glycine 0 N--CA 1.449 -0.493 0 N-CA-C 110.767 -0.933 . . . . 15.0 110.767 178.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.893 HG22 HG22 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -85.79 154.94 3.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 C-N-CA 120.031 -0.667 . . . . 15.0 111.745 -179.294 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.516 ' CE2' ' HG2' ' A' ' 57' ' ' ARG . 30.4 m-85 -139.2 106.8 5.59 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.041 -0.981 . . . . 15.0 109.736 178.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.793 HG22 ' N ' ' A' ' 55' ' ' GLY . 0.7 OUTLIER -55.17 146.11 4.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 116.041 -0.527 . . . . 15.0 111.025 -179.072 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.477 ' HG3' ' N ' ' A' ' 39' ' ' ALA . 0.2 OUTLIER -80.23 -46.24 16.61 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.502 -0.925 . . . . 15.0 108.502 178.616 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.731 ' O ' HG12 ' A' ' 20' ' ' ILE . . . -172.07 171.45 4.97 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 115.764 -0.653 . . . . 15.0 110.242 178.471 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.548 ' HA ' ' CG1' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -96.63 109.49 23.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 109.118 -0.697 . . . . 15.0 109.118 179.135 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.789 ' HB ' ' O ' ' A' ' 19' ' ' GLY . 0.5 OUTLIER -78.16 118.31 71.43 Favored Pre-proline 0 C--N 1.326 -0.44 0 N-CA-C 113.261 0.837 . . . . 15.0 113.261 -177.106 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.625 ' HA ' ' CG ' ' A' ' 47' ' ' GLU . 36.9 Cg_endo -64.71 60.46 0.28 Allowed 'Trans proline' 0 C--N 1.357 0.992 0 C-N-CA 123.539 2.826 . . . . 15.0 112.793 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.517 ' N ' ' HG2' ' A' ' 47' ' ' GLU . 11.2 tt0 -147.41 -46.75 0.17 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.52 -0.309 . . . . 15.0 111.244 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.777 ' HA3' ' HA3' ' A' ' 19' ' ' GLY . . . -87.87 169.33 38.53 Favored Glycine 0 C--N 1.33 0.229 0 C-N-CA 120.36 -0.924 . . . . 15.0 113.851 -179.285 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.918 ' HB3' ' O ' ' A' ' 17' ' ' SER . . . -59.36 -13.3 7.81 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.465 0.542 . . . . 15.0 112.465 -179.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.532 ' HB1' HG22 ' A' ' 52' ' ' ILE . . . -71.94 -56.15 6.2 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.934 -0.306 . . . . 15.0 110.578 -179.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.625 ' CG ' ' HA ' ' A' ' 42' ' ' PRO . 2.8 pp20? -57.61 -43.89 85.08 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 115.988 -0.551 . . . . 15.0 110.354 179.001 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 50.1 m -53.84 -70.55 0.09 Allowed 'General case' 0 CA--C 1.519 -0.225 0 CA-C-N 115.825 -0.625 . . . . 15.0 110.583 -179.477 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.487 ' CB ' HD11 ' A' ' 11' ' ' LEU . 4.4 t0 -58.1 -41.24 83.08 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.058 -0.719 . . . . 15.0 109.058 178.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.63 39.06 15.07 Favored Glycine 0 N--CA 1.446 -0.672 0 CA-C-N 115.295 -0.866 . . . . 15.0 111.771 179.285 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.676 ' HG3' HD13 ' A' ' 11' ' ' LEU . 0.5 OUTLIER -79.67 -51.05 9.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.976 0.417 . . . . 15.0 110.571 -179.388 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.601 ' CG2' HD12 ' A' ' 20' ' ' ILE . 10.8 tp -81.12 158.36 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 CA-C-N 115.93 -0.577 . . . . 15.0 110.106 179.465 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.453 ' N ' ' OD2' ' A' ' 56' ' ' ASP . 80.4 m80 -145.54 159.27 43.36 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-O 121.591 0.71 . . . . 15.0 112.36 -178.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.572 ' HA ' ' CG2' ' A' ' 37' ' ' VAL . 5.0 mtpt -42.13 132.63 3.24 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.213 -1.358 . . . . 15.0 113.01 -178.595 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.793 ' N ' HG22 ' A' ' 37' ' ' VAL . . . 49.9 31.28 16.9 Favored Glycine 0 C--N 1.334 0.455 0 CA-C-N 115.697 -0.683 . . . . 15.0 113.279 179.187 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.453 ' OD2' ' N ' ' A' ' 53' ' ' HIS . 6.2 m-20 -65.7 129.39 39.6 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.726 -0.39 . . . . 15.0 110.526 179.531 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.516 ' HG2' ' CE2' ' A' ' 36' ' ' TYR . 0.5 OUTLIER -82.57 95.96 7.92 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.222 -0.445 . . . . 15.0 110.677 -179.921 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.893 HG22 HG22 ' A' ' 35' ' ' ILE . 1.4 m -86.63 117.06 30.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 CA-C-O 120.927 0.394 . . . . 15.0 110.873 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.532 ' N ' HD22 ' A' ' 59' ' ' LEU . 3.1 mm? -107.0 -17.0 14.3 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.915 -0.584 . . . . 15.0 112.482 -179.064 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.45 ' O ' HD23 ' A' ' 87' ' ' LEU . . . -149.05 148.73 30.05 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.199 0.524 . . . . 15.0 112.411 -178.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.643 HG22 HD21 ' A' ' 87' ' ' LEU . 17.5 t -139.13 101.36 1.55 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.26 0 CA-C-N 115.446 -0.797 . . . . 15.0 109.409 178.853 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.812 ' ND2' HG22 ' A' ' 81' ' ' THR . 1.6 m-80 64.79 15.5 9.86 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.658 -0.497 . . . . 15.0 109.658 -178.066 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 107.06 4.82 35.66 Favored Glycine 0 C--N 1.337 0.613 0 CA-C-N 115.832 -0.622 . . . . 15.0 113.331 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.636 ' O ' HG13 ' A' ' 64' ' ' VAL . 4.5 p -93.87 107.83 19.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.022 0.439 . . . . 15.0 110.886 179.487 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 67.2 m -56.5 133.7 53.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.21 -0.45 . . . . 15.0 111.079 -179.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.663 HD11 ' HB2' ' A' ' 74' ' ' ALA . 0.2 OUTLIER -94.76 -26.23 16.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.016 -0.538 . . . . 15.0 110.902 179.924 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 14.3 tt0 -46.03 104.12 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.308 -0.406 . . . . 15.0 111.048 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.75 60.13 0.54 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.79 -0.719 . . . . 15.0 112.464 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.609 ' HB1' ' CB ' ' A' ' 73' ' ' GLN . . . -173.04 166.94 5.02 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.959 0.409 . . . . 15.0 111.148 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.471 ' CB ' ' HA ' ' A' ' 26' ' ' VAL . 9.1 p -93.18 -172.3 2.92 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.125 -0.489 . . . . 15.0 111.053 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.76 ' CD2' HG23 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -63.86 -58.91 5.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.787 -0.642 . . . . 15.0 110.583 179.868 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.422 ' O ' ' HG3' ' A' ' 76' ' ' GLU . 18.0 ttpp -52.59 -34.06 48.95 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.003 -0.544 . . . . 15.0 110.557 179.396 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.609 ' CB ' ' HB1' ' A' ' 69' ' ' ALA . 9.5 mt-30 -59.36 -49.35 78.16 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.613 -0.514 . . . . 15.0 109.613 179.241 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.778 ' HB3' HG13 ' A' ' 35' ' ' ILE . . . -67.06 -44.75 79.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.932 -0.577 . . . . 15.0 109.512 178.431 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 1.014 HG23 HG21 ' A' ' 22' ' ' VAL . 0.5 OUTLIER -43.96 -40.88 1.63 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.27 0 N-CA-C 108.797 -0.816 . . . . 15.0 108.797 178.202 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.422 ' HG3' ' O ' ' A' ' 72' ' ' LYS . 9.0 mt-10 -67.42 -44.08 79.64 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 114.744 -1.117 . . . . 15.0 110.19 178.462 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.622 ' O ' HG11 ' A' ' 61' ' ' VAL . 42.5 p -64.13 -55.48 21.65 Favored 'General case' 0 C--O 1.231 0.131 0 C-N-CA 121.056 -0.258 . . . . 15.0 111.509 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.528 HD23 HG21 ' A' ' 61' ' ' VAL . 4.6 mt -53.38 -47.26 69.64 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 121.127 0.489 . . . . 15.0 109.9 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.405 ' HB2' ' O ' ' A' ' 75' ' ' VAL . 0.0 OUTLIER -68.53 -59.49 3.11 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.518 -0.765 . . . . 15.0 110.529 179.29 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 68.5 m-20 -66.06 60.27 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.931 -0.577 . . . . 15.0 112.154 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.812 HG22 ' ND2' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -95.76 -73.02 0.61 Allowed 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 110.127 -0.323 . . . . 15.0 110.127 179.1 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 122.01 -103.71 0.87 Allowed Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.702 -0.761 . . . . 15.0 113.439 179.029 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.403 ' O ' ' N ' ' A' ' 14' ' ' ASN . 0.3 OUTLIER -64.53 -84.43 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 111.965 0.357 . . . . 15.0 111.965 -178.884 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.469 HG12 ' N ' ' A' ' 85' ' ' VAL . 69.9 t -109.72 160.02 8.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.946 0.403 . . . . 15.0 110.873 -179.398 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.688 HG23 ' CB ' ' A' ' 13' ' ' LYS . 8.7 t -97.81 81.65 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.156 0.503 . . . . 15.0 110.457 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.423 ' NE2' HD11 ' A' ' 88' ' ' LEU . 20.5 t60 -101.13 83.87 2.56 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.72 -0.673 . . . . 15.0 110.33 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.778 ' HB3' HD21 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -103.85 115.58 30.72 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.921 -0.581 . . . . 15.0 111.873 -179.115 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.729 HD12 ' HB3' ' A' ' 8' ' ' GLU . 0.2 OUTLIER -92.15 100.49 13.1 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.327 -0.62 . . . . 15.0 109.327 178.573 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.778 HD21 ' HB3' ' A' ' 87' ' ' LEU . 0.1 OUTLIER -104.04 -159.46 0.72 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.26 0.553 . . . . 15.0 111.725 -178.658 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.502 ' HA ' ' HA ' ' A' ' 6' ' ' ILE . 5.3 tt0 -140.57 143.7 35.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.35 -0.841 . . . . 15.0 110.32 179.322 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 7.9 tppt? -55.48 105.89 0.21 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.227 -0.442 . . . . 15.0 110.954 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -66.1 150.1 51.72 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.869 -0.681 . . . . 15.0 112.616 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -86.1 124.19 32.24 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.837 0.351 . . . . 15.0 110.857 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.6 m -82.77 163.4 51.64 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.149 -0.478 . . . . 15.0 110.92 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_exo -51.27 -57.61 2.12 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.594 2.196 . . . . 15.0 112.329 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 5.8 p . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.221 -0.895 . . . . 15.0 110.893 179.973 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo . . . . . 0 N--CA 1.488 1.189 0 CA-C-O 120.876 0.282 . . . . 15.0 111.805 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.414 ' HA ' ' HD2' ' A' ' 3' ' ' PRO . 4.7 mttp -150.75 100.86 3.08 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.45 . . . . 15.0 110.811 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.414 ' HD2' ' HA ' ' A' ' 2' ' ' LYS . 24.6 Cg_endo -62.15 -82.95 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.391 2.06 . . . . 15.0 112.422 -179.821 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 92.91 -34.77 4.36 Favored Glycine 0 C--N 1.332 0.311 0 C-N-CA 120.68 -0.772 . . . . 15.0 112.599 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -62.16 159.09 15.41 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.345 0.593 . . . . 15.0 111.126 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.488 HD11 ' OE1' ' A' ' 90' ' ' GLU . 1.3 mp -104.4 147.31 10.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.195 -0.912 . . . . 15.0 110.944 -179.429 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.607 ' CZ ' HD12 ' A' ' 89' ' ' LEU . 2.9 p90 -140.82 164.96 28.82 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.214 -0.448 . . . . 15.0 110.415 178.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.715 ' HB3' HD12 ' A' ' 88' ' ' LEU . 1.9 pt-20 -130.17 143.85 51.02 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.234 0.54 . . . . 15.0 111.6 -179.438 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.667 ' CG1' HD11 ' A' ' 89' ' ' LEU . 0.3 OUTLIER -101.26 114.52 40.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.277 -0.874 . . . . 15.0 109.706 179.111 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -106.04 69.88 0.83 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.076 -0.511 . . . . 15.0 111.772 -179.063 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.65 HD11 ' CB ' ' A' ' 49' ' ' ASP . 8.5 tp -88.19 161.89 16.99 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.006 -0.543 . . . . 15.0 110.316 179.223 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.523 ' C ' ' H ' ' A' ' 14' ' ' ASN . . . -96.69 98.6 10.3 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.537 -0.301 . . . . 15.0 111.151 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.889 ' HB2' HG23 ' A' ' 85' ' ' VAL . 0.3 OUTLIER -65.38 26.46 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 112.706 0.632 . . . . 15.0 112.706 -179.995 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.523 ' H ' ' C ' ' A' ' 12' ' ' ALA . 15.6 m-20 -112.82 148.15 35.46 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.665 0.269 . . . . 15.0 110.579 179.765 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.431 ' CB ' ' O ' ' A' ' 14' ' ' ASN . 1.0 OUTLIER 82.29 -45.45 0.16 Allowed 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.267 -0.424 . . . . 15.0 111.293 -179.832 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -155.07 156.44 35.87 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.861 0.363 . . . . 15.0 110.819 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.742 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 0.2 OUTLIER -86.07 -159.71 0.49 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.134 -0.484 . . . . 15.0 110.652 179.976 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.413 HD22 ' HE3' ' A' ' 13' ' ' LYS . 2.5 mm? -83.41 -169.37 2.51 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 120.986 0.422 . . . . 15.0 110.74 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.705 ' O ' ' HB ' ' A' ' 41' ' ' ILE . . . -160.8 40.07 0.43 Allowed Glycine 0 N--CA 1.448 -0.532 0 N-CA-C 111.439 -0.664 . . . . 15.0 111.439 -179.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.653 HG12 ' O ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -112.7 139.08 39.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 120.907 0.384 . . . . 15.0 111.876 -179.227 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 30.3 t -96.03 104.96 16.93 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 107.924 -1.139 . . . . 15.0 107.924 177.371 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.978 HG21 HG23 ' A' ' 75' ' ' VAL . 32.6 m -93.63 156.84 3.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 113.09 0.774 . . . . 15.0 113.09 -177.091 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.31 -175.03 4.83 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.128 -0.942 . . . . 15.0 110.703 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.585 ' O ' HG22 ' A' ' 26' ' ' VAL . . . 68.71 -119.52 10.09 Favored Glycine 0 C--N 1.332 0.309 0 C-N-CA 120.831 -0.699 . . . . 15.0 112.542 179.794 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.526 ' HA3' ' N ' ' A' ' 71' ' ' HIS . . . 67.1 -66.65 0.21 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.922 -0.656 . . . . 15.0 113.336 179.563 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.585 HG22 ' O ' ' A' ' 24' ' ' GLY . 0.0 OUTLIER -32.62 142.48 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 N-CA-C 112.063 0.394 . . . . 15.0 112.063 -179.492 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -75.63 59.6 1.17 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.065 -0.516 . . . . 15.0 110.857 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.5 m -151.6 -66.3 0.18 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.231 -0.44 . . . . 15.0 110.566 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 29.5 t -65.44 -51.25 61.51 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.111 -0.495 . . . . 15.0 110.424 179.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.472 HG11 ' CD1' ' A' ' 36' ' ' TYR . 27.0 m -88.07 -175.35 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.02 -0.536 . . . . 15.0 110.689 179.601 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 38.1 ttm180 -90.4 137.63 32.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.969 0.414 . . . . 15.0 111.096 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 42.1 m170 55.53 -86.36 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.756 -0.656 . . . . 15.0 111.345 179.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.411 ' O ' ' O ' ' A' ' 69' ' ' ALA . . . -171.94 27.79 0.1 OUTLIER Glycine 0 C--N 1.33 0.24 0 C-N-CA 120.922 -0.656 . . . . 15.0 112.48 -179.709 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.432 ' O ' HG21 ' A' ' 30' ' ' VAL . . . -81.7 151.79 31.13 Favored Glycine 0 N--CA 1.451 -0.363 0 N-CA-C 110.857 -0.897 . . . . 15.0 110.857 179.029 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.925 HG22 HG22 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -88.94 154.1 3.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 119.99 -0.684 . . . . 15.0 111.704 -179.346 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.494 ' CZ ' ' HG2' ' A' ' 57' ' ' ARG . 29.4 m-85 -141.73 107.52 5.13 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.154 -0.93 . . . . 15.0 110.008 179.114 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.781 HG22 ' N ' ' A' ' 55' ' ' GLY . 0.7 OUTLIER -55.81 153.16 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.191 0.52 . . . . 15.0 111.295 -179.131 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.514 ' O ' ' HG2' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -85.72 -48.33 8.93 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.379 -0.971 . . . . 15.0 108.379 178.33 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.653 ' O ' HG12 ' A' ' 20' ' ' ILE . . . -172.39 173.78 4.04 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 115.354 -0.839 . . . . 15.0 110.145 178.722 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.622 ' HA ' HG12 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -96.97 112.16 28.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 109.436 -0.579 . . . . 15.0 109.436 179.125 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.705 ' HB ' ' O ' ' A' ' 19' ' ' GLY . 0.4 OUTLIER -78.36 118.72 73.96 Favored Pre-proline 0 C--N 1.329 -0.298 0 N-CA-C 113.349 0.87 . . . . 15.0 113.349 -177.245 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.613 ' HA ' ' HG2' ' A' ' 47' ' ' GLU . 36.9 Cg_endo -64.36 61.66 0.25 Allowed 'Trans proline' 0 C--N 1.357 0.998 0 C-N-CA 123.509 2.806 . . . . 15.0 112.918 179.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.514 ' H ' ' HG2' ' A' ' 47' ' ' GLU . 2.2 mm-40 -150.8 -46.6 0.12 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.611 -0.268 . . . . 15.0 111.618 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.651 ' HA3' ' HA3' ' A' ' 19' ' ' GLY . . . -87.82 166.65 35.89 Favored Glycine 0 C--N 1.331 0.268 0 C-N-CA 120.311 -0.947 . . . . 15.0 113.879 -179.142 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.742 ' HB3' ' O ' ' A' ' 17' ' ' SER . . . -55.96 -14.83 2.76 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.703 0.631 . . . . 15.0 112.703 -179.612 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.16 -57.5 4.2 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.707 0.289 . . . . 15.0 111.109 -179.504 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.613 ' HG2' ' HA ' ' A' ' 42' ' ' PRO . 2.9 pp20? -57.11 -41.91 79.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 15.0 110.478 179.545 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 40.1 t -53.7 -70.37 0.1 Allowed 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 115.896 -0.593 . . . . 15.0 110.668 -179.508 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.65 ' CB ' HD11 ' A' ' 11' ' ' LEU . 1.5 m-20 -61.1 -39.57 90.48 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.219 0.533 . . . . 15.0 109.575 179.049 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.01 44.21 8.32 Favored Glycine 0 N--CA 1.447 -0.599 0 CA-C-N 115.439 -0.801 . . . . 15.0 111.835 179.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.652 ' CG ' HG23 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -79.5 -53.4 6.91 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.962 0.411 . . . . 15.0 110.647 -179.397 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.625 ' CG1' HD12 ' A' ' 20' ' ' ILE . 10.3 tp -81.08 163.1 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 CA-C-N 115.936 -0.575 . . . . 15.0 110.442 179.695 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.424 ' N ' ' OD2' ' A' ' 56' ' ' ASP . 42.3 m80 -146.57 158.82 43.97 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-O 121.606 0.717 . . . . 15.0 112.126 -179.072 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.564 ' HA ' ' CG2' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -43.15 133.33 3.95 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.246 -1.343 . . . . 15.0 112.928 -178.58 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.781 ' N ' HG22 ' A' ' 37' ' ' VAL . . . 49.84 32.14 17.83 Favored Glycine 0 C--N 1.336 0.545 0 CA-C-N 115.841 -0.618 . . . . 15.0 113.053 179.275 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.512 ' OD2' HD12 ' A' ' 52' ' ' ILE . 4.6 m-20 -65.47 124.75 23.11 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.706 -0.397 . . . . 15.0 110.216 179.498 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.861 ' HD2' HD21 ' A' ' 59' ' ' LEU . 0.0 OUTLIER -81.82 92.85 6.74 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.203 -0.453 . . . . 15.0 110.505 -179.959 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.925 HG22 HG22 ' A' ' 35' ' ' ILE . 1.3 m -84.76 120.85 36.04 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 CA-C-N 116.195 -0.457 . . . . 15.0 111.383 -179.372 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.861 HD21 ' HD2' ' A' ' 57' ' ' ARG . 3.4 mm? -107.24 -20.88 13.15 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 115.73 -0.668 . . . . 15.0 112.455 -179.36 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.494 ' O ' HD23 ' A' ' 87' ' ' LEU . . . -147.75 153.74 39.64 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.33 0.586 . . . . 15.0 112.569 -178.585 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.83 HG11 ' O ' ' A' ' 77' ' ' THR . 25.9 t -138.97 99.56 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.331 0 CA-C-N 115.231 -0.895 . . . . 15.0 109.048 178.788 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.593 ' ND2' HG22 ' A' ' 81' ' ' THR . 1.6 m-80 65.37 16.36 10.49 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.535 -0.543 . . . . 15.0 109.535 -177.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 107.07 5.59 35.02 Favored Glycine 0 C--N 1.337 0.633 0 CA-C-N 115.689 -0.687 . . . . 15.0 113.63 179.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.664 ' O ' HG13 ' A' ' 64' ' ' VAL . 5.9 p -93.88 105.34 16.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 117.339 0.57 . . . . 15.0 110.809 179.306 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -55.58 130.73 44.13 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.053 -0.521 . . . . 15.0 111.11 -179.57 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.735 HD21 ' HA ' ' A' ' 74' ' ' ALA . 0.1 OUTLIER -97.76 -24.16 15.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.97 -0.559 . . . . 15.0 111.036 179.925 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -45.41 106.23 0.07 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.426 -0.352 . . . . 15.0 110.999 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.85 58.95 0.53 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.785 -0.721 . . . . 15.0 112.289 -179.655 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.579 ' HB1' ' CD ' ' A' ' 73' ' ' GLN . . . -172.98 171.75 4.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.848 0.356 . . . . 15.0 110.945 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.567 ' HB ' HG13 ' A' ' 26' ' ' VAL . 13.5 p -93.37 -172.64 2.99 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.092 0.472 . . . . 15.0 111.376 -179.749 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.783 ' CD2' HG23 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -64.24 -59.58 4.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.654 -0.703 . . . . 15.0 110.668 -179.975 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.406 ' N ' ' CG ' ' A' ' 71' ' ' HIS . 29.9 ttpt -52.44 -32.78 41.13 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.895 -0.593 . . . . 15.0 110.643 179.777 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.579 ' CD ' ' HB1' ' A' ' 69' ' ' ALA . 10.4 mt-30 -59.45 -51.76 68.49 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.542 -0.54 . . . . 15.0 109.542 179.264 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.735 ' HA ' HD21 ' A' ' 66' ' ' LEU . . . -67.23 -44.49 79.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.008 -0.542 . . . . 15.0 110.033 178.511 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.978 HG23 HG21 ' A' ' 22' ' ' VAL . 0.5 OUTLIER -41.9 -41.76 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.239 0 N-CA-C 109.249 -0.649 . . . . 15.0 109.249 178.688 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.463 ' O ' ' HB2' ' A' ' 80' ' ' ASN . 54.0 mt-10 -67.3 -44.88 78.12 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 114.882 -1.054 . . . . 15.0 110.453 178.639 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.83 ' O ' HG11 ' A' ' 61' ' ' VAL . 37.2 p -64.05 -55.1 24.64 Favored 'General case' 0 N--CA 1.461 0.122 0 C-N-CA 121.159 -0.216 . . . . 15.0 111.555 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.757 HD21 HG21 ' A' ' 58' ' ' VAL . 6.5 mt -53.31 -45.98 69.23 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-O 121.237 0.542 . . . . 15.0 109.997 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.403 ' HB2' ' O ' ' A' ' 75' ' ' VAL . 0.0 OUTLIER -68.35 -58.91 3.65 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.334 -0.848 . . . . 15.0 110.643 179.493 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.463 ' HB2' ' O ' ' A' ' 76' ' ' GLU . 11.2 m-80 -66.08 62.71 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.074 -0.512 . . . . 15.0 111.928 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.593 HG22 ' ND2' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -92.74 -76.26 0.47 Allowed 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 110.155 -0.313 . . . . 15.0 110.155 179.284 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 122.2 -105.17 0.95 Allowed Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.728 -0.749 . . . . 15.0 113.052 179.165 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.429 ' O ' ' HB3' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -64.87 -84.07 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.753 0.311 . . . . 15.0 111.209 -179.42 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.453 HG12 ' N ' ' A' ' 85' ' ' VAL . 79.0 t -110.17 158.61 10.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.021 0.439 . . . . 15.0 111.083 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.889 HG23 ' HB2' ' A' ' 13' ' ' LYS . 3.3 t -97.68 83.15 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.176 0.513 . . . . 15.0 110.213 179.68 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -100.09 82.08 2.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.736 -0.666 . . . . 15.0 110.242 179.778 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.789 ' HB3' HD21 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -103.98 127.04 51.52 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.914 -0.584 . . . . 15.0 111.85 -179.022 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.715 HD12 ' HB3' ' A' ' 8' ' ' GLU . 0.2 OUTLIER -102.17 100.54 10.76 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.292 -0.633 . . . . 15.0 109.292 178.433 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.789 HD21 ' HB3' ' A' ' 87' ' ' LEU . 0.1 OUTLIER -104.85 -161.49 0.82 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.405 0.621 . . . . 15.0 111.795 -178.582 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.488 ' OE1' HD11 ' A' ' 6' ' ' ILE . 3.2 tt0 -141.5 135.55 30.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.064 -0.971 . . . . 15.0 109.876 179.232 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.1 105.56 0.07 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.951 0.405 . . . . 15.0 111.169 -179.663 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -72.11 -160.29 4.68 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.938 -0.648 . . . . 15.0 112.641 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -76.4 125.47 29.25 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.846 0.355 . . . . 15.0 110.862 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 94.2 p -79.37 160.28 70.65 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 15.0 110.876 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_exo -51.19 148.63 17.81 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.609 2.206 . . . . 15.0 112.299 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 6.3 t . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.237 -0.887 . . . . 15.0 110.858 -179.985 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_endo . . . . . 0 N--CA 1.489 1.225 0 CA-C-O 120.812 0.255 . . . . 15.0 111.759 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.476 ' CB ' ' CD ' ' A' ' 3' ' ' PRO . 7.8 mttt -155.28 -66.42 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.198 -0.455 . . . . 15.0 111.138 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.476 ' CD ' ' CB ' ' A' ' 2' ' ' LYS . 13.4 Cg_endo -55.97 -80.77 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.388 2.059 . . . . 15.0 112.242 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 88.81 -22.95 19.09 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.58 -0.819 . . . . 15.0 112.763 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -62.08 145.75 52.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.36 0.6 . . . . 15.0 110.962 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.618 HD11 ' OE1' ' A' ' 90' ' ' GLU . 1.4 mp -104.38 141.22 20.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.149 -0.932 . . . . 15.0 111.097 -179.352 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.514 ' CZ ' HD12 ' A' ' 89' ' ' LEU . 3.0 p90 -140.65 166.37 24.93 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.274 -0.421 . . . . 15.0 110.569 178.647 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.732 ' CB ' HD12 ' A' ' 88' ' ' LEU . 9.5 pt-20 -129.43 143.87 51.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.196 0.522 . . . . 15.0 111.432 -179.336 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.639 ' CG1' HD11 ' A' ' 89' ' ' LEU . 0.3 OUTLIER -101.37 117.26 46.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.424 -0.807 . . . . 15.0 109.382 178.82 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 55.1 tt0 -105.97 75.71 1.13 Allowed 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.456 0.539 . . . . 15.0 112.456 -178.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.596 ' HB3' ' HB ' ' A' ' 85' ' ' VAL . 6.4 tp -87.93 161.21 17.58 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.24 -0.652 . . . . 15.0 109.24 178.179 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.474 ' O ' ' N ' ' A' ' 14' ' ' ASN . . . -96.8 94.55 7.32 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 120.816 -0.354 . . . . 15.0 111.819 -179.516 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.615 ' CB ' HG23 ' A' ' 85' ' ' VAL . 0.3 OUTLIER -65.09 61.82 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.334 0.588 . . . . 15.0 111.203 179.283 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.474 ' N ' ' O ' ' A' ' 12' ' ' ALA . 9.4 m-20 -116.16 -80.25 0.6 Allowed 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.799 -0.637 . . . . 15.0 111.585 -179.655 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.28 -24.62 59.28 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.112 -0.495 . . . . 15.0 111.721 -179.206 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -155.15 162.94 40.84 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.881 0.372 . . . . 15.0 111.219 -179.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.827 ' C ' HD22 ' A' ' 18' ' ' LEU . 0.5 OUTLIER -93.66 -79.04 0.42 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.043 -0.526 . . . . 15.0 111.019 -179.904 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.827 HD22 ' C ' ' A' ' 17' ' ' SER . 3.1 mm? -139.11 -168.44 2.44 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 121.165 0.507 . . . . 15.0 111.066 -179.533 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.618 ' O ' ' HB ' ' A' ' 41' ' ' ILE . . . -162.87 31.85 0.29 Allowed Glycine 0 CA--C 1.505 -0.561 0 N-CA-C 110.931 -0.868 . . . . 15.0 110.931 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.741 HD13 ' HB ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -112.5 143.65 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 CA-C-O 121.104 0.478 . . . . 15.0 112.146 -178.709 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 27.1 t -96.07 102.47 14.27 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 107.014 -1.476 . . . . 15.0 107.014 176.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.977 HG21 HG23 ' A' ' 75' ' ' VAL . 32.8 m -93.36 155.28 3.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 113.439 0.903 . . . . 15.0 113.439 -176.23 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.3 -175.44 4.99 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 114.8 -1.091 . . . . 15.0 110.609 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.425 ' O ' ' HB3' ' A' ' 71' ' ' HIS . . . 68.73 -120.23 10.84 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 120.823 -0.703 . . . . 15.0 112.602 179.725 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.543 ' HA3' ' N ' ' A' ' 71' ' ' HIS . . . 69.07 -66.38 0.49 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.795 -0.717 . . . . 15.0 113.431 179.449 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.505 ' O ' HG22 ' A' ' 30' ' ' VAL . 1.0 OUTLIER -27.66 140.25 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 N-CA-C 112.471 0.545 . . . . 15.0 112.471 -179.271 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -76.61 60.14 1.61 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.983 -0.553 . . . . 15.0 111.034 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -151.72 -50.45 0.11 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.373 -0.376 . . . . 15.0 111.01 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.8 t -84.21 -37.58 21.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.202 -0.453 . . . . 15.0 111.071 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.505 HG22 ' O ' ' A' ' 26' ' ' VAL . 21.7 m -80.75 -174.75 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.306 -0.406 . . . . 15.0 111.238 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.437 ' HB3' ' CD2' ' A' ' 32' ' ' HIS . 2.8 mtt-85 -58.8 -54.17 50.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.449 . . . . 15.0 111.022 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . 0.437 ' CD2' ' HB3' ' A' ' 31' ' ' ARG . 47.6 m-70 -146.37 -50.47 0.22 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.264 -0.426 . . . . 15.0 111.043 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -169.28 26.24 0.11 Allowed Glycine 0 N--CA 1.453 -0.19 0 C-N-CA 120.825 -0.702 . . . . 15.0 112.512 -179.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.481 ' O ' HG11 ' A' ' 30' ' ' VAL . . . -90.58 149.18 19.95 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.684 -0.769 . . . . 15.0 111.197 179.101 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.82 HG22 HG22 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -87.68 154.69 3.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 117.341 0.571 . . . . 15.0 111.568 -179.39 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.427 ' CZ ' ' HG3' ' A' ' 57' ' ' ARG . 26.6 m-85 -140.76 106.83 5.19 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.241 -0.891 . . . . 15.0 109.829 179.312 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.783 HG22 ' N ' ' A' ' 55' ' ' GLY . 0.8 OUTLIER -55.58 148.25 3.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.18 0.514 . . . . 15.0 111.553 -178.938 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.41 ' O ' ' HG2' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -80.41 -47.7 14.01 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.316 -0.994 . . . . 15.0 108.316 178.2 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.626 ' O ' HG12 ' A' ' 20' ' ' ILE . . . -172.02 172.76 4.59 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 115.254 -0.885 . . . . 15.0 110.291 178.606 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.665 ' HA ' HG12 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -97.42 107.84 20.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.936 0.398 . . . . 15.0 110.889 179.946 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.618 ' HB ' ' O ' ' A' ' 19' ' ' GLY . 0.6 OUTLIER -78.86 108.03 7.28 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 115.789 -0.641 . . . . 15.0 112.611 -178.671 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.477 ' N ' ' HG2' ' A' ' 47' ' ' GLU . 30.7 Cg_endo -62.93 69.67 0.13 Allowed 'Trans proline' 0 C--N 1.355 0.904 0 C-N-CA 123.139 2.559 . . . . 15.0 112.535 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.463 ' HB2' HG22 ' A' ' 41' ' ' ILE . 0.7 OUTLIER -151.79 -52.93 0.12 Allowed 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.365 -0.834 . . . . 15.0 109.675 179.501 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.521 ' HA3' ' CA ' ' A' ' 19' ' ' GLY . . . -87.93 155.99 27.07 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.611 -0.804 . . . . 15.0 112.402 179.254 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -39.11 -18.81 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 113.638 0.977 . . . . 15.0 113.638 -179.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.478 ' N ' ' O ' ' A' ' 44' ' ' GLY . . . -71.68 -71.89 0.25 Allowed 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 111.783 0.29 . . . . 15.0 111.783 -179.31 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.508 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 3.9 tp10 -58.22 -40.4 81.57 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 120.423 -0.511 . . . . 15.0 110.379 179.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 16.5 m -54.27 -59.18 5.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.974 -0.557 . . . . 15.0 110.463 179.439 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.569 ' CB ' HD11 ' A' ' 11' ' ' LEU . 3.6 t70 -68.46 -38.37 81.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.155 -0.475 . . . . 15.0 110.107 179.303 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.81 42.8 8.7 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.695 -0.684 . . . . 15.0 112.988 179.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.488 ' HG3' HD13 ' A' ' 11' ' ' LEU . 2.8 mmp_? -90.2 -50.68 5.85 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.877 0.37 . . . . 15.0 110.521 179.475 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.632 ' CG1' HD12 ' A' ' 20' ' ' ILE . 10.1 tp -81.22 158.9 4.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.048 -0.524 . . . . 15.0 110.773 179.69 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.424 ' O ' ' HB2' ' A' ' 56' ' ' ASP . 72.8 m80 -141.0 158.24 44.22 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-O 121.645 0.736 . . . . 15.0 112.244 -179.407 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.573 ' HA ' ' CG2' ' A' ' 37' ' ' VAL . 2.3 mtpt -42.25 134.12 2.96 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.407 -1.269 . . . . 15.0 112.794 -178.704 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.783 ' N ' HG22 ' A' ' 37' ' ' VAL . . . 49.76 33.41 19.46 Favored Glycine 0 C--N 1.334 0.444 0 CA-C-N 115.815 -0.63 . . . . 15.0 113.616 179.157 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.424 ' HB2' ' O ' ' A' ' 53' ' ' HIS . 0.2 OUTLIER -66.01 133.17 50.25 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 117.169 0.485 . . . . 15.0 110.679 179.529 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.427 ' HG3' ' CZ ' ' A' ' 36' ' ' TYR . 6.2 ttt85 -86.47 88.42 7.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.193 -0.458 . . . . 15.0 110.363 179.604 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.82 HG22 HG22 ' A' ' 35' ' ' ILE . 1.7 m -79.43 114.77 20.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.057 0.456 . . . . 15.0 111.003 -179.558 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.416 ' HA ' ' HB2' ' A' ' 66' ' ' LEU . 32.0 mt -107.09 -16.71 14.36 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.762 -0.654 . . . . 15.0 112.46 -179.244 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.636 ' HB3' ' HB2' ' A' ' 88' ' ' LEU . . . -147.88 146.46 29.08 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 112.563 0.579 . . . . 15.0 112.563 -178.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.879 HG11 ' O ' ' A' ' 77' ' ' THR . 57.3 t -139.02 102.77 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.368 -0.833 . . . . 15.0 109.098 178.674 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.76 ' ND2' HG22 ' A' ' 81' ' ' THR . 1.3 m-80 64.9 14.94 9.61 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.87 -0.419 . . . . 15.0 109.87 -178.163 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 107.0 5.47 35.29 Favored Glycine 0 C--N 1.336 0.552 0 CA-C-N 115.989 -0.55 . . . . 15.0 113.361 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.644 ' O ' HG13 ' A' ' 64' ' ' VAL . 6.1 p -93.87 107.59 19.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 117.077 0.439 . . . . 15.0 111.192 179.645 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 44.2 m -58.48 133.04 55.44 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.294 -0.412 . . . . 15.0 110.798 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.496 HD11 ' HA ' ' A' ' 74' ' ' ALA . 1.2 mm? -91.1 -21.86 21.0 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.07 -0.514 . . . . 15.0 111.185 -179.699 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -43.55 98.06 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 120.912 0.387 . . . . 15.0 111.149 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.87 63.28 0.55 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.817 -0.706 . . . . 15.0 112.333 -179.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.664 ' HB1' ' CB ' ' A' ' 73' ' ' GLN . . . -173.13 150.65 1.97 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.907 0.384 . . . . 15.0 111.098 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.434 ' HA ' ' N ' ' A' ' 26' ' ' VAL . 2.9 p -81.05 -171.96 3.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 15.0 111.015 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.769 ' CD2' HG23 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -62.08 -59.68 4.71 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.847 -0.615 . . . . 15.0 110.537 -179.953 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 13.3 ttpp -52.65 -34.64 52.45 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.685 -0.689 . . . . 15.0 111.046 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.664 ' CB ' ' HB1' ' A' ' 69' ' ' ALA . 2.8 mt-30 -59.31 -49.97 75.78 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.71 -0.478 . . . . 15.0 109.71 179.526 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.608 ' HB3' HG13 ' A' ' 35' ' ' ILE . . . -66.2 -45.68 79.93 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.929 -0.578 . . . . 15.0 109.532 178.423 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.977 HG23 HG21 ' A' ' 22' ' ' VAL . 0.5 OUTLIER -43.59 -40.81 1.41 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.209 0 N-CA-C 108.853 -0.795 . . . . 15.0 108.853 178.158 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -67.28 -44.87 78.23 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 114.845 -1.071 . . . . 15.0 110.126 178.365 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.879 ' O ' HG11 ' A' ' 61' ' ' VAL . 61.3 p -64.19 -54.24 36.76 Favored 'General case' 0 N--CA 1.461 0.08 0 CA-C-N 116.621 -0.263 . . . . 15.0 111.349 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.821 HD23 HG21 ' A' ' 61' ' ' VAL . 4.4 mt -53.43 -48.59 68.62 Favored 'General case' 0 CA--C 1.521 -0.146 0 CA-C-O 121.099 0.476 . . . . 15.0 110.138 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.405 ' O ' ' N ' ' A' ' 81' ' ' THR . 0.3 OUTLIER -68.54 -58.16 4.71 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.559 -0.746 . . . . 15.0 110.748 179.558 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -65.88 63.53 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.089 -0.505 . . . . 15.0 111.952 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.76 HG22 ' ND2' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -94.99 -73.53 0.58 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.65 0.262 . . . . 15.0 110.468 179.362 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 122.2 -105.22 0.96 Allowed Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.828 -0.701 . . . . 15.0 113.132 179.4 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.468 ' O ' ' HB3' ' A' ' 13' ' ' LYS . 0.4 OUTLIER -64.67 -82.17 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.705 0.288 . . . . 15.0 111.484 -179.279 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.434 HG12 ' N ' ' A' ' 85' ' ' VAL . 50.0 t -109.76 158.05 10.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.904 0.383 . . . . 15.0 110.423 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.615 HG23 ' CB ' ' A' ' 13' ' ' LYS . 50.7 t -98.23 77.85 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.231 -0.441 . . . . 15.0 110.627 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -98.63 88.37 4.06 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.021 -0.536 . . . . 15.0 110.893 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.803 ' HB3' HD21 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -103.89 125.84 50.59 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.104 -0.498 . . . . 15.0 111.633 -179.474 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.732 HD12 ' CB ' ' A' ' 8' ' ' GLU . 4.6 mp -101.59 101.85 12.47 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.428 -0.582 . . . . 15.0 109.428 178.657 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.803 HD21 ' HB3' ' A' ' 87' ' ' LEU . 0.1 OUTLIER -105.83 -163.62 0.95 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.536 0.684 . . . . 15.0 112.119 -178.325 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.618 ' OE1' HD11 ' A' ' 6' ' ' ILE . 2.2 tt0 -142.47 137.62 30.42 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 114.803 -1.09 . . . . 15.0 109.758 179.063 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.95 106.85 0.13 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.942 0.401 . . . . 15.0 111.05 -179.687 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -68.02 170.94 36.33 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.955 -0.64 . . . . 15.0 112.765 -179.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -86.27 61.96 7.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.855 0.36 . . . . 15.0 110.832 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 4.7 m -74.78 113.06 20.79 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.236 -0.438 . . . . 15.0 110.938 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -53.95 -26.71 41.45 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.445 2.096 . . . . 15.0 112.254 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 32.2 p . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.163 -0.922 . . . . 15.0 110.913 179.969 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_endo . . . . . 0 N--CA 1.489 1.214 0 CA-C-O 120.801 0.25 . . . . 15.0 111.805 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.18 137.56 13.42 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 15.0 110.835 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.402 ' CB ' ' HG2' ' A' ' 91' ' ' LYS . 20.6 Cg_endo -61.69 -78.03 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.477 2.118 . . . . 15.0 112.411 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 94.53 -33.52 5.27 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.699 -0.762 . . . . 15.0 112.622 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -63.8 147.2 52.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.353 0.597 . . . . 15.0 111.143 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.425 HG13 ' HB2' ' A' ' 90' ' ' GLU . 1.4 mp -104.41 144.18 14.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.135 -0.939 . . . . 15.0 111.088 -179.553 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.831 ' CZ ' HD12 ' A' ' 89' ' ' LEU . 3.9 p90 -140.65 165.53 27.22 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.327 -0.397 . . . . 15.0 110.729 178.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.737 ' HB2' HD12 ' A' ' 88' ' ' LEU . 11.0 pt-20 -130.14 143.52 50.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.117 0.484 . . . . 15.0 111.467 -179.642 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.58 HG11 ' CD1' ' A' ' 52' ' ' ILE . 0.5 OUTLIER -101.55 117.45 46.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.582 -0.735 . . . . 15.0 109.998 179.115 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -106.43 71.81 0.89 Allowed 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 112.243 0.46 . . . . 15.0 112.243 -179.221 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.548 ' HB3' ' HB ' ' A' ' 85' ' ' VAL . 7.9 tp -88.0 164.25 15.89 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.538 -0.542 . . . . 15.0 109.538 178.697 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -96.09 93.02 6.72 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.025 0.441 . . . . 15.0 111.297 -179.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.731 ' CB ' HG23 ' A' ' 85' ' ' VAL . 0.1 OUTLIER -57.74 -26.13 61.4 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.857 -0.61 . . . . 15.0 110.935 179.769 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -83.94 -44.69 13.97 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.189 -0.46 . . . . 15.0 110.926 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -54.72 -41.66 70.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.989 0.423 . . . . 15.0 110.544 179.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -165.53 175.65 8.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.93 -0.577 . . . . 15.0 110.757 179.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.878 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 0.3 OUTLIER -86.09 -158.71 0.42 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.27 -0.423 . . . . 15.0 110.299 179.647 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.679 ' N ' HD22 ' A' ' 18' ' ' LEU . 0.4 OUTLIER -102.32 -170.81 1.86 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.826 0.346 . . . . 15.0 110.702 179.57 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.633 ' O ' ' HB ' ' A' ' 41' ' ' ILE . . . -166.77 34.09 0.22 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 121.09 -0.576 . . . . 15.0 112.183 -179.665 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.674 HG13 HG12 ' A' ' 40' ' ' VAL . 0.1 OUTLIER -112.63 140.65 31.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 121.023 0.439 . . . . 15.0 111.892 -179.464 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.456 ' HB3' HD11 ' A' ' 41' ' ' ILE . 31.3 t -96.3 107.16 19.48 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 107.735 -1.209 . . . . 15.0 107.735 177.221 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 1.025 HG21 HG23 ' A' ' 75' ' ' VAL . 30.4 m -93.31 152.5 3.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 N-CA-C 113.061 0.763 . . . . 15.0 113.061 -176.807 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.419 HG23 ' HB3' ' A' ' 38' ' ' LYS . 35.4 p -149.42 178.68 8.58 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 115.036 -0.984 . . . . 15.0 110.874 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.551 ' O ' HG22 ' A' ' 26' ' ' VAL . . . 71.83 -118.69 7.14 Favored Glycine 0 C--N 1.332 0.345 0 C-N-CA 120.987 -0.625 . . . . 15.0 112.697 179.813 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.536 ' HA3' ' N ' ' A' ' 71' ' ' HIS . . . 68.21 -66.28 0.37 Allowed Glycine 0 C--N 1.331 0.254 0 C-N-CA 120.874 -0.679 . . . . 15.0 113.585 179.563 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.551 HG22 ' O ' ' A' ' 24' ' ' GLY . 0.0 OUTLIER -29.64 137.89 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 N-CA-C 112.247 0.462 . . . . 15.0 112.247 -179.355 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -75.46 63.5 1.48 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.905 -0.589 . . . . 15.0 111.038 -179.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 29.5 m -151.71 -50.3 0.11 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.247 -0.433 . . . . 15.0 111.067 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 11.0 t -88.04 -29.27 20.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.231 -0.441 . . . . 15.0 111.146 -179.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.49 HG22 ' O ' ' A' ' 26' ' ' VAL . 34.4 m -85.4 -176.85 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.367 -0.379 . . . . 15.0 111.312 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -61.47 -46.95 87.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.14 -0.482 . . . . 15.0 111.101 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 74.6 m-70 -148.29 -61.94 0.25 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.405 -0.361 . . . . 15.0 111.226 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.4 ' O ' ' O ' ' A' ' 69' ' ' ALA . . . -163.67 24.98 0.19 Allowed Glycine 0 N--CA 1.453 -0.205 0 C-N-CA 120.853 -0.689 . . . . 15.0 112.586 -179.642 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -89.61 156.97 26.14 Favored Glycine 0 N--CA 1.449 -0.462 0 N-CA-C 110.626 -0.99 . . . . 15.0 110.626 178.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.966 HG22 HG22 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -93.69 151.5 3.69 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.388 0 CA-C-N 117.66 0.73 . . . . 15.0 112.013 -179.366 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.515 ' CZ ' ' HG2' ' A' ' 57' ' ' ARG . 49.9 m-85 -133.46 107.65 8.17 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.718 -1.128 . . . . 15.0 109.162 178.707 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.822 HG22 ' N ' ' A' ' 55' ' ' GLY . 0.6 OUTLIER -54.85 152.91 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 121.261 0.553 . . . . 15.0 110.723 -178.575 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.651 ' HG3' ' N ' ' A' ' 39' ' ' ALA . 1.4 ppmt? -88.17 -47.32 8.55 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 108.795 -0.817 . . . . 15.0 108.795 179.313 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.651 ' N ' ' HG3' ' A' ' 38' ' ' LYS . . . -173.06 167.14 4.98 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.669 -0.696 . . . . 15.0 110.202 178.305 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.674 HG12 HG13 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -96.84 111.87 27.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.647 -0.501 . . . . 15.0 109.647 179.14 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.633 ' HB ' ' O ' ' A' ' 19' ' ' GLY . 0.3 OUTLIER -78.39 111.37 18.36 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 115.728 -0.669 . . . . 15.0 112.664 -177.676 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.442 ' HD2' ' HA ' ' A' ' 41' ' ' ILE . 37.1 Cg_endo -65.23 65.35 0.33 Allowed 'Trans proline' 0 C--N 1.355 0.899 0 C-N-CA 123.07 2.514 . . . . 15.0 112.763 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.507 ' HB2' HG22 ' A' ' 41' ' ' ILE . 5.5 mt-30 -149.52 -52.03 0.15 Allowed 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.402 -0.817 . . . . 15.0 109.196 179.293 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.543 ' HA3' ' HA3' ' A' ' 19' ' ' GLY . . . -88.03 154.34 25.42 Favored Glycine 0 N--CA 1.445 -0.719 0 CA-C-N 115.443 -0.799 . . . . 15.0 112.516 179.109 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.878 ' HB3' ' O ' ' A' ' 17' ' ' SER . . . -40.61 -17.73 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 113.804 1.038 . . . . 15.0 113.804 -179.528 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.446 ' N ' ' O ' ' A' ' 44' ' ' GLY . . . -71.67 -70.54 0.32 Allowed 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.707 -0.397 . . . . 15.0 111.477 -179.247 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.518 ' HG2' ' HB ' ' A' ' 40' ' ' VAL . 6.8 tm-20 -58.08 -37.17 73.98 Favored 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 120.678 -0.409 . . . . 15.0 110.039 179.508 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 37.4 m -56.25 -65.76 0.55 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.021 -0.536 . . . . 15.0 110.335 179.265 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.458 ' CB ' HD11 ' A' ' 11' ' ' LEU . 18.6 m-20 -62.55 -38.4 89.86 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.123 0.487 . . . . 15.0 109.931 179.135 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.51 43.56 8.42 Favored Glycine 0 N--CA 1.449 -0.493 0 CA-C-N 115.59 -0.732 . . . . 15.0 112.446 179.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.568 ' CG ' HG23 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -79.8 -58.26 3.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.867 0.365 . . . . 15.0 110.616 -179.982 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.58 ' CD1' HG11 ' A' ' 9' ' ' VAL . 1.4 mm -86.13 163.41 2.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.114 -0.494 . . . . 15.0 110.887 179.809 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.563 ' N ' HG22 ' A' ' 52' ' ' ILE . 43.2 m80 -139.37 154.67 47.88 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-O 121.61 0.719 . . . . 15.0 111.415 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.543 ' HA ' ' CG2' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -36.07 133.93 0.43 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.368 -1.287 . . . . 15.0 113.016 -178.549 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.822 ' N ' HG22 ' A' ' 37' ' ' VAL . . . 50.74 34.16 28.45 Favored Glycine 0 C--N 1.334 0.468 0 CA-C-N 115.806 -0.633 . . . . 15.0 113.929 179.091 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.457 ' H ' HG13 ' A' ' 37' ' ' VAL . 1.9 m-20 -65.4 130.62 43.99 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 117.296 0.548 . . . . 15.0 110.525 179.203 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.575 ' CD ' HD21 ' A' ' 59' ' ' LEU . 0.0 OUTLIER -82.34 85.73 6.82 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.002 -0.545 . . . . 15.0 110.543 179.818 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.966 HG22 HG22 ' A' ' 35' ' ' ILE . 1.0 OUTLIER -81.67 114.33 22.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.15 0.5 . . . . 15.0 111.266 -179.549 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.575 HD21 ' CD ' ' A' ' 57' ' ' ARG . 18.6 mt -107.23 -15.74 14.58 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.702 -0.681 . . . . 15.0 112.142 -179.563 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.559 ' O ' HD23 ' A' ' 87' ' ' LEU . . . -147.58 151.01 35.55 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.292 0.567 . . . . 15.0 112.337 -178.767 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.583 HG21 ' HB ' ' A' ' 77' ' ' THR . 10.7 t -139.04 102.83 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.257 -0.883 . . . . 15.0 109.105 178.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.683 ' ND2' HG22 ' A' ' 81' ' ' THR . 1.5 m-80 65.0 14.73 9.54 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.575 -0.528 . . . . 15.0 109.575 -177.817 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 106.49 6.57 35.63 Favored Glycine 0 C--N 1.337 0.606 0 CA-C-N 115.824 -0.626 . . . . 15.0 113.336 179.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.656 ' O ' HG13 ' A' ' 64' ' ' VAL . 8.9 p -93.86 106.64 18.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.098 0.475 . . . . 15.0 111.066 179.54 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 49.1 m -58.8 124.62 20.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.187 -0.46 . . . . 15.0 110.716 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.544 HD13 HG23 ' A' ' 58' ' ' VAL . 0.2 OUTLIER -92.05 -14.58 29.09 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.169 -0.469 . . . . 15.0 111.467 -179.654 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -45.23 103.77 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.89 0.376 . . . . 15.0 111.183 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.85 63.82 0.55 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.793 -0.717 . . . . 15.0 112.525 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.659 ' HB1' ' CB ' ' A' ' 73' ' ' GLN . . . -173.13 166.86 4.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.837 0.351 . . . . 15.0 111.077 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.475 ' HB ' HG13 ' A' ' 26' ' ' VAL . 2.6 p -93.23 -170.49 2.41 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.023 0.44 . . . . 15.0 110.943 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.672 ' CD2' HG23 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -63.96 -58.37 6.94 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.782 -0.645 . . . . 15.0 110.613 179.979 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.421 ' O ' ' HG3' ' A' ' 76' ' ' GLU . 28.9 ttmt -52.84 -35.51 57.47 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.095 -0.502 . . . . 15.0 110.823 179.392 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.659 ' CB ' ' HB1' ' A' ' 69' ' ' ALA . 3.6 mt-30 -59.21 -46.88 87.29 Favored 'General case' 0 CA--C 1.518 -0.287 0 N-CA-C 109.497 -0.557 . . . . 15.0 109.497 179.277 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.583 ' HB3' HG13 ' A' ' 35' ' ' ILE . . . -66.88 -47.8 70.72 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.596 -0.729 . . . . 15.0 109.717 178.458 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 1.025 HG23 HG21 ' A' ' 22' ' ' VAL . 0.5 OUTLIER -41.75 -42.03 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.254 0 CA-C-O 121.62 0.724 . . . . 15.0 109.182 178.575 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.421 ' HG3' ' O ' ' A' ' 72' ' ' LYS . 20.8 mt-10 -67.35 -44.02 80.07 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.644 -1.162 . . . . 15.0 110.884 179.006 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.583 ' HB ' HG21 ' A' ' 61' ' ' VAL . 4.9 p -64.42 -56.33 14.98 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 120.845 -0.342 . . . . 15.0 111.606 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.591 HD21 HG21 ' A' ' 58' ' ' VAL . 5.2 mt -53.28 -45.49 68.9 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-O 121.177 0.513 . . . . 15.0 109.931 -179.745 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -68.37 -58.32 4.55 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.462 -0.79 . . . . 15.0 110.232 179.345 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 32.9 m-20 -66.14 58.51 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.845 -0.616 . . . . 15.0 112.196 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.683 HG22 ' ND2' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -95.7 -72.82 0.61 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.742 0.306 . . . . 15.0 110.234 179.249 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 122.15 -103.36 0.84 Allowed Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.72 -0.752 . . . . 15.0 113.332 179.141 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.403 ' O ' ' HB3' ' A' ' 13' ' ' LYS . 0.4 OUTLIER -64.54 -84.66 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.105 0.409 . . . . 15.0 112.105 -178.857 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.454 HG12 ' N ' ' A' ' 85' ' ' VAL . 78.5 t -109.6 158.98 9.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.937 0.399 . . . . 15.0 110.976 -179.322 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.731 HG23 ' CB ' ' A' ' 13' ' ' LYS . 9.4 t -98.04 80.65 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.231 0.538 . . . . 15.0 110.596 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -99.71 86.96 3.43 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.73 -0.668 . . . . 15.0 110.038 179.603 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.725 ' HB3' HD21 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -103.86 121.19 42.56 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.926 -0.579 . . . . 15.0 111.983 -178.873 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.737 HD12 ' HB2' ' A' ' 8' ' ' GLU . 4.6 mp -97.19 101.25 12.77 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.421 -0.585 . . . . 15.0 109.421 178.488 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.831 HD12 ' CZ ' ' A' ' 7' ' ' PHE . 0.1 OUTLIER -105.61 -162.14 0.85 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.488 0.661 . . . . 15.0 111.964 -178.649 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.425 ' HB2' HG13 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -142.01 136.9 30.72 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 114.836 -1.075 . . . . 15.0 109.34 178.874 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.402 ' HG2' ' CB ' ' A' ' 3' ' ' PRO . 0.3 OUTLIER -46.69 105.03 0.06 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.03 0.443 . . . . 15.0 111.114 -179.486 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -70.02 -162.09 3.59 Favored Glycine 0 N--CA 1.451 -0.333 0 CA-C-N 115.738 -0.664 . . . . 15.0 112.849 -179.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -76.22 120.17 21.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.817 0.341 . . . . 15.0 110.888 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.4 m -88.38 145.48 35.76 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.249 -0.432 . . . . 15.0 110.8 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -52.25 -175.53 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.51 2.14 . . . . 15.0 112.327 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 69.1 p . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.222 -0.894 . . . . 15.0 110.863 179.985 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_endo . . . . . 0 N--CA 1.489 1.218 0 CA-C-O 120.776 0.24 . . . . 15.0 111.727 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.5 ' CB ' ' HD3' ' A' ' 3' ' ' PRO . 1.3 mtpp -155.31 -58.85 0.02 OUTLIER Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.264 -0.425 . . . . 15.0 111.369 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.5 ' HD3' ' CB ' ' A' ' 2' ' ' LYS . 41.7 Cg_exo -56.96 -163.11 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.166 1.91 . . . . 15.0 112.419 -179.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 90.37 -23.51 21.45 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.658 -0.782 . . . . 15.0 112.041 -179.531 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -72.19 143.55 48.85 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 121.334 0.588 . . . . 15.0 110.646 179.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.445 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 1.2 mp -74.09 150.99 7.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.18 -0.918 . . . . 15.0 110.797 -179.641 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.606 ' CZ ' HD12 ' A' ' 89' ' ' LEU . 0.3 OUTLIER -146.91 158.35 43.9 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.024 -0.535 . . . . 15.0 110.305 179.479 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.708 ' HB3' HD12 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -126.64 142.85 51.41 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.348 0.594 . . . . 15.0 111.937 -178.955 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.541 ' CG1' HD11 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -101.45 114.97 42.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.083 -0.962 . . . . 15.0 109.397 178.79 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -105.8 73.08 0.99 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.198 -0.455 . . . . 15.0 112.183 -178.544 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.592 HD13 ' HG3' ' A' ' 51' ' ' ARG . 5.7 tp -88.36 166.14 14.48 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.714 -0.476 . . . . 15.0 109.714 178.707 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -95.39 94.2 7.69 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.048 0.452 . . . . 15.0 111.266 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.648 ' CB ' HG23 ' A' ' 85' ' ' VAL . 0.1 OUTLIER -57.2 -27.1 61.68 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.807 -0.633 . . . . 15.0 111.114 179.901 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 99.8 m-20 -83.99 -45.09 13.49 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.3 -0.409 . . . . 15.0 110.875 -179.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -58.77 -43.32 90.34 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.041 0.448 . . . . 15.0 110.411 179.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.509 ' HB3' ' HB2' ' A' ' 45' ' ' ALA . 9.9 t-20 -165.58 163.57 19.33 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.837 -0.62 . . . . 15.0 110.642 179.719 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.87 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 0.5 OUTLIER -85.9 -166.94 1.67 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.379 -0.373 . . . . 15.0 110.176 179.595 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.652 ' N ' HD22 ' A' ' 18' ' ' LEU . 1.6 mm? -96.77 -173.53 2.75 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.937 0.399 . . . . 15.0 110.779 179.473 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.701 ' HA3' ' HA3' ' A' ' 44' ' ' GLY . . . -160.89 42.83 0.41 Allowed Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.924 -0.655 . . . . 15.0 111.915 -179.772 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.638 HG12 ' O ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -112.74 141.29 28.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 120.915 0.388 . . . . 15.0 111.768 -179.471 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.403 ' H ' HD13 ' A' ' 41' ' ' ILE . 43.0 t -96.18 103.44 15.34 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 107.721 -1.214 . . . . 15.0 107.721 177.29 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.948 HG21 HG23 ' A' ' 75' ' ' VAL . 27.3 m -93.51 155.39 3.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 113.339 0.866 . . . . 15.0 113.339 -176.714 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.33 -178.4 6.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 114.811 -1.086 . . . . 15.0 110.19 179.498 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.448 ' O ' ' CB ' ' A' ' 71' ' ' HIS . . . 73.0 -120.58 7.32 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.486 -0.864 . . . . 15.0 112.523 179.724 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.569 ' HA3' ' N ' ' A' ' 71' ' ' HIS . . . 68.3 -63.69 0.4 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.945 -0.645 . . . . 15.0 113.522 179.361 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.674 ' O ' HG22 ' A' ' 30' ' ' VAL . 1.7 m -32.32 146.96 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 N-CA-C 112.233 0.457 . . . . 15.0 112.233 -179.123 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.412 ' CB ' ' O ' ' A' ' 32' ' ' HIS . 15.1 m-20 -79.84 57.85 2.68 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.951 -0.568 . . . . 15.0 111.195 -179.714 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -151.76 -61.43 0.17 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.832 0.349 . . . . 15.0 111.238 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.4 m -71.93 -35.22 69.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 15.0 111.347 -179.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.674 HG22 ' O ' ' A' ' 26' ' ' VAL . 24.7 m -84.77 -173.78 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.895 0.379 . . . . 15.0 111.445 -179.613 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 41.4 ttt85 -57.08 -39.67 75.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.082 -0.508 . . . . 15.0 111.486 -179.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . 0.418 ' H ' HG23 ' A' ' 30' ' ' VAL . 1.6 p-80 -174.63 -35.7 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.592 -0.276 . . . . 15.0 111.656 -179.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -173.77 20.62 0.06 OUTLIER Glycine 0 CA--C 1.519 0.324 0 C-N-CA 120.594 -0.813 . . . . 15.0 113.104 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.52 ' O ' HG11 ' A' ' 30' ' ' VAL . . . -97.31 152.06 19.92 Favored Glycine 0 N--CA 1.448 -0.516 0 N-CA-C 110.294 -1.122 . . . . 15.0 110.294 178.623 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.934 HD12 ' HB3' ' A' ' 74' ' ' ALA . 0.1 OUTLIER -95.35 154.18 3.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 119.668 -0.813 . . . . 15.0 112.382 -178.962 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 31.8 m-85 -136.06 107.51 6.9 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.649 -1.16 . . . . 15.0 109.206 179.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.792 HG22 ' N ' ' A' ' 55' ' ' GLY . 0.6 OUTLIER -55.05 148.1 3.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.035 -0.529 . . . . 15.0 111.557 -178.446 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.459 ' O ' ' HG2' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -80.26 -49.6 11.37 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.452 -0.944 . . . . 15.0 108.452 178.397 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.638 ' O ' HG12 ' A' ' 20' ' ' ILE . . . -172.27 173.11 4.31 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-N 115.661 -0.7 . . . . 15.0 110.338 178.687 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.578 ' HA ' HG12 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -96.96 112.01 28.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 109.388 -0.597 . . . . 15.0 109.388 179.041 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.695 ' HB ' ' O ' ' A' ' 19' ' ' GLY . 0.5 OUTLIER -78.28 118.81 74.52 Favored Pre-proline 0 C--N 1.328 -0.328 0 N-CA-C 113.18 0.808 . . . . 15.0 113.18 -177.301 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.605 ' HA ' ' CG ' ' A' ' 47' ' ' GLU . 36.2 Cg_endo -64.09 62.38 0.23 Allowed 'Trans proline' 0 C--N 1.357 1.012 0 C-N-CA 123.592 2.861 . . . . 15.0 112.874 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.526 ' H ' ' HG2' ' A' ' 47' ' ' GLU . 9.8 mt-30 -152.03 -47.14 0.11 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.524 -0.307 . . . . 15.0 111.596 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.701 ' HA3' ' HA3' ' A' ' 19' ' ' GLY . . . -87.9 167.47 36.52 Favored Glycine 0 C--N 1.331 0.258 0 C-N-CA 120.354 -0.927 . . . . 15.0 113.825 -179.191 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.87 ' HB3' ' O ' ' A' ' 17' ' ' SER . . . -56.99 -12.68 2.16 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.634 0.605 . . . . 15.0 112.634 -179.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.79 -58.56 3.36 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 120.762 0.315 . . . . 15.0 110.406 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.605 ' CG ' ' HA ' ' A' ' 42' ' ' PRO . 2.6 pp20? -57.68 -43.16 84.88 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.763 -0.653 . . . . 15.0 110.525 179.079 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 66.7 m -53.65 -70.96 0.08 Allowed 'General case' 0 CA--C 1.518 -0.265 0 CA-C-N 115.931 -0.577 . . . . 15.0 110.574 -179.411 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.524 ' CB ' HD11 ' A' ' 11' ' ' LEU . 1.6 t0 -58.13 -41.51 83.8 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.128 -0.693 . . . . 15.0 109.128 178.736 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.67 40.12 13.03 Favored Glycine 0 N--CA 1.446 -0.645 0 CA-C-N 115.31 -0.859 . . . . 15.0 111.632 179.378 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.592 ' HG3' HD13 ' A' ' 11' ' ' LEU . 0.2 OUTLIER -79.76 -50.63 10.28 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.935 0.398 . . . . 15.0 110.723 -179.252 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.607 ' CG1' HD12 ' A' ' 20' ' ' ILE . 9.3 tp -81.07 162.34 3.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.043 -0.526 . . . . 15.0 110.249 179.433 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.474 ' N ' ' OD2' ' A' ' 56' ' ' ASP . 76.1 m80 -147.54 158.71 44.11 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-O 121.644 0.735 . . . . 15.0 112.281 -178.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.567 ' HA ' ' CG2' ' A' ' 37' ' ' VAL . 8.1 mtpt -43.09 133.28 3.89 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 114.13 -1.396 . . . . 15.0 112.956 -178.68 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.792 ' N ' HG22 ' A' ' 37' ' ' VAL . . . 50.06 29.44 14.78 Favored Glycine 0 C--N 1.332 0.34 0 CA-C-N 115.587 -0.733 . . . . 15.0 113.364 179.206 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.474 ' OD2' ' N ' ' A' ' 53' ' ' HIS . 17.4 m-20 -65.86 130.29 42.74 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.759 -0.376 . . . . 15.0 110.605 179.568 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.451 ' HE ' HD21 ' A' ' 59' ' ' LEU . 8.9 ttt180 -80.85 94.97 6.56 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.307 -0.406 . . . . 15.0 111.123 -179.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.914 HG22 HG22 ' A' ' 35' ' ' ILE . 1.4 m -84.44 112.72 22.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 CA-C-N 116.315 -0.402 . . . . 15.0 110.621 179.743 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.451 HD21 ' HE ' ' A' ' 57' ' ' ARG . 30.5 mt -107.4 -13.18 15.16 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 112.628 0.603 . . . . 15.0 112.628 -179.116 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.462 ' O ' HD23 ' A' ' 87' ' ' LEU . . . -151.77 148.15 27.52 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.511 0.56 . . . . 15.0 112.511 -178.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.726 HG11 ' O ' ' A' ' 77' ' ' THR . 19.0 t -139.2 101.6 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.24 -0.891 . . . . 15.0 109.409 178.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.824 ' ND2' HG22 ' A' ' 81' ' ' THR . 1.6 m-80 64.9 15.32 9.84 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.667 -0.494 . . . . 15.0 109.667 -178.141 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 107.22 6.17 34.15 Favored Glycine 0 C--N 1.336 0.575 0 CA-C-N 115.867 -0.606 . . . . 15.0 113.46 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.676 ' O ' HG13 ' A' ' 64' ' ' VAL . 6.3 p -93.83 103.94 15.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 117.25 0.525 . . . . 15.0 110.786 179.313 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -55.8 132.29 49.0 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.055 -0.52 . . . . 15.0 111.22 -179.561 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.593 HD13 ' HB3' ' A' ' 69' ' ' ALA . 0.2 OUTLIER -87.64 -20.33 26.48 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.971 -0.559 . . . . 15.0 110.714 179.679 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -43.39 96.1 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.295 -0.411 . . . . 15.0 111.131 179.833 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 104.36 69.65 0.78 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.802 -0.713 . . . . 15.0 112.216 -179.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.593 ' HB3' HD13 ' A' ' 66' ' ' LEU . . . -173.02 159.35 3.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.787 0.327 . . . . 15.0 111.038 -179.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.472 ' HA ' ' N ' ' A' ' 26' ' ' VAL . 15.9 p -93.04 -173.96 3.43 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.219 -0.446 . . . . 15.0 111.275 -179.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.768 ' CD2' HG23 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -61.22 -60.79 3.2 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.862 -0.608 . . . . 15.0 110.438 -179.978 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -52.65 -31.96 39.6 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.717 -0.674 . . . . 15.0 110.473 179.449 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.578 ' HB3' ' HB1' ' A' ' 69' ' ' ALA . 1.5 tt0 -59.56 -53.93 52.44 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.007 -0.542 . . . . 15.0 109.955 179.424 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.934 ' HB3' HD12 ' A' ' 35' ' ' ILE . . . -64.89 -44.78 88.52 Favored 'General case' 0 CA--C 1.518 -0.267 0 N-CA-C 109.432 -0.581 . . . . 15.0 109.432 178.581 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.948 HG23 HG21 ' A' ' 22' ' ' VAL . 0.5 OUTLIER -44.04 -40.6 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.21 0 N-CA-C 108.68 -0.859 . . . . 15.0 108.68 178.021 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.405 ' O ' ' CB ' ' A' ' 80' ' ' ASN . 1.8 mm-40 -67.36 -45.03 77.53 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 114.835 -1.075 . . . . 15.0 109.828 178.093 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.726 ' O ' HG11 ' A' ' 61' ' ' VAL . 80.3 p -64.13 -53.81 43.71 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 116.616 -0.265 . . . . 15.0 111.398 179.751 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.568 HD22 HD11 ' A' ' 87' ' ' LEU . 5.4 mt -53.37 -48.84 68.23 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-O 121.237 0.541 . . . . 15.0 109.851 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 16.2 ttt180 -68.57 -60.67 2.25 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.356 -0.838 . . . . 15.0 110.636 179.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.405 ' CB ' ' O ' ' A' ' 76' ' ' GLU . 36.6 m-20 -65.97 61.47 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.93 -0.577 . . . . 15.0 112.133 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.824 HG22 ' ND2' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -95.56 -68.77 0.78 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.779 0.323 . . . . 15.0 110.174 179.178 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 121.92 -105.9 1.03 Allowed Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.883 -0.675 . . . . 15.0 112.889 179.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.413 ' O ' ' HB3' ' A' ' 13' ' ' LYS . 0.2 OUTLIER -64.81 -83.05 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 111.943 0.349 . . . . 15.0 111.943 -179.241 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.476 HG12 ' N ' ' A' ' 85' ' ' VAL . 78.1 t -109.78 160.31 8.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.979 0.418 . . . . 15.0 110.944 -179.475 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.656 HG12 ' O ' ' A' ' 85' ' ' VAL . 8.7 t -97.65 82.24 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.109 0.48 . . . . 15.0 110.402 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.48 ' CE1' HD11 ' A' ' 88' ' ' LEU . 2.8 t60 -101.01 82.26 2.35 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.769 -0.65 . . . . 15.0 110.624 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.814 ' HB3' HD21 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -100.56 120.24 39.73 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.919 -0.582 . . . . 15.0 111.679 -179.332 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.708 HD12 ' HB3' ' A' ' 8' ' ' GLU . 0.2 OUTLIER -97.11 101.48 13.06 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.464 -0.569 . . . . 15.0 109.464 178.794 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.814 HD21 ' HB3' ' A' ' 87' ' ' LEU . 0.1 OUTLIER -105.86 -162.99 0.9 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.694 0.759 . . . . 15.0 112.388 -178.392 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.445 ' HA ' ' HA ' ' A' ' 6' ' ' ILE . 7.4 tt0 -139.58 120.91 14.94 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 114.475 -1.239 . . . . 15.0 109.116 178.731 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -46.86 101.92 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.005 0.431 . . . . 15.0 111.398 -179.094 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -62.04 137.28 45.89 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.946 -0.645 . . . . 15.0 112.499 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -85.25 134.44 34.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.836 0.35 . . . . 15.0 110.904 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -90.19 169.95 11.24 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 15.0 110.872 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -52.77 -49.83 16.18 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.563 2.175 . . . . 15.0 112.301 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 3.1 p . . . . . 0 C--O 1.25 1.089 0 CA-C-O 118.214 -0.898 . . . . 15.0 110.892 179.983 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo . . . . . 0 N--CA 1.486 1.08 0 CA-C-O 120.811 0.254 . . . . 15.0 111.698 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.465 ' CB ' ' CD ' ' A' ' 3' ' ' PRO . 1.2 mtpt -155.24 -66.56 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.25 -0.432 . . . . 15.0 111.198 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.465 ' CD ' ' CB ' ' A' ' 2' ' ' LYS . 59.1 Cg_endo -71.0 -94.88 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.206 1.937 . . . . 15.0 112.266 -179.839 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 87.1 -39.44 3.1 Favored Glycine 0 C--N 1.334 0.443 0 C-N-CA 120.527 -0.844 . . . . 15.0 112.865 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -62.07 163.32 8.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.31 0.576 . . . . 15.0 111.349 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.431 HG13 ' HB2' ' A' ' 90' ' ' GLU . 1.2 mp -104.39 150.17 7.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.135 -0.939 . . . . 15.0 110.791 -179.494 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.792 ' CE1' HD12 ' A' ' 89' ' ' LEU . 5.8 p90 -140.69 156.77 46.13 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.413 -0.358 . . . . 15.0 110.678 179.102 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.711 ' CB ' HD12 ' A' ' 88' ' ' LEU . 10.2 pt-20 -124.22 142.84 50.91 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.339 0.59 . . . . 15.0 111.551 -179.399 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.53 ' CG1' HD11 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -101.54 116.47 45.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.132 -0.94 . . . . 15.0 109.716 178.978 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -106.21 73.53 0.99 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.292 -0.413 . . . . 15.0 112.101 -179.017 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.689 HD13 ' HG3' ' A' ' 51' ' ' ARG . 9.7 tp -88.25 160.28 17.75 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.219 -0.446 . . . . 15.0 109.867 178.809 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.517 ' C ' ' H ' ' A' ' 14' ' ' ASN . . . -96.94 95.0 7.53 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.683 0.277 . . . . 15.0 111.716 -179.62 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.889 ' HB2' HG23 ' A' ' 85' ' ' VAL . 0.6 OUTLIER -65.82 28.53 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 112.619 0.6 . . . . 15.0 112.619 179.565 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.517 ' H ' ' C ' ' A' ' 12' ' ' ALA . 76.7 m-20 -109.97 -62.64 1.48 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.744 0.307 . . . . 15.0 111.154 -179.658 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -48.83 -43.77 38.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.272 -0.422 . . . . 15.0 111.05 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 7.9 m-80 -165.41 172.2 12.49 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.14 -0.482 . . . . 15.0 110.811 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.654 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 0.6 OUTLIER -86.07 -168.85 2.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 15.0 110.696 179.834 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 51.2 mt -86.54 -170.26 3.0 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 116.153 -0.476 . . . . 15.0 110.699 179.469 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.793 ' HA3' ' HA3' ' A' ' 44' ' ' GLY . . . -170.86 45.33 0.19 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.729 -0.748 . . . . 15.0 112.347 -179.72 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.744 HG12 ' O ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -112.52 139.12 38.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 120.827 0.346 . . . . 15.0 111.231 -179.913 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.414 ' H ' HD13 ' A' ' 41' ' ' ILE . 13.0 t -90.28 103.32 16.01 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.419 -0.956 . . . . 15.0 108.419 177.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 1.006 HG21 HG23 ' A' ' 75' ' ' VAL . 34.7 m -93.94 155.81 3.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 112.645 0.609 . . . . 15.0 112.645 -177.443 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.36 -177.08 5.64 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.31 -0.859 . . . . 15.0 110.779 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.445 ' O ' ' HB3' ' A' ' 71' ' ' HIS . . . 68.83 -119.46 9.87 Favored Glycine 0 C--N 1.332 0.336 0 C-N-CA 120.84 -0.695 . . . . 15.0 112.532 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.531 ' HA3' ' N ' ' A' ' 71' ' ' HIS . . . 68.11 -66.26 0.36 Allowed Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.833 -0.698 . . . . 15.0 113.492 179.466 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.548 ' O ' HG22 ' A' ' 30' ' ' VAL . 1.7 m -30.36 144.74 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 N-CA-C 112.384 0.513 . . . . 15.0 112.384 -179.322 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 49.5 t-20 -75.68 61.08 1.33 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.964 -0.562 . . . . 15.0 110.935 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.4 m -151.73 -66.37 0.18 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.204 -0.453 . . . . 15.0 111.028 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.8 m -68.43 -42.59 78.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.213 -0.449 . . . . 15.0 111.084 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.548 HG22 ' O ' ' A' ' 26' ' ' VAL . 16.6 m -75.12 -173.01 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.269 -0.423 . . . . 15.0 111.202 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.02 -58.36 6.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.204 -0.453 . . . . 15.0 110.934 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 93.0 m-70 -137.12 -54.56 0.7 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.23 -0.441 . . . . 15.0 111.061 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -167.76 22.05 0.1 Allowed Glycine 0 CA--C 1.517 0.215 0 C-N-CA 120.807 -0.711 . . . . 15.0 112.756 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.422 ' O ' HG11 ' A' ' 30' ' ' VAL . . . -85.63 152.86 26.71 Favored Glycine 0 N--CA 1.449 -0.453 0 N-CA-C 110.882 -0.887 . . . . 15.0 110.882 178.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.949 HG22 HG22 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -89.73 154.39 3.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 117.522 0.661 . . . . 15.0 111.929 -179.357 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.44 ' CE2' ' HG2' ' A' ' 57' ' ' ARG . 35.3 m-85 -139.28 107.86 5.88 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.98 -1.009 . . . . 15.0 109.998 178.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.819 HG22 ' N ' ' A' ' 55' ' ' GLY . 0.6 OUTLIER -55.29 156.22 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.857 -0.61 . . . . 15.0 111.037 -179.097 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.551 ' O ' ' HG2' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -91.09 -47.24 7.66 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.344 -0.984 . . . . 15.0 108.344 178.526 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.744 ' O ' HG12 ' A' ' 20' ' ' ILE . . . -172.48 171.96 4.49 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.329 -0.85 . . . . 15.0 110.062 178.611 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.56 ' HA ' ' CG1' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -96.45 108.41 21.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 109.178 -0.675 . . . . 15.0 109.178 179.191 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.756 ' HB ' ' O ' ' A' ' 19' ' ' GLY . 0.7 OUTLIER -77.99 118.43 72.11 Favored Pre-proline 0 C--N 1.328 -0.362 0 N-CA-C 113.528 0.936 . . . . 15.0 113.528 -176.904 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.597 ' HA ' ' CG ' ' A' ' 47' ' ' GLU . 36.8 Cg_endo -64.31 61.81 0.25 Allowed 'Trans proline' 0 C--N 1.356 0.971 0 C-N-CA 123.602 2.868 . . . . 15.0 112.907 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.508 ' H ' ' HG2' ' A' ' 47' ' ' GLU . 5.4 mm100 -149.42 -46.42 0.14 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.513 -0.312 . . . . 15.0 111.398 179.779 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.793 ' HA3' ' HA3' ' A' ' 19' ' ' GLY . . . -87.88 167.74 36.82 Favored Glycine 0 C--N 1.33 0.204 0 C-N-CA 120.443 -0.884 . . . . 15.0 113.825 -179.249 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.654 ' HB3' ' O ' ' A' ' 17' ' ' SER . . . -59.61 -13.53 9.85 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.168 -0.516 . . . . 15.0 112.244 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.22 -55.99 6.28 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 120.701 0.286 . . . . 15.0 110.79 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.597 ' CG ' ' HA ' ' A' ' 42' ' ' PRO . 2.9 pp20? -57.73 -42.48 83.95 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-N 115.973 -0.558 . . . . 15.0 110.45 179.144 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 32.8 t -53.51 -69.44 0.12 Allowed 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 115.804 -0.635 . . . . 15.0 110.459 -179.244 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.563 ' HB2' HD11 ' A' ' 11' ' ' LEU . 0.4 OUTLIER -59.42 -42.04 90.92 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.07 -0.715 . . . . 15.0 109.07 178.729 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.75 43.02 9.34 Favored Glycine 0 N--CA 1.447 -0.622 0 CA-C-N 115.36 -0.836 . . . . 15.0 111.645 179.42 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.689 ' HG3' HD13 ' A' ' 11' ' ' LEU . 0.7 OUTLIER -79.89 -41.63 25.79 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.712 0.291 . . . . 15.0 111.071 -179.111 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.56 ' CG2' HG11 ' A' ' 37' ' ' VAL . 5.9 mm -91.25 161.49 2.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 120.921 0.391 . . . . 15.0 110.922 179.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.552 ' N ' HG22 ' A' ' 52' ' ' ILE . 75.8 m80 -142.38 154.91 45.03 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-O 121.447 0.641 . . . . 15.0 111.083 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.551 ' HG2' ' O ' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -37.68 133.13 0.83 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.552 -1.203 . . . . 15.0 112.934 -178.552 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.819 ' N ' HG22 ' A' ' 37' ' ' VAL . . . 50.05 33.48 21.87 Favored Glycine 0 C--N 1.335 0.489 0 CA-C-N 115.822 -0.626 . . . . 15.0 113.716 179.243 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.431 ' H ' HG13 ' A' ' 37' ' ' VAL . 2.8 m-20 -65.34 130.71 44.3 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 117.178 0.489 . . . . 15.0 110.181 179.16 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.44 ' HG2' ' CE2' ' A' ' 36' ' ' TYR . 30.9 mtt180 -83.28 94.83 8.0 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.341 -0.39 . . . . 15.0 110.522 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.949 HG22 HG22 ' A' ' 35' ' ' ILE . 1.1 m -87.87 117.22 31.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 121.039 0.447 . . . . 15.0 111.055 -179.713 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.555 HD12 ' HG3' ' A' ' 67' ' ' GLU . 2.9 mm? -107.17 -14.23 14.96 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 115.797 -0.638 . . . . 15.0 112.567 -179.129 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.576 ' HB3' ' HB2' ' A' ' 88' ' ' LEU . . . -149.98 146.56 27.08 Favored 'General case' 0 N--CA 1.462 0.162 0 N-CA-C 112.591 0.589 . . . . 15.0 112.591 -178.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.82 HG11 ' O ' ' A' ' 77' ' ' THR . 45.9 t -139.25 100.26 1.37 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.224 0 CA-C-N 115.32 -0.854 . . . . 15.0 109.385 178.751 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.787 ' ND2' HG22 ' A' ' 81' ' ' THR . 1.4 m-80 65.05 16.57 10.64 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.086 -0.507 . . . . 15.0 109.937 -178.157 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 107.05 4.39 35.83 Favored Glycine 0 C--N 1.336 0.531 0 CA-C-N 115.848 -0.614 . . . . 15.0 113.387 179.601 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.626 ' O ' HG13 ' A' ' 64' ' ' VAL . 4.3 p -93.79 107.04 18.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 121.087 0.47 . . . . 15.0 110.78 179.499 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -57.55 130.73 47.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 15.0 111.049 -179.526 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.937 HD11 ' HB2' ' A' ' 74' ' ' ALA . 0.2 OUTLIER -87.69 -27.06 22.65 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.067 -0.515 . . . . 15.0 110.811 179.98 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.555 ' HG3' HD12 ' A' ' 59' ' ' LEU . 82.2 mt-10 -47.39 103.49 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.338 -0.392 . . . . 15.0 111.019 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.8 58.73 0.54 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.756 -0.735 . . . . 15.0 112.425 -179.734 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.562 ' HB1' ' CB ' ' A' ' 73' ' ' GLN . . . -173.1 165.61 4.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.901 0.382 . . . . 15.0 111.07 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.497 HG22 ' HA ' ' A' ' 26' ' ' VAL . 17.3 p -93.13 -172.93 3.11 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.095 -0.502 . . . . 15.0 111.046 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.776 ' CD2' HG23 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -63.07 -59.7 4.43 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.797 -0.638 . . . . 15.0 110.563 -179.924 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.41 ' HA ' ' HB ' ' A' ' 75' ' ' VAL . 7.6 ttpt -52.56 -33.77 47.28 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.838 -0.619 . . . . 15.0 110.807 179.719 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.562 ' CB ' ' HB1' ' A' ' 69' ' ' ALA . 7.0 mt-30 -59.5 -50.79 72.57 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.688 -0.486 . . . . 15.0 109.688 179.339 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.937 ' HB2' HD11 ' A' ' 66' ' ' LEU . . . -66.97 -43.82 82.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.95 -0.568 . . . . 15.0 109.697 178.416 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 1.006 HG23 HG21 ' A' ' 22' ' ' VAL . 0.5 OUTLIER -43.34 -41.76 1.35 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.289 0 N-CA-C 108.878 -0.786 . . . . 15.0 108.878 178.319 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.407 ' O ' ' CB ' ' A' ' 80' ' ' ASN . 2.0 mt-10 -67.17 -44.3 80.07 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 114.822 -1.081 . . . . 15.0 110.022 178.323 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.82 ' O ' HG11 ' A' ' 61' ' ' VAL . 59.4 p -64.06 -54.38 34.96 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-N 116.665 -0.243 . . . . 15.0 111.596 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.717 HD21 HG21 ' A' ' 58' ' ' VAL . 8.8 mt -53.45 -48.98 68.35 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.317 0.58 . . . . 15.0 110.03 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.417 ' HB2' ' O ' ' A' ' 75' ' ' VAL . 0.0 OUTLIER -68.44 -59.15 3.38 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.251 -0.886 . . . . 15.0 110.723 179.722 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.407 ' CB ' ' O ' ' A' ' 76' ' ' GLU . 71.4 m-20 -65.97 62.87 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.1 -0.5 . . . . 15.0 111.909 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.787 HG22 ' ND2' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -95.46 -73.66 0.58 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 110.146 -0.316 . . . . 15.0 110.146 179.205 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 122.15 -105.4 0.98 Allowed Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.696 -0.764 . . . . 15.0 113.268 179.048 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.404 ' O ' ' HB3' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -64.88 -83.64 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.761 0.315 . . . . 15.0 111.18 -179.39 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.476 HG12 ' N ' ' A' ' 85' ' ' VAL . 79.7 t -109.82 160.18 8.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.257 -0.428 . . . . 15.0 110.864 -179.755 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.889 HG23 ' HB2' ' A' ' 13' ' ' LYS . 3.6 t -97.63 81.64 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.137 0.494 . . . . 15.0 110.18 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -96.41 80.23 3.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.727 -0.669 . . . . 15.0 110.391 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.67 ' HB3' HD21 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -102.12 124.68 48.15 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.063 -0.517 . . . . 15.0 111.649 -179.269 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.711 HD12 ' CB ' ' A' ' 8' ' ' GLU . 4.7 mp -102.01 99.01 9.13 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.658 -0.497 . . . . 15.0 109.658 178.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.792 HD12 ' CE1' ' A' ' 7' ' ' PHE . 0.1 OUTLIER -102.93 -161.42 0.84 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.383 0.611 . . . . 15.0 111.841 -178.772 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.431 ' HB2' HG13 ' A' ' 6' ' ' ILE . 3.1 tt0 -140.93 144.01 34.92 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.059 -0.973 . . . . 15.0 109.772 179.108 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 7.1 tptp -55.17 104.95 0.14 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.877 0.37 . . . . 15.0 110.961 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -62.42 105.91 1.1 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.845 -0.693 . . . . 15.0 112.6 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -84.21 108.83 17.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.855 0.36 . . . . 15.0 110.849 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -86.55 139.43 33.6 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.19 -0.459 . . . . 15.0 110.911 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -53.28 -46.92 30.41 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.501 2.134 . . . . 15.0 112.267 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 17.1 m . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.217 -0.897 . . . . 15.0 110.915 179.971 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo . . . . . 0 N--CA 1.487 1.138 0 CA-C-O 120.852 0.272 . . . . 15.0 111.745 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -155.18 159.36 31.83 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.149 -0.478 . . . . 15.0 110.782 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -56.46 -164.05 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.585 2.19 . . . . 15.0 112.19 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 85.69 -17.24 36.47 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.533 -0.841 . . . . 15.0 112.505 -179.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -62.01 162.88 8.59 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-O 121.226 0.536 . . . . 15.0 110.941 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.467 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 1.3 mp -104.38 146.2 12.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.318 -0.856 . . . . 15.0 111.176 -179.226 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.645 ' CE1' HD12 ' A' ' 89' ' ' LEU . 6.8 p90 -140.64 164.31 30.53 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.063 -0.517 . . . . 15.0 110.203 178.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.753 ' HB2' HD12 ' A' ' 88' ' ' LEU . 0.3 OUTLIER -130.2 143.24 50.66 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.284 0.564 . . . . 15.0 111.66 -179.506 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.575 ' CG1' HD11 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -101.42 114.35 40.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.184 -0.916 . . . . 15.0 109.397 178.859 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -106.01 72.25 0.93 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.213 -0.449 . . . . 15.0 112.137 -178.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.629 HD13 ' HG3' ' A' ' 51' ' ' ARG . 5.4 tp -88.21 166.39 14.39 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.429 -0.582 . . . . 15.0 109.429 178.61 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.501 ' HB3' ' HB2' ' A' ' 15' ' ' ASP . . . -96.02 97.66 9.77 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.05 0.453 . . . . 15.0 111.262 -179.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.74 ' CB ' HG23 ' A' ' 85' ' ' VAL . 0.1 OUTLIER -63.88 -29.44 70.62 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.735 -0.666 . . . . 15.0 111.42 -179.861 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 22.9 t30 -84.3 -30.9 25.21 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.426 -0.352 . . . . 15.0 111.039 -179.524 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.501 ' HB2' ' HB3' ' A' ' 12' ' ' ALA . 0.8 OUTLIER -77.59 -37.01 51.36 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.03 0.443 . . . . 15.0 110.132 179.319 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.516 ' HB3' ' HB2' ' A' ' 45' ' ' ALA . 2.4 m120 -165.6 156.12 13.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.802 -0.635 . . . . 15.0 110.702 179.769 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.931 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 0.3 OUTLIER -85.86 -162.83 0.78 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.421 -0.354 . . . . 15.0 110.163 179.589 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.4 mp -108.2 -175.72 2.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.955 0.407 . . . . 15.0 110.715 179.452 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.808 ' O ' ' HB ' ' A' ' 41' ' ' ILE . . . -161.12 46.07 0.39 Allowed Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 121.034 -0.603 . . . . 15.0 111.794 -179.791 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.757 HG12 ' O ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -112.77 136.67 48.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 120.927 0.394 . . . . 15.0 111.581 -179.609 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 37.4 t -88.65 103.13 15.64 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.285 -1.006 . . . . 15.0 108.285 177.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.887 HG21 HG23 ' A' ' 75' ' ' VAL . 8.0 m -93.6 149.11 4.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 112.643 0.609 . . . . 15.0 112.643 -177.433 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.489 ' HA ' ' ND1' ' A' ' 71' ' ' HIS . 5.4 t -150.02 179.24 8.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.39 -0.823 . . . . 15.0 110.468 179.185 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.696 ' O ' HG22 ' A' ' 26' ' ' VAL . . . 82.78 -117.32 4.38 Favored Glycine 0 C--N 1.331 0.298 0 C-N-CA 120.542 -0.837 . . . . 15.0 112.649 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.579 ' HA3' ' N ' ' A' ' 71' ' ' HIS . . . 63.34 -65.87 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 121.084 -0.579 . . . . 15.0 113.742 179.184 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.696 HG22 ' O ' ' A' ' 24' ' ' GLY . 0.0 OUTLIER -26.57 139.86 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 N-CA-C 112.633 0.605 . . . . 15.0 112.633 -178.994 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.425 ' HA ' ' O ' ' A' ' 32' ' ' HIS . 54.2 t-20 -77.62 57.67 1.65 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.768 -0.651 . . . . 15.0 110.927 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 5.9 m -151.69 -61.18 0.17 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.24 -0.437 . . . . 15.0 110.767 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.64 -34.77 77.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.15 -0.477 . . . . 15.0 110.692 179.755 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.642 HG22 ' O ' ' A' ' 26' ' ' VAL . 33.2 m -88.02 -174.34 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.064 -0.516 . . . . 15.0 111.003 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -70.53 -51.5 28.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.394 -0.367 . . . . 15.0 111.241 -179.764 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . 0.425 ' O ' ' HA ' ' A' ' 27' ' ' ASN . 86.4 m-70 -132.52 -70.97 0.54 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.401 -0.363 . . . . 15.0 111.255 -179.745 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -162.75 24.84 0.21 Allowed Glycine 0 C--O 1.23 -0.145 0 C-N-CA 120.904 -0.665 . . . . 15.0 112.388 -179.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -86.89 148.19 21.5 Favored Glycine 0 N--CA 1.448 -0.522 0 N-CA-C 110.171 -1.172 . . . . 15.0 110.171 178.658 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 1.056 HD12 ' HB3' ' A' ' 74' ' ' ALA . 0.3 OUTLIER -88.68 153.78 3.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 C-N-CA 119.574 -0.85 . . . . 15.0 112.297 -178.894 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.477 ' CE2' ' CG ' ' A' ' 57' ' ' ARG . 32.4 m-85 -134.16 107.89 7.97 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.644 -1.162 . . . . 15.0 109.056 179.321 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.797 HG22 ' N ' ' A' ' 55' ' ' GLY . 0.7 OUTLIER -54.96 148.02 3.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.144 0.497 . . . . 15.0 111.189 -178.479 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.445 ' O ' ' HG2' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -80.05 -49.06 12.31 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.882 -0.784 . . . . 15.0 108.882 178.91 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.757 ' O ' HG12 ' A' ' 20' ' ' ILE . . . -172.33 172.45 4.46 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 115.999 -0.546 . . . . 15.0 110.184 178.439 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.556 ' HA ' ' CG1' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -96.72 110.01 24.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 108.957 -0.757 . . . . 15.0 108.957 178.905 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.808 ' HB ' ' O ' ' A' ' 19' ' ' GLY . 0.5 OUTLIER -78.0 115.25 48.98 Favored Pre-proline 0 C--N 1.326 -0.433 0 N-CA-C 113.275 0.843 . . . . 15.0 113.275 -177.053 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.617 ' HA ' ' CG ' ' A' ' 47' ' ' GLU . 30.3 Cg_exo -62.56 59.49 0.14 Allowed 'Trans proline' 0 C--N 1.358 1.07 0 C-N-CA 123.612 2.875 . . . . 15.0 112.95 179.706 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.528 ' N ' ' HG2' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -147.45 -47.38 0.17 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.594 0.235 . . . . 15.0 111.341 -179.985 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.739 ' HA3' ' HA3' ' A' ' 19' ' ' GLY . . . -87.67 168.89 38.37 Favored Glycine 0 C--N 1.33 0.217 0 C-N-CA 120.398 -0.906 . . . . 15.0 113.801 -179.136 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.931 ' HB3' ' O ' ' A' ' 17' ' ' SER . . . -58.12 -13.78 5.52 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.702 0.63 . . . . 15.0 112.702 -179.673 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.03 -56.46 5.59 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.97 -0.292 . . . . 15.0 110.69 -179.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.617 ' CG ' ' HA ' ' A' ' 42' ' ' PRO . 2.8 pp20? -57.61 -43.33 84.68 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.997 -0.547 . . . . 15.0 110.434 179.172 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -53.81 -70.21 0.1 Allowed 'General case' 0 CA--C 1.518 -0.256 0 CA-C-N 115.902 -0.59 . . . . 15.0 110.523 -179.473 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.539 ' CB ' HD11 ' A' ' 11' ' ' LEU . 0.1 OUTLIER -58.13 -41.59 83.99 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.137 -0.69 . . . . 15.0 109.137 178.786 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.72 40.49 12.26 Favored Glycine 0 N--CA 1.445 -0.702 0 CA-C-N 115.305 -0.861 . . . . 15.0 111.676 179.309 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.629 ' HG3' HD13 ' A' ' 11' ' ' LEU . 0.1 OUTLIER -79.74 -49.9 11.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.891 0.376 . . . . 15.0 110.65 -179.351 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.611 ' CG1' HD12 ' A' ' 20' ' ' ILE . 8.8 tp -81.14 161.21 3.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.02 -0.536 . . . . 15.0 110.241 179.464 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.444 ' N ' ' OD2' ' A' ' 56' ' ' ASP . 75.2 m80 -146.07 156.77 43.69 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-O 121.581 0.705 . . . . 15.0 112.258 -179.047 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.557 ' HA ' ' CG2' ' A' ' 37' ' ' VAL . 0.6 OUTLIER -43.28 132.51 4.37 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.3 -1.318 . . . . 15.0 112.902 -178.666 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.797 ' N ' HG22 ' A' ' 37' ' ' VAL . . . 50.98 29.87 21.34 Favored Glycine 0 C--N 1.335 0.475 0 CA-C-N 115.785 -0.643 . . . . 15.0 113.456 179.137 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.444 ' OD2' ' N ' ' A' ' 53' ' ' HIS . 6.4 m-20 -65.76 128.81 37.46 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.827 -0.349 . . . . 15.0 110.51 179.516 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.477 ' CG ' ' CE2' ' A' ' 36' ' ' TYR . 2.3 mtp85 -80.62 95.45 6.56 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.476 -0.329 . . . . 15.0 110.663 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.953 HG22 HG22 ' A' ' 35' ' ' ILE . 1.5 m -85.76 113.42 23.91 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-O 121.094 0.474 . . . . 15.0 111.177 -179.654 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.502 ' N ' HD22 ' A' ' 59' ' ' LEU . 3.6 mm? -107.35 -12.08 15.41 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 115.677 -0.692 . . . . 15.0 112.505 -179.288 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.819 ' HB3' ' HB2' ' A' ' 88' ' ' LEU . . . -150.71 148.25 28.33 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 112.762 0.653 . . . . 15.0 112.762 -178.709 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.685 HG11 ' O ' ' A' ' 77' ' ' THR . 15.4 t -139.12 99.51 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.231 -0.895 . . . . 15.0 109.107 178.741 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.73 ' OD1' HG22 ' A' ' 81' ' ' THR . 9.2 m120 65.22 16.41 10.53 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.871 -0.418 . . . . 15.0 109.871 -177.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 107.2 4.93 35.3 Favored Glycine 0 C--N 1.336 0.544 0 CA-C-N 116.039 -0.528 . . . . 15.0 113.465 179.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.663 ' O ' HG13 ' A' ' 64' ' ' VAL . 5.2 p -93.8 106.37 17.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 117.168 0.484 . . . . 15.0 110.783 179.506 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.2 m -56.33 130.15 43.38 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.171 -0.468 . . . . 15.0 111.051 -179.609 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.551 HD21 ' OG1' ' A' ' 77' ' ' THR . 0.2 OUTLIER -89.44 -21.38 23.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.075 -0.511 . . . . 15.0 110.997 179.946 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -45.76 101.5 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.869 0.366 . . . . 15.0 111.062 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.78 63.11 0.55 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.791 -0.718 . . . . 15.0 112.4 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.733 ' HB1' ' CB ' ' A' ' 73' ' ' GLN . . . -173.02 160.59 4.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.89 0.376 . . . . 15.0 111.035 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.453 ' HB ' ' HA ' ' A' ' 26' ' ' VAL . 3.0 p -93.17 -170.54 2.43 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.084 0.468 . . . . 15.0 111.055 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.715 ' CD2' HG23 ' A' ' 22' ' ' VAL . 0.2 OUTLIER -60.75 -61.02 2.89 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.691 -0.686 . . . . 15.0 110.13 179.908 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.556 ' O ' HG12 ' A' ' 75' ' ' VAL . 12.7 ttpp -53.21 -34.79 58.55 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.716 -0.674 . . . . 15.0 110.863 179.234 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.733 ' CB ' ' HB1' ' A' ' 69' ' ' ALA . 3.3 mt-30 -59.42 -54.9 41.37 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.645 -0.502 . . . . 15.0 109.645 179.575 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 1.056 ' HB3' HD12 ' A' ' 35' ' ' ILE . . . -63.9 -43.55 95.65 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.823 -0.626 . . . . 15.0 109.536 178.458 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.887 HG23 HG21 ' A' ' 22' ' ' VAL . 0.5 OUTLIER -44.25 -40.06 1.68 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.296 0 N-CA-C 108.771 -0.825 . . . . 15.0 108.771 178.176 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.522 ' O ' ' HB2' ' A' ' 80' ' ' ASN . 3.6 mm-40 -67.42 -45.01 77.39 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 114.793 -1.094 . . . . 15.0 110.302 178.377 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.685 ' O ' HG11 ' A' ' 61' ' ' VAL . 32.9 p -64.02 -54.64 31.08 Favored 'General case' 0 C--O 1.231 0.124 0 C-N-CA 121.055 -0.258 . . . . 15.0 111.509 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.559 HD21 HG21 ' A' ' 58' ' ' VAL . 6.5 mt -53.37 -46.6 69.68 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-O 121.262 0.553 . . . . 15.0 109.8 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.425 ' HB2' ' O ' ' A' ' 75' ' ' VAL . 8.9 tpp180 -68.49 -59.81 2.88 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.266 -0.879 . . . . 15.0 110.5 179.284 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.522 ' HB2' ' O ' ' A' ' 76' ' ' GLU . 10.9 m-80 -66.12 62.11 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.98 -0.554 . . . . 15.0 111.833 179.801 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.73 HG22 ' OD1' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -93.74 -74.16 0.54 Allowed 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.804 -0.443 . . . . 15.0 109.804 179.182 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 122.03 -106.15 1.05 Allowed Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.802 -0.713 . . . . 15.0 113.195 179.019 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -64.7 -82.13 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 111.984 0.365 . . . . 15.0 111.984 -179.067 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.436 HG12 ' N ' ' A' ' 85' ' ' VAL . 62.4 t -109.87 158.29 10.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.06 0.457 . . . . 15.0 110.87 -179.335 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.74 HG23 ' CB ' ' A' ' 13' ' ' LYS . 14.0 t -97.93 80.96 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 116.084 -0.507 . . . . 15.0 110.569 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -103.13 83.39 2.2 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.901 -0.591 . . . . 15.0 110.265 179.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.805 ' HB3' HD21 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -99.93 118.32 36.11 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.952 -0.567 . . . . 15.0 111.756 -179.088 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.819 ' HB2' ' HB3' ' A' ' 60' ' ' ALA . 4.3 mp -92.14 101.1 13.62 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.757 -0.46 . . . . 15.0 109.757 178.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.805 HD21 ' HB3' ' A' ' 87' ' ' LEU . 0.2 OUTLIER -105.65 -159.71 0.72 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.303 0.573 . . . . 15.0 111.66 -178.836 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.467 ' HA ' ' HA ' ' A' ' 6' ' ' ILE . 3.1 tt0 -140.58 145.23 36.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.311 -0.859 . . . . 15.0 110.195 179.243 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.85 106.87 0.34 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.249 -0.432 . . . . 15.0 110.977 -179.837 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -69.59 167.03 48.2 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.842 -0.695 . . . . 15.0 112.581 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -86.2 142.77 28.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.783 0.325 . . . . 15.0 110.896 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -81.76 150.63 66.41 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.224 -0.444 . . . . 15.0 110.884 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_exo -51.47 -53.25 7.4 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.594 2.196 . . . . 15.0 112.34 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 23.3 m . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.206 -0.902 . . . . 15.0 110.861 -179.996 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_endo . . . . . 0 N--CA 1.488 1.187 0 CA-C-O 120.857 0.274 . . . . 15.0 111.81 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 13.9 pttp -149.49 129.08 6.43 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 15.0 110.867 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.9 -160.26 0.07 OUTLIER 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.491 2.127 . . . . 15.0 112.222 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 92.18 -25.94 15.37 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.622 -0.799 . . . . 15.0 112.18 -179.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -62.33 133.88 55.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.271 0.558 . . . . 15.0 110.633 179.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.531 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 1.5 mp -104.46 144.98 13.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.342 -0.844 . . . . 15.0 111.301 -179.188 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.579 ' CE1' HD12 ' A' ' 89' ' ' LEU . 3.8 p90 -144.56 165.03 29.15 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.061 -0.518 . . . . 15.0 110.415 178.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.727 ' CB ' HD12 ' A' ' 88' ' ' LEU . 10.7 pt-20 -130.19 143.84 51.01 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.201 0.524 . . . . 15.0 111.6 -179.05 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.454 HG23 ' HB3' ' A' ' 51' ' ' ARG . 0.2 OUTLIER -101.64 117.13 46.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.441 -0.799 . . . . 15.0 109.542 178.615 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 -106.14 74.86 1.06 Allowed 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 112.33 0.493 . . . . 15.0 112.33 -178.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.559 HD11 ' CB ' ' A' ' 49' ' ' ASP . 6.8 tp -88.19 166.34 14.44 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.389 -0.597 . . . . 15.0 109.389 178.43 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -96.2 95.76 8.35 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.041 0.448 . . . . 15.0 111.28 -179.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.662 ' CB ' HG23 ' A' ' 85' ' ' VAL . 0.2 OUTLIER -60.47 -26.03 66.48 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.73 -0.668 . . . . 15.0 111.195 179.869 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 54.1 m-20 -83.81 -39.69 19.67 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.322 -0.399 . . . . 15.0 110.641 -179.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -69.98 -37.68 75.8 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.078 0.466 . . . . 15.0 109.994 179.243 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.679 ' HB3' ' HB2' ' A' ' 45' ' ' ALA . 8.4 m-80 -165.52 163.21 19.5 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.73 -0.668 . . . . 15.0 110.673 179.572 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.601 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 1.5 m -85.97 -137.73 0.08 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.333 -0.394 . . . . 15.0 110.052 179.651 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.0 mp -116.87 -174.54 2.6 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 120.826 0.346 . . . . 15.0 110.561 179.318 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.649 ' O ' ' HB ' ' A' ' 41' ' ' ILE . . . -160.99 36.86 0.42 Allowed Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 121.136 -0.554 . . . . 15.0 111.782 -179.636 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.616 HD13 ' HB ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -112.66 141.68 27.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 120.996 0.427 . . . . 15.0 112.027 -179.291 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 31.4 t -96.24 102.69 14.52 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 107.301 -1.37 . . . . 15.0 107.301 176.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.998 HG21 HG23 ' A' ' 75' ' ' VAL . 14.1 m -93.33 148.26 4.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 113.536 0.939 . . . . 15.0 113.536 -176.293 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.533 ' O ' ' O ' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -149.86 157.92 43.66 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.005 -0.998 . . . . 15.0 110.699 179.586 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.412 ' O ' HG12 ' A' ' 35' ' ' ILE . . . 67.71 112.67 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.444 -0.884 . . . . 15.0 113.42 178.653 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.508 ' HA3' ' N ' ' A' ' 71' ' ' HIS . . . -163.74 -38.97 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 121.112 -0.566 . . . . 15.0 112.301 179.244 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.508 ' HA ' ' HA ' ' A' ' 70' ' ' THR . 0.2 OUTLIER -40.78 162.58 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-O 120.868 0.366 . . . . 15.0 111.823 179.935 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -87.91 51.72 2.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.454 . . . . 15.0 110.887 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -151.63 -62.15 0.17 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.094 -0.503 . . . . 15.0 110.663 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.75 -52.34 51.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.192 -0.458 . . . . 15.0 110.609 179.753 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.441 HG22 ' O ' ' A' ' 26' ' ' VAL . 16.4 m -87.98 -177.68 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.137 -0.483 . . . . 15.0 110.771 179.726 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 5.1 ppt_? -88.41 127.1 35.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.851 0.358 . . . . 15.0 111.184 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 57.1 m80 62.76 -82.14 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.005 -0.543 . . . . 15.0 111.424 179.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -177.25 33.08 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.721 -0.752 . . . . 15.0 112.661 -179.525 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -93.52 156.35 22.58 Favored Glycine 0 N--CA 1.45 -0.388 0 N-CA-C 110.846 -0.902 . . . . 15.0 110.846 179.079 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.955 HG22 HG22 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -97.64 153.6 3.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 119.854 -0.738 . . . . 15.0 111.997 -179.29 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.533 ' O ' ' O ' ' A' ' 23' ' ' THR . 26.8 m-85 -134.17 106.82 7.37 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.963 -1.017 . . . . 15.0 109.7 179.225 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.806 HG22 ' N ' ' A' ' 55' ' ' GLY . 0.7 OUTLIER -54.63 146.64 3.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.106 0.479 . . . . 15.0 111.282 -178.593 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.475 ' HB3' ' OG1' ' A' ' 23' ' ' THR . 0.0 OUTLIER -79.94 -48.87 12.71 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.319 -0.993 . . . . 15.0 108.319 178.78 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.597 ' O ' HG12 ' A' ' 20' ' ' ILE . . . -172.23 171.07 4.95 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.285 -0.87 . . . . 15.0 110.119 178.612 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.567 ' HA ' HG12 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -97.1 110.26 24.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.085 0.469 . . . . 15.0 110.182 179.558 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.649 ' HB ' ' O ' ' A' ' 19' ' ' GLY . 0.4 OUTLIER -78.47 109.58 10.99 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 115.701 -0.682 . . . . 15.0 112.32 -178.326 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.466 ' N ' ' HG2' ' A' ' 47' ' ' GLU . 31.4 Cg_endo -63.45 65.88 0.18 Allowed 'Trans proline' 0 C--N 1.355 0.919 0 C-N-CA 123.159 2.572 . . . . 15.0 112.568 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.424 ' N ' ' O ' ' A' ' 41' ' ' ILE . 5.2 tp60 -147.32 -53.34 0.21 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.322 -0.854 . . . . 15.0 109.112 179.469 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.57 ' HA3' ' HA3' ' A' ' 19' ' ' GLY . . . -87.93 157.18 28.19 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.667 -0.778 . . . . 15.0 112.51 179.175 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.679 ' HB2' ' HB3' ' A' ' 16' ' ' ASN . . . -41.58 -17.38 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 113.588 0.958 . . . . 15.0 113.588 -179.531 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.43 ' N ' ' O ' ' A' ' 44' ' ' GLY . . . -71.65 -70.72 0.31 Allowed 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.75 -0.38 . . . . 15.0 111.345 -179.409 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.501 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 4.3 tp10 -58.54 -40.6 83.43 Favored 'General case' 0 N--CA 1.463 0.179 0 C-N-CA 120.587 -0.445 . . . . 15.0 110.436 179.546 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.8 m -54.15 -63.56 1.11 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.997 -0.547 . . . . 15.0 110.338 179.355 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.559 ' CB ' HD11 ' A' ' 11' ' ' LEU . 1.9 t70 -63.5 -40.05 96.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.108 -0.496 . . . . 15.0 109.899 179.081 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.58 43.37 8.49 Favored Glycine 0 N--CA 1.449 -0.437 0 CA-C-N 115.678 -0.692 . . . . 15.0 112.836 179.472 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.541 ' HG3' HD13 ' A' ' 11' ' ' LEU . 1.1 mmt-85 -89.34 -52.81 4.85 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.938 0.399 . . . . 15.0 110.557 179.696 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.568 ' CG1' HD12 ' A' ' 20' ' ' ILE . 9.7 tp -81.0 159.16 4.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.036 -0.529 . . . . 15.0 110.398 179.546 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.41 ' O ' ' HB2' ' A' ' 56' ' ' ASP . 80.3 m80 -139.69 160.88 38.87 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-O 121.794 0.807 . . . . 15.0 112.758 -178.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.574 ' HA ' ' CG2' ' A' ' 37' ' ' VAL . 0.2 OUTLIER -44.67 134.29 5.53 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.002 -1.453 . . . . 15.0 113.1 -178.657 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.806 ' N ' HG22 ' A' ' 37' ' ' VAL . . . 49.66 31.8 15.97 Favored Glycine 0 C--N 1.334 0.442 0 CA-C-N 115.738 -0.664 . . . . 15.0 113.636 178.802 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.41 ' HB2' ' O ' ' A' ' 53' ' ' HIS . 0.3 OUTLIER -65.97 131.71 46.88 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.506 -0.478 . . . . 15.0 110.683 179.442 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.491 ' HG2' ' CE2' ' A' ' 36' ' ' TYR . 6.6 mtp85 -82.65 87.41 6.73 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.351 -0.386 . . . . 15.0 110.113 179.411 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.955 HG22 HG22 ' A' ' 35' ' ' ILE . 1.3 m -79.31 113.25 18.4 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 CA-C-O 121.158 0.504 . . . . 15.0 111.087 -179.379 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 21.3 mt -107.56 -14.48 14.82 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 115.472 -0.786 . . . . 15.0 112.493 -179.173 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.714 ' HB3' ' HB2' ' A' ' 88' ' ' LEU . . . -147.5 150.41 34.51 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.604 0.594 . . . . 15.0 112.604 -178.414 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.781 HG11 ' O ' ' A' ' 77' ' ' THR . 80.9 t -139.05 102.72 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.175 -0.92 . . . . 15.0 109.018 178.746 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.815 ' ND2' HG22 ' A' ' 81' ' ' THR . 1.7 m-80 65.11 14.89 9.68 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.723 -0.473 . . . . 15.0 109.723 -177.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 106.4 6.71 35.72 Favored Glycine 0 C--N 1.336 0.566 0 CA-C-N 115.839 -0.619 . . . . 15.0 113.366 179.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.68 ' O ' HG13 ' A' ' 64' ' ' VAL . 6.5 p -93.79 104.96 16.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 117.17 0.485 . . . . 15.0 110.874 179.486 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 50.8 m -58.47 121.3 10.55 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.148 -0.478 . . . . 15.0 110.733 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.47 HD13 HG23 ' A' ' 58' ' ' VAL . 0.5 OUTLIER -87.56 -10.04 52.7 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.031 -0.532 . . . . 15.0 111.185 -179.879 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -46.12 98.48 0.01 OUTLIER 'General case' 0 C--N 1.334 -0.105 0 CA-C-O 120.916 0.389 . . . . 15.0 110.799 179.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.94 68.66 0.62 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.75 -0.738 . . . . 15.0 112.193 -179.515 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.454 ' HB1' ' CB ' ' A' ' 73' ' ' GLN . . . -172.87 167.7 5.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.783 0.325 . . . . 15.0 110.863 -179.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.508 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 7.0 p -92.98 -175.05 3.76 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.238 -0.437 . . . . 15.0 111.335 -179.604 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.681 ' CD2' HG23 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -63.32 -61.2 2.51 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.928 -0.578 . . . . 15.0 110.283 -179.873 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.401 ' HA ' ' HB ' ' A' ' 75' ' ' VAL . 3.0 ttpp -52.7 -33.06 45.92 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.772 -0.649 . . . . 15.0 110.732 179.568 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.454 ' CB ' ' HB1' ' A' ' 69' ' ' ALA . 5.9 mt-30 -59.41 -48.25 82.36 Favored 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 109.403 -0.591 . . . . 15.0 109.403 179.236 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.461 ' HA ' ' OG1' ' A' ' 77' ' ' THR . . . -65.37 -47.99 74.5 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.719 -0.673 . . . . 15.0 109.214 178.307 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.998 HG23 HG21 ' A' ' 22' ' ' VAL . 0.5 OUTLIER -43.39 -39.42 1.17 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.242 0 N-CA-C 108.74 -0.837 . . . . 15.0 108.74 178.07 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -67.31 -45.92 75.06 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 114.739 -1.119 . . . . 15.0 110.349 178.468 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.781 ' O ' HG11 ' A' ' 61' ' ' VAL . 10.0 p -64.37 -53.18 52.6 Favored 'General case' 0 C--O 1.231 0.129 0 C-N-CA 120.893 -0.323 . . . . 15.0 111.309 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.696 HD23 HG21 ' A' ' 61' ' ' VAL . 5.7 mt -53.36 -48.28 68.69 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-O 121.219 0.533 . . . . 15.0 109.944 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -68.4 -59.04 3.47 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.353 -0.84 . . . . 15.0 110.351 179.357 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 75.1 m-20 -66.02 61.47 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.846 -0.615 . . . . 15.0 111.911 179.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.815 HG22 ' ND2' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -95.72 -71.01 0.69 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.693 0.282 . . . . 15.0 110.51 179.519 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 122.15 -104.42 0.91 Allowed Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.824 -0.703 . . . . 15.0 113.186 179.345 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.426 ' O ' ' HB3' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -64.64 -83.41 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 111.965 0.357 . . . . 15.0 111.965 -179.066 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.439 HG12 ' N ' ' A' ' 85' ' ' VAL . 53.9 t -109.46 159.91 8.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.94 0.4 . . . . 15.0 110.839 -179.543 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.662 HG23 ' CB ' ' A' ' 13' ' ' LYS . 24.5 t -97.87 79.59 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.161 -0.472 . . . . 15.0 110.52 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -100.63 85.39 2.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.856 -0.611 . . . . 15.0 110.594 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.713 ' HB3' HD21 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -99.57 123.11 43.53 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.083 -0.508 . . . . 15.0 111.513 -179.468 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.727 HD12 ' CB ' ' A' ' 8' ' ' GLU . 4.7 mp -98.5 100.74 12.02 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.891 -0.411 . . . . 15.0 109.891 179.014 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.713 HD21 ' HB3' ' A' ' 87' ' ' LEU . 0.1 OUTLIER -105.93 -162.29 0.85 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.428 0.632 . . . . 15.0 111.903 -178.87 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.531 ' HA ' ' HA ' ' A' ' 6' ' ' ILE . 3.1 tt0 -138.25 142.26 39.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 114.977 -1.01 . . . . 15.0 109.952 178.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 4.2 tptt -54.25 103.32 0.08 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.36 -0.382 . . . . 15.0 111.129 -179.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -72.09 145.44 37.93 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.862 -0.685 . . . . 15.0 112.522 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 15.1 tt0 -81.18 144.49 31.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.847 0.356 . . . . 15.0 110.892 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.25 111.76 48.83 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.161 -0.472 . . . . 15.0 110.972 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -58.44 149.67 73.1 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.48 2.12 . . . . 15.0 112.163 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.427 HG23 ' OXT' ' A' ' 96' ' ' THR . 2.2 t . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.284 -0.865 . . . . 15.0 110.882 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo . . . . . 0 N--CA 1.487 1.12 0 CA-C-O 120.828 0.262 . . . . 15.0 111.709 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.509 ' CB ' ' HD3' ' A' ' 3' ' ' PRO . 22.3 mttt -155.33 -58.85 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.144 -0.48 . . . . 15.0 111.147 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.509 ' HD3' ' CB ' ' A' ' 2' ' ' LYS . 35.0 Cg_exo -57.65 -161.25 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.197 1.931 . . . . 15.0 112.17 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 87.15 -19.5 30.57 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.619 -0.801 . . . . 15.0 112.559 -179.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.0 160.1 13.06 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-O 121.341 0.591 . . . . 15.0 110.855 179.858 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.427 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 1.4 mp -104.58 142.66 17.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.168 -0.924 . . . . 15.0 111.181 -179.224 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.536 ' CZ ' HD12 ' A' ' 89' ' ' LEU . 2.3 p90 -140.66 158.17 44.37 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.122 -0.49 . . . . 15.0 110.456 178.794 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.771 ' HB2' HD12 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -123.96 143.6 50.3 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.289 0.566 . . . . 15.0 111.566 -179.37 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.695 ' CG1' HD11 ' A' ' 89' ' ' LEU . 0.5 OUTLIER -101.31 114.6 41.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.295 -0.866 . . . . 15.0 109.6 179.08 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -106.24 70.38 0.84 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.261 -0.427 . . . . 15.0 112.021 -178.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.648 HD11 ' CB ' ' A' ' 49' ' ' ASP . 8.6 tp -88.26 162.1 16.82 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.137 -0.483 . . . . 15.0 110.007 179.069 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.525 ' C ' ' H ' ' A' ' 14' ' ' ASN . . . -96.58 99.28 10.92 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.703 0.287 . . . . 15.0 111.042 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.908 ' HB2' HG23 ' A' ' 85' ' ' VAL . 0.3 OUTLIER -65.45 27.04 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 112.651 0.611 . . . . 15.0 112.651 -179.892 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.525 ' H ' ' C ' ' A' ' 12' ' ' ALA . 1.0 OUTLIER -109.69 150.26 28.55 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.672 0.272 . . . . 15.0 110.673 179.86 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.412 ' CB ' ' O ' ' A' ' 14' ' ' ASN . 5.9 t0 80.79 -46.48 0.26 Allowed 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.311 -0.404 . . . . 15.0 111.105 -179.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -154.94 158.53 39.38 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.775 0.322 . . . . 15.0 110.69 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.639 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 0.0 OUTLIER -85.97 -163.0 0.8 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.342 -0.39 . . . . 15.0 110.845 -179.888 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.475 HD12 ' HE3' ' A' ' 13' ' ' LYS . 3.9 mp -77.41 -168.35 1.13 Allowed 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 116.163 -0.471 . . . . 15.0 110.581 179.745 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.639 ' O ' ' HB ' ' A' ' 41' ' ' ILE . . . -160.78 38.42 0.43 Allowed Glycine 0 N--CA 1.449 -0.48 0 N-CA-C 111.527 -0.629 . . . . 15.0 111.527 -179.774 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.719 HG12 ' O ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -112.62 140.78 30.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-O 120.937 0.399 . . . . 15.0 111.835 -179.363 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.452 ' HB3' HD11 ' A' ' 41' ' ' ILE . 30.8 t -96.09 105.92 18.03 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 107.79 -1.189 . . . . 15.0 107.79 177.491 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.887 HG21 HG23 ' A' ' 75' ' ' VAL . 14.5 m -93.67 151.91 3.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 113.087 0.773 . . . . 15.0 113.087 -176.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -149.46 174.02 12.94 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 114.752 -1.113 . . . . 15.0 110.489 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.584 ' O ' HG22 ' A' ' 26' ' ' VAL . . . 80.94 -118.54 4.65 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.491 -0.861 . . . . 15.0 112.356 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.544 ' HA3' ' N ' ' A' ' 71' ' ' HIS . . . 66.66 -65.72 0.18 Allowed Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.967 -0.635 . . . . 15.0 113.497 179.268 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.584 HG22 ' O ' ' A' ' 24' ' ' GLY . 0.0 OUTLIER -28.43 139.78 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 N-CA-C 112.38 0.511 . . . . 15.0 112.38 -179.188 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 11.2 m-80 -75.53 61.3 1.29 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.913 -0.585 . . . . 15.0 111.024 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -151.7 -64.46 0.18 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.28 -0.418 . . . . 15.0 110.927 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 59.7 p -69.1 -49.13 59.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.176 -0.465 . . . . 15.0 110.954 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.525 HG22 ' O ' ' A' ' 26' ' ' VAL . 23.1 m -70.6 -173.56 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.159 -0.473 . . . . 15.0 111.114 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.69 -67.13 0.31 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.291 -0.413 . . . . 15.0 111.055 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 10.1 p-80 -139.32 -45.3 0.46 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.315 -0.402 . . . . 15.0 111.052 -179.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -168.38 25.54 0.12 Allowed Glycine 0 N--CA 1.453 -0.212 0 C-N-CA 120.894 -0.669 . . . . 15.0 112.508 -179.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.406 ' O ' HG11 ' A' ' 30' ' ' VAL . . . -94.47 152.53 20.64 Favored Glycine 0 N--CA 1.448 -0.509 0 N-CA-C 110.443 -1.063 . . . . 15.0 110.443 178.747 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.918 HG22 HG22 ' A' ' 58' ' ' VAL . 0.1 OUTLIER -95.79 153.22 3.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 C-N-CA 119.731 -0.787 . . . . 15.0 112.329 -179.021 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.464 ' CZ ' ' HG2' ' A' ' 57' ' ' ARG . 29.3 m-85 -135.04 106.55 6.86 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.699 -1.137 . . . . 15.0 109.158 179.117 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.801 HG22 ' N ' ' A' ' 55' ' ' GLY . 0.8 OUTLIER -55.22 148.05 3.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.127 0.489 . . . . 15.0 111.571 -178.392 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.424 ' O ' ' HG2' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -80.37 -49.59 11.29 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.509 -0.923 . . . . 15.0 108.509 178.3 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.719 ' O ' HG12 ' A' ' 20' ' ' ILE . . . -172.17 172.71 4.5 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.963 -0.562 . . . . 15.0 110.879 178.808 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.55 ' HA ' HG12 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -96.81 112.72 29.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 N-CA-C 109.598 -0.519 . . . . 15.0 109.598 179.296 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.639 ' HB ' ' O ' ' A' ' 19' ' ' GLY . 0.3 OUTLIER -78.45 119.33 76.92 Favored Pre-proline 0 C--N 1.328 -0.327 0 N-CA-C 113.334 0.864 . . . . 15.0 113.334 -177.403 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.606 ' HA ' ' CG ' ' A' ' 47' ' ' GLU . 38.0 Cg_endo -65.15 61.1 0.32 Allowed 'Trans proline' 0 C--N 1.356 0.966 0 C-N-CA 123.448 2.766 . . . . 15.0 112.944 179.676 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.509 ' H ' ' HG2' ' A' ' 47' ' ' GLU . 0.1 OUTLIER -151.32 -44.75 0.11 Allowed 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 111.663 0.246 . . . . 15.0 111.663 179.903 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.599 ' HA3' ' HA3' ' A' ' 19' ' ' GLY . . . -87.71 165.54 35.16 Favored Glycine 0 CA--C 1.518 0.255 0 C-N-CA 120.328 -0.939 . . . . 15.0 113.719 -179.159 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.639 ' HB3' ' O ' ' A' ' 17' ' ' SER . . . -55.47 -15.88 3.19 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.796 0.665 . . . . 15.0 112.796 -179.543 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.2 -57.11 4.51 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.648 0.261 . . . . 15.0 111.204 -179.485 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.606 ' CG ' ' HA ' ' A' ' 42' ' ' PRO . 2.6 pp20? -56.93 -41.72 78.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.913 0.387 . . . . 15.0 110.386 179.711 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -53.91 -68.82 0.15 Allowed 'General case' 0 CA--C 1.52 -0.182 0 CA-C-N 115.91 -0.587 . . . . 15.0 110.851 -179.393 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.648 ' CB ' HD11 ' A' ' 11' ' ' LEU . 11.8 t0 -63.2 -39.13 93.75 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.57 -0.529 . . . . 15.0 109.57 179.13 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.07 45.55 7.52 Favored Glycine 0 N--CA 1.447 -0.595 0 CA-C-N 115.452 -0.795 . . . . 15.0 111.758 179.67 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.589 ' CG ' HG23 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -79.41 -53.15 7.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.966 0.413 . . . . 15.0 110.578 -179.377 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.659 ' CG1' HD12 ' A' ' 20' ' ' ILE . 7.9 tp -82.34 164.97 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 CA-C-N 115.947 -0.569 . . . . 15.0 110.392 179.676 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.451 ' O ' ' HB2' ' A' ' 56' ' ' ASP . 76.3 m80 -147.68 158.01 43.81 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-O 121.674 0.75 . . . . 15.0 112.285 -179.147 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.552 ' HA ' ' CG2' ' A' ' 37' ' ' VAL . 8.5 mtpt -43.4 134.08 4.03 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.302 -1.317 . . . . 15.0 112.94 -178.617 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.801 ' N ' HG22 ' A' ' 37' ' ' VAL . . . 49.9 31.12 16.63 Favored Glycine 0 C--N 1.334 0.432 0 CA-C-N 115.692 -0.686 . . . . 15.0 113.659 179.051 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.451 ' HB2' ' O ' ' A' ' 53' ' ' HIS . 0.4 OUTLIER -66.09 129.94 41.52 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 117.094 0.447 . . . . 15.0 110.786 179.563 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.862 ' HD2' HD21 ' A' ' 59' ' ' LEU . 0.0 OUTLIER -81.33 89.96 6.12 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.299 -0.41 . . . . 15.0 110.138 179.371 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.918 HG22 HG22 ' A' ' 35' ' ' ILE . 1.4 m -82.8 114.17 23.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 CA-C-O 121.073 0.463 . . . . 15.0 111.584 -179.146 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.862 HD21 ' HD2' ' A' ' 57' ' ' ARG . 3.4 mm? -107.69 -12.84 15.16 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 115.614 -0.721 . . . . 15.0 112.501 -179.498 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.674 ' HB3' ' HB2' ' A' ' 88' ' ' LEU . . . -149.72 149.0 29.91 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 112.659 0.614 . . . . 15.0 112.659 -178.527 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.85 HG11 ' O ' ' A' ' 77' ' ' THR . 23.1 t -142.29 99.04 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.27 0 CA-C-N 115.304 -0.862 . . . . 15.0 109.441 178.842 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.617 ' ND2' HG22 ' A' ' 81' ' ' THR . 1.6 m-80 65.05 16.67 10.69 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.155 -0.475 . . . . 15.0 109.896 -178.282 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 107.17 6.04 34.36 Favored Glycine 0 C--N 1.336 0.536 0 CA-C-N 115.813 -0.631 . . . . 15.0 113.564 179.48 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.663 ' O ' HG13 ' A' ' 64' ' ' VAL . 4.6 p -93.75 103.71 14.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 117.292 0.546 . . . . 15.0 110.628 179.155 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -57.91 127.69 33.35 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.134 -0.484 . . . . 15.0 111.071 -179.417 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.668 HD13 ' HB3' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -87.69 -15.86 35.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.021 -0.536 . . . . 15.0 111.063 179.962 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -45.24 95.32 0.01 OUTLIER 'General case' 0 N--CA 1.461 0.114 0 CA-C-O 120.871 0.367 . . . . 15.0 111.008 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 103.75 69.35 0.79 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.79 -0.719 . . . . 15.0 112.238 -179.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.706 ' HB1' ' CB ' ' A' ' 73' ' ' GLN . . . -173.03 142.73 1.09 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.901 0.381 . . . . 15.0 111.049 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.429 ' CB ' ' HA ' ' A' ' 26' ' ' VAL . 13.7 p -74.3 -172.5 1.45 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.162 -0.472 . . . . 15.0 111.241 -179.774 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.761 ' CD2' HG23 ' A' ' 22' ' ' VAL . 0.1 OUTLIER -62.19 -59.49 4.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.914 -0.584 . . . . 15.0 110.475 179.99 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.453 ' O ' HG12 ' A' ' 75' ' ' VAL . 6.6 ttmt -52.81 -33.8 50.77 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.871 -0.604 . . . . 15.0 110.623 179.399 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.706 ' CB ' ' HB1' ' A' ' 69' ' ' ALA . 5.2 mt-30 -59.54 -52.93 63.45 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.708 -0.478 . . . . 15.0 109.708 179.313 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.868 ' HB3' HD12 ' A' ' 35' ' ' ILE . . . -67.08 -42.4 84.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.099 -0.501 . . . . 15.0 109.725 178.48 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.887 HG23 HG21 ' A' ' 22' ' ' VAL . 0.5 OUTLIER -44.31 -39.51 1.63 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.221 0 N-CA-C 108.985 -0.746 . . . . 15.0 108.985 178.528 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -67.3 -44.17 79.88 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.751 -1.113 . . . . 15.0 110.314 178.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.85 ' O ' HG11 ' A' ' 61' ' ' VAL . 27.6 p -64.04 -56.15 17.11 Favored 'General case' 0 N--CA 1.462 0.151 0 C-N-CA 121.047 -0.261 . . . . 15.0 111.375 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.588 HD23 HG21 ' A' ' 61' ' ' VAL . 4.6 mt -53.49 -46.94 70.22 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 121.179 0.514 . . . . 15.0 109.958 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 3.3 tmt_? -68.49 -60.27 2.55 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.434 -0.803 . . . . 15.0 110.739 179.53 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 15.2 m-20 -65.96 60.83 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.846 -0.615 . . . . 15.0 112.222 -179.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.617 HG22 ' ND2' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -95.57 -76.08 0.51 Allowed 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.744 -0.465 . . . . 15.0 109.744 178.91 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 112.75 -98.51 0.96 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.634 -0.793 . . . . 15.0 113.58 178.63 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.46 ' O ' ' HB3' ' A' ' 13' ' ' LYS . 0.5 OUTLIER -63.92 -87.92 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 111.682 0.252 . . . . 15.0 111.682 -178.907 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.453 HG12 ' N ' ' A' ' 85' ' ' VAL . 72.0 t -110.06 158.23 10.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.066 0.46 . . . . 15.0 110.925 -179.738 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.908 HG23 ' HB2' ' A' ' 13' ' ' LYS . 3.8 t -97.87 81.92 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.094 -0.503 . . . . 15.0 110.256 179.698 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.452 ' CE1' HD11 ' A' ' 88' ' ' LEU . 1.4 t60 -100.7 82.81 2.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.766 -0.652 . . . . 15.0 109.99 179.585 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.852 ' HB3' HD21 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -103.79 115.97 31.44 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.799 -0.637 . . . . 15.0 112.05 -178.745 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.771 HD12 ' HB2' ' A' ' 8' ' ' GLU . 4.0 mp -92.21 102.13 14.64 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.451 -0.574 . . . . 15.0 109.451 178.576 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.852 HD21 ' HB3' ' A' ' 87' ' ' LEU . 0.1 OUTLIER -105.81 -161.74 0.82 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.487 0.661 . . . . 15.0 112.102 -178.317 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.427 ' HA ' ' HA ' ' A' ' 6' ' ' ILE . 3.5 tt0 -143.98 135.38 25.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 114.879 -1.055 . . . . 15.0 109.621 179.148 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.08 103.56 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.005 0.431 . . . . 15.0 111.087 -179.566 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -63.12 137.59 43.48 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.944 -0.646 . . . . 15.0 112.706 -179.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -86.38 91.67 8.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.794 0.33 . . . . 15.0 110.818 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -72.88 148.08 89.21 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.231 -0.441 . . . . 15.0 110.871 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -52.25 -34.98 61.9 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.596 2.197 . . . . 15.0 112.307 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 70.2 p . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.232 -0.889 . . . . 15.0 110.911 179.972 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo . . . . . 0 N--CA 1.488 1.2 0 CA-C-O 120.788 0.245 . . . . 15.0 111.812 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.19 110.97 4.68 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.218 -0.446 . . . . 15.0 110.859 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -67.42 -165.42 0.11 Allowed 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.403 2.069 . . . . 15.0 112.477 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 87.02 -19.34 30.87 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.781 -0.723 . . . . 15.0 112.328 -179.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -72.3 161.83 30.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.317 0.58 . . . . 15.0 111.216 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.519 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 1.2 mp -97.88 145.78 8.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.177 -0.919 . . . . 15.0 110.624 -179.73 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.879 ' CE1' HD12 ' A' ' 89' ' ' LEU . 3.0 p90 -141.93 141.32 32.96 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.035 0.445 . . . . 15.0 111.206 179.418 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.79 ' HB2' HD12 ' A' ' 88' ' ' LEU . 5.6 pm0 -113.53 141.8 46.71 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.804 -0.635 . . . . 15.0 111.15 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.489 ' N ' ' O ' ' A' ' 87' ' ' LEU . 0.2 OUTLIER -101.41 114.02 39.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.45 -0.796 . . . . 15.0 109.839 179.335 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -105.96 71.16 0.88 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.033 -0.53 . . . . 15.0 111.896 -178.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.489 HD11 ' CB ' ' A' ' 49' ' ' ASP . 5.4 tp -88.65 166.83 13.84 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.155 -0.475 . . . . 15.0 109.949 179.016 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.445 ' CB ' ' HB2' ' A' ' 15' ' ' ASP . . . -96.08 96.88 9.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.028 0.442 . . . . 15.0 111.163 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.768 ' CB ' HG23 ' A' ' 85' ' ' VAL . 0.1 OUTLIER -63.46 -28.43 69.96 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.725 -0.671 . . . . 15.0 111.442 -179.721 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -84.32 -19.06 34.36 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.466 -0.334 . . . . 15.0 111.524 -179.37 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.445 ' HB2' ' CB ' ' A' ' 12' ' ' ALA . 0.3 OUTLIER -92.18 -36.71 13.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.879 0.371 . . . . 15.0 110.462 179.538 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.495 ' HB3' ' HB2' ' A' ' 45' ' ' ALA . 1.1 t30 -165.45 161.23 18.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.006 -0.543 . . . . 15.0 110.74 179.757 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.893 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 0.3 OUTLIER -85.95 -157.5 0.34 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.266 -0.425 . . . . 15.0 110.234 179.675 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 9.8 mt -105.49 -169.69 1.63 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.968 0.413 . . . . 15.0 110.794 179.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.663 ' O ' ' HB ' ' A' ' 41' ' ' ILE . . . -161.13 38.59 0.42 Allowed Glycine 0 N--CA 1.449 -0.459 0 CA-C-N 115.867 -0.606 . . . . 15.0 111.752 -179.831 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.725 HG12 ' O ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -112.69 140.75 30.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 121.02 0.438 . . . . 15.0 111.94 -179.358 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.409 ' HB3' HD11 ' A' ' 41' ' ' ILE . 41.0 t -96.11 106.18 18.32 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 107.837 -1.171 . . . . 15.0 107.837 177.296 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.999 HG21 HG23 ' A' ' 75' ' ' VAL . 31.2 m -93.54 152.5 3.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 113.083 0.771 . . . . 15.0 113.083 -177.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.415 ' OG1' ' HB2' ' A' ' 38' ' ' LYS . 0.3 OUTLIER -149.46 179.27 8.09 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 114.863 -1.062 . . . . 15.0 110.728 -179.962 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.431 ' O ' ' CB ' ' A' ' 71' ' ' HIS . . . 74.22 -120.23 6.56 Favored Glycine 0 C--N 1.33 0.24 0 C-N-CA 120.672 -0.775 . . . . 15.0 112.327 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.537 ' HA3' ' N ' ' A' ' 71' ' ' HIS . . . 67.52 -65.69 0.27 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.848 -0.691 . . . . 15.0 113.631 179.31 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.569 ' O ' HG22 ' A' ' 30' ' ' VAL . 2.0 m -31.22 140.84 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 N-CA-C 112.328 0.492 . . . . 15.0 112.328 -179.17 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 14.2 p-10 -75.47 64.62 1.62 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.944 -0.571 . . . . 15.0 111.035 -179.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.5 m -151.67 -61.52 0.17 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.263 -0.426 . . . . 15.0 111.075 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 91.3 p -76.45 -42.88 42.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.18 -0.464 . . . . 15.0 111.155 -179.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.569 HG22 ' O ' ' A' ' 26' ' ' VAL . 35.3 m -73.78 -176.17 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.274 -0.421 . . . . 15.0 111.275 -179.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.14 -59.96 4.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.118 -0.492 . . . . 15.0 111.078 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 10.5 m80 -143.55 -47.93 0.3 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.306 -0.407 . . . . 15.0 111.149 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -169.44 22.56 0.09 OUTLIER Glycine 0 CA--C 1.519 0.292 0 C-N-CA 120.668 -0.777 . . . . 15.0 112.888 -179.701 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -87.55 154.46 26.02 Favored Glycine 0 N--CA 1.451 -0.354 0 N-CA-C 110.788 -0.925 . . . . 15.0 110.788 178.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.685 HG22 HG13 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -92.5 152.02 3.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 C-N-CA 119.895 -0.722 . . . . 15.0 111.906 -179.242 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.515 ' CZ ' ' HG2' ' A' ' 57' ' ' ARG . 53.8 m-85 -137.3 106.64 6.08 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.835 -1.075 . . . . 15.0 109.892 179.333 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.869 HG22 ' N ' ' A' ' 55' ' ' GLY . 0.6 OUTLIER -57.46 146.0 7.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.977 -0.556 . . . . 15.0 111.144 -179.089 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.485 ' O ' ' HG2' ' A' ' 54' ' ' LYS . 0.6 OUTLIER -80.33 -48.87 12.32 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.947 -0.76 . . . . 15.0 108.947 178.837 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.725 ' O ' HG12 ' A' ' 20' ' ' ILE . . . -172.07 172.6 4.61 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.906 -0.588 . . . . 15.0 110.736 178.811 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.533 ' HA ' HG12 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -96.86 112.93 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 N-CA-C 109.781 -0.451 . . . . 15.0 109.781 179.433 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.663 ' HB ' ' O ' ' A' ' 19' ' ' GLY . 0.3 OUTLIER -78.56 118.49 72.65 Favored Pre-proline 0 C--N 1.328 -0.331 0 N-CA-C 113.021 0.749 . . . . 15.0 113.021 -177.764 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.612 ' HA ' ' CG ' ' A' ' 47' ' ' GLU . 37.2 Cg_endo -64.8 60.63 0.29 Allowed 'Trans proline' 0 C--N 1.356 0.935 0 C-N-CA 123.416 2.744 . . . . 15.0 112.91 179.842 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.527 ' N ' ' HG2' ' A' ' 47' ' ' GLU . 41.1 tt0 -149.87 -46.26 0.13 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.632 -0.258 . . . . 15.0 111.511 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.608 ' HA3' ' HA3' ' A' ' 19' ' ' GLY . . . -87.8 166.91 36.12 Favored Glycine 0 CA--C 1.519 0.314 0 C-N-CA 120.417 -0.897 . . . . 15.0 114.008 -178.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.893 ' HB3' ' O ' ' A' ' 17' ' ' SER . . . -55.29 -15.43 2.45 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.911 0.708 . . . . 15.0 112.911 -179.677 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.429 ' HB1' HG22 ' A' ' 52' ' ' ILE . . . -71.97 -57.4 4.33 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 121.005 -0.278 . . . . 15.0 111.051 -179.418 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.612 ' CG ' ' HA ' ' A' ' 42' ' ' PRO . 2.9 pp20? -57.05 -42.99 81.57 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.035 -0.529 . . . . 15.0 110.378 179.358 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -53.88 -70.47 0.1 Allowed 'General case' 0 CA--C 1.52 -0.194 0 CA-C-N 115.893 -0.594 . . . . 15.0 110.498 -179.623 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.489 ' CB ' HD11 ' A' ' 11' ' ' LEU . 14.4 t0 -58.21 -39.92 80.26 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.349 -0.611 . . . . 15.0 109.349 178.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.76 35.02 26.24 Favored Glycine 0 N--CA 1.447 -0.631 0 CA-C-N 115.384 -0.825 . . . . 15.0 111.595 179.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.488 ' HG3' HD13 ' A' ' 11' ' ' LEU . 0.3 OUTLIER -79.73 -46.5 16.94 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.05 0.452 . . . . 15.0 110.524 -179.431 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.685 ' CG1' HD12 ' A' ' 20' ' ' ILE . 7.0 tp -80.94 149.95 4.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.697 -0.683 . . . . 15.0 109.616 179.371 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.456 ' O ' HG21 ' A' ' 37' ' ' VAL . 80.4 m80 -139.7 156.94 46.52 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 113.14 0.793 . . . . 15.0 113.14 -178.269 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.564 ' HA ' ' CG2' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -45.31 133.28 7.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 113.784 -1.553 . . . . 15.0 112.961 -178.897 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.869 ' N ' HG22 ' A' ' 37' ' ' VAL . . . 49.04 27.25 6.66 Favored Glycine 0 C--N 1.335 0.486 0 CA-C-N 115.766 -0.652 . . . . 15.0 113.784 178.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.801 ' CG ' HD13 ' A' ' 89' ' ' LEU . 1.2 p30 -66.32 133.23 50.11 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 119.485 -0.886 . . . . 15.0 110.077 179.512 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.529 ' HD2' HD21 ' A' ' 59' ' ' LEU . 0.0 OUTLIER -80.76 97.58 7.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 15.0 110.434 -179.845 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.685 HG13 HG22 ' A' ' 35' ' ' ILE . 1.3 m -82.24 112.74 20.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.265 -0.425 . . . . 15.0 110.392 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.529 HD21 ' HD2' ' A' ' 57' ' ' ARG . 3.5 mm? -107.26 -21.62 12.89 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 115.826 -0.625 . . . . 15.0 112.384 -179.041 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.607 ' O ' HD23 ' A' ' 87' ' ' LEU . . . -147.45 150.47 34.67 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.251 0.548 . . . . 15.0 112.365 -178.56 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.745 HG21 HD23 ' A' ' 78' ' ' LEU . 60.4 t -138.92 102.46 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.264 -0.88 . . . . 15.0 109.022 178.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.781 ' ND2' HG22 ' A' ' 81' ' ' THR . 1.8 m-80 65.09 15.62 10.1 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.706 -0.479 . . . . 15.0 109.706 -177.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 105.69 6.46 37.92 Favored Glycine 0 C--N 1.336 0.539 0 CA-C-N 115.785 -0.643 . . . . 15.0 113.349 179.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.667 ' O ' HG13 ' A' ' 64' ' ' VAL . 6.1 p -93.76 105.69 17.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 121.124 0.488 . . . . 15.0 110.843 179.398 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -58.78 115.45 3.09 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.148 -0.478 . . . . 15.0 110.726 -179.748 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.619 HD21 ' HA ' ' A' ' 74' ' ' ALA . 3.1 mt -89.45 -16.44 30.86 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.718 -0.674 . . . . 15.0 111.339 -179.619 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -45.79 105.44 0.06 Allowed 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.878 0.371 . . . . 15.0 111.017 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.96 66.15 0.57 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.814 -0.707 . . . . 15.0 112.433 -179.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.555 ' HB1' ' CG ' ' A' ' 73' ' ' GLN . . . -172.9 172.71 3.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.807 0.337 . . . . 15.0 110.851 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.481 HG22 ' HA ' ' A' ' 26' ' ' VAL . 19.3 p -93.16 -175.83 3.97 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.961 0.41 . . . . 15.0 111.091 -179.768 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.771 ' CD2' HG23 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -62.42 -60.98 2.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.969 -0.559 . . . . 15.0 110.428 -179.994 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 7.3 ttmt -52.49 -33.68 45.9 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.773 -0.649 . . . . 15.0 110.497 179.455 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.555 ' CG ' ' HB1' ' A' ' 69' ' ' ALA . 0.5 OUTLIER -59.4 -49.01 79.46 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.567 -0.531 . . . . 15.0 109.567 179.194 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.619 ' HA ' HD21 ' A' ' 66' ' ' LEU . . . -66.96 -48.57 68.16 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 116.009 -0.541 . . . . 15.0 109.658 178.392 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.999 HG23 HG21 ' A' ' 22' ' ' VAL . 0.5 OUTLIER -40.39 -42.1 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.212 0 CA-C-N 115.476 -0.784 . . . . 15.0 109.444 178.48 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.404 ' N ' HG12 ' A' ' 75' ' ' VAL . 21.9 mt-10 -67.4 -46.07 74.33 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 114.843 -1.071 . . . . 15.0 110.45 178.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.592 ' O ' HG11 ' A' ' 61' ' ' VAL . 2.0 p -64.64 -53.08 53.18 Favored 'General case' 0 C--O 1.231 0.099 0 C-N-CA 120.918 -0.313 . . . . 15.0 111.378 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.745 HD23 HG21 ' A' ' 61' ' ' VAL . 4.4 mt -53.66 -48.38 69.48 Favored 'General case' 0 CA--C 1.52 -0.18 0 CA-C-O 121.135 0.493 . . . . 15.0 110.15 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.415 ' O ' ' N ' ' A' ' 81' ' ' THR . 3.0 ttm-85 -68.34 -56.65 7.81 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.558 -0.747 . . . . 15.0 110.493 179.511 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -66.0 62.51 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.017 -0.538 . . . . 15.0 111.752 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.781 HG22 ' ND2' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -95.55 -71.94 0.65 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.783 0.325 . . . . 15.0 110.438 179.426 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 122.17 -103.82 0.87 Allowed Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.753 -0.737 . . . . 15.0 113.157 179.272 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.58 -83.66 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 111.866 0.321 . . . . 15.0 111.866 -179.089 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.424 HG12 ' N ' ' A' ' 85' ' ' VAL . 67.3 t -109.47 157.59 9.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.105 0.478 . . . . 15.0 111.082 -179.416 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.768 HG23 ' CB ' ' A' ' 13' ' ' LYS . 10.6 t -97.81 81.86 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.011 -0.54 . . . . 15.0 110.559 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 59.6 t60 -104.96 86.54 2.47 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.747 -0.66 . . . . 15.0 110.892 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.658 HD22 HD21 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -103.81 129.75 51.28 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.996 -0.547 . . . . 15.0 111.537 -179.601 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.79 HD12 ' HB2' ' A' ' 8' ' ' GLU . 5.2 mp -102.33 101.3 11.54 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.928 -0.397 . . . . 15.0 109.928 178.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.879 HD12 ' CE1' ' A' ' 7' ' ' PHE . 0.4 OUTLIER -105.84 -161.94 0.83 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.3 0.572 . . . . 15.0 111.939 -178.699 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.519 ' HA ' ' HA ' ' A' ' 6' ' ' ILE . 26.0 tt0 -146.28 134.91 22.18 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.159 -0.928 . . . . 15.0 109.951 179.238 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 4.7 tptt -46.83 111.86 0.44 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.311 -0.404 . . . . 15.0 111.096 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -61.91 151.74 44.08 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.785 -0.721 . . . . 15.0 112.614 -179.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -76.33 119.44 20.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.859 0.361 . . . . 15.0 110.973 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -85.64 168.46 19.73 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.099 -0.5 . . . . 15.0 110.843 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_exo -51.12 -33.63 44.46 Favored 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 122.592 2.195 . . . . 15.0 112.236 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.22 -0.895 . . . . 15.0 110.9 179.929 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_endo . . . . . 0 N--CA 1.488 1.155 0 CA-C-O 120.836 0.265 . . . . 15.0 111.831 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 11.3 mttt -145.15 127.99 8.27 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.113 -0.494 . . . . 15.0 110.687 179.946 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_exo -56.23 -165.59 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.342 2.028 . . . . 15.0 112.505 -179.822 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 87.32 -20.3 27.08 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.8 -0.714 . . . . 15.0 112.253 -179.625 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -72.55 158.86 34.89 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.381 0.61 . . . . 15.0 111.273 -179.979 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.507 HG13 ' HB2' ' A' ' 90' ' ' GLU . 1.3 mp -104.33 144.11 14.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.051 -0.977 . . . . 15.0 110.62 -179.714 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.63 ' CE1' HD12 ' A' ' 89' ' ' LEU . 4.9 p90 -140.65 165.51 27.28 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.594 -0.275 . . . . 15.0 110.544 178.912 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.721 ' CB ' HD12 ' A' ' 88' ' ' LEU . 4.9 pt-20 -130.07 142.62 50.59 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.381 0.61 . . . . 15.0 111.417 -179.546 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.582 ' CG1' HD11 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -101.44 114.97 42.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.073 -0.967 . . . . 15.0 109.718 179.143 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -105.89 71.46 0.9 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.118 -0.492 . . . . 15.0 111.874 -178.976 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.662 HD13 ' HG3' ' A' ' 51' ' ' ARG . 6.2 tp -88.05 167.99 13.2 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.942 -0.572 . . . . 15.0 110.007 179.121 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -94.64 98.84 11.09 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.98 0.419 . . . . 15.0 110.867 179.88 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.601 ' CA ' HG23 ' A' ' 85' ' ' VAL . 0.2 OUTLIER -54.05 -27.2 30.85 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.899 -0.592 . . . . 15.0 111.13 -179.827 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.433 ' O ' ' CB ' ' A' ' 15' ' ' ASP . 2.9 m-80 -84.64 154.19 22.69 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.357 -0.383 . . . . 15.0 110.551 179.692 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.433 ' CB ' ' O ' ' A' ' 14' ' ' ASN . 5.9 t70 82.82 -48.1 0.16 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.219 -0.446 . . . . 15.0 110.884 -179.356 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -155.11 147.46 23.94 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.402 -0.363 . . . . 15.0 110.582 179.768 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.612 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 0.4 OUTLIER -86.17 -169.17 2.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.054 0.454 . . . . 15.0 111.311 -179.642 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.423 ' O ' ' HA3' ' A' ' 44' ' ' GLY . 3.9 mm? -62.79 -163.62 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.745 -0.661 . . . . 15.0 110.627 179.581 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.742 ' O ' ' HB ' ' A' ' 41' ' ' ILE . . . -160.56 21.44 0.24 Allowed Glycine 0 C--O 1.226 -0.378 0 C-N-CA 120.4 -0.905 . . . . 15.0 113.395 -179.495 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.937 HG21 HG21 ' A' ' 52' ' ' ILE . 2.9 pt -113.13 139.16 39.82 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.382 0 CA-C-N 117.394 0.597 . . . . 15.0 111.709 178.738 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.514 ' O ' ' HB3' ' A' ' 38' ' ' LYS . 6.2 t -84.98 116.09 23.18 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 105.167 -2.16 . . . . 15.0 105.167 174.841 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 1.016 HG21 HG23 ' A' ' 75' ' ' VAL . 35.6 m -93.74 152.35 3.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 113.58 0.955 . . . . 15.0 113.58 -175.521 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.57 -179.18 6.89 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 114.782 -1.099 . . . . 15.0 110.564 179.642 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.591 ' O ' HG22 ' A' ' 26' ' ' VAL . . . 71.4 -121.03 8.68 Favored Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.814 -0.708 . . . . 15.0 112.613 179.658 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.52 ' HA3' ' N ' ' A' ' 71' ' ' HIS . . . 66.82 -65.71 0.19 Allowed Glycine 0 C--N 1.331 0.251 0 C-N-CA 121.028 -0.606 . . . . 15.0 113.576 179.43 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.643 ' O ' HG22 ' A' ' 30' ' ' VAL . 0.0 OUTLIER -32.83 137.78 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 N-CA-C 112.375 0.509 . . . . 15.0 112.375 -179.208 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.406 ' CB ' ' O ' ' A' ' 32' ' ' HIS . 1.6 m-20 -76.58 59.64 1.53 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.826 -0.625 . . . . 15.0 111.103 -179.856 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -151.74 -48.48 0.11 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.373 -0.376 . . . . 15.0 110.884 179.972 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 22.0 t -87.12 -31.84 20.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.203 -0.453 . . . . 15.0 110.962 -179.929 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.643 HG22 ' O ' ' A' ' 26' ' ' VAL . 33.4 m -87.9 -175.62 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.459 . . . . 15.0 111.223 -179.965 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 3.4 ttt85 -58.11 -60.81 3.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.23 -0.441 . . . . 15.0 111.102 -179.86 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . 0.406 ' O ' ' CB ' ' A' ' 27' ' ' ASN . 22.9 m80 -136.3 -58.45 0.74 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.371 -0.377 . . . . 15.0 111.163 -179.87 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -166.72 26.11 0.15 Allowed Glycine 0 N--CA 1.453 -0.223 0 C-N-CA 120.806 -0.711 . . . . 15.0 112.599 -179.723 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -90.69 153.25 22.41 Favored Glycine 0 N--CA 1.449 -0.488 0 N-CA-C 110.828 -0.909 . . . . 15.0 110.828 179.024 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.833 HG22 HG22 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -90.72 153.6 3.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 C-N-CA 120.028 -0.669 . . . . 15.0 111.648 -179.358 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.413 ' CE2' ' HG2' ' A' ' 57' ' ' ARG . 47.5 m-85 -134.43 108.39 8.12 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 114.98 -1.009 . . . . 15.0 109.534 179.4 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.784 HG22 ' N ' ' A' ' 55' ' ' GLY . 0.6 OUTLIER -54.94 148.45 2.89 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.45 0 CA-C-O 121.105 0.479 . . . . 15.0 110.731 -178.835 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.514 ' HB3' ' O ' ' A' ' 21' ' ' SER . 0.1 OUTLIER -86.17 -45.66 11.13 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 108.37 -0.974 . . . . 15.0 108.37 178.167 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.624 ' O ' ' HB ' ' A' ' 20' ' ' ILE . . . -173.76 171.37 3.78 Favored 'General case' 0 C--O 1.226 -0.157 0 C-N-CA 120.512 -0.475 . . . . 15.0 112.214 178.762 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.754 ' HA ' HG22 ' A' ' 20' ' ' ILE . 0.1 OUTLIER -97.32 81.57 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.291 0.567 . . . . 15.0 109.75 178.889 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.742 ' HB ' ' O ' ' A' ' 19' ' ' GLY . 27.2 mm -47.95 120.79 8.19 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 115.263 -0.88 . . . . 15.0 113.039 -178.351 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.602 ' HA ' ' HG2' ' A' ' 47' ' ' GLU . 40.8 Cg_endo -66.16 60.94 0.48 Allowed 'Trans proline' 0 C--N 1.354 0.831 0 C-N-CA 123.336 2.691 . . . . 15.0 112.762 179.682 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.534 ' N ' ' HG2' ' A' ' 47' ' ' GLU . 4.6 mt-30 -158.85 -41.08 0.06 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.646 0.26 . . . . 15.0 111.63 179.878 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.502 ' HA3' ' CA ' ' A' ' 19' ' ' GLY . . . -87.29 163.0 33.95 Favored Glycine 0 CA--C 1.519 0.318 0 C-N-CA 120.629 -0.796 . . . . 15.0 113.652 -179.151 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.612 ' HB3' ' O ' ' A' ' 17' ' ' SER . . . -53.28 -15.21 0.88 Allowed 'General case' 0 N--CA 1.462 0.166 0 N-CA-C 112.708 0.633 . . . . 15.0 112.708 -179.721 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.99 -59.35 2.79 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.651 0.262 . . . . 15.0 110.946 -179.554 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.602 ' HG2' ' HA ' ' A' ' 42' ' ' PRO . 2.6 pp20? -56.97 -42.82 80.88 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.109 -0.496 . . . . 15.0 110.824 179.557 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.3 m -53.69 -70.77 0.09 Allowed 'General case' 0 CA--C 1.519 -0.22 0 CA-C-N 115.965 -0.561 . . . . 15.0 110.597 -179.333 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.559 ' CB ' HD11 ' A' ' 11' ' ' LEU . 1.9 t0 -61.19 -39.43 90.17 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.472 -0.566 . . . . 15.0 109.472 178.981 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.92 38.66 15.15 Favored Glycine 0 N--CA 1.447 -0.571 0 CA-C-N 115.438 -0.801 . . . . 15.0 111.638 179.802 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.662 ' HG3' HD13 ' A' ' 11' ' ' LEU . 21.7 mmt-85 -79.71 -33.71 40.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.872 0.368 . . . . 15.0 111.106 -179.18 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.937 HG21 HG21 ' A' ' 20' ' ' ILE . 21.2 mm -91.21 159.12 2.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.091 -0.504 . . . . 15.0 111.181 -179.737 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.48 ' N ' ' CG2' ' A' ' 52' ' ' ILE . 29.2 m80 -141.69 138.5 32.49 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-N 115.69 -0.686 . . . . 15.0 110.663 179.394 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.532 ' HA ' ' CG2' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -35.59 131.11 0.51 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.479 -1.237 . . . . 15.0 113.039 -178.373 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.784 ' N ' HG22 ' A' ' 37' ' ' VAL . . . 56.28 29.08 55.99 Favored Glycine 0 C--N 1.332 0.353 0 CA-C-N 115.665 -0.698 . . . . 15.0 113.629 179.176 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.447 ' OD2' ' N ' ' A' ' 53' ' ' HIS . 0.4 OUTLIER -65.34 130.48 43.49 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.941 -0.304 . . . . 15.0 110.597 179.346 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.413 ' HG2' ' CE2' ' A' ' 36' ' ' TYR . 2.2 mtt180 -80.63 90.04 5.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.436 -0.347 . . . . 15.0 110.672 179.934 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.833 HG22 HG22 ' A' ' 35' ' ' ILE . 1.4 m -79.37 116.82 23.98 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 CA-C-O 121.017 0.437 . . . . 15.0 110.613 -179.875 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 29.1 mt -107.04 -15.09 14.77 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.785 -0.643 . . . . 15.0 112.559 -178.946 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.888 ' HB3' ' HB2' ' A' ' 88' ' ' LEU . . . -149.11 148.49 29.74 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 112.595 0.591 . . . . 15.0 112.595 -178.8 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.762 HG21 ' OG1' ' A' ' 77' ' ' THR . 20.8 t -139.18 100.5 1.42 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.251 0 CA-C-N 115.115 -0.948 . . . . 15.0 109.115 178.795 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.819 ' ND2' HG22 ' A' ' 81' ' ' THR . 1.7 m-80 65.03 16.08 10.36 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.76 -0.459 . . . . 15.0 109.76 -178.096 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 107.21 5.24 35.05 Favored Glycine 0 C--N 1.336 0.566 0 CA-C-N 115.925 -0.58 . . . . 15.0 113.558 179.666 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.66 ' O ' HG13 ' A' ' 64' ' ' VAL . 5.7 p -93.84 106.34 17.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 117.275 0.538 . . . . 15.0 110.988 179.417 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -56.59 136.33 54.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.201 -0.454 . . . . 15.0 110.914 -179.808 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.516 HD11 ' HB2' ' A' ' 74' ' ' ALA . 0.6 OUTLIER -95.55 -20.16 19.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.06 -0.518 . . . . 15.0 111.065 -179.964 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -46.53 99.96 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.876 0.369 . . . . 15.0 111.082 179.984 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 104.88 66.4 0.69 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.767 -0.73 . . . . 15.0 112.207 -179.799 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.564 ' HB1' ' HB3' ' A' ' 73' ' ' GLN . . . -173.09 162.02 4.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.841 0.353 . . . . 15.0 111.117 -179.771 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.465 ' HB ' HG13 ' A' ' 26' ' ' VAL . 15.6 p -93.22 -173.75 3.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.002 0.429 . . . . 15.0 111.019 -179.873 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.684 ' CD2' HG23 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -62.59 -58.79 6.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.907 -0.588 . . . . 15.0 110.329 179.841 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.422 ' HA ' ' HB ' ' A' ' 75' ' ' VAL . 28.4 ttmt -52.56 -33.9 47.82 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.017 -0.538 . . . . 15.0 110.534 179.117 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.564 ' HB3' ' HB1' ' A' ' 69' ' ' ALA . 1.1 tt0 -59.45 -50.04 75.45 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.5 -0.555 . . . . 15.0 109.5 179.32 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.516 ' HB2' HD11 ' A' ' 66' ' ' LEU . . . -66.86 -44.48 80.88 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 109.531 -0.544 . . . . 15.0 109.531 178.313 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 1.016 HG23 HG21 ' A' ' 22' ' ' VAL . 0.5 OUTLIER -43.57 -39.4 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.363 0 N-CA-C 108.732 -0.84 . . . . 15.0 108.732 178.099 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.518 ' O ' ' HB2' ' A' ' 80' ' ' ASN . 1.5 mm-40 -67.06 -46.32 74.68 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.573 -1.194 . . . . 15.0 110.381 178.577 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.762 ' OG1' HG21 ' A' ' 61' ' ' VAL . 31.4 p -64.09 -53.24 52.77 Favored 'General case' 0 N--CA 1.462 0.161 0 C-N-CA 120.951 -0.3 . . . . 15.0 111.575 -179.969 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.6 HD22 HD11 ' A' ' 87' ' ' LEU . 6.0 mt -53.49 -48.15 69.19 Favored 'General case' 0 CA--C 1.52 -0.18 0 CA-C-O 121.261 0.553 . . . . 15.0 109.866 179.929 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.411 ' HB2' ' O ' ' A' ' 75' ' ' VAL . 18.1 ttp180 -68.64 -60.77 2.17 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.318 -0.855 . . . . 15.0 110.833 179.505 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.518 ' HB2' ' O ' ' A' ' 76' ' ' GLU . 15.1 m-80 -66.11 58.23 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 112.476 0.547 . . . . 15.0 112.476 -179.677 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.819 HG22 ' ND2' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -95.67 -69.28 0.76 Allowed 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.809 -0.441 . . . . 15.0 109.809 178.804 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 118.37 -104.42 1.12 Allowed Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.817 -0.706 . . . . 15.0 113.386 178.891 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.452 ' O ' ' HB3' ' A' ' 13' ' ' LYS . 0.4 OUTLIER -64.93 -80.95 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 112.525 0.565 . . . . 15.0 112.525 -178.724 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.426 HG12 ' N ' ' A' ' 85' ' ' VAL . 55.1 t -110.07 158.11 10.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.113 0.482 . . . . 15.0 111.298 -178.89 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.671 HG12 ' O ' ' A' ' 85' ' ' VAL . 8.0 t -97.99 81.15 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.986 -0.552 . . . . 15.0 110.426 179.867 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.473 ' NE2' HD11 ' A' ' 88' ' ' LEU . 78.9 t60 -100.42 84.66 2.82 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.754 -0.657 . . . . 15.0 110.362 179.79 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.792 ' HB3' HD21 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -103.52 119.44 38.9 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.949 -0.568 . . . . 15.0 111.986 -179.008 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.888 ' HB2' ' HB3' ' A' ' 60' ' ' ALA . 4.3 mp -92.87 103.23 15.58 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.52 -0.548 . . . . 15.0 109.52 178.673 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.792 HD21 ' HB3' ' A' ' 87' ' ' LEU . 0.2 OUTLIER -105.48 -163.32 0.94 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.273 0.559 . . . . 15.0 111.635 -178.69 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.507 ' HB2' HG13 ' A' ' 6' ' ' ILE . 8.3 tt0 -145.27 134.58 22.96 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.385 -0.825 . . . . 15.0 110.354 179.476 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 4.0 tptt -48.04 104.04 0.05 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.106 -0.497 . . . . 15.0 111.009 -179.92 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -62.06 162.21 27.72 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.919 -0.658 . . . . 15.0 112.68 -179.647 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -84.93 107.62 17.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.807 0.337 . . . . 15.0 110.85 179.975 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.2 m -61.7 130.62 92.39 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.22 -0.445 . . . . 15.0 110.851 179.977 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -53.1 -31.09 52.78 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.479 2.119 . . . . 15.0 112.259 -179.973 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.179 -0.915 . . . . 15.0 110.878 -179.969 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo . . . . . 0 N--CA 1.487 1.108 0 CA-C-O 120.835 0.264 . . . . 15.0 111.668 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.59 154.45 38.05 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.152 -0.476 . . . . 15.0 110.737 179.974 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -61.99 -164.57 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.488 2.126 . . . . 15.0 112.266 179.958 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 89.21 -22.43 23.13 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.676 -0.773 . . . . 15.0 112.202 -179.578 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -72.33 145.25 47.93 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-O 121.24 0.543 . . . . 15.0 110.849 179.763 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.548 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 1.4 mp -104.53 141.42 20.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.425 -0.807 . . . . 15.0 111.375 -179.379 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.826 ' CE1' HD12 ' A' ' 89' ' ' LEU . 3.6 p90 -140.62 165.67 26.84 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.123 -0.49 . . . . 15.0 110.112 178.514 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.72 ' HB3' HD12 ' A' ' 88' ' ' LEU . 4.8 pt-20 -130.13 144.38 51.32 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.427 0.632 . . . . 15.0 111.842 -178.93 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.516 ' CG2' ' HB3' ' A' ' 51' ' ' ARG . 0.2 OUTLIER -101.42 115.25 42.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.034 -0.984 . . . . 15.0 109.354 178.75 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -105.92 72.72 0.96 Allowed 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 112.4 0.518 . . . . 15.0 112.4 -178.523 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.673 HD13 ' HG3' ' A' ' 51' ' ' ARG . 5.2 tp -88.06 162.56 16.72 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.465 -0.569 . . . . 15.0 109.465 178.467 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -96.52 93.31 6.72 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.947 0.403 . . . . 15.0 111.343 -179.868 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.627 ' CB ' HG23 ' A' ' 85' ' ' VAL . 0.0 OUTLIER -58.15 -28.8 65.04 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.957 -0.565 . . . . 15.0 110.714 179.644 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -84.27 67.77 9.92 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.032 -0.531 . . . . 15.0 110.83 179.932 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 171.18 -39.88 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.076 -0.511 . . . . 15.0 110.414 179.912 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.479 ' HB3' ' HB2' ' A' ' 45' ' ' ALA . 2.4 t-20 -165.42 149.31 8.37 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.788 -0.642 . . . . 15.0 110.487 179.802 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.716 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 0.5 OUTLIER -85.94 -168.4 2.22 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.356 -0.384 . . . . 15.0 110.518 179.908 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.641 ' N ' HD22 ' A' ' 18' ' ' LEU . 2.1 mm? -89.14 -175.57 4.84 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 116.171 -0.468 . . . . 15.0 110.714 179.432 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.775 ' HA3' ' HA3' ' A' ' 44' ' ' GLY . . . -160.88 45.61 0.4 Allowed Glycine 0 N--CA 1.449 -0.499 0 N-CA-C 111.481 -0.648 . . . . 15.0 111.481 -179.771 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.663 HG12 ' O ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -112.53 139.19 38.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 120.843 0.354 . . . . 15.0 111.4 -179.326 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.4 ' H ' HD13 ' A' ' 41' ' ' ILE . 8.1 t -91.78 102.64 15.25 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 107.999 -1.111 . . . . 15.0 107.999 177.723 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.961 HG21 HG23 ' A' ' 75' ' ' VAL . 35.5 m -93.8 155.27 3.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 113.033 0.753 . . . . 15.0 113.033 -176.995 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.22 -176.39 5.35 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.174 -0.921 . . . . 15.0 110.92 -179.69 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.474 ' O ' ' HB3' ' A' ' 71' ' ' HIS . . . 68.73 -119.46 9.99 Favored Glycine 0 C--N 1.333 0.389 0 C-N-CA 120.951 -0.642 . . . . 15.0 112.611 179.834 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.572 ' HA2' ' HA ' ' A' ' 35' ' ' ILE . . . 68.6 -66.53 0.42 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.823 -0.703 . . . . 15.0 113.612 179.468 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.448 ' O ' HG22 ' A' ' 30' ' ' VAL . 1.3 m -29.38 141.82 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 N-CA-C 112.087 0.403 . . . . 15.0 112.087 -179.262 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -75.45 61.59 1.28 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.122 -0.49 . . . . 15.0 111.074 -179.602 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.6 m -151.73 -51.86 0.12 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.26 -0.427 . . . . 15.0 111.11 179.942 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -85.36 -44.39 12.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.446 . . . . 15.0 111.204 -179.793 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.539 HG11 ' O ' ' A' ' 34' ' ' GLY . 17.5 m -70.33 -173.77 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.333 -0.394 . . . . 15.0 111.258 -179.875 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -57.98 -51.73 68.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 15.0 111.073 -179.892 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 19.6 p-80 -153.31 -46.88 0.09 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.343 -0.389 . . . . 15.0 111.058 -179.865 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -167.44 19.24 0.09 OUTLIER Glycine 0 CA--C 1.519 0.291 0 C-N-CA 120.739 -0.743 . . . . 15.0 112.881 -179.767 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.539 ' O ' HG11 ' A' ' 30' ' ' VAL . . . -90.12 152.3 22.13 Favored Glycine 0 N--CA 1.449 -0.468 0 N-CA-C 110.249 -1.14 . . . . 15.0 110.249 178.493 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.919 ' CG2' HG22 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -97.58 147.38 6.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 117.893 0.847 . . . . 15.0 111.658 -179.263 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.509 ' N ' HD13 ' A' ' 35' ' ' ILE . 2.9 m-85 -130.96 113.59 14.19 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.563 -0.744 . . . . 15.0 109.755 -179.313 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.748 HG22 ' N ' ' A' ' 55' ' ' GLY . 0.8 OUTLIER -55.16 161.16 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-O 121.308 0.575 . . . . 15.0 111.238 -179.216 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.531 ' O ' ' HG2' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -91.6 -46.21 8.07 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.456 -0.942 . . . . 15.0 108.456 178.388 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.663 ' O ' HG12 ' A' ' 20' ' ' ILE . . . -172.27 173.71 4.14 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 115.302 -0.863 . . . . 15.0 110.193 178.772 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.61 ' HA ' HG12 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -96.81 108.75 21.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 109.472 -0.566 . . . . 15.0 109.472 179.268 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.75 ' HB ' ' O ' ' A' ' 19' ' ' GLY . 0.7 OUTLIER -78.28 116.33 58.16 Favored Pre-proline 0 C--N 1.328 -0.369 0 N-CA-C 113.482 0.919 . . . . 15.0 113.482 -177.245 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.618 ' HA ' ' CG ' ' A' ' 47' ' ' GLU . 36.0 Cg_exo -61.78 60.02 0.12 Allowed 'Trans proline' 0 C--N 1.358 1.045 0 C-N-CA 123.707 2.938 . . . . 15.0 113.271 179.821 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.533 ' N ' ' HG2' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -147.44 -46.97 0.17 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.649 0.261 . . . . 15.0 111.484 179.769 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.775 ' HA3' ' HA3' ' A' ' 19' ' ' GLY . . . -87.87 169.06 38.18 Favored Glycine 0 C--N 1.331 0.264 0 C-N-CA 120.386 -0.911 . . . . 15.0 114.007 -179.124 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.716 ' HB3' ' O ' ' A' ' 17' ' ' SER . . . -58.1 -14.88 7.64 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.023 -0.588 . . . . 15.0 112.499 -179.765 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.499 ' HB1' HG22 ' A' ' 52' ' ' ILE . . . -72.22 -56.26 5.85 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.587 0.232 . . . . 15.0 110.996 -179.656 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.618 ' CG ' ' HA ' ' A' ' 42' ' ' PRO . 2.9 pp20? -57.41 -42.91 83.19 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.222 -0.445 . . . . 15.0 110.309 179.256 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -53.71 -71.12 0.08 Allowed 'General case' 0 CA--C 1.519 -0.221 0 CA-C-N 115.801 -0.636 . . . . 15.0 110.488 -179.457 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.584 ' HB2' HD11 ' A' ' 11' ' ' LEU . 0.2 OUTLIER -58.34 -40.07 81.18 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.286 -0.635 . . . . 15.0 109.286 178.826 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.83 37.79 18.27 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 115.359 -0.837 . . . . 15.0 111.756 179.415 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.673 ' HG3' HD13 ' A' ' 11' ' ' LEU . 2.8 mmp_? -79.85 -48.09 14.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.861 0.362 . . . . 15.0 110.775 -179.447 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.556 ' CG1' HD12 ' A' ' 20' ' ' ILE . 10.5 tp -81.04 155.7 4.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.104 -0.498 . . . . 15.0 110.391 179.62 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.525 ' O ' ' HB2' ' A' ' 56' ' ' ASP . 53.1 m80 -142.33 161.49 37.91 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-O 121.694 0.759 . . . . 15.0 112.345 -179.032 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.531 ' HG2' ' O ' ' A' ' 38' ' ' LYS . 0.8 OUTLIER -44.27 133.33 5.47 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.445 -1.252 . . . . 15.0 112.561 -178.707 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.748 ' N ' HG22 ' A' ' 37' ' ' VAL . . . 49.59 36.62 25.05 Favored Glycine 0 C--N 1.334 0.441 0 C-N-CA 121.009 -0.615 . . . . 15.0 113.101 179.45 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.525 ' HB2' ' O ' ' A' ' 53' ' ' HIS . 1.4 t0 -65.46 125.11 24.12 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.816 -0.353 . . . . 15.0 110.261 179.539 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.428 ' NE ' ' HG2' ' A' ' 90' ' ' GLU . 1.3 mtt180 -83.15 81.69 8.58 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.321 -0.4 . . . . 15.0 110.05 179.614 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.924 HG12 HD22 ' A' ' 89' ' ' LEU . 1.1 m -79.23 119.77 29.16 Favored 'Isoleucine or valine' 0 C--O 1.24 0.556 0 CA-C-O 121.276 0.56 . . . . 15.0 110.747 -179.502 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -107.64 -13.63 15.0 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 115.236 -0.893 . . . . 15.0 112.516 -179.091 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.485 ' O ' HD23 ' A' ' 87' ' ' LEU . . . -149.63 151.25 33.45 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 112.82 0.674 . . . . 15.0 112.82 -178.543 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.856 HG11 ' O ' ' A' ' 77' ' ' THR . 20.8 t -140.7 100.76 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.171 -0.922 . . . . 15.0 109.198 178.71 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.627 ' OD1' HG22 ' A' ' 81' ' ' THR . 12.1 m120 64.87 15.29 9.8 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.779 -0.452 . . . . 15.0 109.779 -177.968 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 107.19 6.64 33.77 Favored Glycine 0 C--N 1.336 0.561 0 CA-C-N 115.926 -0.579 . . . . 15.0 113.476 179.602 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.674 ' O ' HG13 ' A' ' 64' ' ' VAL . 5.7 p -93.76 104.08 15.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 117.273 0.537 . . . . 15.0 110.588 179.206 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -56.07 134.16 52.44 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.099 -0.5 . . . . 15.0 111.318 -179.336 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.513 HD21 ' HA ' ' A' ' 74' ' ' ALA . 0.1 OUTLIER -97.78 -21.23 17.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.881 -0.6 . . . . 15.0 110.81 179.887 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -44.35 99.27 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 116.339 -0.392 . . . . 15.0 111.219 179.988 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.49 64.74 0.57 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.798 -0.715 . . . . 15.0 112.328 -179.774 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.456 ' HB1' ' CB ' ' A' ' 73' ' ' GLN . . . -173.03 169.03 4.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.89 0.376 . . . . 15.0 111.185 -179.774 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.443 ' HA ' ' N ' ' A' ' 26' ' ' VAL . 5.7 p -93.28 -171.7 2.73 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.184 -0.462 . . . . 15.0 111.27 -179.855 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.776 ' CD2' HG23 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -65.69 -59.61 3.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.737 -0.665 . . . . 15.0 110.866 -179.859 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.439 ' N ' ' CG ' ' A' ' 71' ' ' HIS . 16.7 ttmt -52.4 -32.27 38.06 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.804 -0.634 . . . . 15.0 110.647 179.952 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.456 ' CB ' ' HB1' ' A' ' 69' ' ' ALA . 8.4 mt-30 -59.23 -49.85 76.26 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.778 -0.453 . . . . 15.0 109.778 179.432 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.655 ' CB ' HG21 ' A' ' 35' ' ' ILE . . . -67.39 -46.42 73.33 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 109.615 -0.513 . . . . 15.0 109.615 178.302 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.961 HG23 HG21 ' A' ' 22' ' ' VAL . 0.5 OUTLIER -40.97 -40.3 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.283 0 N-CA-C 108.97 -0.752 . . . . 15.0 108.97 178.324 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.459 ' O ' ' HB2' ' A' ' 80' ' ' ASN . 46.9 mt-10 -67.36 -47.48 70.29 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 114.666 -1.152 . . . . 15.0 110.541 178.659 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.856 ' O ' HG11 ' A' ' 61' ' ' VAL . 67.4 p -64.2 -52.45 58.82 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 121.045 -0.262 . . . . 15.0 111.511 179.974 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.789 HD21 HG21 ' A' ' 58' ' ' VAL . 5.0 mt -53.4 -47.68 69.35 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-O 121.193 0.521 . . . . 15.0 109.761 179.959 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.414 ' HB2' ' O ' ' A' ' 75' ' ' VAL . 5.2 ttm180 -68.62 -62.37 1.42 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.375 -0.829 . . . . 15.0 110.42 179.112 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.459 ' HB2' ' O ' ' A' ' 76' ' ' GLU . 15.8 m-80 -66.01 62.35 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.02 -0.537 . . . . 15.0 111.78 179.766 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.627 HG22 ' OD1' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -88.11 -70.4 0.64 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.865 0.364 . . . . 15.0 110.213 179.442 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 121.99 -107.85 1.23 Allowed Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 121.047 -0.597 . . . . 15.0 112.686 179.54 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.497 ' O ' ' HB3' ' A' ' 13' ' ' LYS . 0.4 OUTLIER -65.0 -82.99 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.773 0.32 . . . . 15.0 111.664 -179.567 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.469 HG12 ' N ' ' A' ' 85' ' ' VAL . 63.1 t -110.2 160.61 9.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.327 -0.397 . . . . 15.0 110.436 179.999 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.627 HG23 ' CB ' ' A' ' 13' ' ' LYS . 19.9 t -98.01 80.89 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.127 0.489 . . . . 15.0 110.503 179.83 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 7.1 t60 -100.45 82.05 2.43 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 115.762 -0.654 . . . . 15.0 110.241 179.832 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.539 HD11 ' HA ' ' A' ' 78' ' ' LEU . 0.1 OUTLIER -102.0 126.26 48.89 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.777 -0.647 . . . . 15.0 111.909 -178.961 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.72 HD12 ' HB3' ' A' ' 8' ' ' GLU . 0.2 OUTLIER -102.3 103.44 13.91 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.648 -0.501 . . . . 15.0 109.648 178.813 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.924 HD22 HG12 ' A' ' 58' ' ' VAL . 0.1 OUTLIER -105.76 -163.82 0.97 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.366 0.603 . . . . 15.0 111.782 -178.955 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.548 ' HA ' ' HA ' ' A' ' 6' ' ' ILE . 3.6 tt0 -138.11 134.2 34.35 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.052 -0.976 . . . . 15.0 109.676 178.996 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.413 ' HD2' ' HA ' ' A' ' 91' ' ' LYS . 0.0 OUTLIER -46.67 97.99 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.316 -0.402 . . . . 15.0 111.414 -179.356 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -66.49 -161.8 1.15 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.944 -0.646 . . . . 15.0 112.579 179.988 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -76.3 100.64 5.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.783 0.325 . . . . 15.0 110.819 179.994 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 79.2 p -90.04 153.74 47.1 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.214 -0.448 . . . . 15.0 111.002 179.997 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_exo -51.82 126.66 20.53 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.61 2.207 . . . . 15.0 112.277 179.939 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 59.4 p . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.242 -0.885 . . . . 15.0 110.901 179.974 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo . . . . . 0 N--CA 1.488 1.19 0 CA-C-O 120.87 0.279 . . . . 15.0 111.809 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.517 ' CB ' ' HD3' ' A' ' 3' ' ' PRO . 2.5 mtmm -155.21 -62.77 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.464 . . . . 15.0 111.068 179.884 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.517 ' HD3' ' CB ' ' A' ' 2' ' ' LYS . 89.1 Cg_exo -47.65 89.16 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.546 2.164 . . . . 15.0 112.577 179.818 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 2' ' ' LYS . . . 88.88 -23.24 18.06 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.538 -0.839 . . . . 15.0 112.435 -179.783 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -61.88 143.22 56.72 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-O 121.412 0.625 . . . . 15.0 110.749 179.859 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.422 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 1.4 mp -88.44 144.85 8.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.069 -0.969 . . . . 15.0 111.27 -179.289 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.644 ' CZ ' HD12 ' A' ' 89' ' ' LEU . 4.0 p90 -140.91 166.39 24.9 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.098 -0.501 . . . . 15.0 110.465 178.797 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.713 ' CB ' HD12 ' A' ' 88' ' ' LEU . 9.4 pt-20 -130.07 144.95 51.62 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.235 0.54 . . . . 15.0 111.613 -179.287 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.681 HG23 ' HG2' ' A' ' 51' ' ' ARG . 0.4 OUTLIER -101.57 116.18 44.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.395 -0.82 . . . . 15.0 109.93 179.019 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -106.56 69.14 0.77 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.236 -0.438 . . . . 15.0 111.807 -179.448 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.645 HD11 ' CB ' ' A' ' 49' ' ' ASP . 6.1 tp -88.07 160.75 17.69 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.298 -0.41 . . . . 15.0 109.961 179.058 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.534 ' C ' ' H ' ' A' ' 14' ' ' ASN . . . -97.1 95.71 7.96 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.292 0.479 . . . . 15.0 112.292 -179.177 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.881 ' HB2' HG23 ' A' ' 85' ' ' VAL . 3.5 tppt? -65.82 26.72 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 112.131 0.419 . . . . 15.0 112.131 178.894 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.534 ' H ' ' C ' ' A' ' 12' ' ' ALA . 25.7 m-80 -115.58 123.64 48.95 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.947 0.403 . . . . 15.0 111.58 -179.425 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 65.04 11.3 7.0 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.929 -0.578 . . . . 15.0 111.89 179.4 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.469 ' HB3' ' HB2' ' A' ' 45' ' ' ALA . 35.8 m-80 -165.39 120.21 1.28 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.804 0.335 . . . . 15.0 110.891 179.771 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.849 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 0.4 OUTLIER -85.86 -166.84 1.65 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.229 -0.441 . . . . 15.0 110.16 179.552 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.606 HD22 ' HZ1' ' A' ' 13' ' ' LYS . 0.3 OUTLIER -90.18 -172.58 3.53 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.717 -0.393 . . . . 15.0 110.841 179.579 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.714 ' O ' ' HB ' ' A' ' 41' ' ' ILE . . . -161.05 36.27 0.41 Allowed Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.968 -0.634 . . . . 15.0 112.279 -179.703 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.759 HD12 ' HB ' ' A' ' 52' ' ' ILE . 0.0 OUTLIER -112.82 136.95 47.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 120.993 0.425 . . . . 15.0 111.719 -179.676 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.429 ' O ' ' HB3' ' A' ' 38' ' ' LYS . 27.5 t -95.96 100.41 12.09 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 107.845 -1.168 . . . . 15.0 107.845 177.294 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.652 HG12 ' CG2' ' A' ' 20' ' ' ILE . 1.0 OUTLIER -93.78 155.74 3.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 112.334 0.494 . . . . 15.0 112.334 -177.226 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.465 ' HA ' ' CE1' ' A' ' 71' ' ' HIS . 6.0 t -149.82 176.02 11.1 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.47 -0.787 . . . . 15.0 110.472 179.429 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.721 ' O ' HG22 ' A' ' 26' ' ' VAL . . . 86.95 -112.03 3.74 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.558 -0.829 . . . . 15.0 112.505 179.849 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.591 ' HA3' ' N ' ' A' ' 71' ' ' HIS . . . 62.58 -66.2 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 121.067 -0.587 . . . . 15.0 113.653 179.199 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.721 HG22 ' O ' ' A' ' 24' ' ' GLY . 0.0 OUTLIER -28.94 143.12 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 N-CA-C 112.528 0.566 . . . . 15.0 112.528 -179.038 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.402 ' CB ' ' O ' ' A' ' 32' ' ' HIS . 13.4 p30 -75.67 61.87 1.41 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.738 -0.664 . . . . 15.0 110.968 -179.844 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -151.65 -66.97 0.18 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.376 -0.375 . . . . 15.0 111.045 179.994 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 72.4 m -65.4 -49.76 68.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.183 -0.462 . . . . 15.0 110.877 -179.939 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.521 HG21 ' O ' ' A' ' 34' ' ' GLY . 34.5 m -75.95 -174.1 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.185 -0.462 . . . . 15.0 111.119 -179.966 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.81 -78.89 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.337 -0.392 . . . . 15.0 111.258 -179.755 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . 0.402 ' O ' ' CB ' ' A' ' 27' ' ' ASN . 34.4 p-80 -126.92 -42.85 1.72 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.431 -0.35 . . . . 15.0 111.223 -179.818 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -170.06 26.62 0.11 Allowed Glycine 0 N--CA 1.453 -0.2 0 C-N-CA 120.745 -0.74 . . . . 15.0 112.554 -179.772 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.521 ' O ' HG21 ' A' ' 30' ' ' VAL . . . -92.61 154.75 22.3 Favored Glycine 0 N--CA 1.448 -0.521 0 N-CA-C 110.33 -1.108 . . . . 15.0 110.33 178.723 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 1.0 HG22 HG22 ' A' ' 58' ' ' VAL . 0.2 OUTLIER -98.86 152.82 4.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 119.768 -0.773 . . . . 15.0 112.318 -179.154 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.41 ' CZ ' ' HG3' ' A' ' 57' ' ' ARG . 14.7 m-85 -137.19 111.21 8.31 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.65 -1.159 . . . . 15.0 109.087 179.406 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.769 HG22 ' N ' ' A' ' 55' ' ' GLY . 0.8 OUTLIER -55.37 168.69 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.42 0.628 . . . . 15.0 111.572 -178.315 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.523 ' O ' ' HG2' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -99.75 -45.12 5.85 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.374 -0.973 . . . . 15.0 108.374 178.189 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.58 ' O ' HG12 ' A' ' 20' ' ' ILE . . . -172.66 171.45 4.48 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 115.437 -0.801 . . . . 15.0 110.363 178.466 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.466 ' HA ' HG12 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -96.76 110.68 25.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 108.803 -0.814 . . . . 15.0 108.803 178.877 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.714 ' HB ' ' O ' ' A' ' 19' ' ' GLY . 0.4 OUTLIER -77.55 115.66 51.51 Favored Pre-proline 0 C--N 1.329 -0.288 0 N-CA-C 113.597 0.962 . . . . 15.0 113.597 -176.693 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.616 ' HA ' ' HG2' ' A' ' 47' ' ' GLU . 38.9 Cg_exo -61.55 61.14 0.11 Allowed 'Trans proline' 0 C--N 1.358 1.073 0 C-N-CA 123.726 2.951 . . . . 15.0 113.003 179.578 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.517 ' H ' ' HG2' ' A' ' 47' ' ' GLU . 3.5 mt-30 -150.57 -47.93 0.12 Allowed 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 111.738 0.273 . . . . 15.0 111.738 179.957 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.609 ' HA3' ' HA3' ' A' ' 19' ' ' GLY . . . -87.81 166.66 35.91 Favored Glycine 0 CA--C 1.519 0.303 0 C-N-CA 120.356 -0.926 . . . . 15.0 113.79 -179.082 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.849 ' HB3' ' O ' ' A' ' 17' ' ' SER . . . -55.48 -14.87 2.22 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.66 0.615 . . . . 15.0 112.66 -179.817 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.93 -57.95 3.87 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.702 0.287 . . . . 15.0 110.945 -179.397 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.616 ' HG2' ' HA ' ' A' ' 42' ' ' PRO . 2.8 pp20? -56.94 -42.2 79.64 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.989 0.423 . . . . 15.0 110.391 179.415 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -53.82 -72.25 0.06 Allowed 'General case' 0 CA--C 1.519 -0.214 0 CA-C-N 115.883 -0.598 . . . . 15.0 110.466 -179.636 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.645 ' CB ' HD11 ' A' ' 11' ' ' LEU . 0.5 OUTLIER -58.68 -40.4 83.46 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.456 -0.572 . . . . 15.0 109.456 179.01 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.93 50.03 5.38 Favored Glycine 0 N--CA 1.447 -0.584 0 CA-C-N 115.388 -0.824 . . . . 15.0 111.766 179.604 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.681 ' HG2' HG23 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -79.49 -51.59 9.13 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.764 0.316 . . . . 15.0 110.775 -179.34 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.759 ' HB ' HD12 ' A' ' 20' ' ' ILE . 3.1 mm -91.45 162.72 2.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.993 0.425 . . . . 15.0 111.083 179.694 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.596 ' N ' HG22 ' A' ' 52' ' ' ILE . 52.0 m80 -141.5 157.6 44.93 Favored 'General case' 0 CA--C 1.513 -0.466 0 CA-C-N 115.797 -0.638 . . . . 15.0 110.616 179.718 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.523 ' HG2' ' O ' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -35.61 132.58 0.44 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.848 -1.069 . . . . 15.0 112.647 -178.501 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.769 ' N ' HG22 ' A' ' 37' ' ' VAL . . . 49.71 38.02 28.58 Favored Glycine 0 C--N 1.332 0.338 0 CA-C-N 115.923 -0.58 . . . . 15.0 113.64 179.524 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -65.88 128.59 36.62 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 117.499 0.65 . . . . 15.0 110.523 179.388 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.439 ' HA ' ' O ' ' A' ' 35' ' ' ILE . 56.3 ttt180 -83.25 88.02 6.94 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.429 -0.35 . . . . 15.0 110.537 179.808 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 1.0 HG22 HG22 ' A' ' 35' ' ' ILE . 1.8 m -82.94 112.53 20.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.17 0.509 . . . . 15.0 111.353 -179.44 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.4 ' HA ' ' HB2' ' A' ' 66' ' ' LEU . 35.6 mt -107.27 -9.47 16.06 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 115.685 -0.689 . . . . 15.0 112.654 -179.306 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.55 ' HB3' ' HB2' ' A' ' 88' ' ' LEU . . . -151.25 144.81 24.94 Favored 'General case' 0 N--CA 1.463 0.194 0 N-CA-C 112.565 0.58 . . . . 15.0 112.565 -178.857 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.881 HG11 ' O ' ' A' ' 77' ' ' THR . 32.7 t -139.07 98.96 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.258 0 CA-C-N 115.497 -0.774 . . . . 15.0 109.452 178.878 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.667 ' ND2' HG22 ' A' ' 81' ' ' THR . 1.7 m-80 65.06 17.76 11.2 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.066 -0.516 . . . . 15.0 109.874 -178.415 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 107.24 4.57 35.33 Favored Glycine 0 C--N 1.336 0.536 0 CA-C-N 115.836 -0.62 . . . . 15.0 113.676 179.488 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.664 ' O ' HG13 ' A' ' 64' ' ' VAL . 4.9 p -93.87 105.28 16.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 117.323 0.562 . . . . 15.0 110.818 179.319 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -56.87 134.59 55.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.142 -0.481 . . . . 15.0 110.983 -179.692 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.59 HD13 ' HB3' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -87.64 -19.35 27.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.121 -0.49 . . . . 15.0 111.034 -179.998 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -46.92 95.56 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 120.892 0.377 . . . . 15.0 110.888 179.943 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.77 66.75 0.59 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.785 -0.721 . . . . 15.0 112.217 -179.588 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.65 ' HB1' ' CB ' ' A' ' 73' ' ' GLN . . . -172.95 154.36 2.82 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.859 0.362 . . . . 15.0 110.976 -179.867 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.427 ' HA ' ' C ' ' A' ' 25' ' ' GLY . 13.7 p -93.04 -170.91 2.54 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.114 -0.494 . . . . 15.0 111.396 -179.626 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.591 ' N ' ' HA3' ' A' ' 25' ' ' GLY . 1.5 t-160 -58.12 -62.17 2.02 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.618 -0.719 . . . . 15.0 110.063 179.75 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 3.4 ttpt -53.02 -36.23 60.3 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.236 -0.893 . . . . 15.0 111.051 179.483 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.65 ' CB ' ' HB1' ' A' ' 69' ' ' ALA . 7.0 mt-30 -59.41 -57.31 13.53 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.304 -0.407 . . . . 15.0 110.163 179.88 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.894 ' HB3' HD12 ' A' ' 35' ' ' ILE . . . -63.27 -43.63 97.4 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.715 -0.476 . . . . 15.0 109.715 178.835 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.588 HG23 ' CG2' ' A' ' 22' ' ' VAL . 0.5 OUTLIER -43.66 -42.74 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.223 0 N-CA-C 108.807 -0.812 . . . . 15.0 108.807 178.176 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.41 ' N ' HG12 ' A' ' 75' ' ' VAL . 21.7 mt-10 -67.45 -42.91 82.3 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 114.856 -1.066 . . . . 15.0 110.535 178.556 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.881 ' O ' HG11 ' A' ' 61' ' ' VAL . 69.9 p -63.9 -56.18 17.22 Favored 'General case' 0 N--CA 1.462 0.135 0 C-N-CA 120.997 -0.281 . . . . 15.0 111.5 -179.924 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.811 HD21 HG21 ' A' ' 58' ' ' VAL . 5.6 mt -53.37 -47.14 69.71 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-O 121.197 0.523 . . . . 15.0 110.007 179.953 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.409 ' O ' ' N ' ' A' ' 81' ' ' THR . 7.1 tpp85 -68.53 -59.12 3.37 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.395 -0.82 . . . . 15.0 110.691 179.489 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.408 ' CB ' ' O ' ' A' ' 76' ' ' GLU . 2.9 m-20 -65.92 63.0 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.035 -0.53 . . . . 15.0 111.848 179.909 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.667 HG22 ' ND2' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -91.79 -73.55 0.54 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.728 0.299 . . . . 15.0 110.33 179.322 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.434 ' O ' ' HG3' ' A' ' 13' ' ' LYS . . . 120.98 -103.43 0.9 Allowed Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.773 -0.727 . . . . 15.0 112.672 179.431 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -64.85 -87.03 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.723 0.297 . . . . 15.0 111.05 -179.841 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.507 HG12 ' N ' ' A' ' 85' ' ' VAL . 93.7 t -110.07 161.9 8.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.881 0.372 . . . . 15.0 110.625 179.956 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.881 HG23 ' HB2' ' A' ' 13' ' ' LYS . 3.3 t -97.43 84.54 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.176 0.512 . . . . 15.0 110.368 179.825 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 10.9 t60 -101.28 82.63 2.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.59 -0.732 . . . . 15.0 110.001 179.493 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.695 ' HB3' HD21 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -103.92 126.36 50.98 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.818 -0.628 . . . . 15.0 112.01 -178.907 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.713 HD12 ' CB ' ' A' ' 8' ' ' GLU . 4.9 mp -102.38 100.48 10.63 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.4 -0.593 . . . . 15.0 109.4 178.487 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.695 HD21 ' HB3' ' A' ' 87' ' ' LEU . 0.1 OUTLIER -105.57 -162.24 0.86 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.611 0.719 . . . . 15.0 112.027 -178.566 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.422 ' HA ' ' HA ' ' A' ' 6' ' ' ILE . 1.3 tt0 -139.89 133.88 30.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 114.73 -1.123 . . . . 15.0 109.485 178.856 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.15 93.81 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.89 0.376 . . . . 15.0 111.069 -179.562 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -72.09 75.92 0.76 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.959 -0.639 . . . . 15.0 112.738 -179.769 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.46 99.63 11.79 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.829 0.347 . . . . 15.0 110.796 179.898 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 99.1 p -71.86 155.29 92.25 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.203 -0.453 . . . . 15.0 110.992 -179.963 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -52.48 -36.98 72.21 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.648 2.232 . . . . 15.0 112.287 179.987 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.3 m . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.29 -0.862 . . . . 15.0 110.915 -179.982 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_endo . . . . . 0 N--CA 1.489 1.211 0 CA-C-O 120.79 0.246 . . . . 15.0 111.768 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.469 ' HB3' ' CD ' ' A' ' 3' ' ' PRO . 45.6 tptt -155.06 -66.5 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.21 -0.45 . . . . 15.0 110.797 179.81 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.469 ' CD ' ' HB3' ' A' ' 2' ' ' LYS . 55.3 Cg_endo -69.62 -167.99 0.25 Allowed 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.146 1.897 . . . . 15.0 112.209 179.772 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 84.55 -15.35 41.66 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.538 -0.839 . . . . 15.0 112.246 -179.704 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -62.12 159.18 15.11 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-O 121.102 0.477 . . . . 15.0 110.673 179.837 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.471 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 1.1 mp -104.3 144.44 14.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.593 -0.73 . . . . 15.0 111.125 -179.274 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.658 ' CZ ' HD12 ' A' ' 89' ' ' LEU . 2.3 p90 -140.41 151.3 44.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.171 -0.468 . . . . 15.0 110.611 179.119 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.656 ' CB ' HD12 ' A' ' 88' ' ' LEU . 13.7 pt-20 -116.9 143.08 46.12 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.206 0.527 . . . . 15.0 111.402 -179.467 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.678 ' CG1' HD11 ' A' ' 89' ' ' LEU . 0.4 OUTLIER -101.46 116.92 45.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.401 -0.818 . . . . 15.0 109.766 179.056 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.404 ' OE1' ' CE1' ' A' ' 86' ' ' HIS . 3.8 tp10 -106.0 72.25 0.93 Allowed 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.198 0.444 . . . . 15.0 112.198 -178.932 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.738 HD13 ' HB2' ' A' ' 51' ' ' ARG . 6.7 tp -88.23 165.41 15.07 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.035 -0.53 . . . . 15.0 109.592 178.699 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.567 ' HB1' ' HB2' ' A' ' 15' ' ' ASP . . . -96.03 96.33 8.8 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.004 0.431 . . . . 15.0 110.991 179.952 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.737 ' CB ' HG23 ' A' ' 85' ' ' VAL . 0.1 OUTLIER -63.29 -29.78 71.04 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.785 -0.643 . . . . 15.0 111.261 -179.863 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.403 ' N ' ' O ' ' A' ' 83' ' ' GLN . 55.1 t30 -84.44 -37.07 21.87 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.228 -0.442 . . . . 15.0 110.96 -179.639 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.567 ' HB2' ' HB1' ' A' ' 12' ' ' ALA . 2.6 t0 -64.75 -36.16 83.39 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.03 0.443 . . . . 15.0 110.283 179.454 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.552 ' HB3' ' HB2' ' A' ' 45' ' ' ALA . 11.8 m-20 -165.5 171.11 13.63 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.881 -0.6 . . . . 15.0 110.776 179.68 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.908 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 0.5 OUTLIER -86.0 -155.27 0.24 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.251 -0.431 . . . . 15.0 110.142 179.637 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.675 ' N ' HD22 ' A' ' 18' ' ' LEU . 0.3 OUTLIER -105.05 -167.42 1.34 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.051 0.453 . . . . 15.0 110.721 179.413 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.595 ' O ' ' HB ' ' A' ' 41' ' ' ILE . . . -169.73 34.87 0.18 Allowed Glycine 0 CA--C 1.506 -0.53 0 N-CA-C 111.102 -0.799 . . . . 15.0 111.102 -179.673 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.652 HD12 HG12 ' A' ' 52' ' ' ILE . 0.0 OUTLIER -114.23 142.11 28.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 112.652 0.612 . . . . 15.0 112.652 -179.188 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.704 ' CB ' HD11 ' A' ' 41' ' ' ILE . 2.3 t -96.86 104.1 16.08 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 107.903 -1.147 . . . . 15.0 107.903 176.315 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.984 HG21 HG23 ' A' ' 75' ' ' VAL . 27.5 m -93.63 147.36 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 N-CA-C 112.981 0.734 . . . . 15.0 112.981 -177.248 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.549 ' HA ' ' CE1' ' A' ' 71' ' ' HIS . 6.4 t -150.04 -177.46 5.93 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 115.553 -0.749 . . . . 15.0 111.327 179.205 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.641 ' O ' HG22 ' A' ' 26' ' ' VAL . . . 73.58 -115.95 5.23 Favored Glycine 0 C--N 1.336 0.565 0 C-N-CA 121.067 -0.587 . . . . 15.0 112.457 179.86 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.563 ' HA3' ' N ' ' A' ' 71' ' ' HIS . . . 64.18 -65.22 0.05 OUTLIER Glycine 0 C--N 1.33 0.233 0 C-N-CA 121.091 -0.576 . . . . 15.0 114.05 178.977 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.641 HG22 ' O ' ' A' ' 24' ' ' GLY . 0.0 OUTLIER -30.11 144.0 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 N-CA-C 112.145 0.424 . . . . 15.0 112.145 -179.121 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -75.51 58.21 1.01 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.137 -0.483 . . . . 15.0 110.974 -179.644 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 5.3 m -151.92 -60.7 0.16 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.243 -0.435 . . . . 15.0 110.792 179.965 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 9.0 t -70.31 -46.67 63.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.069 -0.514 . . . . 15.0 110.914 -179.927 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.498 HG22 ' O ' ' A' ' 26' ' ' VAL . 14.2 m -77.05 -170.03 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.237 -0.438 . . . . 15.0 111.093 -179.959 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 5.2 mmt180 -57.42 -71.47 0.1 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.273 -0.421 . . . . 15.0 111.009 -179.997 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . 0.442 ' CD2' ' N ' ' A' ' 33' ' ' GLY . 8.5 p-80 -134.93 -42.3 0.74 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.318 -0.401 . . . . 15.0 111.37 -179.817 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.442 ' N ' ' CD2' ' A' ' 32' ' ' HIS . . . -170.16 22.49 0.09 OUTLIER Glycine 0 CA--C 1.52 0.344 0 C-N-CA 120.504 -0.855 . . . . 15.0 113.086 -179.66 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.438 ' O ' HG21 ' A' ' 30' ' ' VAL . . . -92.58 154.25 22.06 Favored Glycine 0 N--CA 1.451 -0.33 0 N-CA-C 110.163 -1.175 . . . . 15.0 110.163 178.405 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.987 HG22 HG22 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -101.34 147.33 8.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 118.181 0.99 . . . . 15.0 111.795 -179.209 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.736 ' N ' HD13 ' A' ' 35' ' ' ILE . 13.5 m-85 -131.28 113.18 13.49 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-N 115.433 -0.803 . . . . 15.0 109.537 -179.61 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.797 HG22 ' N ' ' A' ' 55' ' ' GLY . 0.7 OUTLIER -54.87 148.68 2.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 115.471 -0.786 . . . . 15.0 111.363 -178.736 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.484 ' O ' ' HG2' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -81.08 -48.39 12.24 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.775 -0.824 . . . . 15.0 108.775 178.654 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.501 ' O ' HG12 ' A' ' 20' ' ' ILE . . . -172.5 169.04 5.27 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.567 -0.742 . . . . 15.0 110.766 178.572 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.647 HG12 HG13 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -97.49 122.08 48.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.793 0.33 . . . . 15.0 110.526 179.676 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.704 HD11 ' CB ' ' A' ' 21' ' ' SER . 1.5 mm -78.5 109.26 9.93 Favored Pre-proline 0 N--CA 1.464 0.229 0 N-CA-C 112.956 0.724 . . . . 15.0 112.956 -178.627 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.474 ' HA ' ' OE1' ' A' ' 47' ' ' GLU . 38.2 Cg_endo -65.72 65.46 0.4 Allowed 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 122.828 2.352 . . . . 15.0 112.246 179.49 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -162.55 -44.94 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.434 -0.803 . . . . 15.0 109.508 179.816 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.556 ' HA3' ' HA3' ' A' ' 19' ' ' GLY . . . -87.43 151.35 23.31 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.774 -0.727 . . . . 15.0 112.338 179.351 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.908 ' HB3' ' O ' ' A' ' 17' ' ' SER . . . -40.19 -19.6 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 113.465 0.913 . . . . 15.0 113.465 -179.312 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.445 ' N ' ' O ' ' A' ' 44' ' ' GLY . . . -71.58 -71.13 0.28 Allowed 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.809 -0.356 . . . . 15.0 111.076 -179.654 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.56 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 9.0 tm-20 -58.22 -36.58 73.35 Favored 'General case' 0 N--CA 1.462 0.153 0 C-N-CA 120.81 -0.356 . . . . 15.0 110.284 179.36 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 53.6 m -56.16 -67.69 0.27 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.173 -0.467 . . . . 15.0 110.395 179.464 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.558 ' CB ' HD11 ' A' ' 11' ' ' LEU . 2.6 m-20 -62.11 -37.64 85.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.129 -0.487 . . . . 15.0 109.932 179.179 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.32 38.19 15.63 Favored Glycine 0 N--CA 1.448 -0.521 0 CA-C-N 115.694 -0.684 . . . . 15.0 112.028 179.943 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.738 ' HB2' HD13 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -79.69 -53.58 6.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.124 0.487 . . . . 15.0 110.286 -179.846 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.652 HG12 HD12 ' A' ' 20' ' ' ILE . 11.0 tp -87.82 158.04 3.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.587 -0.733 . . . . 15.0 110.158 179.477 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 67.6 m80 -139.78 160.52 39.71 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-O 121.777 0.799 . . . . 15.0 112.898 -178.705 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.592 ' HA ' ' CG2' ' A' ' 37' ' ' VAL . 1.1 mtpt -43.97 134.7 4.49 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 114.007 -1.451 . . . . 15.0 112.702 -178.843 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.797 ' N ' HG22 ' A' ' 37' ' ' VAL . . . 49.75 31.95 16.87 Favored Glycine 0 C--N 1.333 0.408 0 CA-C-N 115.945 -0.571 . . . . 15.0 113.284 179.282 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -65.56 122.59 17.57 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.629 -0.428 . . . . 15.0 109.874 179.15 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.503 ' NE ' HD21 ' A' ' 59' ' ' LEU . 36.9 ttt85 -80.98 85.44 6.26 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.429 -0.35 . . . . 15.0 110.421 -179.859 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.987 HG22 HG22 ' A' ' 35' ' ' ILE . 1.3 m -79.67 121.76 33.58 Favored 'Isoleucine or valine' 0 C--O 1.24 0.601 0 CA-C-O 121.211 0.529 . . . . 15.0 111.559 -179.365 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.503 HD21 ' NE ' ' A' ' 57' ' ' ARG . 3.8 mm? -107.91 -15.63 14.5 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 115.09 -0.959 . . . . 15.0 111.984 -179.861 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.641 ' HB3' ' HB2' ' A' ' 88' ' ' LEU . . . -147.91 148.16 30.51 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.113 0.483 . . . . 15.0 112.263 -178.565 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.688 HG11 ' O ' ' A' ' 77' ' ' THR . 39.6 t -139.02 102.69 1.8 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.249 0 CA-C-N 115.577 -0.738 . . . . 15.0 109.451 178.825 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.797 ' ND2' HG22 ' A' ' 81' ' ' THR . 1.1 m-80 64.83 14.46 9.21 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.763 -0.458 . . . . 15.0 109.763 -178.195 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 107.01 6.49 34.3 Favored Glycine 0 C--N 1.336 0.573 0 CA-C-N 115.863 -0.608 . . . . 15.0 113.244 179.828 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.666 ' O ' HG13 ' A' ' 64' ' ' VAL . 6.3 p -93.67 105.22 16.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 121.098 0.475 . . . . 15.0 110.579 179.216 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -58.46 123.67 16.98 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.145 -0.479 . . . . 15.0 111.142 -179.442 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.847 HD13 HG23 ' A' ' 58' ' ' VAL . 0.2 OUTLIER -92.07 -16.96 25.69 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.918 -0.583 . . . . 15.0 111.096 179.877 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -43.43 95.26 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.874 0.369 . . . . 15.0 111.239 -179.994 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 107.83 71.42 0.74 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.799 -0.715 . . . . 15.0 112.301 -179.73 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.597 ' HB1' ' CG ' ' A' ' 73' ' ' GLN . . . -173.02 169.46 4.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.831 0.348 . . . . 15.0 111.107 -179.778 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 15.6 p -93.42 -175.21 3.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.927 0.394 . . . . 15.0 111.27 -179.749 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.772 ' NE2' HG23 ' A' ' 22' ' ' VAL . 0.1 OUTLIER -65.78 -58.56 5.35 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.882 -0.599 . . . . 15.0 110.623 -179.902 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.442 ' O ' ' HG3' ' A' ' 76' ' ' GLU . 23.3 ttpp -52.21 -31.03 30.09 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.747 -0.464 . . . . 15.0 109.747 178.925 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.597 ' CG ' ' HB1' ' A' ' 69' ' ' ALA . 1.1 tt0 -59.5 -49.19 78.73 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.916 -0.584 . . . . 15.0 109.609 178.813 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.626 ' CB ' HG21 ' A' ' 35' ' ' ILE . . . -67.11 -45.79 76.15 Favored 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 109.568 -0.53 . . . . 15.0 109.568 178.512 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.984 HG23 HG21 ' A' ' 22' ' ' VAL . 0.5 OUTLIER -42.2 -42.12 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.27 0 N-CA-C 108.792 -0.818 . . . . 15.0 108.792 178.257 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.499 ' O ' ' HB2' ' A' ' 80' ' ' ASN . 8.9 mt-10 -67.3 -45.28 77.01 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 114.651 -1.159 . . . . 15.0 110.361 178.477 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.688 ' O ' HG11 ' A' ' 61' ' ' VAL . 72.9 p -64.1 -54.54 32.42 Favored 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 111.545 0.202 . . . . 15.0 111.545 -179.949 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.597 HD21 HG21 ' A' ' 58' ' ' VAL . 8.3 mt -53.47 -46.35 69.92 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 121.308 0.575 . . . . 15.0 109.881 -179.989 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.451 ' HB2' ' O ' ' A' ' 75' ' ' VAL . 0.2 OUTLIER -68.51 -58.89 3.63 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.204 -0.907 . . . . 15.0 110.805 179.677 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.499 ' HB2' ' O ' ' A' ' 76' ' ' GLU . 6.5 m-80 -66.23 56.98 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 112.393 0.516 . . . . 15.0 112.393 -179.86 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.797 HG22 ' ND2' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -95.69 -75.02 0.53 Allowed 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.94 -0.393 . . . . 15.0 109.94 178.853 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 122.06 -104.02 0.89 Allowed Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.641 -0.79 . . . . 15.0 113.537 178.804 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.403 ' O ' ' N ' ' A' ' 14' ' ' ASN . 0.2 OUTLIER -63.08 -84.9 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.06 0.393 . . . . 15.0 112.06 -178.699 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.453 HG12 ' N ' ' A' ' 85' ' ' VAL . 55.4 t -109.46 160.18 8.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.891 0.377 . . . . 15.0 110.706 -179.408 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.737 HG23 ' CB ' ' A' ' 13' ' ' LYS . 9.3 t -97.8 81.42 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-O 121.118 0.485 . . . . 15.0 110.382 -179.926 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.404 ' CE1' ' OE1' ' A' ' 10' ' ' GLU . 0.5 OUTLIER -99.66 86.29 3.3 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.736 -0.665 . . . . 15.0 110.229 179.863 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.822 ' HB3' HD21 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -103.82 127.33 51.33 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.882 -0.599 . . . . 15.0 111.718 -179.018 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.656 HD12 ' CB ' ' A' ' 8' ' ' GLU . 4.4 mp -102.18 99.44 9.57 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.552 -0.536 . . . . 15.0 109.552 178.742 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.822 HD21 ' HB3' ' A' ' 87' ' ' LEU . 0.1 OUTLIER -105.88 -162.66 0.88 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.56 0.695 . . . . 15.0 112.406 -178.317 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.471 ' HA ' ' HA ' ' A' ' 6' ' ' ILE . 1.9 tt0 -138.37 142.27 39.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 114.617 -1.174 . . . . 15.0 109.288 178.669 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -53.79 100.75 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.002 0.429 . . . . 15.0 111.107 -179.522 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -62.06 97.17 0.15 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.956 -0.64 . . . . 15.0 112.604 -179.768 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.36 112.31 21.32 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.826 0.346 . . . . 15.0 110.86 179.935 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -84.41 146.43 47.48 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.163 -0.471 . . . . 15.0 110.923 -179.964 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -52.87 -36.06 72.87 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.595 2.197 . . . . 15.0 112.25 179.994 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 2.4 t . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.223 -0.894 . . . . 15.0 110.89 -179.957 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo . . . . . 0 N--CA 1.487 1.099 0 CA-C-O 120.864 0.277 . . . . 15.0 111.848 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 10.5 mttt -145.14 99.35 4.61 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.114 -0.494 . . . . 15.0 110.687 179.993 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -55.16 -167.49 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.458 2.105 . . . . 15.0 112.661 -179.735 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 87.46 -21.49 21.39 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.812 -0.709 . . . . 15.0 112.033 -179.473 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -72.72 143.27 48.08 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 121.439 0.638 . . . . 15.0 111.142 179.851 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.411 HG13 ' HB2' ' A' ' 90' ' ' GLU . 1.2 mp -74.76 147.56 8.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 115.002 -0.999 . . . . 15.0 110.651 179.799 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.612 ' CZ ' HD12 ' A' ' 89' ' ' LEU . 2.0 p90 -140.67 160.25 40.44 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.438 -0.346 . . . . 15.0 110.532 179.085 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.713 ' CB ' HD12 ' A' ' 88' ' ' LEU . 9.5 pt-20 -126.46 144.95 50.68 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.249 0.547 . . . . 15.0 111.48 -179.338 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.703 ' CG1' HD11 ' A' ' 89' ' ' LEU . 0.5 OUTLIER -101.29 115.07 42.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.331 -0.85 . . . . 15.0 109.722 179.157 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -106.13 69.56 0.81 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.107 -0.497 . . . . 15.0 111.643 -179.302 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.646 HD11 ' CB ' ' A' ' 49' ' ' ASP . 7.0 tp -88.15 161.68 17.14 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.013 -0.54 . . . . 15.0 110.082 179.213 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.53 ' C ' ' H ' ' A' ' 14' ' ' ASN . . . -96.63 101.0 12.53 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.717 0.294 . . . . 15.0 111.113 179.918 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.883 ' HB2' HG23 ' A' ' 85' ' ' VAL . 0.4 OUTLIER -65.49 26.59 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 112.511 0.56 . . . . 15.0 112.511 179.882 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.53 ' H ' ' C ' ' A' ' 12' ' ' ALA . 49.5 t30 -109.49 152.53 25.3 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.672 0.272 . . . . 15.0 110.541 179.665 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.407 ' CB ' ' O ' ' A' ' 14' ' ' ASN . 6.3 t70 80.69 -49.21 0.3 Allowed 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.323 -0.399 . . . . 15.0 111.26 -179.91 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -154.99 162.18 41.16 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.855 0.359 . . . . 15.0 110.988 -179.912 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.576 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 0.6 OUTLIER -86.03 -166.02 1.41 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.179 -0.464 . . . . 15.0 110.892 179.955 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.41 ' H ' HD22 ' A' ' 18' ' ' LEU . 2.7 mm? -72.25 -167.83 0.35 Allowed 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 116.12 -0.491 . . . . 15.0 110.709 179.698 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.631 ' O ' ' HB ' ' A' ' 41' ' ' ILE . . . -160.85 35.64 0.42 Allowed Glycine 0 CA--C 1.506 -0.513 0 N-CA-C 111.308 -0.717 . . . . 15.0 111.308 179.987 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.669 HG12 ' O ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -112.61 140.13 33.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.011 0.434 . . . . 15.0 111.948 -179.169 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.455 ' HB3' HD11 ' A' ' 41' ' ' ILE . 33.2 t -96.01 105.82 17.91 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 107.696 -1.224 . . . . 15.0 107.696 177.275 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.989 HG21 HG23 ' A' ' 75' ' ' VAL . 33.2 m -93.57 152.77 3.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 112.984 0.735 . . . . 15.0 112.984 -176.908 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -149.42 -178.8 6.62 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 115.014 -0.994 . . . . 15.0 110.823 -179.736 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.437 ' O ' ' HB3' ' A' ' 71' ' ' HIS . . . 71.17 -119.19 7.81 Favored Glycine 0 C--N 1.332 0.308 0 C-N-CA 120.744 -0.741 . . . . 15.0 112.319 -179.95 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.536 ' HA3' ' N ' ' A' ' 71' ' ' HIS . . . 68.47 -66.46 0.41 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.784 -0.722 . . . . 15.0 113.448 179.338 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.525 ' O ' HG22 ' A' ' 30' ' ' VAL . 0.9 OUTLIER -26.27 138.69 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 N-CA-C 112.5 0.555 . . . . 15.0 112.5 -179.297 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 8.1 p-10 -76.72 57.47 1.28 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.97 -0.559 . . . . 15.0 111.093 -179.929 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.2 m -151.85 -51.84 0.12 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.332 -0.395 . . . . 15.0 110.895 179.971 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 6.0 m -80.53 -41.18 24.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.108 -0.496 . . . . 15.0 110.934 -179.918 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.525 HG22 ' O ' ' A' ' 26' ' ' VAL . 13.9 m -79.21 -169.96 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.284 -0.416 . . . . 15.0 111.095 -179.948 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.59 -62.94 1.5 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.284 -0.416 . . . . 15.0 111.05 -179.853 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . 0.446 ' CD2' ' HG3' ' A' ' 67' ' ' GLU . 11.0 p-80 -139.22 -51.51 0.53 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.356 -0.384 . . . . 15.0 111.257 -179.764 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -168.28 24.75 0.11 Allowed Glycine 0 CA--C 1.518 0.241 0 C-N-CA 120.791 -0.719 . . . . 15.0 112.628 -179.872 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -91.43 154.08 22.55 Favored Glycine 0 N--CA 1.45 -0.398 0 N-CA-C 110.681 -0.967 . . . . 15.0 110.681 178.891 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.943 HG22 HG22 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -92.55 154.72 3.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 117.685 0.742 . . . . 15.0 111.928 -179.265 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.419 ' CE2' ' HG2' ' A' ' 57' ' ' ARG . 30.4 m-85 -139.19 106.07 5.41 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.042 -0.981 . . . . 15.0 109.691 178.849 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.804 HG22 ' N ' ' A' ' 55' ' ' GLY . 0.7 OUTLIER -55.39 146.4 4.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.929 -0.578 . . . . 15.0 111.335 -178.873 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.426 ' O ' ' HG2' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -80.32 -48.51 12.88 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.475 -0.935 . . . . 15.0 108.475 178.356 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.669 ' O ' HG12 ' A' ' 20' ' ' ILE . . . -172.16 172.36 4.62 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.667 -0.697 . . . . 15.0 110.703 178.68 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.606 ' HA ' HG12 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -96.9 113.07 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 N-CA-C 109.712 -0.477 . . . . 15.0 109.712 179.397 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.631 ' HB ' ' O ' ' A' ' 19' ' ' GLY . 0.3 OUTLIER -78.6 119.34 76.92 Favored Pre-proline 0 C--N 1.33 -0.268 0 N-CA-C 113.281 0.845 . . . . 15.0 113.281 -177.411 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.609 ' HA ' ' CG ' ' A' ' 47' ' ' GLU . 38.3 Cg_endo -65.27 61.2 0.34 Allowed 'Trans proline' 0 C--N 1.355 0.904 0 C-N-CA 123.512 2.808 . . . . 15.0 112.958 179.713 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.528 ' H ' ' HG2' ' A' ' 47' ' ' GLU . 1.8 mm-40 -152.11 -44.63 0.11 Allowed 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 111.767 0.284 . . . . 15.0 111.767 179.81 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.578 ' HA3' ' HA3' ' A' ' 19' ' ' GLY . . . -87.77 164.77 34.47 Favored Glycine 0 CA--C 1.519 0.299 0 C-N-CA 120.347 -0.93 . . . . 15.0 113.828 -179.049 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.576 ' HB3' ' O ' ' A' ' 17' ' ' SER . . . -53.95 -16.34 1.83 Allowed 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 112.847 0.684 . . . . 15.0 112.847 -179.559 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.29 -57.85 3.88 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.609 0.243 . . . . 15.0 111.27 -179.35 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.609 ' CG ' ' HA ' ' A' ' 42' ' ' PRO . 2.9 pp20? -56.74 -40.84 76.47 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.03 0.443 . . . . 15.0 110.312 179.552 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 33.4 t -53.85 -69.79 0.11 Allowed 'General case' 0 CA--C 1.52 -0.182 0 CA-C-N 115.818 -0.628 . . . . 15.0 110.753 -179.449 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.646 ' CB ' HD11 ' A' ' 11' ' ' LEU . 2.0 m-20 -62.61 -38.42 90.11 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.598 -0.519 . . . . 15.0 109.598 179.257 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.03 44.53 8.11 Favored Glycine 0 N--CA 1.447 -0.611 0 CA-C-N 115.573 -0.739 . . . . 15.0 111.703 179.851 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.643 ' HB2' HD13 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -79.43 -53.46 6.88 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.884 0.373 . . . . 15.0 110.832 -179.273 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.66 ' CG1' HD12 ' A' ' 20' ' ' ILE . 8.4 tp -81.93 164.55 2.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.996 -0.547 . . . . 15.0 110.482 179.72 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.439 ' O ' ' HB2' ' A' ' 56' ' ' ASP . 78.8 m80 -147.44 156.98 43.38 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.701 0.762 . . . . 15.0 112.181 -179.142 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.57 ' HA ' ' CG2' ' A' ' 37' ' ' VAL . 6.1 mtpt -42.31 133.73 3.11 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.31 -1.314 . . . . 15.0 112.99 -178.646 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.804 ' N ' HG22 ' A' ' 37' ' ' VAL . . . 49.81 31.87 17.19 Favored Glycine 0 C--N 1.334 0.449 0 CA-C-N 115.635 -0.711 . . . . 15.0 113.644 179.061 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.439 ' HB2' ' O ' ' A' ' 53' ' ' HIS . 0.3 OUTLIER -65.9 130.5 43.47 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 117.179 0.49 . . . . 15.0 110.493 179.413 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.419 ' HG2' ' CE2' ' A' ' 36' ' ' TYR . 40.3 mtt180 -83.9 87.23 7.09 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.242 -0.435 . . . . 15.0 110.17 179.62 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.943 HG22 HG22 ' A' ' 35' ' ' ILE . 1.3 m -79.66 117.93 26.27 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 CA-C-O 121.086 0.469 . . . . 15.0 111.566 -179.12 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.438 ' O ' ' N ' ' A' ' 66' ' ' LEU . 27.7 mt -107.48 -18.84 13.75 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 115.504 -0.771 . . . . 15.0 112.493 -179.423 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.766 ' HB3' ' HB2' ' A' ' 88' ' ' LEU . . . -148.79 148.52 30.04 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 112.946 0.721 . . . . 15.0 112.946 -178.575 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.822 HG11 ' O ' ' A' ' 77' ' ' THR . 56.7 t -139.2 94.53 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 CA-C-N 115.101 -0.954 . . . . 15.0 109.076 178.892 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.497 ' OD1' HG22 ' A' ' 81' ' ' THR . 6.0 m120 70.5 16.6 6.98 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.047 -0.524 . . . . 15.0 109.87 -178.101 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 107.17 4.75 35.44 Favored Glycine 0 C--N 1.336 0.549 0 CA-C-N 115.851 -0.613 . . . . 15.0 113.429 179.559 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.655 ' O ' HG13 ' A' ' 64' ' ' VAL . 5.9 p -93.82 105.58 17.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.131 0.491 . . . . 15.0 110.845 179.446 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.6 t -55.71 139.4 45.09 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.057 -0.52 . . . . 15.0 111.206 -179.518 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.963 HD11 ' HB2' ' A' ' 74' ' ' ALA . 0.2 OUTLIER -97.43 -22.97 16.28 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.966 -0.561 . . . . 15.0 110.78 179.875 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.446 ' HG3' ' CD2' ' A' ' 32' ' ' HIS . 1.6 tt0 -46.38 103.36 0.04 OUTLIER 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.237 -0.438 . . . . 15.0 111.125 -179.952 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 102.89 61.63 0.71 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.759 -0.734 . . . . 15.0 112.309 -179.865 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.745 ' HB1' ' CB ' ' A' ' 73' ' ' GLN . . . -173.09 142.57 1.06 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.874 0.368 . . . . 15.0 111.079 -179.823 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.451 ' CB ' ' HA ' ' A' ' 26' ' ' VAL . 2.3 p -72.87 -171.85 0.93 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.252 -0.431 . . . . 15.0 110.953 -179.959 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.778 ' CD2' HG23 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -62.95 -58.43 7.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.95 -0.568 . . . . 15.0 110.447 179.827 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.462 ' O ' HG12 ' A' ' 75' ' ' VAL . 1.8 ttpp -52.5 -33.91 47.05 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.826 -0.625 . . . . 15.0 110.855 179.691 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.745 ' CB ' ' HB1' ' A' ' 69' ' ' ALA . 2.0 mt-30 -59.31 -51.47 69.82 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.35 -0.611 . . . . 15.0 109.35 179.32 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.963 ' HB2' HD11 ' A' ' 66' ' ' LEU . . . -66.86 -43.96 82.22 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.804 -0.634 . . . . 15.0 109.797 178.532 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.989 HG23 HG21 ' A' ' 22' ' ' VAL . 0.5 OUTLIER -43.35 -39.94 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.236 0 N-CA-C 109.029 -0.73 . . . . 15.0 109.029 178.419 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -67.22 -45.83 75.61 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 114.778 -1.101 . . . . 15.0 110.048 178.342 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.822 ' O ' HG11 ' A' ' 61' ' ' VAL . 35.4 p -64.28 -53.48 48.26 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-N 116.526 -0.306 . . . . 15.0 111.454 179.848 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.678 HD23 HG21 ' A' ' 61' ' ' VAL . 4.5 mt -53.88 -48.53 69.99 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 121.205 0.526 . . . . 15.0 110.102 179.914 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.406 ' O ' ' N ' ' A' ' 81' ' ' THR . 0.0 OUTLIER -68.34 -57.68 5.55 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.405 -0.816 . . . . 15.0 110.737 179.655 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 64.8 m-20 -65.84 62.49 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.961 -0.563 . . . . 15.0 112.088 -179.86 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.497 HG22 ' OD1' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -95.41 -73.99 0.57 Allowed 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.798 -0.445 . . . . 15.0 109.798 179.015 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 114.87 -101.11 1.04 Allowed Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.744 -0.741 . . . . 15.0 113.263 178.781 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.48 ' O ' ' HB3' ' A' ' 13' ' ' LYS . 0.1 OUTLIER -64.63 -86.27 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.612 0.244 . . . . 15.0 111.527 -179.208 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.461 HG12 ' N ' ' A' ' 85' ' ' VAL . 79.0 t -110.3 159.52 10.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.98 0.419 . . . . 15.0 110.738 -179.893 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.883 HG23 ' HB2' ' A' ' 13' ' ' LYS . 3.6 t -97.62 83.66 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.146 0.498 . . . . 15.0 110.228 179.648 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -101.75 83.89 2.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.707 -0.679 . . . . 15.0 110.238 179.727 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.834 ' HB3' HD21 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -103.92 128.18 51.43 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.87 -0.605 . . . . 15.0 111.827 -179.106 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.766 ' HB2' ' HB3' ' A' ' 60' ' ' ALA . 4.6 mp -102.28 100.86 11.08 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.629 -0.508 . . . . 15.0 109.629 178.805 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.834 HD21 ' HB3' ' A' ' 87' ' ' LEU . 0.1 OUTLIER -105.64 -161.78 0.83 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.388 0.613 . . . . 15.0 111.848 -178.552 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.411 ' HB2' HG13 ' A' ' 6' ' ' ILE . 3.1 tt0 -142.23 135.38 28.8 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.052 -0.976 . . . . 15.0 109.878 179.21 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 2.8 tptt -47.47 103.95 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.919 0.39 . . . . 15.0 111.188 -179.681 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -70.38 76.4 0.49 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.785 -0.721 . . . . 15.0 112.5 -179.943 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -80.48 120.66 24.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.78 0.324 . . . . 15.0 110.872 179.957 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.2 t -77.74 150.02 78.28 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.241 -0.436 . . . . 15.0 110.987 179.968 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_exo -51.27 -26.51 20.57 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.582 2.188 . . . . 15.0 112.312 179.932 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 62.2 p . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.209 -0.9 . . . . 15.0 110.887 -179.989 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo . . . . . 0 N--CA 1.487 1.127 0 CA-C-O 120.818 0.257 . . . . 15.0 111.688 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 39.0 mtmt -146.32 153.91 48.82 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.454 . . . . 15.0 110.941 -179.954 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -65.5 -161.51 0.05 OUTLIER 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.636 2.224 . . . . 15.0 112.364 179.975 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 90.69 -23.73 21.26 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.676 -0.773 . . . . 15.0 112.28 -179.711 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -62.22 136.19 57.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.236 0.541 . . . . 15.0 110.729 179.839 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.514 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 1.4 mp -104.38 138.51 28.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.405 -0.816 . . . . 15.0 111.215 -179.415 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.968 ' CE1' HD12 ' A' ' 89' ' ' LEU . 10.8 p90 -141.82 143.59 33.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.264 -0.425 . . . . 15.0 110.882 178.874 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.795 ' HB2' HD12 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -109.96 142.42 41.36 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.339 0.59 . . . . 15.0 111.534 -179.404 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.683 HG12 HD11 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -101.55 114.89 42.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.117 -0.947 . . . . 15.0 109.831 179.124 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -105.95 71.45 0.9 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.015 -0.539 . . . . 15.0 111.931 -178.988 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.651 HD13 ' HG3' ' A' ' 51' ' ' ARG . 5.6 tp -87.98 165.76 14.98 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.151 -0.477 . . . . 15.0 109.727 178.972 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -94.71 94.2 7.98 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.916 0.389 . . . . 15.0 111.057 -179.995 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.654 ' CB ' HG23 ' A' ' 85' ' ' VAL . 0.2 OUTLIER -54.11 -28.97 43.0 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.977 -0.556 . . . . 15.0 110.885 179.924 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.409 ' O ' ' CB ' ' A' ' 15' ' ' ASP . 41.7 m-20 -84.78 145.76 27.72 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.197 -0.456 . . . . 15.0 110.839 179.799 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.409 ' CB ' ' O ' ' A' ' 14' ' ' ASN . 4.9 m-20 81.69 -23.32 0.22 Allowed 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.096 -0.502 . . . . 15.0 112.0 179.711 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.465 ' HB2' ' HB2' ' A' ' 45' ' ' ALA . 4.9 p30 -165.36 138.38 4.45 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.873 0.368 . . . . 15.0 111.134 -179.917 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.759 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 0.3 OUTLIER -86.11 -163.3 0.86 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.122 -0.49 . . . . 15.0 110.541 179.693 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.588 ' N ' HD22 ' A' ' 18' ' ' LEU . 1.1 mm? -91.91 -172.46 3.18 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 116.383 -0.372 . . . . 15.0 110.779 179.503 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.624 ' HA3' ' HA3' ' A' ' 44' ' ' GLY . . . -160.98 39.44 0.42 Allowed Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 121.043 -0.599 . . . . 15.0 112.024 -179.794 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.661 HD12 ' CG2' ' A' ' 52' ' ' ILE . 0.0 OUTLIER -112.51 144.71 19.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 121.06 0.457 . . . . 15.0 111.686 -179.493 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 55.0 p -96.06 101.49 13.16 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.267 -1.012 . . . . 15.0 108.267 177.958 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 1.024 HG21 HG23 ' A' ' 75' ' ' VAL . 33.8 m -93.77 145.61 7.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 113.092 0.775 . . . . 15.0 113.092 -177.273 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.555 ' HA ' ' ND1' ' A' ' 71' ' ' HIS . 0.9 OUTLIER -149.49 -177.65 5.98 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 115.384 -0.826 . . . . 15.0 110.773 178.74 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.477 ' O ' ' HB3' ' A' ' 71' ' ' HIS . . . 76.32 -118.19 5.23 Favored Glycine 0 C--N 1.333 0.401 0 C-N-CA 120.87 -0.681 . . . . 15.0 112.361 -179.753 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.528 ' HA3' ' N ' ' A' ' 71' ' ' HIS . . . 64.42 -64.66 0.06 OUTLIER Glycine 0 CA--C 1.519 0.31 0 C-N-CA 121.139 -0.553 . . . . 15.0 114.116 178.956 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.609 ' O ' HG22 ' A' ' 30' ' ' VAL . 1.5 m -25.97 142.18 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 N-CA-C 112.892 0.701 . . . . 15.0 112.892 -178.999 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 44.4 t-20 -78.4 55.41 1.57 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.681 -0.69 . . . . 15.0 110.934 179.856 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 15.0 m -152.03 -63.92 0.17 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.915 0.388 . . . . 15.0 110.938 -179.933 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 47.7 t -68.86 -49.99 53.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.029 -0.532 . . . . 15.0 110.885 -179.892 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.609 HG22 ' O ' ' A' ' 26' ' ' VAL . 35.8 m -84.4 -176.74 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.25 -0.432 . . . . 15.0 111.027 179.912 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -89.09 121.86 31.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.956 0.408 . . . . 15.0 111.158 -179.867 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 65.08 -91.36 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.951 -0.568 . . . . 15.0 111.384 179.722 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.456 ' O ' ' O ' ' A' ' 69' ' ' ALA . . . -164.85 27.97 0.2 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.78 -0.724 . . . . 15.0 112.131 -179.717 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -84.81 149.47 24.37 Favored Glycine 0 N--CA 1.449 -0.47 0 N-CA-C 110.523 -1.031 . . . . 15.0 110.523 178.845 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 1.028 HG22 HG22 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -90.13 150.92 3.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 119.923 -0.711 . . . . 15.0 111.78 -179.215 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.453 ' CZ ' ' HG3' ' A' ' 57' ' ' ARG . 44.1 m-85 -136.49 108.54 7.19 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 114.904 -1.044 . . . . 15.0 109.124 178.942 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.785 HG22 ' N ' ' A' ' 55' ' ' GLY . 0.8 OUTLIER -55.17 153.72 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 121.269 0.557 . . . . 15.0 111.266 -178.567 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.576 ' O ' ' HG2' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -86.34 -46.05 10.65 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.745 -0.835 . . . . 15.0 108.745 178.848 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.624 ' O ' HG12 ' A' ' 20' ' ' ILE . . . -172.34 169.34 5.34 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.804 -0.635 . . . . 15.0 110.683 178.527 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.529 ' HA ' HG12 ' A' ' 20' ' ' ILE . 0.1 OUTLIER -96.73 109.86 23.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 N-CA-C 109.288 -0.634 . . . . 15.0 109.288 179.049 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.595 ' HB ' ' O ' ' A' ' 19' ' ' GLY . 0.3 OUTLIER -78.36 118.48 72.54 Favored Pre-proline 0 C--N 1.328 -0.348 0 N-CA-C 113.522 0.934 . . . . 15.0 113.522 -176.967 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.626 ' HA ' ' CG ' ' A' ' 47' ' ' GLU . 36.9 Cg_endo -64.48 61.59 0.26 Allowed 'Trans proline' 0 C--N 1.358 1.042 0 C-N-CA 123.536 2.824 . . . . 15.0 112.991 179.865 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.51 ' N ' ' HG2' ' A' ' 47' ' ' GLU . 41.8 mt-30 -149.88 -46.72 0.13 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.597 -0.274 . . . . 15.0 111.54 179.763 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.624 ' HA3' ' HA3' ' A' ' 19' ' ' GLY . . . -88.03 167.59 36.41 Favored Glycine 0 CA--C 1.518 0.27 0 C-N-CA 120.332 -0.937 . . . . 15.0 113.946 -179.212 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.759 ' HB3' ' O ' ' A' ' 17' ' ' SER . . . -56.6 -13.48 2.44 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.678 0.622 . . . . 15.0 112.678 -179.852 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.444 ' HB1' HG22 ' A' ' 52' ' ' ILE . . . -71.95 -58.23 3.63 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-O 120.773 0.321 . . . . 15.0 110.868 -179.618 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.626 ' CG ' ' HA ' ' A' ' 42' ' ' PRO . 2.6 pp20? -57.38 -42.0 81.33 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.732 -0.667 . . . . 15.0 110.423 179.285 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -53.78 -71.28 0.08 Allowed 'General case' 0 CA--C 1.519 -0.22 0 CA-C-N 115.783 -0.644 . . . . 15.0 110.549 -179.359 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.594 ' CB ' HD11 ' A' ' 11' ' ' LEU . 0.1 OUTLIER -58.24 -40.71 82.47 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.137 -0.69 . . . . 15.0 109.137 178.838 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.416 ' O ' ' CE1' ' A' ' 53' ' ' HIS . . . 80.98 39.54 13.02 Favored Glycine 0 N--CA 1.446 -0.683 0 CA-C-N 115.197 -0.91 . . . . 15.0 112.011 179.212 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.651 ' HG3' HD13 ' A' ' 11' ' ' LEU . 3.0 mmt-85 -80.07 -59.31 2.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.963 0.411 . . . . 15.0 110.386 -179.773 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.661 ' CG2' HD12 ' A' ' 20' ' ' ILE . 6.6 tp -80.86 146.18 7.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.86 -0.609 . . . . 15.0 109.568 179.115 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.514 ' O ' ' HB2' ' A' ' 56' ' ' ASP . 57.4 m80 -139.47 167.37 22.24 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-O 121.77 0.795 . . . . 15.0 112.762 -178.253 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.58 ' HA ' ' CG2' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -40.29 132.72 1.94 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.109 -1.405 . . . . 15.0 113.27 -178.353 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.785 ' N ' HG22 ' A' ' 37' ' ' VAL . . . 49.7 36.23 25.0 Favored Glycine 0 C--N 1.335 0.511 0 CA-C-N 115.613 -0.721 . . . . 15.0 113.566 179.115 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.514 ' HB2' ' O ' ' A' ' 53' ' ' HIS . 1.7 t0 -65.66 132.32 48.51 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.99 0.395 . . . . 15.0 110.34 179.206 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.453 ' HG3' ' CZ ' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -85.11 77.25 10.11 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.983 -0.553 . . . . 15.0 110.134 179.545 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 1.028 HG22 HG22 ' A' ' 35' ' ' ILE . 0.8 OUTLIER -79.23 115.62 21.82 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 CA-C-O 121.293 0.568 . . . . 15.0 111.027 -179.25 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 35.0 mt -107.32 -14.12 14.96 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 115.555 -0.748 . . . . 15.0 112.522 -178.967 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.698 ' HB3' ' HB2' ' A' ' 88' ' ' LEU . . . -147.56 149.9 33.46 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 112.642 0.608 . . . . 15.0 112.642 -178.51 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.644 HG11 ' O ' ' A' ' 77' ' ' THR . 15.6 t -139.12 101.54 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.27 0 CA-C-N 115.255 -0.884 . . . . 15.0 109.139 178.741 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.807 ' ND2' HG22 ' A' ' 81' ' ' THR . 1.7 m-80 65.04 15.54 10.05 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.668 -0.493 . . . . 15.0 109.668 -177.901 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 106.82 4.9 36.29 Favored Glycine 0 C--N 1.337 0.614 0 CA-C-N 115.822 -0.626 . . . . 15.0 113.286 179.77 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.643 ' O ' HG13 ' A' ' 64' ' ' VAL . 5.8 p -93.83 108.67 20.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 117.017 0.408 . . . . 15.0 111.046 179.616 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -57.11 137.98 55.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.259 -0.428 . . . . 15.0 111.064 -179.741 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.927 HD11 ' HB2' ' A' ' 74' ' ' ALA . 0.2 OUTLIER -97.74 -23.08 16.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.076 -0.511 . . . . 15.0 111.003 179.96 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -47.57 104.0 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.389 -0.369 . . . . 15.0 111.091 179.937 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.76 54.87 0.58 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.744 -0.741 . . . . 15.0 112.288 -179.871 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.678 ' HB1' ' CB ' ' A' ' 73' ' ' GLN . . . -173.07 146.85 1.53 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.857 0.36 . . . . 15.0 111.012 -179.953 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.462 HG22 ' HA ' ' A' ' 26' ' ' VAL . 11.3 p -72.94 -172.33 1.02 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.146 0.498 . . . . 15.0 111.097 -179.771 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.742 ' NE2' HG23 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -65.29 -57.83 7.44 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.636 -0.711 . . . . 15.0 110.751 -179.806 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.49 ' O ' HG12 ' A' ' 75' ' ' VAL . 5.4 ttpp -52.5 -32.91 42.52 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.352 -0.385 . . . . 15.0 110.285 179.316 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.678 ' CB ' ' HB1' ' A' ' 69' ' ' ALA . 4.9 mt-30 -59.56 -48.93 79.74 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.32 -0.622 . . . . 15.0 109.32 178.843 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.927 ' HB2' HD11 ' A' ' 66' ' ' LEU . . . -67.16 -44.12 80.56 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-N 115.944 -0.571 . . . . 15.0 109.582 178.24 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 1.024 HG23 HG21 ' A' ' 22' ' ' VAL . 0.5 OUTLIER -44.03 -39.28 1.47 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.26 0 N-CA-C 108.706 -0.85 . . . . 15.0 108.706 178.312 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -67.17 -45.3 77.41 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 114.668 -1.151 . . . . 15.0 110.132 178.249 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.644 ' O ' HG11 ' A' ' 61' ' ' VAL . 39.0 p -64.12 -54.79 28.43 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.634 -0.257 . . . . 15.0 111.599 179.851 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.59 HD21 HG21 ' A' ' 58' ' ' VAL . 5.9 mt -53.33 -47.68 69.12 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-O 121.215 0.531 . . . . 15.0 109.851 -179.853 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.4 ' HB2' ' O ' ' A' ' 75' ' ' VAL . 0.0 OUTLIER -68.49 -59.09 3.41 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.423 -0.808 . . . . 15.0 110.551 179.403 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -66.15 59.71 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.947 -0.57 . . . . 15.0 112.411 -179.903 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.807 HG22 ' ND2' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -95.63 -71.51 0.67 Allowed 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 110.006 -0.368 . . . . 15.0 110.006 178.917 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 121.97 -105.39 0.98 Allowed Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.833 -0.699 . . . . 15.0 113.157 179.118 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.75 -81.62 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 112.151 0.426 . . . . 15.0 112.151 -179.06 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.45 HG12 ' N ' ' A' ' 85' ' ' VAL . 72.2 t -109.97 159.1 9.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.136 0.493 . . . . 15.0 111.21 -179.136 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.678 HG12 ' O ' ' A' ' 85' ' ' VAL . 6.8 t -97.82 81.56 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.909 -0.587 . . . . 15.0 110.553 179.935 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -100.45 84.34 2.76 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.729 -0.668 . . . . 15.0 110.419 179.786 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.642 ' HB3' HD21 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -103.55 118.62 37.15 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.985 -0.552 . . . . 15.0 111.916 -179.102 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.795 HD12 ' HB2' ' A' ' 8' ' ' GLU . 3.8 mp -92.01 103.65 16.14 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.17 -0.678 . . . . 15.0 109.17 178.445 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.968 HD12 ' CE1' ' A' ' 7' ' ' PHE . 0.1 OUTLIER -105.61 -164.91 1.06 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.615 0.721 . . . . 15.0 112.352 -178.035 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.514 ' HA ' ' HA ' ' A' ' 6' ' ' ILE . 0.7 OUTLIER -144.93 135.86 24.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 114.626 -1.17 . . . . 15.0 109.487 179.146 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -46.81 98.65 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.942 0.401 . . . . 15.0 111.253 -179.497 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -61.99 -165.01 0.38 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.869 -0.681 . . . . 15.0 112.641 -179.83 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 12.0 mt-30 -76.43 134.88 39.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.829 0.347 . . . . 15.0 110.945 -179.961 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -90.18 111.59 47.75 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 15.0 110.887 179.933 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -55.25 129.64 36.32 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.441 2.094 . . . . 15.0 112.278 -179.981 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 11.7 t . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.234 -0.889 . . . . 15.0 110.856 -179.989 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo . . . . . 0 N--CA 1.487 1.142 0 CA-C-O 120.799 0.25 . . . . 15.0 111.666 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.11 91.98 5.4 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 15.0 110.897 -179.973 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_exo -56.4 -163.04 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.573 2.182 . . . . 15.0 112.218 -179.944 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 87.68 -19.98 30.14 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.591 -0.814 . . . . 15.0 112.339 -179.712 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -62.16 154.04 28.44 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.169 0.509 . . . . 15.0 110.844 179.855 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.525 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 1.2 mp -104.35 141.34 20.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.496 -0.775 . . . . 15.0 111.129 -179.376 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.637 ' CE1' HD12 ' A' ' 89' ' ' LEU . 2.3 p90 -140.44 153.79 46.41 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.234 -0.439 . . . . 15.0 110.557 178.949 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.605 ' CB ' HD12 ' A' ' 88' ' ' LEU . 13.3 pt-20 -119.86 143.12 48.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.29 0.567 . . . . 15.0 111.748 -179.164 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.544 HG23 ' HB3' ' A' ' 51' ' ' ARG . 0.2 OUTLIER -101.67 117.79 47.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.277 -0.874 . . . . 15.0 109.72 178.817 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 51.5 tt0 -106.2 73.38 0.98 Allowed 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.094 0.405 . . . . 15.0 112.094 -179.165 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.532 HD11 ' CB ' ' A' ' 49' ' ' ASP . 9.5 tp -88.43 160.69 17.43 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.245 -0.434 . . . . 15.0 109.975 178.9 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.518 ' C ' ' H ' ' A' ' 14' ' ' ASN . . . -97.0 94.69 7.32 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 111.853 0.316 . . . . 15.0 111.853 -179.615 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.896 ' HB2' HG23 ' A' ' 85' ' ' VAL . 0.5 OUTLIER -65.74 27.56 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 112.522 0.564 . . . . 15.0 112.522 179.476 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.518 ' H ' ' C ' ' A' ' 12' ' ' ALA . 33.3 m-20 -115.41 126.51 54.46 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.944 0.402 . . . . 15.0 111.569 -179.45 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.3 t70 75.85 -1.89 2.88 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.989 -0.55 . . . . 15.0 112.107 179.381 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.412 ' HB2' ' HB2' ' A' ' 45' ' ' ALA . 8.0 p30 -165.52 138.96 4.49 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.943 0.401 . . . . 15.0 111.281 179.993 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.832 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 0.8 OUTLIER -88.04 -151.79 0.2 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.953 -0.567 . . . . 15.0 110.345 179.569 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -91.83 -170.69 2.64 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 121.066 0.46 . . . . 15.0 110.865 179.716 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.614 ' O ' ' HB ' ' A' ' 41' ' ' ILE . . . -161.0 33.68 0.39 Allowed Glycine 0 C--O 1.223 -0.55 0 N-CA-C 110.84 -0.904 . . . . 15.0 110.84 -179.815 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.662 HG13 HG12 ' A' ' 40' ' ' VAL . 0.0 OUTLIER -114.0 139.94 37.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 112.445 0.535 . . . . 15.0 112.445 -179.217 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.668 ' CB ' HD11 ' A' ' 41' ' ' ILE . 4.3 t -96.17 105.47 17.53 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 107.882 -1.155 . . . . 15.0 107.882 176.492 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 1.02 HG21 HG23 ' A' ' 75' ' ' VAL . 6.8 m -93.69 154.91 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 N-CA-C 113.28 0.844 . . . . 15.0 113.28 -176.952 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.52 -178.74 6.6 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.191 -0.913 . . . . 15.0 111.032 179.852 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.538 ' O ' HG22 ' A' ' 26' ' ' VAL . . . 69.04 -119.07 9.29 Favored Glycine 0 C--N 1.333 0.364 0 C-N-CA 120.968 -0.634 . . . . 15.0 112.531 179.719 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.559 ' HA3' ' N ' ' A' ' 71' ' ' HIS . . . 68.11 -65.79 0.36 Allowed Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.919 -0.658 . . . . 15.0 113.615 179.339 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.538 HG22 ' O ' ' A' ' 24' ' ' GLY . 0.0 OUTLIER -27.36 139.29 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 N-CA-C 112.209 0.448 . . . . 15.0 112.209 -179.337 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 7.8 p-10 -75.22 61.99 1.2 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.08 -0.509 . . . . 15.0 111.006 -179.59 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.5 m -151.75 -59.68 0.16 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.274 -0.421 . . . . 15.0 111.055 179.957 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 91.4 p -74.86 -47.65 29.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.118 -0.492 . . . . 15.0 111.168 -179.779 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.517 HG22 ' O ' ' A' ' 26' ' ' VAL . 35.1 m -70.12 -174.14 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.328 -0.396 . . . . 15.0 111.154 -179.89 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 6.8 mmp_? -54.5 -59.1 5.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.227 -0.442 . . . . 15.0 111.217 -179.792 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 1.7 p-80 -149.92 -44.83 0.13 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.44 -0.346 . . . . 15.0 111.325 -179.782 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.402 ' O ' ' O ' ' A' ' 69' ' ' ALA . . . -167.53 24.45 0.12 Allowed Glycine 0 CA--C 1.517 0.179 0 C-N-CA 120.605 -0.807 . . . . 15.0 112.894 -179.689 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -91.92 154.04 22.28 Favored Glycine 0 N--CA 1.45 -0.406 0 N-CA-C 110.074 -1.21 . . . . 15.0 110.074 178.341 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 1.053 HG22 HG22 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -101.39 147.13 8.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 118.184 0.992 . . . . 15.0 111.767 -179.249 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.769 ' N ' HD13 ' A' ' 35' ' ' ILE . 15.9 m-85 -130.94 109.2 10.36 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-N 115.307 -0.861 . . . . 15.0 109.539 -179.634 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.763 HG22 ' N ' ' A' ' 55' ' ' GLY . 0.7 OUTLIER -55.46 167.11 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.916 -0.583 . . . . 15.0 110.739 -179.27 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.42 -48.14 4.66 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.059 -0.719 . . . . 15.0 109.059 178.77 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.58 ' O ' HG12 ' A' ' 20' ' ' ILE . . . -171.5 169.18 6.22 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.269 -0.878 . . . . 15.0 110.463 179.341 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.662 HG12 HG13 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -97.24 123.57 49.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.727 0.298 . . . . 15.0 110.838 -179.908 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.716 ' O ' ' HB3' ' A' ' 47' ' ' GLU . 1.7 mm -78.68 108.14 7.37 Favored Pre-proline 0 N--CA 1.468 0.443 0 N-CA-C 113.199 0.815 . . . . 15.0 113.199 -178.651 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.458 ' HD3' ' O ' ' A' ' 40' ' ' VAL . 25.8 Cg_exo -62.35 72.52 0.11 Allowed 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 122.99 2.46 . . . . 15.0 112.264 179.341 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.422 ' N ' ' O ' ' A' ' 41' ' ' ILE . 0.6 OUTLIER -174.32 -41.66 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.687 -0.688 . . . . 15.0 110.245 179.926 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.595 ' HA3' ' HA3' ' A' ' 19' ' ' GLY . . . -87.3 150.63 22.85 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.651 -0.785 . . . . 15.0 112.409 179.613 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.832 ' HB3' ' O ' ' A' ' 17' ' ' SER . . . -39.5 -22.73 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 113.191 0.811 . . . . 15.0 113.191 -179.369 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.427 ' N ' ' O ' ' A' ' 44' ' ' GLY . . . -71.82 -70.2 0.34 Allowed 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.937 -0.305 . . . . 15.0 111.294 -179.625 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.716 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 4.3 tp10 -58.03 -38.94 77.17 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.904 0.383 . . . . 15.0 110.657 179.653 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -53.82 -60.6 3.11 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.092 -0.504 . . . . 15.0 110.358 179.867 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.532 ' CB ' HD11 ' A' ' 11' ' ' LEU . 0.7 OUTLIER -66.71 -38.73 87.32 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.142 -0.481 . . . . 15.0 109.982 179.07 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.48 41.05 10.3 Favored Glycine 0 N--CA 1.449 -0.486 0 CA-C-N 115.699 -0.682 . . . . 15.0 112.486 179.664 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.544 ' HB3' HG23 ' A' ' 9' ' ' VAL . 5.3 mmp_? -86.3 -55.91 3.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.906 0.384 . . . . 15.0 110.74 179.858 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.564 ' CG1' HD12 ' A' ' 20' ' ' ILE . 9.0 tp -81.12 160.63 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 CA-C-N 116.037 -0.529 . . . . 15.0 110.71 179.808 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.462 ' O ' ' HB2' ' A' ' 56' ' ' ASP . 62.2 m80 -141.17 160.54 39.88 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-O 121.73 0.776 . . . . 15.0 112.575 -179.077 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.625 ' HA ' ' CG2' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -45.77 137.45 5.44 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.398 -1.274 . . . . 15.0 112.497 -178.671 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.763 ' N ' HG22 ' A' ' 37' ' ' VAL . . . 49.73 32.7 17.88 Favored Glycine 0 C--N 1.334 0.452 0 CA-C-N 115.874 -0.603 . . . . 15.0 113.467 179.676 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.475 ' CB ' HD11 ' A' ' 52' ' ' ILE . 0.3 OUTLIER -66.06 127.59 32.72 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.314 -0.554 . . . . 15.0 110.205 179.09 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.538 ' HE ' HD21 ' A' ' 59' ' ' LEU . 5.8 ttt180 -83.17 83.32 7.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.277 -0.42 . . . . 15.0 110.097 179.713 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 1.053 HG22 HG22 ' A' ' 35' ' ' ILE . 1.0 OUTLIER -79.47 123.6 36.59 Favored 'Isoleucine or valine' 0 C--O 1.241 0.646 0 CA-C-O 121.089 0.471 . . . . 15.0 111.329 -179.259 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.581 HD12 ' HG2' ' A' ' 67' ' ' GLU . 3.4 mm? -107.62 -18.78 13.75 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.189 -0.914 . . . . 15.0 112.491 -179.461 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.482 ' O ' HD23 ' A' ' 87' ' ' LEU . . . -147.87 149.1 31.64 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 112.799 0.666 . . . . 15.0 112.799 -178.35 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.796 HG11 ' O ' ' A' ' 77' ' ' THR . 43.7 t -139.33 100.6 1.4 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.225 0 CA-C-N 115.297 -0.865 . . . . 15.0 109.281 178.596 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.822 ' ND2' HG22 ' A' ' 81' ' ' THR . 1.5 m-80 65.46 15.9 10.25 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.135 -0.484 . . . . 15.0 109.833 -178.149 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 106.79 5.47 35.89 Favored Glycine 0 C--N 1.336 0.559 0 CA-C-N 115.868 -0.605 . . . . 15.0 113.321 179.615 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.646 ' O ' HG13 ' A' ' 64' ' ' VAL . 5.4 p -93.8 106.17 17.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.092 0.473 . . . . 15.0 110.713 179.405 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -57.66 127.84 34.03 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.159 -0.473 . . . . 15.0 111.147 -179.472 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.568 HD13 ' HB3' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -88.87 -23.96 22.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.986 -0.552 . . . . 15.0 110.741 179.81 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.581 ' HG2' HD12 ' A' ' 59' ' ' LEU . 4.4 mm-40 -45.25 97.16 0.01 OUTLIER 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 116.374 -0.375 . . . . 15.0 110.928 179.863 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.79 62.6 0.54 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.791 -0.718 . . . . 15.0 112.073 -179.544 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.651 ' HB1' ' CB ' ' A' ' 73' ' ' GLN . . . -172.93 146.22 1.51 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.897 0.379 . . . . 15.0 110.86 -179.789 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.42 ' CB ' ' HA ' ' A' ' 26' ' ' VAL . 6.8 p -72.81 -171.85 0.92 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.072 0.463 . . . . 15.0 111.304 -179.62 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.642 ' NE2' HG23 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -65.39 -58.47 5.81 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.753 -0.658 . . . . 15.0 110.724 -179.91 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.413 ' HA ' ' HB ' ' A' ' 75' ' ' VAL . 15.6 ttpp -52.52 -31.46 35.54 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.018 -0.537 . . . . 15.0 110.52 179.725 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.651 ' CB ' ' HB1' ' A' ' 69' ' ' ALA . 4.1 mt-30 -59.59 -49.03 79.34 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.651 -0.5 . . . . 15.0 109.651 179.239 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.558 ' HA ' HD21 ' A' ' 66' ' ' LEU . . . -67.2 -45.16 77.72 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 109.495 -0.557 . . . . 15.0 109.495 178.404 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 1.02 HG23 HG21 ' A' ' 22' ' ' VAL . 0.5 OUTLIER -43.06 -41.92 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.272 0 N-CA-C 108.888 -0.782 . . . . 15.0 108.888 178.305 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.503 ' O ' ' HB2' ' A' ' 80' ' ' ASN . 1.6 mt-10 -67.17 -44.59 79.33 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 114.861 -1.063 . . . . 15.0 110.073 178.212 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.796 ' O ' HG11 ' A' ' 61' ' ' VAL . 68.7 p -64.08 -54.4 34.67 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-N 116.566 -0.288 . . . . 15.0 111.577 179.93 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.585 HD21 HG21 ' A' ' 58' ' ' VAL . 8.6 mt -53.56 -47.02 70.44 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.351 0.596 . . . . 15.0 109.903 179.855 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.427 ' HB2' ' O ' ' A' ' 75' ' ' VAL . 0.1 OUTLIER -68.44 -59.49 3.13 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.194 -0.912 . . . . 15.0 110.837 179.728 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.503 ' HB2' ' O ' ' A' ' 76' ' ' GLU . 12.0 m-80 -66.09 61.06 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.161 -0.472 . . . . 15.0 112.131 -179.859 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.822 HG22 ' ND2' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -95.7 -71.46 0.67 Allowed 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 110.0 -0.37 . . . . 15.0 110.0 179.02 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 116.85 -102.02 1.0 Allowed Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.838 -0.696 . . . . 15.0 112.979 179.055 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.81 -87.51 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.632 0.253 . . . . 15.0 111.437 -179.456 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.494 HG12 ' N ' ' A' ' 85' ' ' VAL . 84.1 t -109.85 160.69 8.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.951 0.405 . . . . 15.0 110.873 -179.816 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.896 HG23 ' HB2' ' A' ' 13' ' ' LYS . 3.3 t -97.71 81.43 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 121.258 0.551 . . . . 15.0 110.143 179.804 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -96.03 81.32 3.37 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.668 -0.697 . . . . 15.0 110.107 179.827 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.618 ' HB3' HD21 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -103.21 124.38 48.51 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.963 -0.562 . . . . 15.0 111.891 -178.947 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.661 ' N ' HD13 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -102.34 101.98 12.29 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.371 -0.603 . . . . 15.0 109.371 178.548 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.637 HD12 ' CE1' ' A' ' 7' ' ' PHE . 0.1 OUTLIER -105.65 -163.57 0.95 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.553 0.692 . . . . 15.0 112.09 -178.581 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.525 ' HA ' ' HA ' ' A' ' 6' ' ' ILE . 0.9 OUTLIER -138.79 134.87 34.01 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.731 -1.122 . . . . 15.0 109.433 178.845 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.87 105.15 0.06 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.857 0.36 . . . . 15.0 111.379 -179.219 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -63.0 144.36 49.44 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.777 -0.725 . . . . 15.0 112.581 -179.912 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -84.06 146.48 27.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.802 0.334 . . . . 15.0 110.91 179.972 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -83.31 143.83 45.63 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.234 -0.439 . . . . 15.0 110.89 -179.947 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -53.24 -48.02 24.32 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.554 2.169 . . . . 15.0 112.301 179.987 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 3.1 m . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.246 -0.883 . . . . 15.0 110.891 -179.943 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_endo . . . . . 0 N--CA 1.488 1.168 0 CA-C-O 120.806 0.253 . . . . 15.0 111.868 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.461 ' HB2' ' HD3' ' A' ' 3' ' ' PRO . 0.0 OUTLIER -147.41 -66.48 0.02 OUTLIER Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.227 -0.442 . . . . 15.0 110.991 179.809 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.461 ' HD3' ' HB2' ' A' ' 2' ' ' LYS . 72.2 Cg_endo -76.34 -169.14 0.65 Allowed 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.19 1.927 . . . . 15.0 112.371 179.908 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 83.15 -14.27 40.05 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.676 -0.773 . . . . 15.0 112.409 -179.764 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -72.36 134.24 45.36 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.31 0.576 . . . . 15.0 110.932 179.962 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.438 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 1.1 mp -81.96 147.3 6.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.217 -0.901 . . . . 15.0 111.0 -179.728 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.812 ' CZ ' HD12 ' A' ' 89' ' ' LEU . 4.0 p90 -140.65 157.71 45.05 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.191 -0.459 . . . . 15.0 110.58 179.087 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.723 ' HB2' HD12 ' A' ' 88' ' ' LEU . 11.3 pt-20 -124.71 141.83 51.83 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.226 0.536 . . . . 15.0 111.362 -179.557 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.566 HG23 ' HB3' ' A' ' 51' ' ' ARG . 0.2 OUTLIER -101.56 117.98 47.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.38 -0.827 . . . . 15.0 109.771 178.984 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -106.22 75.47 1.09 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.29 -0.414 . . . . 15.0 112.115 -179.064 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.566 ' HB3' ' HB ' ' A' ' 85' ' ' VAL . 11.4 tp -88.45 159.98 17.74 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.615 -0.513 . . . . 15.0 109.615 178.728 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.512 ' C ' ' H ' ' A' ' 14' ' ' ASN . . . -96.9 94.26 7.12 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 112.043 0.386 . . . . 15.0 112.043 -179.393 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.91 ' HB2' HG23 ' A' ' 85' ' ' VAL . 0.6 OUTLIER -65.82 29.21 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 112.435 0.531 . . . . 15.0 112.435 179.312 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.512 ' H ' ' C ' ' A' ' 12' ' ' ALA . 37.9 t30 -110.45 123.89 50.74 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.951 0.405 . . . . 15.0 111.68 -179.346 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.5 t0 64.78 11.24 6.71 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.864 -0.607 . . . . 15.0 112.039 179.333 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.436 ' HB2' ' HB2' ' A' ' 45' ' ' ALA . 9.3 p30 -165.63 133.05 2.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.969 0.414 . . . . 15.0 111.323 179.78 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.752 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 0.4 OUTLIER -89.78 -162.57 0.9 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.899 -0.592 . . . . 15.0 110.386 179.503 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.595 ' N ' HD22 ' A' ' 18' ' ' LEU . 2.2 mm? -81.99 -169.97 2.64 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 121.109 0.48 . . . . 15.0 110.722 179.476 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.596 ' O ' ' HB ' ' A' ' 41' ' ' ILE . . . -162.96 33.4 0.3 Allowed Glycine 0 C--O 1.223 -0.572 0 N-CA-C 110.83 -0.908 . . . . 15.0 110.83 -179.766 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.663 HD13 ' HB ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -113.87 143.26 23.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 112.243 0.46 . . . . 15.0 112.243 -179.159 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.742 ' CB ' HD11 ' A' ' 41' ' ' ILE . 1.7 t -96.41 103.45 15.36 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 107.745 -1.206 . . . . 15.0 107.745 176.676 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 1.028 HG21 HG23 ' A' ' 75' ' ' VAL . 29.6 m -93.5 149.82 4.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.368 0.604 . . . . 15.0 112.612 -177.367 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -149.51 -178.46 6.44 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.167 -0.924 . . . . 15.0 110.949 -179.411 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.556 ' O ' HG22 ' A' ' 26' ' ' VAL . . . 69.52 -117.64 7.86 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 120.802 -0.713 . . . . 15.0 112.251 -179.973 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.51 ' HA3' ' N ' ' A' ' 71' ' ' HIS . . . 67.2 -64.25 0.23 Allowed Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.904 -0.665 . . . . 15.0 113.668 179.362 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.556 HG22 ' O ' ' A' ' 24' ' ' GLY . 0.0 OUTLIER -28.99 137.51 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 N-CA-C 112.459 0.54 . . . . 15.0 112.459 -179.255 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 11.5 m-80 -75.56 61.3 1.3 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.802 -0.635 . . . . 15.0 111.016 -179.729 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -151.74 -53.76 0.13 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.341 -0.39 . . . . 15.0 111.074 179.971 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.6 m -81.92 -45.64 15.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.155 -0.475 . . . . 15.0 111.133 -179.812 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.555 HG22 ' O ' ' A' ' 26' ' ' VAL . 34.8 m -72.15 -175.23 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.22 -0.445 . . . . 15.0 111.271 -179.838 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.5 -60.55 3.16 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.204 -0.453 . . . . 15.0 111.202 -179.942 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 5.4 p-80 -146.62 -46.81 0.19 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.357 -0.383 . . . . 15.0 111.235 -179.847 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -169.2 25.81 0.11 Allowed Glycine 0 N--CA 1.453 -0.2 0 C-N-CA 120.749 -0.738 . . . . 15.0 112.686 -179.73 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -94.28 153.41 21.05 Favored Glycine 0 N--CA 1.449 -0.47 0 N-CA-C 110.629 -0.989 . . . . 15.0 110.629 178.838 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.952 HG22 HG22 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -94.18 152.77 3.52 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.321 0 CA-C-N 117.727 0.764 . . . . 15.0 112.073 -179.252 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.51 ' CZ ' ' HG2' ' A' ' 57' ' ' ARG . 44.5 m-85 -136.04 106.29 6.39 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.84 -1.073 . . . . 15.0 109.613 178.849 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.817 HG22 ' N ' ' A' ' 55' ' ' GLY . 0.6 OUTLIER -55.22 145.74 5.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.911 -0.586 . . . . 15.0 111.491 -178.846 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.458 ' O ' ' HG2' ' A' ' 54' ' ' LYS . 1.2 ttpt -81.91 -47.45 12.74 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.342 -0.984 . . . . 15.0 108.342 178.213 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.545 ' O ' HG12 ' A' ' 20' ' ' ILE . . . -172.2 169.79 5.35 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.625 -0.716 . . . . 15.0 111.366 178.679 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.577 HG12 HG13 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -97.5 121.04 47.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-N 116.254 -0.43 . . . . 15.0 111.131 -179.871 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.742 HD11 ' CB ' ' A' ' 21' ' ' SER . 1.5 mm -78.98 110.33 14.16 Favored Pre-proline 0 N--CA 1.466 0.368 0 N-CA-C 113.135 0.791 . . . . 15.0 113.135 -178.919 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.524 ' HA ' ' OE1' ' A' ' 47' ' ' GLU . 17.8 Cg_exo -65.8 63.68 0.42 Allowed 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 122.858 2.372 . . . . 15.0 112.213 179.243 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 1.9 mm-40 -159.48 -45.81 0.05 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.654 -0.703 . . . . 15.0 109.85 179.873 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.513 ' HA3' ' HA3' ' A' ' 19' ' ' GLY . . . -87.42 151.51 23.47 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.68 -0.772 . . . . 15.0 112.374 179.518 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.752 ' HB3' ' O ' ' A' ' 17' ' ' SER . . . -39.96 -19.58 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 113.494 0.924 . . . . 15.0 113.494 -179.326 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.448 ' N ' ' O ' ' A' ' 44' ' ' GLY . . . -71.72 -70.95 0.29 Allowed 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.829 -0.348 . . . . 15.0 111.426 -179.453 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.592 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 9.9 tm-20 -58.2 -38.25 76.37 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.823 0.344 . . . . 15.0 110.336 179.599 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.3 m -53.9 -64.97 0.66 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.164 -0.471 . . . . 15.0 110.449 179.821 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.491 ' CB ' HD11 ' A' ' 11' ' ' LEU . 0.4 OUTLIER -63.21 -37.51 87.54 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.151 -0.477 . . . . 15.0 109.979 179.112 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.49 37.46 17.31 Favored Glycine 0 N--CA 1.449 -0.439 0 CA-C-N 115.726 -0.67 . . . . 15.0 112.377 179.695 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.566 ' HB3' HG23 ' A' ' 9' ' ' VAL . 0.9 OUTLIER -82.8 -54.65 4.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.938 0.399 . . . . 15.0 110.543 179.91 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.656 HG12 HD12 ' A' ' 20' ' ' ILE . 11.4 tp -81.18 159.07 4.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.979 -0.555 . . . . 15.0 110.177 179.458 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.4 ' N ' ' OD2' ' A' ' 56' ' ' ASP . 76.1 m80 -142.16 160.67 39.76 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 121.766 0.793 . . . . 15.0 112.813 -178.784 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.585 ' HA ' ' CG2' ' A' ' 37' ' ' VAL . 1.2 mtpt -44.01 134.73 4.53 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 113.93 -1.486 . . . . 15.0 112.762 -178.788 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.817 ' N ' HG22 ' A' ' 37' ' ' VAL . . . 49.75 29.82 13.54 Favored Glycine 0 C--N 1.334 0.428 0 CA-C-N 115.791 -0.64 . . . . 15.0 113.448 179.261 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.4 ' OD2' ' N ' ' A' ' 53' ' ' HIS . 6.2 m-20 -65.78 128.75 37.26 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.761 -0.376 . . . . 15.0 110.413 179.359 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.612 ' HD2' HD21 ' A' ' 59' ' ' LEU . 0.0 OUTLIER -82.08 93.49 7.02 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.362 -0.381 . . . . 15.0 110.54 -179.988 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.952 HG22 HG22 ' A' ' 35' ' ' ILE . 1.2 m -86.26 115.7 27.86 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 CA-C-O 121.112 0.482 . . . . 15.0 111.586 -179.32 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.612 HD21 ' HD2' ' A' ' 57' ' ' ARG . 4.5 mm? -107.68 -14.67 14.76 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 115.633 -0.712 . . . . 15.0 112.542 -179.496 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.587 ' HB3' ' HB2' ' A' ' 88' ' ' LEU . . . -147.56 150.33 34.27 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 112.743 0.646 . . . . 15.0 112.743 -178.394 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.9 HG11 ' O ' ' A' ' 77' ' ' THR . 98.2 t -139.21 103.01 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.202 -0.908 . . . . 15.0 109.066 178.808 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.697 ' ND2' HG22 ' A' ' 81' ' ' THR . 1.2 m-80 65.23 16.9 10.79 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.516 -0.55 . . . . 15.0 109.516 -178.038 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.0 6.97 44.98 Favored Glycine 0 C--N 1.335 0.49 0 CA-C-N 115.789 -0.641 . . . . 15.0 113.135 179.814 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.658 ' O ' HG13 ' A' ' 64' ' ' VAL . 6.0 p -93.86 106.56 18.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.062 0.458 . . . . 15.0 110.724 179.394 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -58.3 122.98 14.56 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.179 -0.464 . . . . 15.0 110.955 -179.488 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.493 HD11 ' OG1' ' A' ' 77' ' ' THR . 3.7 mt -94.38 -12.53 27.73 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.836 -0.62 . . . . 15.0 111.286 -179.92 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -44.65 98.05 0.01 OUTLIER 'General case' 0 N--CA 1.461 0.1 0 CA-C-O 120.865 0.364 . . . . 15.0 110.894 179.855 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.85 67.53 0.6 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.838 -0.696 . . . . 15.0 112.102 -179.46 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.614 ' HB1' ' CB ' ' A' ' 73' ' ' GLN . . . -172.91 148.16 1.76 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.78 0.324 . . . . 15.0 110.837 -179.683 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.468 ' HB ' ' HA ' ' A' ' 26' ' ' VAL . 1.4 p -72.86 -174.2 1.41 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.019 0.438 . . . . 15.0 111.041 -179.731 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.752 ' CD2' HG23 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -63.51 -59.03 5.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.885 -0.598 . . . . 15.0 110.658 -179.822 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.413 ' HA ' ' HB ' ' A' ' 75' ' ' VAL . 18.1 ttpp -52.44 -33.19 43.09 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.987 -0.551 . . . . 15.0 110.75 179.669 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.614 ' CB ' ' HB1' ' A' ' 69' ' ' ALA . 3.0 mt-30 -59.57 -49.98 75.65 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.428 -0.582 . . . . 15.0 109.428 179.123 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.458 ' HA ' ' OG1' ' A' ' 77' ' ' THR . . . -67.05 -45.93 75.93 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.743 -0.662 . . . . 15.0 109.836 178.482 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 1.028 HG23 HG21 ' A' ' 22' ' ' VAL . 0.5 OUTLIER -41.87 -41.49 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.27 0 CA-C-O 121.524 0.678 . . . . 15.0 109.218 178.553 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -67.33 -44.93 77.88 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.762 -1.108 . . . . 15.0 110.681 178.941 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.9 ' O ' HG11 ' A' ' 61' ' ' VAL . 15.3 p -64.38 -54.9 25.61 Favored 'General case' 0 N--CA 1.463 0.184 0 C-N-CA 121.028 -0.269 . . . . 15.0 111.599 -179.96 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.739 HD23 HG21 ' A' ' 61' ' ' VAL . 6.5 mt -53.43 -47.79 69.32 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-O 121.122 0.487 . . . . 15.0 110.188 -179.752 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.424 ' HB2' ' O ' ' A' ' 75' ' ' VAL . 3.1 ttp180 -68.32 -57.48 5.87 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.554 -0.748 . . . . 15.0 110.479 179.521 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -66.11 61.69 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.016 -0.538 . . . . 15.0 111.906 179.859 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.697 HG22 ' ND2' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -95.57 -74.97 0.54 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.719 0.295 . . . . 15.0 110.234 179.236 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.401 ' O ' ' HG3' ' A' ' 13' ' ' LYS . . . 120.36 -102.33 0.86 Allowed Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.775 -0.726 . . . . 15.0 112.88 179.381 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -64.7 -86.02 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.609 0.242 . . . . 15.0 111.209 -179.627 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.491 HG12 ' N ' ' A' ' 85' ' ' VAL . 86.8 t -109.77 160.36 8.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.886 0.374 . . . . 15.0 110.778 -179.924 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.91 HG23 ' HB2' ' A' ' 13' ' ' LYS . 3.1 t -97.66 81.86 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.214 0.53 . . . . 15.0 110.195 179.868 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -96.08 82.29 3.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.687 -0.688 . . . . 15.0 110.344 179.895 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.756 ' HB3' HD21 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -101.95 121.83 42.89 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.933 -0.576 . . . . 15.0 111.719 -179.281 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.723 HD12 ' HB2' ' A' ' 8' ' ' GLU . 4.7 mp -99.4 100.76 11.86 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.521 -0.548 . . . . 15.0 109.521 178.745 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.812 HD12 ' CZ ' ' A' ' 7' ' ' PHE . 0.1 OUTLIER -105.52 -161.52 0.81 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.456 0.646 . . . . 15.0 112.031 -178.501 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.438 ' HA ' ' HA ' ' A' ' 6' ' ' ILE . 1.1 tt0 -138.88 142.58 38.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 114.862 -1.063 . . . . 15.0 109.629 178.969 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 2.5 tppp? -54.48 106.04 0.18 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.978 0.418 . . . . 15.0 111.242 -179.421 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -72.32 66.55 1.25 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.971 -0.633 . . . . 15.0 112.438 179.914 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -76.35 122.69 24.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.876 0.369 . . . . 15.0 110.976 -179.935 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.7 m -78.56 163.45 61.23 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.164 -0.471 . . . . 15.0 110.904 179.941 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -53.46 -62.44 0.33 Allowed 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.601 2.201 . . . . 15.0 112.297 -179.97 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 3.1 m . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.261 -0.876 . . . . 15.0 110.934 179.972 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_endo . . . . . 0 N--CA 1.488 1.199 0 CA-C-O 120.922 0.301 . . . . 15.0 111.81 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.17 149.3 19.32 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.087 -0.506 . . . . 15.0 110.803 179.946 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -55.09 -168.18 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.438 2.092 . . . . 15.0 112.31 -179.975 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 83.27 -14.02 42.14 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.583 -0.818 . . . . 15.0 112.332 -179.616 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -69.4 155.94 39.64 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-O 121.268 0.556 . . . . 15.0 110.867 179.884 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.443 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 1.4 mp -104.32 143.85 15.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.257 -0.883 . . . . 15.0 111.034 -179.441 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.519 ' CE1' HD12 ' A' ' 89' ' ' LEU . 4.8 p90 -140.45 166.81 23.71 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.182 -0.463 . . . . 15.0 110.37 178.871 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.725 ' HB3' HD12 ' A' ' 88' ' ' LEU . 4.2 pt-20 -130.22 142.87 50.53 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.269 0.557 . . . . 15.0 111.88 -179.21 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.676 ' CG1' HD11 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -101.38 115.93 44.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.237 -0.892 . . . . 15.0 109.332 178.805 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.406 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 4.1 tt0 -105.96 76.37 1.17 Allowed 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 112.696 0.628 . . . . 15.0 112.696 -178.394 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.512 ' HB3' ' HB ' ' A' ' 85' ' ' VAL . 6.9 tp -88.16 162.03 16.93 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.018 -0.734 . . . . 15.0 109.018 177.995 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.441 ' O ' ' N ' ' A' ' 14' ' ' ASN . . . -96.92 89.98 5.05 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 112.431 0.53 . . . . 15.0 112.431 -179.185 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.689 ' HB2' HG23 ' A' ' 85' ' ' VAL . 0.1 OUTLIER -65.58 54.67 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.033 -0.531 . . . . 15.0 111.552 178.9 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.441 ' N ' ' O ' ' A' ' 12' ' ' ALA . 42.6 t-20 -108.98 -87.53 0.5 Allowed 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 111.734 0.272 . . . . 15.0 111.734 -179.347 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -101.35 24.29 9.79 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.666 0.27 . . . . 15.0 111.373 -179.462 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.491 ' HB2' ' HB2' ' A' ' 45' ' ' ALA . 1.0 OUTLIER -165.41 128.86 2.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.95 0.405 . . . . 15.0 111.113 179.897 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.802 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 0.0 OUTLIER -89.73 -162.63 0.9 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.928 -0.578 . . . . 15.0 110.545 179.615 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.587 ' N ' HD22 ' A' ' 18' ' ' LEU . 2.4 mm? -80.15 -166.43 1.04 Allowed 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 116.359 -0.382 . . . . 15.0 110.457 179.595 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.663 ' O ' ' HB ' ' A' ' 41' ' ' ILE . . . -167.51 37.1 0.22 Allowed Glycine 0 CA--C 1.506 -0.52 0 N-CA-C 111.566 -0.614 . . . . 15.0 111.566 -179.609 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.681 HD13 ' HB ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -112.5 142.28 25.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 112.216 0.45 . . . . 15.0 112.216 -179.04 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.435 ' H ' HD13 ' A' ' 41' ' ' ILE . 30.9 t -95.46 101.66 13.4 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 107.079 -1.452 . . . . 15.0 107.079 176.657 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.965 HG21 HG23 ' A' ' 75' ' ' VAL . 35.5 m -93.26 156.7 3.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 113.236 0.828 . . . . 15.0 113.236 -176.364 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.25 -175.03 4.82 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 114.966 -1.016 . . . . 15.0 110.647 -179.694 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.553 ' O ' HG22 ' A' ' 26' ' ' VAL . . . 68.79 -121.38 12.15 Favored Glycine 0 C--N 1.332 0.32 0 C-N-CA 120.868 -0.682 . . . . 15.0 112.469 179.8 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.521 ' HA3' ' N ' ' A' ' 71' ' ' HIS . . . 66.76 -64.42 0.18 Allowed Glycine 0 CA--C 1.518 0.269 0 C-N-CA 120.997 -0.621 . . . . 15.0 113.679 179.285 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.553 HG22 ' O ' ' A' ' 24' ' ' GLY . 0.0 OUTLIER -30.46 146.97 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 N-CA-C 112.591 0.589 . . . . 15.0 112.591 -179.204 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -75.75 56.31 0.92 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.872 -0.604 . . . . 15.0 111.066 -179.946 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.3 m -151.96 -63.61 0.17 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.914 0.388 . . . . 15.0 111.202 -179.986 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 30.9 t -67.07 -50.43 61.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.046 -0.524 . . . . 15.0 111.325 -179.575 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.532 HG11 ' O ' ' A' ' 34' ' ' GLY . 19.6 m -69.45 -175.94 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.378 -0.374 . . . . 15.0 111.415 -179.644 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.405 ' HD3' ' NH2' ' A' ' 57' ' ' ARG . 46.2 mtp85 -62.4 -53.06 60.53 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.162 -0.472 . . . . 15.0 111.089 -179.859 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . 0.418 ' CD2' ' HG2' ' A' ' 67' ' ' GLU . 42.1 p-80 -142.24 -52.79 0.41 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.449 -0.341 . . . . 15.0 111.201 179.939 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -169.18 19.01 0.08 OUTLIER Glycine 0 CA--C 1.519 0.328 0 C-N-CA 120.522 -0.847 . . . . 15.0 113.097 -179.802 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.532 ' O ' HG11 ' A' ' 30' ' ' VAL . . . -85.27 152.92 27.21 Favored Glycine 0 N--CA 1.45 -0.401 0 N-CA-C 110.797 -0.921 . . . . 15.0 110.797 178.89 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.944 HG22 HG22 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -90.54 154.97 3.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 117.642 0.721 . . . . 15.0 111.851 -179.352 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 30.4 m-85 -141.8 107.34 5.06 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.028 -0.987 . . . . 15.0 109.737 178.918 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.776 HG22 ' N ' ' A' ' 55' ' ' GLY . 0.8 OUTLIER -55.3 150.83 2.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.035 -0.53 . . . . 15.0 111.315 -178.9 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.496 ' O ' ' HG2' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -82.37 -47.04 12.78 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.416 -0.957 . . . . 15.0 108.416 178.412 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.588 ' O ' HG12 ' A' ' 20' ' ' ILE . . . -172.17 173.37 4.3 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.361 -0.836 . . . . 15.0 110.231 178.569 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.629 ' HA ' HG12 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -97.36 108.69 22.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.892 0.377 . . . . 15.0 110.349 179.647 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.663 ' HB ' ' O ' ' A' ' 19' ' ' GLY . 0.8 OUTLIER -78.96 110.53 14.86 Favored Pre-proline 0 C--O 1.234 0.245 0 N-CA-C 113.046 0.758 . . . . 15.0 113.046 -178.322 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.563 ' HA ' ' OE1' ' A' ' 47' ' ' GLU . 22.7 Cg_exo -64.28 66.58 0.24 Allowed 'Trans proline' 0 C--N 1.356 0.96 0 C-N-CA 123.177 2.585 . . . . 15.0 112.721 179.771 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.536 ' HB2' HG22 ' A' ' 41' ' ' ILE . 12.8 mt-30 -148.42 -52.88 0.18 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.483 -0.781 . . . . 15.0 109.258 179.233 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.644 ' HA3' ' HA3' ' A' ' 19' ' ' GLY . . . -88.24 156.19 26.91 Favored Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.612 -0.804 . . . . 15.0 112.474 179.044 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.802 ' HB3' ' O ' ' A' ' 17' ' ' SER . . . -42.5 -16.46 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 113.432 0.901 . . . . 15.0 113.432 -179.696 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.437 ' N ' ' O ' ' A' ' 44' ' ' GLY . . . -71.57 -70.27 0.33 Allowed 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.92 -0.312 . . . . 15.0 111.474 -179.258 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.563 ' OE1' ' HA ' ' A' ' 42' ' ' PRO . 10.2 tm-20 -58.31 -36.13 72.89 Favored 'General case' 0 N--CA 1.463 0.211 0 C-N-CA 120.504 -0.479 . . . . 15.0 110.064 179.408 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 48.8 m -57.57 -66.99 0.37 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.925 -0.58 . . . . 15.0 110.186 179.411 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.454 ' CB ' HD11 ' A' ' 11' ' ' LEU . 0.8 OUTLIER -60.55 -37.65 81.94 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.096 0.475 . . . . 15.0 109.881 179.004 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.44 37.43 17.54 Favored Glycine 0 N--CA 1.449 -0.461 0 CA-C-N 115.58 -0.736 . . . . 15.0 112.504 179.585 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.556 ' HB3' HG23 ' A' ' 9' ' ' VAL . 14.3 mmt180 -84.77 -49.75 8.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.94 0.4 . . . . 15.0 110.621 179.999 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.649 HG12 HD12 ' A' ' 20' ' ' ILE . 11.1 tp -81.19 157.22 4.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.016 -0.538 . . . . 15.0 110.347 179.537 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 76.6 m80 -139.65 158.1 44.67 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-O 121.753 0.787 . . . . 15.0 112.71 -179.006 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.599 ' HA ' ' CG2' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -44.25 134.95 4.72 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.137 -1.392 . . . . 15.0 112.477 -178.893 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.776 ' N ' HG22 ' A' ' 37' ' ' VAL . . . 49.7 34.32 21.0 Favored Glycine 0 C--N 1.334 0.456 0 C-N-CA 121.135 -0.555 . . . . 15.0 112.907 179.569 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.43 ' OD2' HD12 ' A' ' 52' ' ' ILE . 1.1 m-20 -65.5 130.64 44.04 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 121.003 -0.279 . . . . 15.0 110.439 179.636 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.405 ' NH2' ' HD3' ' A' ' 31' ' ' ARG . 59.7 ttt180 -86.33 86.45 7.34 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.112 -0.494 . . . . 15.0 110.432 179.792 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.944 HG22 HG22 ' A' ' 35' ' ' ILE . 1.3 m -79.41 116.68 23.79 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 CA-C-O 121.095 0.474 . . . . 15.0 110.948 -179.618 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 20.0 mt -107.19 -18.71 13.81 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.563 -0.744 . . . . 15.0 112.254 -179.323 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.424 ' HA ' ' O ' ' A' ' 64' ' ' VAL . . . -148.29 148.79 30.83 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 112.479 0.548 . . . . 15.0 112.479 -178.898 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.791 HG11 ' O ' ' A' ' 77' ' ' THR . 26.1 t -139.16 102.18 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.339 -0.846 . . . . 15.0 109.173 178.878 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.743 ' ND2' HG22 ' A' ' 81' ' ' THR . 1.4 m-80 64.8 15.03 9.58 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.699 -0.482 . . . . 15.0 109.699 -177.966 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 107.1 5.76 34.79 Favored Glycine 0 C--N 1.337 0.606 0 CA-C-N 115.86 -0.609 . . . . 15.0 113.425 179.727 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.657 ' O ' HG13 ' A' ' 64' ' ' VAL . 6.2 p -93.92 106.83 18.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 117.181 0.49 . . . . 15.0 111.083 179.474 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.99 134.24 55.6 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.217 -0.447 . . . . 15.0 110.995 -179.877 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.611 HD21 ' HA ' ' A' ' 74' ' ' ALA . 0.1 OUTLIER -95.5 -22.78 17.44 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.024 -0.535 . . . . 15.0 111.015 -179.958 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.418 ' HG2' ' CD2' ' A' ' 32' ' ' HIS . 1.8 tt0 -46.27 100.42 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.899 0.38 . . . . 15.0 111.064 179.942 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.73 63.67 0.55 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.814 -0.708 . . . . 15.0 112.222 -179.719 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.59 ' HB1' ' CG ' ' A' ' 73' ' ' GLN . . . -173.03 167.12 5.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.829 0.347 . . . . 15.0 111.117 -179.798 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.437 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 16.2 p -93.23 -175.11 3.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.227 -0.442 . . . . 15.0 111.095 -179.883 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.773 ' CD2' HG23 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -62.17 -60.49 3.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.918 -0.583 . . . . 15.0 110.447 179.977 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.425 ' N ' ' CG ' ' A' ' 71' ' ' HIS . 8.0 ttpp -52.41 -31.12 32.66 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.814 -0.63 . . . . 15.0 110.517 179.448 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.59 ' CG ' ' HB1' ' A' ' 69' ' ' ALA . 0.3 OUTLIER -59.32 -52.02 67.42 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.64 -0.504 . . . . 15.0 109.64 179.335 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.611 ' HA ' HD21 ' A' ' 66' ' ' LEU . . . -66.95 -45.96 76.18 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.092 -0.504 . . . . 15.0 109.706 178.495 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.965 HG23 HG21 ' A' ' 22' ' ' VAL . 0.5 OUTLIER -41.43 -40.04 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.221 0 N-CA-C 109.123 -0.695 . . . . 15.0 109.123 178.43 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.421 ' HG3' ' O ' ' A' ' 72' ' ' LYS . 22.5 mt-10 -67.47 -46.72 72.18 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 114.731 -1.122 . . . . 15.0 110.244 178.488 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.791 ' O ' HG11 ' A' ' 61' ' ' VAL . 44.8 p -64.33 -51.9 61.14 Favored 'General case' 0 N--CA 1.461 0.102 0 C-N-CA 120.991 -0.283 . . . . 15.0 111.24 179.637 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.617 HD21 HG21 ' A' ' 58' ' ' VAL . 5.6 mt -53.53 -49.98 66.44 Favored 'General case' 0 CA--C 1.521 -0.168 0 CA-C-O 121.22 0.533 . . . . 15.0 109.878 179.934 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.46 -61.45 1.83 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.357 -0.838 . . . . 15.0 110.467 179.387 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -65.92 62.71 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.926 -0.579 . . . . 15.0 111.792 179.844 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.743 HG22 ' ND2' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -91.85 -69.81 0.72 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.648 0.261 . . . . 15.0 110.443 179.52 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 122.32 -107.19 1.13 Allowed Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.872 -0.68 . . . . 15.0 112.939 179.441 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.81 -83.56 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.775 0.321 . . . . 15.0 111.545 -179.45 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.474 HG12 ' N ' ' A' ' 85' ' ' VAL . 62.7 t -109.82 159.92 9.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.855 0.36 . . . . 15.0 110.335 179.999 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.689 HG23 ' HB2' ' A' ' 13' ' ' LYS . 24.4 t -97.85 80.16 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-O 121.016 0.436 . . . . 15.0 110.687 -179.943 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -98.46 81.89 2.79 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.893 -0.594 . . . . 15.0 110.447 179.865 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.772 ' HB3' HD21 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -101.15 118.03 36.19 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.045 -0.525 . . . . 15.0 111.742 -179.229 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.725 HD12 ' HB3' ' A' ' 8' ' ' GLU . 0.2 OUTLIER -94.99 101.47 13.23 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.302 -0.629 . . . . 15.0 109.302 178.657 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.772 HD21 ' HB3' ' A' ' 87' ' ' LEU . 0.2 OUTLIER -104.6 -162.29 0.88 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.417 0.627 . . . . 15.0 111.752 -178.629 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.443 ' HA ' ' HA ' ' A' ' 6' ' ' ILE . 2.2 tt0 -139.86 143.1 36.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.085 -0.961 . . . . 15.0 109.888 179.062 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -54.03 102.99 0.07 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.904 0.383 . . . . 15.0 110.96 -179.642 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -69.11 -169.32 6.1 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.84 -0.695 . . . . 15.0 112.65 -179.757 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 7.9 mm-40 -82.48 122.2 27.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.833 0.349 . . . . 15.0 110.895 -179.956 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 33.6 m -87.54 161.61 44.79 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.162 -0.472 . . . . 15.0 110.849 179.948 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -50.16 -33.76 36.81 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.529 2.153 . . . . 15.0 112.344 -179.976 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.22 -0.895 . . . . 15.0 110.878 179.94 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo . . . . . 0 N--CA 1.488 1.183 0 CA-C-O 120.892 0.288 . . . . 15.0 111.793 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.499 ' HB3' ' HD3' ' A' ' 3' ' ' PRO . 0.0 OUTLIER -155.43 -64.82 0.02 OUTLIER Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.13 -0.487 . . . . 15.0 110.739 179.893 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.499 ' HD3' ' HB3' ' A' ' 2' ' ' LYS . 72.9 Cg_exo -40.96 120.66 1.11 Allowed 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.717 2.278 . . . . 15.0 113.017 179.621 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 82.9 -24.12 5.44 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.27 -0.967 . . . . 15.0 112.295 179.651 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.403 ' HB2' ' O ' ' A' ' 2' ' ' LYS . 1.5 m-20 -61.43 141.63 57.53 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-O 121.457 0.646 . . . . 15.0 110.853 -179.926 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.461 ' HA ' ' HA ' ' A' ' 90' ' ' GLU . 1.3 mp -74.19 147.32 9.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 114.894 -1.048 . . . . 15.0 111.655 -179.112 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.554 ' CZ ' HD12 ' A' ' 89' ' ' LEU . 3.3 p90 -141.68 165.06 28.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.884 -0.598 . . . . 15.0 110.263 178.759 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.774 ' HB2' HD12 ' A' ' 88' ' ' LEU . 0.2 OUTLIER -130.16 142.21 50.6 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.272 0.558 . . . . 15.0 111.615 -179.442 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.655 ' CG1' HD11 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -101.49 117.29 46.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.327 -0.851 . . . . 15.0 109.819 178.958 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -106.24 74.44 1.03 Allowed 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 112.166 0.432 . . . . 15.0 112.166 -179.031 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.585 HD13 ' CG ' ' A' ' 51' ' ' ARG . 8.7 tp -88.42 165.64 14.78 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.847 -0.427 . . . . 15.0 109.847 178.778 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -94.75 94.7 8.25 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.039 0.447 . . . . 15.0 111.186 -179.945 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.516 ' CB ' HG23 ' A' ' 85' ' ' VAL . 0.0 OUTLIER -54.56 -29.89 52.45 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.797 -0.638 . . . . 15.0 111.2 179.945 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.457 ' O ' ' CB ' ' A' ' 15' ' ' ASP . 93.0 m-20 -84.51 147.46 27.04 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.239 -0.437 . . . . 15.0 110.617 179.908 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.457 ' CB ' ' O ' ' A' ' 14' ' ' ASN . 1.8 t0 86.03 -39.01 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.054 -0.521 . . . . 15.0 111.157 -179.617 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 34.6 m-20 -155.31 145.5 21.78 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.818 0.342 . . . . 15.0 110.973 179.938 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.686 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 0.4 OUTLIER -86.09 -163.77 0.93 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.128 -0.487 . . . . 15.0 110.698 179.908 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.576 ' H ' HD22 ' A' ' 18' ' ' LEU . 1.4 mm? -80.48 -170.27 2.5 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 116.245 -0.434 . . . . 15.0 110.449 179.35 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.643 ' O ' ' HB ' ' A' ' 41' ' ' ILE . . . -161.57 31.02 0.32 Allowed Glycine 0 CA--C 1.507 -0.431 0 N-CA-C 111.535 -0.626 . . . . 15.0 111.535 -179.835 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.64 HD12 ' CG1' ' A' ' 52' ' ' ILE . 0.0 OUTLIER -112.62 139.76 35.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 121.061 0.458 . . . . 15.0 111.936 -179.206 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.468 ' O ' ' HB3' ' A' ' 38' ' ' LYS . 42.4 t -96.25 100.22 11.87 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 107.587 -1.264 . . . . 15.0 107.587 176.951 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.741 HG23 ' CD2' ' A' ' 71' ' ' HIS . 1.3 m -93.68 152.01 3.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 112.622 0.601 . . . . 15.0 112.622 -176.971 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.538 HG22 ' HB2' ' A' ' 38' ' ' LYS . 15.3 t -149.47 177.52 9.64 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.393 -0.822 . . . . 15.0 110.689 179.632 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.66 ' O ' HG22 ' A' ' 26' ' ' VAL . . . 83.05 -115.07 3.95 Favored Glycine 0 C--N 1.332 0.353 0 C-N-CA 120.723 -0.751 . . . . 15.0 112.136 -179.779 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.563 ' HA3' ' N ' ' A' ' 71' ' ' HIS . . . 63.79 -65.24 0.04 OUTLIER Glycine 0 C--N 1.331 0.266 0 C-N-CA 121.002 -0.618 . . . . 15.0 113.781 178.933 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.66 HG22 ' O ' ' A' ' 24' ' ' GLY . 0.0 OUTLIER -30.73 143.13 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 N-CA-C 112.234 0.457 . . . . 15.0 112.234 -179.116 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.409 ' CB ' ' O ' ' A' ' 32' ' ' HIS . 14.3 p-10 -75.59 62.26 1.41 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.956 -0.565 . . . . 15.0 111.0 -179.692 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 40.9 m -151.73 -67.13 0.17 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.308 -0.405 . . . . 15.0 111.088 -179.96 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -68.98 -32.45 72.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.137 -0.483 . . . . 15.0 111.071 -179.8 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.587 HG22 ' O ' ' A' ' 26' ' ' VAL . 19.8 m -88.09 -172.85 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.239 -0.437 . . . . 15.0 111.269 -179.895 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -61.94 -63.14 1.35 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.138 -0.483 . . . . 15.0 111.031 -179.984 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . 0.409 ' O ' ' CB ' ' A' ' 27' ' ' ASN . 90.8 m-70 -136.26 -49.72 0.68 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.294 -0.412 . . . . 15.0 111.103 -179.853 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -171.13 26.13 0.1 OUTLIER Glycine 0 C--N 1.329 0.155 0 C-N-CA 120.789 -0.72 . . . . 15.0 112.595 -179.755 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -89.51 154.43 24.13 Favored Glycine 0 N--CA 1.449 -0.472 0 N-CA-C 110.749 -0.94 . . . . 15.0 110.749 178.836 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.832 HG22 HG22 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -93.6 153.82 3.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 117.648 0.724 . . . . 15.0 111.828 -179.265 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.511 ' CE2' ' CG ' ' A' ' 57' ' ' ARG . 42.7 m-85 -138.39 106.28 5.67 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.957 -1.02 . . . . 15.0 109.859 179.69 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.818 HG22 ' N ' ' A' ' 55' ' ' GLY . 0.7 OUTLIER -55.27 145.29 5.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.164 -0.471 . . . . 15.0 111.002 -179.179 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.538 ' HB2' HG22 ' A' ' 23' ' ' THR . 0.2 OUTLIER -80.13 -47.57 14.55 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.661 -0.866 . . . . 15.0 108.661 178.512 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.567 ' O ' HG12 ' A' ' 20' ' ' ILE . . . -172.23 170.45 5.14 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 115.698 -0.683 . . . . 15.0 110.309 178.397 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.595 ' HA ' HG12 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -97.07 111.7 27.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.928 0.394 . . . . 15.0 110.264 179.638 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.643 ' HB ' ' O ' ' A' ' 19' ' ' GLY . 0.4 OUTLIER -78.65 109.99 12.57 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 115.781 -0.645 . . . . 15.0 112.632 -178.293 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.45 ' N ' ' HG2' ' A' ' 47' ' ' GLU . 24.5 Cg_exo -62.47 68.55 0.12 Allowed 'Trans proline' 0 C--N 1.356 0.935 0 C-N-CA 123.211 2.607 . . . . 15.0 112.507 179.828 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.478 ' HB2' HG22 ' A' ' 41' ' ' ILE . 8.1 mm-40 -153.43 -52.93 0.1 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.628 -0.715 . . . . 15.0 109.825 179.638 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.499 ' HA3' ' HA3' ' A' ' 19' ' ' GLY . . . -87.78 155.9 27.15 Favored Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.66 -0.781 . . . . 15.0 112.481 179.393 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.686 ' HB3' ' O ' ' A' ' 17' ' ' SER . . . -41.05 -16.8 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 113.517 0.932 . . . . 15.0 113.517 -179.546 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.463 ' N ' ' O ' ' A' ' 44' ' ' GLY . . . -71.68 -71.76 0.26 Allowed 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.819 -0.353 . . . . 15.0 111.155 -179.739 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.542 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 4.1 tp10 -58.27 -39.78 80.13 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 121.033 0.445 . . . . 15.0 110.402 179.569 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.2 m -53.98 -64.5 0.81 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.904 -0.589 . . . . 15.0 110.434 179.537 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.526 ' CB ' HD11 ' A' ' 11' ' ' LEU . 3.7 m-20 -64.79 -37.62 88.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.163 -0.471 . . . . 15.0 110.175 179.273 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.62 38.22 14.85 Favored Glycine 0 N--CA 1.45 -0.41 0 CA-C-N 115.744 -0.662 . . . . 15.0 112.571 179.581 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.585 ' CG ' HD13 ' A' ' 11' ' ' LEU . 0.2 OUTLIER -82.33 -54.47 5.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.968 0.413 . . . . 15.0 110.614 179.864 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.64 ' CG1' HD12 ' A' ' 20' ' ' ILE . 9.6 tp -81.09 159.72 4.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.873 -0.603 . . . . 15.0 110.379 179.705 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.421 ' O ' ' HB2' ' A' ' 56' ' ' ASP . 53.2 m80 -140.74 159.47 42.14 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-O 121.742 0.782 . . . . 15.0 112.728 -178.875 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.595 ' HA ' ' CG2' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -44.14 134.45 4.8 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.054 -1.43 . . . . 15.0 113.057 -178.728 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.818 ' N ' HG22 ' A' ' 37' ' ' VAL . . . 49.83 31.4 16.58 Favored Glycine 0 C--N 1.335 0.483 0 CA-C-N 115.779 -0.646 . . . . 15.0 113.618 178.934 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.421 ' HB2' ' O ' ' A' ' 53' ' ' HIS . 0.4 OUTLIER -65.92 130.22 42.51 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.628 -0.429 . . . . 15.0 110.655 179.504 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.511 ' CG ' ' CE2' ' A' ' 36' ' ' TYR . 3.5 mtt180 -82.08 88.35 6.44 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.177 -0.465 . . . . 15.0 110.407 179.564 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.832 HG22 HG22 ' A' ' 35' ' ' ILE . 1.5 m -79.45 111.93 16.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 CA-C-O 121.199 0.523 . . . . 15.0 111.061 -179.554 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.414 ' N ' HD22 ' A' ' 59' ' ' LEU . 4.0 mm? -107.38 -15.14 14.7 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 115.558 -0.746 . . . . 15.0 112.33 -179.224 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.783 ' HB3' ' HB2' ' A' ' 88' ' ' LEU . . . -147.91 145.68 28.72 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.099 0.476 . . . . 15.0 112.217 -178.782 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.836 HG23 HD11 ' A' ' 66' ' ' LEU . 47.1 t -138.93 103.48 2.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.624 -0.716 . . . . 15.0 109.378 178.918 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.879 ' ND2' HG22 ' A' ' 81' ' ' THR . 1.7 m-80 64.97 16.43 10.55 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.727 -0.471 . . . . 15.0 109.727 -178.114 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.99 5.81 43.61 Favored Glycine 0 C--N 1.336 0.545 0 CA-C-N 115.744 -0.662 . . . . 15.0 113.103 179.958 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.649 ' O ' HG13 ' A' ' 64' ' ' VAL . 5.7 p -93.78 108.33 20.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 121.007 0.432 . . . . 15.0 110.915 179.573 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 13.7 m -58.74 124.41 19.67 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.178 0.514 . . . . 15.0 110.796 -179.781 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.836 HD11 HG23 ' A' ' 61' ' ' VAL . 0.2 OUTLIER -89.11 -18.7 26.69 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.489 -0.778 . . . . 15.0 111.21 -179.652 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -46.66 101.84 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 120.832 0.349 . . . . 15.0 110.985 179.88 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.75 66.38 0.58 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.788 -0.72 . . . . 15.0 112.291 -179.707 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.641 ' HB1' ' HB3' ' A' ' 73' ' ' GLN . . . -173.03 164.21 4.88 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.849 0.357 . . . . 15.0 111.031 -179.821 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.445 ' HB ' HG13 ' A' ' 26' ' ' VAL . 18.5 p -93.24 -174.66 3.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.998 0.428 . . . . 15.0 111.232 -179.831 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.741 ' CD2' HG23 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -61.53 -61.88 2.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.85 -0.614 . . . . 15.0 109.826 179.774 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 16.1 ttpt -52.88 -35.61 58.09 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.876 -0.602 . . . . 15.0 110.085 179.005 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.641 ' HB3' ' HB1' ' A' ' 69' ' ' ALA . 3.5 tt0 -59.64 -48.96 79.62 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.944 -0.571 . . . . 15.0 109.501 179.035 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.467 ' HA ' ' OG1' ' A' ' 77' ' ' THR . . . -66.93 -46.71 73.94 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-N 115.92 -0.582 . . . . 15.0 109.491 178.344 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.59 HG23 ' CG2' ' A' ' 22' ' ' VAL . 0.5 OUTLIER -42.54 -39.72 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.27 0 N-CA-C 108.814 -0.81 . . . . 15.0 108.814 178.218 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.462 ' O ' ' HB2' ' A' ' 80' ' ' ASN . 1.0 OUTLIER -67.29 -46.34 73.9 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 114.663 -1.153 . . . . 15.0 110.57 178.59 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.622 ' O ' HG11 ' A' ' 61' ' ' VAL . 6.9 p -64.07 -53.74 44.98 Favored 'General case' 0 N--CA 1.462 0.16 0 C-N-CA 120.974 -0.29 . . . . 15.0 111.636 -179.87 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.696 HD23 HG21 ' A' ' 61' ' ' VAL . 6.9 mt -53.31 -46.8 69.55 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-O 121.259 0.552 . . . . 15.0 110.017 179.982 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.448 ' HB2' ' O ' ' A' ' 75' ' ' VAL . 0.0 OUTLIER -68.45 -57.41 5.89 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.344 -0.844 . . . . 15.0 110.784 179.576 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.462 ' HB2' ' O ' ' A' ' 76' ' ' GLU . 9.3 m-80 -66.14 61.53 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.103 -0.499 . . . . 15.0 112.155 -179.882 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.879 HG22 ' ND2' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -95.67 -68.44 0.8 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.836 0.35 . . . . 15.0 110.158 179.098 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 122.14 -108.33 1.28 Allowed Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 121.004 -0.617 . . . . 15.0 112.957 179.396 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.443 ' O ' ' HB3' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -65.26 -79.08 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.912 0.387 . . . . 15.0 111.773 -179.326 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.464 HG12 ' N ' ' A' ' 85' ' ' VAL . 75.6 t -109.88 159.42 9.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.942 -0.572 . . . . 15.0 111.035 -179.219 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.678 HG12 ' O ' ' A' ' 85' ' ' VAL . 5.9 t -97.9 81.14 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.122 0.486 . . . . 15.0 110.485 179.96 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 13.7 t60 -97.94 82.83 3.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.784 -0.644 . . . . 15.0 110.297 179.67 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.813 ' HB3' HD21 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -101.2 119.72 39.17 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.928 -0.578 . . . . 15.0 111.857 -179.132 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.783 ' HB2' ' HB3' ' A' ' 60' ' ' ALA . 4.0 mp -96.05 100.71 12.34 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.557 -0.535 . . . . 15.0 109.557 178.841 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.813 HD21 ' HB3' ' A' ' 87' ' ' LEU . 0.1 OUTLIER -105.61 -160.86 0.77 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.42 0.629 . . . . 15.0 111.974 -178.589 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.461 ' HA ' ' HA ' ' A' ' 6' ' ' ILE . 3.5 tt0 -138.91 139.89 38.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 114.978 -1.01 . . . . 15.0 109.979 179.107 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 14.0 tppt? -51.17 106.71 0.14 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.312 -0.404 . . . . 15.0 111.003 -179.913 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -68.1 146.03 45.6 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.872 -0.68 . . . . 15.0 112.714 -179.789 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 41.2 tt0 -86.37 123.2 31.34 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.791 0.329 . . . . 15.0 110.819 179.845 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -77.3 140.27 65.11 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.284 -0.416 . . . . 15.0 110.98 -179.877 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -53.44 -61.3 0.47 Allowed 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.561 2.174 . . . . 15.0 112.227 179.969 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 5.0 m . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.255 -0.879 . . . . 15.0 110.941 -179.996 . . . . . . . . 0 0 . 1 stop_ save_